data_1oq6_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1oq6 _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.3 m . . . . . 0 CA--C 1.531 0.238 0 N-CA-C 112.068 0.395 . . . . 1.65 112.068 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -72.76 174.97 6.91 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 108.472 -0.936 . . . . 2.31 108.472 179.245 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -129.45 141.09 51.11 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 107.304 -1.369 . . . . 1.04 107.304 168.429 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 6.8 mtpm? -139.76 158.43 44.12 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-O 122.225 1.012 . . . . 4.35 109.661 168.028 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -112.67 107.4 16.06 Favored 'General case' 0 N--CA 1.431 -1.402 0 C-N-CA 130.03 3.332 . . . . 1.59 104.974 -171.734 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 2.2 pp -84.12 167.02 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 C-N-CA 118.917 -1.113 . . . . 6.01 108.599 166.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -137.76 134.01 34.76 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 105.174 -2.158 . . . . 1.34 105.174 170.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 24.2 ptt? -153.11 168.57 25.49 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 118.492 0.587 . . . . 4.1 109.75 178.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 19.9 mm100 -92.81 163.99 13.51 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 124.122 0.969 . . . . 2.46 109.819 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.9 m -124.17 157.16 31.58 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.126 0 C-N-CA 125.403 1.481 . . . . 3.32 110.08 179.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 38.5 m -155.04 166.7 32.75 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 124.8 1.24 . . . . 1.83 108.655 170.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 63.11 74.66 0.4 Allowed Glycine 0 CA--C 1.528 0.877 0 N-CA-C 110.845 -0.902 . . . . 1.83 110.845 178.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -146.71 155.97 42.81 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 123.228 0.611 . . . . 3.08 110.526 -175.096 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -85.6 -62.81 1.44 Allowed 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 125.915 1.686 . . . . 4.74 109.644 172.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.6 p -155.07 161.04 41.42 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 121.724 0.773 . . . . 2.27 112.085 -169.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -72.93 56.1 0.41 Allowed 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 126.751 2.02 . . . . 2.36 111.112 -178.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -152.6 -52.57 0.11 Allowed 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 124.804 1.242 . . . . 1.66 108.448 -175.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 30.9 m -59.07 -39.26 81.57 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 108.904 -0.776 . . . . 1.16 108.904 170.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -41.3 -36.83 0.86 Allowed 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.663 1.585 . . . . 1.98 112.697 166.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -69.75 -53.91 16.18 Favored 'General case' 0 N--CA 1.452 -0.34 0 O-C-N 120.228 -1.545 . . . . 1.69 109.264 175.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 2.5 mpp_? -57.08 -36.68 70.86 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-O 118.166 -0.921 . . . . 5.59 111.639 -174.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.281 2.0 pt -56.78 -57.19 10.47 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 C-N-CA 119.342 -0.943 . . . . 1.92 110.742 175.079 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -57.13 -45.66 83.33 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 123.533 0.733 . . . . 2.32 112.08 178.001 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 13.4 mptt -66.73 -43.25 84.69 Favored 'General case' 0 CA--C 1.531 0.22 0 O-C-N 121.683 -0.636 . . . . 2.73 109.838 -174.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -60.33 -44.37 97.61 Favored Glycine 0 CA--C 1.527 0.811 0 N-CA-C 110.024 -1.23 . . . . 0.61 110.024 171.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -60.39 -40.91 92.62 Favored 'General case' 0 CA--C 1.532 0.255 0 O-C-N 122.48 -0.423 . . . . 3.48 110.069 -175.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 19.9 ttmt -43.5 -32.25 0.86 Allowed 'General case' 0 CA--C 1.535 0.369 0 O-C-N 121.747 -0.596 . . . . 4.01 112.405 173.133 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.93 -4.2 30.58 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 113.588 0.958 . . . . 6.95 113.588 -172.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.83 166.39 37.78 Favored Pre-proline 0 CA--C 1.539 0.537 0 C-N-CA 125.111 1.364 . . . . 4.52 111.655 173.232 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_endo -70.5 157.1 59.97 Favored 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 122.881 2.387 . . . . 1.49 110.629 -178.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 72.46 -36.15 0.68 Allowed Glycine 0 CA--C 1.525 0.71 0 C-N-CA 124.972 1.273 . . . . 1.07 112.798 -179.031 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.5 t -68.45 144.78 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.732 0 CA-C-N 118.411 1.106 . . . . 1.86 109.286 176.113 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -133.16 -39.24 0.94 Allowed 'General case' 0 N--CA 1.451 -0.377 0 CA-C-O 118.705 -0.664 . . . . 1.89 110.945 179.196 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -139.55 166.28 25.0 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-N 119.251 0.932 . . . . 2.62 111.963 166.055 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -158.17 138.32 12.44 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 115.659 -0.7 . . . . 1.61 110.322 -176.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -149.62 109.83 4.16 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 106.206 -1.776 . . . . 0.47 106.206 -163.681 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.7 p -81.48 119.09 30.41 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 N-CA-C 108.523 -0.917 . . . . 1.6 108.523 177.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 55.7 t-20 -99.65 57.28 1.01 Allowed 'General case' 0 C--O 1.236 0.352 0 CA-C-O 123.017 1.389 . . . . 0.78 107.803 -178.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.48 -19.92 63.75 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 114.095 -1.411 . . . . 2.03 110.372 -172.773 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -46.21 -37.0 6.57 Favored 'General case' 0 C--N 1.34 0.189 0 C-N-CA 123.974 0.91 . . . . 1.56 111.839 168.086 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 14.9 t -124.31 37.19 4.46 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 109.831 -0.433 . . . . 1.57 109.831 173.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 52.12 31.98 9.77 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 126.317 1.847 . . . . 2.99 113.034 171.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 95.6 m -122.99 159.92 27.34 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 125.07 1.348 . . . . 1.8 108.536 -175.28 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 6.5 p -129.03 143.96 39.65 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 O-C-N 121.249 -0.907 . . . . 1.69 109.413 172.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 20.1 m120 -127.84 138.9 52.86 Favored 'General case' 0 C--N 1.344 0.354 0 N-CA-C 107.774 -1.195 . . . . 0.37 107.774 179.198 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 93.3 t -134.17 125.46 48.05 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 N-CA-C 105.062 -2.199 . . . . 3.06 105.062 -174.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 13.7 mm -104.4 101.0 11.67 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 C-N-CA 126.249 1.82 . . . . 1.69 107.983 -175.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 41.9 p90 -142.23 173.04 11.89 Favored 'General case' 0 CA--C 1.513 -0.457 0 O-C-N 121.785 -0.572 . . . . 2.9 111.183 -172.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -92.97 115.17 64.52 Favored Pre-proline 0 CA--C 1.534 0.343 0 O-C-N 124.199 0.937 . . . . 3.04 108.884 173.188 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -81.76 13.08 2.56 Favored 'Trans proline' 0 N--CA 1.451 -0.998 0 C-N-CA 122.465 2.11 . . . . 0.75 113.386 -176.054 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -92.35 -32.27 15.04 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 119.45 1.023 . . . . 2.01 109.588 164.052 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -101.1 -55.43 2.56 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 108.495 -0.928 . . . . 2.69 108.495 -169.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.499 0.2 OUTLIER -83.67 176.75 8.75 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 115.301 1.593 . . . . 1.71 115.301 155.845 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -171.31 -147.54 5.7 Favored Glycine 0 N--CA 1.434 -1.454 0 N-CA-C 103.126 -3.99 . . . . 2.52 103.126 -174.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 23.6 p -76.75 -32.58 57.85 Favored 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 125.108 1.363 . . . . 2.35 109.551 174.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -49.98 -61.59 2.06 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 124.723 1.209 . . . . 2.07 113.282 -162.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.0 -34.21 73.02 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 114.408 -1.269 . . . . 1.81 108.765 -171.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.6 mp -60.68 -51.41 73.42 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.95 0 CA-C-N 114.999 -1.0 . . . . 2.61 109.79 178.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.49 -47.11 85.43 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 108.828 -0.804 . . . . 1.4 108.828 -178.068 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -48.7 -54.64 14.03 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 122.038 0.923 . . . . 3.19 110.974 174.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.07 -47.17 81.17 Favored 'General case' 0 N--CA 1.44 -0.973 0 CA-C-O 118.664 -0.684 . . . . 3.24 111.776 -178.524 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.2 mm -46.76 -50.99 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 C-N-CA 126.412 1.885 . . . . 1.9 109.033 -177.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -57.73 -57.58 12.12 Favored 'General case' 0 C--N 1.34 0.159 0 C-N-CA 123.387 0.675 . . . . 1.49 110.173 175.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 13.9 mmtt -55.45 -35.6 65.64 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 112.963 0.727 . . . . 5.52 112.963 -178.14 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 31.6 mt -71.07 -18.35 62.56 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.74 1.616 . . . . 1.83 111.451 177.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 87.15 44.17 5.73 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 110.593 -1.003 . . . . 0.87 110.593 178.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -137.93 172.97 12.14 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 124.094 0.957 . . . . 4.0 109.72 179.125 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 8.3 t60 -146.35 133.9 20.92 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 109.239 -0.652 . . . . 3.11 109.239 165.048 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 4.5 m -98.8 161.05 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 C-N-CA 123.823 0.849 . . . . 3.77 110.15 176.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 12.0 t -129.55 141.9 45.31 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 C-N-CA 124.902 1.281 . . . . 1.83 107.843 -176.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 28.7 mm . . . . . 0 N--CA 1.454 -0.231 0 C-N-CA 125.025 1.33 . . . . 2.95 108.426 -175.203 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 55.1 m . . . . . 0 N--CA 1.447 -0.624 0 N-CA-C 106.507 -1.664 . . . . 1.56 106.507 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -111.33 -174.7 2.53 Favored 'General case' 0 N--CA 1.439 -1.025 0 C-N-CA 125.487 1.515 . . . . 2.34 107.257 156.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -136.28 152.01 50.25 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 107.473 -1.306 . . . . 1.17 107.473 172.711 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 23.9 mttt -143.67 163.35 33.5 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 122.937 0.495 . . . . 3.37 110.286 161.075 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -122.47 84.81 2.32 Favored 'General case' 0 N--CA 1.44 -0.969 0 C-N-CA 128.687 2.795 . . . . 1.56 106.009 -166.429 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 3.1 mp -82.49 160.6 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.405 0 N-CA-C 105.691 -1.966 . . . . 2.99 105.691 -178.15 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -120.35 132.92 55.49 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 106.243 -1.762 . . . . 1.72 106.243 178.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 2.8 ttm -138.54 161.63 36.57 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 108.355 -0.98 . . . . 3.15 108.355 -177.161 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -97.42 146.91 24.74 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 124.235 1.014 . . . . 2.42 108.936 177.078 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 49.1 t -103.85 149.76 7.52 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 C-N-CA 123.77 0.828 . . . . 2.23 109.019 -178.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 56.3 m -152.93 164.88 37.1 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 118.866 0.757 . . . . 1.94 110.092 171.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 64.02 72.13 0.74 Allowed Glycine 0 CA--C 1.527 0.84 0 N-CA-C 110.93 -0.868 . . . . 1.73 110.93 178.2 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -154.78 170.11 22.37 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 123.825 0.85 . . . . 3.09 109.857 -172.727 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -111.87 -44.64 3.43 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 123.922 0.889 . . . . 3.38 111.229 168.642 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 20.0 p -147.97 176.43 10.17 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 119.111 0.869 . . . . 2.66 111.631 -174.105 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -72.26 -24.41 61.36 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 115.508 -0.769 . . . . 3.39 111.809 177.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.7 -49.7 72.09 Favored 'General case' 0 C--O 1.233 0.209 0 O-C-N 121.377 -0.827 . . . . 1.92 110.79 -175.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 5.2 p -65.06 -38.96 92.49 Favored 'General case' 0 CA--C 1.532 0.279 0 O-C-N 121.633 -0.667 . . . . 2.45 110.518 173.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.61 -29.28 61.97 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-O 121.386 0.613 . . . . 1.52 112.074 173.242 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -69.9 -53.41 18.07 Favored 'General case' 0 N--CA 1.45 -0.445 0 O-C-N 119.935 -1.728 . . . . 1.66 108.791 171.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -46.67 -50.96 16.99 Favored 'General case' 0 C--N 1.341 0.231 0 CA-C-O 118.486 -0.769 . . . . 4.86 110.755 178.109 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.268 3.4 pt -57.09 -58.21 6.78 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.159 0 C-N-CA 119.727 -0.789 . . . . 1.71 110.69 -176.302 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -51.96 -45.47 64.4 Favored 'General case' 0 N--CA 1.457 -0.095 0 CA-C-N 119.006 0.821 . . . . 2.42 111.068 179.184 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.36 -40.15 85.75 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 119.585 -0.846 . . . . 2.45 110.895 -177.239 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -68.93 -24.62 75.7 Favored Glycine 0 CA--C 1.529 0.916 0 O-C-N 121.542 -0.724 . . . . 0.64 111.633 174.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -70.1 -43.92 70.06 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 108.11 -1.07 . . . . 2.58 108.11 173.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 3.4 ttpp -50.0 -24.67 2.74 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 125.323 1.449 . . . . 3.16 113.505 173.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -83.24 -0.21 48.48 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 118.443 -0.789 . . . . 4.95 112.942 -179.5 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 4.0 ptm -93.96 156.0 39.66 Favored Pre-proline 0 CA--C 1.536 0.43 0 CA-C-N 119.31 0.959 . . . . 4.01 111.658 -178.144 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -62.13 133.22 42.78 Favored 'Trans proline' 0 N--CA 1.456 -0.711 0 C-N-CA 122.433 2.089 . . . . 0.87 109.809 173.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 100.11 -39.2 2.82 Favored Glycine 0 CA--C 1.525 0.7 0 CA-C-O 119.08 -0.844 . . . . 0.91 112.595 176.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 47.5 t -88.02 118.66 34.12 Favored 'Isoleucine or valine' 0 C--N 1.343 0.314 0 CA-C-N 118.796 1.298 . . . . 1.84 110.143 177.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 98.1 m -88.82 -52.66 5.0 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-O 118.76 -0.638 . . . . 2.36 110.058 -176.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -138.23 161.26 37.3 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 123.838 0.855 . . . . 2.72 108.757 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -158.22 141.03 14.71 Favored 'General case' 0 C--O 1.238 0.454 0 O-C-N 121.923 -0.486 . . . . 1.38 111.255 -173.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -151.37 110.07 3.83 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 106.648 -1.612 . . . . 0.47 106.648 -165.118 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.7 p -80.97 136.07 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 N-CA-C 107.816 -1.179 . . . . 1.86 107.816 176.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 52.7 t-20 -121.97 56.01 1.1 Allowed 'General case' 0 C--O 1.235 0.342 0 CA-C-O 123.03 1.395 . . . . 0.84 107.929 -176.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.09 -19.55 64.87 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 113.807 -1.542 . . . . 2.1 110.615 -176.018 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -45.46 -37.88 5.63 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 124.067 0.947 . . . . 1.68 111.948 165.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 12.2 t -124.53 38.18 4.25 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 109.063 -0.717 . . . . 1.61 109.063 172.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 53.77 24.1 4.18 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.773 1.629 . . . . 3.25 113.78 171.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 88.0 m -116.51 162.91 16.86 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.814 1.245 . . . . 1.66 108.878 -174.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.4 p -125.94 145.42 33.42 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 C-N-CA 124.536 1.135 . . . . 1.63 108.044 167.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 10.2 m120 -124.17 136.86 54.5 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 107.494 -1.299 . . . . 0.35 107.494 172.519 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.1 p -134.93 123.66 41.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 106.252 -1.759 . . . . 2.96 106.252 -173.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 13.5 mm -104.32 94.72 3.32 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 N-CA-C 107.194 -1.41 . . . . 1.78 107.194 -168.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 31.1 p90 -131.28 164.26 26.0 Favored 'General case' 0 CA--C 1.512 -0.506 0 O-C-N 122.203 -0.31 . . . . 2.85 111.691 -169.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 35.7 t0 -83.53 109.23 16.63 Favored Pre-proline 0 CA--C 1.532 0.279 0 O-C-N 124.444 1.09 . . . . 3.02 109.553 174.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -74.22 4.87 3.97 Favored 'Trans proline' 0 N--CA 1.451 -0.981 0 C-N-CA 122.663 2.242 . . . . 0.72 113.06 -176.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -85.44 -28.68 24.91 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 119.338 0.972 . . . . 1.73 109.215 166.428 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -102.52 -61.16 1.43 Allowed 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 107.941 -1.133 . . . . 4.3 107.941 -169.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.283 0.7 OUTLIER -86.75 -176.46 5.8 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 124.933 1.293 . . . . 1.92 112.901 162.489 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 131.78 94.02 0.61 Allowed Glycine 0 N--CA 1.442 -0.903 0 N-CA-C 103.515 -3.834 . . . . 2.31 103.515 -144.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 75.0 p -19.17 -23.25 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.308 1 C-N-CA 138.132 6.573 . . . . 2.0 118.809 -147.43 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -28.21 -62.54 0.1 Allowed 'General case' 0 N--CA 1.442 -0.846 0 C-N-CA 126.503 1.921 . . . . 2.0 113.19 165.174 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -75.27 -32.43 61.05 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 118.396 -1.322 . . . . 2.11 110.014 -168.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.6 mp -60.17 -51.72 69.6 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.625 0 CA-C-N 115.579 -0.737 . . . . 1.79 109.794 175.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.96 -48.21 82.63 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 119.067 0.849 . . . . 1.28 109.151 -178.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -46.13 -58.74 3.37 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-O 121.864 0.84 . . . . 2.57 111.24 174.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 15.2 mmmt -67.74 -34.69 77.33 Favored 'General case' 0 N--CA 1.441 -0.913 0 CA-C-O 118.354 -0.832 . . . . 4.65 112.082 -177.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.4 mm -53.45 -52.65 30.48 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 N-CA-C 107.943 -1.132 . . . . 1.52 107.943 176.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 40.9 mm-40 -58.15 -54.77 43.25 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 123.469 0.708 . . . . 1.54 109.837 176.123 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 13.0 mmtt -59.48 -33.85 71.84 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 113.288 0.848 . . . . 4.83 113.288 -176.325 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 32.1 mt -70.78 -18.47 62.75 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.735 1.214 . . . . 2.16 111.289 174.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 95.9 39.88 4.23 Favored Glycine 0 CA--C 1.524 0.597 0 C-N-CA 124.892 1.234 . . . . 0.82 111.007 175.173 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -136.54 175.47 9.58 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 117.805 0.803 . . . . 3.26 111.462 -174.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -130.69 147.5 52.37 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 123.487 0.715 . . . . 3.52 109.497 167.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 4.1 p -126.52 152.77 34.49 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 N-CA-C 106.581 -1.637 . . . . 2.47 106.581 176.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 11.6 t -129.31 141.89 45.4 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 N-CA-C 107.032 -1.47 . . . . 2.02 107.032 -178.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 5.0 mp . . . . . 0 N--CA 1.455 -0.201 0 N-CA-C 108.759 -0.83 . . . . 2.66 108.759 -175.04 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.9 m . . . . . 0 N--CA 1.453 -0.317 0 N-CA-C 106.797 -1.557 . . . . 1.49 106.797 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -88.6 -178.29 5.78 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 108.359 -0.978 . . . . 1.95 108.359 163.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 2.9 mm100 -134.58 148.44 50.45 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 107.038 -1.467 . . . . 1.15 107.038 169.104 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 37.4 mtpt -140.32 156.91 46.26 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 123.415 0.686 . . . . 3.62 109.167 163.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 8.0 mp0 -115.48 89.69 3.16 Favored 'General case' 0 N--CA 1.442 -0.836 0 C-N-CA 127.746 2.418 . . . . 1.86 106.326 -170.289 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.6 mp -83.32 161.25 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.397 0 N-CA-C 105.742 -1.947 . . . . 3.01 105.742 -177.321 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -127.81 126.34 41.5 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 125.395 1.478 . . . . 1.63 107.021 177.333 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 2.7 mpp? -132.58 170.87 14.57 Favored 'General case' 0 CA--C 1.528 0.124 0 C-N-CA 123.419 0.688 . . . . 3.0 109.204 173.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 18.5 mm100 -97.66 145.27 26.47 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 124.438 1.095 . . . . 2.61 109.476 178.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 60.3 t -97.5 151.22 4.33 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.158 0 N-CA-C 108.938 -0.764 . . . . 2.26 108.938 178.316 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 13.0 t -141.77 176.77 8.65 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 108.196 -1.039 . . . . 2.09 108.196 170.284 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 53.14 57.53 14.66 Favored Glycine 0 CA--C 1.529 0.909 0 C-N-CA 124.112 0.863 . . . . 1.53 111.573 -178.306 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -139.78 137.98 35.49 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 123.767 0.827 . . . . 2.63 109.557 -179.344 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -144.44 8.14 1.35 Allowed 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.809 0.843 . . . . 4.68 112.716 166.789 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 8.8 m -108.97 -21.0 12.84 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 124.691 1.196 . . . . 3.39 111.825 -171.408 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 64.46 -68.06 0.1 Allowed 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.707 1.603 . . . . 2.79 110.881 -165.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -44.13 -49.66 8.88 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 125.81 1.644 . . . . 1.87 112.603 -175.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 96.6 m -52.54 -35.76 54.18 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 123.953 0.901 . . . . 1.19 113.126 -178.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.35 -23.24 67.32 Favored 'General case' 0 CA--C 1.539 0.557 0 O-C-N 122.034 -0.416 . . . . 1.74 111.157 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.13 -52.78 17.36 Favored 'General case' 0 N--CA 1.454 -0.245 0 O-C-N 121.028 -1.045 . . . . 1.61 109.592 171.13 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 4.2 mtt-85 -50.97 -47.99 61.23 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 123.379 0.672 . . . . 4.91 110.219 -176.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 6.8 pt -57.24 -55.07 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.196 0 C-N-CA 119.751 -0.779 . . . . 1.78 111.121 179.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -54.17 -42.96 70.21 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.753 0.821 . . . . 3.19 111.92 179.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 31.9 mmtp -70.66 -47.34 60.44 Favored 'General case' 0 CA--C 1.534 0.357 0 O-C-N 121.061 -1.024 . . . . 3.06 110.914 -178.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.37 -28.36 70.9 Favored Glycine 0 CA--C 1.53 0.995 0 O-C-N 121.545 -0.722 . . . . 0.64 111.349 174.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.1 tt -68.86 -47.87 64.87 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 125.789 1.636 . . . . 3.02 109.215 174.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.2 ttmm -50.45 -34.7 25.66 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 118.664 0.665 . . . . 3.59 111.713 175.149 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 14.5 mmt-85 -62.69 -7.15 4.34 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 114.877 1.436 . . . . 5.64 114.877 179.338 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 27.4 mtm -71.56 169.72 14.61 Favored Pre-proline 0 CA--C 1.533 0.312 0 CA-C-N 120.355 1.434 . . . . 4.19 112.44 170.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -60.78 162.78 17.57 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 121.777 1.651 . . . . 1.01 110.039 159.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 77.33 -38.72 1.63 Allowed Glycine 0 C--N 1.333 0.373 0 C-N-CA 125.88 1.705 . . . . 0.87 114.02 171.455 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 16.3 t -83.66 134.08 27.73 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.875 0 C-N-CA 123.054 0.542 . . . . 1.74 109.603 -177.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 88.0 m -113.6 -46.45 3.05 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 122.948 0.499 . . . . 2.09 110.276 -175.183 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -139.48 165.13 28.05 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-N 118.047 0.385 . . . . 1.74 110.144 173.347 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -158.02 139.03 13.22 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 108.721 -0.844 . . . . 1.48 108.721 -172.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -155.93 111.85 3.05 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 123.258 0.623 . . . . 0.49 109.347 -165.571 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 4.8 p -86.79 102.57 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 CA-C-O 121.224 0.535 . . . . 1.72 109.991 -177.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 51.7 t-20 -86.31 56.97 4.23 Favored 'General case' 0 C--O 1.235 0.333 0 O-C-N 120.687 -1.258 . . . . 0.78 109.423 -179.213 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -69.47 -19.86 63.75 Favored 'General case' 0 C--O 1.226 -0.158 0 CA-C-N 115.003 -0.998 . . . . 1.99 110.972 -176.195 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -45.27 -36.98 4.33 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.665 0.786 . . . . 1.67 112.078 166.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 11.3 t -123.38 30.21 6.37 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 122.494 0.318 . . . . 1.7 110.964 172.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 62.11 26.83 16.16 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.348 1.459 . . . . 2.51 114.297 172.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 88.4 m -120.32 163.13 18.29 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.79 1.236 . . . . 1.7 109.524 -174.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 5.8 p -129.91 142.92 42.58 Favored 'Isoleucine or valine' 0 C--O 1.232 0.15 0 C-N-CA 124.302 1.041 . . . . 1.76 108.835 171.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 10.4 m120 -126.12 129.79 49.78 Favored 'General case' 0 CA--C 1.517 -0.296 0 N-CA-C 108.151 -1.055 . . . . 0.36 108.151 177.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 6.7 p -128.38 128.92 68.84 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 106.331 -1.729 . . . . 3.04 106.331 -175.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 7.9 mm -104.97 100.65 10.98 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 N-CA-C 107.15 -1.426 . . . . 1.63 107.15 -172.003 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 50.2 p90 -138.46 165.15 27.55 Favored 'General case' 0 CA--C 1.516 -0.341 0 O-C-N 122.226 -0.296 . . . . 2.9 111.626 -172.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 37.7 t0 -85.97 110.68 32.43 Favored Pre-proline 0 C--O 1.236 0.382 0 O-C-N 124.458 1.099 . . . . 2.97 108.858 175.12 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -71.5 4.26 3.09 Favored 'Trans proline' 0 N--CA 1.452 -0.957 0 C-N-CA 122.772 2.315 . . . . 0.63 113.135 -178.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -89.2 -27.32 20.73 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 119.478 1.035 . . . . 1.76 109.397 168.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -104.63 -51.53 3.06 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 109.575 -0.528 . . . . 2.88 109.575 -171.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.285 1.1 p -97.7 -177.48 3.8 Favored 'General case' 0 CA--C 1.518 -0.252 0 C-N-CA 123.993 0.917 . . . . 1.65 112.275 160.76 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 145.32 88.6 0.09 OUTLIER Glycine 0 N--CA 1.441 -1.011 0 N-CA-C 104.448 -3.461 . . . . 2.52 104.448 -155.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 45.1 p -13.07 -17.96 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.556 1 C-N-CA 137.936 6.494 . . . . 2.49 119.956 -143.228 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -27.61 -63.48 0.09 Allowed 'General case' 0 N--CA 1.443 -0.803 0 C-N-CA 127.01 2.124 . . . . 1.53 114.317 166.405 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.73 -37.3 65.14 Favored 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 118.485 -1.286 . . . . 1.71 109.069 -168.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.5 mp -53.93 -57.5 5.53 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.808 0 CA-C-N 114.402 -1.272 . . . . 2.37 109.884 175.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.04 -48.0 81.42 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 119.047 0.84 . . . . 1.23 109.55 -178.414 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -45.57 -57.39 4.2 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 123.312 0.645 . . . . 3.25 111.932 176.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.7 mmmm -68.3 -42.34 79.61 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-O 118.545 -0.741 . . . . 4.62 111.376 -179.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -46.0 -52.65 2.84 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 C-N-CA 125.003 1.321 . . . . 1.83 108.579 177.048 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -59.45 -58.44 8.61 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 124.503 1.121 . . . . 1.54 110.545 176.391 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -55.62 -34.87 65.28 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 113.006 0.743 . . . . 4.57 113.006 -176.792 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 26.6 mt -68.87 -17.32 63.97 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.774 1.229 . . . . 1.53 111.721 177.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 92.11 43.47 4.38 Favored Glycine 0 CA--C 1.522 0.531 0 N-CA-C 110.129 -1.189 . . . . 0.45 110.129 178.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -141.46 171.52 13.94 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 124.189 0.996 . . . . 3.35 110.015 -176.364 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 8.8 t-80 -143.71 127.48 17.2 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 107.842 -1.17 . . . . 2.92 107.842 172.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 5.8 p -97.22 151.74 4.15 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 N-CA-C 108.114 -1.069 . . . . 2.35 108.114 174.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 38.3 t -120.0 139.76 46.26 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 C-N-CA 125.173 1.389 . . . . 1.67 108.358 -179.455 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 26.7 mm . . . . . 0 C--N 1.331 -0.234 0 CA-C-O 122.119 0.961 . . . . 1.98 109.737 -169.772 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.7 m . . . . . 0 N--CA 1.45 -0.436 0 N-CA-C 108.655 -0.868 . . . . 1.39 108.655 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -69.78 176.57 3.54 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 109.146 -0.687 . . . . 2.3 109.146 173.133 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.67 155.07 45.6 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 124.205 1.002 . . . . 0.93 108.431 176.39 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 10.8 ttmt -147.33 158.85 44.12 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 107.733 -1.21 . . . . 4.02 107.733 168.268 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -119.13 98.68 6.29 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 127.728 2.411 . . . . 1.91 104.669 -176.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 23.0 mm -84.37 164.32 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.171 0 N-CA-C 106.839 -1.541 . . . . 3.27 106.839 173.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -134.18 124.83 26.67 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 107.065 -1.458 . . . . 1.73 107.065 176.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 24.7 mtm -134.63 172.87 12.33 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.62 0.768 . . . . 2.86 109.101 -179.145 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 21.5 mm100 -103.19 154.7 19.04 Favored 'General case' 0 C--O 1.222 -0.35 0 C-N-CA 125.394 1.477 . . . . 2.45 109.313 178.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.3 m -117.98 165.37 13.39 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 CA-C-N 119.38 0.991 . . . . 3.12 110.419 174.274 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 53.8 m -137.74 171.04 15.03 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.231 1.412 . . . . 1.76 108.902 175.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 80.03 -44.82 2.87 Favored Glycine 0 CA--C 1.533 1.187 0 C-N-CA 123.488 0.566 . . . . 3.19 113.311 173.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -38.55 122.37 1.11 Allowed 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 125.13 1.372 . . . . 3.23 113.319 -177.231 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -139.48 12.53 2.55 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.896 0.878 . . . . 4.17 112.014 177.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 8.9 m -115.59 -26.48 7.47 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 125.528 1.531 . . . . 3.44 111.512 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 64.68 -63.71 0.17 Allowed 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.646 1.578 . . . . 2.55 110.482 -162.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -41.59 -54.66 3.14 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 125.895 1.678 . . . . 2.14 112.748 -179.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 90.0 m -55.82 -31.43 62.68 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 113.183 0.808 . . . . 1.48 113.183 -178.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.4 -26.8 68.09 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 121.108 0.48 . . . . 1.65 110.514 176.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.93 -50.74 31.42 Favored 'General case' 0 N--CA 1.452 -0.354 0 O-C-N 120.321 -1.487 . . . . 1.72 109.053 170.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 55.2 mtm180 -51.33 -46.32 62.6 Favored 'General case' 0 N--CA 1.456 -0.154 0 CA-C-O 118.871 -0.585 . . . . 6.27 110.978 -177.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 4.5 pt -58.43 -55.86 19.96 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.237 0 C-N-CA 119.784 -0.766 . . . . 1.78 110.681 178.098 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -53.29 -42.28 66.45 Favored 'General case' 0 C--O 1.225 -0.211 0 CA-C-N 119.568 1.076 . . . . 2.69 111.715 179.804 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 32.0 mmtp -70.65 -44.93 66.1 Favored 'General case' 0 CA--C 1.536 0.414 0 O-C-N 121.228 -0.92 . . . . 3.03 110.897 -178.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -66.11 -25.8 72.28 Favored Glycine 0 CA--C 1.53 0.991 0 O-C-N 121.583 -0.698 . . . . 1.01 111.875 176.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 7.7 tt -70.38 -53.73 15.38 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 126.915 2.086 . . . . 2.87 107.693 172.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -51.1 -18.51 0.86 Allowed 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 126.658 1.983 . . . . 4.39 113.987 179.114 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -72.74 -16.05 61.66 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.044 1.338 . . . . 5.03 113.035 176.365 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 7.1 ptp -68.01 160.28 75.18 Favored Pre-proline 0 CA--C 1.537 0.456 0 CA-C-N 118.934 0.788 . . . . 4.4 111.178 -179.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -61.51 134.75 53.06 Favored 'Trans proline' 0 N--CA 1.454 -0.829 0 C-N-CA 121.622 1.548 . . . . 0.67 109.287 167.064 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 106.58 -54.16 0.59 Allowed Glycine 0 CA--C 1.529 0.943 0 C-N-CA 124.558 1.075 . . . . 1.0 111.933 174.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 56.2 t -73.24 113.11 10.58 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 O-C-N 120.912 -1.346 . . . . 1.91 110.914 -173.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -80.83 -48.08 12.93 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-O 117.745 -1.122 . . . . 2.39 108.712 -179.505 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -140.65 156.93 46.11 Favored 'General case' 0 C--N 1.342 0.264 0 CA-C-N 119.249 0.931 . . . . 2.26 110.496 -177.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -154.96 148.56 25.33 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 112.23 0.455 . . . . 1.72 112.23 179.08 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -155.93 124.14 5.78 Favored 'General case' 0 C--N 1.342 0.245 0 N-CA-C 108.75 -0.833 . . . . 0.56 108.75 -165.487 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 6.6 p -93.13 107.46 19.17 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 C-N-CA 123.694 0.798 . . . . 1.89 109.614 -177.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 52.8 t-20 -88.89 58.36 4.56 Favored 'General case' 0 C--O 1.238 0.469 0 O-C-N 120.492 -1.38 . . . . 0.81 109.364 -177.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -68.27 -19.43 64.71 Favored 'General case' 0 N--CA 1.457 -0.114 0 CA-C-N 114.459 -1.246 . . . . 1.8 111.393 -175.223 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -45.85 -35.77 4.75 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 123.601 0.76 . . . . 1.84 111.922 166.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 5.3 t -124.58 34.47 5.01 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.063 0.545 . . . . 1.79 109.856 173.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 51.79 25.71 3.11 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.609 1.564 . . . . 2.78 113.547 175.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 6.9 m -113.51 163.83 14.41 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.582 1.153 . . . . 1.9 108.468 -176.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.7 p -131.5 144.82 36.39 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.121 0 C-N-CA 124.442 1.097 . . . . 1.58 108.947 173.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 20.7 m120 -129.55 133.49 47.24 Favored 'General case' 0 C--N 1.342 0.271 0 C-N-CA 124.219 1.008 . . . . 0.39 108.399 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 40.1 t -128.74 123.67 59.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 N-CA-C 105.415 -2.069 . . . . 3.09 105.415 -177.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 13.5 mm -101.46 94.46 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 N-CA-C 106.978 -1.49 . . . . 1.59 106.978 -173.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 28.8 p90 -135.17 173.82 11.29 Favored 'General case' 0 CA--C 1.508 -0.657 0 O-C-N 122.118 -0.364 . . . . 2.98 111.331 -167.188 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 47.5 p-10 -97.12 109.03 47.52 Favored Pre-proline 0 N--CA 1.447 -0.61 0 O-C-N 124.703 1.252 . . . . 4.09 112.425 -175.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -69.26 13.93 0.24 Allowed 'Trans proline' 0 CA--C 1.544 1.017 0 C-N-CA 121.43 1.42 . . . . 1.09 113.241 178.132 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -99.4 -31.33 11.72 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 125.508 1.523 . . . . 2.14 110.841 170.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -114.82 -55.1 2.52 Favored 'General case' 0 C--N 1.345 0.376 0 CA-C-N 118.663 0.665 . . . . 2.95 109.533 -177.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.441 1.3 p -83.12 -179.81 7.53 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 114.047 1.128 . . . . 1.66 114.047 160.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 135.09 93.09 0.42 Allowed Glycine 0 N--CA 1.445 -0.75 0 N-CA-C 104.512 -3.435 . . . . 2.29 104.512 -148.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 46.1 p -16.45 -17.44 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.462 1 C-N-CA 138.843 6.857 . . . . 2.44 119.685 -151.025 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -27.32 -63.38 0.09 Allowed 'General case' 0 N--CA 1.442 -0.83 0 C-N-CA 126.477 1.911 . . . . 1.93 113.966 163.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.14 -37.07 64.16 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 118.935 -1.106 . . . . 1.66 109.143 -168.397 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 5.9 mt -53.66 -56.53 8.38 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.616 0 C-N-CA 125.5 1.52 . . . . 2.71 110.862 174.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.92 -46.02 92.33 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 119.506 1.048 . . . . 1.23 109.665 -179.104 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 -49.58 -59.76 3.48 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 122.002 0.906 . . . . 3.4 111.617 176.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 6.2 mmmt -67.05 -35.6 80.23 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-O 118.068 -0.968 . . . . 4.27 111.346 -177.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.1 mm -49.54 -54.56 6.42 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 N-CA-C 108.106 -1.072 . . . . 1.74 108.106 175.096 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -58.92 -53.96 52.52 Favored 'General case' 0 C--N 1.34 0.162 0 C-N-CA 123.33 0.652 . . . . 1.89 109.952 176.134 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.25 -28.77 67.01 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 113.199 0.814 . . . . 6.48 113.199 -177.286 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 20.5 mt -73.49 -18.19 61.14 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.973 1.309 . . . . 1.98 111.603 175.062 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 89.96 39.39 6.15 Favored Glycine 0 CA--C 1.524 0.634 0 C-N-CA 124.664 1.126 . . . . 0.46 110.345 -178.104 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -134.59 175.65 9.34 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 123.756 0.823 . . . . 3.14 110.415 -179.631 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -143.19 138.77 29.96 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 107.406 -1.331 . . . . 3.57 107.406 171.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 9.2 p -117.98 133.32 65.17 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 C-N-CA 125.212 1.405 . . . . 2.37 107.864 178.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 41.9 t -100.85 140.92 18.53 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 C-N-CA 125.956 1.702 . . . . 1.9 109.01 -179.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 21.7 mm . . . . . 0 C--N 1.329 -0.294 0 C-N-CA 124.078 0.951 . . . . 2.04 108.755 -174.293 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.529 0.171 0 N-CA-C 107.797 -1.186 . . . . 2.61 107.797 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -71.73 153.37 42.06 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 107.037 -1.468 . . . . 3.87 107.037 171.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.33 148.61 44.83 Favored 'General case' 0 CA--C 1.518 -0.28 0 C-N-CA 123.602 0.761 . . . . 1.24 110.146 -177.346 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 7.0 mtpm? -141.01 159.97 41.07 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 122.157 0.979 . . . . 4.35 111.756 166.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -108.39 104.25 13.57 Favored 'General case' 0 N--CA 1.434 -1.238 0 C-N-CA 130.755 3.622 . . . . 1.95 103.919 -176.284 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 5.6 mm -88.68 160.09 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.35 0 N-CA-C 106.982 -1.488 . . . . 2.71 106.982 172.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -124.98 137.93 54.24 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 106.517 -1.66 . . . . 1.42 106.517 169.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 57.9 mtt -144.37 166.16 25.89 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 118.412 0.551 . . . . 3.91 109.659 173.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 11.6 mm100 -88.56 155.4 19.66 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 125.176 1.391 . . . . 2.35 109.945 175.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 99.3 t -112.34 138.75 40.19 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 C-N-CA 123.935 0.894 . . . . 2.75 110.259 -179.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 73.3 m -137.84 165.19 27.08 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.814 1.245 . . . . 1.66 109.938 172.376 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 65.73 72.16 0.78 Allowed Glycine 0 CA--C 1.527 0.836 0 N-CA-C 110.891 -0.884 . . . . 1.71 110.891 176.276 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -152.56 158.14 42.06 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 123.739 0.816 . . . . 2.92 109.843 -173.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -105.09 -56.72 2.13 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 124.996 1.319 . . . . 3.51 110.463 168.539 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 31.7 p -127.91 156.68 42.23 Favored 'General case' 0 C--N 1.34 0.175 0 CA-C-O 121.814 0.816 . . . . 2.24 111.504 -170.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -76.33 53.09 0.81 Allowed 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.771 0.829 . . . . 2.5 110.401 176.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -151.49 -50.36 0.12 Allowed 'General case' 0 C--O 1.232 0.136 0 C-N-CA 123.131 0.572 . . . . 1.76 111.645 -174.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 5.8 p -56.04 -39.18 71.59 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 119.348 0.976 . . . . 2.43 109.7 168.316 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -50.32 -23.28 2.22 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.869 1.267 . . . . 1.6 113.9 171.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -72.09 -47.14 53.55 Favored 'General case' 0 N--CA 1.453 -0.3 0 O-C-N 120.447 -1.408 . . . . 1.58 110.133 171.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -57.98 -36.56 72.77 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-O 118.961 -0.543 . . . . 5.23 110.612 -174.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 2.6 pt -59.68 -55.45 23.82 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.203 0 C-N-CA 119.578 -0.849 . . . . 1.75 110.67 178.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -57.49 -47.03 82.98 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 123.286 0.634 . . . . 3.28 111.294 178.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 14.7 mptt -66.61 -45.86 77.77 Favored 'General case' 0 CA--C 1.532 0.273 0 O-C-N 121.62 -0.675 . . . . 2.64 109.864 -176.192 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -67.75 -23.87 74.07 Favored Glycine 0 CA--C 1.527 0.795 0 CA-C-O 119.04 -0.867 . . . . 0.66 111.957 176.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -73.57 -41.23 63.19 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.715 1.206 . . . . 3.53 109.753 170.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 2.1 ttpp -56.71 -16.39 6.29 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.78 1.632 . . . . 3.8 113.86 178.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.4 mmt180 -83.33 -7.44 59.58 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 126.547 1.939 . . . . 4.62 112.338 176.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 96.1 mmm -77.99 150.89 78.59 Favored Pre-proline 0 C--O 1.233 0.209 0 CA-C-N 119.226 0.921 . . . . 3.88 111.35 -179.133 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -56.56 135.37 69.97 Favored 'Trans proline' 0 N--CA 1.45 -1.064 0 C-N-CA 121.953 1.769 . . . . 0.62 108.973 171.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 89.12 -9.66 76.0 Favored Glycine 0 CA--C 1.525 0.716 0 CA-C-O 118.079 -1.401 . . . . 0.61 113.738 178.081 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 23.4 t -103.78 122.66 56.75 Favored 'Isoleucine or valine' 0 C--N 1.342 0.269 0 CA-C-N 120.349 2.074 . . . . 1.65 109.636 176.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -89.38 -55.41 3.67 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-O 118.611 -0.709 . . . . 2.43 109.151 177.127 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -139.61 156.97 46.55 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 118.875 0.761 . . . . 2.61 110.425 -175.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -155.6 143.75 20.02 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 122.99 0.516 . . . . 1.89 111.164 -174.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -155.35 114.39 3.58 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 109.531 -0.544 . . . . 0.59 109.531 -165.576 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 4.0 p -81.25 116.7 25.99 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 N-CA-C 108.697 -0.853 . . . . 1.78 108.697 175.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 50.1 t-20 -96.15 57.61 1.76 Allowed 'General case' 0 C--O 1.236 0.378 0 CA-C-O 122.961 1.362 . . . . 0.81 107.869 177.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.35 -18.47 63.8 Favored 'General case' 0 C--O 1.225 -0.203 0 CA-C-N 114.265 -1.334 . . . . 2.19 110.419 -173.584 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -46.56 -31.14 2.61 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 124.072 0.949 . . . . 1.61 112.502 169.045 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 6.1 t -129.59 33.4 4.48 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 122.787 0.435 . . . . 1.73 110.007 173.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 25.6 mp0 57.17 29.97 17.55 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.02 1.328 . . . . 3.64 113.279 175.206 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 62.0 m -118.39 159.62 23.13 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.47 1.108 . . . . 1.64 109.241 -176.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.6 p -128.72 143.75 40.16 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 O-C-N 121.21 -0.931 . . . . 1.69 108.71 171.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -132.85 128.74 37.33 Favored 'General case' 0 C--N 1.342 0.263 0 N-CA-C 108.125 -1.065 . . . . 0.42 108.125 -178.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 4.7 p -129.82 128.23 65.01 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.595 0 N-CA-C 106.054 -1.832 . . . . 2.92 106.054 -172.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 11.2 mm -105.27 88.65 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 C-N-CA 125.653 1.581 . . . . 1.7 107.168 -174.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 31.3 p90 -125.8 175.3 7.73 Favored 'General case' 0 CA--C 1.512 -0.493 0 O-C-N 122.106 -0.371 . . . . 2.94 110.059 -173.012 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -102.43 100.61 16.31 Favored Pre-proline 0 N--CA 1.445 -0.693 0 C-N-CA 125.197 1.399 . . . . 4.2 108.688 -176.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_endo -72.01 14.39 0.44 Allowed 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 122.288 1.992 . . . . 0.78 113.911 -176.085 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -81.77 -30.96 32.12 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 108.92 -0.77 . . . . 1.88 108.92 162.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -114.26 -62.61 1.57 Allowed 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 123.769 0.828 . . . . 3.77 108.856 -166.678 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.468 0.6 OUTLIER -77.11 -179.25 5.47 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 114.985 1.476 . . . . 1.55 114.985 162.483 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 179.99 -150.32 9.13 Favored Glycine 0 N--CA 1.431 -1.7 1 N-CA-C 102.717 -4.153 . . . . 2.54 102.717 -172.46 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 20.7 p -72.54 -36.75 68.34 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 124.569 1.148 . . . . 2.44 108.75 175.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -42.07 -63.05 0.8 Allowed 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 126.136 1.775 . . . . 1.71 113.409 -171.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -72.0 -38.79 69.59 Favored 'General case' 0 CA--C 1.515 -0.378 0 C-N-CA 118.483 -1.287 . . . . 1.85 109.032 -170.169 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.3 mp -54.46 -55.93 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.931 0 CA-C-N 115.014 -0.994 . . . . 1.9 109.663 178.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.2 -46.08 85.49 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 119.094 0.861 . . . . 1.13 109.991 -176.481 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -47.54 -57.58 5.25 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 122.664 1.221 . . . . 2.63 110.676 175.573 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 11.5 mmmt -68.3 -37.26 80.44 Favored 'General case' 0 N--CA 1.437 -1.121 0 CA-C-N 115.409 -0.814 . . . . 4.62 111.974 -177.122 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.3 mm -52.34 -53.08 20.96 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 N-CA-C 107.937 -1.134 . . . . 1.72 107.937 176.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 21.1 mm-40 -59.32 -56.58 20.22 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.702 0.801 . . . . 1.93 110.404 176.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 5.8 mmmt -54.81 -37.28 65.91 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 113.29 0.848 . . . . 5.6 113.29 -178.482 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 11.4 mt -71.14 -18.15 62.52 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.542 1.137 . . . . 1.8 111.883 175.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 93.58 44.17 3.76 Favored Glycine 0 CA--C 1.525 0.659 0 C-N-CA 124.581 1.086 . . . . 0.46 110.799 176.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -139.98 172.85 12.18 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 124.033 0.933 . . . . 3.11 110.588 -176.635 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -139.98 118.04 11.87 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 109.086 -0.709 . . . . 3.03 109.086 173.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 5.7 p -91.49 147.74 5.07 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 N-CA-C 107.892 -1.151 . . . . 2.44 107.892 172.058 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 41.2 t -123.26 141.52 43.26 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.102 0 C-N-CA 124.574 1.15 . . . . 1.67 108.691 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 4.8 mp . . . . . 0 CA--C 1.532 0.273 0 C-N-CA 124.052 0.941 . . . . 2.64 108.47 -173.353 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 11.5 m . . . . . 0 N--CA 1.448 -0.559 0 N-CA-C 108.457 -0.942 . . . . 1.51 108.457 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -72.24 165.47 24.37 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 108.918 -0.771 . . . . 2.72 108.918 163.342 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -124.02 151.9 43.21 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 124.91 1.284 . . . . 1.09 111.02 -177.2 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.3 mmpt? -137.81 157.12 47.1 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 122.938 0.495 . . . . 5.15 110.22 165.26 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -104.24 97.95 7.83 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 127.799 2.439 . . . . 1.92 106.28 177.846 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 10.0 mm -87.01 160.02 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.258 0 N-CA-C 107.378 -1.342 . . . . 2.89 107.378 177.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -131.5 139.03 49.21 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 125.71 1.604 . . . . 1.68 107.566 178.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 12.5 ptp -156.43 175.19 14.34 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.129 0.571 . . . . 2.67 110.132 179.059 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 29.9 mm100 -99.44 162.57 12.96 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 125.265 1.426 . . . . 2.47 109.545 179.057 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -130.54 157.08 42.93 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.146 0 C-N-CA 124.343 1.057 . . . . 3.18 110.261 176.499 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 62.0 m -146.4 164.7 31.61 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 124.465 1.106 . . . . 1.66 109.343 177.109 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 70.53 68.37 1.65 Allowed Glycine 0 CA--C 1.526 0.756 0 N-CA-C 110.02 -1.232 . . . . 1.52 110.02 179.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -144.82 165.27 28.58 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 123.723 0.809 . . . . 2.32 110.065 -178.312 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.1 p -113.88 -72.1 0.72 Allowed 'General case' 0 CA--C 1.527 0.068 0 C-N-CA 124.438 1.095 . . . . 3.06 108.939 168.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 14.4 p -105.82 152.22 23.51 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 121.781 0.801 . . . . 2.48 112.023 -173.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -75.54 54.5 0.76 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.379 1.072 . . . . 2.55 110.527 176.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -146.87 -49.09 0.19 Allowed 'General case' 0 CA--C 1.526 0.045 0 C-N-CA 123.774 0.829 . . . . 2.19 110.597 -179.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 61.9 m -56.99 -36.89 70.91 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 118.67 0.668 . . . . 1.26 110.638 172.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -50.3 -26.71 5.1 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.758 0.823 . . . . 1.53 112.595 171.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.45 -48.24 50.63 Favored 'General case' 0 N--CA 1.452 -0.328 0 O-C-N 120.162 -1.586 . . . . 1.61 109.204 174.017 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 61.7 mtt85 -54.36 -42.86 70.77 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 123.542 0.737 . . . . 6.38 109.885 -175.249 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.258 2.1 pt -58.56 -57.8 9.41 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 C-N-CA 120.044 -0.662 . . . . 1.63 110.478 177.478 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -53.1 -40.28 64.0 Favored 'General case' 0 C--O 1.224 -0.28 0 CA-C-N 118.839 0.745 . . . . 2.19 111.632 178.248 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 4.1 mptp? -71.32 -48.31 51.33 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 119.446 1.021 . . . . 2.68 111.041 -177.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -60.87 -36.43 92.01 Favored Glycine 0 CA--C 1.529 0.962 0 N-CA-C 110.897 -0.881 . . . . 0.56 110.897 175.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 8.4 tt -62.54 -49.49 75.1 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 124.739 1.216 . . . . 2.9 107.971 175.082 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -57.14 -22.77 42.52 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 124.582 1.153 . . . . 4.36 113.062 178.816 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.7 mmt180 -72.65 -10.99 60.45 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.956 0.902 . . . . 4.39 112.309 175.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 3.1 ptt? -75.79 153.64 85.14 Favored Pre-proline 0 CA--C 1.533 0.302 0 CA-C-N 119.071 0.85 . . . . 5.95 111.692 -179.358 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -60.86 136.08 63.76 Favored 'Trans proline' 0 N--CA 1.451 -0.995 0 C-N-CA 121.589 1.526 . . . . 0.83 108.972 172.135 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 100.15 -28.79 14.06 Favored Glycine 0 CA--C 1.53 1.003 0 CA-C-O 118.504 -1.164 . . . . 0.76 112.978 177.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 24.8 t -95.52 123.16 47.57 Favored 'Isoleucine or valine' 0 C--N 1.346 0.422 0 CA-C-N 119.62 1.71 . . . . 1.61 111.185 176.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 86.9 m -90.32 -53.65 4.36 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-O 117.858 -1.068 . . . . 2.57 110.378 -179.007 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -135.97 158.11 45.2 Favored 'General case' 0 C--N 1.343 0.318 0 CA-C-N 119.576 1.08 . . . . 2.45 110.698 177.235 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -156.91 148.17 22.11 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 114.38 1.252 . . . . 1.43 114.38 177.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -155.15 113.19 3.44 Favored 'General case' 0 C--N 1.344 0.365 0 N-CA-C 107.241 -1.392 . . . . 0.59 107.241 -162.328 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 6.4 p -82.36 114.68 23.62 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 N-CA-C 108.952 -0.758 . . . . 1.74 108.952 178.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -94.05 57.93 2.48 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 122.994 1.378 . . . . 2.98 108.718 -178.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.85 -17.54 64.94 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 114.361 -1.291 . . . . 1.95 111.094 -177.342 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -41.29 -39.7 1.46 Allowed 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 124.901 1.28 . . . . 1.93 112.747 168.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 9.1 t -127.43 35.88 4.47 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 117.666 0.212 . . . . 1.87 110.621 172.094 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 61.54 36.23 17.04 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.462 1.105 . . . . 4.37 113.195 173.162 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 4.8 m -123.5 161.21 25.33 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.051 1.34 . . . . 1.69 109.369 -176.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -127.68 144.18 38.35 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 C-N-CA 124.423 1.089 . . . . 2.01 108.417 172.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -131.83 145.04 51.33 Favored 'General case' 0 C--N 1.347 0.491 0 N-CA-C 108.327 -0.99 . . . . 0.45 108.327 177.108 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 5.4 p -145.46 125.24 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 N-CA-C 106.642 -1.614 . . . . 3.05 106.642 -172.262 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 9.6 mm -105.79 83.53 0.72 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.49 0 C-N-CA 126.286 1.834 . . . . 1.59 106.984 -171.029 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 51.6 p90 -119.56 175.9 5.62 Favored 'General case' 0 CA--C 1.506 -0.731 0 N-CA-C 109.197 -0.668 . . . . 3.45 109.197 -172.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -101.65 95.26 5.07 Favored Pre-proline 0 N--CA 1.443 -0.78 0 O-C-N 124.813 1.321 . . . . 4.3 110.199 -176.263 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -74.49 14.7 0.74 Allowed 'Trans proline' 0 CA--C 1.537 0.661 0 C-N-CA 122.833 2.355 . . . . 1.0 113.56 -173.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -89.09 -21.79 23.21 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 124.021 0.928 . . . . 2.37 109.5 166.117 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -113.63 -62.19 1.63 Allowed 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 125.212 1.405 . . . . 3.52 107.723 -175.497 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.285 0.7 OUTLIER -82.62 -179.75 7.53 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 115.223 1.564 . . . . 2.19 115.223 170.319 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -163.53 -128.42 0.95 Allowed Glycine 0 N--CA 1.434 -1.496 0 N-CA-C 104.164 -3.574 . . . . 2.59 104.164 175.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 18.3 p -81.82 -30.54 32.14 Favored 'General case' 0 C--N 1.318 -0.792 0 C-N-CA 126.874 2.07 . . . . 2.34 110.636 172.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -53.2 -62.44 1.65 Allowed 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 124.327 1.051 . . . . 1.73 112.769 -157.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -75.14 -24.58 57.99 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 113.931 -1.486 . . . . 2.11 110.285 -172.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.5 mt -66.85 -49.16 76.68 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 C-N-CA 124.341 1.056 . . . . 2.61 109.576 -178.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.18 -43.94 93.55 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 107.806 -1.183 . . . . 1.93 107.806 -177.501 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -48.5 -59.64 3.32 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 123.833 0.853 . . . . 2.76 111.032 172.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 10.3 mmtp -60.65 -42.37 96.83 Favored 'General case' 0 N--CA 1.441 -0.912 0 O-C-N 121.712 -0.617 . . . . 4.0 111.716 -178.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -48.82 -54.69 4.57 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 C-N-CA 125.007 1.323 . . . . 1.57 108.745 176.345 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 29.5 mm-40 -60.9 -53.85 52.3 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 123.481 0.712 . . . . 1.91 110.197 178.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -56.15 -38.41 70.82 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 112.668 0.618 . . . . 4.94 112.668 -176.382 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 15.9 mt -69.98 -17.06 63.27 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.617 1.167 . . . . 1.89 111.911 176.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 92.86 41.36 4.69 Favored Glycine 0 CA--C 1.522 0.513 0 N-CA-C 110.73 -0.948 . . . . 0.56 110.73 175.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -133.81 175.3 9.58 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 123.672 0.789 . . . . 3.52 110.145 178.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 4.2 t60 -139.34 143.73 37.93 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 109.162 -0.681 . . . . 2.99 109.162 170.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 12.4 p -112.84 150.07 15.11 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 C-N-CA 126.385 1.874 . . . . 2.96 107.987 -175.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 13.5 t -132.33 147.67 32.05 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 C-N-CA 124.283 1.033 . . . . 1.63 108.301 -179.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 4.6 mp . . . . . 0 N--CA 1.449 -0.501 0 C-N-CA 124.609 1.163 . . . . 2.92 108.567 179.98 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.4 m . . . . . 0 N--CA 1.456 -0.171 0 N-CA-C 106.077 -1.823 . . . . 1.85 106.077 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -70.82 173.75 6.93 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 107.774 -1.195 . . . . 2.1 107.774 163.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -129.3 151.53 49.85 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 123.491 0.717 . . . . 1.7 109.099 172.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 69.6 mmtt -140.92 157.72 44.97 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.213 1.005 . . . . 4.06 111.07 166.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -116.21 91.79 3.7 Favored 'General case' 0 N--CA 1.435 -1.181 0 C-N-CA 128.226 2.61 . . . . 1.46 106.61 -168.442 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 8.0 mm -82.41 158.48 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.261 0 N-CA-C 106.977 -1.49 . . . . 2.84 106.977 -178.178 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -131.44 139.01 49.29 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 107.093 -1.447 . . . . 1.48 107.093 172.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -155.43 176.28 12.79 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 122.992 0.517 . . . . 2.79 109.738 170.541 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 27.4 mm100 -95.35 165.37 12.41 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.627 1.171 . . . . 2.61 110.152 -178.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 31.6 t -128.44 132.19 68.26 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 C-N-CA 124.597 1.159 . . . . 2.3 109.804 -174.111 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 32.9 m -117.74 176.29 5.26 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 125.195 1.398 . . . . 1.74 109.348 169.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 82.15 -44.88 3.23 Favored Glycine 0 CA--C 1.53 0.994 0 O-C-N 121.553 -0.717 . . . . 2.24 111.603 178.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -44.52 142.18 1.71 Allowed 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 124.121 0.968 . . . . 3.38 112.691 176.066 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -147.71 -45.71 0.16 Allowed 'General case' 0 CA--C 1.53 0.173 0 C-N-CA 124.559 1.144 . . . . 4.08 110.432 171.787 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 24.3 p -71.16 -16.58 62.54 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 112.616 0.599 . . . . 3.04 112.616 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 59.97 28.32 17.82 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.808 1.243 . . . . 3.03 112.209 -179.193 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -130.66 -51.9 1.07 Allowed 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 124.609 1.164 . . . . 1.77 110.252 -179.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 52.5 m -51.06 -31.68 19.49 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 125.145 1.378 . . . . 1.64 112.548 172.174 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.5 -26.38 31.14 Favored 'General case' 0 CA--C 1.539 0.548 0 O-C-N 121.885 -0.509 . . . . 1.7 111.865 173.302 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.02 -46.4 62.2 Favored 'General case' 0 N--CA 1.454 -0.248 0 O-C-N 120.304 -1.497 . . . . 1.57 110.638 169.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 8.9 mtt85 -51.68 -44.69 63.17 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-O 119.171 -0.443 . . . . 4.55 110.346 -177.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.262 2.3 pt -59.76 -55.4 24.2 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.201 0 C-N-CA 119.642 -0.823 . . . . 1.76 111.217 -178.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -55.67 -42.63 75.38 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-N 118.693 0.679 . . . . 2.16 112.08 177.454 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -70.88 -46.84 61.88 Favored 'General case' 0 CA--C 1.533 0.294 0 O-C-N 121.68 -0.637 . . . . 2.83 110.078 -175.158 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -58.38 -44.38 95.23 Favored Glycine 0 CA--C 1.527 0.815 0 N-CA-C 110.127 -1.189 . . . . 0.73 110.127 173.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -61.65 -43.14 99.41 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.688 0.795 . . . . 3.7 109.486 -179.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 7.3 ttmt -51.98 -29.87 22.47 Favored 'General case' 0 CA--C 1.531 0.237 0 O-C-N 121.036 -1.04 . . . . 3.66 111.595 173.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.84 -0.75 19.45 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-O 118.065 -0.969 . . . . 5.75 113.352 -175.806 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 93.8 mmm -89.05 152.7 48.57 Favored Pre-proline 0 CA--C 1.535 0.393 0 C-N-CA 126.738 2.015 . . . . 4.09 111.164 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -60.08 138.92 84.87 Favored 'Trans proline' 0 N--CA 1.453 -0.901 0 C-N-CA 122.236 1.958 . . . . 0.84 109.547 175.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 97.29 -30.99 8.2 Favored Glycine 0 CA--C 1.523 0.588 0 CA-C-O 119.0 -0.889 . . . . 0.59 112.536 179.478 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 16.3 t -92.04 140.19 16.59 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.212 0 CA-C-N 119.241 1.521 . . . . 1.83 109.114 -179.103 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -119.43 -42.79 2.64 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 118.273 -0.87 . . . . 2.14 111.129 179.798 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -138.73 161.85 36.15 Favored 'General case' 0 CA--C 1.518 -0.278 0 CA-C-N 119.838 1.199 . . . . 2.13 111.433 171.693 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -157.68 138.94 13.56 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 123.125 0.57 . . . . 1.39 111.018 -175.467 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -150.13 102.61 3.11 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 106.7 -1.593 . . . . 0.67 106.7 -163.057 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 10.4 p -82.13 107.0 13.68 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 CA-C-O 121.252 0.549 . . . . 1.88 110.498 -179.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 48.9 t30 -84.43 56.82 3.97 Favored 'General case' 0 CA--C 1.537 0.476 0 O-C-N 120.567 -1.333 . . . . 1.13 109.992 179.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -74.93 -16.1 60.66 Favored 'General case' 0 N--CA 1.461 0.101 0 CA-C-N 115.446 -0.797 . . . . 1.91 110.422 176.706 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -45.64 -37.37 5.62 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.742 0.817 . . . . 2.15 111.396 167.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 15.0 t -98.54 -68.48 0.8 Allowed 'General case' 0 C--N 1.344 0.329 0 CA-C-O 117.703 -1.141 . . . . 3.56 110.198 165.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 159.93 43.55 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 127.61 2.364 . . . . 2.86 110.864 -176.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 79.7 m -142.64 162.4 35.56 Favored 'General case' 0 CA--C 1.534 0.333 0 O-C-N 120.464 -1.397 . . . . 1.83 108.805 -171.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.4 p -125.75 145.92 32.36 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 O-C-N 121.232 -0.917 . . . . 1.69 108.981 172.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -127.79 143.51 51.12 Favored 'General case' 0 C--N 1.345 0.38 0 N-CA-C 108.017 -1.105 . . . . 0.47 108.017 170.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.2 p -140.41 127.11 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 N-CA-C 107.226 -1.398 . . . . 2.86 107.226 -176.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 18.5 mm -103.5 90.05 1.58 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.604 0 C-N-CA 125.935 1.694 . . . . 1.93 107.107 -173.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 6.8 p90 -128.82 166.42 19.09 Favored 'General case' 0 CA--C 1.508 -0.669 0 CA-C-O 121.452 0.644 . . . . 2.91 111.751 -174.285 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -96.04 108.99 44.5 Favored Pre-proline 0 N--CA 1.444 -0.736 0 CA-C-N 114.172 -1.376 . . . . 4.22 109.187 -172.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -73.45 13.97 0.66 Allowed 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 123.009 2.473 . . . . 0.86 112.99 -173.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -85.23 -35.47 21.57 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 123.823 0.849 . . . . 2.34 108.728 166.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -109.99 -54.36 2.57 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 108.638 -0.875 . . . . 3.18 108.638 -168.816 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.314 0.9 OUTLIER -86.56 -173.98 4.77 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-O 121.037 0.446 . . . . 1.71 111.674 162.594 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 128.88 88.64 0.56 Allowed Glycine 0 N--CA 1.442 -0.948 0 N-CA-C 103.702 -3.759 . . . . 2.36 103.702 -150.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 26.5 p -13.75 -18.41 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.499 1 C-N-CA 138.735 6.814 . . . . 2.47 119.748 -146.434 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -28.12 -63.36 0.1 Allowed 'General case' 0 N--CA 1.441 -0.877 0 C-N-CA 126.857 2.063 . . . . 1.7 113.841 164.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -72.02 -41.1 67.94 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 118.098 -1.441 . . . . 1.71 109.164 -167.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.5 mp -52.32 -54.72 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.845 0 CA-C-N 114.303 -1.317 . . . . 2.16 109.146 175.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.55 -45.7 85.99 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 118.963 0.801 . . . . 1.69 109.294 -175.393 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -52.12 -53.37 43.49 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 122.396 1.093 . . . . 2.93 110.27 178.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.2 mmpt? -70.71 -37.54 73.57 Favored 'General case' 0 N--CA 1.432 -1.363 0 CA-C-O 118.233 -0.889 . . . . 3.43 112.369 -177.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.5 mm -47.61 -51.65 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 C-N-CA 124.66 1.184 . . . . 1.66 108.233 177.088 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -54.0 -60.31 3.5 Favored 'General case' 0 C--N 1.34 0.182 0 C-N-CA 123.625 0.77 . . . . 2.55 110.781 174.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -63.71 -29.52 70.73 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 112.679 0.622 . . . . 5.86 112.679 -172.241 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 23.8 mt -70.03 -18.35 63.3 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.425 1.49 . . . . 1.9 111.02 172.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 95.32 39.07 4.59 Favored Glycine 0 CA--C 1.524 0.645 0 C-N-CA 124.959 1.266 . . . . 0.44 110.937 175.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -137.74 175.43 9.59 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.605 0.762 . . . . 3.43 111.863 -173.104 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 4.3 t-80 -152.08 111.68 3.96 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 125.008 1.323 . . . . 3.29 107.495 -176.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 3.6 m -82.96 160.99 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.239 0 N-CA-C 108.877 -0.786 . . . . 3.67 108.877 169.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 21.6 t -122.96 142.12 40.74 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 N-CA-C 108.468 -0.938 . . . . 1.88 108.468 176.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 45.4 mm . . . . . 0 N--CA 1.452 -0.353 0 C-N-CA 125.277 1.431 . . . . 2.53 108.164 -175.69 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 25.1 m . . . . . 0 N--CA 1.45 -0.44 0 N-CA-C 106.499 -1.667 . . . . 1.47 106.499 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -77.01 179.74 6.05 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 108.817 -0.808 . . . . 2.36 108.817 160.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -135.38 147.79 49.17 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 106.693 -1.595 . . . . 1.45 106.693 166.576 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 20.0 mmtp -140.53 156.05 46.43 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 123.343 0.657 . . . . 4.66 109.921 165.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -108.06 99.14 8.6 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 128.011 2.524 . . . . 1.91 107.615 -174.763 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.9 mm -82.97 157.44 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.98 0 N-CA-C 107.205 -1.405 . . . . 2.75 107.205 177.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -135.66 129.99 33.63 Favored 'General case' 0 C--O 1.231 0.112 0 C-N-CA 124.606 1.162 . . . . 1.65 107.893 178.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 10.0 ptt? -156.16 175.54 13.84 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.019 0.528 . . . . 3.56 110.485 -176.015 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -101.2 162.16 13.1 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 127.505 2.322 . . . . 3.77 110.701 -177.787 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 46.1 t -119.34 144.86 26.54 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 C-N-CA 124.436 1.094 . . . . 2.52 109.316 -176.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 41.3 t -135.72 175.61 9.44 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.767 1.227 . . . . 3.08 109.153 173.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 51.66 58.16 10.79 Favored Glycine 0 CA--C 1.529 0.917 0 C-N-CA 124.661 1.124 . . . . 1.68 111.254 -175.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -134.41 150.64 50.89 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 123.634 0.773 . . . . 2.5 110.827 -172.88 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -99.62 -57.21 2.2 Favored 'General case' 0 CA--C 1.528 0.113 0 C-N-CA 125.23 1.412 . . . . 3.43 111.204 169.22 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 20.8 p -144.29 165.44 27.89 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 121.808 0.813 . . . . 2.84 111.941 -169.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -75.64 54.26 0.77 Allowed 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.209 1.404 . . . . 2.88 110.746 178.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -147.62 -58.53 0.26 Allowed 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 124.373 1.069 . . . . 2.11 108.709 177.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 26.8 m -57.15 -40.98 78.29 Favored 'General case' 0 CA--C 1.53 0.186 0 O-C-N 121.994 -0.441 . . . . 1.44 110.168 176.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.23 -21.03 7.98 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.801 0.84 . . . . 2.0 113.032 174.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -72.44 -47.37 49.55 Favored 'General case' 0 N--CA 1.453 -0.298 0 O-C-N 120.667 -1.271 . . . . 1.63 110.793 170.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 54.4 mmm-85 -53.37 -44.65 68.77 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 109.77 -0.456 . . . . 5.03 109.77 -172.129 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.5 pt -57.85 -54.02 37.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 CA-C-O 118.69 -0.672 . . . . 1.8 110.5 178.333 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -57.14 -40.73 77.74 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.797 0.839 . . . . 2.38 112.133 179.452 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 31.9 mmtp -70.7 -43.98 67.87 Favored 'General case' 0 CA--C 1.534 0.358 0 O-C-N 121.414 -0.804 . . . . 2.91 110.552 -178.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -63.74 -38.68 96.55 Favored Glycine 0 CA--C 1.53 1.019 0 N-CA-C 110.931 -0.868 . . . . 0.51 110.931 173.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.8 tt -60.51 -41.54 94.57 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 125.462 1.505 . . . . 2.88 109.512 176.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 10.7 ttmt -54.41 -23.37 15.55 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 112.592 0.59 . . . . 3.93 112.592 173.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.82 -2.58 24.2 Favored 'General case' 0 CA--C 1.542 0.659 0 O-C-N 121.285 -0.884 . . . . 4.54 112.19 177.634 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 9.9 mmt -69.78 152.0 96.22 Favored Pre-proline 0 CA--C 1.532 0.273 0 CA-C-N 119.42 1.009 . . . . 4.05 111.689 173.054 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -58.22 141.08 96.43 Favored 'Trans proline' 0 N--CA 1.452 -0.932 0 C-N-CA 122.005 1.803 . . . . 1.08 109.47 170.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 86.13 -27.31 5.62 Favored Glycine 0 CA--C 1.524 0.616 0 CA-C-O 119.436 -0.647 . . . . 0.83 113.849 178.295 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 13.7 t -82.57 127.02 40.05 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 CA-C-N 118.777 1.289 . . . . 1.6 108.693 -179.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.9 m -110.53 -37.26 5.53 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-O 118.601 -0.714 . . . . 1.88 110.889 -175.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -148.53 166.94 26.71 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 119.253 0.933 . . . . 1.84 110.038 170.333 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -157.25 148.81 22.17 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 123.481 0.712 . . . . 1.37 110.507 -175.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -154.46 110.28 3.19 Favored 'General case' 0 CA--C 1.529 0.161 0 N-CA-C 108.437 -0.949 . . . . 0.59 108.437 -165.258 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 4.7 p -88.44 93.87 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 C-N-CA 124.142 0.977 . . . . 2.29 110.37 -178.146 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 52.5 t-20 -82.79 56.79 3.53 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 120.475 -1.391 . . . . 0.82 110.224 -178.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -67.01 -21.34 65.95 Favored 'General case' 0 C--O 1.227 -0.097 0 C-N-CA 123.677 0.791 . . . . 1.99 110.33 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -48.26 -33.78 9.29 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.626 0.77 . . . . 1.82 112.144 170.151 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 3.4 t -121.97 27.66 7.96 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 118.026 0.375 . . . . 2.22 110.424 174.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 47.55 58.47 4.92 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 124.824 1.25 . . . . 3.07 111.616 -178.096 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 33.2 m -145.44 164.28 32.05 Favored 'General case' 0 N--CA 1.44 -0.927 0 O-C-N 120.713 -1.242 . . . . 1.75 107.716 175.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.9 p -139.47 145.01 27.7 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 N-CA-C 108.71 -0.848 . . . . 1.74 108.71 174.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 19.5 m120 -131.8 139.45 48.89 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 124.407 1.083 . . . . 0.31 108.481 -176.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 22.3 t -133.59 129.53 55.73 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 N-CA-C 105.796 -1.927 . . . . 3.25 105.796 -178.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 13.6 mm -105.99 95.23 3.63 Favored 'Isoleucine or valine' 0 C--O 1.24 0.585 0 C-N-CA 124.946 1.298 . . . . 1.54 107.583 -174.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 10.8 p90 -131.95 164.48 26.05 Favored 'General case' 0 CA--C 1.513 -0.446 0 O-C-N 122.03 -0.419 . . . . 3.52 111.955 -172.172 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 30.9 t0 -81.46 110.78 20.53 Favored Pre-proline 0 CA--C 1.534 0.365 0 O-C-N 124.392 1.057 . . . . 2.87 110.134 172.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -73.09 5.97 2.79 Favored 'Trans proline' 0 N--CA 1.452 -0.96 0 C-N-CA 123.007 2.472 . . . . 0.66 113.124 -178.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -87.79 -34.09 18.41 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 119.493 1.042 . . . . 1.71 108.797 169.268 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -99.03 -60.47 1.53 Allowed 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 108.687 -0.857 . . . . 3.01 108.687 -174.417 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.345 0.6 OUTLIER -83.53 -174.86 5.53 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 123.807 0.843 . . . . 1.89 112.229 162.05 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 126.37 94.95 0.94 Allowed Glycine 0 N--CA 1.442 -0.909 0 N-CA-C 103.913 -3.675 . . . . 2.2 103.913 -144.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 68.6 p -14.31 -23.52 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.383 1 C-N-CA 138.161 6.584 . . . . 1.98 119.169 -151.749 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -27.47 -62.74 0.09 Allowed 'General case' 0 N--CA 1.443 -0.787 0 C-N-CA 127.177 2.191 . . . . 1.89 113.532 167.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.54 -39.55 62.25 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 118.732 -1.187 . . . . 1.6 109.72 -166.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.2 mp -54.68 -57.67 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.026 0 CA-C-N 113.687 -1.597 . . . . 2.23 109.399 176.397 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -60.76 -43.28 98.22 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 118.093 0.406 . . . . 1.59 109.923 -174.482 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -46.86 -58.82 3.54 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.15 0.58 . . . . 2.74 111.41 171.85 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 3.4 mmpt? -65.44 -42.82 92.01 Favored 'General case' 0 N--CA 1.442 -0.84 0 O-C-N 121.705 -0.622 . . . . 3.27 112.331 -179.304 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -47.1 -54.11 2.86 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 C-N-CA 125.403 1.481 . . . . 1.67 107.795 178.11 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -60.54 -57.54 12.29 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 124.559 1.144 . . . . 1.68 110.633 177.048 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 11.7 mptt -59.66 -31.41 69.52 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 112.795 0.665 . . . . 6.13 112.795 -173.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.6 mt -67.74 -16.95 64.38 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.307 1.043 . . . . 2.15 112.179 174.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 89.84 46.04 4.35 Favored Glycine 0 C--N 1.336 0.58 0 N-CA-C 109.68 -1.368 . . . . 0.75 109.68 179.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -143.72 175.25 10.12 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 124.562 1.145 . . . . 3.45 108.678 -176.352 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 7.7 t-160 -145.28 144.48 30.79 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 109.076 -0.713 . . . . 3.37 109.076 174.088 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 5.8 p -113.21 144.37 21.0 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 N-CA-C 107.002 -1.481 . . . . 2.6 107.002 179.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 5.7 t -122.86 140.81 45.46 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 N-CA-C 107.615 -1.254 . . . . 1.98 107.615 -178.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 4.7 mp . . . . . 0 N--CA 1.45 -0.475 0 N-CA-C 107.975 -1.12 . . . . 2.62 107.975 -175.912 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.5 m . . . . . 0 N--CA 1.446 -0.67 0 N-CA-C 108.838 -0.801 . . . . 1.42 108.838 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -65.94 171.63 4.31 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 108.077 -1.083 . . . . 2.29 108.077 162.211 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -131.5 153.88 49.34 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 124.258 1.023 . . . . 1.26 109.673 176.501 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -144.94 160.63 41.01 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 124.725 1.21 . . . . 4.16 109.842 170.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -121.25 94.77 4.44 Favored 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 128.082 2.553 . . . . 1.98 106.094 -170.087 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 17.1 mm -82.62 162.05 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.232 0 N-CA-C 107.109 -1.441 . . . . 2.93 107.109 -179.095 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -133.3 140.24 47.33 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 107.068 -1.456 . . . . 1.56 107.068 170.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -152.55 175.46 12.74 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 118.522 0.601 . . . . 2.79 110.059 172.226 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 22.8 mm100 -98.45 157.99 15.87 Favored 'General case' 0 C--O 1.227 -0.084 0 C-N-CA 124.234 1.014 . . . . 2.61 110.049 177.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 43.4 t -111.19 162.19 9.01 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 C-N-CA 124.844 1.257 . . . . 2.44 109.612 -174.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 58.0 m -149.23 164.47 34.7 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 107.535 -1.283 . . . . 1.73 107.535 165.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 93.32 -29.97 7.71 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 123.39 0.519 . . . . 2.47 112.562 -178.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -53.21 108.2 0.31 Allowed 'General case' 0 C--O 1.225 -0.205 0 CA-C-N 118.026 0.913 . . . . 2.93 112.77 178.233 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -155.91 14.18 0.34 Allowed 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 114.299 1.222 . . . . 4.51 114.299 178.326 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 8.3 m -104.28 -58.7 1.84 Allowed 'General case' 0 C--O 1.226 -0.163 0 N-CA-C 108.245 -1.021 . . . . 5.03 108.245 -175.16 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -172.86 -56.56 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 126.34 1.856 . . . . 6.56 106.579 174.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -164.38 32.1 0.07 Allowed 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 113.204 0.816 . . . . 3.31 113.204 -168.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 95.6 m -58.1 -31.62 67.31 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 121.378 -0.826 . . . . 1.19 111.424 174.248 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.57 -25.43 17.13 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.197 0.599 . . . . 1.86 112.609 170.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.26 -48.26 57.61 Favored 'General case' 0 N--CA 1.453 -0.307 0 O-C-N 120.261 -1.525 . . . . 1.97 110.204 169.367 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 21.0 mmm180 -55.66 -46.86 77.46 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 109.603 -0.517 . . . . 5.39 109.603 -178.116 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.0 pt -57.21 -54.96 23.71 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.36 0 C-N-CA 119.816 -0.754 . . . . 1.8 110.921 178.242 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -55.68 -40.06 71.81 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 119.097 0.862 . . . . 2.22 112.324 -179.511 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -71.13 -46.19 62.08 Favored 'General case' 0 N--CA 1.453 -0.284 0 O-C-N 121.722 -0.611 . . . . 2.85 109.707 -176.218 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -60.11 -47.62 90.12 Favored Glycine 0 CA--C 1.528 0.856 0 N-CA-C 110.204 -1.158 . . . . 0.92 110.204 172.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 6.1 tt -52.97 -42.87 65.92 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.793 1.637 . . . . 3.12 110.118 177.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 8.6 ttmt -57.54 -32.36 67.0 Favored 'General case' 0 CA--C 1.535 0.373 0 O-C-N 120.942 -1.099 . . . . 4.51 112.917 174.104 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -69.01 -7.53 36.44 Favored 'General case' 0 CA--C 1.536 0.427 0 O-C-N 121.297 -0.877 . . . . 6.4 112.551 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 20.5 mmt -79.69 148.45 69.24 Favored Pre-proline 0 CA--C 1.532 0.273 0 CA-C-N 119.019 0.827 . . . . 5.69 110.419 -174.129 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -56.11 137.17 78.54 Favored 'Trans proline' 0 N--CA 1.452 -0.966 0 C-N-CA 121.89 1.727 . . . . 1.05 108.746 176.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 90.89 -7.15 81.59 Favored Glycine 0 N--CA 1.449 -0.481 0 CA-C-O 117.671 -1.627 . . . . 0.88 114.35 179.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.6 t -110.37 135.18 50.2 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 CA-C-N 119.825 1.813 . . . . 1.7 109.107 177.294 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 8.4 m -107.45 -49.86 3.18 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 123.442 0.697 . . . . 2.17 110.194 -176.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -138.96 163.88 31.21 Favored 'General case' 0 C--N 1.343 0.299 0 CA-C-N 118.916 0.78 . . . . 2.05 111.456 177.164 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -159.43 144.33 15.5 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 113.152 0.797 . . . . 1.42 113.152 -179.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -149.7 105.53 3.44 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 107.97 -1.122 . . . . 1.0 107.97 -164.159 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 4.0 p -83.71 100.98 7.72 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 C-N-CA 123.03 0.532 . . . . 2.27 110.521 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 45.1 t30 -82.55 57.4 3.7 Favored 'General case' 0 CA--C 1.538 0.516 0 O-C-N 120.372 -1.455 . . . . 1.27 110.513 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -76.33 -12.11 60.01 Favored 'General case' 0 C--O 1.226 -0.178 0 C-N-CA 124.384 1.074 . . . . 1.95 111.156 176.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -43.84 -38.0 3.09 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 123.59 0.756 . . . . 1.86 111.215 167.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 9.2 t -102.1 -75.95 0.59 Allowed 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 118.755 -0.64 . . . . 3.74 109.578 163.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 179.37 26.76 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.983 1.313 . . . . 3.25 113.375 -177.053 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 91.9 m -128.51 167.35 17.2 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 124.133 0.973 . . . . 1.64 108.759 -163.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 1.2 p -138.35 145.36 28.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 N-CA-C 108.516 -0.92 . . . . 2.01 108.516 179.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -131.09 139.7 49.9 Favored 'General case' 0 C--N 1.343 0.297 0 N-CA-C 108.187 -1.042 . . . . 0.57 108.187 173.416 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 39.8 t -131.34 127.95 60.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 N-CA-C 105.591 -2.003 . . . . 3.26 105.591 179.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 13.2 mm -102.44 93.01 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 N-CA-C 106.884 -1.524 . . . . 1.8 106.884 -177.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 9.5 p90 -127.01 168.67 14.25 Favored 'General case' 0 CA--C 1.509 -0.632 0 O-C-N 121.964 -0.46 . . . . 2.98 110.663 -170.207 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -99.1 103.44 20.01 Favored Pre-proline 0 N--CA 1.445 -0.716 0 C-N-CA 124.292 1.037 . . . . 4.39 109.123 -176.265 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -72.72 10.4 1.06 Allowed 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 123.402 2.734 . . . . 1.06 113.723 -172.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -86.44 -25.72 25.08 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 108.893 -0.78 . . . . 2.19 108.893 167.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -112.42 -55.33 2.53 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 123.816 0.847 . . . . 3.07 109.151 -175.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.324 9.5 p -90.57 -160.56 0.72 Allowed 'General case' 0 C--N 1.343 0.288 0 CA-C-O 119.411 -0.328 . . . . 1.54 110.76 165.155 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 118.33 88.41 1.23 Allowed Glycine 0 N--CA 1.445 -0.734 0 N-CA-C 104.192 -3.563 . . . . 2.34 104.192 -148.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 47.0 p -12.51 -18.28 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.419 1 C-N-CA 138.573 6.749 . . . . 2.54 119.53 -147.082 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -27.29 -63.05 0.09 Allowed 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 127.434 2.294 . . . . 1.6 114.327 166.091 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -72.96 -41.1 64.78 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 117.556 -1.657 . . . . 1.66 109.196 -168.056 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.1 mp -53.97 -52.49 35.73 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.051 0 CA-C-N 113.821 -1.536 . . . . 1.96 109.542 177.041 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.19 -48.1 79.78 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 119.398 0.999 . . . . 1.73 109.046 -176.793 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.522 ' CD ' ' HZ2' ' A' ' 66' ' ' LYS . 4.1 mm-40 -47.83 -56.29 7.8 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 122.4 1.095 . . . . 3.29 110.709 176.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.9 mmpt? -70.58 -39.08 74.08 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-O 118.532 -0.747 . . . . 3.38 112.063 -176.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -45.55 -53.78 1.86 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 C-N-CA 125.142 1.377 . . . . 1.63 108.046 173.412 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -58.46 -59.66 5.01 Favored 'General case' 0 C--N 1.341 0.2 0 C-N-CA 124.058 0.943 . . . . 1.98 110.288 177.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.522 ' HZ2' ' CD ' ' A' ' 62' ' ' GLU . 14.1 mptt -58.73 -31.97 68.79 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 112.84 0.681 . . . . 6.11 112.84 -175.337 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 24.8 mt -69.73 -17.23 63.44 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.969 1.308 . . . . 1.89 111.295 176.11 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 94.2 41.85 4.17 Favored Glycine 0 CA--C 1.523 0.569 0 C-N-CA 124.642 1.115 . . . . 0.52 110.367 176.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -140.61 171.57 13.93 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 123.909 0.884 . . . . 3.38 110.238 -176.089 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -151.08 141.93 22.88 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 108.306 -0.998 . . . . 3.54 108.306 168.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.0 m -99.27 165.38 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 C-N-CA 124.891 1.277 . . . . 3.81 108.531 174.34 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 16.6 t -122.42 143.81 33.92 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 C-N-CA 124.66 1.184 . . . . 2.16 108.325 177.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 21.9 mm . . . . . 0 N--CA 1.455 -0.201 0 C-N-CA 125.429 1.492 . . . . 2.82 108.482 -176.938 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 28.2 m . . . . . 0 N--CA 1.444 -0.729 0 N-CA-C 108.051 -1.092 . . . . 1.44 108.051 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -108.68 -179.94 4.01 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 128.065 2.546 . . . . 2.12 108.985 166.153 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 3.5 mm100 -139.19 147.66 42.11 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.95 1.3 . . . . 1.23 108.015 167.544 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -140.96 159.8 41.43 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 123.735 0.814 . . . . 4.03 109.384 160.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -114.89 86.55 2.47 Favored 'General case' 0 N--CA 1.442 -0.83 0 C-N-CA 127.902 2.481 . . . . 1.57 106.727 -170.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 2.6 mp -83.5 161.67 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.295 0 N-CA-C 106.262 -1.755 . . . . 3.15 106.262 -176.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -128.85 137.68 51.61 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 125.649 1.58 . . . . 1.38 108.077 -178.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 1.9 mpt? -140.3 171.4 14.2 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 122.923 0.489 . . . . 3.01 110.302 172.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -88.54 159.7 17.8 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 127.005 2.122 . . . . 3.75 109.797 167.091 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 88.9 t -117.86 152.63 19.84 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 C-N-CA 124.623 1.169 . . . . 2.31 108.525 -179.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 70.8 m -149.49 160.41 43.48 Favored 'General case' 0 N--CA 1.455 -0.198 0 O-C-N 121.342 -0.849 . . . . 1.75 109.853 171.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 70.02 70.29 1.21 Allowed Glycine 0 CA--C 1.528 0.861 0 N-CA-C 110.462 -1.055 . . . . 1.64 110.462 -178.408 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -145.2 157.89 43.96 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 124.152 0.981 . . . . 2.75 109.529 -175.283 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.7 p -108.63 -66.03 1.08 Allowed 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 125.612 1.565 . . . . 3.15 108.692 171.129 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 20.3 p -123.71 161.11 25.8 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 124.485 1.114 . . . . 2.6 111.414 -170.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -76.67 53.49 0.89 Allowed 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.322 1.049 . . . . 2.45 110.813 178.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -138.42 -53.49 0.61 Allowed 'General case' 0 CA--C 1.521 -0.153 0 C-N-CA 124.677 1.191 . . . . 1.77 109.234 175.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 59.7 m -57.4 -41.44 80.33 Favored 'General case' 0 CA--C 1.533 0.289 0 O-C-N 121.734 -0.604 . . . . 1.25 111.6 -176.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.67 -19.13 47.52 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 112.642 0.608 . . . . 2.07 112.642 176.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.72 -49.12 42.22 Favored 'General case' 0 N--CA 1.455 -0.221 0 O-C-N 120.634 -1.291 . . . . 1.7 109.757 169.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 6.3 mtt-85 -53.72 -49.27 68.49 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 123.383 0.673 . . . . 4.99 109.397 -175.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 5.1 pt -55.23 -53.46 34.81 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 O-C-N 123.883 0.739 . . . . 1.73 109.973 179.423 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -53.72 -45.62 70.53 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.078 0.951 . . . . 2.31 112.273 179.51 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.5 mptp? -69.25 -46.71 66.64 Favored 'General case' 0 CA--C 1.532 0.259 0 O-C-N 121.163 -0.96 . . . . 2.36 110.351 -177.091 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -63.94 -31.71 81.73 Favored Glycine 0 CA--C 1.529 0.956 0 N-CA-C 111.439 -0.665 . . . . 0.51 111.439 176.2 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 7.6 tt -64.91 -44.05 90.84 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 126.018 1.727 . . . . 3.2 109.486 177.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -53.1 -26.51 16.67 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 112.034 0.383 . . . . 3.48 112.034 176.037 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 2.3 mtt180 -70.96 1.6 5.42 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 113.671 0.989 . . . . 4.64 113.671 177.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 6.6 mmt -71.48 155.52 92.57 Favored Pre-proline 0 CA--C 1.534 0.348 0 CA-C-N 119.519 1.054 . . . . 4.0 111.314 167.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -62.62 152.78 75.97 Favored 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 122.411 2.074 . . . . 1.15 110.418 171.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 74.88 -27.03 1.12 Allowed Glycine 0 CA--C 1.533 1.193 0 O-C-N 121.482 -0.761 . . . . 0.94 113.486 177.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 10.3 t -76.4 145.76 9.92 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 CA-C-N 118.83 1.315 . . . . 1.62 109.056 173.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -132.22 -38.94 1.06 Allowed 'General case' 0 CA--C 1.529 0.143 0 CA-C-O 118.512 -0.756 . . . . 1.86 112.304 -176.185 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -140.61 166.49 24.6 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-N 119.589 1.086 . . . . 2.26 111.867 163.503 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -158.13 137.26 11.59 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 112.769 0.655 . . . . 1.56 112.769 -179.278 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -149.97 107.86 3.71 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 106.463 -1.68 . . . . 0.47 106.463 -161.55 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.4 p -82.02 128.44 38.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 108.324 -0.991 . . . . 1.91 108.324 177.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 39.3 t30 -105.69 57.26 0.67 Allowed 'General case' 0 C--O 1.235 0.341 0 CA-C-O 123.263 1.506 . . . . 1.04 107.887 179.005 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -74.74 -13.49 60.6 Favored 'General case' 0 C--O 1.226 -0.178 0 CA-C-N 113.96 -1.473 . . . . 1.95 110.636 177.003 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -44.0 -36.55 2.54 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.914 0.886 . . . . 1.87 111.378 165.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 15.2 t -108.21 -68.73 0.89 Allowed 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 117.739 -1.124 . . . . 3.37 110.85 167.318 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 161.34 49.13 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 127.561 2.344 . . . . 3.8 109.535 -174.108 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -142.52 160.62 39.92 Favored 'General case' 0 N--CA 1.446 -0.667 0 O-C-N 120.292 -1.505 . . . . 1.84 109.16 -178.228 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.6 p -130.18 142.79 42.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 108.113 -1.069 . . . . 1.56 108.113 171.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -127.04 138.77 53.28 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 107.594 -1.262 . . . . 0.41 107.594 176.123 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 3.1 p -137.68 129.67 40.61 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 N-CA-C 106.003 -1.851 . . . . 2.83 106.003 -176.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 11.2 mm -104.92 99.49 8.56 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.612 0 N-CA-C 106.743 -1.577 . . . . 1.56 106.743 -171.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 51.2 p90 -139.84 169.44 17.72 Favored 'General case' 0 CA--C 1.512 -0.507 0 C-N-CA 122.629 0.372 . . . . 3.59 110.662 -173.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 52.6 t0 -90.4 109.27 32.6 Favored Pre-proline 0 C--O 1.235 0.33 0 O-C-N 124.435 1.085 . . . . 3.32 109.533 173.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 78.9 Cg_endo -72.41 5.57 2.71 Favored 'Trans proline' 0 N--CA 1.452 -0.95 0 C-N-CA 122.758 2.305 . . . . 0.96 113.698 179.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -83.37 -33.24 25.85 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 119.393 0.997 . . . . 2.28 108.692 165.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -107.44 -60.83 1.64 Allowed 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 123.446 0.698 . . . . 2.68 110.943 -168.386 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.495 0.2 OUTLIER -79.2 -177.1 5.49 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 114.513 1.301 . . . . 1.69 114.513 155.956 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 176.78 -147.91 8.7 Favored Glycine 0 N--CA 1.434 -1.469 0 N-CA-C 103.354 -3.898 . . . . 2.71 103.354 -165.37 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 12.9 p -75.39 -42.68 53.29 Favored 'General case' 0 N--CA 1.443 -0.795 0 C-N-CA 124.711 1.204 . . . . 2.43 108.794 174.32 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -46.67 -63.83 0.92 Allowed 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 114.125 1.157 . . . . 1.88 114.125 -165.026 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.82 -34.57 71.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 122.34 1.067 . . . . 1.64 108.98 -165.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.5 mp -53.78 -58.55 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.122 0 CA-C-N 114.143 -1.389 . . . . 2.45 109.534 170.045 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.94 -45.4 92.73 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 123.038 0.535 . . . . 1.6 109.957 -173.395 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -43.8 -58.48 2.7 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.236 1.014 . . . . 3.89 110.872 172.518 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -67.3 -44.69 78.61 Favored 'General case' 0 N--CA 1.442 -0.845 0 O-C-N 121.937 -0.477 . . . . 4.89 111.809 -178.814 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -48.46 -53.03 7.23 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 C-N-CA 125.799 1.64 . . . . 1.72 107.89 -179.324 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 41.0 mm-40 -60.56 -58.19 9.52 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 124.549 1.14 . . . . 2.0 110.339 176.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 5.9 mmmt -53.66 -37.28 63.01 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 113.25 0.833 . . . . 5.38 113.25 -177.256 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 12.1 mt -68.93 -17.74 64.0 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.275 1.03 . . . . 2.19 111.985 177.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 92.62 49.61 2.71 Favored Glycine 0 CA--C 1.523 0.534 0 N-CA-C 109.932 -1.267 . . . . 0.65 109.932 178.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -147.06 170.27 17.5 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 124.135 0.974 . . . . 3.1 109.799 -175.405 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 12.9 t-80 -140.78 123.72 16.37 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 108.249 -1.019 . . . . 3.13 108.249 174.244 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 7.5 p -92.7 144.57 9.07 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.146 0 N-CA-C 107.027 -1.471 . . . . 2.38 107.027 170.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 44.7 t -123.04 139.98 48.14 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.182 0 N-CA-C 107.952 -1.129 . . . . 2.23 107.952 178.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 5.2 mp . . . . . 0 N--CA 1.451 -0.401 0 N-CA-C 107.749 -1.204 . . . . 2.86 107.749 -173.803 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.5 m . . . . . 0 N--CA 1.448 -0.541 0 N-CA-C 110.739 -0.097 . . . . 1.36 110.739 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -63.31 175.15 1.03 Allowed 'General case' 0 CA--C 1.531 0.245 0 CA-C-O 121.494 0.664 . . . . 3.1 111.543 165.815 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.2 mm100 -137.97 143.79 40.85 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 125.215 1.406 . . . . 1.05 107.968 165.315 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 46.2 mttm -141.47 156.06 45.79 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 123.808 0.843 . . . . 4.65 109.428 164.367 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 12.0 mp0 -114.62 86.34 2.42 Favored 'General case' 0 N--CA 1.445 -0.685 0 C-N-CA 127.164 2.186 . . . . 1.65 108.08 -167.138 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.5 mt -83.61 157.99 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 N-CA-C 107.296 -1.372 . . . . 3.23 107.296 -176.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -126.95 136.2 51.94 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 126.183 1.793 . . . . 1.77 107.455 178.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 2.1 mpt? -138.74 169.57 17.56 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 118.337 0.517 . . . . 2.86 110.064 174.069 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -87.59 160.16 18.3 Favored 'General case' 0 N--CA 1.456 -0.133 0 C-N-CA 124.441 1.096 . . . . 3.15 109.001 170.48 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 60.3 t -116.55 152.05 18.31 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 C-N-CA 124.202 1.001 . . . . 2.27 108.384 177.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 58.6 m -149.58 173.48 13.58 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.755 1.222 . . . . 1.81 108.29 172.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 79.79 -37.12 2.09 Favored Glycine 0 CA--C 1.532 1.151 0 O-C-N 121.737 -0.602 . . . . 2.1 112.557 -177.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 3.8 ppp? -47.78 153.64 0.58 Allowed 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.119 1.368 . . . . 4.53 113.855 179.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.2 p -114.26 -71.51 0.74 Allowed 'General case' 0 N--CA 1.457 -0.086 0 C-N-CA 124.804 1.242 . . . . 3.11 108.681 170.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 6.7 p -99.09 148.13 24.35 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 121.835 0.826 . . . . 2.2 111.331 -178.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -77.84 53.44 1.14 Allowed 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.477 0.711 . . . . 2.44 110.493 178.247 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -143.05 -51.09 0.35 Allowed 'General case' 0 C--O 1.231 0.102 0 C-N-CA 123.65 0.78 . . . . 1.68 110.682 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 56.1 m -56.01 -36.2 67.68 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 118.728 0.695 . . . . 1.2 110.15 171.025 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -47.97 -33.35 7.67 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.186 1.394 . . . . 1.66 112.407 172.442 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.37 -53.27 14.68 Favored 'General case' 0 N--CA 1.454 -0.27 0 O-C-N 121.528 -0.733 . . . . 1.57 110.128 172.576 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 6.4 mpt_? -55.3 -50.07 70.51 Favored 'General case' 0 CA--C 1.521 -0.148 0 C-N-CA 122.434 0.294 . . . . 6.86 110.251 -175.172 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.258 2.3 pp -52.86 -50.52 42.87 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 O-C-N 123.183 0.302 . . . . 2.64 110.99 177.578 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -59.08 -39.27 81.62 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 114.029 1.122 . . . . 2.76 114.029 176.221 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -73.95 -38.07 64.35 Favored 'General case' 0 CA--C 1.533 0.305 0 O-C-N 120.82 -1.175 . . . . 3.47 111.974 -178.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -66.04 -41.39 95.19 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 109.858 -1.297 . . . . 0.48 109.858 170.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 8.0 tt -53.56 -50.45 65.51 Favored 'General case' 0 C--N 1.333 -0.133 0 N-CA-C 108.84 -0.8 . . . . 2.9 108.84 174.124 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -50.7 -19.9 1.07 Allowed 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.853 1.261 . . . . 4.31 114.125 178.583 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.67 -9.32 59.62 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 118.897 0.772 . . . . 4.99 112.528 -179.092 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 8.1 ptp -68.78 154.68 94.49 Favored Pre-proline 0 CA--C 1.534 0.337 0 CA-C-N 119.43 1.013 . . . . 4.64 111.474 177.215 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -58.4 137.35 79.95 Favored 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 121.539 1.493 . . . . 0.68 109.388 166.123 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 100.83 -35.51 4.8 Favored Glycine 0 CA--C 1.529 0.95 0 CA-C-O 119.274 -0.737 . . . . 0.59 113.283 175.354 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 54.7 t -89.21 110.39 21.48 Favored 'Isoleucine or valine' 0 C--N 1.34 0.178 0 CA-C-N 118.76 1.28 . . . . 2.04 109.671 178.062 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -81.63 -49.46 10.48 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-O 118.122 -0.942 . . . . 1.78 108.577 -178.856 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -137.36 163.14 31.74 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 119.016 0.826 . . . . 2.16 112.096 173.72 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -157.06 146.92 20.73 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.697 -0.683 . . . . 1.45 112.082 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -156.07 115.04 3.48 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 106.365 -1.717 . . . . 0.65 106.365 -163.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.5 p -81.39 130.89 35.09 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.688 0 N-CA-C 107.911 -1.144 . . . . 1.79 107.911 175.541 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 54.1 t-20 -109.63 55.82 0.63 Allowed 'General case' 0 C--O 1.236 0.359 0 N-CA-C 107.187 -1.412 . . . . 0.8 107.187 178.495 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.16 -18.34 62.5 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 114.157 -1.383 . . . . 2.09 109.86 -172.658 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -43.13 -37.78 2.16 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.09 0.956 . . . . 1.63 112.246 164.105 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 8.9 t -124.23 38.51 4.18 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 122.727 0.411 . . . . 1.68 109.943 173.346 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 50.11 31.85 5.35 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.932 1.693 . . . . 2.61 113.412 174.483 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 90.4 m -121.31 157.29 30.7 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 108.264 -1.013 . . . . 1.63 108.264 -177.005 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 5.4 p -125.52 142.41 42.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 N-CA-C 108.355 -0.98 . . . . 1.66 108.355 172.17 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -127.37 139.84 52.59 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 108.425 -0.954 . . . . 0.39 108.425 -179.515 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 5.5 p -141.29 126.17 17.92 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 N-CA-C 106.936 -1.505 . . . . 3.05 106.936 -172.472 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 14.8 mm -107.22 91.8 1.88 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.513 0 C-N-CA 126.092 1.757 . . . . 1.56 107.07 -167.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 43.6 p90 -135.38 165.53 25.26 Favored 'General case' 0 CA--C 1.51 -0.583 0 O-C-N 121.975 -0.453 . . . . 3.44 112.037 -166.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 59.7 t0 -86.55 109.92 27.67 Favored Pre-proline 0 C--O 1.235 0.321 0 O-C-N 124.574 1.172 . . . . 3.05 109.821 176.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -71.23 1.93 4.89 Favored 'Trans proline' 0 N--CA 1.453 -0.892 0 C-N-CA 123.029 2.486 . . . . 0.62 113.44 -178.401 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -88.78 -27.17 21.31 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 119.428 1.013 . . . . 1.98 109.471 168.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -101.71 -53.33 2.99 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 123.492 0.717 . . . . 2.75 109.13 -170.122 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.265 1.0 OUTLIER -101.66 -176.44 3.14 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 125.256 1.422 . . . . 1.51 111.998 163.431 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 146.95 91.09 0.1 OUTLIER Glycine 0 N--CA 1.442 -0.931 0 N-CA-C 103.629 -3.789 . . . . 2.32 103.629 -155.406 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 77.0 p -13.95 -15.06 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.546 1 C-N-CA 137.737 6.415 . . . . 2.46 120.32 -145.848 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -25.49 -62.04 0.07 Allowed 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 126.924 2.09 . . . . 1.49 114.503 162.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.07 -43.13 58.82 Favored 'General case' 0 C--N 1.332 -0.176 0 C-N-CA 119.088 -1.045 . . . . 1.74 109.027 -167.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.7 mt -46.92 -60.03 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.706 0 C-N-CA 126.543 1.937 . . . . 2.53 110.893 172.025 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.78 -46.84 81.26 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 119.778 1.172 . . . . 1.14 110.195 179.541 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -51.88 -55.18 21.66 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 121.795 0.807 . . . . 3.39 112.022 179.014 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -69.8 -37.96 76.47 Favored 'General case' 0 N--CA 1.438 -1.028 0 O-C-N 121.419 -0.801 . . . . 3.15 111.471 -178.792 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.7 mm -49.95 -54.28 8.26 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 N-CA-C 107.362 -1.347 . . . . 1.86 107.362 175.369 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 27.0 mm-40 -58.36 -58.23 9.41 Favored 'General case' 0 C--N 1.342 0.259 0 C-N-CA 124.745 1.218 . . . . 2.2 110.387 178.345 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 7.8 mptt -54.48 -39.84 67.9 Favored 'General case' 0 CA--C 1.534 0.334 0 O-C-N 121.877 -0.514 . . . . 5.46 112.153 -177.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 44.2 mt -70.63 -17.08 62.88 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.232 1.013 . . . . 1.99 112.114 178.1 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 94.46 33.84 6.62 Favored Glycine 0 CA--C 1.524 0.641 0 C-N-CA 124.303 0.954 . . . . 0.47 111.617 173.378 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -124.19 169.94 11.23 Favored 'General case' 0 N--CA 1.457 -0.123 0 C-N-CA 124.793 1.237 . . . . 3.19 109.277 177.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -135.16 120.33 18.86 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 107.794 -1.187 . . . . 2.93 107.794 172.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 7.6 p -89.55 145.1 7.81 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 N-CA-C 107.597 -1.261 . . . . 2.44 107.597 172.168 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 48.8 t -121.21 141.16 42.89 Favored 'Isoleucine or valine' 0 C--O 1.232 0.136 0 C-N-CA 123.884 0.874 . . . . 2.09 108.93 178.042 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 29.8 mm . . . . . 0 N--CA 1.455 -0.182 0 C-N-CA 124.684 1.194 . . . . 2.09 109.479 -168.878 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 5.5 m . . . . . 0 N--CA 1.455 -0.181 0 N-CA-C 106.708 -1.59 . . . . 1.89 106.708 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -63.55 169.4 3.9 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 107.998 -1.112 . . . . 2.89 107.998 161.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -129.28 153.71 47.55 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 108.657 -0.868 . . . . 1.59 108.657 171.531 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -139.76 153.26 47.12 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 123.423 0.689 . . . . 4.01 110.048 168.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -107.69 90.87 3.43 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 127.633 2.373 . . . . 1.63 107.731 -176.4 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 3.4 mm -83.65 159.45 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.179 0 N-CA-C 106.787 -1.56 . . . . 2.83 106.787 -178.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -134.14 131.72 39.01 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 124.641 1.176 . . . . 1.75 108.385 178.441 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 3.7 mpp? -137.47 167.3 21.92 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.377 0.671 . . . . 2.93 110.008 174.45 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 21.4 mm100 -88.01 160.16 17.98 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.14 0.976 . . . . 2.58 109.452 174.652 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 81.4 t -115.01 144.2 23.08 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 C-N-CA 124.053 0.941 . . . . 2.71 109.971 -179.291 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 9.1 m -147.21 175.15 10.97 Favored 'General case' 0 C--N 1.341 0.228 0 C-N-CA 125.523 1.529 . . . . 1.77 108.604 171.409 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 55.68 52.47 48.13 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 110.788 -0.925 . . . . 1.87 110.788 175.695 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -125.51 149.5 48.24 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 124.559 1.144 . . . . 3.74 109.424 -170.886 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -87.85 -58.54 2.53 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 124.039 0.936 . . . . 4.81 109.966 170.379 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 17.7 p -154.68 170.55 21.28 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-O 121.777 0.798 . . . . 2.58 111.279 175.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.35 -34.4 68.77 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 124.409 1.084 . . . . 2.93 111.893 178.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.76 -49.82 73.5 Favored 'General case' 0 N--CA 1.453 -0.292 0 O-C-N 121.992 -0.443 . . . . 1.77 109.898 178.587 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 77.5 m -61.49 -38.92 89.04 Favored 'General case' 0 N--CA 1.456 -0.153 0 O-C-N 121.619 -0.675 . . . . 1.3 110.422 174.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.83 -23.13 41.7 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 112.105 0.409 . . . . 1.52 112.105 173.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.07 -47.63 61.14 Favored 'General case' 0 N--CA 1.456 -0.165 0 O-C-N 120.039 -1.663 . . . . 1.61 110.116 169.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 2.0 mtp85 -51.45 -43.59 62.13 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 122.92 0.488 . . . . 4.55 110.039 -175.402 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.287 1.9 pt -60.88 -60.35 2.79 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.274 0 CA-C-O 118.371 -0.823 . . . . 1.74 111.196 178.74 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -54.91 -40.54 69.95 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 119.964 1.256 . . . . 2.28 112.002 -179.45 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 14.7 mptt -68.07 -50.2 56.6 Favored 'General case' 0 CA--C 1.537 0.453 0 O-C-N 121.353 -0.842 . . . . 2.97 110.38 -179.08 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -67.39 -23.18 73.4 Favored Glycine 0 CA--C 1.53 1.022 0 O-C-N 121.489 -0.757 . . . . 0.7 112.265 177.241 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -71.01 -47.75 57.03 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 125.375 1.47 . . . . 3.65 108.652 173.106 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.452 ' HZ1' ' CG ' ' A' ' 36' ' ' ASP . 19.9 ttmt -46.5 -39.54 10.96 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 118.959 0.8 . . . . 4.35 111.397 178.831 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.6 mtt180 -67.14 -5.93 15.54 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 114.691 1.367 . . . . 4.53 114.691 -177.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.67 162.32 73.74 Favored Pre-proline 0 CA--C 1.541 0.626 0 CA-C-N 119.367 0.985 . . . . 5.21 111.055 179.304 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -73.68 117.34 5.01 Favored 'Trans proline' 0 N--CA 1.453 -0.898 0 C-N-CA 121.507 1.471 . . . . 1.07 109.191 172.392 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 116.47 -19.39 12.91 Favored Glycine 0 CA--C 1.527 0.794 0 C-N-CA 123.895 0.76 . . . . 1.02 113.789 169.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 86.6 t -89.97 145.96 6.77 Favored 'Isoleucine or valine' 0 C--N 1.339 0.143 0 CA-C-N 118.685 1.243 . . . . 1.97 108.539 167.386 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.2 m -118.38 -36.63 3.49 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 118.441 -0.79 . . . . 2.0 111.256 177.295 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.452 ' CG ' ' HZ1' ' A' ' 29' ' ' LYS . 0.8 OUTLIER -138.83 164.22 30.21 Favored 'General case' 0 C--N 1.343 0.307 0 CA-C-N 119.955 1.252 . . . . 2.09 111.728 168.015 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -159.27 144.98 16.17 Favored 'General case' 0 C--N 1.332 -0.171 0 C-N-CA 123.104 0.562 . . . . 1.63 111.868 -178.264 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -155.49 110.19 2.94 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 107.608 -1.256 . . . . 0.48 107.608 -165.529 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.1 p -82.61 103.97 10.59 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 CA-C-O 121.336 0.588 . . . . 1.87 110.79 178.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 51.6 t-20 -84.34 57.67 4.39 Favored 'General case' 0 CA--C 1.537 0.451 0 O-C-N 120.336 -1.477 . . . . 0.84 110.173 179.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.08 -19.05 64.06 Favored 'General case' 0 N--CA 1.461 0.119 0 CA-C-N 115.593 -0.731 . . . . 2.05 111.24 -176.506 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -44.09 -33.4 1.47 Allowed 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 123.816 0.846 . . . . 1.75 111.872 166.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 6.6 t -129.62 42.08 3.34 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 121.392 0.615 . . . . 1.78 109.866 173.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 39.12 40.97 0.54 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 126.614 1.966 . . . . 2.55 114.01 -178.28 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 83.8 m -120.34 157.23 29.68 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 124.55 1.14 . . . . 1.77 108.568 -178.297 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 1.6 p -125.87 140.26 49.06 Favored 'Isoleucine or valine' 0 C--O 1.232 0.151 0 N-CA-C 108.278 -1.008 . . . . 1.72 108.278 172.527 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -126.69 137.26 53.25 Favored 'General case' 0 C--N 1.344 0.365 0 N-CA-C 108.26 -1.015 . . . . 0.33 108.26 176.306 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 40.7 t -131.31 125.2 56.55 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 N-CA-C 105.426 -2.065 . . . . 3.13 105.426 -177.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 14.7 mm -100.46 88.24 1.47 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.592 0 N-CA-C 106.829 -1.545 . . . . 1.59 106.829 -176.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 13.2 p90 -124.36 167.7 14.02 Favored 'General case' 0 CA--C 1.507 -0.711 0 CA-C-N 115.794 -0.639 . . . . 3.48 111.503 -171.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -99.84 107.48 46.61 Favored Pre-proline 0 N--CA 1.445 -0.677 0 CA-C-N 113.879 -1.51 . . . . 4.38 108.113 -171.091 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -72.44 6.18 2.42 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 122.698 2.265 . . . . 0.84 113.138 -173.109 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -84.28 -25.2 29.5 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 123.478 0.711 . . . . 2.2 109.334 168.401 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 -117.54 -53.64 2.41 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.202 1.001 . . . . 3.02 110.977 -169.636 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.258 0.8 OUTLIER -89.72 -175.77 4.76 Favored 'General case' 0 CA--C 1.517 -0.3 0 C-N-CA 123.766 0.826 . . . . 1.78 113.177 160.343 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 141.34 87.5 0.11 Allowed Glycine 0 N--CA 1.44 -1.092 0 N-CA-C 104.902 -3.279 . . . . 2.53 104.902 -158.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 82.4 p -9.48 -18.52 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.559 1 C-N-CA 138.126 6.571 . . . . 1.96 119.977 -143.238 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -28.18 -65.98 0.08 Allowed 'General case' 0 N--CA 1.44 -0.972 0 C-N-CA 127.6 2.36 . . . . 1.82 113.977 169.639 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -76.81 -25.41 53.25 Favored 'General case' 0 C--N 1.334 -0.106 0 C-N-CA 118.105 -1.438 . . . . 2.01 110.042 -169.113 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -63.5 -53.79 40.77 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.855 0 CA-C-O 118.58 -0.724 . . . . 1.81 109.072 176.554 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.46 -44.44 96.4 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 108.828 -0.805 . . . . 1.6 108.828 -175.547 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -48.13 -58.69 4.15 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-O 121.592 0.711 . . . . 3.8 111.726 172.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 13.3 mmmt -65.44 -37.99 88.53 Favored 'General case' 0 N--CA 1.44 -0.946 0 O-C-N 121.618 -0.676 . . . . 4.6 111.739 -177.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 2.5 mm -51.79 -51.81 25.75 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 C-N-CA 125.634 1.574 . . . . 1.61 108.302 178.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -57.45 -54.49 46.26 Favored 'General case' 0 C--N 1.341 0.218 0 C-N-CA 123.094 0.558 . . . . 2.04 110.243 174.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 5.8 mmtt -53.89 -38.44 64.78 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 112.874 0.694 . . . . 4.95 112.874 -179.306 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 32.5 mt -70.95 -17.92 62.66 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 125.737 1.615 . . . . 1.82 111.632 177.452 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 93.37 35.64 6.19 Favored Glycine 0 CA--C 1.525 0.668 0 C-N-CA 124.658 1.123 . . . . 0.57 111.229 176.119 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -131.96 172.15 12.7 Favored 'General case' 0 N--CA 1.457 -0.123 0 C-N-CA 123.818 0.847 . . . . 3.32 110.923 -178.319 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 3.7 t-80 -148.85 116.38 6.21 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 109.041 -0.725 . . . . 2.99 109.041 170.446 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 25.7 m -81.59 166.35 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 N-CA-C 109.072 -0.714 . . . . 3.9 109.072 176.235 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 12.1 t -124.51 142.51 41.09 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 C-N-CA 124.173 0.989 . . . . 2.07 108.458 178.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 17.9 mm . . . . . 0 N--CA 1.453 -0.303 0 C-N-CA 124.115 0.966 . . . . 2.23 109.061 -174.084 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 39.2 m . . . . . 0 N--CA 1.449 -0.486 0 N-CA-C 103.908 -2.627 . . . . 1.73 103.908 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -80.07 -179.7 7.17 Favored 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 125.113 1.365 . . . . 3.05 108.025 177.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.2 mm100 -138.78 136.52 35.77 Favored 'General case' 0 CA--C 1.514 -0.438 0 O-C-N 120.843 -1.161 . . . . 1.32 108.275 171.548 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.8 mtpt -133.98 151.79 51.6 Favored 'General case' 0 N--CA 1.455 -0.222 0 O-C-N 124.089 0.868 . . . . 3.82 109.958 167.658 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -101.9 93.5 5.32 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 127.968 2.507 . . . . 1.43 107.457 -176.059 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 2.5 mm -84.01 159.91 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.248 0 N-CA-C 106.669 -1.604 . . . . 2.98 106.669 -178.029 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -133.78 130.9 38.67 Favored 'General case' 0 N--CA 1.456 -0.136 0 N-CA-C 108.073 -1.084 . . . . 1.69 108.073 176.153 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 4.0 mpp? -139.15 172.1 13.32 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.256 1.022 . . . . 2.69 110.19 176.609 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.36 162.46 12.94 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 126.188 1.795 . . . . 3.5 109.468 173.368 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.1 m -118.76 151.5 20.95 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 C-N-CA 123.659 0.784 . . . . 3.03 111.35 174.406 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 48.4 m -142.44 165.4 27.51 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 125.495 1.518 . . . . 1.81 109.411 176.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 63.58 67.06 2.21 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 110.686 -0.966 . . . . 2.1 110.686 177.645 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -139.72 157.69 45.35 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 123.928 0.891 . . . . 3.66 110.753 -175.432 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -76.83 -70.15 0.48 Allowed 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 108.178 -1.045 . . . . 4.28 108.178 157.12 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 25.8 p -158.41 -178.91 7.62 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 121.732 0.777 . . . . 2.96 112.05 -166.357 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.65 175.6 0.45 Allowed 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 124.793 1.237 . . . . 3.25 110.086 170.455 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 72.03 -56.21 0.65 Allowed 'General case' 0 CA--C 1.528 0.123 0 C-N-CA 124.875 1.27 . . . . 2.69 110.196 -174.179 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 28.3 m -57.57 -46.27 84.18 Favored 'General case' 0 C--N 1.33 -0.259 0 O-C-N 121.442 -0.786 . . . . 1.45 109.361 171.328 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -52.01 -23.76 5.63 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.107 0.963 . . . . 1.76 112.965 172.227 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -72.22 -49.49 34.79 Favored 'General case' 0 N--CA 1.454 -0.258 0 O-C-N 120.87 -1.144 . . . . 1.66 110.607 171.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 8.1 mmm180 -56.11 -42.74 77.32 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 109.791 -0.448 . . . . 5.93 109.791 -171.588 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 4.1 pt -56.62 -55.99 16.46 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 O-C-N 123.382 0.426 . . . . 1.67 110.676 176.351 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -55.45 -43.15 75.18 Favored 'General case' 0 C--O 1.226 -0.163 0 C-N-CA 123.825 0.85 . . . . 3.54 111.75 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 4.0 mptp? -72.0 -42.82 65.97 Favored 'General case' 0 CA--C 1.535 0.366 0 O-C-N 121.168 -0.957 . . . . 2.84 110.537 -174.537 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.93 -39.16 97.7 Favored Glycine 0 CA--C 1.53 0.991 0 N-CA-C 110.525 -1.03 . . . . 0.66 110.525 170.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 6.8 tt -60.51 -36.31 78.05 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.23 1.012 . . . . 3.13 109.703 175.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.5 ttpm? -61.95 -24.02 66.73 Favored 'General case' 0 CA--C 1.53 0.187 0 O-C-N 120.565 -1.335 . . . . 3.94 112.841 172.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 11.3 mmt180 -77.85 -3.81 43.44 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 119.043 0.838 . . . . 4.39 111.524 -179.069 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 70.3 mmm -83.95 147.84 52.35 Favored Pre-proline 0 CA--C 1.535 0.369 0 CA-C-N 118.918 0.781 . . . . 4.1 111.076 -176.632 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -59.25 136.15 70.46 Favored 'Trans proline' 0 N--CA 1.451 -0.986 0 C-N-CA 122.34 2.027 . . . . 0.65 108.961 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 94.66 -23.94 30.24 Favored Glycine 0 CA--C 1.528 0.848 0 CA-C-O 118.919 -0.934 . . . . 0.56 113.084 -178.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 17.0 t -92.35 130.28 41.69 Favored 'Isoleucine or valine' 0 C--N 1.34 0.161 0 CA-C-N 118.6 1.2 . . . . 1.63 109.966 -177.139 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 9.3 m -112.13 -39.51 4.45 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 123.823 0.849 . . . . 2.13 111.142 -171.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -145.27 157.21 44.11 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 118.867 0.758 . . . . 2.8 109.738 175.038 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -152.0 126.7 9.54 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 123.765 0.826 . . . . 1.84 110.375 -170.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -142.36 107.85 5.06 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 125.723 1.609 . . . . 1.03 108.772 -164.45 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.1 p -82.31 88.09 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 N-CA-C 108.734 -0.839 . . . . 2.59 108.734 178.41 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 48.9 t-20 -83.31 56.65 3.63 Favored 'General case' 0 CA--C 1.537 0.462 0 O-C-N 120.6 -1.312 . . . . 0.9 110.108 -177.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -68.27 -20.74 64.81 Favored 'General case' 0 C--O 1.223 -0.332 0 C-N-CA 124.398 1.079 . . . . 2.07 110.541 -179.792 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -45.7 -30.12 1.48 Allowed 'General case' 0 CA--C 1.529 0.154 0 N-CA-C 112.811 0.671 . . . . 1.68 112.811 168.363 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 5.7 t -131.66 32.25 4.16 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 118.019 0.372 . . . . 1.92 110.476 173.087 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 9.1 mp0 50.02 52.79 13.99 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.302 1.041 . . . . 4.12 112.591 179.569 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.3 m -137.69 160.43 39.24 Favored 'General case' 0 N--CA 1.443 -0.797 0 O-C-N 121.286 -0.884 . . . . 2.03 109.144 176.295 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.5 p -129.91 136.64 58.49 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 N-CA-C 107.044 -1.465 . . . . 1.59 107.044 169.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -125.07 129.51 50.4 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 107.559 -1.275 . . . . 0.55 107.559 -178.665 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 3.7 p -132.97 131.14 58.95 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.828 0 N-CA-C 105.1 -2.185 . . . . 3.04 105.1 -176.486 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 2.1 mp -104.2 111.2 32.87 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.762 0 N-CA-C 106.097 -1.816 . . . . 3.44 106.097 178.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 21.4 p90 -143.15 167.58 21.78 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 116.039 -0.528 . . . . 2.84 109.914 -178.047 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -87.78 121.82 70.63 Favored Pre-proline 0 CA--C 1.54 0.58 0 O-C-N 125.047 1.467 . . . . 3.39 111.506 171.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_endo -80.76 12.12 2.72 Favored 'Trans proline' 0 CA--C 1.537 0.672 0 C-N-CA 123.536 2.824 . . . . 1.04 114.181 -176.565 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -98.0 -36.23 10.19 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 119.573 1.079 . . . . 2.61 109.578 167.539 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -90.81 -57.22 2.89 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 106.966 -1.494 . . . . 3.23 106.966 -175.09 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.317 6.0 p -95.92 -160.32 0.78 Allowed 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 109.439 -0.578 . . . . 1.66 109.439 162.027 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 116.57 92.31 1.7 Allowed Glycine 0 CA--C 1.528 0.856 0 N-CA-C 106.274 -2.731 . . . . 2.29 106.274 -146.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 80.9 p -12.73 -19.16 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.435 1 C-N-CA 138.007 6.523 . . . . 2.08 119.849 -143.792 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -26.46 -63.39 0.08 Allowed 'General case' 0 N--CA 1.443 -0.787 0 C-N-CA 127.212 2.205 . . . . 2.01 113.647 170.671 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -75.31 -42.63 54.18 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 118.212 -1.395 . . . . 1.82 109.629 -166.116 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -50.29 -53.95 10.22 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.962 0 CA-C-N 113.965 -1.471 . . . . 1.91 110.278 173.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -68.17 -46.08 71.72 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 109.591 -0.522 . . . . 2.24 109.591 -173.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -45.93 -56.93 4.83 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 122.319 1.056 . . . . 3.41 111.344 171.485 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.0 mmpt? -71.52 -38.62 71.08 Favored 'General case' 0 N--CA 1.432 -1.343 0 CA-C-O 118.624 -0.703 . . . . 3.24 112.438 -175.063 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -48.69 -52.82 8.27 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 N-CA-C 106.968 -1.493 . . . . 1.76 106.968 175.494 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 37.9 mm-40 -58.82 -58.48 8.44 Favored 'General case' 0 C--N 1.343 0.32 0 C-N-CA 124.392 1.077 . . . . 2.5 110.413 177.449 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 9.4 mmtm -57.71 -32.66 67.61 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 113.457 0.91 . . . . 4.69 113.457 -176.416 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 11.4 mt -70.23 -18.19 63.15 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.609 1.163 . . . . 1.75 111.701 174.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 90.58 44.65 4.52 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 110.483 -1.047 . . . . 0.54 110.483 179.068 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -137.27 174.96 10.05 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 124.674 1.19 . . . . 3.4 108.549 177.26 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 32.1 t60 -137.54 156.36 48.2 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 109.425 -0.583 . . . . 3.03 109.425 167.137 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 12.8 p -128.09 137.79 56.51 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.113 0 C-N-CA 125.038 1.335 . . . . 2.54 108.03 -177.091 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 13.0 t -110.74 136.14 47.7 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 C-N-CA 124.622 1.169 . . . . 1.85 108.75 -178.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 27.8 mm . . . . . 0 N--CA 1.45 -0.429 0 C-N-CA 124.463 1.105 . . . . 2.0 108.945 -172.24 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.454 -0.26 0 N-CA-C 106.366 -1.716 . . . . 2.05 106.366 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -79.97 -175.43 4.96 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 108.577 -0.897 . . . . 2.32 108.577 173.33 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.4 mm100 -136.53 144.84 44.47 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 107.979 -1.119 . . . . 1.26 107.979 170.566 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 51.7 mttt -143.91 162.18 36.79 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 123.602 0.761 . . . . 3.65 110.706 163.225 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -110.77 87.77 2.61 Favored 'General case' 0 N--CA 1.439 -0.98 0 C-N-CA 129.216 3.006 . . . . 1.69 105.447 -173.316 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 3.4 mp -83.71 162.03 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 N-CA-C 105.771 -1.937 . . . . 3.24 105.771 -179.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -133.72 142.1 47.83 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 125.281 1.432 . . . . 1.41 107.362 179.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -155.73 175.59 13.73 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 109.125 -0.695 . . . . 3.44 109.125 172.082 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 30.0 mm100 -98.55 152.36 19.65 Favored 'General case' 0 C--O 1.223 -0.307 0 C-N-CA 125.477 1.511 . . . . 2.77 108.396 -177.371 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.8 p -111.32 156.43 12.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 CA-C-N 119.166 0.894 . . . . 3.79 110.282 -178.72 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 7.6 m -132.92 168.84 17.71 Favored 'General case' 0 C--N 1.339 0.131 0 C-N-CA 124.474 1.11 . . . . 1.35 109.791 171.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 58.59 52.44 52.96 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 110.8 -0.92 . . . . 1.58 110.8 -179.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -131.44 162.36 30.36 Favored 'General case' 0 CA--C 1.521 -0.158 0 C-N-CA 124.377 1.071 . . . . 3.38 109.881 -176.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -154.57 -58.61 0.11 Allowed 'General case' 0 CA--C 1.528 0.125 0 C-N-CA 125.457 1.503 . . . . 5.0 109.572 168.679 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 9.2 p -81.17 133.19 35.41 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 121.476 0.655 . . . . 2.3 109.932 175.509 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -75.6 55.16 0.82 Allowed 'General case' 0 CA--C 1.535 0.391 0 O-C-N 121.626 -0.671 . . . . 2.93 109.473 170.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -152.07 -57.15 0.14 Allowed 'General case' 0 N--CA 1.457 -0.076 0 C-N-CA 124.071 0.948 . . . . 1.66 110.457 -169.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 67.9 m -60.61 -42.46 96.85 Favored 'General case' 0 C--N 1.333 -0.141 0 O-C-N 121.237 -0.915 . . . . 1.37 109.605 169.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.64 -19.86 6.94 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 113.009 0.744 . . . . 2.1 113.009 170.243 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -73.01 -50.24 24.24 Favored 'General case' 0 N--CA 1.454 -0.228 0 O-C-N 120.299 -1.501 . . . . 1.73 110.687 169.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 3.7 mpt_? -49.78 -45.16 49.44 Favored 'General case' 0 CA--C 1.52 -0.198 0 C-N-CA 122.384 0.274 . . . . 5.42 110.276 -174.441 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.8 pt -57.15 -54.4 30.81 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 O-C-N 123.337 0.398 . . . . 1.68 110.678 -176.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -58.01 -43.79 86.91 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 124.033 0.933 . . . . 2.34 112.027 176.077 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -66.9 -47.02 73.08 Favored 'General case' 0 CA--C 1.534 0.331 0 O-C-N 121.701 -0.624 . . . . 3.02 110.206 -175.444 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.35 -40.47 99.08 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 110.227 -1.149 . . . . 0.62 110.227 173.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -62.29 -37.83 87.03 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 122.115 -0.638 . . . . 3.31 109.823 179.264 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.8 ttpm? -52.28 -18.99 1.79 Allowed 'General case' 0 CA--C 1.532 0.286 0 O-C-N 121.201 -0.937 . . . . 3.99 113.358 173.274 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 2.9 mtt180 -88.41 -0.54 57.3 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 119.051 0.841 . . . . 5.5 112.277 -179.201 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -77.97 158.56 77.46 Favored Pre-proline 0 CA--C 1.531 0.215 0 CA-C-N 119.366 0.984 . . . . 4.34 111.923 172.537 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -56.87 145.58 83.34 Favored 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 122.494 2.129 . . . . 0.93 110.476 170.487 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 82.85 -28.89 3.47 Favored Glycine 0 CA--C 1.53 0.992 0 CA-C-O 119.443 -0.643 . . . . 0.69 113.142 176.079 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 16.0 t -84.87 133.65 28.82 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 CA-C-N 118.953 1.377 . . . . 1.55 109.655 177.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -115.54 -41.19 3.28 Favored 'General case' 0 N--CA 1.457 -0.106 0 C-N-CA 123.746 0.819 . . . . 2.02 110.184 -175.71 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -143.45 163.16 33.89 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 118.844 0.747 . . . . 2.12 109.214 176.026 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -156.14 143.69 19.35 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 122.43 0.292 . . . . 1.79 111.76 178.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -151.59 101.92 2.83 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 106.245 -1.761 . . . . 0.49 106.245 -166.762 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.0 p -81.21 142.83 13.28 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 N-CA-C 108.028 -1.101 . . . . 2.08 108.028 176.518 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 53.4 t-20 -136.63 64.07 1.56 Allowed 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 122.705 1.241 . . . . 1.08 110.115 -171.196 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -70.79 -20.05 62.63 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 115.048 -0.978 . . . . 4.17 111.253 -173.573 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -46.65 -38.14 9.29 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 124.184 0.993 . . . . 1.92 112.202 172.17 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 9.0 t -119.4 29.33 7.69 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.012 0.525 . . . . 1.79 110.371 174.21 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 43.79 59.93 2.9 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 126.049 1.74 . . . . 2.74 112.023 -177.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 90.0 m -146.31 164.02 33.69 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 108.697 -0.853 . . . . 2.05 108.697 178.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -138.65 143.52 32.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 108.334 -0.988 . . . . 1.76 108.334 176.03 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -126.95 137.49 53.13 Favored 'General case' 0 C--N 1.344 0.343 0 N-CA-C 107.787 -1.19 . . . . 0.38 107.787 178.422 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 31.2 t -130.12 130.18 65.75 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 N-CA-C 105.13 -2.174 . . . . 3.36 105.13 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 13.0 mm -101.3 99.15 7.83 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.578 0 N-CA-C 106.959 -1.497 . . . . 1.65 106.959 -177.33 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 54.5 p90 -141.42 168.91 18.65 Favored 'General case' 0 CA--C 1.51 -0.591 0 O-C-N 122.055 -0.403 . . . . 4.06 110.245 -171.311 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 42.0 t0 -86.52 107.87 15.5 Favored Pre-proline 0 C--N 1.327 -0.389 0 O-C-N 124.482 1.114 . . . . 3.13 109.639 174.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -73.48 4.24 4.12 Favored 'Trans proline' 0 N--CA 1.451 -1.013 0 C-N-CA 122.222 1.948 . . . . 1.11 112.68 -179.093 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -82.35 -36.03 27.24 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 119.622 1.101 . . . . 2.19 108.508 166.101 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -103.41 -60.47 1.56 Allowed 'General case' 0 N--CA 1.453 -0.315 0 O-C-N 123.724 0.64 . . . . 4.04 109.694 -167.099 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.459 0.5 OUTLIER -81.54 -172.64 3.95 Favored 'General case' 0 CA--C 1.521 -0.149 0 N-CA-C 113.729 1.011 . . . . 1.57 113.729 156.512 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 159.66 -148.6 17.47 Favored Glycine 0 N--CA 1.434 -1.473 1 N-CA-C 102.492 -4.243 . . . . 2.93 102.492 -157.246 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 33.2 p -78.34 -37.6 44.12 Favored 'General case' 0 N--CA 1.444 -0.772 0 C-N-CA 124.772 1.229 . . . . 2.32 110.104 178.327 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -49.13 -62.54 1.48 Allowed 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.715 1.206 . . . . 1.73 113.403 -163.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.68 -32.25 67.64 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.198 -1.365 . . . . 1.62 108.973 -169.236 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.7 mp -60.04 -55.36 24.63 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.795 0 CA-C-N 114.937 -1.029 . . . . 2.52 109.876 175.253 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.91 -45.82 89.41 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 119.167 0.894 . . . . 1.33 110.1 -178.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -48.76 -56.57 8.25 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 121.449 0.642 . . . . 3.39 111.691 174.146 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 3.5 mmmt -64.92 -42.99 94.24 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-O 118.923 -0.561 . . . . 4.47 112.043 -178.464 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.4 mm -50.39 -52.74 14.46 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.707 0 C-N-CA 125.71 1.604 . . . . 1.72 107.804 -179.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -56.27 -56.56 19.5 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 123.769 0.828 . . . . 2.35 110.661 175.178 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 12.7 mptt -58.76 -34.66 71.67 Favored 'General case' 0 CA--C 1.536 0.436 0 O-C-N 121.716 -0.615 . . . . 5.5 112.435 -175.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 11.8 mt -70.5 -16.63 62.92 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.646 1.178 . . . . 1.89 111.965 175.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 86.0 42.13 6.84 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 110.288 -1.125 . . . . 0.69 110.288 179.178 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -134.95 175.98 9.08 Favored 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 124.315 1.046 . . . . 3.28 109.458 -179.562 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -144.46 157.11 44.4 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 109.2 -0.667 . . . . 3.25 109.2 170.662 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 8.0 p -138.33 137.42 43.89 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.19 0 N-CA-C 107.757 -1.201 . . . . 2.57 107.757 -173.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 29.6 t -103.53 137.51 31.71 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 C-N-CA 125.364 1.466 . . . . 1.71 109.002 -175.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 48.4 mm . . . . . 0 N--CA 1.447 -0.576 0 C-N-CA 124.728 1.211 . . . . 2.39 107.979 -176.386 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.0 m . . . . . 0 N--CA 1.447 -0.624 0 N-CA-C 108.713 -0.847 . . . . 1.39 108.713 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -70.16 168.95 14.58 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 108.241 -1.022 . . . . 2.02 108.241 162.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -129.09 153.56 47.53 Favored 'General case' 0 N--CA 1.457 -0.12 0 C-N-CA 124.548 1.139 . . . . 1.14 109.99 178.281 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 85.5 mttt -146.07 162.7 37.33 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 124.28 1.032 . . . . 4.46 109.992 168.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 8.9 mp0 -121.18 87.93 2.85 Favored 'General case' 0 N--CA 1.441 -0.89 0 C-N-CA 127.979 2.512 . . . . 1.62 106.122 -168.366 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 2.6 mp -83.06 161.66 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.369 0 N-CA-C 105.887 -1.894 . . . . 2.92 105.887 -177.102 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -128.31 135.21 49.3 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 125.944 1.698 . . . . 1.41 106.595 178.283 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 43.1 mtt -140.89 171.98 13.33 Favored 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 109.498 -0.556 . . . . 3.0 109.498 174.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 21.8 mm100 -96.96 139.33 33.14 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 125.701 1.601 . . . . 2.49 108.624 176.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 81.0 t -92.66 153.91 3.25 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 N-CA-C 108.893 -0.78 . . . . 2.52 108.893 175.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 62.9 m -150.77 165.48 33.39 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.074 0.949 . . . . 1.95 109.264 173.177 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 60.32 61.84 6.67 Favored Glycine 0 CA--C 1.528 0.874 0 N-CA-C 110.745 -0.942 . . . . 1.57 110.745 -178.697 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -135.58 156.38 48.96 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 123.834 0.854 . . . . 2.84 110.153 -174.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -105.34 -55.81 2.27 Favored 'General case' 0 CA--C 1.528 0.118 0 C-N-CA 125.199 1.4 . . . . 3.4 109.764 168.051 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 16.9 p -139.67 159.48 42.07 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 121.914 0.864 . . . . 2.52 111.93 -172.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -75.87 39.88 0.18 Allowed 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.963 1.305 . . . . 3.08 111.899 179.43 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -128.67 -53.68 1.24 Allowed 'General case' 0 CA--C 1.524 -0.058 0 C-N-CA 124.599 1.159 . . . . 1.66 108.612 178.647 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 21.0 m -58.72 -38.15 77.72 Favored 'General case' 0 CA--C 1.532 0.274 0 O-C-N 121.556 -0.715 . . . . 1.2 109.714 170.726 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.65 -26.69 34.74 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 116.06 -0.518 . . . . 1.52 112.082 172.551 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.92 -48.95 41.81 Favored 'General case' 0 N--CA 1.455 -0.177 0 O-C-N 120.08 -1.637 . . . . 1.63 109.629 172.368 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 26.9 mmm180 -50.17 -46.02 53.85 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 123.022 0.529 . . . . 6.2 110.543 -175.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.5 pt -59.0 -53.35 49.1 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 C-N-CA 120.245 -0.582 . . . . 1.64 111.066 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -54.42 -44.93 72.83 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 123.296 0.638 . . . . 2.3 111.687 177.16 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 32.1 mmtp -70.55 -44.0 68.35 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 118.839 0.745 . . . . 3.1 110.657 -175.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -58.95 -39.55 94.26 Favored Glycine 0 CA--C 1.528 0.903 0 N-CA-C 110.488 -1.045 . . . . 0.5 110.488 172.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -66.21 -42.8 88.25 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 109.056 -0.72 . . . . 3.55 109.056 179.365 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.6 ttpp -56.96 -14.99 4.06 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.719 1.608 . . . . 3.8 114.128 177.283 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.83 -11.6 56.79 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.93 1.692 . . . . 5.06 111.794 176.74 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 93.3 mmm -71.6 154.72 93.08 Favored Pre-proline 0 CA--C 1.53 0.185 0 CA-C-N 119.03 0.832 . . . . 3.97 111.378 179.263 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -56.21 141.86 87.63 Favored 'Trans proline' 0 N--CA 1.451 -1.008 0 C-N-CA 121.47 1.447 . . . . 0.66 108.596 163.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 88.42 -12.56 64.54 Favored Glycine 0 N--CA 1.448 -0.559 0 CA-C-O 117.932 -1.482 . . . . 0.88 114.463 173.391 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 40.6 t -109.46 125.41 66.6 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 CA-C-N 119.787 1.793 . . . . 1.74 109.061 177.586 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 99.7 m -97.49 -50.66 4.43 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-O 118.205 -0.902 . . . . 2.3 110.067 -176.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -138.71 159.8 41.22 Favored 'General case' 0 C--N 1.342 0.258 0 CA-C-N 119.337 0.971 . . . . 2.11 110.803 176.436 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -156.39 146.39 21.19 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 122.98 0.512 . . . . 1.66 112.066 -178.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -155.94 121.31 4.85 Favored 'General case' 0 C--N 1.342 0.273 0 N-CA-C 109.047 -0.723 . . . . 0.56 109.047 -165.792 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.2 p -92.87 102.27 13.46 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 C-N-CA 123.055 0.542 . . . . 1.76 110.201 -177.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 50.5 t-20 -85.53 57.36 4.42 Favored 'General case' 0 CA--C 1.533 0.323 0 O-C-N 120.518 -1.364 . . . . 0.81 109.462 179.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.31 -19.97 64.71 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 115.495 -0.775 . . . . 2.03 110.468 -175.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -47.42 -33.83 6.48 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.771 0.828 . . . . 1.67 112.132 168.726 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 15.3 t -120.54 28.76 7.8 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 118.148 0.431 . . . . 1.7 111.158 174.48 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 46.86 57.11 5.91 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 124.557 1.143 . . . . 2.8 112.109 -176.505 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 67.2 m -146.59 157.05 43.65 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 108.159 -1.052 . . . . 1.67 108.159 178.442 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.4 p -124.92 144.43 34.95 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 N-CA-C 108.071 -1.085 . . . . 1.58 108.071 172.128 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -125.51 137.52 53.95 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 108.132 -1.062 . . . . 0.32 108.132 175.347 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 4.4 p -135.1 123.67 40.55 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 N-CA-C 106.165 -1.791 . . . . 2.89 106.165 -176.258 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 12.6 mm -101.58 90.02 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 N-CA-C 106.266 -1.753 . . . . 1.59 106.266 -172.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 24.8 p90 -126.55 168.63 14.02 Favored 'General case' 0 CA--C 1.506 -0.742 0 CA-C-O 120.923 0.392 . . . . 3.53 110.149 -169.474 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -98.87 103.31 18.64 Favored Pre-proline 0 N--CA 1.44 -0.941 0 CA-C-N 114.537 -1.211 . . . . 4.38 108.157 -176.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -73.67 12.02 0.97 Allowed 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 122.632 2.222 . . . . 0.64 113.277 -172.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -83.52 -25.26 31.19 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 109.061 -0.718 . . . . 2.16 109.061 165.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -116.77 -58.4 2.08 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 123.81 0.844 . . . . 2.83 109.454 -170.187 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.307 6.6 p -88.22 -171.98 3.6 Favored 'General case' 0 C--N 1.344 0.327 0 CA-C-N 118.181 0.446 . . . . 1.62 110.304 165.522 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 135.7 87.15 0.23 Allowed Glycine 0 N--CA 1.442 -0.936 0 N-CA-C 105.164 -3.174 . . . . 2.34 105.164 -155.151 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 52.2 p -8.22 -17.02 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.378 1 C-N-CA 137.794 6.438 . . . . 2.25 120.248 -142.018 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -28.08 -66.34 0.08 Allowed 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 127.226 2.211 . . . . 2.01 113.59 166.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.48 -36.39 71.14 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 116.978 -1.889 . . . . 1.9 109.415 -166.033 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.5 mp -54.19 -57.39 6.07 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.047 0 CA-C-N 114.325 -1.307 . . . . 2.06 109.178 175.501 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.09 -47.13 86.02 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 119.306 0.957 . . . . 1.27 110.527 -178.032 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -48.89 -55.8 10.66 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 121.902 0.858 . . . . 4.58 111.14 177.059 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -70.42 -37.61 74.44 Favored 'General case' 0 N--CA 1.437 -1.104 0 CA-C-O 118.042 -0.98 . . . . 3.25 111.877 -177.71 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.1 mm -49.69 -52.74 11.85 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 N-CA-C 107.525 -1.287 . . . . 1.64 107.525 178.464 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -57.53 -58.5 8.04 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 123.939 0.896 . . . . 1.81 110.64 175.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -58.97 -32.79 69.98 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 112.955 0.724 . . . . 4.85 112.955 -175.217 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 15.1 mt -70.58 -17.96 62.9 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.667 1.187 . . . . 1.77 111.663 175.425 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 91.97 42.51 4.68 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.676 -0.97 . . . . 0.47 110.676 178.154 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -136.91 173.26 11.89 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 124.239 1.015 . . . . 3.16 109.881 -179.835 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -137.99 128.33 26.21 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 107.773 -1.195 . . . . 2.99 107.773 172.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 4.2 p -104.19 146.69 11.29 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 N-CA-C 107.35 -1.352 . . . . 2.49 107.35 170.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 91.3 t -116.29 146.63 20.46 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 C-N-CA 126.733 2.013 . . . . 1.88 107.022 176.279 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 4.9 mp . . . . . 0 C--N 1.329 -0.321 0 C-N-CA 124.221 1.008 . . . . 2.52 108.786 -174.613 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 57.9 m . . . . . 0 N--CA 1.454 -0.228 0 N-CA-C 106.774 -1.565 . . . . 1.39 106.774 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -75.95 177.27 7.15 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 109.311 -0.626 . . . . 2.16 109.311 171.604 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -138.52 140.75 39.24 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 107.532 -1.284 . . . . 1.02 107.532 174.92 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -138.39 160.97 38.16 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 124.573 1.149 . . . . 4.36 109.74 168.438 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -119.37 95.87 4.97 Favored 'General case' 0 N--CA 1.441 -0.892 0 C-N-CA 128.903 2.881 . . . . 1.45 106.678 -171.734 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 7.0 mm -84.67 161.71 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.128 0 N-CA-C 106.879 -1.526 . . . . 2.9 106.879 178.274 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -137.34 133.05 34.45 Favored 'General case' 0 C--O 1.23 0.076 0 C-N-CA 124.782 1.233 . . . . 1.78 107.782 -179.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 9.3 ptp -157.65 175.75 13.51 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 118.664 0.665 . . . . 3.13 111.0 -178.238 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 28.7 mm100 -93.71 164.22 13.23 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.443 1.497 . . . . 2.46 110.655 -178.016 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 60.5 t -121.02 158.67 23.47 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 C-N-CA 124.964 1.306 . . . . 2.17 109.427 -177.447 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 14.1 m -149.38 166.4 29.16 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 123.918 0.887 . . . . 1.63 110.08 167.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 68.13 47.52 58.67 Favored Glycine 0 CA--C 1.528 0.862 0 N-CA-C 110.522 -1.031 . . . . 1.66 110.522 -171.302 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -125.94 156.93 38.98 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 124.643 1.177 . . . . 2.77 109.589 -178.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER 179.85 -44.08 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 127.871 2.468 . . . . 4.56 110.881 179.43 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 36.6 m -56.89 -22.59 38.43 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.658 0.783 . . . . 3.44 112.704 177.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 57.38 33.32 23.12 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.58 1.152 . . . . 3.45 111.602 178.008 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -159.3 -45.09 0.05 Allowed 'General case' 0 C--O 1.226 -0.179 0 C-N-CA 124.433 1.093 . . . . 1.59 109.736 -175.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 94.4 m -50.31 -38.44 41.57 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.196 0.998 . . . . 1.23 112.278 171.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.11 -23.53 34.89 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 122.935 0.494 . . . . 1.78 112.252 174.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -72.6 -50.1 27.64 Favored 'General case' 0 N--CA 1.457 -0.115 0 O-C-N 120.556 -1.34 . . . . 1.6 111.114 167.022 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 6.6 mmp_? -49.33 -46.42 46.79 Favored 'General case' 0 CA--C 1.52 -0.209 0 N-CA-C 109.691 -0.485 . . . . 8.02 109.691 179.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.272 2.0 pt -59.23 -59.34 3.99 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.442 0 C-N-CA 119.337 -0.945 . . . . 1.74 111.033 178.505 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -51.59 -41.68 61.37 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 119.526 1.057 . . . . 3.27 112.298 -179.135 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.2 mptp? -71.38 -43.64 66.49 Favored 'General case' 0 CA--C 1.538 0.484 0 O-C-N 121.13 -0.981 . . . . 2.63 110.708 -177.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -65.76 -32.11 81.94 Favored Glycine 0 CA--C 1.534 1.239 0 O-C-N 121.456 -0.778 . . . . 0.6 111.65 174.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.0 tt -63.59 -48.29 77.99 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 126.111 1.764 . . . . 3.06 107.914 175.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 12.8 ttmt -47.51 -37.34 11.8 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.039 0.536 . . . . 3.99 112.435 174.324 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -66.17 -0.28 2.41 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 114.043 1.127 . . . . 4.45 114.043 -176.671 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 13.5 ptp -77.29 164.17 60.13 Favored Pre-proline 0 CA--C 1.538 0.49 0 CA-C-N 119.735 1.152 . . . . 5.49 111.788 172.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -69.0 137.56 37.98 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 121.543 1.495 . . . . 0.68 109.756 168.407 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 99.91 -31.53 8.3 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 123.49 0.567 . . . . 0.55 113.187 172.243 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 47.1 t -82.56 140.33 16.53 Favored 'Isoleucine or valine' 0 C--N 1.341 0.205 0 CA-C-N 118.672 1.236 . . . . 1.86 109.289 171.119 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -114.68 -38.05 4.09 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 118.812 -0.613 . . . . 1.78 110.652 178.327 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -143.67 163.23 33.85 Favored 'General case' 0 C--N 1.341 0.238 0 CA-C-N 119.566 1.076 . . . . 1.87 110.281 175.16 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -159.37 134.85 8.44 Favored 'General case' 0 C--O 1.239 0.516 0 C-N-CA 123.386 0.674 . . . . 1.83 112.05 -171.416 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -148.06 111.86 5.09 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 124.213 1.005 . . . . 0.46 109.723 -164.795 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.1 p -84.2 98.18 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 C-N-CA 123.53 0.732 . . . . 1.75 110.403 179.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 49.6 t-20 -84.21 56.59 3.82 Favored 'General case' 0 CA--C 1.537 0.46 0 O-C-N 120.28 -1.512 . . . . 0.8 110.027 179.618 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.99 -17.98 63.31 Favored 'General case' 0 N--CA 1.462 0.128 0 C-N-CA 123.625 0.77 . . . . 1.99 110.849 -178.24 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -44.34 -38.18 3.79 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 123.68 0.792 . . . . 1.7 111.673 166.416 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 6.5 t -124.89 39.12 4.05 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 122.929 0.492 . . . . 1.61 109.725 172.002 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 50.17 32.06 5.65 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.741 1.617 . . . . 2.88 113.804 173.24 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 40.2 m -119.8 163.96 16.7 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.947 1.299 . . . . 1.77 108.43 -177.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.8 p -133.15 145.22 34.38 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 O-C-N 121.038 -1.039 . . . . 1.67 109.136 171.139 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -132.42 129.48 39.35 Favored 'General case' 0 C--N 1.344 0.346 0 C-N-CA 124.743 1.217 . . . . 0.38 108.445 -178.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.7 p -126.53 128.92 71.66 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 N-CA-C 105.524 -2.028 . . . . 3.0 105.524 -174.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 10.9 mm -105.42 100.44 10.58 Favored 'Isoleucine or valine' 0 C--O 1.239 0.527 0 C-N-CA 124.945 1.298 . . . . 1.51 107.898 -173.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 48.0 p90 -141.62 171.05 14.59 Favored 'General case' 0 CA--C 1.512 -0.485 0 O-C-N 121.937 -0.477 . . . . 2.94 111.801 -170.598 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 60.7 t0 -90.62 105.59 12.39 Favored Pre-proline 0 CA--C 1.534 0.362 0 O-C-N 124.742 1.276 . . . . 3.04 110.696 174.597 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -74.88 9.83 1.87 Allowed 'Trans proline' 0 N--CA 1.452 -0.925 0 C-N-CA 122.108 1.872 . . . . 0.76 113.55 179.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -84.15 -27.88 27.81 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 119.238 0.926 . . . . 1.87 108.824 164.051 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -108.43 -58.1 2.04 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 123.344 0.658 . . . . 2.63 109.359 -170.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.422 0.3 OUTLIER -81.72 179.72 7.72 Favored 'General case' 0 CA--C 1.514 -0.416 0 N-CA-C 116.308 1.966 . . . . 1.51 116.308 161.859 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -176.19 -152.35 9.54 Favored Glycine 0 N--CA 1.43 -1.708 1 N-CA-C 102.272 -4.331 . . . . 2.39 102.272 -176.875 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 19.4 p -73.03 -32.4 65.07 Favored 'General case' 0 C--N 1.318 -0.792 0 C-N-CA 124.959 1.304 . . . . 2.31 109.206 178.068 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -42.56 -62.64 0.93 Allowed 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 125.839 1.655 . . . . 1.67 113.671 -172.706 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -75.02 -34.69 61.95 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.042 -0.981 . . . . 1.61 109.165 -169.697 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -56.17 -52.77 47.09 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.89 0 CA-C-O 117.67 -1.157 . . . . 2.2 111.232 175.495 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.41 -46.96 87.95 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 119.864 1.211 . . . . 1.18 109.355 -179.184 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -48.81 -57.3 6.59 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-O 122.105 0.955 . . . . 2.62 111.22 176.449 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.9 mmtp -63.02 -44.54 95.67 Favored 'General case' 0 N--CA 1.435 -1.176 0 CA-C-O 118.659 -0.686 . . . . 3.72 110.77 -179.379 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -47.43 -52.62 5.19 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 C-N-CA 125.208 1.403 . . . . 1.87 108.887 177.559 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -61.67 -55.5 29.81 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 123.762 0.825 . . . . 1.76 110.699 177.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.4 mmmp? -58.07 -31.02 66.67 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 113.366 0.876 . . . . 6.22 113.366 -178.261 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 22.8 mt -73.11 -17.15 61.43 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.583 1.553 . . . . 1.81 112.121 174.426 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 93.17 42.55 4.29 Favored Glycine 0 C--N 1.337 0.631 0 C-N-CA 124.918 1.246 . . . . 0.59 110.693 175.597 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -145.13 177.05 9.07 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 123.348 0.659 . . . . 3.34 111.41 -169.629 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 4.9 t60 -142.25 131.79 23.88 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 107.825 -1.176 . . . . 3.45 107.825 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 8.2 p -107.52 138.87 31.58 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.089 0 N-CA-C 108.018 -1.105 . . . . 2.63 108.018 175.697 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 5.2 t -116.81 140.79 37.8 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.126 0 N-CA-C 108.598 -0.89 . . . . 2.06 108.598 -177.199 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 4.9 mp . . . . . 0 N--CA 1.45 -0.472 0 N-CA-C 108.065 -1.087 . . . . 2.66 108.065 179.433 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 8.1 m . . . . . 0 CA--C 1.533 0.296 0 N-CA-C 109.691 -0.485 . . . . 1.43 109.691 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -64.37 169.97 4.24 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 107.738 -1.208 . . . . 2.05 107.738 162.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -131.48 150.46 52.14 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 108.597 -0.89 . . . . 1.29 108.597 173.428 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 44.4 mtpt -143.45 156.79 44.74 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-O 121.695 0.759 . . . . 3.54 110.61 169.314 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -100.4 112.77 25.15 Favored 'General case' 0 N--CA 1.44 -0.959 0 C-N-CA 128.188 2.595 . . . . 2.38 107.272 -178.301 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 2.3 pp -82.64 164.16 2.87 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.157 0 C-N-CA 119.357 -0.937 . . . . 6.34 108.559 165.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -143.09 113.01 7.07 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 106.16 -1.792 . . . . 1.43 106.16 175.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 59.9 mtt -140.29 170.12 16.4 Favored 'General case' 0 C--N 1.334 -0.096 0 CA-C-N 118.306 0.503 . . . . 4.48 110.165 -172.595 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 28.8 mm100 -96.0 161.03 14.16 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 123.839 0.856 . . . . 2.57 110.173 -176.626 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 44.9 t -120.23 146.2 25.43 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 N-CA-C 108.347 -0.983 . . . . 2.4 108.347 -175.316 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 72.3 m -138.61 163.67 31.46 Favored 'General case' 0 N--CA 1.456 -0.154 0 C-N-CA 124.541 1.136 . . . . 1.9 109.275 171.114 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 56.92 63.58 5.19 Favored Glycine 0 CA--C 1.528 0.85 0 C-N-CA 123.57 0.605 . . . . 1.65 111.668 173.544 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 11.2 ptm -120.47 147.01 45.67 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 124.153 0.981 . . . . 4.29 110.762 -177.053 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -81.98 -68.81 0.67 Allowed 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.513 1.125 . . . . 5.14 108.65 166.259 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 16.3 p -154.45 169.79 22.92 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-O 121.512 0.672 . . . . 2.55 111.119 178.531 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.15 -38.95 66.07 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 124.569 1.148 . . . . 3.25 111.925 179.258 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.31 -46.15 90.89 Favored 'General case' 0 N--CA 1.453 -0.287 0 O-C-N 121.959 -0.463 . . . . 2.06 110.182 -179.491 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 67.3 m -66.87 -43.75 82.75 Favored 'General case' 0 N--CA 1.454 -0.233 0 O-C-N 121.849 -0.532 . . . . 1.6 109.898 175.528 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.0 -18.88 26.95 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 112.856 0.687 . . . . 1.79 112.856 176.113 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.27 -50.44 39.49 Favored 'General case' 0 N--CA 1.449 -0.49 0 O-C-N 119.937 -1.727 . . . . 1.61 109.074 169.058 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -52.73 -45.07 66.83 Favored 'General case' 0 C--N 1.34 0.16 0 CA-C-O 118.462 -0.78 . . . . 7.41 110.426 -177.275 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.268 3.3 pt -55.4 -59.59 2.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 CA-C-O 118.788 -0.625 . . . . 2.05 110.289 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -52.51 -45.23 66.14 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 119.516 1.053 . . . . 2.67 111.923 178.199 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 35.6 mmtm -66.84 -42.62 85.44 Favored 'General case' 0 CA--C 1.537 0.479 0 O-C-N 121.301 -0.874 . . . . 3.0 111.427 -177.346 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -63.1 -28.57 72.36 Favored Glycine 0 CA--C 1.53 1.023 0 N-CA-C 111.165 -0.774 . . . . 0.58 111.165 171.063 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -66.19 -47.63 73.28 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 108.801 -0.814 . . . . 2.61 108.801 175.394 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 24.9 ttmt -52.09 -37.08 52.85 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 122.822 0.449 . . . . 3.75 111.553 174.435 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 13.6 mmt180 -59.62 -11.49 4.99 Favored 'General case' 0 CA--C 1.542 0.669 0 O-C-N 121.097 -1.002 . . . . 4.11 113.477 177.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 4.0 ptm -82.74 152.56 66.52 Favored Pre-proline 0 CA--C 1.535 0.376 0 CA-C-N 120.058 1.299 . . . . 4.07 112.222 178.464 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -62.25 120.7 8.39 Favored 'Trans proline' 0 N--CA 1.452 -0.92 0 C-N-CA 122.283 1.989 . . . . 1.06 109.17 171.683 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 114.25 -24.85 11.09 Favored Glycine 0 CA--C 1.527 0.792 0 CA-C-O 118.336 -1.258 . . . . 1.08 113.451 172.264 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 61.5 t -96.99 118.14 42.86 Favored 'Isoleucine or valine' 0 C--N 1.343 0.317 0 CA-C-N 119.408 1.604 . . . . 2.02 110.876 174.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 39.6 m -95.59 -35.88 11.46 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-O 117.801 -1.095 . . . . 2.41 112.483 -175.1 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -145.23 164.27 31.88 Favored 'General case' 0 C--N 1.344 0.329 0 CA-C-N 120.273 1.397 . . . . 2.05 110.622 164.258 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -158.52 135.17 9.54 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 116.313 -0.403 . . . . 1.91 110.864 -174.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -149.1 110.14 4.35 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 106.115 -1.809 . . . . 0.66 106.115 -161.445 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 10.3 p -89.37 131.79 35.76 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.764 0 N-CA-C 108.384 -0.969 . . . . 1.78 108.384 179.196 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 64.1 t-20 -118.96 71.4 0.85 Allowed 'General case' 0 C--O 1.234 0.273 0 C-N-CA 124.758 1.223 . . . . 1.24 109.083 -178.029 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -67.6 -25.59 65.84 Favored 'General case' 0 C--O 1.226 -0.167 0 CA-C-N 115.146 -0.933 . . . . 4.37 110.22 -178.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -51.42 -34.78 36.31 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-O 118.802 -0.618 . . . . 2.05 111.666 172.254 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.3 t -115.13 22.78 13.05 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 118.278 0.49 . . . . 2.43 111.402 172.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 47.14 44.52 15.48 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.574 1.55 . . . . 3.76 113.743 179.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 51.8 m -139.89 145.64 38.27 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 108.417 -0.957 . . . . 2.09 108.417 -179.704 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 5.2 p -110.73 143.57 20.41 Favored 'Isoleucine or valine' 0 C--O 1.232 0.18 0 C-N-CA 124.404 1.082 . . . . 1.67 109.095 175.5 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 26.9 m120 -127.08 137.74 53.08 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 107.446 -1.316 . . . . 0.65 107.446 178.523 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 59.9 t -131.47 124.25 54.27 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 N-CA-C 105.279 -2.119 . . . . 3.22 105.279 -177.446 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 17.0 mm -102.17 87.51 1.23 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.421 0 C-N-CA 125.498 1.519 . . . . 1.68 106.981 -173.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 6.8 p90 -120.24 171.33 8.57 Favored 'General case' 0 CA--C 1.509 -0.631 0 CA-C-N 116.227 -0.442 . . . . 3.05 110.333 -168.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -101.28 107.71 51.76 Favored Pre-proline 0 N--CA 1.449 -0.512 0 N-CA-C 108.822 -0.807 . . . . 4.61 108.822 -175.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -71.45 7.71 1.42 Allowed 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 123.037 2.492 . . . . 1.12 113.552 -174.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -83.03 -22.62 33.52 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 118.706 0.685 . . . . 2.54 109.312 167.524 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -122.36 -55.82 1.83 Allowed 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.367 1.067 . . . . 3.37 110.642 -169.546 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.278 0.8 OUTLIER -86.41 -171.78 3.72 Favored 'General case' 0 CA--C 1.52 -0.18 0 C-N-CA 123.998 0.919 . . . . 2.05 112.391 161.136 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 134.3 87.02 0.27 Allowed Glycine 0 N--CA 1.443 -0.885 0 N-CA-C 104.265 -3.534 . . . . 2.42 104.265 -153.004 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 68.2 p -14.78 -21.2 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.604 1 C-N-CA 138.119 6.568 . . . . 2.52 119.42 -143.589 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -28.51 -62.6 0.11 Allowed 'General case' 0 N--CA 1.442 -0.859 0 C-N-CA 127.651 2.381 . . . . 2.53 114.13 165.44 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.72 -31.23 61.78 Favored 'General case' 0 C--N 1.332 -0.162 0 C-N-CA 119.06 -1.056 . . . . 2.22 109.64 -168.005 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.4 mp -57.95 -55.0 24.43 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.634 0 C-N-CA 123.688 0.795 . . . . 1.87 109.794 174.506 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.29 -44.09 88.35 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 119.213 0.915 . . . . 1.47 110.027 -178.354 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -52.77 -53.9 41.6 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 122.143 0.973 . . . . 3.08 111.015 176.16 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -65.32 -40.27 93.5 Favored 'General case' 0 N--CA 1.443 -0.816 0 O-C-N 121.171 -0.956 . . . . 3.3 111.725 -179.453 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 5.0 mm -49.34 -52.53 11.14 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 C-N-CA 125.298 1.439 . . . . 1.98 108.548 175.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -56.04 -57.12 13.48 Favored 'General case' 0 C--N 1.342 0.245 0 C-N-CA 123.262 0.625 . . . . 2.23 110.858 175.44 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.47 -38.21 71.37 Favored 'General case' 0 CA--C 1.537 0.46 0 O-C-N 121.844 -0.535 . . . . 5.92 111.895 -176.704 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 37.4 mt -67.23 -17.8 64.97 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.975 1.31 . . . . 2.21 111.57 176.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 92.68 32.93 7.74 Favored Glycine 0 CA--C 1.523 0.564 0 C-N-CA 124.543 1.068 . . . . 0.67 111.065 176.366 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -128.94 174.14 9.78 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 117.932 0.866 . . . . 3.29 110.558 -179.121 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 2.6 t-80 -138.99 128.55 24.52 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 108.126 -1.064 . . . . 2.93 108.126 173.177 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.2 t -104.67 152.29 6.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 C-N-CA 124.766 1.226 . . . . 3.37 107.82 173.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 96.6 t -117.34 144.88 24.06 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 C-N-CA 125.687 1.595 . . . . 1.71 108.657 -179.438 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 34.1 mm . . . . . 0 N--CA 1.453 -0.28 0 C-N-CA 125.162 1.385 . . . . 1.97 109.27 -170.798 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.1 m . . . . . 0 N--CA 1.451 -0.404 0 N-CA-C 107.053 -1.462 . . . . 1.52 107.053 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -69.05 178.06 2.41 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-O 121.332 0.587 . . . . 2.65 109.856 169.463 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -132.14 145.82 51.63 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 106.628 -1.619 . . . . 0.93 106.628 162.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 12.9 mmtp -137.63 159.36 42.18 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 124.351 1.06 . . . . 4.64 109.394 164.491 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -119.05 102.02 8.44 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 126.915 2.086 . . . . 1.61 107.725 -174.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 3.1 mm -83.95 162.92 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 N-CA-C 107.827 -1.175 . . . . 2.91 107.827 177.114 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -136.74 117.74 14.28 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 119.404 1.002 . . . . 1.61 110.116 176.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 57.5 mtm -135.33 176.53 8.59 Favored 'General case' 0 CA--C 1.535 0.385 0 O-C-N 121.481 -0.762 . . . . 2.73 110.388 -174.518 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.61 168.46 9.07 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 125.958 1.703 . . . . 3.66 110.018 173.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.7 m -128.7 153.92 38.89 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 C-N-CA 124.019 0.928 . . . . 3.08 111.571 174.552 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 71.1 m -119.59 175.13 6.0 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 125.391 1.476 . . . . 2.03 110.131 174.601 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 80.45 -44.87 2.97 Favored Glycine 0 CA--C 1.533 1.2 0 C-N-CA 123.717 0.675 . . . . 2.7 113.435 171.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -42.2 141.05 0.99 Allowed 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 125.698 1.599 . . . . 3.23 113.91 -178.154 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -148.58 -45.55 0.15 Allowed 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.788 1.235 . . . . 3.85 113.792 178.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 21.8 p -76.02 -4.85 43.52 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 120.286 1.403 . . . . 3.35 112.434 -179.195 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 60.81 33.28 20.09 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 124.688 1.195 . . . . 3.47 111.826 174.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -143.79 -44.02 0.27 Allowed 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 123.844 0.858 . . . . 1.76 111.136 -179.243 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 11.5 p -51.79 -33.27 34.71 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.53 0.732 . . . . 2.67 112.268 174.345 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -49.96 -34.2 20.07 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.265 1.026 . . . . 1.59 111.855 172.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -69.98 -49.65 49.56 Favored 'General case' 0 N--CA 1.453 -0.305 0 O-C-N 120.331 -1.48 . . . . 1.54 109.887 172.12 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 20.1 mmm180 -52.74 -44.03 66.15 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 119.007 -0.52 . . . . 6.0 110.655 -174.017 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.2 pt -59.75 -54.22 37.55 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 C-N-CA 119.885 -0.726 . . . . 1.63 111.559 178.208 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -55.28 -44.75 75.94 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-N 118.795 0.725 . . . . 2.19 111.753 177.408 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 30.7 mmtp -71.77 -39.9 69.64 Favored 'General case' 0 CA--C 1.53 0.183 0 O-C-N 121.61 -0.681 . . . . 2.78 110.84 -174.613 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.95 -43.61 98.65 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 109.627 -1.389 . . . . 0.74 109.627 170.336 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -59.31 -36.93 76.52 Favored 'General case' 0 CA--C 1.541 0.606 0 O-C-N 121.442 -1.034 . . . . 3.45 109.362 178.655 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.6 ttpp -58.68 -20.06 45.07 Favored 'General case' 0 CA--C 1.537 0.473 0 O-C-N 120.556 -1.34 . . . . 3.14 113.685 174.214 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 22.3 mtt-85 -83.82 -6.22 59.38 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.847 0.859 . . . . 3.8 111.933 177.229 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 21.9 mmt -86.17 154.23 57.32 Favored Pre-proline 0 CA--C 1.531 0.24 0 CA-C-N 118.763 0.71 . . . . 5.64 109.467 -174.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -56.08 148.17 60.36 Favored 'Trans proline' 0 N--CA 1.453 -0.87 0 C-N-CA 121.816 1.678 . . . . 0.73 110.34 176.21 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 84.36 -33.18 3.22 Favored Glycine 0 CA--C 1.524 0.636 0 CA-C-O 119.855 -0.414 . . . . 0.55 113.197 175.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 15.3 t -82.78 137.86 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 CA-C-N 118.206 1.003 . . . . 1.52 109.204 177.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -110.63 -49.89 3.0 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-O 118.255 -0.878 . . . . 2.07 109.661 175.91 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -138.39 160.84 38.49 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 119.173 0.897 . . . . 2.33 109.98 179.331 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -156.61 147.54 21.93 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 122.846 0.458 . . . . 1.86 110.685 -179.473 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -154.07 116.93 4.45 Favored 'General case' 0 C--N 1.34 0.193 0 N-CA-C 108.64 -0.874 . . . . 0.5 108.64 -164.14 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.6 p -93.9 96.65 6.23 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 C-N-CA 123.921 0.888 . . . . 1.73 110.026 -175.103 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 51.1 t-20 -83.35 56.96 3.76 Favored 'General case' 0 CA--C 1.536 0.407 0 O-C-N 120.641 -1.287 . . . . 0.8 110.248 -175.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -70.5 -21.15 62.79 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 115.486 -0.779 . . . . 2.1 110.933 -176.468 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -45.56 -34.67 3.47 Favored 'General case' 0 C--N 1.338 0.096 0 C-N-CA 124.043 0.937 . . . . 1.6 112.194 167.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 8.7 t -131.8 45.43 2.78 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 108.863 -0.791 . . . . 2.26 108.863 172.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 37.47 52.54 1.29 Allowed 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.886 1.674 . . . . 4.02 113.793 175.091 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -134.34 165.97 23.9 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 108.263 -1.014 . . . . 2.54 108.263 173.641 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.7 p -139.18 139.37 39.89 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 N-CA-C 107.352 -1.351 . . . . 1.73 107.352 173.224 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 20.4 m120 -126.85 137.42 53.18 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 107.816 -1.179 . . . . 0.34 107.816 -178.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.1 p -135.0 124.23 42.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 N-CA-C 106.562 -1.644 . . . . 3.0 106.562 -173.488 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 7.5 mm -107.12 96.92 5.03 Favored 'Isoleucine or valine' 0 C--O 1.24 0.56 0 C-N-CA 125.332 1.453 . . . . 1.75 107.871 -168.048 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 46.8 p90 -137.94 165.38 26.66 Favored 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 112.198 0.444 . . . . 2.92 112.198 -170.284 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 26.8 t0 -84.2 110.49 26.64 Favored Pre-proline 0 CA--C 1.535 0.379 0 O-C-N 124.412 1.07 . . . . 3.08 110.551 173.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -72.38 4.4 3.43 Favored 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 123.149 2.566 . . . . 0.68 113.508 -178.345 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -86.12 -29.57 23.21 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 119.46 1.027 . . . . 1.9 109.194 167.542 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -104.87 -57.56 2.01 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 123.578 0.751 . . . . 3.65 109.102 -168.471 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.308 1.3 p -89.76 -173.91 4.1 Favored 'General case' 0 CA--C 1.521 -0.159 0 CA-C-O 121.015 0.436 . . . . 1.63 111.134 158.361 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 136.78 87.77 0.21 Allowed Glycine 0 N--CA 1.442 -0.965 0 N-CA-C 103.71 -3.756 . . . . 2.46 103.71 -152.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 66.6 p -12.35 -17.73 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.49 1 C-N-CA 137.778 6.431 . . . . 2.0 119.863 -144.112 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -26.44 -62.98 0.08 Allowed 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 127.085 2.154 . . . . 1.6 113.834 165.213 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -72.91 -42.09 63.89 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 117.643 -1.623 . . . . 1.66 109.866 -168.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.4 mp -49.71 -57.57 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.816 0 CA-C-N 114.237 -1.347 . . . . 1.93 109.258 175.444 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.17 -45.82 83.34 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 118.586 0.63 . . . . 1.73 110.856 -174.656 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -45.06 -60.07 2.28 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 122.574 1.178 . . . . 3.11 110.374 172.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 4.6 mmpt? -70.18 -38.73 75.44 Favored 'General case' 0 N--CA 1.431 -1.384 0 CA-C-N 115.341 -0.845 . . . . 3.96 112.005 -173.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -48.66 -54.1 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 C-N-CA 124.889 1.276 . . . . 1.59 107.8 175.372 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -60.09 -54.63 43.7 Favored 'General case' 0 C--N 1.34 0.182 0 C-N-CA 123.722 0.809 . . . . 1.68 110.231 176.71 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.9 tmtm? -56.83 -35.38 68.74 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 112.937 0.717 . . . . 4.49 112.937 -176.185 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 12.9 mt -70.59 -18.7 62.89 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 125.705 1.602 . . . . 1.72 111.645 175.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 93.05 44.25 3.88 Favored Glycine 0 CA--C 1.525 0.681 0 C-N-CA 124.642 1.115 . . . . 0.62 110.553 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -139.6 173.99 10.97 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 123.688 0.795 . . . . 3.23 110.663 -177.929 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 18.8 t-160 -148.78 128.12 13.0 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 108.601 -0.889 . . . . 3.4 108.601 175.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 14.5 p -100.28 135.1 37.63 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 C-N-CA 126.259 1.824 . . . . 2.44 108.336 178.621 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 15.8 t -100.32 131.94 46.88 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 C-N-CA 124.272 1.029 . . . . 1.79 109.227 -179.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 27.6 mm . . . . . 0 N--CA 1.451 -0.417 0 C-N-CA 124.508 1.123 . . . . 2.02 108.601 -173.125 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.2 m . . . . . 0 N--CA 1.451 -0.42 0 N-CA-C 105.029 -2.212 . . . . 1.38 105.029 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -78.16 157.02 29.55 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 106.925 -1.509 . . . . 2.32 106.925 167.578 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -111.03 148.37 32.74 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 124.436 1.095 . . . . 1.14 108.106 176.65 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.92 153.66 51.37 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 121.769 0.795 . . . . 5.05 109.075 159.425 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -84.05 144.39 29.11 Favored 'General case' 0 N--CA 1.442 -0.87 0 C-N-CA 126.651 1.981 . . . . 2.04 107.472 168.273 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -125.17 164.16 24.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 107.664 -1.235 . . . . 3.96 107.664 168.027 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -136.22 124.05 22.61 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 106.669 -1.604 . . . . 1.41 106.669 177.34 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 39.3 mtm -139.6 170.37 16.03 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 108.784 -0.821 . . . . 2.94 108.784 -178.328 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 30.8 mm100 -97.68 163.03 13.0 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.288 1.035 . . . . 2.91 109.618 177.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 52.4 t -121.96 149.06 25.23 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 C-N-CA 124.815 1.246 . . . . 2.35 109.138 -173.25 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 17.9 m -155.44 174.3 15.44 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.716 1.206 . . . . 2.02 108.395 169.42 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 64.42 65.6 2.91 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 109.931 -1.268 . . . . 1.91 109.931 -179.017 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 5.5 ppp? -139.54 154.32 47.63 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 123.917 0.887 . . . . 4.46 110.103 -171.442 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.8 p -99.54 -63.89 1.09 Allowed 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 125.945 1.698 . . . . 4.61 108.638 171.225 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 19.9 p -138.0 161.75 35.88 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 124.291 1.036 . . . . 2.26 110.636 -175.416 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -76.48 49.82 0.62 Allowed 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.43 1.092 . . . . 2.4 111.124 179.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -142.31 -49.54 0.37 Allowed 'General case' 0 N--CA 1.457 -0.119 0 C-N-CA 124.878 1.271 . . . . 1.81 109.008 178.368 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 38.3 m -57.8 -36.82 72.73 Favored 'General case' 0 CA--C 1.533 0.298 0 O-C-N 121.365 -0.835 . . . . 1.17 110.059 168.512 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -51.28 -31.8 22.52 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.951 0.901 . . . . 1.63 112.209 170.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -73.58 -53.4 10.59 Favored 'General case' 0 N--CA 1.453 -0.31 0 O-C-N 120.663 -1.273 . . . . 1.78 109.647 170.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 48.9 mmm-85 -47.56 -46.16 27.71 Favored 'General case' 0 C--O 1.23 0.068 0 C-N-CA 123.609 0.764 . . . . 4.56 111.215 -175.054 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 5.4 pt -55.1 -53.13 37.52 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 CA-C-O 119.129 -0.462 . . . . 1.77 111.823 177.686 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -60.23 -42.28 94.88 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 118.819 0.736 . . . . 2.25 111.257 179.599 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.6 mptm? -68.24 -44.23 76.13 Favored 'General case' 0 CA--C 1.528 0.108 0 O-C-N 121.743 -0.598 . . . . 3.7 109.897 -176.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -57.32 -47.82 85.06 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 109.468 -1.453 . . . . 0.79 109.468 171.721 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -58.5 -40.49 82.96 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.702 0.801 . . . . 3.7 110.318 -175.373 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 12.8 ttmt -44.22 -34.75 1.99 Allowed 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 118.608 0.64 . . . . 3.74 112.358 173.709 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 43.7 ttm-85 -67.27 -8.6 33.23 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 113.414 0.894 . . . . 4.57 113.414 -172.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 1.6 mpp? -87.56 158.51 51.29 Favored Pre-proline 0 CA--C 1.537 0.463 0 CA-C-N 119.347 0.976 . . . . 5.06 111.419 178.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -62.99 153.81 71.15 Favored 'Trans proline' 0 N--CA 1.456 -0.694 0 C-N-CA 123.142 2.561 . . . . 1.0 112.077 -176.239 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 74.0 -35.65 0.91 Allowed Glycine 0 CA--C 1.525 0.683 0 C-N-CA 124.761 1.172 . . . . 0.92 112.616 -178.142 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 11.6 t -71.88 130.97 35.2 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 O-C-N 121.074 -1.25 . . . . 1.77 108.655 175.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -118.61 -43.11 2.71 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 118.677 -0.678 . . . . 1.88 109.88 179.844 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -140.73 164.85 29.09 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 119.221 0.919 . . . . 2.02 112.016 168.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -157.69 140.65 15.07 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.139 -0.937 . . . . 1.31 109.185 -171.595 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -153.52 107.11 2.99 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 106.198 -1.778 . . . . 0.49 106.198 -164.839 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 4.2 p -80.23 122.85 36.19 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 N-CA-C 107.232 -1.396 . . . . 1.9 107.232 175.392 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 57.7 t-20 -102.2 56.27 0.8 Allowed 'General case' 0 C--O 1.235 0.311 0 N-CA-C 106.893 -1.521 . . . . 0.78 106.893 178.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.14 -20.95 64.04 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 114.259 -1.337 . . . . 2.43 109.589 -173.146 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -45.52 -37.15 5.09 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 124.118 0.967 . . . . 1.66 112.267 167.015 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 6.3 t -122.75 40.24 3.74 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 121.65 0.738 . . . . 2.06 109.235 173.686 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 39.0 46.61 1.13 Allowed 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 126.888 2.075 . . . . 2.62 113.015 178.718 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 52.3 m -128.03 155.51 44.21 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 125.0 1.32 . . . . 2.19 108.3 -178.439 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.0 p -121.56 142.23 38.69 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 N-CA-C 108.417 -0.957 . . . . 1.71 108.417 168.45 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 21.4 m120 -126.1 139.1 53.65 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 107.28 -1.378 . . . . 0.56 107.28 174.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 20.5 t -132.89 135.84 56.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 N-CA-C 104.941 -2.244 . . . . 3.26 104.941 -178.45 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 15.0 mm -112.05 92.24 2.01 Favored 'Isoleucine or valine' 0 C--O 1.24 0.578 0 N-CA-C 106.758 -1.571 . . . . 1.9 106.758 -179.452 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -127.27 171.89 11.08 Favored 'General case' 0 CA--C 1.509 -0.625 0 CA-C-N 116.596 -0.275 . . . . 3.78 110.492 -176.368 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 -94.38 105.66 19.15 Favored Pre-proline 0 N--CA 1.448 -0.533 0 O-C-N 124.397 1.061 . . . . 3.8 108.615 176.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -69.98 5.75 1.66 Allowed 'Trans proline' 0 CA--C 1.538 0.679 0 C-N-CA 122.323 2.015 . . . . 0.72 113.03 -179.245 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -85.66 -27.94 25.06 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 123.72 0.808 . . . . 1.79 109.43 169.044 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -112.47 -61.43 1.73 Allowed 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.281 1.032 . . . . 2.81 110.05 -173.455 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.486 0.5 OUTLIER -85.12 -169.1 2.49 Favored 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 114.055 1.131 . . . . 1.53 114.055 162.908 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 158.59 -150.13 20.66 Favored Glycine 0 N--CA 1.434 -1.437 0 N-CA-C 103.56 -3.816 . . . . 2.68 103.56 -157.456 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 15.0 p -75.96 -37.38 58.67 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 124.986 1.314 . . . . 2.6 109.687 -179.322 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -54.48 -63.79 1.04 Allowed 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 124.404 1.082 . . . . 1.89 113.191 -164.277 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.77 -35.73 79.2 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 118.483 -1.287 . . . . 1.82 108.87 -167.726 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.7 mp -55.17 -58.57 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.115 0 CA-C-N 114.205 -1.361 . . . . 2.64 109.212 173.52 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.63 -46.58 88.58 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 119.698 1.136 . . . . 1.82 109.363 -175.46 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -48.86 -55.65 11.05 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 121.394 0.616 . . . . 4.07 110.515 177.005 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.0 mmpt? -71.2 -40.68 71.03 Favored 'General case' 0 N--CA 1.435 -1.191 0 CA-C-O 118.333 -0.842 . . . . 3.18 112.907 -177.36 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 3.4 mm -47.93 -52.4 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 C-N-CA 126.387 1.875 . . . . 1.64 107.703 176.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -53.74 -61.09 2.53 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 115.689 -0.687 . . . . 3.52 111.138 173.246 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -62.23 -29.38 70.35 Favored 'General case' 0 CA--C 1.542 0.669 0 O-C-N 121.779 -0.576 . . . . 6.07 112.088 -172.256 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 36.4 mt -71.06 -19.94 62.43 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.778 1.631 . . . . 1.76 111.377 173.043 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 89.56 40.85 5.88 Favored Glycine 0 CA--C 1.525 0.704 0 C-N-CA 124.688 1.137 . . . . 0.56 111.474 176.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -131.6 174.45 10.1 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 124.201 1.0 . . . . 3.14 110.268 178.207 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 10.9 t-160 -151.05 126.26 9.94 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 109.608 -0.515 . . . . 3.7 109.608 167.073 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 20.3 m -82.27 167.7 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 N-CA-C 109.216 -0.661 . . . . 3.56 109.216 176.013 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 15.2 t -130.9 145.52 35.39 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 N-CA-C 107.837 -1.171 . . . . 1.97 107.837 178.723 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 29.4 mm . . . . . 0 CA--C 1.532 0.265 0 C-N-CA 124.356 1.062 . . . . 2.62 109.108 -171.252 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 50.3 m . . . . . 0 N--CA 1.453 -0.308 0 N-CA-C 112.843 0.683 . . . . 1.77 112.843 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -70.54 -177.39 1.49 Allowed 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 121.321 0.582 . . . . 2.11 109.693 174.522 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -134.79 146.02 48.95 Favored 'General case' 0 N--CA 1.447 -0.575 0 N-CA-C 107.258 -1.386 . . . . 1.27 107.258 168.081 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 50.1 mtmt -142.42 162.14 36.25 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 123.271 0.628 . . . . 4.49 109.378 159.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.3 mp0 -121.22 86.38 2.56 Favored 'General case' 0 N--CA 1.442 -0.86 0 C-N-CA 127.904 2.482 . . . . 1.9 106.855 -166.144 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 3.4 mp -82.56 163.06 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.258 0 N-CA-C 106.427 -1.694 . . . . 3.0 106.427 -175.133 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -138.67 134.37 33.57 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 125.469 1.508 . . . . 1.74 108.31 -176.146 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -156.28 174.32 15.57 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 118.346 0.521 . . . . 3.84 110.736 175.344 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 29.0 mm100 -93.57 160.68 14.68 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.931 1.293 . . . . 2.68 109.923 -178.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 21.3 t -119.43 154.87 22.05 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 C-N-CA 124.23 1.012 . . . . 2.19 109.27 -171.117 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 32.1 t -154.47 175.82 13.11 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 118.588 0.631 . . . . 2.54 110.358 170.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 59.09 72.53 0.59 Allowed Glycine 0 CA--C 1.528 0.854 0 N-CA-C 110.252 -1.139 . . . . 2.05 110.252 -174.322 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -144.83 159.96 42.04 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 123.746 0.818 . . . . 3.05 110.567 -172.447 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -100.11 -65.12 0.99 Allowed 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 125.955 1.702 . . . . 4.22 110.246 169.1 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 2.0 p -150.54 164.15 36.69 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 123.32 0.648 . . . . 2.46 110.371 -166.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -72.75 32.86 0.07 Allowed 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.661 1.584 . . . . 2.4 113.751 -172.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -114.9 -47.84 2.86 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 126.314 1.845 . . . . 1.75 108.74 171.616 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 38.0 m -66.0 -38.09 87.58 Favored 'General case' 0 N--CA 1.455 -0.185 0 O-C-N 121.435 -0.791 . . . . 1.25 110.653 -170.296 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.62 -28.75 61.14 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 116.25 -0.432 . . . . 1.94 111.306 173.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.84 -50.25 65.27 Favored 'General case' 0 N--CA 1.455 -0.207 0 O-C-N 120.158 -1.589 . . . . 1.67 109.118 171.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 28.5 mmm180 -53.04 -48.53 67.55 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 118.792 -0.623 . . . . 6.36 110.336 -178.152 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.271 1.8 pt -58.14 -56.34 16.59 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.44 0 C-N-CA 119.304 -0.958 . . . . 1.74 110.765 179.703 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -53.68 -42.03 67.51 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 119.594 1.088 . . . . 2.62 112.582 179.325 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -70.02 -43.67 70.87 Favored 'General case' 0 CA--C 1.535 0.394 0 O-C-N 121.163 -0.961 . . . . 3.16 110.717 -177.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -66.89 -33.19 83.25 Favored Glycine 0 CA--C 1.529 0.964 0 N-CA-C 111.254 -0.738 . . . . 0.65 111.254 175.281 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -66.03 -46.36 78.16 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 125.021 1.328 . . . . 3.46 107.635 178.444 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.427 ' HZ2' ' CG ' ' A' ' 36' ' ' ASP . 14.3 ttmt -49.11 -34.88 14.96 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 118.758 0.708 . . . . 4.37 112.405 176.805 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -59.61 -20.99 59.69 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 113.124 0.787 . . . . 6.62 113.124 179.575 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.52 158.83 84.02 Favored Pre-proline 0 CA--C 1.54 0.573 0 C-N-CA 123.99 0.916 . . . . 5.05 111.93 -174.045 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 78.9 Cg_endo -73.05 115.52 4.38 Favored 'Trans proline' 0 N--CA 1.453 -0.901 0 C-N-CA 121.871 1.714 . . . . 1.04 109.691 175.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 124.38 -36.55 2.88 Favored Glycine 0 CA--C 1.529 0.915 0 C-N-CA 124.343 0.973 . . . . 1.11 112.446 172.57 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 57.8 t -80.17 142.32 14.08 Favored 'Isoleucine or valine' 0 C--N 1.34 0.192 0 CA-C-N 118.01 0.905 . . . . 1.73 109.193 173.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.5 m -115.47 -41.79 3.22 Favored 'General case' 0 C--N 1.338 0.068 0 C-N-CA 123.292 0.637 . . . . 2.78 110.947 -176.034 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.427 ' CG ' ' HZ2' ' A' ' 29' ' ' LYS . 1.0 OUTLIER -136.91 165.83 25.07 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 123.629 0.771 . . . . 2.04 110.329 169.654 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -158.92 142.81 15.25 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 122.73 0.412 . . . . 1.83 111.261 -177.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -154.97 107.5 2.75 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 106.228 -1.767 . . . . 0.48 106.228 -167.497 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 4.2 p -80.02 135.8 24.73 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 N-CA-C 107.613 -1.255 . . . . 1.74 107.613 174.251 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 54.4 t-20 -122.24 55.98 1.12 Allowed 'General case' 0 C--O 1.235 0.294 0 CA-C-O 122.844 1.307 . . . . 1.02 107.895 -179.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.72 -20.21 66.2 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-N 114.169 -1.378 . . . . 2.31 110.515 179.107 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -49.63 -37.2 27.21 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 118.829 -0.605 . . . . 1.79 112.124 167.014 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 13.5 t -114.33 23.57 12.71 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 118.362 0.528 . . . . 1.79 111.206 171.436 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 65.67 20.18 11.52 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.665 1.586 . . . . 2.7 114.353 175.078 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 25.6 m -122.05 164.17 18.15 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.657 1.183 . . . . 1.7 109.797 -173.209 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.7 p -128.5 146.75 33.44 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 O-C-N 120.789 -1.194 . . . . 1.62 109.521 172.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -129.59 136.77 50.19 Favored 'General case' 0 C--N 1.345 0.41 0 N-CA-C 107.814 -1.18 . . . . 0.42 107.814 175.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -130.75 130.07 64.29 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.797 0 N-CA-C 105.245 -2.131 . . . . 3.47 105.245 179.687 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 11.9 mm -103.48 99.33 8.17 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 N-CA-C 106.051 -1.833 . . . . 1.52 106.051 -174.401 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 46.0 p90 -136.05 169.86 16.93 Favored 'General case' 0 CA--C 1.51 -0.564 0 O-C-N 121.976 -0.453 . . . . 2.86 110.98 -170.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 31.1 t0 -90.69 105.49 12.13 Favored Pre-proline 0 C--O 1.234 0.246 0 O-C-N 124.491 1.119 . . . . 3.02 109.208 175.072 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -75.32 8.31 2.59 Favored 'Trans proline' 0 N--CA 1.45 -1.054 0 C-N-CA 122.396 2.064 . . . . 0.76 112.353 -177.59 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -87.94 -28.38 21.53 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 119.328 0.967 . . . . 2.22 108.928 167.133 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -102.61 -59.11 1.76 Allowed 'General case' 0 C--N 1.344 0.326 0 N-CA-C 108.872 -0.788 . . . . 2.42 108.872 -176.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.334 0.7 OUTLIER -86.46 -172.75 4.19 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 125.345 1.458 . . . . 1.72 114.1 166.759 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 167.99 -143.19 7.99 Favored Glycine 0 N--CA 1.43 -1.706 1 N-CA-C 101.819 -4.512 . . . . 2.63 101.819 -164.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 36.5 p -77.35 -34.77 55.1 Favored 'General case' 0 N--CA 1.442 -0.851 0 C-N-CA 125.918 1.687 . . . . 2.44 109.494 176.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -48.8 -62.92 1.26 Allowed 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 125.166 1.386 . . . . 1.52 113.247 -161.262 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -75.31 -30.11 60.24 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 114.936 -1.029 . . . . 1.87 109.795 -173.425 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 4.6 mt -57.76 -57.42 10.47 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.739 0 CA-C-O 118.405 -0.807 . . . . 2.9 110.609 177.043 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.25 -43.82 92.4 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 119.079 0.854 . . . . 1.19 108.73 -176.844 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -50.66 -56.5 11.6 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 123.481 0.712 . . . . 3.12 110.459 178.524 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -66.03 -43.05 88.75 Favored 'General case' 0 N--CA 1.438 -1.072 0 CA-C-O 118.42 -0.8 . . . . 2.98 111.879 -179.836 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 3.3 mm -47.98 -51.71 8.35 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 125.781 1.633 . . . . 1.91 108.78 176.483 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 38.9 mm-40 -56.13 -58.6 7.25 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.577 0.751 . . . . 1.53 110.598 174.648 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.09 -36.34 72.71 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 121.412 -0.805 . . . . 5.97 112.466 -176.586 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 37.9 mt -68.35 -17.62 64.29 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 125.154 1.382 . . . . 1.83 111.02 177.106 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 91.68 38.15 5.91 Favored Glycine 0 C--N 1.338 0.65 0 C-N-CA 124.334 0.969 . . . . 0.52 110.984 174.224 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -133.44 174.81 10.01 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 123.593 0.757 . . . . 3.28 110.702 -177.877 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -140.12 167.81 21.26 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 108.706 -0.85 . . . . 2.84 108.706 169.094 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 45.5 t -140.01 145.59 26.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 N-CA-C 105.476 -2.046 . . . . 3.24 105.476 -171.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 5.8 t -120.64 136.9 56.16 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 C-N-CA 124.671 1.188 . . . . 2.08 107.854 -177.422 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 45.7 mm . . . . . 0 N--CA 1.453 -0.298 0 N-CA-C 106.969 -1.493 . . . . 2.58 106.969 -178.67 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 5.2 m . . . . . 0 N--CA 1.451 -0.425 0 N-CA-C 106.995 -1.483 . . . . 1.4 106.995 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -68.25 168.86 11.5 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 107.717 -1.216 . . . . 2.47 107.717 164.607 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -127.42 147.78 50.29 Favored 'General case' 0 CA--C 1.516 -0.33 0 C-N-CA 124.415 1.086 . . . . 0.98 108.359 177.112 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 52.7 mtmt -144.93 159.61 42.64 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 121.839 0.828 . . . . 4.25 111.573 163.572 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -97.34 145.82 25.76 Favored 'General case' 0 N--CA 1.442 -0.873 0 C-N-CA 127.787 2.435 . . . . 1.71 108.16 175.553 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -127.87 158.58 39.49 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 N-CA-C 105.841 -1.911 . . . . 3.47 105.841 173.588 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -136.87 127.96 27.8 Favored 'General case' 0 C--O 1.226 -0.14 0 N-CA-C 107.854 -1.165 . . . . 1.5 107.854 179.46 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 3.5 ptp -156.02 177.51 11.34 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 118.434 0.561 . . . . 3.37 110.781 -172.947 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 27.7 mm100 -97.47 161.79 13.62 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.243 1.417 . . . . 2.52 110.453 -175.628 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 49.6 t -116.0 157.76 16.69 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 C-N-CA 124.951 1.3 . . . . 2.21 109.818 -174.281 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 6.3 m -153.35 169.78 22.26 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.486 0.714 . . . . 1.6 110.615 169.441 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 60.44 59.93 9.43 Favored Glycine 0 CA--C 1.529 0.945 0 N-CA-C 110.016 -1.234 . . . . 1.92 110.016 -174.825 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -144.71 167.69 21.96 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 124.21 1.004 . . . . 2.76 109.982 -174.448 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -143.22 -67.49 0.36 Allowed 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 124.769 1.228 . . . . 3.41 108.982 171.342 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 12.2 p -98.84 150.86 21.45 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-O 121.643 0.735 . . . . 2.34 111.205 -178.493 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -78.18 47.11 0.65 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.616 0.766 . . . . 2.9 110.794 177.358 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -135.29 -53.72 0.79 Allowed 'General case' 0 N--CA 1.457 -0.12 0 C-N-CA 124.305 1.042 . . . . 1.71 109.288 177.952 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 34.7 m -55.78 -38.18 69.56 Favored 'General case' 0 C--N 1.338 0.096 0 O-C-N 121.552 -0.718 . . . . 1.19 109.64 168.166 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.25 -22.88 44.36 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 112.547 0.573 . . . . 1.59 112.547 175.766 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -73.24 -40.76 64.42 Favored 'General case' 0 C--O 1.232 0.135 0 O-C-N 120.684 -1.26 . . . . 1.75 110.727 170.665 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 18.1 mmm180 -56.75 -39.36 73.85 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 123.391 0.676 . . . . 5.59 109.761 -171.429 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.3 pt -60.18 -65.62 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 C-N-CA 119.454 -0.898 . . . . 2.96 111.183 177.38 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -46.95 -45.13 20.54 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-N 119.778 1.172 . . . . 2.47 112.156 177.858 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 11.2 mptt -70.84 -33.34 70.56 Favored 'General case' 0 CA--C 1.538 0.504 0 O-C-N 121.377 -0.827 . . . . 2.86 110.641 -176.725 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -72.03 -29.11 67.33 Favored Glycine 0 CA--C 1.531 1.071 0 O-C-N 121.377 -0.827 . . . . 0.68 112.061 169.715 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.0 mp -69.78 -43.9 71.2 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 118.378 1.089 . . . . 4.1 109.432 175.975 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 61.8 tttm -50.35 -31.74 15.42 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.644 0.777 . . . . 3.51 111.964 174.206 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 52.8 mtt180 -75.8 -4.38 40.31 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 113.651 0.982 . . . . 6.36 113.651 179.484 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 93.0 mmm -93.17 150.47 39.19 Favored Pre-proline 0 C--O 1.232 0.161 0 CA-C-N 119.422 1.01 . . . . 4.12 110.264 -178.116 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -56.95 144.06 90.27 Favored 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 121.869 1.713 . . . . 0.7 109.143 173.99 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 88.69 -32.34 4.57 Favored Glycine 0 CA--C 1.525 0.686 0 CA-C-O 119.419 -0.656 . . . . 0.54 113.343 179.238 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 14.0 t -87.3 136.88 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.176 0 CA-C-N 118.888 1.344 . . . . 1.88 108.438 179.867 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -109.57 -40.9 4.72 Favored 'General case' 0 N--CA 1.456 -0.135 0 CA-C-O 118.305 -0.855 . . . . 1.93 110.663 177.679 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -150.61 164.46 35.99 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 108.336 -0.987 . . . . 1.87 108.336 172.94 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -157.77 145.04 18.29 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 109.256 -0.646 . . . . 1.98 109.256 176.693 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -143.54 115.25 8.18 Favored 'General case' 0 N--CA 1.457 -0.114 0 C-N-CA 124.663 1.185 . . . . 0.8 108.974 -164.296 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.4 p -84.45 116.69 28.58 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.569 0 N-CA-C 108.646 -0.872 . . . . 1.85 108.646 173.679 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 53.3 t-20 -101.3 56.85 0.84 Allowed 'General case' 0 C--O 1.235 0.298 0 N-CA-C 107.224 -1.398 . . . . 0.87 107.224 176.647 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.36 -21.58 65.62 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 114.552 -1.203 . . . . 2.13 110.02 -177.003 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -46.32 -35.36 5.28 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 123.687 0.795 . . . . 1.99 112.14 166.653 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 13.3 t -125.37 37.18 4.43 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 122.462 0.305 . . . . 1.94 110.383 171.695 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 50.06 34.69 8.64 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.681 1.592 . . . . 2.62 113.264 172.988 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 87.0 m -126.03 157.47 37.83 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.445 1.098 . . . . 1.98 108.621 -176.595 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 14.9 p -134.12 144.93 34.0 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 O-C-N 121.284 -0.885 . . . . 1.7 109.875 172.239 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 25.9 m120 -128.05 136.22 50.94 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 125.344 1.458 . . . . 0.49 108.305 -179.083 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 20.6 t -129.5 126.11 62.75 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 N-CA-C 105.475 -2.046 . . . . 3.44 105.475 -176.369 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 21.9 mm -105.85 103.01 14.7 Favored 'Isoleucine or valine' 0 C--O 1.239 0.548 0 N-CA-C 108.007 -1.108 . . . . 1.67 108.007 -174.184 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 7.7 p90 -141.62 169.87 16.78 Favored 'General case' 0 CA--C 1.512 -0.504 0 O-C-N 122.218 -0.301 . . . . 3.53 111.364 -170.964 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -89.54 109.57 32.82 Favored Pre-proline 0 N--CA 1.449 -0.517 0 O-C-N 124.299 1.0 . . . . 3.81 109.444 177.021 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -71.14 8.33 1.12 Allowed 'Trans proline' 0 CA--C 1.54 0.777 0 C-N-CA 122.698 2.265 . . . . 0.66 113.068 179.923 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -88.07 -25.15 23.2 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.033 0.933 . . . . 1.96 109.596 168.837 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -115.52 -59.44 2.0 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 124.305 1.042 . . . . 3.36 109.697 -171.062 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.323 3.8 p -91.74 -166.29 1.53 Allowed 'General case' 0 C--N 1.342 0.246 0 N-CA-C 110.35 -0.241 . . . . 1.63 110.35 163.132 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 122.84 87.59 0.85 Allowed Glycine 0 N--CA 1.444 -0.784 0 N-CA-C 104.103 -3.599 . . . . 2.16 104.103 -142.456 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 72.3 p -14.11 -18.99 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.36 1 C-N-CA 138.344 6.657 . . . . 2.37 119.476 -148.022 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -26.39 -62.34 0.08 Allowed 'General case' 0 N--CA 1.443 -0.776 0 C-N-CA 127.124 2.17 . . . . 1.78 113.756 166.391 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.69 -41.1 63.11 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 117.97 -1.492 . . . . 1.66 109.931 -168.654 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.2 mp -52.81 -53.63 20.19 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.807 0 CA-C-N 114.446 -1.252 . . . . 1.94 109.193 176.305 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -66.92 -45.55 77.55 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 122.69 0.396 . . . . 1.65 110.093 -173.765 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -46.06 -57.36 4.52 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 122.57 1.176 . . . . 2.68 110.761 170.185 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 5.0 mmmt -67.66 -39.09 84.58 Favored 'General case' 0 N--CA 1.435 -1.178 0 CA-C-N 115.741 -0.663 . . . . 3.78 112.409 -176.323 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -52.25 -50.38 37.26 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 N-CA-C 107.49 -1.3 . . . . 1.7 107.49 -177.554 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 25.3 mm-40 -57.62 -58.31 8.9 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.033 0.933 . . . . 1.93 110.55 174.044 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 24.9 mmtt -52.94 -37.03 60.6 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 113.287 0.847 . . . . 4.6 113.287 -178.448 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 18.2 mt -70.64 -18.09 62.86 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.52 1.528 . . . . 1.94 111.542 178.232 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 90.32 41.9 5.37 Favored Glycine 0 CA--C 1.525 0.67 0 C-N-CA 124.649 1.119 . . . . 0.5 110.488 179.022 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -138.19 175.46 9.56 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 124.157 0.983 . . . . 3.27 109.249 -176.345 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 15.1 t-160 -141.05 157.57 45.13 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 108.649 -0.871 . . . . 3.43 108.649 171.182 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 9.5 p -135.83 141.35 42.19 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 N-CA-C 106.528 -1.656 . . . . 2.53 106.528 -178.037 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 3.4 t -115.73 130.52 70.24 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 N-CA-C 108.599 -0.889 . . . . 1.62 108.599 -175.145 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 45.5 mm . . . . . 0 C--N 1.327 -0.375 0 C-N-CA 124.114 0.966 . . . . 2.19 108.452 -170.059 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 49.3 m . . . . . 0 CA--C 1.531 0.229 0 CA-C-O 120.88 0.371 . . . . 2.4 111.451 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -62.92 177.23 0.59 Allowed 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 121.266 0.555 . . . . 2.11 110.675 173.637 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -134.69 140.39 45.96 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 108.684 -0.858 . . . . 1.18 108.684 173.959 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -133.16 156.79 46.82 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 124.671 1.188 . . . . 5.0 108.999 164.664 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -105.36 121.32 43.65 Favored 'General case' 0 N--CA 1.434 -1.261 0 N-CA-C 101.683 -3.451 . . . . 1.81 101.683 174.034 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 24.8 mm -101.26 165.17 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.388 0 N-CA-C 106.639 -1.615 . . . . 3.01 106.639 168.013 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -139.02 132.62 30.46 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 107.076 -1.453 . . . . 1.44 107.076 177.581 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -156.95 178.45 10.35 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 118.883 0.765 . . . . 3.03 110.848 174.211 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 25.0 mm100 -91.47 166.33 12.91 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.314 1.445 . . . . 2.37 110.405 -178.68 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -131.64 157.04 43.11 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.136 0 C-N-CA 124.057 0.943 . . . . 3.28 110.723 174.936 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 63.7 m -149.84 166.73 28.62 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 125.5 1.52 . . . . 1.59 109.018 177.352 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 71.66 67.03 1.96 Allowed Glycine 0 CA--C 1.525 0.691 0 N-CA-C 109.211 -1.556 . . . . 1.74 109.211 -177.394 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -147.55 166.66 26.66 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 124.153 0.981 . . . . 3.47 109.522 -174.731 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.3 p -126.22 -61.36 1.22 Allowed 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 124.049 0.939 . . . . 3.21 109.497 168.623 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 30.8 p -109.31 151.61 26.35 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 123.694 0.798 . . . . 2.17 111.297 -176.174 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -76.24 53.25 0.8 Allowed 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.604 0.762 . . . . 2.39 110.201 174.764 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -145.52 -51.96 0.26 Allowed 'General case' 0 C--O 1.23 0.048 0 C-N-CA 123.49 0.716 . . . . 1.79 110.908 -175.844 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 7.5 p -55.41 -38.02 68.39 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 119.129 0.877 . . . . 2.51 109.997 167.764 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -47.84 -31.07 4.59 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.483 1.513 . . . . 1.81 112.899 171.17 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -72.84 -55.25 6.95 Favored 'General case' 0 N--CA 1.454 -0.272 0 O-C-N 121.099 -1.001 . . . . 1.55 109.912 172.454 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 3.5 mpp_? -54.56 -40.4 68.68 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 118.736 -0.649 . . . . 5.46 111.5 -174.892 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 5.4 pt -55.45 -54.45 25.24 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 C-N-CA 119.554 -0.858 . . . . 1.73 110.802 175.535 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -57.69 -39.2 76.62 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 123.639 0.776 . . . . 3.1 111.313 179.496 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 56.5 mmtt -71.43 -45.8 61.73 Favored 'General case' 0 CA--C 1.534 0.339 0 O-C-N 121.484 -0.76 . . . . 3.11 110.201 -175.079 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.77 -39.47 98.01 Favored Glycine 0 CA--C 1.53 0.988 0 N-CA-C 110.376 -1.09 . . . . 0.58 110.376 172.329 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.0 tt -60.01 -36.11 76.51 Favored 'General case' 0 CA--C 1.538 0.516 0 O-C-N 121.744 -0.857 . . . . 3.16 110.279 174.818 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -60.79 -27.99 68.41 Favored 'General case' 0 N--CA 1.454 -0.242 0 O-C-N 120.876 -1.14 . . . . 4.38 111.999 174.464 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 4.4 mmt85 -72.39 -5.92 39.85 Favored 'General case' 0 CA--C 1.536 0.441 0 O-C-N 121.508 -0.745 . . . . 4.51 112.009 -177.88 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 78.7 mmm -78.23 148.22 74.09 Favored Pre-proline 0 CA--C 1.533 0.32 0 CA-C-N 119.146 0.884 . . . . 4.03 111.05 -179.544 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -56.96 142.62 93.65 Favored 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 122.393 2.062 . . . . 0.67 108.832 176.953 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 86.68 -20.54 23.14 Favored Glycine 0 CA--C 1.532 1.107 0 CA-C-O 118.567 -1.13 . . . . 0.67 113.498 -178.988 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 14.4 t -94.49 123.78 46.73 Favored 'Isoleucine or valine' 0 C--N 1.344 0.334 0 CA-C-N 119.904 1.852 . . . . 1.93 110.414 -178.244 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -103.37 -37.26 7.7 Favored 'General case' 0 CA--C 1.524 -0.054 0 C-N-CA 124.519 1.127 . . . . 2.17 111.21 -171.889 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -149.89 162.37 40.45 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 108.775 -0.824 . . . . 2.13 108.775 174.726 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -155.45 139.28 16.22 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 122.781 0.432 . . . . 1.51 110.203 -177.268 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -155.78 110.19 2.87 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 109.03 -0.73 . . . . 0.51 109.03 -165.56 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.8 p -83.02 106.29 13.64 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.638 0 N-CA-C 109.256 -0.646 . . . . 2.0 109.256 178.785 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 55.3 t-20 -84.59 56.98 4.08 Favored 'General case' 0 CA--C 1.533 0.323 0 O-C-N 120.821 -1.174 . . . . 0.89 108.819 176.188 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.67 -19.98 64.42 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 115.271 -0.877 . . . . 2.28 109.441 -176.86 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -48.37 -38.77 20.18 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.483 0.713 . . . . 1.69 111.952 167.491 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 8.8 t -117.08 36.09 4.37 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 118.029 0.377 . . . . 1.7 110.383 170.764 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 55.42 26.59 9.0 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.476 1.11 . . . . 4.15 113.639 172.565 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 66.0 m -122.52 162.72 21.23 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.884 1.274 . . . . 1.68 108.679 -173.411 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.4 p -126.64 146.21 32.89 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 O-C-N 121.051 -1.03 . . . . 1.79 109.498 170.931 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -131.58 131.02 42.96 Favored 'General case' 0 C--N 1.343 0.295 0 N-CA-C 108.113 -1.069 . . . . 0.34 108.113 177.449 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 4.3 p -132.83 132.03 59.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 106.188 -1.782 . . . . 2.98 106.188 -175.024 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 16.9 mm -109.39 105.53 18.98 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 C-N-CA 125.374 1.47 . . . . 1.63 107.745 -170.841 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 49.1 p90 -146.43 169.26 19.24 Favored 'General case' 0 CA--C 1.516 -0.365 0 O-C-N 122.073 -0.392 . . . . 2.89 111.677 -171.647 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 41.4 t0 -88.28 108.29 21.2 Favored Pre-proline 0 CA--C 1.533 0.305 0 O-C-N 124.484 1.115 . . . . 3.06 110.262 175.731 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -70.89 0.94 5.72 Favored 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 123.036 2.491 . . . . 0.64 113.351 -179.21 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -84.15 -30.68 25.68 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 119.502 1.046 . . . . 1.73 109.144 167.686 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -105.09 -55.76 2.28 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 124.099 0.96 . . . . 2.72 112.007 -167.544 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.263 1.6 p -92.33 -177.63 4.69 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-O 121.496 0.665 . . . . 1.6 110.319 155.681 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 155.42 89.77 0.07 OUTLIER Glycine 0 N--CA 1.443 -0.883 0 N-CA-C 105.937 -2.865 . . . . 2.42 105.937 -165.545 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 82.1 p -7.89 -16.62 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.561 1 C-N-CA 136.279 5.832 . . . . 2.48 119.977 -136.369 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -25.45 -63.23 0.06 Allowed 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 127.756 2.422 . . . . 1.64 114.352 169.827 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.81 -43.0 57.0 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 118.349 -1.341 . . . . 1.82 109.467 -166.316 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -47.9 -56.19 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.099 0 CA-C-N 113.242 -1.799 . . . . 2.08 110.511 171.985 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -67.0 -46.02 75.82 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 118.952 0.796 . . . . 1.71 110.423 -175.047 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -45.19 -57.99 3.56 Favored 'General case' 0 C--N 1.342 0.282 0 CA-C-O 122.59 1.186 . . . . 3.37 110.975 171.954 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.9 mmpt? -71.39 -37.75 71.55 Favored 'General case' 0 N--CA 1.431 -1.399 0 CA-C-O 118.417 -0.801 . . . . 3.2 112.225 -174.864 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -47.61 -52.47 5.92 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 N-CA-C 107.482 -1.303 . . . . 1.62 107.482 175.629 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -59.8 -56.55 20.35 Favored 'General case' 0 C--N 1.343 0.295 0 C-N-CA 123.693 0.797 . . . . 2.03 110.211 175.845 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 2.7 mmmt -60.29 -28.54 68.17 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 114.018 1.118 . . . . 5.3 114.018 -175.683 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 11.8 mt -70.99 -18.24 62.61 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 125.925 1.69 . . . . 1.91 111.373 173.741 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 90.72 45.2 4.32 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 110.217 -1.153 . . . . 0.49 110.217 178.642 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -141.02 173.42 11.5 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 124.039 0.935 . . . . 3.36 110.363 -177.195 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 17.3 t60 -133.64 139.95 46.79 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 109.212 -0.662 . . . . 3.64 109.212 170.596 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 6.1 p -112.61 126.18 69.98 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 N-CA-C 107.558 -1.275 . . . . 2.39 107.558 174.863 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 26.5 t -104.46 138.38 29.38 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.154 0 N-CA-C 108.341 -0.985 . . . . 1.82 108.341 -177.487 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 4.9 mp . . . . . 0 N--CA 1.45 -0.451 0 C-N-CA 124.197 0.999 . . . . 2.52 108.388 -179.196 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.0 m . . . . . 0 C--O 1.232 0.147 0 N-CA-C 107.061 -1.459 . . . . 1.57 107.061 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -80.02 -178.27 6.42 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 123.552 0.741 . . . . 2.1 109.723 179.335 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -136.79 141.82 42.94 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 107.79 -1.189 . . . . 1.08 107.79 168.939 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -139.85 163.93 31.34 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 124.509 1.124 . . . . 4.42 109.673 168.427 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.8 90.59 3.13 Favored 'General case' 0 N--CA 1.441 -0.905 0 C-N-CA 128.504 2.722 . . . . 1.67 106.985 -159.826 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 7.5 mm -83.75 162.22 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.026 0 N-CA-C 107.324 -1.362 . . . . 2.81 107.324 -176.288 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -140.38 134.86 31.46 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 124.704 1.202 . . . . 1.51 108.728 179.742 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -156.28 172.23 18.84 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.361 0.664 . . . . 3.2 110.52 176.929 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -87.27 168.86 12.81 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.997 1.319 . . . . 3.82 110.383 174.898 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 5.9 m -126.33 152.32 33.69 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 C-N-CA 124.856 1.262 . . . . 3.32 111.976 -179.636 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 16.2 m -139.19 146.72 40.88 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 126.031 1.732 . . . . 1.95 107.896 164.298 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 123.75 -30.35 4.9 Favored Glycine 0 CA--C 1.531 1.054 0 C-N-CA 124.93 1.252 . . . . 2.16 111.751 -177.363 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -54.07 137.66 39.47 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 121.389 0.614 . . . . 2.77 112.485 -178.31 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -144.2 -60.37 0.38 Allowed 'General case' 0 C--N 1.333 -0.142 0 C-N-CA 125.484 1.513 . . . . 3.27 107.65 178.228 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 26.2 p -78.55 -5.34 52.45 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.625 1.17 . . . . 3.55 112.983 177.559 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 68.59 -55.84 0.52 Allowed 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 126.128 1.771 . . . . 3.21 112.111 -170.102 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -46.4 -43.78 16.59 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 125.017 1.327 . . . . 2.42 113.402 -173.753 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 29.5 m -57.82 -25.42 60.6 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 112.689 0.626 . . . . 2.2 112.689 -179.061 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.38 -35.05 67.28 Favored 'General case' 0 CA--C 1.537 0.454 0 O-C-N 121.755 -0.591 . . . . 1.84 110.609 172.876 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.97 -46.74 61.82 Favored 'General case' 0 C--O 1.232 0.171 0 O-C-N 120.533 -1.354 . . . . 1.56 109.322 171.799 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 6.5 mmm180 -51.2 -45.22 61.77 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-O 117.697 -1.144 . . . . 7.4 111.914 -177.765 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.312 2.4 pt -60.31 -59.82 3.52 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-O 117.786 -1.102 . . . . 1.96 110.701 -179.033 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -43.37 -47.75 6.9 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 120.264 1.393 . . . . 2.26 112.254 172.747 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -74.94 -17.72 60.51 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 113.429 0.9 . . . . 3.77 113.429 -176.841 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -76.69 -45.23 13.47 Favored Glycine 0 CA--C 1.531 1.033 0 N-CA-C 110.407 -1.077 . . . . 0.81 110.407 161.072 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 26.8 mt -61.18 -39.58 90.7 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 117.69 0.745 . . . . 3.68 109.814 -175.498 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 9.8 tmtt? -50.31 -28.57 8.1 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.006 1.322 . . . . 4.01 112.678 173.519 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 4.3 mtm180 -80.44 -1.64 42.36 Favored 'General case' 0 CA--C 1.535 0.382 0 O-C-N 121.637 -0.664 . . . . 7.89 112.643 -177.748 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 61.1 mmm -98.93 146.86 32.39 Favored Pre-proline 0 CA--C 1.533 0.317 0 CA-C-N 118.876 0.762 . . . . 4.3 110.853 -172.15 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -58.22 137.01 78.36 Favored 'Trans proline' 0 N--CA 1.45 -1.034 0 C-N-CA 122.387 2.058 . . . . 0.62 109.264 -179.622 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 95.77 -35.3 4.39 Favored Glycine 0 CA--C 1.527 0.839 0 CA-C-O 119.382 -0.677 . . . . 0.58 111.969 -175.536 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 9.0 t -85.65 132.19 32.52 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.153 0 CA-C-N 119.27 1.535 . . . . 1.95 109.689 -174.712 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -103.1 -46.53 4.61 Favored 'General case' 0 C--N 1.342 0.255 0 CA-C-N 118.269 0.486 . . . . 3.01 110.526 178.88 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -152.8 174.85 13.54 Favored 'General case' 0 CA--C 1.515 -0.371 0 C-N-CA 124.196 0.998 . . . . 3.46 111.101 166.685 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -157.95 148.48 20.66 Favored 'General case' 0 N--CA 1.441 -0.907 0 C-N-CA 124.109 0.964 . . . . 1.6 109.435 -173.956 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -153.85 117.35 4.63 Favored 'General case' 0 CA--C 1.528 0.119 0 N-CA-C 108.054 -1.091 . . . . 0.56 108.054 -158.772 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.7 p -96.24 96.48 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 C-N-CA 124.289 1.036 . . . . 1.6 110.439 -172.923 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 51.2 t-20 -84.04 57.06 3.98 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 122.628 1.204 . . . . 0.93 109.889 -176.968 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -68.45 -21.77 64.62 Favored 'General case' 0 CA--C 1.527 0.07 0 CA-C-N 115.231 -0.895 . . . . 2.31 110.742 -176.569 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -45.33 -34.74 3.12 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 123.611 0.764 . . . . 1.86 112.045 166.315 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 4.9 t -126.54 39.34 3.95 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 122.56 0.344 . . . . 2.51 110.141 174.329 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 42.5 53.38 4.66 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.285 1.034 . . . . 3.51 112.757 175.04 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 41.8 m -145.81 150.54 36.38 Favored 'General case' 0 N--CA 1.438 -1.065 0 N-CA-C 107.889 -1.152 . . . . 1.63 107.889 177.991 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 8.9 p -122.5 142.34 39.36 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 N-CA-C 108.465 -0.939 . . . . 1.94 108.465 171.159 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -125.3 141.98 51.76 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 124.818 1.247 . . . . 0.43 108.173 -179.407 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 35.9 t -135.68 127.31 45.27 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.325 0 N-CA-C 105.981 -1.859 . . . . 3.29 105.981 -178.543 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 21.1 mm -100.38 100.42 10.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 C-N-CA 125.774 1.63 . . . . 1.89 107.764 -175.096 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 17.6 p90 -137.53 166.02 24.88 Favored 'General case' 0 CA--C 1.518 -0.259 0 O-C-N 122.192 -0.317 . . . . 2.95 111.764 -173.597 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -84.34 123.92 74.39 Favored Pre-proline 0 C--O 1.24 0.585 0 C-N-CA 123.813 0.845 . . . . 3.1 108.915 171.494 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -86.94 11.82 3.16 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 123.823 3.015 . . . . 0.89 113.162 -175.155 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -97.19 -46.05 6.29 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 108.448 -0.945 . . . . 2.14 108.448 168.423 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -77.79 -44.98 25.85 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 123.951 0.9 . . . . 3.36 109.129 -178.888 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.262 26.3 p -112.01 -137.29 0.37 Allowed 'General case' 0 CA--C 1.518 -0.254 0 C-N-CA 122.107 0.163 . . . . 1.88 110.667 165.17 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 105.67 128.23 6.09 Favored Glycine 0 N--CA 1.44 -1.098 0 N-CA-C 105.679 -2.968 . . . . 2.05 105.679 -123.938 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 24.0 p -30.56 -30.29 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.463 1 C-N-CA 134.66 5.184 . . . . 2.63 113.76 -177.385 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -29.01 -62.42 0.12 Allowed 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 126.018 1.727 . . . . 2.01 112.733 167.258 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.87 -44.22 50.17 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 117.505 -1.678 . . . . 1.66 109.907 -170.578 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.1 mp -51.64 -50.14 31.87 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.945 0 CA-C-N 112.915 -1.948 . . . . 2.02 110.067 -178.997 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.2 -50.64 67.28 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 107.933 -1.136 . . . . 2.12 107.933 -178.162 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.409 ' OE2' ' NZ ' ' A' ' 66' ' ' LYS . 1.3 tm-20 -44.52 -54.29 6.17 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 122.362 1.077 . . . . 3.0 110.77 178.871 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.1 mmpt? -71.4 -40.33 70.56 Favored 'General case' 0 N--CA 1.434 -1.271 0 CA-C-O 118.154 -0.926 . . . . 3.61 113.016 179.094 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.3 mm -48.27 -50.98 10.82 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.793 0 N-CA-C 107.805 -1.183 . . . . 1.91 107.805 176.664 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 76.1 mm-40 -57.92 -60.73 3.26 Favored 'General case' 0 C--N 1.343 0.283 0 C-N-CA 124.967 1.307 . . . . 2.98 110.284 177.096 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.409 ' NZ ' ' OE2' ' A' ' 62' ' ' GLU . 7.0 mptt -56.37 -35.38 67.63 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 112.577 0.584 . . . . 5.86 112.577 -177.059 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 35.1 mt -70.08 -18.04 63.25 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.348 1.059 . . . . 1.76 111.529 177.909 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 98.04 35.38 5.08 Favored Glycine 0 CA--C 1.525 0.716 0 C-N-CA 124.342 0.973 . . . . 0.72 111.535 174.453 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -127.47 169.34 13.76 Favored 'General case' 0 N--CA 1.457 -0.102 0 C-N-CA 124.378 1.071 . . . . 3.45 108.914 173.727 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 85.9 t60 -137.67 133.66 34.53 Favored 'General case' 0 N--CA 1.453 -0.275 0 N-CA-C 106.187 -1.783 . . . . 3.28 106.187 162.768 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 23.4 m -91.35 144.57 8.91 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.691 0 CA-C-N 119.244 0.929 . . . . 3.64 108.863 172.841 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.5 t -103.06 130.94 52.41 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 N-CA-C 107.75 -1.204 . . . . 2.19 107.75 178.97 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 28.0 mm . . . . . 0 N--CA 1.453 -0.281 0 C-N-CA 124.363 1.065 . . . . 2.05 108.424 -173.196 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.7 m . . . . . 0 N--CA 1.452 -0.37 0 N-CA-C 107.257 -1.386 . . . . 1.25 107.257 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -66.63 178.11 1.39 Allowed 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 123.378 0.671 . . . . 3.46 109.529 172.381 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -135.22 150.84 50.17 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 108.393 -0.966 . . . . 0.97 108.393 173.753 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 26.7 mmtp -139.74 162.1 35.95 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.481 1.113 . . . . 3.51 108.628 163.984 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.3 mp0 -123.02 96.36 4.98 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 127.101 2.16 . . . . 2.39 105.953 -176.937 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 23.9 mm -83.29 164.16 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.16 0 N-CA-C 107.067 -1.457 . . . . 2.96 107.067 178.327 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -138.48 123.53 19.05 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 125.207 1.403 . . . . 1.62 107.585 179.389 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -133.03 166.46 22.36 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 118.85 0.75 . . . . 3.63 109.938 178.246 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -84.5 168.13 15.73 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.557 1.143 . . . . 3.67 109.368 169.194 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 38.4 t -125.05 146.09 31.28 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 C-N-CA 124.567 1.147 . . . . 2.28 109.411 -175.22 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 11.8 m -154.8 171.16 20.05 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.918 0.887 . . . . 2.02 110.418 172.863 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 64.06 70.38 1.08 Allowed Glycine 0 C--N 1.34 0.761 0 N-CA-C 110.5 -1.04 . . . . 1.88 110.5 178.261 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -153.05 156.46 38.79 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 116.922 0.361 . . . . 3.97 111.304 -170.124 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -89.76 -60.89 1.82 Allowed 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 125.226 1.411 . . . . 4.52 109.49 168.255 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 21.6 p -144.09 160.81 40.26 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-O 121.836 0.827 . . . . 2.44 112.895 -167.269 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -74.69 45.47 0.25 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.473 1.509 . . . . 2.56 111.492 175.559 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -137.98 -49.75 0.57 Allowed 'General case' 0 C--N 1.335 -0.057 0 C-N-CA 124.614 1.166 . . . . 1.78 108.637 177.804 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 78.3 m -53.52 -38.86 64.17 Favored 'General case' 0 C--O 1.232 0.132 0 O-C-N 121.593 -0.692 . . . . 1.21 110.76 165.643 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -45.75 -35.03 4.0 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.006 1.322 . . . . 1.9 112.411 170.667 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.61 -54.45 10.4 Favored 'General case' 0 N--CA 1.451 -0.382 0 O-C-N 121.026 -1.046 . . . . 1.6 109.64 174.655 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 43.3 mtm105 -48.85 -50.71 33.35 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 123.539 0.735 . . . . 7.52 110.45 -175.595 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 4.9 pt -54.49 -52.75 37.12 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.164 0 O-C-N 123.761 0.663 . . . . 1.73 109.849 -179.051 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -56.34 -39.86 73.53 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 123.93 0.892 . . . . 2.16 111.431 179.68 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 26.5 mmtt -73.68 -44.89 55.43 Favored 'General case' 0 CA--C 1.531 0.215 0 O-C-N 121.201 -0.937 . . . . 2.9 111.509 -176.259 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -59.34 -42.44 97.41 Favored Glycine 0 CA--C 1.529 0.928 0 N-CA-C 109.988 -1.245 . . . . 0.62 109.988 172.197 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 8.5 tt -58.55 -39.61 80.7 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.571 1.149 . . . . 2.94 110.289 175.668 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -61.52 -30.17 70.46 Favored 'General case' 0 N--CA 1.452 -0.366 0 O-C-N 121.064 -1.023 . . . . 4.33 111.66 174.915 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 16.0 mtt180 -72.13 -8.09 52.71 Favored 'General case' 0 CA--C 1.533 0.295 0 O-C-N 121.495 -0.753 . . . . 4.52 112.638 -178.888 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 69.2 mmm -73.96 150.55 88.17 Favored Pre-proline 0 CA--C 1.533 0.289 0 CA-C-N 119.291 0.951 . . . . 4.19 110.432 179.867 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -56.34 147.31 68.1 Favored 'Trans proline' 0 N--CA 1.451 -1.026 0 C-N-CA 121.595 1.53 . . . . 0.67 108.402 172.573 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 86.15 -22.65 11.62 Favored Glycine 0 CA--C 1.525 0.682 0 C-N-CA 124.143 0.878 . . . . 0.63 113.194 -179.93 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 15.6 t -98.19 127.15 50.94 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 CA-C-N 119.459 1.63 . . . . 1.93 109.903 -175.788 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -113.11 -31.34 6.68 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 123.388 0.675 . . . . 1.85 112.04 -173.37 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -146.67 160.7 41.87 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-N 119.289 0.949 . . . . 2.11 108.931 167.004 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -156.73 138.88 14.58 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 116.832 -0.167 . . . . 1.38 111.307 177.582 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -154.23 113.92 3.8 Favored 'General case' 0 C--N 1.341 0.221 0 N-CA-C 107.381 -1.34 . . . . 0.48 107.381 -160.466 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 6.0 p -93.15 102.11 13.31 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 C-N-CA 123.267 0.627 . . . . 1.9 110.058 -175.501 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 52.0 t-20 -83.04 58.65 4.51 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 122.536 1.16 . . . . 0.81 110.012 -177.415 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.1 -20.01 65.72 Favored 'General case' 0 C--O 1.225 -0.194 0 CA-C-N 114.943 -1.026 . . . . 1.96 110.675 -177.692 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -48.55 -30.13 4.96 Favored 'General case' 0 CA--C 1.528 0.134 0 C-N-CA 123.789 0.835 . . . . 1.55 112.644 170.424 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 4.3 t -129.74 32.67 4.55 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 109.792 -0.448 . . . . 2.04 109.792 172.583 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 29.0 mp0 54.41 40.53 31.86 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.64 1.176 . . . . 4.0 113.086 175.067 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -124.86 163.55 21.96 Favored 'General case' 0 N--CA 1.454 -0.259 0 O-C-N 121.327 -0.858 . . . . 2.07 109.585 176.11 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.7 p -133.56 140.75 46.04 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 N-CA-C 108.795 -0.817 . . . . 1.71 108.795 171.893 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 18.7 m120 -129.46 138.55 51.48 Favored 'General case' 0 C--N 1.344 0.365 0 N-CA-C 108.193 -1.039 . . . . 0.33 108.193 -178.232 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 3.8 p -136.65 128.67 44.05 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 N-CA-C 106.529 -1.656 . . . . 2.83 106.529 -176.11 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 9.8 mm -105.9 96.52 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 C-N-CA 125.918 1.687 . . . . 1.49 107.278 -171.602 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 44.1 p90 -136.96 165.06 26.87 Favored 'General case' 0 CA--C 1.515 -0.375 0 O-C-N 122.18 -0.325 . . . . 2.93 111.596 -170.76 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 45.0 t0 -86.58 108.85 19.72 Favored Pre-proline 0 C--N 1.329 -0.29 0 C-N-CA 125.198 1.399 . . . . 2.91 109.666 176.8 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -71.26 2.03 4.81 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 123.209 2.606 . . . . 0.65 113.4 -177.878 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -90.31 -30.22 17.62 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 119.395 0.998 . . . . 1.89 109.345 169.057 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -101.71 -51.73 3.37 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.359 0.664 . . . . 3.09 110.361 -170.315 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.9 p -99.81 -174.11 2.62 Favored 'General case' 0 C--O 1.225 -0.205 0 C-N-CA 123.872 0.869 . . . . 1.71 110.598 158.096 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 145.16 92.63 0.14 Allowed Glycine 0 N--CA 1.443 -0.899 0 N-CA-C 104.87 -3.292 . . . . 2.43 104.87 -158.228 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 48.8 p -10.24 -18.9 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.577 1 C-N-CA 137.068 6.147 . . . . 2.12 119.829 -139.087 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -26.8 -61.84 0.08 Allowed 'General case' 0 N--CA 1.439 -0.987 0 C-N-CA 127.893 2.477 . . . . 1.74 114.418 170.11 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.14 -44.76 59.62 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 117.991 -1.484 . . . . 1.84 109.259 -168.15 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.2 mt -53.21 -52.76 27.7 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 CA-C-N 112.918 -1.946 . . . . 2.09 110.682 178.462 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.92 -45.6 85.15 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 120.06 1.3 . . . . 1.83 109.2 -177.019 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -47.59 -57.32 5.6 Favored 'General case' 0 C--N 1.343 0.318 0 CA-C-O 123.148 1.451 . . . . 2.84 109.466 177.264 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.4 mmpt? -71.17 -36.04 71.85 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-N 114.768 -1.105 . . . . 3.47 112.979 -175.403 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -50.04 -53.17 11.89 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 N-CA-C 107.405 -1.331 . . . . 1.78 107.405 174.501 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 -60.73 -55.72 29.77 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 115.458 -0.792 . . . . 1.84 110.74 176.04 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -57.13 -34.47 68.41 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 113.484 0.92 . . . . 5.38 113.484 -176.674 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 13.6 mt -71.54 -19.49 62.16 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 125.815 1.646 . . . . 1.8 111.918 174.356 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 95.89 45.37 2.89 Favored Glycine 0 CA--C 1.525 0.678 0 C-N-CA 125.169 1.366 . . . . 0.54 111.378 175.914 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -140.39 173.7 11.24 Favored 'General case' 0 N--CA 1.458 -0.068 0 C-N-CA 124.216 1.006 . . . . 3.39 110.504 -178.061 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -152.44 126.74 9.25 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 109.49 -0.559 . . . . 3.4 109.49 171.946 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 16.1 m -83.89 164.64 2.6 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 C-N-CA 123.623 0.769 . . . . 3.83 109.61 173.932 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 1.9 t -125.6 136.33 61.16 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 O-C-N 121.439 -0.788 . . . . 2.32 108.944 176.434 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 11.2 mm . . . . . 0 N--CA 1.454 -0.267 0 C-N-CA 123.767 0.827 . . . . 2.13 109.329 -171.483 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 21.5 m . . . . . 0 N--CA 1.447 -0.608 0 N-CA-C 106.992 -1.485 . . . . 1.83 106.992 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -91.31 -175.99 4.42 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 108.073 -1.084 . . . . 2.08 108.073 157.831 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.6 mm100 -134.47 146.89 50.19 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 106.628 -1.619 . . . . 1.16 106.628 165.616 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 75.2 mttt -141.75 156.78 45.58 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 123.918 0.887 . . . . 3.86 110.806 161.504 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -111.03 92.02 3.88 Favored 'General case' 0 N--CA 1.44 -0.969 0 C-N-CA 128.156 2.582 . . . . 1.36 107.152 -167.954 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 6.8 mm -83.14 162.01 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.218 0 N-CA-C 106.916 -1.512 . . . . 2.79 106.916 -175.559 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -141.16 116.07 9.78 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 124.409 1.084 . . . . 1.51 108.769 -173.804 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 66.3 mtm -138.18 173.17 11.9 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 118.527 0.603 . . . . 2.64 110.539 -175.122 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.67 168.43 9.69 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 125.934 1.694 . . . . 3.55 108.94 172.598 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 19.6 m -129.04 174.88 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 C-N-CA 123.455 0.702 . . . . 3.04 110.12 172.851 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 57.8 m -151.02 175.14 12.37 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 124.304 1.042 . . . . 1.71 108.328 173.32 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 85.82 -35.01 3.27 Favored Glycine 0 CA--C 1.531 1.09 0 O-C-N 122.019 -0.426 . . . . 2.4 112.573 178.304 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -48.16 141.84 5.88 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.096 0.959 . . . . 2.81 112.877 179.325 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -103.94 -46.19 4.55 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 124.684 1.194 . . . . 2.92 110.09 171.809 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 18.4 p -132.62 161.3 34.26 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 123.752 0.821 . . . . 2.52 110.918 -175.342 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -77.02 56.75 1.27 Allowed 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.104 0.962 . . . . 2.67 110.631 178.293 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -142.52 -57.88 0.44 Allowed 'General case' 0 N--CA 1.456 -0.138 0 C-N-CA 123.854 0.862 . . . . 2.05 109.549 176.322 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 58.9 m -54.08 -43.32 70.24 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 121.011 0.434 . . . . 1.39 111.65 -174.63 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.59 -22.6 13.8 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.232 1.013 . . . . 1.81 112.963 178.069 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.24 -47.64 60.46 Favored 'General case' 0 N--CA 1.452 -0.363 0 O-C-N 121.163 -0.961 . . . . 1.94 110.267 172.163 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 52.7 mtp85 -58.61 -48.57 80.55 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 109.486 -0.561 . . . . 5.14 109.486 -171.107 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 5.4 pt -55.63 -51.48 58.1 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 O-C-N 123.684 0.615 . . . . 1.86 110.005 179.02 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -55.64 -43.86 76.61 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 113.455 0.909 . . . . 4.52 113.455 179.116 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 13.4 mptt -72.69 -40.98 65.8 Favored 'General case' 0 CA--C 1.536 0.425 0 O-C-N 121.505 -0.747 . . . . 3.08 109.643 -175.954 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -57.16 -39.89 90.69 Favored Glycine 0 CA--C 1.532 1.141 0 N-CA-C 111.147 -0.781 . . . . 0.64 111.147 168.727 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.8 tt -65.3 -44.24 88.54 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.401 1.08 . . . . 2.98 109.363 179.136 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.414 ' NZ ' ' OD1' ' A' ' 36' ' ' ASP . 27.0 ttmt -54.5 -39.13 67.26 Favored 'General case' 0 CA--C 1.53 0.178 0 O-C-N 121.258 -0.902 . . . . 4.9 111.075 175.383 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.91 -8.66 7.53 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 114.389 1.255 . . . . 5.65 114.389 -179.589 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 82.6 mmm -81.85 151.98 68.31 Favored Pre-proline 0 CA--C 1.536 0.425 0 CA-C-N 120.089 1.313 . . . . 4.3 111.521 -177.633 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -59.05 150.89 70.18 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 122.427 2.085 . . . . 0.86 110.628 178.985 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 79.31 -25.92 2.67 Favored Glycine 0 CA--C 1.531 1.06 0 C-N-CA 123.702 0.668 . . . . 0.75 112.685 -177.466 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 15.4 t -86.45 141.05 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 CA-C-N 118.901 1.35 . . . . 1.65 108.879 176.102 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -119.76 -43.22 2.58 Favored 'General case' 0 C--N 1.34 0.153 0 CA-C-O 118.716 -0.659 . . . . 2.55 111.243 179.113 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.414 ' OD1' ' NZ ' ' A' ' 29' ' ' LYS . 0.5 OUTLIER -143.33 169.13 18.22 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 118.978 0.808 . . . . 1.89 110.82 176.69 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -159.64 154.18 24.13 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.908 -0.587 . . . . 1.93 111.079 -177.343 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -155.76 94.52 1.57 Allowed 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 125.567 1.547 . . . . 1.0 109.173 -168.393 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.5 p -78.93 93.98 1.67 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 CA-C-O 121.867 0.842 . . . . 2.13 109.355 -177.852 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 44.8 t30 -81.67 58.75 3.88 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 122.212 1.006 . . . . 0.86 109.854 -176.196 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -69.78 -19.99 63.49 Favored 'General case' 0 N--CA 1.457 -0.081 0 C-N-CA 124.462 1.105 . . . . 2.22 111.016 -179.212 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -43.32 -39.78 3.26 Favored 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 124.064 0.946 . . . . 1.64 111.931 169.832 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 9.9 t -128.1 40.3 3.7 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 122.574 0.35 . . . . 2.17 110.291 172.07 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 50.85 51.98 15.9 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.731 1.213 . . . . 3.3 113.741 172.259 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -131.49 161.15 33.22 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 124.588 1.155 . . . . 3.14 109.013 175.529 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.5 p -131.62 134.74 60.15 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 N-CA-C 107.706 -1.22 . . . . 1.58 107.706 167.669 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -123.03 126.79 47.78 Favored 'General case' 0 C--N 1.341 0.233 0 N-CA-C 108.559 -0.904 . . . . 0.59 108.559 177.524 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 46.8 t -126.32 130.96 71.95 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 N-CA-C 105.638 -1.986 . . . . 3.37 105.638 -177.169 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 10.6 mm -105.08 99.72 9.04 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 C-N-CA 125.336 1.455 . . . . 1.83 107.694 -175.548 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 53.2 p90 -139.61 171.31 14.42 Favored 'General case' 0 CA--C 1.515 -0.369 0 C-N-CA 122.719 0.408 . . . . 3.68 111.111 -174.61 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 45.8 t0 -89.23 107.08 15.81 Favored Pre-proline 0 C--O 1.234 0.255 0 CA-C-O 118.35 -0.833 . . . . 3.22 109.278 176.683 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -71.78 4.92 2.77 Favored 'Trans proline' 0 N--CA 1.451 -0.978 0 C-N-CA 122.178 1.918 . . . . 0.93 112.915 -179.236 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -86.73 -33.46 19.98 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 119.462 1.028 . . . . 2.07 109.163 166.604 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 13.2 tt0 -103.42 -57.04 2.1 Favored 'General case' 0 C--N 1.343 0.323 0 C-N-CA 122.871 0.468 . . . . 2.68 110.278 -169.336 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.405 0.6 OUTLIER -84.7 -178.66 6.93 Favored 'General case' 0 C--O 1.224 -0.242 0 CA-C-O 122.537 1.16 . . . . 1.79 113.77 155.513 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -179.18 -144.27 5.71 Favored Glycine 0 N--CA 1.434 -1.474 1 N-CA-C 102.944 -4.062 . . . . 2.53 102.944 -173.312 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 19.2 p -72.76 -40.29 66.11 Favored 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 124.509 1.124 . . . . 2.73 108.398 174.51 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -38.77 -62.65 0.59 Allowed 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 126.235 1.814 . . . . 2.07 114.119 -169.682 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -72.62 -42.33 64.58 Favored 'General case' 0 CA--C 1.517 -0.321 0 C-N-CA 119.079 -1.048 . . . . 1.79 108.98 -168.753 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -53.35 -55.68 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.17 0 CA-C-N 113.437 -1.71 . . . . 2.02 110.394 177.85 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.83 -46.9 87.81 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 119.827 1.194 . . . . 1.5 110.085 -178.759 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -47.58 -57.76 5.06 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 122.406 1.098 . . . . 2.91 110.722 176.836 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.2 -39.81 74.96 Favored 'General case' 0 N--CA 1.436 -1.155 0 CA-C-O 118.621 -0.704 . . . . 3.42 112.3 -176.802 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.1 mm -48.54 -52.14 9.35 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 C-N-CA 125.175 1.39 . . . . 1.85 107.481 175.084 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -60.71 -58.0 10.33 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 124.372 1.069 . . . . 1.92 110.875 177.665 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 3.4 mptp? -56.62 -37.61 70.94 Favored 'General case' 0 CA--C 1.536 0.42 0 O-C-N 121.499 -0.75 . . . . 4.75 112.375 -176.766 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 13.7 mt -69.82 -17.77 63.42 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.461 1.105 . . . . 2.13 111.787 176.14 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 91.02 45.46 4.15 Favored Glycine 0 C--N 1.336 0.557 0 C-N-CA 124.369 0.985 . . . . 0.81 110.986 174.342 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -137.49 175.28 9.74 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 123.972 0.909 . . . . 3.21 110.685 -177.872 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 2.3 t-80 -142.66 128.26 19.13 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 109.061 -0.718 . . . . 3.05 109.061 169.657 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 11.7 p -88.76 148.85 4.26 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 C-N-CA 125.056 1.343 . . . . 2.53 108.127 169.679 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 41.1 t -120.3 138.84 49.52 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 C-N-CA 125.249 1.42 . . . . 1.78 108.615 179.057 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 26.8 mm . . . . . 0 CA--C 1.532 0.259 0 C-N-CA 124.805 1.242 . . . . 1.89 109.564 -168.138 . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 57.9 m . . . . . 0 N--CA 1.443 -0.803 0 N-CA-C 108.224 -1.028 . . . . 1.7 108.224 . . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -64.95 174.92 1.7 Allowed 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 109.095 -0.706 . . . . 2.86 109.095 155.013 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -135.08 148.95 49.98 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 106.702 -1.592 . . . . 1.56 106.702 168.559 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 10.5 mmpt? -138.62 157.12 46.74 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 123.401 0.68 . . . . 4.88 109.677 165.138 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.68 103.88 12.49 Favored 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 128.745 2.818 . . . . 1.61 107.847 -177.79 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 2.1 pp -84.95 165.56 2.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 N-CA-C 109.006 -0.739 . . . . 5.76 109.006 168.537 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -137.19 119.34 15.53 Favored 'General case' 0 C--O 1.226 -0.169 0 N-CA-C 106.879 -1.526 . . . . 1.76 106.879 173.438 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 22.8 mmt -137.4 172.34 13.13 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 119.596 1.089 . . . . 6.29 110.411 -177.511 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 17.9 mm100 -91.87 158.87 16.07 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 123.813 0.845 . . . . 2.37 110.014 -178.214 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 22.1 t -117.22 153.66 18.99 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 C-N-CA 124.373 1.069 . . . . 2.11 109.079 -176.457 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 37.5 m -149.5 175.71 11.25 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.089 0.956 . . . . 1.74 109.143 172.004 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 82.12 -36.64 2.54 Favored Glycine 0 CA--C 1.533 1.181 0 O-C-N 121.525 -0.734 . . . . 2.01 112.485 -179.132 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -42.05 143.69 0.54 Allowed 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.643 1.577 . . . . 2.6 113.786 177.721 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -110.42 -49.04 3.09 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 125.234 1.414 . . . . 3.03 111.532 169.796 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 18.4 p -130.64 161.97 30.42 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 123.186 0.594 . . . . 2.46 110.807 -176.136 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -77.0 55.88 1.16 Allowed 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.187 0.995 . . . . 2.8 110.572 179.423 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -143.89 -56.3 0.38 Allowed 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 124.118 0.967 . . . . 2.06 109.789 178.132 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 59.4 m -55.88 -40.72 73.38 Favored 'General case' 0 CA--C 1.532 0.269 0 O-C-N 121.916 -0.49 . . . . 1.19 111.989 -173.93 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.29 -24.37 42.69 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.022 0.529 . . . . 1.86 112.32 177.686 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.8 -52.64 34.69 Favored 'General case' 0 N--CA 1.452 -0.355 0 O-C-N 120.353 -1.467 . . . . 1.6 108.937 172.809 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 6.6 mtt-85 -53.74 -46.84 71.01 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.318 0.647 . . . . 4.71 110.239 -175.255 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.1 pt -57.85 -53.89 39.12 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.455 0 C-N-CA 119.756 -0.778 . . . . 1.62 110.85 -179.763 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -55.01 -43.69 73.88 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 119.299 0.954 . . . . 2.6 111.862 177.321 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.2 mptp? -68.83 -46.18 69.24 Favored 'General case' 0 CA--C 1.533 0.291 0 O-C-N 121.298 -0.877 . . . . 2.43 110.61 -175.807 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -63.08 -38.85 97.24 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 110.48 -1.048 . . . . 0.67 110.48 175.061 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -60.32 -44.56 95.35 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 108.069 -1.086 . . . . 3.75 108.069 179.294 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -54.51 -26.07 29.47 Favored 'General case' 0 CA--C 1.542 0.665 0 O-C-N 121.561 -0.712 . . . . 3.81 112.683 175.093 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -71.22 -9.11 57.55 Favored 'General case' 0 CA--C 1.539 0.527 0 O-C-N 120.583 -1.323 . . . . 4.35 112.659 177.295 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -73.79 158.03 86.6 Favored Pre-proline 0 CA--C 1.539 0.528 0 CA-C-N 118.99 0.813 . . . . 4.3 111.552 -179.066 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -70.98 114.5 3.92 Favored 'Trans proline' 0 N--CA 1.45 -1.058 0 C-N-CA 121.811 1.674 . . . . 1.05 109.74 175.577 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 121.32 -30.27 5.46 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 124.08 0.848 . . . . 1.2 113.002 170.818 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 61.6 t -83.37 141.05 15.38 Favored 'Isoleucine or valine' 0 C--N 1.342 0.254 0 CA-C-N 118.338 1.069 . . . . 1.84 109.445 172.133 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 7.0 m -118.29 -38.31 3.2 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-O 118.39 -0.814 . . . . 2.18 111.126 -177.27 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -136.7 163.6 30.21 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 119.542 1.065 . . . . 2.24 111.843 167.132 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -158.36 140.86 14.39 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 112.541 0.571 . . . . 1.43 112.541 -177.845 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -153.82 106.85 2.91 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 106.648 -1.612 . . . . 0.44 106.648 -165.94 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 4.8 p -81.16 127.99 39.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 N-CA-C 107.351 -1.352 . . . . 1.62 107.351 174.667 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 54.7 t-20 -111.75 57.62 0.64 Allowed 'General case' 0 C--O 1.235 0.291 0 CA-C-O 122.968 1.366 . . . . 0.92 107.974 179.878 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.78 -20.1 66.14 Favored 'General case' 0 C--O 1.227 -0.11 0 CA-C-N 113.976 -1.465 . . . . 1.99 111.12 -176.161 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -46.94 -34.58 5.64 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.447 0.699 . . . . 1.67 112.312 166.842 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 14.7 t -122.09 27.66 7.91 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-O 121.284 0.564 . . . . 1.87 110.215 174.249 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 54.39 27.54 8.29 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 126.387 1.875 . . . . 2.63 114.431 178.469 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 12.2 m -115.82 153.63 31.12 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.112 0.965 . . . . 1.67 109.136 -178.124 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.1 p -117.36 142.9 29.35 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 C-N-CA 124.121 0.968 . . . . 1.59 109.121 170.667 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 21.1 m120 -125.95 131.86 52.2 Favored 'General case' 0 C--N 1.343 0.316 0 N-CA-C 106.673 -1.602 . . . . 0.36 106.673 174.217 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -132.24 128.06 58.24 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.706 0 N-CA-C 105.755 -1.942 . . . . 3.1 105.755 -178.962 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 10.7 mm -108.96 96.83 5.0 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 C-N-CA 126.113 1.765 . . . . 1.7 108.104 -168.778 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 44.9 p90 -130.93 172.54 11.93 Favored 'General case' 0 CA--C 1.511 -0.552 0 O-C-N 121.317 -0.864 . . . . 3.05 110.913 -169.649 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 36.0 t0 -90.28 107.7 21.52 Favored Pre-proline 0 CA--C 1.536 0.426 0 O-C-N 124.526 1.142 . . . . 2.81 110.051 174.826 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -75.42 6.84 3.32 Favored 'Trans proline' 0 N--CA 1.451 -1.028 0 C-N-CA 122.434 2.089 . . . . 0.62 113.072 -178.903 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -81.77 -26.25 34.61 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 119.473 1.033 . . . . 1.72 108.926 165.484 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -108.65 -66.59 1.04 Allowed 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 107.989 -1.115 . . . . 3.81 107.989 -170.727 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.417 0.2 OUTLIER -76.67 178.09 7.02 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 116.573 2.064 . . . . 2.0 116.573 165.156 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -163.68 -145.05 4.23 Favored Glycine 0 N--CA 1.432 -1.622 1 N-CA-C 102.424 -4.27 . . . . 2.55 102.424 176.39 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 30.9 p -75.23 -37.68 60.95 Favored 'General case' 0 N--CA 1.444 -0.747 0 C-N-CA 125.34 1.456 . . . . 2.23 109.087 172.891 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -49.42 -61.2 2.23 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 124.936 1.294 . . . . 2.3 113.912 -165.601 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.87 -33.66 68.56 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 118.773 -1.171 . . . . 2.4 108.834 -168.98 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.5 mp -55.84 -52.5 48.23 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 C-N-CA 123.874 0.87 . . . . 2.39 109.835 174.193 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -61.51 -43.16 99.37 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 109.845 -0.428 . . . . 2.03 109.845 -176.708 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -48.89 -58.06 5.43 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.163 0.985 . . . . 2.86 110.631 171.976 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -67.45 -36.14 80.61 Favored 'General case' 0 N--CA 1.442 -0.85 0 O-C-N 121.396 -0.815 . . . . 4.01 112.592 -177.711 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -52.07 -52.18 25.47 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 C-N-CA 124.839 1.256 . . . . 1.68 107.839 176.307 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -57.77 -55.56 33.26 Favored 'General case' 0 C--N 1.34 0.189 0 C-N-CA 122.944 0.498 . . . . 2.21 109.965 175.433 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 7.7 mmtt -58.01 -35.02 70.65 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 113.12 0.785 . . . . 5.14 113.12 -175.34 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 24.8 mt -70.3 -17.69 63.09 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 125.287 1.435 . . . . 2.12 111.416 175.838 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 96.31 38.58 4.49 Favored Glycine 0 CA--C 1.522 0.521 0 C-N-CA 124.754 1.169 . . . . 0.75 110.803 175.574 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -136.93 175.58 9.49 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 117.654 0.727 . . . . 3.06 111.029 -176.357 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 5.9 t60 -138.68 137.34 36.74 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 109.546 -0.538 . . . . 3.42 109.546 169.392 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 8.6 p -110.24 144.01 19.15 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 N-CA-C 106.644 -1.613 . . . . 2.43 106.644 177.403 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 20.5 t -113.39 131.82 64.04 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 N-CA-C 108.455 -0.942 . . . . 1.71 108.455 178.997 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 47.8 mm . . . . . 0 N--CA 1.45 -0.43 0 C-N-CA 124.79 1.236 . . . . 2.14 107.772 -174.789 . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.4 m . . . . . 0 N--CA 1.448 -0.56 0 N-CA-C 105.447 -2.057 . . . . 1.25 105.447 . . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -89.62 -173.5 3.97 Favored 'General case' 0 N--CA 1.445 -0.679 0 C-N-CA 124.327 1.051 . . . . 2.17 108.814 175.174 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.8 mm100 -135.96 147.88 48.25 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 107.425 -1.324 . . . . 1.03 107.425 164.707 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 86.6 mttt -139.36 159.22 42.66 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 109.164 -0.68 . . . . 4.11 109.164 158.037 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -112.59 100.1 8.46 Favored 'General case' 0 N--CA 1.436 -1.152 0 C-N-CA 128.28 2.632 . . . . 1.31 105.321 -171.681 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 7.0 mm -80.79 161.31 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.267 0 N-CA-C 106.601 -1.629 . . . . 2.91 106.601 178.912 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -133.33 122.56 24.01 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 106.756 -1.572 . . . . 1.72 106.756 174.093 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 71.8 mtm -140.46 168.59 19.45 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 123.451 0.7 . . . . 2.62 109.784 -178.687 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 20.6 mm100 -94.69 148.93 21.76 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 125.216 1.407 . . . . 2.5 109.413 177.763 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 69.7 t -99.73 145.72 10.09 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 C-N-CA 123.541 0.736 . . . . 2.29 109.346 178.041 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 32.3 t -145.03 176.87 9.18 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 124.475 1.11 . . . . 2.33 108.816 168.881 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 52.29 60.26 7.94 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 124.292 0.949 . . . . 1.89 110.773 -176.455 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -128.73 151.33 49.67 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 124.198 0.999 . . . . 2.89 110.328 -172.79 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -97.26 -55.38 2.86 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 124.421 1.088 . . . . 4.24 109.196 168.639 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 22.8 p -150.27 165.92 31.53 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-O 121.839 0.828 . . . . 2.43 111.757 -174.5 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -74.27 48.64 0.33 Allowed 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.462 1.505 . . . . 2.65 111.357 175.701 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -144.02 -51.76 0.32 Allowed 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 124.795 1.238 . . . . 1.63 108.18 175.697 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 27.1 m -59.37 -36.97 76.75 Favored 'General case' 0 CA--C 1.531 0.248 0 O-C-N 121.38 -0.825 . . . . 1.18 109.745 167.998 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.17 -21.8 59.98 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 112.95 0.722 . . . . 1.7 112.95 173.668 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -73.79 -50.94 18.12 Favored 'General case' 0 C--N 1.339 0.152 0 O-C-N 121.019 -1.05 . . . . 1.57 110.032 169.943 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 17.3 mtm180 -50.04 -42.39 49.53 Favored 'General case' 0 N--CA 1.456 -0.143 0 C-N-CA 123.32 0.648 . . . . 6.89 111.196 -175.663 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.9 pt -57.82 -53.66 42.12 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.156 0 C-N-CA 119.847 -0.741 . . . . 1.8 111.891 177.341 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -57.88 -46.46 84.84 Favored 'General case' 0 C--O 1.224 -0.266 0 C-N-CA 123.339 0.655 . . . . 3.35 110.708 -179.876 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -72.34 -40.3 67.51 Favored 'General case' 0 C--N 1.331 -0.234 0 O-C-N 121.908 -0.495 . . . . 3.1 111.034 -173.535 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -59.44 -45.28 95.77 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 109.757 -1.337 . . . . 0.65 109.757 169.695 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -61.94 -37.47 84.83 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 121.879 -0.777 . . . . 3.48 109.655 -179.839 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 3.3 ttpp -53.98 -25.38 20.64 Favored 'General case' 0 CA--C 1.533 0.3 0 O-C-N 120.724 -1.235 . . . . 3.11 113.198 174.505 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -82.15 -1.21 48.17 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.043 0.937 . . . . 4.42 111.836 -179.088 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 21.4 mmt -93.77 149.35 36.93 Favored Pre-proline 0 CA--C 1.535 0.401 0 C-N-CA 124.194 0.998 . . . . 5.63 109.995 -175.092 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -58.45 142.86 98.24 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 122.52 2.146 . . . . 0.76 111.477 -176.65 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 85.65 -27.3 5.36 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 123.511 0.577 . . . . 0.58 112.927 179.422 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.4 t -80.12 140.18 17.11 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 CA-C-N 118.363 1.081 . . . . 1.65 108.795 176.33 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 69.8 m -106.7 -60.12 1.71 Allowed 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 118.474 -0.774 . . . . 2.17 109.116 178.488 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -140.65 165.35 27.72 Favored 'General case' 0 N--CA 1.446 -0.675 0 N-CA-C 109.052 -0.721 . . . . 2.58 109.052 179.821 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -156.43 143.9 19.18 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 109.381 -0.6 . . . . 1.76 109.381 -168.335 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -152.2 116.16 4.9 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 123.892 0.877 . . . . 0.78 108.761 -167.209 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.6 p -82.2 124.35 39.11 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 N-CA-C 107.208 -1.405 . . . . 1.76 107.208 171.542 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 47.2 t30 -108.57 55.38 0.64 Allowed 'General case' 0 C--O 1.235 0.326 0 CA-C-O 123.07 1.414 . . . . 0.93 107.22 178.161 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.65 -18.35 62.85 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 114.171 -1.377 . . . . 2.03 110.311 -174.207 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -43.38 -37.61 2.38 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 124.267 1.027 . . . . 1.63 111.991 166.033 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 9.3 t -125.87 32.89 5.18 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 122.719 0.407 . . . . 1.57 110.435 173.58 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 59.1 27.62 16.65 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.923 1.689 . . . . 2.92 113.609 174.437 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 60.3 m -115.97 164.28 14.67 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.747 1.219 . . . . 1.78 109.723 -174.594 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 5.7 p -136.25 143.72 35.02 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 C-N-CA 124.516 1.126 . . . . 1.59 108.637 171.998 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -134.92 122.1 21.47 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 124.647 1.179 . . . . 0.58 108.153 -175.405 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.7 p -123.85 130.59 73.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 N-CA-C 106.176 -1.787 . . . . 2.96 106.176 -172.705 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 9.7 mm -105.39 97.47 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 N-CA-C 107.158 -1.423 . . . . 1.61 107.158 -174.92 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 3.6 p90 -129.72 164.89 23.0 Favored 'General case' 0 CA--C 1.512 -0.481 0 O-C-N 122.161 -0.337 . . . . 3.57 110.641 -176.554 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -81.65 124.01 80.16 Favored Pre-proline 0 CA--C 1.536 0.418 0 N-CA-C 108.314 -0.995 . . . . 3.12 108.314 167.189 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -86.57 15.54 2.17 Favored 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 122.904 2.403 . . . . 0.66 112.888 -175.385 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -97.88 -40.52 8.47 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 123.999 0.92 . . . . 2.09 109.069 169.248 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -90.59 -62.08 1.54 Allowed 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 107.143 -1.428 . . . . 3.84 107.143 -177.337 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.518 0.2 OUTLIER -78.31 -175.65 4.3 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 115.328 1.603 . . . . 1.85 115.328 159.336 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 154.64 -168.3 32.73 Favored Glycine 0 N--CA 1.435 -1.381 1 N-CA-C 102.81 -4.116 . . . . 2.53 102.81 -148.83 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 16.7 p -73.34 -34.91 65.9 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 124.14 0.976 . . . . 2.08 109.244 -176.679 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -46.96 -60.88 2.15 Favored 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 125.055 1.342 . . . . 1.73 113.441 -169.556 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.07 -40.99 74.71 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 118.995 -1.082 . . . . 1.57 108.793 -167.524 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.5 mp -50.71 -54.57 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.944 0 CA-C-N 113.891 -1.504 . . . . 2.23 109.787 174.087 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -65.82 -44.58 85.19 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 118.669 0.668 . . . . 2.4 110.28 -174.008 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -45.84 -56.7 5.06 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 122.597 1.189 . . . . 2.8 110.046 173.252 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.86 -40.47 68.95 Favored 'General case' 0 N--CA 1.438 -1.05 0 N-CA-C 113.536 0.939 . . . . 4.93 113.536 -176.314 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -48.26 -52.49 7.78 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 C-N-CA 125.003 1.321 . . . . 1.59 108.017 173.961 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -59.65 -58.83 6.87 Favored 'General case' 0 C--N 1.341 0.219 0 C-N-CA 123.429 0.692 . . . . 1.63 110.333 176.588 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 6.6 mmmt -57.76 -33.02 68.06 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 113.62 0.97 . . . . 5.24 113.62 -175.732 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 22.6 mt -71.81 -19.02 62.05 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.181 1.392 . . . . 2.02 111.666 174.853 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 96.81 43.68 3.05 Favored Glycine 0 CA--C 1.524 0.645 0 C-N-CA 124.704 1.145 . . . . 0.43 111.442 174.735 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -140.1 174.49 10.47 Favored 'General case' 0 N--CA 1.457 -0.085 0 C-N-CA 124.488 1.115 . . . . 3.3 110.157 -177.799 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 6.9 t-80 -141.55 125.91 17.62 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 109.387 -0.597 . . . . 2.94 109.387 174.279 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 7.8 p -92.77 152.14 3.5 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 108.479 -0.934 . . . . 2.48 108.479 174.566 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 38.1 t -127.3 143.65 39.9 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 C-N-CA 124.808 1.243 . . . . 1.84 108.323 178.488 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 5.2 mp . . . . . 0 N--CA 1.453 -0.281 0 C-N-CA 124.558 1.143 . . . . 2.74 108.789 -172.804 . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.3 m . . . . . 0 N--CA 1.449 -0.484 0 N-CA-C 105.596 -2.002 . . . . 1.49 105.596 . . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -84.92 -175.7 5.88 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 108.199 -1.038 . . . . 2.09 108.199 163.839 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.18 146.78 49.05 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 107.583 -1.266 . . . . 1.13 107.583 169.2 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 54.2 mttm -140.27 156.16 46.58 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 121.44 0.638 . . . . 3.56 110.279 161.873 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -112.89 87.01 2.49 Favored 'General case' 0 N--CA 1.439 -0.978 0 C-N-CA 128.343 2.657 . . . . 1.45 106.444 -168.508 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 20.6 mm -82.62 159.64 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.396 0 N-CA-C 106.575 -1.639 . . . . 2.98 106.575 -176.035 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -131.77 138.18 48.47 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 125.784 1.634 . . . . 1.61 106.743 -179.694 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -156.31 175.84 13.47 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 118.511 0.596 . . . . 3.64 110.786 172.649 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 30.1 mm100 -94.6 159.35 15.12 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 124.638 1.175 . . . . 2.68 109.886 -178.405 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 62.0 t -114.26 156.53 15.2 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 C-N-CA 125.075 1.35 . . . . 2.19 108.769 -176.454 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 25.3 m -150.01 165.63 32.13 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 123.725 0.81 . . . . 1.64 109.518 168.006 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 63.68 47.56 85.5 Favored Glycine 0 CA--C 1.528 0.899 0 N-CA-C 110.31 -1.116 . . . . 1.6 110.31 -171.52 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -120.55 165.17 15.37 Favored 'General case' 0 N--CA 1.457 -0.121 0 C-N-CA 124.663 1.185 . . . . 2.7 108.972 175.3 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 174.51 -41.96 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 127.864 2.466 . . . . 4.7 110.528 175.447 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 47.9 t -48.02 -41.02 24.5 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.327 1.051 . . . . 4.08 110.932 172.173 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 64.56 19.15 11.72 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.621 1.169 . . . . 3.29 111.92 -178.0 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -134.58 -44.22 0.75 Allowed 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 125.395 1.478 . . . . 1.8 109.439 176.035 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 20.5 m -47.24 -38.48 12.35 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 123.413 0.685 . . . . 1.65 112.599 169.131 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -49.26 -33.29 12.52 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.382 0.673 . . . . 1.71 112.068 174.545 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.6 -52.88 15.77 Favored 'General case' 0 N--CA 1.456 -0.173 0 O-C-N 120.789 -1.194 . . . . 1.55 110.416 171.699 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 46.4 mmm-85 -50.42 -50.63 51.36 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 123.933 0.893 . . . . 4.52 110.114 -175.968 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 5.1 pt -56.86 -54.61 27.47 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 CA-C-O 118.79 -0.624 . . . . 1.94 109.946 -179.839 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -55.46 -38.6 69.26 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 119.273 0.942 . . . . 2.29 112.12 179.474 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 42.7 mmtm -71.58 -44.14 65.01 Favored 'General case' 0 CA--C 1.534 0.327 0 O-C-N 121.345 -0.847 . . . . 2.87 111.564 -177.49 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -69.58 -33.21 71.65 Favored Glycine 0 CA--C 1.528 0.871 0 C-N-CA 120.218 -0.991 . . . . 0.57 110.914 173.088 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 9.6 tt -56.37 -48.64 76.43 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 107.833 -1.173 . . . . 3.11 107.833 173.227 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -54.87 -19.44 6.56 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 113.428 0.899 . . . . 4.45 113.428 176.249 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 94.5 mtt180 -77.54 -4.68 46.94 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 119.679 1.127 . . . . 5.92 112.289 177.704 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 7.3 ptp -71.11 155.68 92.9 Favored Pre-proline 0 CA--C 1.534 0.339 0 CA-C-N 119.58 1.082 . . . . 4.35 111.37 173.335 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -58.86 133.04 51.18 Favored 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 121.769 1.646 . . . . 0.65 109.046 163.5 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 108.54 -35.12 5.16 Favored Glycine 0 CA--C 1.53 1.015 0 CA-C-O 119.442 -0.643 . . . . 0.59 113.39 171.892 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 59.9 t -89.28 128.62 41.22 Favored 'Isoleucine or valine' 0 C--N 1.34 0.173 0 CA-C-N 118.454 1.127 . . . . 1.91 110.303 178.772 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 30.7 m -111.06 -28.58 8.25 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 123.582 0.753 . . . . 1.96 111.817 -174.747 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -146.78 164.1 33.86 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 119.033 0.833 . . . . 2.34 111.359 164.791 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -156.18 133.95 11.07 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 112.571 0.582 . . . . 1.48 112.571 -176.478 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -150.34 115.88 5.49 Favored 'General case' 0 C--N 1.341 0.235 0 N-CA-C 108.279 -1.008 . . . . 0.45 108.279 -163.266 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.4 p -93.3 100.13 10.75 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 C-N-CA 123.478 0.711 . . . . 1.71 110.049 -175.985 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 53.1 t-20 -83.71 57.3 4.02 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 122.651 1.215 . . . . 0.85 109.287 -179.145 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.98 -19.74 63.33 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 114.915 -1.038 . . . . 2.01 110.155 -175.713 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -46.7 -35.67 6.31 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 123.876 0.87 . . . . 1.63 112.036 166.046 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 5.6 t -122.11 37.33 4.4 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 121.496 0.665 . . . . 2.05 109.553 173.56 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 41.22 40.01 1.07 Allowed 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 126.655 1.982 . . . . 2.64 113.503 179.109 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 95.1 m -124.33 160.49 27.96 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 124.971 1.308 . . . . 1.82 107.865 -178.799 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.6 p -130.79 146.81 33.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 O-C-N 121.356 -0.84 . . . . 1.69 109.321 170.133 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -128.77 138.84 52.31 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 108.253 -1.017 . . . . 0.38 108.253 -179.639 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 34.2 t -135.05 129.28 50.59 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 N-CA-C 106.284 -1.747 . . . . 3.27 106.284 -179.395 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 11.4 mm -104.4 99.8 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 N-CA-C 106.874 -1.528 . . . . 1.66 106.874 -173.552 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 53.6 p90 -138.3 167.49 21.75 Favored 'General case' 0 CA--C 1.509 -0.602 0 O-C-N 121.622 -0.673 . . . . 3.56 111.623 -170.591 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -87.75 109.43 26.88 Favored Pre-proline 0 C--O 1.236 0.343 0 O-C-N 124.448 1.092 . . . . 3.04 109.646 174.992 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -74.56 5.18 3.92 Favored 'Trans proline' 0 N--CA 1.451 -0.989 0 C-N-CA 122.759 2.306 . . . . 0.57 112.973 -177.323 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -86.08 -27.61 24.59 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 119.506 1.048 . . . . 1.69 109.294 166.721 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.51 -57.5 2.03 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 108.22 -1.03 . . . . 3.46 108.22 -168.666 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.288 1.0 OUTLIER -93.95 -173.63 3.18 Favored 'General case' 0 C--O 1.225 -0.215 0 C-N-CA 124.435 1.094 . . . . 1.49 112.494 161.566 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 141.64 91.25 0.17 Allowed Glycine 0 N--CA 1.441 -1.029 0 N-CA-C 103.222 -3.951 . . . . 2.26 103.222 -155.896 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -13.02 -13.92 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.7 1 C-N-CA 138.476 6.71 . . . . 3.96 120.472 -149.249 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -26.26 -62.62 0.08 Allowed 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 126.885 2.074 . . . . 1.54 114.867 161.228 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.87 -41.5 59.69 Favored 'General case' 0 CA--C 1.521 -0.145 0 CA-C-O 122.255 1.026 . . . . 1.72 108.931 -167.802 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.7 mt -44.82 -57.36 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.771 0 C-N-CA 125.829 1.651 . . . . 2.81 110.53 170.452 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.95 -46.35 88.23 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 119.444 1.02 . . . . 1.27 110.747 178.999 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -49.3 -55.49 12.6 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 121.944 0.878 . . . . 3.4 111.001 179.019 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.95 -41.11 78.44 Favored 'General case' 0 N--CA 1.441 -0.886 0 C-N-CA 124.135 0.974 . . . . 3.98 112.319 179.207 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -48.71 -53.18 7.53 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 N-CA-C 108.318 -0.993 . . . . 1.57 108.318 175.91 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -59.96 -58.58 7.96 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 124.147 0.979 . . . . 1.51 110.699 177.03 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 2.9 mttp -55.23 -39.73 70.06 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 112.959 0.725 . . . . 4.86 112.959 -175.849 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 20.8 mt -67.34 -17.81 64.9 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.327 1.051 . . . . 1.79 111.515 177.361 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 96.58 41.03 3.73 Favored Glycine 0 C--N 1.335 0.512 0 C-N-CA 124.827 1.203 . . . . 0.46 110.758 173.947 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -138.54 175.89 9.17 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 123.829 0.852 . . . . 3.35 110.334 -175.255 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 16.4 t-160 -142.32 148.6 38.25 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 108.419 -0.956 . . . . 3.47 108.419 174.88 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -118.42 152.9 20.55 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.14 0 C-N-CA 125.617 1.567 . . . . 3.08 106.942 177.176 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 59.0 t -124.14 145.72 30.81 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 C-N-CA 124.902 1.281 . . . . 1.86 108.274 179.141 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 38.9 mm . . . . . 0 N--CA 1.456 -0.174 0 C-N-CA 124.616 1.167 . . . . 2.41 108.884 -173.895 . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 11.7 m . . . . . 0 N--CA 1.451 -0.399 0 CA-C-O 120.759 0.314 . . . . 1.34 111.309 . . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -78.05 161.49 27.42 Favored 'General case' 0 N--CA 1.435 -1.192 0 N-CA-C 106.001 -1.852 . . . . 3.4 106.001 171.351 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 9.8 mm100 -129.88 149.34 51.66 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 108.518 -0.919 . . . . 2.57 108.518 -178.006 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 71.7 tttt -145.6 155.33 42.97 Favored 'General case' 0 N--CA 1.438 -1.053 0 C-N-CA 124.003 0.921 . . . . 5.03 108.973 175.103 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -112.96 92.86 4.16 Favored 'General case' 0 N--CA 1.437 -1.086 0 C-N-CA 129.566 3.146 . . . . 1.68 105.229 -173.494 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 19.4 mm -83.78 163.38 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.301 0 N-CA-C 106.797 -1.557 . . . . 3.15 106.797 175.665 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -133.22 138.03 46.36 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 125.457 1.503 . . . . 1.4 107.291 177.92 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -155.85 171.38 20.15 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 118.347 0.522 . . . . 2.67 109.733 175.946 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -93.32 164.83 13.07 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 124.921 1.288 . . . . 3.58 109.893 -174.424 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.8 t -126.29 146.61 31.82 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 C-N-CA 123.754 0.822 . . . . 2.19 109.622 -173.579 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 59.9 m -127.48 171.69 11.36 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.742 1.217 . . . . 1.49 109.042 170.795 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 79.71 -35.85 2.07 Favored Glycine 0 CA--C 1.534 1.26 0 O-C-N 121.514 -0.741 . . . . 2.28 112.871 -179.297 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -44.01 142.64 1.33 Allowed 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 114.248 1.203 . . . . 3.19 114.248 -179.712 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -153.02 -60.89 0.15 Allowed 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 126.351 1.861 . . . . 3.81 107.002 177.995 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 31.3 m -63.94 -25.53 68.18 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.077 0.951 . . . . 3.2 112.94 -176.959 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 68.55 -60.18 0.44 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 126.005 1.722 . . . . 2.67 110.956 -169.102 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -48.07 -45.5 32.56 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.71 1.204 . . . . 1.83 111.682 178.861 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 89.9 m -57.48 -32.32 66.86 Favored 'General case' 0 CA--C 1.529 0.143 0 N-CA-C 112.766 0.654 . . . . 1.54 112.766 177.761 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.47 -19.17 65.4 Favored 'General case' 0 CA--C 1.538 0.487 0 O-C-N 121.904 -0.498 . . . . 1.65 111.051 175.12 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.22 -47.41 61.56 Favored 'General case' 0 N--CA 1.453 -0.279 0 O-C-N 119.452 -2.03 . . . . 1.82 108.607 169.734 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 61.8 mtp180 -55.45 -41.24 72.59 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 118.77 -0.633 . . . . 5.27 110.076 -176.386 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.3 1.4 pt -57.82 -58.38 6.52 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.425 0 C-N-CA 119.373 -0.931 . . . . 1.68 110.708 174.877 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -47.88 -42.55 27.1 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 119.191 0.905 . . . . 2.67 112.883 176.293 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 24.4 mmtp -70.25 -48.74 55.56 Favored 'General case' 0 CA--C 1.535 0.378 0 O-C-N 120.938 -1.101 . . . . 3.38 111.291 -179.573 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.86 -29.38 73.91 Favored Glycine 0 CA--C 1.53 1.0 0 O-C-N 121.665 -0.647 . . . . 0.92 111.582 176.281 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.3 tt -67.4 -54.42 20.56 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 125.314 1.446 . . . . 2.93 107.775 176.547 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 6.7 ttmt -48.32 -33.11 8.36 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.523 0.729 . . . . 3.39 112.115 178.22 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 3.6 mmt180 -55.76 -15.7 3.48 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 114.507 1.299 . . . . 5.2 114.507 177.906 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 9.9 ptp -67.68 156.72 88.32 Favored Pre-proline 0 CA--C 1.535 0.38 0 CA-C-N 119.719 1.145 . . . . 4.44 112.252 175.941 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -60.74 137.89 76.0 Favored 'Trans proline' 0 N--CA 1.456 -0.735 0 C-N-CA 121.378 1.385 . . . . 0.8 109.522 165.846 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 99.33 -28.63 14.51 Favored Glycine 0 CA--C 1.53 0.983 0 CA-C-O 119.14 -0.811 . . . . 0.54 113.729 170.553 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 61.5 t -88.64 136.75 22.61 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 CA-C-N 119.288 1.544 . . . . 1.9 109.119 171.613 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -108.04 -41.2 5.0 Favored 'General case' 0 C--N 1.341 0.216 0 CA-C-O 118.356 -0.83 . . . . 2.67 110.733 178.508 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -143.21 165.93 26.1 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-N 119.113 0.87 . . . . 2.37 110.403 170.963 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -158.02 148.16 20.28 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 123.538 0.735 . . . . 1.53 110.073 179.923 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -156.19 118.37 4.03 Favored 'General case' 0 C--O 1.232 0.143 0 N-CA-C 107.723 -1.214 . . . . 0.63 107.723 -163.364 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.0 p -89.92 101.4 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 C-N-CA 123.082 0.553 . . . . 1.66 110.232 -177.07 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 51.4 t-20 -84.07 56.7 3.83 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-O 122.693 1.235 . . . . 0.82 109.277 179.629 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.07 -19.92 64.08 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 115.229 -0.896 . . . . 2.1 110.152 -175.467 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -46.91 -36.8 8.01 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.032 0.933 . . . . 1.58 112.363 166.752 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 14.5 t -115.5 23.67 12.2 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 118.499 0.59 . . . . 1.8 111.327 174.161 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 55.04 50.37 15.56 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.4 1.08 . . . . 3.55 112.859 -179.706 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 7.1 m -145.9 154.78 42.33 Favored 'General case' 0 N--CA 1.445 -0.722 0 O-C-N 120.418 -1.426 . . . . 1.91 109.045 178.844 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.3 p -117.81 144.37 25.97 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 N-CA-C 108.455 -0.943 . . . . 1.71 108.455 171.347 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -124.68 142.62 51.25 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 108.153 -1.055 . . . . 0.39 108.153 176.985 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 4.0 p -139.78 129.35 29.09 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 N-CA-C 106.822 -1.548 . . . . 2.84 106.822 -174.993 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 14.5 mm -108.31 89.03 1.21 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.654 0 C-N-CA 126.007 1.723 . . . . 2.13 107.711 -167.461 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 34.7 p90 -137.12 172.9 12.32 Favored 'General case' 0 CA--C 1.511 -0.542 0 C-N-CA 122.671 0.388 . . . . 2.83 111.967 -167.703 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 66.4 t0 -93.36 104.71 13.06 Favored Pre-proline 0 C--O 1.236 0.345 0 O-C-N 125.094 1.496 . . . . 3.08 110.177 -179.412 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -73.71 3.19 5.11 Favored 'Trans proline' 0 N--CA 1.448 -1.154 0 C-N-CA 122.003 1.802 . . . . 0.87 112.447 -179.286 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -82.23 -29.35 31.38 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 119.819 1.19 . . . . 2.16 109.205 165.726 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -108.32 -55.99 2.31 Favored 'General case' 0 C--N 1.343 0.317 0 C-N-CA 122.797 0.439 . . . . 2.52 110.308 -166.355 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.31 0.6 OUTLIER -89.05 177.54 6.62 Favored 'General case' 0 CA--C 1.514 -0.432 0 CA-C-O 123.312 1.53 . . . . 1.61 114.212 160.345 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -160.02 -135.9 1.93 Allowed Glycine 0 N--CA 1.433 -1.567 0 N-CA-C 103.978 -3.649 . . . . 2.54 103.978 175.43 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 23.6 p -76.57 -35.29 58.28 Favored 'General case' 0 N--CA 1.444 -0.751 0 C-N-CA 127.031 2.132 . . . . 2.46 109.75 177.917 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -49.48 -62.8 1.35 Allowed 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 125.49 1.516 . . . . 1.7 113.926 -165.379 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.83 -35.0 69.76 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 114.676 -1.147 . . . . 1.61 108.472 -168.364 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.8 mt -54.26 -57.18 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.908 0 C-N-CA 125.95 1.7 . . . . 2.73 111.179 173.155 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.69 -45.22 95.01 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 119.804 1.184 . . . . 1.15 109.626 -179.724 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -49.56 -59.36 3.84 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-O 121.392 0.615 . . . . 3.24 111.958 176.756 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 4.7 mmpt? -63.61 -40.53 97.16 Favored 'General case' 0 N--CA 1.437 -1.087 0 CA-C-O 118.459 -0.781 . . . . 2.83 111.096 -179.452 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.3 mm -49.01 -54.3 5.69 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.558 0 C-N-CA 124.171 0.989 . . . . 1.61 108.441 177.204 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 27.0 mm-40 -59.32 -55.71 31.34 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 123.594 0.757 . . . . 1.62 110.436 177.0 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 10.2 mmtt -57.11 -36.48 70.69 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 112.905 0.706 . . . . 5.3 112.905 -174.931 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 13.0 mt -71.11 -17.8 62.55 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.889 1.276 . . . . 1.76 112.144 175.874 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 96.96 39.47 4.06 Favored Glycine 0 CA--C 1.523 0.589 0 C-N-CA 124.571 1.082 . . . . 0.5 111.093 175.36 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -135.31 175.86 9.2 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 124.131 0.972 . . . . 3.34 110.303 -178.39 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 22.4 t-160 -143.86 133.55 23.7 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 107.711 -1.218 . . . . 3.44 107.711 172.631 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 6.5 p -108.86 139.99 29.28 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 C-N-CA 125.296 1.439 . . . . 2.4 107.407 179.782 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 86.3 t -108.72 138.74 34.23 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.137 0 CA-C-O 121.833 0.825 . . . . 1.74 109.069 -179.566 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 45.8 mm . . . . . 0 N--CA 1.451 -0.416 0 C-N-CA 125.224 1.41 . . . . 2.58 109.123 -169.767 . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 11.7 m . . . . . 0 N--CA 1.451 -0.399 0 CA-C-O 120.759 0.314 . . . . 1.34 111.309 . . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -78.05 161.49 27.42 Favored 'General case' 0 N--CA 1.435 -1.192 0 N-CA-C 106.001 -1.852 . . . . 3.4 106.001 171.351 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 9.8 mm100 -129.88 149.34 51.66 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 108.518 -0.919 . . . . 2.57 108.518 -178.006 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 71.7 tttt -145.6 155.33 42.97 Favored 'General case' 0 N--CA 1.438 -1.053 0 C-N-CA 124.003 0.921 . . . . 5.03 108.973 175.103 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -112.96 92.86 4.16 Favored 'General case' 0 N--CA 1.437 -1.086 0 C-N-CA 129.566 3.146 . . . . 1.68 105.229 -173.494 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 19.4 mm -83.78 163.38 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.301 0 N-CA-C 106.797 -1.557 . . . . 3.15 106.797 175.665 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -133.22 138.03 46.36 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 125.457 1.503 . . . . 1.4 107.291 177.92 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -155.85 171.38 20.15 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 118.347 0.522 . . . . 2.67 109.733 175.946 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -93.32 164.83 13.07 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 124.921 1.288 . . . . 3.58 109.893 -174.424 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.8 t -126.29 146.61 31.82 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 C-N-CA 123.754 0.822 . . . . 2.19 109.622 -173.579 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 59.9 m -127.48 171.69 11.36 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.742 1.217 . . . . 1.49 109.042 170.795 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 79.71 -35.85 2.07 Favored Glycine 0 CA--C 1.534 1.26 0 O-C-N 121.514 -0.741 . . . . 2.28 112.871 -179.297 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -44.01 142.64 1.33 Allowed 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 114.248 1.203 . . . . 3.19 114.248 -179.712 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -153.02 -60.89 0.15 Allowed 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 126.351 1.861 . . . . 3.81 107.002 177.995 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 31.3 m -63.94 -25.53 68.18 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.077 0.951 . . . . 3.2 112.94 -176.959 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 68.55 -60.18 0.44 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 126.005 1.722 . . . . 2.67 110.956 -169.102 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -48.07 -45.5 32.56 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.71 1.204 . . . . 1.83 111.682 178.861 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 89.9 m -57.48 -32.32 66.86 Favored 'General case' 0 CA--C 1.529 0.143 0 N-CA-C 112.766 0.654 . . . . 1.54 112.766 177.761 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.47 -19.17 65.4 Favored 'General case' 0 CA--C 1.538 0.487 0 O-C-N 121.904 -0.498 . . . . 1.65 111.051 175.12 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.22 -47.41 61.56 Favored 'General case' 0 N--CA 1.453 -0.279 0 O-C-N 119.452 -2.03 . . . . 1.82 108.607 169.734 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 61.8 mtp180 -55.45 -41.24 72.59 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 118.77 -0.633 . . . . 5.27 110.076 -176.386 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.3 1.4 pt -57.82 -58.38 6.52 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.425 0 C-N-CA 119.373 -0.931 . . . . 1.68 110.708 174.877 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -47.88 -42.55 27.1 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 119.191 0.905 . . . . 2.67 112.883 176.293 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 24.4 mmtp -70.25 -48.74 55.56 Favored 'General case' 0 CA--C 1.535 0.378 0 O-C-N 120.938 -1.101 . . . . 3.38 111.291 -179.573 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.86 -29.38 73.91 Favored Glycine 0 CA--C 1.53 1.0 0 O-C-N 121.665 -0.647 . . . . 0.92 111.582 176.281 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.3 tt -67.4 -54.42 20.56 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 125.314 1.446 . . . . 2.93 107.775 176.547 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 6.7 ttmt -48.32 -33.11 8.36 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.523 0.729 . . . . 3.39 112.115 178.22 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 3.6 mmt180 -55.76 -15.7 3.48 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 114.507 1.299 . . . . 5.2 114.507 177.906 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 9.9 ptp -67.68 156.72 88.32 Favored Pre-proline 0 CA--C 1.535 0.38 0 CA-C-N 119.719 1.145 . . . . 4.44 112.252 175.941 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -60.74 137.89 76.0 Favored 'Trans proline' 0 N--CA 1.456 -0.735 0 C-N-CA 121.378 1.385 . . . . 0.8 109.522 165.846 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 99.33 -28.63 14.51 Favored Glycine 0 CA--C 1.53 0.983 0 CA-C-O 119.14 -0.811 . . . . 0.54 113.729 170.553 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 61.5 t -88.64 136.75 22.61 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 CA-C-N 119.288 1.544 . . . . 1.9 109.119 171.613 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -108.04 -41.2 5.0 Favored 'General case' 0 C--N 1.341 0.216 0 CA-C-O 118.356 -0.83 . . . . 2.67 110.733 178.508 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -143.21 165.93 26.1 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-N 119.113 0.87 . . . . 2.37 110.403 170.963 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -158.02 148.16 20.28 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 123.538 0.735 . . . . 1.53 110.073 179.923 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -156.19 118.37 4.03 Favored 'General case' 0 C--O 1.232 0.143 0 N-CA-C 107.723 -1.214 . . . . 0.63 107.723 -163.364 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.0 p -89.92 101.4 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 C-N-CA 123.082 0.553 . . . . 1.66 110.232 -177.07 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 51.4 t-20 -84.07 56.7 3.83 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-O 122.693 1.235 . . . . 0.82 109.277 179.629 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.07 -19.92 64.08 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 115.229 -0.896 . . . . 2.1 110.152 -175.467 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -46.91 -36.8 8.01 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.032 0.933 . . . . 1.58 112.363 166.752 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 14.5 t -115.5 23.67 12.2 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 118.499 0.59 . . . . 1.8 111.327 174.161 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 55.04 50.37 15.56 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.4 1.08 . . . . 3.55 112.859 -179.706 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 7.1 m -145.9 154.78 42.33 Favored 'General case' 0 N--CA 1.445 -0.722 0 O-C-N 120.418 -1.426 . . . . 1.91 109.045 178.844 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.3 p -117.81 144.37 25.97 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 N-CA-C 108.455 -0.943 . . . . 1.71 108.455 171.347 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -124.68 142.62 51.25 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 108.153 -1.055 . . . . 0.39 108.153 176.985 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 4.0 p -139.78 129.35 29.09 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 N-CA-C 106.822 -1.548 . . . . 2.84 106.822 -174.993 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 14.5 mm -108.31 89.03 1.21 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.654 0 C-N-CA 126.007 1.723 . . . . 2.13 107.711 -167.461 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 34.7 p90 -137.12 172.9 12.32 Favored 'General case' 0 CA--C 1.511 -0.542 0 C-N-CA 122.671 0.388 . . . . 2.83 111.967 -167.703 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 66.4 t0 -93.36 104.71 13.06 Favored Pre-proline 0 C--O 1.236 0.345 0 O-C-N 125.094 1.496 . . . . 3.08 110.177 -179.412 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -73.71 3.19 5.11 Favored 'Trans proline' 0 N--CA 1.448 -1.154 0 C-N-CA 122.003 1.802 . . . . 0.87 112.447 -179.286 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -82.23 -29.35 31.38 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 119.819 1.19 . . . . 2.16 109.205 165.726 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -108.32 -55.99 2.31 Favored 'General case' 0 C--N 1.343 0.317 0 C-N-CA 122.797 0.439 . . . . 2.52 110.308 -166.355 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.31 0.6 OUTLIER -89.05 177.54 6.62 Favored 'General case' 0 CA--C 1.514 -0.432 0 CA-C-O 123.312 1.53 . . . . 1.61 114.212 160.345 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -160.02 -135.9 1.93 Allowed Glycine 0 N--CA 1.433 -1.567 0 N-CA-C 103.978 -3.649 . . . . 2.54 103.978 175.43 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 23.6 p -76.57 -35.29 58.28 Favored 'General case' 0 N--CA 1.444 -0.751 0 C-N-CA 127.031 2.132 . . . . 2.46 109.75 177.917 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -49.48 -62.8 1.35 Allowed 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 125.49 1.516 . . . . 1.7 113.926 -165.379 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.83 -35.0 69.76 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 114.676 -1.147 . . . . 1.61 108.472 -168.364 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.8 mt -54.26 -57.18 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.908 0 C-N-CA 125.95 1.7 . . . . 2.73 111.179 173.155 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.69 -45.22 95.01 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 119.804 1.184 . . . . 1.15 109.626 -179.724 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -49.56 -59.36 3.84 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-O 121.392 0.615 . . . . 3.24 111.958 176.756 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 4.7 mmpt? -63.61 -40.53 97.16 Favored 'General case' 0 N--CA 1.437 -1.087 0 CA-C-O 118.459 -0.781 . . . . 2.83 111.096 -179.452 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.3 mm -49.01 -54.3 5.69 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.558 0 C-N-CA 124.171 0.989 . . . . 1.61 108.441 177.204 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 27.0 mm-40 -59.32 -55.71 31.34 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 123.594 0.757 . . . . 1.62 110.436 177.0 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 10.2 mmtt -57.11 -36.48 70.69 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 112.905 0.706 . . . . 5.3 112.905 -174.931 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 13.0 mt -71.11 -17.8 62.55 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.889 1.276 . . . . 1.76 112.144 175.874 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 96.96 39.47 4.06 Favored Glycine 0 CA--C 1.523 0.589 0 C-N-CA 124.571 1.082 . . . . 0.5 111.093 175.36 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -135.31 175.86 9.2 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 124.131 0.972 . . . . 3.34 110.303 -178.39 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 22.4 t-160 -143.86 133.55 23.7 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 107.711 -1.218 . . . . 3.44 107.711 172.631 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 6.5 p -108.86 139.99 29.28 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 C-N-CA 125.296 1.439 . . . . 2.4 107.407 179.782 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 86.3 t -108.72 138.74 34.23 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.137 0 CA-C-O 121.833 0.825 . . . . 1.74 109.069 -179.566 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 45.8 mm . . . . . 0 N--CA 1.451 -0.416 0 C-N-CA 125.224 1.41 . . . . 2.58 109.123 -169.767 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.5 ttm . . . . . 0 N--CA 1.47 0.54 0 N-CA-C 106.048 -1.834 . . . . 11.84 106.048 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.1 tt -161.66 -74.94 0.05 Allowed 'General case' 0 C--O 1.224 -0.256 0 N-CA-C 107.727 -1.212 . . . . 6.85 107.727 172.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.3 m 48.71 93.18 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 126.057 1.743 . . . . 1.65 112.068 176.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -72.76 174.97 6.91 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 108.472 -0.936 . . . . 2.31 108.472 179.245 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -129.45 141.09 51.11 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 107.304 -1.369 . . . . 1.04 107.304 168.429 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 6.8 mtpm? -139.76 158.43 44.12 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-O 122.225 1.012 . . . . 4.35 109.661 168.028 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -112.67 107.4 16.06 Favored 'General case' 0 N--CA 1.431 -1.402 0 C-N-CA 130.03 3.332 . . . . 1.59 104.974 -171.734 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 2.2 pp -84.12 167.02 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 C-N-CA 118.917 -1.113 . . . . 6.01 108.599 166.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -137.76 134.01 34.76 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 105.174 -2.158 . . . . 1.34 105.174 170.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 24.2 ptt? -153.11 168.57 25.49 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 118.492 0.587 . . . . 4.1 109.75 178.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 19.9 mm100 -92.81 163.99 13.51 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 124.122 0.969 . . . . 2.46 109.819 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.9 m -124.17 157.16 31.58 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.126 0 C-N-CA 125.403 1.481 . . . . 3.32 110.08 179.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 38.5 m -155.04 166.7 32.75 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 124.8 1.24 . . . . 1.83 108.655 170.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 63.11 74.66 0.4 Allowed Glycine 0 CA--C 1.528 0.877 0 N-CA-C 110.845 -0.902 . . . . 1.83 110.845 178.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -146.71 155.97 42.81 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 123.228 0.611 . . . . 3.08 110.526 -175.096 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -85.6 -62.81 1.44 Allowed 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 125.915 1.686 . . . . 4.74 109.644 172.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.6 p -155.07 161.04 41.42 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 121.724 0.773 . . . . 2.27 112.085 -169.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -72.93 56.1 0.41 Allowed 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 126.751 2.02 . . . . 2.36 111.112 -178.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -152.6 -52.57 0.11 Allowed 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 124.804 1.242 . . . . 1.66 108.448 -175.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 30.9 m -59.07 -39.26 81.57 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 108.904 -0.776 . . . . 1.16 108.904 170.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -41.3 -36.83 0.86 Allowed 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.663 1.585 . . . . 1.98 112.697 166.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -69.75 -53.91 16.18 Favored 'General case' 0 N--CA 1.452 -0.34 0 O-C-N 120.228 -1.545 . . . . 1.69 109.264 175.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 2.5 mpp_? -57.08 -36.68 70.86 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-O 118.166 -0.921 . . . . 5.59 111.639 -174.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.281 2.0 pt -56.78 -57.19 10.47 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 C-N-CA 119.342 -0.943 . . . . 1.92 110.742 175.079 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -57.13 -45.66 83.33 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 123.533 0.733 . . . . 2.32 112.08 178.001 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 13.4 mptt -66.73 -43.25 84.69 Favored 'General case' 0 CA--C 1.531 0.22 0 O-C-N 121.683 -0.636 . . . . 2.73 109.838 -174.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -60.33 -44.37 97.61 Favored Glycine 0 CA--C 1.527 0.811 0 N-CA-C 110.024 -1.23 . . . . 0.61 110.024 171.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -60.39 -40.91 92.62 Favored 'General case' 0 CA--C 1.532 0.255 0 O-C-N 122.48 -0.423 . . . . 3.48 110.069 -175.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 19.9 ttmt -43.5 -32.25 0.86 Allowed 'General case' 0 CA--C 1.535 0.369 0 O-C-N 121.747 -0.596 . . . . 4.01 112.405 173.133 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.93 -4.2 30.58 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 113.588 0.958 . . . . 6.95 113.588 -172.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.83 166.39 37.78 Favored Pre-proline 0 CA--C 1.539 0.537 0 C-N-CA 125.111 1.364 . . . . 4.52 111.655 173.232 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_endo -70.5 157.1 59.97 Favored 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 122.881 2.387 . . . . 1.49 110.629 -178.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 72.46 -36.15 0.68 Allowed Glycine 0 CA--C 1.525 0.71 0 C-N-CA 124.972 1.273 . . . . 1.07 112.798 -179.031 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.5 t -68.45 144.78 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.732 0 CA-C-N 118.411 1.106 . . . . 1.86 109.286 176.113 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -133.16 -39.24 0.94 Allowed 'General case' 0 N--CA 1.451 -0.377 0 CA-C-O 118.705 -0.664 . . . . 1.89 110.945 179.196 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -139.55 166.28 25.0 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-N 119.251 0.932 . . . . 2.62 111.963 166.055 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -158.17 138.32 12.44 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 115.659 -0.7 . . . . 1.61 110.322 -176.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -149.62 109.83 4.16 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 106.206 -1.776 . . . . 0.47 106.206 -163.681 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.7 p -81.48 119.09 30.41 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 N-CA-C 108.523 -0.917 . . . . 1.6 108.523 177.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 55.7 t-20 -99.65 57.28 1.01 Allowed 'General case' 0 C--O 1.236 0.352 0 CA-C-O 123.017 1.389 . . . . 0.78 107.803 -178.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.48 -19.92 63.75 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 114.095 -1.411 . . . . 2.03 110.372 -172.773 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -46.21 -37.0 6.57 Favored 'General case' 0 C--N 1.34 0.189 0 C-N-CA 123.974 0.91 . . . . 1.56 111.839 168.086 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 14.9 t -124.31 37.19 4.46 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 109.831 -0.433 . . . . 1.57 109.831 173.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 52.12 31.98 9.77 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 126.317 1.847 . . . . 2.99 113.034 171.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 95.6 m -122.99 159.92 27.34 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 125.07 1.348 . . . . 1.8 108.536 -175.28 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 6.5 p -129.03 143.96 39.65 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 O-C-N 121.249 -0.907 . . . . 1.69 109.413 172.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 20.1 m120 -127.84 138.9 52.86 Favored 'General case' 0 C--N 1.344 0.354 0 N-CA-C 107.774 -1.195 . . . . 0.37 107.774 179.198 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 93.3 t -134.17 125.46 48.05 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 N-CA-C 105.062 -2.199 . . . . 3.06 105.062 -174.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 13.7 mm -104.4 101.0 11.67 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 C-N-CA 126.249 1.82 . . . . 1.69 107.983 -175.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 41.9 p90 -142.23 173.04 11.89 Favored 'General case' 0 CA--C 1.513 -0.457 0 O-C-N 121.785 -0.572 . . . . 2.9 111.183 -172.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -92.97 115.17 64.52 Favored Pre-proline 0 CA--C 1.534 0.343 0 O-C-N 124.199 0.937 . . . . 3.04 108.884 173.188 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -81.76 13.08 2.56 Favored 'Trans proline' 0 N--CA 1.451 -0.998 0 C-N-CA 122.465 2.11 . . . . 0.75 113.386 -176.054 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -92.35 -32.27 15.04 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 119.45 1.023 . . . . 2.01 109.588 164.052 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -101.1 -55.43 2.56 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 108.495 -0.928 . . . . 2.69 108.495 -169.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.499 0.2 OUTLIER -83.67 176.75 8.75 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 115.301 1.593 . . . . 1.71 115.301 155.845 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -171.31 -147.54 5.7 Favored Glycine 0 N--CA 1.434 -1.454 0 N-CA-C 103.126 -3.99 . . . . 2.52 103.126 -174.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 23.6 p -76.75 -32.58 57.85 Favored 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 125.108 1.363 . . . . 2.35 109.551 174.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -49.98 -61.59 2.06 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 124.723 1.209 . . . . 2.07 113.282 -162.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.0 -34.21 73.02 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 114.408 -1.269 . . . . 1.81 108.765 -171.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.6 mp -60.68 -51.41 73.42 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.95 0 CA-C-N 114.999 -1.0 . . . . 2.61 109.79 178.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.49 -47.11 85.43 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 108.828 -0.804 . . . . 1.4 108.828 -178.068 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -48.7 -54.64 14.03 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 122.038 0.923 . . . . 3.19 110.974 174.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.07 -47.17 81.17 Favored 'General case' 0 N--CA 1.44 -0.973 0 CA-C-O 118.664 -0.684 . . . . 3.24 111.776 -178.524 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.2 mm -46.76 -50.99 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 C-N-CA 126.412 1.885 . . . . 1.9 109.033 -177.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -57.73 -57.58 12.12 Favored 'General case' 0 C--N 1.34 0.159 0 C-N-CA 123.387 0.675 . . . . 1.49 110.173 175.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 13.9 mmtt -55.45 -35.6 65.64 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 112.963 0.727 . . . . 5.52 112.963 -178.14 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 31.6 mt -71.07 -18.35 62.56 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.74 1.616 . . . . 1.83 111.451 177.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 87.15 44.17 5.73 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 110.593 -1.003 . . . . 0.87 110.593 178.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -137.93 172.97 12.14 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 124.094 0.957 . . . . 4.0 109.72 179.125 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 8.3 t60 -146.35 133.9 20.92 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 109.239 -0.652 . . . . 3.11 109.239 165.048 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 4.5 m -98.8 161.05 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 C-N-CA 123.823 0.849 . . . . 3.77 110.15 176.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 12.0 t -129.55 141.9 45.31 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 C-N-CA 124.902 1.281 . . . . 1.83 107.843 -176.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 28.7 mm -118.59 80.5 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 C-N-CA 125.025 1.33 . . . . 2.95 108.426 -175.203 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -79.56 -1.35 37.41 Favored 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 124.503 1.121 . . . . 2.89 113.97 176.012 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -94.63 -34.67 6.2 Favored Glycine 0 CA--C 1.531 1.053 0 C-N-CA 125.39 1.471 . . . . 3.1 113.567 -173.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 46.8 ttm-85 . . . . . 0 C--O 1.25 1.081 0 CA-C-O 116.779 -1.582 . . . . 12.11 108.85 178.403 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 34.5 mtt . . . . . 0 N--CA 1.475 0.777 0 N-CA-C 109.478 -0.564 . . . . 10.91 109.478 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -53.19 -46.34 68.95 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.215 0.606 . . . . 6.74 109.789 -178.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 55.1 m -115.03 163.15 16.01 Favored 'General case' 0 N--CA 1.447 -0.624 0 C-N-CA 125.93 1.692 . . . . 1.56 106.507 162.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -111.33 -174.7 2.53 Favored 'General case' 0 N--CA 1.439 -1.025 0 C-N-CA 125.487 1.515 . . . . 2.34 107.257 156.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -136.28 152.01 50.25 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 107.473 -1.306 . . . . 1.17 107.473 172.711 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 23.9 mttt -143.67 163.35 33.5 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 122.937 0.495 . . . . 3.37 110.286 161.075 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -122.47 84.81 2.32 Favored 'General case' 0 N--CA 1.44 -0.969 0 C-N-CA 128.687 2.795 . . . . 1.56 106.009 -166.429 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 3.1 mp -82.49 160.6 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.405 0 N-CA-C 105.691 -1.966 . . . . 2.99 105.691 -178.15 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -120.35 132.92 55.49 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 106.243 -1.762 . . . . 1.72 106.243 178.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 2.8 ttm -138.54 161.63 36.57 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 108.355 -0.98 . . . . 3.15 108.355 -177.161 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -97.42 146.91 24.74 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 124.235 1.014 . . . . 2.42 108.936 177.078 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 49.1 t -103.85 149.76 7.52 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 C-N-CA 123.77 0.828 . . . . 2.23 109.019 -178.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 56.3 m -152.93 164.88 37.1 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 118.866 0.757 . . . . 1.94 110.092 171.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 64.02 72.13 0.74 Allowed Glycine 0 CA--C 1.527 0.84 0 N-CA-C 110.93 -0.868 . . . . 1.73 110.93 178.2 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -154.78 170.11 22.37 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 123.825 0.85 . . . . 3.09 109.857 -172.727 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -111.87 -44.64 3.43 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 123.922 0.889 . . . . 3.38 111.229 168.642 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 20.0 p -147.97 176.43 10.17 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 119.111 0.869 . . . . 2.66 111.631 -174.105 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -72.26 -24.41 61.36 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 115.508 -0.769 . . . . 3.39 111.809 177.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.7 -49.7 72.09 Favored 'General case' 0 C--O 1.233 0.209 0 O-C-N 121.377 -0.827 . . . . 1.92 110.79 -175.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 5.2 p -65.06 -38.96 92.49 Favored 'General case' 0 CA--C 1.532 0.279 0 O-C-N 121.633 -0.667 . . . . 2.45 110.518 173.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.61 -29.28 61.97 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-O 121.386 0.613 . . . . 1.52 112.074 173.242 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -69.9 -53.41 18.07 Favored 'General case' 0 N--CA 1.45 -0.445 0 O-C-N 119.935 -1.728 . . . . 1.66 108.791 171.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -46.67 -50.96 16.99 Favored 'General case' 0 C--N 1.341 0.231 0 CA-C-O 118.486 -0.769 . . . . 4.86 110.755 178.109 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.268 3.4 pt -57.09 -58.21 6.78 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.159 0 C-N-CA 119.727 -0.789 . . . . 1.71 110.69 -176.302 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -51.96 -45.47 64.4 Favored 'General case' 0 N--CA 1.457 -0.095 0 CA-C-N 119.006 0.821 . . . . 2.42 111.068 179.184 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.36 -40.15 85.75 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 119.585 -0.846 . . . . 2.45 110.895 -177.239 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -68.93 -24.62 75.7 Favored Glycine 0 CA--C 1.529 0.916 0 O-C-N 121.542 -0.724 . . . . 0.64 111.633 174.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -70.1 -43.92 70.06 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 108.11 -1.07 . . . . 2.58 108.11 173.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 3.4 ttpp -50.0 -24.67 2.74 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 125.323 1.449 . . . . 3.16 113.505 173.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -83.24 -0.21 48.48 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 118.443 -0.789 . . . . 4.95 112.942 -179.5 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 4.0 ptm -93.96 156.0 39.66 Favored Pre-proline 0 CA--C 1.536 0.43 0 CA-C-N 119.31 0.959 . . . . 4.01 111.658 -178.144 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -62.13 133.22 42.78 Favored 'Trans proline' 0 N--CA 1.456 -0.711 0 C-N-CA 122.433 2.089 . . . . 0.87 109.809 173.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 100.11 -39.2 2.82 Favored Glycine 0 CA--C 1.525 0.7 0 CA-C-O 119.08 -0.844 . . . . 0.91 112.595 176.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 47.5 t -88.02 118.66 34.12 Favored 'Isoleucine or valine' 0 C--N 1.343 0.314 0 CA-C-N 118.796 1.298 . . . . 1.84 110.143 177.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 98.1 m -88.82 -52.66 5.0 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-O 118.76 -0.638 . . . . 2.36 110.058 -176.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -138.23 161.26 37.3 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 123.838 0.855 . . . . 2.72 108.757 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -158.22 141.03 14.71 Favored 'General case' 0 C--O 1.238 0.454 0 O-C-N 121.923 -0.486 . . . . 1.38 111.255 -173.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -151.37 110.07 3.83 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 106.648 -1.612 . . . . 0.47 106.648 -165.118 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.7 p -80.97 136.07 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 N-CA-C 107.816 -1.179 . . . . 1.86 107.816 176.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 52.7 t-20 -121.97 56.01 1.1 Allowed 'General case' 0 C--O 1.235 0.342 0 CA-C-O 123.03 1.395 . . . . 0.84 107.929 -176.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.09 -19.55 64.87 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 113.807 -1.542 . . . . 2.1 110.615 -176.018 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -45.46 -37.88 5.63 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 124.067 0.947 . . . . 1.68 111.948 165.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 12.2 t -124.53 38.18 4.25 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 109.063 -0.717 . . . . 1.61 109.063 172.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 53.77 24.1 4.18 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.773 1.629 . . . . 3.25 113.78 171.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 88.0 m -116.51 162.91 16.86 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.814 1.245 . . . . 1.66 108.878 -174.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.4 p -125.94 145.42 33.42 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 C-N-CA 124.536 1.135 . . . . 1.63 108.044 167.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 10.2 m120 -124.17 136.86 54.5 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 107.494 -1.299 . . . . 0.35 107.494 172.519 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.1 p -134.93 123.66 41.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 106.252 -1.759 . . . . 2.96 106.252 -173.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 13.5 mm -104.32 94.72 3.32 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 N-CA-C 107.194 -1.41 . . . . 1.78 107.194 -168.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 31.1 p90 -131.28 164.26 26.0 Favored 'General case' 0 CA--C 1.512 -0.506 0 O-C-N 122.203 -0.31 . . . . 2.85 111.691 -169.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 35.7 t0 -83.53 109.23 16.63 Favored Pre-proline 0 CA--C 1.532 0.279 0 O-C-N 124.444 1.09 . . . . 3.02 109.553 174.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -74.22 4.87 3.97 Favored 'Trans proline' 0 N--CA 1.451 -0.981 0 C-N-CA 122.663 2.242 . . . . 0.72 113.06 -176.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -85.44 -28.68 24.91 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 119.338 0.972 . . . . 1.73 109.215 166.428 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -102.52 -61.16 1.43 Allowed 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 107.941 -1.133 . . . . 4.3 107.941 -169.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.283 0.7 OUTLIER -86.75 -176.46 5.8 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 124.933 1.293 . . . . 1.92 112.901 162.489 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 131.78 94.02 0.61 Allowed Glycine 0 N--CA 1.442 -0.903 0 N-CA-C 103.515 -3.834 . . . . 2.31 103.515 -144.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 75.0 p -19.17 -23.25 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.308 1 C-N-CA 138.132 6.573 . . . . 2.0 118.809 -147.43 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -28.21 -62.54 0.1 Allowed 'General case' 0 N--CA 1.442 -0.846 0 C-N-CA 126.503 1.921 . . . . 2.0 113.19 165.174 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -75.27 -32.43 61.05 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 118.396 -1.322 . . . . 2.11 110.014 -168.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.6 mp -60.17 -51.72 69.6 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.625 0 CA-C-N 115.579 -0.737 . . . . 1.79 109.794 175.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.96 -48.21 82.63 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 119.067 0.849 . . . . 1.28 109.151 -178.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -46.13 -58.74 3.37 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-O 121.864 0.84 . . . . 2.57 111.24 174.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 15.2 mmmt -67.74 -34.69 77.33 Favored 'General case' 0 N--CA 1.441 -0.913 0 CA-C-O 118.354 -0.832 . . . . 4.65 112.082 -177.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.4 mm -53.45 -52.65 30.48 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 N-CA-C 107.943 -1.132 . . . . 1.52 107.943 176.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 40.9 mm-40 -58.15 -54.77 43.25 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 123.469 0.708 . . . . 1.54 109.837 176.123 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 13.0 mmtt -59.48 -33.85 71.84 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 113.288 0.848 . . . . 4.83 113.288 -176.325 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 32.1 mt -70.78 -18.47 62.75 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.735 1.214 . . . . 2.16 111.289 174.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 95.9 39.88 4.23 Favored Glycine 0 CA--C 1.524 0.597 0 C-N-CA 124.892 1.234 . . . . 0.82 111.007 175.173 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -136.54 175.47 9.58 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 117.805 0.803 . . . . 3.26 111.462 -174.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -130.69 147.5 52.37 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 123.487 0.715 . . . . 3.52 109.497 167.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 4.1 p -126.52 152.77 34.49 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 N-CA-C 106.581 -1.637 . . . . 2.47 106.581 176.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 11.6 t -129.31 141.89 45.4 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 N-CA-C 107.032 -1.47 . . . . 2.02 107.032 -178.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 5.0 mp -113.05 80.86 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.201 0 N-CA-C 108.759 -0.83 . . . . 2.66 108.759 -175.04 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 26.2 mm-40 -76.77 -2.51 33.49 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 125.648 1.579 . . . . 3.4 113.642 174.249 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -129.83 61.45 0.66 Allowed Glycine 0 CA--C 1.523 0.549 0 N-CA-C 108.252 -1.939 . . . . 4.06 108.252 175.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 5.6 ttt-85 . . . . . 0 C--O 1.251 1.136 0 CA-C-O 117.846 -1.073 . . . . 13.96 112.867 -175.386 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.473 0.722 0 N-CA-C 107.036 -1.468 . . . . 11.52 107.036 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 29.8 mt -106.55 -74.9 0.64 Allowed 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 107.781 -1.192 . . . . 5.91 107.781 175.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.9 m -137.18 140.38 41.74 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 125.795 1.638 . . . . 1.49 106.797 177.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -88.6 -178.29 5.78 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 108.359 -0.978 . . . . 1.95 108.359 163.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 2.9 mm100 -134.58 148.44 50.45 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 107.038 -1.467 . . . . 1.15 107.038 169.104 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 37.4 mtpt -140.32 156.91 46.26 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 123.415 0.686 . . . . 3.62 109.167 163.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 8.0 mp0 -115.48 89.69 3.16 Favored 'General case' 0 N--CA 1.442 -0.836 0 C-N-CA 127.746 2.418 . . . . 1.86 106.326 -170.289 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.6 mp -83.32 161.25 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.397 0 N-CA-C 105.742 -1.947 . . . . 3.01 105.742 -177.321 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -127.81 126.34 41.5 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 125.395 1.478 . . . . 1.63 107.021 177.333 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 2.7 mpp? -132.58 170.87 14.57 Favored 'General case' 0 CA--C 1.528 0.124 0 C-N-CA 123.419 0.688 . . . . 3.0 109.204 173.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 18.5 mm100 -97.66 145.27 26.47 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 124.438 1.095 . . . . 2.61 109.476 178.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 60.3 t -97.5 151.22 4.33 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.158 0 N-CA-C 108.938 -0.764 . . . . 2.26 108.938 178.316 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 13.0 t -141.77 176.77 8.65 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 108.196 -1.039 . . . . 2.09 108.196 170.284 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 53.14 57.53 14.66 Favored Glycine 0 CA--C 1.529 0.909 0 C-N-CA 124.112 0.863 . . . . 1.53 111.573 -178.306 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -139.78 137.98 35.49 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 123.767 0.827 . . . . 2.63 109.557 -179.344 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -144.44 8.14 1.35 Allowed 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.809 0.843 . . . . 4.68 112.716 166.789 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 8.8 m -108.97 -21.0 12.84 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 124.691 1.196 . . . . 3.39 111.825 -171.408 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 64.46 -68.06 0.1 Allowed 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.707 1.603 . . . . 2.79 110.881 -165.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -44.13 -49.66 8.88 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 125.81 1.644 . . . . 1.87 112.603 -175.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 96.6 m -52.54 -35.76 54.18 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 123.953 0.901 . . . . 1.19 113.126 -178.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.35 -23.24 67.32 Favored 'General case' 0 CA--C 1.539 0.557 0 O-C-N 122.034 -0.416 . . . . 1.74 111.157 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.13 -52.78 17.36 Favored 'General case' 0 N--CA 1.454 -0.245 0 O-C-N 121.028 -1.045 . . . . 1.61 109.592 171.13 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 4.2 mtt-85 -50.97 -47.99 61.23 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 123.379 0.672 . . . . 4.91 110.219 -176.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 6.8 pt -57.24 -55.07 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.196 0 C-N-CA 119.751 -0.779 . . . . 1.78 111.121 179.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -54.17 -42.96 70.21 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.753 0.821 . . . . 3.19 111.92 179.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 31.9 mmtp -70.66 -47.34 60.44 Favored 'General case' 0 CA--C 1.534 0.357 0 O-C-N 121.061 -1.024 . . . . 3.06 110.914 -178.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.37 -28.36 70.9 Favored Glycine 0 CA--C 1.53 0.995 0 O-C-N 121.545 -0.722 . . . . 0.64 111.349 174.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.1 tt -68.86 -47.87 64.87 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 125.789 1.636 . . . . 3.02 109.215 174.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.2 ttmm -50.45 -34.7 25.66 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 118.664 0.665 . . . . 3.59 111.713 175.149 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 14.5 mmt-85 -62.69 -7.15 4.34 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 114.877 1.436 . . . . 5.64 114.877 179.338 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 27.4 mtm -71.56 169.72 14.61 Favored Pre-proline 0 CA--C 1.533 0.312 0 CA-C-N 120.355 1.434 . . . . 4.19 112.44 170.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -60.78 162.78 17.57 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 121.777 1.651 . . . . 1.01 110.039 159.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 77.33 -38.72 1.63 Allowed Glycine 0 C--N 1.333 0.373 0 C-N-CA 125.88 1.705 . . . . 0.87 114.02 171.455 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 16.3 t -83.66 134.08 27.73 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.875 0 C-N-CA 123.054 0.542 . . . . 1.74 109.603 -177.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 88.0 m -113.6 -46.45 3.05 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 122.948 0.499 . . . . 2.09 110.276 -175.183 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -139.48 165.13 28.05 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-N 118.047 0.385 . . . . 1.74 110.144 173.347 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -158.02 139.03 13.22 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 108.721 -0.844 . . . . 1.48 108.721 -172.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -155.93 111.85 3.05 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 123.258 0.623 . . . . 0.49 109.347 -165.571 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 4.8 p -86.79 102.57 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 CA-C-O 121.224 0.535 . . . . 1.72 109.991 -177.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 51.7 t-20 -86.31 56.97 4.23 Favored 'General case' 0 C--O 1.235 0.333 0 O-C-N 120.687 -1.258 . . . . 0.78 109.423 -179.213 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -69.47 -19.86 63.75 Favored 'General case' 0 C--O 1.226 -0.158 0 CA-C-N 115.003 -0.998 . . . . 1.99 110.972 -176.195 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -45.27 -36.98 4.33 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.665 0.786 . . . . 1.67 112.078 166.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 11.3 t -123.38 30.21 6.37 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 122.494 0.318 . . . . 1.7 110.964 172.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 62.11 26.83 16.16 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.348 1.459 . . . . 2.51 114.297 172.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 88.4 m -120.32 163.13 18.29 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.79 1.236 . . . . 1.7 109.524 -174.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 5.8 p -129.91 142.92 42.58 Favored 'Isoleucine or valine' 0 C--O 1.232 0.15 0 C-N-CA 124.302 1.041 . . . . 1.76 108.835 171.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 10.4 m120 -126.12 129.79 49.78 Favored 'General case' 0 CA--C 1.517 -0.296 0 N-CA-C 108.151 -1.055 . . . . 0.36 108.151 177.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 6.7 p -128.38 128.92 68.84 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 106.331 -1.729 . . . . 3.04 106.331 -175.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 7.9 mm -104.97 100.65 10.98 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 N-CA-C 107.15 -1.426 . . . . 1.63 107.15 -172.003 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 50.2 p90 -138.46 165.15 27.55 Favored 'General case' 0 CA--C 1.516 -0.341 0 O-C-N 122.226 -0.296 . . . . 2.9 111.626 -172.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 37.7 t0 -85.97 110.68 32.43 Favored Pre-proline 0 C--O 1.236 0.382 0 O-C-N 124.458 1.099 . . . . 2.97 108.858 175.12 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -71.5 4.26 3.09 Favored 'Trans proline' 0 N--CA 1.452 -0.957 0 C-N-CA 122.772 2.315 . . . . 0.63 113.135 -178.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -89.2 -27.32 20.73 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 119.478 1.035 . . . . 1.76 109.397 168.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -104.63 -51.53 3.06 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 109.575 -0.528 . . . . 2.88 109.575 -171.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.285 1.1 p -97.7 -177.48 3.8 Favored 'General case' 0 CA--C 1.518 -0.252 0 C-N-CA 123.993 0.917 . . . . 1.65 112.275 160.76 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 145.32 88.6 0.09 OUTLIER Glycine 0 N--CA 1.441 -1.011 0 N-CA-C 104.448 -3.461 . . . . 2.52 104.448 -155.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 45.1 p -13.07 -17.96 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.556 1 C-N-CA 137.936 6.494 . . . . 2.49 119.956 -143.228 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -27.61 -63.48 0.09 Allowed 'General case' 0 N--CA 1.443 -0.803 0 C-N-CA 127.01 2.124 . . . . 1.53 114.317 166.405 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.73 -37.3 65.14 Favored 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 118.485 -1.286 . . . . 1.71 109.069 -168.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.5 mp -53.93 -57.5 5.53 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.808 0 CA-C-N 114.402 -1.272 . . . . 2.37 109.884 175.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.04 -48.0 81.42 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 119.047 0.84 . . . . 1.23 109.55 -178.414 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -45.57 -57.39 4.2 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 123.312 0.645 . . . . 3.25 111.932 176.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.7 mmmm -68.3 -42.34 79.61 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-O 118.545 -0.741 . . . . 4.62 111.376 -179.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -46.0 -52.65 2.84 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 C-N-CA 125.003 1.321 . . . . 1.83 108.579 177.048 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -59.45 -58.44 8.61 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 124.503 1.121 . . . . 1.54 110.545 176.391 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -55.62 -34.87 65.28 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 113.006 0.743 . . . . 4.57 113.006 -176.792 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 26.6 mt -68.87 -17.32 63.97 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.774 1.229 . . . . 1.53 111.721 177.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 92.11 43.47 4.38 Favored Glycine 0 CA--C 1.522 0.531 0 N-CA-C 110.129 -1.189 . . . . 0.45 110.129 178.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -141.46 171.52 13.94 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 124.189 0.996 . . . . 3.35 110.015 -176.364 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 8.8 t-80 -143.71 127.48 17.2 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 107.842 -1.17 . . . . 2.92 107.842 172.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 5.8 p -97.22 151.74 4.15 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 N-CA-C 108.114 -1.069 . . . . 2.35 108.114 174.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 38.3 t -120.0 139.76 46.26 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 C-N-CA 125.173 1.389 . . . . 1.67 108.358 -179.455 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 26.7 mm -102.48 64.6 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 122.119 0.961 . . . . 1.98 109.737 -169.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -65.66 -14.39 61.12 Favored 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 114.193 1.183 . . . . 3.31 114.193 -173.771 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -64.36 -36.93 93.81 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 125.101 1.334 . . . . 2.66 111.676 175.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 2.1 tpm_? . . . . . 0 C--O 1.255 1.378 0 C-N-CA 125.861 1.665 . . . . 12.9 113.739 177.492 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 33.1 mtt . . . . . 0 N--CA 1.474 0.764 0 N-CA-C 108.936 -0.765 . . . . 10.27 108.936 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 11.1 tp -110.71 156.19 21.38 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 107.42 -1.326 . . . . 5.95 107.42 175.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.7 m -64.5 99.43 0.3 Allowed 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 108.655 -0.868 . . . . 1.39 108.655 172.057 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -69.78 176.57 3.54 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 109.146 -0.687 . . . . 2.3 109.146 173.133 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.67 155.07 45.6 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 124.205 1.002 . . . . 0.93 108.431 176.39 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 10.8 ttmt -147.33 158.85 44.12 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 107.733 -1.21 . . . . 4.02 107.733 168.268 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -119.13 98.68 6.29 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 127.728 2.411 . . . . 1.91 104.669 -176.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 23.0 mm -84.37 164.32 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.171 0 N-CA-C 106.839 -1.541 . . . . 3.27 106.839 173.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -134.18 124.83 26.67 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 107.065 -1.458 . . . . 1.73 107.065 176.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 24.7 mtm -134.63 172.87 12.33 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.62 0.768 . . . . 2.86 109.101 -179.145 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 21.5 mm100 -103.19 154.7 19.04 Favored 'General case' 0 C--O 1.222 -0.35 0 C-N-CA 125.394 1.477 . . . . 2.45 109.313 178.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.3 m -117.98 165.37 13.39 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 CA-C-N 119.38 0.991 . . . . 3.12 110.419 174.274 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 53.8 m -137.74 171.04 15.03 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.231 1.412 . . . . 1.76 108.902 175.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 80.03 -44.82 2.87 Favored Glycine 0 CA--C 1.533 1.187 0 C-N-CA 123.488 0.566 . . . . 3.19 113.311 173.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -38.55 122.37 1.11 Allowed 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 125.13 1.372 . . . . 3.23 113.319 -177.231 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -139.48 12.53 2.55 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.896 0.878 . . . . 4.17 112.014 177.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 8.9 m -115.59 -26.48 7.47 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 125.528 1.531 . . . . 3.44 111.512 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 64.68 -63.71 0.17 Allowed 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.646 1.578 . . . . 2.55 110.482 -162.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -41.59 -54.66 3.14 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 125.895 1.678 . . . . 2.14 112.748 -179.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 90.0 m -55.82 -31.43 62.68 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 113.183 0.808 . . . . 1.48 113.183 -178.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.4 -26.8 68.09 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 121.108 0.48 . . . . 1.65 110.514 176.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.93 -50.74 31.42 Favored 'General case' 0 N--CA 1.452 -0.354 0 O-C-N 120.321 -1.487 . . . . 1.72 109.053 170.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 55.2 mtm180 -51.33 -46.32 62.6 Favored 'General case' 0 N--CA 1.456 -0.154 0 CA-C-O 118.871 -0.585 . . . . 6.27 110.978 -177.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 4.5 pt -58.43 -55.86 19.96 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.237 0 C-N-CA 119.784 -0.766 . . . . 1.78 110.681 178.098 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -53.29 -42.28 66.45 Favored 'General case' 0 C--O 1.225 -0.211 0 CA-C-N 119.568 1.076 . . . . 2.69 111.715 179.804 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 32.0 mmtp -70.65 -44.93 66.1 Favored 'General case' 0 CA--C 1.536 0.414 0 O-C-N 121.228 -0.92 . . . . 3.03 110.897 -178.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -66.11 -25.8 72.28 Favored Glycine 0 CA--C 1.53 0.991 0 O-C-N 121.583 -0.698 . . . . 1.01 111.875 176.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 7.7 tt -70.38 -53.73 15.38 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 126.915 2.086 . . . . 2.87 107.693 172.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -51.1 -18.51 0.86 Allowed 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 126.658 1.983 . . . . 4.39 113.987 179.114 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -72.74 -16.05 61.66 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.044 1.338 . . . . 5.03 113.035 176.365 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 7.1 ptp -68.01 160.28 75.18 Favored Pre-proline 0 CA--C 1.537 0.456 0 CA-C-N 118.934 0.788 . . . . 4.4 111.178 -179.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -61.51 134.75 53.06 Favored 'Trans proline' 0 N--CA 1.454 -0.829 0 C-N-CA 121.622 1.548 . . . . 0.67 109.287 167.064 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 106.58 -54.16 0.59 Allowed Glycine 0 CA--C 1.529 0.943 0 C-N-CA 124.558 1.075 . . . . 1.0 111.933 174.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 56.2 t -73.24 113.11 10.58 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 O-C-N 120.912 -1.346 . . . . 1.91 110.914 -173.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -80.83 -48.08 12.93 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-O 117.745 -1.122 . . . . 2.39 108.712 -179.505 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -140.65 156.93 46.11 Favored 'General case' 0 C--N 1.342 0.264 0 CA-C-N 119.249 0.931 . . . . 2.26 110.496 -177.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -154.96 148.56 25.33 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 112.23 0.455 . . . . 1.72 112.23 179.08 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -155.93 124.14 5.78 Favored 'General case' 0 C--N 1.342 0.245 0 N-CA-C 108.75 -0.833 . . . . 0.56 108.75 -165.487 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 6.6 p -93.13 107.46 19.17 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 C-N-CA 123.694 0.798 . . . . 1.89 109.614 -177.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 52.8 t-20 -88.89 58.36 4.56 Favored 'General case' 0 C--O 1.238 0.469 0 O-C-N 120.492 -1.38 . . . . 0.81 109.364 -177.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -68.27 -19.43 64.71 Favored 'General case' 0 N--CA 1.457 -0.114 0 CA-C-N 114.459 -1.246 . . . . 1.8 111.393 -175.223 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -45.85 -35.77 4.75 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 123.601 0.76 . . . . 1.84 111.922 166.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 5.3 t -124.58 34.47 5.01 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.063 0.545 . . . . 1.79 109.856 173.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 51.79 25.71 3.11 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.609 1.564 . . . . 2.78 113.547 175.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 6.9 m -113.51 163.83 14.41 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.582 1.153 . . . . 1.9 108.468 -176.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.7 p -131.5 144.82 36.39 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.121 0 C-N-CA 124.442 1.097 . . . . 1.58 108.947 173.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 20.7 m120 -129.55 133.49 47.24 Favored 'General case' 0 C--N 1.342 0.271 0 C-N-CA 124.219 1.008 . . . . 0.39 108.399 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 40.1 t -128.74 123.67 59.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 N-CA-C 105.415 -2.069 . . . . 3.09 105.415 -177.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 13.5 mm -101.46 94.46 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 N-CA-C 106.978 -1.49 . . . . 1.59 106.978 -173.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 28.8 p90 -135.17 173.82 11.29 Favored 'General case' 0 CA--C 1.508 -0.657 0 O-C-N 122.118 -0.364 . . . . 2.98 111.331 -167.188 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 47.5 p-10 -97.12 109.03 47.52 Favored Pre-proline 0 N--CA 1.447 -0.61 0 O-C-N 124.703 1.252 . . . . 4.09 112.425 -175.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -69.26 13.93 0.24 Allowed 'Trans proline' 0 CA--C 1.544 1.017 0 C-N-CA 121.43 1.42 . . . . 1.09 113.241 178.132 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -99.4 -31.33 11.72 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 125.508 1.523 . . . . 2.14 110.841 170.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -114.82 -55.1 2.52 Favored 'General case' 0 C--N 1.345 0.376 0 CA-C-N 118.663 0.665 . . . . 2.95 109.533 -177.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.441 1.3 p -83.12 -179.81 7.53 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 114.047 1.128 . . . . 1.66 114.047 160.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 135.09 93.09 0.42 Allowed Glycine 0 N--CA 1.445 -0.75 0 N-CA-C 104.512 -3.435 . . . . 2.29 104.512 -148.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 46.1 p -16.45 -17.44 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.462 1 C-N-CA 138.843 6.857 . . . . 2.44 119.685 -151.025 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -27.32 -63.38 0.09 Allowed 'General case' 0 N--CA 1.442 -0.83 0 C-N-CA 126.477 1.911 . . . . 1.93 113.966 163.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.14 -37.07 64.16 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 118.935 -1.106 . . . . 1.66 109.143 -168.397 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 5.9 mt -53.66 -56.53 8.38 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.616 0 C-N-CA 125.5 1.52 . . . . 2.71 110.862 174.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.92 -46.02 92.33 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 119.506 1.048 . . . . 1.23 109.665 -179.104 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 -49.58 -59.76 3.48 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 122.002 0.906 . . . . 3.4 111.617 176.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 6.2 mmmt -67.05 -35.6 80.23 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-O 118.068 -0.968 . . . . 4.27 111.346 -177.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.1 mm -49.54 -54.56 6.42 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 N-CA-C 108.106 -1.072 . . . . 1.74 108.106 175.096 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -58.92 -53.96 52.52 Favored 'General case' 0 C--N 1.34 0.162 0 C-N-CA 123.33 0.652 . . . . 1.89 109.952 176.134 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.25 -28.77 67.01 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 113.199 0.814 . . . . 6.48 113.199 -177.286 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 20.5 mt -73.49 -18.19 61.14 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.973 1.309 . . . . 1.98 111.603 175.062 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 89.96 39.39 6.15 Favored Glycine 0 CA--C 1.524 0.634 0 C-N-CA 124.664 1.126 . . . . 0.46 110.345 -178.104 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -134.59 175.65 9.34 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 123.756 0.823 . . . . 3.14 110.415 -179.631 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -143.19 138.77 29.96 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 107.406 -1.331 . . . . 3.57 107.406 171.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 9.2 p -117.98 133.32 65.17 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 C-N-CA 125.212 1.405 . . . . 2.37 107.864 178.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 41.9 t -100.85 140.92 18.53 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 C-N-CA 125.956 1.702 . . . . 1.9 109.01 -179.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 21.7 mm -99.38 69.82 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 C-N-CA 124.078 0.951 . . . . 2.04 108.755 -174.293 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -123.95 4.33 8.7 Favored 'General case' 0 N--CA 1.44 -0.956 0 C-N-CA 127.596 2.359 . . . . 4.27 112.149 174.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -85.64 -50.25 4.06 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 111.781 -0.527 . . . . 5.23 111.781 -176.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.109 0 N-CA-C 105.532 -2.025 . . . . 9.93 105.532 -170.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.472 0.669 0 N-CA-C 108.444 -0.947 . . . . 12.58 108.444 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -81.89 172.4 13.36 Favored 'General case' 0 CA--C 1.531 0.24 0 O-C-N 124.39 1.056 . . . . 5.94 108.284 163.63 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 75.82 89.91 0.08 Allowed 'General case' 0 CA--C 1.529 0.171 0 N-CA-C 107.797 -1.186 . . . . 2.61 107.797 -173.291 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -71.73 153.37 42.06 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 107.037 -1.468 . . . . 3.87 107.037 171.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.33 148.61 44.83 Favored 'General case' 0 CA--C 1.518 -0.28 0 C-N-CA 123.602 0.761 . . . . 1.24 110.146 -177.346 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 7.0 mtpm? -141.01 159.97 41.07 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 122.157 0.979 . . . . 4.35 111.756 166.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -108.39 104.25 13.57 Favored 'General case' 0 N--CA 1.434 -1.238 0 C-N-CA 130.755 3.622 . . . . 1.95 103.919 -176.284 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 5.6 mm -88.68 160.09 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.35 0 N-CA-C 106.982 -1.488 . . . . 2.71 106.982 172.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -124.98 137.93 54.24 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 106.517 -1.66 . . . . 1.42 106.517 169.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 57.9 mtt -144.37 166.16 25.89 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 118.412 0.551 . . . . 3.91 109.659 173.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 11.6 mm100 -88.56 155.4 19.66 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 125.176 1.391 . . . . 2.35 109.945 175.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 99.3 t -112.34 138.75 40.19 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 C-N-CA 123.935 0.894 . . . . 2.75 110.259 -179.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 73.3 m -137.84 165.19 27.08 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.814 1.245 . . . . 1.66 109.938 172.376 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 65.73 72.16 0.78 Allowed Glycine 0 CA--C 1.527 0.836 0 N-CA-C 110.891 -0.884 . . . . 1.71 110.891 176.276 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -152.56 158.14 42.06 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 123.739 0.816 . . . . 2.92 109.843 -173.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -105.09 -56.72 2.13 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 124.996 1.319 . . . . 3.51 110.463 168.539 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 31.7 p -127.91 156.68 42.23 Favored 'General case' 0 C--N 1.34 0.175 0 CA-C-O 121.814 0.816 . . . . 2.24 111.504 -170.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -76.33 53.09 0.81 Allowed 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.771 0.829 . . . . 2.5 110.401 176.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -151.49 -50.36 0.12 Allowed 'General case' 0 C--O 1.232 0.136 0 C-N-CA 123.131 0.572 . . . . 1.76 111.645 -174.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 5.8 p -56.04 -39.18 71.59 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 119.348 0.976 . . . . 2.43 109.7 168.316 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -50.32 -23.28 2.22 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.869 1.267 . . . . 1.6 113.9 171.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -72.09 -47.14 53.55 Favored 'General case' 0 N--CA 1.453 -0.3 0 O-C-N 120.447 -1.408 . . . . 1.58 110.133 171.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -57.98 -36.56 72.77 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-O 118.961 -0.543 . . . . 5.23 110.612 -174.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 2.6 pt -59.68 -55.45 23.82 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.203 0 C-N-CA 119.578 -0.849 . . . . 1.75 110.67 178.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -57.49 -47.03 82.98 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 123.286 0.634 . . . . 3.28 111.294 178.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 14.7 mptt -66.61 -45.86 77.77 Favored 'General case' 0 CA--C 1.532 0.273 0 O-C-N 121.62 -0.675 . . . . 2.64 109.864 -176.192 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -67.75 -23.87 74.07 Favored Glycine 0 CA--C 1.527 0.795 0 CA-C-O 119.04 -0.867 . . . . 0.66 111.957 176.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -73.57 -41.23 63.19 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.715 1.206 . . . . 3.53 109.753 170.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 2.1 ttpp -56.71 -16.39 6.29 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.78 1.632 . . . . 3.8 113.86 178.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.4 mmt180 -83.33 -7.44 59.58 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 126.547 1.939 . . . . 4.62 112.338 176.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 96.1 mmm -77.99 150.89 78.59 Favored Pre-proline 0 C--O 1.233 0.209 0 CA-C-N 119.226 0.921 . . . . 3.88 111.35 -179.133 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -56.56 135.37 69.97 Favored 'Trans proline' 0 N--CA 1.45 -1.064 0 C-N-CA 121.953 1.769 . . . . 0.62 108.973 171.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 89.12 -9.66 76.0 Favored Glycine 0 CA--C 1.525 0.716 0 CA-C-O 118.079 -1.401 . . . . 0.61 113.738 178.081 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 23.4 t -103.78 122.66 56.75 Favored 'Isoleucine or valine' 0 C--N 1.342 0.269 0 CA-C-N 120.349 2.074 . . . . 1.65 109.636 176.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -89.38 -55.41 3.67 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-O 118.611 -0.709 . . . . 2.43 109.151 177.127 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -139.61 156.97 46.55 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 118.875 0.761 . . . . 2.61 110.425 -175.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -155.6 143.75 20.02 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 122.99 0.516 . . . . 1.89 111.164 -174.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -155.35 114.39 3.58 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 109.531 -0.544 . . . . 0.59 109.531 -165.576 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 4.0 p -81.25 116.7 25.99 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 N-CA-C 108.697 -0.853 . . . . 1.78 108.697 175.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 50.1 t-20 -96.15 57.61 1.76 Allowed 'General case' 0 C--O 1.236 0.378 0 CA-C-O 122.961 1.362 . . . . 0.81 107.869 177.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.35 -18.47 63.8 Favored 'General case' 0 C--O 1.225 -0.203 0 CA-C-N 114.265 -1.334 . . . . 2.19 110.419 -173.584 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -46.56 -31.14 2.61 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 124.072 0.949 . . . . 1.61 112.502 169.045 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 6.1 t -129.59 33.4 4.48 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 122.787 0.435 . . . . 1.73 110.007 173.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 25.6 mp0 57.17 29.97 17.55 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.02 1.328 . . . . 3.64 113.279 175.206 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 62.0 m -118.39 159.62 23.13 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.47 1.108 . . . . 1.64 109.241 -176.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.6 p -128.72 143.75 40.16 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 O-C-N 121.21 -0.931 . . . . 1.69 108.71 171.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -132.85 128.74 37.33 Favored 'General case' 0 C--N 1.342 0.263 0 N-CA-C 108.125 -1.065 . . . . 0.42 108.125 -178.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 4.7 p -129.82 128.23 65.01 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.595 0 N-CA-C 106.054 -1.832 . . . . 2.92 106.054 -172.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 11.2 mm -105.27 88.65 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 C-N-CA 125.653 1.581 . . . . 1.7 107.168 -174.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 31.3 p90 -125.8 175.3 7.73 Favored 'General case' 0 CA--C 1.512 -0.493 0 O-C-N 122.106 -0.371 . . . . 2.94 110.059 -173.012 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -102.43 100.61 16.31 Favored Pre-proline 0 N--CA 1.445 -0.693 0 C-N-CA 125.197 1.399 . . . . 4.2 108.688 -176.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_endo -72.01 14.39 0.44 Allowed 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 122.288 1.992 . . . . 0.78 113.911 -176.085 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -81.77 -30.96 32.12 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 108.92 -0.77 . . . . 1.88 108.92 162.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -114.26 -62.61 1.57 Allowed 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 123.769 0.828 . . . . 3.77 108.856 -166.678 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.468 0.6 OUTLIER -77.11 -179.25 5.47 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 114.985 1.476 . . . . 1.55 114.985 162.483 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 179.99 -150.32 9.13 Favored Glycine 0 N--CA 1.431 -1.7 1 N-CA-C 102.717 -4.153 . . . . 2.54 102.717 -172.46 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 20.7 p -72.54 -36.75 68.34 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 124.569 1.148 . . . . 2.44 108.75 175.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -42.07 -63.05 0.8 Allowed 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 126.136 1.775 . . . . 1.71 113.409 -171.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -72.0 -38.79 69.59 Favored 'General case' 0 CA--C 1.515 -0.378 0 C-N-CA 118.483 -1.287 . . . . 1.85 109.032 -170.169 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.3 mp -54.46 -55.93 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.931 0 CA-C-N 115.014 -0.994 . . . . 1.9 109.663 178.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.2 -46.08 85.49 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 119.094 0.861 . . . . 1.13 109.991 -176.481 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -47.54 -57.58 5.25 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 122.664 1.221 . . . . 2.63 110.676 175.573 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 11.5 mmmt -68.3 -37.26 80.44 Favored 'General case' 0 N--CA 1.437 -1.121 0 CA-C-N 115.409 -0.814 . . . . 4.62 111.974 -177.122 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.3 mm -52.34 -53.08 20.96 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 N-CA-C 107.937 -1.134 . . . . 1.72 107.937 176.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 21.1 mm-40 -59.32 -56.58 20.22 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.702 0.801 . . . . 1.93 110.404 176.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 5.8 mmmt -54.81 -37.28 65.91 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 113.29 0.848 . . . . 5.6 113.29 -178.482 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 11.4 mt -71.14 -18.15 62.52 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.542 1.137 . . . . 1.8 111.883 175.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 93.58 44.17 3.76 Favored Glycine 0 CA--C 1.525 0.659 0 C-N-CA 124.581 1.086 . . . . 0.46 110.799 176.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -139.98 172.85 12.18 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 124.033 0.933 . . . . 3.11 110.588 -176.635 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -139.98 118.04 11.87 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 109.086 -0.709 . . . . 3.03 109.086 173.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 5.7 p -91.49 147.74 5.07 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 N-CA-C 107.892 -1.151 . . . . 2.44 107.892 172.058 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 41.2 t -123.26 141.52 43.26 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.102 0 C-N-CA 124.574 1.15 . . . . 1.67 108.691 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 4.8 mp -107.46 79.27 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 C-N-CA 124.052 0.941 . . . . 2.64 108.47 -173.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -77.91 3.59 14.15 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.592 1.557 . . . . 2.94 114.565 177.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 61.68 72.57 0.62 Allowed Glycine 0 CA--C 1.53 1.028 0 N-CA-C 110.692 -0.963 . . . . 3.24 110.692 178.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.253 1.265 0 C-N-CA 126.918 2.087 . . . . 12.21 105.503 178.354 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 82.4 mtp . . . . . 0 N--CA 1.473 0.713 0 N-CA-C 106.905 -1.517 . . . . 10.1 106.905 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -102.42 159.81 15.1 Favored 'General case' 0 C--O 1.23 0.063 0 O-C-N 124.149 0.905 . . . . 5.44 109.021 175.747 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 11.5 m -92.92 108.48 20.03 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 124.746 1.219 . . . . 1.51 108.457 176.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -72.24 165.47 24.37 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 108.918 -0.771 . . . . 2.72 108.918 163.342 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -124.02 151.9 43.21 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 124.91 1.284 . . . . 1.09 111.02 -177.2 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.3 mmpt? -137.81 157.12 47.1 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 122.938 0.495 . . . . 5.15 110.22 165.26 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -104.24 97.95 7.83 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 127.799 2.439 . . . . 1.92 106.28 177.846 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 10.0 mm -87.01 160.02 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.258 0 N-CA-C 107.378 -1.342 . . . . 2.89 107.378 177.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -131.5 139.03 49.21 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 125.71 1.604 . . . . 1.68 107.566 178.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 12.5 ptp -156.43 175.19 14.34 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.129 0.571 . . . . 2.67 110.132 179.059 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 29.9 mm100 -99.44 162.57 12.96 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 125.265 1.426 . . . . 2.47 109.545 179.057 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -130.54 157.08 42.93 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.146 0 C-N-CA 124.343 1.057 . . . . 3.18 110.261 176.499 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 62.0 m -146.4 164.7 31.61 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 124.465 1.106 . . . . 1.66 109.343 177.109 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 70.53 68.37 1.65 Allowed Glycine 0 CA--C 1.526 0.756 0 N-CA-C 110.02 -1.232 . . . . 1.52 110.02 179.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -144.82 165.27 28.58 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 123.723 0.809 . . . . 2.32 110.065 -178.312 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.1 p -113.88 -72.1 0.72 Allowed 'General case' 0 CA--C 1.527 0.068 0 C-N-CA 124.438 1.095 . . . . 3.06 108.939 168.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 14.4 p -105.82 152.22 23.51 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 121.781 0.801 . . . . 2.48 112.023 -173.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -75.54 54.5 0.76 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.379 1.072 . . . . 2.55 110.527 176.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -146.87 -49.09 0.19 Allowed 'General case' 0 CA--C 1.526 0.045 0 C-N-CA 123.774 0.829 . . . . 2.19 110.597 -179.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 61.9 m -56.99 -36.89 70.91 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 118.67 0.668 . . . . 1.26 110.638 172.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -50.3 -26.71 5.1 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.758 0.823 . . . . 1.53 112.595 171.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.45 -48.24 50.63 Favored 'General case' 0 N--CA 1.452 -0.328 0 O-C-N 120.162 -1.586 . . . . 1.61 109.204 174.017 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 61.7 mtt85 -54.36 -42.86 70.77 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 123.542 0.737 . . . . 6.38 109.885 -175.249 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.258 2.1 pt -58.56 -57.8 9.41 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 C-N-CA 120.044 -0.662 . . . . 1.63 110.478 177.478 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -53.1 -40.28 64.0 Favored 'General case' 0 C--O 1.224 -0.28 0 CA-C-N 118.839 0.745 . . . . 2.19 111.632 178.248 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 4.1 mptp? -71.32 -48.31 51.33 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 119.446 1.021 . . . . 2.68 111.041 -177.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -60.87 -36.43 92.01 Favored Glycine 0 CA--C 1.529 0.962 0 N-CA-C 110.897 -0.881 . . . . 0.56 110.897 175.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 8.4 tt -62.54 -49.49 75.1 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 124.739 1.216 . . . . 2.9 107.971 175.082 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -57.14 -22.77 42.52 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 124.582 1.153 . . . . 4.36 113.062 178.816 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.7 mmt180 -72.65 -10.99 60.45 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.956 0.902 . . . . 4.39 112.309 175.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 3.1 ptt? -75.79 153.64 85.14 Favored Pre-proline 0 CA--C 1.533 0.302 0 CA-C-N 119.071 0.85 . . . . 5.95 111.692 -179.358 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -60.86 136.08 63.76 Favored 'Trans proline' 0 N--CA 1.451 -0.995 0 C-N-CA 121.589 1.526 . . . . 0.83 108.972 172.135 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 100.15 -28.79 14.06 Favored Glycine 0 CA--C 1.53 1.003 0 CA-C-O 118.504 -1.164 . . . . 0.76 112.978 177.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 24.8 t -95.52 123.16 47.57 Favored 'Isoleucine or valine' 0 C--N 1.346 0.422 0 CA-C-N 119.62 1.71 . . . . 1.61 111.185 176.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 86.9 m -90.32 -53.65 4.36 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-O 117.858 -1.068 . . . . 2.57 110.378 -179.007 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -135.97 158.11 45.2 Favored 'General case' 0 C--N 1.343 0.318 0 CA-C-N 119.576 1.08 . . . . 2.45 110.698 177.235 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -156.91 148.17 22.11 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 114.38 1.252 . . . . 1.43 114.38 177.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -155.15 113.19 3.44 Favored 'General case' 0 C--N 1.344 0.365 0 N-CA-C 107.241 -1.392 . . . . 0.59 107.241 -162.328 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 6.4 p -82.36 114.68 23.62 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 N-CA-C 108.952 -0.758 . . . . 1.74 108.952 178.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -94.05 57.93 2.48 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 122.994 1.378 . . . . 2.98 108.718 -178.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.85 -17.54 64.94 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 114.361 -1.291 . . . . 1.95 111.094 -177.342 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -41.29 -39.7 1.46 Allowed 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 124.901 1.28 . . . . 1.93 112.747 168.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 9.1 t -127.43 35.88 4.47 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 117.666 0.212 . . . . 1.87 110.621 172.094 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 61.54 36.23 17.04 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.462 1.105 . . . . 4.37 113.195 173.162 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 4.8 m -123.5 161.21 25.33 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.051 1.34 . . . . 1.69 109.369 -176.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -127.68 144.18 38.35 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 C-N-CA 124.423 1.089 . . . . 2.01 108.417 172.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -131.83 145.04 51.33 Favored 'General case' 0 C--N 1.347 0.491 0 N-CA-C 108.327 -0.99 . . . . 0.45 108.327 177.108 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 5.4 p -145.46 125.24 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 N-CA-C 106.642 -1.614 . . . . 3.05 106.642 -172.262 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 9.6 mm -105.79 83.53 0.72 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.49 0 C-N-CA 126.286 1.834 . . . . 1.59 106.984 -171.029 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 51.6 p90 -119.56 175.9 5.62 Favored 'General case' 0 CA--C 1.506 -0.731 0 N-CA-C 109.197 -0.668 . . . . 3.45 109.197 -172.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -101.65 95.26 5.07 Favored Pre-proline 0 N--CA 1.443 -0.78 0 O-C-N 124.813 1.321 . . . . 4.3 110.199 -176.263 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -74.49 14.7 0.74 Allowed 'Trans proline' 0 CA--C 1.537 0.661 0 C-N-CA 122.833 2.355 . . . . 1.0 113.56 -173.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -89.09 -21.79 23.21 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 124.021 0.928 . . . . 2.37 109.5 166.117 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -113.63 -62.19 1.63 Allowed 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 125.212 1.405 . . . . 3.52 107.723 -175.497 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.285 0.7 OUTLIER -82.62 -179.75 7.53 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 115.223 1.564 . . . . 2.19 115.223 170.319 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -163.53 -128.42 0.95 Allowed Glycine 0 N--CA 1.434 -1.496 0 N-CA-C 104.164 -3.574 . . . . 2.59 104.164 175.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 18.3 p -81.82 -30.54 32.14 Favored 'General case' 0 C--N 1.318 -0.792 0 C-N-CA 126.874 2.07 . . . . 2.34 110.636 172.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -53.2 -62.44 1.65 Allowed 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 124.327 1.051 . . . . 1.73 112.769 -157.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -75.14 -24.58 57.99 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 113.931 -1.486 . . . . 2.11 110.285 -172.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.5 mt -66.85 -49.16 76.68 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 C-N-CA 124.341 1.056 . . . . 2.61 109.576 -178.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.18 -43.94 93.55 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 107.806 -1.183 . . . . 1.93 107.806 -177.501 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -48.5 -59.64 3.32 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 123.833 0.853 . . . . 2.76 111.032 172.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 10.3 mmtp -60.65 -42.37 96.83 Favored 'General case' 0 N--CA 1.441 -0.912 0 O-C-N 121.712 -0.617 . . . . 4.0 111.716 -178.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -48.82 -54.69 4.57 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 C-N-CA 125.007 1.323 . . . . 1.57 108.745 176.345 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 29.5 mm-40 -60.9 -53.85 52.3 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 123.481 0.712 . . . . 1.91 110.197 178.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -56.15 -38.41 70.82 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 112.668 0.618 . . . . 4.94 112.668 -176.382 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 15.9 mt -69.98 -17.06 63.27 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.617 1.167 . . . . 1.89 111.911 176.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 92.86 41.36 4.69 Favored Glycine 0 CA--C 1.522 0.513 0 N-CA-C 110.73 -0.948 . . . . 0.56 110.73 175.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -133.81 175.3 9.58 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 123.672 0.789 . . . . 3.52 110.145 178.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 4.2 t60 -139.34 143.73 37.93 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 109.162 -0.681 . . . . 2.99 109.162 170.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 12.4 p -112.84 150.07 15.11 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 C-N-CA 126.385 1.874 . . . . 2.96 107.987 -175.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 13.5 t -132.33 147.67 32.05 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 C-N-CA 124.283 1.033 . . . . 1.63 108.301 -179.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 4.6 mp -127.1 82.29 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 C-N-CA 124.609 1.163 . . . . 2.92 108.567 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -77.83 -2.36 36.13 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 124.809 1.244 . . . . 3.27 113.536 170.094 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -92.59 -31.91 8.49 Favored Glycine 0 CA--C 1.526 0.735 0 C-N-CA 124.208 0.908 . . . . 2.89 113.478 -169.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 23.9 ttt85 . . . . . 0 C--O 1.249 1.077 0 CA-C-O 117.18 -1.39 . . . . 11.37 109.628 -177.132 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 56.7 mtt . . . . . 0 N--CA 1.473 0.724 0 N-CA-C 108.777 -0.823 . . . . 10.59 108.777 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -151.61 166.34 31.54 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 108.18 -1.044 . . . . 6.61 108.18 177.102 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.4 m -127.1 115.76 19.65 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 106.077 -1.823 . . . . 1.85 106.077 167.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -70.82 173.75 6.93 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 107.774 -1.195 . . . . 2.1 107.774 163.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -129.3 151.53 49.85 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 123.491 0.717 . . . . 1.7 109.099 172.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 69.6 mmtt -140.92 157.72 44.97 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.213 1.005 . . . . 4.06 111.07 166.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -116.21 91.79 3.7 Favored 'General case' 0 N--CA 1.435 -1.181 0 C-N-CA 128.226 2.61 . . . . 1.46 106.61 -168.442 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 8.0 mm -82.41 158.48 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.261 0 N-CA-C 106.977 -1.49 . . . . 2.84 106.977 -178.178 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -131.44 139.01 49.29 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 107.093 -1.447 . . . . 1.48 107.093 172.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -155.43 176.28 12.79 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 122.992 0.517 . . . . 2.79 109.738 170.541 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 27.4 mm100 -95.35 165.37 12.41 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.627 1.171 . . . . 2.61 110.152 -178.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 31.6 t -128.44 132.19 68.26 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 C-N-CA 124.597 1.159 . . . . 2.3 109.804 -174.111 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 32.9 m -117.74 176.29 5.26 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 125.195 1.398 . . . . 1.74 109.348 169.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 82.15 -44.88 3.23 Favored Glycine 0 CA--C 1.53 0.994 0 O-C-N 121.553 -0.717 . . . . 2.24 111.603 178.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -44.52 142.18 1.71 Allowed 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 124.121 0.968 . . . . 3.38 112.691 176.066 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -147.71 -45.71 0.16 Allowed 'General case' 0 CA--C 1.53 0.173 0 C-N-CA 124.559 1.144 . . . . 4.08 110.432 171.787 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 24.3 p -71.16 -16.58 62.54 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 112.616 0.599 . . . . 3.04 112.616 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 59.97 28.32 17.82 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.808 1.243 . . . . 3.03 112.209 -179.193 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -130.66 -51.9 1.07 Allowed 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 124.609 1.164 . . . . 1.77 110.252 -179.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 52.5 m -51.06 -31.68 19.49 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 125.145 1.378 . . . . 1.64 112.548 172.174 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.5 -26.38 31.14 Favored 'General case' 0 CA--C 1.539 0.548 0 O-C-N 121.885 -0.509 . . . . 1.7 111.865 173.302 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.02 -46.4 62.2 Favored 'General case' 0 N--CA 1.454 -0.248 0 O-C-N 120.304 -1.497 . . . . 1.57 110.638 169.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 8.9 mtt85 -51.68 -44.69 63.17 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-O 119.171 -0.443 . . . . 4.55 110.346 -177.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.262 2.3 pt -59.76 -55.4 24.2 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.201 0 C-N-CA 119.642 -0.823 . . . . 1.76 111.217 -178.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -55.67 -42.63 75.38 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-N 118.693 0.679 . . . . 2.16 112.08 177.454 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -70.88 -46.84 61.88 Favored 'General case' 0 CA--C 1.533 0.294 0 O-C-N 121.68 -0.637 . . . . 2.83 110.078 -175.158 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -58.38 -44.38 95.23 Favored Glycine 0 CA--C 1.527 0.815 0 N-CA-C 110.127 -1.189 . . . . 0.73 110.127 173.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -61.65 -43.14 99.41 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.688 0.795 . . . . 3.7 109.486 -179.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 7.3 ttmt -51.98 -29.87 22.47 Favored 'General case' 0 CA--C 1.531 0.237 0 O-C-N 121.036 -1.04 . . . . 3.66 111.595 173.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.84 -0.75 19.45 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-O 118.065 -0.969 . . . . 5.75 113.352 -175.806 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 93.8 mmm -89.05 152.7 48.57 Favored Pre-proline 0 CA--C 1.535 0.393 0 C-N-CA 126.738 2.015 . . . . 4.09 111.164 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -60.08 138.92 84.87 Favored 'Trans proline' 0 N--CA 1.453 -0.901 0 C-N-CA 122.236 1.958 . . . . 0.84 109.547 175.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 97.29 -30.99 8.2 Favored Glycine 0 CA--C 1.523 0.588 0 CA-C-O 119.0 -0.889 . . . . 0.59 112.536 179.478 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 16.3 t -92.04 140.19 16.59 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.212 0 CA-C-N 119.241 1.521 . . . . 1.83 109.114 -179.103 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -119.43 -42.79 2.64 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 118.273 -0.87 . . . . 2.14 111.129 179.798 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -138.73 161.85 36.15 Favored 'General case' 0 CA--C 1.518 -0.278 0 CA-C-N 119.838 1.199 . . . . 2.13 111.433 171.693 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -157.68 138.94 13.56 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 123.125 0.57 . . . . 1.39 111.018 -175.467 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -150.13 102.61 3.11 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 106.7 -1.593 . . . . 0.67 106.7 -163.057 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 10.4 p -82.13 107.0 13.68 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 CA-C-O 121.252 0.549 . . . . 1.88 110.498 -179.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 48.9 t30 -84.43 56.82 3.97 Favored 'General case' 0 CA--C 1.537 0.476 0 O-C-N 120.567 -1.333 . . . . 1.13 109.992 179.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -74.93 -16.1 60.66 Favored 'General case' 0 N--CA 1.461 0.101 0 CA-C-N 115.446 -0.797 . . . . 1.91 110.422 176.706 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -45.64 -37.37 5.62 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.742 0.817 . . . . 2.15 111.396 167.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 15.0 t -98.54 -68.48 0.8 Allowed 'General case' 0 C--N 1.344 0.329 0 CA-C-O 117.703 -1.141 . . . . 3.56 110.198 165.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 159.93 43.55 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 127.61 2.364 . . . . 2.86 110.864 -176.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 79.7 m -142.64 162.4 35.56 Favored 'General case' 0 CA--C 1.534 0.333 0 O-C-N 120.464 -1.397 . . . . 1.83 108.805 -171.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.4 p -125.75 145.92 32.36 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 O-C-N 121.232 -0.917 . . . . 1.69 108.981 172.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -127.79 143.51 51.12 Favored 'General case' 0 C--N 1.345 0.38 0 N-CA-C 108.017 -1.105 . . . . 0.47 108.017 170.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.2 p -140.41 127.11 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 N-CA-C 107.226 -1.398 . . . . 2.86 107.226 -176.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 18.5 mm -103.5 90.05 1.58 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.604 0 C-N-CA 125.935 1.694 . . . . 1.93 107.107 -173.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 6.8 p90 -128.82 166.42 19.09 Favored 'General case' 0 CA--C 1.508 -0.669 0 CA-C-O 121.452 0.644 . . . . 2.91 111.751 -174.285 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -96.04 108.99 44.5 Favored Pre-proline 0 N--CA 1.444 -0.736 0 CA-C-N 114.172 -1.376 . . . . 4.22 109.187 -172.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -73.45 13.97 0.66 Allowed 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 123.009 2.473 . . . . 0.86 112.99 -173.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -85.23 -35.47 21.57 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 123.823 0.849 . . . . 2.34 108.728 166.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -109.99 -54.36 2.57 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 108.638 -0.875 . . . . 3.18 108.638 -168.816 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.314 0.9 OUTLIER -86.56 -173.98 4.77 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-O 121.037 0.446 . . . . 1.71 111.674 162.594 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 128.88 88.64 0.56 Allowed Glycine 0 N--CA 1.442 -0.948 0 N-CA-C 103.702 -3.759 . . . . 2.36 103.702 -150.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 26.5 p -13.75 -18.41 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.499 1 C-N-CA 138.735 6.814 . . . . 2.47 119.748 -146.434 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -28.12 -63.36 0.1 Allowed 'General case' 0 N--CA 1.441 -0.877 0 C-N-CA 126.857 2.063 . . . . 1.7 113.841 164.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -72.02 -41.1 67.94 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 118.098 -1.441 . . . . 1.71 109.164 -167.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.5 mp -52.32 -54.72 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.845 0 CA-C-N 114.303 -1.317 . . . . 2.16 109.146 175.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.55 -45.7 85.99 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 118.963 0.801 . . . . 1.69 109.294 -175.393 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -52.12 -53.37 43.49 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 122.396 1.093 . . . . 2.93 110.27 178.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.2 mmpt? -70.71 -37.54 73.57 Favored 'General case' 0 N--CA 1.432 -1.363 0 CA-C-O 118.233 -0.889 . . . . 3.43 112.369 -177.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.5 mm -47.61 -51.65 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 C-N-CA 124.66 1.184 . . . . 1.66 108.233 177.088 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -54.0 -60.31 3.5 Favored 'General case' 0 C--N 1.34 0.182 0 C-N-CA 123.625 0.77 . . . . 2.55 110.781 174.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -63.71 -29.52 70.73 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 112.679 0.622 . . . . 5.86 112.679 -172.241 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 23.8 mt -70.03 -18.35 63.3 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.425 1.49 . . . . 1.9 111.02 172.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 95.32 39.07 4.59 Favored Glycine 0 CA--C 1.524 0.645 0 C-N-CA 124.959 1.266 . . . . 0.44 110.937 175.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -137.74 175.43 9.59 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.605 0.762 . . . . 3.43 111.863 -173.104 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 4.3 t-80 -152.08 111.68 3.96 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 125.008 1.323 . . . . 3.29 107.495 -176.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 3.6 m -82.96 160.99 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.239 0 N-CA-C 108.877 -0.786 . . . . 3.67 108.877 169.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 21.6 t -122.96 142.12 40.74 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 N-CA-C 108.468 -0.938 . . . . 1.88 108.468 176.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 45.4 mm -114.23 79.24 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 C-N-CA 125.277 1.431 . . . . 2.53 108.164 -175.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -80.37 -0.61 37.67 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 124.38 1.072 . . . . 3.23 113.53 173.054 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -112.27 -19.16 7.27 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 125.212 1.387 . . . . 2.82 115.343 -164.221 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 6.4 tpp180 . . . . . 0 C--O 1.25 1.126 0 CA-C-O 116.6 -1.667 . . . . 10.22 108.36 178.206 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 44.6 mtt . . . . . 0 N--CA 1.475 0.813 0 N-CA-C 109.137 -0.69 . . . . 9.13 109.137 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 173.83 -89.15 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 105.561 -2.014 . . . . 6.62 105.561 178.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 25.1 m -157.79 139.74 14.13 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 106.499 -1.667 . . . . 1.47 106.499 -174.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -77.01 179.74 6.05 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 108.817 -0.808 . . . . 2.36 108.817 160.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -135.38 147.79 49.17 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 106.693 -1.595 . . . . 1.45 106.693 166.576 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 20.0 mmtp -140.53 156.05 46.43 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 123.343 0.657 . . . . 4.66 109.921 165.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -108.06 99.14 8.6 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 128.011 2.524 . . . . 1.91 107.615 -174.763 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.9 mm -82.97 157.44 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.98 0 N-CA-C 107.205 -1.405 . . . . 2.75 107.205 177.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -135.66 129.99 33.63 Favored 'General case' 0 C--O 1.231 0.112 0 C-N-CA 124.606 1.162 . . . . 1.65 107.893 178.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 10.0 ptt? -156.16 175.54 13.84 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.019 0.528 . . . . 3.56 110.485 -176.015 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -101.2 162.16 13.1 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 127.505 2.322 . . . . 3.77 110.701 -177.787 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 46.1 t -119.34 144.86 26.54 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 C-N-CA 124.436 1.094 . . . . 2.52 109.316 -176.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 41.3 t -135.72 175.61 9.44 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.767 1.227 . . . . 3.08 109.153 173.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 51.66 58.16 10.79 Favored Glycine 0 CA--C 1.529 0.917 0 C-N-CA 124.661 1.124 . . . . 1.68 111.254 -175.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -134.41 150.64 50.89 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 123.634 0.773 . . . . 2.5 110.827 -172.88 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -99.62 -57.21 2.2 Favored 'General case' 0 CA--C 1.528 0.113 0 C-N-CA 125.23 1.412 . . . . 3.43 111.204 169.22 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 20.8 p -144.29 165.44 27.89 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 121.808 0.813 . . . . 2.84 111.941 -169.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -75.64 54.26 0.77 Allowed 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.209 1.404 . . . . 2.88 110.746 178.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -147.62 -58.53 0.26 Allowed 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 124.373 1.069 . . . . 2.11 108.709 177.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 26.8 m -57.15 -40.98 78.29 Favored 'General case' 0 CA--C 1.53 0.186 0 O-C-N 121.994 -0.441 . . . . 1.44 110.168 176.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.23 -21.03 7.98 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.801 0.84 . . . . 2.0 113.032 174.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -72.44 -47.37 49.55 Favored 'General case' 0 N--CA 1.453 -0.298 0 O-C-N 120.667 -1.271 . . . . 1.63 110.793 170.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 54.4 mmm-85 -53.37 -44.65 68.77 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 109.77 -0.456 . . . . 5.03 109.77 -172.129 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.5 pt -57.85 -54.02 37.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 CA-C-O 118.69 -0.672 . . . . 1.8 110.5 178.333 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -57.14 -40.73 77.74 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.797 0.839 . . . . 2.38 112.133 179.452 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 31.9 mmtp -70.7 -43.98 67.87 Favored 'General case' 0 CA--C 1.534 0.358 0 O-C-N 121.414 -0.804 . . . . 2.91 110.552 -178.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -63.74 -38.68 96.55 Favored Glycine 0 CA--C 1.53 1.019 0 N-CA-C 110.931 -0.868 . . . . 0.51 110.931 173.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.8 tt -60.51 -41.54 94.57 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 125.462 1.505 . . . . 2.88 109.512 176.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 10.7 ttmt -54.41 -23.37 15.55 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 112.592 0.59 . . . . 3.93 112.592 173.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.82 -2.58 24.2 Favored 'General case' 0 CA--C 1.542 0.659 0 O-C-N 121.285 -0.884 . . . . 4.54 112.19 177.634 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 9.9 mmt -69.78 152.0 96.22 Favored Pre-proline 0 CA--C 1.532 0.273 0 CA-C-N 119.42 1.009 . . . . 4.05 111.689 173.054 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -58.22 141.08 96.43 Favored 'Trans proline' 0 N--CA 1.452 -0.932 0 C-N-CA 122.005 1.803 . . . . 1.08 109.47 170.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 86.13 -27.31 5.62 Favored Glycine 0 CA--C 1.524 0.616 0 CA-C-O 119.436 -0.647 . . . . 0.83 113.849 178.295 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 13.7 t -82.57 127.02 40.05 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 CA-C-N 118.777 1.289 . . . . 1.6 108.693 -179.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.9 m -110.53 -37.26 5.53 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-O 118.601 -0.714 . . . . 1.88 110.889 -175.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -148.53 166.94 26.71 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 119.253 0.933 . . . . 1.84 110.038 170.333 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -157.25 148.81 22.17 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 123.481 0.712 . . . . 1.37 110.507 -175.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -154.46 110.28 3.19 Favored 'General case' 0 CA--C 1.529 0.161 0 N-CA-C 108.437 -0.949 . . . . 0.59 108.437 -165.258 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 4.7 p -88.44 93.87 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 C-N-CA 124.142 0.977 . . . . 2.29 110.37 -178.146 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 52.5 t-20 -82.79 56.79 3.53 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 120.475 -1.391 . . . . 0.82 110.224 -178.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -67.01 -21.34 65.95 Favored 'General case' 0 C--O 1.227 -0.097 0 C-N-CA 123.677 0.791 . . . . 1.99 110.33 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -48.26 -33.78 9.29 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.626 0.77 . . . . 1.82 112.144 170.151 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 3.4 t -121.97 27.66 7.96 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 118.026 0.375 . . . . 2.22 110.424 174.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 47.55 58.47 4.92 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 124.824 1.25 . . . . 3.07 111.616 -178.096 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 33.2 m -145.44 164.28 32.05 Favored 'General case' 0 N--CA 1.44 -0.927 0 O-C-N 120.713 -1.242 . . . . 1.75 107.716 175.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.9 p -139.47 145.01 27.7 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 N-CA-C 108.71 -0.848 . . . . 1.74 108.71 174.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 19.5 m120 -131.8 139.45 48.89 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 124.407 1.083 . . . . 0.31 108.481 -176.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 22.3 t -133.59 129.53 55.73 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 N-CA-C 105.796 -1.927 . . . . 3.25 105.796 -178.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 13.6 mm -105.99 95.23 3.63 Favored 'Isoleucine or valine' 0 C--O 1.24 0.585 0 C-N-CA 124.946 1.298 . . . . 1.54 107.583 -174.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 10.8 p90 -131.95 164.48 26.05 Favored 'General case' 0 CA--C 1.513 -0.446 0 O-C-N 122.03 -0.419 . . . . 3.52 111.955 -172.172 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 30.9 t0 -81.46 110.78 20.53 Favored Pre-proline 0 CA--C 1.534 0.365 0 O-C-N 124.392 1.057 . . . . 2.87 110.134 172.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -73.09 5.97 2.79 Favored 'Trans proline' 0 N--CA 1.452 -0.96 0 C-N-CA 123.007 2.472 . . . . 0.66 113.124 -178.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -87.79 -34.09 18.41 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 119.493 1.042 . . . . 1.71 108.797 169.268 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -99.03 -60.47 1.53 Allowed 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 108.687 -0.857 . . . . 3.01 108.687 -174.417 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.345 0.6 OUTLIER -83.53 -174.86 5.53 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 123.807 0.843 . . . . 1.89 112.229 162.05 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 126.37 94.95 0.94 Allowed Glycine 0 N--CA 1.442 -0.909 0 N-CA-C 103.913 -3.675 . . . . 2.2 103.913 -144.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 68.6 p -14.31 -23.52 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.383 1 C-N-CA 138.161 6.584 . . . . 1.98 119.169 -151.749 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -27.47 -62.74 0.09 Allowed 'General case' 0 N--CA 1.443 -0.787 0 C-N-CA 127.177 2.191 . . . . 1.89 113.532 167.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.54 -39.55 62.25 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 118.732 -1.187 . . . . 1.6 109.72 -166.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.2 mp -54.68 -57.67 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.026 0 CA-C-N 113.687 -1.597 . . . . 2.23 109.399 176.397 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -60.76 -43.28 98.22 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 118.093 0.406 . . . . 1.59 109.923 -174.482 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -46.86 -58.82 3.54 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.15 0.58 . . . . 2.74 111.41 171.85 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 3.4 mmpt? -65.44 -42.82 92.01 Favored 'General case' 0 N--CA 1.442 -0.84 0 O-C-N 121.705 -0.622 . . . . 3.27 112.331 -179.304 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -47.1 -54.11 2.86 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 C-N-CA 125.403 1.481 . . . . 1.67 107.795 178.11 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -60.54 -57.54 12.29 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 124.559 1.144 . . . . 1.68 110.633 177.048 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 11.7 mptt -59.66 -31.41 69.52 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 112.795 0.665 . . . . 6.13 112.795 -173.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.6 mt -67.74 -16.95 64.38 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.307 1.043 . . . . 2.15 112.179 174.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 89.84 46.04 4.35 Favored Glycine 0 C--N 1.336 0.58 0 N-CA-C 109.68 -1.368 . . . . 0.75 109.68 179.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -143.72 175.25 10.12 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 124.562 1.145 . . . . 3.45 108.678 -176.352 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 7.7 t-160 -145.28 144.48 30.79 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 109.076 -0.713 . . . . 3.37 109.076 174.088 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 5.8 p -113.21 144.37 21.0 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 N-CA-C 107.002 -1.481 . . . . 2.6 107.002 179.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 5.7 t -122.86 140.81 45.46 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 N-CA-C 107.615 -1.254 . . . . 1.98 107.615 -178.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 4.7 mp -108.95 80.16 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.475 0 N-CA-C 107.975 -1.12 . . . . 2.62 107.975 -175.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -66.28 -15.31 63.11 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 113.985 1.106 . . . . 3.96 113.985 172.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 78.4 79.08 0.78 Allowed Glycine 0 CA--C 1.526 0.72 0 N-CA-C 109.521 -1.432 . . . . 3.91 109.521 -175.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 10.7 tpt180 . . . . . 0 C--O 1.252 1.198 0 C-N-CA 126.998 2.119 . . . . 16.28 112.597 -176.553 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 55.3 mtt . . . . . 0 N--CA 1.472 0.65 0 N-CA-C 107.045 -1.465 . . . . 11.3 107.045 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 7.2 mt -85.06 157.01 20.84 Favored 'General case' 0 N--CA 1.456 -0.147 0 O-C-N 124.069 0.856 . . . . 5.07 109.078 171.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.5 m -59.83 104.71 0.31 Allowed 'General case' 0 N--CA 1.446 -0.67 0 C-N-CA 124.29 1.036 . . . . 1.42 108.838 169.328 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -65.94 171.63 4.31 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 108.077 -1.083 . . . . 2.29 108.077 162.211 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -131.5 153.88 49.34 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 124.258 1.023 . . . . 1.26 109.673 176.501 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -144.94 160.63 41.01 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 124.725 1.21 . . . . 4.16 109.842 170.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -121.25 94.77 4.44 Favored 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 128.082 2.553 . . . . 1.98 106.094 -170.087 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 17.1 mm -82.62 162.05 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.232 0 N-CA-C 107.109 -1.441 . . . . 2.93 107.109 -179.095 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -133.3 140.24 47.33 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 107.068 -1.456 . . . . 1.56 107.068 170.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -152.55 175.46 12.74 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 118.522 0.601 . . . . 2.79 110.059 172.226 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 22.8 mm100 -98.45 157.99 15.87 Favored 'General case' 0 C--O 1.227 -0.084 0 C-N-CA 124.234 1.014 . . . . 2.61 110.049 177.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 43.4 t -111.19 162.19 9.01 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 C-N-CA 124.844 1.257 . . . . 2.44 109.612 -174.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 58.0 m -149.23 164.47 34.7 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 107.535 -1.283 . . . . 1.73 107.535 165.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 93.32 -29.97 7.71 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 123.39 0.519 . . . . 2.47 112.562 -178.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -53.21 108.2 0.31 Allowed 'General case' 0 C--O 1.225 -0.205 0 CA-C-N 118.026 0.913 . . . . 2.93 112.77 178.233 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -155.91 14.18 0.34 Allowed 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 114.299 1.222 . . . . 4.51 114.299 178.326 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 8.3 m -104.28 -58.7 1.84 Allowed 'General case' 0 C--O 1.226 -0.163 0 N-CA-C 108.245 -1.021 . . . . 5.03 108.245 -175.16 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -172.86 -56.56 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 126.34 1.856 . . . . 6.56 106.579 174.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -164.38 32.1 0.07 Allowed 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 113.204 0.816 . . . . 3.31 113.204 -168.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 95.6 m -58.1 -31.62 67.31 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 121.378 -0.826 . . . . 1.19 111.424 174.248 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.57 -25.43 17.13 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.197 0.599 . . . . 1.86 112.609 170.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.26 -48.26 57.61 Favored 'General case' 0 N--CA 1.453 -0.307 0 O-C-N 120.261 -1.525 . . . . 1.97 110.204 169.367 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 21.0 mmm180 -55.66 -46.86 77.46 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 109.603 -0.517 . . . . 5.39 109.603 -178.116 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.0 pt -57.21 -54.96 23.71 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.36 0 C-N-CA 119.816 -0.754 . . . . 1.8 110.921 178.242 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -55.68 -40.06 71.81 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 119.097 0.862 . . . . 2.22 112.324 -179.511 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -71.13 -46.19 62.08 Favored 'General case' 0 N--CA 1.453 -0.284 0 O-C-N 121.722 -0.611 . . . . 2.85 109.707 -176.218 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -60.11 -47.62 90.12 Favored Glycine 0 CA--C 1.528 0.856 0 N-CA-C 110.204 -1.158 . . . . 0.92 110.204 172.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 6.1 tt -52.97 -42.87 65.92 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.793 1.637 . . . . 3.12 110.118 177.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 8.6 ttmt -57.54 -32.36 67.0 Favored 'General case' 0 CA--C 1.535 0.373 0 O-C-N 120.942 -1.099 . . . . 4.51 112.917 174.104 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -69.01 -7.53 36.44 Favored 'General case' 0 CA--C 1.536 0.427 0 O-C-N 121.297 -0.877 . . . . 6.4 112.551 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 20.5 mmt -79.69 148.45 69.24 Favored Pre-proline 0 CA--C 1.532 0.273 0 CA-C-N 119.019 0.827 . . . . 5.69 110.419 -174.129 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -56.11 137.17 78.54 Favored 'Trans proline' 0 N--CA 1.452 -0.966 0 C-N-CA 121.89 1.727 . . . . 1.05 108.746 176.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 90.89 -7.15 81.59 Favored Glycine 0 N--CA 1.449 -0.481 0 CA-C-O 117.671 -1.627 . . . . 0.88 114.35 179.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.6 t -110.37 135.18 50.2 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 CA-C-N 119.825 1.813 . . . . 1.7 109.107 177.294 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 8.4 m -107.45 -49.86 3.18 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 123.442 0.697 . . . . 2.17 110.194 -176.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -138.96 163.88 31.21 Favored 'General case' 0 C--N 1.343 0.299 0 CA-C-N 118.916 0.78 . . . . 2.05 111.456 177.164 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -159.43 144.33 15.5 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 113.152 0.797 . . . . 1.42 113.152 -179.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -149.7 105.53 3.44 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 107.97 -1.122 . . . . 1.0 107.97 -164.159 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 4.0 p -83.71 100.98 7.72 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 C-N-CA 123.03 0.532 . . . . 2.27 110.521 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 45.1 t30 -82.55 57.4 3.7 Favored 'General case' 0 CA--C 1.538 0.516 0 O-C-N 120.372 -1.455 . . . . 1.27 110.513 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -76.33 -12.11 60.01 Favored 'General case' 0 C--O 1.226 -0.178 0 C-N-CA 124.384 1.074 . . . . 1.95 111.156 176.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -43.84 -38.0 3.09 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 123.59 0.756 . . . . 1.86 111.215 167.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 9.2 t -102.1 -75.95 0.59 Allowed 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 118.755 -0.64 . . . . 3.74 109.578 163.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 179.37 26.76 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.983 1.313 . . . . 3.25 113.375 -177.053 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 91.9 m -128.51 167.35 17.2 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 124.133 0.973 . . . . 1.64 108.759 -163.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 1.2 p -138.35 145.36 28.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 N-CA-C 108.516 -0.92 . . . . 2.01 108.516 179.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -131.09 139.7 49.9 Favored 'General case' 0 C--N 1.343 0.297 0 N-CA-C 108.187 -1.042 . . . . 0.57 108.187 173.416 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 39.8 t -131.34 127.95 60.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 N-CA-C 105.591 -2.003 . . . . 3.26 105.591 179.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 13.2 mm -102.44 93.01 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 N-CA-C 106.884 -1.524 . . . . 1.8 106.884 -177.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 9.5 p90 -127.01 168.67 14.25 Favored 'General case' 0 CA--C 1.509 -0.632 0 O-C-N 121.964 -0.46 . . . . 2.98 110.663 -170.207 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -99.1 103.44 20.01 Favored Pre-proline 0 N--CA 1.445 -0.716 0 C-N-CA 124.292 1.037 . . . . 4.39 109.123 -176.265 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -72.72 10.4 1.06 Allowed 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 123.402 2.734 . . . . 1.06 113.723 -172.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -86.44 -25.72 25.08 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 108.893 -0.78 . . . . 2.19 108.893 167.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -112.42 -55.33 2.53 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 123.816 0.847 . . . . 3.07 109.151 -175.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.324 9.5 p -90.57 -160.56 0.72 Allowed 'General case' 0 C--N 1.343 0.288 0 CA-C-O 119.411 -0.328 . . . . 1.54 110.76 165.155 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 118.33 88.41 1.23 Allowed Glycine 0 N--CA 1.445 -0.734 0 N-CA-C 104.192 -3.563 . . . . 2.34 104.192 -148.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 47.0 p -12.51 -18.28 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.419 1 C-N-CA 138.573 6.749 . . . . 2.54 119.53 -147.082 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -27.29 -63.05 0.09 Allowed 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 127.434 2.294 . . . . 1.6 114.327 166.091 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -72.96 -41.1 64.78 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 117.556 -1.657 . . . . 1.66 109.196 -168.056 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.1 mp -53.97 -52.49 35.73 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.051 0 CA-C-N 113.821 -1.536 . . . . 1.96 109.542 177.041 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.19 -48.1 79.78 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 119.398 0.999 . . . . 1.73 109.046 -176.793 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.522 ' CD ' ' HZ2' ' A' ' 66' ' ' LYS . 4.1 mm-40 -47.83 -56.29 7.8 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 122.4 1.095 . . . . 3.29 110.709 176.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.9 mmpt? -70.58 -39.08 74.08 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-O 118.532 -0.747 . . . . 3.38 112.063 -176.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -45.55 -53.78 1.86 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 C-N-CA 125.142 1.377 . . . . 1.63 108.046 173.412 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -58.46 -59.66 5.01 Favored 'General case' 0 C--N 1.341 0.2 0 C-N-CA 124.058 0.943 . . . . 1.98 110.288 177.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.522 ' HZ2' ' CD ' ' A' ' 62' ' ' GLU . 14.1 mptt -58.73 -31.97 68.79 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 112.84 0.681 . . . . 6.11 112.84 -175.337 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 24.8 mt -69.73 -17.23 63.44 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.969 1.308 . . . . 1.89 111.295 176.11 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 94.2 41.85 4.17 Favored Glycine 0 CA--C 1.523 0.569 0 C-N-CA 124.642 1.115 . . . . 0.52 110.367 176.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -140.61 171.57 13.93 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 123.909 0.884 . . . . 3.38 110.238 -176.089 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -151.08 141.93 22.88 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 108.306 -0.998 . . . . 3.54 108.306 168.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.0 m -99.27 165.38 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 C-N-CA 124.891 1.277 . . . . 3.81 108.531 174.34 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 16.6 t -122.42 143.81 33.92 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 C-N-CA 124.66 1.184 . . . . 2.16 108.325 177.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 21.9 mm -124.74 79.45 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.201 0 C-N-CA 125.429 1.492 . . . . 2.82 108.482 -176.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -78.66 -1.73 35.77 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 114.042 1.127 . . . . 3.26 114.042 174.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -92.99 -45.37 3.61 Favored Glycine 0 CA--C 1.529 0.915 0 C-N-CA 124.755 1.169 . . . . 3.64 113.688 -169.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.255 1.346 0 N-CA-C 106.81 -1.552 . . . . 11.37 106.81 -170.271 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.477 0.916 0 N-CA-C 106.53 -1.655 . . . . 13.14 106.53 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -58.3 -31.85 67.89 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 119.712 1.142 . . . . 6.96 110.67 167.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 28.2 m -125.75 158.61 34.44 Favored 'General case' 0 N--CA 1.444 -0.729 0 C-N-CA 126.286 1.834 . . . . 1.44 108.051 179.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -108.68 -179.94 4.01 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 128.065 2.546 . . . . 2.12 108.985 166.153 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 3.5 mm100 -139.19 147.66 42.11 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.95 1.3 . . . . 1.23 108.015 167.544 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -140.96 159.8 41.43 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 123.735 0.814 . . . . 4.03 109.384 160.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -114.89 86.55 2.47 Favored 'General case' 0 N--CA 1.442 -0.83 0 C-N-CA 127.902 2.481 . . . . 1.57 106.727 -170.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 2.6 mp -83.5 161.67 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.295 0 N-CA-C 106.262 -1.755 . . . . 3.15 106.262 -176.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -128.85 137.68 51.61 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 125.649 1.58 . . . . 1.38 108.077 -178.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 1.9 mpt? -140.3 171.4 14.2 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 122.923 0.489 . . . . 3.01 110.302 172.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -88.54 159.7 17.8 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 127.005 2.122 . . . . 3.75 109.797 167.091 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 88.9 t -117.86 152.63 19.84 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 C-N-CA 124.623 1.169 . . . . 2.31 108.525 -179.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 70.8 m -149.49 160.41 43.48 Favored 'General case' 0 N--CA 1.455 -0.198 0 O-C-N 121.342 -0.849 . . . . 1.75 109.853 171.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 70.02 70.29 1.21 Allowed Glycine 0 CA--C 1.528 0.861 0 N-CA-C 110.462 -1.055 . . . . 1.64 110.462 -178.408 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -145.2 157.89 43.96 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 124.152 0.981 . . . . 2.75 109.529 -175.283 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.7 p -108.63 -66.03 1.08 Allowed 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 125.612 1.565 . . . . 3.15 108.692 171.129 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 20.3 p -123.71 161.11 25.8 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 124.485 1.114 . . . . 2.6 111.414 -170.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -76.67 53.49 0.89 Allowed 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.322 1.049 . . . . 2.45 110.813 178.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -138.42 -53.49 0.61 Allowed 'General case' 0 CA--C 1.521 -0.153 0 C-N-CA 124.677 1.191 . . . . 1.77 109.234 175.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 59.7 m -57.4 -41.44 80.33 Favored 'General case' 0 CA--C 1.533 0.289 0 O-C-N 121.734 -0.604 . . . . 1.25 111.6 -176.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.67 -19.13 47.52 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 112.642 0.608 . . . . 2.07 112.642 176.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.72 -49.12 42.22 Favored 'General case' 0 N--CA 1.455 -0.221 0 O-C-N 120.634 -1.291 . . . . 1.7 109.757 169.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 6.3 mtt-85 -53.72 -49.27 68.49 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 123.383 0.673 . . . . 4.99 109.397 -175.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 5.1 pt -55.23 -53.46 34.81 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 O-C-N 123.883 0.739 . . . . 1.73 109.973 179.423 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -53.72 -45.62 70.53 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.078 0.951 . . . . 2.31 112.273 179.51 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.5 mptp? -69.25 -46.71 66.64 Favored 'General case' 0 CA--C 1.532 0.259 0 O-C-N 121.163 -0.96 . . . . 2.36 110.351 -177.091 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -63.94 -31.71 81.73 Favored Glycine 0 CA--C 1.529 0.956 0 N-CA-C 111.439 -0.665 . . . . 0.51 111.439 176.2 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 7.6 tt -64.91 -44.05 90.84 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 126.018 1.727 . . . . 3.2 109.486 177.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -53.1 -26.51 16.67 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 112.034 0.383 . . . . 3.48 112.034 176.037 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 2.3 mtt180 -70.96 1.6 5.42 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 113.671 0.989 . . . . 4.64 113.671 177.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 6.6 mmt -71.48 155.52 92.57 Favored Pre-proline 0 CA--C 1.534 0.348 0 CA-C-N 119.519 1.054 . . . . 4.0 111.314 167.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -62.62 152.78 75.97 Favored 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 122.411 2.074 . . . . 1.15 110.418 171.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 74.88 -27.03 1.12 Allowed Glycine 0 CA--C 1.533 1.193 0 O-C-N 121.482 -0.761 . . . . 0.94 113.486 177.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 10.3 t -76.4 145.76 9.92 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 CA-C-N 118.83 1.315 . . . . 1.62 109.056 173.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -132.22 -38.94 1.06 Allowed 'General case' 0 CA--C 1.529 0.143 0 CA-C-O 118.512 -0.756 . . . . 1.86 112.304 -176.185 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -140.61 166.49 24.6 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-N 119.589 1.086 . . . . 2.26 111.867 163.503 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -158.13 137.26 11.59 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 112.769 0.655 . . . . 1.56 112.769 -179.278 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -149.97 107.86 3.71 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 106.463 -1.68 . . . . 0.47 106.463 -161.55 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.4 p -82.02 128.44 38.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 108.324 -0.991 . . . . 1.91 108.324 177.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 39.3 t30 -105.69 57.26 0.67 Allowed 'General case' 0 C--O 1.235 0.341 0 CA-C-O 123.263 1.506 . . . . 1.04 107.887 179.005 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -74.74 -13.49 60.6 Favored 'General case' 0 C--O 1.226 -0.178 0 CA-C-N 113.96 -1.473 . . . . 1.95 110.636 177.003 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -44.0 -36.55 2.54 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.914 0.886 . . . . 1.87 111.378 165.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 15.2 t -108.21 -68.73 0.89 Allowed 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 117.739 -1.124 . . . . 3.37 110.85 167.318 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 161.34 49.13 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 127.561 2.344 . . . . 3.8 109.535 -174.108 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -142.52 160.62 39.92 Favored 'General case' 0 N--CA 1.446 -0.667 0 O-C-N 120.292 -1.505 . . . . 1.84 109.16 -178.228 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.6 p -130.18 142.79 42.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 108.113 -1.069 . . . . 1.56 108.113 171.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -127.04 138.77 53.28 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 107.594 -1.262 . . . . 0.41 107.594 176.123 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 3.1 p -137.68 129.67 40.61 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 N-CA-C 106.003 -1.851 . . . . 2.83 106.003 -176.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 11.2 mm -104.92 99.49 8.56 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.612 0 N-CA-C 106.743 -1.577 . . . . 1.56 106.743 -171.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 51.2 p90 -139.84 169.44 17.72 Favored 'General case' 0 CA--C 1.512 -0.507 0 C-N-CA 122.629 0.372 . . . . 3.59 110.662 -173.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 52.6 t0 -90.4 109.27 32.6 Favored Pre-proline 0 C--O 1.235 0.33 0 O-C-N 124.435 1.085 . . . . 3.32 109.533 173.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 78.9 Cg_endo -72.41 5.57 2.71 Favored 'Trans proline' 0 N--CA 1.452 -0.95 0 C-N-CA 122.758 2.305 . . . . 0.96 113.698 179.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -83.37 -33.24 25.85 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 119.393 0.997 . . . . 2.28 108.692 165.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -107.44 -60.83 1.64 Allowed 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 123.446 0.698 . . . . 2.68 110.943 -168.386 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.495 0.2 OUTLIER -79.2 -177.1 5.49 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 114.513 1.301 . . . . 1.69 114.513 155.956 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 176.78 -147.91 8.7 Favored Glycine 0 N--CA 1.434 -1.469 0 N-CA-C 103.354 -3.898 . . . . 2.71 103.354 -165.37 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 12.9 p -75.39 -42.68 53.29 Favored 'General case' 0 N--CA 1.443 -0.795 0 C-N-CA 124.711 1.204 . . . . 2.43 108.794 174.32 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -46.67 -63.83 0.92 Allowed 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 114.125 1.157 . . . . 1.88 114.125 -165.026 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.82 -34.57 71.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 122.34 1.067 . . . . 1.64 108.98 -165.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.5 mp -53.78 -58.55 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.122 0 CA-C-N 114.143 -1.389 . . . . 2.45 109.534 170.045 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.94 -45.4 92.73 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 123.038 0.535 . . . . 1.6 109.957 -173.395 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -43.8 -58.48 2.7 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.236 1.014 . . . . 3.89 110.872 172.518 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -67.3 -44.69 78.61 Favored 'General case' 0 N--CA 1.442 -0.845 0 O-C-N 121.937 -0.477 . . . . 4.89 111.809 -178.814 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -48.46 -53.03 7.23 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 C-N-CA 125.799 1.64 . . . . 1.72 107.89 -179.324 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 41.0 mm-40 -60.56 -58.19 9.52 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 124.549 1.14 . . . . 2.0 110.339 176.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 5.9 mmmt -53.66 -37.28 63.01 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 113.25 0.833 . . . . 5.38 113.25 -177.256 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 12.1 mt -68.93 -17.74 64.0 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.275 1.03 . . . . 2.19 111.985 177.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 92.62 49.61 2.71 Favored Glycine 0 CA--C 1.523 0.534 0 N-CA-C 109.932 -1.267 . . . . 0.65 109.932 178.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -147.06 170.27 17.5 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 124.135 0.974 . . . . 3.1 109.799 -175.405 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 12.9 t-80 -140.78 123.72 16.37 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 108.249 -1.019 . . . . 3.13 108.249 174.244 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 7.5 p -92.7 144.57 9.07 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.146 0 N-CA-C 107.027 -1.471 . . . . 2.38 107.027 170.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 44.7 t -123.04 139.98 48.14 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.182 0 N-CA-C 107.952 -1.129 . . . . 2.23 107.952 178.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 5.2 mp -111.37 83.11 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 N-CA-C 107.749 -1.204 . . . . 2.86 107.749 -173.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 71.2 mt-10 -79.33 -3.71 47.47 Favored 'General case' 0 N--CA 1.443 -0.794 0 C-N-CA 124.349 1.06 . . . . 2.55 113.642 170.435 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -98.1 -23.9 12.39 Favored Glycine 0 CA--C 1.524 0.651 0 C-N-CA 125.137 1.351 . . . . 2.78 114.666 -165.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 32.4 ttt180 . . . . . 0 C--O 1.25 1.082 0 CA-C-O 116.472 -1.727 . . . . 12.37 108.873 -169.585 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 82.2 mtp . . . . . 0 N--CA 1.475 0.789 0 N-CA-C 106.228 -1.768 . . . . 9.13 106.228 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.5 tp 50.14 78.84 0.09 Allowed 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.361 1.465 . . . . 6.89 113.071 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.5 m -68.68 107.09 2.86 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 124.329 1.052 . . . . 1.36 110.739 -179.261 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -63.31 175.15 1.03 Allowed 'General case' 0 CA--C 1.531 0.245 0 CA-C-O 121.494 0.664 . . . . 3.1 111.543 165.815 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.2 mm100 -137.97 143.79 40.85 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 125.215 1.406 . . . . 1.05 107.968 165.315 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 46.2 mttm -141.47 156.06 45.79 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 123.808 0.843 . . . . 4.65 109.428 164.367 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 12.0 mp0 -114.62 86.34 2.42 Favored 'General case' 0 N--CA 1.445 -0.685 0 C-N-CA 127.164 2.186 . . . . 1.65 108.08 -167.138 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.5 mt -83.61 157.99 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 N-CA-C 107.296 -1.372 . . . . 3.23 107.296 -176.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -126.95 136.2 51.94 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 126.183 1.793 . . . . 1.77 107.455 178.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 2.1 mpt? -138.74 169.57 17.56 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 118.337 0.517 . . . . 2.86 110.064 174.069 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -87.59 160.16 18.3 Favored 'General case' 0 N--CA 1.456 -0.133 0 C-N-CA 124.441 1.096 . . . . 3.15 109.001 170.48 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 60.3 t -116.55 152.05 18.31 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 C-N-CA 124.202 1.001 . . . . 2.27 108.384 177.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 58.6 m -149.58 173.48 13.58 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.755 1.222 . . . . 1.81 108.29 172.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 79.79 -37.12 2.09 Favored Glycine 0 CA--C 1.532 1.151 0 O-C-N 121.737 -0.602 . . . . 2.1 112.557 -177.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 3.8 ppp? -47.78 153.64 0.58 Allowed 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.119 1.368 . . . . 4.53 113.855 179.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.2 p -114.26 -71.51 0.74 Allowed 'General case' 0 N--CA 1.457 -0.086 0 C-N-CA 124.804 1.242 . . . . 3.11 108.681 170.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 6.7 p -99.09 148.13 24.35 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 121.835 0.826 . . . . 2.2 111.331 -178.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -77.84 53.44 1.14 Allowed 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.477 0.711 . . . . 2.44 110.493 178.247 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -143.05 -51.09 0.35 Allowed 'General case' 0 C--O 1.231 0.102 0 C-N-CA 123.65 0.78 . . . . 1.68 110.682 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 56.1 m -56.01 -36.2 67.68 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 118.728 0.695 . . . . 1.2 110.15 171.025 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -47.97 -33.35 7.67 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.186 1.394 . . . . 1.66 112.407 172.442 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.37 -53.27 14.68 Favored 'General case' 0 N--CA 1.454 -0.27 0 O-C-N 121.528 -0.733 . . . . 1.57 110.128 172.576 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 6.4 mpt_? -55.3 -50.07 70.51 Favored 'General case' 0 CA--C 1.521 -0.148 0 C-N-CA 122.434 0.294 . . . . 6.86 110.251 -175.172 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.258 2.3 pp -52.86 -50.52 42.87 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 O-C-N 123.183 0.302 . . . . 2.64 110.99 177.578 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -59.08 -39.27 81.62 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 114.029 1.122 . . . . 2.76 114.029 176.221 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -73.95 -38.07 64.35 Favored 'General case' 0 CA--C 1.533 0.305 0 O-C-N 120.82 -1.175 . . . . 3.47 111.974 -178.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -66.04 -41.39 95.19 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 109.858 -1.297 . . . . 0.48 109.858 170.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 8.0 tt -53.56 -50.45 65.51 Favored 'General case' 0 C--N 1.333 -0.133 0 N-CA-C 108.84 -0.8 . . . . 2.9 108.84 174.124 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -50.7 -19.9 1.07 Allowed 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.853 1.261 . . . . 4.31 114.125 178.583 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.67 -9.32 59.62 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 118.897 0.772 . . . . 4.99 112.528 -179.092 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 8.1 ptp -68.78 154.68 94.49 Favored Pre-proline 0 CA--C 1.534 0.337 0 CA-C-N 119.43 1.013 . . . . 4.64 111.474 177.215 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -58.4 137.35 79.95 Favored 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 121.539 1.493 . . . . 0.68 109.388 166.123 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 100.83 -35.51 4.8 Favored Glycine 0 CA--C 1.529 0.95 0 CA-C-O 119.274 -0.737 . . . . 0.59 113.283 175.354 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 54.7 t -89.21 110.39 21.48 Favored 'Isoleucine or valine' 0 C--N 1.34 0.178 0 CA-C-N 118.76 1.28 . . . . 2.04 109.671 178.062 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -81.63 -49.46 10.48 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-O 118.122 -0.942 . . . . 1.78 108.577 -178.856 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -137.36 163.14 31.74 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 119.016 0.826 . . . . 2.16 112.096 173.72 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -157.06 146.92 20.73 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.697 -0.683 . . . . 1.45 112.082 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -156.07 115.04 3.48 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 106.365 -1.717 . . . . 0.65 106.365 -163.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.5 p -81.39 130.89 35.09 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.688 0 N-CA-C 107.911 -1.144 . . . . 1.79 107.911 175.541 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 54.1 t-20 -109.63 55.82 0.63 Allowed 'General case' 0 C--O 1.236 0.359 0 N-CA-C 107.187 -1.412 . . . . 0.8 107.187 178.495 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.16 -18.34 62.5 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 114.157 -1.383 . . . . 2.09 109.86 -172.658 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -43.13 -37.78 2.16 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.09 0.956 . . . . 1.63 112.246 164.105 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 8.9 t -124.23 38.51 4.18 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 122.727 0.411 . . . . 1.68 109.943 173.346 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 50.11 31.85 5.35 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.932 1.693 . . . . 2.61 113.412 174.483 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 90.4 m -121.31 157.29 30.7 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 108.264 -1.013 . . . . 1.63 108.264 -177.005 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 5.4 p -125.52 142.41 42.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 N-CA-C 108.355 -0.98 . . . . 1.66 108.355 172.17 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -127.37 139.84 52.59 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 108.425 -0.954 . . . . 0.39 108.425 -179.515 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 5.5 p -141.29 126.17 17.92 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 N-CA-C 106.936 -1.505 . . . . 3.05 106.936 -172.472 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 14.8 mm -107.22 91.8 1.88 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.513 0 C-N-CA 126.092 1.757 . . . . 1.56 107.07 -167.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 43.6 p90 -135.38 165.53 25.26 Favored 'General case' 0 CA--C 1.51 -0.583 0 O-C-N 121.975 -0.453 . . . . 3.44 112.037 -166.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 59.7 t0 -86.55 109.92 27.67 Favored Pre-proline 0 C--O 1.235 0.321 0 O-C-N 124.574 1.172 . . . . 3.05 109.821 176.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -71.23 1.93 4.89 Favored 'Trans proline' 0 N--CA 1.453 -0.892 0 C-N-CA 123.029 2.486 . . . . 0.62 113.44 -178.401 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -88.78 -27.17 21.31 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 119.428 1.013 . . . . 1.98 109.471 168.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -101.71 -53.33 2.99 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 123.492 0.717 . . . . 2.75 109.13 -170.122 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.265 1.0 OUTLIER -101.66 -176.44 3.14 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 125.256 1.422 . . . . 1.51 111.998 163.431 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 146.95 91.09 0.1 OUTLIER Glycine 0 N--CA 1.442 -0.931 0 N-CA-C 103.629 -3.789 . . . . 2.32 103.629 -155.406 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 77.0 p -13.95 -15.06 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.546 1 C-N-CA 137.737 6.415 . . . . 2.46 120.32 -145.848 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -25.49 -62.04 0.07 Allowed 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 126.924 2.09 . . . . 1.49 114.503 162.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.07 -43.13 58.82 Favored 'General case' 0 C--N 1.332 -0.176 0 C-N-CA 119.088 -1.045 . . . . 1.74 109.027 -167.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.7 mt -46.92 -60.03 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.706 0 C-N-CA 126.543 1.937 . . . . 2.53 110.893 172.025 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.78 -46.84 81.26 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 119.778 1.172 . . . . 1.14 110.195 179.541 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -51.88 -55.18 21.66 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 121.795 0.807 . . . . 3.39 112.022 179.014 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -69.8 -37.96 76.47 Favored 'General case' 0 N--CA 1.438 -1.028 0 O-C-N 121.419 -0.801 . . . . 3.15 111.471 -178.792 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.7 mm -49.95 -54.28 8.26 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 N-CA-C 107.362 -1.347 . . . . 1.86 107.362 175.369 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 27.0 mm-40 -58.36 -58.23 9.41 Favored 'General case' 0 C--N 1.342 0.259 0 C-N-CA 124.745 1.218 . . . . 2.2 110.387 178.345 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 7.8 mptt -54.48 -39.84 67.9 Favored 'General case' 0 CA--C 1.534 0.334 0 O-C-N 121.877 -0.514 . . . . 5.46 112.153 -177.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 44.2 mt -70.63 -17.08 62.88 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.232 1.013 . . . . 1.99 112.114 178.1 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 94.46 33.84 6.62 Favored Glycine 0 CA--C 1.524 0.641 0 C-N-CA 124.303 0.954 . . . . 0.47 111.617 173.378 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -124.19 169.94 11.23 Favored 'General case' 0 N--CA 1.457 -0.123 0 C-N-CA 124.793 1.237 . . . . 3.19 109.277 177.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -135.16 120.33 18.86 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 107.794 -1.187 . . . . 2.93 107.794 172.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 7.6 p -89.55 145.1 7.81 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 N-CA-C 107.597 -1.261 . . . . 2.44 107.597 172.168 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 48.8 t -121.21 141.16 42.89 Favored 'Isoleucine or valine' 0 C--O 1.232 0.136 0 C-N-CA 123.884 0.874 . . . . 2.09 108.93 178.042 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 29.8 mm -110.78 76.99 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 C-N-CA 124.684 1.194 . . . . 2.09 109.479 -168.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -72.25 -3.65 24.87 Favored 'General case' 0 N--CA 1.447 -0.575 0 N-CA-C 114.49 1.292 . . . . 3.41 114.49 178.351 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 65.99 83.79 0.1 OUTLIER Glycine 0 CA--C 1.529 0.928 0 N-CA-C 109.606 -1.398 . . . . 2.78 109.606 -175.34 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 33.2 tpt85 . . . . . 0 C--O 1.253 1.248 0 CA-C-O 115.855 -2.021 . . . . 14.49 111.737 -173.803 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 37.8 mtt . . . . . 0 N--CA 1.473 0.696 0 N-CA-C 107.625 -1.25 . . . . 10.89 107.625 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -156.79 165.88 34.97 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 108.862 -0.792 . . . . 7.11 108.862 179.537 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 5.5 m -121.13 103.04 8.71 Favored 'General case' 0 N--CA 1.455 -0.181 0 N-CA-C 106.708 -1.59 . . . . 1.89 106.708 166.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -63.55 169.4 3.9 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 107.998 -1.112 . . . . 2.89 107.998 161.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -129.28 153.71 47.55 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 108.657 -0.868 . . . . 1.59 108.657 171.531 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -139.76 153.26 47.12 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 123.423 0.689 . . . . 4.01 110.048 168.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -107.69 90.87 3.43 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 127.633 2.373 . . . . 1.63 107.731 -176.4 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 3.4 mm -83.65 159.45 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.179 0 N-CA-C 106.787 -1.56 . . . . 2.83 106.787 -178.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -134.14 131.72 39.01 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 124.641 1.176 . . . . 1.75 108.385 178.441 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 3.7 mpp? -137.47 167.3 21.92 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.377 0.671 . . . . 2.93 110.008 174.45 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 21.4 mm100 -88.01 160.16 17.98 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.14 0.976 . . . . 2.58 109.452 174.652 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 81.4 t -115.01 144.2 23.08 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 C-N-CA 124.053 0.941 . . . . 2.71 109.971 -179.291 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 9.1 m -147.21 175.15 10.97 Favored 'General case' 0 C--N 1.341 0.228 0 C-N-CA 125.523 1.529 . . . . 1.77 108.604 171.409 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 55.68 52.47 48.13 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 110.788 -0.925 . . . . 1.87 110.788 175.695 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -125.51 149.5 48.24 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 124.559 1.144 . . . . 3.74 109.424 -170.886 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -87.85 -58.54 2.53 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 124.039 0.936 . . . . 4.81 109.966 170.379 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 17.7 p -154.68 170.55 21.28 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-O 121.777 0.798 . . . . 2.58 111.279 175.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.35 -34.4 68.77 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 124.409 1.084 . . . . 2.93 111.893 178.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.76 -49.82 73.5 Favored 'General case' 0 N--CA 1.453 -0.292 0 O-C-N 121.992 -0.443 . . . . 1.77 109.898 178.587 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 77.5 m -61.49 -38.92 89.04 Favored 'General case' 0 N--CA 1.456 -0.153 0 O-C-N 121.619 -0.675 . . . . 1.3 110.422 174.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.83 -23.13 41.7 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 112.105 0.409 . . . . 1.52 112.105 173.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.07 -47.63 61.14 Favored 'General case' 0 N--CA 1.456 -0.165 0 O-C-N 120.039 -1.663 . . . . 1.61 110.116 169.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 2.0 mtp85 -51.45 -43.59 62.13 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 122.92 0.488 . . . . 4.55 110.039 -175.402 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.287 1.9 pt -60.88 -60.35 2.79 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.274 0 CA-C-O 118.371 -0.823 . . . . 1.74 111.196 178.74 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -54.91 -40.54 69.95 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 119.964 1.256 . . . . 2.28 112.002 -179.45 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 14.7 mptt -68.07 -50.2 56.6 Favored 'General case' 0 CA--C 1.537 0.453 0 O-C-N 121.353 -0.842 . . . . 2.97 110.38 -179.08 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -67.39 -23.18 73.4 Favored Glycine 0 CA--C 1.53 1.022 0 O-C-N 121.489 -0.757 . . . . 0.7 112.265 177.241 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -71.01 -47.75 57.03 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 125.375 1.47 . . . . 3.65 108.652 173.106 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.452 ' HZ1' ' CG ' ' A' ' 36' ' ' ASP . 19.9 ttmt -46.5 -39.54 10.96 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 118.959 0.8 . . . . 4.35 111.397 178.831 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.6 mtt180 -67.14 -5.93 15.54 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 114.691 1.367 . . . . 4.53 114.691 -177.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.67 162.32 73.74 Favored Pre-proline 0 CA--C 1.541 0.626 0 CA-C-N 119.367 0.985 . . . . 5.21 111.055 179.304 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -73.68 117.34 5.01 Favored 'Trans proline' 0 N--CA 1.453 -0.898 0 C-N-CA 121.507 1.471 . . . . 1.07 109.191 172.392 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 116.47 -19.39 12.91 Favored Glycine 0 CA--C 1.527 0.794 0 C-N-CA 123.895 0.76 . . . . 1.02 113.789 169.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 86.6 t -89.97 145.96 6.77 Favored 'Isoleucine or valine' 0 C--N 1.339 0.143 0 CA-C-N 118.685 1.243 . . . . 1.97 108.539 167.386 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.2 m -118.38 -36.63 3.49 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 118.441 -0.79 . . . . 2.0 111.256 177.295 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.452 ' CG ' ' HZ1' ' A' ' 29' ' ' LYS . 0.8 OUTLIER -138.83 164.22 30.21 Favored 'General case' 0 C--N 1.343 0.307 0 CA-C-N 119.955 1.252 . . . . 2.09 111.728 168.015 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -159.27 144.98 16.17 Favored 'General case' 0 C--N 1.332 -0.171 0 C-N-CA 123.104 0.562 . . . . 1.63 111.868 -178.264 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -155.49 110.19 2.94 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 107.608 -1.256 . . . . 0.48 107.608 -165.529 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.1 p -82.61 103.97 10.59 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 CA-C-O 121.336 0.588 . . . . 1.87 110.79 178.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 51.6 t-20 -84.34 57.67 4.39 Favored 'General case' 0 CA--C 1.537 0.451 0 O-C-N 120.336 -1.477 . . . . 0.84 110.173 179.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.08 -19.05 64.06 Favored 'General case' 0 N--CA 1.461 0.119 0 CA-C-N 115.593 -0.731 . . . . 2.05 111.24 -176.506 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -44.09 -33.4 1.47 Allowed 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 123.816 0.846 . . . . 1.75 111.872 166.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 6.6 t -129.62 42.08 3.34 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 121.392 0.615 . . . . 1.78 109.866 173.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 39.12 40.97 0.54 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 126.614 1.966 . . . . 2.55 114.01 -178.28 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 83.8 m -120.34 157.23 29.68 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 124.55 1.14 . . . . 1.77 108.568 -178.297 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 1.6 p -125.87 140.26 49.06 Favored 'Isoleucine or valine' 0 C--O 1.232 0.151 0 N-CA-C 108.278 -1.008 . . . . 1.72 108.278 172.527 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -126.69 137.26 53.25 Favored 'General case' 0 C--N 1.344 0.365 0 N-CA-C 108.26 -1.015 . . . . 0.33 108.26 176.306 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 40.7 t -131.31 125.2 56.55 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 N-CA-C 105.426 -2.065 . . . . 3.13 105.426 -177.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 14.7 mm -100.46 88.24 1.47 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.592 0 N-CA-C 106.829 -1.545 . . . . 1.59 106.829 -176.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 13.2 p90 -124.36 167.7 14.02 Favored 'General case' 0 CA--C 1.507 -0.711 0 CA-C-N 115.794 -0.639 . . . . 3.48 111.503 -171.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -99.84 107.48 46.61 Favored Pre-proline 0 N--CA 1.445 -0.677 0 CA-C-N 113.879 -1.51 . . . . 4.38 108.113 -171.091 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -72.44 6.18 2.42 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 122.698 2.265 . . . . 0.84 113.138 -173.109 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -84.28 -25.2 29.5 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 123.478 0.711 . . . . 2.2 109.334 168.401 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 -117.54 -53.64 2.41 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.202 1.001 . . . . 3.02 110.977 -169.636 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.258 0.8 OUTLIER -89.72 -175.77 4.76 Favored 'General case' 0 CA--C 1.517 -0.3 0 C-N-CA 123.766 0.826 . . . . 1.78 113.177 160.343 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 141.34 87.5 0.11 Allowed Glycine 0 N--CA 1.44 -1.092 0 N-CA-C 104.902 -3.279 . . . . 2.53 104.902 -158.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 82.4 p -9.48 -18.52 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.559 1 C-N-CA 138.126 6.571 . . . . 1.96 119.977 -143.238 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -28.18 -65.98 0.08 Allowed 'General case' 0 N--CA 1.44 -0.972 0 C-N-CA 127.6 2.36 . . . . 1.82 113.977 169.639 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -76.81 -25.41 53.25 Favored 'General case' 0 C--N 1.334 -0.106 0 C-N-CA 118.105 -1.438 . . . . 2.01 110.042 -169.113 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -63.5 -53.79 40.77 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.855 0 CA-C-O 118.58 -0.724 . . . . 1.81 109.072 176.554 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.46 -44.44 96.4 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 108.828 -0.805 . . . . 1.6 108.828 -175.547 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -48.13 -58.69 4.15 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-O 121.592 0.711 . . . . 3.8 111.726 172.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 13.3 mmmt -65.44 -37.99 88.53 Favored 'General case' 0 N--CA 1.44 -0.946 0 O-C-N 121.618 -0.676 . . . . 4.6 111.739 -177.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 2.5 mm -51.79 -51.81 25.75 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 C-N-CA 125.634 1.574 . . . . 1.61 108.302 178.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -57.45 -54.49 46.26 Favored 'General case' 0 C--N 1.341 0.218 0 C-N-CA 123.094 0.558 . . . . 2.04 110.243 174.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 5.8 mmtt -53.89 -38.44 64.78 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 112.874 0.694 . . . . 4.95 112.874 -179.306 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 32.5 mt -70.95 -17.92 62.66 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 125.737 1.615 . . . . 1.82 111.632 177.452 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 93.37 35.64 6.19 Favored Glycine 0 CA--C 1.525 0.668 0 C-N-CA 124.658 1.123 . . . . 0.57 111.229 176.119 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -131.96 172.15 12.7 Favored 'General case' 0 N--CA 1.457 -0.123 0 C-N-CA 123.818 0.847 . . . . 3.32 110.923 -178.319 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 3.7 t-80 -148.85 116.38 6.21 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 109.041 -0.725 . . . . 2.99 109.041 170.446 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 25.7 m -81.59 166.35 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 N-CA-C 109.072 -0.714 . . . . 3.9 109.072 176.235 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 12.1 t -124.51 142.51 41.09 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 C-N-CA 124.173 0.989 . . . . 2.07 108.458 178.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 17.9 mm -112.52 72.73 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 C-N-CA 124.115 0.966 . . . . 2.23 109.061 -174.084 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -72.93 -9.99 59.31 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 114.043 1.127 . . . . 3.15 114.043 176.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -122.98 62.42 0.55 Allowed Glycine 0 CA--C 1.523 0.542 0 N-CA-C 108.4 -1.88 . . . . 3.26 108.4 174.215 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.177 0 CA-C-O 116.761 -1.59 . . . . 13.0 111.125 179.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.9 mmt . . . . . 0 N--CA 1.472 0.66 0 N-CA-C 108.492 -0.929 . . . . 10.53 108.492 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 63.0 tp -137.15 124.93 22.47 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 105.538 -2.023 . . . . 7.66 105.538 173.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 39.2 m -131.4 116.54 17.67 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 103.908 -2.627 . . . . 1.73 103.908 170.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -80.07 -179.7 7.17 Favored 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 125.113 1.365 . . . . 3.05 108.025 177.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.2 mm100 -138.78 136.52 35.77 Favored 'General case' 0 CA--C 1.514 -0.438 0 O-C-N 120.843 -1.161 . . . . 1.32 108.275 171.548 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.8 mtpt -133.98 151.79 51.6 Favored 'General case' 0 N--CA 1.455 -0.222 0 O-C-N 124.089 0.868 . . . . 3.82 109.958 167.658 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -101.9 93.5 5.32 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 127.968 2.507 . . . . 1.43 107.457 -176.059 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 2.5 mm -84.01 159.91 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.248 0 N-CA-C 106.669 -1.604 . . . . 2.98 106.669 -178.029 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -133.78 130.9 38.67 Favored 'General case' 0 N--CA 1.456 -0.136 0 N-CA-C 108.073 -1.084 . . . . 1.69 108.073 176.153 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 4.0 mpp? -139.15 172.1 13.32 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.256 1.022 . . . . 2.69 110.19 176.609 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.36 162.46 12.94 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 126.188 1.795 . . . . 3.5 109.468 173.368 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.1 m -118.76 151.5 20.95 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 C-N-CA 123.659 0.784 . . . . 3.03 111.35 174.406 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 48.4 m -142.44 165.4 27.51 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 125.495 1.518 . . . . 1.81 109.411 176.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 63.58 67.06 2.21 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 110.686 -0.966 . . . . 2.1 110.686 177.645 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -139.72 157.69 45.35 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 123.928 0.891 . . . . 3.66 110.753 -175.432 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -76.83 -70.15 0.48 Allowed 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 108.178 -1.045 . . . . 4.28 108.178 157.12 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 25.8 p -158.41 -178.91 7.62 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 121.732 0.777 . . . . 2.96 112.05 -166.357 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.65 175.6 0.45 Allowed 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 124.793 1.237 . . . . 3.25 110.086 170.455 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 72.03 -56.21 0.65 Allowed 'General case' 0 CA--C 1.528 0.123 0 C-N-CA 124.875 1.27 . . . . 2.69 110.196 -174.179 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 28.3 m -57.57 -46.27 84.18 Favored 'General case' 0 C--N 1.33 -0.259 0 O-C-N 121.442 -0.786 . . . . 1.45 109.361 171.328 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -52.01 -23.76 5.63 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.107 0.963 . . . . 1.76 112.965 172.227 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -72.22 -49.49 34.79 Favored 'General case' 0 N--CA 1.454 -0.258 0 O-C-N 120.87 -1.144 . . . . 1.66 110.607 171.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 8.1 mmm180 -56.11 -42.74 77.32 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 109.791 -0.448 . . . . 5.93 109.791 -171.588 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 4.1 pt -56.62 -55.99 16.46 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 O-C-N 123.382 0.426 . . . . 1.67 110.676 176.351 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -55.45 -43.15 75.18 Favored 'General case' 0 C--O 1.226 -0.163 0 C-N-CA 123.825 0.85 . . . . 3.54 111.75 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 4.0 mptp? -72.0 -42.82 65.97 Favored 'General case' 0 CA--C 1.535 0.366 0 O-C-N 121.168 -0.957 . . . . 2.84 110.537 -174.537 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.93 -39.16 97.7 Favored Glycine 0 CA--C 1.53 0.991 0 N-CA-C 110.525 -1.03 . . . . 0.66 110.525 170.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 6.8 tt -60.51 -36.31 78.05 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.23 1.012 . . . . 3.13 109.703 175.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.5 ttpm? -61.95 -24.02 66.73 Favored 'General case' 0 CA--C 1.53 0.187 0 O-C-N 120.565 -1.335 . . . . 3.94 112.841 172.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 11.3 mmt180 -77.85 -3.81 43.44 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 119.043 0.838 . . . . 4.39 111.524 -179.069 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 70.3 mmm -83.95 147.84 52.35 Favored Pre-proline 0 CA--C 1.535 0.369 0 CA-C-N 118.918 0.781 . . . . 4.1 111.076 -176.632 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -59.25 136.15 70.46 Favored 'Trans proline' 0 N--CA 1.451 -0.986 0 C-N-CA 122.34 2.027 . . . . 0.65 108.961 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 94.66 -23.94 30.24 Favored Glycine 0 CA--C 1.528 0.848 0 CA-C-O 118.919 -0.934 . . . . 0.56 113.084 -178.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 17.0 t -92.35 130.28 41.69 Favored 'Isoleucine or valine' 0 C--N 1.34 0.161 0 CA-C-N 118.6 1.2 . . . . 1.63 109.966 -177.139 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 9.3 m -112.13 -39.51 4.45 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 123.823 0.849 . . . . 2.13 111.142 -171.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -145.27 157.21 44.11 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 118.867 0.758 . . . . 2.8 109.738 175.038 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -152.0 126.7 9.54 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 123.765 0.826 . . . . 1.84 110.375 -170.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -142.36 107.85 5.06 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 125.723 1.609 . . . . 1.03 108.772 -164.45 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.1 p -82.31 88.09 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 N-CA-C 108.734 -0.839 . . . . 2.59 108.734 178.41 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 48.9 t-20 -83.31 56.65 3.63 Favored 'General case' 0 CA--C 1.537 0.462 0 O-C-N 120.6 -1.312 . . . . 0.9 110.108 -177.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -68.27 -20.74 64.81 Favored 'General case' 0 C--O 1.223 -0.332 0 C-N-CA 124.398 1.079 . . . . 2.07 110.541 -179.792 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -45.7 -30.12 1.48 Allowed 'General case' 0 CA--C 1.529 0.154 0 N-CA-C 112.811 0.671 . . . . 1.68 112.811 168.363 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 5.7 t -131.66 32.25 4.16 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 118.019 0.372 . . . . 1.92 110.476 173.087 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 9.1 mp0 50.02 52.79 13.99 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.302 1.041 . . . . 4.12 112.591 179.569 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.3 m -137.69 160.43 39.24 Favored 'General case' 0 N--CA 1.443 -0.797 0 O-C-N 121.286 -0.884 . . . . 2.03 109.144 176.295 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.5 p -129.91 136.64 58.49 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 N-CA-C 107.044 -1.465 . . . . 1.59 107.044 169.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -125.07 129.51 50.4 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 107.559 -1.275 . . . . 0.55 107.559 -178.665 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 3.7 p -132.97 131.14 58.95 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.828 0 N-CA-C 105.1 -2.185 . . . . 3.04 105.1 -176.486 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 2.1 mp -104.2 111.2 32.87 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.762 0 N-CA-C 106.097 -1.816 . . . . 3.44 106.097 178.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 21.4 p90 -143.15 167.58 21.78 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 116.039 -0.528 . . . . 2.84 109.914 -178.047 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -87.78 121.82 70.63 Favored Pre-proline 0 CA--C 1.54 0.58 0 O-C-N 125.047 1.467 . . . . 3.39 111.506 171.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_endo -80.76 12.12 2.72 Favored 'Trans proline' 0 CA--C 1.537 0.672 0 C-N-CA 123.536 2.824 . . . . 1.04 114.181 -176.565 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -98.0 -36.23 10.19 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 119.573 1.079 . . . . 2.61 109.578 167.539 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -90.81 -57.22 2.89 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 106.966 -1.494 . . . . 3.23 106.966 -175.09 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.317 6.0 p -95.92 -160.32 0.78 Allowed 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 109.439 -0.578 . . . . 1.66 109.439 162.027 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 116.57 92.31 1.7 Allowed Glycine 0 CA--C 1.528 0.856 0 N-CA-C 106.274 -2.731 . . . . 2.29 106.274 -146.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 80.9 p -12.73 -19.16 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.435 1 C-N-CA 138.007 6.523 . . . . 2.08 119.849 -143.792 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -26.46 -63.39 0.08 Allowed 'General case' 0 N--CA 1.443 -0.787 0 C-N-CA 127.212 2.205 . . . . 2.01 113.647 170.671 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -75.31 -42.63 54.18 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 118.212 -1.395 . . . . 1.82 109.629 -166.116 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -50.29 -53.95 10.22 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.962 0 CA-C-N 113.965 -1.471 . . . . 1.91 110.278 173.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -68.17 -46.08 71.72 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 109.591 -0.522 . . . . 2.24 109.591 -173.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -45.93 -56.93 4.83 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 122.319 1.056 . . . . 3.41 111.344 171.485 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.0 mmpt? -71.52 -38.62 71.08 Favored 'General case' 0 N--CA 1.432 -1.343 0 CA-C-O 118.624 -0.703 . . . . 3.24 112.438 -175.063 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -48.69 -52.82 8.27 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 N-CA-C 106.968 -1.493 . . . . 1.76 106.968 175.494 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 37.9 mm-40 -58.82 -58.48 8.44 Favored 'General case' 0 C--N 1.343 0.32 0 C-N-CA 124.392 1.077 . . . . 2.5 110.413 177.449 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 9.4 mmtm -57.71 -32.66 67.61 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 113.457 0.91 . . . . 4.69 113.457 -176.416 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 11.4 mt -70.23 -18.19 63.15 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.609 1.163 . . . . 1.75 111.701 174.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 90.58 44.65 4.52 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 110.483 -1.047 . . . . 0.54 110.483 179.068 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -137.27 174.96 10.05 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 124.674 1.19 . . . . 3.4 108.549 177.26 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 32.1 t60 -137.54 156.36 48.2 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 109.425 -0.583 . . . . 3.03 109.425 167.137 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 12.8 p -128.09 137.79 56.51 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.113 0 C-N-CA 125.038 1.335 . . . . 2.54 108.03 -177.091 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 13.0 t -110.74 136.14 47.7 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 C-N-CA 124.622 1.169 . . . . 1.85 108.75 -178.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 27.8 mm -100.68 75.32 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 C-N-CA 124.463 1.105 . . . . 2.0 108.945 -172.24 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -68.09 -7.61 31.07 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 114.616 1.339 . . . . 3.54 114.616 178.598 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 77.81 64.47 2.04 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 109.991 -1.244 . . . . 3.07 109.991 -177.64 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 71.7 ttt180 . . . . . 0 C--O 1.25 1.118 0 C-N-CA 125.685 1.594 . . . . 14.99 111.596 -172.509 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 38.5 mtt . . . . . 0 N--CA 1.472 0.65 0 N-CA-C 107.097 -1.446 . . . . 13.06 107.097 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -145.09 114.37 7.06 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 104.344 -2.465 . . . . 8.41 104.344 -174.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -148.28 105.34 3.61 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 106.366 -1.716 . . . . 2.05 106.366 169.727 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -79.97 -175.43 4.96 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 108.577 -0.897 . . . . 2.32 108.577 173.33 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.4 mm100 -136.53 144.84 44.47 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 107.979 -1.119 . . . . 1.26 107.979 170.566 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 51.7 mttt -143.91 162.18 36.79 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 123.602 0.761 . . . . 3.65 110.706 163.225 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -110.77 87.77 2.61 Favored 'General case' 0 N--CA 1.439 -0.98 0 C-N-CA 129.216 3.006 . . . . 1.69 105.447 -173.316 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 3.4 mp -83.71 162.03 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 N-CA-C 105.771 -1.937 . . . . 3.24 105.771 -179.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -133.72 142.1 47.83 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 125.281 1.432 . . . . 1.41 107.362 179.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -155.73 175.59 13.73 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 109.125 -0.695 . . . . 3.44 109.125 172.082 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 30.0 mm100 -98.55 152.36 19.65 Favored 'General case' 0 C--O 1.223 -0.307 0 C-N-CA 125.477 1.511 . . . . 2.77 108.396 -177.371 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.8 p -111.32 156.43 12.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 CA-C-N 119.166 0.894 . . . . 3.79 110.282 -178.72 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 7.6 m -132.92 168.84 17.71 Favored 'General case' 0 C--N 1.339 0.131 0 C-N-CA 124.474 1.11 . . . . 1.35 109.791 171.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 58.59 52.44 52.96 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 110.8 -0.92 . . . . 1.58 110.8 -179.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -131.44 162.36 30.36 Favored 'General case' 0 CA--C 1.521 -0.158 0 C-N-CA 124.377 1.071 . . . . 3.38 109.881 -176.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -154.57 -58.61 0.11 Allowed 'General case' 0 CA--C 1.528 0.125 0 C-N-CA 125.457 1.503 . . . . 5.0 109.572 168.679 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 9.2 p -81.17 133.19 35.41 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 121.476 0.655 . . . . 2.3 109.932 175.509 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -75.6 55.16 0.82 Allowed 'General case' 0 CA--C 1.535 0.391 0 O-C-N 121.626 -0.671 . . . . 2.93 109.473 170.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -152.07 -57.15 0.14 Allowed 'General case' 0 N--CA 1.457 -0.076 0 C-N-CA 124.071 0.948 . . . . 1.66 110.457 -169.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 67.9 m -60.61 -42.46 96.85 Favored 'General case' 0 C--N 1.333 -0.141 0 O-C-N 121.237 -0.915 . . . . 1.37 109.605 169.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.64 -19.86 6.94 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 113.009 0.744 . . . . 2.1 113.009 170.243 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -73.01 -50.24 24.24 Favored 'General case' 0 N--CA 1.454 -0.228 0 O-C-N 120.299 -1.501 . . . . 1.73 110.687 169.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 3.7 mpt_? -49.78 -45.16 49.44 Favored 'General case' 0 CA--C 1.52 -0.198 0 C-N-CA 122.384 0.274 . . . . 5.42 110.276 -174.441 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.8 pt -57.15 -54.4 30.81 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 O-C-N 123.337 0.398 . . . . 1.68 110.678 -176.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -58.01 -43.79 86.91 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 124.033 0.933 . . . . 2.34 112.027 176.077 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -66.9 -47.02 73.08 Favored 'General case' 0 CA--C 1.534 0.331 0 O-C-N 121.701 -0.624 . . . . 3.02 110.206 -175.444 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.35 -40.47 99.08 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 110.227 -1.149 . . . . 0.62 110.227 173.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -62.29 -37.83 87.03 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 122.115 -0.638 . . . . 3.31 109.823 179.264 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.8 ttpm? -52.28 -18.99 1.79 Allowed 'General case' 0 CA--C 1.532 0.286 0 O-C-N 121.201 -0.937 . . . . 3.99 113.358 173.274 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 2.9 mtt180 -88.41 -0.54 57.3 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 119.051 0.841 . . . . 5.5 112.277 -179.201 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -77.97 158.56 77.46 Favored Pre-proline 0 CA--C 1.531 0.215 0 CA-C-N 119.366 0.984 . . . . 4.34 111.923 172.537 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -56.87 145.58 83.34 Favored 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 122.494 2.129 . . . . 0.93 110.476 170.487 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 82.85 -28.89 3.47 Favored Glycine 0 CA--C 1.53 0.992 0 CA-C-O 119.443 -0.643 . . . . 0.69 113.142 176.079 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 16.0 t -84.87 133.65 28.82 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 CA-C-N 118.953 1.377 . . . . 1.55 109.655 177.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -115.54 -41.19 3.28 Favored 'General case' 0 N--CA 1.457 -0.106 0 C-N-CA 123.746 0.819 . . . . 2.02 110.184 -175.71 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -143.45 163.16 33.89 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 118.844 0.747 . . . . 2.12 109.214 176.026 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -156.14 143.69 19.35 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 122.43 0.292 . . . . 1.79 111.76 178.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -151.59 101.92 2.83 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 106.245 -1.761 . . . . 0.49 106.245 -166.762 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.0 p -81.21 142.83 13.28 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 N-CA-C 108.028 -1.101 . . . . 2.08 108.028 176.518 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 53.4 t-20 -136.63 64.07 1.56 Allowed 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 122.705 1.241 . . . . 1.08 110.115 -171.196 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -70.79 -20.05 62.63 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 115.048 -0.978 . . . . 4.17 111.253 -173.573 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -46.65 -38.14 9.29 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 124.184 0.993 . . . . 1.92 112.202 172.17 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 9.0 t -119.4 29.33 7.69 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.012 0.525 . . . . 1.79 110.371 174.21 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 43.79 59.93 2.9 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 126.049 1.74 . . . . 2.74 112.023 -177.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 90.0 m -146.31 164.02 33.69 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 108.697 -0.853 . . . . 2.05 108.697 178.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -138.65 143.52 32.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 108.334 -0.988 . . . . 1.76 108.334 176.03 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -126.95 137.49 53.13 Favored 'General case' 0 C--N 1.344 0.343 0 N-CA-C 107.787 -1.19 . . . . 0.38 107.787 178.422 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 31.2 t -130.12 130.18 65.75 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 N-CA-C 105.13 -2.174 . . . . 3.36 105.13 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 13.0 mm -101.3 99.15 7.83 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.578 0 N-CA-C 106.959 -1.497 . . . . 1.65 106.959 -177.33 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 54.5 p90 -141.42 168.91 18.65 Favored 'General case' 0 CA--C 1.51 -0.591 0 O-C-N 122.055 -0.403 . . . . 4.06 110.245 -171.311 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 42.0 t0 -86.52 107.87 15.5 Favored Pre-proline 0 C--N 1.327 -0.389 0 O-C-N 124.482 1.114 . . . . 3.13 109.639 174.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -73.48 4.24 4.12 Favored 'Trans proline' 0 N--CA 1.451 -1.013 0 C-N-CA 122.222 1.948 . . . . 1.11 112.68 -179.093 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -82.35 -36.03 27.24 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 119.622 1.101 . . . . 2.19 108.508 166.101 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -103.41 -60.47 1.56 Allowed 'General case' 0 N--CA 1.453 -0.315 0 O-C-N 123.724 0.64 . . . . 4.04 109.694 -167.099 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.459 0.5 OUTLIER -81.54 -172.64 3.95 Favored 'General case' 0 CA--C 1.521 -0.149 0 N-CA-C 113.729 1.011 . . . . 1.57 113.729 156.512 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 159.66 -148.6 17.47 Favored Glycine 0 N--CA 1.434 -1.473 1 N-CA-C 102.492 -4.243 . . . . 2.93 102.492 -157.246 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 33.2 p -78.34 -37.6 44.12 Favored 'General case' 0 N--CA 1.444 -0.772 0 C-N-CA 124.772 1.229 . . . . 2.32 110.104 178.327 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -49.13 -62.54 1.48 Allowed 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.715 1.206 . . . . 1.73 113.403 -163.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.68 -32.25 67.64 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.198 -1.365 . . . . 1.62 108.973 -169.236 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.7 mp -60.04 -55.36 24.63 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.795 0 CA-C-N 114.937 -1.029 . . . . 2.52 109.876 175.253 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.91 -45.82 89.41 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 119.167 0.894 . . . . 1.33 110.1 -178.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -48.76 -56.57 8.25 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 121.449 0.642 . . . . 3.39 111.691 174.146 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 3.5 mmmt -64.92 -42.99 94.24 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-O 118.923 -0.561 . . . . 4.47 112.043 -178.464 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.4 mm -50.39 -52.74 14.46 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.707 0 C-N-CA 125.71 1.604 . . . . 1.72 107.804 -179.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -56.27 -56.56 19.5 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 123.769 0.828 . . . . 2.35 110.661 175.178 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 12.7 mptt -58.76 -34.66 71.67 Favored 'General case' 0 CA--C 1.536 0.436 0 O-C-N 121.716 -0.615 . . . . 5.5 112.435 -175.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 11.8 mt -70.5 -16.63 62.92 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.646 1.178 . . . . 1.89 111.965 175.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 86.0 42.13 6.84 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 110.288 -1.125 . . . . 0.69 110.288 179.178 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -134.95 175.98 9.08 Favored 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 124.315 1.046 . . . . 3.28 109.458 -179.562 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -144.46 157.11 44.4 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 109.2 -0.667 . . . . 3.25 109.2 170.662 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 8.0 p -138.33 137.42 43.89 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.19 0 N-CA-C 107.757 -1.201 . . . . 2.57 107.757 -173.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 29.6 t -103.53 137.51 31.71 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 C-N-CA 125.364 1.466 . . . . 1.71 109.002 -175.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 48.4 mm -105.98 80.23 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 C-N-CA 124.728 1.211 . . . . 2.39 107.979 -176.386 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 -76.46 -0.16 21.94 Favored 'General case' 0 N--CA 1.443 -0.779 0 C-N-CA 123.799 0.84 . . . . 2.73 113.241 169.498 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -93.59 -22.29 26.8 Favored Glycine 0 CA--C 1.525 0.672 0 C-N-CA 125.222 1.392 . . . . 3.6 114.517 -171.182 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.025 0 CA-C-O 116.452 -1.737 . . . . 11.83 110.219 -169.014 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 mpt? . . . . . 0 N--CA 1.472 0.663 0 N-CA-C 108.032 -1.099 . . . . 10.24 108.032 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 19.7 mt -84.35 155.84 22.15 Favored 'General case' 0 C--N 1.332 -0.169 0 O-C-N 123.993 0.808 . . . . 5.19 109.45 175.135 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.0 m -67.02 107.86 2.41 Favored 'General case' 0 N--CA 1.447 -0.624 0 C-N-CA 124.369 1.067 . . . . 1.39 108.713 171.013 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -70.16 168.95 14.58 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 108.241 -1.022 . . . . 2.02 108.241 162.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -129.09 153.56 47.53 Favored 'General case' 0 N--CA 1.457 -0.12 0 C-N-CA 124.548 1.139 . . . . 1.14 109.99 178.281 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 85.5 mttt -146.07 162.7 37.33 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 124.28 1.032 . . . . 4.46 109.992 168.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 8.9 mp0 -121.18 87.93 2.85 Favored 'General case' 0 N--CA 1.441 -0.89 0 C-N-CA 127.979 2.512 . . . . 1.62 106.122 -168.366 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 2.6 mp -83.06 161.66 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.369 0 N-CA-C 105.887 -1.894 . . . . 2.92 105.887 -177.102 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -128.31 135.21 49.3 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 125.944 1.698 . . . . 1.41 106.595 178.283 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 43.1 mtt -140.89 171.98 13.33 Favored 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 109.498 -0.556 . . . . 3.0 109.498 174.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 21.8 mm100 -96.96 139.33 33.14 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 125.701 1.601 . . . . 2.49 108.624 176.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 81.0 t -92.66 153.91 3.25 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 N-CA-C 108.893 -0.78 . . . . 2.52 108.893 175.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 62.9 m -150.77 165.48 33.39 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.074 0.949 . . . . 1.95 109.264 173.177 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 60.32 61.84 6.67 Favored Glycine 0 CA--C 1.528 0.874 0 N-CA-C 110.745 -0.942 . . . . 1.57 110.745 -178.697 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -135.58 156.38 48.96 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 123.834 0.854 . . . . 2.84 110.153 -174.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -105.34 -55.81 2.27 Favored 'General case' 0 CA--C 1.528 0.118 0 C-N-CA 125.199 1.4 . . . . 3.4 109.764 168.051 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 16.9 p -139.67 159.48 42.07 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 121.914 0.864 . . . . 2.52 111.93 -172.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -75.87 39.88 0.18 Allowed 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.963 1.305 . . . . 3.08 111.899 179.43 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -128.67 -53.68 1.24 Allowed 'General case' 0 CA--C 1.524 -0.058 0 C-N-CA 124.599 1.159 . . . . 1.66 108.612 178.647 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 21.0 m -58.72 -38.15 77.72 Favored 'General case' 0 CA--C 1.532 0.274 0 O-C-N 121.556 -0.715 . . . . 1.2 109.714 170.726 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.65 -26.69 34.74 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 116.06 -0.518 . . . . 1.52 112.082 172.551 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.92 -48.95 41.81 Favored 'General case' 0 N--CA 1.455 -0.177 0 O-C-N 120.08 -1.637 . . . . 1.63 109.629 172.368 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 26.9 mmm180 -50.17 -46.02 53.85 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 123.022 0.529 . . . . 6.2 110.543 -175.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.5 pt -59.0 -53.35 49.1 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 C-N-CA 120.245 -0.582 . . . . 1.64 111.066 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -54.42 -44.93 72.83 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 123.296 0.638 . . . . 2.3 111.687 177.16 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 32.1 mmtp -70.55 -44.0 68.35 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 118.839 0.745 . . . . 3.1 110.657 -175.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -58.95 -39.55 94.26 Favored Glycine 0 CA--C 1.528 0.903 0 N-CA-C 110.488 -1.045 . . . . 0.5 110.488 172.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -66.21 -42.8 88.25 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 109.056 -0.72 . . . . 3.55 109.056 179.365 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.6 ttpp -56.96 -14.99 4.06 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.719 1.608 . . . . 3.8 114.128 177.283 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.83 -11.6 56.79 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.93 1.692 . . . . 5.06 111.794 176.74 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 93.3 mmm -71.6 154.72 93.08 Favored Pre-proline 0 CA--C 1.53 0.185 0 CA-C-N 119.03 0.832 . . . . 3.97 111.378 179.263 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -56.21 141.86 87.63 Favored 'Trans proline' 0 N--CA 1.451 -1.008 0 C-N-CA 121.47 1.447 . . . . 0.66 108.596 163.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 88.42 -12.56 64.54 Favored Glycine 0 N--CA 1.448 -0.559 0 CA-C-O 117.932 -1.482 . . . . 0.88 114.463 173.391 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 40.6 t -109.46 125.41 66.6 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 CA-C-N 119.787 1.793 . . . . 1.74 109.061 177.586 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 99.7 m -97.49 -50.66 4.43 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-O 118.205 -0.902 . . . . 2.3 110.067 -176.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -138.71 159.8 41.22 Favored 'General case' 0 C--N 1.342 0.258 0 CA-C-N 119.337 0.971 . . . . 2.11 110.803 176.436 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -156.39 146.39 21.19 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 122.98 0.512 . . . . 1.66 112.066 -178.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -155.94 121.31 4.85 Favored 'General case' 0 C--N 1.342 0.273 0 N-CA-C 109.047 -0.723 . . . . 0.56 109.047 -165.792 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.2 p -92.87 102.27 13.46 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 C-N-CA 123.055 0.542 . . . . 1.76 110.201 -177.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 50.5 t-20 -85.53 57.36 4.42 Favored 'General case' 0 CA--C 1.533 0.323 0 O-C-N 120.518 -1.364 . . . . 0.81 109.462 179.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.31 -19.97 64.71 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 115.495 -0.775 . . . . 2.03 110.468 -175.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -47.42 -33.83 6.48 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.771 0.828 . . . . 1.67 112.132 168.726 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 15.3 t -120.54 28.76 7.8 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 118.148 0.431 . . . . 1.7 111.158 174.48 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 46.86 57.11 5.91 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 124.557 1.143 . . . . 2.8 112.109 -176.505 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 67.2 m -146.59 157.05 43.65 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 108.159 -1.052 . . . . 1.67 108.159 178.442 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.4 p -124.92 144.43 34.95 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 N-CA-C 108.071 -1.085 . . . . 1.58 108.071 172.128 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -125.51 137.52 53.95 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 108.132 -1.062 . . . . 0.32 108.132 175.347 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 4.4 p -135.1 123.67 40.55 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 N-CA-C 106.165 -1.791 . . . . 2.89 106.165 -176.258 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 12.6 mm -101.58 90.02 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 N-CA-C 106.266 -1.753 . . . . 1.59 106.266 -172.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 24.8 p90 -126.55 168.63 14.02 Favored 'General case' 0 CA--C 1.506 -0.742 0 CA-C-O 120.923 0.392 . . . . 3.53 110.149 -169.474 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -98.87 103.31 18.64 Favored Pre-proline 0 N--CA 1.44 -0.941 0 CA-C-N 114.537 -1.211 . . . . 4.38 108.157 -176.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -73.67 12.02 0.97 Allowed 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 122.632 2.222 . . . . 0.64 113.277 -172.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -83.52 -25.26 31.19 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 109.061 -0.718 . . . . 2.16 109.061 165.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -116.77 -58.4 2.08 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 123.81 0.844 . . . . 2.83 109.454 -170.187 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.307 6.6 p -88.22 -171.98 3.6 Favored 'General case' 0 C--N 1.344 0.327 0 CA-C-N 118.181 0.446 . . . . 1.62 110.304 165.522 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 135.7 87.15 0.23 Allowed Glycine 0 N--CA 1.442 -0.936 0 N-CA-C 105.164 -3.174 . . . . 2.34 105.164 -155.151 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 52.2 p -8.22 -17.02 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.378 1 C-N-CA 137.794 6.438 . . . . 2.25 120.248 -142.018 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -28.08 -66.34 0.08 Allowed 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 127.226 2.211 . . . . 2.01 113.59 166.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.48 -36.39 71.14 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 116.978 -1.889 . . . . 1.9 109.415 -166.033 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.5 mp -54.19 -57.39 6.07 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.047 0 CA-C-N 114.325 -1.307 . . . . 2.06 109.178 175.501 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.09 -47.13 86.02 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 119.306 0.957 . . . . 1.27 110.527 -178.032 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -48.89 -55.8 10.66 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 121.902 0.858 . . . . 4.58 111.14 177.059 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -70.42 -37.61 74.44 Favored 'General case' 0 N--CA 1.437 -1.104 0 CA-C-O 118.042 -0.98 . . . . 3.25 111.877 -177.71 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.1 mm -49.69 -52.74 11.85 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 N-CA-C 107.525 -1.287 . . . . 1.64 107.525 178.464 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -57.53 -58.5 8.04 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 123.939 0.896 . . . . 1.81 110.64 175.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -58.97 -32.79 69.98 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 112.955 0.724 . . . . 4.85 112.955 -175.217 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 15.1 mt -70.58 -17.96 62.9 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.667 1.187 . . . . 1.77 111.663 175.425 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 91.97 42.51 4.68 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.676 -0.97 . . . . 0.47 110.676 178.154 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -136.91 173.26 11.89 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 124.239 1.015 . . . . 3.16 109.881 -179.835 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -137.99 128.33 26.21 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 107.773 -1.195 . . . . 2.99 107.773 172.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 4.2 p -104.19 146.69 11.29 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 N-CA-C 107.35 -1.352 . . . . 2.49 107.35 170.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 91.3 t -116.29 146.63 20.46 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 C-N-CA 126.733 2.013 . . . . 1.88 107.022 176.279 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 4.9 mp -116.96 79.54 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 C-N-CA 124.221 1.008 . . . . 2.52 108.786 -174.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -76.76 0.99 18.54 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 125.911 1.685 . . . . 3.35 113.569 173.151 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -138.25 59.8 0.6 Allowed Glycine 0 CA--C 1.522 0.523 0 N-CA-C 108.363 -1.895 . . . . 4.19 108.363 177.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 17.9 ttt180 . . . . . 0 C--O 1.25 1.126 0 CA-C-O 117.075 -1.44 . . . . 14.32 110.302 177.063 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.9 ptp . . . . . 0 N--CA 1.471 0.594 0 N-CA-C 106.127 -1.805 . . . . 9.85 106.127 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 66.14 148.47 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.56 0 O-C-N 124.439 1.087 . . . . 5.54 110.364 -168.344 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 57.9 m -145.18 119.91 9.85 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 106.774 -1.565 . . . . 1.39 106.774 -174.229 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -75.95 177.27 7.15 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 109.311 -0.626 . . . . 2.16 109.311 171.604 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -138.52 140.75 39.24 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 107.532 -1.284 . . . . 1.02 107.532 174.92 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -138.39 160.97 38.16 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 124.573 1.149 . . . . 4.36 109.74 168.438 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -119.37 95.87 4.97 Favored 'General case' 0 N--CA 1.441 -0.892 0 C-N-CA 128.903 2.881 . . . . 1.45 106.678 -171.734 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 7.0 mm -84.67 161.71 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.128 0 N-CA-C 106.879 -1.526 . . . . 2.9 106.879 178.274 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -137.34 133.05 34.45 Favored 'General case' 0 C--O 1.23 0.076 0 C-N-CA 124.782 1.233 . . . . 1.78 107.782 -179.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 9.3 ptp -157.65 175.75 13.51 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 118.664 0.665 . . . . 3.13 111.0 -178.238 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 28.7 mm100 -93.71 164.22 13.23 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.443 1.497 . . . . 2.46 110.655 -178.016 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 60.5 t -121.02 158.67 23.47 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 C-N-CA 124.964 1.306 . . . . 2.17 109.427 -177.447 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 14.1 m -149.38 166.4 29.16 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 123.918 0.887 . . . . 1.63 110.08 167.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 68.13 47.52 58.67 Favored Glycine 0 CA--C 1.528 0.862 0 N-CA-C 110.522 -1.031 . . . . 1.66 110.522 -171.302 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -125.94 156.93 38.98 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 124.643 1.177 . . . . 2.77 109.589 -178.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER 179.85 -44.08 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 127.871 2.468 . . . . 4.56 110.881 179.43 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 36.6 m -56.89 -22.59 38.43 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.658 0.783 . . . . 3.44 112.704 177.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 57.38 33.32 23.12 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.58 1.152 . . . . 3.45 111.602 178.008 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -159.3 -45.09 0.05 Allowed 'General case' 0 C--O 1.226 -0.179 0 C-N-CA 124.433 1.093 . . . . 1.59 109.736 -175.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 94.4 m -50.31 -38.44 41.57 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.196 0.998 . . . . 1.23 112.278 171.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.11 -23.53 34.89 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 122.935 0.494 . . . . 1.78 112.252 174.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -72.6 -50.1 27.64 Favored 'General case' 0 N--CA 1.457 -0.115 0 O-C-N 120.556 -1.34 . . . . 1.6 111.114 167.022 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 6.6 mmp_? -49.33 -46.42 46.79 Favored 'General case' 0 CA--C 1.52 -0.209 0 N-CA-C 109.691 -0.485 . . . . 8.02 109.691 179.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.272 2.0 pt -59.23 -59.34 3.99 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.442 0 C-N-CA 119.337 -0.945 . . . . 1.74 111.033 178.505 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -51.59 -41.68 61.37 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 119.526 1.057 . . . . 3.27 112.298 -179.135 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.2 mptp? -71.38 -43.64 66.49 Favored 'General case' 0 CA--C 1.538 0.484 0 O-C-N 121.13 -0.981 . . . . 2.63 110.708 -177.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -65.76 -32.11 81.94 Favored Glycine 0 CA--C 1.534 1.239 0 O-C-N 121.456 -0.778 . . . . 0.6 111.65 174.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.0 tt -63.59 -48.29 77.99 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 126.111 1.764 . . . . 3.06 107.914 175.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 12.8 ttmt -47.51 -37.34 11.8 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.039 0.536 . . . . 3.99 112.435 174.324 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -66.17 -0.28 2.41 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 114.043 1.127 . . . . 4.45 114.043 -176.671 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 13.5 ptp -77.29 164.17 60.13 Favored Pre-proline 0 CA--C 1.538 0.49 0 CA-C-N 119.735 1.152 . . . . 5.49 111.788 172.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -69.0 137.56 37.98 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 121.543 1.495 . . . . 0.68 109.756 168.407 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 99.91 -31.53 8.3 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 123.49 0.567 . . . . 0.55 113.187 172.243 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 47.1 t -82.56 140.33 16.53 Favored 'Isoleucine or valine' 0 C--N 1.341 0.205 0 CA-C-N 118.672 1.236 . . . . 1.86 109.289 171.119 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -114.68 -38.05 4.09 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 118.812 -0.613 . . . . 1.78 110.652 178.327 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -143.67 163.23 33.85 Favored 'General case' 0 C--N 1.341 0.238 0 CA-C-N 119.566 1.076 . . . . 1.87 110.281 175.16 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -159.37 134.85 8.44 Favored 'General case' 0 C--O 1.239 0.516 0 C-N-CA 123.386 0.674 . . . . 1.83 112.05 -171.416 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -148.06 111.86 5.09 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 124.213 1.005 . . . . 0.46 109.723 -164.795 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.1 p -84.2 98.18 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 C-N-CA 123.53 0.732 . . . . 1.75 110.403 179.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 49.6 t-20 -84.21 56.59 3.82 Favored 'General case' 0 CA--C 1.537 0.46 0 O-C-N 120.28 -1.512 . . . . 0.8 110.027 179.618 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.99 -17.98 63.31 Favored 'General case' 0 N--CA 1.462 0.128 0 C-N-CA 123.625 0.77 . . . . 1.99 110.849 -178.24 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -44.34 -38.18 3.79 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 123.68 0.792 . . . . 1.7 111.673 166.416 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 6.5 t -124.89 39.12 4.05 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 122.929 0.492 . . . . 1.61 109.725 172.002 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 50.17 32.06 5.65 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.741 1.617 . . . . 2.88 113.804 173.24 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 40.2 m -119.8 163.96 16.7 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.947 1.299 . . . . 1.77 108.43 -177.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.8 p -133.15 145.22 34.38 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 O-C-N 121.038 -1.039 . . . . 1.67 109.136 171.139 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -132.42 129.48 39.35 Favored 'General case' 0 C--N 1.344 0.346 0 C-N-CA 124.743 1.217 . . . . 0.38 108.445 -178.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.7 p -126.53 128.92 71.66 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 N-CA-C 105.524 -2.028 . . . . 3.0 105.524 -174.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 10.9 mm -105.42 100.44 10.58 Favored 'Isoleucine or valine' 0 C--O 1.239 0.527 0 C-N-CA 124.945 1.298 . . . . 1.51 107.898 -173.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 48.0 p90 -141.62 171.05 14.59 Favored 'General case' 0 CA--C 1.512 -0.485 0 O-C-N 121.937 -0.477 . . . . 2.94 111.801 -170.598 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 60.7 t0 -90.62 105.59 12.39 Favored Pre-proline 0 CA--C 1.534 0.362 0 O-C-N 124.742 1.276 . . . . 3.04 110.696 174.597 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -74.88 9.83 1.87 Allowed 'Trans proline' 0 N--CA 1.452 -0.925 0 C-N-CA 122.108 1.872 . . . . 0.76 113.55 179.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -84.15 -27.88 27.81 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 119.238 0.926 . . . . 1.87 108.824 164.051 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -108.43 -58.1 2.04 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 123.344 0.658 . . . . 2.63 109.359 -170.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.422 0.3 OUTLIER -81.72 179.72 7.72 Favored 'General case' 0 CA--C 1.514 -0.416 0 N-CA-C 116.308 1.966 . . . . 1.51 116.308 161.859 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -176.19 -152.35 9.54 Favored Glycine 0 N--CA 1.43 -1.708 1 N-CA-C 102.272 -4.331 . . . . 2.39 102.272 -176.875 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 19.4 p -73.03 -32.4 65.07 Favored 'General case' 0 C--N 1.318 -0.792 0 C-N-CA 124.959 1.304 . . . . 2.31 109.206 178.068 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -42.56 -62.64 0.93 Allowed 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 125.839 1.655 . . . . 1.67 113.671 -172.706 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -75.02 -34.69 61.95 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.042 -0.981 . . . . 1.61 109.165 -169.697 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -56.17 -52.77 47.09 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.89 0 CA-C-O 117.67 -1.157 . . . . 2.2 111.232 175.495 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.41 -46.96 87.95 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 119.864 1.211 . . . . 1.18 109.355 -179.184 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -48.81 -57.3 6.59 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-O 122.105 0.955 . . . . 2.62 111.22 176.449 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.9 mmtp -63.02 -44.54 95.67 Favored 'General case' 0 N--CA 1.435 -1.176 0 CA-C-O 118.659 -0.686 . . . . 3.72 110.77 -179.379 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -47.43 -52.62 5.19 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 C-N-CA 125.208 1.403 . . . . 1.87 108.887 177.559 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -61.67 -55.5 29.81 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 123.762 0.825 . . . . 1.76 110.699 177.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.4 mmmp? -58.07 -31.02 66.67 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 113.366 0.876 . . . . 6.22 113.366 -178.261 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 22.8 mt -73.11 -17.15 61.43 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.583 1.553 . . . . 1.81 112.121 174.426 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 93.17 42.55 4.29 Favored Glycine 0 C--N 1.337 0.631 0 C-N-CA 124.918 1.246 . . . . 0.59 110.693 175.597 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -145.13 177.05 9.07 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 123.348 0.659 . . . . 3.34 111.41 -169.629 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 4.9 t60 -142.25 131.79 23.88 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 107.825 -1.176 . . . . 3.45 107.825 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 8.2 p -107.52 138.87 31.58 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.089 0 N-CA-C 108.018 -1.105 . . . . 2.63 108.018 175.697 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 5.2 t -116.81 140.79 37.8 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.126 0 N-CA-C 108.598 -0.89 . . . . 2.06 108.598 -177.199 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 4.9 mp -116.13 79.73 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 N-CA-C 108.065 -1.087 . . . . 2.66 108.065 179.433 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -77.93 1.09 21.72 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 125.176 1.39 . . . . 3.41 113.148 168.452 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -76.55 -13.67 83.23 Favored Glycine 0 CA--C 1.525 0.698 0 C-N-CA 124.854 1.216 . . . . 2.61 113.154 178.482 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 46.1 ttt180 . . . . . 0 C--O 1.251 1.136 0 CA-C-O 116.282 -1.818 . . . . 12.38 107.569 177.172 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 44.4 mtt . . . . . 0 N--CA 1.47 0.532 0 N-CA-C 107.52 -1.289 . . . . 12.95 107.52 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 6.6 tp -150.75 122.25 7.94 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 102.811 -3.033 . . . . 6.35 102.811 167.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 8.1 m 65.19 104.14 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.296 0 O-C-N 124.484 1.115 . . . . 1.43 109.691 -170.077 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -64.37 169.97 4.24 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 107.738 -1.208 . . . . 2.05 107.738 162.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -131.48 150.46 52.14 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 108.597 -0.89 . . . . 1.29 108.597 173.428 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 44.4 mtpt -143.45 156.79 44.74 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-O 121.695 0.759 . . . . 3.54 110.61 169.314 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -100.4 112.77 25.15 Favored 'General case' 0 N--CA 1.44 -0.959 0 C-N-CA 128.188 2.595 . . . . 2.38 107.272 -178.301 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 2.3 pp -82.64 164.16 2.87 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.157 0 C-N-CA 119.357 -0.937 . . . . 6.34 108.559 165.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -143.09 113.01 7.07 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 106.16 -1.792 . . . . 1.43 106.16 175.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 59.9 mtt -140.29 170.12 16.4 Favored 'General case' 0 C--N 1.334 -0.096 0 CA-C-N 118.306 0.503 . . . . 4.48 110.165 -172.595 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 28.8 mm100 -96.0 161.03 14.16 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 123.839 0.856 . . . . 2.57 110.173 -176.626 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 44.9 t -120.23 146.2 25.43 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 N-CA-C 108.347 -0.983 . . . . 2.4 108.347 -175.316 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 72.3 m -138.61 163.67 31.46 Favored 'General case' 0 N--CA 1.456 -0.154 0 C-N-CA 124.541 1.136 . . . . 1.9 109.275 171.114 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 56.92 63.58 5.19 Favored Glycine 0 CA--C 1.528 0.85 0 C-N-CA 123.57 0.605 . . . . 1.65 111.668 173.544 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 11.2 ptm -120.47 147.01 45.67 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 124.153 0.981 . . . . 4.29 110.762 -177.053 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -81.98 -68.81 0.67 Allowed 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.513 1.125 . . . . 5.14 108.65 166.259 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 16.3 p -154.45 169.79 22.92 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-O 121.512 0.672 . . . . 2.55 111.119 178.531 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.15 -38.95 66.07 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 124.569 1.148 . . . . 3.25 111.925 179.258 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.31 -46.15 90.89 Favored 'General case' 0 N--CA 1.453 -0.287 0 O-C-N 121.959 -0.463 . . . . 2.06 110.182 -179.491 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 67.3 m -66.87 -43.75 82.75 Favored 'General case' 0 N--CA 1.454 -0.233 0 O-C-N 121.849 -0.532 . . . . 1.6 109.898 175.528 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.0 -18.88 26.95 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 112.856 0.687 . . . . 1.79 112.856 176.113 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.27 -50.44 39.49 Favored 'General case' 0 N--CA 1.449 -0.49 0 O-C-N 119.937 -1.727 . . . . 1.61 109.074 169.058 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -52.73 -45.07 66.83 Favored 'General case' 0 C--N 1.34 0.16 0 CA-C-O 118.462 -0.78 . . . . 7.41 110.426 -177.275 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.268 3.3 pt -55.4 -59.59 2.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 CA-C-O 118.788 -0.625 . . . . 2.05 110.289 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -52.51 -45.23 66.14 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 119.516 1.053 . . . . 2.67 111.923 178.199 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 35.6 mmtm -66.84 -42.62 85.44 Favored 'General case' 0 CA--C 1.537 0.479 0 O-C-N 121.301 -0.874 . . . . 3.0 111.427 -177.346 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -63.1 -28.57 72.36 Favored Glycine 0 CA--C 1.53 1.023 0 N-CA-C 111.165 -0.774 . . . . 0.58 111.165 171.063 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -66.19 -47.63 73.28 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 108.801 -0.814 . . . . 2.61 108.801 175.394 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 24.9 ttmt -52.09 -37.08 52.85 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 122.822 0.449 . . . . 3.75 111.553 174.435 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 13.6 mmt180 -59.62 -11.49 4.99 Favored 'General case' 0 CA--C 1.542 0.669 0 O-C-N 121.097 -1.002 . . . . 4.11 113.477 177.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 4.0 ptm -82.74 152.56 66.52 Favored Pre-proline 0 CA--C 1.535 0.376 0 CA-C-N 120.058 1.299 . . . . 4.07 112.222 178.464 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -62.25 120.7 8.39 Favored 'Trans proline' 0 N--CA 1.452 -0.92 0 C-N-CA 122.283 1.989 . . . . 1.06 109.17 171.683 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 114.25 -24.85 11.09 Favored Glycine 0 CA--C 1.527 0.792 0 CA-C-O 118.336 -1.258 . . . . 1.08 113.451 172.264 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 61.5 t -96.99 118.14 42.86 Favored 'Isoleucine or valine' 0 C--N 1.343 0.317 0 CA-C-N 119.408 1.604 . . . . 2.02 110.876 174.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 39.6 m -95.59 -35.88 11.46 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-O 117.801 -1.095 . . . . 2.41 112.483 -175.1 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -145.23 164.27 31.88 Favored 'General case' 0 C--N 1.344 0.329 0 CA-C-N 120.273 1.397 . . . . 2.05 110.622 164.258 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -158.52 135.17 9.54 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 116.313 -0.403 . . . . 1.91 110.864 -174.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -149.1 110.14 4.35 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 106.115 -1.809 . . . . 0.66 106.115 -161.445 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 10.3 p -89.37 131.79 35.76 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.764 0 N-CA-C 108.384 -0.969 . . . . 1.78 108.384 179.196 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 64.1 t-20 -118.96 71.4 0.85 Allowed 'General case' 0 C--O 1.234 0.273 0 C-N-CA 124.758 1.223 . . . . 1.24 109.083 -178.029 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -67.6 -25.59 65.84 Favored 'General case' 0 C--O 1.226 -0.167 0 CA-C-N 115.146 -0.933 . . . . 4.37 110.22 -178.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -51.42 -34.78 36.31 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-O 118.802 -0.618 . . . . 2.05 111.666 172.254 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.3 t -115.13 22.78 13.05 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 118.278 0.49 . . . . 2.43 111.402 172.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 47.14 44.52 15.48 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.574 1.55 . . . . 3.76 113.743 179.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 51.8 m -139.89 145.64 38.27 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 108.417 -0.957 . . . . 2.09 108.417 -179.704 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 5.2 p -110.73 143.57 20.41 Favored 'Isoleucine or valine' 0 C--O 1.232 0.18 0 C-N-CA 124.404 1.082 . . . . 1.67 109.095 175.5 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 26.9 m120 -127.08 137.74 53.08 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 107.446 -1.316 . . . . 0.65 107.446 178.523 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 59.9 t -131.47 124.25 54.27 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 N-CA-C 105.279 -2.119 . . . . 3.22 105.279 -177.446 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 17.0 mm -102.17 87.51 1.23 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.421 0 C-N-CA 125.498 1.519 . . . . 1.68 106.981 -173.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 6.8 p90 -120.24 171.33 8.57 Favored 'General case' 0 CA--C 1.509 -0.631 0 CA-C-N 116.227 -0.442 . . . . 3.05 110.333 -168.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -101.28 107.71 51.76 Favored Pre-proline 0 N--CA 1.449 -0.512 0 N-CA-C 108.822 -0.807 . . . . 4.61 108.822 -175.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -71.45 7.71 1.42 Allowed 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 123.037 2.492 . . . . 1.12 113.552 -174.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -83.03 -22.62 33.52 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 118.706 0.685 . . . . 2.54 109.312 167.524 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -122.36 -55.82 1.83 Allowed 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.367 1.067 . . . . 3.37 110.642 -169.546 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.278 0.8 OUTLIER -86.41 -171.78 3.72 Favored 'General case' 0 CA--C 1.52 -0.18 0 C-N-CA 123.998 0.919 . . . . 2.05 112.391 161.136 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 134.3 87.02 0.27 Allowed Glycine 0 N--CA 1.443 -0.885 0 N-CA-C 104.265 -3.534 . . . . 2.42 104.265 -153.004 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 68.2 p -14.78 -21.2 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.604 1 C-N-CA 138.119 6.568 . . . . 2.52 119.42 -143.589 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -28.51 -62.6 0.11 Allowed 'General case' 0 N--CA 1.442 -0.859 0 C-N-CA 127.651 2.381 . . . . 2.53 114.13 165.44 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.72 -31.23 61.78 Favored 'General case' 0 C--N 1.332 -0.162 0 C-N-CA 119.06 -1.056 . . . . 2.22 109.64 -168.005 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.4 mp -57.95 -55.0 24.43 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.634 0 C-N-CA 123.688 0.795 . . . . 1.87 109.794 174.506 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.29 -44.09 88.35 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 119.213 0.915 . . . . 1.47 110.027 -178.354 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -52.77 -53.9 41.6 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 122.143 0.973 . . . . 3.08 111.015 176.16 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -65.32 -40.27 93.5 Favored 'General case' 0 N--CA 1.443 -0.816 0 O-C-N 121.171 -0.956 . . . . 3.3 111.725 -179.453 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 5.0 mm -49.34 -52.53 11.14 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 C-N-CA 125.298 1.439 . . . . 1.98 108.548 175.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -56.04 -57.12 13.48 Favored 'General case' 0 C--N 1.342 0.245 0 C-N-CA 123.262 0.625 . . . . 2.23 110.858 175.44 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.47 -38.21 71.37 Favored 'General case' 0 CA--C 1.537 0.46 0 O-C-N 121.844 -0.535 . . . . 5.92 111.895 -176.704 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 37.4 mt -67.23 -17.8 64.97 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.975 1.31 . . . . 2.21 111.57 176.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 92.68 32.93 7.74 Favored Glycine 0 CA--C 1.523 0.564 0 C-N-CA 124.543 1.068 . . . . 0.67 111.065 176.366 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -128.94 174.14 9.78 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 117.932 0.866 . . . . 3.29 110.558 -179.121 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 2.6 t-80 -138.99 128.55 24.52 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 108.126 -1.064 . . . . 2.93 108.126 173.177 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.2 t -104.67 152.29 6.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 C-N-CA 124.766 1.226 . . . . 3.37 107.82 173.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 96.6 t -117.34 144.88 24.06 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 C-N-CA 125.687 1.595 . . . . 1.71 108.657 -179.438 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 34.1 mm -110.62 76.7 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 C-N-CA 125.162 1.385 . . . . 1.97 109.27 -170.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -75.11 -6.09 47.71 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 113.81 1.041 . . . . 2.81 113.81 173.566 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -83.32 -77.86 1.09 Allowed Glycine 0 CA--C 1.525 0.687 0 N-CA-C 109.808 -1.317 . . . . 3.57 109.808 177.308 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 17.3 ttt-85 . . . . . 0 C--O 1.251 1.152 0 C-N-CA 125.492 1.517 . . . . 14.18 111.084 -171.41 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.476 0.869 0 N-CA-C 113.061 0.763 . . . . 10.21 113.061 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.0 mm? 64.03 -176.4 0.16 Allowed 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 118.692 0.678 . . . . 5.3 110.394 -173.127 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.1 m -114.58 117.8 31.93 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 125.803 1.641 . . . . 1.52 107.053 -176.133 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -69.05 178.06 2.41 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-O 121.332 0.587 . . . . 2.65 109.856 169.463 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -132.14 145.82 51.63 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 106.628 -1.619 . . . . 0.93 106.628 162.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 12.9 mmtp -137.63 159.36 42.18 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 124.351 1.06 . . . . 4.64 109.394 164.491 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -119.05 102.02 8.44 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 126.915 2.086 . . . . 1.61 107.725 -174.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 3.1 mm -83.95 162.92 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 N-CA-C 107.827 -1.175 . . . . 2.91 107.827 177.114 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -136.74 117.74 14.28 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 119.404 1.002 . . . . 1.61 110.116 176.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 57.5 mtm -135.33 176.53 8.59 Favored 'General case' 0 CA--C 1.535 0.385 0 O-C-N 121.481 -0.762 . . . . 2.73 110.388 -174.518 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.61 168.46 9.07 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 125.958 1.703 . . . . 3.66 110.018 173.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.7 m -128.7 153.92 38.89 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 C-N-CA 124.019 0.928 . . . . 3.08 111.571 174.552 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 71.1 m -119.59 175.13 6.0 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 125.391 1.476 . . . . 2.03 110.131 174.601 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 80.45 -44.87 2.97 Favored Glycine 0 CA--C 1.533 1.2 0 C-N-CA 123.717 0.675 . . . . 2.7 113.435 171.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -42.2 141.05 0.99 Allowed 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 125.698 1.599 . . . . 3.23 113.91 -178.154 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -148.58 -45.55 0.15 Allowed 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.788 1.235 . . . . 3.85 113.792 178.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 21.8 p -76.02 -4.85 43.52 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 120.286 1.403 . . . . 3.35 112.434 -179.195 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 60.81 33.28 20.09 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 124.688 1.195 . . . . 3.47 111.826 174.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -143.79 -44.02 0.27 Allowed 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 123.844 0.858 . . . . 1.76 111.136 -179.243 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 11.5 p -51.79 -33.27 34.71 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.53 0.732 . . . . 2.67 112.268 174.345 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -49.96 -34.2 20.07 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.265 1.026 . . . . 1.59 111.855 172.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -69.98 -49.65 49.56 Favored 'General case' 0 N--CA 1.453 -0.305 0 O-C-N 120.331 -1.48 . . . . 1.54 109.887 172.12 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 20.1 mmm180 -52.74 -44.03 66.15 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 119.007 -0.52 . . . . 6.0 110.655 -174.017 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.2 pt -59.75 -54.22 37.55 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 C-N-CA 119.885 -0.726 . . . . 1.63 111.559 178.208 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -55.28 -44.75 75.94 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-N 118.795 0.725 . . . . 2.19 111.753 177.408 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 30.7 mmtp -71.77 -39.9 69.64 Favored 'General case' 0 CA--C 1.53 0.183 0 O-C-N 121.61 -0.681 . . . . 2.78 110.84 -174.613 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.95 -43.61 98.65 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 109.627 -1.389 . . . . 0.74 109.627 170.336 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -59.31 -36.93 76.52 Favored 'General case' 0 CA--C 1.541 0.606 0 O-C-N 121.442 -1.034 . . . . 3.45 109.362 178.655 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.6 ttpp -58.68 -20.06 45.07 Favored 'General case' 0 CA--C 1.537 0.473 0 O-C-N 120.556 -1.34 . . . . 3.14 113.685 174.214 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 22.3 mtt-85 -83.82 -6.22 59.38 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.847 0.859 . . . . 3.8 111.933 177.229 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 21.9 mmt -86.17 154.23 57.32 Favored Pre-proline 0 CA--C 1.531 0.24 0 CA-C-N 118.763 0.71 . . . . 5.64 109.467 -174.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -56.08 148.17 60.36 Favored 'Trans proline' 0 N--CA 1.453 -0.87 0 C-N-CA 121.816 1.678 . . . . 0.73 110.34 176.21 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 84.36 -33.18 3.22 Favored Glycine 0 CA--C 1.524 0.636 0 CA-C-O 119.855 -0.414 . . . . 0.55 113.197 175.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 15.3 t -82.78 137.86 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 CA-C-N 118.206 1.003 . . . . 1.52 109.204 177.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -110.63 -49.89 3.0 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-O 118.255 -0.878 . . . . 2.07 109.661 175.91 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -138.39 160.84 38.49 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 119.173 0.897 . . . . 2.33 109.98 179.331 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -156.61 147.54 21.93 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 122.846 0.458 . . . . 1.86 110.685 -179.473 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -154.07 116.93 4.45 Favored 'General case' 0 C--N 1.34 0.193 0 N-CA-C 108.64 -0.874 . . . . 0.5 108.64 -164.14 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.6 p -93.9 96.65 6.23 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 C-N-CA 123.921 0.888 . . . . 1.73 110.026 -175.103 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 51.1 t-20 -83.35 56.96 3.76 Favored 'General case' 0 CA--C 1.536 0.407 0 O-C-N 120.641 -1.287 . . . . 0.8 110.248 -175.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -70.5 -21.15 62.79 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 115.486 -0.779 . . . . 2.1 110.933 -176.468 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -45.56 -34.67 3.47 Favored 'General case' 0 C--N 1.338 0.096 0 C-N-CA 124.043 0.937 . . . . 1.6 112.194 167.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 8.7 t -131.8 45.43 2.78 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 108.863 -0.791 . . . . 2.26 108.863 172.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 37.47 52.54 1.29 Allowed 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.886 1.674 . . . . 4.02 113.793 175.091 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -134.34 165.97 23.9 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 108.263 -1.014 . . . . 2.54 108.263 173.641 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.7 p -139.18 139.37 39.89 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 N-CA-C 107.352 -1.351 . . . . 1.73 107.352 173.224 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 20.4 m120 -126.85 137.42 53.18 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 107.816 -1.179 . . . . 0.34 107.816 -178.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.1 p -135.0 124.23 42.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 N-CA-C 106.562 -1.644 . . . . 3.0 106.562 -173.488 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 7.5 mm -107.12 96.92 5.03 Favored 'Isoleucine or valine' 0 C--O 1.24 0.56 0 C-N-CA 125.332 1.453 . . . . 1.75 107.871 -168.048 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 46.8 p90 -137.94 165.38 26.66 Favored 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 112.198 0.444 . . . . 2.92 112.198 -170.284 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 26.8 t0 -84.2 110.49 26.64 Favored Pre-proline 0 CA--C 1.535 0.379 0 O-C-N 124.412 1.07 . . . . 3.08 110.551 173.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -72.38 4.4 3.43 Favored 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 123.149 2.566 . . . . 0.68 113.508 -178.345 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -86.12 -29.57 23.21 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 119.46 1.027 . . . . 1.9 109.194 167.542 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -104.87 -57.56 2.01 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 123.578 0.751 . . . . 3.65 109.102 -168.471 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.308 1.3 p -89.76 -173.91 4.1 Favored 'General case' 0 CA--C 1.521 -0.159 0 CA-C-O 121.015 0.436 . . . . 1.63 111.134 158.361 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 136.78 87.77 0.21 Allowed Glycine 0 N--CA 1.442 -0.965 0 N-CA-C 103.71 -3.756 . . . . 2.46 103.71 -152.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 66.6 p -12.35 -17.73 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.49 1 C-N-CA 137.778 6.431 . . . . 2.0 119.863 -144.112 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -26.44 -62.98 0.08 Allowed 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 127.085 2.154 . . . . 1.6 113.834 165.213 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -72.91 -42.09 63.89 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 117.643 -1.623 . . . . 1.66 109.866 -168.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.4 mp -49.71 -57.57 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.816 0 CA-C-N 114.237 -1.347 . . . . 1.93 109.258 175.444 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.17 -45.82 83.34 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 118.586 0.63 . . . . 1.73 110.856 -174.656 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -45.06 -60.07 2.28 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 122.574 1.178 . . . . 3.11 110.374 172.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 4.6 mmpt? -70.18 -38.73 75.44 Favored 'General case' 0 N--CA 1.431 -1.384 0 CA-C-N 115.341 -0.845 . . . . 3.96 112.005 -173.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -48.66 -54.1 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 C-N-CA 124.889 1.276 . . . . 1.59 107.8 175.372 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -60.09 -54.63 43.7 Favored 'General case' 0 C--N 1.34 0.182 0 C-N-CA 123.722 0.809 . . . . 1.68 110.231 176.71 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.9 tmtm? -56.83 -35.38 68.74 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 112.937 0.717 . . . . 4.49 112.937 -176.185 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 12.9 mt -70.59 -18.7 62.89 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 125.705 1.602 . . . . 1.72 111.645 175.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 93.05 44.25 3.88 Favored Glycine 0 CA--C 1.525 0.681 0 C-N-CA 124.642 1.115 . . . . 0.62 110.553 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -139.6 173.99 10.97 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 123.688 0.795 . . . . 3.23 110.663 -177.929 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 18.8 t-160 -148.78 128.12 13.0 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 108.601 -0.889 . . . . 3.4 108.601 175.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 14.5 p -100.28 135.1 37.63 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 C-N-CA 126.259 1.824 . . . . 2.44 108.336 178.621 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 15.8 t -100.32 131.94 46.88 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 C-N-CA 124.272 1.029 . . . . 1.79 109.227 -179.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 27.6 mm -88.11 75.52 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 C-N-CA 124.508 1.123 . . . . 2.02 108.601 -173.125 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -71.2 -0.54 10.06 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 113.767 1.025 . . . . 4.76 113.767 -178.306 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 65.52 69.46 1.34 Allowed Glycine 0 CA--C 1.523 0.583 0 C-N-CA 124.978 1.275 . . . . 2.77 111.394 173.155 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 6.6 mtt180 . . . . . 0 C--O 1.255 1.386 0 C-N-CA 125.629 1.572 . . . . 14.23 106.893 -172.589 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.0 mtt . . . . . 0 N--CA 1.474 0.769 0 N-CA-C 109.349 -0.611 . . . . 13.69 109.349 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.1 pp -163.03 135.0 5.19 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 106.654 -1.61 . . . . 6.75 106.654 171.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.2 m -146.67 116.53 7.24 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 105.029 -2.212 . . . . 1.38 105.029 174.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -78.16 157.02 29.55 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 106.925 -1.509 . . . . 2.32 106.925 167.578 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -111.03 148.37 32.74 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 124.436 1.095 . . . . 1.14 108.106 176.65 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.92 153.66 51.37 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 121.769 0.795 . . . . 5.05 109.075 159.425 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -84.05 144.39 29.11 Favored 'General case' 0 N--CA 1.442 -0.87 0 C-N-CA 126.651 1.981 . . . . 2.04 107.472 168.273 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -125.17 164.16 24.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 107.664 -1.235 . . . . 3.96 107.664 168.027 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -136.22 124.05 22.61 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 106.669 -1.604 . . . . 1.41 106.669 177.34 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 39.3 mtm -139.6 170.37 16.03 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 108.784 -0.821 . . . . 2.94 108.784 -178.328 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 30.8 mm100 -97.68 163.03 13.0 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.288 1.035 . . . . 2.91 109.618 177.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 52.4 t -121.96 149.06 25.23 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 C-N-CA 124.815 1.246 . . . . 2.35 109.138 -173.25 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 17.9 m -155.44 174.3 15.44 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.716 1.206 . . . . 2.02 108.395 169.42 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 64.42 65.6 2.91 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 109.931 -1.268 . . . . 1.91 109.931 -179.017 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 5.5 ppp? -139.54 154.32 47.63 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 123.917 0.887 . . . . 4.46 110.103 -171.442 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.8 p -99.54 -63.89 1.09 Allowed 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 125.945 1.698 . . . . 4.61 108.638 171.225 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 19.9 p -138.0 161.75 35.88 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 124.291 1.036 . . . . 2.26 110.636 -175.416 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -76.48 49.82 0.62 Allowed 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.43 1.092 . . . . 2.4 111.124 179.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -142.31 -49.54 0.37 Allowed 'General case' 0 N--CA 1.457 -0.119 0 C-N-CA 124.878 1.271 . . . . 1.81 109.008 178.368 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 38.3 m -57.8 -36.82 72.73 Favored 'General case' 0 CA--C 1.533 0.298 0 O-C-N 121.365 -0.835 . . . . 1.17 110.059 168.512 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -51.28 -31.8 22.52 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.951 0.901 . . . . 1.63 112.209 170.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -73.58 -53.4 10.59 Favored 'General case' 0 N--CA 1.453 -0.31 0 O-C-N 120.663 -1.273 . . . . 1.78 109.647 170.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 48.9 mmm-85 -47.56 -46.16 27.71 Favored 'General case' 0 C--O 1.23 0.068 0 C-N-CA 123.609 0.764 . . . . 4.56 111.215 -175.054 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 5.4 pt -55.1 -53.13 37.52 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 CA-C-O 119.129 -0.462 . . . . 1.77 111.823 177.686 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -60.23 -42.28 94.88 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 118.819 0.736 . . . . 2.25 111.257 179.599 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.6 mptm? -68.24 -44.23 76.13 Favored 'General case' 0 CA--C 1.528 0.108 0 O-C-N 121.743 -0.598 . . . . 3.7 109.897 -176.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -57.32 -47.82 85.06 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 109.468 -1.453 . . . . 0.79 109.468 171.721 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -58.5 -40.49 82.96 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.702 0.801 . . . . 3.7 110.318 -175.373 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 12.8 ttmt -44.22 -34.75 1.99 Allowed 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 118.608 0.64 . . . . 3.74 112.358 173.709 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 43.7 ttm-85 -67.27 -8.6 33.23 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 113.414 0.894 . . . . 4.57 113.414 -172.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 1.6 mpp? -87.56 158.51 51.29 Favored Pre-proline 0 CA--C 1.537 0.463 0 CA-C-N 119.347 0.976 . . . . 5.06 111.419 178.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -62.99 153.81 71.15 Favored 'Trans proline' 0 N--CA 1.456 -0.694 0 C-N-CA 123.142 2.561 . . . . 1.0 112.077 -176.239 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 74.0 -35.65 0.91 Allowed Glycine 0 CA--C 1.525 0.683 0 C-N-CA 124.761 1.172 . . . . 0.92 112.616 -178.142 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 11.6 t -71.88 130.97 35.2 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 O-C-N 121.074 -1.25 . . . . 1.77 108.655 175.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -118.61 -43.11 2.71 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 118.677 -0.678 . . . . 1.88 109.88 179.844 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -140.73 164.85 29.09 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 119.221 0.919 . . . . 2.02 112.016 168.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -157.69 140.65 15.07 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.139 -0.937 . . . . 1.31 109.185 -171.595 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -153.52 107.11 2.99 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 106.198 -1.778 . . . . 0.49 106.198 -164.839 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 4.2 p -80.23 122.85 36.19 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 N-CA-C 107.232 -1.396 . . . . 1.9 107.232 175.392 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 57.7 t-20 -102.2 56.27 0.8 Allowed 'General case' 0 C--O 1.235 0.311 0 N-CA-C 106.893 -1.521 . . . . 0.78 106.893 178.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.14 -20.95 64.04 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 114.259 -1.337 . . . . 2.43 109.589 -173.146 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -45.52 -37.15 5.09 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 124.118 0.967 . . . . 1.66 112.267 167.015 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 6.3 t -122.75 40.24 3.74 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 121.65 0.738 . . . . 2.06 109.235 173.686 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 39.0 46.61 1.13 Allowed 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 126.888 2.075 . . . . 2.62 113.015 178.718 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 52.3 m -128.03 155.51 44.21 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 125.0 1.32 . . . . 2.19 108.3 -178.439 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.0 p -121.56 142.23 38.69 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 N-CA-C 108.417 -0.957 . . . . 1.71 108.417 168.45 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 21.4 m120 -126.1 139.1 53.65 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 107.28 -1.378 . . . . 0.56 107.28 174.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 20.5 t -132.89 135.84 56.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 N-CA-C 104.941 -2.244 . . . . 3.26 104.941 -178.45 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 15.0 mm -112.05 92.24 2.01 Favored 'Isoleucine or valine' 0 C--O 1.24 0.578 0 N-CA-C 106.758 -1.571 . . . . 1.9 106.758 -179.452 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -127.27 171.89 11.08 Favored 'General case' 0 CA--C 1.509 -0.625 0 CA-C-N 116.596 -0.275 . . . . 3.78 110.492 -176.368 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 -94.38 105.66 19.15 Favored Pre-proline 0 N--CA 1.448 -0.533 0 O-C-N 124.397 1.061 . . . . 3.8 108.615 176.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -69.98 5.75 1.66 Allowed 'Trans proline' 0 CA--C 1.538 0.679 0 C-N-CA 122.323 2.015 . . . . 0.72 113.03 -179.245 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -85.66 -27.94 25.06 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 123.72 0.808 . . . . 1.79 109.43 169.044 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -112.47 -61.43 1.73 Allowed 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.281 1.032 . . . . 2.81 110.05 -173.455 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.486 0.5 OUTLIER -85.12 -169.1 2.49 Favored 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 114.055 1.131 . . . . 1.53 114.055 162.908 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 158.59 -150.13 20.66 Favored Glycine 0 N--CA 1.434 -1.437 0 N-CA-C 103.56 -3.816 . . . . 2.68 103.56 -157.456 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 15.0 p -75.96 -37.38 58.67 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 124.986 1.314 . . . . 2.6 109.687 -179.322 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -54.48 -63.79 1.04 Allowed 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 124.404 1.082 . . . . 1.89 113.191 -164.277 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.77 -35.73 79.2 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 118.483 -1.287 . . . . 1.82 108.87 -167.726 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.7 mp -55.17 -58.57 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.115 0 CA-C-N 114.205 -1.361 . . . . 2.64 109.212 173.52 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.63 -46.58 88.58 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 119.698 1.136 . . . . 1.82 109.363 -175.46 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -48.86 -55.65 11.05 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 121.394 0.616 . . . . 4.07 110.515 177.005 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.0 mmpt? -71.2 -40.68 71.03 Favored 'General case' 0 N--CA 1.435 -1.191 0 CA-C-O 118.333 -0.842 . . . . 3.18 112.907 -177.36 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 3.4 mm -47.93 -52.4 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 C-N-CA 126.387 1.875 . . . . 1.64 107.703 176.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -53.74 -61.09 2.53 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 115.689 -0.687 . . . . 3.52 111.138 173.246 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -62.23 -29.38 70.35 Favored 'General case' 0 CA--C 1.542 0.669 0 O-C-N 121.779 -0.576 . . . . 6.07 112.088 -172.256 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 36.4 mt -71.06 -19.94 62.43 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.778 1.631 . . . . 1.76 111.377 173.043 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 89.56 40.85 5.88 Favored Glycine 0 CA--C 1.525 0.704 0 C-N-CA 124.688 1.137 . . . . 0.56 111.474 176.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -131.6 174.45 10.1 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 124.201 1.0 . . . . 3.14 110.268 178.207 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 10.9 t-160 -151.05 126.26 9.94 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 109.608 -0.515 . . . . 3.7 109.608 167.073 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 20.3 m -82.27 167.7 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 N-CA-C 109.216 -0.661 . . . . 3.56 109.216 176.013 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 15.2 t -130.9 145.52 35.39 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 N-CA-C 107.837 -1.171 . . . . 1.97 107.837 178.723 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 29.4 mm -121.54 76.09 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 C-N-CA 124.356 1.062 . . . . 2.62 109.108 -171.252 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -81.08 -0.07 38.28 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 115.325 1.602 . . . . 3.14 115.325 -173.61 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 80.55 81.18 0.81 Allowed Glycine 0 CA--C 1.527 0.829 0 N-CA-C 109.648 -1.381 . . . . 4.05 109.648 -175.635 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.254 1.318 0 N-CA-C 104.714 -2.328 . . . . 13.28 104.714 177.068 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.474 0.765 0 N-CA-C 108.444 -0.947 . . . . 11.16 108.444 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 10.3 mp -72.48 -175.6 1.66 Allowed 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 108.316 -0.994 . . . . 5.85 108.316 161.555 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 50.3 m -22.54 108.65 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 127.088 2.155 . . . . 1.77 112.843 164.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -70.54 -177.39 1.49 Allowed 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 121.321 0.582 . . . . 2.11 109.693 174.522 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -134.79 146.02 48.95 Favored 'General case' 0 N--CA 1.447 -0.575 0 N-CA-C 107.258 -1.386 . . . . 1.27 107.258 168.081 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 50.1 mtmt -142.42 162.14 36.25 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 123.271 0.628 . . . . 4.49 109.378 159.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.3 mp0 -121.22 86.38 2.56 Favored 'General case' 0 N--CA 1.442 -0.86 0 C-N-CA 127.904 2.482 . . . . 1.9 106.855 -166.144 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 3.4 mp -82.56 163.06 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.258 0 N-CA-C 106.427 -1.694 . . . . 3.0 106.427 -175.133 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -138.67 134.37 33.57 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 125.469 1.508 . . . . 1.74 108.31 -176.146 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -156.28 174.32 15.57 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 118.346 0.521 . . . . 3.84 110.736 175.344 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 29.0 mm100 -93.57 160.68 14.68 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.931 1.293 . . . . 2.68 109.923 -178.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 21.3 t -119.43 154.87 22.05 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 C-N-CA 124.23 1.012 . . . . 2.19 109.27 -171.117 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 32.1 t -154.47 175.82 13.11 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 118.588 0.631 . . . . 2.54 110.358 170.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 59.09 72.53 0.59 Allowed Glycine 0 CA--C 1.528 0.854 0 N-CA-C 110.252 -1.139 . . . . 2.05 110.252 -174.322 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -144.83 159.96 42.04 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 123.746 0.818 . . . . 3.05 110.567 -172.447 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -100.11 -65.12 0.99 Allowed 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 125.955 1.702 . . . . 4.22 110.246 169.1 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 2.0 p -150.54 164.15 36.69 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 123.32 0.648 . . . . 2.46 110.371 -166.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -72.75 32.86 0.07 Allowed 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.661 1.584 . . . . 2.4 113.751 -172.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -114.9 -47.84 2.86 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 126.314 1.845 . . . . 1.75 108.74 171.616 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 38.0 m -66.0 -38.09 87.58 Favored 'General case' 0 N--CA 1.455 -0.185 0 O-C-N 121.435 -0.791 . . . . 1.25 110.653 -170.296 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.62 -28.75 61.14 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 116.25 -0.432 . . . . 1.94 111.306 173.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.84 -50.25 65.27 Favored 'General case' 0 N--CA 1.455 -0.207 0 O-C-N 120.158 -1.589 . . . . 1.67 109.118 171.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 28.5 mmm180 -53.04 -48.53 67.55 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 118.792 -0.623 . . . . 6.36 110.336 -178.152 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.271 1.8 pt -58.14 -56.34 16.59 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.44 0 C-N-CA 119.304 -0.958 . . . . 1.74 110.765 179.703 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -53.68 -42.03 67.51 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 119.594 1.088 . . . . 2.62 112.582 179.325 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -70.02 -43.67 70.87 Favored 'General case' 0 CA--C 1.535 0.394 0 O-C-N 121.163 -0.961 . . . . 3.16 110.717 -177.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -66.89 -33.19 83.25 Favored Glycine 0 CA--C 1.529 0.964 0 N-CA-C 111.254 -0.738 . . . . 0.65 111.254 175.281 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -66.03 -46.36 78.16 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 125.021 1.328 . . . . 3.46 107.635 178.444 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.427 ' HZ2' ' CG ' ' A' ' 36' ' ' ASP . 14.3 ttmt -49.11 -34.88 14.96 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 118.758 0.708 . . . . 4.37 112.405 176.805 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -59.61 -20.99 59.69 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 113.124 0.787 . . . . 6.62 113.124 179.575 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.52 158.83 84.02 Favored Pre-proline 0 CA--C 1.54 0.573 0 C-N-CA 123.99 0.916 . . . . 5.05 111.93 -174.045 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 78.9 Cg_endo -73.05 115.52 4.38 Favored 'Trans proline' 0 N--CA 1.453 -0.901 0 C-N-CA 121.871 1.714 . . . . 1.04 109.691 175.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 124.38 -36.55 2.88 Favored Glycine 0 CA--C 1.529 0.915 0 C-N-CA 124.343 0.973 . . . . 1.11 112.446 172.57 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 57.8 t -80.17 142.32 14.08 Favored 'Isoleucine or valine' 0 C--N 1.34 0.192 0 CA-C-N 118.01 0.905 . . . . 1.73 109.193 173.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.5 m -115.47 -41.79 3.22 Favored 'General case' 0 C--N 1.338 0.068 0 C-N-CA 123.292 0.637 . . . . 2.78 110.947 -176.034 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.427 ' CG ' ' HZ2' ' A' ' 29' ' ' LYS . 1.0 OUTLIER -136.91 165.83 25.07 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 123.629 0.771 . . . . 2.04 110.329 169.654 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -158.92 142.81 15.25 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 122.73 0.412 . . . . 1.83 111.261 -177.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -154.97 107.5 2.75 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 106.228 -1.767 . . . . 0.48 106.228 -167.497 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 4.2 p -80.02 135.8 24.73 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 N-CA-C 107.613 -1.255 . . . . 1.74 107.613 174.251 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 54.4 t-20 -122.24 55.98 1.12 Allowed 'General case' 0 C--O 1.235 0.294 0 CA-C-O 122.844 1.307 . . . . 1.02 107.895 -179.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.72 -20.21 66.2 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-N 114.169 -1.378 . . . . 2.31 110.515 179.107 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -49.63 -37.2 27.21 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 118.829 -0.605 . . . . 1.79 112.124 167.014 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 13.5 t -114.33 23.57 12.71 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 118.362 0.528 . . . . 1.79 111.206 171.436 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 65.67 20.18 11.52 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.665 1.586 . . . . 2.7 114.353 175.078 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 25.6 m -122.05 164.17 18.15 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.657 1.183 . . . . 1.7 109.797 -173.209 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.7 p -128.5 146.75 33.44 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 O-C-N 120.789 -1.194 . . . . 1.62 109.521 172.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -129.59 136.77 50.19 Favored 'General case' 0 C--N 1.345 0.41 0 N-CA-C 107.814 -1.18 . . . . 0.42 107.814 175.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -130.75 130.07 64.29 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.797 0 N-CA-C 105.245 -2.131 . . . . 3.47 105.245 179.687 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 11.9 mm -103.48 99.33 8.17 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 N-CA-C 106.051 -1.833 . . . . 1.52 106.051 -174.401 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 46.0 p90 -136.05 169.86 16.93 Favored 'General case' 0 CA--C 1.51 -0.564 0 O-C-N 121.976 -0.453 . . . . 2.86 110.98 -170.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 31.1 t0 -90.69 105.49 12.13 Favored Pre-proline 0 C--O 1.234 0.246 0 O-C-N 124.491 1.119 . . . . 3.02 109.208 175.072 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -75.32 8.31 2.59 Favored 'Trans proline' 0 N--CA 1.45 -1.054 0 C-N-CA 122.396 2.064 . . . . 0.76 112.353 -177.59 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -87.94 -28.38 21.53 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 119.328 0.967 . . . . 2.22 108.928 167.133 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -102.61 -59.11 1.76 Allowed 'General case' 0 C--N 1.344 0.326 0 N-CA-C 108.872 -0.788 . . . . 2.42 108.872 -176.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.334 0.7 OUTLIER -86.46 -172.75 4.19 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 125.345 1.458 . . . . 1.72 114.1 166.759 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 167.99 -143.19 7.99 Favored Glycine 0 N--CA 1.43 -1.706 1 N-CA-C 101.819 -4.512 . . . . 2.63 101.819 -164.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 36.5 p -77.35 -34.77 55.1 Favored 'General case' 0 N--CA 1.442 -0.851 0 C-N-CA 125.918 1.687 . . . . 2.44 109.494 176.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -48.8 -62.92 1.26 Allowed 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 125.166 1.386 . . . . 1.52 113.247 -161.262 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -75.31 -30.11 60.24 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 114.936 -1.029 . . . . 1.87 109.795 -173.425 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 4.6 mt -57.76 -57.42 10.47 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.739 0 CA-C-O 118.405 -0.807 . . . . 2.9 110.609 177.043 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.25 -43.82 92.4 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 119.079 0.854 . . . . 1.19 108.73 -176.844 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -50.66 -56.5 11.6 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 123.481 0.712 . . . . 3.12 110.459 178.524 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -66.03 -43.05 88.75 Favored 'General case' 0 N--CA 1.438 -1.072 0 CA-C-O 118.42 -0.8 . . . . 2.98 111.879 -179.836 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 3.3 mm -47.98 -51.71 8.35 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 125.781 1.633 . . . . 1.91 108.78 176.483 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 38.9 mm-40 -56.13 -58.6 7.25 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.577 0.751 . . . . 1.53 110.598 174.648 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.09 -36.34 72.71 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 121.412 -0.805 . . . . 5.97 112.466 -176.586 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 37.9 mt -68.35 -17.62 64.29 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 125.154 1.382 . . . . 1.83 111.02 177.106 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 91.68 38.15 5.91 Favored Glycine 0 C--N 1.338 0.65 0 C-N-CA 124.334 0.969 . . . . 0.52 110.984 174.224 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -133.44 174.81 10.01 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 123.593 0.757 . . . . 3.28 110.702 -177.877 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -140.12 167.81 21.26 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 108.706 -0.85 . . . . 2.84 108.706 169.094 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 45.5 t -140.01 145.59 26.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 N-CA-C 105.476 -2.046 . . . . 3.24 105.476 -171.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 5.8 t -120.64 136.9 56.16 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 C-N-CA 124.671 1.188 . . . . 2.08 107.854 -177.422 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 45.7 mm -110.53 74.82 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 N-CA-C 106.969 -1.493 . . . . 2.58 106.969 -178.67 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -74.54 -6.12 46.65 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.411 1.085 . . . . 3.49 112.591 -178.378 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -131.22 63.8 0.62 Allowed Glycine 0 CA--C 1.524 0.612 0 C-N-CA 126.132 1.825 . . . . 3.06 108.549 174.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 9.9 ttt180 . . . . . 0 C--O 1.251 1.175 0 CA-C-O 117.279 -1.344 . . . . 14.11 109.799 173.132 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.7 mtt . . . . . 0 N--CA 1.471 0.612 0 N-CA-C 106.584 -1.635 . . . . 13.41 106.584 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -148.87 37.63 0.8 Allowed 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 124.754 1.222 . . . . 7.9 109.718 -172.517 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 5.2 m -100.08 96.74 7.71 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 106.995 -1.483 . . . . 1.4 106.995 175.459 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -68.25 168.86 11.5 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 107.717 -1.216 . . . . 2.47 107.717 164.607 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -127.42 147.78 50.29 Favored 'General case' 0 CA--C 1.516 -0.33 0 C-N-CA 124.415 1.086 . . . . 0.98 108.359 177.112 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 52.7 mtmt -144.93 159.61 42.64 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 121.839 0.828 . . . . 4.25 111.573 163.572 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -97.34 145.82 25.76 Favored 'General case' 0 N--CA 1.442 -0.873 0 C-N-CA 127.787 2.435 . . . . 1.71 108.16 175.553 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -127.87 158.58 39.49 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 N-CA-C 105.841 -1.911 . . . . 3.47 105.841 173.588 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -136.87 127.96 27.8 Favored 'General case' 0 C--O 1.226 -0.14 0 N-CA-C 107.854 -1.165 . . . . 1.5 107.854 179.46 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 3.5 ptp -156.02 177.51 11.34 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 118.434 0.561 . . . . 3.37 110.781 -172.947 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 27.7 mm100 -97.47 161.79 13.62 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.243 1.417 . . . . 2.52 110.453 -175.628 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 49.6 t -116.0 157.76 16.69 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 C-N-CA 124.951 1.3 . . . . 2.21 109.818 -174.281 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 6.3 m -153.35 169.78 22.26 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.486 0.714 . . . . 1.6 110.615 169.441 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 60.44 59.93 9.43 Favored Glycine 0 CA--C 1.529 0.945 0 N-CA-C 110.016 -1.234 . . . . 1.92 110.016 -174.825 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -144.71 167.69 21.96 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 124.21 1.004 . . . . 2.76 109.982 -174.448 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -143.22 -67.49 0.36 Allowed 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 124.769 1.228 . . . . 3.41 108.982 171.342 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 12.2 p -98.84 150.86 21.45 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-O 121.643 0.735 . . . . 2.34 111.205 -178.493 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -78.18 47.11 0.65 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.616 0.766 . . . . 2.9 110.794 177.358 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -135.29 -53.72 0.79 Allowed 'General case' 0 N--CA 1.457 -0.12 0 C-N-CA 124.305 1.042 . . . . 1.71 109.288 177.952 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 34.7 m -55.78 -38.18 69.56 Favored 'General case' 0 C--N 1.338 0.096 0 O-C-N 121.552 -0.718 . . . . 1.19 109.64 168.166 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.25 -22.88 44.36 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 112.547 0.573 . . . . 1.59 112.547 175.766 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -73.24 -40.76 64.42 Favored 'General case' 0 C--O 1.232 0.135 0 O-C-N 120.684 -1.26 . . . . 1.75 110.727 170.665 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 18.1 mmm180 -56.75 -39.36 73.85 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 123.391 0.676 . . . . 5.59 109.761 -171.429 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.3 pt -60.18 -65.62 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 C-N-CA 119.454 -0.898 . . . . 2.96 111.183 177.38 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -46.95 -45.13 20.54 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-N 119.778 1.172 . . . . 2.47 112.156 177.858 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 11.2 mptt -70.84 -33.34 70.56 Favored 'General case' 0 CA--C 1.538 0.504 0 O-C-N 121.377 -0.827 . . . . 2.86 110.641 -176.725 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -72.03 -29.11 67.33 Favored Glycine 0 CA--C 1.531 1.071 0 O-C-N 121.377 -0.827 . . . . 0.68 112.061 169.715 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.0 mp -69.78 -43.9 71.2 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 118.378 1.089 . . . . 4.1 109.432 175.975 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 61.8 tttm -50.35 -31.74 15.42 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.644 0.777 . . . . 3.51 111.964 174.206 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 52.8 mtt180 -75.8 -4.38 40.31 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 113.651 0.982 . . . . 6.36 113.651 179.484 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 93.0 mmm -93.17 150.47 39.19 Favored Pre-proline 0 C--O 1.232 0.161 0 CA-C-N 119.422 1.01 . . . . 4.12 110.264 -178.116 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -56.95 144.06 90.27 Favored 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 121.869 1.713 . . . . 0.7 109.143 173.99 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 88.69 -32.34 4.57 Favored Glycine 0 CA--C 1.525 0.686 0 CA-C-O 119.419 -0.656 . . . . 0.54 113.343 179.238 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 14.0 t -87.3 136.88 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.176 0 CA-C-N 118.888 1.344 . . . . 1.88 108.438 179.867 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -109.57 -40.9 4.72 Favored 'General case' 0 N--CA 1.456 -0.135 0 CA-C-O 118.305 -0.855 . . . . 1.93 110.663 177.679 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -150.61 164.46 35.99 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 108.336 -0.987 . . . . 1.87 108.336 172.94 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -157.77 145.04 18.29 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 109.256 -0.646 . . . . 1.98 109.256 176.693 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -143.54 115.25 8.18 Favored 'General case' 0 N--CA 1.457 -0.114 0 C-N-CA 124.663 1.185 . . . . 0.8 108.974 -164.296 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.4 p -84.45 116.69 28.58 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.569 0 N-CA-C 108.646 -0.872 . . . . 1.85 108.646 173.679 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 53.3 t-20 -101.3 56.85 0.84 Allowed 'General case' 0 C--O 1.235 0.298 0 N-CA-C 107.224 -1.398 . . . . 0.87 107.224 176.647 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.36 -21.58 65.62 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 114.552 -1.203 . . . . 2.13 110.02 -177.003 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -46.32 -35.36 5.28 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 123.687 0.795 . . . . 1.99 112.14 166.653 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 13.3 t -125.37 37.18 4.43 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 122.462 0.305 . . . . 1.94 110.383 171.695 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 50.06 34.69 8.64 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.681 1.592 . . . . 2.62 113.264 172.988 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 87.0 m -126.03 157.47 37.83 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.445 1.098 . . . . 1.98 108.621 -176.595 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 14.9 p -134.12 144.93 34.0 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 O-C-N 121.284 -0.885 . . . . 1.7 109.875 172.239 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 25.9 m120 -128.05 136.22 50.94 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 125.344 1.458 . . . . 0.49 108.305 -179.083 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 20.6 t -129.5 126.11 62.75 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 N-CA-C 105.475 -2.046 . . . . 3.44 105.475 -176.369 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 21.9 mm -105.85 103.01 14.7 Favored 'Isoleucine or valine' 0 C--O 1.239 0.548 0 N-CA-C 108.007 -1.108 . . . . 1.67 108.007 -174.184 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 7.7 p90 -141.62 169.87 16.78 Favored 'General case' 0 CA--C 1.512 -0.504 0 O-C-N 122.218 -0.301 . . . . 3.53 111.364 -170.964 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -89.54 109.57 32.82 Favored Pre-proline 0 N--CA 1.449 -0.517 0 O-C-N 124.299 1.0 . . . . 3.81 109.444 177.021 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -71.14 8.33 1.12 Allowed 'Trans proline' 0 CA--C 1.54 0.777 0 C-N-CA 122.698 2.265 . . . . 0.66 113.068 179.923 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -88.07 -25.15 23.2 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.033 0.933 . . . . 1.96 109.596 168.837 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -115.52 -59.44 2.0 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 124.305 1.042 . . . . 3.36 109.697 -171.062 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.323 3.8 p -91.74 -166.29 1.53 Allowed 'General case' 0 C--N 1.342 0.246 0 N-CA-C 110.35 -0.241 . . . . 1.63 110.35 163.132 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 122.84 87.59 0.85 Allowed Glycine 0 N--CA 1.444 -0.784 0 N-CA-C 104.103 -3.599 . . . . 2.16 104.103 -142.456 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 72.3 p -14.11 -18.99 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.36 1 C-N-CA 138.344 6.657 . . . . 2.37 119.476 -148.022 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -26.39 -62.34 0.08 Allowed 'General case' 0 N--CA 1.443 -0.776 0 C-N-CA 127.124 2.17 . . . . 1.78 113.756 166.391 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.69 -41.1 63.11 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 117.97 -1.492 . . . . 1.66 109.931 -168.654 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.2 mp -52.81 -53.63 20.19 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.807 0 CA-C-N 114.446 -1.252 . . . . 1.94 109.193 176.305 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -66.92 -45.55 77.55 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 122.69 0.396 . . . . 1.65 110.093 -173.765 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -46.06 -57.36 4.52 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 122.57 1.176 . . . . 2.68 110.761 170.185 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 5.0 mmmt -67.66 -39.09 84.58 Favored 'General case' 0 N--CA 1.435 -1.178 0 CA-C-N 115.741 -0.663 . . . . 3.78 112.409 -176.323 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -52.25 -50.38 37.26 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 N-CA-C 107.49 -1.3 . . . . 1.7 107.49 -177.554 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 25.3 mm-40 -57.62 -58.31 8.9 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.033 0.933 . . . . 1.93 110.55 174.044 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 24.9 mmtt -52.94 -37.03 60.6 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 113.287 0.847 . . . . 4.6 113.287 -178.448 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 18.2 mt -70.64 -18.09 62.86 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.52 1.528 . . . . 1.94 111.542 178.232 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 90.32 41.9 5.37 Favored Glycine 0 CA--C 1.525 0.67 0 C-N-CA 124.649 1.119 . . . . 0.5 110.488 179.022 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -138.19 175.46 9.56 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 124.157 0.983 . . . . 3.27 109.249 -176.345 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 15.1 t-160 -141.05 157.57 45.13 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 108.649 -0.871 . . . . 3.43 108.649 171.182 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 9.5 p -135.83 141.35 42.19 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 N-CA-C 106.528 -1.656 . . . . 2.53 106.528 -178.037 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 3.4 t -115.73 130.52 70.24 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 N-CA-C 108.599 -0.889 . . . . 1.62 108.599 -175.145 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 45.5 mm -101.38 74.55 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 124.114 0.966 . . . . 2.19 108.452 -170.059 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -72.16 0.69 9.03 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 114.528 1.307 . . . . 3.45 114.528 -178.568 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 68.03 76.23 0.43 Allowed Glycine 0 CA--C 1.525 0.699 0 N-CA-C 110.195 -1.162 . . . . 2.83 110.195 -179.084 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.019 0 N-CA-C 106.334 -1.728 . . . . 12.62 106.334 173.547 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 77' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.3 mtt . . . . . 0 N--CA 1.472 0.656 0 N-CA-C 106.827 -1.546 . . . . 12.95 106.827 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.3 tp -165.34 170.41 14.68 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 104.502 -2.406 . . . . 6.84 104.502 175.087 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 49.3 m 58.9 86.51 0.09 Allowed 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.71 0.804 . . . . 2.4 111.451 178.629 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -62.92 177.23 0.59 Allowed 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 121.266 0.555 . . . . 2.11 110.675 173.637 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -134.69 140.39 45.96 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 108.684 -0.858 . . . . 1.18 108.684 173.959 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -133.16 156.79 46.82 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 124.671 1.188 . . . . 5.0 108.999 164.664 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -105.36 121.32 43.65 Favored 'General case' 0 N--CA 1.434 -1.261 0 N-CA-C 101.683 -3.451 . . . . 1.81 101.683 174.034 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 24.8 mm -101.26 165.17 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.388 0 N-CA-C 106.639 -1.615 . . . . 3.01 106.639 168.013 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -139.02 132.62 30.46 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 107.076 -1.453 . . . . 1.44 107.076 177.581 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -156.95 178.45 10.35 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 118.883 0.765 . . . . 3.03 110.848 174.211 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 25.0 mm100 -91.47 166.33 12.91 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.314 1.445 . . . . 2.37 110.405 -178.68 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -131.64 157.04 43.11 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.136 0 C-N-CA 124.057 0.943 . . . . 3.28 110.723 174.936 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 63.7 m -149.84 166.73 28.62 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 125.5 1.52 . . . . 1.59 109.018 177.352 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 71.66 67.03 1.96 Allowed Glycine 0 CA--C 1.525 0.691 0 N-CA-C 109.211 -1.556 . . . . 1.74 109.211 -177.394 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -147.55 166.66 26.66 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 124.153 0.981 . . . . 3.47 109.522 -174.731 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.3 p -126.22 -61.36 1.22 Allowed 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 124.049 0.939 . . . . 3.21 109.497 168.623 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 30.8 p -109.31 151.61 26.35 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 123.694 0.798 . . . . 2.17 111.297 -176.174 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -76.24 53.25 0.8 Allowed 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.604 0.762 . . . . 2.39 110.201 174.764 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -145.52 -51.96 0.26 Allowed 'General case' 0 C--O 1.23 0.048 0 C-N-CA 123.49 0.716 . . . . 1.79 110.908 -175.844 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 7.5 p -55.41 -38.02 68.39 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 119.129 0.877 . . . . 2.51 109.997 167.764 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -47.84 -31.07 4.59 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.483 1.513 . . . . 1.81 112.899 171.17 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -72.84 -55.25 6.95 Favored 'General case' 0 N--CA 1.454 -0.272 0 O-C-N 121.099 -1.001 . . . . 1.55 109.912 172.454 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 3.5 mpp_? -54.56 -40.4 68.68 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 118.736 -0.649 . . . . 5.46 111.5 -174.892 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 5.4 pt -55.45 -54.45 25.24 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 C-N-CA 119.554 -0.858 . . . . 1.73 110.802 175.535 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -57.69 -39.2 76.62 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 123.639 0.776 . . . . 3.1 111.313 179.496 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 56.5 mmtt -71.43 -45.8 61.73 Favored 'General case' 0 CA--C 1.534 0.339 0 O-C-N 121.484 -0.76 . . . . 3.11 110.201 -175.079 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.77 -39.47 98.01 Favored Glycine 0 CA--C 1.53 0.988 0 N-CA-C 110.376 -1.09 . . . . 0.58 110.376 172.329 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.0 tt -60.01 -36.11 76.51 Favored 'General case' 0 CA--C 1.538 0.516 0 O-C-N 121.744 -0.857 . . . . 3.16 110.279 174.818 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -60.79 -27.99 68.41 Favored 'General case' 0 N--CA 1.454 -0.242 0 O-C-N 120.876 -1.14 . . . . 4.38 111.999 174.464 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 4.4 mmt85 -72.39 -5.92 39.85 Favored 'General case' 0 CA--C 1.536 0.441 0 O-C-N 121.508 -0.745 . . . . 4.51 112.009 -177.88 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 78.7 mmm -78.23 148.22 74.09 Favored Pre-proline 0 CA--C 1.533 0.32 0 CA-C-N 119.146 0.884 . . . . 4.03 111.05 -179.544 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -56.96 142.62 93.65 Favored 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 122.393 2.062 . . . . 0.67 108.832 176.953 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 86.68 -20.54 23.14 Favored Glycine 0 CA--C 1.532 1.107 0 CA-C-O 118.567 -1.13 . . . . 0.67 113.498 -178.988 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 14.4 t -94.49 123.78 46.73 Favored 'Isoleucine or valine' 0 C--N 1.344 0.334 0 CA-C-N 119.904 1.852 . . . . 1.93 110.414 -178.244 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -103.37 -37.26 7.7 Favored 'General case' 0 CA--C 1.524 -0.054 0 C-N-CA 124.519 1.127 . . . . 2.17 111.21 -171.889 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -149.89 162.37 40.45 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 108.775 -0.824 . . . . 2.13 108.775 174.726 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -155.45 139.28 16.22 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 122.781 0.432 . . . . 1.51 110.203 -177.268 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -155.78 110.19 2.87 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 109.03 -0.73 . . . . 0.51 109.03 -165.56 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.8 p -83.02 106.29 13.64 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.638 0 N-CA-C 109.256 -0.646 . . . . 2.0 109.256 178.785 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 55.3 t-20 -84.59 56.98 4.08 Favored 'General case' 0 CA--C 1.533 0.323 0 O-C-N 120.821 -1.174 . . . . 0.89 108.819 176.188 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.67 -19.98 64.42 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 115.271 -0.877 . . . . 2.28 109.441 -176.86 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -48.37 -38.77 20.18 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.483 0.713 . . . . 1.69 111.952 167.491 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 8.8 t -117.08 36.09 4.37 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 118.029 0.377 . . . . 1.7 110.383 170.764 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 55.42 26.59 9.0 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.476 1.11 . . . . 4.15 113.639 172.565 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 66.0 m -122.52 162.72 21.23 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.884 1.274 . . . . 1.68 108.679 -173.411 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.4 p -126.64 146.21 32.89 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 O-C-N 121.051 -1.03 . . . . 1.79 109.498 170.931 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -131.58 131.02 42.96 Favored 'General case' 0 C--N 1.343 0.295 0 N-CA-C 108.113 -1.069 . . . . 0.34 108.113 177.449 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 4.3 p -132.83 132.03 59.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 106.188 -1.782 . . . . 2.98 106.188 -175.024 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 16.9 mm -109.39 105.53 18.98 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 C-N-CA 125.374 1.47 . . . . 1.63 107.745 -170.841 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 49.1 p90 -146.43 169.26 19.24 Favored 'General case' 0 CA--C 1.516 -0.365 0 O-C-N 122.073 -0.392 . . . . 2.89 111.677 -171.647 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 41.4 t0 -88.28 108.29 21.2 Favored Pre-proline 0 CA--C 1.533 0.305 0 O-C-N 124.484 1.115 . . . . 3.06 110.262 175.731 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -70.89 0.94 5.72 Favored 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 123.036 2.491 . . . . 0.64 113.351 -179.21 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -84.15 -30.68 25.68 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 119.502 1.046 . . . . 1.73 109.144 167.686 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -105.09 -55.76 2.28 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 124.099 0.96 . . . . 2.72 112.007 -167.544 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.263 1.6 p -92.33 -177.63 4.69 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-O 121.496 0.665 . . . . 1.6 110.319 155.681 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 155.42 89.77 0.07 OUTLIER Glycine 0 N--CA 1.443 -0.883 0 N-CA-C 105.937 -2.865 . . . . 2.42 105.937 -165.545 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 82.1 p -7.89 -16.62 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.561 1 C-N-CA 136.279 5.832 . . . . 2.48 119.977 -136.369 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -25.45 -63.23 0.06 Allowed 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 127.756 2.422 . . . . 1.64 114.352 169.827 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.81 -43.0 57.0 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 118.349 -1.341 . . . . 1.82 109.467 -166.316 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -47.9 -56.19 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.099 0 CA-C-N 113.242 -1.799 . . . . 2.08 110.511 171.985 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -67.0 -46.02 75.82 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 118.952 0.796 . . . . 1.71 110.423 -175.047 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -45.19 -57.99 3.56 Favored 'General case' 0 C--N 1.342 0.282 0 CA-C-O 122.59 1.186 . . . . 3.37 110.975 171.954 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.9 mmpt? -71.39 -37.75 71.55 Favored 'General case' 0 N--CA 1.431 -1.399 0 CA-C-O 118.417 -0.801 . . . . 3.2 112.225 -174.864 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -47.61 -52.47 5.92 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 N-CA-C 107.482 -1.303 . . . . 1.62 107.482 175.629 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -59.8 -56.55 20.35 Favored 'General case' 0 C--N 1.343 0.295 0 C-N-CA 123.693 0.797 . . . . 2.03 110.211 175.845 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 2.7 mmmt -60.29 -28.54 68.17 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 114.018 1.118 . . . . 5.3 114.018 -175.683 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 11.8 mt -70.99 -18.24 62.61 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 125.925 1.69 . . . . 1.91 111.373 173.741 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 90.72 45.2 4.32 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 110.217 -1.153 . . . . 0.49 110.217 178.642 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -141.02 173.42 11.5 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 124.039 0.935 . . . . 3.36 110.363 -177.195 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 17.3 t60 -133.64 139.95 46.79 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 109.212 -0.662 . . . . 3.64 109.212 170.596 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 6.1 p -112.61 126.18 69.98 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 N-CA-C 107.558 -1.275 . . . . 2.39 107.558 174.863 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 26.5 t -104.46 138.38 29.38 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.154 0 N-CA-C 108.341 -0.985 . . . . 1.82 108.341 -177.487 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 4.9 mp -109.09 77.32 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 C-N-CA 124.197 0.999 . . . . 2.52 108.388 -179.196 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -73.15 -4.21 31.34 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 125.463 1.505 . . . . 2.7 113.743 171.985 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -87.0 -76.8 1.26 Allowed Glycine 0 CA--C 1.525 0.7 0 N-CA-C 109.406 -1.477 . . . . 3.16 109.406 176.417 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 2.2 ttt180 . . . . . 0 C--O 1.251 1.14 0 C-N-CA 125.629 1.572 . . . . 13.46 110.457 -177.896 . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 77' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.476 0.848 0 N-CA-C 104.522 -2.399 . . . . 8.56 104.522 . . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.7 tt 69.73 155.73 0.14 Allowed 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 107.52 -1.289 . . . . 5.93 107.52 -139.019 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.0 m -108.57 118.24 36.27 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 125.423 1.489 . . . . 1.57 107.061 -179.914 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -80.02 -178.27 6.42 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 123.552 0.741 . . . . 2.1 109.723 179.335 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -136.79 141.82 42.94 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 107.79 -1.189 . . . . 1.08 107.79 168.939 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -139.85 163.93 31.34 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 124.509 1.124 . . . . 4.42 109.673 168.427 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.8 90.59 3.13 Favored 'General case' 0 N--CA 1.441 -0.905 0 C-N-CA 128.504 2.722 . . . . 1.67 106.985 -159.826 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 7.5 mm -83.75 162.22 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.026 0 N-CA-C 107.324 -1.362 . . . . 2.81 107.324 -176.288 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -140.38 134.86 31.46 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 124.704 1.202 . . . . 1.51 108.728 179.742 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -156.28 172.23 18.84 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.361 0.664 . . . . 3.2 110.52 176.929 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -87.27 168.86 12.81 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.997 1.319 . . . . 3.82 110.383 174.898 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 5.9 m -126.33 152.32 33.69 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 C-N-CA 124.856 1.262 . . . . 3.32 111.976 -179.636 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 16.2 m -139.19 146.72 40.88 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 126.031 1.732 . . . . 1.95 107.896 164.298 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 123.75 -30.35 4.9 Favored Glycine 0 CA--C 1.531 1.054 0 C-N-CA 124.93 1.252 . . . . 2.16 111.751 -177.363 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -54.07 137.66 39.47 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 121.389 0.614 . . . . 2.77 112.485 -178.31 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -144.2 -60.37 0.38 Allowed 'General case' 0 C--N 1.333 -0.142 0 C-N-CA 125.484 1.513 . . . . 3.27 107.65 178.228 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 26.2 p -78.55 -5.34 52.45 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.625 1.17 . . . . 3.55 112.983 177.559 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 68.59 -55.84 0.52 Allowed 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 126.128 1.771 . . . . 3.21 112.111 -170.102 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -46.4 -43.78 16.59 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 125.017 1.327 . . . . 2.42 113.402 -173.753 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 29.5 m -57.82 -25.42 60.6 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 112.689 0.626 . . . . 2.2 112.689 -179.061 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.38 -35.05 67.28 Favored 'General case' 0 CA--C 1.537 0.454 0 O-C-N 121.755 -0.591 . . . . 1.84 110.609 172.876 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.97 -46.74 61.82 Favored 'General case' 0 C--O 1.232 0.171 0 O-C-N 120.533 -1.354 . . . . 1.56 109.322 171.799 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 6.5 mmm180 -51.2 -45.22 61.77 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-O 117.697 -1.144 . . . . 7.4 111.914 -177.765 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.312 2.4 pt -60.31 -59.82 3.52 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-O 117.786 -1.102 . . . . 1.96 110.701 -179.033 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -43.37 -47.75 6.9 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 120.264 1.393 . . . . 2.26 112.254 172.747 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -74.94 -17.72 60.51 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 113.429 0.9 . . . . 3.77 113.429 -176.841 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -76.69 -45.23 13.47 Favored Glycine 0 CA--C 1.531 1.033 0 N-CA-C 110.407 -1.077 . . . . 0.81 110.407 161.072 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 26.8 mt -61.18 -39.58 90.7 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 117.69 0.745 . . . . 3.68 109.814 -175.498 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 9.8 tmtt? -50.31 -28.57 8.1 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.006 1.322 . . . . 4.01 112.678 173.519 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 4.3 mtm180 -80.44 -1.64 42.36 Favored 'General case' 0 CA--C 1.535 0.382 0 O-C-N 121.637 -0.664 . . . . 7.89 112.643 -177.748 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 61.1 mmm -98.93 146.86 32.39 Favored Pre-proline 0 CA--C 1.533 0.317 0 CA-C-N 118.876 0.762 . . . . 4.3 110.853 -172.15 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -58.22 137.01 78.36 Favored 'Trans proline' 0 N--CA 1.45 -1.034 0 C-N-CA 122.387 2.058 . . . . 0.62 109.264 -179.622 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 95.77 -35.3 4.39 Favored Glycine 0 CA--C 1.527 0.839 0 CA-C-O 119.382 -0.677 . . . . 0.58 111.969 -175.536 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 9.0 t -85.65 132.19 32.52 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.153 0 CA-C-N 119.27 1.535 . . . . 1.95 109.689 -174.712 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -103.1 -46.53 4.61 Favored 'General case' 0 C--N 1.342 0.255 0 CA-C-N 118.269 0.486 . . . . 3.01 110.526 178.88 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -152.8 174.85 13.54 Favored 'General case' 0 CA--C 1.515 -0.371 0 C-N-CA 124.196 0.998 . . . . 3.46 111.101 166.685 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -157.95 148.48 20.66 Favored 'General case' 0 N--CA 1.441 -0.907 0 C-N-CA 124.109 0.964 . . . . 1.6 109.435 -173.956 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -153.85 117.35 4.63 Favored 'General case' 0 CA--C 1.528 0.119 0 N-CA-C 108.054 -1.091 . . . . 0.56 108.054 -158.772 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.7 p -96.24 96.48 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 C-N-CA 124.289 1.036 . . . . 1.6 110.439 -172.923 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 51.2 t-20 -84.04 57.06 3.98 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 122.628 1.204 . . . . 0.93 109.889 -176.968 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -68.45 -21.77 64.62 Favored 'General case' 0 CA--C 1.527 0.07 0 CA-C-N 115.231 -0.895 . . . . 2.31 110.742 -176.569 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -45.33 -34.74 3.12 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 123.611 0.764 . . . . 1.86 112.045 166.315 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 4.9 t -126.54 39.34 3.95 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 122.56 0.344 . . . . 2.51 110.141 174.329 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 42.5 53.38 4.66 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.285 1.034 . . . . 3.51 112.757 175.04 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 41.8 m -145.81 150.54 36.38 Favored 'General case' 0 N--CA 1.438 -1.065 0 N-CA-C 107.889 -1.152 . . . . 1.63 107.889 177.991 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 8.9 p -122.5 142.34 39.36 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 N-CA-C 108.465 -0.939 . . . . 1.94 108.465 171.159 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -125.3 141.98 51.76 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 124.818 1.247 . . . . 0.43 108.173 -179.407 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 35.9 t -135.68 127.31 45.27 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.325 0 N-CA-C 105.981 -1.859 . . . . 3.29 105.981 -178.543 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 21.1 mm -100.38 100.42 10.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 C-N-CA 125.774 1.63 . . . . 1.89 107.764 -175.096 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 17.6 p90 -137.53 166.02 24.88 Favored 'General case' 0 CA--C 1.518 -0.259 0 O-C-N 122.192 -0.317 . . . . 2.95 111.764 -173.597 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -84.34 123.92 74.39 Favored Pre-proline 0 C--O 1.24 0.585 0 C-N-CA 123.813 0.845 . . . . 3.1 108.915 171.494 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -86.94 11.82 3.16 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 123.823 3.015 . . . . 0.89 113.162 -175.155 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -97.19 -46.05 6.29 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 108.448 -0.945 . . . . 2.14 108.448 168.423 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -77.79 -44.98 25.85 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 123.951 0.9 . . . . 3.36 109.129 -178.888 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.262 26.3 p -112.01 -137.29 0.37 Allowed 'General case' 0 CA--C 1.518 -0.254 0 C-N-CA 122.107 0.163 . . . . 1.88 110.667 165.17 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 105.67 128.23 6.09 Favored Glycine 0 N--CA 1.44 -1.098 0 N-CA-C 105.679 -2.968 . . . . 2.05 105.679 -123.938 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 24.0 p -30.56 -30.29 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.463 1 C-N-CA 134.66 5.184 . . . . 2.63 113.76 -177.385 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -29.01 -62.42 0.12 Allowed 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 126.018 1.727 . . . . 2.01 112.733 167.258 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.87 -44.22 50.17 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 117.505 -1.678 . . . . 1.66 109.907 -170.578 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.1 mp -51.64 -50.14 31.87 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.945 0 CA-C-N 112.915 -1.948 . . . . 2.02 110.067 -178.997 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.2 -50.64 67.28 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 107.933 -1.136 . . . . 2.12 107.933 -178.162 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.409 ' OE2' ' NZ ' ' A' ' 66' ' ' LYS . 1.3 tm-20 -44.52 -54.29 6.17 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 122.362 1.077 . . . . 3.0 110.77 178.871 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.1 mmpt? -71.4 -40.33 70.56 Favored 'General case' 0 N--CA 1.434 -1.271 0 CA-C-O 118.154 -0.926 . . . . 3.61 113.016 179.094 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.3 mm -48.27 -50.98 10.82 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.793 0 N-CA-C 107.805 -1.183 . . . . 1.91 107.805 176.664 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 76.1 mm-40 -57.92 -60.73 3.26 Favored 'General case' 0 C--N 1.343 0.283 0 C-N-CA 124.967 1.307 . . . . 2.98 110.284 177.096 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.409 ' NZ ' ' OE2' ' A' ' 62' ' ' GLU . 7.0 mptt -56.37 -35.38 67.63 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 112.577 0.584 . . . . 5.86 112.577 -177.059 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 35.1 mt -70.08 -18.04 63.25 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.348 1.059 . . . . 1.76 111.529 177.909 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 98.04 35.38 5.08 Favored Glycine 0 CA--C 1.525 0.716 0 C-N-CA 124.342 0.973 . . . . 0.72 111.535 174.453 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -127.47 169.34 13.76 Favored 'General case' 0 N--CA 1.457 -0.102 0 C-N-CA 124.378 1.071 . . . . 3.45 108.914 173.727 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 85.9 t60 -137.67 133.66 34.53 Favored 'General case' 0 N--CA 1.453 -0.275 0 N-CA-C 106.187 -1.783 . . . . 3.28 106.187 162.768 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 23.4 m -91.35 144.57 8.91 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.691 0 CA-C-N 119.244 0.929 . . . . 3.64 108.863 172.841 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.5 t -103.06 130.94 52.41 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 N-CA-C 107.75 -1.204 . . . . 2.19 107.75 178.97 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 28.0 mm -109.62 75.27 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 C-N-CA 124.363 1.065 . . . . 2.05 108.424 -173.196 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -72.64 -14.88 61.7 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 113.917 1.08 . . . . 3.14 113.917 -178.43 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -104.13 63.88 0.36 Allowed Glycine 0 CA--C 1.525 0.715 0 N-CA-C 108.115 -1.994 . . . . 3.8 108.115 168.191 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 50.9 tpt85 . . . . . 0 C--O 1.249 1.032 0 CA-C-O 117.908 -1.044 . . . . 13.85 112.196 -174.172 . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 77' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 37.9 mtt . . . . . 0 N--CA 1.472 0.664 0 N-CA-C 108.85 -0.796 . . . . 10.79 108.85 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.4 tt -150.61 136.68 18.47 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 106.146 -1.798 . . . . 6.63 106.146 -175.237 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.7 m -128.2 98.95 5.26 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 107.257 -1.386 . . . . 1.25 107.257 179.528 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -66.63 178.11 1.39 Allowed 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 123.378 0.671 . . . . 3.46 109.529 172.381 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -135.22 150.84 50.17 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 108.393 -0.966 . . . . 0.97 108.393 173.753 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 26.7 mmtp -139.74 162.1 35.95 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.481 1.113 . . . . 3.51 108.628 163.984 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.3 mp0 -123.02 96.36 4.98 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 127.101 2.16 . . . . 2.39 105.953 -176.937 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 23.9 mm -83.29 164.16 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.16 0 N-CA-C 107.067 -1.457 . . . . 2.96 107.067 178.327 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -138.48 123.53 19.05 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 125.207 1.403 . . . . 1.62 107.585 179.389 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -133.03 166.46 22.36 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 118.85 0.75 . . . . 3.63 109.938 178.246 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -84.5 168.13 15.73 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.557 1.143 . . . . 3.67 109.368 169.194 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 38.4 t -125.05 146.09 31.28 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 C-N-CA 124.567 1.147 . . . . 2.28 109.411 -175.22 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 11.8 m -154.8 171.16 20.05 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.918 0.887 . . . . 2.02 110.418 172.863 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 64.06 70.38 1.08 Allowed Glycine 0 C--N 1.34 0.761 0 N-CA-C 110.5 -1.04 . . . . 1.88 110.5 178.261 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -153.05 156.46 38.79 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 116.922 0.361 . . . . 3.97 111.304 -170.124 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -89.76 -60.89 1.82 Allowed 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 125.226 1.411 . . . . 4.52 109.49 168.255 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 21.6 p -144.09 160.81 40.26 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-O 121.836 0.827 . . . . 2.44 112.895 -167.269 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -74.69 45.47 0.25 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.473 1.509 . . . . 2.56 111.492 175.559 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -137.98 -49.75 0.57 Allowed 'General case' 0 C--N 1.335 -0.057 0 C-N-CA 124.614 1.166 . . . . 1.78 108.637 177.804 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 78.3 m -53.52 -38.86 64.17 Favored 'General case' 0 C--O 1.232 0.132 0 O-C-N 121.593 -0.692 . . . . 1.21 110.76 165.643 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -45.75 -35.03 4.0 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.006 1.322 . . . . 1.9 112.411 170.667 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.61 -54.45 10.4 Favored 'General case' 0 N--CA 1.451 -0.382 0 O-C-N 121.026 -1.046 . . . . 1.6 109.64 174.655 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 43.3 mtm105 -48.85 -50.71 33.35 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 123.539 0.735 . . . . 7.52 110.45 -175.595 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 4.9 pt -54.49 -52.75 37.12 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.164 0 O-C-N 123.761 0.663 . . . . 1.73 109.849 -179.051 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -56.34 -39.86 73.53 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 123.93 0.892 . . . . 2.16 111.431 179.68 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 26.5 mmtt -73.68 -44.89 55.43 Favored 'General case' 0 CA--C 1.531 0.215 0 O-C-N 121.201 -0.937 . . . . 2.9 111.509 -176.259 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -59.34 -42.44 97.41 Favored Glycine 0 CA--C 1.529 0.928 0 N-CA-C 109.988 -1.245 . . . . 0.62 109.988 172.197 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 8.5 tt -58.55 -39.61 80.7 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.571 1.149 . . . . 2.94 110.289 175.668 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -61.52 -30.17 70.46 Favored 'General case' 0 N--CA 1.452 -0.366 0 O-C-N 121.064 -1.023 . . . . 4.33 111.66 174.915 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 16.0 mtt180 -72.13 -8.09 52.71 Favored 'General case' 0 CA--C 1.533 0.295 0 O-C-N 121.495 -0.753 . . . . 4.52 112.638 -178.888 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 69.2 mmm -73.96 150.55 88.17 Favored Pre-proline 0 CA--C 1.533 0.289 0 CA-C-N 119.291 0.951 . . . . 4.19 110.432 179.867 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -56.34 147.31 68.1 Favored 'Trans proline' 0 N--CA 1.451 -1.026 0 C-N-CA 121.595 1.53 . . . . 0.67 108.402 172.573 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 86.15 -22.65 11.62 Favored Glycine 0 CA--C 1.525 0.682 0 C-N-CA 124.143 0.878 . . . . 0.63 113.194 -179.93 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 15.6 t -98.19 127.15 50.94 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 CA-C-N 119.459 1.63 . . . . 1.93 109.903 -175.788 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -113.11 -31.34 6.68 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 123.388 0.675 . . . . 1.85 112.04 -173.37 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -146.67 160.7 41.87 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-N 119.289 0.949 . . . . 2.11 108.931 167.004 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -156.73 138.88 14.58 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 116.832 -0.167 . . . . 1.38 111.307 177.582 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -154.23 113.92 3.8 Favored 'General case' 0 C--N 1.341 0.221 0 N-CA-C 107.381 -1.34 . . . . 0.48 107.381 -160.466 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 6.0 p -93.15 102.11 13.31 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 C-N-CA 123.267 0.627 . . . . 1.9 110.058 -175.501 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 52.0 t-20 -83.04 58.65 4.51 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 122.536 1.16 . . . . 0.81 110.012 -177.415 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.1 -20.01 65.72 Favored 'General case' 0 C--O 1.225 -0.194 0 CA-C-N 114.943 -1.026 . . . . 1.96 110.675 -177.692 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -48.55 -30.13 4.96 Favored 'General case' 0 CA--C 1.528 0.134 0 C-N-CA 123.789 0.835 . . . . 1.55 112.644 170.424 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 4.3 t -129.74 32.67 4.55 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 109.792 -0.448 . . . . 2.04 109.792 172.583 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 29.0 mp0 54.41 40.53 31.86 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.64 1.176 . . . . 4.0 113.086 175.067 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -124.86 163.55 21.96 Favored 'General case' 0 N--CA 1.454 -0.259 0 O-C-N 121.327 -0.858 . . . . 2.07 109.585 176.11 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.7 p -133.56 140.75 46.04 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 N-CA-C 108.795 -0.817 . . . . 1.71 108.795 171.893 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 18.7 m120 -129.46 138.55 51.48 Favored 'General case' 0 C--N 1.344 0.365 0 N-CA-C 108.193 -1.039 . . . . 0.33 108.193 -178.232 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 3.8 p -136.65 128.67 44.05 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 N-CA-C 106.529 -1.656 . . . . 2.83 106.529 -176.11 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 9.8 mm -105.9 96.52 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 C-N-CA 125.918 1.687 . . . . 1.49 107.278 -171.602 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 44.1 p90 -136.96 165.06 26.87 Favored 'General case' 0 CA--C 1.515 -0.375 0 O-C-N 122.18 -0.325 . . . . 2.93 111.596 -170.76 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 45.0 t0 -86.58 108.85 19.72 Favored Pre-proline 0 C--N 1.329 -0.29 0 C-N-CA 125.198 1.399 . . . . 2.91 109.666 176.8 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -71.26 2.03 4.81 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 123.209 2.606 . . . . 0.65 113.4 -177.878 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -90.31 -30.22 17.62 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 119.395 0.998 . . . . 1.89 109.345 169.057 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -101.71 -51.73 3.37 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.359 0.664 . . . . 3.09 110.361 -170.315 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.9 p -99.81 -174.11 2.62 Favored 'General case' 0 C--O 1.225 -0.205 0 C-N-CA 123.872 0.869 . . . . 1.71 110.598 158.096 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 145.16 92.63 0.14 Allowed Glycine 0 N--CA 1.443 -0.899 0 N-CA-C 104.87 -3.292 . . . . 2.43 104.87 -158.228 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 48.8 p -10.24 -18.9 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.577 1 C-N-CA 137.068 6.147 . . . . 2.12 119.829 -139.087 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -26.8 -61.84 0.08 Allowed 'General case' 0 N--CA 1.439 -0.987 0 C-N-CA 127.893 2.477 . . . . 1.74 114.418 170.11 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.14 -44.76 59.62 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 117.991 -1.484 . . . . 1.84 109.259 -168.15 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.2 mt -53.21 -52.76 27.7 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 CA-C-N 112.918 -1.946 . . . . 2.09 110.682 178.462 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.92 -45.6 85.15 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 120.06 1.3 . . . . 1.83 109.2 -177.019 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -47.59 -57.32 5.6 Favored 'General case' 0 C--N 1.343 0.318 0 CA-C-O 123.148 1.451 . . . . 2.84 109.466 177.264 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.4 mmpt? -71.17 -36.04 71.85 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-N 114.768 -1.105 . . . . 3.47 112.979 -175.403 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -50.04 -53.17 11.89 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 N-CA-C 107.405 -1.331 . . . . 1.78 107.405 174.501 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 -60.73 -55.72 29.77 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 115.458 -0.792 . . . . 1.84 110.74 176.04 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -57.13 -34.47 68.41 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 113.484 0.92 . . . . 5.38 113.484 -176.674 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 13.6 mt -71.54 -19.49 62.16 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 125.815 1.646 . . . . 1.8 111.918 174.356 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 95.89 45.37 2.89 Favored Glycine 0 CA--C 1.525 0.678 0 C-N-CA 125.169 1.366 . . . . 0.54 111.378 175.914 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -140.39 173.7 11.24 Favored 'General case' 0 N--CA 1.458 -0.068 0 C-N-CA 124.216 1.006 . . . . 3.39 110.504 -178.061 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -152.44 126.74 9.25 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 109.49 -0.559 . . . . 3.4 109.49 171.946 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 16.1 m -83.89 164.64 2.6 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 C-N-CA 123.623 0.769 . . . . 3.83 109.61 173.932 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 1.9 t -125.6 136.33 61.16 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 O-C-N 121.439 -0.788 . . . . 2.32 108.944 176.434 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 11.2 mm -102.59 71.68 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 C-N-CA 123.767 0.827 . . . . 2.13 109.329 -171.483 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -72.82 2.16 7.26 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 114.75 1.389 . . . . 2.75 114.75 -175.108 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 72.75 82.39 0.32 Allowed Glycine 0 CA--C 1.527 0.834 0 N-CA-C 109.03 -1.628 . . . . 3.56 109.03 -175.85 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.253 1.26 0 CA-C-O 116.347 -1.787 . . . . 15.68 107.04 -174.625 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 77' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 44.6 mtt . . . . . 0 N--CA 1.473 0.709 0 CA-C-O 118.937 -0.554 . . . . 10.81 109.571 . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.7 pp -52.61 -36.85 57.16 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 122.873 0.469 . . . . 6.6 111.472 177.016 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 21.5 m -113.41 146.98 38.63 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 125.73 1.612 . . . . 1.83 106.992 163.214 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -91.31 -175.99 4.42 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 108.073 -1.084 . . . . 2.08 108.073 157.831 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.6 mm100 -134.47 146.89 50.19 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 106.628 -1.619 . . . . 1.16 106.628 165.616 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 75.2 mttt -141.75 156.78 45.58 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 123.918 0.887 . . . . 3.86 110.806 161.504 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -111.03 92.02 3.88 Favored 'General case' 0 N--CA 1.44 -0.969 0 C-N-CA 128.156 2.582 . . . . 1.36 107.152 -167.954 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 6.8 mm -83.14 162.01 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.218 0 N-CA-C 106.916 -1.512 . . . . 2.79 106.916 -175.559 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -141.16 116.07 9.78 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 124.409 1.084 . . . . 1.51 108.769 -173.804 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 66.3 mtm -138.18 173.17 11.9 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 118.527 0.603 . . . . 2.64 110.539 -175.122 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.67 168.43 9.69 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 125.934 1.694 . . . . 3.55 108.94 172.598 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 19.6 m -129.04 174.88 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 C-N-CA 123.455 0.702 . . . . 3.04 110.12 172.851 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 57.8 m -151.02 175.14 12.37 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 124.304 1.042 . . . . 1.71 108.328 173.32 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 85.82 -35.01 3.27 Favored Glycine 0 CA--C 1.531 1.09 0 O-C-N 122.019 -0.426 . . . . 2.4 112.573 178.304 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -48.16 141.84 5.88 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.096 0.959 . . . . 2.81 112.877 179.325 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -103.94 -46.19 4.55 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 124.684 1.194 . . . . 2.92 110.09 171.809 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 18.4 p -132.62 161.3 34.26 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 123.752 0.821 . . . . 2.52 110.918 -175.342 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -77.02 56.75 1.27 Allowed 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.104 0.962 . . . . 2.67 110.631 178.293 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -142.52 -57.88 0.44 Allowed 'General case' 0 N--CA 1.456 -0.138 0 C-N-CA 123.854 0.862 . . . . 2.05 109.549 176.322 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 58.9 m -54.08 -43.32 70.24 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 121.011 0.434 . . . . 1.39 111.65 -174.63 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.59 -22.6 13.8 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.232 1.013 . . . . 1.81 112.963 178.069 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.24 -47.64 60.46 Favored 'General case' 0 N--CA 1.452 -0.363 0 O-C-N 121.163 -0.961 . . . . 1.94 110.267 172.163 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 52.7 mtp85 -58.61 -48.57 80.55 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 109.486 -0.561 . . . . 5.14 109.486 -171.107 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 5.4 pt -55.63 -51.48 58.1 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 O-C-N 123.684 0.615 . . . . 1.86 110.005 179.02 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -55.64 -43.86 76.61 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 113.455 0.909 . . . . 4.52 113.455 179.116 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 13.4 mptt -72.69 -40.98 65.8 Favored 'General case' 0 CA--C 1.536 0.425 0 O-C-N 121.505 -0.747 . . . . 3.08 109.643 -175.954 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -57.16 -39.89 90.69 Favored Glycine 0 CA--C 1.532 1.141 0 N-CA-C 111.147 -0.781 . . . . 0.64 111.147 168.727 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.8 tt -65.3 -44.24 88.54 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.401 1.08 . . . . 2.98 109.363 179.136 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.414 ' NZ ' ' OD1' ' A' ' 36' ' ' ASP . 27.0 ttmt -54.5 -39.13 67.26 Favored 'General case' 0 CA--C 1.53 0.178 0 O-C-N 121.258 -0.902 . . . . 4.9 111.075 175.383 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.91 -8.66 7.53 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 114.389 1.255 . . . . 5.65 114.389 -179.589 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 82.6 mmm -81.85 151.98 68.31 Favored Pre-proline 0 CA--C 1.536 0.425 0 CA-C-N 120.089 1.313 . . . . 4.3 111.521 -177.633 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -59.05 150.89 70.18 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 122.427 2.085 . . . . 0.86 110.628 178.985 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 79.31 -25.92 2.67 Favored Glycine 0 CA--C 1.531 1.06 0 C-N-CA 123.702 0.668 . . . . 0.75 112.685 -177.466 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 15.4 t -86.45 141.05 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 CA-C-N 118.901 1.35 . . . . 1.65 108.879 176.102 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -119.76 -43.22 2.58 Favored 'General case' 0 C--N 1.34 0.153 0 CA-C-O 118.716 -0.659 . . . . 2.55 111.243 179.113 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.414 ' OD1' ' NZ ' ' A' ' 29' ' ' LYS . 0.5 OUTLIER -143.33 169.13 18.22 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 118.978 0.808 . . . . 1.89 110.82 176.69 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -159.64 154.18 24.13 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.908 -0.587 . . . . 1.93 111.079 -177.343 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -155.76 94.52 1.57 Allowed 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 125.567 1.547 . . . . 1.0 109.173 -168.393 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.5 p -78.93 93.98 1.67 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 CA-C-O 121.867 0.842 . . . . 2.13 109.355 -177.852 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 44.8 t30 -81.67 58.75 3.88 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 122.212 1.006 . . . . 0.86 109.854 -176.196 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -69.78 -19.99 63.49 Favored 'General case' 0 N--CA 1.457 -0.081 0 C-N-CA 124.462 1.105 . . . . 2.22 111.016 -179.212 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -43.32 -39.78 3.26 Favored 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 124.064 0.946 . . . . 1.64 111.931 169.832 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 9.9 t -128.1 40.3 3.7 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 122.574 0.35 . . . . 2.17 110.291 172.07 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 50.85 51.98 15.9 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.731 1.213 . . . . 3.3 113.741 172.259 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -131.49 161.15 33.22 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 124.588 1.155 . . . . 3.14 109.013 175.529 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.5 p -131.62 134.74 60.15 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 N-CA-C 107.706 -1.22 . . . . 1.58 107.706 167.669 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -123.03 126.79 47.78 Favored 'General case' 0 C--N 1.341 0.233 0 N-CA-C 108.559 -0.904 . . . . 0.59 108.559 177.524 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 46.8 t -126.32 130.96 71.95 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 N-CA-C 105.638 -1.986 . . . . 3.37 105.638 -177.169 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 10.6 mm -105.08 99.72 9.04 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 C-N-CA 125.336 1.455 . . . . 1.83 107.694 -175.548 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 53.2 p90 -139.61 171.31 14.42 Favored 'General case' 0 CA--C 1.515 -0.369 0 C-N-CA 122.719 0.408 . . . . 3.68 111.111 -174.61 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 45.8 t0 -89.23 107.08 15.81 Favored Pre-proline 0 C--O 1.234 0.255 0 CA-C-O 118.35 -0.833 . . . . 3.22 109.278 176.683 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -71.78 4.92 2.77 Favored 'Trans proline' 0 N--CA 1.451 -0.978 0 C-N-CA 122.178 1.918 . . . . 0.93 112.915 -179.236 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -86.73 -33.46 19.98 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 119.462 1.028 . . . . 2.07 109.163 166.604 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 13.2 tt0 -103.42 -57.04 2.1 Favored 'General case' 0 C--N 1.343 0.323 0 C-N-CA 122.871 0.468 . . . . 2.68 110.278 -169.336 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.405 0.6 OUTLIER -84.7 -178.66 6.93 Favored 'General case' 0 C--O 1.224 -0.242 0 CA-C-O 122.537 1.16 . . . . 1.79 113.77 155.513 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -179.18 -144.27 5.71 Favored Glycine 0 N--CA 1.434 -1.474 1 N-CA-C 102.944 -4.062 . . . . 2.53 102.944 -173.312 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 19.2 p -72.76 -40.29 66.11 Favored 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 124.509 1.124 . . . . 2.73 108.398 174.51 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -38.77 -62.65 0.59 Allowed 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 126.235 1.814 . . . . 2.07 114.119 -169.682 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -72.62 -42.33 64.58 Favored 'General case' 0 CA--C 1.517 -0.321 0 C-N-CA 119.079 -1.048 . . . . 1.79 108.98 -168.753 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -53.35 -55.68 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.17 0 CA-C-N 113.437 -1.71 . . . . 2.02 110.394 177.85 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.83 -46.9 87.81 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 119.827 1.194 . . . . 1.5 110.085 -178.759 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -47.58 -57.76 5.06 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 122.406 1.098 . . . . 2.91 110.722 176.836 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.2 -39.81 74.96 Favored 'General case' 0 N--CA 1.436 -1.155 0 CA-C-O 118.621 -0.704 . . . . 3.42 112.3 -176.802 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.1 mm -48.54 -52.14 9.35 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 C-N-CA 125.175 1.39 . . . . 1.85 107.481 175.084 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -60.71 -58.0 10.33 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 124.372 1.069 . . . . 1.92 110.875 177.665 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 3.4 mptp? -56.62 -37.61 70.94 Favored 'General case' 0 CA--C 1.536 0.42 0 O-C-N 121.499 -0.75 . . . . 4.75 112.375 -176.766 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 13.7 mt -69.82 -17.77 63.42 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.461 1.105 . . . . 2.13 111.787 176.14 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 91.02 45.46 4.15 Favored Glycine 0 C--N 1.336 0.557 0 C-N-CA 124.369 0.985 . . . . 0.81 110.986 174.342 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -137.49 175.28 9.74 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 123.972 0.909 . . . . 3.21 110.685 -177.872 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 2.3 t-80 -142.66 128.26 19.13 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 109.061 -0.718 . . . . 3.05 109.061 169.657 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 11.7 p -88.76 148.85 4.26 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 C-N-CA 125.056 1.343 . . . . 2.53 108.127 169.679 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 41.1 t -120.3 138.84 49.52 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 C-N-CA 125.249 1.42 . . . . 1.78 108.615 179.057 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 26.8 mm -101.72 75.33 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 C-N-CA 124.805 1.242 . . . . 1.89 109.564 -168.138 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -73.6 3.68 5.95 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 115.181 1.549 . . . . 3.27 115.181 -177.022 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 64.58 68.95 1.47 Allowed Glycine 0 CA--C 1.526 0.735 0 N-CA-C 110.254 -1.139 . . . . 3.11 110.254 179.573 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.254 1.325 0 N-CA-C 105.005 -2.22 . . . . 13.11 105.005 172.042 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 77' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.8 mtt . . . . . 0 N--CA 1.473 0.696 0 N-CA-C 106.026 -1.842 . . . . 10.46 106.026 . . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -160.8 143.89 13.1 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 106.536 -1.653 . . . . 6.23 106.536 -174.777 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 57.9 m -81.45 126.06 31.19 Favored 'General case' 0 N--CA 1.443 -0.803 0 C-N-CA 125.673 1.589 . . . . 1.7 108.224 176.142 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -64.95 174.92 1.7 Allowed 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 109.095 -0.706 . . . . 2.86 109.095 155.013 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -135.08 148.95 49.98 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 106.702 -1.592 . . . . 1.56 106.702 168.559 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 10.5 mmpt? -138.62 157.12 46.74 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 123.401 0.68 . . . . 4.88 109.677 165.138 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.68 103.88 12.49 Favored 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 128.745 2.818 . . . . 1.61 107.847 -177.79 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 2.1 pp -84.95 165.56 2.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 N-CA-C 109.006 -0.739 . . . . 5.76 109.006 168.537 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -137.19 119.34 15.53 Favored 'General case' 0 C--O 1.226 -0.169 0 N-CA-C 106.879 -1.526 . . . . 1.76 106.879 173.438 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 22.8 mmt -137.4 172.34 13.13 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 119.596 1.089 . . . . 6.29 110.411 -177.511 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 17.9 mm100 -91.87 158.87 16.07 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 123.813 0.845 . . . . 2.37 110.014 -178.214 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 22.1 t -117.22 153.66 18.99 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 C-N-CA 124.373 1.069 . . . . 2.11 109.079 -176.457 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 37.5 m -149.5 175.71 11.25 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.089 0.956 . . . . 1.74 109.143 172.004 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 82.12 -36.64 2.54 Favored Glycine 0 CA--C 1.533 1.181 0 O-C-N 121.525 -0.734 . . . . 2.01 112.485 -179.132 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -42.05 143.69 0.54 Allowed 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.643 1.577 . . . . 2.6 113.786 177.721 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -110.42 -49.04 3.09 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 125.234 1.414 . . . . 3.03 111.532 169.796 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 18.4 p -130.64 161.97 30.42 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 123.186 0.594 . . . . 2.46 110.807 -176.136 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -77.0 55.88 1.16 Allowed 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.187 0.995 . . . . 2.8 110.572 179.423 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -143.89 -56.3 0.38 Allowed 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 124.118 0.967 . . . . 2.06 109.789 178.132 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 59.4 m -55.88 -40.72 73.38 Favored 'General case' 0 CA--C 1.532 0.269 0 O-C-N 121.916 -0.49 . . . . 1.19 111.989 -173.93 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.29 -24.37 42.69 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.022 0.529 . . . . 1.86 112.32 177.686 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.8 -52.64 34.69 Favored 'General case' 0 N--CA 1.452 -0.355 0 O-C-N 120.353 -1.467 . . . . 1.6 108.937 172.809 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 6.6 mtt-85 -53.74 -46.84 71.01 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.318 0.647 . . . . 4.71 110.239 -175.255 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.1 pt -57.85 -53.89 39.12 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.455 0 C-N-CA 119.756 -0.778 . . . . 1.62 110.85 -179.763 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -55.01 -43.69 73.88 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 119.299 0.954 . . . . 2.6 111.862 177.321 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.2 mptp? -68.83 -46.18 69.24 Favored 'General case' 0 CA--C 1.533 0.291 0 O-C-N 121.298 -0.877 . . . . 2.43 110.61 -175.807 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -63.08 -38.85 97.24 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 110.48 -1.048 . . . . 0.67 110.48 175.061 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -60.32 -44.56 95.35 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 108.069 -1.086 . . . . 3.75 108.069 179.294 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -54.51 -26.07 29.47 Favored 'General case' 0 CA--C 1.542 0.665 0 O-C-N 121.561 -0.712 . . . . 3.81 112.683 175.093 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -71.22 -9.11 57.55 Favored 'General case' 0 CA--C 1.539 0.527 0 O-C-N 120.583 -1.323 . . . . 4.35 112.659 177.295 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -73.79 158.03 86.6 Favored Pre-proline 0 CA--C 1.539 0.528 0 CA-C-N 118.99 0.813 . . . . 4.3 111.552 -179.066 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -70.98 114.5 3.92 Favored 'Trans proline' 0 N--CA 1.45 -1.058 0 C-N-CA 121.811 1.674 . . . . 1.05 109.74 175.577 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 121.32 -30.27 5.46 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 124.08 0.848 . . . . 1.2 113.002 170.818 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 61.6 t -83.37 141.05 15.38 Favored 'Isoleucine or valine' 0 C--N 1.342 0.254 0 CA-C-N 118.338 1.069 . . . . 1.84 109.445 172.133 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 7.0 m -118.29 -38.31 3.2 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-O 118.39 -0.814 . . . . 2.18 111.126 -177.27 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -136.7 163.6 30.21 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 119.542 1.065 . . . . 2.24 111.843 167.132 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -158.36 140.86 14.39 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 112.541 0.571 . . . . 1.43 112.541 -177.845 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -153.82 106.85 2.91 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 106.648 -1.612 . . . . 0.44 106.648 -165.94 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 4.8 p -81.16 127.99 39.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 N-CA-C 107.351 -1.352 . . . . 1.62 107.351 174.667 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 54.7 t-20 -111.75 57.62 0.64 Allowed 'General case' 0 C--O 1.235 0.291 0 CA-C-O 122.968 1.366 . . . . 0.92 107.974 179.878 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.78 -20.1 66.14 Favored 'General case' 0 C--O 1.227 -0.11 0 CA-C-N 113.976 -1.465 . . . . 1.99 111.12 -176.161 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -46.94 -34.58 5.64 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.447 0.699 . . . . 1.67 112.312 166.842 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 14.7 t -122.09 27.66 7.91 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-O 121.284 0.564 . . . . 1.87 110.215 174.249 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 54.39 27.54 8.29 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 126.387 1.875 . . . . 2.63 114.431 178.469 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 12.2 m -115.82 153.63 31.12 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.112 0.965 . . . . 1.67 109.136 -178.124 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.1 p -117.36 142.9 29.35 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 C-N-CA 124.121 0.968 . . . . 1.59 109.121 170.667 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 21.1 m120 -125.95 131.86 52.2 Favored 'General case' 0 C--N 1.343 0.316 0 N-CA-C 106.673 -1.602 . . . . 0.36 106.673 174.217 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -132.24 128.06 58.24 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.706 0 N-CA-C 105.755 -1.942 . . . . 3.1 105.755 -178.962 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 10.7 mm -108.96 96.83 5.0 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 C-N-CA 126.113 1.765 . . . . 1.7 108.104 -168.778 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 44.9 p90 -130.93 172.54 11.93 Favored 'General case' 0 CA--C 1.511 -0.552 0 O-C-N 121.317 -0.864 . . . . 3.05 110.913 -169.649 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 36.0 t0 -90.28 107.7 21.52 Favored Pre-proline 0 CA--C 1.536 0.426 0 O-C-N 124.526 1.142 . . . . 2.81 110.051 174.826 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -75.42 6.84 3.32 Favored 'Trans proline' 0 N--CA 1.451 -1.028 0 C-N-CA 122.434 2.089 . . . . 0.62 113.072 -178.903 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -81.77 -26.25 34.61 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 119.473 1.033 . . . . 1.72 108.926 165.484 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -108.65 -66.59 1.04 Allowed 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 107.989 -1.115 . . . . 3.81 107.989 -170.727 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.417 0.2 OUTLIER -76.67 178.09 7.02 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 116.573 2.064 . . . . 2.0 116.573 165.156 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -163.68 -145.05 4.23 Favored Glycine 0 N--CA 1.432 -1.622 1 N-CA-C 102.424 -4.27 . . . . 2.55 102.424 176.39 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 30.9 p -75.23 -37.68 60.95 Favored 'General case' 0 N--CA 1.444 -0.747 0 C-N-CA 125.34 1.456 . . . . 2.23 109.087 172.891 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -49.42 -61.2 2.23 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 124.936 1.294 . . . . 2.3 113.912 -165.601 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.87 -33.66 68.56 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 118.773 -1.171 . . . . 2.4 108.834 -168.98 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.5 mp -55.84 -52.5 48.23 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 C-N-CA 123.874 0.87 . . . . 2.39 109.835 174.193 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -61.51 -43.16 99.37 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 109.845 -0.428 . . . . 2.03 109.845 -176.708 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -48.89 -58.06 5.43 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.163 0.985 . . . . 2.86 110.631 171.976 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -67.45 -36.14 80.61 Favored 'General case' 0 N--CA 1.442 -0.85 0 O-C-N 121.396 -0.815 . . . . 4.01 112.592 -177.711 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -52.07 -52.18 25.47 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 C-N-CA 124.839 1.256 . . . . 1.68 107.839 176.307 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -57.77 -55.56 33.26 Favored 'General case' 0 C--N 1.34 0.189 0 C-N-CA 122.944 0.498 . . . . 2.21 109.965 175.433 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 7.7 mmtt -58.01 -35.02 70.65 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 113.12 0.785 . . . . 5.14 113.12 -175.34 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 24.8 mt -70.3 -17.69 63.09 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 125.287 1.435 . . . . 2.12 111.416 175.838 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 96.31 38.58 4.49 Favored Glycine 0 CA--C 1.522 0.521 0 C-N-CA 124.754 1.169 . . . . 0.75 110.803 175.574 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -136.93 175.58 9.49 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 117.654 0.727 . . . . 3.06 111.029 -176.357 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 5.9 t60 -138.68 137.34 36.74 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 109.546 -0.538 . . . . 3.42 109.546 169.392 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 8.6 p -110.24 144.01 19.15 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 N-CA-C 106.644 -1.613 . . . . 2.43 106.644 177.403 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 20.5 t -113.39 131.82 64.04 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 N-CA-C 108.455 -0.942 . . . . 1.71 108.455 178.997 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 47.8 mm -96.88 77.15 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 C-N-CA 124.79 1.236 . . . . 2.14 107.772 -174.789 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -71.27 -12.2 61.32 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 113.724 1.009 . . . . 3.24 113.724 -179.315 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 77.95 85.23 0.5 Allowed Glycine 0 CA--C 1.526 0.76 0 N-CA-C 109.255 -1.538 . . . . 2.67 109.255 -174.066 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.252 1.188 0 N-CA-C 105.893 -1.891 . . . . 14.44 105.893 176.435 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 77' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 56.1 mtt . . . . . 0 N--CA 1.475 0.8 0 CA-C-O 118.975 -0.536 . . . . 10.83 110.16 . . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.9 mp 66.52 178.55 0.22 Allowed 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.749 0.82 . . . . 5.72 110.276 -169.986 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.4 m -112.75 140.03 47.87 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 105.447 -2.057 . . . . 1.25 105.447 174.596 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -89.62 -173.5 3.97 Favored 'General case' 0 N--CA 1.445 -0.679 0 C-N-CA 124.327 1.051 . . . . 2.17 108.814 175.174 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.8 mm100 -135.96 147.88 48.25 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 107.425 -1.324 . . . . 1.03 107.425 164.707 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 86.6 mttt -139.36 159.22 42.66 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 109.164 -0.68 . . . . 4.11 109.164 158.037 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -112.59 100.1 8.46 Favored 'General case' 0 N--CA 1.436 -1.152 0 C-N-CA 128.28 2.632 . . . . 1.31 105.321 -171.681 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 7.0 mm -80.79 161.31 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.267 0 N-CA-C 106.601 -1.629 . . . . 2.91 106.601 178.912 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -133.33 122.56 24.01 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 106.756 -1.572 . . . . 1.72 106.756 174.093 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 71.8 mtm -140.46 168.59 19.45 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 123.451 0.7 . . . . 2.62 109.784 -178.687 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 20.6 mm100 -94.69 148.93 21.76 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 125.216 1.407 . . . . 2.5 109.413 177.763 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 69.7 t -99.73 145.72 10.09 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 C-N-CA 123.541 0.736 . . . . 2.29 109.346 178.041 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 32.3 t -145.03 176.87 9.18 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 124.475 1.11 . . . . 2.33 108.816 168.881 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 52.29 60.26 7.94 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 124.292 0.949 . . . . 1.89 110.773 -176.455 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -128.73 151.33 49.67 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 124.198 0.999 . . . . 2.89 110.328 -172.79 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -97.26 -55.38 2.86 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 124.421 1.088 . . . . 4.24 109.196 168.639 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 22.8 p -150.27 165.92 31.53 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-O 121.839 0.828 . . . . 2.43 111.757 -174.5 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -74.27 48.64 0.33 Allowed 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.462 1.505 . . . . 2.65 111.357 175.701 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -144.02 -51.76 0.32 Allowed 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 124.795 1.238 . . . . 1.63 108.18 175.697 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 27.1 m -59.37 -36.97 76.75 Favored 'General case' 0 CA--C 1.531 0.248 0 O-C-N 121.38 -0.825 . . . . 1.18 109.745 167.998 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.17 -21.8 59.98 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 112.95 0.722 . . . . 1.7 112.95 173.668 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -73.79 -50.94 18.12 Favored 'General case' 0 C--N 1.339 0.152 0 O-C-N 121.019 -1.05 . . . . 1.57 110.032 169.943 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 17.3 mtm180 -50.04 -42.39 49.53 Favored 'General case' 0 N--CA 1.456 -0.143 0 C-N-CA 123.32 0.648 . . . . 6.89 111.196 -175.663 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.9 pt -57.82 -53.66 42.12 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.156 0 C-N-CA 119.847 -0.741 . . . . 1.8 111.891 177.341 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -57.88 -46.46 84.84 Favored 'General case' 0 C--O 1.224 -0.266 0 C-N-CA 123.339 0.655 . . . . 3.35 110.708 -179.876 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -72.34 -40.3 67.51 Favored 'General case' 0 C--N 1.331 -0.234 0 O-C-N 121.908 -0.495 . . . . 3.1 111.034 -173.535 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -59.44 -45.28 95.77 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 109.757 -1.337 . . . . 0.65 109.757 169.695 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -61.94 -37.47 84.83 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 121.879 -0.777 . . . . 3.48 109.655 -179.839 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 3.3 ttpp -53.98 -25.38 20.64 Favored 'General case' 0 CA--C 1.533 0.3 0 O-C-N 120.724 -1.235 . . . . 3.11 113.198 174.505 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -82.15 -1.21 48.17 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.043 0.937 . . . . 4.42 111.836 -179.088 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 21.4 mmt -93.77 149.35 36.93 Favored Pre-proline 0 CA--C 1.535 0.401 0 C-N-CA 124.194 0.998 . . . . 5.63 109.995 -175.092 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -58.45 142.86 98.24 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 122.52 2.146 . . . . 0.76 111.477 -176.65 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 85.65 -27.3 5.36 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 123.511 0.577 . . . . 0.58 112.927 179.422 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.4 t -80.12 140.18 17.11 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 CA-C-N 118.363 1.081 . . . . 1.65 108.795 176.33 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 69.8 m -106.7 -60.12 1.71 Allowed 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 118.474 -0.774 . . . . 2.17 109.116 178.488 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -140.65 165.35 27.72 Favored 'General case' 0 N--CA 1.446 -0.675 0 N-CA-C 109.052 -0.721 . . . . 2.58 109.052 179.821 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -156.43 143.9 19.18 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 109.381 -0.6 . . . . 1.76 109.381 -168.335 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -152.2 116.16 4.9 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 123.892 0.877 . . . . 0.78 108.761 -167.209 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.6 p -82.2 124.35 39.11 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 N-CA-C 107.208 -1.405 . . . . 1.76 107.208 171.542 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 47.2 t30 -108.57 55.38 0.64 Allowed 'General case' 0 C--O 1.235 0.326 0 CA-C-O 123.07 1.414 . . . . 0.93 107.22 178.161 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.65 -18.35 62.85 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 114.171 -1.377 . . . . 2.03 110.311 -174.207 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -43.38 -37.61 2.38 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 124.267 1.027 . . . . 1.63 111.991 166.033 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 9.3 t -125.87 32.89 5.18 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 122.719 0.407 . . . . 1.57 110.435 173.58 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 59.1 27.62 16.65 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.923 1.689 . . . . 2.92 113.609 174.437 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 60.3 m -115.97 164.28 14.67 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.747 1.219 . . . . 1.78 109.723 -174.594 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 5.7 p -136.25 143.72 35.02 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 C-N-CA 124.516 1.126 . . . . 1.59 108.637 171.998 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -134.92 122.1 21.47 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 124.647 1.179 . . . . 0.58 108.153 -175.405 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.7 p -123.85 130.59 73.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 N-CA-C 106.176 -1.787 . . . . 2.96 106.176 -172.705 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 9.7 mm -105.39 97.47 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 N-CA-C 107.158 -1.423 . . . . 1.61 107.158 -174.92 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 3.6 p90 -129.72 164.89 23.0 Favored 'General case' 0 CA--C 1.512 -0.481 0 O-C-N 122.161 -0.337 . . . . 3.57 110.641 -176.554 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -81.65 124.01 80.16 Favored Pre-proline 0 CA--C 1.536 0.418 0 N-CA-C 108.314 -0.995 . . . . 3.12 108.314 167.189 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -86.57 15.54 2.17 Favored 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 122.904 2.403 . . . . 0.66 112.888 -175.385 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -97.88 -40.52 8.47 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 123.999 0.92 . . . . 2.09 109.069 169.248 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -90.59 -62.08 1.54 Allowed 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 107.143 -1.428 . . . . 3.84 107.143 -177.337 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.518 0.2 OUTLIER -78.31 -175.65 4.3 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 115.328 1.603 . . . . 1.85 115.328 159.336 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 154.64 -168.3 32.73 Favored Glycine 0 N--CA 1.435 -1.381 1 N-CA-C 102.81 -4.116 . . . . 2.53 102.81 -148.83 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 16.7 p -73.34 -34.91 65.9 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 124.14 0.976 . . . . 2.08 109.244 -176.679 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -46.96 -60.88 2.15 Favored 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 125.055 1.342 . . . . 1.73 113.441 -169.556 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.07 -40.99 74.71 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 118.995 -1.082 . . . . 1.57 108.793 -167.524 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.5 mp -50.71 -54.57 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.944 0 CA-C-N 113.891 -1.504 . . . . 2.23 109.787 174.087 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -65.82 -44.58 85.19 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 118.669 0.668 . . . . 2.4 110.28 -174.008 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -45.84 -56.7 5.06 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 122.597 1.189 . . . . 2.8 110.046 173.252 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.86 -40.47 68.95 Favored 'General case' 0 N--CA 1.438 -1.05 0 N-CA-C 113.536 0.939 . . . . 4.93 113.536 -176.314 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -48.26 -52.49 7.78 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 C-N-CA 125.003 1.321 . . . . 1.59 108.017 173.961 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -59.65 -58.83 6.87 Favored 'General case' 0 C--N 1.341 0.219 0 C-N-CA 123.429 0.692 . . . . 1.63 110.333 176.588 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 6.6 mmmt -57.76 -33.02 68.06 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 113.62 0.97 . . . . 5.24 113.62 -175.732 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 22.6 mt -71.81 -19.02 62.05 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.181 1.392 . . . . 2.02 111.666 174.853 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 96.81 43.68 3.05 Favored Glycine 0 CA--C 1.524 0.645 0 C-N-CA 124.704 1.145 . . . . 0.43 111.442 174.735 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -140.1 174.49 10.47 Favored 'General case' 0 N--CA 1.457 -0.085 0 C-N-CA 124.488 1.115 . . . . 3.3 110.157 -177.799 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 6.9 t-80 -141.55 125.91 17.62 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 109.387 -0.597 . . . . 2.94 109.387 174.279 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 7.8 p -92.77 152.14 3.5 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 108.479 -0.934 . . . . 2.48 108.479 174.566 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 38.1 t -127.3 143.65 39.9 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 C-N-CA 124.808 1.243 . . . . 1.84 108.323 178.488 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 5.2 mp -118.17 81.19 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 C-N-CA 124.558 1.143 . . . . 2.74 108.789 -172.804 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -79.04 -5.8 54.86 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 114.34 1.237 . . . . 2.9 114.34 173.624 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 79.44 68.86 1.44 Allowed Glycine 0 CA--C 1.53 0.994 0 C-N-CA 124.12 0.867 . . . . 3.24 111.973 175.896 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 3.1 ttp180 . . . . . 0 C--O 1.248 0.996 0 CA-C-O 115.98 -1.962 . . . . 13.47 110.758 175.418 . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 77' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 37.3 mtt . . . . . 0 N--CA 1.476 0.852 0 N-CA-C 110.238 -0.282 . . . . 9.84 110.238 . . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -174.63 -65.1 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 107.099 -1.445 . . . . 6.53 107.099 171.921 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.3 m -140.84 133.44 28.66 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 127.02 2.128 . . . . 1.49 105.596 177.763 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -84.92 -175.7 5.88 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 108.199 -1.038 . . . . 2.09 108.199 163.839 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.18 146.78 49.05 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 107.583 -1.266 . . . . 1.13 107.583 169.2 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 54.2 mttm -140.27 156.16 46.58 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 121.44 0.638 . . . . 3.56 110.279 161.873 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -112.89 87.01 2.49 Favored 'General case' 0 N--CA 1.439 -0.978 0 C-N-CA 128.343 2.657 . . . . 1.45 106.444 -168.508 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 20.6 mm -82.62 159.64 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.396 0 N-CA-C 106.575 -1.639 . . . . 2.98 106.575 -176.035 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -131.77 138.18 48.47 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 125.784 1.634 . . . . 1.61 106.743 -179.694 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -156.31 175.84 13.47 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 118.511 0.596 . . . . 3.64 110.786 172.649 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 30.1 mm100 -94.6 159.35 15.12 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 124.638 1.175 . . . . 2.68 109.886 -178.405 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 62.0 t -114.26 156.53 15.2 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 C-N-CA 125.075 1.35 . . . . 2.19 108.769 -176.454 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 25.3 m -150.01 165.63 32.13 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 123.725 0.81 . . . . 1.64 109.518 168.006 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 63.68 47.56 85.5 Favored Glycine 0 CA--C 1.528 0.899 0 N-CA-C 110.31 -1.116 . . . . 1.6 110.31 -171.52 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -120.55 165.17 15.37 Favored 'General case' 0 N--CA 1.457 -0.121 0 C-N-CA 124.663 1.185 . . . . 2.7 108.972 175.3 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 174.51 -41.96 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 127.864 2.466 . . . . 4.7 110.528 175.447 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 47.9 t -48.02 -41.02 24.5 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.327 1.051 . . . . 4.08 110.932 172.173 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 64.56 19.15 11.72 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.621 1.169 . . . . 3.29 111.92 -178.0 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -134.58 -44.22 0.75 Allowed 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 125.395 1.478 . . . . 1.8 109.439 176.035 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 20.5 m -47.24 -38.48 12.35 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 123.413 0.685 . . . . 1.65 112.599 169.131 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -49.26 -33.29 12.52 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.382 0.673 . . . . 1.71 112.068 174.545 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.6 -52.88 15.77 Favored 'General case' 0 N--CA 1.456 -0.173 0 O-C-N 120.789 -1.194 . . . . 1.55 110.416 171.699 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 46.4 mmm-85 -50.42 -50.63 51.36 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 123.933 0.893 . . . . 4.52 110.114 -175.968 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 5.1 pt -56.86 -54.61 27.47 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 CA-C-O 118.79 -0.624 . . . . 1.94 109.946 -179.839 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -55.46 -38.6 69.26 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 119.273 0.942 . . . . 2.29 112.12 179.474 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 42.7 mmtm -71.58 -44.14 65.01 Favored 'General case' 0 CA--C 1.534 0.327 0 O-C-N 121.345 -0.847 . . . . 2.87 111.564 -177.49 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -69.58 -33.21 71.65 Favored Glycine 0 CA--C 1.528 0.871 0 C-N-CA 120.218 -0.991 . . . . 0.57 110.914 173.088 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 9.6 tt -56.37 -48.64 76.43 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 107.833 -1.173 . . . . 3.11 107.833 173.227 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -54.87 -19.44 6.56 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 113.428 0.899 . . . . 4.45 113.428 176.249 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 94.5 mtt180 -77.54 -4.68 46.94 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 119.679 1.127 . . . . 5.92 112.289 177.704 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 7.3 ptp -71.11 155.68 92.9 Favored Pre-proline 0 CA--C 1.534 0.339 0 CA-C-N 119.58 1.082 . . . . 4.35 111.37 173.335 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -58.86 133.04 51.18 Favored 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 121.769 1.646 . . . . 0.65 109.046 163.5 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 108.54 -35.12 5.16 Favored Glycine 0 CA--C 1.53 1.015 0 CA-C-O 119.442 -0.643 . . . . 0.59 113.39 171.892 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 59.9 t -89.28 128.62 41.22 Favored 'Isoleucine or valine' 0 C--N 1.34 0.173 0 CA-C-N 118.454 1.127 . . . . 1.91 110.303 178.772 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 30.7 m -111.06 -28.58 8.25 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 123.582 0.753 . . . . 1.96 111.817 -174.747 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -146.78 164.1 33.86 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 119.033 0.833 . . . . 2.34 111.359 164.791 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -156.18 133.95 11.07 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 112.571 0.582 . . . . 1.48 112.571 -176.478 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -150.34 115.88 5.49 Favored 'General case' 0 C--N 1.341 0.235 0 N-CA-C 108.279 -1.008 . . . . 0.45 108.279 -163.266 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.4 p -93.3 100.13 10.75 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 C-N-CA 123.478 0.711 . . . . 1.71 110.049 -175.985 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 53.1 t-20 -83.71 57.3 4.02 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 122.651 1.215 . . . . 0.85 109.287 -179.145 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.98 -19.74 63.33 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 114.915 -1.038 . . . . 2.01 110.155 -175.713 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -46.7 -35.67 6.31 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 123.876 0.87 . . . . 1.63 112.036 166.046 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 5.6 t -122.11 37.33 4.4 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 121.496 0.665 . . . . 2.05 109.553 173.56 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 41.22 40.01 1.07 Allowed 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 126.655 1.982 . . . . 2.64 113.503 179.109 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 95.1 m -124.33 160.49 27.96 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 124.971 1.308 . . . . 1.82 107.865 -178.799 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.6 p -130.79 146.81 33.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 O-C-N 121.356 -0.84 . . . . 1.69 109.321 170.133 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -128.77 138.84 52.31 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 108.253 -1.017 . . . . 0.38 108.253 -179.639 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 34.2 t -135.05 129.28 50.59 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 N-CA-C 106.284 -1.747 . . . . 3.27 106.284 -179.395 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 11.4 mm -104.4 99.8 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 N-CA-C 106.874 -1.528 . . . . 1.66 106.874 -173.552 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 53.6 p90 -138.3 167.49 21.75 Favored 'General case' 0 CA--C 1.509 -0.602 0 O-C-N 121.622 -0.673 . . . . 3.56 111.623 -170.591 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -87.75 109.43 26.88 Favored Pre-proline 0 C--O 1.236 0.343 0 O-C-N 124.448 1.092 . . . . 3.04 109.646 174.992 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -74.56 5.18 3.92 Favored 'Trans proline' 0 N--CA 1.451 -0.989 0 C-N-CA 122.759 2.306 . . . . 0.57 112.973 -177.323 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -86.08 -27.61 24.59 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 119.506 1.048 . . . . 1.69 109.294 166.721 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.51 -57.5 2.03 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 108.22 -1.03 . . . . 3.46 108.22 -168.666 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.288 1.0 OUTLIER -93.95 -173.63 3.18 Favored 'General case' 0 C--O 1.225 -0.215 0 C-N-CA 124.435 1.094 . . . . 1.49 112.494 161.566 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 141.64 91.25 0.17 Allowed Glycine 0 N--CA 1.441 -1.029 0 N-CA-C 103.222 -3.951 . . . . 2.26 103.222 -155.896 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -13.02 -13.92 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.7 1 C-N-CA 138.476 6.71 . . . . 3.96 120.472 -149.249 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -26.26 -62.62 0.08 Allowed 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 126.885 2.074 . . . . 1.54 114.867 161.228 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.87 -41.5 59.69 Favored 'General case' 0 CA--C 1.521 -0.145 0 CA-C-O 122.255 1.026 . . . . 1.72 108.931 -167.802 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.7 mt -44.82 -57.36 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.771 0 C-N-CA 125.829 1.651 . . . . 2.81 110.53 170.452 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.95 -46.35 88.23 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 119.444 1.02 . . . . 1.27 110.747 178.999 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -49.3 -55.49 12.6 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 121.944 0.878 . . . . 3.4 111.001 179.019 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.95 -41.11 78.44 Favored 'General case' 0 N--CA 1.441 -0.886 0 C-N-CA 124.135 0.974 . . . . 3.98 112.319 179.207 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -48.71 -53.18 7.53 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 N-CA-C 108.318 -0.993 . . . . 1.57 108.318 175.91 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -59.96 -58.58 7.96 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 124.147 0.979 . . . . 1.51 110.699 177.03 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 2.9 mttp -55.23 -39.73 70.06 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 112.959 0.725 . . . . 4.86 112.959 -175.849 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 20.8 mt -67.34 -17.81 64.9 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.327 1.051 . . . . 1.79 111.515 177.361 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 96.58 41.03 3.73 Favored Glycine 0 C--N 1.335 0.512 0 C-N-CA 124.827 1.203 . . . . 0.46 110.758 173.947 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -138.54 175.89 9.17 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 123.829 0.852 . . . . 3.35 110.334 -175.255 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 16.4 t-160 -142.32 148.6 38.25 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 108.419 -0.956 . . . . 3.47 108.419 174.88 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -118.42 152.9 20.55 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.14 0 C-N-CA 125.617 1.567 . . . . 3.08 106.942 177.176 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 59.0 t -124.14 145.72 30.81 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 C-N-CA 124.902 1.281 . . . . 1.86 108.274 179.141 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 38.9 mm -116.45 81.05 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.174 0 C-N-CA 124.616 1.167 . . . . 2.41 108.884 -173.895 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 57.1 mt-10 -72.37 -7.38 49.33 Favored 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 114.29 1.219 . . . . 3.03 114.29 172.693 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 61.37 77.14 0.2 Allowed Glycine 0 CA--C 1.528 0.862 0 N-CA-C 110.002 -1.239 . . . . 2.95 110.002 -177.453 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.042 0 CA-C-O 116.144 -1.884 . . . . 13.42 107.142 -164.225 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 77' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.42 ' N ' ' OE2' ' A' ' 4' ' ' GLU . 20.1 mtt . . . . . 0 N--CA 1.48 1.034 0 N-CA-C 109.287 -0.635 . . . . 10.47 109.287 . . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.0 mp -64.98 175.31 1.58 Allowed 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 108.014 -1.106 . . . . 6.04 108.014 159.166 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 11.7 m -37.65 103.94 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 126.113 1.765 . . . . 1.34 111.309 173.557 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.42 ' OE2' ' N ' ' A' ' 1' ' ' MET . 36.8 mt-10 -78.05 161.49 27.42 Favored 'General case' 0 N--CA 1.435 -1.192 0 N-CA-C 106.001 -1.852 . . . . 3.4 106.001 171.351 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 9.8 mm100 -129.88 149.34 51.66 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 108.518 -0.919 . . . . 2.57 108.518 -178.006 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 71.7 tttt -145.6 155.33 42.97 Favored 'General case' 0 N--CA 1.438 -1.053 0 C-N-CA 124.003 0.921 . . . . 5.03 108.973 175.103 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -112.96 92.86 4.16 Favored 'General case' 0 N--CA 1.437 -1.086 0 C-N-CA 129.566 3.146 . . . . 1.68 105.229 -173.494 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 19.4 mm -83.78 163.38 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.301 0 N-CA-C 106.797 -1.557 . . . . 3.15 106.797 175.665 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -133.22 138.03 46.36 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 125.457 1.503 . . . . 1.4 107.291 177.92 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -155.85 171.38 20.15 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 118.347 0.522 . . . . 2.67 109.733 175.946 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -93.32 164.83 13.07 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 124.921 1.288 . . . . 3.58 109.893 -174.424 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.8 t -126.29 146.61 31.82 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 C-N-CA 123.754 0.822 . . . . 2.19 109.622 -173.579 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 59.9 m -127.48 171.69 11.36 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.742 1.217 . . . . 1.49 109.042 170.795 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 79.71 -35.85 2.07 Favored Glycine 0 CA--C 1.534 1.26 0 O-C-N 121.514 -0.741 . . . . 2.28 112.871 -179.297 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -44.01 142.64 1.33 Allowed 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 114.248 1.203 . . . . 3.19 114.248 -179.712 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -153.02 -60.89 0.15 Allowed 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 126.351 1.861 . . . . 3.81 107.002 177.995 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 31.3 m -63.94 -25.53 68.18 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.077 0.951 . . . . 3.2 112.94 -176.959 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 68.55 -60.18 0.44 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 126.005 1.722 . . . . 2.67 110.956 -169.102 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -48.07 -45.5 32.56 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.71 1.204 . . . . 1.83 111.682 178.861 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 89.9 m -57.48 -32.32 66.86 Favored 'General case' 0 CA--C 1.529 0.143 0 N-CA-C 112.766 0.654 . . . . 1.54 112.766 177.761 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.47 -19.17 65.4 Favored 'General case' 0 CA--C 1.538 0.487 0 O-C-N 121.904 -0.498 . . . . 1.65 111.051 175.12 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.22 -47.41 61.56 Favored 'General case' 0 N--CA 1.453 -0.279 0 O-C-N 119.452 -2.03 . . . . 1.82 108.607 169.734 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 61.8 mtp180 -55.45 -41.24 72.59 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 118.77 -0.633 . . . . 5.27 110.076 -176.386 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.3 1.4 pt -57.82 -58.38 6.52 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.425 0 C-N-CA 119.373 -0.931 . . . . 1.68 110.708 174.877 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -47.88 -42.55 27.1 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 119.191 0.905 . . . . 2.67 112.883 176.293 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 24.4 mmtp -70.25 -48.74 55.56 Favored 'General case' 0 CA--C 1.535 0.378 0 O-C-N 120.938 -1.101 . . . . 3.38 111.291 -179.573 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.86 -29.38 73.91 Favored Glycine 0 CA--C 1.53 1.0 0 O-C-N 121.665 -0.647 . . . . 0.92 111.582 176.281 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.3 tt -67.4 -54.42 20.56 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 125.314 1.446 . . . . 2.93 107.775 176.547 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 6.7 ttmt -48.32 -33.11 8.36 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.523 0.729 . . . . 3.39 112.115 178.22 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 3.6 mmt180 -55.76 -15.7 3.48 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 114.507 1.299 . . . . 5.2 114.507 177.906 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 9.9 ptp -67.68 156.72 88.32 Favored Pre-proline 0 CA--C 1.535 0.38 0 CA-C-N 119.719 1.145 . . . . 4.44 112.252 175.941 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -60.74 137.89 76.0 Favored 'Trans proline' 0 N--CA 1.456 -0.735 0 C-N-CA 121.378 1.385 . . . . 0.8 109.522 165.846 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 99.33 -28.63 14.51 Favored Glycine 0 CA--C 1.53 0.983 0 CA-C-O 119.14 -0.811 . . . . 0.54 113.729 170.553 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 61.5 t -88.64 136.75 22.61 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 CA-C-N 119.288 1.544 . . . . 1.9 109.119 171.613 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -108.04 -41.2 5.0 Favored 'General case' 0 C--N 1.341 0.216 0 CA-C-O 118.356 -0.83 . . . . 2.67 110.733 178.508 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -143.21 165.93 26.1 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-N 119.113 0.87 . . . . 2.37 110.403 170.963 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -158.02 148.16 20.28 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 123.538 0.735 . . . . 1.53 110.073 179.923 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -156.19 118.37 4.03 Favored 'General case' 0 C--O 1.232 0.143 0 N-CA-C 107.723 -1.214 . . . . 0.63 107.723 -163.364 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.0 p -89.92 101.4 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 C-N-CA 123.082 0.553 . . . . 1.66 110.232 -177.07 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 51.4 t-20 -84.07 56.7 3.83 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-O 122.693 1.235 . . . . 0.82 109.277 179.629 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.07 -19.92 64.08 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 115.229 -0.896 . . . . 2.1 110.152 -175.467 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -46.91 -36.8 8.01 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.032 0.933 . . . . 1.58 112.363 166.752 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 14.5 t -115.5 23.67 12.2 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 118.499 0.59 . . . . 1.8 111.327 174.161 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 55.04 50.37 15.56 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.4 1.08 . . . . 3.55 112.859 -179.706 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 7.1 m -145.9 154.78 42.33 Favored 'General case' 0 N--CA 1.445 -0.722 0 O-C-N 120.418 -1.426 . . . . 1.91 109.045 178.844 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.3 p -117.81 144.37 25.97 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 N-CA-C 108.455 -0.943 . . . . 1.71 108.455 171.347 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -124.68 142.62 51.25 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 108.153 -1.055 . . . . 0.39 108.153 176.985 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 4.0 p -139.78 129.35 29.09 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 N-CA-C 106.822 -1.548 . . . . 2.84 106.822 -174.993 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 14.5 mm -108.31 89.03 1.21 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.654 0 C-N-CA 126.007 1.723 . . . . 2.13 107.711 -167.461 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 34.7 p90 -137.12 172.9 12.32 Favored 'General case' 0 CA--C 1.511 -0.542 0 C-N-CA 122.671 0.388 . . . . 2.83 111.967 -167.703 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 66.4 t0 -93.36 104.71 13.06 Favored Pre-proline 0 C--O 1.236 0.345 0 O-C-N 125.094 1.496 . . . . 3.08 110.177 -179.412 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -73.71 3.19 5.11 Favored 'Trans proline' 0 N--CA 1.448 -1.154 0 C-N-CA 122.003 1.802 . . . . 0.87 112.447 -179.286 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -82.23 -29.35 31.38 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 119.819 1.19 . . . . 2.16 109.205 165.726 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -108.32 -55.99 2.31 Favored 'General case' 0 C--N 1.343 0.317 0 C-N-CA 122.797 0.439 . . . . 2.52 110.308 -166.355 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.31 0.6 OUTLIER -89.05 177.54 6.62 Favored 'General case' 0 CA--C 1.514 -0.432 0 CA-C-O 123.312 1.53 . . . . 1.61 114.212 160.345 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -160.02 -135.9 1.93 Allowed Glycine 0 N--CA 1.433 -1.567 0 N-CA-C 103.978 -3.649 . . . . 2.54 103.978 175.43 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 23.6 p -76.57 -35.29 58.28 Favored 'General case' 0 N--CA 1.444 -0.751 0 C-N-CA 127.031 2.132 . . . . 2.46 109.75 177.917 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -49.48 -62.8 1.35 Allowed 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 125.49 1.516 . . . . 1.7 113.926 -165.379 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.83 -35.0 69.76 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 114.676 -1.147 . . . . 1.61 108.472 -168.364 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.8 mt -54.26 -57.18 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.908 0 C-N-CA 125.95 1.7 . . . . 2.73 111.179 173.155 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.69 -45.22 95.01 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 119.804 1.184 . . . . 1.15 109.626 -179.724 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -49.56 -59.36 3.84 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-O 121.392 0.615 . . . . 3.24 111.958 176.756 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 4.7 mmpt? -63.61 -40.53 97.16 Favored 'General case' 0 N--CA 1.437 -1.087 0 CA-C-O 118.459 -0.781 . . . . 2.83 111.096 -179.452 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.3 mm -49.01 -54.3 5.69 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.558 0 C-N-CA 124.171 0.989 . . . . 1.61 108.441 177.204 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 27.0 mm-40 -59.32 -55.71 31.34 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 123.594 0.757 . . . . 1.62 110.436 177.0 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 10.2 mmtt -57.11 -36.48 70.69 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 112.905 0.706 . . . . 5.3 112.905 -174.931 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 13.0 mt -71.11 -17.8 62.55 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.889 1.276 . . . . 1.76 112.144 175.874 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 96.96 39.47 4.06 Favored Glycine 0 CA--C 1.523 0.589 0 C-N-CA 124.571 1.082 . . . . 0.5 111.093 175.36 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -135.31 175.86 9.2 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 124.131 0.972 . . . . 3.34 110.303 -178.39 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 22.4 t-160 -143.86 133.55 23.7 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 107.711 -1.218 . . . . 3.44 107.711 172.631 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 6.5 p -108.86 139.99 29.28 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 C-N-CA 125.296 1.439 . . . . 2.4 107.407 179.782 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 86.3 t -108.72 138.74 34.23 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.137 0 CA-C-O 121.833 0.825 . . . . 1.74 109.069 -179.566 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 45.8 mm -104.86 77.92 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 C-N-CA 125.224 1.41 . . . . 2.58 109.123 -169.767 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -74.93 2.46 10.32 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.646 1.179 . . . . 3.3 113.696 173.615 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -112.49 -8.24 21.4 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 125.093 1.33 . . . . 3.93 114.617 -170.497 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.083 0 C-N-CA 124.74 1.216 . . . . 10.8 107.935 -173.798 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 77' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.42 ' N ' ' OE2' ' A' ' 4' ' ' GLU . 20.1 mtt . . . . . 0 N--CA 1.48 1.034 0 N-CA-C 109.287 -0.635 . . . . 10.47 109.287 . . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.0 mp -64.98 175.31 1.58 Allowed 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 108.014 -1.106 . . . . 6.04 108.014 159.166 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 11.7 m -37.65 103.94 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 126.113 1.765 . . . . 1.34 111.309 173.557 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.42 ' OE2' ' N ' ' A' ' 1' ' ' MET . 36.8 mt-10 -78.05 161.49 27.42 Favored 'General case' 0 N--CA 1.435 -1.192 0 N-CA-C 106.001 -1.852 . . . . 3.4 106.001 171.351 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 9.8 mm100 -129.88 149.34 51.66 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 108.518 -0.919 . . . . 2.57 108.518 -178.006 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 71.7 tttt -145.6 155.33 42.97 Favored 'General case' 0 N--CA 1.438 -1.053 0 C-N-CA 124.003 0.921 . . . . 5.03 108.973 175.103 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -112.96 92.86 4.16 Favored 'General case' 0 N--CA 1.437 -1.086 0 C-N-CA 129.566 3.146 . . . . 1.68 105.229 -173.494 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 19.4 mm -83.78 163.38 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.301 0 N-CA-C 106.797 -1.557 . . . . 3.15 106.797 175.665 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -133.22 138.03 46.36 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 125.457 1.503 . . . . 1.4 107.291 177.92 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -155.85 171.38 20.15 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 118.347 0.522 . . . . 2.67 109.733 175.946 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -93.32 164.83 13.07 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 124.921 1.288 . . . . 3.58 109.893 -174.424 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.8 t -126.29 146.61 31.82 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 C-N-CA 123.754 0.822 . . . . 2.19 109.622 -173.579 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 59.9 m -127.48 171.69 11.36 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.742 1.217 . . . . 1.49 109.042 170.795 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 79.71 -35.85 2.07 Favored Glycine 0 CA--C 1.534 1.26 0 O-C-N 121.514 -0.741 . . . . 2.28 112.871 -179.297 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -44.01 142.64 1.33 Allowed 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 114.248 1.203 . . . . 3.19 114.248 -179.712 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -153.02 -60.89 0.15 Allowed 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 126.351 1.861 . . . . 3.81 107.002 177.995 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 31.3 m -63.94 -25.53 68.18 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.077 0.951 . . . . 3.2 112.94 -176.959 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 68.55 -60.18 0.44 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 126.005 1.722 . . . . 2.67 110.956 -169.102 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -48.07 -45.5 32.56 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.71 1.204 . . . . 1.83 111.682 178.861 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 89.9 m -57.48 -32.32 66.86 Favored 'General case' 0 CA--C 1.529 0.143 0 N-CA-C 112.766 0.654 . . . . 1.54 112.766 177.761 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.47 -19.17 65.4 Favored 'General case' 0 CA--C 1.538 0.487 0 O-C-N 121.904 -0.498 . . . . 1.65 111.051 175.12 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.22 -47.41 61.56 Favored 'General case' 0 N--CA 1.453 -0.279 0 O-C-N 119.452 -2.03 . . . . 1.82 108.607 169.734 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 61.8 mtp180 -55.45 -41.24 72.59 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 118.77 -0.633 . . . . 5.27 110.076 -176.386 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.3 1.4 pt -57.82 -58.38 6.52 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.425 0 C-N-CA 119.373 -0.931 . . . . 1.68 110.708 174.877 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -47.88 -42.55 27.1 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 119.191 0.905 . . . . 2.67 112.883 176.293 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 24.4 mmtp -70.25 -48.74 55.56 Favored 'General case' 0 CA--C 1.535 0.378 0 O-C-N 120.938 -1.101 . . . . 3.38 111.291 -179.573 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.86 -29.38 73.91 Favored Glycine 0 CA--C 1.53 1.0 0 O-C-N 121.665 -0.647 . . . . 0.92 111.582 176.281 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.3 tt -67.4 -54.42 20.56 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 125.314 1.446 . . . . 2.93 107.775 176.547 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 6.7 ttmt -48.32 -33.11 8.36 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.523 0.729 . . . . 3.39 112.115 178.22 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 3.6 mmt180 -55.76 -15.7 3.48 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 114.507 1.299 . . . . 5.2 114.507 177.906 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 9.9 ptp -67.68 156.72 88.32 Favored Pre-proline 0 CA--C 1.535 0.38 0 CA-C-N 119.719 1.145 . . . . 4.44 112.252 175.941 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -60.74 137.89 76.0 Favored 'Trans proline' 0 N--CA 1.456 -0.735 0 C-N-CA 121.378 1.385 . . . . 0.8 109.522 165.846 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 99.33 -28.63 14.51 Favored Glycine 0 CA--C 1.53 0.983 0 CA-C-O 119.14 -0.811 . . . . 0.54 113.729 170.553 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 61.5 t -88.64 136.75 22.61 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 CA-C-N 119.288 1.544 . . . . 1.9 109.119 171.613 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -108.04 -41.2 5.0 Favored 'General case' 0 C--N 1.341 0.216 0 CA-C-O 118.356 -0.83 . . . . 2.67 110.733 178.508 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -143.21 165.93 26.1 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-N 119.113 0.87 . . . . 2.37 110.403 170.963 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -158.02 148.16 20.28 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 123.538 0.735 . . . . 1.53 110.073 179.923 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -156.19 118.37 4.03 Favored 'General case' 0 C--O 1.232 0.143 0 N-CA-C 107.723 -1.214 . . . . 0.63 107.723 -163.364 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.0 p -89.92 101.4 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 C-N-CA 123.082 0.553 . . . . 1.66 110.232 -177.07 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 51.4 t-20 -84.07 56.7 3.83 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-O 122.693 1.235 . . . . 0.82 109.277 179.629 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.07 -19.92 64.08 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 115.229 -0.896 . . . . 2.1 110.152 -175.467 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -46.91 -36.8 8.01 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.032 0.933 . . . . 1.58 112.363 166.752 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 14.5 t -115.5 23.67 12.2 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 118.499 0.59 . . . . 1.8 111.327 174.161 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 55.04 50.37 15.56 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.4 1.08 . . . . 3.55 112.859 -179.706 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 7.1 m -145.9 154.78 42.33 Favored 'General case' 0 N--CA 1.445 -0.722 0 O-C-N 120.418 -1.426 . . . . 1.91 109.045 178.844 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.3 p -117.81 144.37 25.97 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 N-CA-C 108.455 -0.943 . . . . 1.71 108.455 171.347 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -124.68 142.62 51.25 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 108.153 -1.055 . . . . 0.39 108.153 176.985 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 4.0 p -139.78 129.35 29.09 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 N-CA-C 106.822 -1.548 . . . . 2.84 106.822 -174.993 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 14.5 mm -108.31 89.03 1.21 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.654 0 C-N-CA 126.007 1.723 . . . . 2.13 107.711 -167.461 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 34.7 p90 -137.12 172.9 12.32 Favored 'General case' 0 CA--C 1.511 -0.542 0 C-N-CA 122.671 0.388 . . . . 2.83 111.967 -167.703 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 66.4 t0 -93.36 104.71 13.06 Favored Pre-proline 0 C--O 1.236 0.345 0 O-C-N 125.094 1.496 . . . . 3.08 110.177 -179.412 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -73.71 3.19 5.11 Favored 'Trans proline' 0 N--CA 1.448 -1.154 0 C-N-CA 122.003 1.802 . . . . 0.87 112.447 -179.286 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -82.23 -29.35 31.38 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 119.819 1.19 . . . . 2.16 109.205 165.726 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -108.32 -55.99 2.31 Favored 'General case' 0 C--N 1.343 0.317 0 C-N-CA 122.797 0.439 . . . . 2.52 110.308 -166.355 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.31 0.6 OUTLIER -89.05 177.54 6.62 Favored 'General case' 0 CA--C 1.514 -0.432 0 CA-C-O 123.312 1.53 . . . . 1.61 114.212 160.345 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -160.02 -135.9 1.93 Allowed Glycine 0 N--CA 1.433 -1.567 0 N-CA-C 103.978 -3.649 . . . . 2.54 103.978 175.43 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 23.6 p -76.57 -35.29 58.28 Favored 'General case' 0 N--CA 1.444 -0.751 0 C-N-CA 127.031 2.132 . . . . 2.46 109.75 177.917 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -49.48 -62.8 1.35 Allowed 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 125.49 1.516 . . . . 1.7 113.926 -165.379 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.83 -35.0 69.76 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 114.676 -1.147 . . . . 1.61 108.472 -168.364 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.8 mt -54.26 -57.18 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.908 0 C-N-CA 125.95 1.7 . . . . 2.73 111.179 173.155 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.69 -45.22 95.01 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 119.804 1.184 . . . . 1.15 109.626 -179.724 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -49.56 -59.36 3.84 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-O 121.392 0.615 . . . . 3.24 111.958 176.756 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 4.7 mmpt? -63.61 -40.53 97.16 Favored 'General case' 0 N--CA 1.437 -1.087 0 CA-C-O 118.459 -0.781 . . . . 2.83 111.096 -179.452 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.3 mm -49.01 -54.3 5.69 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.558 0 C-N-CA 124.171 0.989 . . . . 1.61 108.441 177.204 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 27.0 mm-40 -59.32 -55.71 31.34 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 123.594 0.757 . . . . 1.62 110.436 177.0 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 10.2 mmtt -57.11 -36.48 70.69 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 112.905 0.706 . . . . 5.3 112.905 -174.931 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 13.0 mt -71.11 -17.8 62.55 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.889 1.276 . . . . 1.76 112.144 175.874 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 96.96 39.47 4.06 Favored Glycine 0 CA--C 1.523 0.589 0 C-N-CA 124.571 1.082 . . . . 0.5 111.093 175.36 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -135.31 175.86 9.2 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 124.131 0.972 . . . . 3.34 110.303 -178.39 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 22.4 t-160 -143.86 133.55 23.7 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 107.711 -1.218 . . . . 3.44 107.711 172.631 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 6.5 p -108.86 139.99 29.28 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 C-N-CA 125.296 1.439 . . . . 2.4 107.407 179.782 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 86.3 t -108.72 138.74 34.23 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.137 0 CA-C-O 121.833 0.825 . . . . 1.74 109.069 -179.566 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 45.8 mm -104.86 77.92 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 C-N-CA 125.224 1.41 . . . . 2.58 109.123 -169.767 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -74.93 2.46 10.32 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.646 1.179 . . . . 3.3 113.696 173.615 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -112.49 -8.24 21.4 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 125.093 1.33 . . . . 3.93 114.617 -170.497 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.083 0 C-N-CA 124.74 1.216 . . . . 10.8 107.935 -173.798 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 77' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.3 m . . . . . 0 CA--C 1.531 0.238 0 N-CA-C 112.068 0.395 . . . . 1.05 112.068 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -72.76 174.97 6.91 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 108.472 -0.936 . . . . 2.3100000000000001 108.472 179.245 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -129.45 141.09 51.11 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 107.304 -1.369 . . . . 1.04 107.304 168.429 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 6.8 mtpm? -139.76 158.43 44.12 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-O 122.225 1.012 . . . . 3.46 109.661 168.028 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -112.67 107.4 16.06 Favored 'General case' 0 N--CA 1.431 -1.402 0 C-N-CA 130.03 3.332 . . . . 1.5900000000000001 104.974 -171.734 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.476 HD12 ' C ' ' A' ' 8' ' ' ILE . 2.2 pp -84.12 167.02 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 C-N-CA 118.917 -1.113 . . . . 4.9000000000000004 108.599 166.939 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -137.76 134.01 34.76 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 105.174 -2.158 . . . . 0.44 105.174 170.352 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 24.2 ptt? -153.11 168.57 25.49 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 118.492 0.587 . . . . 3.1600000000000001 109.75 178.212 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 19.9 mm100 -92.81 163.99 13.51 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 124.122 0.969 . . . . 2.46 109.819 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.9 m -124.17 157.16 31.58 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.126 0 C-N-CA 125.403 1.481 . . . . 1.8799999999999999 110.08 179.565 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 38.5 m -155.04 166.7 32.75 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 124.8 1.24 . . . . 1.28 108.655 170.795 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 63.11 74.66 0.4 Allowed Glycine 0 CA--C 1.528 0.877 0 N-CA-C 110.845 -0.902 . . . . 1.8300000000000001 110.845 178.398 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -146.71 155.97 42.81 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 123.228 0.611 . . . . 2.29 110.526 -175.096 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -85.6 -62.81 1.44 Allowed 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 125.915 1.686 . . . . 3.5800000000000001 109.644 172.922 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.6 p -155.07 161.04 41.42 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 121.724 0.773 . . . . 2.27 112.085 -169.694 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -72.93 56.1 0.41 Allowed 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 126.751 2.02 . . . . 1.8200000000000001 111.112 -178.753 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -152.6 -52.57 0.11 Allowed 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 124.804 1.242 . . . . 0.69999999999999996 108.448 -175.826 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 30.9 m -59.07 -39.26 81.57 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 108.904 -0.776 . . . . 1.1599999999999999 108.904 170.357 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.705 ' HB1' HG21 ' A' ' 39' ' ' VAL . . . -41.3 -36.83 0.86 Allowed 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.663 1.585 . . . . 0.76000000000000001 112.697 166.569 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -69.75 -53.91 16.18 Favored 'General case' 0 N--CA 1.452 -0.34 0 O-C-N 120.228 -1.545 . . . . 0.41999999999999998 109.264 175.628 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 2.5 mpp_? -57.08 -36.68 70.86 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-O 118.166 -0.921 . . . . 4.4000000000000004 111.639 -174.45 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.281 2.0 pt -56.78 -57.19 10.47 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 C-N-CA 119.342 -0.943 . . . . 0.65000000000000002 110.742 175.079 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -57.13 -45.66 83.33 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 123.533 0.733 . . . . 2.3199999999999998 112.08 178.001 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 13.4 mptt -66.73 -43.25 84.69 Favored 'General case' 0 CA--C 1.531 0.22 0 O-C-N 121.683 -0.636 . . . . 1.8200000000000001 109.838 -174.824 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -60.33 -44.37 97.61 Favored Glycine 0 CA--C 1.527 0.811 0 N-CA-C 110.024 -1.23 . . . . 0.60999999999999999 110.024 171.519 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -60.39 -40.91 92.62 Favored 'General case' 0 CA--C 1.532 0.255 0 O-C-N 122.48 -0.423 . . . . 2.3300000000000001 110.069 -175.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 19.9 ttmt -43.5 -32.25 0.86 Allowed 'General case' 0 CA--C 1.535 0.369 0 O-C-N 121.747 -0.596 . . . . 2.9700000000000002 112.405 173.133 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.93 -4.2 30.58 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 113.588 0.958 . . . . 5.9500000000000002 113.588 -172.812 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.83 166.39 37.78 Favored Pre-proline 0 CA--C 1.539 0.537 0 C-N-CA 125.111 1.364 . . . . 3.79 111.655 173.232 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_endo -70.5 157.1 59.97 Favored 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 122.881 2.387 . . . . 1.3100000000000001 110.629 -178.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 72.46 -36.15 0.68 Allowed Glycine 0 CA--C 1.525 0.71 0 C-N-CA 124.972 1.273 . . . . 0.92000000000000004 112.798 -179.031 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.5 t -68.45 144.78 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.732 0 CA-C-N 118.411 1.106 . . . . 0.94999999999999996 109.286 176.113 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -133.16 -39.24 0.94 Allowed 'General case' 0 N--CA 1.451 -0.377 0 CA-C-O 118.705 -0.664 . . . . 1.04 110.945 179.196 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -139.55 166.28 25.0 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-N 119.251 0.932 . . . . 2.6200000000000001 111.963 166.055 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -158.17 138.32 12.44 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 115.659 -0.7 . . . . 0.44 110.322 -176.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -149.62 109.83 4.16 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 106.206 -1.776 . . . . 0.41999999999999998 106.206 -163.681 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.705 HG21 ' HB1' ' A' ' 21' ' ' ALA . 9.7 p -81.48 119.09 30.41 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 N-CA-C 108.523 -0.917 . . . . 0.5 108.523 177.286 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 55.7 t-20 -99.65 57.28 1.01 Allowed 'General case' 0 C--O 1.236 0.352 0 CA-C-O 123.017 1.389 . . . . 0.57999999999999996 107.803 -178.362 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.453 HD22 ' HA ' ' A' ' 41' ' ' LEU . 0.2 OUTLIER -69.48 -19.92 63.75 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 114.095 -1.411 . . . . 0.96999999999999997 110.372 -172.773 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -46.21 -37.0 6.57 Favored 'General case' 0 C--N 1.34 0.189 0 C-N-CA 123.974 0.91 . . . . 0.53000000000000003 111.839 168.086 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 14.9 t -124.31 37.19 4.46 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 109.831 -0.433 . . . . 1.24 109.831 173.668 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 52.12 31.98 9.77 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 126.317 1.847 . . . . 2.9900000000000002 113.034 171.507 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 95.6 m -122.99 159.92 27.34 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 125.07 1.348 . . . . 0.65000000000000002 108.536 -175.28 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 6.5 p -129.03 143.96 39.65 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 O-C-N 121.249 -0.907 . . . . 0.31 109.413 172.828 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 20.1 m120 -127.84 138.9 52.86 Favored 'General case' 0 C--N 1.344 0.354 0 N-CA-C 107.774 -1.195 . . . . 0.34999999999999998 107.774 179.198 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 93.3 t -134.17 125.46 48.05 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 N-CA-C 105.062 -2.199 . . . . 1.8899999999999999 105.062 -174.506 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 13.7 mm -104.4 101.0 11.67 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 C-N-CA 126.249 1.82 . . . . 0.44 107.983 -175.845 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 41.9 p90 -142.23 173.04 11.89 Favored 'General case' 0 CA--C 1.513 -0.457 0 O-C-N 121.785 -0.572 . . . . 1.72 111.183 -172.767 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -92.97 115.17 64.52 Favored Pre-proline 0 CA--C 1.534 0.343 0 O-C-N 124.199 0.937 . . . . 3.04 108.884 173.188 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -81.76 13.08 2.56 Favored 'Trans proline' 0 N--CA 1.451 -0.998 0 C-N-CA 122.465 2.11 . . . . 0.66000000000000003 113.386 -176.054 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -92.35 -32.27 15.04 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 119.45 1.023 . . . . 0.93000000000000005 109.588 164.052 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -101.1 -55.43 2.56 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 108.495 -0.928 . . . . 2.6899999999999999 108.495 -169.325 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.499 0.2 OUTLIER -83.67 176.75 8.75 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 115.301 1.593 . . . . 0.64000000000000001 115.301 155.845 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -171.31 -147.54 5.7 Favored Glycine 0 N--CA 1.434 -1.454 0 N-CA-C 103.126 -3.99 . . . . 2.52 103.126 -174.466 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 23.6 p -76.75 -32.58 57.85 Favored 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 125.108 1.363 . . . . 1.3999999999999999 109.551 174.453 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -49.98 -61.59 2.06 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 124.723 1.209 . . . . 0.71999999999999997 113.282 -162.869 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.0 -34.21 73.02 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 114.408 -1.269 . . . . 0.60999999999999999 108.765 -171.8 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.6 mp -60.68 -51.41 73.42 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.95 0 CA-C-N 114.999 -1.0 . . . . 1.23 109.79 178.718 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.49 -47.11 85.43 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 108.828 -0.804 . . . . 1.1499999999999999 108.828 -178.068 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -48.7 -54.64 14.03 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 122.038 0.923 . . . . 3.1899999999999999 110.974 174.922 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.07 -47.17 81.17 Favored 'General case' 0 N--CA 1.44 -0.973 0 CA-C-O 118.664 -0.684 . . . . 2.3999999999999999 111.776 -178.524 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.501 HD12 HG13 ' A' ' 71' ' ' VAL . 1.2 mm -46.76 -50.99 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 C-N-CA 126.412 1.885 . . . . 0.51000000000000001 109.033 -177.091 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -57.73 -57.58 12.12 Favored 'General case' 0 C--N 1.34 0.159 0 C-N-CA 123.387 0.675 . . . . 1.49 110.173 175.95 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 13.9 mmtt -55.45 -35.6 65.64 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 112.963 0.727 . . . . 4.8499999999999996 112.963 -178.14 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 31.6 mt -71.07 -18.35 62.56 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.74 1.616 . . . . 0.93000000000000005 111.451 177.558 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 87.15 44.17 5.73 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 110.593 -1.003 . . . . 0.83999999999999997 110.593 178.411 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -137.93 172.97 12.14 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 124.094 0.957 . . . . 2.6800000000000002 109.72 179.125 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 8.3 t60 -146.35 133.9 20.92 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 109.239 -0.652 . . . . 1.96 109.239 165.048 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.501 HG13 HD12 ' A' ' 64' ' ' ILE . 4.5 m -98.8 161.05 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 C-N-CA 123.823 0.849 . . . . 2.4900000000000002 110.15 176.82 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 12.0 t -129.55 141.9 45.31 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 C-N-CA 124.902 1.281 . . . . 0.56000000000000005 107.843 -176.968 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 28.7 mm . . . . . 0 N--CA 1.454 -0.231 0 C-N-CA 125.025 1.33 . . . . 1.6499999999999999 108.426 -175.203 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 55.1 m . . . . . 0 N--CA 1.447 -0.624 0 N-CA-C 106.507 -1.664 . . . . 1.3999999999999999 106.507 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -111.33 -174.7 2.53 Favored 'General case' 0 N--CA 1.439 -1.025 0 C-N-CA 125.487 1.515 . . . . 2.3399999999999999 107.257 156.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -136.28 152.01 50.25 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 107.473 -1.306 . . . . 1.1699999999999999 107.473 172.711 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 23.9 mttt -143.67 163.35 33.5 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 122.937 0.495 . . . . 2.6800000000000002 110.286 161.075 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -122.47 84.81 2.32 Favored 'General case' 0 N--CA 1.44 -0.969 0 C-N-CA 128.687 2.795 . . . . 1.5600000000000001 106.009 -166.429 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.439 ' N ' HD12 ' A' ' 8' ' ' ILE . 3.1 mp -82.49 160.6 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.405 0 N-CA-C 105.691 -1.966 . . . . 2.0299999999999998 105.691 -178.15 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -120.35 132.92 55.49 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 106.243 -1.762 . . . . 0.53000000000000003 106.243 178.618 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 2.8 ttm -138.54 161.63 36.57 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 108.355 -0.98 . . . . 2.2400000000000002 108.355 -177.161 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -97.42 146.91 24.74 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 124.235 1.014 . . . . 2.4199999999999999 108.936 177.078 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 49.1 t -103.85 149.76 7.52 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 C-N-CA 123.77 0.828 . . . . 1.24 109.019 -178.773 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 56.3 m -152.93 164.88 37.1 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 118.866 0.757 . . . . 1.1699999999999999 110.092 171.823 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 64.02 72.13 0.74 Allowed Glycine 0 CA--C 1.527 0.84 0 N-CA-C 110.93 -0.868 . . . . 1.73 110.93 178.2 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -154.78 170.11 22.37 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 123.825 0.85 . . . . 2.0699999999999998 109.857 -172.727 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -111.87 -44.64 3.43 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 123.922 0.889 . . . . 2.3300000000000001 111.229 168.642 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 20.0 p -147.97 176.43 10.17 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 119.111 0.869 . . . . 2.6600000000000001 111.631 -174.105 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -72.26 -24.41 61.36 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 115.508 -0.769 . . . . 2.6200000000000001 111.809 177.997 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.7 -49.7 72.09 Favored 'General case' 0 C--O 1.233 0.209 0 O-C-N 121.377 -0.827 . . . . 0.71999999999999997 110.79 -175.614 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 5.2 p -65.06 -38.96 92.49 Favored 'General case' 0 CA--C 1.532 0.279 0 O-C-N 121.633 -0.667 . . . . 2.4500000000000002 110.518 173.793 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.756 ' HB1' HG21 ' A' ' 39' ' ' VAL . . . -56.61 -29.28 61.97 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-O 121.386 0.613 . . . . 0.40999999999999998 112.074 173.242 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -69.9 -53.41 18.07 Favored 'General case' 0 N--CA 1.45 -0.445 0 O-C-N 119.935 -1.728 . . . . 0.5 108.791 171.757 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -46.67 -50.96 16.99 Favored 'General case' 0 C--N 1.341 0.231 0 CA-C-O 118.486 -0.769 . . . . 3.9199999999999999 110.755 178.109 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.502 HG21 ' CD1' ' A' ' 69' ' ' TYR 0.268 3.4 pt -57.09 -58.21 6.78 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.159 0 C-N-CA 119.727 -0.789 . . . . 0.51000000000000001 110.69 -176.302 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -51.96 -45.47 64.4 Favored 'General case' 0 N--CA 1.457 -0.095 0 CA-C-N 119.006 0.821 . . . . 2.4199999999999999 111.068 179.184 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.36 -40.15 85.75 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 119.585 -0.846 . . . . 1.53 110.895 -177.239 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -68.93 -24.62 75.7 Favored Glycine 0 CA--C 1.529 0.916 0 O-C-N 121.542 -0.724 . . . . 0.64000000000000001 111.633 174.446 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.434 ' CD2' HG21 ' A' ' 34' ' ' VAL . 0.9 OUTLIER -70.1 -43.92 70.06 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 108.11 -1.07 . . . . 1.6799999999999999 108.11 173.838 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 3.4 ttpp -50.0 -24.67 2.74 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 125.323 1.449 . . . . 2.3999999999999999 113.505 173.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -83.24 -0.21 48.48 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 118.443 -0.789 . . . . 3.9100000000000001 112.942 -179.5 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' MET . . . . . 0.633 ' CE ' ' HB1' ' A' ' 59' ' ' ALA . 4.0 ptm -93.96 156.0 39.66 Favored Pre-proline 0 CA--C 1.536 0.43 0 CA-C-N 119.31 0.959 . . . . 3.2200000000000002 111.658 -178.144 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -62.13 133.22 42.78 Favored 'Trans proline' 0 N--CA 1.456 -0.711 0 C-N-CA 122.433 2.089 . . . . 0.81000000000000005 109.809 173.414 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 100.11 -39.2 2.82 Favored Glycine 0 CA--C 1.525 0.7 0 CA-C-O 119.08 -0.844 . . . . 0.79000000000000004 112.595 176.734 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.434 HG21 ' CD2' ' A' ' 28' ' ' LEU . 47.5 t -88.02 118.66 34.12 Favored 'Isoleucine or valine' 0 C--N 1.343 0.314 0 CA-C-N 118.796 1.298 . . . . 1.0900000000000001 110.143 177.653 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 98.1 m -88.82 -52.66 5.0 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-O 118.76 -0.638 . . . . 1.3899999999999999 110.058 -176.236 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -138.23 161.26 37.3 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 123.838 0.855 . . . . 2.7200000000000002 108.757 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -158.22 141.03 14.71 Favored 'General case' 0 C--O 1.238 0.454 0 O-C-N 121.923 -0.486 . . . . 0.44 111.255 -173.846 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -151.37 110.07 3.83 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 106.648 -1.612 . . . . 0.42999999999999999 106.648 -165.118 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.756 HG21 ' HB1' ' A' ' 21' ' ' ALA . 8.7 p -80.97 136.07 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 N-CA-C 107.816 -1.179 . . . . 0.71999999999999997 107.816 176.915 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 52.7 t-20 -121.97 56.01 1.1 Allowed 'General case' 0 C--O 1.235 0.342 0 CA-C-O 123.03 1.395 . . . . 0.58999999999999997 107.929 -176.693 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.429 HD22 ' HA ' ' A' ' 41' ' ' LEU . 0.2 OUTLIER -68.09 -19.55 64.87 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 113.807 -1.542 . . . . 1.04 110.615 -176.018 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -45.46 -37.88 5.63 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 124.067 0.947 . . . . 0.68000000000000005 111.948 165.95 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 12.2 t -124.53 38.18 4.25 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 109.063 -0.717 . . . . 1.3600000000000001 109.063 172.826 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 53.77 24.1 4.18 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.773 1.629 . . . . 3.25 113.78 171.085 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 88.0 m -116.51 162.91 16.86 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.814 1.245 . . . . 0.69999999999999996 108.878 -174.347 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.4 p -125.94 145.42 33.42 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 C-N-CA 124.536 1.135 . . . . 0.34000000000000002 108.044 167.813 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 10.2 m120 -124.17 136.86 54.5 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 107.494 -1.299 . . . . 0.33000000000000002 107.494 172.519 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.1 p -134.93 123.66 41.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 106.252 -1.759 . . . . 1.8799999999999999 106.252 -173.608 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 13.5 mm -104.32 94.72 3.32 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 N-CA-C 107.194 -1.41 . . . . 0.56000000000000005 107.194 -168.842 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 31.1 p90 -131.28 164.26 26.0 Favored 'General case' 0 CA--C 1.512 -0.506 0 O-C-N 122.203 -0.31 . . . . 1.6499999999999999 111.691 -169.45 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 35.7 t0 -83.53 109.23 16.63 Favored Pre-proline 0 CA--C 1.532 0.279 0 O-C-N 124.444 1.09 . . . . 3.02 109.553 174.68 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -74.22 4.87 3.97 Favored 'Trans proline' 0 N--CA 1.451 -0.981 0 C-N-CA 122.663 2.242 . . . . 0.59999999999999998 113.06 -176.877 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -85.44 -28.68 24.91 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 119.338 0.972 . . . . 0.77000000000000002 109.215 166.428 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -102.52 -61.16 1.43 Allowed 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 107.941 -1.133 . . . . 4.2999999999999998 107.941 -169.189 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.829 HG22 ' HB3' ' A' ' 59' ' ' ALA 0.283 0.7 OUTLIER -86.75 -176.46 5.8 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 124.933 1.293 . . . . 0.78000000000000003 112.901 162.489 . . . . . . . . 4 4 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 131.78 94.02 0.61 Allowed Glycine 0 N--CA 1.442 -0.903 0 N-CA-C 103.515 -3.834 . . . . 2.3100000000000001 103.515 -144.356 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 75.0 p -19.17 -23.25 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.308 1 C-N-CA 138.132 6.573 . . . . 1.28 118.809 -147.43 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -28.21 -62.54 0.1 Allowed 'General case' 0 N--CA 1.442 -0.846 0 C-N-CA 126.503 1.921 . . . . 0.91000000000000003 113.19 165.174 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.829 ' HB3' HG22 ' A' ' 55' ' ' THR . . . -75.27 -32.43 61.05 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 118.396 -1.322 . . . . 0.87 110.014 -168.644 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.6 mp -60.17 -51.72 69.6 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.625 0 CA-C-N 115.579 -0.737 . . . . 0.82999999999999996 109.794 175.484 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.96 -48.21 82.63 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 119.067 0.849 . . . . 1.1699999999999999 109.151 -178.987 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -46.13 -58.74 3.37 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-O 121.864 0.84 . . . . 2.5699999999999998 111.24 174.439 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 15.2 mmmt -67.74 -34.69 77.33 Favored 'General case' 0 N--CA 1.441 -0.913 0 CA-C-O 118.354 -0.832 . . . . 3.7000000000000002 112.082 -177.935 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.4 mm -53.45 -52.65 30.48 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 N-CA-C 107.943 -1.132 . . . . 0.41999999999999998 107.943 176.272 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 40.9 mm-40 -58.15 -54.77 43.25 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 123.469 0.708 . . . . 1.54 109.837 176.123 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 13.0 mmtt -59.48 -33.85 71.84 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 113.288 0.848 . . . . 4.1299999999999999 113.288 -176.325 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 32.1 mt -70.78 -18.47 62.75 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.735 1.214 . . . . 1.02 111.289 174.34 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 95.9 39.88 4.23 Favored Glycine 0 CA--C 1.524 0.597 0 C-N-CA 124.892 1.234 . . . . 0.72999999999999998 111.007 175.173 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.502 ' CD1' HG21 ' A' ' 24' ' ' ILE . 0.2 OUTLIER -136.54 175.47 9.58 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 117.805 0.803 . . . . 1.8700000000000001 111.462 -174.987 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -130.69 147.5 52.37 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 123.487 0.715 . . . . 2.9300000000000002 109.497 167.969 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 4.1 p -126.52 152.77 34.49 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 N-CA-C 106.581 -1.637 . . . . 1.5 106.581 176.377 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 11.6 t -129.31 141.89 45.4 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 N-CA-C 107.032 -1.47 . . . . 0.73999999999999999 107.032 -178.571 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 5.0 mp . . . . . 0 N--CA 1.455 -0.201 0 N-CA-C 108.759 -0.83 . . . . 1.3500000000000001 108.759 -175.04 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.9 m . . . . . 0 N--CA 1.453 -0.317 0 N-CA-C 106.797 -1.557 . . . . 0.89000000000000001 106.797 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -88.6 -178.29 5.78 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 108.359 -0.978 . . . . 1.95 108.359 163.675 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 2.9 mm100 -134.58 148.44 50.45 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 107.038 -1.467 . . . . 1.1499999999999999 107.038 169.104 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 37.4 mtpt -140.32 156.91 46.26 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 123.415 0.686 . . . . 2.79 109.167 163.078 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 8.0 mp0 -115.48 89.69 3.16 Favored 'General case' 0 N--CA 1.442 -0.836 0 C-N-CA 127.746 2.418 . . . . 1.8600000000000001 106.326 -170.289 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.514 ' N ' HD12 ' A' ' 8' ' ' ILE . 1.6 mp -83.32 161.25 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.397 0 N-CA-C 105.742 -1.947 . . . . 2.1400000000000001 105.742 -177.321 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -127.81 126.34 41.5 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 125.395 1.478 . . . . 0.41999999999999998 107.021 177.333 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 2.7 mpp? -132.58 170.87 14.57 Favored 'General case' 0 CA--C 1.528 0.124 0 C-N-CA 123.419 0.688 . . . . 2.1000000000000001 109.204 173.926 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 18.5 mm100 -97.66 145.27 26.47 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 124.438 1.095 . . . . 2.6099999999999999 109.476 178.713 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 60.3 t -97.5 151.22 4.33 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.158 0 N-CA-C 108.938 -0.764 . . . . 1.26 108.938 178.316 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 13.0 t -141.77 176.77 8.65 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 108.196 -1.039 . . . . 1.6499999999999999 108.196 170.284 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 53.14 57.53 14.66 Favored Glycine 0 CA--C 1.529 0.909 0 C-N-CA 124.112 0.863 . . . . 1.53 111.573 -178.306 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -139.78 137.98 35.49 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 123.767 0.827 . . . . 1.9299999999999999 109.557 -179.344 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -144.44 8.14 1.35 Allowed 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.809 0.843 . . . . 3.7799999999999998 112.716 166.789 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 8.8 m -108.97 -21.0 12.84 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 124.691 1.196 . . . . 2.9100000000000001 111.825 -171.408 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 64.46 -68.06 0.1 Allowed 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.707 1.603 . . . . 2.5499999999999998 110.881 -165.297 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -44.13 -49.66 8.88 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 125.81 1.644 . . . . 0.83999999999999997 112.603 -175.418 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 96.6 m -52.54 -35.76 54.18 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 123.953 0.901 . . . . 1.1899999999999999 113.126 -178.965 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.78 ' HB1' HG21 ' A' ' 39' ' ' VAL . . . -63.35 -23.24 67.32 Favored 'General case' 0 CA--C 1.539 0.557 0 O-C-N 122.034 -0.416 . . . . 0.41999999999999998 111.157 179.638 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.13 -52.78 17.36 Favored 'General case' 0 N--CA 1.454 -0.245 0 O-C-N 121.028 -1.045 . . . . 0.31 109.592 171.13 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 4.2 mtt-85 -50.97 -47.99 61.23 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 123.379 0.672 . . . . 3.77 110.219 -176.72 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.442 HG21 ' CD1' ' A' ' 69' ' ' TYR . 6.8 pt -57.24 -55.07 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.196 0 C-N-CA 119.751 -0.779 . . . . 0.48999999999999999 111.121 179.487 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -54.17 -42.96 70.21 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.753 0.821 . . . . 3.1899999999999999 111.92 179.699 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 31.9 mmtp -70.66 -47.34 60.44 Favored 'General case' 0 CA--C 1.534 0.357 0 O-C-N 121.061 -1.024 . . . . 1.95 110.914 -178.248 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.37 -28.36 70.9 Favored Glycine 0 CA--C 1.53 0.995 0 O-C-N 121.545 -0.722 . . . . 0.64000000000000001 111.349 174.862 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.1 tt -68.86 -47.87 64.87 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 125.789 1.636 . . . . 1.8899999999999999 109.215 174.521 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.2 ttmm -50.45 -34.7 25.66 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 118.664 0.665 . . . . 2.7400000000000002 111.713 175.149 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 14.5 mmt-85 -62.69 -7.15 4.34 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 114.877 1.436 . . . . 4.4000000000000004 114.877 179.338 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' MET . . . . . 0.472 ' SD ' ' HB1' ' A' ' 59' ' ' ALA . 27.4 mtm -71.56 169.72 14.61 Favored Pre-proline 0 CA--C 1.533 0.312 0 CA-C-N 120.355 1.434 . . . . 3.4500000000000002 112.44 170.8 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -60.78 162.78 17.57 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 121.777 1.651 . . . . 1.01 110.039 159.655 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 77.33 -38.72 1.63 Allowed Glycine 0 C--N 1.333 0.373 0 C-N-CA 125.88 1.705 . . . . 0.51000000000000001 114.02 171.455 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 16.3 t -83.66 134.08 27.73 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.875 0 C-N-CA 123.054 0.542 . . . . 0.52000000000000002 109.603 -177.428 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 88.0 m -113.6 -46.45 3.05 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 122.948 0.499 . . . . 1.3700000000000001 110.276 -175.183 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -139.48 165.13 28.05 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-N 118.047 0.385 . . . . 1.74 110.144 173.347 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -158.02 139.03 13.22 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 108.721 -0.844 . . . . 0.41999999999999998 108.721 -172.343 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -155.93 111.85 3.05 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 123.258 0.623 . . . . 0.48999999999999999 109.347 -165.571 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.896 HG22 HD23 ' A' ' 41' ' ' LEU . 4.8 p -86.79 102.57 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 CA-C-O 121.224 0.535 . . . . 0.55000000000000004 109.991 -177.037 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 51.7 t-20 -86.31 56.97 4.23 Favored 'General case' 0 C--O 1.235 0.333 0 O-C-N 120.687 -1.258 . . . . 0.57999999999999996 109.423 -179.213 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.896 HD23 HG22 ' A' ' 39' ' ' VAL . 0.3 OUTLIER -69.47 -19.86 63.75 Favored 'General case' 0 C--O 1.226 -0.158 0 CA-C-N 115.003 -0.998 . . . . 0.88 110.972 -176.195 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -45.27 -36.98 4.33 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.665 0.786 . . . . 0.56999999999999995 112.078 166.92 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 11.3 t -123.38 30.21 6.37 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 122.494 0.318 . . . . 1.23 110.964 172.897 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 62.11 26.83 16.16 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.348 1.459 . . . . 2.5099999999999998 114.297 172.847 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 88.4 m -120.32 163.13 18.29 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.79 1.236 . . . . 0.72999999999999998 109.524 -174.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 5.8 p -129.91 142.92 42.58 Favored 'Isoleucine or valine' 0 C--O 1.232 0.15 0 C-N-CA 124.302 1.041 . . . . 0.33000000000000002 108.835 171.732 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 10.4 m120 -126.12 129.79 49.78 Favored 'General case' 0 CA--C 1.517 -0.296 0 N-CA-C 108.151 -1.055 . . . . 0.35999999999999999 108.151 177.496 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 6.7 p -128.38 128.92 68.84 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 106.331 -1.729 . . . . 1.8 106.331 -175.751 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 7.9 mm -104.97 100.65 10.98 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 N-CA-C 107.15 -1.426 . . . . 0.42999999999999999 107.15 -172.003 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.462 ' CE2' HD13 ' A' ' 8' ' ' ILE . 50.2 p90 -138.46 165.15 27.55 Favored 'General case' 0 CA--C 1.516 -0.341 0 O-C-N 122.226 -0.296 . . . . 1.71 111.626 -172.97 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 37.7 t0 -85.97 110.68 32.43 Favored Pre-proline 0 C--O 1.236 0.382 0 O-C-N 124.458 1.099 . . . . 2.9700000000000002 108.858 175.12 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -71.5 4.26 3.09 Favored 'Trans proline' 0 N--CA 1.452 -0.957 0 C-N-CA 122.772 2.315 . . . . 0.55000000000000004 113.135 -178.76 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -89.2 -27.32 20.73 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 119.478 1.035 . . . . 0.71999999999999997 109.397 168.717 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -104.63 -51.53 3.06 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 109.575 -0.528 . . . . 2.8799999999999999 109.575 -171.683 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.464 HG22 ' HB3' ' A' ' 59' ' ' ALA 0.285 1.1 p -97.7 -177.48 3.8 Favored 'General case' 0 CA--C 1.518 -0.252 0 C-N-CA 123.993 0.917 . . . . 0.51000000000000001 112.275 160.76 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 145.32 88.6 0.09 OUTLIER Glycine 0 N--CA 1.441 -1.011 0 N-CA-C 104.448 -3.461 . . . . 2.52 104.448 -155.295 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 45.1 p -13.07 -17.96 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.556 1 C-N-CA 137.936 6.494 . . . . 1.1399999999999999 119.956 -143.228 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -27.61 -63.48 0.09 Allowed 'General case' 0 N--CA 1.443 -0.803 0 C-N-CA 127.01 2.124 . . . . 0.5 114.317 166.405 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.472 ' HB1' ' SD ' ' A' ' 31' ' ' MET . . . -73.73 -37.3 65.14 Favored 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 118.485 -1.286 . . . . 0.5 109.069 -168.861 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.5 mp -53.93 -57.5 5.53 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.808 0 CA-C-N 114.402 -1.272 . . . . 1.03 109.884 175.638 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.04 -48.0 81.42 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 119.047 0.84 . . . . 1.1200000000000001 109.55 -178.414 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -45.57 -57.39 4.2 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 123.312 0.645 . . . . 3.25 111.932 176.393 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.7 mmmm -68.3 -42.34 79.61 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-O 118.545 -0.741 . . . . 3.5299999999999998 111.376 -179.538 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -46.0 -52.65 2.84 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 C-N-CA 125.003 1.321 . . . . 0.42999999999999999 108.579 177.048 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -59.45 -58.44 8.61 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 124.503 1.121 . . . . 1.54 110.545 176.391 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -55.62 -34.87 65.28 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 113.006 0.743 . . . . 3.73 113.006 -176.792 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 26.6 mt -68.87 -17.32 63.97 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.774 1.229 . . . . 0.55000000000000004 111.721 177.484 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 92.11 43.47 4.38 Favored Glycine 0 CA--C 1.522 0.531 0 N-CA-C 110.129 -1.189 . . . . 0.40999999999999998 110.129 178.813 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.442 ' CD1' HG21 ' A' ' 24' ' ' ILE . 0.4 OUTLIER -141.46 171.52 13.94 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 124.189 0.996 . . . . 1.97 110.015 -176.364 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 8.8 t-80 -143.71 127.48 17.2 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 107.842 -1.17 . . . . 1.72 107.842 172.732 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 5.8 p -97.22 151.74 4.15 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 N-CA-C 108.114 -1.069 . . . . 1.4399999999999999 108.114 174.53 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 38.3 t -120.0 139.76 46.26 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 C-N-CA 125.173 1.389 . . . . 0.56999999999999995 108.358 -179.455 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 26.7 mm . . . . . 0 C--N 1.331 -0.234 0 CA-C-O 122.119 0.961 . . . . 1.1100000000000001 109.737 -169.772 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.7 m . . . . . 0 N--CA 1.45 -0.436 0 N-CA-C 108.655 -0.868 . . . . 0.84999999999999998 108.655 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -69.78 176.57 3.54 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 109.146 -0.687 . . . . 2.2999999999999998 109.146 173.133 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.67 155.07 45.6 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 124.205 1.002 . . . . 0.92000000000000004 108.431 176.39 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 10.8 ttmt -147.33 158.85 44.12 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 107.733 -1.21 . . . . 3.0699999999999998 107.733 168.268 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -119.13 98.68 6.29 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 127.728 2.411 . . . . 1.9099999999999999 104.669 -176.493 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 23.0 mm -84.37 164.32 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.171 0 N-CA-C 106.839 -1.541 . . . . 2.4300000000000002 106.839 173.875 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -134.18 124.83 26.67 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 107.065 -1.458 . . . . 0.48999999999999999 107.065 176.942 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 24.7 mtm -134.63 172.87 12.33 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.62 0.768 . . . . 2.0800000000000001 109.101 -179.145 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 21.5 mm100 -103.19 154.7 19.04 Favored 'General case' 0 C--O 1.222 -0.35 0 C-N-CA 125.394 1.477 . . . . 2.4500000000000002 109.313 178.089 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.591 HG21 HD21 ' A' ' 41' ' ' LEU . 6.3 m -117.98 165.37 13.39 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 CA-C-N 119.38 0.991 . . . . 1.73 110.419 174.274 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 53.8 m -137.74 171.04 15.03 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.231 1.412 . . . . 1.22 108.902 175.804 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 80.03 -44.82 2.87 Favored Glycine 0 CA--C 1.533 1.187 0 C-N-CA 123.488 0.566 . . . . 3.1899999999999999 113.311 173.622 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -38.55 122.37 1.11 Allowed 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 125.13 1.372 . . . . 2.8900000000000001 113.319 -177.231 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -139.48 12.53 2.55 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.896 0.878 . . . . 3.3199999999999998 112.014 177.842 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 8.9 m -115.59 -26.48 7.47 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 125.528 1.531 . . . . 2.9399999999999999 111.512 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 64.68 -63.71 0.17 Allowed 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.646 1.578 . . . . 2.4700000000000002 110.482 -162.207 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -41.59 -54.66 3.14 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 125.895 1.678 . . . . 0.87 112.748 -179.767 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 90.0 m -55.82 -31.43 62.68 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 113.183 0.808 . . . . 1.48 113.183 -178.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.817 ' HB1' HG21 ' A' ' 39' ' ' VAL . . . -61.4 -26.8 68.09 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 121.108 0.48 . . . . 0.41999999999999998 110.514 176.519 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.93 -50.74 31.42 Favored 'General case' 0 N--CA 1.452 -0.354 0 O-C-N 120.321 -1.487 . . . . 0.40000000000000002 109.053 170.035 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 55.2 mtm180 -51.33 -46.32 62.6 Favored 'General case' 0 N--CA 1.456 -0.154 0 CA-C-O 118.871 -0.585 . . . . 5.29 110.978 -177.417 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.462 HG21 ' CD1' ' A' ' 69' ' ' TYR . 4.5 pt -58.43 -55.86 19.96 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.237 0 C-N-CA 119.784 -0.766 . . . . 0.48999999999999999 110.681 178.098 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -53.29 -42.28 66.45 Favored 'General case' 0 C--O 1.225 -0.211 0 CA-C-N 119.568 1.076 . . . . 2.6899999999999999 111.715 179.804 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 32.0 mmtp -70.65 -44.93 66.1 Favored 'General case' 0 CA--C 1.536 0.414 0 O-C-N 121.228 -0.92 . . . . 1.95 110.897 -178.949 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -66.11 -25.8 72.28 Favored Glycine 0 CA--C 1.53 0.991 0 O-C-N 121.583 -0.698 . . . . 1.01 111.875 176.731 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 7.7 tt -70.38 -53.73 15.38 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 126.915 2.086 . . . . 1.8100000000000001 107.693 172.698 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -51.1 -18.51 0.86 Allowed 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 126.658 1.983 . . . . 3.4199999999999999 113.987 179.114 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -72.74 -16.05 61.66 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.044 1.338 . . . . 4.0300000000000002 113.035 176.365 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 7.1 ptp -68.01 160.28 75.18 Favored Pre-proline 0 CA--C 1.537 0.456 0 CA-C-N 118.934 0.788 . . . . 3.77 111.178 -179.736 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -61.51 134.75 53.06 Favored 'Trans proline' 0 N--CA 1.454 -0.829 0 C-N-CA 121.622 1.548 . . . . 0.57999999999999996 109.287 167.064 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 106.58 -54.16 0.59 Allowed Glycine 0 CA--C 1.529 0.943 0 C-N-CA 124.558 1.075 . . . . 1.0 111.933 174.868 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 56.2 t -73.24 113.11 10.58 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 O-C-N 120.912 -1.346 . . . . 0.93000000000000005 110.914 -173.776 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -80.83 -48.08 12.93 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-O 117.745 -1.122 . . . . 1.1699999999999999 108.712 -179.505 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -140.65 156.93 46.11 Favored 'General case' 0 C--N 1.342 0.264 0 CA-C-N 119.249 0.931 . . . . 2.2599999999999998 110.496 -177.478 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -154.96 148.56 25.33 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 112.23 0.455 . . . . 0.44 112.23 179.08 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -155.93 124.14 5.78 Favored 'General case' 0 C--N 1.342 0.245 0 N-CA-C 108.75 -0.833 . . . . 0.45000000000000001 108.75 -165.487 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.936 HG22 HD23 ' A' ' 41' ' ' LEU . 6.6 p -93.13 107.46 19.17 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 C-N-CA 123.694 0.798 . . . . 0.53000000000000003 109.614 -177.658 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 52.8 t-20 -88.89 58.36 4.56 Favored 'General case' 0 C--O 1.238 0.469 0 O-C-N 120.492 -1.38 . . . . 0.60999999999999999 109.364 -177.809 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.936 HD23 HG22 ' A' ' 39' ' ' VAL . 0.3 OUTLIER -68.27 -19.43 64.71 Favored 'General case' 0 N--CA 1.457 -0.114 0 CA-C-N 114.459 -1.246 . . . . 0.87 111.393 -175.223 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -45.85 -35.77 4.75 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 123.601 0.76 . . . . 0.68000000000000005 111.922 166.778 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 5.3 t -124.58 34.47 5.01 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.063 0.545 . . . . 1.3100000000000001 109.856 173.941 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 51.79 25.71 3.11 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.609 1.564 . . . . 2.7799999999999998 113.547 175.945 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 6.9 m -113.51 163.83 14.41 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.582 1.153 . . . . 0.63 108.468 -176.603 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.7 p -131.5 144.82 36.39 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.121 0 C-N-CA 124.442 1.097 . . . . 0.33000000000000002 108.947 173.754 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 20.7 m120 -129.55 133.49 47.24 Favored 'General case' 0 C--N 1.342 0.271 0 C-N-CA 124.219 1.008 . . . . 0.33000000000000002 108.399 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 40.1 t -128.74 123.67 59.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 N-CA-C 105.415 -2.069 . . . . 2.0099999999999998 105.415 -177.578 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 13.5 mm -101.46 94.46 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 N-CA-C 106.978 -1.49 . . . . 0.45000000000000001 106.978 -173.372 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 28.8 p90 -135.17 173.82 11.29 Favored 'General case' 0 CA--C 1.508 -0.657 0 O-C-N 122.118 -0.364 . . . . 1.76 111.331 -167.188 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 47.5 p-10 -97.12 109.03 47.52 Favored Pre-proline 0 N--CA 1.447 -0.61 0 O-C-N 124.703 1.252 . . . . 4.0899999999999999 112.425 -175.776 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -69.26 13.93 0.24 Allowed 'Trans proline' 0 CA--C 1.544 1.017 0 C-N-CA 121.43 1.42 . . . . 1.0700000000000001 113.241 178.132 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -99.4 -31.33 11.72 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 125.508 1.523 . . . . 1.0600000000000001 110.841 170.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -114.82 -55.1 2.52 Favored 'General case' 0 C--N 1.345 0.376 0 CA-C-N 118.663 0.665 . . . . 2.9500000000000002 109.533 -177.865 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.441 1.3 p -83.12 -179.81 7.53 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 114.047 1.128 . . . . 0.58999999999999997 114.047 160.983 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 135.09 93.09 0.42 Allowed Glycine 0 N--CA 1.445 -0.75 0 N-CA-C 104.512 -3.435 . . . . 2.29 104.512 -148.587 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 46.1 p -16.45 -17.44 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.462 1 C-N-CA 138.843 6.857 . . . . 1.3700000000000001 119.685 -151.025 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -27.32 -63.38 0.09 Allowed 'General case' 0 N--CA 1.442 -0.83 0 C-N-CA 126.477 1.911 . . . . 0.56999999999999995 113.966 163.784 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.14 -37.07 64.16 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 118.935 -1.106 . . . . 0.46000000000000002 109.143 -168.397 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 5.9 mt -53.66 -56.53 8.38 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.616 0 C-N-CA 125.5 1.52 . . . . 1.3600000000000001 110.862 174.623 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.92 -46.02 92.33 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 119.506 1.048 . . . . 1.23 109.665 -179.104 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 -49.58 -59.76 3.48 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 122.002 0.906 . . . . 3.3999999999999999 111.617 176.565 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 6.2 mmmt -67.05 -35.6 80.23 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-O 118.068 -0.968 . . . . 3.3199999999999998 111.346 -177.643 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.1 mm -49.54 -54.56 6.42 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 N-CA-C 108.106 -1.072 . . . . 0.40000000000000002 108.106 175.096 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -58.92 -53.96 52.52 Favored 'General case' 0 C--N 1.34 0.162 0 C-N-CA 123.33 0.652 . . . . 1.8899999999999999 109.952 176.134 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.25 -28.77 67.01 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 113.199 0.814 . . . . 5.5499999999999998 113.199 -177.286 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 20.5 mt -73.49 -18.19 61.14 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.973 1.309 . . . . 0.69999999999999996 111.603 175.062 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 89.96 39.39 6.15 Favored Glycine 0 CA--C 1.524 0.634 0 C-N-CA 124.664 1.126 . . . . 0.41999999999999998 110.345 -178.104 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.462 ' CD1' HG21 ' A' ' 24' ' ' ILE . 0.2 OUTLIER -134.59 175.65 9.34 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 123.756 0.823 . . . . 1.8300000000000001 110.415 -179.631 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -143.19 138.77 29.96 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 107.406 -1.331 . . . . 2.25 107.406 171.947 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 9.2 p -117.98 133.32 65.17 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 C-N-CA 125.212 1.405 . . . . 1.3700000000000001 107.864 178.511 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 41.9 t -100.85 140.92 18.53 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 C-N-CA 125.956 1.702 . . . . 0.58999999999999997 109.01 -179.651 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 21.7 mm . . . . . 0 C--N 1.329 -0.294 0 C-N-CA 124.078 0.951 . . . . 0.93000000000000005 108.755 -174.293 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.529 0.171 0 N-CA-C 107.797 -1.186 . . . . 1.04 107.797 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -71.73 153.37 42.06 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 107.037 -1.468 . . . . 3.8700000000000001 107.037 171.671 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.33 148.61 44.83 Favored 'General case' 0 CA--C 1.518 -0.28 0 C-N-CA 123.602 0.761 . . . . 0.98999999999999999 110.146 -177.346 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 7.0 mtpm? -141.01 159.97 41.07 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 122.157 0.979 . . . . 3.6200000000000001 111.756 166.972 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -108.39 104.25 13.57 Favored 'General case' 0 N--CA 1.434 -1.238 0 C-N-CA 130.755 3.622 . . . . 1.95 103.919 -176.284 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 5.6 mm -88.68 160.09 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.35 0 N-CA-C 106.982 -1.488 . . . . 1.9099999999999999 106.982 172.401 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -124.98 137.93 54.24 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 106.517 -1.66 . . . . 0.54000000000000004 106.517 169.524 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 57.9 mtt -144.37 166.16 25.89 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 118.412 0.551 . . . . 2.79 109.659 173.659 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 11.6 mm100 -88.56 155.4 19.66 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 125.176 1.391 . . . . 2.3500000000000001 109.945 175.567 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 99.3 t -112.34 138.75 40.19 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 C-N-CA 123.935 0.894 . . . . 1.4199999999999999 110.259 -179.697 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 73.3 m -137.84 165.19 27.08 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.814 1.245 . . . . 1.0900000000000001 109.938 172.376 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 65.73 72.16 0.78 Allowed Glycine 0 CA--C 1.527 0.836 0 N-CA-C 110.891 -0.884 . . . . 1.71 110.891 176.276 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -152.56 158.14 42.06 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 123.739 0.816 . . . . 1.95 109.843 -173.951 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -105.09 -56.72 2.13 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 124.996 1.319 . . . . 2.4399999999999999 110.463 168.539 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 31.7 p -127.91 156.68 42.23 Favored 'General case' 0 C--N 1.34 0.175 0 CA-C-O 121.814 0.816 . . . . 2.23 111.504 -170.623 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -76.33 53.09 0.81 Allowed 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.771 0.829 . . . . 1.75 110.401 176.876 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -151.49 -50.36 0.12 Allowed 'General case' 0 C--O 1.232 0.136 0 C-N-CA 123.131 0.572 . . . . 0.72999999999999998 111.645 -174.686 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 5.8 p -56.04 -39.18 71.59 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 119.348 0.976 . . . . 2.4300000000000002 109.7 168.316 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.573 ' HB1' HG21 ' A' ' 39' ' ' VAL . . . -50.32 -23.28 2.22 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.869 1.267 . . . . 0.41999999999999998 113.9 171.238 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -72.09 -47.14 53.55 Favored 'General case' 0 N--CA 1.453 -0.3 0 O-C-N 120.447 -1.408 . . . . 0.37 110.133 171.41 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -57.98 -36.56 72.77 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-O 118.961 -0.543 . . . . 4.1900000000000004 110.612 -174.792 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.573 ' HA ' HD13 ' A' ' 67' ' ' LEU . 2.6 pt -59.68 -55.45 23.82 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.203 0 C-N-CA 119.578 -0.849 . . . . 0.56000000000000005 110.67 178.458 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -57.49 -47.03 82.98 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 123.286 0.634 . . . . 3.2799999999999998 111.294 178.918 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 14.7 mptt -66.61 -45.86 77.77 Favored 'General case' 0 CA--C 1.532 0.273 0 O-C-N 121.62 -0.675 . . . . 1.73 109.864 -176.192 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -67.75 -23.87 74.07 Favored Glycine 0 CA--C 1.527 0.795 0 CA-C-O 119.04 -0.867 . . . . 0.66000000000000003 111.957 176.657 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -73.57 -41.23 63.19 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.715 1.206 . . . . 2.4300000000000002 109.753 170.732 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 2.1 ttpp -56.71 -16.39 6.29 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.78 1.632 . . . . 2.9199999999999999 113.86 178.686 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.4 mmt180 -83.33 -7.44 59.58 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 126.547 1.939 . . . . 3.6800000000000002 112.338 176.865 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 96.1 mmm -77.99 150.89 78.59 Favored Pre-proline 0 C--O 1.233 0.209 0 CA-C-N 119.226 0.921 . . . . 3.1800000000000002 111.35 -179.133 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -56.56 135.37 69.97 Favored 'Trans proline' 0 N--CA 1.45 -1.064 0 C-N-CA 121.953 1.769 . . . . 0.59999999999999998 108.973 171.225 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 89.12 -9.66 76.0 Favored Glycine 0 CA--C 1.525 0.716 0 CA-C-O 118.079 -1.401 . . . . 0.54000000000000004 113.738 178.081 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 23.4 t -103.78 122.66 56.75 Favored 'Isoleucine or valine' 0 C--N 1.342 0.269 0 CA-C-N 120.349 2.074 . . . . 0.60999999999999999 109.636 176.459 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -89.38 -55.41 3.67 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-O 118.611 -0.709 . . . . 1.3200000000000001 109.151 177.127 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -139.61 156.97 46.55 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 118.875 0.761 . . . . 2.6099999999999999 110.425 -175.413 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -155.6 143.75 20.02 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 122.99 0.516 . . . . 0.41999999999999998 111.164 -174.549 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -155.35 114.39 3.58 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 109.531 -0.544 . . . . 0.58999999999999997 109.531 -165.576 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.573 HG21 ' HB1' ' A' ' 21' ' ' ALA . 4.0 p -81.25 116.7 25.99 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 N-CA-C 108.697 -0.853 . . . . 0.55000000000000004 108.697 175.814 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 50.1 t-20 -96.15 57.61 1.76 Allowed 'General case' 0 C--O 1.236 0.378 0 CA-C-O 122.961 1.362 . . . . 0.60999999999999999 107.869 177.659 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.402 HD23 HG22 ' A' ' 39' ' ' VAL . 0.2 OUTLIER -69.35 -18.47 63.8 Favored 'General case' 0 C--O 1.225 -0.203 0 CA-C-N 114.265 -1.334 . . . . 0.95999999999999996 110.419 -173.584 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -46.56 -31.14 2.61 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 124.072 0.949 . . . . 0.56999999999999995 112.502 169.045 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 6.1 t -129.59 33.4 4.48 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 122.787 0.435 . . . . 1.27 110.007 173.932 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 25.6 mp0 57.17 29.97 17.55 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.02 1.328 . . . . 3.6400000000000001 113.279 175.206 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 62.0 m -118.39 159.62 23.13 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.47 1.108 . . . . 0.68999999999999995 109.241 -176.136 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.6 p -128.72 143.75 40.16 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 O-C-N 121.21 -0.931 . . . . 0.33000000000000002 108.71 171.539 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -132.85 128.74 37.33 Favored 'General case' 0 C--N 1.342 0.263 0 N-CA-C 108.125 -1.065 . . . . 0.41999999999999998 108.125 -178.52 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 4.7 p -129.82 128.23 65.01 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.595 0 N-CA-C 106.054 -1.832 . . . . 1.75 106.054 -172.971 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 11.2 mm -105.27 88.65 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 C-N-CA 125.653 1.581 . . . . 0.42999999999999999 107.168 -174.336 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 31.3 p90 -125.8 175.3 7.73 Favored 'General case' 0 CA--C 1.512 -0.493 0 O-C-N 122.106 -0.371 . . . . 1.72 110.059 -173.012 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -102.43 100.61 16.31 Favored Pre-proline 0 N--CA 1.445 -0.693 0 C-N-CA 125.197 1.399 . . . . 4.2000000000000002 108.688 -176.309 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_endo -72.01 14.39 0.44 Allowed 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 122.288 1.992 . . . . 0.60999999999999999 113.911 -176.085 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -81.77 -30.96 32.12 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 108.92 -0.77 . . . . 0.81999999999999995 108.92 162.717 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -114.26 -62.61 1.57 Allowed 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 123.769 0.828 . . . . 3.77 108.856 -166.678 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.468 0.6 OUTLIER -77.11 -179.25 5.47 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 114.985 1.476 . . . . 0.51000000000000001 114.985 162.483 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 179.99 -150.32 9.13 Favored Glycine 0 N--CA 1.431 -1.7 1 N-CA-C 102.717 -4.153 . . . . 2.54 102.717 -172.46 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 20.7 p -72.54 -36.75 68.34 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 124.569 1.148 . . . . 1.3200000000000001 108.75 175.385 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -42.07 -63.05 0.8 Allowed 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 126.136 1.775 . . . . 0.55000000000000004 113.409 -171.69 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -72.0 -38.79 69.59 Favored 'General case' 0 CA--C 1.515 -0.378 0 C-N-CA 118.483 -1.287 . . . . 0.62 109.032 -170.169 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.3 mp -54.46 -55.93 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.931 0 CA-C-N 115.014 -0.994 . . . . 0.77000000000000002 109.663 178.834 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.2 -46.08 85.49 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 119.094 0.861 . . . . 1.1299999999999999 109.991 -176.481 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -47.54 -57.58 5.25 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 122.664 1.221 . . . . 2.6299999999999999 110.676 175.573 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 11.5 mmmt -68.3 -37.26 80.44 Favored 'General case' 0 N--CA 1.437 -1.121 0 CA-C-N 115.409 -0.814 . . . . 3.77 111.974 -177.122 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.3 mm -52.34 -53.08 20.96 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 N-CA-C 107.937 -1.134 . . . . 0.38 107.937 176.787 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 21.1 mm-40 -59.32 -56.58 20.22 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.702 0.801 . . . . 1.9299999999999999 110.404 176.698 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 5.8 mmmt -54.81 -37.28 65.91 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 113.29 0.848 . . . . 4.7000000000000002 113.29 -178.482 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.573 HD13 ' HA ' ' A' ' 24' ' ' ILE . 11.4 mt -71.14 -18.15 62.52 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.542 1.137 . . . . 0.65000000000000002 111.883 175.855 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 93.58 44.17 3.76 Favored Glycine 0 CA--C 1.525 0.659 0 C-N-CA 124.581 1.086 . . . . 0.41999999999999998 110.799 176.748 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.459 ' CD1' HG21 ' A' ' 24' ' ' ILE . 0.3 OUTLIER -139.98 172.85 12.18 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 124.033 0.933 . . . . 1.8100000000000001 110.588 -176.635 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -139.98 118.04 11.87 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 109.086 -0.709 . . . . 1.8999999999999999 109.086 173.774 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 5.7 p -91.49 147.74 5.07 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 N-CA-C 107.892 -1.151 . . . . 1.3999999999999999 107.892 172.058 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 41.2 t -123.26 141.52 43.26 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.102 0 C-N-CA 124.574 1.15 . . . . 0.60999999999999999 108.691 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 4.8 mp . . . . . 0 CA--C 1.532 0.273 0 C-N-CA 124.052 0.941 . . . . 1.3600000000000001 108.47 -173.353 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 11.5 m . . . . . 0 N--CA 1.448 -0.559 0 N-CA-C 108.457 -0.942 . . . . 0.89000000000000001 108.457 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -72.24 165.47 24.37 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 108.918 -0.771 . . . . 2.7200000000000002 108.918 163.342 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -124.02 151.9 43.21 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 124.91 1.284 . . . . 1.0900000000000001 111.02 -177.2 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.3 mmpt? -137.81 157.12 47.1 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 122.938 0.495 . . . . 4.0599999999999996 110.22 165.26 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -104.24 97.95 7.83 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 127.799 2.439 . . . . 1.9199999999999999 106.28 177.846 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 10.0 mm -87.01 160.02 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.258 0 N-CA-C 107.378 -1.342 . . . . 2.1200000000000001 107.378 177.833 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -131.5 139.03 49.21 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 125.71 1.604 . . . . 0.47999999999999998 107.566 178.33 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 12.5 ptp -156.43 175.19 14.34 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.129 0.571 . . . . 1.8700000000000001 110.132 179.059 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 29.9 mm100 -99.44 162.57 12.96 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 125.265 1.426 . . . . 2.4700000000000002 109.545 179.057 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.425 HG13 HG11 ' A' ' 46' ' ' VAL . 0.0 OUTLIER -130.54 157.08 42.93 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.146 0 C-N-CA 124.343 1.057 . . . . 2.0699999999999998 110.261 176.499 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 62.0 m -146.4 164.7 31.61 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 124.465 1.106 . . . . 0.94999999999999996 109.343 177.109 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 70.53 68.37 1.65 Allowed Glycine 0 CA--C 1.526 0.756 0 N-CA-C 110.02 -1.232 . . . . 1.52 110.02 179.49 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -144.82 165.27 28.58 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 123.723 0.809 . . . . 1.7 110.065 -178.312 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.1 p -113.88 -72.1 0.72 Allowed 'General case' 0 CA--C 1.527 0.068 0 C-N-CA 124.438 1.095 . . . . 2.3700000000000001 108.939 168.29 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 14.4 p -105.82 152.22 23.51 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 121.781 0.801 . . . . 2.0899999999999999 112.023 -173.371 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -75.54 54.5 0.76 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.379 1.072 . . . . 1.9399999999999999 110.527 176.51 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -146.87 -49.09 0.19 Allowed 'General case' 0 CA--C 1.526 0.045 0 C-N-CA 123.774 0.829 . . . . 0.87 110.597 -179.317 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 61.9 m -56.99 -36.89 70.91 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 118.67 0.668 . . . . 1.26 110.638 172.657 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.77 ' HB1' HG21 ' A' ' 39' ' ' VAL . . . -50.3 -26.71 5.1 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.758 0.823 . . . . 0.40999999999999998 112.595 171.65 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.45 -48.24 50.63 Favored 'General case' 0 N--CA 1.452 -0.328 0 O-C-N 120.162 -1.586 . . . . 0.37 109.204 174.017 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 61.7 mtt85 -54.36 -42.86 70.77 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 123.542 0.737 . . . . 5.2000000000000002 109.885 -175.249 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.488 HG21 ' CD1' ' A' ' 69' ' ' TYR 0.258 2.1 pt -58.56 -57.8 9.41 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 C-N-CA 120.044 -0.662 . . . . 0.5 110.478 177.478 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -53.1 -40.28 64.0 Favored 'General case' 0 C--O 1.224 -0.28 0 CA-C-N 118.839 0.745 . . . . 2.1899999999999999 111.632 178.248 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 4.1 mptp? -71.32 -48.31 51.33 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 119.446 1.021 . . . . 1.6699999999999999 111.041 -177.455 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -60.87 -36.43 92.01 Favored Glycine 0 CA--C 1.529 0.962 0 N-CA-C 110.897 -0.881 . . . . 0.56000000000000005 110.897 175.882 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 8.4 tt -62.54 -49.49 75.1 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 124.739 1.216 . . . . 1.8300000000000001 107.971 175.082 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -57.14 -22.77 42.52 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 124.582 1.153 . . . . 3.4100000000000001 113.062 178.816 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.7 mmt180 -72.65 -10.99 60.45 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.956 0.902 . . . . 3.4700000000000002 112.309 175.868 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' MET . . . . . 0.45 ' CE ' ' HB3' ' A' ' 59' ' ' ALA . 3.1 ptt? -75.79 153.64 85.14 Favored Pre-proline 0 CA--C 1.533 0.302 0 CA-C-N 119.071 0.85 . . . . 4.7599999999999998 111.692 -179.358 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -60.86 136.08 63.76 Favored 'Trans proline' 0 N--CA 1.451 -0.995 0 C-N-CA 121.589 1.526 . . . . 0.77000000000000002 108.972 172.135 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 100.15 -28.79 14.06 Favored Glycine 0 CA--C 1.53 1.003 0 CA-C-O 118.504 -1.164 . . . . 0.68000000000000005 112.978 177.877 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 24.8 t -95.52 123.16 47.57 Favored 'Isoleucine or valine' 0 C--N 1.346 0.422 0 CA-C-N 119.62 1.71 . . . . 0.68999999999999995 111.185 176.775 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 86.9 m -90.32 -53.65 4.36 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-O 117.858 -1.068 . . . . 1.2 110.378 -179.007 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -135.97 158.11 45.2 Favored 'General case' 0 C--N 1.343 0.318 0 CA-C-N 119.576 1.08 . . . . 2.4500000000000002 110.698 177.235 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -156.91 148.17 22.11 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 114.38 1.252 . . . . 0.47999999999999998 114.38 177.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -155.15 113.19 3.44 Favored 'General case' 0 C--N 1.344 0.365 0 N-CA-C 107.241 -1.392 . . . . 0.48999999999999999 107.241 -162.328 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.77 HG21 ' HB1' ' A' ' 21' ' ' ALA . 6.4 p -82.36 114.68 23.62 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 N-CA-C 108.952 -0.758 . . . . 0.52000000000000002 108.952 178.855 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -94.05 57.93 2.48 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 122.994 1.378 . . . . 2.0600000000000001 108.718 -178.998 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.69 HD23 HG22 ' A' ' 39' ' ' VAL . 0.2 OUTLIER -66.85 -17.54 64.94 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 114.361 -1.291 . . . . 0.85999999999999999 111.094 -177.342 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -41.29 -39.7 1.46 Allowed 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 124.901 1.28 . . . . 0.67000000000000004 112.747 168.605 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 9.1 t -127.43 35.88 4.47 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 117.666 0.212 . . . . 1.24 110.621 172.094 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 61.54 36.23 17.04 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.462 1.105 . . . . 4.3700000000000001 113.195 173.162 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 4.8 m -123.5 161.21 25.33 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.051 1.34 . . . . 0.73999999999999999 109.369 -176.545 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.425 HG11 HG13 ' A' ' 12' ' ' VAL . 0.8 OUTLIER -127.68 144.18 38.35 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 C-N-CA 124.423 1.089 . . . . 0.64000000000000001 108.417 172.898 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -131.83 145.04 51.33 Favored 'General case' 0 C--N 1.347 0.491 0 N-CA-C 108.327 -0.99 . . . . 0.45000000000000001 108.327 177.108 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 5.4 p -145.46 125.24 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 N-CA-C 106.642 -1.614 . . . . 1.79 106.642 -172.262 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 9.6 mm -105.79 83.53 0.72 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.49 0 C-N-CA 126.286 1.834 . . . . 0.46000000000000002 106.984 -171.029 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 51.6 p90 -119.56 175.9 5.62 Favored 'General case' 0 CA--C 1.506 -0.731 0 N-CA-C 109.197 -0.668 . . . . 1.97 109.197 -172.702 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -101.65 95.26 5.07 Favored Pre-proline 0 N--CA 1.443 -0.78 0 O-C-N 124.813 1.321 . . . . 4.2999999999999998 110.199 -176.263 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -74.49 14.7 0.74 Allowed 'Trans proline' 0 CA--C 1.537 0.661 0 C-N-CA 122.833 2.355 . . . . 0.93999999999999995 113.56 -173.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -89.09 -21.79 23.21 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 124.021 0.928 . . . . 1.48 109.5 166.117 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -113.63 -62.19 1.63 Allowed 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 125.212 1.405 . . . . 3.52 107.723 -175.497 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.285 0.7 OUTLIER -82.62 -179.75 7.53 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 115.223 1.564 . . . . 0.78000000000000003 115.223 170.319 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -163.53 -128.42 0.95 Allowed Glycine 0 N--CA 1.434 -1.496 0 N-CA-C 104.164 -3.574 . . . . 2.5899999999999999 104.164 175.525 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 18.3 p -81.82 -30.54 32.14 Favored 'General case' 0 C--N 1.318 -0.792 0 C-N-CA 126.874 2.07 . . . . 1.3400000000000001 110.636 172.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -53.2 -62.44 1.65 Allowed 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 124.327 1.051 . . . . 0.62 112.769 -157.598 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.45 ' HB3' ' CE ' ' A' ' 31' ' ' MET . . . -75.14 -24.58 57.99 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 113.931 -1.486 . . . . 0.77000000000000002 110.285 -172.644 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.5 mt -66.85 -49.16 76.68 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 C-N-CA 124.341 1.056 . . . . 1.3 109.576 -178.914 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.18 -43.94 93.55 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 107.806 -1.183 . . . . 1.9299999999999999 107.806 -177.501 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -48.5 -59.64 3.32 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 123.833 0.853 . . . . 2.7599999999999998 111.032 172.596 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 10.3 mmtp -60.65 -42.37 96.83 Favored 'General case' 0 N--CA 1.441 -0.912 0 O-C-N 121.712 -0.617 . . . . 3.0600000000000001 111.716 -178.777 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -48.82 -54.69 4.57 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 C-N-CA 125.007 1.323 . . . . 0.44 108.745 176.345 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 29.5 mm-40 -60.9 -53.85 52.3 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 123.481 0.712 . . . . 1.9099999999999999 110.197 178.274 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -56.15 -38.41 70.82 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 112.668 0.618 . . . . 4.2000000000000002 112.668 -176.382 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 15.9 mt -69.98 -17.06 63.27 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.617 1.167 . . . . 0.67000000000000004 111.911 176.611 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 92.86 41.36 4.69 Favored Glycine 0 CA--C 1.522 0.513 0 N-CA-C 110.73 -0.948 . . . . 0.51000000000000001 110.73 175.812 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.488 ' CD1' HG21 ' A' ' 24' ' ' ILE . 0.2 OUTLIER -133.81 175.3 9.58 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 123.672 0.789 . . . . 2.1000000000000001 110.145 178.993 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 4.2 t60 -139.34 143.73 37.93 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 109.162 -0.681 . . . . 1.71 109.162 170.276 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 12.4 p -112.84 150.07 15.11 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 C-N-CA 126.385 1.874 . . . . 1.9299999999999999 107.987 -175.808 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 13.5 t -132.33 147.67 32.05 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 C-N-CA 124.283 1.033 . . . . 0.56000000000000005 108.301 -179.493 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 4.6 mp . . . . . 0 N--CA 1.449 -0.501 0 C-N-CA 124.609 1.163 . . . . 1.45 108.567 179.98 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.4 m . . . . . 0 N--CA 1.456 -0.171 0 N-CA-C 106.077 -1.823 . . . . 0.68999999999999995 106.077 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -70.82 173.75 6.93 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 107.774 -1.195 . . . . 2.1000000000000001 107.774 163.33 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -129.3 151.53 49.85 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 123.491 0.717 . . . . 1.7 109.099 172.621 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 69.6 mmtt -140.92 157.72 44.97 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.213 1.005 . . . . 3.1800000000000002 111.07 166.818 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -116.21 91.79 3.7 Favored 'General case' 0 N--CA 1.435 -1.181 0 C-N-CA 128.226 2.61 . . . . 1.46 106.61 -168.442 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 8.0 mm -82.41 158.48 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.261 0 N-CA-C 106.977 -1.49 . . . . 1.9399999999999999 106.977 -178.178 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -131.44 139.01 49.29 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 107.093 -1.447 . . . . 0.62 107.093 172.112 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -155.43 176.28 12.79 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 122.992 0.517 . . . . 1.8200000000000001 109.738 170.541 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 27.4 mm100 -95.35 165.37 12.41 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.627 1.171 . . . . 2.6099999999999999 110.152 -178.594 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 31.6 t -128.44 132.19 68.26 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 C-N-CA 124.597 1.159 . . . . 1.1599999999999999 109.804 -174.111 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 32.9 m -117.74 176.29 5.26 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 125.195 1.398 . . . . 0.89000000000000001 109.348 169.691 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 82.15 -44.88 3.23 Favored Glycine 0 CA--C 1.53 0.994 0 O-C-N 121.553 -0.717 . . . . 2.2400000000000002 111.603 178.862 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -44.52 142.18 1.71 Allowed 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 124.121 0.968 . . . . 2.27 112.691 176.066 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -147.71 -45.71 0.16 Allowed 'General case' 0 CA--C 1.53 0.173 0 C-N-CA 124.559 1.144 . . . . 3.2400000000000002 110.432 171.787 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 24.3 p -71.16 -16.58 62.54 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 112.616 0.599 . . . . 3.04 112.616 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 59.97 28.32 17.82 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.808 1.243 . . . . 2.0499999999999998 112.209 -179.193 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -130.66 -51.9 1.07 Allowed 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 124.609 1.164 . . . . 0.90000000000000002 110.252 -179.605 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 52.5 m -51.06 -31.68 19.49 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 125.145 1.378 . . . . 1.6399999999999999 112.548 172.174 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.5 -26.38 31.14 Favored 'General case' 0 CA--C 1.539 0.548 0 O-C-N 121.885 -0.509 . . . . 0.40999999999999998 111.865 173.302 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.02 -46.4 62.2 Favored 'General case' 0 N--CA 1.454 -0.248 0 O-C-N 120.304 -1.497 . . . . 0.38 110.638 169.832 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 8.9 mtt85 -51.68 -44.69 63.17 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-O 119.171 -0.443 . . . . 3.6600000000000001 110.346 -177.257 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.425 HG21 ' CD1' ' A' ' 69' ' ' TYR 0.262 2.3 pt -59.76 -55.4 24.2 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.201 0 C-N-CA 119.642 -0.823 . . . . 0.64000000000000001 111.217 -178.954 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -55.67 -42.63 75.38 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-N 118.693 0.679 . . . . 2.1600000000000001 112.08 177.454 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -70.88 -46.84 61.88 Favored 'General case' 0 CA--C 1.533 0.294 0 O-C-N 121.68 -0.637 . . . . 1.8200000000000001 110.078 -175.158 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -58.38 -44.38 95.23 Favored Glycine 0 CA--C 1.527 0.815 0 N-CA-C 110.127 -1.189 . . . . 0.72999999999999998 110.127 173.35 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -61.65 -43.14 99.41 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.688 0.795 . . . . 2.3900000000000001 109.486 -179.475 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 7.3 ttmt -51.98 -29.87 22.47 Favored 'General case' 0 CA--C 1.531 0.237 0 O-C-N 121.036 -1.04 . . . . 2.77 111.595 173.638 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.84 -0.75 19.45 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-O 118.065 -0.969 . . . . 4.4100000000000001 113.352 -175.806 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 93.8 mmm -89.05 152.7 48.57 Favored Pre-proline 0 CA--C 1.535 0.393 0 C-N-CA 126.738 2.015 . . . . 3.5 111.164 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -60.08 138.92 84.87 Favored 'Trans proline' 0 N--CA 1.453 -0.901 0 C-N-CA 122.236 1.958 . . . . 0.73999999999999999 109.547 175.786 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 97.29 -30.99 8.2 Favored Glycine 0 CA--C 1.523 0.588 0 CA-C-O 119.0 -0.889 . . . . 0.47999999999999998 112.536 179.478 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 16.3 t -92.04 140.19 16.59 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.212 0 CA-C-N 119.241 1.521 . . . . 0.62 109.114 -179.103 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -119.43 -42.79 2.64 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 118.273 -0.87 . . . . 0.98999999999999999 111.129 179.798 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -138.73 161.85 36.15 Favored 'General case' 0 CA--C 1.518 -0.278 0 CA-C-N 119.838 1.199 . . . . 2.1299999999999999 111.433 171.693 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -157.68 138.94 13.56 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 123.125 0.57 . . . . 0.47999999999999998 111.018 -175.467 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -150.13 102.61 3.11 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 106.7 -1.593 . . . . 0.67000000000000004 106.7 -163.057 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 10.4 p -82.13 107.0 13.68 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 CA-C-O 121.252 0.549 . . . . 0.60999999999999999 110.498 -179.201 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 48.9 t30 -84.43 56.82 3.97 Favored 'General case' 0 CA--C 1.537 0.476 0 O-C-N 120.567 -1.333 . . . . 0.93000000000000005 109.992 179.531 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.418 HD22 ' HA ' ' A' ' 41' ' ' LEU . 0.4 OUTLIER -74.93 -16.1 60.66 Favored 'General case' 0 N--CA 1.461 0.101 0 CA-C-N 115.446 -0.797 . . . . 0.92000000000000004 110.422 176.706 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -45.64 -37.37 5.62 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.742 0.817 . . . . 1.27 111.396 167.745 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 15.0 t -98.54 -68.48 0.8 Allowed 'General case' 0 C--N 1.344 0.329 0 CA-C-O 117.703 -1.141 . . . . 3.5600000000000001 110.198 165.512 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 159.93 43.55 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 127.61 2.364 . . . . 2.8599999999999999 110.864 -176.841 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 79.7 m -142.64 162.4 35.56 Favored 'General case' 0 CA--C 1.534 0.333 0 O-C-N 120.464 -1.397 . . . . 0.83999999999999997 108.805 -171.595 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.4 p -125.75 145.92 32.36 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 O-C-N 121.232 -0.917 . . . . 0.45000000000000001 108.981 172.75 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -127.79 143.51 51.12 Favored 'General case' 0 C--N 1.345 0.38 0 N-CA-C 108.017 -1.105 . . . . 0.46999999999999997 108.017 170.835 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.2 p -140.41 127.11 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 N-CA-C 107.226 -1.398 . . . . 1.74 107.226 -176.405 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 18.5 mm -103.5 90.05 1.58 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.604 0 C-N-CA 125.935 1.694 . . . . 0.51000000000000001 107.107 -173.64 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 6.8 p90 -128.82 166.42 19.09 Favored 'General case' 0 CA--C 1.508 -0.669 0 CA-C-O 121.452 0.644 . . . . 1.7 111.751 -174.285 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -96.04 108.99 44.5 Favored Pre-proline 0 N--CA 1.444 -0.736 0 CA-C-N 114.172 -1.376 . . . . 4.2199999999999998 109.187 -172.881 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -73.45 13.97 0.66 Allowed 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 123.009 2.473 . . . . 0.85999999999999999 112.99 -173.523 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -85.23 -35.47 21.57 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 123.823 0.849 . . . . 1.3100000000000001 108.728 166.294 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -109.99 -54.36 2.57 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 108.638 -0.875 . . . . 3.1800000000000002 108.638 -168.816 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.571 HG22 ' HB3' ' A' ' 59' ' ' ALA 0.314 0.9 OUTLIER -86.56 -173.98 4.77 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-O 121.037 0.446 . . . . 0.56999999999999995 111.674 162.594 . . . . . . . . 4 4 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 128.88 88.64 0.56 Allowed Glycine 0 N--CA 1.442 -0.948 0 N-CA-C 103.702 -3.759 . . . . 2.3599999999999999 103.702 -150.379 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 26.5 p -13.75 -18.41 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.499 1 C-N-CA 138.735 6.814 . . . . 1.1699999999999999 119.748 -146.434 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -28.12 -63.36 0.1 Allowed 'General case' 0 N--CA 1.441 -0.877 0 C-N-CA 126.857 2.063 . . . . 0.5 113.841 164.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.571 ' HB3' HG22 ' A' ' 55' ' ' THR . . . -72.02 -41.1 67.94 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 118.098 -1.441 . . . . 0.47999999999999998 109.164 -167.431 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.5 mp -52.32 -54.72 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.845 0 CA-C-N 114.303 -1.317 . . . . 0.85999999999999999 109.146 175.578 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.55 -45.7 85.99 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 118.963 0.801 . . . . 1.6899999999999999 109.294 -175.393 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -52.12 -53.37 43.49 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 122.396 1.093 . . . . 2.9300000000000002 110.27 178.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.414 ' HA ' ' CE ' ' A' ' 63' ' ' LYS . 1.2 mmpt? -70.71 -37.54 73.57 Favored 'General case' 0 N--CA 1.432 -1.363 0 CA-C-O 118.233 -0.889 . . . . 2.4900000000000002 112.369 -177.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.5 mm -47.61 -51.65 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 C-N-CA 124.66 1.184 . . . . 0.40000000000000002 108.233 177.088 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -54.0 -60.31 3.5 Favored 'General case' 0 C--N 1.34 0.182 0 C-N-CA 123.625 0.77 . . . . 2.5499999999999998 110.781 174.315 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -63.71 -29.52 70.73 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 112.679 0.622 . . . . 5.2000000000000002 112.679 -172.241 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 23.8 mt -70.03 -18.35 63.3 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.425 1.49 . . . . 0.75 111.02 172.936 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 95.32 39.07 4.59 Favored Glycine 0 CA--C 1.524 0.645 0 C-N-CA 124.959 1.266 . . . . 0.39000000000000001 110.937 175.319 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.425 ' CD1' HG21 ' A' ' 24' ' ' ILE . 0.7 OUTLIER -137.74 175.43 9.59 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.605 0.762 . . . . 2.0299999999999998 111.863 -173.104 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 4.3 t-80 -152.08 111.68 3.96 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 125.008 1.323 . . . . 2.3900000000000001 107.495 -176.686 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 3.6 m -82.96 160.99 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.239 0 N-CA-C 108.877 -0.786 . . . . 2.3599999999999999 108.877 169.554 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 21.6 t -122.96 142.12 40.74 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 N-CA-C 108.468 -0.938 . . . . 0.70999999999999996 108.468 176.712 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 45.4 mm . . . . . 0 N--CA 1.452 -0.353 0 C-N-CA 125.277 1.431 . . . . 1.25 108.164 -175.69 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 25.1 m . . . . . 0 N--CA 1.45 -0.44 0 N-CA-C 106.499 -1.667 . . . . 0.89000000000000001 106.499 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -77.01 179.74 6.05 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 108.817 -0.808 . . . . 2.3599999999999999 108.817 160.521 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -135.38 147.79 49.17 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 106.693 -1.595 . . . . 1.45 106.693 166.576 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 20.0 mmtp -140.53 156.05 46.43 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 123.343 0.657 . . . . 3.5499999999999998 109.921 165.857 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -108.06 99.14 8.6 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 128.011 2.524 . . . . 1.9099999999999999 107.615 -174.763 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.9 mm -82.97 157.44 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.98 0 N-CA-C 107.205 -1.405 . . . . 1.8899999999999999 107.205 177.85 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -135.66 129.99 33.63 Favored 'General case' 0 C--O 1.231 0.112 0 C-N-CA 124.606 1.162 . . . . 0.45000000000000001 107.893 178.653 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 10.0 ptt? -156.16 175.54 13.84 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.019 0.528 . . . . 2.6600000000000001 110.485 -176.015 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -101.2 162.16 13.1 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 127.505 2.322 . . . . 3.77 110.701 -177.787 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 46.1 t -119.34 144.86 26.54 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 C-N-CA 124.436 1.094 . . . . 1.3500000000000001 109.316 -176.418 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 41.3 t -135.72 175.61 9.44 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.767 1.227 . . . . 2.4100000000000001 109.153 173.402 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 51.66 58.16 10.79 Favored Glycine 0 CA--C 1.529 0.917 0 C-N-CA 124.661 1.124 . . . . 1.6799999999999999 111.254 -175.908 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -134.41 150.64 50.89 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 123.634 0.773 . . . . 1.6899999999999999 110.827 -172.88 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -99.62 -57.21 2.2 Favored 'General case' 0 CA--C 1.528 0.113 0 C-N-CA 125.23 1.412 . . . . 2.3900000000000001 111.204 169.22 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 20.8 p -144.29 165.44 27.89 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 121.808 0.813 . . . . 2.3500000000000001 111.941 -169.664 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -75.64 54.26 0.77 Allowed 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.209 1.404 . . . . 2.0 110.746 178.725 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -147.62 -58.53 0.26 Allowed 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 124.373 1.069 . . . . 0.85999999999999999 108.709 177.558 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 26.8 m -57.15 -40.98 78.29 Favored 'General case' 0 CA--C 1.53 0.186 0 O-C-N 121.994 -0.441 . . . . 1.4399999999999999 110.168 176.889 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.23 -21.03 7.98 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.801 0.84 . . . . 0.55000000000000004 113.032 174.952 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.515 ' HA ' HG11 ' A' ' 39' ' ' VAL . . . -72.44 -47.37 49.55 Favored 'General case' 0 N--CA 1.453 -0.298 0 O-C-N 120.667 -1.271 . . . . 0.47999999999999998 110.793 170.545 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 54.4 mmm-85 -53.37 -44.65 68.77 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 109.77 -0.456 . . . . 4.3700000000000001 109.77 -172.129 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.501 ' HA ' HD13 ' A' ' 67' ' ' LEU . 3.5 pt -57.85 -54.02 37.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 CA-C-O 118.69 -0.672 . . . . 0.55000000000000004 110.5 178.333 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -57.14 -40.73 77.74 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.797 0.839 . . . . 2.3799999999999999 112.133 179.452 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 31.9 mmtp -70.7 -43.98 67.87 Favored 'General case' 0 CA--C 1.534 0.358 0 O-C-N 121.414 -0.804 . . . . 1.9199999999999999 110.552 -178.581 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -63.74 -38.68 96.55 Favored Glycine 0 CA--C 1.53 1.019 0 N-CA-C 110.931 -0.868 . . . . 0.51000000000000001 110.931 173.809 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.47 HD23 ' C ' ' A' ' 28' ' ' LEU . 4.8 tt -60.51 -41.54 94.57 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 125.462 1.505 . . . . 1.8500000000000001 109.512 176.774 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 10.7 ttmt -54.41 -23.37 15.55 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 112.592 0.59 . . . . 2.79 112.592 173.759 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.82 -2.58 24.2 Favored 'General case' 0 CA--C 1.542 0.659 0 O-C-N 121.285 -0.884 . . . . 3.6600000000000001 112.19 177.634 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' MET . . . . . 0.415 ' SD ' ' HB1' ' A' ' 59' ' ' ALA . 9.9 mmt -69.78 152.0 96.22 Favored Pre-proline 0 CA--C 1.532 0.273 0 CA-C-N 119.42 1.009 . . . . 3.2799999999999998 111.689 173.054 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -58.22 141.08 96.43 Favored 'Trans proline' 0 N--CA 1.452 -0.932 0 C-N-CA 122.005 1.803 . . . . 0.93999999999999995 109.47 170.809 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 86.13 -27.31 5.62 Favored Glycine 0 CA--C 1.524 0.616 0 CA-C-O 119.436 -0.647 . . . . 0.75 113.849 178.295 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 13.7 t -82.57 127.02 40.05 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 CA-C-N 118.777 1.289 . . . . 0.52000000000000002 108.693 -179.178 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.9 m -110.53 -37.26 5.53 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-O 118.601 -0.714 . . . . 0.85999999999999999 110.889 -175.61 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -148.53 166.94 26.71 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 119.253 0.933 . . . . 1.8400000000000001 110.038 170.333 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -157.25 148.81 22.17 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 123.481 0.712 . . . . 0.57999999999999996 110.507 -175.848 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -154.46 110.28 3.19 Favored 'General case' 0 CA--C 1.529 0.161 0 N-CA-C 108.437 -0.949 . . . . 0.58999999999999997 108.437 -165.258 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.515 HG11 ' HA ' ' A' ' 22' ' ' ALA . 4.7 p -88.44 93.87 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 C-N-CA 124.142 0.977 . . . . 0.81000000000000005 110.37 -178.146 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 52.5 t-20 -82.79 56.79 3.53 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 120.475 -1.391 . . . . 0.60999999999999999 110.224 -178.834 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.436 HD23 ' CG2' ' A' ' 39' ' ' VAL . 0.3 OUTLIER -67.01 -21.34 65.95 Favored 'General case' 0 C--O 1.227 -0.097 0 C-N-CA 123.677 0.791 . . . . 0.89000000000000001 110.33 179.907 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -48.26 -33.78 9.29 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.626 0.77 . . . . 0.63 112.144 170.151 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 3.4 t -121.97 27.66 7.96 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 118.026 0.375 . . . . 1.26 110.424 174.778 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 47.55 58.47 4.92 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 124.824 1.25 . . . . 3.0699999999999998 111.616 -178.096 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 33.2 m -145.44 164.28 32.05 Favored 'General case' 0 N--CA 1.44 -0.927 0 O-C-N 120.713 -1.242 . . . . 0.67000000000000004 107.716 175.785 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.9 p -139.47 145.01 27.7 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 N-CA-C 108.71 -0.848 . . . . 0.47999999999999998 108.71 174.799 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 19.5 m120 -131.8 139.45 48.89 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 124.407 1.083 . . . . 0.27000000000000002 108.481 -176.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 22.3 t -133.59 129.53 55.73 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 N-CA-C 105.796 -1.927 . . . . 2.1200000000000001 105.796 -178.482 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 13.6 mm -105.99 95.23 3.63 Favored 'Isoleucine or valine' 0 C--O 1.24 0.585 0 C-N-CA 124.946 1.298 . . . . 0.44 107.583 -174.902 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 10.8 p90 -131.95 164.48 26.05 Favored 'General case' 0 CA--C 1.513 -0.446 0 O-C-N 122.03 -0.419 . . . . 2.0499999999999998 111.955 -172.172 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 30.9 t0 -81.46 110.78 20.53 Favored Pre-proline 0 CA--C 1.534 0.365 0 O-C-N 124.392 1.057 . . . . 2.8700000000000001 110.134 172.584 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -73.09 5.97 2.79 Favored 'Trans proline' 0 N--CA 1.452 -0.96 0 C-N-CA 123.007 2.472 . . . . 0.56999999999999995 113.124 -178.708 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -87.79 -34.09 18.41 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 119.493 1.042 . . . . 0.75 108.797 169.268 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -99.03 -60.47 1.53 Allowed 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 108.687 -0.857 . . . . 3.0099999999999998 108.687 -174.417 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.566 HG22 ' HB3' ' A' ' 59' ' ' ALA 0.345 0.6 OUTLIER -83.53 -174.86 5.53 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 123.807 0.843 . . . . 0.48999999999999999 112.229 162.05 . . . . . . . . 4 4 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 126.37 94.95 0.94 Allowed Glycine 0 N--CA 1.442 -0.909 0 N-CA-C 103.913 -3.675 . . . . 2.2000000000000002 103.913 -144.907 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 68.6 p -14.31 -23.52 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.383 1 C-N-CA 138.161 6.584 . . . . 1.04 119.169 -151.749 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -27.47 -62.74 0.09 Allowed 'General case' 0 N--CA 1.443 -0.787 0 C-N-CA 127.177 2.191 . . . . 0.53000000000000003 113.532 167.222 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.566 ' HB3' HG22 ' A' ' 55' ' ' THR . . . -74.54 -39.55 62.25 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 118.732 -1.187 . . . . 0.5 109.72 -166.741 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.2 mp -54.68 -57.67 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.026 0 CA-C-N 113.687 -1.597 . . . . 0.94999999999999996 109.399 176.397 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -60.76 -43.28 98.22 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 118.093 0.406 . . . . 1.46 109.923 -174.482 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -46.86 -58.82 3.54 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.15 0.58 . . . . 2.7400000000000002 111.41 171.85 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 3.4 mmpt? -65.44 -42.82 92.01 Favored 'General case' 0 N--CA 1.442 -0.84 0 O-C-N 121.705 -0.622 . . . . 2.3500000000000001 112.331 -179.304 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -47.1 -54.11 2.86 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 C-N-CA 125.403 1.481 . . . . 0.65000000000000002 107.795 178.11 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -60.54 -57.54 12.29 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 124.559 1.144 . . . . 1.6799999999999999 110.633 177.048 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 11.7 mptt -59.66 -31.41 69.52 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 112.795 0.665 . . . . 5.3200000000000003 112.795 -173.763 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.501 HD13 ' HA ' ' A' ' 24' ' ' ILE . 8.6 mt -67.74 -16.95 64.38 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.307 1.043 . . . . 0.87 112.179 174.634 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 89.84 46.04 4.35 Favored Glycine 0 C--N 1.336 0.58 0 N-CA-C 109.68 -1.368 . . . . 0.66000000000000003 109.68 179.657 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.422 ' CD1' HG21 ' A' ' 24' ' ' ILE . 0.2 OUTLIER -143.72 175.25 10.12 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 124.562 1.145 . . . . 2.1699999999999999 108.678 -176.352 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 7.7 t-160 -145.28 144.48 30.79 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 109.076 -0.713 . . . . 1.8700000000000001 109.076 174.088 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 5.8 p -113.21 144.37 21.0 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 N-CA-C 107.002 -1.481 . . . . 1.53 107.002 179.18 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 5.7 t -122.86 140.81 45.46 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 N-CA-C 107.615 -1.254 . . . . 0.68999999999999995 107.615 -178.912 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 4.7 mp . . . . . 0 N--CA 1.45 -0.475 0 N-CA-C 107.975 -1.12 . . . . 1.26 107.975 -175.912 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.5 m . . . . . 0 N--CA 1.446 -0.67 0 N-CA-C 108.838 -0.801 . . . . 0.81999999999999995 108.838 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -65.94 171.63 4.31 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 108.077 -1.083 . . . . 2.29 108.077 162.211 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -131.5 153.88 49.34 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 124.258 1.023 . . . . 1.0800000000000001 109.673 176.501 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -144.94 160.63 41.01 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 124.725 1.21 . . . . 3.23 109.842 170.803 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -121.25 94.77 4.44 Favored 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 128.082 2.553 . . . . 1.98 106.094 -170.087 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 17.1 mm -82.62 162.05 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.232 0 N-CA-C 107.109 -1.441 . . . . 2.04 107.109 -179.095 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -133.3 140.24 47.33 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 107.068 -1.456 . . . . 0.69999999999999996 107.068 170.975 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -152.55 175.46 12.74 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 118.522 0.601 . . . . 2.1299999999999999 110.059 172.226 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 22.8 mm100 -98.45 157.99 15.87 Favored 'General case' 0 C--O 1.227 -0.084 0 C-N-CA 124.234 1.014 . . . . 2.6099999999999999 110.049 177.59 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 43.4 t -111.19 162.19 9.01 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 C-N-CA 124.844 1.257 . . . . 1.21 109.612 -174.847 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 58.0 m -149.23 164.47 34.7 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 107.535 -1.283 . . . . 0.93000000000000005 107.535 165.703 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 93.32 -29.97 7.71 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 123.39 0.519 . . . . 2.4700000000000002 112.562 -178.664 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -53.21 108.2 0.31 Allowed 'General case' 0 C--O 1.225 -0.205 0 CA-C-N 118.026 0.913 . . . . 2.27 112.77 178.233 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -155.91 14.18 0.34 Allowed 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 114.299 1.222 . . . . 3.8100000000000001 114.299 178.326 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 8.3 m -104.28 -58.7 1.84 Allowed 'General case' 0 C--O 1.226 -0.163 0 N-CA-C 108.245 -1.021 . . . . 5.0300000000000002 108.245 -175.16 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -172.86 -56.56 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 126.34 1.856 . . . . 5.4900000000000002 106.579 174.909 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -164.38 32.1 0.07 Allowed 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 113.204 0.816 . . . . 2.0600000000000001 113.204 -168.725 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 95.6 m -58.1 -31.62 67.31 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 121.378 -0.826 . . . . 1.1899999999999999 111.424 174.248 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.57 -25.43 17.13 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.197 0.599 . . . . 0.91000000000000003 112.609 170.963 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.59 ' HA ' HG11 ' A' ' 39' ' ' VAL . . . -70.26 -48.26 57.61 Favored 'General case' 0 N--CA 1.453 -0.307 0 O-C-N 120.261 -1.525 . . . . 0.65000000000000002 110.204 169.367 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 21.0 mmm180 -55.66 -46.86 77.46 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 109.603 -0.517 . . . . 4.2699999999999996 109.603 -178.116 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.411 HG21 ' CD1' ' A' ' 69' ' ' TYR . 3.0 pt -57.21 -54.96 23.71 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.36 0 C-N-CA 119.816 -0.754 . . . . 0.53000000000000003 110.921 178.242 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -55.68 -40.06 71.81 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 119.097 0.862 . . . . 2.2200000000000002 112.324 -179.511 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -71.13 -46.19 62.08 Favored 'General case' 0 N--CA 1.453 -0.284 0 O-C-N 121.722 -0.611 . . . . 1.8899999999999999 109.707 -176.218 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -60.11 -47.62 90.12 Favored Glycine 0 CA--C 1.528 0.856 0 N-CA-C 110.204 -1.158 . . . . 0.92000000000000004 110.204 172.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.441 HD23 ' C ' ' A' ' 28' ' ' LEU . 6.1 tt -52.97 -42.87 65.92 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.793 1.637 . . . . 1.95 110.118 177.599 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 8.6 ttmt -57.54 -32.36 67.0 Favored 'General case' 0 CA--C 1.535 0.373 0 O-C-N 120.942 -1.099 . . . . 3.4500000000000002 112.917 174.104 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -69.01 -7.53 36.44 Favored 'General case' 0 CA--C 1.536 0.427 0 O-C-N 121.297 -0.877 . . . . 5.6500000000000004 112.551 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 20.5 mmt -79.69 148.45 69.24 Favored Pre-proline 0 CA--C 1.532 0.273 0 CA-C-N 119.019 0.827 . . . . 4.7400000000000002 110.419 -174.129 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -56.11 137.17 78.54 Favored 'Trans proline' 0 N--CA 1.452 -0.966 0 C-N-CA 121.89 1.727 . . . . 0.88 108.746 176.102 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 90.89 -7.15 81.59 Favored Glycine 0 N--CA 1.449 -0.481 0 CA-C-O 117.671 -1.627 . . . . 0.88 114.35 179.725 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.6 t -110.37 135.18 50.2 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 CA-C-N 119.825 1.813 . . . . 0.64000000000000001 109.107 177.294 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 8.4 m -107.45 -49.86 3.18 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 123.442 0.697 . . . . 1.1200000000000001 110.194 -176.532 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -138.96 163.88 31.21 Favored 'General case' 0 C--N 1.343 0.299 0 CA-C-N 118.916 0.78 . . . . 2.0499999999999998 111.456 177.164 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -159.43 144.33 15.5 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 113.152 0.797 . . . . 0.77000000000000002 113.152 -179.389 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -149.7 105.53 3.44 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 107.97 -1.122 . . . . 1.0 107.97 -164.159 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.59 HG11 ' HA ' ' A' ' 22' ' ' ALA . 4.0 p -83.71 100.98 7.72 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 C-N-CA 123.03 0.532 . . . . 1.02 110.521 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 45.1 t30 -82.55 57.4 3.7 Favored 'General case' 0 CA--C 1.538 0.516 0 O-C-N 120.372 -1.455 . . . . 1.05 110.513 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.45 HD23 ' CG2' ' A' ' 39' ' ' VAL . 0.5 OUTLIER -76.33 -12.11 60.01 Favored 'General case' 0 C--O 1.226 -0.178 0 C-N-CA 124.384 1.074 . . . . 1.03 111.156 176.858 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -43.84 -38.0 3.09 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 123.59 0.756 . . . . 1.21 111.215 167.406 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.47 HG23 ' H ' ' A' ' 44' ' ' GLU . 9.2 t -102.1 -75.95 0.59 Allowed 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 118.755 -0.64 . . . . 3.7400000000000002 109.578 163.575 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.47 ' H ' HG23 ' A' ' 43' ' ' THR . 3.0 tt0 179.37 26.76 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.983 1.313 . . . . 3.25 113.375 -177.053 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 91.9 m -128.51 167.35 17.2 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 124.133 0.973 . . . . 0.76000000000000001 108.759 -163.481 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 1.2 p -138.35 145.36 28.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 N-CA-C 108.516 -0.92 . . . . 0.67000000000000004 108.516 179.433 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -131.09 139.7 49.9 Favored 'General case' 0 C--N 1.343 0.297 0 N-CA-C 108.187 -1.042 . . . . 0.56000000000000005 108.187 173.416 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 39.8 t -131.34 127.95 60.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 N-CA-C 105.591 -2.003 . . . . 2.1600000000000001 105.591 179.742 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 13.2 mm -102.44 93.01 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 N-CA-C 106.884 -1.524 . . . . 0.63 106.884 -177.49 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 9.5 p90 -127.01 168.67 14.25 Favored 'General case' 0 CA--C 1.509 -0.632 0 O-C-N 121.964 -0.46 . . . . 1.76 110.663 -170.207 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -99.1 103.44 20.01 Favored Pre-proline 0 N--CA 1.445 -0.716 0 C-N-CA 124.292 1.037 . . . . 4.3899999999999997 109.123 -176.265 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -72.72 10.4 1.06 Allowed 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 123.402 2.734 . . . . 1.0600000000000001 113.723 -172.712 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -86.44 -25.72 25.08 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 108.893 -0.78 . . . . 1.23 108.893 167.898 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -112.42 -55.33 2.53 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 123.816 0.847 . . . . 3.0699999999999998 109.151 -175.46 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.433 HG22 ' HB3' ' A' ' 59' ' ' ALA 0.324 9.5 p -90.57 -160.56 0.72 Allowed 'General case' 0 C--N 1.343 0.288 0 CA-C-O 119.411 -0.328 . . . . 0.68000000000000005 110.76 165.155 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 118.33 88.41 1.23 Allowed Glycine 0 N--CA 1.445 -0.734 0 N-CA-C 104.192 -3.563 . . . . 2.3399999999999999 104.192 -148.648 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 47.0 p -12.51 -18.28 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.419 1 C-N-CA 138.573 6.749 . . . . 1.25 119.53 -147.082 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -27.29 -63.05 0.09 Allowed 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 127.434 2.294 . . . . 0.60999999999999999 114.327 166.091 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.433 ' HB3' HG22 ' A' ' 55' ' ' THR . . . -72.96 -41.1 64.78 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 117.556 -1.657 . . . . 0.55000000000000004 109.196 -168.056 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.1 mp -53.97 -52.49 35.73 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.051 0 CA-C-N 113.821 -1.536 . . . . 0.89000000000000001 109.542 177.041 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.19 -48.1 79.78 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 119.398 0.999 . . . . 1.7 109.046 -176.793 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -47.83 -56.29 7.8 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 122.4 1.095 . . . . 3.29 110.709 176.969 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.9 mmpt? -70.58 -39.08 74.08 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-O 118.532 -0.747 . . . . 2.6200000000000001 112.063 -176.3 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -45.55 -53.78 1.86 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 C-N-CA 125.142 1.377 . . . . 0.44 108.046 173.412 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -58.46 -59.66 5.01 Favored 'General case' 0 C--N 1.341 0.2 0 C-N-CA 124.058 0.943 . . . . 1.98 110.288 177.568 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -58.73 -31.97 68.79 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 112.84 0.681 . . . . 5.3499999999999996 112.84 -175.337 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 24.8 mt -69.73 -17.23 63.44 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.969 1.308 . . . . 0.65000000000000002 111.295 176.11 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 94.2 41.85 4.17 Favored Glycine 0 CA--C 1.523 0.569 0 C-N-CA 124.642 1.115 . . . . 0.48999999999999999 110.367 176.588 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.411 ' CD1' HG21 ' A' ' 24' ' ' ILE . 0.6 OUTLIER -140.61 171.57 13.93 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 123.909 0.884 . . . . 1.98 110.238 -176.089 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -151.08 141.93 22.88 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 108.306 -0.998 . . . . 2.4700000000000002 108.306 168.567 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.0 m -99.27 165.38 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 C-N-CA 124.891 1.277 . . . . 2.4300000000000002 108.531 174.34 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 16.6 t -122.42 143.81 33.92 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 C-N-CA 124.66 1.184 . . . . 0.81000000000000005 108.325 177.59 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 21.9 mm . . . . . 0 N--CA 1.455 -0.201 0 C-N-CA 125.429 1.492 . . . . 1.5 108.482 -176.938 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 28.2 m . . . . . 0 N--CA 1.444 -0.729 0 N-CA-C 108.051 -1.092 . . . . 1.4399999999999999 108.051 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -108.68 -179.94 4.01 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 128.065 2.546 . . . . 2.1200000000000001 108.985 166.153 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 3.5 mm100 -139.19 147.66 42.11 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.95 1.3 . . . . 1.23 108.015 167.544 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -140.96 159.8 41.43 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 123.735 0.814 . . . . 3.1899999999999999 109.384 160.885 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -114.89 86.55 2.47 Favored 'General case' 0 N--CA 1.442 -0.83 0 C-N-CA 127.902 2.481 . . . . 1.5700000000000001 106.727 -170.775 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.527 HD13 ' CE1' ' A' ' 50' ' ' TYR . 2.6 mp -83.5 161.67 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.295 0 N-CA-C 106.262 -1.755 . . . . 2.29 106.262 -176.497 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -128.85 137.68 51.61 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 125.649 1.58 . . . . 0.65000000000000002 108.077 -178.541 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 1.9 mpt? -140.3 171.4 14.2 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 122.923 0.489 . . . . 2.0800000000000001 110.302 172.882 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -88.54 159.7 17.8 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 127.005 2.122 . . . . 3.75 109.797 167.091 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 88.9 t -117.86 152.63 19.84 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 C-N-CA 124.623 1.169 . . . . 1.1899999999999999 108.525 -179.347 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 70.8 m -149.49 160.41 43.48 Favored 'General case' 0 N--CA 1.455 -0.198 0 O-C-N 121.342 -0.849 . . . . 1.1200000000000001 109.853 171.678 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 70.02 70.29 1.21 Allowed Glycine 0 CA--C 1.528 0.861 0 N-CA-C 110.462 -1.055 . . . . 1.6399999999999999 110.462 -178.408 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -145.2 157.89 43.96 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 124.152 0.981 . . . . 1.9299999999999999 109.529 -175.283 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.7 p -108.63 -66.03 1.08 Allowed 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 125.612 1.565 . . . . 2.3599999999999999 108.692 171.129 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 20.3 p -123.71 161.11 25.8 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 124.485 1.114 . . . . 2.1299999999999999 111.414 -170.801 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -76.67 53.49 0.89 Allowed 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.322 1.049 . . . . 1.9299999999999999 110.813 178.28 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -138.42 -53.49 0.61 Allowed 'General case' 0 CA--C 1.521 -0.153 0 C-N-CA 124.677 1.191 . . . . 0.69999999999999996 109.234 175.813 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 59.7 m -57.4 -41.44 80.33 Favored 'General case' 0 CA--C 1.533 0.289 0 O-C-N 121.734 -0.604 . . . . 1.25 111.6 -176.702 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.466 ' HB1' HG21 ' A' ' 39' ' ' VAL . . . -59.67 -19.13 47.52 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 112.642 0.608 . . . . 0.71999999999999997 112.642 176.66 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.72 -49.12 42.22 Favored 'General case' 0 N--CA 1.455 -0.221 0 O-C-N 120.634 -1.291 . . . . 0.41999999999999998 109.757 169.709 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 6.3 mtt-85 -53.72 -49.27 68.49 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 123.383 0.673 . . . . 3.8300000000000001 109.397 -175.418 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 5.1 pt -55.23 -53.46 34.81 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 O-C-N 123.883 0.739 . . . . 0.46999999999999997 109.973 179.423 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.612 ' HG3' ' HB1' ' A' ' 37' ' ' ALA . 0.3 OUTLIER -53.72 -45.62 70.53 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.078 0.951 . . . . 2.3100000000000001 112.273 179.51 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.5 mptp? -69.25 -46.71 66.64 Favored 'General case' 0 CA--C 1.532 0.259 0 O-C-N 121.163 -0.96 . . . . 1.48 110.351 -177.091 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -63.94 -31.71 81.73 Favored Glycine 0 CA--C 1.529 0.956 0 N-CA-C 111.439 -0.665 . . . . 0.51000000000000001 111.439 176.2 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 7.6 tt -64.91 -44.05 90.84 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 126.018 1.727 . . . . 1.9199999999999999 109.486 177.716 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -53.1 -26.51 16.67 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 112.034 0.383 . . . . 2.5600000000000001 112.034 176.037 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 2.3 mtt180 -70.96 1.6 5.42 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 113.671 0.989 . . . . 3.6899999999999999 113.671 177.459 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 6.6 mmt -71.48 155.52 92.57 Favored Pre-proline 0 CA--C 1.534 0.348 0 CA-C-N 119.519 1.054 . . . . 3.3399999999999999 111.314 167.928 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -62.62 152.78 75.97 Favored 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 122.411 2.074 . . . . 1.02 110.418 171.463 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 74.88 -27.03 1.12 Allowed Glycine 0 CA--C 1.533 1.193 0 O-C-N 121.482 -0.761 . . . . 0.75 113.486 177.864 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 10.3 t -76.4 145.76 9.92 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 CA-C-N 118.83 1.315 . . . . 0.93999999999999995 109.056 173.958 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -132.22 -38.94 1.06 Allowed 'General case' 0 CA--C 1.529 0.143 0 CA-C-O 118.512 -0.756 . . . . 0.87 112.304 -176.185 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -140.61 166.49 24.6 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-N 119.589 1.086 . . . . 2.2599999999999998 111.867 163.503 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.612 ' HB1' ' HG3' ' A' ' 25' ' ' GLU . . . -158.13 137.26 11.59 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 112.769 0.655 . . . . 0.46999999999999997 112.769 -179.278 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -149.97 107.86 3.71 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 106.463 -1.68 . . . . 0.41999999999999998 106.463 -161.55 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.466 HG21 ' HB1' ' A' ' 21' ' ' ALA . 2.4 p -82.02 128.44 38.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 108.324 -0.991 . . . . 0.67000000000000004 108.324 177.782 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 39.3 t30 -105.69 57.26 0.67 Allowed 'General case' 0 C--O 1.235 0.341 0 CA-C-O 123.263 1.506 . . . . 0.87 107.887 179.005 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.424 HD23 HG22 ' A' ' 39' ' ' VAL . 0.3 OUTLIER -74.74 -13.49 60.6 Favored 'General case' 0 C--O 1.226 -0.178 0 CA-C-N 113.96 -1.473 . . . . 0.92000000000000004 110.636 177.003 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -44.0 -36.55 2.54 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.914 0.886 . . . . 1.0800000000000001 111.378 165.459 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 15.2 t -108.21 -68.73 0.89 Allowed 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 117.739 -1.124 . . . . 3.3700000000000001 110.85 167.318 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 161.34 49.13 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 127.561 2.344 . . . . 3.7999999999999998 109.535 -174.108 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -142.52 160.62 39.92 Favored 'General case' 0 N--CA 1.446 -0.667 0 O-C-N 120.292 -1.505 . . . . 0.76000000000000001 109.16 -178.228 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.6 p -130.18 142.79 42.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 108.113 -1.069 . . . . 0.32000000000000001 108.113 171.668 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -127.04 138.77 53.28 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 107.594 -1.262 . . . . 0.33000000000000002 107.594 176.123 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 3.1 p -137.68 129.67 40.61 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 N-CA-C 106.003 -1.851 . . . . 1.7 106.003 -176.726 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 11.2 mm -104.92 99.49 8.56 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.612 0 N-CA-C 106.743 -1.577 . . . . 0.45000000000000001 106.743 -171.883 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.527 ' CE1' HD13 ' A' ' 8' ' ' ILE . 51.2 p90 -139.84 169.44 17.72 Favored 'General case' 0 CA--C 1.512 -0.507 0 C-N-CA 122.629 0.372 . . . . 2.0899999999999999 110.662 -173.601 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 52.6 t0 -90.4 109.27 32.6 Favored Pre-proline 0 C--O 1.235 0.33 0 O-C-N 124.435 1.085 . . . . 3.3199999999999998 109.533 173.737 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 78.9 Cg_endo -72.41 5.57 2.71 Favored 'Trans proline' 0 N--CA 1.452 -0.95 0 C-N-CA 122.758 2.305 . . . . 0.83999999999999997 113.698 179.79 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -83.37 -33.24 25.85 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 119.393 0.997 . . . . 1.0600000000000001 108.692 165.828 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -107.44 -60.83 1.64 Allowed 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 123.446 0.698 . . . . 2.6800000000000002 110.943 -168.386 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.429 HG22 ' HB3' ' A' ' 59' ' ' ALA 0.495 0.2 OUTLIER -79.2 -177.1 5.49 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 114.513 1.301 . . . . 0.64000000000000001 114.513 155.956 . . . . . . . . 4 4 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 176.78 -147.91 8.7 Favored Glycine 0 N--CA 1.434 -1.469 0 N-CA-C 103.354 -3.898 . . . . 2.71 103.354 -165.37 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 12.9 p -75.39 -42.68 53.29 Favored 'General case' 0 N--CA 1.443 -0.795 0 C-N-CA 124.711 1.204 . . . . 1.3 108.794 174.32 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -46.67 -63.83 0.92 Allowed 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 114.125 1.157 . . . . 0.70999999999999996 114.125 -165.026 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.429 ' HB3' HG22 ' A' ' 55' ' ' THR . . . -70.82 -34.57 71.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 122.34 1.067 . . . . 0.64000000000000001 108.98 -165.78 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.5 mp -53.78 -58.55 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.122 0 CA-C-N 114.143 -1.389 . . . . 1.1399999999999999 109.534 170.045 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.94 -45.4 92.73 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 123.038 0.535 . . . . 1.6000000000000001 109.957 -173.395 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -43.8 -58.48 2.7 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.236 1.014 . . . . 3.8900000000000001 110.872 172.518 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -67.3 -44.69 78.61 Favored 'General case' 0 N--CA 1.442 -0.845 0 O-C-N 121.937 -0.477 . . . . 3.71 111.809 -178.814 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -48.46 -53.03 7.23 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 C-N-CA 125.799 1.64 . . . . 0.53000000000000003 107.89 -179.324 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 41.0 mm-40 -60.56 -58.19 9.52 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 124.549 1.14 . . . . 2.0 110.339 176.957 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 5.9 mmmt -53.66 -37.28 63.01 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 113.25 0.833 . . . . 4.4699999999999998 113.25 -177.256 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 12.1 mt -68.93 -17.74 64.0 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.275 1.03 . . . . 0.96999999999999997 111.985 177.622 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 92.62 49.61 2.71 Favored Glycine 0 CA--C 1.523 0.534 0 N-CA-C 109.932 -1.267 . . . . 0.56999999999999995 109.932 178.671 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -147.06 170.27 17.5 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 124.135 0.974 . . . . 1.8 109.799 -175.405 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 12.9 t-80 -140.78 123.72 16.37 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 108.249 -1.019 . . . . 1.9299999999999999 108.249 174.244 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 7.5 p -92.7 144.57 9.07 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.146 0 N-CA-C 107.027 -1.471 . . . . 1.52 107.027 170.754 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 44.7 t -123.04 139.98 48.14 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.182 0 N-CA-C 107.952 -1.129 . . . . 0.98999999999999999 107.952 178.515 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 5.2 mp . . . . . 0 N--CA 1.451 -0.401 0 N-CA-C 107.749 -1.204 . . . . 1.46 107.749 -173.803 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.5 m . . . . . 0 N--CA 1.448 -0.541 0 N-CA-C 110.739 -0.097 . . . . 1.0600000000000001 110.739 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -63.31 175.15 1.03 Allowed 'General case' 0 CA--C 1.531 0.245 0 CA-C-O 121.494 0.664 . . . . 3.1000000000000001 111.543 165.815 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.2 mm100 -137.97 143.79 40.85 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 125.215 1.406 . . . . 1.05 107.968 165.315 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 46.2 mttm -141.47 156.06 45.79 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 123.808 0.843 . . . . 3.6899999999999999 109.428 164.367 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 12.0 mp0 -114.62 86.34 2.42 Favored 'General case' 0 N--CA 1.445 -0.685 0 C-N-CA 127.164 2.186 . . . . 1.6499999999999999 108.08 -167.138 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.5 mt -83.61 157.99 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 N-CA-C 107.296 -1.372 . . . . 2.3199999999999998 107.296 -176.436 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -126.95 136.2 51.94 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 126.183 1.793 . . . . 0.53000000000000003 107.455 178.864 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 2.1 mpt? -138.74 169.57 17.56 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 118.337 0.517 . . . . 2.04 110.064 174.069 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -87.59 160.16 18.3 Favored 'General case' 0 N--CA 1.456 -0.133 0 C-N-CA 124.441 1.096 . . . . 3.1499999999999999 109.001 170.48 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 60.3 t -116.55 152.05 18.31 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 C-N-CA 124.202 1.001 . . . . 1.24 108.384 177.692 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 58.6 m -149.58 173.48 13.58 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.755 1.222 . . . . 1.0800000000000001 108.29 172.652 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 79.79 -37.12 2.09 Favored Glycine 0 CA--C 1.532 1.151 0 O-C-N 121.737 -0.602 . . . . 2.1000000000000001 112.557 -177.838 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 3.8 ppp? -47.78 153.64 0.58 Allowed 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.119 1.368 . . . . 3.3799999999999999 113.855 179.754 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.2 p -114.26 -71.51 0.74 Allowed 'General case' 0 N--CA 1.457 -0.086 0 C-N-CA 124.804 1.242 . . . . 2.3199999999999998 108.681 170.559 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 6.7 p -99.09 148.13 24.35 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 121.835 0.826 . . . . 2.1899999999999999 111.331 -178.727 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -77.84 53.44 1.14 Allowed 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.477 0.711 . . . . 1.75 110.493 178.247 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -143.05 -51.09 0.35 Allowed 'General case' 0 C--O 1.231 0.102 0 C-N-CA 123.65 0.78 . . . . 0.66000000000000003 110.682 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 56.1 m -56.01 -36.2 67.68 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 118.728 0.695 . . . . 1.2 110.15 171.025 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -47.97 -33.35 7.67 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.186 1.394 . . . . 0.47999999999999998 112.407 172.442 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.37 -53.27 14.68 Favored 'General case' 0 N--CA 1.454 -0.27 0 O-C-N 121.528 -0.733 . . . . 0.34999999999999998 110.128 172.576 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 6.4 mpt_? -55.3 -50.07 70.51 Favored 'General case' 0 CA--C 1.521 -0.148 0 C-N-CA 122.434 0.294 . . . . 5.8600000000000003 110.251 -175.172 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.48 HG21 ' CD1' ' A' ' 69' ' ' TYR 0.258 2.3 pp -52.86 -50.52 42.87 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 O-C-N 123.183 0.302 . . . . 1.26 110.99 177.578 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.523 ' HG3' ' HB1' ' A' ' 37' ' ' ALA . 3.0 tp10 -59.08 -39.27 81.62 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 114.029 1.122 . . . . 2.7599999999999998 114.029 176.221 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -73.95 -38.07 64.35 Favored 'General case' 0 CA--C 1.533 0.305 0 O-C-N 120.82 -1.175 . . . . 2.4900000000000002 111.974 -178.436 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -66.04 -41.39 95.19 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 109.858 -1.297 . . . . 0.47999999999999998 109.858 170.806 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 8.0 tt -53.56 -50.45 65.51 Favored 'General case' 0 C--N 1.333 -0.133 0 N-CA-C 108.84 -0.8 . . . . 1.8400000000000001 108.84 174.124 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -50.7 -19.9 1.07 Allowed 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.853 1.261 . . . . 3.3799999999999999 114.125 178.583 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.67 -9.32 59.62 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 118.897 0.772 . . . . 4.3399999999999999 112.528 -179.092 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 8.1 ptp -68.78 154.68 94.49 Favored Pre-proline 0 CA--C 1.534 0.337 0 CA-C-N 119.43 1.013 . . . . 3.8300000000000001 111.474 177.215 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -58.4 137.35 79.95 Favored 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 121.539 1.493 . . . . 0.57999999999999996 109.388 166.123 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 100.83 -35.51 4.8 Favored Glycine 0 CA--C 1.529 0.95 0 CA-C-O 119.274 -0.737 . . . . 0.51000000000000001 113.283 175.354 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 54.7 t -89.21 110.39 21.48 Favored 'Isoleucine or valine' 0 C--N 1.34 0.178 0 CA-C-N 118.76 1.28 . . . . 0.85999999999999999 109.671 178.062 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -81.63 -49.46 10.48 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-O 118.122 -0.942 . . . . 0.90000000000000002 108.577 -178.856 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -137.36 163.14 31.74 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 119.016 0.826 . . . . 2.1600000000000001 112.096 173.72 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.523 ' HB1' ' HG3' ' A' ' 25' ' ' GLU . . . -157.06 146.92 20.73 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.697 -0.683 . . . . 0.5 112.082 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -156.07 115.04 3.48 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 106.365 -1.717 . . . . 0.46999999999999997 106.365 -163.948 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.5 p -81.39 130.89 35.09 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.688 0 N-CA-C 107.911 -1.144 . . . . 0.75 107.911 175.541 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 54.1 t-20 -109.63 55.82 0.63 Allowed 'General case' 0 C--O 1.236 0.359 0 N-CA-C 107.187 -1.412 . . . . 0.59999999999999998 107.187 178.495 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.16 -18.34 62.5 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 114.157 -1.383 . . . . 1.01 109.86 -172.658 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -43.13 -37.78 2.16 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.09 0.956 . . . . 0.60999999999999999 112.246 164.105 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 8.9 t -124.23 38.51 4.18 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 122.727 0.411 . . . . 1.3 109.943 173.346 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 50.11 31.85 5.35 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.932 1.693 . . . . 2.6099999999999999 113.412 174.483 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 90.4 m -121.31 157.29 30.7 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 108.264 -1.013 . . . . 0.66000000000000003 108.264 -177.005 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 5.4 p -125.52 142.41 42.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 N-CA-C 108.355 -0.98 . . . . 0.37 108.355 172.17 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -127.37 139.84 52.59 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 108.425 -0.954 . . . . 0.33000000000000002 108.425 -179.515 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 5.5 p -141.29 126.17 17.92 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 N-CA-C 106.936 -1.505 . . . . 1.8100000000000001 106.936 -172.472 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 14.8 mm -107.22 91.8 1.88 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.513 0 C-N-CA 126.092 1.757 . . . . 0.40999999999999998 107.07 -167.8 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 43.6 p90 -135.38 165.53 25.26 Favored 'General case' 0 CA--C 1.51 -0.583 0 O-C-N 121.975 -0.453 . . . . 1.96 112.037 -166.764 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 59.7 t0 -86.55 109.92 27.67 Favored Pre-proline 0 C--O 1.235 0.321 0 O-C-N 124.574 1.172 . . . . 3.0499999999999998 109.821 176.991 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -71.23 1.93 4.89 Favored 'Trans proline' 0 N--CA 1.453 -0.892 0 C-N-CA 123.029 2.486 . . . . 0.58999999999999997 113.44 -178.401 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -88.78 -27.17 21.31 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 119.428 1.013 . . . . 0.81999999999999995 109.471 168.559 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -101.71 -53.33 2.99 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 123.492 0.717 . . . . 2.75 109.13 -170.122 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.265 1.0 OUTLIER -101.66 -176.44 3.14 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 125.256 1.422 . . . . 0.46000000000000002 111.998 163.431 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 146.95 91.09 0.1 OUTLIER Glycine 0 N--CA 1.442 -0.931 0 N-CA-C 103.629 -3.789 . . . . 2.3199999999999998 103.629 -155.406 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 77.0 p -13.95 -15.06 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.546 1 C-N-CA 137.737 6.415 . . . . 1.45 120.32 -145.848 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -25.49 -62.04 0.07 Allowed 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 126.924 2.09 . . . . 0.54000000000000004 114.503 162.575 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.07 -43.13 58.82 Favored 'General case' 0 C--N 1.332 -0.176 0 C-N-CA 119.088 -1.045 . . . . 0.51000000000000001 109.027 -167.936 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.7 mt -46.92 -60.03 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.706 0 C-N-CA 126.543 1.937 . . . . 1.27 110.893 172.025 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.78 -46.84 81.26 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 119.778 1.172 . . . . 1.0700000000000001 110.195 179.541 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -51.88 -55.18 21.66 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 121.795 0.807 . . . . 3.3900000000000001 112.022 179.014 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -69.8 -37.96 76.47 Favored 'General case' 0 N--CA 1.438 -1.028 0 O-C-N 121.419 -0.801 . . . . 2.27 111.471 -178.792 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.7 mm -49.95 -54.28 8.26 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 N-CA-C 107.362 -1.347 . . . . 0.48999999999999999 107.362 175.369 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 27.0 mm-40 -58.36 -58.23 9.41 Favored 'General case' 0 C--N 1.342 0.259 0 C-N-CA 124.745 1.218 . . . . 2.2000000000000002 110.387 178.345 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 7.8 mptt -54.48 -39.84 67.9 Favored 'General case' 0 CA--C 1.534 0.334 0 O-C-N 121.877 -0.514 . . . . 4.6500000000000004 112.153 -177.736 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.456 ' HB3' HG22 ' A' ' 24' ' ' ILE . 44.2 mt -70.63 -17.08 62.88 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.232 1.013 . . . . 0.78000000000000003 112.114 178.1 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 94.46 33.84 6.62 Favored Glycine 0 CA--C 1.524 0.641 0 C-N-CA 124.303 0.954 . . . . 0.44 111.617 173.378 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.48 ' CD1' HG21 ' A' ' 24' ' ' ILE . 1.4 m-85 -124.19 169.94 11.23 Favored 'General case' 0 N--CA 1.457 -0.123 0 C-N-CA 124.793 1.237 . . . . 1.8799999999999999 109.277 177.449 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -135.16 120.33 18.86 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 107.794 -1.187 . . . . 1.77 107.794 172.902 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 7.6 p -89.55 145.1 7.81 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 N-CA-C 107.597 -1.261 . . . . 1.54 107.597 172.168 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 48.8 t -121.21 141.16 42.89 Favored 'Isoleucine or valine' 0 C--O 1.232 0.136 0 C-N-CA 123.884 0.874 . . . . 0.68999999999999995 108.93 178.042 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 29.8 mm . . . . . 0 N--CA 1.455 -0.182 0 C-N-CA 124.684 1.194 . . . . 1.0600000000000001 109.479 -168.878 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 5.5 m . . . . . 0 N--CA 1.455 -0.181 0 N-CA-C 106.708 -1.59 . . . . 0.79000000000000004 106.708 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -63.55 169.4 3.9 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 107.998 -1.112 . . . . 2.8900000000000001 107.998 161.911 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 7.7 mt-30 -129.28 153.71 47.55 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 108.657 -0.868 . . . . 1.5900000000000001 108.657 171.531 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -139.76 153.26 47.12 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 123.423 0.689 . . . . 3.1400000000000001 110.048 168.805 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -107.69 90.87 3.43 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 127.633 2.373 . . . . 1.6299999999999999 107.731 -176.4 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 3.4 mm -83.65 159.45 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.179 0 N-CA-C 106.787 -1.56 . . . . 1.98 106.787 -178.603 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -134.14 131.72 39.01 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 124.641 1.176 . . . . 0.46999999999999997 108.385 178.441 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 3.7 mpp? -137.47 167.3 21.92 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.377 0.671 . . . . 2.0299999999999998 110.008 174.45 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 21.4 mm100 -88.01 160.16 17.98 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.14 0.976 . . . . 2.5800000000000001 109.452 174.652 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 81.4 t -115.01 144.2 23.08 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 C-N-CA 124.053 0.941 . . . . 1.49 109.971 -179.291 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 9.1 m -147.21 175.15 10.97 Favored 'General case' 0 C--N 1.341 0.228 0 C-N-CA 125.523 1.529 . . . . 1.3 108.604 171.409 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 55.68 52.47 48.13 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 110.788 -0.925 . . . . 1.8700000000000001 110.788 175.695 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -125.51 149.5 48.24 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 124.559 1.144 . . . . 2.6600000000000001 109.424 -170.886 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -87.85 -58.54 2.53 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 124.039 0.936 . . . . 3.5699999999999998 109.966 170.379 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 17.7 p -154.68 170.55 21.28 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-O 121.777 0.798 . . . . 2.5800000000000001 111.279 175.923 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.35 -34.4 68.77 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 124.409 1.084 . . . . 2.4100000000000001 111.893 178.971 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.76 -49.82 73.5 Favored 'General case' 0 N--CA 1.453 -0.292 0 O-C-N 121.992 -0.443 . . . . 0.76000000000000001 109.898 178.587 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 77.5 m -61.49 -38.92 89.04 Favored 'General case' 0 N--CA 1.456 -0.153 0 O-C-N 121.619 -0.675 . . . . 1.3 110.422 174.64 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.565 ' HB1' HG21 ' A' ' 39' ' ' VAL . . . -56.83 -23.13 41.7 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 112.105 0.409 . . . . 0.42999999999999999 112.105 173.685 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.07 -47.63 61.14 Favored 'General case' 0 N--CA 1.456 -0.165 0 O-C-N 120.039 -1.663 . . . . 0.39000000000000001 110.116 169.975 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 2.0 mtp85 -51.45 -43.59 62.13 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 122.92 0.488 . . . . 3.6699999999999999 110.039 -175.402 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.517 HG21 ' CD1' ' A' ' 69' ' ' TYR 0.287 1.9 pt -60.88 -60.35 2.79 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.274 0 CA-C-O 118.371 -0.823 . . . . 0.52000000000000002 111.196 178.74 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -54.91 -40.54 69.95 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 119.964 1.256 . . . . 2.2799999999999998 112.002 -179.45 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 14.7 mptt -68.07 -50.2 56.6 Favored 'General case' 0 CA--C 1.537 0.453 0 O-C-N 121.353 -0.842 . . . . 1.8799999999999999 110.38 -179.08 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -67.39 -23.18 73.4 Favored Glycine 0 CA--C 1.53 1.022 0 O-C-N 121.489 -0.757 . . . . 0.69999999999999996 112.265 177.241 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -71.01 -47.75 57.03 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 125.375 1.47 . . . . 2.3199999999999998 108.652 173.106 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 19.9 ttmt -46.5 -39.54 10.96 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 118.959 0.8 . . . . 3.3599999999999999 111.397 178.831 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.6 mtt180 -67.14 -5.93 15.54 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 114.691 1.367 . . . . 3.5899999999999999 114.691 -177.687 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.67 162.32 73.74 Favored Pre-proline 0 CA--C 1.541 0.626 0 CA-C-N 119.367 0.985 . . . . 4.2199999999999998 111.055 179.304 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -73.68 117.34 5.01 Favored 'Trans proline' 0 N--CA 1.453 -0.898 0 C-N-CA 121.507 1.471 . . . . 1.0 109.191 172.392 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 116.47 -19.39 12.91 Favored Glycine 0 CA--C 1.527 0.794 0 C-N-CA 123.895 0.76 . . . . 0.83999999999999997 113.789 169.915 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.509 HG22 ' HB3' ' A' ' 50' ' ' TYR . 86.6 t -89.97 145.96 6.77 Favored 'Isoleucine or valine' 0 C--N 1.339 0.143 0 CA-C-N 118.685 1.243 . . . . 0.68999999999999995 108.539 167.386 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.2 m -118.38 -36.63 3.49 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 118.441 -0.79 . . . . 1.0600000000000001 111.256 177.295 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -138.83 164.22 30.21 Favored 'General case' 0 C--N 1.343 0.307 0 CA-C-N 119.955 1.252 . . . . 2.0899999999999999 111.728 168.015 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -159.27 144.98 16.17 Favored 'General case' 0 C--N 1.332 -0.171 0 C-N-CA 123.104 0.562 . . . . 0.42999999999999999 111.868 -178.264 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -155.49 110.19 2.94 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 107.608 -1.256 . . . . 0.47999999999999998 107.608 -165.529 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.565 HG21 ' HB1' ' A' ' 21' ' ' ALA . 7.1 p -82.61 103.97 10.59 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 CA-C-O 121.336 0.588 . . . . 0.59999999999999998 110.79 178.722 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 51.6 t-20 -84.34 57.67 4.39 Favored 'General case' 0 CA--C 1.537 0.451 0 O-C-N 120.336 -1.477 . . . . 0.64000000000000001 110.173 179.73 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.426 HD23 ' CG2' ' A' ' 39' ' ' VAL . 0.2 OUTLIER -69.08 -19.05 64.06 Favored 'General case' 0 N--CA 1.461 0.119 0 CA-C-N 115.593 -0.731 . . . . 0.87 111.24 -176.506 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -44.09 -33.4 1.47 Allowed 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 123.816 0.846 . . . . 0.55000000000000004 111.872 166.919 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 6.6 t -129.62 42.08 3.34 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 121.392 0.615 . . . . 1.29 109.866 173.646 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 39.12 40.97 0.54 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 126.614 1.966 . . . . 2.5499999999999998 114.01 -178.28 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 83.8 m -120.34 157.23 29.68 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 124.55 1.14 . . . . 0.65000000000000002 108.568 -178.297 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 1.6 p -125.87 140.26 49.06 Favored 'Isoleucine or valine' 0 C--O 1.232 0.151 0 N-CA-C 108.278 -1.008 . . . . 0.53000000000000003 108.278 172.527 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -126.69 137.26 53.25 Favored 'General case' 0 C--N 1.344 0.365 0 N-CA-C 108.26 -1.015 . . . . 0.33000000000000002 108.26 176.306 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 40.7 t -131.31 125.2 56.55 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 N-CA-C 105.426 -2.065 . . . . 2.0499999999999998 105.426 -177.686 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 14.7 mm -100.46 88.24 1.47 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.592 0 N-CA-C 106.829 -1.545 . . . . 0.40000000000000002 106.829 -176.89 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.509 ' HB3' HG22 ' A' ' 34' ' ' VAL . 13.2 p90 -124.36 167.7 14.02 Favored 'General case' 0 CA--C 1.507 -0.711 0 CA-C-N 115.794 -0.639 . . . . 1.99 111.503 -171.743 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -99.84 107.48 46.61 Favored Pre-proline 0 N--CA 1.445 -0.677 0 CA-C-N 113.879 -1.51 . . . . 4.3799999999999999 108.113 -171.091 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -72.44 6.18 2.42 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 122.698 2.265 . . . . 0.82999999999999996 113.138 -173.109 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -84.28 -25.2 29.5 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 123.478 0.711 . . . . 1.0800000000000001 109.334 168.401 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 -117.54 -53.64 2.41 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.202 1.001 . . . . 3.02 110.977 -169.636 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.258 0.8 OUTLIER -89.72 -175.77 4.76 Favored 'General case' 0 CA--C 1.517 -0.3 0 C-N-CA 123.766 0.826 . . . . 0.51000000000000001 113.177 160.343 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 141.34 87.5 0.11 Allowed Glycine 0 N--CA 1.44 -1.092 0 N-CA-C 104.902 -3.279 . . . . 2.5299999999999998 104.902 -158.867 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 82.4 p -9.48 -18.52 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.559 1 C-N-CA 138.126 6.571 . . . . 1.01 119.977 -143.238 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -28.18 -65.98 0.08 Allowed 'General case' 0 N--CA 1.44 -0.972 0 C-N-CA 127.6 2.36 . . . . 0.56999999999999995 113.977 169.639 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -76.81 -25.41 53.25 Favored 'General case' 0 C--N 1.334 -0.106 0 C-N-CA 118.105 -1.438 . . . . 0.67000000000000004 110.042 -169.113 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -63.5 -53.79 40.77 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.855 0 CA-C-O 118.58 -0.724 . . . . 0.90000000000000002 109.072 176.554 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.46 -44.44 96.4 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 108.828 -0.805 . . . . 1.6000000000000001 108.828 -175.547 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -48.13 -58.69 4.15 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-O 121.592 0.711 . . . . 3.7999999999999998 111.726 172.833 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 13.3 mmmt -65.44 -37.99 88.53 Favored 'General case' 0 N--CA 1.44 -0.946 0 O-C-N 121.618 -0.676 . . . . 3.46 111.739 -177.644 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.421 HD12 HG13 ' A' ' 71' ' ' VAL . 2.5 mm -51.79 -51.81 25.75 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 C-N-CA 125.634 1.574 . . . . 0.57999999999999996 108.302 178.878 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -57.45 -54.49 46.26 Favored 'General case' 0 C--N 1.341 0.218 0 C-N-CA 123.094 0.558 . . . . 2.04 110.243 174.667 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 5.8 mmtt -53.89 -38.44 64.78 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 112.874 0.694 . . . . 4.0199999999999996 112.874 -179.306 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 32.5 mt -70.95 -17.92 62.66 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 125.737 1.615 . . . . 0.79000000000000004 111.632 177.452 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 93.37 35.64 6.19 Favored Glycine 0 CA--C 1.525 0.668 0 C-N-CA 124.658 1.123 . . . . 0.5 111.229 176.119 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.517 ' CD1' HG21 ' A' ' 24' ' ' ILE . 1.0 OUTLIER -131.96 172.15 12.7 Favored 'General case' 0 N--CA 1.457 -0.123 0 C-N-CA 123.818 0.847 . . . . 1.8999999999999999 110.923 -178.319 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 3.7 t-80 -148.85 116.38 6.21 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 109.041 -0.725 . . . . 1.7 109.041 170.446 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.421 HG13 HD12 ' A' ' 64' ' ' ILE . 25.7 m -81.59 166.35 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 N-CA-C 109.072 -0.714 . . . . 2.4700000000000002 109.072 176.235 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 12.1 t -124.51 142.51 41.09 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 C-N-CA 124.173 0.989 . . . . 0.78000000000000003 108.458 178.603 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 17.9 mm . . . . . 0 N--CA 1.453 -0.303 0 C-N-CA 124.115 0.966 . . . . 1.1200000000000001 109.061 -174.084 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 39.2 m . . . . . 0 N--CA 1.449 -0.486 0 N-CA-C 103.908 -2.627 . . . . 1.27 103.908 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -80.07 -179.7 7.17 Favored 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 125.113 1.365 . . . . 3.0499999999999998 108.025 177.775 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.2 mm100 -138.78 136.52 35.77 Favored 'General case' 0 CA--C 1.514 -0.438 0 O-C-N 120.843 -1.161 . . . . 1.3200000000000001 108.275 171.548 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.8 mtpt -133.98 151.79 51.6 Favored 'General case' 0 N--CA 1.455 -0.222 0 O-C-N 124.089 0.868 . . . . 2.9199999999999999 109.958 167.658 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -101.9 93.5 5.32 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 127.968 2.507 . . . . 1.4299999999999999 107.457 -176.059 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 2.5 mm -84.01 159.91 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.248 0 N-CA-C 106.669 -1.604 . . . . 2.0600000000000001 106.669 -178.029 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -133.78 130.9 38.67 Favored 'General case' 0 N--CA 1.456 -0.136 0 N-CA-C 108.073 -1.084 . . . . 0.45000000000000001 108.073 176.153 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 4.0 mpp? -139.15 172.1 13.32 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.256 1.022 . . . . 1.8899999999999999 110.19 176.609 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.36 162.46 12.94 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 126.188 1.795 . . . . 3.5 109.468 173.368 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.1 m -118.76 151.5 20.95 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 C-N-CA 123.659 0.784 . . . . 1.8100000000000001 111.35 174.406 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 48.4 m -142.44 165.4 27.51 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 125.495 1.518 . . . . 1.03 109.411 176.766 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 63.58 67.06 2.21 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 110.686 -0.966 . . . . 2.1000000000000001 110.686 177.645 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -139.72 157.69 45.35 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 123.928 0.891 . . . . 3.5800000000000001 110.753 -175.432 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -76.83 -70.15 0.48 Allowed 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 108.178 -1.045 . . . . 3.1400000000000001 108.178 157.12 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 25.8 p -158.41 -178.91 7.62 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 121.732 0.777 . . . . 2.6099999999999999 112.05 -166.357 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.65 175.6 0.45 Allowed 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 124.793 1.237 . . . . 3.25 110.086 170.455 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.409 ' O ' ' HB3' ' A' ' 22' ' ' ALA . . . 72.03 -56.21 0.65 Allowed 'General case' 0 CA--C 1.528 0.123 0 C-N-CA 124.875 1.27 . . . . 1.0700000000000001 110.196 -174.179 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 28.3 m -57.57 -46.27 84.18 Favored 'General case' 0 C--N 1.33 -0.259 0 O-C-N 121.442 -0.786 . . . . 1.45 109.361 171.328 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -52.01 -23.76 5.63 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.107 0.963 . . . . 0.42999999999999999 112.965 172.227 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.409 ' HB3' ' O ' ' A' ' 19' ' ' ALA . . . -72.22 -49.49 34.79 Favored 'General case' 0 N--CA 1.454 -0.258 0 O-C-N 120.87 -1.144 . . . . 0.34000000000000002 110.607 171.803 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 8.1 mmm180 -56.11 -42.74 77.32 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 109.791 -0.448 . . . . 4.7699999999999996 109.791 -171.588 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.501 ' HA ' HD13 ' A' ' 67' ' ' LEU . 4.1 pt -56.62 -55.99 16.46 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 O-C-N 123.382 0.426 . . . . 0.46999999999999997 110.676 176.351 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -55.45 -43.15 75.18 Favored 'General case' 0 C--O 1.226 -0.163 0 C-N-CA 123.825 0.85 . . . . 3.54 111.75 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 4.0 mptp? -72.0 -42.82 65.97 Favored 'General case' 0 CA--C 1.535 0.366 0 O-C-N 121.168 -0.957 . . . . 1.8999999999999999 110.537 -174.537 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.93 -39.16 97.7 Favored Glycine 0 CA--C 1.53 0.991 0 N-CA-C 110.525 -1.03 . . . . 0.66000000000000003 110.525 170.935 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 6.8 tt -60.51 -36.31 78.05 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.23 1.012 . . . . 1.95 109.703 175.875 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.5 ttpm? -61.95 -24.02 66.73 Favored 'General case' 0 CA--C 1.53 0.187 0 O-C-N 120.565 -1.335 . . . . 3.1099999999999999 112.841 172.616 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 11.3 mmt180 -77.85 -3.81 43.44 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 119.043 0.838 . . . . 3.5299999999999998 111.524 -179.069 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 70.3 mmm -83.95 147.84 52.35 Favored Pre-proline 0 CA--C 1.535 0.369 0 CA-C-N 118.918 0.781 . . . . 3.3999999999999999 111.076 -176.632 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -59.25 136.15 70.46 Favored 'Trans proline' 0 N--CA 1.451 -0.986 0 C-N-CA 122.34 2.027 . . . . 0.56999999999999995 108.961 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 94.66 -23.94 30.24 Favored Glycine 0 CA--C 1.528 0.848 0 CA-C-O 118.919 -0.934 . . . . 0.5 113.084 -178.837 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 17.0 t -92.35 130.28 41.69 Favored 'Isoleucine or valine' 0 C--N 1.34 0.161 0 CA-C-N 118.6 1.2 . . . . 0.57999999999999996 109.966 -177.139 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 9.3 m -112.13 -39.51 4.45 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 123.823 0.849 . . . . 1.2 111.142 -171.874 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -145.27 157.21 44.11 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 118.867 0.758 . . . . 2.7999999999999998 109.738 175.038 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -152.0 126.7 9.54 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 123.765 0.826 . . . . 0.75 110.375 -170.893 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -142.36 107.85 5.06 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 125.723 1.609 . . . . 0.70999999999999996 108.772 -164.45 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.412 HG23 HD23 ' A' ' 41' ' ' LEU . 3.1 p -82.31 88.09 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 N-CA-C 108.734 -0.839 . . . . 1.4099999999999999 108.734 178.41 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 48.9 t-20 -83.31 56.65 3.63 Favored 'General case' 0 CA--C 1.537 0.462 0 O-C-N 120.6 -1.312 . . . . 0.71999999999999997 110.108 -177.861 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.412 HD23 HG23 ' A' ' 39' ' ' VAL . 0.5 OUTLIER -68.27 -20.74 64.81 Favored 'General case' 0 C--O 1.223 -0.332 0 C-N-CA 124.398 1.079 . . . . 1.0 110.541 -179.792 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -45.7 -30.12 1.48 Allowed 'General case' 0 CA--C 1.529 0.154 0 N-CA-C 112.811 0.671 . . . . 0.93000000000000005 112.811 168.363 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 5.7 t -131.66 32.25 4.16 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 118.019 0.372 . . . . 1.29 110.476 173.087 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 9.1 mp0 50.02 52.79 13.99 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.302 1.041 . . . . 4.1200000000000001 112.591 179.569 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.3 m -137.69 160.43 39.24 Favored 'General case' 0 N--CA 1.443 -0.797 0 O-C-N 121.286 -0.884 . . . . 0.94999999999999996 109.144 176.295 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.5 p -129.91 136.64 58.49 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 N-CA-C 107.044 -1.465 . . . . 0.38 107.044 169.794 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -125.07 129.51 50.4 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 107.559 -1.275 . . . . 0.55000000000000004 107.559 -178.665 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 3.7 p -132.97 131.14 58.95 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.828 0 N-CA-C 105.1 -2.185 . . . . 1.78 105.1 -176.486 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 2.1 mp -104.2 111.2 32.87 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.762 0 N-CA-C 106.097 -1.816 . . . . 1.72 106.097 178.875 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 21.4 p90 -143.15 167.58 21.78 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 116.039 -0.528 . . . . 1.6399999999999999 109.914 -178.047 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -87.78 121.82 70.63 Favored Pre-proline 0 CA--C 1.54 0.58 0 O-C-N 125.047 1.467 . . . . 3.3900000000000001 111.506 171.971 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_endo -80.76 12.12 2.72 Favored 'Trans proline' 0 CA--C 1.537 0.672 0 C-N-CA 123.536 2.824 . . . . 0.93000000000000005 114.181 -176.565 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -98.0 -36.23 10.19 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 119.573 1.079 . . . . 1.3700000000000001 109.578 167.539 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -90.81 -57.22 2.89 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 106.966 -1.494 . . . . 3.23 106.966 -175.09 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.317 6.0 p -95.92 -160.32 0.78 Allowed 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 109.439 -0.578 . . . . 0.64000000000000001 109.439 162.027 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 116.57 92.31 1.7 Allowed Glycine 0 CA--C 1.528 0.856 0 N-CA-C 106.274 -2.731 . . . . 2.29 106.274 -146.593 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 80.9 p -12.73 -19.16 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.435 1 C-N-CA 138.007 6.523 . . . . 1.1000000000000001 119.849 -143.792 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -26.46 -63.39 0.08 Allowed 'General case' 0 N--CA 1.443 -0.787 0 C-N-CA 127.212 2.205 . . . . 0.69999999999999996 113.647 170.671 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -75.31 -42.63 54.18 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 118.212 -1.395 . . . . 0.69999999999999996 109.629 -166.116 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -50.29 -53.95 10.22 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.962 0 CA-C-N 113.965 -1.471 . . . . 0.78000000000000003 110.278 173.918 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -68.17 -46.08 71.72 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 109.591 -0.522 . . . . 1.9299999999999999 109.591 -173.696 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -45.93 -56.93 4.83 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 122.319 1.056 . . . . 3.4100000000000001 111.344 171.485 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.0 mmpt? -71.52 -38.62 71.08 Favored 'General case' 0 N--CA 1.432 -1.343 0 CA-C-O 118.624 -0.703 . . . . 2.46 112.438 -175.063 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -48.69 -52.82 8.27 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 N-CA-C 106.968 -1.493 . . . . 0.52000000000000002 106.968 175.494 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 37.9 mm-40 -58.82 -58.48 8.44 Favored 'General case' 0 C--N 1.343 0.32 0 C-N-CA 124.392 1.077 . . . . 2.5 110.413 177.449 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 9.4 mmtm -57.71 -32.66 67.61 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 113.457 0.91 . . . . 3.98 113.457 -176.416 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.501 HD13 ' HA ' ' A' ' 24' ' ' ILE . 11.4 mt -70.23 -18.19 63.15 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.609 1.163 . . . . 0.79000000000000004 111.701 174.901 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 90.58 44.65 4.52 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 110.483 -1.047 . . . . 0.48999999999999999 110.483 179.068 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -137.27 174.96 10.05 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 124.674 1.19 . . . . 2.0 108.549 177.26 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 32.1 t60 -137.54 156.36 48.2 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 109.425 -0.583 . . . . 1.8 109.425 167.137 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 12.8 p -128.09 137.79 56.51 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.113 0 C-N-CA 125.038 1.335 . . . . 1.54 108.03 -177.091 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 13.0 t -110.74 136.14 47.7 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 C-N-CA 124.622 1.169 . . . . 0.68000000000000005 108.75 -178.817 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 27.8 mm . . . . . 0 N--CA 1.45 -0.429 0 C-N-CA 124.463 1.105 . . . . 1.0600000000000001 108.945 -172.24 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.454 -0.26 0 N-CA-C 106.366 -1.716 . . . . 1.03 106.366 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -79.97 -175.43 4.96 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 108.577 -0.897 . . . . 2.3199999999999998 108.577 173.33 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.4 mm100 -136.53 144.84 44.47 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 107.979 -1.119 . . . . 1.26 107.979 170.566 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 51.7 mttt -143.91 162.18 36.79 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 123.602 0.761 . . . . 2.8199999999999998 110.706 163.225 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -110.77 87.77 2.61 Favored 'General case' 0 N--CA 1.439 -0.98 0 C-N-CA 129.216 3.006 . . . . 1.6899999999999999 105.447 -173.316 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.502 ' N ' HD12 ' A' ' 8' ' ' ILE . 3.4 mp -83.71 162.03 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 N-CA-C 105.771 -1.937 . . . . 2.46 105.771 -179.747 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -133.72 142.1 47.83 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 125.281 1.432 . . . . 0.77000000000000002 107.362 179.772 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -155.73 175.59 13.73 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 109.125 -0.695 . . . . 2.4500000000000002 109.125 172.082 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 30.0 mm100 -98.55 152.36 19.65 Favored 'General case' 0 C--O 1.223 -0.307 0 C-N-CA 125.477 1.511 . . . . 2.77 108.396 -177.371 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.8 p -111.32 156.43 12.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 CA-C-N 119.166 0.894 . . . . 2.5800000000000001 110.282 -178.72 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 7.6 m -132.92 168.84 17.71 Favored 'General case' 0 C--N 1.339 0.131 0 C-N-CA 124.474 1.11 . . . . 1.22 109.791 171.733 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 58.59 52.44 52.96 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 110.8 -0.92 . . . . 1.5800000000000001 110.8 -179.732 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -131.44 162.36 30.36 Favored 'General case' 0 CA--C 1.521 -0.158 0 C-N-CA 124.377 1.071 . . . . 2.3300000000000001 109.881 -176.997 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -154.57 -58.61 0.11 Allowed 'General case' 0 CA--C 1.528 0.125 0 C-N-CA 125.457 1.503 . . . . 3.6899999999999999 109.572 168.679 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 9.2 p -81.17 133.19 35.41 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 121.476 0.655 . . . . 2.2999999999999998 109.932 175.509 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -75.6 55.16 0.82 Allowed 'General case' 0 CA--C 1.535 0.391 0 O-C-N 121.626 -0.671 . . . . 1.99 109.473 170.768 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -152.07 -57.15 0.14 Allowed 'General case' 0 N--CA 1.457 -0.076 0 C-N-CA 124.071 0.948 . . . . 0.91000000000000003 110.457 -169.916 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 67.9 m -60.61 -42.46 96.85 Favored 'General case' 0 C--N 1.333 -0.141 0 O-C-N 121.237 -0.915 . . . . 1.3700000000000001 109.605 169.947 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.64 -19.86 6.94 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 113.009 0.744 . . . . 0.63 113.009 170.243 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -73.01 -50.24 24.24 Favored 'General case' 0 N--CA 1.454 -0.228 0 O-C-N 120.299 -1.501 . . . . 0.46999999999999997 110.687 169.719 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 3.7 mpt_? -49.78 -45.16 49.44 Favored 'General case' 0 CA--C 1.52 -0.198 0 C-N-CA 122.384 0.274 . . . . 4.1799999999999997 110.276 -174.441 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.515 ' HA ' HD13 ' A' ' 67' ' ' LEU . 3.8 pt -57.15 -54.4 30.81 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 O-C-N 123.337 0.398 . . . . 0.5 110.678 -176.677 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -58.01 -43.79 86.91 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 124.033 0.933 . . . . 2.3399999999999999 112.027 176.077 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -66.9 -47.02 73.08 Favored 'General case' 0 CA--C 1.534 0.331 0 O-C-N 121.701 -0.624 . . . . 1.8600000000000001 110.206 -175.444 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.35 -40.47 99.08 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 110.227 -1.149 . . . . 0.62 110.227 173.843 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -62.29 -37.83 87.03 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 122.115 -0.638 . . . . 2.1800000000000002 109.823 179.264 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.8 ttpm? -52.28 -18.99 1.79 Allowed 'General case' 0 CA--C 1.532 0.286 0 O-C-N 121.201 -0.937 . . . . 3.21 113.358 173.274 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 2.9 mtt180 -88.41 -0.54 57.3 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 119.051 0.841 . . . . 4.3600000000000003 112.277 -179.201 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' MET . . . . . 0.617 ' SD ' ' HB1' ' A' ' 59' ' ' ALA . 0.5 OUTLIER -77.97 158.56 77.46 Favored Pre-proline 0 CA--C 1.531 0.215 0 CA-C-N 119.366 0.984 . . . . 3.6099999999999999 111.923 172.537 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -56.87 145.58 83.34 Favored 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 122.494 2.129 . . . . 0.78000000000000003 110.476 170.487 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 82.85 -28.89 3.47 Favored Glycine 0 CA--C 1.53 0.992 0 CA-C-O 119.443 -0.643 . . . . 0.59999999999999998 113.142 176.079 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 16.0 t -84.87 133.65 28.82 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 CA-C-N 118.953 1.377 . . . . 0.56000000000000005 109.655 177.737 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -115.54 -41.19 3.28 Favored 'General case' 0 N--CA 1.457 -0.106 0 C-N-CA 123.746 0.819 . . . . 0.87 110.184 -175.71 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -143.45 163.16 33.89 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 118.844 0.747 . . . . 2.1200000000000001 109.214 176.026 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -156.14 143.69 19.35 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 122.43 0.292 . . . . 0.47999999999999998 111.76 178.685 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -151.59 101.92 2.83 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 106.245 -1.761 . . . . 0.46999999999999997 106.245 -166.762 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.0 p -81.21 142.83 13.28 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 N-CA-C 108.028 -1.101 . . . . 0.79000000000000004 108.028 176.518 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 53.4 t-20 -136.63 64.07 1.56 Allowed 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 122.705 1.241 . . . . 0.91000000000000003 110.115 -171.196 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.497 HD22 ' H ' ' A' ' 41' ' ' LEU . 1.8 mm? -70.79 -20.05 62.63 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 115.048 -0.978 . . . . 2.8100000000000001 111.253 -173.573 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -46.65 -38.14 9.29 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 124.184 0.993 . . . . 0.83999999999999997 112.202 172.17 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 9.0 t -119.4 29.33 7.69 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.012 0.525 . . . . 1.29 110.371 174.21 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 43.79 59.93 2.9 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 126.049 1.74 . . . . 2.7400000000000002 112.023 -177.814 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 90.0 m -146.31 164.02 33.69 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 108.697 -0.853 . . . . 0.70999999999999996 108.697 178.887 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -138.65 143.52 32.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 108.334 -0.988 . . . . 0.46999999999999997 108.334 176.03 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -126.95 137.49 53.13 Favored 'General case' 0 C--N 1.344 0.343 0 N-CA-C 107.787 -1.19 . . . . 0.38 107.787 178.422 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 31.2 t -130.12 130.18 65.75 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 N-CA-C 105.13 -2.174 . . . . 2.27 105.13 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 13.0 mm -101.3 99.15 7.83 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.578 0 N-CA-C 106.959 -1.497 . . . . 0.56000000000000005 106.959 -177.33 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.435 ' CE2' HD13 ' A' ' 8' ' ' ILE . 54.5 p90 -141.42 168.91 18.65 Favored 'General case' 0 CA--C 1.51 -0.591 0 O-C-N 122.055 -0.403 . . . . 2.52 110.245 -171.311 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 42.0 t0 -86.52 107.87 15.5 Favored Pre-proline 0 C--N 1.327 -0.389 0 O-C-N 124.482 1.114 . . . . 3.1299999999999999 109.639 174.928 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -73.48 4.24 4.12 Favored 'Trans proline' 0 N--CA 1.451 -1.013 0 C-N-CA 122.222 1.948 . . . . 1.1100000000000001 112.68 -179.093 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -82.35 -36.03 27.24 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 119.622 1.101 . . . . 1.3899999999999999 108.508 166.101 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -103.41 -60.47 1.56 Allowed 'General case' 0 N--CA 1.453 -0.315 0 O-C-N 123.724 0.64 . . . . 4.04 109.694 -167.099 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.48 HG22 ' HB3' ' A' ' 59' ' ' ALA 0.459 0.5 OUTLIER -81.54 -172.64 3.95 Favored 'General case' 0 CA--C 1.521 -0.149 0 N-CA-C 113.729 1.011 . . . . 0.72999999999999998 113.729 156.512 . . . . . . . . 4 4 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 159.66 -148.6 17.47 Favored Glycine 0 N--CA 1.434 -1.473 1 N-CA-C 102.492 -4.243 . . . . 2.9300000000000002 102.492 -157.246 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 33.2 p -78.34 -37.6 44.12 Favored 'General case' 0 N--CA 1.444 -0.772 0 C-N-CA 124.772 1.229 . . . . 1.1799999999999999 110.104 178.327 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -49.13 -62.54 1.48 Allowed 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.715 1.206 . . . . 0.54000000000000004 113.403 -163.584 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.617 ' HB1' ' SD ' ' A' ' 31' ' ' MET . . . -71.68 -32.25 67.64 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.198 -1.365 . . . . 0.46999999999999997 108.973 -169.236 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.7 mp -60.04 -55.36 24.63 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.795 0 CA-C-N 114.937 -1.029 . . . . 1.1399999999999999 109.876 175.253 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.91 -45.82 89.41 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 119.167 0.894 . . . . 1.3300000000000001 110.1 -178.992 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -48.76 -56.57 8.25 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 121.449 0.642 . . . . 3.3900000000000001 111.691 174.146 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 3.5 mmmt -64.92 -42.99 94.24 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-O 118.923 -0.561 . . . . 3.3999999999999999 112.043 -178.464 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.4 mm -50.39 -52.74 14.46 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.707 0 C-N-CA 125.71 1.604 . . . . 0.56000000000000005 107.804 -179.622 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -56.27 -56.56 19.5 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 123.769 0.828 . . . . 2.3500000000000001 110.661 175.178 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 12.7 mptt -58.76 -34.66 71.67 Favored 'General case' 0 CA--C 1.536 0.436 0 O-C-N 121.716 -0.615 . . . . 4.7999999999999998 112.435 -175.971 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.515 HD13 ' HA ' ' A' ' 24' ' ' ILE . 11.8 mt -70.5 -16.63 62.92 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.646 1.178 . . . . 0.69999999999999996 111.965 175.678 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 86.0 42.13 6.84 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 110.288 -1.125 . . . . 0.60999999999999999 110.288 179.178 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -134.95 175.98 9.08 Favored 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 124.315 1.046 . . . . 1.99 109.458 -179.562 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -144.46 157.11 44.4 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 109.2 -0.667 . . . . 2.1099999999999999 109.2 170.662 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 8.0 p -138.33 137.42 43.89 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.19 0 N-CA-C 107.757 -1.201 . . . . 1.52 107.757 -173.732 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 29.6 t -103.53 137.51 31.71 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 C-N-CA 125.364 1.466 . . . . 0.56999999999999995 109.002 -175.901 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 48.4 mm . . . . . 0 N--CA 1.447 -0.576 0 C-N-CA 124.728 1.211 . . . . 1.1200000000000001 107.979 -176.386 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.0 m . . . . . 0 N--CA 1.447 -0.624 0 N-CA-C 108.713 -0.847 . . . . 0.67000000000000004 108.713 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -70.16 168.95 14.58 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 108.241 -1.022 . . . . 2.02 108.241 162.591 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -129.09 153.56 47.53 Favored 'General case' 0 N--CA 1.457 -0.12 0 C-N-CA 124.548 1.139 . . . . 1.1399999999999999 109.99 178.281 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 85.5 mttt -146.07 162.7 37.33 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 124.28 1.032 . . . . 3.6000000000000001 109.992 168.57 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 8.9 mp0 -121.18 87.93 2.85 Favored 'General case' 0 N--CA 1.441 -0.89 0 C-N-CA 127.979 2.512 . . . . 1.6200000000000001 106.122 -168.366 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.47 ' N ' HD12 ' A' ' 8' ' ' ILE . 2.6 mp -83.06 161.66 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.369 0 N-CA-C 105.887 -1.894 . . . . 2.0699999999999998 105.887 -177.102 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -128.31 135.21 49.3 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 125.944 1.698 . . . . 0.64000000000000001 106.595 178.283 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 43.1 mtt -140.89 171.98 13.33 Favored 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 109.498 -0.556 . . . . 2.3300000000000001 109.498 174.721 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 21.8 mm100 -96.96 139.33 33.14 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 125.701 1.601 . . . . 2.4900000000000002 108.624 176.621 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 81.0 t -92.66 153.91 3.25 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 N-CA-C 108.893 -0.78 . . . . 1.3 108.893 175.978 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 62.9 m -150.77 165.48 33.39 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.074 0.949 . . . . 1.2 109.264 173.177 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 60.32 61.84 6.67 Favored Glycine 0 CA--C 1.528 0.874 0 N-CA-C 110.745 -0.942 . . . . 1.5700000000000001 110.745 -178.697 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -135.58 156.38 48.96 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 123.834 0.854 . . . . 1.75 110.153 -174.909 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -105.34 -55.81 2.27 Favored 'General case' 0 CA--C 1.528 0.118 0 C-N-CA 125.199 1.4 . . . . 2.3599999999999999 109.764 168.051 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 16.9 p -139.67 159.48 42.07 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 121.914 0.864 . . . . 2.3199999999999998 111.93 -172.853 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -75.87 39.88 0.18 Allowed 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.963 1.305 . . . . 2.0099999999999998 111.899 179.43 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -128.67 -53.68 1.24 Allowed 'General case' 0 CA--C 1.524 -0.058 0 C-N-CA 124.599 1.159 . . . . 0.78000000000000003 108.612 178.647 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 21.0 m -58.72 -38.15 77.72 Favored 'General case' 0 CA--C 1.532 0.274 0 O-C-N 121.556 -0.715 . . . . 1.2 109.714 170.726 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.656 ' HB1' HG21 ' A' ' 39' ' ' VAL . . . -54.65 -26.69 34.74 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 116.06 -0.518 . . . . 0.40999999999999998 112.082 172.551 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.92 -48.95 41.81 Favored 'General case' 0 N--CA 1.455 -0.177 0 O-C-N 120.08 -1.637 . . . . 0.34000000000000002 109.629 172.368 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 26.9 mmm180 -50.17 -46.02 53.85 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 123.022 0.529 . . . . 5.0800000000000001 110.543 -175.82 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.434 HG21 ' CD1' ' A' ' 69' ' ' TYR . 3.5 pt -59.0 -53.35 49.1 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 C-N-CA 120.245 -0.582 . . . . 0.46000000000000002 111.066 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -54.42 -44.93 72.83 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 123.296 0.638 . . . . 2.2999999999999998 111.687 177.16 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 32.1 mmtp -70.55 -44.0 68.35 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 118.839 0.745 . . . . 2.1299999999999999 110.657 -175.991 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -58.95 -39.55 94.26 Favored Glycine 0 CA--C 1.528 0.903 0 N-CA-C 110.488 -1.045 . . . . 0.5 110.488 172.818 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -66.21 -42.8 88.25 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 109.056 -0.72 . . . . 2.3599999999999999 109.056 179.365 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.6 ttpp -56.96 -14.99 4.06 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.719 1.608 . . . . 2.8900000000000001 114.128 177.283 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.83 -11.6 56.79 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.93 1.692 . . . . 3.9300000000000002 111.794 176.74 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 93.3 mmm -71.6 154.72 93.08 Favored Pre-proline 0 CA--C 1.53 0.185 0 CA-C-N 119.03 0.832 . . . . 3.25 111.378 179.263 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -56.21 141.86 87.63 Favored 'Trans proline' 0 N--CA 1.451 -1.008 0 C-N-CA 121.47 1.447 . . . . 0.58999999999999997 108.596 163.945 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 88.42 -12.56 64.54 Favored Glycine 0 N--CA 1.448 -0.559 0 CA-C-O 117.932 -1.482 . . . . 0.88 114.463 173.391 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 40.6 t -109.46 125.41 66.6 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 CA-C-N 119.787 1.793 . . . . 0.55000000000000004 109.061 177.586 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 99.7 m -97.49 -50.66 4.43 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-O 118.205 -0.902 . . . . 1.1599999999999999 110.067 -176.764 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -138.71 159.8 41.22 Favored 'General case' 0 C--N 1.342 0.258 0 CA-C-N 119.337 0.971 . . . . 2.1099999999999999 110.803 176.436 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -156.39 146.39 21.19 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 122.98 0.512 . . . . 0.38 112.066 -178.89 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -155.94 121.31 4.85 Favored 'General case' 0 C--N 1.342 0.273 0 N-CA-C 109.047 -0.723 . . . . 0.5 109.047 -165.792 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.656 HG21 ' HB1' ' A' ' 21' ' ' ALA . 9.2 p -92.87 102.27 13.46 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 C-N-CA 123.055 0.542 . . . . 0.64000000000000001 110.201 -177.63 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 50.5 t-20 -85.53 57.36 4.42 Favored 'General case' 0 CA--C 1.533 0.323 0 O-C-N 120.518 -1.364 . . . . 0.59999999999999998 109.462 179.809 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.435 HD22 ' HA ' ' A' ' 41' ' ' LEU . 0.2 OUTLIER -68.31 -19.97 64.71 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 115.495 -0.775 . . . . 1.02 110.468 -175.957 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -47.42 -33.83 6.48 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.771 0.828 . . . . 0.62 112.132 168.726 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 15.3 t -120.54 28.76 7.8 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 118.148 0.431 . . . . 1.24 111.158 174.48 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 46.86 57.11 5.91 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 124.557 1.143 . . . . 2.7999999999999998 112.109 -176.505 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 67.2 m -146.59 157.05 43.65 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 108.159 -1.052 . . . . 0.79000000000000004 108.159 178.442 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.4 p -124.92 144.43 34.95 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 N-CA-C 108.071 -1.085 . . . . 0.31 108.071 172.128 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -125.51 137.52 53.95 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 108.132 -1.062 . . . . 0.32000000000000001 108.132 175.347 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 4.4 p -135.1 123.67 40.55 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 N-CA-C 106.165 -1.791 . . . . 1.8200000000000001 106.165 -176.258 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 12.6 mm -101.58 90.02 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 N-CA-C 106.266 -1.753 . . . . 0.44 106.266 -172.869 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 24.8 p90 -126.55 168.63 14.02 Favored 'General case' 0 CA--C 1.506 -0.742 0 CA-C-O 120.923 0.392 . . . . 2.0600000000000001 110.149 -169.474 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -98.87 103.31 18.64 Favored Pre-proline 0 N--CA 1.44 -0.941 0 CA-C-N 114.537 -1.211 . . . . 4.3799999999999999 108.157 -176.977 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -73.67 12.02 0.97 Allowed 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 122.632 2.222 . . . . 0.64000000000000001 113.277 -172.876 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -83.52 -25.26 31.19 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 109.061 -0.718 . . . . 0.95999999999999996 109.061 165.987 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -116.77 -58.4 2.08 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 123.81 0.844 . . . . 2.8300000000000001 109.454 -170.187 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.307 6.6 p -88.22 -171.98 3.6 Favored 'General case' 0 C--N 1.344 0.327 0 CA-C-N 118.181 0.446 . . . . 0.70999999999999996 110.304 165.522 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 135.7 87.15 0.23 Allowed Glycine 0 N--CA 1.442 -0.936 0 N-CA-C 105.164 -3.174 . . . . 2.3399999999999999 105.164 -155.151 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 52.2 p -8.22 -17.02 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.378 1 C-N-CA 137.794 6.438 . . . . 1.1399999999999999 120.248 -142.018 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -28.08 -66.34 0.08 Allowed 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 127.226 2.211 . . . . 0.64000000000000001 113.59 166.963 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.48 -36.39 71.14 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 116.978 -1.889 . . . . 0.67000000000000004 109.415 -166.033 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.5 mp -54.19 -57.39 6.07 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.047 0 CA-C-N 114.325 -1.307 . . . . 0.81999999999999995 109.178 175.501 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.09 -47.13 86.02 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 119.306 0.957 . . . . 1.1899999999999999 110.527 -178.032 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -48.89 -55.8 10.66 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 121.902 0.858 . . . . 4.5800000000000001 111.14 177.059 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -70.42 -37.61 74.44 Favored 'General case' 0 N--CA 1.437 -1.104 0 CA-C-O 118.042 -0.98 . . . . 2.3399999999999999 111.877 -177.71 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.1 mm -49.69 -52.74 11.85 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 N-CA-C 107.525 -1.287 . . . . 0.39000000000000001 107.525 178.464 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -57.53 -58.5 8.04 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 123.939 0.896 . . . . 1.8100000000000001 110.64 175.696 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -58.97 -32.79 69.98 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 112.955 0.724 . . . . 4.0999999999999996 112.955 -175.217 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 15.1 mt -70.58 -17.96 62.9 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.667 1.187 . . . . 0.57999999999999996 111.663 175.425 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 91.97 42.51 4.68 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.676 -0.97 . . . . 0.41999999999999998 110.676 178.154 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.434 ' CD1' HG21 ' A' ' 24' ' ' ILE . 0.3 OUTLIER -136.91 173.26 11.89 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 124.239 1.015 . . . . 1.8700000000000001 109.881 -179.835 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -137.99 128.33 26.21 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 107.773 -1.195 . . . . 1.79 107.773 172.689 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 4.2 p -104.19 146.69 11.29 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 N-CA-C 107.35 -1.352 . . . . 1.3899999999999999 107.35 170.848 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 91.3 t -116.29 146.63 20.46 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 C-N-CA 126.733 2.013 . . . . 0.80000000000000004 107.022 176.279 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 4.9 mp . . . . . 0 C--N 1.329 -0.321 0 C-N-CA 124.221 1.008 . . . . 1.4199999999999999 108.786 -174.613 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 57.9 m . . . . . 0 N--CA 1.454 -0.228 0 N-CA-C 106.774 -1.565 . . . . 0.73999999999999999 106.774 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -75.95 177.27 7.15 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 109.311 -0.626 . . . . 2.1600000000000001 109.311 171.604 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -138.52 140.75 39.24 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 107.532 -1.284 . . . . 1.02 107.532 174.92 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -138.39 160.97 38.16 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 124.573 1.149 . . . . 3.6000000000000001 109.74 168.438 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -119.37 95.87 4.97 Favored 'General case' 0 N--CA 1.441 -0.892 0 C-N-CA 128.903 2.881 . . . . 1.45 106.678 -171.734 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 7.0 mm -84.67 161.71 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.128 0 N-CA-C 106.879 -1.526 . . . . 2.1000000000000001 106.879 178.274 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -137.34 133.05 34.45 Favored 'General case' 0 C--O 1.23 0.076 0 C-N-CA 124.782 1.233 . . . . 0.54000000000000004 107.782 -179.795 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 9.3 ptp -157.65 175.75 13.51 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 118.664 0.665 . . . . 1.97 111.0 -178.238 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 28.7 mm100 -93.71 164.22 13.23 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.443 1.497 . . . . 2.46 110.655 -178.016 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 60.5 t -121.02 158.67 23.47 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 C-N-CA 124.964 1.306 . . . . 1.1699999999999999 109.427 -177.447 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 14.1 m -149.38 166.4 29.16 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 123.918 0.887 . . . . 0.88 110.08 167.866 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 68.13 47.52 58.67 Favored Glycine 0 CA--C 1.528 0.862 0 N-CA-C 110.522 -1.031 . . . . 1.6599999999999999 110.522 -171.302 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -125.94 156.93 38.98 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 124.643 1.177 . . . . 2.1800000000000002 109.589 -178.915 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER 179.85 -44.08 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 127.871 2.468 . . . . 3.7799999999999998 110.881 179.43 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 36.6 m -56.89 -22.59 38.43 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.658 0.783 . . . . 3.0699999999999998 112.704 177.984 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 57.38 33.32 23.12 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.58 1.152 . . . . 2.3900000000000001 111.602 178.008 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -159.3 -45.09 0.05 Allowed 'General case' 0 C--O 1.226 -0.179 0 C-N-CA 124.433 1.093 . . . . 0.78000000000000003 109.736 -175.611 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 94.4 m -50.31 -38.44 41.57 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.196 0.998 . . . . 1.23 112.278 171.826 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.404 ' HB1' HG21 ' A' ' 39' ' ' VAL . . . -56.11 -23.53 34.89 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 122.935 0.494 . . . . 0.47999999999999998 112.252 174.994 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -72.6 -50.1 27.64 Favored 'General case' 0 N--CA 1.457 -0.115 0 O-C-N 120.556 -1.34 . . . . 0.34000000000000002 111.114 167.022 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 6.6 mmp_? -49.33 -46.42 46.79 Favored 'General case' 0 CA--C 1.52 -0.209 0 N-CA-C 109.691 -0.485 . . . . 6.8600000000000003 109.691 179.823 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.498 HG21 ' CD1' ' A' ' 69' ' ' TYR 0.272 2.0 pt -59.23 -59.34 3.99 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.442 0 C-N-CA 119.337 -0.945 . . . . 0.46999999999999997 111.033 178.505 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -51.59 -41.68 61.37 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 119.526 1.057 . . . . 3.27 112.298 -179.135 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.2 mptp? -71.38 -43.64 66.49 Favored 'General case' 0 CA--C 1.538 0.484 0 O-C-N 121.13 -0.981 . . . . 1.73 110.708 -177.987 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -65.76 -32.11 81.94 Favored Glycine 0 CA--C 1.534 1.239 0 O-C-N 121.456 -0.778 . . . . 0.59999999999999998 111.65 174.769 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.0 tt -63.59 -48.29 77.99 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 126.111 1.764 . . . . 1.8999999999999999 107.914 175.892 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 12.8 ttmt -47.51 -37.34 11.8 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.039 0.536 . . . . 2.8399999999999999 112.435 174.324 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -66.17 -0.28 2.41 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 114.043 1.127 . . . . 3.3799999999999999 114.043 -176.671 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 13.5 ptp -77.29 164.17 60.13 Favored Pre-proline 0 CA--C 1.538 0.49 0 CA-C-N 119.735 1.152 . . . . 4.2199999999999998 111.788 172.754 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -69.0 137.56 37.98 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 121.543 1.495 . . . . 0.56999999999999995 109.756 168.407 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 99.91 -31.53 8.3 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 123.49 0.567 . . . . 0.5 113.187 172.243 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 47.1 t -82.56 140.33 16.53 Favored 'Isoleucine or valine' 0 C--N 1.341 0.205 0 CA-C-N 118.672 1.236 . . . . 0.56000000000000005 109.289 171.119 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -114.68 -38.05 4.09 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 118.812 -0.613 . . . . 1.0600000000000001 110.652 178.327 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -143.67 163.23 33.85 Favored 'General case' 0 C--N 1.341 0.238 0 CA-C-N 119.566 1.076 . . . . 1.8700000000000001 110.281 175.16 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -159.37 134.85 8.44 Favored 'General case' 0 C--O 1.239 0.516 0 C-N-CA 123.386 0.674 . . . . 0.42999999999999999 112.05 -171.416 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -148.06 111.86 5.09 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 124.213 1.005 . . . . 0.46000000000000002 109.723 -164.795 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.404 HG21 ' HB1' ' A' ' 21' ' ' ALA . 7.1 p -84.2 98.18 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 C-N-CA 123.53 0.732 . . . . 0.56999999999999995 110.403 179.796 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 49.6 t-20 -84.21 56.59 3.82 Favored 'General case' 0 CA--C 1.537 0.46 0 O-C-N 120.28 -1.512 . . . . 0.58999999999999997 110.027 179.618 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.44 HD22 ' HA ' ' A' ' 41' ' ' LEU . 0.2 OUTLIER -69.99 -17.98 63.31 Favored 'General case' 0 N--CA 1.462 0.128 0 C-N-CA 123.625 0.77 . . . . 0.93999999999999995 110.849 -178.24 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -44.34 -38.18 3.79 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 123.68 0.792 . . . . 0.53000000000000003 111.673 166.416 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 6.5 t -124.89 39.12 4.05 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 122.929 0.492 . . . . 1.27 109.725 172.002 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 50.17 32.06 5.65 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.741 1.617 . . . . 2.8799999999999999 113.804 173.24 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 40.2 m -119.8 163.96 16.7 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.947 1.299 . . . . 0.62 108.43 -177.577 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.8 p -133.15 145.22 34.38 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 O-C-N 121.038 -1.039 . . . . 0.29999999999999999 109.136 171.139 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -132.42 129.48 39.35 Favored 'General case' 0 C--N 1.344 0.346 0 C-N-CA 124.743 1.217 . . . . 0.38 108.445 -178.995 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.7 p -126.53 128.92 71.66 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 N-CA-C 105.524 -2.028 . . . . 1.78 105.524 -174.903 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 10.9 mm -105.42 100.44 10.58 Favored 'Isoleucine or valine' 0 C--O 1.239 0.527 0 C-N-CA 124.945 1.298 . . . . 0.41999999999999998 107.898 -173.912 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 48.0 p90 -141.62 171.05 14.59 Favored 'General case' 0 CA--C 1.512 -0.485 0 O-C-N 121.937 -0.477 . . . . 1.75 111.801 -170.598 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 60.7 t0 -90.62 105.59 12.39 Favored Pre-proline 0 CA--C 1.534 0.362 0 O-C-N 124.742 1.276 . . . . 3.04 110.696 174.597 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -74.88 9.83 1.87 Allowed 'Trans proline' 0 N--CA 1.452 -0.925 0 C-N-CA 122.108 1.872 . . . . 0.63 113.55 179.823 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -84.15 -27.88 27.81 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 119.238 0.926 . . . . 0.83999999999999997 108.824 164.051 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -108.43 -58.1 2.04 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 123.344 0.658 . . . . 2.6299999999999999 109.359 -170.913 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.422 0.3 OUTLIER -81.72 179.72 7.72 Favored 'General case' 0 CA--C 1.514 -0.416 0 N-CA-C 116.308 1.966 . . . . 0.46000000000000002 116.308 161.859 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -176.19 -152.35 9.54 Favored Glycine 0 N--CA 1.43 -1.708 1 N-CA-C 102.272 -4.331 . . . . 2.3900000000000001 102.272 -176.875 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 19.4 p -73.03 -32.4 65.07 Favored 'General case' 0 C--N 1.318 -0.792 0 C-N-CA 124.959 1.304 . . . . 1.2 109.206 178.068 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -42.56 -62.64 0.93 Allowed 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 125.839 1.655 . . . . 0.52000000000000002 113.671 -172.706 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -75.02 -34.69 61.95 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.042 -0.981 . . . . 0.45000000000000001 109.165 -169.697 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -56.17 -52.77 47.09 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.89 0 CA-C-O 117.67 -1.157 . . . . 0.90000000000000002 111.232 175.495 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.41 -46.96 87.95 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 119.864 1.211 . . . . 1.05 109.355 -179.184 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -48.81 -57.3 6.59 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-O 122.105 0.955 . . . . 2.6200000000000001 111.22 176.449 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.9 mmtp -63.02 -44.54 95.67 Favored 'General case' 0 N--CA 1.435 -1.176 0 CA-C-O 118.659 -0.686 . . . . 2.9199999999999999 110.77 -179.379 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -47.43 -52.62 5.19 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 C-N-CA 125.208 1.403 . . . . 0.51000000000000001 108.887 177.559 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -61.67 -55.5 29.81 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 123.762 0.825 . . . . 1.76 110.699 177.908 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.4 mmmp? -58.07 -31.02 66.67 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 113.366 0.876 . . . . 5.29 113.366 -178.261 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 22.8 mt -73.11 -17.15 61.43 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.583 1.553 . . . . 0.70999999999999996 112.121 174.426 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 93.17 42.55 4.29 Favored Glycine 0 C--N 1.337 0.631 0 C-N-CA 124.918 1.246 . . . . 0.51000000000000001 110.693 175.597 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.498 ' CD1' HG21 ' A' ' 24' ' ' ILE . 0.3 OUTLIER -145.13 177.05 9.07 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 123.348 0.659 . . . . 1.95 111.41 -169.629 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 4.9 t60 -142.25 131.79 23.88 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 107.825 -1.176 . . . . 2.0299999999999998 107.825 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 8.2 p -107.52 138.87 31.58 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.089 0 N-CA-C 108.018 -1.105 . . . . 1.6100000000000001 108.018 175.697 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 5.2 t -116.81 140.79 37.8 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.126 0 N-CA-C 108.598 -0.89 . . . . 0.65000000000000002 108.598 -177.199 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 4.9 mp . . . . . 0 N--CA 1.45 -0.472 0 N-CA-C 108.065 -1.087 . . . . 1.24 108.065 179.433 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 8.1 m . . . . . 0 CA--C 1.533 0.296 0 N-CA-C 109.691 -0.485 . . . . 0.87 109.691 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -64.37 169.97 4.24 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 107.738 -1.208 . . . . 2.0499999999999998 107.738 162.61 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -131.48 150.46 52.14 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 108.597 -0.89 . . . . 1.29 108.597 173.428 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 44.4 mtpt -143.45 156.79 44.74 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-O 121.695 0.759 . . . . 2.8199999999999998 110.61 169.314 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -100.4 112.77 25.15 Favored 'General case' 0 N--CA 1.44 -0.959 0 C-N-CA 128.188 2.595 . . . . 2.3799999999999999 107.272 -178.301 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.457 HD12 ' C ' ' A' ' 8' ' ' ILE . 2.3 pp -82.64 164.16 2.87 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.157 0 C-N-CA 119.357 -0.937 . . . . 5.2599999999999998 108.559 165.778 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -143.09 113.01 7.07 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 106.16 -1.792 . . . . 0.64000000000000001 106.16 175.884 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 59.9 mtt -140.29 170.12 16.4 Favored 'General case' 0 C--N 1.334 -0.096 0 CA-C-N 118.306 0.503 . . . . 3.5499999999999998 110.165 -172.595 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 28.8 mm100 -96.0 161.03 14.16 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 123.839 0.856 . . . . 2.5699999999999998 110.173 -176.626 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 44.9 t -120.23 146.2 25.43 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 N-CA-C 108.347 -0.983 . . . . 1.3200000000000001 108.347 -175.316 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 72.3 m -138.61 163.67 31.46 Favored 'General case' 0 N--CA 1.456 -0.154 0 C-N-CA 124.541 1.136 . . . . 0.98999999999999999 109.275 171.114 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 56.92 63.58 5.19 Favored Glycine 0 CA--C 1.528 0.85 0 C-N-CA 123.57 0.605 . . . . 1.6499999999999999 111.668 173.544 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 11.2 ptm -120.47 147.01 45.67 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 124.153 0.981 . . . . 3.0299999999999998 110.762 -177.053 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -81.98 -68.81 0.67 Allowed 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.513 1.125 . . . . 3.9399999999999999 108.65 166.259 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 16.3 p -154.45 169.79 22.92 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-O 121.512 0.672 . . . . 2.5499999999999998 111.119 178.531 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.15 -38.95 66.07 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 124.569 1.148 . . . . 2.5699999999999998 111.925 179.258 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.31 -46.15 90.89 Favored 'General case' 0 N--CA 1.453 -0.287 0 O-C-N 121.959 -0.463 . . . . 1.1299999999999999 110.182 -179.491 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 67.3 m -66.87 -43.75 82.75 Favored 'General case' 0 N--CA 1.454 -0.233 0 O-C-N 121.849 -0.532 . . . . 1.6000000000000001 109.898 175.528 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.0 -18.88 26.95 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 112.856 0.687 . . . . 0.65000000000000002 112.856 176.113 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.27 -50.44 39.49 Favored 'General case' 0 N--CA 1.449 -0.49 0 O-C-N 119.937 -1.727 . . . . 0.52000000000000002 109.074 169.058 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -52.73 -45.07 66.83 Favored 'General case' 0 C--N 1.34 0.16 0 CA-C-O 118.462 -0.78 . . . . 6.3499999999999996 110.426 -177.275 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.4 HG21 ' CD1' ' A' ' 69' ' ' TYR 0.268 3.3 pt -55.4 -59.59 2.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 CA-C-O 118.788 -0.625 . . . . 0.80000000000000004 110.289 179.911 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.46 ' HG3' ' HB1' ' A' ' 37' ' ' ALA . 0.6 OUTLIER -52.51 -45.23 66.14 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 119.516 1.053 . . . . 2.6699999999999999 111.923 178.199 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 35.6 mmtm -66.84 -42.62 85.44 Favored 'General case' 0 CA--C 1.537 0.479 0 O-C-N 121.301 -0.874 . . . . 2.02 111.427 -177.346 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -63.1 -28.57 72.36 Favored Glycine 0 CA--C 1.53 1.023 0 N-CA-C 111.165 -0.774 . . . . 0.57999999999999996 111.165 171.063 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.512 HD22 HG21 ' A' ' 34' ' ' VAL . 0.6 OUTLIER -66.19 -47.63 73.28 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 108.801 -0.814 . . . . 1.6000000000000001 108.801 175.394 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.635 ' HE2' ' HA ' ' A' ' 36' ' ' ASP . 24.9 ttmt -52.09 -37.08 52.85 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 122.822 0.449 . . . . 2.7599999999999998 111.553 174.435 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 13.6 mmt180 -59.62 -11.49 4.99 Favored 'General case' 0 CA--C 1.542 0.669 0 O-C-N 121.097 -1.002 . . . . 3.27 113.477 177.908 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' MET . . . . . 0.629 ' CE ' ' HB1' ' A' ' 59' ' ' ALA . 4.0 ptm -82.74 152.56 66.52 Favored Pre-proline 0 CA--C 1.535 0.376 0 CA-C-N 120.058 1.299 . . . . 3.3100000000000001 112.222 178.464 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -62.25 120.7 8.39 Favored 'Trans proline' 0 N--CA 1.452 -0.92 0 C-N-CA 122.283 1.989 . . . . 1.05 109.17 171.683 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 114.25 -24.85 11.09 Favored Glycine 0 CA--C 1.527 0.792 0 CA-C-O 118.336 -1.258 . . . . 1.01 113.451 172.264 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.512 HG21 HD22 ' A' ' 28' ' ' LEU . 61.5 t -96.99 118.14 42.86 Favored 'Isoleucine or valine' 0 C--N 1.343 0.317 0 CA-C-N 119.408 1.604 . . . . 1.1899999999999999 110.876 174.914 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 39.6 m -95.59 -35.88 11.46 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-O 117.801 -1.095 . . . . 1.3 112.483 -175.1 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.635 ' HA ' ' HE2' ' A' ' 29' ' ' LYS . 0.2 OUTLIER -145.23 164.27 31.88 Favored 'General case' 0 C--N 1.344 0.329 0 CA-C-N 120.273 1.397 . . . . 2.0499999999999998 110.622 164.258 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.46 ' HB1' ' HG3' ' A' ' 25' ' ' GLU . . . -158.52 135.17 9.54 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 116.313 -0.403 . . . . 0.64000000000000001 110.864 -174.97 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -149.1 110.14 4.35 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 106.115 -1.809 . . . . 0.59999999999999998 106.115 -161.445 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 10.3 p -89.37 131.79 35.76 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.764 0 N-CA-C 108.384 -0.969 . . . . 0.57999999999999996 108.384 179.196 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 64.1 t-20 -118.96 71.4 0.85 Allowed 'General case' 0 C--O 1.234 0.273 0 C-N-CA 124.758 1.223 . . . . 0.96999999999999997 109.083 -178.029 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.604 HD22 ' H ' ' A' ' 41' ' ' LEU . 2.0 mm? -67.6 -25.59 65.84 Favored 'General case' 0 C--O 1.226 -0.167 0 CA-C-N 115.146 -0.933 . . . . 3.0600000000000001 110.22 -178.967 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -51.42 -34.78 36.31 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-O 118.802 -0.618 . . . . 0.95999999999999996 111.666 172.254 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.3 t -115.13 22.78 13.05 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 118.278 0.49 . . . . 1.3899999999999999 111.402 172.97 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 47.14 44.52 15.48 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.574 1.55 . . . . 3.7599999999999998 113.743 179.754 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 51.8 m -139.89 145.64 38.27 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 108.417 -0.957 . . . . 1.1399999999999999 108.417 -179.704 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 5.2 p -110.73 143.57 20.41 Favored 'Isoleucine or valine' 0 C--O 1.232 0.18 0 C-N-CA 124.404 1.082 . . . . 0.41999999999999998 109.095 175.5 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 26.9 m120 -127.08 137.74 53.08 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 107.446 -1.316 . . . . 0.55000000000000004 107.446 178.523 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 59.9 t -131.47 124.25 54.27 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 N-CA-C 105.279 -2.119 . . . . 2.0499999999999998 105.279 -177.446 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 17.0 mm -102.17 87.51 1.23 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.421 0 C-N-CA 125.498 1.519 . . . . 0.54000000000000004 106.981 -173.812 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 6.8 p90 -120.24 171.33 8.57 Favored 'General case' 0 CA--C 1.509 -0.631 0 CA-C-N 116.227 -0.442 . . . . 1.8 110.333 -168.684 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -101.28 107.71 51.76 Favored Pre-proline 0 N--CA 1.449 -0.512 0 N-CA-C 108.822 -0.807 . . . . 4.6100000000000003 108.822 -175.898 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -71.45 7.71 1.42 Allowed 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 123.037 2.492 . . . . 1.1100000000000001 113.552 -174.797 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -83.03 -22.62 33.52 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 118.706 0.685 . . . . 1.51 109.312 167.524 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -122.36 -55.82 1.83 Allowed 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.367 1.067 . . . . 3.3700000000000001 110.642 -169.546 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.887 HG22 ' HB3' ' A' ' 59' ' ' ALA 0.278 0.8 OUTLIER -86.41 -171.78 3.72 Favored 'General case' 0 CA--C 1.52 -0.18 0 C-N-CA 123.998 0.919 . . . . 0.75 112.391 161.136 . . . . . . . . 4 4 . 1 . 017 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 134.3 87.02 0.27 Allowed Glycine 0 N--CA 1.443 -0.885 0 N-CA-C 104.265 -3.534 . . . . 2.4199999999999999 104.265 -153.004 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 68.2 p -14.78 -21.2 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.604 1 C-N-CA 138.119 6.568 . . . . 1.6000000000000001 119.42 -143.589 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -28.51 -62.6 0.11 Allowed 'General case' 0 N--CA 1.442 -0.859 0 C-N-CA 127.651 2.381 . . . . 1.1699999999999999 114.13 165.44 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.887 ' HB3' HG22 ' A' ' 55' ' ' THR . . . -74.72 -31.23 61.78 Favored 'General case' 0 C--N 1.332 -0.162 0 C-N-CA 119.06 -1.056 . . . . 0.97999999999999998 109.64 -168.005 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.4 mp -57.95 -55.0 24.43 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.634 0 C-N-CA 123.688 0.795 . . . . 0.80000000000000004 109.794 174.506 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.29 -44.09 88.35 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 119.213 0.915 . . . . 1.46 110.027 -178.354 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -52.77 -53.9 41.6 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 122.143 0.973 . . . . 3.0800000000000001 111.015 176.16 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -65.32 -40.27 93.5 Favored 'General case' 0 N--CA 1.443 -0.816 0 O-C-N 121.171 -0.956 . . . . 2.4500000000000002 111.725 -179.453 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 5.0 mm -49.34 -52.53 11.14 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 C-N-CA 125.298 1.439 . . . . 0.64000000000000001 108.548 175.842 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -56.04 -57.12 13.48 Favored 'General case' 0 C--N 1.342 0.245 0 C-N-CA 123.262 0.625 . . . . 2.23 110.858 175.44 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.47 -38.21 71.37 Favored 'General case' 0 CA--C 1.537 0.46 0 O-C-N 121.844 -0.535 . . . . 5.0099999999999998 111.895 -176.704 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 37.4 mt -67.23 -17.8 64.97 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.975 1.31 . . . . 1.05 111.57 176.937 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 92.68 32.93 7.74 Favored Glycine 0 CA--C 1.523 0.564 0 C-N-CA 124.543 1.068 . . . . 0.62 111.065 176.366 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.4 ' CD1' HG21 ' A' ' 24' ' ' ILE . 0.3 OUTLIER -128.94 174.14 9.78 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 117.932 0.866 . . . . 1.8899999999999999 110.558 -179.121 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 2.6 t-80 -138.99 128.55 24.52 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 108.126 -1.064 . . . . 1.6699999999999999 108.126 173.177 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.2 t -104.67 152.29 6.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 C-N-CA 124.766 1.226 . . . . 2.0699999999999998 107.82 173.885 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 96.6 t -117.34 144.88 24.06 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 C-N-CA 125.687 1.595 . . . . 0.68000000000000005 108.657 -179.438 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 34.1 mm . . . . . 0 N--CA 1.453 -0.28 0 C-N-CA 125.162 1.385 . . . . 1.1000000000000001 109.27 -170.798 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.1 m . . . . . 0 N--CA 1.451 -0.404 0 N-CA-C 107.053 -1.462 . . . . 0.91000000000000003 107.053 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -69.05 178.06 2.41 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-O 121.332 0.587 . . . . 2.6499999999999999 109.856 169.463 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -132.14 145.82 51.63 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 106.628 -1.619 . . . . 0.93000000000000005 106.628 162.965 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 12.9 mmtp -137.63 159.36 42.18 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 124.351 1.06 . . . . 3.6699999999999999 109.394 164.491 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -119.05 102.02 8.44 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 126.915 2.086 . . . . 1.6100000000000001 107.725 -174.906 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 3.1 mm -83.95 162.92 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 N-CA-C 107.827 -1.175 . . . . 1.9399999999999999 107.827 177.114 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -136.74 117.74 14.28 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 119.404 1.002 . . . . 0.85999999999999999 110.116 176.889 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 57.5 mtm -135.33 176.53 8.59 Favored 'General case' 0 CA--C 1.535 0.385 0 O-C-N 121.481 -0.762 . . . . 1.9399999999999999 110.388 -174.518 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.61 168.46 9.07 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 125.958 1.703 . . . . 3.6600000000000001 110.018 173.975 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.497 HG21 HD21 ' A' ' 41' ' ' LEU . 2.7 m -128.7 153.92 38.89 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 C-N-CA 124.019 0.928 . . . . 1.8300000000000001 111.571 174.552 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 71.1 m -119.59 175.13 6.0 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 125.391 1.476 . . . . 1.04 110.131 174.601 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 80.45 -44.87 2.97 Favored Glycine 0 CA--C 1.533 1.2 0 C-N-CA 123.717 0.675 . . . . 2.7000000000000002 113.435 171.93 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -42.2 141.05 0.99 Allowed 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 125.698 1.599 . . . . 2.0600000000000001 113.91 -178.154 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -148.58 -45.55 0.15 Allowed 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.788 1.235 . . . . 3.02 113.792 178.967 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 21.8 p -76.02 -4.85 43.52 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 120.286 1.403 . . . . 3.3500000000000001 112.434 -179.195 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 60.81 33.28 20.09 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 124.688 1.195 . . . . 2.4300000000000002 111.826 174.953 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -143.79 -44.02 0.27 Allowed 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 123.844 0.858 . . . . 1.01 111.136 -179.243 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 11.5 p -51.79 -33.27 34.71 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.53 0.732 . . . . 2.6699999999999999 112.268 174.345 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.539 ' HB1' HG21 ' A' ' 39' ' ' VAL . . . -49.96 -34.2 20.07 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.265 1.026 . . . . 0.40999999999999998 111.855 172.794 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -69.98 -49.65 49.56 Favored 'General case' 0 N--CA 1.453 -0.305 0 O-C-N 120.331 -1.48 . . . . 0.34000000000000002 109.887 172.12 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 20.1 mmm180 -52.74 -44.03 66.15 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 119.007 -0.52 . . . . 4.79 110.655 -174.017 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.2 pt -59.75 -54.22 37.55 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 C-N-CA 119.885 -0.726 . . . . 0.52000000000000002 111.559 178.208 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -55.28 -44.75 75.94 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-N 118.795 0.725 . . . . 2.1899999999999999 111.753 177.408 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 30.7 mmtp -71.77 -39.9 69.64 Favored 'General case' 0 CA--C 1.53 0.183 0 O-C-N 121.61 -0.681 . . . . 1.8500000000000001 110.84 -174.613 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.95 -43.61 98.65 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 109.627 -1.389 . . . . 0.73999999999999999 109.627 170.336 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -59.31 -36.93 76.52 Favored 'General case' 0 CA--C 1.541 0.606 0 O-C-N 121.442 -1.034 . . . . 2.3799999999999999 109.362 178.655 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.6 ttpp -58.68 -20.06 45.07 Favored 'General case' 0 CA--C 1.537 0.473 0 O-C-N 120.556 -1.34 . . . . 2.3900000000000001 113.685 174.214 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 22.3 mtt-85 -83.82 -6.22 59.38 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.847 0.859 . . . . 3.29 111.933 177.229 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 21.9 mmt -86.17 154.23 57.32 Favored Pre-proline 0 CA--C 1.531 0.24 0 CA-C-N 118.763 0.71 . . . . 4.6299999999999999 109.467 -174.978 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -56.08 148.17 60.36 Favored 'Trans proline' 0 N--CA 1.453 -0.87 0 C-N-CA 121.816 1.678 . . . . 0.72999999999999998 110.34 176.21 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 84.36 -33.18 3.22 Favored Glycine 0 CA--C 1.524 0.636 0 CA-C-O 119.855 -0.414 . . . . 0.5 113.197 175.793 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 15.3 t -82.78 137.86 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 CA-C-N 118.206 1.003 . . . . 0.56999999999999995 109.204 177.61 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -110.63 -49.89 3.0 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-O 118.255 -0.878 . . . . 0.91000000000000003 109.661 175.91 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -138.39 160.84 38.49 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 119.173 0.897 . . . . 2.3300000000000001 109.98 179.331 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -156.61 147.54 21.93 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 122.846 0.458 . . . . 0.45000000000000001 110.685 -179.473 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -154.07 116.93 4.45 Favored 'General case' 0 C--N 1.34 0.193 0 N-CA-C 108.64 -0.874 . . . . 0.5 108.64 -164.14 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.874 HG22 HD23 ' A' ' 41' ' ' LEU . 8.6 p -93.9 96.65 6.23 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 C-N-CA 123.921 0.888 . . . . 0.59999999999999998 110.026 -175.103 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 51.1 t-20 -83.35 56.96 3.76 Favored 'General case' 0 CA--C 1.536 0.407 0 O-C-N 120.641 -1.287 . . . . 0.60999999999999999 110.248 -175.927 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.874 HD23 HG22 ' A' ' 39' ' ' VAL . 0.6 OUTLIER -70.5 -21.15 62.79 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 115.486 -0.779 . . . . 1.1399999999999999 110.933 -176.468 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -45.56 -34.67 3.47 Favored 'General case' 0 C--N 1.338 0.096 0 C-N-CA 124.043 0.937 . . . . 0.67000000000000004 112.194 167.81 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 8.7 t -131.8 45.43 2.78 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 108.863 -0.791 . . . . 1.48 108.863 172.816 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 37.47 52.54 1.29 Allowed 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.886 1.674 . . . . 4.0199999999999996 113.793 175.091 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -134.34 165.97 23.9 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 108.263 -1.014 . . . . 1.6200000000000001 108.263 173.641 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.7 p -139.18 139.37 39.89 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 N-CA-C 107.352 -1.351 . . . . 0.45000000000000001 107.352 173.224 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 20.4 m120 -126.85 137.42 53.18 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 107.816 -1.179 . . . . 0.29999999999999999 107.816 -178.58 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.1 p -135.0 124.23 42.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 N-CA-C 106.562 -1.644 . . . . 1.9099999999999999 106.562 -173.488 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 7.5 mm -107.12 96.92 5.03 Favored 'Isoleucine or valine' 0 C--O 1.24 0.56 0 C-N-CA 125.332 1.453 . . . . 0.47999999999999998 107.871 -168.048 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 46.8 p90 -137.94 165.38 26.66 Favored 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 112.198 0.444 . . . . 1.73 112.198 -170.284 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 26.8 t0 -84.2 110.49 26.64 Favored Pre-proline 0 CA--C 1.535 0.379 0 O-C-N 124.412 1.07 . . . . 3.0800000000000001 110.551 173.762 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -72.38 4.4 3.43 Favored 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 123.149 2.566 . . . . 0.63 113.508 -178.345 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -86.12 -29.57 23.21 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 119.46 1.027 . . . . 0.80000000000000004 109.194 167.542 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -104.87 -57.56 2.01 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 123.578 0.751 . . . . 3.6499999999999999 109.102 -168.471 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.404 ' CG2' ' HB3' ' A' ' 59' ' ' ALA 0.308 1.3 p -89.76 -173.91 4.1 Favored 'General case' 0 CA--C 1.521 -0.159 0 CA-C-O 121.015 0.436 . . . . 0.45000000000000001 111.134 158.361 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 136.78 87.77 0.21 Allowed Glycine 0 N--CA 1.442 -0.965 0 N-CA-C 103.71 -3.756 . . . . 2.46 103.71 -152.807 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 66.6 p -12.35 -17.73 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.49 1 C-N-CA 137.778 6.431 . . . . 1.0700000000000001 119.863 -144.112 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -26.44 -62.98 0.08 Allowed 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 127.085 2.154 . . . . 0.55000000000000004 113.834 165.213 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.404 ' HB3' ' CG2' ' A' ' 55' ' ' THR . . . -72.91 -42.09 63.89 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 117.643 -1.623 . . . . 0.52000000000000002 109.866 -168.83 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.4 mp -49.71 -57.57 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.816 0 CA-C-N 114.237 -1.347 . . . . 0.83999999999999997 109.258 175.444 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.17 -45.82 83.34 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 118.586 0.63 . . . . 1.49 110.856 -174.656 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -45.06 -60.07 2.28 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 122.574 1.178 . . . . 3.1099999999999999 110.374 172.848 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 4.6 mmpt? -70.18 -38.73 75.44 Favored 'General case' 0 N--CA 1.431 -1.384 0 CA-C-N 115.341 -0.845 . . . . 3.1499999999999999 112.005 -173.802 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -48.66 -54.1 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 C-N-CA 124.889 1.276 . . . . 0.34999999999999998 107.8 175.372 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -60.09 -54.63 43.7 Favored 'General case' 0 C--N 1.34 0.182 0 C-N-CA 123.722 0.809 . . . . 1.6799999999999999 110.231 176.71 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.9 tmtm? -56.83 -35.38 68.74 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 112.937 0.717 . . . . 3.6899999999999999 112.937 -176.185 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 12.9 mt -70.59 -18.7 62.89 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 125.705 1.602 . . . . 0.69999999999999996 111.645 175.678 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 93.05 44.25 3.88 Favored Glycine 0 CA--C 1.525 0.681 0 C-N-CA 124.642 1.115 . . . . 0.56000000000000005 110.553 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -139.6 173.99 10.97 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 123.688 0.795 . . . . 1.9199999999999999 110.663 -177.929 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 18.8 t-160 -148.78 128.12 13.0 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 108.601 -0.889 . . . . 1.9199999999999999 108.601 175.861 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 14.5 p -100.28 135.1 37.63 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 C-N-CA 126.259 1.824 . . . . 1.45 108.336 178.621 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 15.8 t -100.32 131.94 46.88 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 C-N-CA 124.272 1.029 . . . . 0.79000000000000004 109.227 -179.794 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 27.6 mm . . . . . 0 N--CA 1.451 -0.417 0 C-N-CA 124.508 1.123 . . . . 1.1299999999999999 108.601 -173.125 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.2 m . . . . . 0 N--CA 1.451 -0.42 0 N-CA-C 105.029 -2.212 . . . . 0.82999999999999996 105.029 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -78.16 157.02 29.55 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 106.925 -1.509 . . . . 2.3199999999999998 106.925 167.578 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -111.03 148.37 32.74 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 124.436 1.095 . . . . 1.1399999999999999 108.106 176.65 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.433 ' NZ ' ' OE1' ' A' ' 7' ' ' GLU . 0.0 OUTLIER -135.92 153.66 51.37 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 121.769 0.795 . . . . 4.0599999999999996 109.075 159.425 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.433 ' OE1' ' NZ ' ' A' ' 6' ' ' LYS . 0.5 OUTLIER -84.05 144.39 29.11 Favored 'General case' 0 N--CA 1.442 -0.87 0 C-N-CA 126.651 1.981 . . . . 2.04 107.472 168.273 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -125.17 164.16 24.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 107.664 -1.235 . . . . 2.7400000000000002 107.664 168.027 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -136.22 124.05 22.61 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 106.669 -1.604 . . . . 0.59999999999999998 106.669 177.34 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 39.3 mtm -139.6 170.37 16.03 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 108.784 -0.821 . . . . 1.98 108.784 -178.328 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 30.8 mm100 -97.68 163.03 13.0 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.288 1.035 . . . . 2.9100000000000001 109.618 177.807 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 52.4 t -121.96 149.06 25.23 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 C-N-CA 124.815 1.246 . . . . 1.24 109.138 -173.25 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 17.9 m -155.44 174.3 15.44 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.716 1.206 . . . . 1.29 108.395 169.42 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 64.42 65.6 2.91 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 109.931 -1.268 . . . . 1.9099999999999999 109.931 -179.017 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 5.5 ppp? -139.54 154.32 47.63 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 123.917 0.887 . . . . 3.25 110.103 -171.442 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.8 p -99.54 -63.89 1.09 Allowed 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 125.945 1.698 . . . . 3.48 108.638 171.225 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 19.9 p -138.0 161.75 35.88 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 124.291 1.036 . . . . 2.2599999999999998 110.636 -175.416 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -76.48 49.82 0.62 Allowed 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.43 1.092 . . . . 1.72 111.124 179.552 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -142.31 -49.54 0.37 Allowed 'General case' 0 N--CA 1.457 -0.119 0 C-N-CA 124.878 1.271 . . . . 0.68999999999999995 109.008 178.368 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 38.3 m -57.8 -36.82 72.73 Favored 'General case' 0 CA--C 1.533 0.298 0 O-C-N 121.365 -0.835 . . . . 1.1699999999999999 110.059 168.512 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -51.28 -31.8 22.52 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.951 0.901 . . . . 0.55000000000000004 112.209 170.805 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -73.58 -53.4 10.59 Favored 'General case' 0 N--CA 1.453 -0.31 0 O-C-N 120.663 -1.273 . . . . 0.48999999999999999 109.647 170.77 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 48.9 mmm-85 -47.56 -46.16 27.71 Favored 'General case' 0 C--O 1.23 0.068 0 C-N-CA 123.609 0.764 . . . . 3.8900000000000001 111.215 -175.054 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.448 HG21 ' CD1' ' A' ' 69' ' ' TYR . 5.4 pt -55.1 -53.13 37.52 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 CA-C-O 119.129 -0.462 . . . . 0.45000000000000001 111.823 177.686 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -60.23 -42.28 94.88 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 118.819 0.736 . . . . 2.25 111.257 179.599 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.6 mptm? -68.24 -44.23 76.13 Favored 'General case' 0 CA--C 1.528 0.108 0 O-C-N 121.743 -0.598 . . . . 2.79 109.897 -176.391 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -57.32 -47.82 85.06 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 109.468 -1.453 . . . . 0.79000000000000004 109.468 171.721 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -58.5 -40.49 82.96 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.702 0.801 . . . . 2.3300000000000001 110.318 -175.373 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 12.8 ttmt -44.22 -34.75 1.99 Allowed 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 118.608 0.64 . . . . 2.8100000000000001 112.358 173.709 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 43.7 ttm-85 -67.27 -8.6 33.23 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 113.414 0.894 . . . . 3.8199999999999998 113.414 -172.869 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 1.6 mpp? -87.56 158.51 51.29 Favored Pre-proline 0 CA--C 1.537 0.463 0 CA-C-N 119.347 0.976 . . . . 4.1699999999999999 111.419 178.749 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -62.99 153.81 71.15 Favored 'Trans proline' 0 N--CA 1.456 -0.694 0 C-N-CA 123.142 2.561 . . . . 0.91000000000000003 112.077 -176.239 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 74.0 -35.65 0.91 Allowed Glycine 0 CA--C 1.525 0.683 0 C-N-CA 124.761 1.172 . . . . 0.80000000000000004 112.616 -178.142 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 11.6 t -71.88 130.97 35.2 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 O-C-N 121.074 -1.25 . . . . 0.54000000000000004 108.655 175.866 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -118.61 -43.11 2.71 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 118.677 -0.678 . . . . 0.93999999999999995 109.88 179.844 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -140.73 164.85 29.09 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 119.221 0.919 . . . . 2.02 112.016 168.934 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -157.69 140.65 15.07 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.139 -0.937 . . . . 0.40000000000000002 109.185 -171.595 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -153.52 107.11 2.99 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 106.198 -1.778 . . . . 0.48999999999999999 106.198 -164.839 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 4.2 p -80.23 122.85 36.19 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 N-CA-C 107.232 -1.396 . . . . 0.62 107.232 175.392 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 57.7 t-20 -102.2 56.27 0.8 Allowed 'General case' 0 C--O 1.235 0.311 0 N-CA-C 106.893 -1.521 . . . . 0.57999999999999996 106.893 178.666 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.14 -20.95 64.04 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 114.259 -1.337 . . . . 1.0700000000000001 109.589 -173.146 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -45.52 -37.15 5.09 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 124.118 0.967 . . . . 0.54000000000000004 112.267 167.015 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 6.3 t -122.75 40.24 3.74 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 121.65 0.738 . . . . 1.27 109.235 173.686 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 39.0 46.61 1.13 Allowed 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 126.888 2.075 . . . . 2.6200000000000001 113.015 178.718 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 52.3 m -128.03 155.51 44.21 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 125.0 1.32 . . . . 0.80000000000000004 108.3 -178.439 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.0 p -121.56 142.23 38.69 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 N-CA-C 108.417 -0.957 . . . . 0.40000000000000002 108.417 168.45 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 21.4 m120 -126.1 139.1 53.65 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 107.28 -1.378 . . . . 0.47999999999999998 107.28 174.771 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 20.5 t -132.89 135.84 56.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 N-CA-C 104.941 -2.244 . . . . 2.0099999999999998 104.941 -178.45 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 15.0 mm -112.05 92.24 2.01 Favored 'Isoleucine or valine' 0 C--O 1.24 0.578 0 N-CA-C 106.758 -1.571 . . . . 0.46999999999999997 106.758 -179.452 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -127.27 171.89 11.08 Favored 'General case' 0 CA--C 1.509 -0.625 0 CA-C-N 116.596 -0.275 . . . . 2.3100000000000001 110.492 -176.368 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 -94.38 105.66 19.15 Favored Pre-proline 0 N--CA 1.448 -0.533 0 O-C-N 124.397 1.061 . . . . 3.7999999999999998 108.615 176.948 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -69.98 5.75 1.66 Allowed 'Trans proline' 0 CA--C 1.538 0.679 0 C-N-CA 122.323 2.015 . . . . 0.60999999999999999 113.03 -179.245 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -85.66 -27.94 25.06 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 123.72 0.808 . . . . 0.75 109.43 169.044 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -112.47 -61.43 1.73 Allowed 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.281 1.032 . . . . 2.8100000000000001 110.05 -173.455 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.413 ' HB ' ' H ' ' A' ' 56' ' ' GLY 0.486 0.5 OUTLIER -85.12 -169.1 2.49 Favored 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 114.055 1.131 . . . . 0.81999999999999995 114.055 162.908 . . . . . . . . 4 4 . 1 . 019 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.413 ' H ' ' HB ' ' A' ' 55' ' ' THR . . . 158.59 -150.13 20.66 Favored Glycine 0 N--CA 1.434 -1.437 0 N-CA-C 103.56 -3.816 . . . . 2.6800000000000002 103.56 -157.456 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 15.0 p -75.96 -37.38 58.67 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 124.986 1.314 . . . . 1.49 109.687 -179.322 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -54.48 -63.79 1.04 Allowed 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 124.404 1.082 . . . . 0.70999999999999996 113.191 -164.277 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.77 -35.73 79.2 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 118.483 -1.287 . . . . 0.56999999999999995 108.87 -167.726 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.7 mp -55.17 -58.57 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.115 0 CA-C-N 114.205 -1.361 . . . . 1.25 109.212 173.52 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.63 -46.58 88.58 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 119.698 1.136 . . . . 1.8200000000000001 109.363 -175.46 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -48.86 -55.65 11.05 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 121.394 0.616 . . . . 4.0700000000000003 110.515 177.005 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.0 mmpt? -71.2 -40.68 71.03 Favored 'General case' 0 N--CA 1.435 -1.191 0 CA-C-O 118.333 -0.842 . . . . 2.4300000000000002 112.907 -177.36 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 3.4 mm -47.93 -52.4 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 C-N-CA 126.387 1.875 . . . . 0.62 107.703 176.754 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -53.74 -61.09 2.53 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 115.689 -0.687 . . . . 3.52 111.138 173.246 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -62.23 -29.38 70.35 Favored 'General case' 0 CA--C 1.542 0.669 0 O-C-N 121.779 -0.576 . . . . 5.2999999999999998 112.088 -172.256 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 36.4 mt -71.06 -19.94 62.43 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.778 1.631 . . . . 0.57999999999999996 111.377 173.043 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 89.56 40.85 5.88 Favored Glycine 0 CA--C 1.525 0.704 0 C-N-CA 124.688 1.137 . . . . 0.48999999999999999 111.474 176.741 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.448 ' CD1' HG21 ' A' ' 24' ' ' ILE . 0.5 OUTLIER -131.6 174.45 10.1 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 124.201 1.0 . . . . 1.8400000000000001 110.268 178.207 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 10.9 t-160 -151.05 126.26 9.94 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 109.608 -0.515 . . . . 2.23 109.608 167.073 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 20.3 m -82.27 167.7 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 N-CA-C 109.216 -0.661 . . . . 2.2400000000000002 109.216 176.013 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 15.2 t -130.9 145.52 35.39 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 N-CA-C 107.837 -1.171 . . . . 0.73999999999999999 107.837 178.723 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 29.4 mm . . . . . 0 CA--C 1.532 0.265 0 C-N-CA 124.356 1.062 . . . . 1.3200000000000001 109.108 -171.252 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 50.3 m . . . . . 0 N--CA 1.453 -0.308 0 N-CA-C 112.843 0.683 . . . . 0.89000000000000001 112.843 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -70.54 -177.39 1.49 Allowed 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 121.321 0.582 . . . . 2.1099999999999999 109.693 174.522 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -134.79 146.02 48.95 Favored 'General case' 0 N--CA 1.447 -0.575 0 N-CA-C 107.258 -1.386 . . . . 1.27 107.258 168.081 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 50.1 mtmt -142.42 162.14 36.25 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 123.271 0.628 . . . . 3.4300000000000002 109.378 159.966 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.3 mp0 -121.22 86.38 2.56 Favored 'General case' 0 N--CA 1.442 -0.86 0 C-N-CA 127.904 2.482 . . . . 1.8999999999999999 106.855 -166.144 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.494 ' N ' HD12 ' A' ' 8' ' ' ILE . 3.4 mp -82.56 163.06 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.258 0 N-CA-C 106.427 -1.694 . . . . 2.2000000000000002 106.427 -175.133 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -138.67 134.37 33.57 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 125.469 1.508 . . . . 0.47999999999999998 108.31 -176.146 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -156.28 174.32 15.57 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 118.346 0.521 . . . . 2.71 110.736 175.344 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 29.0 mm100 -93.57 160.68 14.68 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.931 1.293 . . . . 2.6800000000000002 109.923 -178.874 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 21.3 t -119.43 154.87 22.05 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 C-N-CA 124.23 1.012 . . . . 1.22 109.27 -171.117 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 32.1 t -154.47 175.82 13.11 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 118.588 0.631 . . . . 1.97 110.358 170.837 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 59.09 72.53 0.59 Allowed Glycine 0 CA--C 1.528 0.854 0 N-CA-C 110.252 -1.139 . . . . 2.0499999999999998 110.252 -174.322 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -144.83 159.96 42.04 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 123.746 0.818 . . . . 2.0299999999999998 110.567 -172.447 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -100.11 -65.12 0.99 Allowed 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 125.955 1.702 . . . . 3.0699999999999998 110.246 169.1 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 2.0 p -150.54 164.15 36.69 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 123.32 0.648 . . . . 2.0899999999999999 110.371 -166.826 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -72.75 32.86 0.07 Allowed 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.661 1.584 . . . . 1.78 113.751 -172.789 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -114.9 -47.84 2.86 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 126.314 1.845 . . . . 0.70999999999999996 108.74 171.616 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 38.0 m -66.0 -38.09 87.58 Favored 'General case' 0 N--CA 1.455 -0.185 0 O-C-N 121.435 -0.791 . . . . 1.25 110.653 -170.296 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.846 ' HB1' HG21 ' A' ' 39' ' ' VAL . . . -56.62 -28.75 61.14 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 116.25 -0.432 . . . . 0.58999999999999997 111.306 173.981 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.84 -50.25 65.27 Favored 'General case' 0 N--CA 1.455 -0.207 0 O-C-N 120.158 -1.589 . . . . 0.46999999999999997 109.118 171.801 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 28.5 mmm180 -53.04 -48.53 67.55 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 118.792 -0.623 . . . . 5.1699999999999999 110.336 -178.152 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.496 HG21 ' CD1' ' A' ' 69' ' ' TYR 0.271 1.8 pt -58.14 -56.34 16.59 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.44 0 C-N-CA 119.304 -0.958 . . . . 0.48999999999999999 110.765 179.703 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -53.68 -42.03 67.51 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 119.594 1.088 . . . . 2.6200000000000001 112.582 179.325 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -70.02 -43.67 70.87 Favored 'General case' 0 CA--C 1.535 0.394 0 O-C-N 121.163 -0.961 . . . . 2.0099999999999998 110.717 -177.755 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -66.89 -33.19 83.25 Favored Glycine 0 CA--C 1.529 0.964 0 N-CA-C 111.254 -0.738 . . . . 0.65000000000000002 111.254 175.281 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -66.03 -46.36 78.16 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 125.021 1.328 . . . . 2.2599999999999998 107.635 178.444 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 14.3 ttmt -49.11 -34.88 14.96 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 118.758 0.708 . . . . 3.25 112.405 176.805 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -59.61 -20.99 59.69 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 113.124 0.787 . . . . 5.3700000000000001 113.124 179.575 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.52 158.83 84.02 Favored Pre-proline 0 CA--C 1.54 0.573 0 C-N-CA 123.99 0.916 . . . . 4.3099999999999996 111.93 -174.045 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 78.9 Cg_endo -73.05 115.52 4.38 Favored 'Trans proline' 0 N--CA 1.453 -0.901 0 C-N-CA 121.871 1.714 . . . . 1.04 109.691 175.781 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 124.38 -36.55 2.88 Favored Glycine 0 CA--C 1.529 0.915 0 C-N-CA 124.343 0.973 . . . . 0.80000000000000004 112.446 172.57 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 57.8 t -80.17 142.32 14.08 Favored 'Isoleucine or valine' 0 C--N 1.34 0.192 0 CA-C-N 118.01 0.905 . . . . 0.71999999999999997 109.193 173.877 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.5 m -115.47 -41.79 3.22 Favored 'General case' 0 C--N 1.338 0.068 0 C-N-CA 123.292 0.637 . . . . 1.6899999999999999 110.947 -176.034 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -136.91 165.83 25.07 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 123.629 0.771 . . . . 2.04 110.329 169.654 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -158.92 142.81 15.25 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 122.73 0.412 . . . . 0.46000000000000002 111.261 -177.695 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -154.97 107.5 2.75 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 106.228 -1.767 . . . . 0.42999999999999999 106.228 -167.497 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.846 HG21 ' HB1' ' A' ' 21' ' ' ALA . 4.2 p -80.02 135.8 24.73 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 N-CA-C 107.613 -1.255 . . . . 0.83999999999999997 107.613 174.251 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 54.4 t-20 -122.24 55.98 1.12 Allowed 'General case' 0 C--O 1.235 0.294 0 CA-C-O 122.844 1.307 . . . . 0.80000000000000004 107.895 -179.836 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.655 HD23 HG22 ' A' ' 39' ' ' VAL . 0.4 OUTLIER -64.72 -20.21 66.2 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-N 114.169 -1.378 . . . . 0.96999999999999997 110.515 179.107 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -49.63 -37.2 27.21 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 118.829 -0.605 . . . . 0.55000000000000004 112.124 167.014 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 13.5 t -114.33 23.57 12.71 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 118.362 0.528 . . . . 1.26 111.206 171.436 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 65.67 20.18 11.52 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.665 1.586 . . . . 2.7000000000000002 114.353 175.078 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 25.6 m -122.05 164.17 18.15 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.657 1.183 . . . . 0.67000000000000004 109.797 -173.209 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.7 p -128.5 146.75 33.44 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 O-C-N 120.789 -1.194 . . . . 0.37 109.521 172.917 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -129.59 136.77 50.19 Favored 'General case' 0 C--N 1.345 0.41 0 N-CA-C 107.814 -1.18 . . . . 0.35999999999999999 107.814 175.696 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -130.75 130.07 64.29 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.797 0 N-CA-C 105.245 -2.131 . . . . 2.3999999999999999 105.245 179.687 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 11.9 mm -103.48 99.33 8.17 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 N-CA-C 106.051 -1.833 . . . . 0.46999999999999997 106.051 -174.401 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.47 ' CE2' HD13 ' A' ' 8' ' ' ILE . 46.0 p90 -136.05 169.86 16.93 Favored 'General case' 0 CA--C 1.51 -0.564 0 O-C-N 121.976 -0.453 . . . . 1.6599999999999999 110.98 -170.985 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 31.1 t0 -90.69 105.49 12.13 Favored Pre-proline 0 C--O 1.234 0.246 0 O-C-N 124.491 1.119 . . . . 3.02 109.208 175.072 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -75.32 8.31 2.59 Favored 'Trans proline' 0 N--CA 1.45 -1.054 0 C-N-CA 122.396 2.064 . . . . 0.68999999999999995 112.353 -177.59 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -87.94 -28.38 21.53 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 119.328 0.967 . . . . 0.96999999999999997 108.928 167.133 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -102.61 -59.11 1.76 Allowed 'General case' 0 C--N 1.344 0.326 0 N-CA-C 108.872 -0.788 . . . . 2.4199999999999999 108.872 -176.93 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.334 0.7 OUTLIER -86.46 -172.75 4.19 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 125.345 1.458 . . . . 0.55000000000000004 114.1 166.759 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 167.99 -143.19 7.99 Favored Glycine 0 N--CA 1.43 -1.706 1 N-CA-C 101.819 -4.512 . . . . 2.6299999999999999 101.819 -164.97 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 36.5 p -77.35 -34.77 55.1 Favored 'General case' 0 N--CA 1.442 -0.851 0 C-N-CA 125.918 1.687 . . . . 1.29 109.494 176.96 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -48.8 -62.92 1.26 Allowed 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 125.166 1.386 . . . . 0.57999999999999996 113.247 -161.262 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -75.31 -30.11 60.24 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 114.936 -1.029 . . . . 0.65000000000000002 109.795 -173.425 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 4.6 mt -57.76 -57.42 10.47 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.739 0 CA-C-O 118.405 -0.807 . . . . 1.46 110.609 177.043 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.25 -43.82 92.4 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 119.079 0.854 . . . . 1.1100000000000001 108.73 -176.844 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -50.66 -56.5 11.6 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 123.481 0.712 . . . . 3.1200000000000001 110.459 178.524 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -66.03 -43.05 88.75 Favored 'General case' 0 N--CA 1.438 -1.072 0 CA-C-O 118.42 -0.8 . . . . 2.1800000000000002 111.879 -179.836 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 3.3 mm -47.98 -51.71 8.35 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 125.781 1.633 . . . . 0.56999999999999995 108.78 176.483 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 38.9 mm-40 -56.13 -58.6 7.25 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.577 0.751 . . . . 1.53 110.598 174.648 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.09 -36.34 72.71 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 121.412 -0.805 . . . . 5.1600000000000001 112.466 -176.586 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 37.9 mt -68.35 -17.62 64.29 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 125.154 1.382 . . . . 0.68999999999999995 111.02 177.106 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 91.68 38.15 5.91 Favored Glycine 0 C--N 1.338 0.65 0 C-N-CA 124.334 0.969 . . . . 0.46000000000000002 110.984 174.224 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.496 ' CD1' HG21 ' A' ' 24' ' ' ILE . 0.3 OUTLIER -133.44 174.81 10.01 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 123.593 0.757 . . . . 1.8999999999999999 110.702 -177.877 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -140.12 167.81 21.26 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 108.706 -0.85 . . . . 1.6599999999999999 108.706 169.094 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 45.5 t -140.01 145.59 26.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 N-CA-C 105.476 -2.046 . . . . 2.1400000000000001 105.476 -171.807 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 5.8 t -120.64 136.9 56.16 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 C-N-CA 124.671 1.188 . . . . 0.78000000000000003 107.854 -177.422 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 45.7 mm . . . . . 0 N--CA 1.453 -0.298 0 N-CA-C 106.969 -1.493 . . . . 1.4199999999999999 106.969 -178.67 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 5.2 m . . . . . 0 N--CA 1.451 -0.425 0 N-CA-C 106.995 -1.483 . . . . 0.87 106.995 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -68.25 168.86 11.5 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 107.717 -1.216 . . . . 2.4700000000000002 107.717 164.607 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -127.42 147.78 50.29 Favored 'General case' 0 CA--C 1.516 -0.33 0 C-N-CA 124.415 1.086 . . . . 0.97999999999999998 108.359 177.112 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 52.7 mtmt -144.93 159.61 42.64 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 121.839 0.828 . . . . 3.3599999999999999 111.573 163.572 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -97.34 145.82 25.76 Favored 'General case' 0 N--CA 1.442 -0.873 0 C-N-CA 127.787 2.435 . . . . 1.71 108.16 175.553 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.425 HD11 ' CE2' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -127.87 158.58 39.49 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 N-CA-C 105.841 -1.911 . . . . 2.3100000000000001 105.841 173.588 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -136.87 127.96 27.8 Favored 'General case' 0 C--O 1.226 -0.14 0 N-CA-C 107.854 -1.165 . . . . 0.96999999999999997 107.854 179.46 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 3.5 ptp -156.02 177.51 11.34 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 118.434 0.561 . . . . 2.5699999999999998 110.781 -172.947 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 27.7 mm100 -97.47 161.79 13.62 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.243 1.417 . . . . 2.52 110.453 -175.628 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 49.6 t -116.0 157.76 16.69 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 C-N-CA 124.951 1.3 . . . . 1.1499999999999999 109.818 -174.281 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 6.3 m -153.35 169.78 22.26 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.486 0.714 . . . . 0.91000000000000003 110.615 169.441 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 60.44 59.93 9.43 Favored Glycine 0 CA--C 1.529 0.945 0 N-CA-C 110.016 -1.234 . . . . 1.9199999999999999 110.016 -174.825 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -144.71 167.69 21.96 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 124.21 1.004 . . . . 2.0099999999999998 109.982 -174.448 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -143.22 -67.49 0.36 Allowed 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 124.769 1.228 . . . . 2.3199999999999998 108.982 171.342 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 12.2 p -98.84 150.86 21.45 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-O 121.643 0.735 . . . . 2.1699999999999999 111.205 -178.493 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -78.18 47.11 0.65 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.616 0.766 . . . . 1.8899999999999999 110.794 177.358 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -135.29 -53.72 0.79 Allowed 'General case' 0 N--CA 1.457 -0.12 0 C-N-CA 124.305 1.042 . . . . 0.71999999999999997 109.288 177.952 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 34.7 m -55.78 -38.18 69.56 Favored 'General case' 0 C--N 1.338 0.096 0 O-C-N 121.552 -0.718 . . . . 1.1899999999999999 109.64 168.166 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.558 ' HB1' HG21 ' A' ' 39' ' ' VAL . . . -57.25 -22.88 44.36 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 112.547 0.573 . . . . 0.56000000000000005 112.547 175.766 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -73.24 -40.76 64.42 Favored 'General case' 0 C--O 1.232 0.135 0 O-C-N 120.684 -1.26 . . . . 0.44 110.727 170.665 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 18.1 mmm180 -56.75 -39.36 73.85 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 123.391 0.676 . . . . 4.46 109.761 -171.429 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.3 pt -60.18 -65.62 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 C-N-CA 119.454 -0.898 . . . . 1.6699999999999999 111.183 177.38 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.58 ' HG3' ' HB1' ' A' ' 37' ' ' ALA . 2.5 mp0 -46.95 -45.13 20.54 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-N 119.778 1.172 . . . . 2.4700000000000002 112.156 177.858 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 11.2 mptt -70.84 -33.34 70.56 Favored 'General case' 0 CA--C 1.538 0.504 0 O-C-N 121.377 -0.827 . . . . 1.98 110.641 -176.725 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -72.03 -29.11 67.33 Favored Glycine 0 CA--C 1.531 1.071 0 O-C-N 121.377 -0.827 . . . . 0.60999999999999999 112.061 169.715 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.0 mp -69.78 -43.9 71.2 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 118.378 1.089 . . . . 2.8999999999999999 109.432 175.975 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 61.8 tttm -50.35 -31.74 15.42 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.644 0.777 . . . . 2.6800000000000002 111.964 174.206 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 52.8 mtt180 -75.8 -4.38 40.31 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 113.651 0.982 . . . . 5.2300000000000004 113.651 179.484 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 93.0 mmm -93.17 150.47 39.19 Favored Pre-proline 0 C--O 1.232 0.161 0 CA-C-N 119.422 1.01 . . . . 3.5299999999999998 110.264 -178.116 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -56.95 144.06 90.27 Favored 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 121.869 1.713 . . . . 0.62 109.143 173.99 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 88.69 -32.34 4.57 Favored Glycine 0 CA--C 1.525 0.686 0 CA-C-O 119.419 -0.656 . . . . 0.48999999999999999 113.343 179.238 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 14.0 t -87.3 136.88 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.176 0 CA-C-N 118.888 1.344 . . . . 0.60999999999999999 108.438 179.867 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -109.57 -40.9 4.72 Favored 'General case' 0 N--CA 1.456 -0.135 0 CA-C-O 118.305 -0.855 . . . . 0.85999999999999999 110.663 177.679 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -150.61 164.46 35.99 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 108.336 -0.987 . . . . 1.8700000000000001 108.336 172.94 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.58 ' HB1' ' HG3' ' A' ' 25' ' ' GLU . . . -157.77 145.04 18.29 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 109.256 -0.646 . . . . 0.79000000000000004 109.256 176.693 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -143.54 115.25 8.18 Favored 'General case' 0 N--CA 1.457 -0.114 0 C-N-CA 124.663 1.185 . . . . 0.80000000000000004 108.974 -164.296 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.558 HG21 ' HB1' ' A' ' 21' ' ' ALA . 5.4 p -84.45 116.69 28.58 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.569 0 N-CA-C 108.646 -0.872 . . . . 0.59999999999999998 108.646 173.679 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 53.3 t-20 -101.3 56.85 0.84 Allowed 'General case' 0 C--O 1.235 0.298 0 N-CA-C 107.224 -1.398 . . . . 0.73999999999999999 107.224 176.647 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.442 HD23 ' CG2' ' A' ' 39' ' ' VAL . 0.2 OUTLIER -67.36 -21.58 65.62 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 114.552 -1.203 . . . . 1.04 110.02 -177.003 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -46.32 -35.36 5.28 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 123.687 0.795 . . . . 0.76000000000000001 112.14 166.653 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 13.3 t -125.37 37.18 4.43 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 122.462 0.305 . . . . 1.2 110.383 171.695 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 50.06 34.69 8.64 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.681 1.592 . . . . 2.6200000000000001 113.264 172.988 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 87.0 m -126.03 157.47 37.83 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.445 1.098 . . . . 0.71999999999999997 108.621 -176.595 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 14.9 p -134.12 144.93 34.0 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 O-C-N 121.284 -0.885 . . . . 0.51000000000000001 109.875 172.239 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 25.9 m120 -128.05 136.22 50.94 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 125.344 1.458 . . . . 0.40999999999999998 108.305 -179.083 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 20.6 t -129.5 126.11 62.75 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 N-CA-C 105.475 -2.046 . . . . 2.23 105.475 -176.369 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 21.9 mm -105.85 103.01 14.7 Favored 'Isoleucine or valine' 0 C--O 1.239 0.548 0 N-CA-C 108.007 -1.108 . . . . 0.51000000000000001 108.007 -174.184 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.425 ' CE2' HD11 ' A' ' 8' ' ' ILE . 7.7 p90 -141.62 169.87 16.78 Favored 'General case' 0 CA--C 1.512 -0.504 0 O-C-N 122.218 -0.301 . . . . 2.0699999999999998 111.364 -170.964 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -89.54 109.57 32.82 Favored Pre-proline 0 N--CA 1.449 -0.517 0 O-C-N 124.299 1.0 . . . . 3.8100000000000001 109.444 177.021 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -71.14 8.33 1.12 Allowed 'Trans proline' 0 CA--C 1.54 0.777 0 C-N-CA 122.698 2.265 . . . . 0.62 113.068 179.923 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -88.07 -25.15 23.2 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.033 0.933 . . . . 0.88 109.596 168.837 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -115.52 -59.44 2.0 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 124.305 1.042 . . . . 3.3599999999999999 109.697 -171.062 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.323 3.8 p -91.74 -166.29 1.53 Allowed 'General case' 0 C--N 1.342 0.246 0 N-CA-C 110.35 -0.241 . . . . 0.53000000000000003 110.35 163.132 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 122.84 87.59 0.85 Allowed Glycine 0 N--CA 1.444 -0.784 0 N-CA-C 104.103 -3.599 . . . . 2.1600000000000001 104.103 -142.456 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 72.3 p -14.11 -18.99 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.36 1 C-N-CA 138.344 6.657 . . . . 1.3600000000000001 119.476 -148.022 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -26.39 -62.34 0.08 Allowed 'General case' 0 N--CA 1.443 -0.776 0 C-N-CA 127.124 2.17 . . . . 0.55000000000000004 113.756 166.391 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.69 -41.1 63.11 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 117.97 -1.492 . . . . 0.48999999999999999 109.931 -168.654 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.2 mp -52.81 -53.63 20.19 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.807 0 CA-C-N 114.446 -1.252 . . . . 0.87 109.193 176.305 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -66.92 -45.55 77.55 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 122.69 0.396 . . . . 1.4299999999999999 110.093 -173.765 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -46.06 -57.36 4.52 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 122.57 1.176 . . . . 2.6800000000000002 110.761 170.185 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 5.0 mmmt -67.66 -39.09 84.58 Favored 'General case' 0 N--CA 1.435 -1.178 0 CA-C-N 115.741 -0.663 . . . . 2.9100000000000001 112.409 -176.323 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -52.25 -50.38 37.26 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 N-CA-C 107.49 -1.3 . . . . 0.46000000000000002 107.49 -177.554 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 25.3 mm-40 -57.62 -58.31 8.9 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.033 0.933 . . . . 1.9299999999999999 110.55 174.044 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 24.9 mmtt -52.94 -37.03 60.6 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 113.287 0.847 . . . . 3.8999999999999999 113.287 -178.448 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 18.2 mt -70.64 -18.09 62.86 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.52 1.528 . . . . 0.68000000000000005 111.542 178.232 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 90.32 41.9 5.37 Favored Glycine 0 CA--C 1.525 0.67 0 C-N-CA 124.649 1.119 . . . . 0.46000000000000002 110.488 179.022 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -138.19 175.46 9.56 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 124.157 0.983 . . . . 1.99 109.249 -176.345 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 15.1 t-160 -141.05 157.57 45.13 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 108.649 -0.871 . . . . 2.0299999999999998 108.649 171.182 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 9.5 p -135.83 141.35 42.19 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 N-CA-C 106.528 -1.656 . . . . 1.4299999999999999 106.528 -178.037 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 3.4 t -115.73 130.52 70.24 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 N-CA-C 108.599 -0.889 . . . . 0.57999999999999996 108.599 -175.145 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 45.5 mm . . . . . 0 C--N 1.327 -0.375 0 C-N-CA 124.114 0.966 . . . . 1.25 108.452 -170.059 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 49.3 m . . . . . 0 CA--C 1.531 0.229 0 CA-C-O 120.88 0.371 . . . . 0.93999999999999995 111.451 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -62.92 177.23 0.59 Allowed 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 121.266 0.555 . . . . 2.1099999999999999 110.675 173.637 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -134.69 140.39 45.96 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 108.684 -0.858 . . . . 1.1799999999999999 108.684 173.959 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -133.16 156.79 46.82 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 124.671 1.188 . . . . 4.0899999999999999 108.999 164.664 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -105.36 121.32 43.65 Favored 'General case' 0 N--CA 1.434 -1.261 0 N-CA-C 101.683 -3.451 . . . . 1.8100000000000001 101.683 174.034 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 24.8 mm -101.26 165.17 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.388 0 N-CA-C 106.639 -1.615 . . . . 2.0800000000000001 106.639 168.013 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -139.02 132.62 30.46 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 107.076 -1.453 . . . . 0.46999999999999997 107.076 177.581 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -156.95 178.45 10.35 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 118.883 0.765 . . . . 2.0 110.848 174.211 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 25.0 mm100 -91.47 166.33 12.91 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.314 1.445 . . . . 2.3700000000000001 110.405 -178.68 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -131.64 157.04 43.11 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.136 0 C-N-CA 124.057 0.943 . . . . 2.1600000000000001 110.723 174.936 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 63.7 m -149.84 166.73 28.62 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 125.5 1.52 . . . . 0.96999999999999997 109.018 177.352 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 71.66 67.03 1.96 Allowed Glycine 0 CA--C 1.525 0.691 0 N-CA-C 109.211 -1.556 . . . . 1.74 109.211 -177.394 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -147.55 166.66 26.66 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 124.153 0.981 . . . . 2.48 109.522 -174.731 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.3 p -126.22 -61.36 1.22 Allowed 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 124.049 0.939 . . . . 2.2599999999999998 109.497 168.623 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 30.8 p -109.31 151.61 26.35 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 123.694 0.798 . . . . 2.1699999999999999 111.297 -176.174 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -76.24 53.25 0.8 Allowed 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.604 0.762 . . . . 1.71 110.201 174.764 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -145.52 -51.96 0.26 Allowed 'General case' 0 C--O 1.23 0.048 0 C-N-CA 123.49 0.716 . . . . 0.68999999999999995 110.908 -175.844 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 7.5 p -55.41 -38.02 68.39 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 119.129 0.877 . . . . 2.5099999999999998 109.997 167.764 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.426 ' HB1' HG21 ' A' ' 39' ' ' VAL . . . -47.84 -31.07 4.59 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.483 1.513 . . . . 0.48999999999999999 112.899 171.17 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -72.84 -55.25 6.95 Favored 'General case' 0 N--CA 1.454 -0.272 0 O-C-N 121.099 -1.001 . . . . 0.29999999999999999 109.912 172.454 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 3.5 mpp_? -54.56 -40.4 68.68 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 118.736 -0.649 . . . . 4.2999999999999998 111.5 -174.892 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.414 HG21 ' CD1' ' A' ' 69' ' ' TYR . 5.4 pt -55.45 -54.45 25.24 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 C-N-CA 119.554 -0.858 . . . . 0.48999999999999999 110.802 175.535 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -57.69 -39.2 76.62 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 123.639 0.776 . . . . 3.1000000000000001 111.313 179.496 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 56.5 mmtt -71.43 -45.8 61.73 Favored 'General case' 0 CA--C 1.534 0.339 0 O-C-N 121.484 -0.76 . . . . 2.0600000000000001 110.201 -175.079 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.77 -39.47 98.01 Favored Glycine 0 CA--C 1.53 0.988 0 N-CA-C 110.376 -1.09 . . . . 0.57999999999999996 110.376 172.329 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.0 tt -60.01 -36.11 76.51 Favored 'General case' 0 CA--C 1.538 0.516 0 O-C-N 121.744 -0.857 . . . . 1.8999999999999999 110.279 174.818 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -60.79 -27.99 68.41 Favored 'General case' 0 N--CA 1.454 -0.242 0 O-C-N 120.876 -1.14 . . . . 3.54 111.999 174.464 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 4.4 mmt85 -72.39 -5.92 39.85 Favored 'General case' 0 CA--C 1.536 0.441 0 O-C-N 121.508 -0.745 . . . . 3.3799999999999999 112.009 -177.88 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 78.7 mmm -78.23 148.22 74.09 Favored Pre-proline 0 CA--C 1.533 0.32 0 CA-C-N 119.146 0.884 . . . . 3.2999999999999998 111.05 -179.544 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -56.96 142.62 93.65 Favored 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 122.393 2.062 . . . . 0.65000000000000002 108.832 176.953 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 86.68 -20.54 23.14 Favored Glycine 0 CA--C 1.532 1.107 0 CA-C-O 118.567 -1.13 . . . . 0.57999999999999996 113.498 -178.988 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 14.4 t -94.49 123.78 46.73 Favored 'Isoleucine or valine' 0 C--N 1.344 0.334 0 CA-C-N 119.904 1.852 . . . . 0.63 110.414 -178.244 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -103.37 -37.26 7.7 Favored 'General case' 0 CA--C 1.524 -0.054 0 C-N-CA 124.519 1.127 . . . . 1.0600000000000001 111.21 -171.889 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -149.89 162.37 40.45 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 108.775 -0.824 . . . . 2.1299999999999999 108.775 174.726 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -155.45 139.28 16.22 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 122.781 0.432 . . . . 0.46000000000000002 110.203 -177.268 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -155.78 110.19 2.87 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 109.03 -0.73 . . . . 0.51000000000000001 109.03 -165.56 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.426 HG21 ' HB1' ' A' ' 21' ' ' ALA . 2.8 p -83.02 106.29 13.64 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.638 0 N-CA-C 109.256 -0.646 . . . . 0.65000000000000002 109.256 178.785 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 55.3 t-20 -84.59 56.98 4.08 Favored 'General case' 0 CA--C 1.533 0.323 0 O-C-N 120.821 -1.174 . . . . 0.63 108.819 176.188 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.67 -19.98 64.42 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 115.271 -0.877 . . . . 1.1000000000000001 109.441 -176.86 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -48.37 -38.77 20.18 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.483 0.713 . . . . 0.55000000000000004 111.952 167.491 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 8.8 t -117.08 36.09 4.37 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 118.029 0.377 . . . . 1.24 110.383 170.764 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 55.42 26.59 9.0 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.476 1.11 . . . . 4.1500000000000004 113.639 172.565 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 66.0 m -122.52 162.72 21.23 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.884 1.274 . . . . 0.63 108.679 -173.411 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.4 p -126.64 146.21 32.89 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 O-C-N 121.051 -1.03 . . . . 0.34999999999999998 109.498 170.931 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -131.58 131.02 42.96 Favored 'General case' 0 C--N 1.343 0.295 0 N-CA-C 108.113 -1.069 . . . . 0.32000000000000001 108.113 177.449 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 4.3 p -132.83 132.03 59.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 106.188 -1.782 . . . . 1.73 106.188 -175.024 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 16.9 mm -109.39 105.53 18.98 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 C-N-CA 125.374 1.47 . . . . 0.41999999999999998 107.745 -170.841 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 49.1 p90 -146.43 169.26 19.24 Favored 'General case' 0 CA--C 1.516 -0.365 0 O-C-N 122.073 -0.392 . . . . 1.7 111.677 -171.647 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 41.4 t0 -88.28 108.29 21.2 Favored Pre-proline 0 CA--C 1.533 0.305 0 O-C-N 124.484 1.115 . . . . 3.0600000000000001 110.262 175.731 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -70.89 0.94 5.72 Favored 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 123.036 2.491 . . . . 0.64000000000000001 113.351 -179.21 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -84.15 -30.68 25.68 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 119.502 1.046 . . . . 0.80000000000000004 109.144 167.686 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -105.09 -55.76 2.28 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 124.099 0.96 . . . . 2.7200000000000002 112.007 -167.544 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.263 1.6 p -92.33 -177.63 4.69 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-O 121.496 0.665 . . . . 0.51000000000000001 110.319 155.681 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 155.42 89.77 0.07 OUTLIER Glycine 0 N--CA 1.443 -0.883 0 N-CA-C 105.937 -2.865 . . . . 2.4199999999999999 105.937 -165.545 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 82.1 p -7.89 -16.62 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.561 1 C-N-CA 136.279 5.832 . . . . 1.1699999999999999 119.977 -136.369 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -25.45 -63.23 0.06 Allowed 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 127.756 2.422 . . . . 0.67000000000000004 114.352 169.827 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.81 -43.0 57.0 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 118.349 -1.341 . . . . 0.64000000000000001 109.467 -166.316 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -47.9 -56.19 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.099 0 CA-C-N 113.242 -1.799 . . . . 0.87 110.511 171.985 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -67.0 -46.02 75.82 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 118.952 0.796 . . . . 1.46 110.423 -175.047 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -45.19 -57.99 3.56 Favored 'General case' 0 C--N 1.342 0.282 0 CA-C-O 122.59 1.186 . . . . 3.3700000000000001 110.975 171.954 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.9 mmpt? -71.39 -37.75 71.55 Favored 'General case' 0 N--CA 1.431 -1.399 0 CA-C-O 118.417 -0.801 . . . . 2.4199999999999999 112.225 -174.864 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -47.61 -52.47 5.92 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 N-CA-C 107.482 -1.303 . . . . 0.46000000000000002 107.482 175.629 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -59.8 -56.55 20.35 Favored 'General case' 0 C--N 1.343 0.295 0 C-N-CA 123.693 0.797 . . . . 2.0299999999999998 110.211 175.845 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 2.7 mmmt -60.29 -28.54 68.17 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 114.018 1.118 . . . . 4.54 114.018 -175.683 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 11.8 mt -70.99 -18.24 62.61 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 125.925 1.69 . . . . 0.69999999999999996 111.373 173.741 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 90.72 45.2 4.32 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 110.217 -1.153 . . . . 0.45000000000000001 110.217 178.642 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.414 ' CD1' HG21 ' A' ' 24' ' ' ILE . 0.2 OUTLIER -141.02 173.42 11.5 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 124.039 0.935 . . . . 2.02 110.363 -177.195 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 17.3 t60 -133.64 139.95 46.79 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 109.212 -0.662 . . . . 2.1899999999999999 109.212 170.596 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 6.1 p -112.61 126.18 69.98 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 N-CA-C 107.558 -1.275 . . . . 1.51 107.558 174.863 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 26.5 t -104.46 138.38 29.38 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.154 0 N-CA-C 108.341 -0.985 . . . . 0.51000000000000001 108.341 -177.487 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 4.9 mp . . . . . 0 N--CA 1.45 -0.451 0 C-N-CA 124.197 0.999 . . . . 1.27 108.388 -179.196 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.0 m . . . . . 0 C--O 1.232 0.147 0 N-CA-C 107.061 -1.459 . . . . 1.0 107.061 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -80.02 -178.27 6.42 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 123.552 0.741 . . . . 2.1000000000000001 109.723 179.335 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -136.79 141.82 42.94 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 107.79 -1.189 . . . . 1.0800000000000001 107.79 168.939 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -139.85 163.93 31.34 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 124.509 1.124 . . . . 3.6299999999999999 109.673 168.427 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.8 90.59 3.13 Favored 'General case' 0 N--CA 1.441 -0.905 0 C-N-CA 128.504 2.722 . . . . 1.6699999999999999 106.985 -159.826 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.402 HG13 ' CZ ' ' A' ' 50' ' ' TYR . 7.5 mm -83.75 162.22 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.026 0 N-CA-C 107.324 -1.362 . . . . 1.9399999999999999 107.324 -176.288 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -140.38 134.86 31.46 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 124.704 1.202 . . . . 0.58999999999999997 108.728 179.742 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -156.28 172.23 18.84 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.361 0.664 . . . . 2.3799999999999999 110.52 176.929 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -87.27 168.86 12.81 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.997 1.319 . . . . 3.8199999999999998 110.383 174.898 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.661 HG21 HD21 ' A' ' 41' ' ' LEU . 5.9 m -126.33 152.32 33.69 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 C-N-CA 124.856 1.262 . . . . 1.9199999999999999 111.976 -179.636 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 16.2 m -139.19 146.72 40.88 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 126.031 1.732 . . . . 1.0700000000000001 107.896 164.298 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 123.75 -30.35 4.9 Favored Glycine 0 CA--C 1.531 1.054 0 C-N-CA 124.93 1.252 . . . . 2.0600000000000001 111.751 -177.363 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -54.07 137.66 39.47 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 121.389 0.614 . . . . 1.8899999999999999 112.485 -178.31 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -144.2 -60.37 0.38 Allowed 'General case' 0 C--N 1.333 -0.142 0 C-N-CA 125.484 1.513 . . . . 2.4199999999999999 107.65 178.228 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 26.2 p -78.55 -5.34 52.45 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.625 1.17 . . . . 3.25 112.983 177.559 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 68.59 -55.84 0.52 Allowed 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 126.128 1.771 . . . . 2.8500000000000001 112.111 -170.102 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -46.4 -43.78 16.59 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 125.017 1.327 . . . . 1.29 113.402 -173.753 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 29.5 m -57.82 -25.42 60.6 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 112.689 0.626 . . . . 2.2000000000000002 112.689 -179.061 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.72 ' HB1' HG21 ' A' ' 39' ' ' VAL . . . -56.38 -35.05 67.28 Favored 'General case' 0 CA--C 1.537 0.454 0 O-C-N 121.755 -0.591 . . . . 0.65000000000000002 110.609 172.876 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.97 -46.74 61.82 Favored 'General case' 0 C--O 1.232 0.171 0 O-C-N 120.533 -1.354 . . . . 0.35999999999999999 109.322 171.799 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 6.5 mmm180 -51.2 -45.22 61.77 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-O 117.697 -1.144 . . . . 5.8399999999999999 111.914 -177.765 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.312 2.4 pt -60.31 -59.82 3.52 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-O 117.786 -1.102 . . . . 0.65000000000000002 110.701 -179.033 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.633 ' HG3' ' HB1' ' A' ' 37' ' ' ALA . 1.3 mp0 -43.37 -47.75 6.9 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 120.264 1.393 . . . . 2.2599999999999998 112.254 172.747 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -74.94 -17.72 60.51 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 113.429 0.9 . . . . 2.8399999999999999 113.429 -176.841 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -76.69 -45.23 13.47 Favored Glycine 0 CA--C 1.531 1.033 0 N-CA-C 110.407 -1.077 . . . . 0.67000000000000004 110.407 161.072 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 26.8 mt -61.18 -39.58 90.7 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 117.69 0.745 . . . . 2.3599999999999999 109.814 -175.498 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 9.8 tmtt? -50.31 -28.57 8.1 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.006 1.322 . . . . 3.2799999999999998 112.678 173.519 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 4.3 mtm180 -80.44 -1.64 42.36 Favored 'General case' 0 CA--C 1.535 0.382 0 O-C-N 121.637 -0.664 . . . . 6.7300000000000004 112.643 -177.748 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 61.1 mmm -98.93 146.86 32.39 Favored Pre-proline 0 CA--C 1.533 0.317 0 CA-C-N 118.876 0.762 . . . . 3.54 110.853 -172.15 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -58.22 137.01 78.36 Favored 'Trans proline' 0 N--CA 1.45 -1.034 0 C-N-CA 122.387 2.058 . . . . 0.56000000000000005 109.264 -179.622 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 95.77 -35.3 4.39 Favored Glycine 0 CA--C 1.527 0.839 0 CA-C-O 119.382 -0.677 . . . . 0.57999999999999996 111.969 -175.536 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 9.0 t -85.65 132.19 32.52 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.153 0 CA-C-N 119.27 1.535 . . . . 0.66000000000000003 109.689 -174.712 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -103.1 -46.53 4.61 Favored 'General case' 0 C--N 1.342 0.255 0 CA-C-N 118.269 0.486 . . . . 1.77 110.526 178.88 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -152.8 174.85 13.54 Favored 'General case' 0 CA--C 1.515 -0.371 0 C-N-CA 124.196 0.998 . . . . 3.46 111.101 166.685 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.633 ' HB1' ' HG3' ' A' ' 25' ' ' GLU . . . -157.95 148.48 20.66 Favored 'General case' 0 N--CA 1.441 -0.907 0 C-N-CA 124.109 0.964 . . . . 0.52000000000000002 109.435 -173.956 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -153.85 117.35 4.63 Favored 'General case' 0 CA--C 1.528 0.119 0 N-CA-C 108.054 -1.091 . . . . 0.54000000000000004 108.054 -158.772 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.903 HG22 HD23 ' A' ' 41' ' ' LEU . 7.7 p -96.24 96.48 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 C-N-CA 124.289 1.036 . . . . 0.71999999999999997 110.439 -172.923 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 51.2 t-20 -84.04 57.06 3.98 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 122.628 1.204 . . . . 0.76000000000000001 109.889 -176.968 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.903 HD23 HG22 ' A' ' 39' ' ' VAL . 0.5 OUTLIER -68.45 -21.77 64.62 Favored 'General case' 0 CA--C 1.527 0.07 0 CA-C-N 115.231 -0.895 . . . . 1.1699999999999999 110.742 -176.569 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -45.33 -34.74 3.12 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 123.611 0.764 . . . . 1.01 112.045 166.315 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 4.9 t -126.54 39.34 3.95 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 122.56 0.344 . . . . 1.6399999999999999 110.141 174.329 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 42.5 53.38 4.66 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.285 1.034 . . . . 3.5099999999999998 112.757 175.04 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 41.8 m -145.81 150.54 36.38 Favored 'General case' 0 N--CA 1.438 -1.065 0 N-CA-C 107.889 -1.152 . . . . 0.91000000000000003 107.889 177.991 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 8.9 p -122.5 142.34 39.36 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 N-CA-C 108.465 -0.939 . . . . 0.55000000000000004 108.465 171.159 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -125.3 141.98 51.76 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 124.818 1.247 . . . . 0.40999999999999998 108.173 -179.407 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.433 HG13 ' HB2' ' A' ' 37' ' ' ALA . 35.9 t -135.68 127.31 45.27 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.325 0 N-CA-C 105.981 -1.859 . . . . 2.1800000000000002 105.981 -178.543 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 21.1 mm -100.38 100.42 10.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 C-N-CA 125.774 1.63 . . . . 0.46999999999999997 107.764 -175.096 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.402 ' CZ ' HG13 ' A' ' 8' ' ' ILE . 17.6 p90 -137.53 166.02 24.88 Favored 'General case' 0 CA--C 1.518 -0.259 0 O-C-N 122.192 -0.317 . . . . 1.73 111.764 -173.597 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -84.34 123.92 74.39 Favored Pre-proline 0 C--O 1.24 0.585 0 C-N-CA 123.813 0.845 . . . . 3.1000000000000001 108.915 171.494 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -86.94 11.82 3.16 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 123.823 3.015 . . . . 0.73999999999999999 113.162 -175.155 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -97.19 -46.05 6.29 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 108.448 -0.945 . . . . 1.05 108.448 168.423 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -77.79 -44.98 25.85 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 123.951 0.9 . . . . 3.3599999999999999 109.129 -178.888 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.262 26.3 p -112.01 -137.29 0.37 Allowed 'General case' 0 CA--C 1.518 -0.254 0 C-N-CA 122.107 0.163 . . . . 0.84999999999999998 110.667 165.17 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 105.67 128.23 6.09 Favored Glycine 0 N--CA 1.44 -1.098 0 N-CA-C 105.679 -2.968 . . . . 2.0499999999999998 105.679 -123.938 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 24.0 p -30.56 -30.29 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.463 1 C-N-CA 134.66 5.184 . . . . 1.3300000000000001 113.76 -177.385 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -29.01 -62.42 0.12 Allowed 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 126.018 1.727 . . . . 0.68999999999999995 112.733 167.258 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.87 -44.22 50.17 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 117.505 -1.678 . . . . 0.5 109.907 -170.578 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.1 mp -51.64 -50.14 31.87 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.945 0 CA-C-N 112.915 -1.948 . . . . 0.98999999999999999 110.067 -178.997 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.2 -50.64 67.28 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 107.933 -1.136 . . . . 2.1200000000000001 107.933 -178.162 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.409 ' OE2' ' NZ ' ' A' ' 66' ' ' LYS . 1.3 tm-20 -44.52 -54.29 6.17 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 122.362 1.077 . . . . 3.0 110.77 178.871 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.1 mmpt? -71.4 -40.33 70.56 Favored 'General case' 0 N--CA 1.434 -1.271 0 CA-C-O 118.154 -0.926 . . . . 2.5600000000000001 113.016 179.094 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.3 mm -48.27 -50.98 10.82 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.793 0 N-CA-C 107.805 -1.183 . . . . 0.67000000000000004 107.805 176.664 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 76.1 mm-40 -57.92 -60.73 3.26 Favored 'General case' 0 C--N 1.343 0.283 0 C-N-CA 124.967 1.307 . . . . 2.98 110.284 177.096 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.409 ' NZ ' ' OE2' ' A' ' 62' ' ' GLU . 7.0 mptt -56.37 -35.38 67.63 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 112.577 0.584 . . . . 5.0 112.577 -177.059 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 35.1 mt -70.08 -18.04 63.25 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.348 1.059 . . . . 0.68999999999999995 111.529 177.909 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 98.04 35.38 5.08 Favored Glycine 0 CA--C 1.525 0.716 0 C-N-CA 124.342 0.973 . . . . 0.70999999999999996 111.535 174.453 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -127.47 169.34 13.76 Favored 'General case' 0 N--CA 1.457 -0.102 0 C-N-CA 124.378 1.071 . . . . 2.1499999999999999 108.914 173.727 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 85.9 t60 -137.67 133.66 34.53 Favored 'General case' 0 N--CA 1.453 -0.275 0 N-CA-C 106.187 -1.783 . . . . 2.04 106.187 162.768 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 23.4 m -91.35 144.57 8.91 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.691 0 CA-C-N 119.244 0.929 . . . . 2.2599999999999998 108.863 172.841 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.5 t -103.06 130.94 52.41 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 N-CA-C 107.75 -1.204 . . . . 0.89000000000000001 107.75 178.97 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 28.0 mm . . . . . 0 N--CA 1.453 -0.281 0 C-N-CA 124.363 1.065 . . . . 1.0700000000000001 108.424 -173.196 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.7 m . . . . . 0 N--CA 1.452 -0.37 0 N-CA-C 107.257 -1.386 . . . . 0.71999999999999997 107.257 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -66.63 178.11 1.39 Allowed 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 123.378 0.671 . . . . 3.46 109.529 172.381 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -135.22 150.84 50.17 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 108.393 -0.966 . . . . 0.93999999999999995 108.393 173.753 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 26.7 mmtp -139.74 162.1 35.95 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.481 1.113 . . . . 2.8700000000000001 108.628 163.984 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.3 mp0 -123.02 96.36 4.98 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 127.101 2.16 . . . . 2.3900000000000001 105.953 -176.937 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 23.9 mm -83.29 164.16 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.16 0 N-CA-C 107.067 -1.457 . . . . 2.1099999999999999 107.067 178.327 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -138.48 123.53 19.05 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 125.207 1.403 . . . . 0.55000000000000004 107.585 179.389 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -133.03 166.46 22.36 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 118.85 0.75 . . . . 2.8500000000000001 109.938 178.246 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -84.5 168.13 15.73 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.557 1.143 . . . . 3.6699999999999999 109.368 169.194 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 38.4 t -125.05 146.09 31.28 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 C-N-CA 124.567 1.147 . . . . 1.3 109.411 -175.22 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 11.8 m -154.8 171.16 20.05 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.918 0.887 . . . . 1.3200000000000001 110.418 172.863 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 64.06 70.38 1.08 Allowed Glycine 0 C--N 1.34 0.761 0 N-CA-C 110.5 -1.04 . . . . 1.8799999999999999 110.5 178.261 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -153.05 156.46 38.79 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 116.922 0.361 . . . . 2.73 111.304 -170.124 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -89.76 -60.89 1.82 Allowed 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 125.226 1.411 . . . . 3.27 109.49 168.255 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 21.6 p -144.09 160.81 40.26 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-O 121.836 0.827 . . . . 2.4399999999999999 112.895 -167.269 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -74.69 45.47 0.25 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.473 1.509 . . . . 1.6599999999999999 111.492 175.559 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -137.98 -49.75 0.57 Allowed 'General case' 0 C--N 1.335 -0.057 0 C-N-CA 124.614 1.166 . . . . 0.70999999999999996 108.637 177.804 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 78.3 m -53.52 -38.86 64.17 Favored 'General case' 0 C--O 1.232 0.132 0 O-C-N 121.593 -0.692 . . . . 1.21 110.76 165.643 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.592 ' HB1' HG21 ' A' ' 39' ' ' VAL . . . -45.75 -35.03 4.0 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.006 1.322 . . . . 0.66000000000000003 112.411 170.667 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.61 -54.45 10.4 Favored 'General case' 0 N--CA 1.451 -0.382 0 O-C-N 121.026 -1.046 . . . . 0.40999999999999998 109.64 174.655 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 43.3 mtm105 -48.85 -50.71 33.35 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 123.539 0.735 . . . . 6.2300000000000004 110.45 -175.595 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.463 HG21 ' CD1' ' A' ' 69' ' ' TYR . 4.9 pt -54.49 -52.75 37.12 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.164 0 O-C-N 123.761 0.663 . . . . 0.46000000000000002 109.849 -179.051 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.601 ' HG3' ' HB1' ' A' ' 37' ' ' ALA . 0.5 OUTLIER -56.34 -39.86 73.53 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 123.93 0.892 . . . . 2.1600000000000001 111.431 179.68 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 26.5 mmtt -73.68 -44.89 55.43 Favored 'General case' 0 CA--C 1.531 0.215 0 O-C-N 121.201 -0.937 . . . . 1.9199999999999999 111.509 -176.259 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -59.34 -42.44 97.41 Favored Glycine 0 CA--C 1.529 0.928 0 N-CA-C 109.988 -1.245 . . . . 0.62 109.988 172.197 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.535 HD21 HG12 ' A' ' 60' ' ' ILE . 8.5 tt -58.55 -39.61 80.7 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.571 1.149 . . . . 1.97 110.289 175.668 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -61.52 -30.17 70.46 Favored 'General case' 0 N--CA 1.452 -0.366 0 O-C-N 121.064 -1.023 . . . . 3.5299999999999998 111.66 174.915 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 16.0 mtt180 -72.13 -8.09 52.71 Favored 'General case' 0 CA--C 1.533 0.295 0 O-C-N 121.495 -0.753 . . . . 3.5899999999999999 112.638 -178.888 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 69.2 mmm -73.96 150.55 88.17 Favored Pre-proline 0 CA--C 1.533 0.289 0 CA-C-N 119.291 0.951 . . . . 3.4399999999999999 110.432 179.867 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -56.34 147.31 68.1 Favored 'Trans proline' 0 N--CA 1.451 -1.026 0 C-N-CA 121.595 1.53 . . . . 0.62 108.402 172.573 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 86.15 -22.65 11.62 Favored Glycine 0 CA--C 1.525 0.682 0 C-N-CA 124.143 0.878 . . . . 0.47999999999999998 113.194 -179.93 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 15.6 t -98.19 127.15 50.94 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 CA-C-N 119.459 1.63 . . . . 0.57999999999999996 109.903 -175.788 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -113.11 -31.34 6.68 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 123.388 0.675 . . . . 0.91000000000000003 112.04 -173.37 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -146.67 160.7 41.87 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-N 119.289 0.949 . . . . 2.1099999999999999 108.931 167.004 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.601 ' HB1' ' HG3' ' A' ' 25' ' ' GLU . . . -156.73 138.88 14.58 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 116.832 -0.167 . . . . 0.41999999999999998 111.307 177.582 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -154.23 113.92 3.8 Favored 'General case' 0 C--N 1.341 0.221 0 N-CA-C 107.381 -1.34 . . . . 0.45000000000000001 107.381 -160.466 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.592 HG21 ' HB1' ' A' ' 21' ' ' ALA . 6.0 p -93.15 102.11 13.31 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 C-N-CA 123.267 0.627 . . . . 0.66000000000000003 110.058 -175.501 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 52.0 t-20 -83.04 58.65 4.51 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 122.536 1.16 . . . . 0.59999999999999998 110.012 -177.415 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.1 -20.01 65.72 Favored 'General case' 0 C--O 1.225 -0.194 0 CA-C-N 114.943 -1.026 . . . . 0.89000000000000001 110.675 -177.692 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -48.55 -30.13 4.96 Favored 'General case' 0 CA--C 1.528 0.134 0 C-N-CA 123.789 0.835 . . . . 0.63 112.644 170.424 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 4.3 t -129.74 32.67 4.55 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 109.792 -0.448 . . . . 1.22 109.792 172.583 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 29.0 mp0 54.41 40.53 31.86 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.64 1.176 . . . . 4.0 113.086 175.067 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -124.86 163.55 21.96 Favored 'General case' 0 N--CA 1.454 -0.259 0 O-C-N 121.327 -0.858 . . . . 0.98999999999999999 109.585 176.11 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.7 p -133.56 140.75 46.04 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 N-CA-C 108.795 -0.817 . . . . 0.35999999999999999 108.795 171.893 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 18.7 m120 -129.46 138.55 51.48 Favored 'General case' 0 C--N 1.344 0.365 0 N-CA-C 108.193 -1.039 . . . . 0.28999999999999998 108.193 -178.232 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.432 HG21 HD21 ' A' ' 28' ' ' LEU . 3.8 p -136.65 128.67 44.05 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 N-CA-C 106.529 -1.656 . . . . 1.72 106.529 -176.11 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 9.8 mm -105.9 96.52 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 C-N-CA 125.918 1.687 . . . . 0.40999999999999998 107.278 -171.602 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 44.1 p90 -136.96 165.06 26.87 Favored 'General case' 0 CA--C 1.515 -0.375 0 O-C-N 122.18 -0.325 . . . . 1.72 111.596 -170.76 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 45.0 t0 -86.58 108.85 19.72 Favored Pre-proline 0 C--N 1.329 -0.29 0 C-N-CA 125.198 1.399 . . . . 2.9100000000000001 109.666 176.8 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -71.26 2.03 4.81 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 123.209 2.606 . . . . 0.64000000000000001 113.4 -177.878 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -90.31 -30.22 17.62 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 119.395 0.998 . . . . 0.77000000000000002 109.345 169.057 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -101.71 -51.73 3.37 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.359 0.664 . . . . 3.0899999999999999 110.361 -170.315 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.9 p -99.81 -174.11 2.62 Favored 'General case' 0 C--O 1.225 -0.205 0 C-N-CA 123.872 0.869 . . . . 0.63 110.598 158.096 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 145.16 92.63 0.14 Allowed Glycine 0 N--CA 1.443 -0.899 0 N-CA-C 104.87 -3.292 . . . . 2.4300000000000002 104.87 -158.228 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 48.8 p -10.24 -18.9 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.577 1 C-N-CA 137.068 6.147 . . . . 1.0800000000000001 119.829 -139.087 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -26.8 -61.84 0.08 Allowed 'General case' 0 N--CA 1.439 -0.987 0 C-N-CA 127.893 2.477 . . . . 0.73999999999999999 114.418 170.11 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.14 -44.76 59.62 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 117.991 -1.484 . . . . 0.70999999999999996 109.259 -168.15 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.535 HG12 HD21 ' A' ' 28' ' ' LEU . 2.2 mt -53.21 -52.76 27.7 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 CA-C-N 112.918 -1.946 . . . . 0.90000000000000002 110.682 178.462 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.92 -45.6 85.15 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 120.06 1.3 . . . . 1.75 109.2 -177.019 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -47.59 -57.32 5.6 Favored 'General case' 0 C--N 1.343 0.318 0 CA-C-O 123.148 1.451 . . . . 2.8399999999999999 109.466 177.264 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.4 mmpt? -71.17 -36.04 71.85 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-N 114.768 -1.105 . . . . 2.5 112.979 -175.403 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -50.04 -53.17 11.89 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 N-CA-C 107.405 -1.331 . . . . 0.41999999999999998 107.405 174.501 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 -60.73 -55.72 29.77 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 115.458 -0.792 . . . . 1.8400000000000001 110.74 176.04 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -57.13 -34.47 68.41 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 113.484 0.92 . . . . 4.5599999999999996 113.484 -176.674 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.435 HD13 ' HA ' ' A' ' 24' ' ' ILE . 13.6 mt -71.54 -19.49 62.16 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 125.815 1.646 . . . . 0.66000000000000003 111.918 174.356 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 95.89 45.37 2.89 Favored Glycine 0 CA--C 1.525 0.678 0 C-N-CA 125.169 1.366 . . . . 0.48999999999999999 111.378 175.914 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.463 ' CD1' HG21 ' A' ' 24' ' ' ILE . 0.3 OUTLIER -140.39 173.7 11.24 Favored 'General case' 0 N--CA 1.458 -0.068 0 C-N-CA 124.216 1.006 . . . . 2.02 110.504 -178.061 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -152.44 126.74 9.25 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 109.49 -0.559 . . . . 2.0499999999999998 109.49 171.946 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 16.1 m -83.89 164.64 2.6 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 C-N-CA 123.623 0.769 . . . . 2.4399999999999999 109.61 173.932 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 1.9 t -125.6 136.33 61.16 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 O-C-N 121.439 -0.788 . . . . 1.0600000000000001 108.944 176.434 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 11.2 mm . . . . . 0 N--CA 1.454 -0.267 0 C-N-CA 123.767 0.827 . . . . 1.25 109.329 -171.483 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 21.5 m . . . . . 0 N--CA 1.447 -0.608 0 N-CA-C 106.992 -1.485 . . . . 1.3 106.992 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -91.31 -175.99 4.42 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 108.073 -1.084 . . . . 2.0800000000000001 108.073 157.831 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.6 mm100 -134.47 146.89 50.19 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 106.628 -1.619 . . . . 1.1599999999999999 106.628 165.616 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 75.2 mttt -141.75 156.78 45.58 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 123.918 0.887 . . . . 2.96 110.806 161.504 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -111.03 92.02 3.88 Favored 'General case' 0 N--CA 1.44 -0.969 0 C-N-CA 128.156 2.582 . . . . 1.3600000000000001 107.152 -167.954 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 6.8 mm -83.14 162.01 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.218 0 N-CA-C 106.916 -1.512 . . . . 1.97 106.916 -175.559 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -141.16 116.07 9.78 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 124.409 1.084 . . . . 0.60999999999999999 108.769 -173.804 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 66.3 mtm -138.18 173.17 11.9 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 118.527 0.603 . . . . 1.8600000000000001 110.539 -175.122 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.67 168.43 9.69 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 125.934 1.694 . . . . 3.5499999999999998 108.94 172.598 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 19.6 m -129.04 174.88 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 C-N-CA 123.455 0.702 . . . . 2.0699999999999998 110.12 172.851 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 57.8 m -151.02 175.14 12.37 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 124.304 1.042 . . . . 0.93999999999999995 108.328 173.32 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 85.82 -35.01 3.27 Favored Glycine 0 CA--C 1.531 1.09 0 O-C-N 122.019 -0.426 . . . . 2.3999999999999999 112.573 178.304 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -48.16 141.84 5.88 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.096 0.959 . . . . 1.8500000000000001 112.877 179.325 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -103.94 -46.19 4.55 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 124.684 1.194 . . . . 2.2400000000000002 110.09 171.809 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 18.4 p -132.62 161.3 34.26 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 123.752 0.821 . . . . 2.0699999999999998 110.918 -175.342 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -77.02 56.75 1.27 Allowed 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.104 0.962 . . . . 2.0800000000000001 110.631 178.293 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -142.52 -57.88 0.44 Allowed 'General case' 0 N--CA 1.456 -0.138 0 C-N-CA 123.854 0.862 . . . . 0.96999999999999997 109.549 176.322 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 58.9 m -54.08 -43.32 70.24 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 121.011 0.434 . . . . 1.3899999999999999 111.65 -174.63 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.59 -22.6 13.8 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.232 1.013 . . . . 0.54000000000000004 112.963 178.069 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.437 ' HA ' HG11 ' A' ' 39' ' ' VAL . . . -70.24 -47.64 60.46 Favored 'General case' 0 N--CA 1.452 -0.363 0 O-C-N 121.163 -0.961 . . . . 0.60999999999999999 110.267 172.163 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 52.7 mtp85 -58.61 -48.57 80.55 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 109.486 -0.561 . . . . 4.2199999999999998 109.486 -171.107 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.429 ' HA ' HD13 ' A' ' 67' ' ' LEU . 5.4 pt -55.63 -51.48 58.1 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 O-C-N 123.684 0.615 . . . . 0.64000000000000001 110.005 179.02 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -55.64 -43.86 76.61 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 113.455 0.909 . . . . 4.5199999999999996 113.455 179.116 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 13.4 mptt -72.69 -40.98 65.8 Favored 'General case' 0 CA--C 1.536 0.425 0 O-C-N 121.505 -0.747 . . . . 2.1400000000000001 109.643 -175.954 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -57.16 -39.89 90.69 Favored Glycine 0 CA--C 1.532 1.141 0 N-CA-C 111.147 -0.781 . . . . 0.64000000000000001 111.147 168.727 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.8 tt -65.3 -44.24 88.54 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.401 1.08 . . . . 1.8300000000000001 109.363 179.136 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 27.0 ttmt -54.5 -39.13 67.26 Favored 'General case' 0 CA--C 1.53 0.178 0 O-C-N 121.258 -0.902 . . . . 3.6600000000000001 111.075 175.383 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.91 -8.66 7.53 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 114.389 1.255 . . . . 4.3499999999999996 114.389 -179.589 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 82.6 mmm -81.85 151.98 68.31 Favored Pre-proline 0 CA--C 1.536 0.425 0 CA-C-N 120.089 1.313 . . . . 3.4399999999999999 111.521 -177.633 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -59.05 150.89 70.18 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 122.427 2.085 . . . . 0.77000000000000002 110.628 178.985 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 79.31 -25.92 2.67 Favored Glycine 0 CA--C 1.531 1.06 0 C-N-CA 123.702 0.668 . . . . 0.66000000000000003 112.685 -177.466 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 15.4 t -86.45 141.05 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 CA-C-N 118.901 1.35 . . . . 0.82999999999999996 108.879 176.102 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -119.76 -43.22 2.58 Favored 'General case' 0 C--N 1.34 0.153 0 CA-C-O 118.716 -0.659 . . . . 1.3799999999999999 111.243 179.113 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -143.33 169.13 18.22 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 118.978 0.808 . . . . 1.8899999999999999 110.82 176.69 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -159.64 154.18 24.13 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.908 -0.587 . . . . 1.22 111.079 -177.343 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -155.76 94.52 1.57 Allowed 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 125.567 1.547 . . . . 1.0 109.173 -168.393 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.559 ' CG2' HD23 ' A' ' 41' ' ' LEU . 3.5 p -78.93 93.98 1.67 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 CA-C-O 121.867 0.842 . . . . 0.96999999999999997 109.355 -177.852 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 44.8 t30 -81.67 58.75 3.88 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 122.212 1.006 . . . . 0.62 109.854 -176.196 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.559 HD23 ' CG2' ' A' ' 39' ' ' VAL . 0.4 OUTLIER -69.78 -19.99 63.49 Favored 'General case' 0 N--CA 1.457 -0.081 0 C-N-CA 124.462 1.105 . . . . 1.01 111.016 -179.212 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -43.32 -39.78 3.26 Favored 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 124.064 0.946 . . . . 0.68000000000000005 111.931 169.832 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 9.9 t -128.1 40.3 3.7 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 122.574 0.35 . . . . 1.23 110.291 172.07 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 50.85 51.98 15.9 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.731 1.213 . . . . 3.2999999999999998 113.741 172.259 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -131.49 161.15 33.22 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 124.588 1.155 . . . . 2.0899999999999999 109.013 175.529 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.5 p -131.62 134.74 60.15 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 N-CA-C 107.706 -1.22 . . . . 0.34999999999999998 107.706 167.669 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -123.03 126.79 47.78 Favored 'General case' 0 C--N 1.341 0.233 0 N-CA-C 108.559 -0.904 . . . . 0.58999999999999997 108.559 177.524 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 46.8 t -126.32 130.96 71.95 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 N-CA-C 105.638 -1.986 . . . . 2.21 105.638 -177.169 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 10.6 mm -105.08 99.72 9.04 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 C-N-CA 125.336 1.455 . . . . 0.48999999999999999 107.694 -175.548 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 53.2 p90 -139.61 171.31 14.42 Favored 'General case' 0 CA--C 1.515 -0.369 0 C-N-CA 122.719 0.408 . . . . 2.1699999999999999 111.111 -174.61 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 45.8 t0 -89.23 107.08 15.81 Favored Pre-proline 0 C--O 1.234 0.255 0 CA-C-O 118.35 -0.833 . . . . 3.2200000000000002 109.278 176.683 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -71.78 4.92 2.77 Favored 'Trans proline' 0 N--CA 1.451 -0.978 0 C-N-CA 122.178 1.918 . . . . 0.87 112.915 -179.236 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -86.73 -33.46 19.98 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 119.462 1.028 . . . . 1.0800000000000001 109.163 166.604 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 13.2 tt0 -103.42 -57.04 2.1 Favored 'General case' 0 C--N 1.343 0.323 0 C-N-CA 122.871 0.468 . . . . 2.6800000000000002 110.278 -169.336 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.405 0.6 OUTLIER -84.7 -178.66 6.93 Favored 'General case' 0 C--O 1.224 -0.242 0 CA-C-O 122.537 1.16 . . . . 0.56000000000000005 113.77 155.513 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -179.18 -144.27 5.71 Favored Glycine 0 N--CA 1.434 -1.474 1 N-CA-C 102.944 -4.062 . . . . 2.5299999999999998 102.944 -173.312 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 19.2 p -72.76 -40.29 66.11 Favored 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 124.509 1.124 . . . . 1.6000000000000001 108.398 174.51 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -38.77 -62.65 0.59 Allowed 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 126.235 1.814 . . . . 0.81000000000000005 114.119 -169.682 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -72.62 -42.33 64.58 Favored 'General case' 0 CA--C 1.517 -0.321 0 C-N-CA 119.079 -1.048 . . . . 0.59999999999999998 108.98 -168.753 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -53.35 -55.68 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.17 0 CA-C-N 113.437 -1.71 . . . . 0.79000000000000004 110.394 177.85 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.83 -46.9 87.81 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 119.827 1.194 . . . . 1.5 110.085 -178.759 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -47.58 -57.76 5.06 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 122.406 1.098 . . . . 2.9100000000000001 110.722 176.836 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.2 -39.81 74.96 Favored 'General case' 0 N--CA 1.436 -1.155 0 CA-C-O 118.621 -0.704 . . . . 2.6499999999999999 112.3 -176.802 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.1 mm -48.54 -52.14 9.35 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 C-N-CA 125.175 1.39 . . . . 0.53000000000000003 107.481 175.084 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -60.71 -58.0 10.33 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 124.372 1.069 . . . . 1.9199999999999999 110.875 177.665 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 3.4 mptp? -56.62 -37.61 70.94 Favored 'General case' 0 CA--C 1.536 0.42 0 O-C-N 121.499 -0.75 . . . . 4.0099999999999998 112.375 -176.766 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.429 HD13 ' HA ' ' A' ' 24' ' ' ILE . 13.7 mt -69.82 -17.77 63.42 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.461 1.105 . . . . 0.88 111.787 176.14 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 91.02 45.46 4.15 Favored Glycine 0 C--N 1.336 0.557 0 C-N-CA 124.369 0.985 . . . . 0.69999999999999996 110.986 174.342 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.422 ' CD1' HG21 ' A' ' 24' ' ' ILE . 0.4 OUTLIER -137.49 175.28 9.74 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 123.972 0.909 . . . . 1.9099999999999999 110.685 -177.872 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 2.3 t-80 -142.66 128.26 19.13 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 109.061 -0.718 . . . . 1.8700000000000001 109.061 169.657 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 11.7 p -88.76 148.85 4.26 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 C-N-CA 125.056 1.343 . . . . 1.5600000000000001 108.127 169.679 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 41.1 t -120.3 138.84 49.52 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 C-N-CA 125.249 1.42 . . . . 0.64000000000000001 108.615 179.057 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 26.8 mm . . . . . 0 CA--C 1.532 0.259 0 C-N-CA 124.805 1.242 . . . . 0.93999999999999995 109.564 -168.138 . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 57.9 m . . . . . 0 N--CA 1.443 -0.803 0 N-CA-C 108.224 -1.028 . . . . 1.03 108.224 . . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -64.95 174.92 1.7 Allowed 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 109.095 -0.706 . . . . 2.8599999999999999 109.095 155.013 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -135.08 148.95 49.98 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 106.702 -1.592 . . . . 1.5600000000000001 106.702 168.559 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 10.5 mmpt? -138.62 157.12 46.74 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 123.401 0.68 . . . . 3.8700000000000001 109.677 165.138 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.68 103.88 12.49 Favored 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 128.745 2.818 . . . . 1.6100000000000001 107.847 -177.79 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.547 HD11 ' CG1' ' A' ' 48' ' ' VAL . 2.1 pp -84.95 165.56 2.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 N-CA-C 109.006 -0.739 . . . . 4.7800000000000002 109.006 168.537 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -137.19 119.34 15.53 Favored 'General case' 0 C--O 1.226 -0.169 0 N-CA-C 106.879 -1.526 . . . . 0.78000000000000003 106.879 173.438 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 22.8 mmt -137.4 172.34 13.13 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 119.596 1.089 . . . . 5.2199999999999998 110.411 -177.511 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 17.9 mm100 -91.87 158.87 16.07 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 123.813 0.845 . . . . 2.3700000000000001 110.014 -178.214 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 22.1 t -117.22 153.66 18.99 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 C-N-CA 124.373 1.069 . . . . 1.1200000000000001 109.079 -176.457 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 37.5 m -149.5 175.71 11.25 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.089 0.956 . . . . 0.93000000000000005 109.143 172.004 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 82.12 -36.64 2.54 Favored Glycine 0 CA--C 1.533 1.181 0 O-C-N 121.525 -0.734 . . . . 2.0099999999999998 112.485 -179.132 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -42.05 143.69 0.54 Allowed 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.643 1.577 . . . . 1.8100000000000001 113.786 177.721 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -110.42 -49.04 3.09 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 125.234 1.414 . . . . 2.27 111.532 169.796 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 18.4 p -130.64 161.97 30.42 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 123.186 0.594 . . . . 2.0499999999999998 110.807 -176.136 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -77.0 55.88 1.16 Allowed 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.187 0.995 . . . . 2.21 110.572 179.423 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -143.89 -56.3 0.38 Allowed 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 124.118 0.967 . . . . 0.85999999999999999 109.789 178.132 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 59.4 m -55.88 -40.72 73.38 Favored 'General case' 0 CA--C 1.532 0.269 0 O-C-N 121.916 -0.49 . . . . 1.1899999999999999 111.989 -173.93 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.798 ' HB1' HG21 ' A' ' 39' ' ' VAL . . . -56.29 -24.37 42.69 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.022 0.529 . . . . 0.5 112.32 177.686 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.8 -52.64 34.69 Favored 'General case' 0 N--CA 1.452 -0.355 0 O-C-N 120.353 -1.467 . . . . 0.41999999999999998 108.937 172.809 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 6.6 mtt-85 -53.74 -46.84 71.01 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.318 0.647 . . . . 3.75 110.239 -175.255 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.468 HG21 ' CD1' ' A' ' 69' ' ' TYR . 3.1 pt -57.85 -53.89 39.12 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.455 0 C-N-CA 119.756 -0.778 . . . . 0.5 110.85 -179.763 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -55.01 -43.69 73.88 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 119.299 0.954 . . . . 2.6000000000000001 111.862 177.321 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.2 mptp? -68.83 -46.18 69.24 Favored 'General case' 0 CA--C 1.533 0.291 0 O-C-N 121.298 -0.877 . . . . 1.4399999999999999 110.61 -175.807 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -63.08 -38.85 97.24 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 110.48 -1.048 . . . . 0.67000000000000004 110.48 175.061 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.53 HD11 HG21 ' A' ' 34' ' ' VAL . 2.9 tm? -60.32 -44.56 95.35 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 108.069 -1.086 . . . . 2.4199999999999999 108.069 179.294 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -54.51 -26.07 29.47 Favored 'General case' 0 CA--C 1.542 0.665 0 O-C-N 121.561 -0.712 . . . . 2.9100000000000001 112.683 175.093 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -71.22 -9.11 57.55 Favored 'General case' 0 CA--C 1.539 0.527 0 O-C-N 120.583 -1.323 . . . . 3.6600000000000001 112.659 177.295 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -73.79 158.03 86.6 Favored Pre-proline 0 CA--C 1.539 0.528 0 CA-C-N 118.99 0.813 . . . . 3.6200000000000001 111.552 -179.066 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -70.98 114.5 3.92 Favored 'Trans proline' 0 N--CA 1.45 -1.058 0 C-N-CA 121.811 1.674 . . . . 1.05 109.74 175.577 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 121.32 -30.27 5.46 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 124.08 0.848 . . . . 0.84999999999999998 113.002 170.818 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.53 HG21 HD11 ' A' ' 28' ' ' LEU . 61.6 t -83.37 141.05 15.38 Favored 'Isoleucine or valine' 0 C--N 1.342 0.254 0 CA-C-N 118.338 1.069 . . . . 0.67000000000000004 109.445 172.133 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 7.0 m -118.29 -38.31 3.2 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-O 118.39 -0.814 . . . . 1.1699999999999999 111.126 -177.27 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -136.7 163.6 30.21 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 119.542 1.065 . . . . 2.2400000000000002 111.843 167.132 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -158.36 140.86 14.39 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 112.541 0.571 . . . . 0.39000000000000001 112.541 -177.845 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -153.82 106.85 2.91 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 106.648 -1.612 . . . . 0.41999999999999998 106.648 -165.94 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.798 HG21 ' HB1' ' A' ' 21' ' ' ALA . 4.8 p -81.16 127.99 39.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 N-CA-C 107.351 -1.352 . . . . 0.63 107.351 174.667 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 54.7 t-20 -111.75 57.62 0.64 Allowed 'General case' 0 C--O 1.235 0.291 0 CA-C-O 122.968 1.366 . . . . 0.71999999999999997 107.974 179.878 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.591 HD23 HG22 ' A' ' 39' ' ' VAL . 0.2 OUTLIER -65.78 -20.1 66.14 Favored 'General case' 0 C--O 1.227 -0.11 0 CA-C-N 113.976 -1.465 . . . . 0.90000000000000002 111.12 -176.161 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -46.94 -34.58 5.64 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.447 0.699 . . . . 0.60999999999999999 112.312 166.842 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 14.7 t -122.09 27.66 7.91 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-O 121.284 0.564 . . . . 1.24 110.215 174.249 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 54.39 27.54 8.29 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 126.387 1.875 . . . . 2.6299999999999999 114.431 178.469 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 12.2 m -115.82 153.63 31.12 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.112 0.965 . . . . 0.62 109.136 -178.124 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.1 p -117.36 142.9 29.35 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 C-N-CA 124.121 0.968 . . . . 0.35999999999999999 109.121 170.667 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 21.1 m120 -125.95 131.86 52.2 Favored 'General case' 0 C--N 1.343 0.316 0 N-CA-C 106.673 -1.602 . . . . 0.34000000000000002 106.673 174.217 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.547 ' CG1' HD11 ' A' ' 8' ' ' ILE . 0.1 OUTLIER -132.24 128.06 58.24 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.706 0 N-CA-C 105.755 -1.942 . . . . 1.97 105.755 -178.962 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 10.7 mm -108.96 96.83 5.0 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 C-N-CA 126.113 1.765 . . . . 0.47999999999999998 108.104 -168.778 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.477 ' HB3' HG22 ' A' ' 34' ' ' VAL . 44.9 p90 -130.93 172.54 11.93 Favored 'General case' 0 CA--C 1.511 -0.552 0 O-C-N 121.317 -0.864 . . . . 1.8700000000000001 110.913 -169.649 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 36.0 t0 -90.28 107.7 21.52 Favored Pre-proline 0 CA--C 1.536 0.426 0 O-C-N 124.526 1.142 . . . . 2.8100000000000001 110.051 174.826 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -75.42 6.84 3.32 Favored 'Trans proline' 0 N--CA 1.451 -1.028 0 C-N-CA 122.434 2.089 . . . . 0.62 113.072 -178.903 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -81.77 -26.25 34.61 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 119.473 1.033 . . . . 0.81999999999999995 108.926 165.484 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -108.65 -66.59 1.04 Allowed 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 107.989 -1.115 . . . . 3.8100000000000001 107.989 -170.727 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.483 HG22 ' HB3' ' A' ' 59' ' ' ALA 0.417 0.2 OUTLIER -76.67 178.09 7.02 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 116.573 2.064 . . . . 0.64000000000000001 116.573 165.156 . . . . . . . . 4 4 . 1 . 026 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -163.68 -145.05 4.23 Favored Glycine 0 N--CA 1.432 -1.622 1 N-CA-C 102.424 -4.27 . . . . 2.5499999999999998 102.424 176.39 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 30.9 p -75.23 -37.68 60.95 Favored 'General case' 0 N--CA 1.444 -0.747 0 C-N-CA 125.34 1.456 . . . . 1.21 109.087 172.891 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -49.42 -61.2 2.23 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 124.936 1.294 . . . . 1.21 113.912 -165.601 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.483 ' HB3' HG22 ' A' ' 55' ' ' THR . . . -71.87 -33.66 68.56 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 118.773 -1.171 . . . . 1.0800000000000001 108.834 -168.98 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.5 mp -55.84 -52.5 48.23 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 C-N-CA 123.874 0.87 . . . . 1.1100000000000001 109.835 174.193 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -61.51 -43.16 99.37 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 109.845 -0.428 . . . . 1.6299999999999999 109.845 -176.708 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -48.89 -58.06 5.43 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.163 0.985 . . . . 2.8599999999999999 110.631 171.976 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -67.45 -36.14 80.61 Favored 'General case' 0 N--CA 1.442 -0.85 0 O-C-N 121.396 -0.815 . . . . 3.0299999999999998 112.592 -177.711 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -52.07 -52.18 25.47 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 C-N-CA 124.839 1.256 . . . . 0.39000000000000001 107.839 176.307 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -57.77 -55.56 33.26 Favored 'General case' 0 C--N 1.34 0.189 0 C-N-CA 122.944 0.498 . . . . 2.21 109.965 175.433 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 7.7 mmtt -58.01 -35.02 70.65 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 113.12 0.785 . . . . 4.2999999999999998 113.12 -175.34 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 24.8 mt -70.3 -17.69 63.09 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 125.287 1.435 . . . . 0.92000000000000004 111.416 175.838 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 96.31 38.58 4.49 Favored Glycine 0 CA--C 1.522 0.521 0 C-N-CA 124.754 1.169 . . . . 0.65000000000000002 110.803 175.574 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.468 ' CD1' HG21 ' A' ' 24' ' ' ILE . 0.2 OUTLIER -136.93 175.58 9.49 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 117.654 0.727 . . . . 1.76 111.029 -176.357 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 5.9 t60 -138.68 137.34 36.74 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 109.546 -0.538 . . . . 2.1800000000000002 109.546 169.392 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 8.6 p -110.24 144.01 19.15 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 N-CA-C 106.644 -1.613 . . . . 1.5 106.644 177.403 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 20.5 t -113.39 131.82 64.04 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 N-CA-C 108.455 -0.942 . . . . 0.54000000000000004 108.455 178.997 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 47.8 mm . . . . . 0 N--CA 1.45 -0.43 0 C-N-CA 124.79 1.236 . . . . 1.1100000000000001 107.772 -174.789 . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.4 m . . . . . 0 N--CA 1.448 -0.56 0 N-CA-C 105.447 -2.057 . . . . 0.75 105.447 . . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -89.62 -173.5 3.97 Favored 'General case' 0 N--CA 1.445 -0.679 0 C-N-CA 124.327 1.051 . . . . 2.1699999999999999 108.814 175.174 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.8 mm100 -135.96 147.88 48.25 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 107.425 -1.324 . . . . 1.02 107.425 164.707 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 86.6 mttt -139.36 159.22 42.66 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 109.164 -0.68 . . . . 3.25 109.164 158.037 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -112.59 100.1 8.46 Favored 'General case' 0 N--CA 1.436 -1.152 0 C-N-CA 128.28 2.632 . . . . 1.3100000000000001 105.321 -171.681 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 7.0 mm -80.79 161.31 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.267 0 N-CA-C 106.601 -1.629 . . . . 1.9199999999999999 106.601 178.912 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -133.33 122.56 24.01 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 106.756 -1.572 . . . . 0.47999999999999998 106.756 174.093 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 71.8 mtm -140.46 168.59 19.45 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 123.451 0.7 . . . . 1.97 109.784 -178.687 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 20.6 mm100 -94.69 148.93 21.76 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 125.216 1.407 . . . . 2.5 109.413 177.763 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 69.7 t -99.73 145.72 10.09 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 C-N-CA 123.541 0.736 . . . . 1.3300000000000001 109.346 178.041 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 32.3 t -145.03 176.87 9.18 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 124.475 1.11 . . . . 1.73 108.816 168.881 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 52.29 60.26 7.94 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 124.292 0.949 . . . . 1.8899999999999999 110.773 -176.455 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -128.73 151.33 49.67 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 124.198 0.999 . . . . 2.1299999999999999 110.328 -172.79 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -97.26 -55.38 2.86 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 124.421 1.088 . . . . 3.1200000000000001 109.196 168.639 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 22.8 p -150.27 165.92 31.53 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-O 121.839 0.828 . . . . 2.4300000000000002 111.757 -174.5 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -74.27 48.64 0.33 Allowed 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.462 1.505 . . . . 1.8 111.357 175.701 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -144.02 -51.76 0.32 Allowed 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 124.795 1.238 . . . . 0.72999999999999998 108.18 175.697 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.442 ' SG ' ' NH2' ' A' ' 23' ' ' ARG . 27.1 m -59.37 -36.97 76.75 Favored 'General case' 0 CA--C 1.531 0.248 0 O-C-N 121.38 -0.825 . . . . 1.1799999999999999 109.745 167.998 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.425 ' HB1' HG21 ' A' ' 39' ' ' VAL . . . -59.17 -21.8 59.98 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 112.95 0.722 . . . . 0.47999999999999998 112.95 173.668 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -73.79 -50.94 18.12 Favored 'General case' 0 C--N 1.339 0.152 0 O-C-N 121.019 -1.05 . . . . 0.39000000000000001 110.032 169.943 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.442 ' NH2' ' SG ' ' A' ' 20' ' ' CYS . 17.3 mtm180 -50.04 -42.39 49.53 Favored 'General case' 0 N--CA 1.456 -0.143 0 C-N-CA 123.32 0.648 . . . . 5.6500000000000004 111.196 -175.663 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.442 HG21 ' CG ' ' A' ' 69' ' ' TYR . 3.9 pt -57.82 -53.66 42.12 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.156 0 C-N-CA 119.847 -0.741 . . . . 0.63 111.891 177.341 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -57.88 -46.46 84.84 Favored 'General case' 0 C--O 1.224 -0.266 0 C-N-CA 123.339 0.655 . . . . 3.3500000000000001 110.708 -179.876 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -72.34 -40.3 67.51 Favored 'General case' 0 C--N 1.331 -0.234 0 O-C-N 121.908 -0.495 . . . . 2.1499999999999999 111.034 -173.535 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -59.44 -45.28 95.77 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 109.757 -1.337 . . . . 0.65000000000000002 109.757 169.695 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -61.94 -37.47 84.83 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 121.879 -0.777 . . . . 2.3700000000000001 109.655 -179.839 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 3.3 ttpp -53.98 -25.38 20.64 Favored 'General case' 0 CA--C 1.533 0.3 0 O-C-N 120.724 -1.235 . . . . 2.3999999999999999 113.198 174.505 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -82.15 -1.21 48.17 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.043 0.937 . . . . 3.48 111.836 -179.088 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 21.4 mmt -93.77 149.35 36.93 Favored Pre-proline 0 CA--C 1.535 0.401 0 C-N-CA 124.194 0.998 . . . . 4.6500000000000004 109.995 -175.092 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -58.45 142.86 98.24 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 122.52 2.146 . . . . 0.65000000000000002 111.477 -176.65 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 85.65 -27.3 5.36 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 123.511 0.577 . . . . 0.52000000000000002 112.927 179.422 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.4 t -80.12 140.18 17.11 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 CA-C-N 118.363 1.081 . . . . 0.68000000000000005 108.795 176.33 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 69.8 m -106.7 -60.12 1.71 Allowed 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 118.474 -0.774 . . . . 1.3600000000000001 109.116 178.488 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -140.65 165.35 27.72 Favored 'General case' 0 N--CA 1.446 -0.675 0 N-CA-C 109.052 -0.721 . . . . 2.5800000000000001 109.052 179.821 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -156.43 143.9 19.18 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 109.381 -0.6 . . . . 0.40999999999999998 109.381 -168.335 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -152.2 116.16 4.9 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 123.892 0.877 . . . . 0.75 108.761 -167.209 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.425 HG21 ' HB1' ' A' ' 21' ' ' ALA . 8.6 p -82.2 124.35 39.11 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 N-CA-C 107.208 -1.405 . . . . 0.66000000000000003 107.208 171.542 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 47.2 t30 -108.57 55.38 0.64 Allowed 'General case' 0 C--O 1.235 0.326 0 CA-C-O 123.07 1.414 . . . . 0.72999999999999998 107.22 178.161 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.437 HD22 ' HA ' ' A' ' 41' ' ' LEU . 0.2 OUTLIER -70.65 -18.35 62.85 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 114.171 -1.377 . . . . 0.95999999999999996 110.311 -174.207 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -43.38 -37.61 2.38 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 124.267 1.027 . . . . 0.54000000000000004 111.991 166.033 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 9.3 t -125.87 32.89 5.18 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 122.719 0.407 . . . . 1.2 110.435 173.58 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 59.1 27.62 16.65 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.923 1.689 . . . . 2.9199999999999999 113.609 174.437 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 60.3 m -115.97 164.28 14.67 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.747 1.219 . . . . 0.64000000000000001 109.723 -174.594 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 5.7 p -136.25 143.72 35.02 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 C-N-CA 124.516 1.126 . . . . 0.32000000000000001 108.637 171.998 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -134.92 122.1 21.47 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 124.647 1.179 . . . . 0.57999999999999996 108.153 -175.405 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.7 p -123.85 130.59 73.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 N-CA-C 106.176 -1.787 . . . . 1.73 106.176 -172.705 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 9.7 mm -105.39 97.47 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 N-CA-C 107.158 -1.423 . . . . 0.40999999999999998 107.158 -174.92 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 3.6 p90 -129.72 164.89 23.0 Favored 'General case' 0 CA--C 1.512 -0.481 0 O-C-N 122.161 -0.337 . . . . 2.1000000000000001 110.641 -176.554 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -81.65 124.01 80.16 Favored Pre-proline 0 CA--C 1.536 0.418 0 N-CA-C 108.314 -0.995 . . . . 3.1200000000000001 108.314 167.189 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -86.57 15.54 2.17 Favored 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 122.904 2.403 . . . . 0.60999999999999999 112.888 -175.385 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -97.88 -40.52 8.47 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 123.999 0.92 . . . . 1.0600000000000001 109.069 169.248 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -90.59 -62.08 1.54 Allowed 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 107.143 -1.428 . . . . 3.8399999999999999 107.143 -177.337 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.518 0.2 OUTLIER -78.31 -175.65 4.3 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 115.328 1.603 . . . . 0.69999999999999996 115.328 159.336 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 154.64 -168.3 32.73 Favored Glycine 0 N--CA 1.435 -1.381 1 N-CA-C 102.81 -4.116 . . . . 2.5299999999999998 102.81 -148.83 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 16.7 p -73.34 -34.91 65.9 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 124.14 0.976 . . . . 1.0800000000000001 109.244 -176.679 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -46.96 -60.88 2.15 Favored 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 125.055 1.342 . . . . 0.56000000000000005 113.441 -169.556 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.07 -40.99 74.71 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 118.995 -1.082 . . . . 0.44 108.793 -167.524 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.5 mp -50.71 -54.57 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.944 0 CA-C-N 113.891 -1.504 . . . . 0.95999999999999996 109.787 174.087 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -65.82 -44.58 85.19 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 118.669 0.668 . . . . 2.1899999999999999 110.28 -174.008 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -45.84 -56.7 5.06 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 122.597 1.189 . . . . 2.7999999999999998 110.046 173.252 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.86 -40.47 68.95 Favored 'General case' 0 N--CA 1.438 -1.05 0 N-CA-C 113.536 0.939 . . . . 3.9500000000000002 113.536 -176.314 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -48.26 -52.49 7.78 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 C-N-CA 125.003 1.321 . . . . 0.38 108.017 173.961 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -59.65 -58.83 6.87 Favored 'General case' 0 C--N 1.341 0.219 0 C-N-CA 123.429 0.692 . . . . 1.6299999999999999 110.333 176.588 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 6.6 mmmt -57.76 -33.02 68.06 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 113.62 0.97 . . . . 4.3499999999999996 113.62 -175.732 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 22.6 mt -71.81 -19.02 62.05 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.181 1.392 . . . . 0.73999999999999999 111.666 174.853 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 96.81 43.68 3.05 Favored Glycine 0 CA--C 1.524 0.645 0 C-N-CA 124.704 1.145 . . . . 0.39000000000000001 111.442 174.735 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.442 ' CG ' HG21 ' A' ' 24' ' ' ILE . 0.7 OUTLIER -140.1 174.49 10.47 Favored 'General case' 0 N--CA 1.457 -0.085 0 C-N-CA 124.488 1.115 . . . . 1.97 110.157 -177.799 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 6.9 t-80 -141.55 125.91 17.62 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 109.387 -0.597 . . . . 1.72 109.387 174.279 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 7.8 p -92.77 152.14 3.5 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 108.479 -0.934 . . . . 1.5600000000000001 108.479 174.566 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 38.1 t -127.3 143.65 39.9 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 C-N-CA 124.808 1.243 . . . . 0.52000000000000002 108.323 178.488 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 5.2 mp . . . . . 0 N--CA 1.453 -0.281 0 C-N-CA 124.558 1.143 . . . . 1.4099999999999999 108.789 -172.804 . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.3 m . . . . . 0 N--CA 1.449 -0.484 0 N-CA-C 105.596 -2.002 . . . . 0.84999999999999998 105.596 . . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -84.92 -175.7 5.88 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 108.199 -1.038 . . . . 2.0899999999999999 108.199 163.839 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.18 146.78 49.05 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 107.583 -1.266 . . . . 1.1299999999999999 107.583 169.2 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 54.2 mttm -140.27 156.16 46.58 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 121.44 0.638 . . . . 2.77 110.279 161.873 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -112.89 87.01 2.49 Favored 'General case' 0 N--CA 1.439 -0.978 0 C-N-CA 128.343 2.657 . . . . 1.45 106.444 -168.508 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 20.6 mm -82.62 159.64 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.396 0 N-CA-C 106.575 -1.639 . . . . 2.1800000000000002 106.575 -176.035 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -131.77 138.18 48.47 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 125.784 1.634 . . . . 0.59999999999999998 106.743 -179.694 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -156.31 175.84 13.47 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 118.511 0.596 . . . . 2.71 110.786 172.649 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 30.1 mm100 -94.6 159.35 15.12 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 124.638 1.175 . . . . 2.6800000000000002 109.886 -178.405 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 62.0 t -114.26 156.53 15.2 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 C-N-CA 125.075 1.35 . . . . 1.1799999999999999 108.769 -176.454 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 25.3 m -150.01 165.63 32.13 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 123.725 0.81 . . . . 0.91000000000000003 109.518 168.006 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 63.68 47.56 85.5 Favored Glycine 0 CA--C 1.528 0.899 0 N-CA-C 110.31 -1.116 . . . . 1.6000000000000001 110.31 -171.52 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -120.55 165.17 15.37 Favored 'General case' 0 N--CA 1.457 -0.121 0 C-N-CA 124.663 1.185 . . . . 2.0899999999999999 108.972 175.3 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 174.51 -41.96 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 127.864 2.466 . . . . 3.8100000000000001 110.528 175.447 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 47.9 t -48.02 -41.02 24.5 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.327 1.051 . . . . 2.98 110.932 172.173 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 64.56 19.15 11.72 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.621 1.169 . . . . 2.2200000000000002 111.92 -178.0 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -134.58 -44.22 0.75 Allowed 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 125.395 1.478 . . . . 0.81999999999999995 109.439 176.035 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 20.5 m -47.24 -38.48 12.35 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 123.413 0.685 . . . . 1.6499999999999999 112.599 169.131 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.635 ' HB1' HG21 ' A' ' 39' ' ' VAL . . . -49.26 -33.29 12.52 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.382 0.673 . . . . 0.46000000000000002 112.068 174.545 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.6 -52.88 15.77 Favored 'General case' 0 N--CA 1.456 -0.173 0 O-C-N 120.789 -1.194 . . . . 0.32000000000000001 110.416 171.699 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 46.4 mmm-85 -50.42 -50.63 51.36 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 123.933 0.893 . . . . 3.7799999999999998 110.114 -175.968 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 5.1 pt -56.86 -54.61 27.47 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 CA-C-O 118.79 -0.624 . . . . 0.63 109.946 -179.839 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -55.46 -38.6 69.26 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 119.273 0.942 . . . . 2.29 112.12 179.474 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 42.7 mmtm -71.58 -44.14 65.01 Favored 'General case' 0 CA--C 1.534 0.327 0 O-C-N 121.345 -0.847 . . . . 1.8500000000000001 111.564 -177.49 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -69.58 -33.21 71.65 Favored Glycine 0 CA--C 1.528 0.871 0 C-N-CA 120.218 -0.991 . . . . 0.51000000000000001 110.914 173.088 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 9.6 tt -56.37 -48.64 76.43 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 107.833 -1.173 . . . . 2.0 107.833 173.227 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -54.87 -19.44 6.56 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 113.428 0.899 . . . . 3.6099999999999999 113.428 176.249 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 94.5 mtt180 -77.54 -4.68 46.94 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 119.679 1.127 . . . . 4.8300000000000001 112.289 177.704 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 7.3 ptp -71.11 155.68 92.9 Favored Pre-proline 0 CA--C 1.534 0.339 0 CA-C-N 119.58 1.082 . . . . 3.8100000000000001 111.37 173.335 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -58.86 133.04 51.18 Favored 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 121.769 1.646 . . . . 0.58999999999999997 109.046 163.5 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 108.54 -35.12 5.16 Favored Glycine 0 CA--C 1.53 1.015 0 CA-C-O 119.442 -0.643 . . . . 0.5 113.39 171.892 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 59.9 t -89.28 128.62 41.22 Favored 'Isoleucine or valine' 0 C--N 1.34 0.173 0 CA-C-N 118.454 1.127 . . . . 0.62 110.303 178.772 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 30.7 m -111.06 -28.58 8.25 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 123.582 0.753 . . . . 1.0600000000000001 111.817 -174.747 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -146.78 164.1 33.86 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 119.033 0.833 . . . . 2.3399999999999999 111.359 164.791 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -156.18 133.95 11.07 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 112.571 0.582 . . . . 0.42999999999999999 112.571 -176.478 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -150.34 115.88 5.49 Favored 'General case' 0 C--N 1.341 0.235 0 N-CA-C 108.279 -1.008 . . . . 0.44 108.279 -163.266 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.635 HG21 ' HB1' ' A' ' 21' ' ' ALA . 8.4 p -93.3 100.13 10.75 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 C-N-CA 123.478 0.711 . . . . 0.53000000000000003 110.049 -175.985 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 53.1 t-20 -83.71 57.3 4.02 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 122.651 1.215 . . . . 0.63 109.287 -179.145 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.449 HD22 ' HA ' ' A' ' 41' ' ' LEU . 0.2 OUTLIER -69.98 -19.74 63.33 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 114.915 -1.038 . . . . 0.92000000000000004 110.155 -175.713 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -46.7 -35.67 6.31 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 123.876 0.87 . . . . 0.59999999999999998 112.036 166.046 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 5.6 t -122.11 37.33 4.4 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 121.496 0.665 . . . . 1.3300000000000001 109.553 173.56 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 41.22 40.01 1.07 Allowed 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 126.655 1.982 . . . . 2.6400000000000001 113.503 179.109 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 95.1 m -124.33 160.49 27.96 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 124.971 1.308 . . . . 0.68000000000000005 107.865 -178.799 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.6 p -130.79 146.81 33.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 O-C-N 121.356 -0.84 . . . . 0.42999999999999999 109.321 170.133 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -128.77 138.84 52.31 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 108.253 -1.017 . . . . 0.31 108.253 -179.639 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 34.2 t -135.05 129.28 50.59 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 N-CA-C 106.284 -1.747 . . . . 2.1499999999999999 106.284 -179.395 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 11.4 mm -104.4 99.8 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 N-CA-C 106.874 -1.528 . . . . 0.40999999999999998 106.874 -173.552 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 53.6 p90 -138.3 167.49 21.75 Favored 'General case' 0 CA--C 1.509 -0.602 0 O-C-N 121.622 -0.673 . . . . 2.0600000000000001 111.623 -170.591 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -87.75 109.43 26.88 Favored Pre-proline 0 C--O 1.236 0.343 0 O-C-N 124.448 1.092 . . . . 3.04 109.646 174.992 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -74.56 5.18 3.92 Favored 'Trans proline' 0 N--CA 1.451 -0.989 0 C-N-CA 122.759 2.306 . . . . 0.55000000000000004 112.973 -177.323 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -86.08 -27.61 24.59 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 119.506 1.048 . . . . 0.73999999999999999 109.294 166.721 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.51 -57.5 2.03 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 108.22 -1.03 . . . . 3.46 108.22 -168.666 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.288 1.0 OUTLIER -93.95 -173.63 3.18 Favored 'General case' 0 C--O 1.225 -0.215 0 C-N-CA 124.435 1.094 . . . . 0.42999999999999999 112.494 161.566 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 141.64 91.25 0.17 Allowed Glycine 0 N--CA 1.441 -1.029 0 N-CA-C 103.222 -3.951 . . . . 2.2599999999999998 103.222 -155.896 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -13.02 -13.92 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.7 1 C-N-CA 138.476 6.71 . . . . 3.02 120.472 -149.249 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -26.26 -62.62 0.08 Allowed 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 126.885 2.074 . . . . 0.56999999999999995 114.867 161.228 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.87 -41.5 59.69 Favored 'General case' 0 CA--C 1.521 -0.145 0 CA-C-O 122.255 1.026 . . . . 0.48999999999999999 108.931 -167.802 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.7 mt -44.82 -57.36 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.771 0 C-N-CA 125.829 1.651 . . . . 1.51 110.53 170.452 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.95 -46.35 88.23 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 119.444 1.02 . . . . 1.1799999999999999 110.747 178.999 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -49.3 -55.49 12.6 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 121.944 0.878 . . . . 3.3999999999999999 111.001 179.019 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.462 ' HA ' ' HE3' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -68.95 -41.11 78.44 Favored 'General case' 0 N--CA 1.441 -0.886 0 C-N-CA 124.135 0.974 . . . . 3.0899999999999999 112.319 179.207 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -48.71 -53.18 7.53 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 N-CA-C 108.318 -0.993 . . . . 0.39000000000000001 108.318 175.91 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -59.96 -58.58 7.96 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 124.147 0.979 . . . . 1.51 110.699 177.03 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 2.9 mttp -55.23 -39.73 70.06 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 112.959 0.725 . . . . 4.0099999999999998 112.959 -175.849 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 20.8 mt -67.34 -17.81 64.9 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.327 1.051 . . . . 0.60999999999999999 111.515 177.361 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 96.58 41.03 3.73 Favored Glycine 0 C--N 1.335 0.512 0 C-N-CA 124.827 1.203 . . . . 0.41999999999999998 110.758 173.947 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -138.54 175.89 9.17 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 123.829 0.852 . . . . 1.96 110.334 -175.255 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 16.4 t-160 -142.32 148.6 38.25 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 108.419 -0.956 . . . . 2.0600000000000001 108.419 174.88 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -118.42 152.9 20.55 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.14 0 C-N-CA 125.617 1.567 . . . . 1.8600000000000001 106.942 177.176 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 59.0 t -124.14 145.72 30.81 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 C-N-CA 124.902 1.281 . . . . 0.56000000000000005 108.274 179.141 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 38.9 mm . . . . . 0 N--CA 1.456 -0.174 0 C-N-CA 124.616 1.167 . . . . 1.04 108.884 -173.895 . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 11.7 m . . . . . 0 N--CA 1.451 -0.399 0 CA-C-O 120.759 0.314 . . . . 1.2 111.309 . . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -78.05 161.49 27.42 Favored 'General case' 0 N--CA 1.435 -1.192 0 N-CA-C 106.001 -1.852 . . . . 3.3999999999999999 106.001 171.351 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 9.8 mm100 -129.88 149.34 51.66 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 108.518 -0.919 . . . . 2.3300000000000001 108.518 -178.006 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 71.7 tttt -145.6 155.33 42.97 Favored 'General case' 0 N--CA 1.438 -1.053 0 C-N-CA 124.003 0.921 . . . . 4.1299999999999999 108.973 175.103 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -112.96 92.86 4.16 Favored 'General case' 0 N--CA 1.437 -1.086 0 C-N-CA 129.566 3.146 . . . . 1.6799999999999999 105.229 -173.494 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 19.4 mm -83.78 163.38 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.301 0 N-CA-C 106.797 -1.557 . . . . 2.29 106.797 175.665 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -133.22 138.03 46.36 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 125.457 1.503 . . . . 0.46000000000000002 107.291 177.92 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -155.85 171.38 20.15 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 118.347 0.522 . . . . 1.9299999999999999 109.733 175.946 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -93.32 164.83 13.07 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 124.921 1.288 . . . . 3.5800000000000001 109.893 -174.424 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.8 t -126.29 146.61 31.82 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 C-N-CA 123.754 0.822 . . . . 1.1599999999999999 109.622 -173.579 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 59.9 m -127.48 171.69 11.36 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.742 1.217 . . . . 1.0800000000000001 109.042 170.795 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 79.71 -35.85 2.07 Favored Glycine 0 CA--C 1.534 1.26 0 O-C-N 121.514 -0.741 . . . . 2.2799999999999998 112.871 -179.297 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -44.01 142.64 1.33 Allowed 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 114.248 1.203 . . . . 2.6200000000000001 114.248 -179.712 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -153.02 -60.89 0.15 Allowed 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 126.351 1.861 . . . . 2.71 107.002 177.995 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 31.3 m -63.94 -25.53 68.18 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.077 0.951 . . . . 2.77 112.94 -176.959 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 68.55 -60.18 0.44 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 126.005 1.722 . . . . 2.6699999999999999 110.956 -169.102 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -48.07 -45.5 32.56 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.71 1.204 . . . . 0.81000000000000005 111.682 178.861 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 89.9 m -57.48 -32.32 66.86 Favored 'General case' 0 CA--C 1.529 0.143 0 N-CA-C 112.766 0.654 . . . . 1.54 112.766 177.761 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.668 ' HB1' HG21 ' A' ' 39' ' ' VAL . . . -64.47 -19.17 65.4 Favored 'General case' 0 CA--C 1.538 0.487 0 O-C-N 121.904 -0.498 . . . . 0.56000000000000005 111.051 175.12 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.22 -47.41 61.56 Favored 'General case' 0 N--CA 1.453 -0.279 0 O-C-N 119.452 -2.03 . . . . 0.44 108.607 169.734 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 61.8 mtp180 -55.45 -41.24 72.59 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 118.77 -0.633 . . . . 4.1600000000000001 110.076 -176.386 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.484 HG21 ' CD1' ' A' ' 69' ' ' TYR 0.3 1.4 pt -57.82 -58.38 6.52 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.425 0 C-N-CA 119.373 -0.931 . . . . 0.46999999999999997 110.708 174.877 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.4 ' HG3' ' HB1' ' A' ' 37' ' ' ALA . 0.4 OUTLIER -47.88 -42.55 27.1 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 119.191 0.905 . . . . 2.6699999999999999 112.883 176.293 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 24.4 mmtp -70.25 -48.74 55.56 Favored 'General case' 0 CA--C 1.535 0.378 0 O-C-N 120.938 -1.101 . . . . 2.2400000000000002 111.291 -179.573 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.86 -29.38 73.91 Favored Glycine 0 CA--C 1.53 1.0 0 O-C-N 121.665 -0.647 . . . . 0.92000000000000004 111.582 176.281 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.3 tt -67.4 -54.42 20.56 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 125.314 1.446 . . . . 1.8500000000000001 107.775 176.547 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.501 ' HE2' ' HA ' ' A' ' 36' ' ' ASP . 6.7 ttmt -48.32 -33.11 8.36 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.523 0.729 . . . . 2.5499999999999998 112.115 178.22 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 3.6 mmt180 -55.76 -15.7 3.48 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 114.507 1.299 . . . . 4.2000000000000002 114.507 177.906 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 9.9 ptp -67.68 156.72 88.32 Favored Pre-proline 0 CA--C 1.535 0.38 0 CA-C-N 119.719 1.145 . . . . 3.8900000000000001 112.252 175.941 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -60.74 137.89 76.0 Favored 'Trans proline' 0 N--CA 1.456 -0.735 0 C-N-CA 121.378 1.385 . . . . 0.67000000000000004 109.522 165.846 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 99.33 -28.63 14.51 Favored Glycine 0 CA--C 1.53 0.983 0 CA-C-O 119.14 -0.811 . . . . 0.47999999999999998 113.729 170.553 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 61.5 t -88.64 136.75 22.61 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 CA-C-N 119.288 1.544 . . . . 0.56000000000000005 109.119 171.613 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -108.04 -41.2 5.0 Favored 'General case' 0 C--N 1.341 0.216 0 CA-C-O 118.356 -0.83 . . . . 1.4199999999999999 110.733 178.508 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.501 ' HA ' ' HE2' ' A' ' 29' ' ' LYS . 0.4 OUTLIER -143.21 165.93 26.1 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-N 119.113 0.87 . . . . 2.3700000000000001 110.403 170.963 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.4 ' HB1' ' HG3' ' A' ' 25' ' ' GLU . . . -158.02 148.16 20.28 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 123.538 0.735 . . . . 0.51000000000000001 110.073 179.923 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -156.19 118.37 4.03 Favored 'General case' 0 C--O 1.232 0.143 0 N-CA-C 107.723 -1.214 . . . . 0.53000000000000003 107.723 -163.364 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.668 HG21 ' HB1' ' A' ' 21' ' ' ALA . 8.0 p -89.92 101.4 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 C-N-CA 123.082 0.553 . . . . 0.65000000000000002 110.232 -177.07 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 51.4 t-20 -84.07 56.7 3.83 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-O 122.693 1.235 . . . . 0.59999999999999998 109.277 179.629 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.427 HD22 ' HA ' ' A' ' 41' ' ' LEU . 0.2 OUTLIER -69.07 -19.92 64.08 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 115.229 -0.896 . . . . 1.1100000000000001 110.152 -175.467 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -46.91 -36.8 8.01 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.032 0.933 . . . . 0.68000000000000005 112.363 166.752 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 14.5 t -115.5 23.67 12.2 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 118.499 0.59 . . . . 1.3600000000000001 111.327 174.161 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 55.04 50.37 15.56 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.4 1.08 . . . . 3.5499999999999998 112.859 -179.706 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 7.1 m -145.9 154.78 42.33 Favored 'General case' 0 N--CA 1.445 -0.722 0 O-C-N 120.418 -1.426 . . . . 0.77000000000000002 109.045 178.844 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.3 p -117.81 144.37 25.97 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 N-CA-C 108.455 -0.943 . . . . 0.39000000000000001 108.455 171.347 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -124.68 142.62 51.25 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 108.153 -1.055 . . . . 0.39000000000000001 108.153 176.985 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 4.0 p -139.78 129.35 29.09 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 N-CA-C 106.822 -1.548 . . . . 1.78 106.822 -174.993 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 14.5 mm -108.31 89.03 1.21 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.654 0 C-N-CA 126.007 1.723 . . . . 0.63 107.711 -167.461 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 34.7 p90 -137.12 172.9 12.32 Favored 'General case' 0 CA--C 1.511 -0.542 0 C-N-CA 122.671 0.388 . . . . 1.6399999999999999 111.967 -167.703 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 66.4 t0 -93.36 104.71 13.06 Favored Pre-proline 0 C--O 1.236 0.345 0 O-C-N 125.094 1.496 . . . . 3.0800000000000001 110.177 -179.412 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -73.71 3.19 5.11 Favored 'Trans proline' 0 N--CA 1.448 -1.154 0 C-N-CA 122.003 1.802 . . . . 0.76000000000000001 112.447 -179.286 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -82.23 -29.35 31.38 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 119.819 1.19 . . . . 1.0700000000000001 109.205 165.726 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -108.32 -55.99 2.31 Favored 'General case' 0 C--N 1.343 0.317 0 C-N-CA 122.797 0.439 . . . . 2.52 110.308 -166.355 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.31 0.6 OUTLIER -89.05 177.54 6.62 Favored 'General case' 0 CA--C 1.514 -0.432 0 CA-C-O 123.312 1.53 . . . . 0.52000000000000002 114.212 160.345 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -160.02 -135.9 1.93 Allowed Glycine 0 N--CA 1.433 -1.567 0 N-CA-C 103.978 -3.649 . . . . 2.54 103.978 175.43 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 23.6 p -76.57 -35.29 58.28 Favored 'General case' 0 N--CA 1.444 -0.751 0 C-N-CA 127.031 2.132 . . . . 1.3600000000000001 109.75 177.917 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -49.48 -62.8 1.35 Allowed 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 125.49 1.516 . . . . 0.55000000000000004 113.926 -165.379 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.83 -35.0 69.76 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 114.676 -1.147 . . . . 0.44 108.472 -168.364 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.8 mt -54.26 -57.18 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.908 0 C-N-CA 125.95 1.7 . . . . 1.3200000000000001 111.179 173.155 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.69 -45.22 95.01 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 119.804 1.184 . . . . 1.0900000000000001 109.626 -179.724 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -49.56 -59.36 3.84 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-O 121.392 0.615 . . . . 3.2400000000000002 111.958 176.756 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 4.7 mmpt? -63.61 -40.53 97.16 Favored 'General case' 0 N--CA 1.437 -1.087 0 CA-C-O 118.459 -0.781 . . . . 2.2000000000000002 111.096 -179.452 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.3 mm -49.01 -54.3 5.69 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.558 0 C-N-CA 124.171 0.989 . . . . 0.34999999999999998 108.441 177.204 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 27.0 mm-40 -59.32 -55.71 31.34 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 123.594 0.757 . . . . 1.6200000000000001 110.436 177.0 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 10.2 mmtt -57.11 -36.48 70.69 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 112.905 0.706 . . . . 4.4299999999999997 112.905 -174.931 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 13.0 mt -71.11 -17.8 62.55 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.889 1.276 . . . . 0.64000000000000001 112.144 175.874 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 96.96 39.47 4.06 Favored Glycine 0 CA--C 1.523 0.589 0 C-N-CA 124.571 1.082 . . . . 0.45000000000000001 111.093 175.36 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.484 ' CD1' HG21 ' A' ' 24' ' ' ILE . 0.6 OUTLIER -135.31 175.86 9.2 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 124.131 0.972 . . . . 1.9399999999999999 110.303 -178.39 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 22.4 t-160 -143.86 133.55 23.7 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 107.711 -1.218 . . . . 2.04 107.711 172.631 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 6.5 p -108.86 139.99 29.28 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 C-N-CA 125.296 1.439 . . . . 1.49 107.407 179.782 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 86.3 t -108.72 138.74 34.23 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.137 0 CA-C-O 121.833 0.825 . . . . 0.68000000000000005 109.069 -179.566 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 45.8 mm . . . . . 0 N--CA 1.451 -0.416 0 C-N-CA 125.224 1.41 . . . . 1.1699999999999999 109.123 -169.767 . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 11.7 m . . . . . 0 N--CA 1.451 -0.399 0 CA-C-O 120.759 0.314 . . . . 1.2 111.309 . . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -78.05 161.49 27.42 Favored 'General case' 0 N--CA 1.435 -1.192 0 N-CA-C 106.001 -1.852 . . . . 3.3999999999999999 106.001 171.351 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 9.8 mm100 -129.88 149.34 51.66 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 108.518 -0.919 . . . . 2.3300000000000001 108.518 -178.006 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 71.7 tttt -145.6 155.33 42.97 Favored 'General case' 0 N--CA 1.438 -1.053 0 C-N-CA 124.003 0.921 . . . . 4.1299999999999999 108.973 175.103 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -112.96 92.86 4.16 Favored 'General case' 0 N--CA 1.437 -1.086 0 C-N-CA 129.566 3.146 . . . . 1.6799999999999999 105.229 -173.494 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 19.4 mm -83.78 163.38 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.301 0 N-CA-C 106.797 -1.557 . . . . 2.29 106.797 175.665 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -133.22 138.03 46.36 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 125.457 1.503 . . . . 0.46000000000000002 107.291 177.92 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -155.85 171.38 20.15 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 118.347 0.522 . . . . 1.9299999999999999 109.733 175.946 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -93.32 164.83 13.07 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 124.921 1.288 . . . . 3.5800000000000001 109.893 -174.424 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.8 t -126.29 146.61 31.82 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 C-N-CA 123.754 0.822 . . . . 1.1599999999999999 109.622 -173.579 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 59.9 m -127.48 171.69 11.36 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.742 1.217 . . . . 1.0800000000000001 109.042 170.795 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 79.71 -35.85 2.07 Favored Glycine 0 CA--C 1.534 1.26 0 O-C-N 121.514 -0.741 . . . . 2.2799999999999998 112.871 -179.297 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -44.01 142.64 1.33 Allowed 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 114.248 1.203 . . . . 2.6200000000000001 114.248 -179.712 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -153.02 -60.89 0.15 Allowed 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 126.351 1.861 . . . . 2.71 107.002 177.995 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 31.3 m -63.94 -25.53 68.18 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.077 0.951 . . . . 2.77 112.94 -176.959 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 68.55 -60.18 0.44 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 126.005 1.722 . . . . 2.6699999999999999 110.956 -169.102 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -48.07 -45.5 32.56 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.71 1.204 . . . . 0.81000000000000005 111.682 178.861 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 89.9 m -57.48 -32.32 66.86 Favored 'General case' 0 CA--C 1.529 0.143 0 N-CA-C 112.766 0.654 . . . . 1.54 112.766 177.761 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.668 ' HB1' HG21 ' A' ' 39' ' ' VAL . . . -64.47 -19.17 65.4 Favored 'General case' 0 CA--C 1.538 0.487 0 O-C-N 121.904 -0.498 . . . . 0.56000000000000005 111.051 175.12 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.22 -47.41 61.56 Favored 'General case' 0 N--CA 1.453 -0.279 0 O-C-N 119.452 -2.03 . . . . 0.44 108.607 169.734 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 61.8 mtp180 -55.45 -41.24 72.59 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 118.77 -0.633 . . . . 4.1600000000000001 110.076 -176.386 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.484 HG21 ' CD1' ' A' ' 69' ' ' TYR 0.3 1.4 pt -57.82 -58.38 6.52 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.425 0 C-N-CA 119.373 -0.931 . . . . 0.46999999999999997 110.708 174.877 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.4 ' HG3' ' HB1' ' A' ' 37' ' ' ALA . 0.4 OUTLIER -47.88 -42.55 27.1 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 119.191 0.905 . . . . 2.6699999999999999 112.883 176.293 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 24.4 mmtp -70.25 -48.74 55.56 Favored 'General case' 0 CA--C 1.535 0.378 0 O-C-N 120.938 -1.101 . . . . 2.2400000000000002 111.291 -179.573 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.86 -29.38 73.91 Favored Glycine 0 CA--C 1.53 1.0 0 O-C-N 121.665 -0.647 . . . . 0.92000000000000004 111.582 176.281 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.3 tt -67.4 -54.42 20.56 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 125.314 1.446 . . . . 1.8500000000000001 107.775 176.547 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.501 ' HE2' ' HA ' ' A' ' 36' ' ' ASP . 6.7 ttmt -48.32 -33.11 8.36 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.523 0.729 . . . . 2.5499999999999998 112.115 178.22 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 3.6 mmt180 -55.76 -15.7 3.48 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 114.507 1.299 . . . . 4.2000000000000002 114.507 177.906 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 9.9 ptp -67.68 156.72 88.32 Favored Pre-proline 0 CA--C 1.535 0.38 0 CA-C-N 119.719 1.145 . . . . 3.8900000000000001 112.252 175.941 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -60.74 137.89 76.0 Favored 'Trans proline' 0 N--CA 1.456 -0.735 0 C-N-CA 121.378 1.385 . . . . 0.67000000000000004 109.522 165.846 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 99.33 -28.63 14.51 Favored Glycine 0 CA--C 1.53 0.983 0 CA-C-O 119.14 -0.811 . . . . 0.47999999999999998 113.729 170.553 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 61.5 t -88.64 136.75 22.61 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 CA-C-N 119.288 1.544 . . . . 0.56000000000000005 109.119 171.613 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -108.04 -41.2 5.0 Favored 'General case' 0 C--N 1.341 0.216 0 CA-C-O 118.356 -0.83 . . . . 1.4199999999999999 110.733 178.508 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.501 ' HA ' ' HE2' ' A' ' 29' ' ' LYS . 0.4 OUTLIER -143.21 165.93 26.1 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-N 119.113 0.87 . . . . 2.3700000000000001 110.403 170.963 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.4 ' HB1' ' HG3' ' A' ' 25' ' ' GLU . . . -158.02 148.16 20.28 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 123.538 0.735 . . . . 0.51000000000000001 110.073 179.923 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -156.19 118.37 4.03 Favored 'General case' 0 C--O 1.232 0.143 0 N-CA-C 107.723 -1.214 . . . . 0.53000000000000003 107.723 -163.364 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.668 HG21 ' HB1' ' A' ' 21' ' ' ALA . 8.0 p -89.92 101.4 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 C-N-CA 123.082 0.553 . . . . 0.65000000000000002 110.232 -177.07 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 51.4 t-20 -84.07 56.7 3.83 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-O 122.693 1.235 . . . . 0.59999999999999998 109.277 179.629 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.427 HD22 ' HA ' ' A' ' 41' ' ' LEU . 0.2 OUTLIER -69.07 -19.92 64.08 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 115.229 -0.896 . . . . 1.1100000000000001 110.152 -175.467 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -46.91 -36.8 8.01 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.032 0.933 . . . . 0.68000000000000005 112.363 166.752 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 14.5 t -115.5 23.67 12.2 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 118.499 0.59 . . . . 1.3600000000000001 111.327 174.161 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 55.04 50.37 15.56 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.4 1.08 . . . . 3.5499999999999998 112.859 -179.706 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 7.1 m -145.9 154.78 42.33 Favored 'General case' 0 N--CA 1.445 -0.722 0 O-C-N 120.418 -1.426 . . . . 0.77000000000000002 109.045 178.844 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.3 p -117.81 144.37 25.97 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 N-CA-C 108.455 -0.943 . . . . 0.39000000000000001 108.455 171.347 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -124.68 142.62 51.25 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 108.153 -1.055 . . . . 0.39000000000000001 108.153 176.985 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 4.0 p -139.78 129.35 29.09 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 N-CA-C 106.822 -1.548 . . . . 1.78 106.822 -174.993 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 14.5 mm -108.31 89.03 1.21 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.654 0 C-N-CA 126.007 1.723 . . . . 0.63 107.711 -167.461 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 34.7 p90 -137.12 172.9 12.32 Favored 'General case' 0 CA--C 1.511 -0.542 0 C-N-CA 122.671 0.388 . . . . 1.6399999999999999 111.967 -167.703 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 66.4 t0 -93.36 104.71 13.06 Favored Pre-proline 0 C--O 1.236 0.345 0 O-C-N 125.094 1.496 . . . . 3.0800000000000001 110.177 -179.412 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -73.71 3.19 5.11 Favored 'Trans proline' 0 N--CA 1.448 -1.154 0 C-N-CA 122.003 1.802 . . . . 0.76000000000000001 112.447 -179.286 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -82.23 -29.35 31.38 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 119.819 1.19 . . . . 1.0700000000000001 109.205 165.726 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -108.32 -55.99 2.31 Favored 'General case' 0 C--N 1.343 0.317 0 C-N-CA 122.797 0.439 . . . . 2.52 110.308 -166.355 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.31 0.6 OUTLIER -89.05 177.54 6.62 Favored 'General case' 0 CA--C 1.514 -0.432 0 CA-C-O 123.312 1.53 . . . . 0.52000000000000002 114.212 160.345 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -160.02 -135.9 1.93 Allowed Glycine 0 N--CA 1.433 -1.567 0 N-CA-C 103.978 -3.649 . . . . 2.54 103.978 175.43 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 23.6 p -76.57 -35.29 58.28 Favored 'General case' 0 N--CA 1.444 -0.751 0 C-N-CA 127.031 2.132 . . . . 1.3600000000000001 109.75 177.917 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -49.48 -62.8 1.35 Allowed 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 125.49 1.516 . . . . 0.55000000000000004 113.926 -165.379 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.83 -35.0 69.76 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 114.676 -1.147 . . . . 0.44 108.472 -168.364 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.8 mt -54.26 -57.18 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.908 0 C-N-CA 125.95 1.7 . . . . 1.3200000000000001 111.179 173.155 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.69 -45.22 95.01 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 119.804 1.184 . . . . 1.0900000000000001 109.626 -179.724 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -49.56 -59.36 3.84 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-O 121.392 0.615 . . . . 3.2400000000000002 111.958 176.756 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 4.7 mmpt? -63.61 -40.53 97.16 Favored 'General case' 0 N--CA 1.437 -1.087 0 CA-C-O 118.459 -0.781 . . . . 2.2000000000000002 111.096 -179.452 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.3 mm -49.01 -54.3 5.69 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.558 0 C-N-CA 124.171 0.989 . . . . 0.34999999999999998 108.441 177.204 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 27.0 mm-40 -59.32 -55.71 31.34 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 123.594 0.757 . . . . 1.6200000000000001 110.436 177.0 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 10.2 mmtt -57.11 -36.48 70.69 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 112.905 0.706 . . . . 4.4299999999999997 112.905 -174.931 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 13.0 mt -71.11 -17.8 62.55 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.889 1.276 . . . . 0.64000000000000001 112.144 175.874 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 96.96 39.47 4.06 Favored Glycine 0 CA--C 1.523 0.589 0 C-N-CA 124.571 1.082 . . . . 0.45000000000000001 111.093 175.36 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.484 ' CD1' HG21 ' A' ' 24' ' ' ILE . 0.6 OUTLIER -135.31 175.86 9.2 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 124.131 0.972 . . . . 1.9399999999999999 110.303 -178.39 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 22.4 t-160 -143.86 133.55 23.7 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 107.711 -1.218 . . . . 2.04 107.711 172.631 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 6.5 p -108.86 139.99 29.28 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 C-N-CA 125.296 1.439 . . . . 1.49 107.407 179.782 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 86.3 t -108.72 138.74 34.23 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.137 0 CA-C-O 121.833 0.825 . . . . 0.68000000000000005 109.069 -179.566 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 45.8 mm . . . . . 0 N--CA 1.451 -0.416 0 C-N-CA 125.224 1.41 . . . . 1.1699999999999999 109.123 -169.767 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.5 ttm . . . . . 0 N--CA 1.47 0.54 0 N-CA-C 106.048 -1.834 . . . . 11.02 106.048 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.1 tt -161.66 -74.94 0.05 Allowed 'General case' 0 C--O 1.224 -0.256 0 N-CA-C 107.727 -1.212 . . . . 5.79 107.727 172.288 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.3 m 48.71 93.18 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 126.057 1.743 . . . . 1.05 112.068 176.138 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -72.76 174.97 6.91 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 108.472 -0.936 . . . . 2.3100000000000001 108.472 179.245 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -129.45 141.09 51.11 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 107.304 -1.369 . . . . 1.04 107.304 168.429 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 6.8 mtpm? -139.76 158.43 44.12 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-O 122.225 1.012 . . . . 3.46 109.661 168.028 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -112.67 107.4 16.06 Favored 'General case' 0 N--CA 1.431 -1.402 0 C-N-CA 130.03 3.332 . . . . 1.5900000000000001 104.974 -171.734 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.476 HD12 ' C ' ' A' ' 8' ' ' ILE . 2.2 pp -84.12 167.02 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 C-N-CA 118.917 -1.113 . . . . 4.9000000000000004 108.599 166.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -137.76 134.01 34.76 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 105.174 -2.158 . . . . 0.44 105.174 170.352 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 24.2 ptt? -153.11 168.57 25.49 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 118.492 0.587 . . . . 3.1600000000000001 109.75 178.212 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 19.9 mm100 -92.81 163.99 13.51 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 124.122 0.969 . . . . 2.46 109.819 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.9 m -124.17 157.16 31.58 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.126 0 C-N-CA 125.403 1.481 . . . . 1.8799999999999999 110.08 179.565 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 38.5 m -155.04 166.7 32.75 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 124.8 1.24 . . . . 1.28 108.655 170.795 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 63.11 74.66 0.4 Allowed Glycine 0 CA--C 1.528 0.877 0 N-CA-C 110.845 -0.902 . . . . 1.8300000000000001 110.845 178.398 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -146.71 155.97 42.81 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 123.228 0.611 . . . . 2.29 110.526 -175.096 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -85.6 -62.81 1.44 Allowed 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 125.915 1.686 . . . . 3.5800000000000001 109.644 172.922 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.6 p -155.07 161.04 41.42 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 121.724 0.773 . . . . 2.27 112.085 -169.694 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -72.93 56.1 0.41 Allowed 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 126.751 2.02 . . . . 1.8200000000000001 111.112 -178.753 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -152.6 -52.57 0.11 Allowed 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 124.804 1.242 . . . . 0.69999999999999996 108.448 -175.826 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 30.9 m -59.07 -39.26 81.57 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 108.904 -0.776 . . . . 1.1599999999999999 108.904 170.357 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.705 ' HB1' HG21 ' A' ' 39' ' ' VAL . . . -41.3 -36.83 0.86 Allowed 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.663 1.585 . . . . 0.76000000000000001 112.697 166.569 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -69.75 -53.91 16.18 Favored 'General case' 0 N--CA 1.452 -0.34 0 O-C-N 120.228 -1.545 . . . . 0.41999999999999998 109.264 175.628 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 2.5 mpp_? -57.08 -36.68 70.86 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-O 118.166 -0.921 . . . . 4.4000000000000004 111.639 -174.45 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.281 2.0 pt -56.78 -57.19 10.47 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 C-N-CA 119.342 -0.943 . . . . 0.65000000000000002 110.742 175.079 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -57.13 -45.66 83.33 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 123.533 0.733 . . . . 2.3199999999999998 112.08 178.001 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 13.4 mptt -66.73 -43.25 84.69 Favored 'General case' 0 CA--C 1.531 0.22 0 O-C-N 121.683 -0.636 . . . . 1.8200000000000001 109.838 -174.824 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -60.33 -44.37 97.61 Favored Glycine 0 CA--C 1.527 0.811 0 N-CA-C 110.024 -1.23 . . . . 0.60999999999999999 110.024 171.519 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -60.39 -40.91 92.62 Favored 'General case' 0 CA--C 1.532 0.255 0 O-C-N 122.48 -0.423 . . . . 2.3300000000000001 110.069 -175.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 19.9 ttmt -43.5 -32.25 0.86 Allowed 'General case' 0 CA--C 1.535 0.369 0 O-C-N 121.747 -0.596 . . . . 2.9700000000000002 112.405 173.133 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.93 -4.2 30.58 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 113.588 0.958 . . . . 5.9500000000000002 113.588 -172.812 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.83 166.39 37.78 Favored Pre-proline 0 CA--C 1.539 0.537 0 C-N-CA 125.111 1.364 . . . . 3.79 111.655 173.232 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_endo -70.5 157.1 59.97 Favored 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 122.881 2.387 . . . . 1.3100000000000001 110.629 -178.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 72.46 -36.15 0.68 Allowed Glycine 0 CA--C 1.525 0.71 0 C-N-CA 124.972 1.273 . . . . 0.92000000000000004 112.798 -179.031 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.5 t -68.45 144.78 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.732 0 CA-C-N 118.411 1.106 . . . . 0.94999999999999996 109.286 176.113 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -133.16 -39.24 0.94 Allowed 'General case' 0 N--CA 1.451 -0.377 0 CA-C-O 118.705 -0.664 . . . . 1.04 110.945 179.196 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -139.55 166.28 25.0 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-N 119.251 0.932 . . . . 2.6200000000000001 111.963 166.055 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -158.17 138.32 12.44 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 115.659 -0.7 . . . . 0.44 110.322 -176.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -149.62 109.83 4.16 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 106.206 -1.776 . . . . 0.41999999999999998 106.206 -163.681 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.705 HG21 ' HB1' ' A' ' 21' ' ' ALA . 9.7 p -81.48 119.09 30.41 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 N-CA-C 108.523 -0.917 . . . . 0.5 108.523 177.286 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 55.7 t-20 -99.65 57.28 1.01 Allowed 'General case' 0 C--O 1.236 0.352 0 CA-C-O 123.017 1.389 . . . . 0.57999999999999996 107.803 -178.362 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.453 HD22 ' HA ' ' A' ' 41' ' ' LEU . 0.2 OUTLIER -69.48 -19.92 63.75 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 114.095 -1.411 . . . . 0.96999999999999997 110.372 -172.773 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -46.21 -37.0 6.57 Favored 'General case' 0 C--N 1.34 0.189 0 C-N-CA 123.974 0.91 . . . . 0.53000000000000003 111.839 168.086 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 14.9 t -124.31 37.19 4.46 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 109.831 -0.433 . . . . 1.24 109.831 173.668 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 52.12 31.98 9.77 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 126.317 1.847 . . . . 2.9900000000000002 113.034 171.507 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 95.6 m -122.99 159.92 27.34 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 125.07 1.348 . . . . 0.65000000000000002 108.536 -175.28 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 6.5 p -129.03 143.96 39.65 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 O-C-N 121.249 -0.907 . . . . 0.31 109.413 172.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 20.1 m120 -127.84 138.9 52.86 Favored 'General case' 0 C--N 1.344 0.354 0 N-CA-C 107.774 -1.195 . . . . 0.34999999999999998 107.774 179.198 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 93.3 t -134.17 125.46 48.05 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 N-CA-C 105.062 -2.199 . . . . 1.8899999999999999 105.062 -174.506 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 13.7 mm -104.4 101.0 11.67 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 C-N-CA 126.249 1.82 . . . . 0.44 107.983 -175.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 41.9 p90 -142.23 173.04 11.89 Favored 'General case' 0 CA--C 1.513 -0.457 0 O-C-N 121.785 -0.572 . . . . 1.72 111.183 -172.767 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -92.97 115.17 64.52 Favored Pre-proline 0 CA--C 1.534 0.343 0 O-C-N 124.199 0.937 . . . . 3.04 108.884 173.188 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -81.76 13.08 2.56 Favored 'Trans proline' 0 N--CA 1.451 -0.998 0 C-N-CA 122.465 2.11 . . . . 0.66000000000000003 113.386 -176.054 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -92.35 -32.27 15.04 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 119.45 1.023 . . . . 0.93000000000000005 109.588 164.052 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -101.1 -55.43 2.56 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 108.495 -0.928 . . . . 2.6899999999999999 108.495 -169.325 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.499 0.2 OUTLIER -83.67 176.75 8.75 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 115.301 1.593 . . . . 0.64000000000000001 115.301 155.845 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -171.31 -147.54 5.7 Favored Glycine 0 N--CA 1.434 -1.454 0 N-CA-C 103.126 -3.99 . . . . 2.52 103.126 -174.466 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 23.6 p -76.75 -32.58 57.85 Favored 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 125.108 1.363 . . . . 1.3999999999999999 109.551 174.453 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -49.98 -61.59 2.06 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 124.723 1.209 . . . . 0.71999999999999997 113.282 -162.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.0 -34.21 73.02 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 114.408 -1.269 . . . . 0.60999999999999999 108.765 -171.8 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.6 mp -60.68 -51.41 73.42 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.95 0 CA-C-N 114.999 -1.0 . . . . 1.23 109.79 178.718 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.49 -47.11 85.43 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 108.828 -0.804 . . . . 1.1499999999999999 108.828 -178.068 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -48.7 -54.64 14.03 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 122.038 0.923 . . . . 3.1899999999999999 110.974 174.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.07 -47.17 81.17 Favored 'General case' 0 N--CA 1.44 -0.973 0 CA-C-O 118.664 -0.684 . . . . 2.3999999999999999 111.776 -178.524 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.501 HD12 HG13 ' A' ' 71' ' ' VAL . 1.2 mm -46.76 -50.99 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 C-N-CA 126.412 1.885 . . . . 0.51000000000000001 109.033 -177.091 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -57.73 -57.58 12.12 Favored 'General case' 0 C--N 1.34 0.159 0 C-N-CA 123.387 0.675 . . . . 1.49 110.173 175.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 13.9 mmtt -55.45 -35.6 65.64 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 112.963 0.727 . . . . 4.8499999999999996 112.963 -178.14 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 31.6 mt -71.07 -18.35 62.56 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.74 1.616 . . . . 0.93000000000000005 111.451 177.558 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 87.15 44.17 5.73 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 110.593 -1.003 . . . . 0.83999999999999997 110.593 178.411 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -137.93 172.97 12.14 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 124.094 0.957 . . . . 2.6800000000000002 109.72 179.125 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 8.3 t60 -146.35 133.9 20.92 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 109.239 -0.652 . . . . 1.96 109.239 165.048 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.501 HG13 HD12 ' A' ' 64' ' ' ILE . 4.5 m -98.8 161.05 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 C-N-CA 123.823 0.849 . . . . 2.4900000000000002 110.15 176.82 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 12.0 t -129.55 141.9 45.31 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 C-N-CA 124.902 1.281 . . . . 0.56000000000000005 107.843 -176.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 28.7 mm -118.59 80.5 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 C-N-CA 125.025 1.33 . . . . 1.6499999999999999 108.426 -175.203 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -79.56 -1.35 37.41 Favored 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 124.503 1.121 . . . . 2.8900000000000001 113.97 176.012 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -94.63 -34.67 6.2 Favored Glycine 0 CA--C 1.531 1.053 0 C-N-CA 125.39 1.471 . . . . 3.1000000000000001 113.567 -173.13 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 46.8 ttm-85 . . . . . 0 C--O 1.25 1.081 0 CA-C-O 116.779 -1.582 . . . . 11.279999999999999 108.85 178.403 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 34.5 mtt . . . . . 0 N--CA 1.475 0.777 0 N-CA-C 109.478 -0.564 . . . . 10.15 109.478 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -53.19 -46.34 68.95 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.215 0.606 . . . . 5.5599999999999996 109.789 -178.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 55.1 m -115.03 163.15 16.01 Favored 'General case' 0 N--CA 1.447 -0.624 0 C-N-CA 125.93 1.692 . . . . 1.3999999999999999 106.507 162.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -111.33 -174.7 2.53 Favored 'General case' 0 N--CA 1.439 -1.025 0 C-N-CA 125.487 1.515 . . . . 2.3399999999999999 107.257 156.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -136.28 152.01 50.25 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 107.473 -1.306 . . . . 1.1699999999999999 107.473 172.711 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 23.9 mttt -143.67 163.35 33.5 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 122.937 0.495 . . . . 2.6800000000000002 110.286 161.075 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -122.47 84.81 2.32 Favored 'General case' 0 N--CA 1.44 -0.969 0 C-N-CA 128.687 2.795 . . . . 1.5600000000000001 106.009 -166.429 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.439 ' N ' HD12 ' A' ' 8' ' ' ILE . 3.1 mp -82.49 160.6 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.405 0 N-CA-C 105.691 -1.966 . . . . 2.0299999999999998 105.691 -178.15 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -120.35 132.92 55.49 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 106.243 -1.762 . . . . 0.53000000000000003 106.243 178.618 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 2.8 ttm -138.54 161.63 36.57 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 108.355 -0.98 . . . . 2.2400000000000002 108.355 -177.161 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -97.42 146.91 24.74 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 124.235 1.014 . . . . 2.4199999999999999 108.936 177.078 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 49.1 t -103.85 149.76 7.52 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 C-N-CA 123.77 0.828 . . . . 1.24 109.019 -178.773 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 56.3 m -152.93 164.88 37.1 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 118.866 0.757 . . . . 1.1699999999999999 110.092 171.823 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 64.02 72.13 0.74 Allowed Glycine 0 CA--C 1.527 0.84 0 N-CA-C 110.93 -0.868 . . . . 1.73 110.93 178.2 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -154.78 170.11 22.37 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 123.825 0.85 . . . . 2.0699999999999998 109.857 -172.727 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -111.87 -44.64 3.43 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 123.922 0.889 . . . . 2.3300000000000001 111.229 168.642 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 20.0 p -147.97 176.43 10.17 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 119.111 0.869 . . . . 2.6600000000000001 111.631 -174.105 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -72.26 -24.41 61.36 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 115.508 -0.769 . . . . 2.6200000000000001 111.809 177.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.7 -49.7 72.09 Favored 'General case' 0 C--O 1.233 0.209 0 O-C-N 121.377 -0.827 . . . . 0.71999999999999997 110.79 -175.614 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 5.2 p -65.06 -38.96 92.49 Favored 'General case' 0 CA--C 1.532 0.279 0 O-C-N 121.633 -0.667 . . . . 2.4500000000000002 110.518 173.793 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.756 ' HB1' HG21 ' A' ' 39' ' ' VAL . . . -56.61 -29.28 61.97 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-O 121.386 0.613 . . . . 0.40999999999999998 112.074 173.242 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -69.9 -53.41 18.07 Favored 'General case' 0 N--CA 1.45 -0.445 0 O-C-N 119.935 -1.728 . . . . 0.5 108.791 171.757 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -46.67 -50.96 16.99 Favored 'General case' 0 C--N 1.341 0.231 0 CA-C-O 118.486 -0.769 . . . . 3.9199999999999999 110.755 178.109 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.502 HG21 ' CD1' ' A' ' 69' ' ' TYR 0.268 3.4 pt -57.09 -58.21 6.78 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.159 0 C-N-CA 119.727 -0.789 . . . . 0.51000000000000001 110.69 -176.302 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -51.96 -45.47 64.4 Favored 'General case' 0 N--CA 1.457 -0.095 0 CA-C-N 119.006 0.821 . . . . 2.4199999999999999 111.068 179.184 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.36 -40.15 85.75 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 119.585 -0.846 . . . . 1.53 110.895 -177.239 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -68.93 -24.62 75.7 Favored Glycine 0 CA--C 1.529 0.916 0 O-C-N 121.542 -0.724 . . . . 0.64000000000000001 111.633 174.446 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.434 ' CD2' HG21 ' A' ' 34' ' ' VAL . 0.9 OUTLIER -70.1 -43.92 70.06 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 108.11 -1.07 . . . . 1.6799999999999999 108.11 173.838 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 3.4 ttpp -50.0 -24.67 2.74 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 125.323 1.449 . . . . 2.3999999999999999 113.505 173.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -83.24 -0.21 48.48 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 118.443 -0.789 . . . . 3.9100000000000001 112.942 -179.5 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' MET . . . . . 0.633 ' CE ' ' HB1' ' A' ' 59' ' ' ALA . 4.0 ptm -93.96 156.0 39.66 Favored Pre-proline 0 CA--C 1.536 0.43 0 CA-C-N 119.31 0.959 . . . . 3.2200000000000002 111.658 -178.144 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -62.13 133.22 42.78 Favored 'Trans proline' 0 N--CA 1.456 -0.711 0 C-N-CA 122.433 2.089 . . . . 0.81000000000000005 109.809 173.414 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 100.11 -39.2 2.82 Favored Glycine 0 CA--C 1.525 0.7 0 CA-C-O 119.08 -0.844 . . . . 0.79000000000000004 112.595 176.734 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.434 HG21 ' CD2' ' A' ' 28' ' ' LEU . 47.5 t -88.02 118.66 34.12 Favored 'Isoleucine or valine' 0 C--N 1.343 0.314 0 CA-C-N 118.796 1.298 . . . . 1.0900000000000001 110.143 177.653 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 98.1 m -88.82 -52.66 5.0 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-O 118.76 -0.638 . . . . 1.3899999999999999 110.058 -176.236 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -138.23 161.26 37.3 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 123.838 0.855 . . . . 2.7200000000000002 108.757 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -158.22 141.03 14.71 Favored 'General case' 0 C--O 1.238 0.454 0 O-C-N 121.923 -0.486 . . . . 0.44 111.255 -173.846 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -151.37 110.07 3.83 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 106.648 -1.612 . . . . 0.42999999999999999 106.648 -165.118 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.756 HG21 ' HB1' ' A' ' 21' ' ' ALA . 8.7 p -80.97 136.07 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 N-CA-C 107.816 -1.179 . . . . 0.71999999999999997 107.816 176.915 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 52.7 t-20 -121.97 56.01 1.1 Allowed 'General case' 0 C--O 1.235 0.342 0 CA-C-O 123.03 1.395 . . . . 0.58999999999999997 107.929 -176.693 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.429 HD22 ' HA ' ' A' ' 41' ' ' LEU . 0.2 OUTLIER -68.09 -19.55 64.87 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 113.807 -1.542 . . . . 1.04 110.615 -176.018 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -45.46 -37.88 5.63 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 124.067 0.947 . . . . 0.68000000000000005 111.948 165.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 12.2 t -124.53 38.18 4.25 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 109.063 -0.717 . . . . 1.3600000000000001 109.063 172.826 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 53.77 24.1 4.18 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.773 1.629 . . . . 3.25 113.78 171.085 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 88.0 m -116.51 162.91 16.86 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.814 1.245 . . . . 0.69999999999999996 108.878 -174.347 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.4 p -125.94 145.42 33.42 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 C-N-CA 124.536 1.135 . . . . 0.34000000000000002 108.044 167.813 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 10.2 m120 -124.17 136.86 54.5 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 107.494 -1.299 . . . . 0.33000000000000002 107.494 172.519 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.1 p -134.93 123.66 41.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 106.252 -1.759 . . . . 1.8799999999999999 106.252 -173.608 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 13.5 mm -104.32 94.72 3.32 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 N-CA-C 107.194 -1.41 . . . . 0.56000000000000005 107.194 -168.842 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 31.1 p90 -131.28 164.26 26.0 Favored 'General case' 0 CA--C 1.512 -0.506 0 O-C-N 122.203 -0.31 . . . . 1.6499999999999999 111.691 -169.45 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 35.7 t0 -83.53 109.23 16.63 Favored Pre-proline 0 CA--C 1.532 0.279 0 O-C-N 124.444 1.09 . . . . 3.02 109.553 174.68 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -74.22 4.87 3.97 Favored 'Trans proline' 0 N--CA 1.451 -0.981 0 C-N-CA 122.663 2.242 . . . . 0.59999999999999998 113.06 -176.877 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -85.44 -28.68 24.91 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 119.338 0.972 . . . . 0.77000000000000002 109.215 166.428 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -102.52 -61.16 1.43 Allowed 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 107.941 -1.133 . . . . 4.2999999999999998 107.941 -169.189 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.829 HG22 ' HB3' ' A' ' 59' ' ' ALA 0.283 0.7 OUTLIER -86.75 -176.46 5.8 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 124.933 1.293 . . . . 0.78000000000000003 112.901 162.489 . . . . . . . . 4 4 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 131.78 94.02 0.61 Allowed Glycine 0 N--CA 1.442 -0.903 0 N-CA-C 103.515 -3.834 . . . . 2.3100000000000001 103.515 -144.356 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 75.0 p -19.17 -23.25 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.308 1 C-N-CA 138.132 6.573 . . . . 1.28 118.809 -147.43 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -28.21 -62.54 0.1 Allowed 'General case' 0 N--CA 1.442 -0.846 0 C-N-CA 126.503 1.921 . . . . 0.91000000000000003 113.19 165.174 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.829 ' HB3' HG22 ' A' ' 55' ' ' THR . . . -75.27 -32.43 61.05 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 118.396 -1.322 . . . . 0.87 110.014 -168.644 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.6 mp -60.17 -51.72 69.6 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.625 0 CA-C-N 115.579 -0.737 . . . . 0.82999999999999996 109.794 175.484 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.96 -48.21 82.63 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 119.067 0.849 . . . . 1.1699999999999999 109.151 -178.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -46.13 -58.74 3.37 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-O 121.864 0.84 . . . . 2.5699999999999998 111.24 174.439 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 15.2 mmmt -67.74 -34.69 77.33 Favored 'General case' 0 N--CA 1.441 -0.913 0 CA-C-O 118.354 -0.832 . . . . 3.7000000000000002 112.082 -177.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.4 mm -53.45 -52.65 30.48 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 N-CA-C 107.943 -1.132 . . . . 0.41999999999999998 107.943 176.272 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 40.9 mm-40 -58.15 -54.77 43.25 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 123.469 0.708 . . . . 1.54 109.837 176.123 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 13.0 mmtt -59.48 -33.85 71.84 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 113.288 0.848 . . . . 4.1299999999999999 113.288 -176.325 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 32.1 mt -70.78 -18.47 62.75 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.735 1.214 . . . . 1.02 111.289 174.34 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 95.9 39.88 4.23 Favored Glycine 0 CA--C 1.524 0.597 0 C-N-CA 124.892 1.234 . . . . 0.72999999999999998 111.007 175.173 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.502 ' CD1' HG21 ' A' ' 24' ' ' ILE . 0.2 OUTLIER -136.54 175.47 9.58 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 117.805 0.803 . . . . 1.8700000000000001 111.462 -174.987 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -130.69 147.5 52.37 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 123.487 0.715 . . . . 2.9300000000000002 109.497 167.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 4.1 p -126.52 152.77 34.49 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 N-CA-C 106.581 -1.637 . . . . 1.5 106.581 176.377 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 11.6 t -129.31 141.89 45.4 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 N-CA-C 107.032 -1.47 . . . . 0.73999999999999999 107.032 -178.571 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 5.0 mp -113.05 80.86 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.201 0 N-CA-C 108.759 -0.83 . . . . 1.3500000000000001 108.759 -175.04 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 26.2 mm-40 -76.77 -2.51 33.49 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 125.648 1.579 . . . . 3.3999999999999999 113.642 174.249 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -129.83 61.45 0.66 Allowed Glycine 0 CA--C 1.523 0.549 0 N-CA-C 108.252 -1.939 . . . . 4.0599999999999996 108.252 175.76 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 5.6 ttt-85 . . . . . 0 C--O 1.251 1.136 0 CA-C-O 117.846 -1.073 . . . . 13.029999999999999 112.867 -175.386 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.473 0.722 0 N-CA-C 107.036 -1.468 . . . . 10.59 107.036 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 29.8 mt -106.55 -74.9 0.64 Allowed 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 107.781 -1.192 . . . . 5.0800000000000001 107.781 175.344 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.9 m -137.18 140.38 41.74 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 125.795 1.638 . . . . 0.89000000000000001 106.797 177.437 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -88.6 -178.29 5.78 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 108.359 -0.978 . . . . 1.95 108.359 163.675 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 2.9 mm100 -134.58 148.44 50.45 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 107.038 -1.467 . . . . 1.1499999999999999 107.038 169.104 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 37.4 mtpt -140.32 156.91 46.26 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 123.415 0.686 . . . . 2.79 109.167 163.078 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 8.0 mp0 -115.48 89.69 3.16 Favored 'General case' 0 N--CA 1.442 -0.836 0 C-N-CA 127.746 2.418 . . . . 1.8600000000000001 106.326 -170.289 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.514 ' N ' HD12 ' A' ' 8' ' ' ILE . 1.6 mp -83.32 161.25 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.397 0 N-CA-C 105.742 -1.947 . . . . 2.1400000000000001 105.742 -177.321 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -127.81 126.34 41.5 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 125.395 1.478 . . . . 0.41999999999999998 107.021 177.333 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 2.7 mpp? -132.58 170.87 14.57 Favored 'General case' 0 CA--C 1.528 0.124 0 C-N-CA 123.419 0.688 . . . . 2.1000000000000001 109.204 173.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 18.5 mm100 -97.66 145.27 26.47 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 124.438 1.095 . . . . 2.6099999999999999 109.476 178.713 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 60.3 t -97.5 151.22 4.33 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.158 0 N-CA-C 108.938 -0.764 . . . . 1.26 108.938 178.316 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 13.0 t -141.77 176.77 8.65 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 108.196 -1.039 . . . . 1.6499999999999999 108.196 170.284 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 53.14 57.53 14.66 Favored Glycine 0 CA--C 1.529 0.909 0 C-N-CA 124.112 0.863 . . . . 1.53 111.573 -178.306 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -139.78 137.98 35.49 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 123.767 0.827 . . . . 1.9299999999999999 109.557 -179.344 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -144.44 8.14 1.35 Allowed 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.809 0.843 . . . . 3.7799999999999998 112.716 166.789 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 8.8 m -108.97 -21.0 12.84 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 124.691 1.196 . . . . 2.9100000000000001 111.825 -171.408 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 64.46 -68.06 0.1 Allowed 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.707 1.603 . . . . 2.5499999999999998 110.881 -165.297 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -44.13 -49.66 8.88 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 125.81 1.644 . . . . 0.83999999999999997 112.603 -175.418 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 96.6 m -52.54 -35.76 54.18 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 123.953 0.901 . . . . 1.1899999999999999 113.126 -178.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.78 ' HB1' HG21 ' A' ' 39' ' ' VAL . . . -63.35 -23.24 67.32 Favored 'General case' 0 CA--C 1.539 0.557 0 O-C-N 122.034 -0.416 . . . . 0.41999999999999998 111.157 179.638 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.13 -52.78 17.36 Favored 'General case' 0 N--CA 1.454 -0.245 0 O-C-N 121.028 -1.045 . . . . 0.31 109.592 171.13 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 4.2 mtt-85 -50.97 -47.99 61.23 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 123.379 0.672 . . . . 3.77 110.219 -176.72 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.442 HG21 ' CD1' ' A' ' 69' ' ' TYR . 6.8 pt -57.24 -55.07 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.196 0 C-N-CA 119.751 -0.779 . . . . 0.48999999999999999 111.121 179.487 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -54.17 -42.96 70.21 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.753 0.821 . . . . 3.1899999999999999 111.92 179.699 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 31.9 mmtp -70.66 -47.34 60.44 Favored 'General case' 0 CA--C 1.534 0.357 0 O-C-N 121.061 -1.024 . . . . 1.95 110.914 -178.248 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.37 -28.36 70.9 Favored Glycine 0 CA--C 1.53 0.995 0 O-C-N 121.545 -0.722 . . . . 0.64000000000000001 111.349 174.862 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.1 tt -68.86 -47.87 64.87 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 125.789 1.636 . . . . 1.8899999999999999 109.215 174.521 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.2 ttmm -50.45 -34.7 25.66 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 118.664 0.665 . . . . 2.7400000000000002 111.713 175.149 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 14.5 mmt-85 -62.69 -7.15 4.34 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 114.877 1.436 . . . . 4.4000000000000004 114.877 179.338 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' MET . . . . . 0.472 ' SD ' ' HB1' ' A' ' 59' ' ' ALA . 27.4 mtm -71.56 169.72 14.61 Favored Pre-proline 0 CA--C 1.533 0.312 0 CA-C-N 120.355 1.434 . . . . 3.4500000000000002 112.44 170.8 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -60.78 162.78 17.57 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 121.777 1.651 . . . . 1.01 110.039 159.655 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 77.33 -38.72 1.63 Allowed Glycine 0 C--N 1.333 0.373 0 C-N-CA 125.88 1.705 . . . . 0.51000000000000001 114.02 171.455 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 16.3 t -83.66 134.08 27.73 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.875 0 C-N-CA 123.054 0.542 . . . . 0.52000000000000002 109.603 -177.428 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 88.0 m -113.6 -46.45 3.05 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 122.948 0.499 . . . . 1.3700000000000001 110.276 -175.183 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -139.48 165.13 28.05 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-N 118.047 0.385 . . . . 1.74 110.144 173.347 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -158.02 139.03 13.22 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 108.721 -0.844 . . . . 0.41999999999999998 108.721 -172.343 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -155.93 111.85 3.05 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 123.258 0.623 . . . . 0.48999999999999999 109.347 -165.571 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.896 HG22 HD23 ' A' ' 41' ' ' LEU . 4.8 p -86.79 102.57 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 CA-C-O 121.224 0.535 . . . . 0.55000000000000004 109.991 -177.037 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 51.7 t-20 -86.31 56.97 4.23 Favored 'General case' 0 C--O 1.235 0.333 0 O-C-N 120.687 -1.258 . . . . 0.57999999999999996 109.423 -179.213 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.896 HD23 HG22 ' A' ' 39' ' ' VAL . 0.3 OUTLIER -69.47 -19.86 63.75 Favored 'General case' 0 C--O 1.226 -0.158 0 CA-C-N 115.003 -0.998 . . . . 0.88 110.972 -176.195 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -45.27 -36.98 4.33 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.665 0.786 . . . . 0.56999999999999995 112.078 166.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 11.3 t -123.38 30.21 6.37 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 122.494 0.318 . . . . 1.23 110.964 172.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 62.11 26.83 16.16 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.348 1.459 . . . . 2.5099999999999998 114.297 172.847 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 88.4 m -120.32 163.13 18.29 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.79 1.236 . . . . 0.72999999999999998 109.524 -174.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 5.8 p -129.91 142.92 42.58 Favored 'Isoleucine or valine' 0 C--O 1.232 0.15 0 C-N-CA 124.302 1.041 . . . . 0.33000000000000002 108.835 171.732 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 10.4 m120 -126.12 129.79 49.78 Favored 'General case' 0 CA--C 1.517 -0.296 0 N-CA-C 108.151 -1.055 . . . . 0.35999999999999999 108.151 177.496 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 6.7 p -128.38 128.92 68.84 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 106.331 -1.729 . . . . 1.8 106.331 -175.751 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 7.9 mm -104.97 100.65 10.98 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 N-CA-C 107.15 -1.426 . . . . 0.42999999999999999 107.15 -172.003 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.462 ' CE2' HD13 ' A' ' 8' ' ' ILE . 50.2 p90 -138.46 165.15 27.55 Favored 'General case' 0 CA--C 1.516 -0.341 0 O-C-N 122.226 -0.296 . . . . 1.71 111.626 -172.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 37.7 t0 -85.97 110.68 32.43 Favored Pre-proline 0 C--O 1.236 0.382 0 O-C-N 124.458 1.099 . . . . 2.9700000000000002 108.858 175.12 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -71.5 4.26 3.09 Favored 'Trans proline' 0 N--CA 1.452 -0.957 0 C-N-CA 122.772 2.315 . . . . 0.55000000000000004 113.135 -178.76 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -89.2 -27.32 20.73 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 119.478 1.035 . . . . 0.71999999999999997 109.397 168.717 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -104.63 -51.53 3.06 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 109.575 -0.528 . . . . 2.8799999999999999 109.575 -171.683 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.464 HG22 ' HB3' ' A' ' 59' ' ' ALA 0.285 1.1 p -97.7 -177.48 3.8 Favored 'General case' 0 CA--C 1.518 -0.252 0 C-N-CA 123.993 0.917 . . . . 0.51000000000000001 112.275 160.76 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 145.32 88.6 0.09 OUTLIER Glycine 0 N--CA 1.441 -1.011 0 N-CA-C 104.448 -3.461 . . . . 2.52 104.448 -155.295 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 45.1 p -13.07 -17.96 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.556 1 C-N-CA 137.936 6.494 . . . . 1.1399999999999999 119.956 -143.228 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -27.61 -63.48 0.09 Allowed 'General case' 0 N--CA 1.443 -0.803 0 C-N-CA 127.01 2.124 . . . . 0.5 114.317 166.405 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.472 ' HB1' ' SD ' ' A' ' 31' ' ' MET . . . -73.73 -37.3 65.14 Favored 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 118.485 -1.286 . . . . 0.5 109.069 -168.861 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.5 mp -53.93 -57.5 5.53 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.808 0 CA-C-N 114.402 -1.272 . . . . 1.03 109.884 175.638 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.04 -48.0 81.42 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 119.047 0.84 . . . . 1.1200000000000001 109.55 -178.414 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -45.57 -57.39 4.2 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 123.312 0.645 . . . . 3.25 111.932 176.393 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.7 mmmm -68.3 -42.34 79.61 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-O 118.545 -0.741 . . . . 3.5299999999999998 111.376 -179.538 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -46.0 -52.65 2.84 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 C-N-CA 125.003 1.321 . . . . 0.42999999999999999 108.579 177.048 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -59.45 -58.44 8.61 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 124.503 1.121 . . . . 1.54 110.545 176.391 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -55.62 -34.87 65.28 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 113.006 0.743 . . . . 3.73 113.006 -176.792 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 26.6 mt -68.87 -17.32 63.97 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.774 1.229 . . . . 0.55000000000000004 111.721 177.484 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 92.11 43.47 4.38 Favored Glycine 0 CA--C 1.522 0.531 0 N-CA-C 110.129 -1.189 . . . . 0.40999999999999998 110.129 178.813 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.442 ' CD1' HG21 ' A' ' 24' ' ' ILE . 0.4 OUTLIER -141.46 171.52 13.94 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 124.189 0.996 . . . . 1.97 110.015 -176.364 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 8.8 t-80 -143.71 127.48 17.2 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 107.842 -1.17 . . . . 1.72 107.842 172.732 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 5.8 p -97.22 151.74 4.15 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 N-CA-C 108.114 -1.069 . . . . 1.4399999999999999 108.114 174.53 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 38.3 t -120.0 139.76 46.26 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 C-N-CA 125.173 1.389 . . . . 0.56999999999999995 108.358 -179.455 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 26.7 mm -102.48 64.6 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 122.119 0.961 . . . . 1.1100000000000001 109.737 -169.772 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -65.66 -14.39 61.12 Favored 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 114.193 1.183 . . . . 3.3100000000000001 114.193 -173.771 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -64.36 -36.93 93.81 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 125.101 1.334 . . . . 2.6600000000000001 111.676 175.604 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 2.1 tpm_? . . . . . 0 C--O 1.255 1.378 0 C-N-CA 125.861 1.665 . . . . 11.73 113.739 177.492 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 33.1 mtt . . . . . 0 N--CA 1.474 0.764 0 N-CA-C 108.936 -0.765 . . . . 9.5899999999999999 108.936 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 11.1 tp -110.71 156.19 21.38 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 107.42 -1.326 . . . . 5.2800000000000002 107.42 175.443 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.7 m -64.5 99.43 0.3 Allowed 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 108.655 -0.868 . . . . 0.84999999999999998 108.655 172.057 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -69.78 176.57 3.54 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 109.146 -0.687 . . . . 2.2999999999999998 109.146 173.133 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.67 155.07 45.6 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 124.205 1.002 . . . . 0.92000000000000004 108.431 176.39 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 10.8 ttmt -147.33 158.85 44.12 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 107.733 -1.21 . . . . 3.0699999999999998 107.733 168.268 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -119.13 98.68 6.29 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 127.728 2.411 . . . . 1.9099999999999999 104.669 -176.493 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 23.0 mm -84.37 164.32 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.171 0 N-CA-C 106.839 -1.541 . . . . 2.4300000000000002 106.839 173.875 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -134.18 124.83 26.67 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 107.065 -1.458 . . . . 0.48999999999999999 107.065 176.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 24.7 mtm -134.63 172.87 12.33 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.62 0.768 . . . . 2.0800000000000001 109.101 -179.145 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 21.5 mm100 -103.19 154.7 19.04 Favored 'General case' 0 C--O 1.222 -0.35 0 C-N-CA 125.394 1.477 . . . . 2.4500000000000002 109.313 178.089 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.591 HG21 HD21 ' A' ' 41' ' ' LEU . 6.3 m -117.98 165.37 13.39 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 CA-C-N 119.38 0.991 . . . . 1.73 110.419 174.274 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 53.8 m -137.74 171.04 15.03 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.231 1.412 . . . . 1.22 108.902 175.804 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 80.03 -44.82 2.87 Favored Glycine 0 CA--C 1.533 1.187 0 C-N-CA 123.488 0.566 . . . . 3.1899999999999999 113.311 173.622 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -38.55 122.37 1.11 Allowed 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 125.13 1.372 . . . . 2.8900000000000001 113.319 -177.231 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -139.48 12.53 2.55 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.896 0.878 . . . . 3.3199999999999998 112.014 177.842 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 8.9 m -115.59 -26.48 7.47 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 125.528 1.531 . . . . 2.9399999999999999 111.512 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 64.68 -63.71 0.17 Allowed 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.646 1.578 . . . . 2.4700000000000002 110.482 -162.207 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -41.59 -54.66 3.14 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 125.895 1.678 . . . . 0.87 112.748 -179.767 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 90.0 m -55.82 -31.43 62.68 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 113.183 0.808 . . . . 1.48 113.183 -178.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.817 ' HB1' HG21 ' A' ' 39' ' ' VAL . . . -61.4 -26.8 68.09 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 121.108 0.48 . . . . 0.41999999999999998 110.514 176.519 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.93 -50.74 31.42 Favored 'General case' 0 N--CA 1.452 -0.354 0 O-C-N 120.321 -1.487 . . . . 0.40000000000000002 109.053 170.035 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 55.2 mtm180 -51.33 -46.32 62.6 Favored 'General case' 0 N--CA 1.456 -0.154 0 CA-C-O 118.871 -0.585 . . . . 5.29 110.978 -177.417 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.462 HG21 ' CD1' ' A' ' 69' ' ' TYR . 4.5 pt -58.43 -55.86 19.96 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.237 0 C-N-CA 119.784 -0.766 . . . . 0.48999999999999999 110.681 178.098 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -53.29 -42.28 66.45 Favored 'General case' 0 C--O 1.225 -0.211 0 CA-C-N 119.568 1.076 . . . . 2.6899999999999999 111.715 179.804 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 32.0 mmtp -70.65 -44.93 66.1 Favored 'General case' 0 CA--C 1.536 0.414 0 O-C-N 121.228 -0.92 . . . . 1.95 110.897 -178.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -66.11 -25.8 72.28 Favored Glycine 0 CA--C 1.53 0.991 0 O-C-N 121.583 -0.698 . . . . 1.01 111.875 176.731 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 7.7 tt -70.38 -53.73 15.38 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 126.915 2.086 . . . . 1.8100000000000001 107.693 172.698 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -51.1 -18.51 0.86 Allowed 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 126.658 1.983 . . . . 3.4199999999999999 113.987 179.114 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -72.74 -16.05 61.66 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.044 1.338 . . . . 4.0300000000000002 113.035 176.365 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 7.1 ptp -68.01 160.28 75.18 Favored Pre-proline 0 CA--C 1.537 0.456 0 CA-C-N 118.934 0.788 . . . . 3.77 111.178 -179.736 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -61.51 134.75 53.06 Favored 'Trans proline' 0 N--CA 1.454 -0.829 0 C-N-CA 121.622 1.548 . . . . 0.57999999999999996 109.287 167.064 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 106.58 -54.16 0.59 Allowed Glycine 0 CA--C 1.529 0.943 0 C-N-CA 124.558 1.075 . . . . 1.0 111.933 174.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 56.2 t -73.24 113.11 10.58 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 O-C-N 120.912 -1.346 . . . . 0.93000000000000005 110.914 -173.776 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -80.83 -48.08 12.93 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-O 117.745 -1.122 . . . . 1.1699999999999999 108.712 -179.505 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -140.65 156.93 46.11 Favored 'General case' 0 C--N 1.342 0.264 0 CA-C-N 119.249 0.931 . . . . 2.2599999999999998 110.496 -177.478 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -154.96 148.56 25.33 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 112.23 0.455 . . . . 0.44 112.23 179.08 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -155.93 124.14 5.78 Favored 'General case' 0 C--N 1.342 0.245 0 N-CA-C 108.75 -0.833 . . . . 0.45000000000000001 108.75 -165.487 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.936 HG22 HD23 ' A' ' 41' ' ' LEU . 6.6 p -93.13 107.46 19.17 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 C-N-CA 123.694 0.798 . . . . 0.53000000000000003 109.614 -177.658 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 52.8 t-20 -88.89 58.36 4.56 Favored 'General case' 0 C--O 1.238 0.469 0 O-C-N 120.492 -1.38 . . . . 0.60999999999999999 109.364 -177.809 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.936 HD23 HG22 ' A' ' 39' ' ' VAL . 0.3 OUTLIER -68.27 -19.43 64.71 Favored 'General case' 0 N--CA 1.457 -0.114 0 CA-C-N 114.459 -1.246 . . . . 0.87 111.393 -175.223 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -45.85 -35.77 4.75 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 123.601 0.76 . . . . 0.68000000000000005 111.922 166.778 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 5.3 t -124.58 34.47 5.01 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.063 0.545 . . . . 1.3100000000000001 109.856 173.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 51.79 25.71 3.11 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.609 1.564 . . . . 2.7799999999999998 113.547 175.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 6.9 m -113.51 163.83 14.41 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.582 1.153 . . . . 0.63 108.468 -176.603 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.7 p -131.5 144.82 36.39 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.121 0 C-N-CA 124.442 1.097 . . . . 0.33000000000000002 108.947 173.754 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 20.7 m120 -129.55 133.49 47.24 Favored 'General case' 0 C--N 1.342 0.271 0 C-N-CA 124.219 1.008 . . . . 0.33000000000000002 108.399 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 40.1 t -128.74 123.67 59.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 N-CA-C 105.415 -2.069 . . . . 2.0099999999999998 105.415 -177.578 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 13.5 mm -101.46 94.46 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 N-CA-C 106.978 -1.49 . . . . 0.45000000000000001 106.978 -173.372 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 28.8 p90 -135.17 173.82 11.29 Favored 'General case' 0 CA--C 1.508 -0.657 0 O-C-N 122.118 -0.364 . . . . 1.76 111.331 -167.188 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 47.5 p-10 -97.12 109.03 47.52 Favored Pre-proline 0 N--CA 1.447 -0.61 0 O-C-N 124.703 1.252 . . . . 4.0899999999999999 112.425 -175.776 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -69.26 13.93 0.24 Allowed 'Trans proline' 0 CA--C 1.544 1.017 0 C-N-CA 121.43 1.42 . . . . 1.0700000000000001 113.241 178.132 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -99.4 -31.33 11.72 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 125.508 1.523 . . . . 1.0600000000000001 110.841 170.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -114.82 -55.1 2.52 Favored 'General case' 0 C--N 1.345 0.376 0 CA-C-N 118.663 0.665 . . . . 2.9500000000000002 109.533 -177.865 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.441 1.3 p -83.12 -179.81 7.53 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 114.047 1.128 . . . . 0.58999999999999997 114.047 160.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 135.09 93.09 0.42 Allowed Glycine 0 N--CA 1.445 -0.75 0 N-CA-C 104.512 -3.435 . . . . 2.29 104.512 -148.587 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 46.1 p -16.45 -17.44 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.462 1 C-N-CA 138.843 6.857 . . . . 1.3700000000000001 119.685 -151.025 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -27.32 -63.38 0.09 Allowed 'General case' 0 N--CA 1.442 -0.83 0 C-N-CA 126.477 1.911 . . . . 0.56999999999999995 113.966 163.784 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.14 -37.07 64.16 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 118.935 -1.106 . . . . 0.46000000000000002 109.143 -168.397 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 5.9 mt -53.66 -56.53 8.38 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.616 0 C-N-CA 125.5 1.52 . . . . 1.3600000000000001 110.862 174.623 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.92 -46.02 92.33 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 119.506 1.048 . . . . 1.23 109.665 -179.104 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 -49.58 -59.76 3.48 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 122.002 0.906 . . . . 3.3999999999999999 111.617 176.565 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 6.2 mmmt -67.05 -35.6 80.23 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-O 118.068 -0.968 . . . . 3.3199999999999998 111.346 -177.643 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.1 mm -49.54 -54.56 6.42 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 N-CA-C 108.106 -1.072 . . . . 0.40000000000000002 108.106 175.096 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -58.92 -53.96 52.52 Favored 'General case' 0 C--N 1.34 0.162 0 C-N-CA 123.33 0.652 . . . . 1.8899999999999999 109.952 176.134 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.25 -28.77 67.01 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 113.199 0.814 . . . . 5.5499999999999998 113.199 -177.286 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 20.5 mt -73.49 -18.19 61.14 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.973 1.309 . . . . 0.69999999999999996 111.603 175.062 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 89.96 39.39 6.15 Favored Glycine 0 CA--C 1.524 0.634 0 C-N-CA 124.664 1.126 . . . . 0.41999999999999998 110.345 -178.104 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.462 ' CD1' HG21 ' A' ' 24' ' ' ILE . 0.2 OUTLIER -134.59 175.65 9.34 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 123.756 0.823 . . . . 1.8300000000000001 110.415 -179.631 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -143.19 138.77 29.96 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 107.406 -1.331 . . . . 2.25 107.406 171.947 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 9.2 p -117.98 133.32 65.17 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 C-N-CA 125.212 1.405 . . . . 1.3700000000000001 107.864 178.511 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 41.9 t -100.85 140.92 18.53 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 C-N-CA 125.956 1.702 . . . . 0.58999999999999997 109.01 -179.651 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 21.7 mm -99.38 69.82 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 C-N-CA 124.078 0.951 . . . . 0.93000000000000005 108.755 -174.293 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -123.95 4.33 8.7 Favored 'General case' 0 N--CA 1.44 -0.956 0 C-N-CA 127.596 2.359 . . . . 4.2699999999999996 112.149 174.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -85.64 -50.25 4.06 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 111.781 -0.527 . . . . 4.9299999999999997 111.781 -176.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.109 0 N-CA-C 105.532 -2.025 . . . . 9.4100000000000001 105.532 -170.672 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.472 0.669 0 N-CA-C 108.444 -0.947 . . . . 11.67 108.444 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.436 ' H ' HD23 ' A' ' 2' ' ' LEU . 0.8 OUTLIER -81.89 172.4 13.36 Favored 'General case' 0 CA--C 1.531 0.24 0 O-C-N 124.39 1.056 . . . . 5.0999999999999996 108.284 163.63 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 75.82 89.91 0.08 Allowed 'General case' 0 CA--C 1.529 0.171 0 N-CA-C 107.797 -1.186 . . . . 1.04 107.797 -173.291 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -71.73 153.37 42.06 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 107.037 -1.468 . . . . 3.8700000000000001 107.037 171.671 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.33 148.61 44.83 Favored 'General case' 0 CA--C 1.518 -0.28 0 C-N-CA 123.602 0.761 . . . . 0.98999999999999999 110.146 -177.346 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 7.0 mtpm? -141.01 159.97 41.07 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 122.157 0.979 . . . . 3.6200000000000001 111.756 166.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -108.39 104.25 13.57 Favored 'General case' 0 N--CA 1.434 -1.238 0 C-N-CA 130.755 3.622 . . . . 1.95 103.919 -176.284 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 5.6 mm -88.68 160.09 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.35 0 N-CA-C 106.982 -1.488 . . . . 1.9099999999999999 106.982 172.401 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -124.98 137.93 54.24 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 106.517 -1.66 . . . . 0.54000000000000004 106.517 169.524 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 57.9 mtt -144.37 166.16 25.89 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 118.412 0.551 . . . . 2.79 109.659 173.659 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 11.6 mm100 -88.56 155.4 19.66 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 125.176 1.391 . . . . 2.3500000000000001 109.945 175.567 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 99.3 t -112.34 138.75 40.19 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 C-N-CA 123.935 0.894 . . . . 1.4199999999999999 110.259 -179.697 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 73.3 m -137.84 165.19 27.08 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.814 1.245 . . . . 1.0900000000000001 109.938 172.376 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 65.73 72.16 0.78 Allowed Glycine 0 CA--C 1.527 0.836 0 N-CA-C 110.891 -0.884 . . . . 1.71 110.891 176.276 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -152.56 158.14 42.06 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 123.739 0.816 . . . . 1.95 109.843 -173.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -105.09 -56.72 2.13 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 124.996 1.319 . . . . 2.4399999999999999 110.463 168.539 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 31.7 p -127.91 156.68 42.23 Favored 'General case' 0 C--N 1.34 0.175 0 CA-C-O 121.814 0.816 . . . . 2.23 111.504 -170.623 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -76.33 53.09 0.81 Allowed 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.771 0.829 . . . . 1.75 110.401 176.876 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -151.49 -50.36 0.12 Allowed 'General case' 0 C--O 1.232 0.136 0 C-N-CA 123.131 0.572 . . . . 0.72999999999999998 111.645 -174.686 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 5.8 p -56.04 -39.18 71.59 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 119.348 0.976 . . . . 2.4300000000000002 109.7 168.316 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.573 ' HB1' HG21 ' A' ' 39' ' ' VAL . . . -50.32 -23.28 2.22 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.869 1.267 . . . . 0.41999999999999998 113.9 171.238 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -72.09 -47.14 53.55 Favored 'General case' 0 N--CA 1.453 -0.3 0 O-C-N 120.447 -1.408 . . . . 0.37 110.133 171.41 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -57.98 -36.56 72.77 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-O 118.961 -0.543 . . . . 4.1900000000000004 110.612 -174.792 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.573 ' HA ' HD13 ' A' ' 67' ' ' LEU . 2.6 pt -59.68 -55.45 23.82 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.203 0 C-N-CA 119.578 -0.849 . . . . 0.56000000000000005 110.67 178.458 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -57.49 -47.03 82.98 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 123.286 0.634 . . . . 3.2799999999999998 111.294 178.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 14.7 mptt -66.61 -45.86 77.77 Favored 'General case' 0 CA--C 1.532 0.273 0 O-C-N 121.62 -0.675 . . . . 1.73 109.864 -176.192 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -67.75 -23.87 74.07 Favored Glycine 0 CA--C 1.527 0.795 0 CA-C-O 119.04 -0.867 . . . . 0.66000000000000003 111.957 176.657 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -73.57 -41.23 63.19 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.715 1.206 . . . . 2.4300000000000002 109.753 170.732 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 2.1 ttpp -56.71 -16.39 6.29 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.78 1.632 . . . . 2.9199999999999999 113.86 178.686 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.4 mmt180 -83.33 -7.44 59.58 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 126.547 1.939 . . . . 3.6800000000000002 112.338 176.865 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 96.1 mmm -77.99 150.89 78.59 Favored Pre-proline 0 C--O 1.233 0.209 0 CA-C-N 119.226 0.921 . . . . 3.1800000000000002 111.35 -179.133 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -56.56 135.37 69.97 Favored 'Trans proline' 0 N--CA 1.45 -1.064 0 C-N-CA 121.953 1.769 . . . . 0.59999999999999998 108.973 171.225 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 89.12 -9.66 76.0 Favored Glycine 0 CA--C 1.525 0.716 0 CA-C-O 118.079 -1.401 . . . . 0.54000000000000004 113.738 178.081 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 23.4 t -103.78 122.66 56.75 Favored 'Isoleucine or valine' 0 C--N 1.342 0.269 0 CA-C-N 120.349 2.074 . . . . 0.60999999999999999 109.636 176.459 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -89.38 -55.41 3.67 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-O 118.611 -0.709 . . . . 1.3200000000000001 109.151 177.127 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -139.61 156.97 46.55 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 118.875 0.761 . . . . 2.6099999999999999 110.425 -175.413 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -155.6 143.75 20.02 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 122.99 0.516 . . . . 0.41999999999999998 111.164 -174.549 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -155.35 114.39 3.58 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 109.531 -0.544 . . . . 0.58999999999999997 109.531 -165.576 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.573 HG21 ' HB1' ' A' ' 21' ' ' ALA . 4.0 p -81.25 116.7 25.99 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 N-CA-C 108.697 -0.853 . . . . 0.55000000000000004 108.697 175.814 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 50.1 t-20 -96.15 57.61 1.76 Allowed 'General case' 0 C--O 1.236 0.378 0 CA-C-O 122.961 1.362 . . . . 0.60999999999999999 107.869 177.659 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.402 HD23 HG22 ' A' ' 39' ' ' VAL . 0.2 OUTLIER -69.35 -18.47 63.8 Favored 'General case' 0 C--O 1.225 -0.203 0 CA-C-N 114.265 -1.334 . . . . 0.95999999999999996 110.419 -173.584 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -46.56 -31.14 2.61 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 124.072 0.949 . . . . 0.56999999999999995 112.502 169.045 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 6.1 t -129.59 33.4 4.48 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 122.787 0.435 . . . . 1.27 110.007 173.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 25.6 mp0 57.17 29.97 17.55 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.02 1.328 . . . . 3.6400000000000001 113.279 175.206 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 62.0 m -118.39 159.62 23.13 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.47 1.108 . . . . 0.68999999999999995 109.241 -176.136 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.6 p -128.72 143.75 40.16 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 O-C-N 121.21 -0.931 . . . . 0.33000000000000002 108.71 171.539 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -132.85 128.74 37.33 Favored 'General case' 0 C--N 1.342 0.263 0 N-CA-C 108.125 -1.065 . . . . 0.41999999999999998 108.125 -178.52 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 4.7 p -129.82 128.23 65.01 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.595 0 N-CA-C 106.054 -1.832 . . . . 1.75 106.054 -172.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 11.2 mm -105.27 88.65 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 C-N-CA 125.653 1.581 . . . . 0.42999999999999999 107.168 -174.336 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 31.3 p90 -125.8 175.3 7.73 Favored 'General case' 0 CA--C 1.512 -0.493 0 O-C-N 122.106 -0.371 . . . . 1.72 110.059 -173.012 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -102.43 100.61 16.31 Favored Pre-proline 0 N--CA 1.445 -0.693 0 C-N-CA 125.197 1.399 . . . . 4.2000000000000002 108.688 -176.309 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_endo -72.01 14.39 0.44 Allowed 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 122.288 1.992 . . . . 0.60999999999999999 113.911 -176.085 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -81.77 -30.96 32.12 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 108.92 -0.77 . . . . 0.81999999999999995 108.92 162.717 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -114.26 -62.61 1.57 Allowed 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 123.769 0.828 . . . . 3.77 108.856 -166.678 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.468 0.6 OUTLIER -77.11 -179.25 5.47 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 114.985 1.476 . . . . 0.51000000000000001 114.985 162.483 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 179.99 -150.32 9.13 Favored Glycine 0 N--CA 1.431 -1.7 1 N-CA-C 102.717 -4.153 . . . . 2.54 102.717 -172.46 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 20.7 p -72.54 -36.75 68.34 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 124.569 1.148 . . . . 1.3200000000000001 108.75 175.385 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -42.07 -63.05 0.8 Allowed 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 126.136 1.775 . . . . 0.55000000000000004 113.409 -171.69 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -72.0 -38.79 69.59 Favored 'General case' 0 CA--C 1.515 -0.378 0 C-N-CA 118.483 -1.287 . . . . 0.62 109.032 -170.169 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.3 mp -54.46 -55.93 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.931 0 CA-C-N 115.014 -0.994 . . . . 0.77000000000000002 109.663 178.834 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.2 -46.08 85.49 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 119.094 0.861 . . . . 1.1299999999999999 109.991 -176.481 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -47.54 -57.58 5.25 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 122.664 1.221 . . . . 2.6299999999999999 110.676 175.573 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 11.5 mmmt -68.3 -37.26 80.44 Favored 'General case' 0 N--CA 1.437 -1.121 0 CA-C-N 115.409 -0.814 . . . . 3.77 111.974 -177.122 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.3 mm -52.34 -53.08 20.96 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 N-CA-C 107.937 -1.134 . . . . 0.38 107.937 176.787 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 21.1 mm-40 -59.32 -56.58 20.22 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.702 0.801 . . . . 1.9299999999999999 110.404 176.698 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 5.8 mmmt -54.81 -37.28 65.91 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 113.29 0.848 . . . . 4.7000000000000002 113.29 -178.482 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.573 HD13 ' HA ' ' A' ' 24' ' ' ILE . 11.4 mt -71.14 -18.15 62.52 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.542 1.137 . . . . 0.65000000000000002 111.883 175.855 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 93.58 44.17 3.76 Favored Glycine 0 CA--C 1.525 0.659 0 C-N-CA 124.581 1.086 . . . . 0.41999999999999998 110.799 176.748 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.459 ' CD1' HG21 ' A' ' 24' ' ' ILE . 0.3 OUTLIER -139.98 172.85 12.18 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 124.033 0.933 . . . . 1.8100000000000001 110.588 -176.635 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -139.98 118.04 11.87 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 109.086 -0.709 . . . . 1.8999999999999999 109.086 173.774 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 5.7 p -91.49 147.74 5.07 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 N-CA-C 107.892 -1.151 . . . . 1.3999999999999999 107.892 172.058 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 41.2 t -123.26 141.52 43.26 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.102 0 C-N-CA 124.574 1.15 . . . . 0.60999999999999999 108.691 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 4.8 mp -107.46 79.27 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 C-N-CA 124.052 0.941 . . . . 1.3600000000000001 108.47 -173.353 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -77.91 3.59 14.15 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.592 1.557 . . . . 2.9399999999999999 114.565 177.735 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 61.68 72.57 0.62 Allowed Glycine 0 CA--C 1.53 1.028 0 N-CA-C 110.692 -0.963 . . . . 3.2400000000000002 110.692 178.476 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.253 1.265 0 C-N-CA 126.918 2.087 . . . . 11.48 105.503 178.354 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 82.4 mtp . . . . . 0 N--CA 1.473 0.713 0 N-CA-C 106.905 -1.517 . . . . 9.2200000000000006 106.905 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -102.42 159.81 15.1 Favored 'General case' 0 C--O 1.23 0.063 0 O-C-N 124.149 0.905 . . . . 4.7699999999999996 109.021 175.747 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 11.5 m -92.92 108.48 20.03 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 124.746 1.219 . . . . 0.89000000000000001 108.457 176.837 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -72.24 165.47 24.37 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 108.918 -0.771 . . . . 2.7200000000000002 108.918 163.342 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -124.02 151.9 43.21 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 124.91 1.284 . . . . 1.0900000000000001 111.02 -177.2 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.3 mmpt? -137.81 157.12 47.1 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 122.938 0.495 . . . . 4.0599999999999996 110.22 165.26 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -104.24 97.95 7.83 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 127.799 2.439 . . . . 1.9199999999999999 106.28 177.846 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 10.0 mm -87.01 160.02 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.258 0 N-CA-C 107.378 -1.342 . . . . 2.1200000000000001 107.378 177.833 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -131.5 139.03 49.21 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 125.71 1.604 . . . . 0.47999999999999998 107.566 178.33 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 12.5 ptp -156.43 175.19 14.34 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.129 0.571 . . . . 1.8700000000000001 110.132 179.059 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 29.9 mm100 -99.44 162.57 12.96 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 125.265 1.426 . . . . 2.4700000000000002 109.545 179.057 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.425 HG13 HG11 ' A' ' 46' ' ' VAL . 0.0 OUTLIER -130.54 157.08 42.93 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.146 0 C-N-CA 124.343 1.057 . . . . 2.0699999999999998 110.261 176.499 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 62.0 m -146.4 164.7 31.61 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 124.465 1.106 . . . . 0.94999999999999996 109.343 177.109 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 70.53 68.37 1.65 Allowed Glycine 0 CA--C 1.526 0.756 0 N-CA-C 110.02 -1.232 . . . . 1.52 110.02 179.49 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -144.82 165.27 28.58 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 123.723 0.809 . . . . 1.7 110.065 -178.312 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.1 p -113.88 -72.1 0.72 Allowed 'General case' 0 CA--C 1.527 0.068 0 C-N-CA 124.438 1.095 . . . . 2.3700000000000001 108.939 168.29 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 14.4 p -105.82 152.22 23.51 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 121.781 0.801 . . . . 2.0899999999999999 112.023 -173.371 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -75.54 54.5 0.76 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.379 1.072 . . . . 1.9399999999999999 110.527 176.51 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -146.87 -49.09 0.19 Allowed 'General case' 0 CA--C 1.526 0.045 0 C-N-CA 123.774 0.829 . . . . 0.87 110.597 -179.317 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 61.9 m -56.99 -36.89 70.91 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 118.67 0.668 . . . . 1.26 110.638 172.657 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.77 ' HB1' HG21 ' A' ' 39' ' ' VAL . . . -50.3 -26.71 5.1 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.758 0.823 . . . . 0.40999999999999998 112.595 171.65 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.45 -48.24 50.63 Favored 'General case' 0 N--CA 1.452 -0.328 0 O-C-N 120.162 -1.586 . . . . 0.37 109.204 174.017 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 61.7 mtt85 -54.36 -42.86 70.77 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 123.542 0.737 . . . . 5.2000000000000002 109.885 -175.249 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.488 HG21 ' CD1' ' A' ' 69' ' ' TYR 0.258 2.1 pt -58.56 -57.8 9.41 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 C-N-CA 120.044 -0.662 . . . . 0.5 110.478 177.478 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -53.1 -40.28 64.0 Favored 'General case' 0 C--O 1.224 -0.28 0 CA-C-N 118.839 0.745 . . . . 2.1899999999999999 111.632 178.248 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 4.1 mptp? -71.32 -48.31 51.33 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 119.446 1.021 . . . . 1.6699999999999999 111.041 -177.455 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -60.87 -36.43 92.01 Favored Glycine 0 CA--C 1.529 0.962 0 N-CA-C 110.897 -0.881 . . . . 0.56000000000000005 110.897 175.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 8.4 tt -62.54 -49.49 75.1 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 124.739 1.216 . . . . 1.8300000000000001 107.971 175.082 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -57.14 -22.77 42.52 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 124.582 1.153 . . . . 3.4100000000000001 113.062 178.816 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.7 mmt180 -72.65 -10.99 60.45 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.956 0.902 . . . . 3.4700000000000002 112.309 175.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' MET . . . . . 0.45 ' CE ' ' HB3' ' A' ' 59' ' ' ALA . 3.1 ptt? -75.79 153.64 85.14 Favored Pre-proline 0 CA--C 1.533 0.302 0 CA-C-N 119.071 0.85 . . . . 4.7599999999999998 111.692 -179.358 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -60.86 136.08 63.76 Favored 'Trans proline' 0 N--CA 1.451 -0.995 0 C-N-CA 121.589 1.526 . . . . 0.77000000000000002 108.972 172.135 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 100.15 -28.79 14.06 Favored Glycine 0 CA--C 1.53 1.003 0 CA-C-O 118.504 -1.164 . . . . 0.68000000000000005 112.978 177.877 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 24.8 t -95.52 123.16 47.57 Favored 'Isoleucine or valine' 0 C--N 1.346 0.422 0 CA-C-N 119.62 1.71 . . . . 0.68999999999999995 111.185 176.775 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 86.9 m -90.32 -53.65 4.36 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-O 117.858 -1.068 . . . . 1.2 110.378 -179.007 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -135.97 158.11 45.2 Favored 'General case' 0 C--N 1.343 0.318 0 CA-C-N 119.576 1.08 . . . . 2.4500000000000002 110.698 177.235 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -156.91 148.17 22.11 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 114.38 1.252 . . . . 0.47999999999999998 114.38 177.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -155.15 113.19 3.44 Favored 'General case' 0 C--N 1.344 0.365 0 N-CA-C 107.241 -1.392 . . . . 0.48999999999999999 107.241 -162.328 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.77 HG21 ' HB1' ' A' ' 21' ' ' ALA . 6.4 p -82.36 114.68 23.62 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 N-CA-C 108.952 -0.758 . . . . 0.52000000000000002 108.952 178.855 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -94.05 57.93 2.48 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 122.994 1.378 . . . . 2.0600000000000001 108.718 -178.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.69 HD23 HG22 ' A' ' 39' ' ' VAL . 0.2 OUTLIER -66.85 -17.54 64.94 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 114.361 -1.291 . . . . 0.85999999999999999 111.094 -177.342 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -41.29 -39.7 1.46 Allowed 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 124.901 1.28 . . . . 0.67000000000000004 112.747 168.605 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 9.1 t -127.43 35.88 4.47 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 117.666 0.212 . . . . 1.24 110.621 172.094 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 61.54 36.23 17.04 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.462 1.105 . . . . 4.3700000000000001 113.195 173.162 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 4.8 m -123.5 161.21 25.33 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.051 1.34 . . . . 0.73999999999999999 109.369 -176.545 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.425 HG11 HG13 ' A' ' 12' ' ' VAL . 0.8 OUTLIER -127.68 144.18 38.35 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 C-N-CA 124.423 1.089 . . . . 0.64000000000000001 108.417 172.898 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -131.83 145.04 51.33 Favored 'General case' 0 C--N 1.347 0.491 0 N-CA-C 108.327 -0.99 . . . . 0.45000000000000001 108.327 177.108 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 5.4 p -145.46 125.24 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 N-CA-C 106.642 -1.614 . . . . 1.79 106.642 -172.262 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 9.6 mm -105.79 83.53 0.72 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.49 0 C-N-CA 126.286 1.834 . . . . 0.46000000000000002 106.984 -171.029 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 51.6 p90 -119.56 175.9 5.62 Favored 'General case' 0 CA--C 1.506 -0.731 0 N-CA-C 109.197 -0.668 . . . . 1.97 109.197 -172.702 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -101.65 95.26 5.07 Favored Pre-proline 0 N--CA 1.443 -0.78 0 O-C-N 124.813 1.321 . . . . 4.2999999999999998 110.199 -176.263 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -74.49 14.7 0.74 Allowed 'Trans proline' 0 CA--C 1.537 0.661 0 C-N-CA 122.833 2.355 . . . . 0.93999999999999995 113.56 -173.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -89.09 -21.79 23.21 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 124.021 0.928 . . . . 1.48 109.5 166.117 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -113.63 -62.19 1.63 Allowed 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 125.212 1.405 . . . . 3.52 107.723 -175.497 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.285 0.7 OUTLIER -82.62 -179.75 7.53 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 115.223 1.564 . . . . 0.78000000000000003 115.223 170.319 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -163.53 -128.42 0.95 Allowed Glycine 0 N--CA 1.434 -1.496 0 N-CA-C 104.164 -3.574 . . . . 2.5899999999999999 104.164 175.525 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 18.3 p -81.82 -30.54 32.14 Favored 'General case' 0 C--N 1.318 -0.792 0 C-N-CA 126.874 2.07 . . . . 1.3400000000000001 110.636 172.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -53.2 -62.44 1.65 Allowed 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 124.327 1.051 . . . . 0.62 112.769 -157.598 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.45 ' HB3' ' CE ' ' A' ' 31' ' ' MET . . . -75.14 -24.58 57.99 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 113.931 -1.486 . . . . 0.77000000000000002 110.285 -172.644 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.5 mt -66.85 -49.16 76.68 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 C-N-CA 124.341 1.056 . . . . 1.3 109.576 -178.914 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.18 -43.94 93.55 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 107.806 -1.183 . . . . 1.9299999999999999 107.806 -177.501 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -48.5 -59.64 3.32 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 123.833 0.853 . . . . 2.7599999999999998 111.032 172.596 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 10.3 mmtp -60.65 -42.37 96.83 Favored 'General case' 0 N--CA 1.441 -0.912 0 O-C-N 121.712 -0.617 . . . . 3.0600000000000001 111.716 -178.777 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -48.82 -54.69 4.57 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 C-N-CA 125.007 1.323 . . . . 0.44 108.745 176.345 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 29.5 mm-40 -60.9 -53.85 52.3 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 123.481 0.712 . . . . 1.9099999999999999 110.197 178.274 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -56.15 -38.41 70.82 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 112.668 0.618 . . . . 4.2000000000000002 112.668 -176.382 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 15.9 mt -69.98 -17.06 63.27 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.617 1.167 . . . . 0.67000000000000004 111.911 176.611 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 92.86 41.36 4.69 Favored Glycine 0 CA--C 1.522 0.513 0 N-CA-C 110.73 -0.948 . . . . 0.51000000000000001 110.73 175.812 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.488 ' CD1' HG21 ' A' ' 24' ' ' ILE . 0.2 OUTLIER -133.81 175.3 9.58 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 123.672 0.789 . . . . 2.1000000000000001 110.145 178.993 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 4.2 t60 -139.34 143.73 37.93 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 109.162 -0.681 . . . . 1.71 109.162 170.276 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 12.4 p -112.84 150.07 15.11 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 C-N-CA 126.385 1.874 . . . . 1.9299999999999999 107.987 -175.808 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 13.5 t -132.33 147.67 32.05 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 C-N-CA 124.283 1.033 . . . . 0.56000000000000005 108.301 -179.493 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 4.6 mp -127.1 82.29 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 C-N-CA 124.609 1.163 . . . . 1.45 108.567 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -77.83 -2.36 36.13 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 124.809 1.244 . . . . 3.27 113.536 170.094 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -92.59 -31.91 8.49 Favored Glycine 0 CA--C 1.526 0.735 0 C-N-CA 124.208 0.908 . . . . 2.7200000000000002 113.478 -169.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 23.9 ttt85 . . . . . 0 C--O 1.249 1.077 0 CA-C-O 117.18 -1.39 . . . . 10.75 109.628 -177.132 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 56.7 mtt . . . . . 0 N--CA 1.473 0.724 0 N-CA-C 108.777 -0.823 . . . . 9.7799999999999994 108.777 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -151.61 166.34 31.54 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 108.18 -1.044 . . . . 5.6200000000000001 108.18 177.102 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.4 m -127.1 115.76 19.65 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 106.077 -1.823 . . . . 0.68999999999999995 106.077 167.224 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -70.82 173.75 6.93 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 107.774 -1.195 . . . . 2.1000000000000001 107.774 163.33 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -129.3 151.53 49.85 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 123.491 0.717 . . . . 1.7 109.099 172.621 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 69.6 mmtt -140.92 157.72 44.97 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.213 1.005 . . . . 3.1800000000000002 111.07 166.818 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -116.21 91.79 3.7 Favored 'General case' 0 N--CA 1.435 -1.181 0 C-N-CA 128.226 2.61 . . . . 1.46 106.61 -168.442 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 8.0 mm -82.41 158.48 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.261 0 N-CA-C 106.977 -1.49 . . . . 1.9399999999999999 106.977 -178.178 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -131.44 139.01 49.29 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 107.093 -1.447 . . . . 0.62 107.093 172.112 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -155.43 176.28 12.79 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 122.992 0.517 . . . . 1.8200000000000001 109.738 170.541 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 27.4 mm100 -95.35 165.37 12.41 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.627 1.171 . . . . 2.6099999999999999 110.152 -178.594 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 31.6 t -128.44 132.19 68.26 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 C-N-CA 124.597 1.159 . . . . 1.1599999999999999 109.804 -174.111 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 32.9 m -117.74 176.29 5.26 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 125.195 1.398 . . . . 0.89000000000000001 109.348 169.691 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 82.15 -44.88 3.23 Favored Glycine 0 CA--C 1.53 0.994 0 O-C-N 121.553 -0.717 . . . . 2.2400000000000002 111.603 178.862 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -44.52 142.18 1.71 Allowed 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 124.121 0.968 . . . . 2.27 112.691 176.066 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -147.71 -45.71 0.16 Allowed 'General case' 0 CA--C 1.53 0.173 0 C-N-CA 124.559 1.144 . . . . 3.2400000000000002 110.432 171.787 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 24.3 p -71.16 -16.58 62.54 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 112.616 0.599 . . . . 3.04 112.616 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 59.97 28.32 17.82 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.808 1.243 . . . . 2.0499999999999998 112.209 -179.193 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -130.66 -51.9 1.07 Allowed 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 124.609 1.164 . . . . 0.90000000000000002 110.252 -179.605 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 52.5 m -51.06 -31.68 19.49 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 125.145 1.378 . . . . 1.6399999999999999 112.548 172.174 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.5 -26.38 31.14 Favored 'General case' 0 CA--C 1.539 0.548 0 O-C-N 121.885 -0.509 . . . . 0.40999999999999998 111.865 173.302 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.02 -46.4 62.2 Favored 'General case' 0 N--CA 1.454 -0.248 0 O-C-N 120.304 -1.497 . . . . 0.38 110.638 169.832 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 8.9 mtt85 -51.68 -44.69 63.17 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-O 119.171 -0.443 . . . . 3.6600000000000001 110.346 -177.257 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.425 HG21 ' CD1' ' A' ' 69' ' ' TYR 0.262 2.3 pt -59.76 -55.4 24.2 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.201 0 C-N-CA 119.642 -0.823 . . . . 0.64000000000000001 111.217 -178.954 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -55.67 -42.63 75.38 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-N 118.693 0.679 . . . . 2.1600000000000001 112.08 177.454 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -70.88 -46.84 61.88 Favored 'General case' 0 CA--C 1.533 0.294 0 O-C-N 121.68 -0.637 . . . . 1.8200000000000001 110.078 -175.158 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -58.38 -44.38 95.23 Favored Glycine 0 CA--C 1.527 0.815 0 N-CA-C 110.127 -1.189 . . . . 0.72999999999999998 110.127 173.35 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -61.65 -43.14 99.41 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.688 0.795 . . . . 2.3900000000000001 109.486 -179.475 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 7.3 ttmt -51.98 -29.87 22.47 Favored 'General case' 0 CA--C 1.531 0.237 0 O-C-N 121.036 -1.04 . . . . 2.77 111.595 173.638 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.84 -0.75 19.45 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-O 118.065 -0.969 . . . . 4.4100000000000001 113.352 -175.806 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 93.8 mmm -89.05 152.7 48.57 Favored Pre-proline 0 CA--C 1.535 0.393 0 C-N-CA 126.738 2.015 . . . . 3.5 111.164 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -60.08 138.92 84.87 Favored 'Trans proline' 0 N--CA 1.453 -0.901 0 C-N-CA 122.236 1.958 . . . . 0.73999999999999999 109.547 175.786 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 97.29 -30.99 8.2 Favored Glycine 0 CA--C 1.523 0.588 0 CA-C-O 119.0 -0.889 . . . . 0.47999999999999998 112.536 179.478 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 16.3 t -92.04 140.19 16.59 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.212 0 CA-C-N 119.241 1.521 . . . . 0.62 109.114 -179.103 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -119.43 -42.79 2.64 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 118.273 -0.87 . . . . 0.98999999999999999 111.129 179.798 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -138.73 161.85 36.15 Favored 'General case' 0 CA--C 1.518 -0.278 0 CA-C-N 119.838 1.199 . . . . 2.1299999999999999 111.433 171.693 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -157.68 138.94 13.56 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 123.125 0.57 . . . . 0.47999999999999998 111.018 -175.467 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -150.13 102.61 3.11 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 106.7 -1.593 . . . . 0.67000000000000004 106.7 -163.057 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 10.4 p -82.13 107.0 13.68 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 CA-C-O 121.252 0.549 . . . . 0.60999999999999999 110.498 -179.201 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 48.9 t30 -84.43 56.82 3.97 Favored 'General case' 0 CA--C 1.537 0.476 0 O-C-N 120.567 -1.333 . . . . 0.93000000000000005 109.992 179.531 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.418 HD22 ' HA ' ' A' ' 41' ' ' LEU . 0.4 OUTLIER -74.93 -16.1 60.66 Favored 'General case' 0 N--CA 1.461 0.101 0 CA-C-N 115.446 -0.797 . . . . 0.92000000000000004 110.422 176.706 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -45.64 -37.37 5.62 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.742 0.817 . . . . 1.27 111.396 167.745 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 15.0 t -98.54 -68.48 0.8 Allowed 'General case' 0 C--N 1.344 0.329 0 CA-C-O 117.703 -1.141 . . . . 3.5600000000000001 110.198 165.512 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 159.93 43.55 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 127.61 2.364 . . . . 2.8599999999999999 110.864 -176.841 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 79.7 m -142.64 162.4 35.56 Favored 'General case' 0 CA--C 1.534 0.333 0 O-C-N 120.464 -1.397 . . . . 0.83999999999999997 108.805 -171.595 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.4 p -125.75 145.92 32.36 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 O-C-N 121.232 -0.917 . . . . 0.45000000000000001 108.981 172.75 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -127.79 143.51 51.12 Favored 'General case' 0 C--N 1.345 0.38 0 N-CA-C 108.017 -1.105 . . . . 0.46999999999999997 108.017 170.835 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.2 p -140.41 127.11 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 N-CA-C 107.226 -1.398 . . . . 1.74 107.226 -176.405 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 18.5 mm -103.5 90.05 1.58 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.604 0 C-N-CA 125.935 1.694 . . . . 0.51000000000000001 107.107 -173.64 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 6.8 p90 -128.82 166.42 19.09 Favored 'General case' 0 CA--C 1.508 -0.669 0 CA-C-O 121.452 0.644 . . . . 1.7 111.751 -174.285 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -96.04 108.99 44.5 Favored Pre-proline 0 N--CA 1.444 -0.736 0 CA-C-N 114.172 -1.376 . . . . 4.2199999999999998 109.187 -172.881 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -73.45 13.97 0.66 Allowed 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 123.009 2.473 . . . . 0.85999999999999999 112.99 -173.523 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -85.23 -35.47 21.57 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 123.823 0.849 . . . . 1.3100000000000001 108.728 166.294 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -109.99 -54.36 2.57 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 108.638 -0.875 . . . . 3.1800000000000002 108.638 -168.816 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.571 HG22 ' HB3' ' A' ' 59' ' ' ALA 0.314 0.9 OUTLIER -86.56 -173.98 4.77 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-O 121.037 0.446 . . . . 0.56999999999999995 111.674 162.594 . . . . . . . . 4 4 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 128.88 88.64 0.56 Allowed Glycine 0 N--CA 1.442 -0.948 0 N-CA-C 103.702 -3.759 . . . . 2.3599999999999999 103.702 -150.379 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 26.5 p -13.75 -18.41 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.499 1 C-N-CA 138.735 6.814 . . . . 1.1699999999999999 119.748 -146.434 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -28.12 -63.36 0.1 Allowed 'General case' 0 N--CA 1.441 -0.877 0 C-N-CA 126.857 2.063 . . . . 0.5 113.841 164.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.571 ' HB3' HG22 ' A' ' 55' ' ' THR . . . -72.02 -41.1 67.94 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 118.098 -1.441 . . . . 0.47999999999999998 109.164 -167.431 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.5 mp -52.32 -54.72 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.845 0 CA-C-N 114.303 -1.317 . . . . 0.85999999999999999 109.146 175.578 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.55 -45.7 85.99 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 118.963 0.801 . . . . 1.6899999999999999 109.294 -175.393 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -52.12 -53.37 43.49 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 122.396 1.093 . . . . 2.9300000000000002 110.27 178.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.414 ' HA ' ' CE ' ' A' ' 63' ' ' LYS . 1.2 mmpt? -70.71 -37.54 73.57 Favored 'General case' 0 N--CA 1.432 -1.363 0 CA-C-O 118.233 -0.889 . . . . 2.4900000000000002 112.369 -177.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.5 mm -47.61 -51.65 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 C-N-CA 124.66 1.184 . . . . 0.40000000000000002 108.233 177.088 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -54.0 -60.31 3.5 Favored 'General case' 0 C--N 1.34 0.182 0 C-N-CA 123.625 0.77 . . . . 2.5499999999999998 110.781 174.315 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -63.71 -29.52 70.73 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 112.679 0.622 . . . . 5.2000000000000002 112.679 -172.241 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 23.8 mt -70.03 -18.35 63.3 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.425 1.49 . . . . 0.75 111.02 172.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 95.32 39.07 4.59 Favored Glycine 0 CA--C 1.524 0.645 0 C-N-CA 124.959 1.266 . . . . 0.39000000000000001 110.937 175.319 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.425 ' CD1' HG21 ' A' ' 24' ' ' ILE . 0.7 OUTLIER -137.74 175.43 9.59 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.605 0.762 . . . . 2.0299999999999998 111.863 -173.104 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 4.3 t-80 -152.08 111.68 3.96 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 125.008 1.323 . . . . 2.3900000000000001 107.495 -176.686 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 3.6 m -82.96 160.99 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.239 0 N-CA-C 108.877 -0.786 . . . . 2.3599999999999999 108.877 169.554 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 21.6 t -122.96 142.12 40.74 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 N-CA-C 108.468 -0.938 . . . . 0.70999999999999996 108.468 176.712 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 45.4 mm -114.23 79.24 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 C-N-CA 125.277 1.431 . . . . 1.25 108.164 -175.69 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -80.37 -0.61 37.67 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 124.38 1.072 . . . . 3.23 113.53 173.054 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -112.27 -19.16 7.27 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 125.212 1.387 . . . . 2.8199999999999998 115.343 -164.221 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 6.4 tpp180 . . . . . 0 C--O 1.25 1.126 0 CA-C-O 116.6 -1.667 . . . . 9.5199999999999996 108.36 178.206 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 44.6 mtt . . . . . 0 N--CA 1.475 0.813 0 N-CA-C 109.137 -0.69 . . . . 8.5299999999999994 109.137 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 173.83 -89.15 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 105.561 -2.014 . . . . 5.6600000000000001 105.561 178.855 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 25.1 m -157.79 139.74 14.13 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 106.499 -1.667 . . . . 0.89000000000000001 106.499 -174.371 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -77.01 179.74 6.05 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 108.817 -0.808 . . . . 2.3599999999999999 108.817 160.521 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -135.38 147.79 49.17 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 106.693 -1.595 . . . . 1.45 106.693 166.576 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 20.0 mmtp -140.53 156.05 46.43 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 123.343 0.657 . . . . 3.5499999999999998 109.921 165.857 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -108.06 99.14 8.6 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 128.011 2.524 . . . . 1.9099999999999999 107.615 -174.763 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.9 mm -82.97 157.44 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.98 0 N-CA-C 107.205 -1.405 . . . . 1.8899999999999999 107.205 177.85 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -135.66 129.99 33.63 Favored 'General case' 0 C--O 1.231 0.112 0 C-N-CA 124.606 1.162 . . . . 0.45000000000000001 107.893 178.653 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 10.0 ptt? -156.16 175.54 13.84 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.019 0.528 . . . . 2.6600000000000001 110.485 -176.015 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -101.2 162.16 13.1 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 127.505 2.322 . . . . 3.77 110.701 -177.787 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 46.1 t -119.34 144.86 26.54 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 C-N-CA 124.436 1.094 . . . . 1.3500000000000001 109.316 -176.418 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 41.3 t -135.72 175.61 9.44 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.767 1.227 . . . . 2.4100000000000001 109.153 173.402 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 51.66 58.16 10.79 Favored Glycine 0 CA--C 1.529 0.917 0 C-N-CA 124.661 1.124 . . . . 1.6799999999999999 111.254 -175.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -134.41 150.64 50.89 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 123.634 0.773 . . . . 1.6899999999999999 110.827 -172.88 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -99.62 -57.21 2.2 Favored 'General case' 0 CA--C 1.528 0.113 0 C-N-CA 125.23 1.412 . . . . 2.3900000000000001 111.204 169.22 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 20.8 p -144.29 165.44 27.89 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 121.808 0.813 . . . . 2.3500000000000001 111.941 -169.664 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -75.64 54.26 0.77 Allowed 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.209 1.404 . . . . 2.0 110.746 178.725 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -147.62 -58.53 0.26 Allowed 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 124.373 1.069 . . . . 0.85999999999999999 108.709 177.558 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 26.8 m -57.15 -40.98 78.29 Favored 'General case' 0 CA--C 1.53 0.186 0 O-C-N 121.994 -0.441 . . . . 1.4399999999999999 110.168 176.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.23 -21.03 7.98 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.801 0.84 . . . . 0.55000000000000004 113.032 174.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.515 ' HA ' HG11 ' A' ' 39' ' ' VAL . . . -72.44 -47.37 49.55 Favored 'General case' 0 N--CA 1.453 -0.298 0 O-C-N 120.667 -1.271 . . . . 0.47999999999999998 110.793 170.545 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 54.4 mmm-85 -53.37 -44.65 68.77 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 109.77 -0.456 . . . . 4.3700000000000001 109.77 -172.129 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.501 ' HA ' HD13 ' A' ' 67' ' ' LEU . 3.5 pt -57.85 -54.02 37.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 CA-C-O 118.69 -0.672 . . . . 0.55000000000000004 110.5 178.333 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -57.14 -40.73 77.74 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.797 0.839 . . . . 2.3799999999999999 112.133 179.452 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 31.9 mmtp -70.7 -43.98 67.87 Favored 'General case' 0 CA--C 1.534 0.358 0 O-C-N 121.414 -0.804 . . . . 1.9199999999999999 110.552 -178.581 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -63.74 -38.68 96.55 Favored Glycine 0 CA--C 1.53 1.019 0 N-CA-C 110.931 -0.868 . . . . 0.51000000000000001 110.931 173.809 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.47 HD23 ' C ' ' A' ' 28' ' ' LEU . 4.8 tt -60.51 -41.54 94.57 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 125.462 1.505 . . . . 1.8500000000000001 109.512 176.774 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 10.7 ttmt -54.41 -23.37 15.55 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 112.592 0.59 . . . . 2.79 112.592 173.759 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.82 -2.58 24.2 Favored 'General case' 0 CA--C 1.542 0.659 0 O-C-N 121.285 -0.884 . . . . 3.6600000000000001 112.19 177.634 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' MET . . . . . 0.415 ' SD ' ' HB1' ' A' ' 59' ' ' ALA . 9.9 mmt -69.78 152.0 96.22 Favored Pre-proline 0 CA--C 1.532 0.273 0 CA-C-N 119.42 1.009 . . . . 3.2799999999999998 111.689 173.054 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -58.22 141.08 96.43 Favored 'Trans proline' 0 N--CA 1.452 -0.932 0 C-N-CA 122.005 1.803 . . . . 0.93999999999999995 109.47 170.809 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 86.13 -27.31 5.62 Favored Glycine 0 CA--C 1.524 0.616 0 CA-C-O 119.436 -0.647 . . . . 0.75 113.849 178.295 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 13.7 t -82.57 127.02 40.05 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 CA-C-N 118.777 1.289 . . . . 0.52000000000000002 108.693 -179.178 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.9 m -110.53 -37.26 5.53 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-O 118.601 -0.714 . . . . 0.85999999999999999 110.889 -175.61 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -148.53 166.94 26.71 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 119.253 0.933 . . . . 1.8400000000000001 110.038 170.333 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -157.25 148.81 22.17 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 123.481 0.712 . . . . 0.57999999999999996 110.507 -175.848 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -154.46 110.28 3.19 Favored 'General case' 0 CA--C 1.529 0.161 0 N-CA-C 108.437 -0.949 . . . . 0.58999999999999997 108.437 -165.258 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.515 HG11 ' HA ' ' A' ' 22' ' ' ALA . 4.7 p -88.44 93.87 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 C-N-CA 124.142 0.977 . . . . 0.81000000000000005 110.37 -178.146 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 52.5 t-20 -82.79 56.79 3.53 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 120.475 -1.391 . . . . 0.60999999999999999 110.224 -178.834 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.436 HD23 ' CG2' ' A' ' 39' ' ' VAL . 0.3 OUTLIER -67.01 -21.34 65.95 Favored 'General case' 0 C--O 1.227 -0.097 0 C-N-CA 123.677 0.791 . . . . 0.89000000000000001 110.33 179.907 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -48.26 -33.78 9.29 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.626 0.77 . . . . 0.63 112.144 170.151 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 3.4 t -121.97 27.66 7.96 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 118.026 0.375 . . . . 1.26 110.424 174.778 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 47.55 58.47 4.92 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 124.824 1.25 . . . . 3.0699999999999998 111.616 -178.096 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 33.2 m -145.44 164.28 32.05 Favored 'General case' 0 N--CA 1.44 -0.927 0 O-C-N 120.713 -1.242 . . . . 0.67000000000000004 107.716 175.785 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.9 p -139.47 145.01 27.7 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 N-CA-C 108.71 -0.848 . . . . 0.47999999999999998 108.71 174.799 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 19.5 m120 -131.8 139.45 48.89 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 124.407 1.083 . . . . 0.27000000000000002 108.481 -176.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 22.3 t -133.59 129.53 55.73 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 N-CA-C 105.796 -1.927 . . . . 2.1200000000000001 105.796 -178.482 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 13.6 mm -105.99 95.23 3.63 Favored 'Isoleucine or valine' 0 C--O 1.24 0.585 0 C-N-CA 124.946 1.298 . . . . 0.44 107.583 -174.902 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 10.8 p90 -131.95 164.48 26.05 Favored 'General case' 0 CA--C 1.513 -0.446 0 O-C-N 122.03 -0.419 . . . . 2.0499999999999998 111.955 -172.172 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 30.9 t0 -81.46 110.78 20.53 Favored Pre-proline 0 CA--C 1.534 0.365 0 O-C-N 124.392 1.057 . . . . 2.8700000000000001 110.134 172.584 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -73.09 5.97 2.79 Favored 'Trans proline' 0 N--CA 1.452 -0.96 0 C-N-CA 123.007 2.472 . . . . 0.56999999999999995 113.124 -178.708 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -87.79 -34.09 18.41 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 119.493 1.042 . . . . 0.75 108.797 169.268 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -99.03 -60.47 1.53 Allowed 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 108.687 -0.857 . . . . 3.0099999999999998 108.687 -174.417 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.566 HG22 ' HB3' ' A' ' 59' ' ' ALA 0.345 0.6 OUTLIER -83.53 -174.86 5.53 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 123.807 0.843 . . . . 0.48999999999999999 112.229 162.05 . . . . . . . . 4 4 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 126.37 94.95 0.94 Allowed Glycine 0 N--CA 1.442 -0.909 0 N-CA-C 103.913 -3.675 . . . . 2.2000000000000002 103.913 -144.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 68.6 p -14.31 -23.52 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.383 1 C-N-CA 138.161 6.584 . . . . 1.04 119.169 -151.749 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -27.47 -62.74 0.09 Allowed 'General case' 0 N--CA 1.443 -0.787 0 C-N-CA 127.177 2.191 . . . . 0.53000000000000003 113.532 167.222 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.566 ' HB3' HG22 ' A' ' 55' ' ' THR . . . -74.54 -39.55 62.25 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 118.732 -1.187 . . . . 0.5 109.72 -166.741 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.2 mp -54.68 -57.67 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.026 0 CA-C-N 113.687 -1.597 . . . . 0.94999999999999996 109.399 176.397 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -60.76 -43.28 98.22 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 118.093 0.406 . . . . 1.46 109.923 -174.482 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -46.86 -58.82 3.54 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.15 0.58 . . . . 2.7400000000000002 111.41 171.85 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 3.4 mmpt? -65.44 -42.82 92.01 Favored 'General case' 0 N--CA 1.442 -0.84 0 O-C-N 121.705 -0.622 . . . . 2.3500000000000001 112.331 -179.304 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -47.1 -54.11 2.86 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 C-N-CA 125.403 1.481 . . . . 0.65000000000000002 107.795 178.11 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -60.54 -57.54 12.29 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 124.559 1.144 . . . . 1.6799999999999999 110.633 177.048 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 11.7 mptt -59.66 -31.41 69.52 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 112.795 0.665 . . . . 5.3200000000000003 112.795 -173.763 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.501 HD13 ' HA ' ' A' ' 24' ' ' ILE . 8.6 mt -67.74 -16.95 64.38 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.307 1.043 . . . . 0.87 112.179 174.634 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 89.84 46.04 4.35 Favored Glycine 0 C--N 1.336 0.58 0 N-CA-C 109.68 -1.368 . . . . 0.66000000000000003 109.68 179.657 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.422 ' CD1' HG21 ' A' ' 24' ' ' ILE . 0.2 OUTLIER -143.72 175.25 10.12 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 124.562 1.145 . . . . 2.1699999999999999 108.678 -176.352 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 7.7 t-160 -145.28 144.48 30.79 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 109.076 -0.713 . . . . 1.8700000000000001 109.076 174.088 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 5.8 p -113.21 144.37 21.0 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 N-CA-C 107.002 -1.481 . . . . 1.53 107.002 179.18 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 5.7 t -122.86 140.81 45.46 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 N-CA-C 107.615 -1.254 . . . . 0.68999999999999995 107.615 -178.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 4.7 mp -108.95 80.16 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.475 0 N-CA-C 107.975 -1.12 . . . . 1.26 107.975 -175.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -66.28 -15.31 63.11 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 113.985 1.106 . . . . 3.96 113.985 172.236 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 78.4 79.08 0.78 Allowed Glycine 0 CA--C 1.526 0.72 0 N-CA-C 109.521 -1.432 . . . . 3.9100000000000001 109.521 -175.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 10.7 tpt180 . . . . . 0 C--O 1.252 1.198 0 C-N-CA 126.998 2.119 . . . . 15.210000000000001 112.597 -176.553 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 55.3 mtt . . . . . 0 N--CA 1.472 0.65 0 N-CA-C 107.045 -1.465 . . . . 10.289999999999999 107.045 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 7.2 mt -85.06 157.01 20.84 Favored 'General case' 0 N--CA 1.456 -0.147 0 O-C-N 124.069 0.856 . . . . 4.3600000000000003 109.078 171.851 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.5 m -59.83 104.71 0.31 Allowed 'General case' 0 N--CA 1.446 -0.67 0 C-N-CA 124.29 1.036 . . . . 0.81999999999999995 108.838 169.328 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -65.94 171.63 4.31 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 108.077 -1.083 . . . . 2.29 108.077 162.211 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -131.5 153.88 49.34 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 124.258 1.023 . . . . 1.0800000000000001 109.673 176.501 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -144.94 160.63 41.01 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 124.725 1.21 . . . . 3.23 109.842 170.803 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -121.25 94.77 4.44 Favored 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 128.082 2.553 . . . . 1.98 106.094 -170.087 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 17.1 mm -82.62 162.05 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.232 0 N-CA-C 107.109 -1.441 . . . . 2.04 107.109 -179.095 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -133.3 140.24 47.33 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 107.068 -1.456 . . . . 0.69999999999999996 107.068 170.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -152.55 175.46 12.74 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 118.522 0.601 . . . . 2.1299999999999999 110.059 172.226 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 22.8 mm100 -98.45 157.99 15.87 Favored 'General case' 0 C--O 1.227 -0.084 0 C-N-CA 124.234 1.014 . . . . 2.6099999999999999 110.049 177.59 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 43.4 t -111.19 162.19 9.01 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 C-N-CA 124.844 1.257 . . . . 1.21 109.612 -174.847 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 58.0 m -149.23 164.47 34.7 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 107.535 -1.283 . . . . 0.93000000000000005 107.535 165.703 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 93.32 -29.97 7.71 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 123.39 0.519 . . . . 2.4700000000000002 112.562 -178.664 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -53.21 108.2 0.31 Allowed 'General case' 0 C--O 1.225 -0.205 0 CA-C-N 118.026 0.913 . . . . 2.27 112.77 178.233 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -155.91 14.18 0.34 Allowed 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 114.299 1.222 . . . . 3.8100000000000001 114.299 178.326 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 8.3 m -104.28 -58.7 1.84 Allowed 'General case' 0 C--O 1.226 -0.163 0 N-CA-C 108.245 -1.021 . . . . 5.0300000000000002 108.245 -175.16 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -172.86 -56.56 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 126.34 1.856 . . . . 5.4900000000000002 106.579 174.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -164.38 32.1 0.07 Allowed 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 113.204 0.816 . . . . 2.0600000000000001 113.204 -168.725 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 95.6 m -58.1 -31.62 67.31 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 121.378 -0.826 . . . . 1.1899999999999999 111.424 174.248 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.57 -25.43 17.13 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.197 0.599 . . . . 0.91000000000000003 112.609 170.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.59 ' HA ' HG11 ' A' ' 39' ' ' VAL . . . -70.26 -48.26 57.61 Favored 'General case' 0 N--CA 1.453 -0.307 0 O-C-N 120.261 -1.525 . . . . 0.65000000000000002 110.204 169.367 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 21.0 mmm180 -55.66 -46.86 77.46 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 109.603 -0.517 . . . . 4.2699999999999996 109.603 -178.116 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.411 HG21 ' CD1' ' A' ' 69' ' ' TYR . 3.0 pt -57.21 -54.96 23.71 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.36 0 C-N-CA 119.816 -0.754 . . . . 0.53000000000000003 110.921 178.242 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -55.68 -40.06 71.81 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 119.097 0.862 . . . . 2.2200000000000002 112.324 -179.511 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -71.13 -46.19 62.08 Favored 'General case' 0 N--CA 1.453 -0.284 0 O-C-N 121.722 -0.611 . . . . 1.8899999999999999 109.707 -176.218 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -60.11 -47.62 90.12 Favored Glycine 0 CA--C 1.528 0.856 0 N-CA-C 110.204 -1.158 . . . . 0.92000000000000004 110.204 172.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.441 HD23 ' C ' ' A' ' 28' ' ' LEU . 6.1 tt -52.97 -42.87 65.92 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.793 1.637 . . . . 1.95 110.118 177.599 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 8.6 ttmt -57.54 -32.36 67.0 Favored 'General case' 0 CA--C 1.535 0.373 0 O-C-N 120.942 -1.099 . . . . 3.4500000000000002 112.917 174.104 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -69.01 -7.53 36.44 Favored 'General case' 0 CA--C 1.536 0.427 0 O-C-N 121.297 -0.877 . . . . 5.6500000000000004 112.551 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 20.5 mmt -79.69 148.45 69.24 Favored Pre-proline 0 CA--C 1.532 0.273 0 CA-C-N 119.019 0.827 . . . . 4.7400000000000002 110.419 -174.129 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -56.11 137.17 78.54 Favored 'Trans proline' 0 N--CA 1.452 -0.966 0 C-N-CA 121.89 1.727 . . . . 0.88 108.746 176.102 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 90.89 -7.15 81.59 Favored Glycine 0 N--CA 1.449 -0.481 0 CA-C-O 117.671 -1.627 . . . . 0.88 114.35 179.725 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.6 t -110.37 135.18 50.2 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 CA-C-N 119.825 1.813 . . . . 0.64000000000000001 109.107 177.294 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 8.4 m -107.45 -49.86 3.18 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 123.442 0.697 . . . . 1.1200000000000001 110.194 -176.532 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -138.96 163.88 31.21 Favored 'General case' 0 C--N 1.343 0.299 0 CA-C-N 118.916 0.78 . . . . 2.0499999999999998 111.456 177.164 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -159.43 144.33 15.5 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 113.152 0.797 . . . . 0.77000000000000002 113.152 -179.389 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -149.7 105.53 3.44 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 107.97 -1.122 . . . . 1.0 107.97 -164.159 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.59 HG11 ' HA ' ' A' ' 22' ' ' ALA . 4.0 p -83.71 100.98 7.72 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 C-N-CA 123.03 0.532 . . . . 1.02 110.521 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 45.1 t30 -82.55 57.4 3.7 Favored 'General case' 0 CA--C 1.538 0.516 0 O-C-N 120.372 -1.455 . . . . 1.05 110.513 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.45 HD23 ' CG2' ' A' ' 39' ' ' VAL . 0.5 OUTLIER -76.33 -12.11 60.01 Favored 'General case' 0 C--O 1.226 -0.178 0 C-N-CA 124.384 1.074 . . . . 1.03 111.156 176.858 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -43.84 -38.0 3.09 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 123.59 0.756 . . . . 1.21 111.215 167.406 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.47 HG23 ' H ' ' A' ' 44' ' ' GLU . 9.2 t -102.1 -75.95 0.59 Allowed 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 118.755 -0.64 . . . . 3.7400000000000002 109.578 163.575 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.47 ' H ' HG23 ' A' ' 43' ' ' THR . 3.0 tt0 179.37 26.76 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.983 1.313 . . . . 3.25 113.375 -177.053 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 91.9 m -128.51 167.35 17.2 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 124.133 0.973 . . . . 0.76000000000000001 108.759 -163.481 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 1.2 p -138.35 145.36 28.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 N-CA-C 108.516 -0.92 . . . . 0.67000000000000004 108.516 179.433 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -131.09 139.7 49.9 Favored 'General case' 0 C--N 1.343 0.297 0 N-CA-C 108.187 -1.042 . . . . 0.56000000000000005 108.187 173.416 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 39.8 t -131.34 127.95 60.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 N-CA-C 105.591 -2.003 . . . . 2.1600000000000001 105.591 179.742 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 13.2 mm -102.44 93.01 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 N-CA-C 106.884 -1.524 . . . . 0.63 106.884 -177.49 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 9.5 p90 -127.01 168.67 14.25 Favored 'General case' 0 CA--C 1.509 -0.632 0 O-C-N 121.964 -0.46 . . . . 1.76 110.663 -170.207 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -99.1 103.44 20.01 Favored Pre-proline 0 N--CA 1.445 -0.716 0 C-N-CA 124.292 1.037 . . . . 4.3899999999999997 109.123 -176.265 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -72.72 10.4 1.06 Allowed 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 123.402 2.734 . . . . 1.0600000000000001 113.723 -172.712 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -86.44 -25.72 25.08 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 108.893 -0.78 . . . . 1.23 108.893 167.898 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -112.42 -55.33 2.53 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 123.816 0.847 . . . . 3.0699999999999998 109.151 -175.46 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.433 HG22 ' HB3' ' A' ' 59' ' ' ALA 0.324 9.5 p -90.57 -160.56 0.72 Allowed 'General case' 0 C--N 1.343 0.288 0 CA-C-O 119.411 -0.328 . . . . 0.68000000000000005 110.76 165.155 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 118.33 88.41 1.23 Allowed Glycine 0 N--CA 1.445 -0.734 0 N-CA-C 104.192 -3.563 . . . . 2.3399999999999999 104.192 -148.648 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 47.0 p -12.51 -18.28 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.419 1 C-N-CA 138.573 6.749 . . . . 1.25 119.53 -147.082 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -27.29 -63.05 0.09 Allowed 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 127.434 2.294 . . . . 0.60999999999999999 114.327 166.091 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.433 ' HB3' HG22 ' A' ' 55' ' ' THR . . . -72.96 -41.1 64.78 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 117.556 -1.657 . . . . 0.55000000000000004 109.196 -168.056 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.1 mp -53.97 -52.49 35.73 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.051 0 CA-C-N 113.821 -1.536 . . . . 0.89000000000000001 109.542 177.041 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.19 -48.1 79.78 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 119.398 0.999 . . . . 1.7 109.046 -176.793 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -47.83 -56.29 7.8 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 122.4 1.095 . . . . 3.29 110.709 176.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.9 mmpt? -70.58 -39.08 74.08 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-O 118.532 -0.747 . . . . 2.6200000000000001 112.063 -176.3 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -45.55 -53.78 1.86 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 C-N-CA 125.142 1.377 . . . . 0.44 108.046 173.412 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -58.46 -59.66 5.01 Favored 'General case' 0 C--N 1.341 0.2 0 C-N-CA 124.058 0.943 . . . . 1.98 110.288 177.568 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -58.73 -31.97 68.79 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 112.84 0.681 . . . . 5.3499999999999996 112.84 -175.337 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 24.8 mt -69.73 -17.23 63.44 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.969 1.308 . . . . 0.65000000000000002 111.295 176.11 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 94.2 41.85 4.17 Favored Glycine 0 CA--C 1.523 0.569 0 C-N-CA 124.642 1.115 . . . . 0.48999999999999999 110.367 176.588 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.411 ' CD1' HG21 ' A' ' 24' ' ' ILE . 0.6 OUTLIER -140.61 171.57 13.93 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 123.909 0.884 . . . . 1.98 110.238 -176.089 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -151.08 141.93 22.88 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 108.306 -0.998 . . . . 2.4700000000000002 108.306 168.567 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.0 m -99.27 165.38 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 C-N-CA 124.891 1.277 . . . . 2.4300000000000002 108.531 174.34 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 16.6 t -122.42 143.81 33.92 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 C-N-CA 124.66 1.184 . . . . 0.81000000000000005 108.325 177.59 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 21.9 mm -124.74 79.45 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.201 0 C-N-CA 125.429 1.492 . . . . 1.5 108.482 -176.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -78.66 -1.73 35.77 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 114.042 1.127 . . . . 3.2599999999999998 114.042 174.324 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -92.99 -45.37 3.61 Favored Glycine 0 CA--C 1.529 0.915 0 C-N-CA 124.755 1.169 . . . . 3.6400000000000001 113.688 -169.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.255 1.346 0 N-CA-C 106.81 -1.552 . . . . 10.69 106.81 -170.271 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.477 0.916 0 N-CA-C 106.53 -1.655 . . . . 12.119999999999999 106.53 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -58.3 -31.85 67.89 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 119.712 1.142 . . . . 6.1200000000000001 110.67 167.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 28.2 m -125.75 158.61 34.44 Favored 'General case' 0 N--CA 1.444 -0.729 0 C-N-CA 126.286 1.834 . . . . 1.4399999999999999 108.051 179.823 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -108.68 -179.94 4.01 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 128.065 2.546 . . . . 2.1200000000000001 108.985 166.153 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 3.5 mm100 -139.19 147.66 42.11 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.95 1.3 . . . . 1.23 108.015 167.544 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -140.96 159.8 41.43 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 123.735 0.814 . . . . 3.1899999999999999 109.384 160.885 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -114.89 86.55 2.47 Favored 'General case' 0 N--CA 1.442 -0.83 0 C-N-CA 127.902 2.481 . . . . 1.5700000000000001 106.727 -170.775 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.527 HD13 ' CE1' ' A' ' 50' ' ' TYR . 2.6 mp -83.5 161.67 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.295 0 N-CA-C 106.262 -1.755 . . . . 2.29 106.262 -176.497 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -128.85 137.68 51.61 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 125.649 1.58 . . . . 0.65000000000000002 108.077 -178.541 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 1.9 mpt? -140.3 171.4 14.2 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 122.923 0.489 . . . . 2.0800000000000001 110.302 172.882 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -88.54 159.7 17.8 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 127.005 2.122 . . . . 3.75 109.797 167.091 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 88.9 t -117.86 152.63 19.84 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 C-N-CA 124.623 1.169 . . . . 1.1899999999999999 108.525 -179.347 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 70.8 m -149.49 160.41 43.48 Favored 'General case' 0 N--CA 1.455 -0.198 0 O-C-N 121.342 -0.849 . . . . 1.1200000000000001 109.853 171.678 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 70.02 70.29 1.21 Allowed Glycine 0 CA--C 1.528 0.861 0 N-CA-C 110.462 -1.055 . . . . 1.6399999999999999 110.462 -178.408 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -145.2 157.89 43.96 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 124.152 0.981 . . . . 1.9299999999999999 109.529 -175.283 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.7 p -108.63 -66.03 1.08 Allowed 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 125.612 1.565 . . . . 2.3599999999999999 108.692 171.129 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 20.3 p -123.71 161.11 25.8 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 124.485 1.114 . . . . 2.1299999999999999 111.414 -170.801 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -76.67 53.49 0.89 Allowed 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.322 1.049 . . . . 1.9299999999999999 110.813 178.28 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -138.42 -53.49 0.61 Allowed 'General case' 0 CA--C 1.521 -0.153 0 C-N-CA 124.677 1.191 . . . . 0.69999999999999996 109.234 175.813 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 59.7 m -57.4 -41.44 80.33 Favored 'General case' 0 CA--C 1.533 0.289 0 O-C-N 121.734 -0.604 . . . . 1.25 111.6 -176.702 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.466 ' HB1' HG21 ' A' ' 39' ' ' VAL . . . -59.67 -19.13 47.52 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 112.642 0.608 . . . . 0.71999999999999997 112.642 176.66 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.72 -49.12 42.22 Favored 'General case' 0 N--CA 1.455 -0.221 0 O-C-N 120.634 -1.291 . . . . 0.41999999999999998 109.757 169.709 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 6.3 mtt-85 -53.72 -49.27 68.49 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 123.383 0.673 . . . . 3.8300000000000001 109.397 -175.418 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 5.1 pt -55.23 -53.46 34.81 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 O-C-N 123.883 0.739 . . . . 0.46999999999999997 109.973 179.423 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.612 ' HG3' ' HB1' ' A' ' 37' ' ' ALA . 0.3 OUTLIER -53.72 -45.62 70.53 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.078 0.951 . . . . 2.3100000000000001 112.273 179.51 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.5 mptp? -69.25 -46.71 66.64 Favored 'General case' 0 CA--C 1.532 0.259 0 O-C-N 121.163 -0.96 . . . . 1.48 110.351 -177.091 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -63.94 -31.71 81.73 Favored Glycine 0 CA--C 1.529 0.956 0 N-CA-C 111.439 -0.665 . . . . 0.51000000000000001 111.439 176.2 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 7.6 tt -64.91 -44.05 90.84 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 126.018 1.727 . . . . 1.9199999999999999 109.486 177.716 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -53.1 -26.51 16.67 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 112.034 0.383 . . . . 2.5600000000000001 112.034 176.037 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 2.3 mtt180 -70.96 1.6 5.42 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 113.671 0.989 . . . . 3.6899999999999999 113.671 177.459 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 6.6 mmt -71.48 155.52 92.57 Favored Pre-proline 0 CA--C 1.534 0.348 0 CA-C-N 119.519 1.054 . . . . 3.3399999999999999 111.314 167.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -62.62 152.78 75.97 Favored 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 122.411 2.074 . . . . 1.02 110.418 171.463 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 74.88 -27.03 1.12 Allowed Glycine 0 CA--C 1.533 1.193 0 O-C-N 121.482 -0.761 . . . . 0.75 113.486 177.864 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 10.3 t -76.4 145.76 9.92 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 CA-C-N 118.83 1.315 . . . . 0.93999999999999995 109.056 173.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -132.22 -38.94 1.06 Allowed 'General case' 0 CA--C 1.529 0.143 0 CA-C-O 118.512 -0.756 . . . . 0.87 112.304 -176.185 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -140.61 166.49 24.6 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-N 119.589 1.086 . . . . 2.2599999999999998 111.867 163.503 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.612 ' HB1' ' HG3' ' A' ' 25' ' ' GLU . . . -158.13 137.26 11.59 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 112.769 0.655 . . . . 0.46999999999999997 112.769 -179.278 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -149.97 107.86 3.71 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 106.463 -1.68 . . . . 0.41999999999999998 106.463 -161.55 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.466 HG21 ' HB1' ' A' ' 21' ' ' ALA . 2.4 p -82.02 128.44 38.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 108.324 -0.991 . . . . 0.67000000000000004 108.324 177.782 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 39.3 t30 -105.69 57.26 0.67 Allowed 'General case' 0 C--O 1.235 0.341 0 CA-C-O 123.263 1.506 . . . . 0.87 107.887 179.005 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.424 HD23 HG22 ' A' ' 39' ' ' VAL . 0.3 OUTLIER -74.74 -13.49 60.6 Favored 'General case' 0 C--O 1.226 -0.178 0 CA-C-N 113.96 -1.473 . . . . 0.92000000000000004 110.636 177.003 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -44.0 -36.55 2.54 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.914 0.886 . . . . 1.0800000000000001 111.378 165.459 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 15.2 t -108.21 -68.73 0.89 Allowed 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 117.739 -1.124 . . . . 3.3700000000000001 110.85 167.318 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 161.34 49.13 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 127.561 2.344 . . . . 3.7999999999999998 109.535 -174.108 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -142.52 160.62 39.92 Favored 'General case' 0 N--CA 1.446 -0.667 0 O-C-N 120.292 -1.505 . . . . 0.76000000000000001 109.16 -178.228 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.6 p -130.18 142.79 42.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 108.113 -1.069 . . . . 0.32000000000000001 108.113 171.668 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -127.04 138.77 53.28 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 107.594 -1.262 . . . . 0.33000000000000002 107.594 176.123 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 3.1 p -137.68 129.67 40.61 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 N-CA-C 106.003 -1.851 . . . . 1.7 106.003 -176.726 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 11.2 mm -104.92 99.49 8.56 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.612 0 N-CA-C 106.743 -1.577 . . . . 0.45000000000000001 106.743 -171.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.527 ' CE1' HD13 ' A' ' 8' ' ' ILE . 51.2 p90 -139.84 169.44 17.72 Favored 'General case' 0 CA--C 1.512 -0.507 0 C-N-CA 122.629 0.372 . . . . 2.0899999999999999 110.662 -173.601 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 52.6 t0 -90.4 109.27 32.6 Favored Pre-proline 0 C--O 1.235 0.33 0 O-C-N 124.435 1.085 . . . . 3.3199999999999998 109.533 173.737 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 78.9 Cg_endo -72.41 5.57 2.71 Favored 'Trans proline' 0 N--CA 1.452 -0.95 0 C-N-CA 122.758 2.305 . . . . 0.83999999999999997 113.698 179.79 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -83.37 -33.24 25.85 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 119.393 0.997 . . . . 1.0600000000000001 108.692 165.828 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -107.44 -60.83 1.64 Allowed 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 123.446 0.698 . . . . 2.6800000000000002 110.943 -168.386 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.429 HG22 ' HB3' ' A' ' 59' ' ' ALA 0.495 0.2 OUTLIER -79.2 -177.1 5.49 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 114.513 1.301 . . . . 0.64000000000000001 114.513 155.956 . . . . . . . . 4 4 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 176.78 -147.91 8.7 Favored Glycine 0 N--CA 1.434 -1.469 0 N-CA-C 103.354 -3.898 . . . . 2.71 103.354 -165.37 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 12.9 p -75.39 -42.68 53.29 Favored 'General case' 0 N--CA 1.443 -0.795 0 C-N-CA 124.711 1.204 . . . . 1.3 108.794 174.32 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -46.67 -63.83 0.92 Allowed 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 114.125 1.157 . . . . 0.70999999999999996 114.125 -165.026 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.429 ' HB3' HG22 ' A' ' 55' ' ' THR . . . -70.82 -34.57 71.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 122.34 1.067 . . . . 0.64000000000000001 108.98 -165.78 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.5 mp -53.78 -58.55 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.122 0 CA-C-N 114.143 -1.389 . . . . 1.1399999999999999 109.534 170.045 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.94 -45.4 92.73 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 123.038 0.535 . . . . 1.6000000000000001 109.957 -173.395 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -43.8 -58.48 2.7 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.236 1.014 . . . . 3.8900000000000001 110.872 172.518 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -67.3 -44.69 78.61 Favored 'General case' 0 N--CA 1.442 -0.845 0 O-C-N 121.937 -0.477 . . . . 3.71 111.809 -178.814 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -48.46 -53.03 7.23 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 C-N-CA 125.799 1.64 . . . . 0.53000000000000003 107.89 -179.324 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 41.0 mm-40 -60.56 -58.19 9.52 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 124.549 1.14 . . . . 2.0 110.339 176.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 5.9 mmmt -53.66 -37.28 63.01 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 113.25 0.833 . . . . 4.4699999999999998 113.25 -177.256 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 12.1 mt -68.93 -17.74 64.0 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.275 1.03 . . . . 0.96999999999999997 111.985 177.622 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 92.62 49.61 2.71 Favored Glycine 0 CA--C 1.523 0.534 0 N-CA-C 109.932 -1.267 . . . . 0.56999999999999995 109.932 178.671 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -147.06 170.27 17.5 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 124.135 0.974 . . . . 1.8 109.799 -175.405 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 12.9 t-80 -140.78 123.72 16.37 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 108.249 -1.019 . . . . 1.9299999999999999 108.249 174.244 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 7.5 p -92.7 144.57 9.07 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.146 0 N-CA-C 107.027 -1.471 . . . . 1.52 107.027 170.754 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 44.7 t -123.04 139.98 48.14 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.182 0 N-CA-C 107.952 -1.129 . . . . 0.98999999999999999 107.952 178.515 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 5.2 mp -111.37 83.11 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 N-CA-C 107.749 -1.204 . . . . 1.46 107.749 -173.803 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 71.2 mt-10 -79.33 -3.71 47.47 Favored 'General case' 0 N--CA 1.443 -0.794 0 C-N-CA 124.349 1.06 . . . . 2.5499999999999998 113.642 170.435 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -98.1 -23.9 12.39 Favored Glycine 0 CA--C 1.524 0.651 0 C-N-CA 125.137 1.351 . . . . 2.7799999999999998 114.666 -165.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 32.4 ttt180 . . . . . 0 C--O 1.25 1.082 0 CA-C-O 116.472 -1.727 . . . . 11.57 108.873 -169.585 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 82.2 mtp . . . . . 0 N--CA 1.475 0.789 0 N-CA-C 106.228 -1.768 . . . . 8.6099999999999994 106.228 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.5 tp 50.14 78.84 0.09 Allowed 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.361 1.465 . . . . 6.1600000000000001 113.071 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.5 m -68.68 107.09 2.86 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 124.329 1.052 . . . . 1.0600000000000001 110.739 -179.261 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -63.31 175.15 1.03 Allowed 'General case' 0 CA--C 1.531 0.245 0 CA-C-O 121.494 0.664 . . . . 3.1000000000000001 111.543 165.815 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.2 mm100 -137.97 143.79 40.85 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 125.215 1.406 . . . . 1.05 107.968 165.315 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 46.2 mttm -141.47 156.06 45.79 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 123.808 0.843 . . . . 3.6899999999999999 109.428 164.367 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 12.0 mp0 -114.62 86.34 2.42 Favored 'General case' 0 N--CA 1.445 -0.685 0 C-N-CA 127.164 2.186 . . . . 1.6499999999999999 108.08 -167.138 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.5 mt -83.61 157.99 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 N-CA-C 107.296 -1.372 . . . . 2.3199999999999998 107.296 -176.436 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -126.95 136.2 51.94 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 126.183 1.793 . . . . 0.53000000000000003 107.455 178.864 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 2.1 mpt? -138.74 169.57 17.56 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 118.337 0.517 . . . . 2.04 110.064 174.069 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -87.59 160.16 18.3 Favored 'General case' 0 N--CA 1.456 -0.133 0 C-N-CA 124.441 1.096 . . . . 3.1499999999999999 109.001 170.48 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 60.3 t -116.55 152.05 18.31 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 C-N-CA 124.202 1.001 . . . . 1.24 108.384 177.692 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 58.6 m -149.58 173.48 13.58 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.755 1.222 . . . . 1.0800000000000001 108.29 172.652 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 79.79 -37.12 2.09 Favored Glycine 0 CA--C 1.532 1.151 0 O-C-N 121.737 -0.602 . . . . 2.1000000000000001 112.557 -177.838 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 3.8 ppp? -47.78 153.64 0.58 Allowed 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.119 1.368 . . . . 3.3799999999999999 113.855 179.754 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.2 p -114.26 -71.51 0.74 Allowed 'General case' 0 N--CA 1.457 -0.086 0 C-N-CA 124.804 1.242 . . . . 2.3199999999999998 108.681 170.559 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 6.7 p -99.09 148.13 24.35 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 121.835 0.826 . . . . 2.1899999999999999 111.331 -178.727 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -77.84 53.44 1.14 Allowed 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.477 0.711 . . . . 1.75 110.493 178.247 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -143.05 -51.09 0.35 Allowed 'General case' 0 C--O 1.231 0.102 0 C-N-CA 123.65 0.78 . . . . 0.66000000000000003 110.682 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 56.1 m -56.01 -36.2 67.68 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 118.728 0.695 . . . . 1.2 110.15 171.025 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -47.97 -33.35 7.67 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.186 1.394 . . . . 0.47999999999999998 112.407 172.442 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.37 -53.27 14.68 Favored 'General case' 0 N--CA 1.454 -0.27 0 O-C-N 121.528 -0.733 . . . . 0.34999999999999998 110.128 172.576 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 6.4 mpt_? -55.3 -50.07 70.51 Favored 'General case' 0 CA--C 1.521 -0.148 0 C-N-CA 122.434 0.294 . . . . 5.8600000000000003 110.251 -175.172 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.48 HG21 ' CD1' ' A' ' 69' ' ' TYR 0.258 2.3 pp -52.86 -50.52 42.87 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 O-C-N 123.183 0.302 . . . . 1.26 110.99 177.578 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.523 ' HG3' ' HB1' ' A' ' 37' ' ' ALA . 3.0 tp10 -59.08 -39.27 81.62 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 114.029 1.122 . . . . 2.7599999999999998 114.029 176.221 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -73.95 -38.07 64.35 Favored 'General case' 0 CA--C 1.533 0.305 0 O-C-N 120.82 -1.175 . . . . 2.4900000000000002 111.974 -178.436 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -66.04 -41.39 95.19 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 109.858 -1.297 . . . . 0.47999999999999998 109.858 170.806 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 8.0 tt -53.56 -50.45 65.51 Favored 'General case' 0 C--N 1.333 -0.133 0 N-CA-C 108.84 -0.8 . . . . 1.8400000000000001 108.84 174.124 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -50.7 -19.9 1.07 Allowed 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.853 1.261 . . . . 3.3799999999999999 114.125 178.583 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.67 -9.32 59.62 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 118.897 0.772 . . . . 4.3399999999999999 112.528 -179.092 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 8.1 ptp -68.78 154.68 94.49 Favored Pre-proline 0 CA--C 1.534 0.337 0 CA-C-N 119.43 1.013 . . . . 3.8300000000000001 111.474 177.215 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -58.4 137.35 79.95 Favored 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 121.539 1.493 . . . . 0.57999999999999996 109.388 166.123 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 100.83 -35.51 4.8 Favored Glycine 0 CA--C 1.529 0.95 0 CA-C-O 119.274 -0.737 . . . . 0.51000000000000001 113.283 175.354 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 54.7 t -89.21 110.39 21.48 Favored 'Isoleucine or valine' 0 C--N 1.34 0.178 0 CA-C-N 118.76 1.28 . . . . 0.85999999999999999 109.671 178.062 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -81.63 -49.46 10.48 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-O 118.122 -0.942 . . . . 0.90000000000000002 108.577 -178.856 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -137.36 163.14 31.74 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 119.016 0.826 . . . . 2.1600000000000001 112.096 173.72 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.523 ' HB1' ' HG3' ' A' ' 25' ' ' GLU . . . -157.06 146.92 20.73 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.697 -0.683 . . . . 0.5 112.082 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -156.07 115.04 3.48 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 106.365 -1.717 . . . . 0.46999999999999997 106.365 -163.948 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.5 p -81.39 130.89 35.09 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.688 0 N-CA-C 107.911 -1.144 . . . . 0.75 107.911 175.541 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 54.1 t-20 -109.63 55.82 0.63 Allowed 'General case' 0 C--O 1.236 0.359 0 N-CA-C 107.187 -1.412 . . . . 0.59999999999999998 107.187 178.495 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.16 -18.34 62.5 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 114.157 -1.383 . . . . 1.01 109.86 -172.658 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -43.13 -37.78 2.16 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.09 0.956 . . . . 0.60999999999999999 112.246 164.105 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 8.9 t -124.23 38.51 4.18 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 122.727 0.411 . . . . 1.3 109.943 173.346 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 50.11 31.85 5.35 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.932 1.693 . . . . 2.6099999999999999 113.412 174.483 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 90.4 m -121.31 157.29 30.7 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 108.264 -1.013 . . . . 0.66000000000000003 108.264 -177.005 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 5.4 p -125.52 142.41 42.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 N-CA-C 108.355 -0.98 . . . . 0.37 108.355 172.17 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -127.37 139.84 52.59 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 108.425 -0.954 . . . . 0.33000000000000002 108.425 -179.515 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 5.5 p -141.29 126.17 17.92 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 N-CA-C 106.936 -1.505 . . . . 1.8100000000000001 106.936 -172.472 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 14.8 mm -107.22 91.8 1.88 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.513 0 C-N-CA 126.092 1.757 . . . . 0.40999999999999998 107.07 -167.8 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 43.6 p90 -135.38 165.53 25.26 Favored 'General case' 0 CA--C 1.51 -0.583 0 O-C-N 121.975 -0.453 . . . . 1.96 112.037 -166.764 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 59.7 t0 -86.55 109.92 27.67 Favored Pre-proline 0 C--O 1.235 0.321 0 O-C-N 124.574 1.172 . . . . 3.0499999999999998 109.821 176.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -71.23 1.93 4.89 Favored 'Trans proline' 0 N--CA 1.453 -0.892 0 C-N-CA 123.029 2.486 . . . . 0.58999999999999997 113.44 -178.401 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -88.78 -27.17 21.31 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 119.428 1.013 . . . . 0.81999999999999995 109.471 168.559 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -101.71 -53.33 2.99 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 123.492 0.717 . . . . 2.75 109.13 -170.122 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.265 1.0 OUTLIER -101.66 -176.44 3.14 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 125.256 1.422 . . . . 0.46000000000000002 111.998 163.431 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 146.95 91.09 0.1 OUTLIER Glycine 0 N--CA 1.442 -0.931 0 N-CA-C 103.629 -3.789 . . . . 2.3199999999999998 103.629 -155.406 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 77.0 p -13.95 -15.06 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.546 1 C-N-CA 137.737 6.415 . . . . 1.45 120.32 -145.848 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -25.49 -62.04 0.07 Allowed 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 126.924 2.09 . . . . 0.54000000000000004 114.503 162.575 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.07 -43.13 58.82 Favored 'General case' 0 C--N 1.332 -0.176 0 C-N-CA 119.088 -1.045 . . . . 0.51000000000000001 109.027 -167.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.7 mt -46.92 -60.03 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.706 0 C-N-CA 126.543 1.937 . . . . 1.27 110.893 172.025 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.78 -46.84 81.26 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 119.778 1.172 . . . . 1.0700000000000001 110.195 179.541 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -51.88 -55.18 21.66 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 121.795 0.807 . . . . 3.3900000000000001 112.022 179.014 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -69.8 -37.96 76.47 Favored 'General case' 0 N--CA 1.438 -1.028 0 O-C-N 121.419 -0.801 . . . . 2.27 111.471 -178.792 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.7 mm -49.95 -54.28 8.26 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 N-CA-C 107.362 -1.347 . . . . 0.48999999999999999 107.362 175.369 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 27.0 mm-40 -58.36 -58.23 9.41 Favored 'General case' 0 C--N 1.342 0.259 0 C-N-CA 124.745 1.218 . . . . 2.2000000000000002 110.387 178.345 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 7.8 mptt -54.48 -39.84 67.9 Favored 'General case' 0 CA--C 1.534 0.334 0 O-C-N 121.877 -0.514 . . . . 4.6500000000000004 112.153 -177.736 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.456 ' HB3' HG22 ' A' ' 24' ' ' ILE . 44.2 mt -70.63 -17.08 62.88 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.232 1.013 . . . . 0.78000000000000003 112.114 178.1 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 94.46 33.84 6.62 Favored Glycine 0 CA--C 1.524 0.641 0 C-N-CA 124.303 0.954 . . . . 0.44 111.617 173.378 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.48 ' CD1' HG21 ' A' ' 24' ' ' ILE . 1.4 m-85 -124.19 169.94 11.23 Favored 'General case' 0 N--CA 1.457 -0.123 0 C-N-CA 124.793 1.237 . . . . 1.8799999999999999 109.277 177.449 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -135.16 120.33 18.86 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 107.794 -1.187 . . . . 1.77 107.794 172.902 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 7.6 p -89.55 145.1 7.81 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 N-CA-C 107.597 -1.261 . . . . 1.54 107.597 172.168 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 48.8 t -121.21 141.16 42.89 Favored 'Isoleucine or valine' 0 C--O 1.232 0.136 0 C-N-CA 123.884 0.874 . . . . 0.68999999999999995 108.93 178.042 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 29.8 mm -110.78 76.99 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 C-N-CA 124.684 1.194 . . . . 1.0600000000000001 109.479 -168.878 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -72.25 -3.65 24.87 Favored 'General case' 0 N--CA 1.447 -0.575 0 N-CA-C 114.49 1.292 . . . . 3.4100000000000001 114.49 178.351 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 65.99 83.79 0.1 OUTLIER Glycine 0 CA--C 1.529 0.928 0 N-CA-C 109.606 -1.398 . . . . 2.7799999999999998 109.606 -175.34 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 33.2 tpt85 . . . . . 0 C--O 1.253 1.248 0 CA-C-O 115.855 -2.021 . . . . 13.699999999999999 111.737 -173.803 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 37.8 mtt . . . . . 0 N--CA 1.473 0.696 0 N-CA-C 107.625 -1.25 . . . . 9.9399999999999995 107.625 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -156.79 165.88 34.97 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 108.862 -0.792 . . . . 5.9800000000000004 108.862 179.537 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 5.5 m -121.13 103.04 8.71 Favored 'General case' 0 N--CA 1.455 -0.181 0 N-CA-C 106.708 -1.59 . . . . 0.79000000000000004 106.708 166.914 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -63.55 169.4 3.9 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 107.998 -1.112 . . . . 2.8900000000000001 107.998 161.911 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 7.7 mt-30 -129.28 153.71 47.55 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 108.657 -0.868 . . . . 1.5900000000000001 108.657 171.531 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -139.76 153.26 47.12 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 123.423 0.689 . . . . 3.1400000000000001 110.048 168.805 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -107.69 90.87 3.43 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 127.633 2.373 . . . . 1.6299999999999999 107.731 -176.4 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 3.4 mm -83.65 159.45 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.179 0 N-CA-C 106.787 -1.56 . . . . 1.98 106.787 -178.603 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -134.14 131.72 39.01 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 124.641 1.176 . . . . 0.46999999999999997 108.385 178.441 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 3.7 mpp? -137.47 167.3 21.92 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.377 0.671 . . . . 2.0299999999999998 110.008 174.45 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 21.4 mm100 -88.01 160.16 17.98 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.14 0.976 . . . . 2.5800000000000001 109.452 174.652 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 81.4 t -115.01 144.2 23.08 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 C-N-CA 124.053 0.941 . . . . 1.49 109.971 -179.291 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 9.1 m -147.21 175.15 10.97 Favored 'General case' 0 C--N 1.341 0.228 0 C-N-CA 125.523 1.529 . . . . 1.3 108.604 171.409 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 55.68 52.47 48.13 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 110.788 -0.925 . . . . 1.8700000000000001 110.788 175.695 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -125.51 149.5 48.24 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 124.559 1.144 . . . . 2.6600000000000001 109.424 -170.886 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -87.85 -58.54 2.53 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 124.039 0.936 . . . . 3.5699999999999998 109.966 170.379 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 17.7 p -154.68 170.55 21.28 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-O 121.777 0.798 . . . . 2.5800000000000001 111.279 175.923 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.35 -34.4 68.77 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 124.409 1.084 . . . . 2.4100000000000001 111.893 178.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.76 -49.82 73.5 Favored 'General case' 0 N--CA 1.453 -0.292 0 O-C-N 121.992 -0.443 . . . . 0.76000000000000001 109.898 178.587 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 77.5 m -61.49 -38.92 89.04 Favored 'General case' 0 N--CA 1.456 -0.153 0 O-C-N 121.619 -0.675 . . . . 1.3 110.422 174.64 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.565 ' HB1' HG21 ' A' ' 39' ' ' VAL . . . -56.83 -23.13 41.7 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 112.105 0.409 . . . . 0.42999999999999999 112.105 173.685 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.07 -47.63 61.14 Favored 'General case' 0 N--CA 1.456 -0.165 0 O-C-N 120.039 -1.663 . . . . 0.39000000000000001 110.116 169.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 2.0 mtp85 -51.45 -43.59 62.13 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 122.92 0.488 . . . . 3.6699999999999999 110.039 -175.402 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.517 HG21 ' CD1' ' A' ' 69' ' ' TYR 0.287 1.9 pt -60.88 -60.35 2.79 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.274 0 CA-C-O 118.371 -0.823 . . . . 0.52000000000000002 111.196 178.74 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -54.91 -40.54 69.95 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 119.964 1.256 . . . . 2.2799999999999998 112.002 -179.45 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 14.7 mptt -68.07 -50.2 56.6 Favored 'General case' 0 CA--C 1.537 0.453 0 O-C-N 121.353 -0.842 . . . . 1.8799999999999999 110.38 -179.08 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -67.39 -23.18 73.4 Favored Glycine 0 CA--C 1.53 1.022 0 O-C-N 121.489 -0.757 . . . . 0.69999999999999996 112.265 177.241 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -71.01 -47.75 57.03 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 125.375 1.47 . . . . 2.3199999999999998 108.652 173.106 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 19.9 ttmt -46.5 -39.54 10.96 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 118.959 0.8 . . . . 3.3599999999999999 111.397 178.831 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.6 mtt180 -67.14 -5.93 15.54 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 114.691 1.367 . . . . 3.5899999999999999 114.691 -177.687 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.67 162.32 73.74 Favored Pre-proline 0 CA--C 1.541 0.626 0 CA-C-N 119.367 0.985 . . . . 4.2199999999999998 111.055 179.304 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -73.68 117.34 5.01 Favored 'Trans proline' 0 N--CA 1.453 -0.898 0 C-N-CA 121.507 1.471 . . . . 1.0 109.191 172.392 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 116.47 -19.39 12.91 Favored Glycine 0 CA--C 1.527 0.794 0 C-N-CA 123.895 0.76 . . . . 0.83999999999999997 113.789 169.915 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.509 HG22 ' HB3' ' A' ' 50' ' ' TYR . 86.6 t -89.97 145.96 6.77 Favored 'Isoleucine or valine' 0 C--N 1.339 0.143 0 CA-C-N 118.685 1.243 . . . . 0.68999999999999995 108.539 167.386 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.2 m -118.38 -36.63 3.49 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 118.441 -0.79 . . . . 1.0600000000000001 111.256 177.295 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -138.83 164.22 30.21 Favored 'General case' 0 C--N 1.343 0.307 0 CA-C-N 119.955 1.252 . . . . 2.0899999999999999 111.728 168.015 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -159.27 144.98 16.17 Favored 'General case' 0 C--N 1.332 -0.171 0 C-N-CA 123.104 0.562 . . . . 0.42999999999999999 111.868 -178.264 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -155.49 110.19 2.94 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 107.608 -1.256 . . . . 0.47999999999999998 107.608 -165.529 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.565 HG21 ' HB1' ' A' ' 21' ' ' ALA . 7.1 p -82.61 103.97 10.59 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 CA-C-O 121.336 0.588 . . . . 0.59999999999999998 110.79 178.722 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 51.6 t-20 -84.34 57.67 4.39 Favored 'General case' 0 CA--C 1.537 0.451 0 O-C-N 120.336 -1.477 . . . . 0.64000000000000001 110.173 179.73 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.426 HD23 ' CG2' ' A' ' 39' ' ' VAL . 0.2 OUTLIER -69.08 -19.05 64.06 Favored 'General case' 0 N--CA 1.461 0.119 0 CA-C-N 115.593 -0.731 . . . . 0.87 111.24 -176.506 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -44.09 -33.4 1.47 Allowed 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 123.816 0.846 . . . . 0.55000000000000004 111.872 166.919 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 6.6 t -129.62 42.08 3.34 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 121.392 0.615 . . . . 1.29 109.866 173.646 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 39.12 40.97 0.54 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 126.614 1.966 . . . . 2.5499999999999998 114.01 -178.28 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 83.8 m -120.34 157.23 29.68 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 124.55 1.14 . . . . 0.65000000000000002 108.568 -178.297 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 1.6 p -125.87 140.26 49.06 Favored 'Isoleucine or valine' 0 C--O 1.232 0.151 0 N-CA-C 108.278 -1.008 . . . . 0.53000000000000003 108.278 172.527 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -126.69 137.26 53.25 Favored 'General case' 0 C--N 1.344 0.365 0 N-CA-C 108.26 -1.015 . . . . 0.33000000000000002 108.26 176.306 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 40.7 t -131.31 125.2 56.55 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 N-CA-C 105.426 -2.065 . . . . 2.0499999999999998 105.426 -177.686 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 14.7 mm -100.46 88.24 1.47 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.592 0 N-CA-C 106.829 -1.545 . . . . 0.40000000000000002 106.829 -176.89 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.509 ' HB3' HG22 ' A' ' 34' ' ' VAL . 13.2 p90 -124.36 167.7 14.02 Favored 'General case' 0 CA--C 1.507 -0.711 0 CA-C-N 115.794 -0.639 . . . . 1.99 111.503 -171.743 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -99.84 107.48 46.61 Favored Pre-proline 0 N--CA 1.445 -0.677 0 CA-C-N 113.879 -1.51 . . . . 4.3799999999999999 108.113 -171.091 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -72.44 6.18 2.42 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 122.698 2.265 . . . . 0.82999999999999996 113.138 -173.109 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -84.28 -25.2 29.5 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 123.478 0.711 . . . . 1.0800000000000001 109.334 168.401 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 -117.54 -53.64 2.41 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.202 1.001 . . . . 3.02 110.977 -169.636 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.258 0.8 OUTLIER -89.72 -175.77 4.76 Favored 'General case' 0 CA--C 1.517 -0.3 0 C-N-CA 123.766 0.826 . . . . 0.51000000000000001 113.177 160.343 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 141.34 87.5 0.11 Allowed Glycine 0 N--CA 1.44 -1.092 0 N-CA-C 104.902 -3.279 . . . . 2.5299999999999998 104.902 -158.867 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 82.4 p -9.48 -18.52 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.559 1 C-N-CA 138.126 6.571 . . . . 1.01 119.977 -143.238 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -28.18 -65.98 0.08 Allowed 'General case' 0 N--CA 1.44 -0.972 0 C-N-CA 127.6 2.36 . . . . 0.56999999999999995 113.977 169.639 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -76.81 -25.41 53.25 Favored 'General case' 0 C--N 1.334 -0.106 0 C-N-CA 118.105 -1.438 . . . . 0.67000000000000004 110.042 -169.113 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -63.5 -53.79 40.77 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.855 0 CA-C-O 118.58 -0.724 . . . . 0.90000000000000002 109.072 176.554 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.46 -44.44 96.4 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 108.828 -0.805 . . . . 1.6000000000000001 108.828 -175.547 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -48.13 -58.69 4.15 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-O 121.592 0.711 . . . . 3.7999999999999998 111.726 172.833 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 13.3 mmmt -65.44 -37.99 88.53 Favored 'General case' 0 N--CA 1.44 -0.946 0 O-C-N 121.618 -0.676 . . . . 3.46 111.739 -177.644 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.421 HD12 HG13 ' A' ' 71' ' ' VAL . 2.5 mm -51.79 -51.81 25.75 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 C-N-CA 125.634 1.574 . . . . 0.57999999999999996 108.302 178.878 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -57.45 -54.49 46.26 Favored 'General case' 0 C--N 1.341 0.218 0 C-N-CA 123.094 0.558 . . . . 2.04 110.243 174.667 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 5.8 mmtt -53.89 -38.44 64.78 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 112.874 0.694 . . . . 4.0199999999999996 112.874 -179.306 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 32.5 mt -70.95 -17.92 62.66 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 125.737 1.615 . . . . 0.79000000000000004 111.632 177.452 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 93.37 35.64 6.19 Favored Glycine 0 CA--C 1.525 0.668 0 C-N-CA 124.658 1.123 . . . . 0.5 111.229 176.119 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.517 ' CD1' HG21 ' A' ' 24' ' ' ILE . 1.0 OUTLIER -131.96 172.15 12.7 Favored 'General case' 0 N--CA 1.457 -0.123 0 C-N-CA 123.818 0.847 . . . . 1.8999999999999999 110.923 -178.319 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 3.7 t-80 -148.85 116.38 6.21 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 109.041 -0.725 . . . . 1.7 109.041 170.446 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.421 HG13 HD12 ' A' ' 64' ' ' ILE . 25.7 m -81.59 166.35 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 N-CA-C 109.072 -0.714 . . . . 2.4700000000000002 109.072 176.235 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 12.1 t -124.51 142.51 41.09 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 C-N-CA 124.173 0.989 . . . . 0.78000000000000003 108.458 178.603 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 17.9 mm -112.52 72.73 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 C-N-CA 124.115 0.966 . . . . 1.1200000000000001 109.061 -174.084 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -72.93 -9.99 59.31 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 114.043 1.127 . . . . 3.1499999999999999 114.043 176.67 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -122.98 62.42 0.55 Allowed Glycine 0 CA--C 1.523 0.542 0 N-CA-C 108.4 -1.88 . . . . 3.2599999999999998 108.4 174.215 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.177 0 CA-C-O 116.761 -1.59 . . . . 12.359999999999999 111.125 179.617 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.9 mmt . . . . . 0 N--CA 1.472 0.66 0 N-CA-C 108.492 -0.929 . . . . 9.5700000000000003 108.492 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 63.0 tp -137.15 124.93 22.47 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 105.538 -2.023 . . . . 6.8399999999999999 105.538 173.714 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 39.2 m -131.4 116.54 17.67 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 103.908 -2.627 . . . . 1.27 103.908 170.806 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -80.07 -179.7 7.17 Favored 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 125.113 1.365 . . . . 3.0499999999999998 108.025 177.775 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.2 mm100 -138.78 136.52 35.77 Favored 'General case' 0 CA--C 1.514 -0.438 0 O-C-N 120.843 -1.161 . . . . 1.3200000000000001 108.275 171.548 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.8 mtpt -133.98 151.79 51.6 Favored 'General case' 0 N--CA 1.455 -0.222 0 O-C-N 124.089 0.868 . . . . 2.9199999999999999 109.958 167.658 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -101.9 93.5 5.32 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 127.968 2.507 . . . . 1.4299999999999999 107.457 -176.059 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 2.5 mm -84.01 159.91 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.248 0 N-CA-C 106.669 -1.604 . . . . 2.0600000000000001 106.669 -178.029 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -133.78 130.9 38.67 Favored 'General case' 0 N--CA 1.456 -0.136 0 N-CA-C 108.073 -1.084 . . . . 0.45000000000000001 108.073 176.153 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 4.0 mpp? -139.15 172.1 13.32 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.256 1.022 . . . . 1.8899999999999999 110.19 176.609 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.36 162.46 12.94 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 126.188 1.795 . . . . 3.5 109.468 173.368 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.1 m -118.76 151.5 20.95 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 C-N-CA 123.659 0.784 . . . . 1.8100000000000001 111.35 174.406 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 48.4 m -142.44 165.4 27.51 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 125.495 1.518 . . . . 1.03 109.411 176.766 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 63.58 67.06 2.21 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 110.686 -0.966 . . . . 2.1000000000000001 110.686 177.645 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -139.72 157.69 45.35 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 123.928 0.891 . . . . 3.5800000000000001 110.753 -175.432 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -76.83 -70.15 0.48 Allowed 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 108.178 -1.045 . . . . 3.1400000000000001 108.178 157.12 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 25.8 p -158.41 -178.91 7.62 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 121.732 0.777 . . . . 2.6099999999999999 112.05 -166.357 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.65 175.6 0.45 Allowed 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 124.793 1.237 . . . . 3.25 110.086 170.455 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.409 ' O ' ' HB3' ' A' ' 22' ' ' ALA . . . 72.03 -56.21 0.65 Allowed 'General case' 0 CA--C 1.528 0.123 0 C-N-CA 124.875 1.27 . . . . 1.0700000000000001 110.196 -174.179 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 28.3 m -57.57 -46.27 84.18 Favored 'General case' 0 C--N 1.33 -0.259 0 O-C-N 121.442 -0.786 . . . . 1.45 109.361 171.328 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -52.01 -23.76 5.63 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.107 0.963 . . . . 0.42999999999999999 112.965 172.227 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.409 ' HB3' ' O ' ' A' ' 19' ' ' ALA . . . -72.22 -49.49 34.79 Favored 'General case' 0 N--CA 1.454 -0.258 0 O-C-N 120.87 -1.144 . . . . 0.34000000000000002 110.607 171.803 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 8.1 mmm180 -56.11 -42.74 77.32 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 109.791 -0.448 . . . . 4.7699999999999996 109.791 -171.588 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.501 ' HA ' HD13 ' A' ' 67' ' ' LEU . 4.1 pt -56.62 -55.99 16.46 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 O-C-N 123.382 0.426 . . . . 0.46999999999999997 110.676 176.351 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -55.45 -43.15 75.18 Favored 'General case' 0 C--O 1.226 -0.163 0 C-N-CA 123.825 0.85 . . . . 3.54 111.75 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 4.0 mptp? -72.0 -42.82 65.97 Favored 'General case' 0 CA--C 1.535 0.366 0 O-C-N 121.168 -0.957 . . . . 1.8999999999999999 110.537 -174.537 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.93 -39.16 97.7 Favored Glycine 0 CA--C 1.53 0.991 0 N-CA-C 110.525 -1.03 . . . . 0.66000000000000003 110.525 170.935 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 6.8 tt -60.51 -36.31 78.05 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.23 1.012 . . . . 1.95 109.703 175.875 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.5 ttpm? -61.95 -24.02 66.73 Favored 'General case' 0 CA--C 1.53 0.187 0 O-C-N 120.565 -1.335 . . . . 3.1099999999999999 112.841 172.616 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 11.3 mmt180 -77.85 -3.81 43.44 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 119.043 0.838 . . . . 3.5299999999999998 111.524 -179.069 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 70.3 mmm -83.95 147.84 52.35 Favored Pre-proline 0 CA--C 1.535 0.369 0 CA-C-N 118.918 0.781 . . . . 3.3999999999999999 111.076 -176.632 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -59.25 136.15 70.46 Favored 'Trans proline' 0 N--CA 1.451 -0.986 0 C-N-CA 122.34 2.027 . . . . 0.56999999999999995 108.961 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 94.66 -23.94 30.24 Favored Glycine 0 CA--C 1.528 0.848 0 CA-C-O 118.919 -0.934 . . . . 0.5 113.084 -178.837 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 17.0 t -92.35 130.28 41.69 Favored 'Isoleucine or valine' 0 C--N 1.34 0.161 0 CA-C-N 118.6 1.2 . . . . 0.57999999999999996 109.966 -177.139 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 9.3 m -112.13 -39.51 4.45 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 123.823 0.849 . . . . 1.2 111.142 -171.874 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -145.27 157.21 44.11 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 118.867 0.758 . . . . 2.7999999999999998 109.738 175.038 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -152.0 126.7 9.54 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 123.765 0.826 . . . . 0.75 110.375 -170.893 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -142.36 107.85 5.06 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 125.723 1.609 . . . . 0.70999999999999996 108.772 -164.45 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.412 HG23 HD23 ' A' ' 41' ' ' LEU . 3.1 p -82.31 88.09 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 N-CA-C 108.734 -0.839 . . . . 1.4099999999999999 108.734 178.41 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 48.9 t-20 -83.31 56.65 3.63 Favored 'General case' 0 CA--C 1.537 0.462 0 O-C-N 120.6 -1.312 . . . . 0.71999999999999997 110.108 -177.861 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.412 HD23 HG23 ' A' ' 39' ' ' VAL . 0.5 OUTLIER -68.27 -20.74 64.81 Favored 'General case' 0 C--O 1.223 -0.332 0 C-N-CA 124.398 1.079 . . . . 1.0 110.541 -179.792 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -45.7 -30.12 1.48 Allowed 'General case' 0 CA--C 1.529 0.154 0 N-CA-C 112.811 0.671 . . . . 0.93000000000000005 112.811 168.363 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 5.7 t -131.66 32.25 4.16 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 118.019 0.372 . . . . 1.29 110.476 173.087 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 9.1 mp0 50.02 52.79 13.99 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.302 1.041 . . . . 4.1200000000000001 112.591 179.569 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.3 m -137.69 160.43 39.24 Favored 'General case' 0 N--CA 1.443 -0.797 0 O-C-N 121.286 -0.884 . . . . 0.94999999999999996 109.144 176.295 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.5 p -129.91 136.64 58.49 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 N-CA-C 107.044 -1.465 . . . . 0.38 107.044 169.794 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -125.07 129.51 50.4 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 107.559 -1.275 . . . . 0.55000000000000004 107.559 -178.665 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 3.7 p -132.97 131.14 58.95 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.828 0 N-CA-C 105.1 -2.185 . . . . 1.78 105.1 -176.486 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 2.1 mp -104.2 111.2 32.87 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.762 0 N-CA-C 106.097 -1.816 . . . . 1.72 106.097 178.875 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 21.4 p90 -143.15 167.58 21.78 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 116.039 -0.528 . . . . 1.6399999999999999 109.914 -178.047 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -87.78 121.82 70.63 Favored Pre-proline 0 CA--C 1.54 0.58 0 O-C-N 125.047 1.467 . . . . 3.3900000000000001 111.506 171.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_endo -80.76 12.12 2.72 Favored 'Trans proline' 0 CA--C 1.537 0.672 0 C-N-CA 123.536 2.824 . . . . 0.93000000000000005 114.181 -176.565 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -98.0 -36.23 10.19 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 119.573 1.079 . . . . 1.3700000000000001 109.578 167.539 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -90.81 -57.22 2.89 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 106.966 -1.494 . . . . 3.23 106.966 -175.09 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.317 6.0 p -95.92 -160.32 0.78 Allowed 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 109.439 -0.578 . . . . 0.64000000000000001 109.439 162.027 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 116.57 92.31 1.7 Allowed Glycine 0 CA--C 1.528 0.856 0 N-CA-C 106.274 -2.731 . . . . 2.29 106.274 -146.593 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 80.9 p -12.73 -19.16 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.435 1 C-N-CA 138.007 6.523 . . . . 1.1000000000000001 119.849 -143.792 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -26.46 -63.39 0.08 Allowed 'General case' 0 N--CA 1.443 -0.787 0 C-N-CA 127.212 2.205 . . . . 0.69999999999999996 113.647 170.671 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -75.31 -42.63 54.18 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 118.212 -1.395 . . . . 0.69999999999999996 109.629 -166.116 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -50.29 -53.95 10.22 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.962 0 CA-C-N 113.965 -1.471 . . . . 0.78000000000000003 110.278 173.918 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -68.17 -46.08 71.72 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 109.591 -0.522 . . . . 1.9299999999999999 109.591 -173.696 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -45.93 -56.93 4.83 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 122.319 1.056 . . . . 3.4100000000000001 111.344 171.485 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.0 mmpt? -71.52 -38.62 71.08 Favored 'General case' 0 N--CA 1.432 -1.343 0 CA-C-O 118.624 -0.703 . . . . 2.46 112.438 -175.063 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -48.69 -52.82 8.27 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 N-CA-C 106.968 -1.493 . . . . 0.52000000000000002 106.968 175.494 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 37.9 mm-40 -58.82 -58.48 8.44 Favored 'General case' 0 C--N 1.343 0.32 0 C-N-CA 124.392 1.077 . . . . 2.5 110.413 177.449 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 9.4 mmtm -57.71 -32.66 67.61 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 113.457 0.91 . . . . 3.98 113.457 -176.416 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.501 HD13 ' HA ' ' A' ' 24' ' ' ILE . 11.4 mt -70.23 -18.19 63.15 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.609 1.163 . . . . 0.79000000000000004 111.701 174.901 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 90.58 44.65 4.52 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 110.483 -1.047 . . . . 0.48999999999999999 110.483 179.068 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -137.27 174.96 10.05 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 124.674 1.19 . . . . 2.0 108.549 177.26 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 32.1 t60 -137.54 156.36 48.2 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 109.425 -0.583 . . . . 1.8 109.425 167.137 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 12.8 p -128.09 137.79 56.51 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.113 0 C-N-CA 125.038 1.335 . . . . 1.54 108.03 -177.091 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 13.0 t -110.74 136.14 47.7 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 C-N-CA 124.622 1.169 . . . . 0.68000000000000005 108.75 -178.817 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 27.8 mm -100.68 75.32 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 C-N-CA 124.463 1.105 . . . . 1.0600000000000001 108.945 -172.24 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -68.09 -7.61 31.07 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 114.616 1.339 . . . . 3.54 114.616 178.598 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 77.81 64.47 2.04 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 109.991 -1.244 . . . . 3.0699999999999998 109.991 -177.64 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 71.7 ttt180 . . . . . 0 C--O 1.25 1.118 0 C-N-CA 125.685 1.594 . . . . 14.140000000000001 111.596 -172.509 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 38.5 mtt . . . . . 0 N--CA 1.472 0.65 0 N-CA-C 107.097 -1.446 . . . . 12.16 107.097 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -145.09 114.37 7.06 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 104.344 -2.465 . . . . 7.6799999999999997 104.344 -174.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -148.28 105.34 3.61 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 106.366 -1.716 . . . . 1.03 106.366 169.727 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -79.97 -175.43 4.96 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 108.577 -0.897 . . . . 2.3199999999999998 108.577 173.33 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.4 mm100 -136.53 144.84 44.47 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 107.979 -1.119 . . . . 1.26 107.979 170.566 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 51.7 mttt -143.91 162.18 36.79 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 123.602 0.761 . . . . 2.8199999999999998 110.706 163.225 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -110.77 87.77 2.61 Favored 'General case' 0 N--CA 1.439 -0.98 0 C-N-CA 129.216 3.006 . . . . 1.6899999999999999 105.447 -173.316 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.502 ' N ' HD12 ' A' ' 8' ' ' ILE . 3.4 mp -83.71 162.03 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 N-CA-C 105.771 -1.937 . . . . 2.46 105.771 -179.747 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -133.72 142.1 47.83 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 125.281 1.432 . . . . 0.77000000000000002 107.362 179.772 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -155.73 175.59 13.73 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 109.125 -0.695 . . . . 2.4500000000000002 109.125 172.082 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 30.0 mm100 -98.55 152.36 19.65 Favored 'General case' 0 C--O 1.223 -0.307 0 C-N-CA 125.477 1.511 . . . . 2.77 108.396 -177.371 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.8 p -111.32 156.43 12.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 CA-C-N 119.166 0.894 . . . . 2.5800000000000001 110.282 -178.72 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 7.6 m -132.92 168.84 17.71 Favored 'General case' 0 C--N 1.339 0.131 0 C-N-CA 124.474 1.11 . . . . 1.22 109.791 171.733 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 58.59 52.44 52.96 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 110.8 -0.92 . . . . 1.5800000000000001 110.8 -179.732 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -131.44 162.36 30.36 Favored 'General case' 0 CA--C 1.521 -0.158 0 C-N-CA 124.377 1.071 . . . . 2.3300000000000001 109.881 -176.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -154.57 -58.61 0.11 Allowed 'General case' 0 CA--C 1.528 0.125 0 C-N-CA 125.457 1.503 . . . . 3.6899999999999999 109.572 168.679 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 9.2 p -81.17 133.19 35.41 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 121.476 0.655 . . . . 2.2999999999999998 109.932 175.509 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -75.6 55.16 0.82 Allowed 'General case' 0 CA--C 1.535 0.391 0 O-C-N 121.626 -0.671 . . . . 1.99 109.473 170.768 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -152.07 -57.15 0.14 Allowed 'General case' 0 N--CA 1.457 -0.076 0 C-N-CA 124.071 0.948 . . . . 0.91000000000000003 110.457 -169.916 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 67.9 m -60.61 -42.46 96.85 Favored 'General case' 0 C--N 1.333 -0.141 0 O-C-N 121.237 -0.915 . . . . 1.3700000000000001 109.605 169.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.64 -19.86 6.94 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 113.009 0.744 . . . . 0.63 113.009 170.243 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -73.01 -50.24 24.24 Favored 'General case' 0 N--CA 1.454 -0.228 0 O-C-N 120.299 -1.501 . . . . 0.46999999999999997 110.687 169.719 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 3.7 mpt_? -49.78 -45.16 49.44 Favored 'General case' 0 CA--C 1.52 -0.198 0 C-N-CA 122.384 0.274 . . . . 4.1799999999999997 110.276 -174.441 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.515 ' HA ' HD13 ' A' ' 67' ' ' LEU . 3.8 pt -57.15 -54.4 30.81 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 O-C-N 123.337 0.398 . . . . 0.5 110.678 -176.677 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -58.01 -43.79 86.91 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 124.033 0.933 . . . . 2.3399999999999999 112.027 176.077 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -66.9 -47.02 73.08 Favored 'General case' 0 CA--C 1.534 0.331 0 O-C-N 121.701 -0.624 . . . . 1.8600000000000001 110.206 -175.444 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.35 -40.47 99.08 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 110.227 -1.149 . . . . 0.62 110.227 173.843 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -62.29 -37.83 87.03 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 122.115 -0.638 . . . . 2.1800000000000002 109.823 179.264 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.8 ttpm? -52.28 -18.99 1.79 Allowed 'General case' 0 CA--C 1.532 0.286 0 O-C-N 121.201 -0.937 . . . . 3.21 113.358 173.274 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 2.9 mtt180 -88.41 -0.54 57.3 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 119.051 0.841 . . . . 4.3600000000000003 112.277 -179.201 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' MET . . . . . 0.617 ' SD ' ' HB1' ' A' ' 59' ' ' ALA . 0.5 OUTLIER -77.97 158.56 77.46 Favored Pre-proline 0 CA--C 1.531 0.215 0 CA-C-N 119.366 0.984 . . . . 3.6099999999999999 111.923 172.537 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -56.87 145.58 83.34 Favored 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 122.494 2.129 . . . . 0.78000000000000003 110.476 170.487 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 82.85 -28.89 3.47 Favored Glycine 0 CA--C 1.53 0.992 0 CA-C-O 119.443 -0.643 . . . . 0.59999999999999998 113.142 176.079 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 16.0 t -84.87 133.65 28.82 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 CA-C-N 118.953 1.377 . . . . 0.56000000000000005 109.655 177.737 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -115.54 -41.19 3.28 Favored 'General case' 0 N--CA 1.457 -0.106 0 C-N-CA 123.746 0.819 . . . . 0.87 110.184 -175.71 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -143.45 163.16 33.89 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 118.844 0.747 . . . . 2.1200000000000001 109.214 176.026 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -156.14 143.69 19.35 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 122.43 0.292 . . . . 0.47999999999999998 111.76 178.685 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -151.59 101.92 2.83 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 106.245 -1.761 . . . . 0.46999999999999997 106.245 -166.762 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.0 p -81.21 142.83 13.28 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 N-CA-C 108.028 -1.101 . . . . 0.79000000000000004 108.028 176.518 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 53.4 t-20 -136.63 64.07 1.56 Allowed 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 122.705 1.241 . . . . 0.91000000000000003 110.115 -171.196 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.497 HD22 ' H ' ' A' ' 41' ' ' LEU . 1.8 mm? -70.79 -20.05 62.63 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 115.048 -0.978 . . . . 2.8100000000000001 111.253 -173.573 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -46.65 -38.14 9.29 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 124.184 0.993 . . . . 0.83999999999999997 112.202 172.17 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 9.0 t -119.4 29.33 7.69 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.012 0.525 . . . . 1.29 110.371 174.21 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 43.79 59.93 2.9 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 126.049 1.74 . . . . 2.7400000000000002 112.023 -177.814 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 90.0 m -146.31 164.02 33.69 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 108.697 -0.853 . . . . 0.70999999999999996 108.697 178.887 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -138.65 143.52 32.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 108.334 -0.988 . . . . 0.46999999999999997 108.334 176.03 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -126.95 137.49 53.13 Favored 'General case' 0 C--N 1.344 0.343 0 N-CA-C 107.787 -1.19 . . . . 0.38 107.787 178.422 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 31.2 t -130.12 130.18 65.75 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 N-CA-C 105.13 -2.174 . . . . 2.27 105.13 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 13.0 mm -101.3 99.15 7.83 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.578 0 N-CA-C 106.959 -1.497 . . . . 0.56000000000000005 106.959 -177.33 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.435 ' CE2' HD13 ' A' ' 8' ' ' ILE . 54.5 p90 -141.42 168.91 18.65 Favored 'General case' 0 CA--C 1.51 -0.591 0 O-C-N 122.055 -0.403 . . . . 2.52 110.245 -171.311 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 42.0 t0 -86.52 107.87 15.5 Favored Pre-proline 0 C--N 1.327 -0.389 0 O-C-N 124.482 1.114 . . . . 3.1299999999999999 109.639 174.928 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -73.48 4.24 4.12 Favored 'Trans proline' 0 N--CA 1.451 -1.013 0 C-N-CA 122.222 1.948 . . . . 1.1100000000000001 112.68 -179.093 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -82.35 -36.03 27.24 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 119.622 1.101 . . . . 1.3899999999999999 108.508 166.101 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -103.41 -60.47 1.56 Allowed 'General case' 0 N--CA 1.453 -0.315 0 O-C-N 123.724 0.64 . . . . 4.04 109.694 -167.099 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.48 HG22 ' HB3' ' A' ' 59' ' ' ALA 0.459 0.5 OUTLIER -81.54 -172.64 3.95 Favored 'General case' 0 CA--C 1.521 -0.149 0 N-CA-C 113.729 1.011 . . . . 0.72999999999999998 113.729 156.512 . . . . . . . . 4 4 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 159.66 -148.6 17.47 Favored Glycine 0 N--CA 1.434 -1.473 1 N-CA-C 102.492 -4.243 . . . . 2.9300000000000002 102.492 -157.246 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 33.2 p -78.34 -37.6 44.12 Favored 'General case' 0 N--CA 1.444 -0.772 0 C-N-CA 124.772 1.229 . . . . 1.1799999999999999 110.104 178.327 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -49.13 -62.54 1.48 Allowed 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.715 1.206 . . . . 0.54000000000000004 113.403 -163.584 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.617 ' HB1' ' SD ' ' A' ' 31' ' ' MET . . . -71.68 -32.25 67.64 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.198 -1.365 . . . . 0.46999999999999997 108.973 -169.236 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.7 mp -60.04 -55.36 24.63 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.795 0 CA-C-N 114.937 -1.029 . . . . 1.1399999999999999 109.876 175.253 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.91 -45.82 89.41 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 119.167 0.894 . . . . 1.3300000000000001 110.1 -178.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -48.76 -56.57 8.25 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 121.449 0.642 . . . . 3.3900000000000001 111.691 174.146 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 3.5 mmmt -64.92 -42.99 94.24 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-O 118.923 -0.561 . . . . 3.3999999999999999 112.043 -178.464 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.4 mm -50.39 -52.74 14.46 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.707 0 C-N-CA 125.71 1.604 . . . . 0.56000000000000005 107.804 -179.622 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -56.27 -56.56 19.5 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 123.769 0.828 . . . . 2.3500000000000001 110.661 175.178 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 12.7 mptt -58.76 -34.66 71.67 Favored 'General case' 0 CA--C 1.536 0.436 0 O-C-N 121.716 -0.615 . . . . 4.7999999999999998 112.435 -175.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.515 HD13 ' HA ' ' A' ' 24' ' ' ILE . 11.8 mt -70.5 -16.63 62.92 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.646 1.178 . . . . 0.69999999999999996 111.965 175.678 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 86.0 42.13 6.84 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 110.288 -1.125 . . . . 0.60999999999999999 110.288 179.178 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -134.95 175.98 9.08 Favored 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 124.315 1.046 . . . . 1.99 109.458 -179.562 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -144.46 157.11 44.4 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 109.2 -0.667 . . . . 2.1099999999999999 109.2 170.662 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 8.0 p -138.33 137.42 43.89 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.19 0 N-CA-C 107.757 -1.201 . . . . 1.52 107.757 -173.732 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 29.6 t -103.53 137.51 31.71 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 C-N-CA 125.364 1.466 . . . . 0.56999999999999995 109.002 -175.901 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 48.4 mm -105.98 80.23 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 C-N-CA 124.728 1.211 . . . . 1.1200000000000001 107.979 -176.386 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 -76.46 -0.16 21.94 Favored 'General case' 0 N--CA 1.443 -0.779 0 C-N-CA 123.799 0.84 . . . . 2.73 113.241 169.498 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -93.59 -22.29 26.8 Favored Glycine 0 CA--C 1.525 0.672 0 C-N-CA 125.222 1.392 . . . . 3.6000000000000001 114.517 -171.182 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.025 0 CA-C-O 116.452 -1.737 . . . . 10.94 110.219 -169.014 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 mpt? . . . . . 0 N--CA 1.472 0.663 0 N-CA-C 108.032 -1.099 . . . . 9.5099999999999998 108.032 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 19.7 mt -84.35 155.84 22.15 Favored 'General case' 0 C--N 1.332 -0.169 0 O-C-N 123.993 0.808 . . . . 4.5099999999999998 109.45 175.135 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.0 m -67.02 107.86 2.41 Favored 'General case' 0 N--CA 1.447 -0.624 0 C-N-CA 124.369 1.067 . . . . 0.67000000000000004 108.713 171.013 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -70.16 168.95 14.58 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 108.241 -1.022 . . . . 2.02 108.241 162.591 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -129.09 153.56 47.53 Favored 'General case' 0 N--CA 1.457 -0.12 0 C-N-CA 124.548 1.139 . . . . 1.1399999999999999 109.99 178.281 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 85.5 mttt -146.07 162.7 37.33 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 124.28 1.032 . . . . 3.6000000000000001 109.992 168.57 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 8.9 mp0 -121.18 87.93 2.85 Favored 'General case' 0 N--CA 1.441 -0.89 0 C-N-CA 127.979 2.512 . . . . 1.6200000000000001 106.122 -168.366 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.47 ' N ' HD12 ' A' ' 8' ' ' ILE . 2.6 mp -83.06 161.66 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.369 0 N-CA-C 105.887 -1.894 . . . . 2.0699999999999998 105.887 -177.102 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -128.31 135.21 49.3 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 125.944 1.698 . . . . 0.64000000000000001 106.595 178.283 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 43.1 mtt -140.89 171.98 13.33 Favored 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 109.498 -0.556 . . . . 2.3300000000000001 109.498 174.721 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 21.8 mm100 -96.96 139.33 33.14 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 125.701 1.601 . . . . 2.4900000000000002 108.624 176.621 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 81.0 t -92.66 153.91 3.25 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 N-CA-C 108.893 -0.78 . . . . 1.3 108.893 175.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 62.9 m -150.77 165.48 33.39 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.074 0.949 . . . . 1.2 109.264 173.177 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 60.32 61.84 6.67 Favored Glycine 0 CA--C 1.528 0.874 0 N-CA-C 110.745 -0.942 . . . . 1.5700000000000001 110.745 -178.697 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -135.58 156.38 48.96 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 123.834 0.854 . . . . 1.75 110.153 -174.909 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -105.34 -55.81 2.27 Favored 'General case' 0 CA--C 1.528 0.118 0 C-N-CA 125.199 1.4 . . . . 2.3599999999999999 109.764 168.051 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 16.9 p -139.67 159.48 42.07 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 121.914 0.864 . . . . 2.3199999999999998 111.93 -172.853 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -75.87 39.88 0.18 Allowed 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.963 1.305 . . . . 2.0099999999999998 111.899 179.43 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -128.67 -53.68 1.24 Allowed 'General case' 0 CA--C 1.524 -0.058 0 C-N-CA 124.599 1.159 . . . . 0.78000000000000003 108.612 178.647 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 21.0 m -58.72 -38.15 77.72 Favored 'General case' 0 CA--C 1.532 0.274 0 O-C-N 121.556 -0.715 . . . . 1.2 109.714 170.726 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.656 ' HB1' HG21 ' A' ' 39' ' ' VAL . . . -54.65 -26.69 34.74 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 116.06 -0.518 . . . . 0.40999999999999998 112.082 172.551 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.92 -48.95 41.81 Favored 'General case' 0 N--CA 1.455 -0.177 0 O-C-N 120.08 -1.637 . . . . 0.34000000000000002 109.629 172.368 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 26.9 mmm180 -50.17 -46.02 53.85 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 123.022 0.529 . . . . 5.0800000000000001 110.543 -175.82 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.434 HG21 ' CD1' ' A' ' 69' ' ' TYR . 3.5 pt -59.0 -53.35 49.1 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 C-N-CA 120.245 -0.582 . . . . 0.46000000000000002 111.066 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -54.42 -44.93 72.83 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 123.296 0.638 . . . . 2.2999999999999998 111.687 177.16 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 32.1 mmtp -70.55 -44.0 68.35 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 118.839 0.745 . . . . 2.1299999999999999 110.657 -175.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -58.95 -39.55 94.26 Favored Glycine 0 CA--C 1.528 0.903 0 N-CA-C 110.488 -1.045 . . . . 0.5 110.488 172.818 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -66.21 -42.8 88.25 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 109.056 -0.72 . . . . 2.3599999999999999 109.056 179.365 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.6 ttpp -56.96 -14.99 4.06 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.719 1.608 . . . . 2.8900000000000001 114.128 177.283 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.83 -11.6 56.79 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.93 1.692 . . . . 3.9300000000000002 111.794 176.74 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 93.3 mmm -71.6 154.72 93.08 Favored Pre-proline 0 CA--C 1.53 0.185 0 CA-C-N 119.03 0.832 . . . . 3.25 111.378 179.263 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -56.21 141.86 87.63 Favored 'Trans proline' 0 N--CA 1.451 -1.008 0 C-N-CA 121.47 1.447 . . . . 0.58999999999999997 108.596 163.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 88.42 -12.56 64.54 Favored Glycine 0 N--CA 1.448 -0.559 0 CA-C-O 117.932 -1.482 . . . . 0.88 114.463 173.391 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 40.6 t -109.46 125.41 66.6 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 CA-C-N 119.787 1.793 . . . . 0.55000000000000004 109.061 177.586 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 99.7 m -97.49 -50.66 4.43 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-O 118.205 -0.902 . . . . 1.1599999999999999 110.067 -176.764 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -138.71 159.8 41.22 Favored 'General case' 0 C--N 1.342 0.258 0 CA-C-N 119.337 0.971 . . . . 2.1099999999999999 110.803 176.436 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -156.39 146.39 21.19 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 122.98 0.512 . . . . 0.38 112.066 -178.89 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -155.94 121.31 4.85 Favored 'General case' 0 C--N 1.342 0.273 0 N-CA-C 109.047 -0.723 . . . . 0.5 109.047 -165.792 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.656 HG21 ' HB1' ' A' ' 21' ' ' ALA . 9.2 p -92.87 102.27 13.46 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 C-N-CA 123.055 0.542 . . . . 0.64000000000000001 110.201 -177.63 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 50.5 t-20 -85.53 57.36 4.42 Favored 'General case' 0 CA--C 1.533 0.323 0 O-C-N 120.518 -1.364 . . . . 0.59999999999999998 109.462 179.809 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.435 HD22 ' HA ' ' A' ' 41' ' ' LEU . 0.2 OUTLIER -68.31 -19.97 64.71 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 115.495 -0.775 . . . . 1.02 110.468 -175.957 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -47.42 -33.83 6.48 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.771 0.828 . . . . 0.62 112.132 168.726 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 15.3 t -120.54 28.76 7.8 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 118.148 0.431 . . . . 1.24 111.158 174.48 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 46.86 57.11 5.91 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 124.557 1.143 . . . . 2.7999999999999998 112.109 -176.505 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 67.2 m -146.59 157.05 43.65 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 108.159 -1.052 . . . . 0.79000000000000004 108.159 178.442 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.4 p -124.92 144.43 34.95 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 N-CA-C 108.071 -1.085 . . . . 0.31 108.071 172.128 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -125.51 137.52 53.95 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 108.132 -1.062 . . . . 0.32000000000000001 108.132 175.347 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 4.4 p -135.1 123.67 40.55 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 N-CA-C 106.165 -1.791 . . . . 1.8200000000000001 106.165 -176.258 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 12.6 mm -101.58 90.02 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 N-CA-C 106.266 -1.753 . . . . 0.44 106.266 -172.869 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 24.8 p90 -126.55 168.63 14.02 Favored 'General case' 0 CA--C 1.506 -0.742 0 CA-C-O 120.923 0.392 . . . . 2.0600000000000001 110.149 -169.474 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -98.87 103.31 18.64 Favored Pre-proline 0 N--CA 1.44 -0.941 0 CA-C-N 114.537 -1.211 . . . . 4.3799999999999999 108.157 -176.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -73.67 12.02 0.97 Allowed 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 122.632 2.222 . . . . 0.64000000000000001 113.277 -172.876 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -83.52 -25.26 31.19 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 109.061 -0.718 . . . . 0.95999999999999996 109.061 165.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -116.77 -58.4 2.08 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 123.81 0.844 . . . . 2.8300000000000001 109.454 -170.187 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.307 6.6 p -88.22 -171.98 3.6 Favored 'General case' 0 C--N 1.344 0.327 0 CA-C-N 118.181 0.446 . . . . 0.70999999999999996 110.304 165.522 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 135.7 87.15 0.23 Allowed Glycine 0 N--CA 1.442 -0.936 0 N-CA-C 105.164 -3.174 . . . . 2.3399999999999999 105.164 -155.151 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 52.2 p -8.22 -17.02 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.378 1 C-N-CA 137.794 6.438 . . . . 1.1399999999999999 120.248 -142.018 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -28.08 -66.34 0.08 Allowed 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 127.226 2.211 . . . . 0.64000000000000001 113.59 166.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.48 -36.39 71.14 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 116.978 -1.889 . . . . 0.67000000000000004 109.415 -166.033 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.5 mp -54.19 -57.39 6.07 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.047 0 CA-C-N 114.325 -1.307 . . . . 0.81999999999999995 109.178 175.501 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.09 -47.13 86.02 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 119.306 0.957 . . . . 1.1899999999999999 110.527 -178.032 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -48.89 -55.8 10.66 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 121.902 0.858 . . . . 4.5800000000000001 111.14 177.059 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -70.42 -37.61 74.44 Favored 'General case' 0 N--CA 1.437 -1.104 0 CA-C-O 118.042 -0.98 . . . . 2.3399999999999999 111.877 -177.71 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.1 mm -49.69 -52.74 11.85 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 N-CA-C 107.525 -1.287 . . . . 0.39000000000000001 107.525 178.464 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -57.53 -58.5 8.04 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 123.939 0.896 . . . . 1.8100000000000001 110.64 175.696 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -58.97 -32.79 69.98 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 112.955 0.724 . . . . 4.0999999999999996 112.955 -175.217 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 15.1 mt -70.58 -17.96 62.9 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.667 1.187 . . . . 0.57999999999999996 111.663 175.425 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 91.97 42.51 4.68 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.676 -0.97 . . . . 0.41999999999999998 110.676 178.154 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.434 ' CD1' HG21 ' A' ' 24' ' ' ILE . 0.3 OUTLIER -136.91 173.26 11.89 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 124.239 1.015 . . . . 1.8700000000000001 109.881 -179.835 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -137.99 128.33 26.21 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 107.773 -1.195 . . . . 1.79 107.773 172.689 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 4.2 p -104.19 146.69 11.29 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 N-CA-C 107.35 -1.352 . . . . 1.3899999999999999 107.35 170.848 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 91.3 t -116.29 146.63 20.46 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 C-N-CA 126.733 2.013 . . . . 0.80000000000000004 107.022 176.279 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 4.9 mp -116.96 79.54 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 C-N-CA 124.221 1.008 . . . . 1.4199999999999999 108.786 -174.613 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -76.76 0.99 18.54 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 125.911 1.685 . . . . 3.3500000000000001 113.569 173.151 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -138.25 59.8 0.6 Allowed Glycine 0 CA--C 1.522 0.523 0 N-CA-C 108.363 -1.895 . . . . 4.1900000000000004 108.363 177.817 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 17.9 ttt180 . . . . . 0 C--O 1.25 1.126 0 CA-C-O 117.075 -1.44 . . . . 13.19 110.302 177.063 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.9 ptp . . . . . 0 N--CA 1.471 0.594 0 N-CA-C 106.127 -1.805 . . . . 9.2300000000000004 106.127 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 66.14 148.47 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.56 0 O-C-N 124.439 1.087 . . . . 4.7300000000000004 110.364 -168.344 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 57.9 m -145.18 119.91 9.85 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 106.774 -1.565 . . . . 0.73999999999999999 106.774 -174.229 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -75.95 177.27 7.15 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 109.311 -0.626 . . . . 2.1600000000000001 109.311 171.604 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -138.52 140.75 39.24 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 107.532 -1.284 . . . . 1.02 107.532 174.92 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -138.39 160.97 38.16 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 124.573 1.149 . . . . 3.6000000000000001 109.74 168.438 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -119.37 95.87 4.97 Favored 'General case' 0 N--CA 1.441 -0.892 0 C-N-CA 128.903 2.881 . . . . 1.45 106.678 -171.734 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 7.0 mm -84.67 161.71 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.128 0 N-CA-C 106.879 -1.526 . . . . 2.1000000000000001 106.879 178.274 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -137.34 133.05 34.45 Favored 'General case' 0 C--O 1.23 0.076 0 C-N-CA 124.782 1.233 . . . . 0.54000000000000004 107.782 -179.795 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 9.3 ptp -157.65 175.75 13.51 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 118.664 0.665 . . . . 1.97 111.0 -178.238 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 28.7 mm100 -93.71 164.22 13.23 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.443 1.497 . . . . 2.46 110.655 -178.016 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 60.5 t -121.02 158.67 23.47 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 C-N-CA 124.964 1.306 . . . . 1.1699999999999999 109.427 -177.447 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 14.1 m -149.38 166.4 29.16 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 123.918 0.887 . . . . 0.88 110.08 167.866 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 68.13 47.52 58.67 Favored Glycine 0 CA--C 1.528 0.862 0 N-CA-C 110.522 -1.031 . . . . 1.6599999999999999 110.522 -171.302 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -125.94 156.93 38.98 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 124.643 1.177 . . . . 2.1800000000000002 109.589 -178.915 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER 179.85 -44.08 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 127.871 2.468 . . . . 3.7799999999999998 110.881 179.43 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 36.6 m -56.89 -22.59 38.43 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.658 0.783 . . . . 3.0699999999999998 112.704 177.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 57.38 33.32 23.12 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.58 1.152 . . . . 2.3900000000000001 111.602 178.008 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -159.3 -45.09 0.05 Allowed 'General case' 0 C--O 1.226 -0.179 0 C-N-CA 124.433 1.093 . . . . 0.78000000000000003 109.736 -175.611 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 94.4 m -50.31 -38.44 41.57 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.196 0.998 . . . . 1.23 112.278 171.826 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.404 ' HB1' HG21 ' A' ' 39' ' ' VAL . . . -56.11 -23.53 34.89 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 122.935 0.494 . . . . 0.47999999999999998 112.252 174.994 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -72.6 -50.1 27.64 Favored 'General case' 0 N--CA 1.457 -0.115 0 O-C-N 120.556 -1.34 . . . . 0.34000000000000002 111.114 167.022 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 6.6 mmp_? -49.33 -46.42 46.79 Favored 'General case' 0 CA--C 1.52 -0.209 0 N-CA-C 109.691 -0.485 . . . . 6.8600000000000003 109.691 179.823 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.498 HG21 ' CD1' ' A' ' 69' ' ' TYR 0.272 2.0 pt -59.23 -59.34 3.99 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.442 0 C-N-CA 119.337 -0.945 . . . . 0.46999999999999997 111.033 178.505 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -51.59 -41.68 61.37 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 119.526 1.057 . . . . 3.27 112.298 -179.135 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.2 mptp? -71.38 -43.64 66.49 Favored 'General case' 0 CA--C 1.538 0.484 0 O-C-N 121.13 -0.981 . . . . 1.73 110.708 -177.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -65.76 -32.11 81.94 Favored Glycine 0 CA--C 1.534 1.239 0 O-C-N 121.456 -0.778 . . . . 0.59999999999999998 111.65 174.769 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.0 tt -63.59 -48.29 77.99 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 126.111 1.764 . . . . 1.8999999999999999 107.914 175.892 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 12.8 ttmt -47.51 -37.34 11.8 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.039 0.536 . . . . 2.8399999999999999 112.435 174.324 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -66.17 -0.28 2.41 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 114.043 1.127 . . . . 3.3799999999999999 114.043 -176.671 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 13.5 ptp -77.29 164.17 60.13 Favored Pre-proline 0 CA--C 1.538 0.49 0 CA-C-N 119.735 1.152 . . . . 4.2199999999999998 111.788 172.754 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -69.0 137.56 37.98 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 121.543 1.495 . . . . 0.56999999999999995 109.756 168.407 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 99.91 -31.53 8.3 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 123.49 0.567 . . . . 0.5 113.187 172.243 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 47.1 t -82.56 140.33 16.53 Favored 'Isoleucine or valine' 0 C--N 1.341 0.205 0 CA-C-N 118.672 1.236 . . . . 0.56000000000000005 109.289 171.119 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -114.68 -38.05 4.09 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 118.812 -0.613 . . . . 1.0600000000000001 110.652 178.327 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -143.67 163.23 33.85 Favored 'General case' 0 C--N 1.341 0.238 0 CA-C-N 119.566 1.076 . . . . 1.8700000000000001 110.281 175.16 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -159.37 134.85 8.44 Favored 'General case' 0 C--O 1.239 0.516 0 C-N-CA 123.386 0.674 . . . . 0.42999999999999999 112.05 -171.416 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -148.06 111.86 5.09 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 124.213 1.005 . . . . 0.46000000000000002 109.723 -164.795 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.404 HG21 ' HB1' ' A' ' 21' ' ' ALA . 7.1 p -84.2 98.18 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 C-N-CA 123.53 0.732 . . . . 0.56999999999999995 110.403 179.796 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 49.6 t-20 -84.21 56.59 3.82 Favored 'General case' 0 CA--C 1.537 0.46 0 O-C-N 120.28 -1.512 . . . . 0.58999999999999997 110.027 179.618 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.44 HD22 ' HA ' ' A' ' 41' ' ' LEU . 0.2 OUTLIER -69.99 -17.98 63.31 Favored 'General case' 0 N--CA 1.462 0.128 0 C-N-CA 123.625 0.77 . . . . 0.93999999999999995 110.849 -178.24 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -44.34 -38.18 3.79 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 123.68 0.792 . . . . 0.53000000000000003 111.673 166.416 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 6.5 t -124.89 39.12 4.05 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 122.929 0.492 . . . . 1.27 109.725 172.002 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 50.17 32.06 5.65 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.741 1.617 . . . . 2.8799999999999999 113.804 173.24 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 40.2 m -119.8 163.96 16.7 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.947 1.299 . . . . 0.62 108.43 -177.577 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.8 p -133.15 145.22 34.38 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 O-C-N 121.038 -1.039 . . . . 0.29999999999999999 109.136 171.139 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -132.42 129.48 39.35 Favored 'General case' 0 C--N 1.344 0.346 0 C-N-CA 124.743 1.217 . . . . 0.38 108.445 -178.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.7 p -126.53 128.92 71.66 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 N-CA-C 105.524 -2.028 . . . . 1.78 105.524 -174.903 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 10.9 mm -105.42 100.44 10.58 Favored 'Isoleucine or valine' 0 C--O 1.239 0.527 0 C-N-CA 124.945 1.298 . . . . 0.41999999999999998 107.898 -173.912 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 48.0 p90 -141.62 171.05 14.59 Favored 'General case' 0 CA--C 1.512 -0.485 0 O-C-N 121.937 -0.477 . . . . 1.75 111.801 -170.598 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 60.7 t0 -90.62 105.59 12.39 Favored Pre-proline 0 CA--C 1.534 0.362 0 O-C-N 124.742 1.276 . . . . 3.04 110.696 174.597 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -74.88 9.83 1.87 Allowed 'Trans proline' 0 N--CA 1.452 -0.925 0 C-N-CA 122.108 1.872 . . . . 0.63 113.55 179.823 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -84.15 -27.88 27.81 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 119.238 0.926 . . . . 0.83999999999999997 108.824 164.051 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -108.43 -58.1 2.04 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 123.344 0.658 . . . . 2.6299999999999999 109.359 -170.913 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.422 0.3 OUTLIER -81.72 179.72 7.72 Favored 'General case' 0 CA--C 1.514 -0.416 0 N-CA-C 116.308 1.966 . . . . 0.46000000000000002 116.308 161.859 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -176.19 -152.35 9.54 Favored Glycine 0 N--CA 1.43 -1.708 1 N-CA-C 102.272 -4.331 . . . . 2.3900000000000001 102.272 -176.875 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 19.4 p -73.03 -32.4 65.07 Favored 'General case' 0 C--N 1.318 -0.792 0 C-N-CA 124.959 1.304 . . . . 1.2 109.206 178.068 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -42.56 -62.64 0.93 Allowed 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 125.839 1.655 . . . . 0.52000000000000002 113.671 -172.706 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -75.02 -34.69 61.95 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.042 -0.981 . . . . 0.45000000000000001 109.165 -169.697 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -56.17 -52.77 47.09 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.89 0 CA-C-O 117.67 -1.157 . . . . 0.90000000000000002 111.232 175.495 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.41 -46.96 87.95 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 119.864 1.211 . . . . 1.05 109.355 -179.184 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -48.81 -57.3 6.59 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-O 122.105 0.955 . . . . 2.6200000000000001 111.22 176.449 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.9 mmtp -63.02 -44.54 95.67 Favored 'General case' 0 N--CA 1.435 -1.176 0 CA-C-O 118.659 -0.686 . . . . 2.9199999999999999 110.77 -179.379 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -47.43 -52.62 5.19 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 C-N-CA 125.208 1.403 . . . . 0.51000000000000001 108.887 177.559 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -61.67 -55.5 29.81 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 123.762 0.825 . . . . 1.76 110.699 177.908 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.4 mmmp? -58.07 -31.02 66.67 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 113.366 0.876 . . . . 5.29 113.366 -178.261 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 22.8 mt -73.11 -17.15 61.43 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.583 1.553 . . . . 0.70999999999999996 112.121 174.426 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 93.17 42.55 4.29 Favored Glycine 0 C--N 1.337 0.631 0 C-N-CA 124.918 1.246 . . . . 0.51000000000000001 110.693 175.597 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.498 ' CD1' HG21 ' A' ' 24' ' ' ILE . 0.3 OUTLIER -145.13 177.05 9.07 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 123.348 0.659 . . . . 1.95 111.41 -169.629 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 4.9 t60 -142.25 131.79 23.88 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 107.825 -1.176 . . . . 2.0299999999999998 107.825 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 8.2 p -107.52 138.87 31.58 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.089 0 N-CA-C 108.018 -1.105 . . . . 1.6100000000000001 108.018 175.697 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 5.2 t -116.81 140.79 37.8 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.126 0 N-CA-C 108.598 -0.89 . . . . 0.65000000000000002 108.598 -177.199 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 4.9 mp -116.13 79.73 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 N-CA-C 108.065 -1.087 . . . . 1.24 108.065 179.433 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -77.93 1.09 21.72 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 125.176 1.39 . . . . 3.4100000000000001 113.148 168.452 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -76.55 -13.67 83.23 Favored Glycine 0 CA--C 1.525 0.698 0 C-N-CA 124.854 1.216 . . . . 2.6099999999999999 113.154 178.482 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 46.1 ttt180 . . . . . 0 C--O 1.251 1.136 0 CA-C-O 116.282 -1.818 . . . . 11.619999999999999 107.569 177.172 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 44.4 mtt . . . . . 0 N--CA 1.47 0.532 0 N-CA-C 107.52 -1.289 . . . . 12.1 107.52 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 6.6 tp -150.75 122.25 7.94 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 102.811 -3.033 . . . . 5.6399999999999997 102.811 167.864 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 8.1 m 65.19 104.14 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.296 0 O-C-N 124.484 1.115 . . . . 0.87 109.691 -170.077 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -64.37 169.97 4.24 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 107.738 -1.208 . . . . 2.0499999999999998 107.738 162.61 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -131.48 150.46 52.14 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 108.597 -0.89 . . . . 1.29 108.597 173.428 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 44.4 mtpt -143.45 156.79 44.74 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-O 121.695 0.759 . . . . 2.8199999999999998 110.61 169.314 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -100.4 112.77 25.15 Favored 'General case' 0 N--CA 1.44 -0.959 0 C-N-CA 128.188 2.595 . . . . 2.3799999999999999 107.272 -178.301 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.457 HD12 ' C ' ' A' ' 8' ' ' ILE . 2.3 pp -82.64 164.16 2.87 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.157 0 C-N-CA 119.357 -0.937 . . . . 5.2599999999999998 108.559 165.778 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -143.09 113.01 7.07 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 106.16 -1.792 . . . . 0.64000000000000001 106.16 175.884 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 59.9 mtt -140.29 170.12 16.4 Favored 'General case' 0 C--N 1.334 -0.096 0 CA-C-N 118.306 0.503 . . . . 3.5499999999999998 110.165 -172.595 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 28.8 mm100 -96.0 161.03 14.16 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 123.839 0.856 . . . . 2.5699999999999998 110.173 -176.626 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 44.9 t -120.23 146.2 25.43 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 N-CA-C 108.347 -0.983 . . . . 1.3200000000000001 108.347 -175.316 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 72.3 m -138.61 163.67 31.46 Favored 'General case' 0 N--CA 1.456 -0.154 0 C-N-CA 124.541 1.136 . . . . 0.98999999999999999 109.275 171.114 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 56.92 63.58 5.19 Favored Glycine 0 CA--C 1.528 0.85 0 C-N-CA 123.57 0.605 . . . . 1.6499999999999999 111.668 173.544 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 11.2 ptm -120.47 147.01 45.67 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 124.153 0.981 . . . . 3.0299999999999998 110.762 -177.053 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -81.98 -68.81 0.67 Allowed 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.513 1.125 . . . . 3.9399999999999999 108.65 166.259 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 16.3 p -154.45 169.79 22.92 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-O 121.512 0.672 . . . . 2.5499999999999998 111.119 178.531 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.15 -38.95 66.07 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 124.569 1.148 . . . . 2.5699999999999998 111.925 179.258 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.31 -46.15 90.89 Favored 'General case' 0 N--CA 1.453 -0.287 0 O-C-N 121.959 -0.463 . . . . 1.1299999999999999 110.182 -179.491 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 67.3 m -66.87 -43.75 82.75 Favored 'General case' 0 N--CA 1.454 -0.233 0 O-C-N 121.849 -0.532 . . . . 1.6000000000000001 109.898 175.528 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.0 -18.88 26.95 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 112.856 0.687 . . . . 0.65000000000000002 112.856 176.113 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.27 -50.44 39.49 Favored 'General case' 0 N--CA 1.449 -0.49 0 O-C-N 119.937 -1.727 . . . . 0.52000000000000002 109.074 169.058 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -52.73 -45.07 66.83 Favored 'General case' 0 C--N 1.34 0.16 0 CA-C-O 118.462 -0.78 . . . . 6.3499999999999996 110.426 -177.275 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.4 HG21 ' CD1' ' A' ' 69' ' ' TYR 0.268 3.3 pt -55.4 -59.59 2.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 CA-C-O 118.788 -0.625 . . . . 0.80000000000000004 110.289 179.911 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.46 ' HG3' ' HB1' ' A' ' 37' ' ' ALA . 0.6 OUTLIER -52.51 -45.23 66.14 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 119.516 1.053 . . . . 2.6699999999999999 111.923 178.199 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 35.6 mmtm -66.84 -42.62 85.44 Favored 'General case' 0 CA--C 1.537 0.479 0 O-C-N 121.301 -0.874 . . . . 2.02 111.427 -177.346 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -63.1 -28.57 72.36 Favored Glycine 0 CA--C 1.53 1.023 0 N-CA-C 111.165 -0.774 . . . . 0.57999999999999996 111.165 171.063 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.512 HD22 HG21 ' A' ' 34' ' ' VAL . 0.6 OUTLIER -66.19 -47.63 73.28 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 108.801 -0.814 . . . . 1.6000000000000001 108.801 175.394 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.635 ' HE2' ' HA ' ' A' ' 36' ' ' ASP . 24.9 ttmt -52.09 -37.08 52.85 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 122.822 0.449 . . . . 2.7599999999999998 111.553 174.435 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 13.6 mmt180 -59.62 -11.49 4.99 Favored 'General case' 0 CA--C 1.542 0.669 0 O-C-N 121.097 -1.002 . . . . 3.27 113.477 177.908 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' MET . . . . . 0.629 ' CE ' ' HB1' ' A' ' 59' ' ' ALA . 4.0 ptm -82.74 152.56 66.52 Favored Pre-proline 0 CA--C 1.535 0.376 0 CA-C-N 120.058 1.299 . . . . 3.3100000000000001 112.222 178.464 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -62.25 120.7 8.39 Favored 'Trans proline' 0 N--CA 1.452 -0.92 0 C-N-CA 122.283 1.989 . . . . 1.05 109.17 171.683 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 114.25 -24.85 11.09 Favored Glycine 0 CA--C 1.527 0.792 0 CA-C-O 118.336 -1.258 . . . . 1.01 113.451 172.264 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.512 HG21 HD22 ' A' ' 28' ' ' LEU . 61.5 t -96.99 118.14 42.86 Favored 'Isoleucine or valine' 0 C--N 1.343 0.317 0 CA-C-N 119.408 1.604 . . . . 1.1899999999999999 110.876 174.914 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 39.6 m -95.59 -35.88 11.46 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-O 117.801 -1.095 . . . . 1.3 112.483 -175.1 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.635 ' HA ' ' HE2' ' A' ' 29' ' ' LYS . 0.2 OUTLIER -145.23 164.27 31.88 Favored 'General case' 0 C--N 1.344 0.329 0 CA-C-N 120.273 1.397 . . . . 2.0499999999999998 110.622 164.258 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.46 ' HB1' ' HG3' ' A' ' 25' ' ' GLU . . . -158.52 135.17 9.54 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 116.313 -0.403 . . . . 0.64000000000000001 110.864 -174.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -149.1 110.14 4.35 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 106.115 -1.809 . . . . 0.59999999999999998 106.115 -161.445 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 10.3 p -89.37 131.79 35.76 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.764 0 N-CA-C 108.384 -0.969 . . . . 0.57999999999999996 108.384 179.196 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 64.1 t-20 -118.96 71.4 0.85 Allowed 'General case' 0 C--O 1.234 0.273 0 C-N-CA 124.758 1.223 . . . . 0.96999999999999997 109.083 -178.029 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.604 HD22 ' H ' ' A' ' 41' ' ' LEU . 2.0 mm? -67.6 -25.59 65.84 Favored 'General case' 0 C--O 1.226 -0.167 0 CA-C-N 115.146 -0.933 . . . . 3.0600000000000001 110.22 -178.967 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -51.42 -34.78 36.31 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-O 118.802 -0.618 . . . . 0.95999999999999996 111.666 172.254 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.3 t -115.13 22.78 13.05 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 118.278 0.49 . . . . 1.3899999999999999 111.402 172.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 47.14 44.52 15.48 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.574 1.55 . . . . 3.7599999999999998 113.743 179.754 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 51.8 m -139.89 145.64 38.27 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 108.417 -0.957 . . . . 1.1399999999999999 108.417 -179.704 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 5.2 p -110.73 143.57 20.41 Favored 'Isoleucine or valine' 0 C--O 1.232 0.18 0 C-N-CA 124.404 1.082 . . . . 0.41999999999999998 109.095 175.5 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 26.9 m120 -127.08 137.74 53.08 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 107.446 -1.316 . . . . 0.55000000000000004 107.446 178.523 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 59.9 t -131.47 124.25 54.27 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 N-CA-C 105.279 -2.119 . . . . 2.0499999999999998 105.279 -177.446 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 17.0 mm -102.17 87.51 1.23 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.421 0 C-N-CA 125.498 1.519 . . . . 0.54000000000000004 106.981 -173.812 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 6.8 p90 -120.24 171.33 8.57 Favored 'General case' 0 CA--C 1.509 -0.631 0 CA-C-N 116.227 -0.442 . . . . 1.8 110.333 -168.684 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -101.28 107.71 51.76 Favored Pre-proline 0 N--CA 1.449 -0.512 0 N-CA-C 108.822 -0.807 . . . . 4.6100000000000003 108.822 -175.898 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -71.45 7.71 1.42 Allowed 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 123.037 2.492 . . . . 1.1100000000000001 113.552 -174.797 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -83.03 -22.62 33.52 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 118.706 0.685 . . . . 1.51 109.312 167.524 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -122.36 -55.82 1.83 Allowed 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.367 1.067 . . . . 3.3700000000000001 110.642 -169.546 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.887 HG22 ' HB3' ' A' ' 59' ' ' ALA 0.278 0.8 OUTLIER -86.41 -171.78 3.72 Favored 'General case' 0 CA--C 1.52 -0.18 0 C-N-CA 123.998 0.919 . . . . 0.75 112.391 161.136 . . . . . . . . 4 4 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 134.3 87.02 0.27 Allowed Glycine 0 N--CA 1.443 -0.885 0 N-CA-C 104.265 -3.534 . . . . 2.4199999999999999 104.265 -153.004 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 68.2 p -14.78 -21.2 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.604 1 C-N-CA 138.119 6.568 . . . . 1.6000000000000001 119.42 -143.589 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -28.51 -62.6 0.11 Allowed 'General case' 0 N--CA 1.442 -0.859 0 C-N-CA 127.651 2.381 . . . . 1.1699999999999999 114.13 165.44 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.887 ' HB3' HG22 ' A' ' 55' ' ' THR . . . -74.72 -31.23 61.78 Favored 'General case' 0 C--N 1.332 -0.162 0 C-N-CA 119.06 -1.056 . . . . 0.97999999999999998 109.64 -168.005 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.4 mp -57.95 -55.0 24.43 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.634 0 C-N-CA 123.688 0.795 . . . . 0.80000000000000004 109.794 174.506 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.29 -44.09 88.35 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 119.213 0.915 . . . . 1.46 110.027 -178.354 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -52.77 -53.9 41.6 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 122.143 0.973 . . . . 3.0800000000000001 111.015 176.16 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -65.32 -40.27 93.5 Favored 'General case' 0 N--CA 1.443 -0.816 0 O-C-N 121.171 -0.956 . . . . 2.4500000000000002 111.725 -179.453 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 5.0 mm -49.34 -52.53 11.14 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 C-N-CA 125.298 1.439 . . . . 0.64000000000000001 108.548 175.842 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -56.04 -57.12 13.48 Favored 'General case' 0 C--N 1.342 0.245 0 C-N-CA 123.262 0.625 . . . . 2.23 110.858 175.44 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.47 -38.21 71.37 Favored 'General case' 0 CA--C 1.537 0.46 0 O-C-N 121.844 -0.535 . . . . 5.0099999999999998 111.895 -176.704 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 37.4 mt -67.23 -17.8 64.97 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.975 1.31 . . . . 1.05 111.57 176.937 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 92.68 32.93 7.74 Favored Glycine 0 CA--C 1.523 0.564 0 C-N-CA 124.543 1.068 . . . . 0.62 111.065 176.366 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.4 ' CD1' HG21 ' A' ' 24' ' ' ILE . 0.3 OUTLIER -128.94 174.14 9.78 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 117.932 0.866 . . . . 1.8899999999999999 110.558 -179.121 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 2.6 t-80 -138.99 128.55 24.52 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 108.126 -1.064 . . . . 1.6699999999999999 108.126 173.177 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.2 t -104.67 152.29 6.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 C-N-CA 124.766 1.226 . . . . 2.0699999999999998 107.82 173.885 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 96.6 t -117.34 144.88 24.06 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 C-N-CA 125.687 1.595 . . . . 0.68000000000000005 108.657 -179.438 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 34.1 mm -110.62 76.7 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 C-N-CA 125.162 1.385 . . . . 1.1000000000000001 109.27 -170.798 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -75.11 -6.09 47.71 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 113.81 1.041 . . . . 2.8100000000000001 113.81 173.566 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -83.32 -77.86 1.09 Allowed Glycine 0 CA--C 1.525 0.687 0 N-CA-C 109.808 -1.317 . . . . 3.5699999999999998 109.808 177.308 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 17.3 ttt-85 . . . . . 0 C--O 1.251 1.152 0 C-N-CA 125.492 1.517 . . . . 13.32 111.084 -171.41 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.476 0.869 0 N-CA-C 113.061 0.763 . . . . 9.4700000000000006 113.061 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.0 mm? 64.03 -176.4 0.16 Allowed 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 118.692 0.678 . . . . 4.4500000000000002 110.394 -173.127 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.1 m -114.58 117.8 31.93 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 125.803 1.641 . . . . 0.91000000000000003 107.053 -176.133 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -69.05 178.06 2.41 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-O 121.332 0.587 . . . . 2.6499999999999999 109.856 169.463 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -132.14 145.82 51.63 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 106.628 -1.619 . . . . 0.93000000000000005 106.628 162.965 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 12.9 mmtp -137.63 159.36 42.18 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 124.351 1.06 . . . . 3.6699999999999999 109.394 164.491 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -119.05 102.02 8.44 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 126.915 2.086 . . . . 1.6100000000000001 107.725 -174.906 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 3.1 mm -83.95 162.92 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 N-CA-C 107.827 -1.175 . . . . 1.9399999999999999 107.827 177.114 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -136.74 117.74 14.28 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 119.404 1.002 . . . . 0.85999999999999999 110.116 176.889 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 57.5 mtm -135.33 176.53 8.59 Favored 'General case' 0 CA--C 1.535 0.385 0 O-C-N 121.481 -0.762 . . . . 1.9399999999999999 110.388 -174.518 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.61 168.46 9.07 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 125.958 1.703 . . . . 3.6600000000000001 110.018 173.975 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.497 HG21 HD21 ' A' ' 41' ' ' LEU . 2.7 m -128.7 153.92 38.89 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 C-N-CA 124.019 0.928 . . . . 1.8300000000000001 111.571 174.552 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 71.1 m -119.59 175.13 6.0 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 125.391 1.476 . . . . 1.04 110.131 174.601 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 80.45 -44.87 2.97 Favored Glycine 0 CA--C 1.533 1.2 0 C-N-CA 123.717 0.675 . . . . 2.7000000000000002 113.435 171.93 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -42.2 141.05 0.99 Allowed 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 125.698 1.599 . . . . 2.0600000000000001 113.91 -178.154 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -148.58 -45.55 0.15 Allowed 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.788 1.235 . . . . 3.02 113.792 178.967 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 21.8 p -76.02 -4.85 43.52 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 120.286 1.403 . . . . 3.3500000000000001 112.434 -179.195 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 60.81 33.28 20.09 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 124.688 1.195 . . . . 2.4300000000000002 111.826 174.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -143.79 -44.02 0.27 Allowed 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 123.844 0.858 . . . . 1.01 111.136 -179.243 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 11.5 p -51.79 -33.27 34.71 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.53 0.732 . . . . 2.6699999999999999 112.268 174.345 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.539 ' HB1' HG21 ' A' ' 39' ' ' VAL . . . -49.96 -34.2 20.07 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.265 1.026 . . . . 0.40999999999999998 111.855 172.794 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -69.98 -49.65 49.56 Favored 'General case' 0 N--CA 1.453 -0.305 0 O-C-N 120.331 -1.48 . . . . 0.34000000000000002 109.887 172.12 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 20.1 mmm180 -52.74 -44.03 66.15 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 119.007 -0.52 . . . . 4.79 110.655 -174.017 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.2 pt -59.75 -54.22 37.55 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 C-N-CA 119.885 -0.726 . . . . 0.52000000000000002 111.559 178.208 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -55.28 -44.75 75.94 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-N 118.795 0.725 . . . . 2.1899999999999999 111.753 177.408 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 30.7 mmtp -71.77 -39.9 69.64 Favored 'General case' 0 CA--C 1.53 0.183 0 O-C-N 121.61 -0.681 . . . . 1.8500000000000001 110.84 -174.613 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.95 -43.61 98.65 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 109.627 -1.389 . . . . 0.73999999999999999 109.627 170.336 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -59.31 -36.93 76.52 Favored 'General case' 0 CA--C 1.541 0.606 0 O-C-N 121.442 -1.034 . . . . 2.3799999999999999 109.362 178.655 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.6 ttpp -58.68 -20.06 45.07 Favored 'General case' 0 CA--C 1.537 0.473 0 O-C-N 120.556 -1.34 . . . . 2.3900000000000001 113.685 174.214 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 22.3 mtt-85 -83.82 -6.22 59.38 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.847 0.859 . . . . 3.29 111.933 177.229 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 21.9 mmt -86.17 154.23 57.32 Favored Pre-proline 0 CA--C 1.531 0.24 0 CA-C-N 118.763 0.71 . . . . 4.6299999999999999 109.467 -174.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -56.08 148.17 60.36 Favored 'Trans proline' 0 N--CA 1.453 -0.87 0 C-N-CA 121.816 1.678 . . . . 0.72999999999999998 110.34 176.21 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 84.36 -33.18 3.22 Favored Glycine 0 CA--C 1.524 0.636 0 CA-C-O 119.855 -0.414 . . . . 0.5 113.197 175.793 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 15.3 t -82.78 137.86 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 CA-C-N 118.206 1.003 . . . . 0.56999999999999995 109.204 177.61 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -110.63 -49.89 3.0 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-O 118.255 -0.878 . . . . 0.91000000000000003 109.661 175.91 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -138.39 160.84 38.49 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 119.173 0.897 . . . . 2.3300000000000001 109.98 179.331 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -156.61 147.54 21.93 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 122.846 0.458 . . . . 0.45000000000000001 110.685 -179.473 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -154.07 116.93 4.45 Favored 'General case' 0 C--N 1.34 0.193 0 N-CA-C 108.64 -0.874 . . . . 0.5 108.64 -164.14 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.874 HG22 HD23 ' A' ' 41' ' ' LEU . 8.6 p -93.9 96.65 6.23 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 C-N-CA 123.921 0.888 . . . . 0.59999999999999998 110.026 -175.103 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 51.1 t-20 -83.35 56.96 3.76 Favored 'General case' 0 CA--C 1.536 0.407 0 O-C-N 120.641 -1.287 . . . . 0.60999999999999999 110.248 -175.927 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.874 HD23 HG22 ' A' ' 39' ' ' VAL . 0.6 OUTLIER -70.5 -21.15 62.79 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 115.486 -0.779 . . . . 1.1399999999999999 110.933 -176.468 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -45.56 -34.67 3.47 Favored 'General case' 0 C--N 1.338 0.096 0 C-N-CA 124.043 0.937 . . . . 0.67000000000000004 112.194 167.81 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 8.7 t -131.8 45.43 2.78 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 108.863 -0.791 . . . . 1.48 108.863 172.816 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 37.47 52.54 1.29 Allowed 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.886 1.674 . . . . 4.0199999999999996 113.793 175.091 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -134.34 165.97 23.9 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 108.263 -1.014 . . . . 1.6200000000000001 108.263 173.641 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.7 p -139.18 139.37 39.89 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 N-CA-C 107.352 -1.351 . . . . 0.45000000000000001 107.352 173.224 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 20.4 m120 -126.85 137.42 53.18 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 107.816 -1.179 . . . . 0.29999999999999999 107.816 -178.58 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.1 p -135.0 124.23 42.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 N-CA-C 106.562 -1.644 . . . . 1.9099999999999999 106.562 -173.488 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 7.5 mm -107.12 96.92 5.03 Favored 'Isoleucine or valine' 0 C--O 1.24 0.56 0 C-N-CA 125.332 1.453 . . . . 0.47999999999999998 107.871 -168.048 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 46.8 p90 -137.94 165.38 26.66 Favored 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 112.198 0.444 . . . . 1.73 112.198 -170.284 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 26.8 t0 -84.2 110.49 26.64 Favored Pre-proline 0 CA--C 1.535 0.379 0 O-C-N 124.412 1.07 . . . . 3.0800000000000001 110.551 173.762 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -72.38 4.4 3.43 Favored 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 123.149 2.566 . . . . 0.63 113.508 -178.345 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -86.12 -29.57 23.21 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 119.46 1.027 . . . . 0.80000000000000004 109.194 167.542 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -104.87 -57.56 2.01 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 123.578 0.751 . . . . 3.6499999999999999 109.102 -168.471 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.404 ' CG2' ' HB3' ' A' ' 59' ' ' ALA 0.308 1.3 p -89.76 -173.91 4.1 Favored 'General case' 0 CA--C 1.521 -0.159 0 CA-C-O 121.015 0.436 . . . . 0.45000000000000001 111.134 158.361 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 136.78 87.77 0.21 Allowed Glycine 0 N--CA 1.442 -0.965 0 N-CA-C 103.71 -3.756 . . . . 2.46 103.71 -152.807 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 66.6 p -12.35 -17.73 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.49 1 C-N-CA 137.778 6.431 . . . . 1.0700000000000001 119.863 -144.112 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -26.44 -62.98 0.08 Allowed 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 127.085 2.154 . . . . 0.55000000000000004 113.834 165.213 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.404 ' HB3' ' CG2' ' A' ' 55' ' ' THR . . . -72.91 -42.09 63.89 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 117.643 -1.623 . . . . 0.52000000000000002 109.866 -168.83 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.4 mp -49.71 -57.57 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.816 0 CA-C-N 114.237 -1.347 . . . . 0.83999999999999997 109.258 175.444 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.17 -45.82 83.34 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 118.586 0.63 . . . . 1.49 110.856 -174.656 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -45.06 -60.07 2.28 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 122.574 1.178 . . . . 3.1099999999999999 110.374 172.848 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 4.6 mmpt? -70.18 -38.73 75.44 Favored 'General case' 0 N--CA 1.431 -1.384 0 CA-C-N 115.341 -0.845 . . . . 3.1499999999999999 112.005 -173.802 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -48.66 -54.1 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 C-N-CA 124.889 1.276 . . . . 0.34999999999999998 107.8 175.372 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -60.09 -54.63 43.7 Favored 'General case' 0 C--N 1.34 0.182 0 C-N-CA 123.722 0.809 . . . . 1.6799999999999999 110.231 176.71 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.9 tmtm? -56.83 -35.38 68.74 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 112.937 0.717 . . . . 3.6899999999999999 112.937 -176.185 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 12.9 mt -70.59 -18.7 62.89 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 125.705 1.602 . . . . 0.69999999999999996 111.645 175.678 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 93.05 44.25 3.88 Favored Glycine 0 CA--C 1.525 0.681 0 C-N-CA 124.642 1.115 . . . . 0.56000000000000005 110.553 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -139.6 173.99 10.97 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 123.688 0.795 . . . . 1.9199999999999999 110.663 -177.929 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 18.8 t-160 -148.78 128.12 13.0 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 108.601 -0.889 . . . . 1.9199999999999999 108.601 175.861 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 14.5 p -100.28 135.1 37.63 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 C-N-CA 126.259 1.824 . . . . 1.45 108.336 178.621 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 15.8 t -100.32 131.94 46.88 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 C-N-CA 124.272 1.029 . . . . 0.79000000000000004 109.227 -179.794 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 27.6 mm -88.11 75.52 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 C-N-CA 124.508 1.123 . . . . 1.1299999999999999 108.601 -173.125 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -71.2 -0.54 10.06 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 113.767 1.025 . . . . 4.7599999999999998 113.767 -178.306 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 65.52 69.46 1.34 Allowed Glycine 0 CA--C 1.523 0.583 0 C-N-CA 124.978 1.275 . . . . 2.77 111.394 173.155 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 6.6 mtt180 . . . . . 0 C--O 1.255 1.386 0 C-N-CA 125.629 1.572 . . . . 13.279999999999999 106.893 -172.589 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.0 mtt . . . . . 0 N--CA 1.474 0.769 0 N-CA-C 109.349 -0.611 . . . . 12.640000000000001 109.349 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.1 pp -163.03 135.0 5.19 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 106.654 -1.61 . . . . 5.7599999999999998 106.654 171.702 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.2 m -146.67 116.53 7.24 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 105.029 -2.212 . . . . 0.82999999999999996 105.029 174.781 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -78.16 157.02 29.55 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 106.925 -1.509 . . . . 2.3199999999999998 106.925 167.578 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -111.03 148.37 32.74 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 124.436 1.095 . . . . 1.1399999999999999 108.106 176.65 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.433 ' NZ ' ' OE1' ' A' ' 7' ' ' GLU . 0.0 OUTLIER -135.92 153.66 51.37 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 121.769 0.795 . . . . 4.0599999999999996 109.075 159.425 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.433 ' OE1' ' NZ ' ' A' ' 6' ' ' LYS . 0.5 OUTLIER -84.05 144.39 29.11 Favored 'General case' 0 N--CA 1.442 -0.87 0 C-N-CA 126.651 1.981 . . . . 2.04 107.472 168.273 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -125.17 164.16 24.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 107.664 -1.235 . . . . 2.7400000000000002 107.664 168.027 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -136.22 124.05 22.61 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 106.669 -1.604 . . . . 0.59999999999999998 106.669 177.34 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 39.3 mtm -139.6 170.37 16.03 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 108.784 -0.821 . . . . 1.98 108.784 -178.328 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 30.8 mm100 -97.68 163.03 13.0 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.288 1.035 . . . . 2.9100000000000001 109.618 177.807 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 52.4 t -121.96 149.06 25.23 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 C-N-CA 124.815 1.246 . . . . 1.24 109.138 -173.25 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 17.9 m -155.44 174.3 15.44 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.716 1.206 . . . . 1.29 108.395 169.42 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 64.42 65.6 2.91 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 109.931 -1.268 . . . . 1.9099999999999999 109.931 -179.017 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 5.5 ppp? -139.54 154.32 47.63 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 123.917 0.887 . . . . 3.25 110.103 -171.442 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.8 p -99.54 -63.89 1.09 Allowed 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 125.945 1.698 . . . . 3.48 108.638 171.225 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 19.9 p -138.0 161.75 35.88 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 124.291 1.036 . . . . 2.2599999999999998 110.636 -175.416 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -76.48 49.82 0.62 Allowed 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.43 1.092 . . . . 1.72 111.124 179.552 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -142.31 -49.54 0.37 Allowed 'General case' 0 N--CA 1.457 -0.119 0 C-N-CA 124.878 1.271 . . . . 0.68999999999999995 109.008 178.368 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 38.3 m -57.8 -36.82 72.73 Favored 'General case' 0 CA--C 1.533 0.298 0 O-C-N 121.365 -0.835 . . . . 1.1699999999999999 110.059 168.512 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -51.28 -31.8 22.52 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.951 0.901 . . . . 0.55000000000000004 112.209 170.805 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -73.58 -53.4 10.59 Favored 'General case' 0 N--CA 1.453 -0.31 0 O-C-N 120.663 -1.273 . . . . 0.48999999999999999 109.647 170.77 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 48.9 mmm-85 -47.56 -46.16 27.71 Favored 'General case' 0 C--O 1.23 0.068 0 C-N-CA 123.609 0.764 . . . . 3.8900000000000001 111.215 -175.054 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.448 HG21 ' CD1' ' A' ' 69' ' ' TYR . 5.4 pt -55.1 -53.13 37.52 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 CA-C-O 119.129 -0.462 . . . . 0.45000000000000001 111.823 177.686 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -60.23 -42.28 94.88 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 118.819 0.736 . . . . 2.25 111.257 179.599 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.6 mptm? -68.24 -44.23 76.13 Favored 'General case' 0 CA--C 1.528 0.108 0 O-C-N 121.743 -0.598 . . . . 2.79 109.897 -176.391 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -57.32 -47.82 85.06 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 109.468 -1.453 . . . . 0.79000000000000004 109.468 171.721 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -58.5 -40.49 82.96 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.702 0.801 . . . . 2.3300000000000001 110.318 -175.373 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 12.8 ttmt -44.22 -34.75 1.99 Allowed 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 118.608 0.64 . . . . 2.8100000000000001 112.358 173.709 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 43.7 ttm-85 -67.27 -8.6 33.23 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 113.414 0.894 . . . . 3.8199999999999998 113.414 -172.869 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 1.6 mpp? -87.56 158.51 51.29 Favored Pre-proline 0 CA--C 1.537 0.463 0 CA-C-N 119.347 0.976 . . . . 4.1699999999999999 111.419 178.749 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -62.99 153.81 71.15 Favored 'Trans proline' 0 N--CA 1.456 -0.694 0 C-N-CA 123.142 2.561 . . . . 0.91000000000000003 112.077 -176.239 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 74.0 -35.65 0.91 Allowed Glycine 0 CA--C 1.525 0.683 0 C-N-CA 124.761 1.172 . . . . 0.80000000000000004 112.616 -178.142 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 11.6 t -71.88 130.97 35.2 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 O-C-N 121.074 -1.25 . . . . 0.54000000000000004 108.655 175.866 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -118.61 -43.11 2.71 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 118.677 -0.678 . . . . 0.93999999999999995 109.88 179.844 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -140.73 164.85 29.09 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 119.221 0.919 . . . . 2.02 112.016 168.934 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -157.69 140.65 15.07 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.139 -0.937 . . . . 0.40000000000000002 109.185 -171.595 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -153.52 107.11 2.99 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 106.198 -1.778 . . . . 0.48999999999999999 106.198 -164.839 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 4.2 p -80.23 122.85 36.19 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 N-CA-C 107.232 -1.396 . . . . 0.62 107.232 175.392 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 57.7 t-20 -102.2 56.27 0.8 Allowed 'General case' 0 C--O 1.235 0.311 0 N-CA-C 106.893 -1.521 . . . . 0.57999999999999996 106.893 178.666 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.14 -20.95 64.04 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 114.259 -1.337 . . . . 1.0700000000000001 109.589 -173.146 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -45.52 -37.15 5.09 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 124.118 0.967 . . . . 0.54000000000000004 112.267 167.015 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 6.3 t -122.75 40.24 3.74 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 121.65 0.738 . . . . 1.27 109.235 173.686 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 39.0 46.61 1.13 Allowed 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 126.888 2.075 . . . . 2.6200000000000001 113.015 178.718 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 52.3 m -128.03 155.51 44.21 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 125.0 1.32 . . . . 0.80000000000000004 108.3 -178.439 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.0 p -121.56 142.23 38.69 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 N-CA-C 108.417 -0.957 . . . . 0.40000000000000002 108.417 168.45 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 21.4 m120 -126.1 139.1 53.65 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 107.28 -1.378 . . . . 0.47999999999999998 107.28 174.771 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 20.5 t -132.89 135.84 56.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 N-CA-C 104.941 -2.244 . . . . 2.0099999999999998 104.941 -178.45 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 15.0 mm -112.05 92.24 2.01 Favored 'Isoleucine or valine' 0 C--O 1.24 0.578 0 N-CA-C 106.758 -1.571 . . . . 0.46999999999999997 106.758 -179.452 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -127.27 171.89 11.08 Favored 'General case' 0 CA--C 1.509 -0.625 0 CA-C-N 116.596 -0.275 . . . . 2.3100000000000001 110.492 -176.368 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 -94.38 105.66 19.15 Favored Pre-proline 0 N--CA 1.448 -0.533 0 O-C-N 124.397 1.061 . . . . 3.7999999999999998 108.615 176.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -69.98 5.75 1.66 Allowed 'Trans proline' 0 CA--C 1.538 0.679 0 C-N-CA 122.323 2.015 . . . . 0.60999999999999999 113.03 -179.245 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -85.66 -27.94 25.06 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 123.72 0.808 . . . . 0.75 109.43 169.044 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -112.47 -61.43 1.73 Allowed 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.281 1.032 . . . . 2.8100000000000001 110.05 -173.455 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.413 ' HB ' ' H ' ' A' ' 56' ' ' GLY 0.486 0.5 OUTLIER -85.12 -169.1 2.49 Favored 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 114.055 1.131 . . . . 0.81999999999999995 114.055 162.908 . . . . . . . . 4 4 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.413 ' H ' ' HB ' ' A' ' 55' ' ' THR . . . 158.59 -150.13 20.66 Favored Glycine 0 N--CA 1.434 -1.437 0 N-CA-C 103.56 -3.816 . . . . 2.6800000000000002 103.56 -157.456 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 15.0 p -75.96 -37.38 58.67 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 124.986 1.314 . . . . 1.49 109.687 -179.322 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -54.48 -63.79 1.04 Allowed 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 124.404 1.082 . . . . 0.70999999999999996 113.191 -164.277 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.77 -35.73 79.2 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 118.483 -1.287 . . . . 0.56999999999999995 108.87 -167.726 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.7 mp -55.17 -58.57 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.115 0 CA-C-N 114.205 -1.361 . . . . 1.25 109.212 173.52 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.63 -46.58 88.58 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 119.698 1.136 . . . . 1.8200000000000001 109.363 -175.46 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -48.86 -55.65 11.05 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 121.394 0.616 . . . . 4.0700000000000003 110.515 177.005 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.0 mmpt? -71.2 -40.68 71.03 Favored 'General case' 0 N--CA 1.435 -1.191 0 CA-C-O 118.333 -0.842 . . . . 2.4300000000000002 112.907 -177.36 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 3.4 mm -47.93 -52.4 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 C-N-CA 126.387 1.875 . . . . 0.62 107.703 176.754 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -53.74 -61.09 2.53 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 115.689 -0.687 . . . . 3.52 111.138 173.246 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -62.23 -29.38 70.35 Favored 'General case' 0 CA--C 1.542 0.669 0 O-C-N 121.779 -0.576 . . . . 5.2999999999999998 112.088 -172.256 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 36.4 mt -71.06 -19.94 62.43 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.778 1.631 . . . . 0.57999999999999996 111.377 173.043 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 89.56 40.85 5.88 Favored Glycine 0 CA--C 1.525 0.704 0 C-N-CA 124.688 1.137 . . . . 0.48999999999999999 111.474 176.741 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.448 ' CD1' HG21 ' A' ' 24' ' ' ILE . 0.5 OUTLIER -131.6 174.45 10.1 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 124.201 1.0 . . . . 1.8400000000000001 110.268 178.207 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 10.9 t-160 -151.05 126.26 9.94 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 109.608 -0.515 . . . . 2.23 109.608 167.073 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 20.3 m -82.27 167.7 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 N-CA-C 109.216 -0.661 . . . . 2.2400000000000002 109.216 176.013 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 15.2 t -130.9 145.52 35.39 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 N-CA-C 107.837 -1.171 . . . . 0.73999999999999999 107.837 178.723 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 29.4 mm -121.54 76.09 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 C-N-CA 124.356 1.062 . . . . 1.3200000000000001 109.108 -171.252 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -81.08 -0.07 38.28 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 115.325 1.602 . . . . 3.1400000000000001 115.325 -173.61 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 80.55 81.18 0.81 Allowed Glycine 0 CA--C 1.527 0.829 0 N-CA-C 109.648 -1.381 . . . . 4.0499999999999998 109.648 -175.635 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.254 1.318 0 N-CA-C 104.714 -2.328 . . . . 12.33 104.714 177.068 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.474 0.765 0 N-CA-C 108.444 -0.947 . . . . 10.31 108.444 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 10.3 mp -72.48 -175.6 1.66 Allowed 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 108.316 -0.994 . . . . 5.0199999999999996 108.316 161.555 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 50.3 m -22.54 108.65 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 127.088 2.155 . . . . 0.89000000000000001 112.843 164.795 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -70.54 -177.39 1.49 Allowed 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 121.321 0.582 . . . . 2.1099999999999999 109.693 174.522 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -134.79 146.02 48.95 Favored 'General case' 0 N--CA 1.447 -0.575 0 N-CA-C 107.258 -1.386 . . . . 1.27 107.258 168.081 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 50.1 mtmt -142.42 162.14 36.25 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 123.271 0.628 . . . . 3.4300000000000002 109.378 159.966 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.3 mp0 -121.22 86.38 2.56 Favored 'General case' 0 N--CA 1.442 -0.86 0 C-N-CA 127.904 2.482 . . . . 1.8999999999999999 106.855 -166.144 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.494 ' N ' HD12 ' A' ' 8' ' ' ILE . 3.4 mp -82.56 163.06 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.258 0 N-CA-C 106.427 -1.694 . . . . 2.2000000000000002 106.427 -175.133 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -138.67 134.37 33.57 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 125.469 1.508 . . . . 0.47999999999999998 108.31 -176.146 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -156.28 174.32 15.57 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 118.346 0.521 . . . . 2.71 110.736 175.344 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 29.0 mm100 -93.57 160.68 14.68 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.931 1.293 . . . . 2.6800000000000002 109.923 -178.874 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 21.3 t -119.43 154.87 22.05 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 C-N-CA 124.23 1.012 . . . . 1.22 109.27 -171.117 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 32.1 t -154.47 175.82 13.11 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 118.588 0.631 . . . . 1.97 110.358 170.837 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 59.09 72.53 0.59 Allowed Glycine 0 CA--C 1.528 0.854 0 N-CA-C 110.252 -1.139 . . . . 2.0499999999999998 110.252 -174.322 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -144.83 159.96 42.04 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 123.746 0.818 . . . . 2.0299999999999998 110.567 -172.447 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -100.11 -65.12 0.99 Allowed 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 125.955 1.702 . . . . 3.0699999999999998 110.246 169.1 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 2.0 p -150.54 164.15 36.69 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 123.32 0.648 . . . . 2.0899999999999999 110.371 -166.826 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -72.75 32.86 0.07 Allowed 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.661 1.584 . . . . 1.78 113.751 -172.789 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -114.9 -47.84 2.86 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 126.314 1.845 . . . . 0.70999999999999996 108.74 171.616 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 38.0 m -66.0 -38.09 87.58 Favored 'General case' 0 N--CA 1.455 -0.185 0 O-C-N 121.435 -0.791 . . . . 1.25 110.653 -170.296 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.846 ' HB1' HG21 ' A' ' 39' ' ' VAL . . . -56.62 -28.75 61.14 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 116.25 -0.432 . . . . 0.58999999999999997 111.306 173.981 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.84 -50.25 65.27 Favored 'General case' 0 N--CA 1.455 -0.207 0 O-C-N 120.158 -1.589 . . . . 0.46999999999999997 109.118 171.801 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 28.5 mmm180 -53.04 -48.53 67.55 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 118.792 -0.623 . . . . 5.1699999999999999 110.336 -178.152 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.496 HG21 ' CD1' ' A' ' 69' ' ' TYR 0.271 1.8 pt -58.14 -56.34 16.59 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.44 0 C-N-CA 119.304 -0.958 . . . . 0.48999999999999999 110.765 179.703 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -53.68 -42.03 67.51 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 119.594 1.088 . . . . 2.6200000000000001 112.582 179.325 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -70.02 -43.67 70.87 Favored 'General case' 0 CA--C 1.535 0.394 0 O-C-N 121.163 -0.961 . . . . 2.0099999999999998 110.717 -177.755 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -66.89 -33.19 83.25 Favored Glycine 0 CA--C 1.529 0.964 0 N-CA-C 111.254 -0.738 . . . . 0.65000000000000002 111.254 175.281 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -66.03 -46.36 78.16 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 125.021 1.328 . . . . 2.2599999999999998 107.635 178.444 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 14.3 ttmt -49.11 -34.88 14.96 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 118.758 0.708 . . . . 3.25 112.405 176.805 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -59.61 -20.99 59.69 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 113.124 0.787 . . . . 5.3700000000000001 113.124 179.575 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.52 158.83 84.02 Favored Pre-proline 0 CA--C 1.54 0.573 0 C-N-CA 123.99 0.916 . . . . 4.3099999999999996 111.93 -174.045 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 78.9 Cg_endo -73.05 115.52 4.38 Favored 'Trans proline' 0 N--CA 1.453 -0.901 0 C-N-CA 121.871 1.714 . . . . 1.04 109.691 175.781 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 124.38 -36.55 2.88 Favored Glycine 0 CA--C 1.529 0.915 0 C-N-CA 124.343 0.973 . . . . 0.80000000000000004 112.446 172.57 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 57.8 t -80.17 142.32 14.08 Favored 'Isoleucine or valine' 0 C--N 1.34 0.192 0 CA-C-N 118.01 0.905 . . . . 0.71999999999999997 109.193 173.877 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.5 m -115.47 -41.79 3.22 Favored 'General case' 0 C--N 1.338 0.068 0 C-N-CA 123.292 0.637 . . . . 1.6899999999999999 110.947 -176.034 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -136.91 165.83 25.07 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 123.629 0.771 . . . . 2.04 110.329 169.654 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -158.92 142.81 15.25 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 122.73 0.412 . . . . 0.46000000000000002 111.261 -177.695 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -154.97 107.5 2.75 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 106.228 -1.767 . . . . 0.42999999999999999 106.228 -167.497 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.846 HG21 ' HB1' ' A' ' 21' ' ' ALA . 4.2 p -80.02 135.8 24.73 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 N-CA-C 107.613 -1.255 . . . . 0.83999999999999997 107.613 174.251 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 54.4 t-20 -122.24 55.98 1.12 Allowed 'General case' 0 C--O 1.235 0.294 0 CA-C-O 122.844 1.307 . . . . 0.80000000000000004 107.895 -179.836 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.655 HD23 HG22 ' A' ' 39' ' ' VAL . 0.4 OUTLIER -64.72 -20.21 66.2 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-N 114.169 -1.378 . . . . 0.96999999999999997 110.515 179.107 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -49.63 -37.2 27.21 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 118.829 -0.605 . . . . 0.55000000000000004 112.124 167.014 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 13.5 t -114.33 23.57 12.71 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 118.362 0.528 . . . . 1.26 111.206 171.436 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 65.67 20.18 11.52 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.665 1.586 . . . . 2.7000000000000002 114.353 175.078 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 25.6 m -122.05 164.17 18.15 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.657 1.183 . . . . 0.67000000000000004 109.797 -173.209 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.7 p -128.5 146.75 33.44 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 O-C-N 120.789 -1.194 . . . . 0.37 109.521 172.917 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -129.59 136.77 50.19 Favored 'General case' 0 C--N 1.345 0.41 0 N-CA-C 107.814 -1.18 . . . . 0.35999999999999999 107.814 175.696 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -130.75 130.07 64.29 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.797 0 N-CA-C 105.245 -2.131 . . . . 2.3999999999999999 105.245 179.687 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 11.9 mm -103.48 99.33 8.17 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 N-CA-C 106.051 -1.833 . . . . 0.46999999999999997 106.051 -174.401 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.47 ' CE2' HD13 ' A' ' 8' ' ' ILE . 46.0 p90 -136.05 169.86 16.93 Favored 'General case' 0 CA--C 1.51 -0.564 0 O-C-N 121.976 -0.453 . . . . 1.6599999999999999 110.98 -170.985 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 31.1 t0 -90.69 105.49 12.13 Favored Pre-proline 0 C--O 1.234 0.246 0 O-C-N 124.491 1.119 . . . . 3.02 109.208 175.072 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -75.32 8.31 2.59 Favored 'Trans proline' 0 N--CA 1.45 -1.054 0 C-N-CA 122.396 2.064 . . . . 0.68999999999999995 112.353 -177.59 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -87.94 -28.38 21.53 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 119.328 0.967 . . . . 0.96999999999999997 108.928 167.133 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -102.61 -59.11 1.76 Allowed 'General case' 0 C--N 1.344 0.326 0 N-CA-C 108.872 -0.788 . . . . 2.4199999999999999 108.872 -176.93 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.334 0.7 OUTLIER -86.46 -172.75 4.19 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 125.345 1.458 . . . . 0.55000000000000004 114.1 166.759 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 167.99 -143.19 7.99 Favored Glycine 0 N--CA 1.43 -1.706 1 N-CA-C 101.819 -4.512 . . . . 2.6299999999999999 101.819 -164.97 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 36.5 p -77.35 -34.77 55.1 Favored 'General case' 0 N--CA 1.442 -0.851 0 C-N-CA 125.918 1.687 . . . . 1.29 109.494 176.96 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -48.8 -62.92 1.26 Allowed 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 125.166 1.386 . . . . 0.57999999999999996 113.247 -161.262 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -75.31 -30.11 60.24 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 114.936 -1.029 . . . . 0.65000000000000002 109.795 -173.425 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 4.6 mt -57.76 -57.42 10.47 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.739 0 CA-C-O 118.405 -0.807 . . . . 1.46 110.609 177.043 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.25 -43.82 92.4 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 119.079 0.854 . . . . 1.1100000000000001 108.73 -176.844 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -50.66 -56.5 11.6 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 123.481 0.712 . . . . 3.1200000000000001 110.459 178.524 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -66.03 -43.05 88.75 Favored 'General case' 0 N--CA 1.438 -1.072 0 CA-C-O 118.42 -0.8 . . . . 2.1800000000000002 111.879 -179.836 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 3.3 mm -47.98 -51.71 8.35 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 125.781 1.633 . . . . 0.56999999999999995 108.78 176.483 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 38.9 mm-40 -56.13 -58.6 7.25 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.577 0.751 . . . . 1.53 110.598 174.648 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.09 -36.34 72.71 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 121.412 -0.805 . . . . 5.1600000000000001 112.466 -176.586 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 37.9 mt -68.35 -17.62 64.29 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 125.154 1.382 . . . . 0.68999999999999995 111.02 177.106 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 91.68 38.15 5.91 Favored Glycine 0 C--N 1.338 0.65 0 C-N-CA 124.334 0.969 . . . . 0.46000000000000002 110.984 174.224 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.496 ' CD1' HG21 ' A' ' 24' ' ' ILE . 0.3 OUTLIER -133.44 174.81 10.01 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 123.593 0.757 . . . . 1.8999999999999999 110.702 -177.877 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -140.12 167.81 21.26 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 108.706 -0.85 . . . . 1.6599999999999999 108.706 169.094 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 45.5 t -140.01 145.59 26.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 N-CA-C 105.476 -2.046 . . . . 2.1400000000000001 105.476 -171.807 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 5.8 t -120.64 136.9 56.16 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 C-N-CA 124.671 1.188 . . . . 0.78000000000000003 107.854 -177.422 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 45.7 mm -110.53 74.82 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 N-CA-C 106.969 -1.493 . . . . 1.4199999999999999 106.969 -178.67 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -74.54 -6.12 46.65 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.411 1.085 . . . . 3.4900000000000002 112.591 -178.378 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -131.22 63.8 0.62 Allowed Glycine 0 CA--C 1.524 0.612 0 C-N-CA 126.132 1.825 . . . . 2.8199999999999998 108.549 174.928 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 9.9 ttt180 . . . . . 0 C--O 1.251 1.175 0 CA-C-O 117.279 -1.344 . . . . 13.0 109.799 173.132 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.7 mtt . . . . . 0 N--CA 1.471 0.612 0 N-CA-C 106.584 -1.635 . . . . 12.23 106.584 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -148.87 37.63 0.8 Allowed 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 124.754 1.222 . . . . 6.8399999999999999 109.718 -172.517 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 5.2 m -100.08 96.74 7.71 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 106.995 -1.483 . . . . 0.87 106.995 175.459 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -68.25 168.86 11.5 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 107.717 -1.216 . . . . 2.4700000000000002 107.717 164.607 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -127.42 147.78 50.29 Favored 'General case' 0 CA--C 1.516 -0.33 0 C-N-CA 124.415 1.086 . . . . 0.97999999999999998 108.359 177.112 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 52.7 mtmt -144.93 159.61 42.64 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 121.839 0.828 . . . . 3.3599999999999999 111.573 163.572 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -97.34 145.82 25.76 Favored 'General case' 0 N--CA 1.442 -0.873 0 C-N-CA 127.787 2.435 . . . . 1.71 108.16 175.553 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.425 HD11 ' CE2' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -127.87 158.58 39.49 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 N-CA-C 105.841 -1.911 . . . . 2.3100000000000001 105.841 173.588 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -136.87 127.96 27.8 Favored 'General case' 0 C--O 1.226 -0.14 0 N-CA-C 107.854 -1.165 . . . . 0.96999999999999997 107.854 179.46 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 3.5 ptp -156.02 177.51 11.34 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 118.434 0.561 . . . . 2.5699999999999998 110.781 -172.947 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 27.7 mm100 -97.47 161.79 13.62 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.243 1.417 . . . . 2.52 110.453 -175.628 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 49.6 t -116.0 157.76 16.69 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 C-N-CA 124.951 1.3 . . . . 1.1499999999999999 109.818 -174.281 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 6.3 m -153.35 169.78 22.26 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.486 0.714 . . . . 0.91000000000000003 110.615 169.441 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 60.44 59.93 9.43 Favored Glycine 0 CA--C 1.529 0.945 0 N-CA-C 110.016 -1.234 . . . . 1.9199999999999999 110.016 -174.825 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -144.71 167.69 21.96 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 124.21 1.004 . . . . 2.0099999999999998 109.982 -174.448 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -143.22 -67.49 0.36 Allowed 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 124.769 1.228 . . . . 2.3199999999999998 108.982 171.342 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 12.2 p -98.84 150.86 21.45 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-O 121.643 0.735 . . . . 2.1699999999999999 111.205 -178.493 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -78.18 47.11 0.65 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.616 0.766 . . . . 1.8899999999999999 110.794 177.358 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -135.29 -53.72 0.79 Allowed 'General case' 0 N--CA 1.457 -0.12 0 C-N-CA 124.305 1.042 . . . . 0.71999999999999997 109.288 177.952 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 34.7 m -55.78 -38.18 69.56 Favored 'General case' 0 C--N 1.338 0.096 0 O-C-N 121.552 -0.718 . . . . 1.1899999999999999 109.64 168.166 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.558 ' HB1' HG21 ' A' ' 39' ' ' VAL . . . -57.25 -22.88 44.36 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 112.547 0.573 . . . . 0.56000000000000005 112.547 175.766 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -73.24 -40.76 64.42 Favored 'General case' 0 C--O 1.232 0.135 0 O-C-N 120.684 -1.26 . . . . 0.44 110.727 170.665 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 18.1 mmm180 -56.75 -39.36 73.85 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 123.391 0.676 . . . . 4.46 109.761 -171.429 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.3 pt -60.18 -65.62 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 C-N-CA 119.454 -0.898 . . . . 1.6699999999999999 111.183 177.38 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.58 ' HG3' ' HB1' ' A' ' 37' ' ' ALA . 2.5 mp0 -46.95 -45.13 20.54 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-N 119.778 1.172 . . . . 2.4700000000000002 112.156 177.858 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 11.2 mptt -70.84 -33.34 70.56 Favored 'General case' 0 CA--C 1.538 0.504 0 O-C-N 121.377 -0.827 . . . . 1.98 110.641 -176.725 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -72.03 -29.11 67.33 Favored Glycine 0 CA--C 1.531 1.071 0 O-C-N 121.377 -0.827 . . . . 0.60999999999999999 112.061 169.715 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.0 mp -69.78 -43.9 71.2 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 118.378 1.089 . . . . 2.8999999999999999 109.432 175.975 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 61.8 tttm -50.35 -31.74 15.42 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.644 0.777 . . . . 2.6800000000000002 111.964 174.206 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 52.8 mtt180 -75.8 -4.38 40.31 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 113.651 0.982 . . . . 5.2300000000000004 113.651 179.484 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 93.0 mmm -93.17 150.47 39.19 Favored Pre-proline 0 C--O 1.232 0.161 0 CA-C-N 119.422 1.01 . . . . 3.5299999999999998 110.264 -178.116 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -56.95 144.06 90.27 Favored 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 121.869 1.713 . . . . 0.62 109.143 173.99 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 88.69 -32.34 4.57 Favored Glycine 0 CA--C 1.525 0.686 0 CA-C-O 119.419 -0.656 . . . . 0.48999999999999999 113.343 179.238 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 14.0 t -87.3 136.88 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.176 0 CA-C-N 118.888 1.344 . . . . 0.60999999999999999 108.438 179.867 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -109.57 -40.9 4.72 Favored 'General case' 0 N--CA 1.456 -0.135 0 CA-C-O 118.305 -0.855 . . . . 0.85999999999999999 110.663 177.679 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -150.61 164.46 35.99 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 108.336 -0.987 . . . . 1.8700000000000001 108.336 172.94 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.58 ' HB1' ' HG3' ' A' ' 25' ' ' GLU . . . -157.77 145.04 18.29 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 109.256 -0.646 . . . . 0.79000000000000004 109.256 176.693 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -143.54 115.25 8.18 Favored 'General case' 0 N--CA 1.457 -0.114 0 C-N-CA 124.663 1.185 . . . . 0.80000000000000004 108.974 -164.296 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.558 HG21 ' HB1' ' A' ' 21' ' ' ALA . 5.4 p -84.45 116.69 28.58 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.569 0 N-CA-C 108.646 -0.872 . . . . 0.59999999999999998 108.646 173.679 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 53.3 t-20 -101.3 56.85 0.84 Allowed 'General case' 0 C--O 1.235 0.298 0 N-CA-C 107.224 -1.398 . . . . 0.73999999999999999 107.224 176.647 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.442 HD23 ' CG2' ' A' ' 39' ' ' VAL . 0.2 OUTLIER -67.36 -21.58 65.62 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 114.552 -1.203 . . . . 1.04 110.02 -177.003 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -46.32 -35.36 5.28 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 123.687 0.795 . . . . 0.76000000000000001 112.14 166.653 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 13.3 t -125.37 37.18 4.43 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 122.462 0.305 . . . . 1.2 110.383 171.695 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 50.06 34.69 8.64 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.681 1.592 . . . . 2.6200000000000001 113.264 172.988 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 87.0 m -126.03 157.47 37.83 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.445 1.098 . . . . 0.71999999999999997 108.621 -176.595 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 14.9 p -134.12 144.93 34.0 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 O-C-N 121.284 -0.885 . . . . 0.51000000000000001 109.875 172.239 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 25.9 m120 -128.05 136.22 50.94 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 125.344 1.458 . . . . 0.40999999999999998 108.305 -179.083 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 20.6 t -129.5 126.11 62.75 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 N-CA-C 105.475 -2.046 . . . . 2.23 105.475 -176.369 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 21.9 mm -105.85 103.01 14.7 Favored 'Isoleucine or valine' 0 C--O 1.239 0.548 0 N-CA-C 108.007 -1.108 . . . . 0.51000000000000001 108.007 -174.184 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.425 ' CE2' HD11 ' A' ' 8' ' ' ILE . 7.7 p90 -141.62 169.87 16.78 Favored 'General case' 0 CA--C 1.512 -0.504 0 O-C-N 122.218 -0.301 . . . . 2.0699999999999998 111.364 -170.964 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -89.54 109.57 32.82 Favored Pre-proline 0 N--CA 1.449 -0.517 0 O-C-N 124.299 1.0 . . . . 3.8100000000000001 109.444 177.021 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -71.14 8.33 1.12 Allowed 'Trans proline' 0 CA--C 1.54 0.777 0 C-N-CA 122.698 2.265 . . . . 0.62 113.068 179.923 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -88.07 -25.15 23.2 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.033 0.933 . . . . 0.88 109.596 168.837 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -115.52 -59.44 2.0 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 124.305 1.042 . . . . 3.3599999999999999 109.697 -171.062 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.323 3.8 p -91.74 -166.29 1.53 Allowed 'General case' 0 C--N 1.342 0.246 0 N-CA-C 110.35 -0.241 . . . . 0.53000000000000003 110.35 163.132 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 122.84 87.59 0.85 Allowed Glycine 0 N--CA 1.444 -0.784 0 N-CA-C 104.103 -3.599 . . . . 2.1600000000000001 104.103 -142.456 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 72.3 p -14.11 -18.99 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.36 1 C-N-CA 138.344 6.657 . . . . 1.3600000000000001 119.476 -148.022 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -26.39 -62.34 0.08 Allowed 'General case' 0 N--CA 1.443 -0.776 0 C-N-CA 127.124 2.17 . . . . 0.55000000000000004 113.756 166.391 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.69 -41.1 63.11 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 117.97 -1.492 . . . . 0.48999999999999999 109.931 -168.654 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.2 mp -52.81 -53.63 20.19 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.807 0 CA-C-N 114.446 -1.252 . . . . 0.87 109.193 176.305 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -66.92 -45.55 77.55 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 122.69 0.396 . . . . 1.4299999999999999 110.093 -173.765 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -46.06 -57.36 4.52 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 122.57 1.176 . . . . 2.6800000000000002 110.761 170.185 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 5.0 mmmt -67.66 -39.09 84.58 Favored 'General case' 0 N--CA 1.435 -1.178 0 CA-C-N 115.741 -0.663 . . . . 2.9100000000000001 112.409 -176.323 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -52.25 -50.38 37.26 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 N-CA-C 107.49 -1.3 . . . . 0.46000000000000002 107.49 -177.554 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 25.3 mm-40 -57.62 -58.31 8.9 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.033 0.933 . . . . 1.9299999999999999 110.55 174.044 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 24.9 mmtt -52.94 -37.03 60.6 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 113.287 0.847 . . . . 3.8999999999999999 113.287 -178.448 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 18.2 mt -70.64 -18.09 62.86 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.52 1.528 . . . . 0.68000000000000005 111.542 178.232 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 90.32 41.9 5.37 Favored Glycine 0 CA--C 1.525 0.67 0 C-N-CA 124.649 1.119 . . . . 0.46000000000000002 110.488 179.022 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -138.19 175.46 9.56 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 124.157 0.983 . . . . 1.99 109.249 -176.345 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 15.1 t-160 -141.05 157.57 45.13 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 108.649 -0.871 . . . . 2.0299999999999998 108.649 171.182 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 9.5 p -135.83 141.35 42.19 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 N-CA-C 106.528 -1.656 . . . . 1.4299999999999999 106.528 -178.037 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 3.4 t -115.73 130.52 70.24 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 N-CA-C 108.599 -0.889 . . . . 0.57999999999999996 108.599 -175.145 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 45.5 mm -101.38 74.55 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 124.114 0.966 . . . . 1.25 108.452 -170.059 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -72.16 0.69 9.03 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 114.528 1.307 . . . . 3.4500000000000002 114.528 -178.568 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 68.03 76.23 0.43 Allowed Glycine 0 CA--C 1.525 0.699 0 N-CA-C 110.195 -1.162 . . . . 2.8300000000000001 110.195 -179.084 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.019 0 N-CA-C 106.334 -1.728 . . . . 11.74 106.334 173.547 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 77' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.3 mtt . . . . . 0 N--CA 1.472 0.656 0 N-CA-C 106.827 -1.546 . . . . 12.109999999999999 106.827 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.3 tp -165.34 170.41 14.68 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 104.502 -2.406 . . . . 5.6600000000000001 104.502 175.087 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 49.3 m 58.9 86.51 0.09 Allowed 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.71 0.804 . . . . 0.93999999999999995 111.451 178.629 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -62.92 177.23 0.59 Allowed 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 121.266 0.555 . . . . 2.1099999999999999 110.675 173.637 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -134.69 140.39 45.96 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 108.684 -0.858 . . . . 1.1799999999999999 108.684 173.959 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -133.16 156.79 46.82 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 124.671 1.188 . . . . 4.0899999999999999 108.999 164.664 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -105.36 121.32 43.65 Favored 'General case' 0 N--CA 1.434 -1.261 0 N-CA-C 101.683 -3.451 . . . . 1.8100000000000001 101.683 174.034 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 24.8 mm -101.26 165.17 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.388 0 N-CA-C 106.639 -1.615 . . . . 2.0800000000000001 106.639 168.013 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -139.02 132.62 30.46 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 107.076 -1.453 . . . . 0.46999999999999997 107.076 177.581 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -156.95 178.45 10.35 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 118.883 0.765 . . . . 2.0 110.848 174.211 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 25.0 mm100 -91.47 166.33 12.91 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.314 1.445 . . . . 2.3700000000000001 110.405 -178.68 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -131.64 157.04 43.11 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.136 0 C-N-CA 124.057 0.943 . . . . 2.1600000000000001 110.723 174.936 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 63.7 m -149.84 166.73 28.62 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 125.5 1.52 . . . . 0.96999999999999997 109.018 177.352 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 71.66 67.03 1.96 Allowed Glycine 0 CA--C 1.525 0.691 0 N-CA-C 109.211 -1.556 . . . . 1.74 109.211 -177.394 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -147.55 166.66 26.66 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 124.153 0.981 . . . . 2.48 109.522 -174.731 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.3 p -126.22 -61.36 1.22 Allowed 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 124.049 0.939 . . . . 2.2599999999999998 109.497 168.623 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 30.8 p -109.31 151.61 26.35 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 123.694 0.798 . . . . 2.1699999999999999 111.297 -176.174 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -76.24 53.25 0.8 Allowed 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.604 0.762 . . . . 1.71 110.201 174.764 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -145.52 -51.96 0.26 Allowed 'General case' 0 C--O 1.23 0.048 0 C-N-CA 123.49 0.716 . . . . 0.68999999999999995 110.908 -175.844 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 7.5 p -55.41 -38.02 68.39 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 119.129 0.877 . . . . 2.5099999999999998 109.997 167.764 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.426 ' HB1' HG21 ' A' ' 39' ' ' VAL . . . -47.84 -31.07 4.59 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.483 1.513 . . . . 0.48999999999999999 112.899 171.17 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -72.84 -55.25 6.95 Favored 'General case' 0 N--CA 1.454 -0.272 0 O-C-N 121.099 -1.001 . . . . 0.29999999999999999 109.912 172.454 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 3.5 mpp_? -54.56 -40.4 68.68 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 118.736 -0.649 . . . . 4.2999999999999998 111.5 -174.892 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.414 HG21 ' CD1' ' A' ' 69' ' ' TYR . 5.4 pt -55.45 -54.45 25.24 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 C-N-CA 119.554 -0.858 . . . . 0.48999999999999999 110.802 175.535 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -57.69 -39.2 76.62 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 123.639 0.776 . . . . 3.1000000000000001 111.313 179.496 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 56.5 mmtt -71.43 -45.8 61.73 Favored 'General case' 0 CA--C 1.534 0.339 0 O-C-N 121.484 -0.76 . . . . 2.0600000000000001 110.201 -175.079 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.77 -39.47 98.01 Favored Glycine 0 CA--C 1.53 0.988 0 N-CA-C 110.376 -1.09 . . . . 0.57999999999999996 110.376 172.329 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.0 tt -60.01 -36.11 76.51 Favored 'General case' 0 CA--C 1.538 0.516 0 O-C-N 121.744 -0.857 . . . . 1.8999999999999999 110.279 174.818 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -60.79 -27.99 68.41 Favored 'General case' 0 N--CA 1.454 -0.242 0 O-C-N 120.876 -1.14 . . . . 3.54 111.999 174.464 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 4.4 mmt85 -72.39 -5.92 39.85 Favored 'General case' 0 CA--C 1.536 0.441 0 O-C-N 121.508 -0.745 . . . . 3.3799999999999999 112.009 -177.88 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 78.7 mmm -78.23 148.22 74.09 Favored Pre-proline 0 CA--C 1.533 0.32 0 CA-C-N 119.146 0.884 . . . . 3.2999999999999998 111.05 -179.544 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -56.96 142.62 93.65 Favored 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 122.393 2.062 . . . . 0.65000000000000002 108.832 176.953 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 86.68 -20.54 23.14 Favored Glycine 0 CA--C 1.532 1.107 0 CA-C-O 118.567 -1.13 . . . . 0.57999999999999996 113.498 -178.988 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 14.4 t -94.49 123.78 46.73 Favored 'Isoleucine or valine' 0 C--N 1.344 0.334 0 CA-C-N 119.904 1.852 . . . . 0.63 110.414 -178.244 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -103.37 -37.26 7.7 Favored 'General case' 0 CA--C 1.524 -0.054 0 C-N-CA 124.519 1.127 . . . . 1.0600000000000001 111.21 -171.889 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -149.89 162.37 40.45 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 108.775 -0.824 . . . . 2.1299999999999999 108.775 174.726 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -155.45 139.28 16.22 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 122.781 0.432 . . . . 0.46000000000000002 110.203 -177.268 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -155.78 110.19 2.87 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 109.03 -0.73 . . . . 0.51000000000000001 109.03 -165.56 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.426 HG21 ' HB1' ' A' ' 21' ' ' ALA . 2.8 p -83.02 106.29 13.64 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.638 0 N-CA-C 109.256 -0.646 . . . . 0.65000000000000002 109.256 178.785 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 55.3 t-20 -84.59 56.98 4.08 Favored 'General case' 0 CA--C 1.533 0.323 0 O-C-N 120.821 -1.174 . . . . 0.63 108.819 176.188 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.67 -19.98 64.42 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 115.271 -0.877 . . . . 1.1000000000000001 109.441 -176.86 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -48.37 -38.77 20.18 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.483 0.713 . . . . 0.55000000000000004 111.952 167.491 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 8.8 t -117.08 36.09 4.37 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 118.029 0.377 . . . . 1.24 110.383 170.764 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 55.42 26.59 9.0 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.476 1.11 . . . . 4.1500000000000004 113.639 172.565 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 66.0 m -122.52 162.72 21.23 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.884 1.274 . . . . 0.63 108.679 -173.411 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.4 p -126.64 146.21 32.89 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 O-C-N 121.051 -1.03 . . . . 0.34999999999999998 109.498 170.931 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -131.58 131.02 42.96 Favored 'General case' 0 C--N 1.343 0.295 0 N-CA-C 108.113 -1.069 . . . . 0.32000000000000001 108.113 177.449 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 4.3 p -132.83 132.03 59.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 106.188 -1.782 . . . . 1.73 106.188 -175.024 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 16.9 mm -109.39 105.53 18.98 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 C-N-CA 125.374 1.47 . . . . 0.41999999999999998 107.745 -170.841 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 49.1 p90 -146.43 169.26 19.24 Favored 'General case' 0 CA--C 1.516 -0.365 0 O-C-N 122.073 -0.392 . . . . 1.7 111.677 -171.647 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 41.4 t0 -88.28 108.29 21.2 Favored Pre-proline 0 CA--C 1.533 0.305 0 O-C-N 124.484 1.115 . . . . 3.0600000000000001 110.262 175.731 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -70.89 0.94 5.72 Favored 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 123.036 2.491 . . . . 0.64000000000000001 113.351 -179.21 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -84.15 -30.68 25.68 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 119.502 1.046 . . . . 0.80000000000000004 109.144 167.686 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -105.09 -55.76 2.28 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 124.099 0.96 . . . . 2.7200000000000002 112.007 -167.544 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.263 1.6 p -92.33 -177.63 4.69 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-O 121.496 0.665 . . . . 0.51000000000000001 110.319 155.681 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 155.42 89.77 0.07 OUTLIER Glycine 0 N--CA 1.443 -0.883 0 N-CA-C 105.937 -2.865 . . . . 2.4199999999999999 105.937 -165.545 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 82.1 p -7.89 -16.62 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.561 1 C-N-CA 136.279 5.832 . . . . 1.1699999999999999 119.977 -136.369 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -25.45 -63.23 0.06 Allowed 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 127.756 2.422 . . . . 0.67000000000000004 114.352 169.827 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.81 -43.0 57.0 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 118.349 -1.341 . . . . 0.64000000000000001 109.467 -166.316 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -47.9 -56.19 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.099 0 CA-C-N 113.242 -1.799 . . . . 0.87 110.511 171.985 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -67.0 -46.02 75.82 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 118.952 0.796 . . . . 1.46 110.423 -175.047 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -45.19 -57.99 3.56 Favored 'General case' 0 C--N 1.342 0.282 0 CA-C-O 122.59 1.186 . . . . 3.3700000000000001 110.975 171.954 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.9 mmpt? -71.39 -37.75 71.55 Favored 'General case' 0 N--CA 1.431 -1.399 0 CA-C-O 118.417 -0.801 . . . . 2.4199999999999999 112.225 -174.864 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -47.61 -52.47 5.92 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 N-CA-C 107.482 -1.303 . . . . 0.46000000000000002 107.482 175.629 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -59.8 -56.55 20.35 Favored 'General case' 0 C--N 1.343 0.295 0 C-N-CA 123.693 0.797 . . . . 2.0299999999999998 110.211 175.845 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 2.7 mmmt -60.29 -28.54 68.17 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 114.018 1.118 . . . . 4.54 114.018 -175.683 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 11.8 mt -70.99 -18.24 62.61 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 125.925 1.69 . . . . 0.69999999999999996 111.373 173.741 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 90.72 45.2 4.32 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 110.217 -1.153 . . . . 0.45000000000000001 110.217 178.642 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.414 ' CD1' HG21 ' A' ' 24' ' ' ILE . 0.2 OUTLIER -141.02 173.42 11.5 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 124.039 0.935 . . . . 2.02 110.363 -177.195 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 17.3 t60 -133.64 139.95 46.79 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 109.212 -0.662 . . . . 2.1899999999999999 109.212 170.596 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 6.1 p -112.61 126.18 69.98 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 N-CA-C 107.558 -1.275 . . . . 1.51 107.558 174.863 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 26.5 t -104.46 138.38 29.38 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.154 0 N-CA-C 108.341 -0.985 . . . . 0.51000000000000001 108.341 -177.487 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 4.9 mp -109.09 77.32 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 C-N-CA 124.197 0.999 . . . . 1.27 108.388 -179.196 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -73.15 -4.21 31.34 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 125.463 1.505 . . . . 2.7000000000000002 113.743 171.985 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -87.0 -76.8 1.26 Allowed Glycine 0 CA--C 1.525 0.7 0 N-CA-C 109.406 -1.477 . . . . 3.1600000000000001 109.406 176.417 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 2.2 ttt180 . . . . . 0 C--O 1.251 1.14 0 C-N-CA 125.629 1.572 . . . . 12.470000000000001 110.457 -177.896 . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 77' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.476 0.848 0 N-CA-C 104.522 -2.399 . . . . 7.8799999999999999 104.522 . . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.7 tt 69.73 155.73 0.14 Allowed 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 107.52 -1.289 . . . . 5.1299999999999999 107.52 -139.019 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.0 m -108.57 118.24 36.27 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 125.423 1.489 . . . . 1.0 107.061 -179.914 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -80.02 -178.27 6.42 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 123.552 0.741 . . . . 2.1000000000000001 109.723 179.335 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -136.79 141.82 42.94 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 107.79 -1.189 . . . . 1.0800000000000001 107.79 168.939 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -139.85 163.93 31.34 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 124.509 1.124 . . . . 3.6299999999999999 109.673 168.427 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.8 90.59 3.13 Favored 'General case' 0 N--CA 1.441 -0.905 0 C-N-CA 128.504 2.722 . . . . 1.6699999999999999 106.985 -159.826 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.402 HG13 ' CZ ' ' A' ' 50' ' ' TYR . 7.5 mm -83.75 162.22 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.026 0 N-CA-C 107.324 -1.362 . . . . 1.9399999999999999 107.324 -176.288 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -140.38 134.86 31.46 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 124.704 1.202 . . . . 0.58999999999999997 108.728 179.742 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -156.28 172.23 18.84 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.361 0.664 . . . . 2.3799999999999999 110.52 176.929 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -87.27 168.86 12.81 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.997 1.319 . . . . 3.8199999999999998 110.383 174.898 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.661 HG21 HD21 ' A' ' 41' ' ' LEU . 5.9 m -126.33 152.32 33.69 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 C-N-CA 124.856 1.262 . . . . 1.9199999999999999 111.976 -179.636 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 16.2 m -139.19 146.72 40.88 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 126.031 1.732 . . . . 1.0700000000000001 107.896 164.298 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 123.75 -30.35 4.9 Favored Glycine 0 CA--C 1.531 1.054 0 C-N-CA 124.93 1.252 . . . . 2.0600000000000001 111.751 -177.363 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -54.07 137.66 39.47 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 121.389 0.614 . . . . 1.8899999999999999 112.485 -178.31 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -144.2 -60.37 0.38 Allowed 'General case' 0 C--N 1.333 -0.142 0 C-N-CA 125.484 1.513 . . . . 2.4199999999999999 107.65 178.228 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 26.2 p -78.55 -5.34 52.45 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.625 1.17 . . . . 3.25 112.983 177.559 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 68.59 -55.84 0.52 Allowed 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 126.128 1.771 . . . . 2.8500000000000001 112.111 -170.102 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -46.4 -43.78 16.59 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 125.017 1.327 . . . . 1.29 113.402 -173.753 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 29.5 m -57.82 -25.42 60.6 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 112.689 0.626 . . . . 2.2000000000000002 112.689 -179.061 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.72 ' HB1' HG21 ' A' ' 39' ' ' VAL . . . -56.38 -35.05 67.28 Favored 'General case' 0 CA--C 1.537 0.454 0 O-C-N 121.755 -0.591 . . . . 0.65000000000000002 110.609 172.876 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.97 -46.74 61.82 Favored 'General case' 0 C--O 1.232 0.171 0 O-C-N 120.533 -1.354 . . . . 0.35999999999999999 109.322 171.799 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 6.5 mmm180 -51.2 -45.22 61.77 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-O 117.697 -1.144 . . . . 5.8399999999999999 111.914 -177.765 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.312 2.4 pt -60.31 -59.82 3.52 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-O 117.786 -1.102 . . . . 0.65000000000000002 110.701 -179.033 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.633 ' HG3' ' HB1' ' A' ' 37' ' ' ALA . 1.3 mp0 -43.37 -47.75 6.9 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 120.264 1.393 . . . . 2.2599999999999998 112.254 172.747 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -74.94 -17.72 60.51 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 113.429 0.9 . . . . 2.8399999999999999 113.429 -176.841 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -76.69 -45.23 13.47 Favored Glycine 0 CA--C 1.531 1.033 0 N-CA-C 110.407 -1.077 . . . . 0.67000000000000004 110.407 161.072 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 26.8 mt -61.18 -39.58 90.7 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 117.69 0.745 . . . . 2.3599999999999999 109.814 -175.498 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 9.8 tmtt? -50.31 -28.57 8.1 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.006 1.322 . . . . 3.2799999999999998 112.678 173.519 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 4.3 mtm180 -80.44 -1.64 42.36 Favored 'General case' 0 CA--C 1.535 0.382 0 O-C-N 121.637 -0.664 . . . . 6.7300000000000004 112.643 -177.748 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 61.1 mmm -98.93 146.86 32.39 Favored Pre-proline 0 CA--C 1.533 0.317 0 CA-C-N 118.876 0.762 . . . . 3.54 110.853 -172.15 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -58.22 137.01 78.36 Favored 'Trans proline' 0 N--CA 1.45 -1.034 0 C-N-CA 122.387 2.058 . . . . 0.56000000000000005 109.264 -179.622 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 95.77 -35.3 4.39 Favored Glycine 0 CA--C 1.527 0.839 0 CA-C-O 119.382 -0.677 . . . . 0.57999999999999996 111.969 -175.536 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 9.0 t -85.65 132.19 32.52 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.153 0 CA-C-N 119.27 1.535 . . . . 0.66000000000000003 109.689 -174.712 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -103.1 -46.53 4.61 Favored 'General case' 0 C--N 1.342 0.255 0 CA-C-N 118.269 0.486 . . . . 1.77 110.526 178.88 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -152.8 174.85 13.54 Favored 'General case' 0 CA--C 1.515 -0.371 0 C-N-CA 124.196 0.998 . . . . 3.46 111.101 166.685 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.633 ' HB1' ' HG3' ' A' ' 25' ' ' GLU . . . -157.95 148.48 20.66 Favored 'General case' 0 N--CA 1.441 -0.907 0 C-N-CA 124.109 0.964 . . . . 0.52000000000000002 109.435 -173.956 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -153.85 117.35 4.63 Favored 'General case' 0 CA--C 1.528 0.119 0 N-CA-C 108.054 -1.091 . . . . 0.54000000000000004 108.054 -158.772 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.903 HG22 HD23 ' A' ' 41' ' ' LEU . 7.7 p -96.24 96.48 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 C-N-CA 124.289 1.036 . . . . 0.71999999999999997 110.439 -172.923 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 51.2 t-20 -84.04 57.06 3.98 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 122.628 1.204 . . . . 0.76000000000000001 109.889 -176.968 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.903 HD23 HG22 ' A' ' 39' ' ' VAL . 0.5 OUTLIER -68.45 -21.77 64.62 Favored 'General case' 0 CA--C 1.527 0.07 0 CA-C-N 115.231 -0.895 . . . . 1.1699999999999999 110.742 -176.569 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -45.33 -34.74 3.12 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 123.611 0.764 . . . . 1.01 112.045 166.315 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 4.9 t -126.54 39.34 3.95 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 122.56 0.344 . . . . 1.6399999999999999 110.141 174.329 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 42.5 53.38 4.66 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.285 1.034 . . . . 3.5099999999999998 112.757 175.04 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 41.8 m -145.81 150.54 36.38 Favored 'General case' 0 N--CA 1.438 -1.065 0 N-CA-C 107.889 -1.152 . . . . 0.91000000000000003 107.889 177.991 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 8.9 p -122.5 142.34 39.36 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 N-CA-C 108.465 -0.939 . . . . 0.55000000000000004 108.465 171.159 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -125.3 141.98 51.76 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 124.818 1.247 . . . . 0.40999999999999998 108.173 -179.407 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.433 HG13 ' HB2' ' A' ' 37' ' ' ALA . 35.9 t -135.68 127.31 45.27 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.325 0 N-CA-C 105.981 -1.859 . . . . 2.1800000000000002 105.981 -178.543 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 21.1 mm -100.38 100.42 10.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 C-N-CA 125.774 1.63 . . . . 0.46999999999999997 107.764 -175.096 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.402 ' CZ ' HG13 ' A' ' 8' ' ' ILE . 17.6 p90 -137.53 166.02 24.88 Favored 'General case' 0 CA--C 1.518 -0.259 0 O-C-N 122.192 -0.317 . . . . 1.73 111.764 -173.597 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -84.34 123.92 74.39 Favored Pre-proline 0 C--O 1.24 0.585 0 C-N-CA 123.813 0.845 . . . . 3.1000000000000001 108.915 171.494 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -86.94 11.82 3.16 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 123.823 3.015 . . . . 0.73999999999999999 113.162 -175.155 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -97.19 -46.05 6.29 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 108.448 -0.945 . . . . 1.05 108.448 168.423 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -77.79 -44.98 25.85 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 123.951 0.9 . . . . 3.3599999999999999 109.129 -178.888 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.262 26.3 p -112.01 -137.29 0.37 Allowed 'General case' 0 CA--C 1.518 -0.254 0 C-N-CA 122.107 0.163 . . . . 0.84999999999999998 110.667 165.17 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 105.67 128.23 6.09 Favored Glycine 0 N--CA 1.44 -1.098 0 N-CA-C 105.679 -2.968 . . . . 2.0499999999999998 105.679 -123.938 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 24.0 p -30.56 -30.29 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.463 1 C-N-CA 134.66 5.184 . . . . 1.3300000000000001 113.76 -177.385 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -29.01 -62.42 0.12 Allowed 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 126.018 1.727 . . . . 0.68999999999999995 112.733 167.258 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.87 -44.22 50.17 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 117.505 -1.678 . . . . 0.5 109.907 -170.578 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.1 mp -51.64 -50.14 31.87 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.945 0 CA-C-N 112.915 -1.948 . . . . 0.98999999999999999 110.067 -178.997 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.2 -50.64 67.28 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 107.933 -1.136 . . . . 2.1200000000000001 107.933 -178.162 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.409 ' OE2' ' NZ ' ' A' ' 66' ' ' LYS . 1.3 tm-20 -44.52 -54.29 6.17 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 122.362 1.077 . . . . 3.0 110.77 178.871 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.1 mmpt? -71.4 -40.33 70.56 Favored 'General case' 0 N--CA 1.434 -1.271 0 CA-C-O 118.154 -0.926 . . . . 2.5600000000000001 113.016 179.094 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.3 mm -48.27 -50.98 10.82 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.793 0 N-CA-C 107.805 -1.183 . . . . 0.67000000000000004 107.805 176.664 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 76.1 mm-40 -57.92 -60.73 3.26 Favored 'General case' 0 C--N 1.343 0.283 0 C-N-CA 124.967 1.307 . . . . 2.98 110.284 177.096 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.409 ' NZ ' ' OE2' ' A' ' 62' ' ' GLU . 7.0 mptt -56.37 -35.38 67.63 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 112.577 0.584 . . . . 5.0 112.577 -177.059 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 35.1 mt -70.08 -18.04 63.25 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.348 1.059 . . . . 0.68999999999999995 111.529 177.909 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 98.04 35.38 5.08 Favored Glycine 0 CA--C 1.525 0.716 0 C-N-CA 124.342 0.973 . . . . 0.70999999999999996 111.535 174.453 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -127.47 169.34 13.76 Favored 'General case' 0 N--CA 1.457 -0.102 0 C-N-CA 124.378 1.071 . . . . 2.1499999999999999 108.914 173.727 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 85.9 t60 -137.67 133.66 34.53 Favored 'General case' 0 N--CA 1.453 -0.275 0 N-CA-C 106.187 -1.783 . . . . 2.04 106.187 162.768 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 23.4 m -91.35 144.57 8.91 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.691 0 CA-C-N 119.244 0.929 . . . . 2.2599999999999998 108.863 172.841 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.5 t -103.06 130.94 52.41 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 N-CA-C 107.75 -1.204 . . . . 0.89000000000000001 107.75 178.97 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 28.0 mm -109.62 75.27 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 C-N-CA 124.363 1.065 . . . . 1.0700000000000001 108.424 -173.196 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -72.64 -14.88 61.7 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 113.917 1.08 . . . . 3.1400000000000001 113.917 -178.43 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -104.13 63.88 0.36 Allowed Glycine 0 CA--C 1.525 0.715 0 N-CA-C 108.115 -1.994 . . . . 3.7999999999999998 108.115 168.191 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 50.9 tpt85 . . . . . 0 C--O 1.249 1.032 0 CA-C-O 117.908 -1.044 . . . . 13.17 112.196 -174.172 . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 77' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 37.9 mtt . . . . . 0 N--CA 1.472 0.664 0 N-CA-C 108.85 -0.796 . . . . 10.1 108.85 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.4 tt -150.61 136.68 18.47 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 106.146 -1.798 . . . . 5.6100000000000003 106.146 -175.237 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.7 m -128.2 98.95 5.26 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 107.257 -1.386 . . . . 0.71999999999999997 107.257 179.528 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -66.63 178.11 1.39 Allowed 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 123.378 0.671 . . . . 3.46 109.529 172.381 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -135.22 150.84 50.17 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 108.393 -0.966 . . . . 0.93999999999999995 108.393 173.753 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 26.7 mmtp -139.74 162.1 35.95 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.481 1.113 . . . . 2.8700000000000001 108.628 163.984 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.3 mp0 -123.02 96.36 4.98 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 127.101 2.16 . . . . 2.3900000000000001 105.953 -176.937 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 23.9 mm -83.29 164.16 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.16 0 N-CA-C 107.067 -1.457 . . . . 2.1099999999999999 107.067 178.327 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -138.48 123.53 19.05 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 125.207 1.403 . . . . 0.55000000000000004 107.585 179.389 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -133.03 166.46 22.36 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 118.85 0.75 . . . . 2.8500000000000001 109.938 178.246 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -84.5 168.13 15.73 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.557 1.143 . . . . 3.6699999999999999 109.368 169.194 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 38.4 t -125.05 146.09 31.28 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 C-N-CA 124.567 1.147 . . . . 1.3 109.411 -175.22 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 11.8 m -154.8 171.16 20.05 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.918 0.887 . . . . 1.3200000000000001 110.418 172.863 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 64.06 70.38 1.08 Allowed Glycine 0 C--N 1.34 0.761 0 N-CA-C 110.5 -1.04 . . . . 1.8799999999999999 110.5 178.261 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -153.05 156.46 38.79 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 116.922 0.361 . . . . 2.73 111.304 -170.124 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -89.76 -60.89 1.82 Allowed 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 125.226 1.411 . . . . 3.27 109.49 168.255 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 21.6 p -144.09 160.81 40.26 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-O 121.836 0.827 . . . . 2.4399999999999999 112.895 -167.269 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -74.69 45.47 0.25 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.473 1.509 . . . . 1.6599999999999999 111.492 175.559 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -137.98 -49.75 0.57 Allowed 'General case' 0 C--N 1.335 -0.057 0 C-N-CA 124.614 1.166 . . . . 0.70999999999999996 108.637 177.804 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 78.3 m -53.52 -38.86 64.17 Favored 'General case' 0 C--O 1.232 0.132 0 O-C-N 121.593 -0.692 . . . . 1.21 110.76 165.643 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.592 ' HB1' HG21 ' A' ' 39' ' ' VAL . . . -45.75 -35.03 4.0 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.006 1.322 . . . . 0.66000000000000003 112.411 170.667 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.61 -54.45 10.4 Favored 'General case' 0 N--CA 1.451 -0.382 0 O-C-N 121.026 -1.046 . . . . 0.40999999999999998 109.64 174.655 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 43.3 mtm105 -48.85 -50.71 33.35 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 123.539 0.735 . . . . 6.2300000000000004 110.45 -175.595 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.463 HG21 ' CD1' ' A' ' 69' ' ' TYR . 4.9 pt -54.49 -52.75 37.12 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.164 0 O-C-N 123.761 0.663 . . . . 0.46000000000000002 109.849 -179.051 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.601 ' HG3' ' HB1' ' A' ' 37' ' ' ALA . 0.5 OUTLIER -56.34 -39.86 73.53 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 123.93 0.892 . . . . 2.1600000000000001 111.431 179.68 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 26.5 mmtt -73.68 -44.89 55.43 Favored 'General case' 0 CA--C 1.531 0.215 0 O-C-N 121.201 -0.937 . . . . 1.9199999999999999 111.509 -176.259 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -59.34 -42.44 97.41 Favored Glycine 0 CA--C 1.529 0.928 0 N-CA-C 109.988 -1.245 . . . . 0.62 109.988 172.197 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.535 HD21 HG12 ' A' ' 60' ' ' ILE . 8.5 tt -58.55 -39.61 80.7 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.571 1.149 . . . . 1.97 110.289 175.668 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -61.52 -30.17 70.46 Favored 'General case' 0 N--CA 1.452 -0.366 0 O-C-N 121.064 -1.023 . . . . 3.5299999999999998 111.66 174.915 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 16.0 mtt180 -72.13 -8.09 52.71 Favored 'General case' 0 CA--C 1.533 0.295 0 O-C-N 121.495 -0.753 . . . . 3.5899999999999999 112.638 -178.888 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 69.2 mmm -73.96 150.55 88.17 Favored Pre-proline 0 CA--C 1.533 0.289 0 CA-C-N 119.291 0.951 . . . . 3.4399999999999999 110.432 179.867 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -56.34 147.31 68.1 Favored 'Trans proline' 0 N--CA 1.451 -1.026 0 C-N-CA 121.595 1.53 . . . . 0.62 108.402 172.573 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 86.15 -22.65 11.62 Favored Glycine 0 CA--C 1.525 0.682 0 C-N-CA 124.143 0.878 . . . . 0.47999999999999998 113.194 -179.93 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 15.6 t -98.19 127.15 50.94 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 CA-C-N 119.459 1.63 . . . . 0.57999999999999996 109.903 -175.788 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -113.11 -31.34 6.68 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 123.388 0.675 . . . . 0.91000000000000003 112.04 -173.37 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -146.67 160.7 41.87 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-N 119.289 0.949 . . . . 2.1099999999999999 108.931 167.004 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.601 ' HB1' ' HG3' ' A' ' 25' ' ' GLU . . . -156.73 138.88 14.58 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 116.832 -0.167 . . . . 0.41999999999999998 111.307 177.582 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -154.23 113.92 3.8 Favored 'General case' 0 C--N 1.341 0.221 0 N-CA-C 107.381 -1.34 . . . . 0.45000000000000001 107.381 -160.466 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.592 HG21 ' HB1' ' A' ' 21' ' ' ALA . 6.0 p -93.15 102.11 13.31 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 C-N-CA 123.267 0.627 . . . . 0.66000000000000003 110.058 -175.501 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 52.0 t-20 -83.04 58.65 4.51 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 122.536 1.16 . . . . 0.59999999999999998 110.012 -177.415 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.1 -20.01 65.72 Favored 'General case' 0 C--O 1.225 -0.194 0 CA-C-N 114.943 -1.026 . . . . 0.89000000000000001 110.675 -177.692 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -48.55 -30.13 4.96 Favored 'General case' 0 CA--C 1.528 0.134 0 C-N-CA 123.789 0.835 . . . . 0.63 112.644 170.424 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 4.3 t -129.74 32.67 4.55 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 109.792 -0.448 . . . . 1.22 109.792 172.583 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 29.0 mp0 54.41 40.53 31.86 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.64 1.176 . . . . 4.0 113.086 175.067 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -124.86 163.55 21.96 Favored 'General case' 0 N--CA 1.454 -0.259 0 O-C-N 121.327 -0.858 . . . . 0.98999999999999999 109.585 176.11 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.7 p -133.56 140.75 46.04 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 N-CA-C 108.795 -0.817 . . . . 0.35999999999999999 108.795 171.893 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 18.7 m120 -129.46 138.55 51.48 Favored 'General case' 0 C--N 1.344 0.365 0 N-CA-C 108.193 -1.039 . . . . 0.28999999999999998 108.193 -178.232 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.432 HG21 HD21 ' A' ' 28' ' ' LEU . 3.8 p -136.65 128.67 44.05 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 N-CA-C 106.529 -1.656 . . . . 1.72 106.529 -176.11 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 9.8 mm -105.9 96.52 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 C-N-CA 125.918 1.687 . . . . 0.40999999999999998 107.278 -171.602 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 44.1 p90 -136.96 165.06 26.87 Favored 'General case' 0 CA--C 1.515 -0.375 0 O-C-N 122.18 -0.325 . . . . 1.72 111.596 -170.76 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 45.0 t0 -86.58 108.85 19.72 Favored Pre-proline 0 C--N 1.329 -0.29 0 C-N-CA 125.198 1.399 . . . . 2.9100000000000001 109.666 176.8 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -71.26 2.03 4.81 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 123.209 2.606 . . . . 0.64000000000000001 113.4 -177.878 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -90.31 -30.22 17.62 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 119.395 0.998 . . . . 0.77000000000000002 109.345 169.057 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -101.71 -51.73 3.37 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.359 0.664 . . . . 3.0899999999999999 110.361 -170.315 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.9 p -99.81 -174.11 2.62 Favored 'General case' 0 C--O 1.225 -0.205 0 C-N-CA 123.872 0.869 . . . . 0.63 110.598 158.096 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 145.16 92.63 0.14 Allowed Glycine 0 N--CA 1.443 -0.899 0 N-CA-C 104.87 -3.292 . . . . 2.4300000000000002 104.87 -158.228 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 48.8 p -10.24 -18.9 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.577 1 C-N-CA 137.068 6.147 . . . . 1.0800000000000001 119.829 -139.087 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -26.8 -61.84 0.08 Allowed 'General case' 0 N--CA 1.439 -0.987 0 C-N-CA 127.893 2.477 . . . . 0.73999999999999999 114.418 170.11 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.14 -44.76 59.62 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 117.991 -1.484 . . . . 0.70999999999999996 109.259 -168.15 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.535 HG12 HD21 ' A' ' 28' ' ' LEU . 2.2 mt -53.21 -52.76 27.7 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 CA-C-N 112.918 -1.946 . . . . 0.90000000000000002 110.682 178.462 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.92 -45.6 85.15 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 120.06 1.3 . . . . 1.75 109.2 -177.019 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -47.59 -57.32 5.6 Favored 'General case' 0 C--N 1.343 0.318 0 CA-C-O 123.148 1.451 . . . . 2.8399999999999999 109.466 177.264 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.4 mmpt? -71.17 -36.04 71.85 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-N 114.768 -1.105 . . . . 2.5 112.979 -175.403 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -50.04 -53.17 11.89 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 N-CA-C 107.405 -1.331 . . . . 0.41999999999999998 107.405 174.501 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 -60.73 -55.72 29.77 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 115.458 -0.792 . . . . 1.8400000000000001 110.74 176.04 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -57.13 -34.47 68.41 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 113.484 0.92 . . . . 4.5599999999999996 113.484 -176.674 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.435 HD13 ' HA ' ' A' ' 24' ' ' ILE . 13.6 mt -71.54 -19.49 62.16 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 125.815 1.646 . . . . 0.66000000000000003 111.918 174.356 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 95.89 45.37 2.89 Favored Glycine 0 CA--C 1.525 0.678 0 C-N-CA 125.169 1.366 . . . . 0.48999999999999999 111.378 175.914 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.463 ' CD1' HG21 ' A' ' 24' ' ' ILE . 0.3 OUTLIER -140.39 173.7 11.24 Favored 'General case' 0 N--CA 1.458 -0.068 0 C-N-CA 124.216 1.006 . . . . 2.02 110.504 -178.061 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -152.44 126.74 9.25 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 109.49 -0.559 . . . . 2.0499999999999998 109.49 171.946 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 16.1 m -83.89 164.64 2.6 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 C-N-CA 123.623 0.769 . . . . 2.4399999999999999 109.61 173.932 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 1.9 t -125.6 136.33 61.16 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 O-C-N 121.439 -0.788 . . . . 1.0600000000000001 108.944 176.434 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 11.2 mm -102.59 71.68 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 C-N-CA 123.767 0.827 . . . . 1.25 109.329 -171.483 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -72.82 2.16 7.26 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 114.75 1.389 . . . . 2.75 114.75 -175.108 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 72.75 82.39 0.32 Allowed Glycine 0 CA--C 1.527 0.834 0 N-CA-C 109.03 -1.628 . . . . 3.5600000000000001 109.03 -175.85 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.253 1.26 0 CA-C-O 116.347 -1.787 . . . . 14.58 107.04 -174.625 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 77' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 44.6 mtt . . . . . 0 N--CA 1.473 0.709 0 CA-C-O 118.937 -0.554 . . . . 10.140000000000001 109.571 . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.7 pp -52.61 -36.85 57.16 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 122.873 0.469 . . . . 5.6900000000000004 111.472 177.016 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 21.5 m -113.41 146.98 38.63 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 125.73 1.612 . . . . 1.3 106.992 163.214 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -91.31 -175.99 4.42 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 108.073 -1.084 . . . . 2.0800000000000001 108.073 157.831 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.6 mm100 -134.47 146.89 50.19 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 106.628 -1.619 . . . . 1.1599999999999999 106.628 165.616 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 75.2 mttt -141.75 156.78 45.58 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 123.918 0.887 . . . . 2.96 110.806 161.504 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -111.03 92.02 3.88 Favored 'General case' 0 N--CA 1.44 -0.969 0 C-N-CA 128.156 2.582 . . . . 1.3600000000000001 107.152 -167.954 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 6.8 mm -83.14 162.01 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.218 0 N-CA-C 106.916 -1.512 . . . . 1.97 106.916 -175.559 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -141.16 116.07 9.78 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 124.409 1.084 . . . . 0.60999999999999999 108.769 -173.804 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 66.3 mtm -138.18 173.17 11.9 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 118.527 0.603 . . . . 1.8600000000000001 110.539 -175.122 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.67 168.43 9.69 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 125.934 1.694 . . . . 3.5499999999999998 108.94 172.598 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 19.6 m -129.04 174.88 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 C-N-CA 123.455 0.702 . . . . 2.0699999999999998 110.12 172.851 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 57.8 m -151.02 175.14 12.37 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 124.304 1.042 . . . . 0.93999999999999995 108.328 173.32 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 85.82 -35.01 3.27 Favored Glycine 0 CA--C 1.531 1.09 0 O-C-N 122.019 -0.426 . . . . 2.3999999999999999 112.573 178.304 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -48.16 141.84 5.88 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.096 0.959 . . . . 1.8500000000000001 112.877 179.325 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -103.94 -46.19 4.55 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 124.684 1.194 . . . . 2.2400000000000002 110.09 171.809 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 18.4 p -132.62 161.3 34.26 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 123.752 0.821 . . . . 2.0699999999999998 110.918 -175.342 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -77.02 56.75 1.27 Allowed 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.104 0.962 . . . . 2.0800000000000001 110.631 178.293 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -142.52 -57.88 0.44 Allowed 'General case' 0 N--CA 1.456 -0.138 0 C-N-CA 123.854 0.862 . . . . 0.96999999999999997 109.549 176.322 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 58.9 m -54.08 -43.32 70.24 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 121.011 0.434 . . . . 1.3899999999999999 111.65 -174.63 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.59 -22.6 13.8 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.232 1.013 . . . . 0.54000000000000004 112.963 178.069 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.437 ' HA ' HG11 ' A' ' 39' ' ' VAL . . . -70.24 -47.64 60.46 Favored 'General case' 0 N--CA 1.452 -0.363 0 O-C-N 121.163 -0.961 . . . . 0.60999999999999999 110.267 172.163 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 52.7 mtp85 -58.61 -48.57 80.55 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 109.486 -0.561 . . . . 4.2199999999999998 109.486 -171.107 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.429 ' HA ' HD13 ' A' ' 67' ' ' LEU . 5.4 pt -55.63 -51.48 58.1 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 O-C-N 123.684 0.615 . . . . 0.64000000000000001 110.005 179.02 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -55.64 -43.86 76.61 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 113.455 0.909 . . . . 4.5199999999999996 113.455 179.116 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 13.4 mptt -72.69 -40.98 65.8 Favored 'General case' 0 CA--C 1.536 0.425 0 O-C-N 121.505 -0.747 . . . . 2.1400000000000001 109.643 -175.954 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -57.16 -39.89 90.69 Favored Glycine 0 CA--C 1.532 1.141 0 N-CA-C 111.147 -0.781 . . . . 0.64000000000000001 111.147 168.727 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.8 tt -65.3 -44.24 88.54 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.401 1.08 . . . . 1.8300000000000001 109.363 179.136 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 27.0 ttmt -54.5 -39.13 67.26 Favored 'General case' 0 CA--C 1.53 0.178 0 O-C-N 121.258 -0.902 . . . . 3.6600000000000001 111.075 175.383 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.91 -8.66 7.53 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 114.389 1.255 . . . . 4.3499999999999996 114.389 -179.589 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 82.6 mmm -81.85 151.98 68.31 Favored Pre-proline 0 CA--C 1.536 0.425 0 CA-C-N 120.089 1.313 . . . . 3.4399999999999999 111.521 -177.633 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -59.05 150.89 70.18 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 122.427 2.085 . . . . 0.77000000000000002 110.628 178.985 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 79.31 -25.92 2.67 Favored Glycine 0 CA--C 1.531 1.06 0 C-N-CA 123.702 0.668 . . . . 0.66000000000000003 112.685 -177.466 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 15.4 t -86.45 141.05 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 CA-C-N 118.901 1.35 . . . . 0.82999999999999996 108.879 176.102 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -119.76 -43.22 2.58 Favored 'General case' 0 C--N 1.34 0.153 0 CA-C-O 118.716 -0.659 . . . . 1.3799999999999999 111.243 179.113 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -143.33 169.13 18.22 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 118.978 0.808 . . . . 1.8899999999999999 110.82 176.69 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -159.64 154.18 24.13 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.908 -0.587 . . . . 1.22 111.079 -177.343 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -155.76 94.52 1.57 Allowed 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 125.567 1.547 . . . . 1.0 109.173 -168.393 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.559 ' CG2' HD23 ' A' ' 41' ' ' LEU . 3.5 p -78.93 93.98 1.67 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 CA-C-O 121.867 0.842 . . . . 0.96999999999999997 109.355 -177.852 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 44.8 t30 -81.67 58.75 3.88 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 122.212 1.006 . . . . 0.62 109.854 -176.196 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.559 HD23 ' CG2' ' A' ' 39' ' ' VAL . 0.4 OUTLIER -69.78 -19.99 63.49 Favored 'General case' 0 N--CA 1.457 -0.081 0 C-N-CA 124.462 1.105 . . . . 1.01 111.016 -179.212 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -43.32 -39.78 3.26 Favored 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 124.064 0.946 . . . . 0.68000000000000005 111.931 169.832 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 9.9 t -128.1 40.3 3.7 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 122.574 0.35 . . . . 1.23 110.291 172.07 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 50.85 51.98 15.9 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.731 1.213 . . . . 3.2999999999999998 113.741 172.259 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -131.49 161.15 33.22 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 124.588 1.155 . . . . 2.0899999999999999 109.013 175.529 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.5 p -131.62 134.74 60.15 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 N-CA-C 107.706 -1.22 . . . . 0.34999999999999998 107.706 167.669 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -123.03 126.79 47.78 Favored 'General case' 0 C--N 1.341 0.233 0 N-CA-C 108.559 -0.904 . . . . 0.58999999999999997 108.559 177.524 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 46.8 t -126.32 130.96 71.95 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 N-CA-C 105.638 -1.986 . . . . 2.21 105.638 -177.169 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 10.6 mm -105.08 99.72 9.04 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 C-N-CA 125.336 1.455 . . . . 0.48999999999999999 107.694 -175.548 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 53.2 p90 -139.61 171.31 14.42 Favored 'General case' 0 CA--C 1.515 -0.369 0 C-N-CA 122.719 0.408 . . . . 2.1699999999999999 111.111 -174.61 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 45.8 t0 -89.23 107.08 15.81 Favored Pre-proline 0 C--O 1.234 0.255 0 CA-C-O 118.35 -0.833 . . . . 3.2200000000000002 109.278 176.683 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -71.78 4.92 2.77 Favored 'Trans proline' 0 N--CA 1.451 -0.978 0 C-N-CA 122.178 1.918 . . . . 0.87 112.915 -179.236 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -86.73 -33.46 19.98 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 119.462 1.028 . . . . 1.0800000000000001 109.163 166.604 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 13.2 tt0 -103.42 -57.04 2.1 Favored 'General case' 0 C--N 1.343 0.323 0 C-N-CA 122.871 0.468 . . . . 2.6800000000000002 110.278 -169.336 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.405 0.6 OUTLIER -84.7 -178.66 6.93 Favored 'General case' 0 C--O 1.224 -0.242 0 CA-C-O 122.537 1.16 . . . . 0.56000000000000005 113.77 155.513 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -179.18 -144.27 5.71 Favored Glycine 0 N--CA 1.434 -1.474 1 N-CA-C 102.944 -4.062 . . . . 2.5299999999999998 102.944 -173.312 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 19.2 p -72.76 -40.29 66.11 Favored 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 124.509 1.124 . . . . 1.6000000000000001 108.398 174.51 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -38.77 -62.65 0.59 Allowed 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 126.235 1.814 . . . . 0.81000000000000005 114.119 -169.682 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -72.62 -42.33 64.58 Favored 'General case' 0 CA--C 1.517 -0.321 0 C-N-CA 119.079 -1.048 . . . . 0.59999999999999998 108.98 -168.753 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -53.35 -55.68 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.17 0 CA-C-N 113.437 -1.71 . . . . 0.79000000000000004 110.394 177.85 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.83 -46.9 87.81 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 119.827 1.194 . . . . 1.5 110.085 -178.759 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -47.58 -57.76 5.06 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 122.406 1.098 . . . . 2.9100000000000001 110.722 176.836 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.2 -39.81 74.96 Favored 'General case' 0 N--CA 1.436 -1.155 0 CA-C-O 118.621 -0.704 . . . . 2.6499999999999999 112.3 -176.802 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.1 mm -48.54 -52.14 9.35 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 C-N-CA 125.175 1.39 . . . . 0.53000000000000003 107.481 175.084 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -60.71 -58.0 10.33 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 124.372 1.069 . . . . 1.9199999999999999 110.875 177.665 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 3.4 mptp? -56.62 -37.61 70.94 Favored 'General case' 0 CA--C 1.536 0.42 0 O-C-N 121.499 -0.75 . . . . 4.0099999999999998 112.375 -176.766 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.429 HD13 ' HA ' ' A' ' 24' ' ' ILE . 13.7 mt -69.82 -17.77 63.42 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.461 1.105 . . . . 0.88 111.787 176.14 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 91.02 45.46 4.15 Favored Glycine 0 C--N 1.336 0.557 0 C-N-CA 124.369 0.985 . . . . 0.69999999999999996 110.986 174.342 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.422 ' CD1' HG21 ' A' ' 24' ' ' ILE . 0.4 OUTLIER -137.49 175.28 9.74 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 123.972 0.909 . . . . 1.9099999999999999 110.685 -177.872 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 2.3 t-80 -142.66 128.26 19.13 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 109.061 -0.718 . . . . 1.8700000000000001 109.061 169.657 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 11.7 p -88.76 148.85 4.26 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 C-N-CA 125.056 1.343 . . . . 1.5600000000000001 108.127 169.679 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 41.1 t -120.3 138.84 49.52 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 C-N-CA 125.249 1.42 . . . . 0.64000000000000001 108.615 179.057 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 26.8 mm -101.72 75.33 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 C-N-CA 124.805 1.242 . . . . 0.93999999999999995 109.564 -168.138 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -73.6 3.68 5.95 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 115.181 1.549 . . . . 3.27 115.181 -177.022 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 64.58 68.95 1.47 Allowed Glycine 0 CA--C 1.526 0.735 0 N-CA-C 110.254 -1.139 . . . . 3.1099999999999999 110.254 179.573 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.254 1.325 0 N-CA-C 105.005 -2.22 . . . . 12.26 105.005 172.042 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 77' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.8 mtt . . . . . 0 N--CA 1.473 0.696 0 N-CA-C 106.026 -1.842 . . . . 9.5899999999999999 106.026 . . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -160.8 143.89 13.1 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 106.536 -1.653 . . . . 5.2800000000000002 106.536 -174.777 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 57.9 m -81.45 126.06 31.19 Favored 'General case' 0 N--CA 1.443 -0.803 0 C-N-CA 125.673 1.589 . . . . 1.03 108.224 176.142 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -64.95 174.92 1.7 Allowed 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 109.095 -0.706 . . . . 2.8599999999999999 109.095 155.013 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -135.08 148.95 49.98 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 106.702 -1.592 . . . . 1.5600000000000001 106.702 168.559 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 10.5 mmpt? -138.62 157.12 46.74 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 123.401 0.68 . . . . 3.8700000000000001 109.677 165.138 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.68 103.88 12.49 Favored 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 128.745 2.818 . . . . 1.6100000000000001 107.847 -177.79 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.547 HD11 ' CG1' ' A' ' 48' ' ' VAL . 2.1 pp -84.95 165.56 2.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 N-CA-C 109.006 -0.739 . . . . 4.7800000000000002 109.006 168.537 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -137.19 119.34 15.53 Favored 'General case' 0 C--O 1.226 -0.169 0 N-CA-C 106.879 -1.526 . . . . 0.78000000000000003 106.879 173.438 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 22.8 mmt -137.4 172.34 13.13 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 119.596 1.089 . . . . 5.2199999999999998 110.411 -177.511 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 17.9 mm100 -91.87 158.87 16.07 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 123.813 0.845 . . . . 2.3700000000000001 110.014 -178.214 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 22.1 t -117.22 153.66 18.99 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 C-N-CA 124.373 1.069 . . . . 1.1200000000000001 109.079 -176.457 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 37.5 m -149.5 175.71 11.25 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.089 0.956 . . . . 0.93000000000000005 109.143 172.004 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 82.12 -36.64 2.54 Favored Glycine 0 CA--C 1.533 1.181 0 O-C-N 121.525 -0.734 . . . . 2.0099999999999998 112.485 -179.132 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -42.05 143.69 0.54 Allowed 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.643 1.577 . . . . 1.8100000000000001 113.786 177.721 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -110.42 -49.04 3.09 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 125.234 1.414 . . . . 2.27 111.532 169.796 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 18.4 p -130.64 161.97 30.42 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 123.186 0.594 . . . . 2.0499999999999998 110.807 -176.136 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -77.0 55.88 1.16 Allowed 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.187 0.995 . . . . 2.21 110.572 179.423 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -143.89 -56.3 0.38 Allowed 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 124.118 0.967 . . . . 0.85999999999999999 109.789 178.132 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 59.4 m -55.88 -40.72 73.38 Favored 'General case' 0 CA--C 1.532 0.269 0 O-C-N 121.916 -0.49 . . . . 1.1899999999999999 111.989 -173.93 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.798 ' HB1' HG21 ' A' ' 39' ' ' VAL . . . -56.29 -24.37 42.69 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.022 0.529 . . . . 0.5 112.32 177.686 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.8 -52.64 34.69 Favored 'General case' 0 N--CA 1.452 -0.355 0 O-C-N 120.353 -1.467 . . . . 0.41999999999999998 108.937 172.809 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 6.6 mtt-85 -53.74 -46.84 71.01 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.318 0.647 . . . . 3.75 110.239 -175.255 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.468 HG21 ' CD1' ' A' ' 69' ' ' TYR . 3.1 pt -57.85 -53.89 39.12 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.455 0 C-N-CA 119.756 -0.778 . . . . 0.5 110.85 -179.763 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -55.01 -43.69 73.88 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 119.299 0.954 . . . . 2.6000000000000001 111.862 177.321 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.2 mptp? -68.83 -46.18 69.24 Favored 'General case' 0 CA--C 1.533 0.291 0 O-C-N 121.298 -0.877 . . . . 1.4399999999999999 110.61 -175.807 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -63.08 -38.85 97.24 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 110.48 -1.048 . . . . 0.67000000000000004 110.48 175.061 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.53 HD11 HG21 ' A' ' 34' ' ' VAL . 2.9 tm? -60.32 -44.56 95.35 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 108.069 -1.086 . . . . 2.4199999999999999 108.069 179.294 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -54.51 -26.07 29.47 Favored 'General case' 0 CA--C 1.542 0.665 0 O-C-N 121.561 -0.712 . . . . 2.9100000000000001 112.683 175.093 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -71.22 -9.11 57.55 Favored 'General case' 0 CA--C 1.539 0.527 0 O-C-N 120.583 -1.323 . . . . 3.6600000000000001 112.659 177.295 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -73.79 158.03 86.6 Favored Pre-proline 0 CA--C 1.539 0.528 0 CA-C-N 118.99 0.813 . . . . 3.6200000000000001 111.552 -179.066 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -70.98 114.5 3.92 Favored 'Trans proline' 0 N--CA 1.45 -1.058 0 C-N-CA 121.811 1.674 . . . . 1.05 109.74 175.577 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 121.32 -30.27 5.46 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 124.08 0.848 . . . . 0.84999999999999998 113.002 170.818 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.53 HG21 HD11 ' A' ' 28' ' ' LEU . 61.6 t -83.37 141.05 15.38 Favored 'Isoleucine or valine' 0 C--N 1.342 0.254 0 CA-C-N 118.338 1.069 . . . . 0.67000000000000004 109.445 172.133 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 7.0 m -118.29 -38.31 3.2 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-O 118.39 -0.814 . . . . 1.1699999999999999 111.126 -177.27 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -136.7 163.6 30.21 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 119.542 1.065 . . . . 2.2400000000000002 111.843 167.132 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -158.36 140.86 14.39 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 112.541 0.571 . . . . 0.39000000000000001 112.541 -177.845 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -153.82 106.85 2.91 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 106.648 -1.612 . . . . 0.41999999999999998 106.648 -165.94 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.798 HG21 ' HB1' ' A' ' 21' ' ' ALA . 4.8 p -81.16 127.99 39.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 N-CA-C 107.351 -1.352 . . . . 0.63 107.351 174.667 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 54.7 t-20 -111.75 57.62 0.64 Allowed 'General case' 0 C--O 1.235 0.291 0 CA-C-O 122.968 1.366 . . . . 0.71999999999999997 107.974 179.878 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.591 HD23 HG22 ' A' ' 39' ' ' VAL . 0.2 OUTLIER -65.78 -20.1 66.14 Favored 'General case' 0 C--O 1.227 -0.11 0 CA-C-N 113.976 -1.465 . . . . 0.90000000000000002 111.12 -176.161 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -46.94 -34.58 5.64 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.447 0.699 . . . . 0.60999999999999999 112.312 166.842 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 14.7 t -122.09 27.66 7.91 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-O 121.284 0.564 . . . . 1.24 110.215 174.249 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 54.39 27.54 8.29 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 126.387 1.875 . . . . 2.6299999999999999 114.431 178.469 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 12.2 m -115.82 153.63 31.12 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.112 0.965 . . . . 0.62 109.136 -178.124 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.1 p -117.36 142.9 29.35 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 C-N-CA 124.121 0.968 . . . . 0.35999999999999999 109.121 170.667 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 21.1 m120 -125.95 131.86 52.2 Favored 'General case' 0 C--N 1.343 0.316 0 N-CA-C 106.673 -1.602 . . . . 0.34000000000000002 106.673 174.217 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.547 ' CG1' HD11 ' A' ' 8' ' ' ILE . 0.1 OUTLIER -132.24 128.06 58.24 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.706 0 N-CA-C 105.755 -1.942 . . . . 1.97 105.755 -178.962 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 10.7 mm -108.96 96.83 5.0 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 C-N-CA 126.113 1.765 . . . . 0.47999999999999998 108.104 -168.778 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.477 ' HB3' HG22 ' A' ' 34' ' ' VAL . 44.9 p90 -130.93 172.54 11.93 Favored 'General case' 0 CA--C 1.511 -0.552 0 O-C-N 121.317 -0.864 . . . . 1.8700000000000001 110.913 -169.649 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 36.0 t0 -90.28 107.7 21.52 Favored Pre-proline 0 CA--C 1.536 0.426 0 O-C-N 124.526 1.142 . . . . 2.8100000000000001 110.051 174.826 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -75.42 6.84 3.32 Favored 'Trans proline' 0 N--CA 1.451 -1.028 0 C-N-CA 122.434 2.089 . . . . 0.62 113.072 -178.903 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -81.77 -26.25 34.61 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 119.473 1.033 . . . . 0.81999999999999995 108.926 165.484 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -108.65 -66.59 1.04 Allowed 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 107.989 -1.115 . . . . 3.8100000000000001 107.989 -170.727 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.483 HG22 ' HB3' ' A' ' 59' ' ' ALA 0.417 0.2 OUTLIER -76.67 178.09 7.02 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 116.573 2.064 . . . . 0.64000000000000001 116.573 165.156 . . . . . . . . 4 4 . 1 . 026 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -163.68 -145.05 4.23 Favored Glycine 0 N--CA 1.432 -1.622 1 N-CA-C 102.424 -4.27 . . . . 2.5499999999999998 102.424 176.39 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 30.9 p -75.23 -37.68 60.95 Favored 'General case' 0 N--CA 1.444 -0.747 0 C-N-CA 125.34 1.456 . . . . 1.21 109.087 172.891 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -49.42 -61.2 2.23 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 124.936 1.294 . . . . 1.21 113.912 -165.601 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.483 ' HB3' HG22 ' A' ' 55' ' ' THR . . . -71.87 -33.66 68.56 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 118.773 -1.171 . . . . 1.0800000000000001 108.834 -168.98 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.5 mp -55.84 -52.5 48.23 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 C-N-CA 123.874 0.87 . . . . 1.1100000000000001 109.835 174.193 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -61.51 -43.16 99.37 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 109.845 -0.428 . . . . 1.6299999999999999 109.845 -176.708 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -48.89 -58.06 5.43 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.163 0.985 . . . . 2.8599999999999999 110.631 171.976 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -67.45 -36.14 80.61 Favored 'General case' 0 N--CA 1.442 -0.85 0 O-C-N 121.396 -0.815 . . . . 3.0299999999999998 112.592 -177.711 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -52.07 -52.18 25.47 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 C-N-CA 124.839 1.256 . . . . 0.39000000000000001 107.839 176.307 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -57.77 -55.56 33.26 Favored 'General case' 0 C--N 1.34 0.189 0 C-N-CA 122.944 0.498 . . . . 2.21 109.965 175.433 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 7.7 mmtt -58.01 -35.02 70.65 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 113.12 0.785 . . . . 4.2999999999999998 113.12 -175.34 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 24.8 mt -70.3 -17.69 63.09 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 125.287 1.435 . . . . 0.92000000000000004 111.416 175.838 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 96.31 38.58 4.49 Favored Glycine 0 CA--C 1.522 0.521 0 C-N-CA 124.754 1.169 . . . . 0.65000000000000002 110.803 175.574 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.468 ' CD1' HG21 ' A' ' 24' ' ' ILE . 0.2 OUTLIER -136.93 175.58 9.49 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 117.654 0.727 . . . . 1.76 111.029 -176.357 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 5.9 t60 -138.68 137.34 36.74 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 109.546 -0.538 . . . . 2.1800000000000002 109.546 169.392 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 8.6 p -110.24 144.01 19.15 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 N-CA-C 106.644 -1.613 . . . . 1.5 106.644 177.403 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 20.5 t -113.39 131.82 64.04 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 N-CA-C 108.455 -0.942 . . . . 0.54000000000000004 108.455 178.997 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 47.8 mm -96.88 77.15 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 C-N-CA 124.79 1.236 . . . . 1.1100000000000001 107.772 -174.789 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -71.27 -12.2 61.32 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 113.724 1.009 . . . . 3.2400000000000002 113.724 -179.315 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 77.95 85.23 0.5 Allowed Glycine 0 CA--C 1.526 0.76 0 N-CA-C 109.255 -1.538 . . . . 2.6699999999999999 109.255 -174.066 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.252 1.188 0 N-CA-C 105.893 -1.891 . . . . 13.34 105.893 176.435 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 77' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 56.1 mtt . . . . . 0 N--CA 1.475 0.8 0 CA-C-O 118.975 -0.536 . . . . 9.8699999999999992 110.16 . . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.9 mp 66.52 178.55 0.22 Allowed 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.749 0.82 . . . . 5.0499999999999998 110.276 -169.986 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.4 m -112.75 140.03 47.87 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 105.447 -2.057 . . . . 0.75 105.447 174.596 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -89.62 -173.5 3.97 Favored 'General case' 0 N--CA 1.445 -0.679 0 C-N-CA 124.327 1.051 . . . . 2.1699999999999999 108.814 175.174 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.8 mm100 -135.96 147.88 48.25 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 107.425 -1.324 . . . . 1.02 107.425 164.707 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 86.6 mttt -139.36 159.22 42.66 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 109.164 -0.68 . . . . 3.25 109.164 158.037 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -112.59 100.1 8.46 Favored 'General case' 0 N--CA 1.436 -1.152 0 C-N-CA 128.28 2.632 . . . . 1.3100000000000001 105.321 -171.681 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 7.0 mm -80.79 161.31 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.267 0 N-CA-C 106.601 -1.629 . . . . 1.9199999999999999 106.601 178.912 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -133.33 122.56 24.01 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 106.756 -1.572 . . . . 0.47999999999999998 106.756 174.093 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 71.8 mtm -140.46 168.59 19.45 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 123.451 0.7 . . . . 1.97 109.784 -178.687 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 20.6 mm100 -94.69 148.93 21.76 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 125.216 1.407 . . . . 2.5 109.413 177.763 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 69.7 t -99.73 145.72 10.09 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 C-N-CA 123.541 0.736 . . . . 1.3300000000000001 109.346 178.041 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 32.3 t -145.03 176.87 9.18 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 124.475 1.11 . . . . 1.73 108.816 168.881 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 52.29 60.26 7.94 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 124.292 0.949 . . . . 1.8899999999999999 110.773 -176.455 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -128.73 151.33 49.67 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 124.198 0.999 . . . . 2.1299999999999999 110.328 -172.79 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -97.26 -55.38 2.86 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 124.421 1.088 . . . . 3.1200000000000001 109.196 168.639 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 22.8 p -150.27 165.92 31.53 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-O 121.839 0.828 . . . . 2.4300000000000002 111.757 -174.5 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -74.27 48.64 0.33 Allowed 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.462 1.505 . . . . 1.8 111.357 175.701 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -144.02 -51.76 0.32 Allowed 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 124.795 1.238 . . . . 0.72999999999999998 108.18 175.697 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.442 ' SG ' ' NH2' ' A' ' 23' ' ' ARG . 27.1 m -59.37 -36.97 76.75 Favored 'General case' 0 CA--C 1.531 0.248 0 O-C-N 121.38 -0.825 . . . . 1.1799999999999999 109.745 167.998 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.425 ' HB1' HG21 ' A' ' 39' ' ' VAL . . . -59.17 -21.8 59.98 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 112.95 0.722 . . . . 0.47999999999999998 112.95 173.668 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -73.79 -50.94 18.12 Favored 'General case' 0 C--N 1.339 0.152 0 O-C-N 121.019 -1.05 . . . . 0.39000000000000001 110.032 169.943 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.442 ' NH2' ' SG ' ' A' ' 20' ' ' CYS . 17.3 mtm180 -50.04 -42.39 49.53 Favored 'General case' 0 N--CA 1.456 -0.143 0 C-N-CA 123.32 0.648 . . . . 5.6500000000000004 111.196 -175.663 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.442 HG21 ' CG ' ' A' ' 69' ' ' TYR . 3.9 pt -57.82 -53.66 42.12 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.156 0 C-N-CA 119.847 -0.741 . . . . 0.63 111.891 177.341 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -57.88 -46.46 84.84 Favored 'General case' 0 C--O 1.224 -0.266 0 C-N-CA 123.339 0.655 . . . . 3.3500000000000001 110.708 -179.876 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -72.34 -40.3 67.51 Favored 'General case' 0 C--N 1.331 -0.234 0 O-C-N 121.908 -0.495 . . . . 2.1499999999999999 111.034 -173.535 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -59.44 -45.28 95.77 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 109.757 -1.337 . . . . 0.65000000000000002 109.757 169.695 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -61.94 -37.47 84.83 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 121.879 -0.777 . . . . 2.3700000000000001 109.655 -179.839 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 3.3 ttpp -53.98 -25.38 20.64 Favored 'General case' 0 CA--C 1.533 0.3 0 O-C-N 120.724 -1.235 . . . . 2.3999999999999999 113.198 174.505 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -82.15 -1.21 48.17 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.043 0.937 . . . . 3.48 111.836 -179.088 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 21.4 mmt -93.77 149.35 36.93 Favored Pre-proline 0 CA--C 1.535 0.401 0 C-N-CA 124.194 0.998 . . . . 4.6500000000000004 109.995 -175.092 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -58.45 142.86 98.24 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 122.52 2.146 . . . . 0.65000000000000002 111.477 -176.65 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 85.65 -27.3 5.36 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 123.511 0.577 . . . . 0.52000000000000002 112.927 179.422 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.4 t -80.12 140.18 17.11 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 CA-C-N 118.363 1.081 . . . . 0.68000000000000005 108.795 176.33 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 69.8 m -106.7 -60.12 1.71 Allowed 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 118.474 -0.774 . . . . 1.3600000000000001 109.116 178.488 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -140.65 165.35 27.72 Favored 'General case' 0 N--CA 1.446 -0.675 0 N-CA-C 109.052 -0.721 . . . . 2.5800000000000001 109.052 179.821 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -156.43 143.9 19.18 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 109.381 -0.6 . . . . 0.40999999999999998 109.381 -168.335 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -152.2 116.16 4.9 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 123.892 0.877 . . . . 0.75 108.761 -167.209 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.425 HG21 ' HB1' ' A' ' 21' ' ' ALA . 8.6 p -82.2 124.35 39.11 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 N-CA-C 107.208 -1.405 . . . . 0.66000000000000003 107.208 171.542 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 47.2 t30 -108.57 55.38 0.64 Allowed 'General case' 0 C--O 1.235 0.326 0 CA-C-O 123.07 1.414 . . . . 0.72999999999999998 107.22 178.161 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.437 HD22 ' HA ' ' A' ' 41' ' ' LEU . 0.2 OUTLIER -70.65 -18.35 62.85 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 114.171 -1.377 . . . . 0.95999999999999996 110.311 -174.207 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -43.38 -37.61 2.38 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 124.267 1.027 . . . . 0.54000000000000004 111.991 166.033 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 9.3 t -125.87 32.89 5.18 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 122.719 0.407 . . . . 1.2 110.435 173.58 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 59.1 27.62 16.65 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.923 1.689 . . . . 2.9199999999999999 113.609 174.437 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 60.3 m -115.97 164.28 14.67 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.747 1.219 . . . . 0.64000000000000001 109.723 -174.594 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 5.7 p -136.25 143.72 35.02 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 C-N-CA 124.516 1.126 . . . . 0.32000000000000001 108.637 171.998 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -134.92 122.1 21.47 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 124.647 1.179 . . . . 0.57999999999999996 108.153 -175.405 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.7 p -123.85 130.59 73.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 N-CA-C 106.176 -1.787 . . . . 1.73 106.176 -172.705 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 9.7 mm -105.39 97.47 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 N-CA-C 107.158 -1.423 . . . . 0.40999999999999998 107.158 -174.92 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 3.6 p90 -129.72 164.89 23.0 Favored 'General case' 0 CA--C 1.512 -0.481 0 O-C-N 122.161 -0.337 . . . . 2.1000000000000001 110.641 -176.554 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -81.65 124.01 80.16 Favored Pre-proline 0 CA--C 1.536 0.418 0 N-CA-C 108.314 -0.995 . . . . 3.1200000000000001 108.314 167.189 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -86.57 15.54 2.17 Favored 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 122.904 2.403 . . . . 0.60999999999999999 112.888 -175.385 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -97.88 -40.52 8.47 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 123.999 0.92 . . . . 1.0600000000000001 109.069 169.248 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -90.59 -62.08 1.54 Allowed 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 107.143 -1.428 . . . . 3.8399999999999999 107.143 -177.337 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.518 0.2 OUTLIER -78.31 -175.65 4.3 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 115.328 1.603 . . . . 0.69999999999999996 115.328 159.336 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 154.64 -168.3 32.73 Favored Glycine 0 N--CA 1.435 -1.381 1 N-CA-C 102.81 -4.116 . . . . 2.5299999999999998 102.81 -148.83 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 16.7 p -73.34 -34.91 65.9 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 124.14 0.976 . . . . 1.0800000000000001 109.244 -176.679 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -46.96 -60.88 2.15 Favored 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 125.055 1.342 . . . . 0.56000000000000005 113.441 -169.556 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.07 -40.99 74.71 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 118.995 -1.082 . . . . 0.44 108.793 -167.524 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.5 mp -50.71 -54.57 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.944 0 CA-C-N 113.891 -1.504 . . . . 0.95999999999999996 109.787 174.087 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -65.82 -44.58 85.19 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 118.669 0.668 . . . . 2.1899999999999999 110.28 -174.008 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -45.84 -56.7 5.06 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 122.597 1.189 . . . . 2.7999999999999998 110.046 173.252 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.86 -40.47 68.95 Favored 'General case' 0 N--CA 1.438 -1.05 0 N-CA-C 113.536 0.939 . . . . 3.9500000000000002 113.536 -176.314 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -48.26 -52.49 7.78 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 C-N-CA 125.003 1.321 . . . . 0.38 108.017 173.961 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -59.65 -58.83 6.87 Favored 'General case' 0 C--N 1.341 0.219 0 C-N-CA 123.429 0.692 . . . . 1.6299999999999999 110.333 176.588 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 6.6 mmmt -57.76 -33.02 68.06 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 113.62 0.97 . . . . 4.3499999999999996 113.62 -175.732 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 22.6 mt -71.81 -19.02 62.05 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.181 1.392 . . . . 0.73999999999999999 111.666 174.853 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 96.81 43.68 3.05 Favored Glycine 0 CA--C 1.524 0.645 0 C-N-CA 124.704 1.145 . . . . 0.39000000000000001 111.442 174.735 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.442 ' CG ' HG21 ' A' ' 24' ' ' ILE . 0.7 OUTLIER -140.1 174.49 10.47 Favored 'General case' 0 N--CA 1.457 -0.085 0 C-N-CA 124.488 1.115 . . . . 1.97 110.157 -177.799 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 6.9 t-80 -141.55 125.91 17.62 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 109.387 -0.597 . . . . 1.72 109.387 174.279 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 7.8 p -92.77 152.14 3.5 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 108.479 -0.934 . . . . 1.5600000000000001 108.479 174.566 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 38.1 t -127.3 143.65 39.9 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 C-N-CA 124.808 1.243 . . . . 0.52000000000000002 108.323 178.488 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 5.2 mp -118.17 81.19 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 C-N-CA 124.558 1.143 . . . . 1.4099999999999999 108.789 -172.804 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -79.04 -5.8 54.86 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 114.34 1.237 . . . . 2.8999999999999999 114.34 173.624 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 79.44 68.86 1.44 Allowed Glycine 0 CA--C 1.53 0.994 0 C-N-CA 124.12 0.867 . . . . 3.2400000000000002 111.973 175.896 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 3.1 ttp180 . . . . . 0 C--O 1.248 0.996 0 CA-C-O 115.98 -1.962 . . . . 12.609999999999999 110.758 175.418 . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 77' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 37.3 mtt . . . . . 0 N--CA 1.476 0.852 0 N-CA-C 110.238 -0.282 . . . . 9.1300000000000008 110.238 . . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -174.63 -65.1 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 107.099 -1.445 . . . . 5.4900000000000002 107.099 171.921 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.3 m -140.84 133.44 28.66 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 127.02 2.128 . . . . 0.84999999999999998 105.596 177.763 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -84.92 -175.7 5.88 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 108.199 -1.038 . . . . 2.0899999999999999 108.199 163.839 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.18 146.78 49.05 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 107.583 -1.266 . . . . 1.1299999999999999 107.583 169.2 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 54.2 mttm -140.27 156.16 46.58 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 121.44 0.638 . . . . 2.77 110.279 161.873 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -112.89 87.01 2.49 Favored 'General case' 0 N--CA 1.439 -0.978 0 C-N-CA 128.343 2.657 . . . . 1.45 106.444 -168.508 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 20.6 mm -82.62 159.64 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.396 0 N-CA-C 106.575 -1.639 . . . . 2.1800000000000002 106.575 -176.035 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -131.77 138.18 48.47 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 125.784 1.634 . . . . 0.59999999999999998 106.743 -179.694 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -156.31 175.84 13.47 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 118.511 0.596 . . . . 2.71 110.786 172.649 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 30.1 mm100 -94.6 159.35 15.12 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 124.638 1.175 . . . . 2.6800000000000002 109.886 -178.405 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 62.0 t -114.26 156.53 15.2 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 C-N-CA 125.075 1.35 . . . . 1.1799999999999999 108.769 -176.454 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 25.3 m -150.01 165.63 32.13 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 123.725 0.81 . . . . 0.91000000000000003 109.518 168.006 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 63.68 47.56 85.5 Favored Glycine 0 CA--C 1.528 0.899 0 N-CA-C 110.31 -1.116 . . . . 1.6000000000000001 110.31 -171.52 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -120.55 165.17 15.37 Favored 'General case' 0 N--CA 1.457 -0.121 0 C-N-CA 124.663 1.185 . . . . 2.0899999999999999 108.972 175.3 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 174.51 -41.96 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 127.864 2.466 . . . . 3.8100000000000001 110.528 175.447 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 47.9 t -48.02 -41.02 24.5 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.327 1.051 . . . . 2.98 110.932 172.173 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 64.56 19.15 11.72 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.621 1.169 . . . . 2.2200000000000002 111.92 -178.0 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -134.58 -44.22 0.75 Allowed 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 125.395 1.478 . . . . 0.81999999999999995 109.439 176.035 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 20.5 m -47.24 -38.48 12.35 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 123.413 0.685 . . . . 1.6499999999999999 112.599 169.131 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.635 ' HB1' HG21 ' A' ' 39' ' ' VAL . . . -49.26 -33.29 12.52 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.382 0.673 . . . . 0.46000000000000002 112.068 174.545 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.6 -52.88 15.77 Favored 'General case' 0 N--CA 1.456 -0.173 0 O-C-N 120.789 -1.194 . . . . 0.32000000000000001 110.416 171.699 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 46.4 mmm-85 -50.42 -50.63 51.36 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 123.933 0.893 . . . . 3.7799999999999998 110.114 -175.968 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 5.1 pt -56.86 -54.61 27.47 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 CA-C-O 118.79 -0.624 . . . . 0.63 109.946 -179.839 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -55.46 -38.6 69.26 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 119.273 0.942 . . . . 2.29 112.12 179.474 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 42.7 mmtm -71.58 -44.14 65.01 Favored 'General case' 0 CA--C 1.534 0.327 0 O-C-N 121.345 -0.847 . . . . 1.8500000000000001 111.564 -177.49 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -69.58 -33.21 71.65 Favored Glycine 0 CA--C 1.528 0.871 0 C-N-CA 120.218 -0.991 . . . . 0.51000000000000001 110.914 173.088 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 9.6 tt -56.37 -48.64 76.43 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 107.833 -1.173 . . . . 2.0 107.833 173.227 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -54.87 -19.44 6.56 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 113.428 0.899 . . . . 3.6099999999999999 113.428 176.249 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 94.5 mtt180 -77.54 -4.68 46.94 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 119.679 1.127 . . . . 4.8300000000000001 112.289 177.704 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 7.3 ptp -71.11 155.68 92.9 Favored Pre-proline 0 CA--C 1.534 0.339 0 CA-C-N 119.58 1.082 . . . . 3.8100000000000001 111.37 173.335 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -58.86 133.04 51.18 Favored 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 121.769 1.646 . . . . 0.58999999999999997 109.046 163.5 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 108.54 -35.12 5.16 Favored Glycine 0 CA--C 1.53 1.015 0 CA-C-O 119.442 -0.643 . . . . 0.5 113.39 171.892 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 59.9 t -89.28 128.62 41.22 Favored 'Isoleucine or valine' 0 C--N 1.34 0.173 0 CA-C-N 118.454 1.127 . . . . 0.62 110.303 178.772 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 30.7 m -111.06 -28.58 8.25 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 123.582 0.753 . . . . 1.0600000000000001 111.817 -174.747 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -146.78 164.1 33.86 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 119.033 0.833 . . . . 2.3399999999999999 111.359 164.791 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -156.18 133.95 11.07 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 112.571 0.582 . . . . 0.42999999999999999 112.571 -176.478 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -150.34 115.88 5.49 Favored 'General case' 0 C--N 1.341 0.235 0 N-CA-C 108.279 -1.008 . . . . 0.44 108.279 -163.266 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.635 HG21 ' HB1' ' A' ' 21' ' ' ALA . 8.4 p -93.3 100.13 10.75 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 C-N-CA 123.478 0.711 . . . . 0.53000000000000003 110.049 -175.985 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 53.1 t-20 -83.71 57.3 4.02 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 122.651 1.215 . . . . 0.63 109.287 -179.145 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.449 HD22 ' HA ' ' A' ' 41' ' ' LEU . 0.2 OUTLIER -69.98 -19.74 63.33 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 114.915 -1.038 . . . . 0.92000000000000004 110.155 -175.713 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -46.7 -35.67 6.31 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 123.876 0.87 . . . . 0.59999999999999998 112.036 166.046 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 5.6 t -122.11 37.33 4.4 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 121.496 0.665 . . . . 1.3300000000000001 109.553 173.56 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 41.22 40.01 1.07 Allowed 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 126.655 1.982 . . . . 2.6400000000000001 113.503 179.109 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 95.1 m -124.33 160.49 27.96 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 124.971 1.308 . . . . 0.68000000000000005 107.865 -178.799 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.6 p -130.79 146.81 33.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 O-C-N 121.356 -0.84 . . . . 0.42999999999999999 109.321 170.133 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -128.77 138.84 52.31 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 108.253 -1.017 . . . . 0.31 108.253 -179.639 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 34.2 t -135.05 129.28 50.59 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 N-CA-C 106.284 -1.747 . . . . 2.1499999999999999 106.284 -179.395 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 11.4 mm -104.4 99.8 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 N-CA-C 106.874 -1.528 . . . . 0.40999999999999998 106.874 -173.552 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 53.6 p90 -138.3 167.49 21.75 Favored 'General case' 0 CA--C 1.509 -0.602 0 O-C-N 121.622 -0.673 . . . . 2.0600000000000001 111.623 -170.591 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -87.75 109.43 26.88 Favored Pre-proline 0 C--O 1.236 0.343 0 O-C-N 124.448 1.092 . . . . 3.04 109.646 174.992 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -74.56 5.18 3.92 Favored 'Trans proline' 0 N--CA 1.451 -0.989 0 C-N-CA 122.759 2.306 . . . . 0.55000000000000004 112.973 -177.323 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -86.08 -27.61 24.59 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 119.506 1.048 . . . . 0.73999999999999999 109.294 166.721 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.51 -57.5 2.03 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 108.22 -1.03 . . . . 3.46 108.22 -168.666 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.288 1.0 OUTLIER -93.95 -173.63 3.18 Favored 'General case' 0 C--O 1.225 -0.215 0 C-N-CA 124.435 1.094 . . . . 0.42999999999999999 112.494 161.566 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 141.64 91.25 0.17 Allowed Glycine 0 N--CA 1.441 -1.029 0 N-CA-C 103.222 -3.951 . . . . 2.2599999999999998 103.222 -155.896 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -13.02 -13.92 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.7 1 C-N-CA 138.476 6.71 . . . . 3.02 120.472 -149.249 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -26.26 -62.62 0.08 Allowed 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 126.885 2.074 . . . . 0.56999999999999995 114.867 161.228 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.87 -41.5 59.69 Favored 'General case' 0 CA--C 1.521 -0.145 0 CA-C-O 122.255 1.026 . . . . 0.48999999999999999 108.931 -167.802 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.7 mt -44.82 -57.36 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.771 0 C-N-CA 125.829 1.651 . . . . 1.51 110.53 170.452 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.95 -46.35 88.23 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 119.444 1.02 . . . . 1.1799999999999999 110.747 178.999 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -49.3 -55.49 12.6 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 121.944 0.878 . . . . 3.3999999999999999 111.001 179.019 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.462 ' HA ' ' HE3' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -68.95 -41.11 78.44 Favored 'General case' 0 N--CA 1.441 -0.886 0 C-N-CA 124.135 0.974 . . . . 3.0899999999999999 112.319 179.207 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -48.71 -53.18 7.53 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 N-CA-C 108.318 -0.993 . . . . 0.39000000000000001 108.318 175.91 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -59.96 -58.58 7.96 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 124.147 0.979 . . . . 1.51 110.699 177.03 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 2.9 mttp -55.23 -39.73 70.06 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 112.959 0.725 . . . . 4.0099999999999998 112.959 -175.849 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 20.8 mt -67.34 -17.81 64.9 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.327 1.051 . . . . 0.60999999999999999 111.515 177.361 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 96.58 41.03 3.73 Favored Glycine 0 C--N 1.335 0.512 0 C-N-CA 124.827 1.203 . . . . 0.41999999999999998 110.758 173.947 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -138.54 175.89 9.17 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 123.829 0.852 . . . . 1.96 110.334 -175.255 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 16.4 t-160 -142.32 148.6 38.25 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 108.419 -0.956 . . . . 2.0600000000000001 108.419 174.88 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -118.42 152.9 20.55 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.14 0 C-N-CA 125.617 1.567 . . . . 1.8600000000000001 106.942 177.176 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 59.0 t -124.14 145.72 30.81 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 C-N-CA 124.902 1.281 . . . . 0.56000000000000005 108.274 179.141 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 38.9 mm -116.45 81.05 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.174 0 C-N-CA 124.616 1.167 . . . . 1.04 108.884 -173.895 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 57.1 mt-10 -72.37 -7.38 49.33 Favored 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 114.29 1.219 . . . . 3.0299999999999998 114.29 172.693 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 61.37 77.14 0.2 Allowed Glycine 0 CA--C 1.528 0.862 0 N-CA-C 110.002 -1.239 . . . . 2.9500000000000002 110.002 -177.453 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.042 0 CA-C-O 116.144 -1.884 . . . . 12.609999999999999 107.142 -164.225 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 77' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.432 ' N ' ' OE2' ' A' ' 4' ' ' GLU . 20.1 mtt . . . . . 0 N--CA 1.48 1.034 0 N-CA-C 109.287 -0.635 . . . . 9.7400000000000002 109.287 . . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.0 mp -64.98 175.31 1.58 Allowed 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 108.014 -1.106 . . . . 5.3200000000000003 108.014 159.166 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 11.7 m -37.65 103.94 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 126.113 1.765 . . . . 1.2 111.309 173.557 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.432 ' OE2' ' N ' ' A' ' 1' ' ' MET . 36.8 mt-10 -78.05 161.49 27.42 Favored 'General case' 0 N--CA 1.435 -1.192 0 N-CA-C 106.001 -1.852 . . . . 3.3999999999999999 106.001 171.351 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 9.8 mm100 -129.88 149.34 51.66 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 108.518 -0.919 . . . . 2.3300000000000001 108.518 -178.006 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 71.7 tttt -145.6 155.33 42.97 Favored 'General case' 0 N--CA 1.438 -1.053 0 C-N-CA 124.003 0.921 . . . . 4.1299999999999999 108.973 175.103 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -112.96 92.86 4.16 Favored 'General case' 0 N--CA 1.437 -1.086 0 C-N-CA 129.566 3.146 . . . . 1.6799999999999999 105.229 -173.494 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 19.4 mm -83.78 163.38 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.301 0 N-CA-C 106.797 -1.557 . . . . 2.29 106.797 175.665 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -133.22 138.03 46.36 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 125.457 1.503 . . . . 0.46000000000000002 107.291 177.92 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -155.85 171.38 20.15 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 118.347 0.522 . . . . 1.9299999999999999 109.733 175.946 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -93.32 164.83 13.07 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 124.921 1.288 . . . . 3.5800000000000001 109.893 -174.424 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.8 t -126.29 146.61 31.82 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 C-N-CA 123.754 0.822 . . . . 1.1599999999999999 109.622 -173.579 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 59.9 m -127.48 171.69 11.36 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.742 1.217 . . . . 1.0800000000000001 109.042 170.795 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 79.71 -35.85 2.07 Favored Glycine 0 CA--C 1.534 1.26 0 O-C-N 121.514 -0.741 . . . . 2.2799999999999998 112.871 -179.297 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -44.01 142.64 1.33 Allowed 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 114.248 1.203 . . . . 2.6200000000000001 114.248 -179.712 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -153.02 -60.89 0.15 Allowed 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 126.351 1.861 . . . . 2.71 107.002 177.995 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 31.3 m -63.94 -25.53 68.18 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.077 0.951 . . . . 2.77 112.94 -176.959 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 68.55 -60.18 0.44 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 126.005 1.722 . . . . 2.6699999999999999 110.956 -169.102 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -48.07 -45.5 32.56 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.71 1.204 . . . . 0.81000000000000005 111.682 178.861 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 89.9 m -57.48 -32.32 66.86 Favored 'General case' 0 CA--C 1.529 0.143 0 N-CA-C 112.766 0.654 . . . . 1.54 112.766 177.761 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.668 ' HB1' HG21 ' A' ' 39' ' ' VAL . . . -64.47 -19.17 65.4 Favored 'General case' 0 CA--C 1.538 0.487 0 O-C-N 121.904 -0.498 . . . . 0.56000000000000005 111.051 175.12 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.22 -47.41 61.56 Favored 'General case' 0 N--CA 1.453 -0.279 0 O-C-N 119.452 -2.03 . . . . 0.44 108.607 169.734 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 61.8 mtp180 -55.45 -41.24 72.59 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 118.77 -0.633 . . . . 4.1600000000000001 110.076 -176.386 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.484 HG21 ' CD1' ' A' ' 69' ' ' TYR 0.3 1.4 pt -57.82 -58.38 6.52 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.425 0 C-N-CA 119.373 -0.931 . . . . 0.46999999999999997 110.708 174.877 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.4 ' HG3' ' HB1' ' A' ' 37' ' ' ALA . 0.4 OUTLIER -47.88 -42.55 27.1 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 119.191 0.905 . . . . 2.6699999999999999 112.883 176.293 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 24.4 mmtp -70.25 -48.74 55.56 Favored 'General case' 0 CA--C 1.535 0.378 0 O-C-N 120.938 -1.101 . . . . 2.2400000000000002 111.291 -179.573 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.86 -29.38 73.91 Favored Glycine 0 CA--C 1.53 1.0 0 O-C-N 121.665 -0.647 . . . . 0.92000000000000004 111.582 176.281 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.3 tt -67.4 -54.42 20.56 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 125.314 1.446 . . . . 1.8500000000000001 107.775 176.547 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.501 ' HE2' ' HA ' ' A' ' 36' ' ' ASP . 6.7 ttmt -48.32 -33.11 8.36 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.523 0.729 . . . . 2.5499999999999998 112.115 178.22 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 3.6 mmt180 -55.76 -15.7 3.48 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 114.507 1.299 . . . . 4.2000000000000002 114.507 177.906 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 9.9 ptp -67.68 156.72 88.32 Favored Pre-proline 0 CA--C 1.535 0.38 0 CA-C-N 119.719 1.145 . . . . 3.8900000000000001 112.252 175.941 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -60.74 137.89 76.0 Favored 'Trans proline' 0 N--CA 1.456 -0.735 0 C-N-CA 121.378 1.385 . . . . 0.67000000000000004 109.522 165.846 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 99.33 -28.63 14.51 Favored Glycine 0 CA--C 1.53 0.983 0 CA-C-O 119.14 -0.811 . . . . 0.47999999999999998 113.729 170.553 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 61.5 t -88.64 136.75 22.61 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 CA-C-N 119.288 1.544 . . . . 0.56000000000000005 109.119 171.613 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -108.04 -41.2 5.0 Favored 'General case' 0 C--N 1.341 0.216 0 CA-C-O 118.356 -0.83 . . . . 1.4199999999999999 110.733 178.508 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.501 ' HA ' ' HE2' ' A' ' 29' ' ' LYS . 0.4 OUTLIER -143.21 165.93 26.1 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-N 119.113 0.87 . . . . 2.3700000000000001 110.403 170.963 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.4 ' HB1' ' HG3' ' A' ' 25' ' ' GLU . . . -158.02 148.16 20.28 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 123.538 0.735 . . . . 0.51000000000000001 110.073 179.923 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -156.19 118.37 4.03 Favored 'General case' 0 C--O 1.232 0.143 0 N-CA-C 107.723 -1.214 . . . . 0.53000000000000003 107.723 -163.364 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.668 HG21 ' HB1' ' A' ' 21' ' ' ALA . 8.0 p -89.92 101.4 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 C-N-CA 123.082 0.553 . . . . 0.65000000000000002 110.232 -177.07 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 51.4 t-20 -84.07 56.7 3.83 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-O 122.693 1.235 . . . . 0.59999999999999998 109.277 179.629 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.427 HD22 ' HA ' ' A' ' 41' ' ' LEU . 0.2 OUTLIER -69.07 -19.92 64.08 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 115.229 -0.896 . . . . 1.1100000000000001 110.152 -175.467 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -46.91 -36.8 8.01 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.032 0.933 . . . . 0.68000000000000005 112.363 166.752 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 14.5 t -115.5 23.67 12.2 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 118.499 0.59 . . . . 1.3600000000000001 111.327 174.161 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 55.04 50.37 15.56 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.4 1.08 . . . . 3.5499999999999998 112.859 -179.706 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 7.1 m -145.9 154.78 42.33 Favored 'General case' 0 N--CA 1.445 -0.722 0 O-C-N 120.418 -1.426 . . . . 0.77000000000000002 109.045 178.844 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.3 p -117.81 144.37 25.97 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 N-CA-C 108.455 -0.943 . . . . 0.39000000000000001 108.455 171.347 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -124.68 142.62 51.25 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 108.153 -1.055 . . . . 0.39000000000000001 108.153 176.985 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 4.0 p -139.78 129.35 29.09 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 N-CA-C 106.822 -1.548 . . . . 1.78 106.822 -174.993 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 14.5 mm -108.31 89.03 1.21 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.654 0 C-N-CA 126.007 1.723 . . . . 0.63 107.711 -167.461 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 34.7 p90 -137.12 172.9 12.32 Favored 'General case' 0 CA--C 1.511 -0.542 0 C-N-CA 122.671 0.388 . . . . 1.6399999999999999 111.967 -167.703 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 66.4 t0 -93.36 104.71 13.06 Favored Pre-proline 0 C--O 1.236 0.345 0 O-C-N 125.094 1.496 . . . . 3.0800000000000001 110.177 -179.412 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -73.71 3.19 5.11 Favored 'Trans proline' 0 N--CA 1.448 -1.154 0 C-N-CA 122.003 1.802 . . . . 0.76000000000000001 112.447 -179.286 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -82.23 -29.35 31.38 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 119.819 1.19 . . . . 1.0700000000000001 109.205 165.726 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -108.32 -55.99 2.31 Favored 'General case' 0 C--N 1.343 0.317 0 C-N-CA 122.797 0.439 . . . . 2.52 110.308 -166.355 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.31 0.6 OUTLIER -89.05 177.54 6.62 Favored 'General case' 0 CA--C 1.514 -0.432 0 CA-C-O 123.312 1.53 . . . . 0.52000000000000002 114.212 160.345 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -160.02 -135.9 1.93 Allowed Glycine 0 N--CA 1.433 -1.567 0 N-CA-C 103.978 -3.649 . . . . 2.54 103.978 175.43 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 23.6 p -76.57 -35.29 58.28 Favored 'General case' 0 N--CA 1.444 -0.751 0 C-N-CA 127.031 2.132 . . . . 1.3600000000000001 109.75 177.917 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -49.48 -62.8 1.35 Allowed 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 125.49 1.516 . . . . 0.55000000000000004 113.926 -165.379 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.83 -35.0 69.76 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 114.676 -1.147 . . . . 0.44 108.472 -168.364 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.8 mt -54.26 -57.18 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.908 0 C-N-CA 125.95 1.7 . . . . 1.3200000000000001 111.179 173.155 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.69 -45.22 95.01 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 119.804 1.184 . . . . 1.0900000000000001 109.626 -179.724 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -49.56 -59.36 3.84 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-O 121.392 0.615 . . . . 3.2400000000000002 111.958 176.756 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 4.7 mmpt? -63.61 -40.53 97.16 Favored 'General case' 0 N--CA 1.437 -1.087 0 CA-C-O 118.459 -0.781 . . . . 2.2000000000000002 111.096 -179.452 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.3 mm -49.01 -54.3 5.69 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.558 0 C-N-CA 124.171 0.989 . . . . 0.34999999999999998 108.441 177.204 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 27.0 mm-40 -59.32 -55.71 31.34 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 123.594 0.757 . . . . 1.6200000000000001 110.436 177.0 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 10.2 mmtt -57.11 -36.48 70.69 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 112.905 0.706 . . . . 4.4299999999999997 112.905 -174.931 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 13.0 mt -71.11 -17.8 62.55 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.889 1.276 . . . . 0.64000000000000001 112.144 175.874 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 96.96 39.47 4.06 Favored Glycine 0 CA--C 1.523 0.589 0 C-N-CA 124.571 1.082 . . . . 0.45000000000000001 111.093 175.36 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.484 ' CD1' HG21 ' A' ' 24' ' ' ILE . 0.6 OUTLIER -135.31 175.86 9.2 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 124.131 0.972 . . . . 1.9399999999999999 110.303 -178.39 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 22.4 t-160 -143.86 133.55 23.7 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 107.711 -1.218 . . . . 2.04 107.711 172.631 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 6.5 p -108.86 139.99 29.28 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 C-N-CA 125.296 1.439 . . . . 1.49 107.407 179.782 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 86.3 t -108.72 138.74 34.23 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.137 0 CA-C-O 121.833 0.825 . . . . 0.68000000000000005 109.069 -179.566 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 45.8 mm -104.86 77.92 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 C-N-CA 125.224 1.41 . . . . 1.1699999999999999 109.123 -169.767 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -74.93 2.46 10.32 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.646 1.179 . . . . 3.2999999999999998 113.696 173.615 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -112.49 -8.24 21.4 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 125.093 1.33 . . . . 3.9300000000000002 114.617 -170.497 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.083 0 C-N-CA 124.74 1.216 . . . . 10.08 107.935 -173.798 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 77' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.432 ' N ' ' OE2' ' A' ' 4' ' ' GLU . 20.1 mtt . . . . . 0 N--CA 1.48 1.034 0 N-CA-C 109.287 -0.635 . . . . 9.7400000000000002 109.287 . . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.0 mp -64.98 175.31 1.58 Allowed 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 108.014 -1.106 . . . . 5.3200000000000003 108.014 159.166 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 11.7 m -37.65 103.94 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 126.113 1.765 . . . . 1.2 111.309 173.557 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.432 ' OE2' ' N ' ' A' ' 1' ' ' MET . 36.8 mt-10 -78.05 161.49 27.42 Favored 'General case' 0 N--CA 1.435 -1.192 0 N-CA-C 106.001 -1.852 . . . . 3.3999999999999999 106.001 171.351 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 9.8 mm100 -129.88 149.34 51.66 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 108.518 -0.919 . . . . 2.3300000000000001 108.518 -178.006 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 71.7 tttt -145.6 155.33 42.97 Favored 'General case' 0 N--CA 1.438 -1.053 0 C-N-CA 124.003 0.921 . . . . 4.1299999999999999 108.973 175.103 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -112.96 92.86 4.16 Favored 'General case' 0 N--CA 1.437 -1.086 0 C-N-CA 129.566 3.146 . . . . 1.6799999999999999 105.229 -173.494 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 19.4 mm -83.78 163.38 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.301 0 N-CA-C 106.797 -1.557 . . . . 2.29 106.797 175.665 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -133.22 138.03 46.36 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 125.457 1.503 . . . . 0.46000000000000002 107.291 177.92 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -155.85 171.38 20.15 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 118.347 0.522 . . . . 1.9299999999999999 109.733 175.946 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -93.32 164.83 13.07 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 124.921 1.288 . . . . 3.5800000000000001 109.893 -174.424 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.8 t -126.29 146.61 31.82 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 C-N-CA 123.754 0.822 . . . . 1.1599999999999999 109.622 -173.579 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 59.9 m -127.48 171.69 11.36 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.742 1.217 . . . . 1.0800000000000001 109.042 170.795 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 79.71 -35.85 2.07 Favored Glycine 0 CA--C 1.534 1.26 0 O-C-N 121.514 -0.741 . . . . 2.2799999999999998 112.871 -179.297 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -44.01 142.64 1.33 Allowed 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 114.248 1.203 . . . . 2.6200000000000001 114.248 -179.712 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -153.02 -60.89 0.15 Allowed 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 126.351 1.861 . . . . 2.71 107.002 177.995 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 31.3 m -63.94 -25.53 68.18 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.077 0.951 . . . . 2.77 112.94 -176.959 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 68.55 -60.18 0.44 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 126.005 1.722 . . . . 2.6699999999999999 110.956 -169.102 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -48.07 -45.5 32.56 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.71 1.204 . . . . 0.81000000000000005 111.682 178.861 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 89.9 m -57.48 -32.32 66.86 Favored 'General case' 0 CA--C 1.529 0.143 0 N-CA-C 112.766 0.654 . . . . 1.54 112.766 177.761 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.668 ' HB1' HG21 ' A' ' 39' ' ' VAL . . . -64.47 -19.17 65.4 Favored 'General case' 0 CA--C 1.538 0.487 0 O-C-N 121.904 -0.498 . . . . 0.56000000000000005 111.051 175.12 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.22 -47.41 61.56 Favored 'General case' 0 N--CA 1.453 -0.279 0 O-C-N 119.452 -2.03 . . . . 0.44 108.607 169.734 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 61.8 mtp180 -55.45 -41.24 72.59 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 118.77 -0.633 . . . . 4.1600000000000001 110.076 -176.386 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.484 HG21 ' CD1' ' A' ' 69' ' ' TYR 0.3 1.4 pt -57.82 -58.38 6.52 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.425 0 C-N-CA 119.373 -0.931 . . . . 0.46999999999999997 110.708 174.877 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.4 ' HG3' ' HB1' ' A' ' 37' ' ' ALA . 0.4 OUTLIER -47.88 -42.55 27.1 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 119.191 0.905 . . . . 2.6699999999999999 112.883 176.293 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 24.4 mmtp -70.25 -48.74 55.56 Favored 'General case' 0 CA--C 1.535 0.378 0 O-C-N 120.938 -1.101 . . . . 2.2400000000000002 111.291 -179.573 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.86 -29.38 73.91 Favored Glycine 0 CA--C 1.53 1.0 0 O-C-N 121.665 -0.647 . . . . 0.92000000000000004 111.582 176.281 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.3 tt -67.4 -54.42 20.56 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 125.314 1.446 . . . . 1.8500000000000001 107.775 176.547 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.501 ' HE2' ' HA ' ' A' ' 36' ' ' ASP . 6.7 ttmt -48.32 -33.11 8.36 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.523 0.729 . . . . 2.5499999999999998 112.115 178.22 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 3.6 mmt180 -55.76 -15.7 3.48 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 114.507 1.299 . . . . 4.2000000000000002 114.507 177.906 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 9.9 ptp -67.68 156.72 88.32 Favored Pre-proline 0 CA--C 1.535 0.38 0 CA-C-N 119.719 1.145 . . . . 3.8900000000000001 112.252 175.941 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -60.74 137.89 76.0 Favored 'Trans proline' 0 N--CA 1.456 -0.735 0 C-N-CA 121.378 1.385 . . . . 0.67000000000000004 109.522 165.846 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 99.33 -28.63 14.51 Favored Glycine 0 CA--C 1.53 0.983 0 CA-C-O 119.14 -0.811 . . . . 0.47999999999999998 113.729 170.553 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 61.5 t -88.64 136.75 22.61 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 CA-C-N 119.288 1.544 . . . . 0.56000000000000005 109.119 171.613 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -108.04 -41.2 5.0 Favored 'General case' 0 C--N 1.341 0.216 0 CA-C-O 118.356 -0.83 . . . . 1.4199999999999999 110.733 178.508 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.501 ' HA ' ' HE2' ' A' ' 29' ' ' LYS . 0.4 OUTLIER -143.21 165.93 26.1 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-N 119.113 0.87 . . . . 2.3700000000000001 110.403 170.963 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.4 ' HB1' ' HG3' ' A' ' 25' ' ' GLU . . . -158.02 148.16 20.28 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 123.538 0.735 . . . . 0.51000000000000001 110.073 179.923 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -156.19 118.37 4.03 Favored 'General case' 0 C--O 1.232 0.143 0 N-CA-C 107.723 -1.214 . . . . 0.53000000000000003 107.723 -163.364 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.668 HG21 ' HB1' ' A' ' 21' ' ' ALA . 8.0 p -89.92 101.4 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 C-N-CA 123.082 0.553 . . . . 0.65000000000000002 110.232 -177.07 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 51.4 t-20 -84.07 56.7 3.83 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-O 122.693 1.235 . . . . 0.59999999999999998 109.277 179.629 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.427 HD22 ' HA ' ' A' ' 41' ' ' LEU . 0.2 OUTLIER -69.07 -19.92 64.08 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 115.229 -0.896 . . . . 1.1100000000000001 110.152 -175.467 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -46.91 -36.8 8.01 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.032 0.933 . . . . 0.68000000000000005 112.363 166.752 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 14.5 t -115.5 23.67 12.2 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 118.499 0.59 . . . . 1.3600000000000001 111.327 174.161 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 55.04 50.37 15.56 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.4 1.08 . . . . 3.5499999999999998 112.859 -179.706 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 7.1 m -145.9 154.78 42.33 Favored 'General case' 0 N--CA 1.445 -0.722 0 O-C-N 120.418 -1.426 . . . . 0.77000000000000002 109.045 178.844 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.3 p -117.81 144.37 25.97 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 N-CA-C 108.455 -0.943 . . . . 0.39000000000000001 108.455 171.347 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -124.68 142.62 51.25 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 108.153 -1.055 . . . . 0.39000000000000001 108.153 176.985 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 4.0 p -139.78 129.35 29.09 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 N-CA-C 106.822 -1.548 . . . . 1.78 106.822 -174.993 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 14.5 mm -108.31 89.03 1.21 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.654 0 C-N-CA 126.007 1.723 . . . . 0.63 107.711 -167.461 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 34.7 p90 -137.12 172.9 12.32 Favored 'General case' 0 CA--C 1.511 -0.542 0 C-N-CA 122.671 0.388 . . . . 1.6399999999999999 111.967 -167.703 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 66.4 t0 -93.36 104.71 13.06 Favored Pre-proline 0 C--O 1.236 0.345 0 O-C-N 125.094 1.496 . . . . 3.0800000000000001 110.177 -179.412 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -73.71 3.19 5.11 Favored 'Trans proline' 0 N--CA 1.448 -1.154 0 C-N-CA 122.003 1.802 . . . . 0.76000000000000001 112.447 -179.286 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -82.23 -29.35 31.38 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 119.819 1.19 . . . . 1.0700000000000001 109.205 165.726 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -108.32 -55.99 2.31 Favored 'General case' 0 C--N 1.343 0.317 0 C-N-CA 122.797 0.439 . . . . 2.52 110.308 -166.355 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.31 0.6 OUTLIER -89.05 177.54 6.62 Favored 'General case' 0 CA--C 1.514 -0.432 0 CA-C-O 123.312 1.53 . . . . 0.52000000000000002 114.212 160.345 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -160.02 -135.9 1.93 Allowed Glycine 0 N--CA 1.433 -1.567 0 N-CA-C 103.978 -3.649 . . . . 2.54 103.978 175.43 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 23.6 p -76.57 -35.29 58.28 Favored 'General case' 0 N--CA 1.444 -0.751 0 C-N-CA 127.031 2.132 . . . . 1.3600000000000001 109.75 177.917 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -49.48 -62.8 1.35 Allowed 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 125.49 1.516 . . . . 0.55000000000000004 113.926 -165.379 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.83 -35.0 69.76 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 114.676 -1.147 . . . . 0.44 108.472 -168.364 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.8 mt -54.26 -57.18 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.908 0 C-N-CA 125.95 1.7 . . . . 1.3200000000000001 111.179 173.155 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.69 -45.22 95.01 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 119.804 1.184 . . . . 1.0900000000000001 109.626 -179.724 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -49.56 -59.36 3.84 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-O 121.392 0.615 . . . . 3.2400000000000002 111.958 176.756 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 4.7 mmpt? -63.61 -40.53 97.16 Favored 'General case' 0 N--CA 1.437 -1.087 0 CA-C-O 118.459 -0.781 . . . . 2.2000000000000002 111.096 -179.452 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.3 mm -49.01 -54.3 5.69 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.558 0 C-N-CA 124.171 0.989 . . . . 0.34999999999999998 108.441 177.204 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 27.0 mm-40 -59.32 -55.71 31.34 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 123.594 0.757 . . . . 1.6200000000000001 110.436 177.0 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 10.2 mmtt -57.11 -36.48 70.69 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 112.905 0.706 . . . . 4.4299999999999997 112.905 -174.931 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 13.0 mt -71.11 -17.8 62.55 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.889 1.276 . . . . 0.64000000000000001 112.144 175.874 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 96.96 39.47 4.06 Favored Glycine 0 CA--C 1.523 0.589 0 C-N-CA 124.571 1.082 . . . . 0.45000000000000001 111.093 175.36 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.484 ' CD1' HG21 ' A' ' 24' ' ' ILE . 0.6 OUTLIER -135.31 175.86 9.2 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 124.131 0.972 . . . . 1.9399999999999999 110.303 -178.39 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 22.4 t-160 -143.86 133.55 23.7 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 107.711 -1.218 . . . . 2.04 107.711 172.631 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 6.5 p -108.86 139.99 29.28 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 C-N-CA 125.296 1.439 . . . . 1.49 107.407 179.782 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 86.3 t -108.72 138.74 34.23 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.137 0 CA-C-O 121.833 0.825 . . . . 0.68000000000000005 109.069 -179.566 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 45.8 mm -104.86 77.92 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 C-N-CA 125.224 1.41 . . . . 1.1699999999999999 109.123 -169.767 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -74.93 2.46 10.32 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.646 1.179 . . . . 3.2999999999999998 113.696 173.615 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -112.49 -8.24 21.4 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 125.093 1.33 . . . . 3.9300000000000002 114.617 -170.497 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.083 0 C-N-CA 124.74 1.216 . . . . 10.08 107.935 -173.798 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 77' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.3 m . . . . . 0 CA--C 1.531 0.238 0 N-CA-C 112.068 0.395 . . . . 1.05 112.068 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -72.76 174.97 6.91 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 108.472 -0.936 . . . . 2.3100000000000001 108.472 179.245 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -129.45 141.09 51.11 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 107.304 -1.369 . . . . 1.04 107.304 168.429 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 6.8 mtpm? -139.76 158.43 44.12 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-O 122.225 1.012 . . . . 3.46 109.661 168.028 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -112.67 107.4 16.06 Favored 'General case' 0 N--CA 1.431 -1.402 0 C-N-CA 130.03 3.332 . . . . 1.5900000000000001 104.974 -171.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.476 HD12 ' C ' ' A' ' 8' ' ' ILE . 2.2 pp -84.12 167.02 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 C-N-CA 118.917 -1.113 . . . . 4.9000000000000004 108.599 166.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -137.76 134.01 34.76 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 105.174 -2.158 . . . . 0.44 105.174 170.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 24.2 ptt? -153.11 168.57 25.49 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 118.492 0.587 . . . . 3.1600000000000001 109.75 178.212 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 19.9 mm100 -92.81 163.99 13.51 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 124.122 0.969 . . . . 2.46 109.819 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.9 m -124.17 157.16 31.58 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.126 0 C-N-CA 125.403 1.481 . . . . 1.8799999999999999 110.08 179.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 38.5 m -155.04 166.7 32.75 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 124.8 1.24 . . . . 1.28 108.655 170.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 63.11 74.66 0.4 Allowed Glycine 0 CA--C 1.528 0.877 0 N-CA-C 110.845 -0.902 . . . . 1.8300000000000001 110.845 178.398 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -146.71 155.97 42.81 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 123.228 0.611 . . . . 2.29 110.526 -175.096 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -85.6 -62.81 1.44 Allowed 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 125.915 1.686 . . . . 3.5800000000000001 109.644 172.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.6 p -155.07 161.04 41.42 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 121.724 0.773 . . . . 2.27 112.085 -169.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -72.93 56.1 0.41 Allowed 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 126.751 2.02 . . . . 1.8200000000000001 111.112 -178.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -152.6 -52.57 0.11 Allowed 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 124.804 1.242 . . . . 0.69999999999999996 108.448 -175.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 30.9 m -59.07 -39.26 81.57 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 108.904 -0.776 . . . . 1.1599999999999999 108.904 170.357 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.705 ' HB1' HG21 ' A' ' 39' ' ' VAL . . . -41.3 -36.83 0.86 Allowed 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.663 1.585 . . . . 0.76000000000000001 112.697 166.569 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -69.75 -53.91 16.18 Favored 'General case' 0 N--CA 1.452 -0.34 0 O-C-N 120.228 -1.545 . . . . 0.41999999999999998 109.264 175.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 2.5 mpp_? -57.08 -36.68 70.86 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-O 118.166 -0.921 . . . . 4.4000000000000004 111.639 -174.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.281 2.0 pt -56.78 -57.19 10.47 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 C-N-CA 119.342 -0.943 . . . . 0.65000000000000002 110.742 175.079 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -57.13 -45.66 83.33 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 123.533 0.733 . . . . 2.3199999999999998 112.08 178.001 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 13.4 mptt -66.73 -43.25 84.69 Favored 'General case' 0 CA--C 1.531 0.22 0 O-C-N 121.683 -0.636 . . . . 1.8200000000000001 109.838 -174.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -60.33 -44.37 97.61 Favored Glycine 0 CA--C 1.527 0.811 0 N-CA-C 110.024 -1.23 . . . . 0.60999999999999999 110.024 171.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -60.39 -40.91 92.62 Favored 'General case' 0 CA--C 1.532 0.255 0 O-C-N 122.48 -0.423 . . . . 2.3300000000000001 110.069 -175.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 19.9 ttmt -43.5 -32.25 0.86 Allowed 'General case' 0 CA--C 1.535 0.369 0 O-C-N 121.747 -0.596 . . . . 2.9700000000000002 112.405 173.133 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.93 -4.2 30.58 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 113.588 0.958 . . . . 5.9500000000000002 113.588 -172.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.83 166.39 37.78 Favored Pre-proline 0 CA--C 1.539 0.537 0 C-N-CA 125.111 1.364 . . . . 3.79 111.655 173.232 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_endo -70.5 157.1 59.97 Favored 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 122.881 2.387 . . . . 1.3100000000000001 110.629 -178.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 72.46 -36.15 0.68 Allowed Glycine 0 CA--C 1.525 0.71 0 C-N-CA 124.972 1.273 . . . . 0.92000000000000004 112.798 -179.031 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.5 t -68.45 144.78 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.732 0 CA-C-N 118.411 1.106 . . . . 0.94999999999999996 109.286 176.113 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -133.16 -39.24 0.94 Allowed 'General case' 0 N--CA 1.451 -0.377 0 CA-C-O 118.705 -0.664 . . . . 1.04 110.945 179.196 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -139.55 166.28 25.0 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-N 119.251 0.932 . . . . 2.6200000000000001 111.963 166.055 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -158.17 138.32 12.44 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 115.659 -0.7 . . . . 0.44 110.322 -176.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -149.62 109.83 4.16 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 106.206 -1.776 . . . . 0.41999999999999998 106.206 -163.681 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.705 HG21 ' HB1' ' A' ' 21' ' ' ALA . 9.7 p -81.48 119.09 30.41 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 N-CA-C 108.523 -0.917 . . . . 0.5 108.523 177.286 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 55.7 t-20 -99.65 57.28 1.01 Allowed 'General case' 0 C--O 1.236 0.352 0 CA-C-O 123.017 1.389 . . . . 0.57999999999999996 107.803 -178.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.453 HD22 ' HA ' ' A' ' 41' ' ' LEU . 0.2 OUTLIER -69.48 -19.92 63.75 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 114.095 -1.411 . . . . 0.96999999999999997 110.372 -172.773 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -46.21 -37.0 6.57 Favored 'General case' 0 C--N 1.34 0.189 0 C-N-CA 123.974 0.91 . . . . 0.53000000000000003 111.839 168.086 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 14.9 t -124.31 37.19 4.46 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 109.831 -0.433 . . . . 1.24 109.831 173.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 52.12 31.98 9.77 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 126.317 1.847 . . . . 2.9900000000000002 113.034 171.507 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 95.6 m -122.99 159.92 27.34 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 125.07 1.348 . . . . 0.65000000000000002 108.536 -175.28 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 6.5 p -129.03 143.96 39.65 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 O-C-N 121.249 -0.907 . . . . 0.31 109.413 172.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 20.1 m120 -127.84 138.9 52.86 Favored 'General case' 0 C--N 1.344 0.354 0 N-CA-C 107.774 -1.195 . . . . 0.34999999999999998 107.774 179.198 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 93.3 t -134.17 125.46 48.05 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 N-CA-C 105.062 -2.199 . . . . 1.8899999999999999 105.062 -174.506 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 13.7 mm -104.4 101.0 11.67 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 C-N-CA 126.249 1.82 . . . . 0.44 107.983 -175.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 41.9 p90 -142.23 173.04 11.89 Favored 'General case' 0 CA--C 1.513 -0.457 0 O-C-N 121.785 -0.572 . . . . 1.72 111.183 -172.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -92.97 115.17 64.52 Favored Pre-proline 0 CA--C 1.534 0.343 0 O-C-N 124.199 0.937 . . . . 3.04 108.884 173.188 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -81.76 13.08 2.56 Favored 'Trans proline' 0 N--CA 1.451 -0.998 0 C-N-CA 122.465 2.11 . . . . 0.66000000000000003 113.386 -176.054 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -92.35 -32.27 15.04 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 119.45 1.023 . . . . 0.93000000000000005 109.588 164.052 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -101.1 -55.43 2.56 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 108.495 -0.928 . . . . 2.6899999999999999 108.495 -169.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.499 0.2 OUTLIER -83.67 176.75 8.75 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 115.301 1.593 . . . . 0.64000000000000001 115.301 155.845 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -171.31 -147.54 5.7 Favored Glycine 0 N--CA 1.434 -1.454 0 N-CA-C 103.126 -3.99 . . . . 2.52 103.126 -174.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 23.6 p -76.75 -32.58 57.85 Favored 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 125.108 1.363 . . . . 1.3999999999999999 109.551 174.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -49.98 -61.59 2.06 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 124.723 1.209 . . . . 0.71999999999999997 113.282 -162.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.0 -34.21 73.02 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 114.408 -1.269 . . . . 0.60999999999999999 108.765 -171.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.6 mp -60.68 -51.41 73.42 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.95 0 CA-C-N 114.999 -1.0 . . . . 1.23 109.79 178.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.49 -47.11 85.43 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 108.828 -0.804 . . . . 1.1499999999999999 108.828 -178.068 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -48.7 -54.64 14.03 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 122.038 0.923 . . . . 3.1899999999999999 110.974 174.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.07 -47.17 81.17 Favored 'General case' 0 N--CA 1.44 -0.973 0 CA-C-O 118.664 -0.684 . . . . 2.3999999999999999 111.776 -178.524 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.501 HD12 HG13 ' A' ' 71' ' ' VAL . 1.2 mm -46.76 -50.99 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 C-N-CA 126.412 1.885 . . . . 0.51000000000000001 109.033 -177.091 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -57.73 -57.58 12.12 Favored 'General case' 0 C--N 1.34 0.159 0 C-N-CA 123.387 0.675 . . . . 1.49 110.173 175.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 13.9 mmtt -55.45 -35.6 65.64 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 112.963 0.727 . . . . 4.8499999999999996 112.963 -178.14 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 31.6 mt -71.07 -18.35 62.56 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.74 1.616 . . . . 0.93000000000000005 111.451 177.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 87.15 44.17 5.73 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 110.593 -1.003 . . . . 0.83999999999999997 110.593 178.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -137.93 172.97 12.14 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 124.094 0.957 . . . . 2.6800000000000002 109.72 179.125 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 8.3 t60 -146.35 133.9 20.92 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 109.239 -0.652 . . . . 1.96 109.239 165.048 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.501 HG13 HD12 ' A' ' 64' ' ' ILE . 4.5 m -98.8 161.05 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 C-N-CA 123.823 0.849 . . . . 2.4900000000000002 110.15 176.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 12.0 t -129.55 141.9 45.31 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 C-N-CA 124.902 1.281 . . . . 0.56000000000000005 107.843 -176.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 28.7 mm . . . . . 0 N--CA 1.454 -0.231 0 C-N-CA 125.025 1.33 . . . . 1.6499999999999999 108.426 -175.203 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 55.1 m . . . . . 0 N--CA 1.447 -0.624 0 N-CA-C 106.507 -1.664 . . . . 1.3999999999999999 106.507 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -111.33 -174.7 2.53 Favored 'General case' 0 N--CA 1.439 -1.025 0 C-N-CA 125.487 1.515 . . . . 2.3399999999999999 107.257 156.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -136.28 152.01 50.25 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 107.473 -1.306 . . . . 1.1699999999999999 107.473 172.711 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 23.9 mttt -143.67 163.35 33.5 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 122.937 0.495 . . . . 2.6800000000000002 110.286 161.075 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -122.47 84.81 2.32 Favored 'General case' 0 N--CA 1.44 -0.969 0 C-N-CA 128.687 2.795 . . . . 1.5600000000000001 106.009 -166.429 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.439 ' N ' HD12 ' A' ' 8' ' ' ILE . 3.1 mp -82.49 160.6 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.405 0 N-CA-C 105.691 -1.966 . . . . 2.0299999999999998 105.691 -178.15 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -120.35 132.92 55.49 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 106.243 -1.762 . . . . 0.53000000000000003 106.243 178.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 2.8 ttm -138.54 161.63 36.57 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 108.355 -0.98 . . . . 2.2400000000000002 108.355 -177.161 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -97.42 146.91 24.74 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 124.235 1.014 . . . . 2.4199999999999999 108.936 177.078 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 49.1 t -103.85 149.76 7.52 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 C-N-CA 123.77 0.828 . . . . 1.24 109.019 -178.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 56.3 m -152.93 164.88 37.1 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 118.866 0.757 . . . . 1.1699999999999999 110.092 171.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 64.02 72.13 0.74 Allowed Glycine 0 CA--C 1.527 0.84 0 N-CA-C 110.93 -0.868 . . . . 1.73 110.93 178.2 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -154.78 170.11 22.37 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 123.825 0.85 . . . . 2.0699999999999998 109.857 -172.727 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -111.87 -44.64 3.43 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 123.922 0.889 . . . . 2.3300000000000001 111.229 168.642 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 20.0 p -147.97 176.43 10.17 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 119.111 0.869 . . . . 2.6600000000000001 111.631 -174.105 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -72.26 -24.41 61.36 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 115.508 -0.769 . . . . 2.6200000000000001 111.809 177.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.7 -49.7 72.09 Favored 'General case' 0 C--O 1.233 0.209 0 O-C-N 121.377 -0.827 . . . . 0.71999999999999997 110.79 -175.614 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 5.2 p -65.06 -38.96 92.49 Favored 'General case' 0 CA--C 1.532 0.279 0 O-C-N 121.633 -0.667 . . . . 2.4500000000000002 110.518 173.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.756 ' HB1' HG21 ' A' ' 39' ' ' VAL . . . -56.61 -29.28 61.97 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-O 121.386 0.613 . . . . 0.40999999999999998 112.074 173.242 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -69.9 -53.41 18.07 Favored 'General case' 0 N--CA 1.45 -0.445 0 O-C-N 119.935 -1.728 . . . . 0.5 108.791 171.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -46.67 -50.96 16.99 Favored 'General case' 0 C--N 1.341 0.231 0 CA-C-O 118.486 -0.769 . . . . 3.9199999999999999 110.755 178.109 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.502 HG21 ' CD1' ' A' ' 69' ' ' TYR 0.268 3.4 pt -57.09 -58.21 6.78 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.159 0 C-N-CA 119.727 -0.789 . . . . 0.51000000000000001 110.69 -176.302 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -51.96 -45.47 64.4 Favored 'General case' 0 N--CA 1.457 -0.095 0 CA-C-N 119.006 0.821 . . . . 2.4199999999999999 111.068 179.184 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.36 -40.15 85.75 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 119.585 -0.846 . . . . 1.53 110.895 -177.239 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -68.93 -24.62 75.7 Favored Glycine 0 CA--C 1.529 0.916 0 O-C-N 121.542 -0.724 . . . . 0.64000000000000001 111.633 174.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.434 ' CD2' HG21 ' A' ' 34' ' ' VAL . 0.9 OUTLIER -70.1 -43.92 70.06 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 108.11 -1.07 . . . . 1.6799999999999999 108.11 173.838 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 3.4 ttpp -50.0 -24.67 2.74 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 125.323 1.449 . . . . 2.3999999999999999 113.505 173.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -83.24 -0.21 48.48 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 118.443 -0.789 . . . . 3.9100000000000001 112.942 -179.5 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . 0.633 ' CE ' ' HB1' ' A' ' 59' ' ' ALA . 4.0 ptm -93.96 156.0 39.66 Favored Pre-proline 0 CA--C 1.536 0.43 0 CA-C-N 119.31 0.959 . . . . 3.2200000000000002 111.658 -178.144 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -62.13 133.22 42.78 Favored 'Trans proline' 0 N--CA 1.456 -0.711 0 C-N-CA 122.433 2.089 . . . . 0.81000000000000005 109.809 173.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 100.11 -39.2 2.82 Favored Glycine 0 CA--C 1.525 0.7 0 CA-C-O 119.08 -0.844 . . . . 0.79000000000000004 112.595 176.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.434 HG21 ' CD2' ' A' ' 28' ' ' LEU . 47.5 t -88.02 118.66 34.12 Favored 'Isoleucine or valine' 0 C--N 1.343 0.314 0 CA-C-N 118.796 1.298 . . . . 1.0900000000000001 110.143 177.653 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 98.1 m -88.82 -52.66 5.0 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-O 118.76 -0.638 . . . . 1.3899999999999999 110.058 -176.236 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -138.23 161.26 37.3 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 123.838 0.855 . . . . 2.7200000000000002 108.757 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -158.22 141.03 14.71 Favored 'General case' 0 C--O 1.238 0.454 0 O-C-N 121.923 -0.486 . . . . 0.44 111.255 -173.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -151.37 110.07 3.83 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 106.648 -1.612 . . . . 0.42999999999999999 106.648 -165.118 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.756 HG21 ' HB1' ' A' ' 21' ' ' ALA . 8.7 p -80.97 136.07 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 N-CA-C 107.816 -1.179 . . . . 0.71999999999999997 107.816 176.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 52.7 t-20 -121.97 56.01 1.1 Allowed 'General case' 0 C--O 1.235 0.342 0 CA-C-O 123.03 1.395 . . . . 0.58999999999999997 107.929 -176.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.429 HD22 ' HA ' ' A' ' 41' ' ' LEU . 0.2 OUTLIER -68.09 -19.55 64.87 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 113.807 -1.542 . . . . 1.04 110.615 -176.018 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -45.46 -37.88 5.63 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 124.067 0.947 . . . . 0.68000000000000005 111.948 165.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 12.2 t -124.53 38.18 4.25 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 109.063 -0.717 . . . . 1.3600000000000001 109.063 172.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 53.77 24.1 4.18 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.773 1.629 . . . . 3.25 113.78 171.085 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 88.0 m -116.51 162.91 16.86 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.814 1.245 . . . . 0.69999999999999996 108.878 -174.347 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.4 p -125.94 145.42 33.42 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 C-N-CA 124.536 1.135 . . . . 0.34000000000000002 108.044 167.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 10.2 m120 -124.17 136.86 54.5 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 107.494 -1.299 . . . . 0.33000000000000002 107.494 172.519 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.1 p -134.93 123.66 41.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 106.252 -1.759 . . . . 1.8799999999999999 106.252 -173.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 13.5 mm -104.32 94.72 3.32 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 N-CA-C 107.194 -1.41 . . . . 0.56000000000000005 107.194 -168.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 31.1 p90 -131.28 164.26 26.0 Favored 'General case' 0 CA--C 1.512 -0.506 0 O-C-N 122.203 -0.31 . . . . 1.6499999999999999 111.691 -169.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 35.7 t0 -83.53 109.23 16.63 Favored Pre-proline 0 CA--C 1.532 0.279 0 O-C-N 124.444 1.09 . . . . 3.02 109.553 174.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -74.22 4.87 3.97 Favored 'Trans proline' 0 N--CA 1.451 -0.981 0 C-N-CA 122.663 2.242 . . . . 0.59999999999999998 113.06 -176.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -85.44 -28.68 24.91 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 119.338 0.972 . . . . 0.77000000000000002 109.215 166.428 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -102.52 -61.16 1.43 Allowed 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 107.941 -1.133 . . . . 4.2999999999999998 107.941 -169.189 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.829 HG22 ' HB3' ' A' ' 59' ' ' ALA 0.283 0.7 OUTLIER -86.75 -176.46 5.8 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 124.933 1.293 . . . . 0.78000000000000003 112.901 162.489 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 131.78 94.02 0.61 Allowed Glycine 0 N--CA 1.442 -0.903 0 N-CA-C 103.515 -3.834 . . . . 2.3100000000000001 103.515 -144.356 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 75.0 p -19.17 -23.25 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.308 1 C-N-CA 138.132 6.573 . . . . 1.28 118.809 -147.43 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -28.21 -62.54 0.1 Allowed 'General case' 0 N--CA 1.442 -0.846 0 C-N-CA 126.503 1.921 . . . . 0.91000000000000003 113.19 165.174 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.829 ' HB3' HG22 ' A' ' 55' ' ' THR . . . -75.27 -32.43 61.05 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 118.396 -1.322 . . . . 0.87 110.014 -168.644 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.6 mp -60.17 -51.72 69.6 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.625 0 CA-C-N 115.579 -0.737 . . . . 0.82999999999999996 109.794 175.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.96 -48.21 82.63 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 119.067 0.849 . . . . 1.1699999999999999 109.151 -178.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -46.13 -58.74 3.37 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-O 121.864 0.84 . . . . 2.5699999999999998 111.24 174.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 15.2 mmmt -67.74 -34.69 77.33 Favored 'General case' 0 N--CA 1.441 -0.913 0 CA-C-O 118.354 -0.832 . . . . 3.7000000000000002 112.082 -177.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.4 mm -53.45 -52.65 30.48 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 N-CA-C 107.943 -1.132 . . . . 0.41999999999999998 107.943 176.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 40.9 mm-40 -58.15 -54.77 43.25 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 123.469 0.708 . . . . 1.54 109.837 176.123 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 13.0 mmtt -59.48 -33.85 71.84 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 113.288 0.848 . . . . 4.1299999999999999 113.288 -176.325 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 32.1 mt -70.78 -18.47 62.75 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.735 1.214 . . . . 1.02 111.289 174.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 95.9 39.88 4.23 Favored Glycine 0 CA--C 1.524 0.597 0 C-N-CA 124.892 1.234 . . . . 0.72999999999999998 111.007 175.173 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.502 ' CD1' HG21 ' A' ' 24' ' ' ILE . 0.2 OUTLIER -136.54 175.47 9.58 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 117.805 0.803 . . . . 1.8700000000000001 111.462 -174.987 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -130.69 147.5 52.37 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 123.487 0.715 . . . . 2.9300000000000002 109.497 167.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 4.1 p -126.52 152.77 34.49 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 N-CA-C 106.581 -1.637 . . . . 1.5 106.581 176.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 11.6 t -129.31 141.89 45.4 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 N-CA-C 107.032 -1.47 . . . . 0.73999999999999999 107.032 -178.571 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 5.0 mp . . . . . 0 N--CA 1.455 -0.201 0 N-CA-C 108.759 -0.83 . . . . 1.3500000000000001 108.759 -175.04 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.9 m . . . . . 0 N--CA 1.453 -0.317 0 N-CA-C 106.797 -1.557 . . . . 0.89000000000000001 106.797 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -88.6 -178.29 5.78 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 108.359 -0.978 . . . . 1.95 108.359 163.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 2.9 mm100 -134.58 148.44 50.45 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 107.038 -1.467 . . . . 1.1499999999999999 107.038 169.104 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 37.4 mtpt -140.32 156.91 46.26 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 123.415 0.686 . . . . 2.79 109.167 163.078 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 8.0 mp0 -115.48 89.69 3.16 Favored 'General case' 0 N--CA 1.442 -0.836 0 C-N-CA 127.746 2.418 . . . . 1.8600000000000001 106.326 -170.289 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.514 ' N ' HD12 ' A' ' 8' ' ' ILE . 1.6 mp -83.32 161.25 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.397 0 N-CA-C 105.742 -1.947 . . . . 2.1400000000000001 105.742 -177.321 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -127.81 126.34 41.5 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 125.395 1.478 . . . . 0.41999999999999998 107.021 177.333 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 2.7 mpp? -132.58 170.87 14.57 Favored 'General case' 0 CA--C 1.528 0.124 0 C-N-CA 123.419 0.688 . . . . 2.1000000000000001 109.204 173.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 18.5 mm100 -97.66 145.27 26.47 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 124.438 1.095 . . . . 2.6099999999999999 109.476 178.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 60.3 t -97.5 151.22 4.33 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.158 0 N-CA-C 108.938 -0.764 . . . . 1.26 108.938 178.316 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 13.0 t -141.77 176.77 8.65 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 108.196 -1.039 . . . . 1.6499999999999999 108.196 170.284 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 53.14 57.53 14.66 Favored Glycine 0 CA--C 1.529 0.909 0 C-N-CA 124.112 0.863 . . . . 1.53 111.573 -178.306 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -139.78 137.98 35.49 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 123.767 0.827 . . . . 1.9299999999999999 109.557 -179.344 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -144.44 8.14 1.35 Allowed 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.809 0.843 . . . . 3.7799999999999998 112.716 166.789 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 8.8 m -108.97 -21.0 12.84 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 124.691 1.196 . . . . 2.9100000000000001 111.825 -171.408 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 64.46 -68.06 0.1 Allowed 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.707 1.603 . . . . 2.5499999999999998 110.881 -165.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -44.13 -49.66 8.88 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 125.81 1.644 . . . . 0.83999999999999997 112.603 -175.418 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 96.6 m -52.54 -35.76 54.18 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 123.953 0.901 . . . . 1.1899999999999999 113.126 -178.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.78 ' HB1' HG21 ' A' ' 39' ' ' VAL . . . -63.35 -23.24 67.32 Favored 'General case' 0 CA--C 1.539 0.557 0 O-C-N 122.034 -0.416 . . . . 0.41999999999999998 111.157 179.638 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.13 -52.78 17.36 Favored 'General case' 0 N--CA 1.454 -0.245 0 O-C-N 121.028 -1.045 . . . . 0.31 109.592 171.13 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 4.2 mtt-85 -50.97 -47.99 61.23 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 123.379 0.672 . . . . 3.77 110.219 -176.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.442 HG21 ' CD1' ' A' ' 69' ' ' TYR . 6.8 pt -57.24 -55.07 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.196 0 C-N-CA 119.751 -0.779 . . . . 0.48999999999999999 111.121 179.487 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -54.17 -42.96 70.21 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.753 0.821 . . . . 3.1899999999999999 111.92 179.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 31.9 mmtp -70.66 -47.34 60.44 Favored 'General case' 0 CA--C 1.534 0.357 0 O-C-N 121.061 -1.024 . . . . 1.95 110.914 -178.248 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.37 -28.36 70.9 Favored Glycine 0 CA--C 1.53 0.995 0 O-C-N 121.545 -0.722 . . . . 0.64000000000000001 111.349 174.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.1 tt -68.86 -47.87 64.87 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 125.789 1.636 . . . . 1.8899999999999999 109.215 174.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.2 ttmm -50.45 -34.7 25.66 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 118.664 0.665 . . . . 2.7400000000000002 111.713 175.149 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 14.5 mmt-85 -62.69 -7.15 4.34 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 114.877 1.436 . . . . 4.4000000000000004 114.877 179.338 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . 0.472 ' SD ' ' HB1' ' A' ' 59' ' ' ALA . 27.4 mtm -71.56 169.72 14.61 Favored Pre-proline 0 CA--C 1.533 0.312 0 CA-C-N 120.355 1.434 . . . . 3.4500000000000002 112.44 170.8 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -60.78 162.78 17.57 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 121.777 1.651 . . . . 1.01 110.039 159.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 77.33 -38.72 1.63 Allowed Glycine 0 C--N 1.333 0.373 0 C-N-CA 125.88 1.705 . . . . 0.51000000000000001 114.02 171.455 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 16.3 t -83.66 134.08 27.73 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.875 0 C-N-CA 123.054 0.542 . . . . 0.52000000000000002 109.603 -177.428 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 88.0 m -113.6 -46.45 3.05 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 122.948 0.499 . . . . 1.3700000000000001 110.276 -175.183 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -139.48 165.13 28.05 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-N 118.047 0.385 . . . . 1.74 110.144 173.347 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -158.02 139.03 13.22 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 108.721 -0.844 . . . . 0.41999999999999998 108.721 -172.343 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -155.93 111.85 3.05 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 123.258 0.623 . . . . 0.48999999999999999 109.347 -165.571 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.896 HG22 HD23 ' A' ' 41' ' ' LEU . 4.8 p -86.79 102.57 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 CA-C-O 121.224 0.535 . . . . 0.55000000000000004 109.991 -177.037 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 51.7 t-20 -86.31 56.97 4.23 Favored 'General case' 0 C--O 1.235 0.333 0 O-C-N 120.687 -1.258 . . . . 0.57999999999999996 109.423 -179.213 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.896 HD23 HG22 ' A' ' 39' ' ' VAL . 0.3 OUTLIER -69.47 -19.86 63.75 Favored 'General case' 0 C--O 1.226 -0.158 0 CA-C-N 115.003 -0.998 . . . . 0.88 110.972 -176.195 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -45.27 -36.98 4.33 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.665 0.786 . . . . 0.56999999999999995 112.078 166.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 11.3 t -123.38 30.21 6.37 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 122.494 0.318 . . . . 1.23 110.964 172.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 62.11 26.83 16.16 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.348 1.459 . . . . 2.5099999999999998 114.297 172.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 88.4 m -120.32 163.13 18.29 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.79 1.236 . . . . 0.72999999999999998 109.524 -174.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 5.8 p -129.91 142.92 42.58 Favored 'Isoleucine or valine' 0 C--O 1.232 0.15 0 C-N-CA 124.302 1.041 . . . . 0.33000000000000002 108.835 171.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 10.4 m120 -126.12 129.79 49.78 Favored 'General case' 0 CA--C 1.517 -0.296 0 N-CA-C 108.151 -1.055 . . . . 0.35999999999999999 108.151 177.496 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 6.7 p -128.38 128.92 68.84 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 106.331 -1.729 . . . . 1.8 106.331 -175.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 7.9 mm -104.97 100.65 10.98 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 N-CA-C 107.15 -1.426 . . . . 0.42999999999999999 107.15 -172.003 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.462 ' CE2' HD13 ' A' ' 8' ' ' ILE . 50.2 p90 -138.46 165.15 27.55 Favored 'General case' 0 CA--C 1.516 -0.341 0 O-C-N 122.226 -0.296 . . . . 1.71 111.626 -172.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 37.7 t0 -85.97 110.68 32.43 Favored Pre-proline 0 C--O 1.236 0.382 0 O-C-N 124.458 1.099 . . . . 2.9700000000000002 108.858 175.12 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -71.5 4.26 3.09 Favored 'Trans proline' 0 N--CA 1.452 -0.957 0 C-N-CA 122.772 2.315 . . . . 0.55000000000000004 113.135 -178.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -89.2 -27.32 20.73 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 119.478 1.035 . . . . 0.71999999999999997 109.397 168.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -104.63 -51.53 3.06 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 109.575 -0.528 . . . . 2.8799999999999999 109.575 -171.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.464 HG22 ' HB3' ' A' ' 59' ' ' ALA 0.285 1.1 p -97.7 -177.48 3.8 Favored 'General case' 0 CA--C 1.518 -0.252 0 C-N-CA 123.993 0.917 . . . . 0.51000000000000001 112.275 160.76 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 145.32 88.6 0.09 OUTLIER Glycine 0 N--CA 1.441 -1.011 0 N-CA-C 104.448 -3.461 . . . . 2.52 104.448 -155.295 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 45.1 p -13.07 -17.96 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.556 1 C-N-CA 137.936 6.494 . . . . 1.1399999999999999 119.956 -143.228 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -27.61 -63.48 0.09 Allowed 'General case' 0 N--CA 1.443 -0.803 0 C-N-CA 127.01 2.124 . . . . 0.5 114.317 166.405 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.472 ' HB1' ' SD ' ' A' ' 31' ' ' MET . . . -73.73 -37.3 65.14 Favored 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 118.485 -1.286 . . . . 0.5 109.069 -168.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.5 mp -53.93 -57.5 5.53 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.808 0 CA-C-N 114.402 -1.272 . . . . 1.03 109.884 175.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.04 -48.0 81.42 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 119.047 0.84 . . . . 1.1200000000000001 109.55 -178.414 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -45.57 -57.39 4.2 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 123.312 0.645 . . . . 3.25 111.932 176.393 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.7 mmmm -68.3 -42.34 79.61 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-O 118.545 -0.741 . . . . 3.5299999999999998 111.376 -179.538 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -46.0 -52.65 2.84 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 C-N-CA 125.003 1.321 . . . . 0.42999999999999999 108.579 177.048 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -59.45 -58.44 8.61 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 124.503 1.121 . . . . 1.54 110.545 176.391 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -55.62 -34.87 65.28 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 113.006 0.743 . . . . 3.73 113.006 -176.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 26.6 mt -68.87 -17.32 63.97 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.774 1.229 . . . . 0.55000000000000004 111.721 177.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 92.11 43.47 4.38 Favored Glycine 0 CA--C 1.522 0.531 0 N-CA-C 110.129 -1.189 . . . . 0.40999999999999998 110.129 178.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.442 ' CD1' HG21 ' A' ' 24' ' ' ILE . 0.4 OUTLIER -141.46 171.52 13.94 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 124.189 0.996 . . . . 1.97 110.015 -176.364 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 8.8 t-80 -143.71 127.48 17.2 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 107.842 -1.17 . . . . 1.72 107.842 172.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 5.8 p -97.22 151.74 4.15 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 N-CA-C 108.114 -1.069 . . . . 1.4399999999999999 108.114 174.53 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 38.3 t -120.0 139.76 46.26 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 C-N-CA 125.173 1.389 . . . . 0.56999999999999995 108.358 -179.455 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 26.7 mm . . . . . 0 C--N 1.331 -0.234 0 CA-C-O 122.119 0.961 . . . . 1.1100000000000001 109.737 -169.772 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.7 m . . . . . 0 N--CA 1.45 -0.436 0 N-CA-C 108.655 -0.868 . . . . 0.84999999999999998 108.655 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -69.78 176.57 3.54 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 109.146 -0.687 . . . . 2.2999999999999998 109.146 173.133 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.67 155.07 45.6 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 124.205 1.002 . . . . 0.92000000000000004 108.431 176.39 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 10.8 ttmt -147.33 158.85 44.12 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 107.733 -1.21 . . . . 3.0699999999999998 107.733 168.268 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -119.13 98.68 6.29 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 127.728 2.411 . . . . 1.9099999999999999 104.669 -176.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 23.0 mm -84.37 164.32 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.171 0 N-CA-C 106.839 -1.541 . . . . 2.4300000000000002 106.839 173.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -134.18 124.83 26.67 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 107.065 -1.458 . . . . 0.48999999999999999 107.065 176.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 24.7 mtm -134.63 172.87 12.33 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.62 0.768 . . . . 2.0800000000000001 109.101 -179.145 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 21.5 mm100 -103.19 154.7 19.04 Favored 'General case' 0 C--O 1.222 -0.35 0 C-N-CA 125.394 1.477 . . . . 2.4500000000000002 109.313 178.089 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.591 HG21 HD21 ' A' ' 41' ' ' LEU . 6.3 m -117.98 165.37 13.39 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 CA-C-N 119.38 0.991 . . . . 1.73 110.419 174.274 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 53.8 m -137.74 171.04 15.03 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.231 1.412 . . . . 1.22 108.902 175.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 80.03 -44.82 2.87 Favored Glycine 0 CA--C 1.533 1.187 0 C-N-CA 123.488 0.566 . . . . 3.1899999999999999 113.311 173.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -38.55 122.37 1.11 Allowed 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 125.13 1.372 . . . . 2.8900000000000001 113.319 -177.231 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -139.48 12.53 2.55 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.896 0.878 . . . . 3.3199999999999998 112.014 177.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 8.9 m -115.59 -26.48 7.47 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 125.528 1.531 . . . . 2.9399999999999999 111.512 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 64.68 -63.71 0.17 Allowed 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.646 1.578 . . . . 2.4700000000000002 110.482 -162.207 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -41.59 -54.66 3.14 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 125.895 1.678 . . . . 0.87 112.748 -179.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 90.0 m -55.82 -31.43 62.68 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 113.183 0.808 . . . . 1.48 113.183 -178.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.817 ' HB1' HG21 ' A' ' 39' ' ' VAL . . . -61.4 -26.8 68.09 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 121.108 0.48 . . . . 0.41999999999999998 110.514 176.519 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.93 -50.74 31.42 Favored 'General case' 0 N--CA 1.452 -0.354 0 O-C-N 120.321 -1.487 . . . . 0.40000000000000002 109.053 170.035 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 55.2 mtm180 -51.33 -46.32 62.6 Favored 'General case' 0 N--CA 1.456 -0.154 0 CA-C-O 118.871 -0.585 . . . . 5.29 110.978 -177.417 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.462 HG21 ' CD1' ' A' ' 69' ' ' TYR . 4.5 pt -58.43 -55.86 19.96 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.237 0 C-N-CA 119.784 -0.766 . . . . 0.48999999999999999 110.681 178.098 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -53.29 -42.28 66.45 Favored 'General case' 0 C--O 1.225 -0.211 0 CA-C-N 119.568 1.076 . . . . 2.6899999999999999 111.715 179.804 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 32.0 mmtp -70.65 -44.93 66.1 Favored 'General case' 0 CA--C 1.536 0.414 0 O-C-N 121.228 -0.92 . . . . 1.95 110.897 -178.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -66.11 -25.8 72.28 Favored Glycine 0 CA--C 1.53 0.991 0 O-C-N 121.583 -0.698 . . . . 1.01 111.875 176.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 7.7 tt -70.38 -53.73 15.38 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 126.915 2.086 . . . . 1.8100000000000001 107.693 172.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -51.1 -18.51 0.86 Allowed 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 126.658 1.983 . . . . 3.4199999999999999 113.987 179.114 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -72.74 -16.05 61.66 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.044 1.338 . . . . 4.0300000000000002 113.035 176.365 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 7.1 ptp -68.01 160.28 75.18 Favored Pre-proline 0 CA--C 1.537 0.456 0 CA-C-N 118.934 0.788 . . . . 3.77 111.178 -179.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -61.51 134.75 53.06 Favored 'Trans proline' 0 N--CA 1.454 -0.829 0 C-N-CA 121.622 1.548 . . . . 0.57999999999999996 109.287 167.064 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 106.58 -54.16 0.59 Allowed Glycine 0 CA--C 1.529 0.943 0 C-N-CA 124.558 1.075 . . . . 1.0 111.933 174.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 56.2 t -73.24 113.11 10.58 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 O-C-N 120.912 -1.346 . . . . 0.93000000000000005 110.914 -173.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -80.83 -48.08 12.93 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-O 117.745 -1.122 . . . . 1.1699999999999999 108.712 -179.505 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -140.65 156.93 46.11 Favored 'General case' 0 C--N 1.342 0.264 0 CA-C-N 119.249 0.931 . . . . 2.2599999999999998 110.496 -177.478 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -154.96 148.56 25.33 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 112.23 0.455 . . . . 0.44 112.23 179.08 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -155.93 124.14 5.78 Favored 'General case' 0 C--N 1.342 0.245 0 N-CA-C 108.75 -0.833 . . . . 0.45000000000000001 108.75 -165.487 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.936 HG22 HD23 ' A' ' 41' ' ' LEU . 6.6 p -93.13 107.46 19.17 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 C-N-CA 123.694 0.798 . . . . 0.53000000000000003 109.614 -177.658 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 52.8 t-20 -88.89 58.36 4.56 Favored 'General case' 0 C--O 1.238 0.469 0 O-C-N 120.492 -1.38 . . . . 0.60999999999999999 109.364 -177.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.936 HD23 HG22 ' A' ' 39' ' ' VAL . 0.3 OUTLIER -68.27 -19.43 64.71 Favored 'General case' 0 N--CA 1.457 -0.114 0 CA-C-N 114.459 -1.246 . . . . 0.87 111.393 -175.223 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -45.85 -35.77 4.75 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 123.601 0.76 . . . . 0.68000000000000005 111.922 166.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 5.3 t -124.58 34.47 5.01 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.063 0.545 . . . . 1.3100000000000001 109.856 173.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 51.79 25.71 3.11 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.609 1.564 . . . . 2.7799999999999998 113.547 175.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 6.9 m -113.51 163.83 14.41 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.582 1.153 . . . . 0.63 108.468 -176.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.7 p -131.5 144.82 36.39 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.121 0 C-N-CA 124.442 1.097 . . . . 0.33000000000000002 108.947 173.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 20.7 m120 -129.55 133.49 47.24 Favored 'General case' 0 C--N 1.342 0.271 0 C-N-CA 124.219 1.008 . . . . 0.33000000000000002 108.399 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 40.1 t -128.74 123.67 59.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 N-CA-C 105.415 -2.069 . . . . 2.0099999999999998 105.415 -177.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 13.5 mm -101.46 94.46 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 N-CA-C 106.978 -1.49 . . . . 0.45000000000000001 106.978 -173.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 28.8 p90 -135.17 173.82 11.29 Favored 'General case' 0 CA--C 1.508 -0.657 0 O-C-N 122.118 -0.364 . . . . 1.76 111.331 -167.188 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 47.5 p-10 -97.12 109.03 47.52 Favored Pre-proline 0 N--CA 1.447 -0.61 0 O-C-N 124.703 1.252 . . . . 4.0899999999999999 112.425 -175.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -69.26 13.93 0.24 Allowed 'Trans proline' 0 CA--C 1.544 1.017 0 C-N-CA 121.43 1.42 . . . . 1.0700000000000001 113.241 178.132 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -99.4 -31.33 11.72 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 125.508 1.523 . . . . 1.0600000000000001 110.841 170.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -114.82 -55.1 2.52 Favored 'General case' 0 C--N 1.345 0.376 0 CA-C-N 118.663 0.665 . . . . 2.9500000000000002 109.533 -177.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.441 1.3 p -83.12 -179.81 7.53 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 114.047 1.128 . . . . 0.58999999999999997 114.047 160.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 135.09 93.09 0.42 Allowed Glycine 0 N--CA 1.445 -0.75 0 N-CA-C 104.512 -3.435 . . . . 2.29 104.512 -148.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 46.1 p -16.45 -17.44 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.462 1 C-N-CA 138.843 6.857 . . . . 1.3700000000000001 119.685 -151.025 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -27.32 -63.38 0.09 Allowed 'General case' 0 N--CA 1.442 -0.83 0 C-N-CA 126.477 1.911 . . . . 0.56999999999999995 113.966 163.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.14 -37.07 64.16 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 118.935 -1.106 . . . . 0.46000000000000002 109.143 -168.397 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 5.9 mt -53.66 -56.53 8.38 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.616 0 C-N-CA 125.5 1.52 . . . . 1.3600000000000001 110.862 174.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.92 -46.02 92.33 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 119.506 1.048 . . . . 1.23 109.665 -179.104 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 -49.58 -59.76 3.48 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 122.002 0.906 . . . . 3.3999999999999999 111.617 176.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 6.2 mmmt -67.05 -35.6 80.23 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-O 118.068 -0.968 . . . . 3.3199999999999998 111.346 -177.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.1 mm -49.54 -54.56 6.42 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 N-CA-C 108.106 -1.072 . . . . 0.40000000000000002 108.106 175.096 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -58.92 -53.96 52.52 Favored 'General case' 0 C--N 1.34 0.162 0 C-N-CA 123.33 0.652 . . . . 1.8899999999999999 109.952 176.134 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.25 -28.77 67.01 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 113.199 0.814 . . . . 5.5499999999999998 113.199 -177.286 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 20.5 mt -73.49 -18.19 61.14 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.973 1.309 . . . . 0.69999999999999996 111.603 175.062 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 89.96 39.39 6.15 Favored Glycine 0 CA--C 1.524 0.634 0 C-N-CA 124.664 1.126 . . . . 0.41999999999999998 110.345 -178.104 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.462 ' CD1' HG21 ' A' ' 24' ' ' ILE . 0.2 OUTLIER -134.59 175.65 9.34 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 123.756 0.823 . . . . 1.8300000000000001 110.415 -179.631 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -143.19 138.77 29.96 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 107.406 -1.331 . . . . 2.25 107.406 171.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 9.2 p -117.98 133.32 65.17 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 C-N-CA 125.212 1.405 . . . . 1.3700000000000001 107.864 178.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 41.9 t -100.85 140.92 18.53 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 C-N-CA 125.956 1.702 . . . . 0.58999999999999997 109.01 -179.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 21.7 mm . . . . . 0 C--N 1.329 -0.294 0 C-N-CA 124.078 0.951 . . . . 0.93000000000000005 108.755 -174.293 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.529 0.171 0 N-CA-C 107.797 -1.186 . . . . 1.04 107.797 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -71.73 153.37 42.06 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 107.037 -1.468 . . . . 3.8700000000000001 107.037 171.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.33 148.61 44.83 Favored 'General case' 0 CA--C 1.518 -0.28 0 C-N-CA 123.602 0.761 . . . . 0.98999999999999999 110.146 -177.346 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 7.0 mtpm? -141.01 159.97 41.07 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 122.157 0.979 . . . . 3.6200000000000001 111.756 166.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -108.39 104.25 13.57 Favored 'General case' 0 N--CA 1.434 -1.238 0 C-N-CA 130.755 3.622 . . . . 1.95 103.919 -176.284 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 5.6 mm -88.68 160.09 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.35 0 N-CA-C 106.982 -1.488 . . . . 1.9099999999999999 106.982 172.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -124.98 137.93 54.24 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 106.517 -1.66 . . . . 0.54000000000000004 106.517 169.524 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 57.9 mtt -144.37 166.16 25.89 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 118.412 0.551 . . . . 2.79 109.659 173.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 11.6 mm100 -88.56 155.4 19.66 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 125.176 1.391 . . . . 2.3500000000000001 109.945 175.567 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 99.3 t -112.34 138.75 40.19 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 C-N-CA 123.935 0.894 . . . . 1.4199999999999999 110.259 -179.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 73.3 m -137.84 165.19 27.08 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.814 1.245 . . . . 1.0900000000000001 109.938 172.376 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 65.73 72.16 0.78 Allowed Glycine 0 CA--C 1.527 0.836 0 N-CA-C 110.891 -0.884 . . . . 1.71 110.891 176.276 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -152.56 158.14 42.06 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 123.739 0.816 . . . . 1.95 109.843 -173.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -105.09 -56.72 2.13 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 124.996 1.319 . . . . 2.4399999999999999 110.463 168.539 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 31.7 p -127.91 156.68 42.23 Favored 'General case' 0 C--N 1.34 0.175 0 CA-C-O 121.814 0.816 . . . . 2.23 111.504 -170.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -76.33 53.09 0.81 Allowed 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.771 0.829 . . . . 1.75 110.401 176.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -151.49 -50.36 0.12 Allowed 'General case' 0 C--O 1.232 0.136 0 C-N-CA 123.131 0.572 . . . . 0.72999999999999998 111.645 -174.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 5.8 p -56.04 -39.18 71.59 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 119.348 0.976 . . . . 2.4300000000000002 109.7 168.316 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.573 ' HB1' HG21 ' A' ' 39' ' ' VAL . . . -50.32 -23.28 2.22 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.869 1.267 . . . . 0.41999999999999998 113.9 171.238 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -72.09 -47.14 53.55 Favored 'General case' 0 N--CA 1.453 -0.3 0 O-C-N 120.447 -1.408 . . . . 0.37 110.133 171.41 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -57.98 -36.56 72.77 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-O 118.961 -0.543 . . . . 4.1900000000000004 110.612 -174.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.573 ' HA ' HD13 ' A' ' 67' ' ' LEU . 2.6 pt -59.68 -55.45 23.82 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.203 0 C-N-CA 119.578 -0.849 . . . . 0.56000000000000005 110.67 178.458 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -57.49 -47.03 82.98 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 123.286 0.634 . . . . 3.2799999999999998 111.294 178.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 14.7 mptt -66.61 -45.86 77.77 Favored 'General case' 0 CA--C 1.532 0.273 0 O-C-N 121.62 -0.675 . . . . 1.73 109.864 -176.192 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -67.75 -23.87 74.07 Favored Glycine 0 CA--C 1.527 0.795 0 CA-C-O 119.04 -0.867 . . . . 0.66000000000000003 111.957 176.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -73.57 -41.23 63.19 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.715 1.206 . . . . 2.4300000000000002 109.753 170.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 2.1 ttpp -56.71 -16.39 6.29 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.78 1.632 . . . . 2.9199999999999999 113.86 178.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.4 mmt180 -83.33 -7.44 59.58 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 126.547 1.939 . . . . 3.6800000000000002 112.338 176.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 96.1 mmm -77.99 150.89 78.59 Favored Pre-proline 0 C--O 1.233 0.209 0 CA-C-N 119.226 0.921 . . . . 3.1800000000000002 111.35 -179.133 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -56.56 135.37 69.97 Favored 'Trans proline' 0 N--CA 1.45 -1.064 0 C-N-CA 121.953 1.769 . . . . 0.59999999999999998 108.973 171.225 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 89.12 -9.66 76.0 Favored Glycine 0 CA--C 1.525 0.716 0 CA-C-O 118.079 -1.401 . . . . 0.54000000000000004 113.738 178.081 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 23.4 t -103.78 122.66 56.75 Favored 'Isoleucine or valine' 0 C--N 1.342 0.269 0 CA-C-N 120.349 2.074 . . . . 0.60999999999999999 109.636 176.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -89.38 -55.41 3.67 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-O 118.611 -0.709 . . . . 1.3200000000000001 109.151 177.127 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -139.61 156.97 46.55 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 118.875 0.761 . . . . 2.6099999999999999 110.425 -175.413 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -155.6 143.75 20.02 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 122.99 0.516 . . . . 0.41999999999999998 111.164 -174.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -155.35 114.39 3.58 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 109.531 -0.544 . . . . 0.58999999999999997 109.531 -165.576 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.573 HG21 ' HB1' ' A' ' 21' ' ' ALA . 4.0 p -81.25 116.7 25.99 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 N-CA-C 108.697 -0.853 . . . . 0.55000000000000004 108.697 175.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 50.1 t-20 -96.15 57.61 1.76 Allowed 'General case' 0 C--O 1.236 0.378 0 CA-C-O 122.961 1.362 . . . . 0.60999999999999999 107.869 177.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.402 HD23 HG22 ' A' ' 39' ' ' VAL . 0.2 OUTLIER -69.35 -18.47 63.8 Favored 'General case' 0 C--O 1.225 -0.203 0 CA-C-N 114.265 -1.334 . . . . 0.95999999999999996 110.419 -173.584 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -46.56 -31.14 2.61 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 124.072 0.949 . . . . 0.56999999999999995 112.502 169.045 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 6.1 t -129.59 33.4 4.48 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 122.787 0.435 . . . . 1.27 110.007 173.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 25.6 mp0 57.17 29.97 17.55 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.02 1.328 . . . . 3.6400000000000001 113.279 175.206 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 62.0 m -118.39 159.62 23.13 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.47 1.108 . . . . 0.68999999999999995 109.241 -176.136 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.6 p -128.72 143.75 40.16 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 O-C-N 121.21 -0.931 . . . . 0.33000000000000002 108.71 171.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -132.85 128.74 37.33 Favored 'General case' 0 C--N 1.342 0.263 0 N-CA-C 108.125 -1.065 . . . . 0.41999999999999998 108.125 -178.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 4.7 p -129.82 128.23 65.01 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.595 0 N-CA-C 106.054 -1.832 . . . . 1.75 106.054 -172.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 11.2 mm -105.27 88.65 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 C-N-CA 125.653 1.581 . . . . 0.42999999999999999 107.168 -174.336 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 31.3 p90 -125.8 175.3 7.73 Favored 'General case' 0 CA--C 1.512 -0.493 0 O-C-N 122.106 -0.371 . . . . 1.72 110.059 -173.012 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -102.43 100.61 16.31 Favored Pre-proline 0 N--CA 1.445 -0.693 0 C-N-CA 125.197 1.399 . . . . 4.2000000000000002 108.688 -176.309 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_endo -72.01 14.39 0.44 Allowed 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 122.288 1.992 . . . . 0.60999999999999999 113.911 -176.085 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -81.77 -30.96 32.12 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 108.92 -0.77 . . . . 0.81999999999999995 108.92 162.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -114.26 -62.61 1.57 Allowed 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 123.769 0.828 . . . . 3.77 108.856 -166.678 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.468 0.6 OUTLIER -77.11 -179.25 5.47 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 114.985 1.476 . . . . 0.51000000000000001 114.985 162.483 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 179.99 -150.32 9.13 Favored Glycine 0 N--CA 1.431 -1.7 1 N-CA-C 102.717 -4.153 . . . . 2.54 102.717 -172.46 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 20.7 p -72.54 -36.75 68.34 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 124.569 1.148 . . . . 1.3200000000000001 108.75 175.385 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -42.07 -63.05 0.8 Allowed 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 126.136 1.775 . . . . 0.55000000000000004 113.409 -171.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -72.0 -38.79 69.59 Favored 'General case' 0 CA--C 1.515 -0.378 0 C-N-CA 118.483 -1.287 . . . . 0.62 109.032 -170.169 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.3 mp -54.46 -55.93 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.931 0 CA-C-N 115.014 -0.994 . . . . 0.77000000000000002 109.663 178.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.2 -46.08 85.49 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 119.094 0.861 . . . . 1.1299999999999999 109.991 -176.481 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -47.54 -57.58 5.25 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 122.664 1.221 . . . . 2.6299999999999999 110.676 175.573 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 11.5 mmmt -68.3 -37.26 80.44 Favored 'General case' 0 N--CA 1.437 -1.121 0 CA-C-N 115.409 -0.814 . . . . 3.77 111.974 -177.122 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.3 mm -52.34 -53.08 20.96 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 N-CA-C 107.937 -1.134 . . . . 0.38 107.937 176.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 21.1 mm-40 -59.32 -56.58 20.22 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.702 0.801 . . . . 1.9299999999999999 110.404 176.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 5.8 mmmt -54.81 -37.28 65.91 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 113.29 0.848 . . . . 4.7000000000000002 113.29 -178.482 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.573 HD13 ' HA ' ' A' ' 24' ' ' ILE . 11.4 mt -71.14 -18.15 62.52 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.542 1.137 . . . . 0.65000000000000002 111.883 175.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 93.58 44.17 3.76 Favored Glycine 0 CA--C 1.525 0.659 0 C-N-CA 124.581 1.086 . . . . 0.41999999999999998 110.799 176.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.459 ' CD1' HG21 ' A' ' 24' ' ' ILE . 0.3 OUTLIER -139.98 172.85 12.18 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 124.033 0.933 . . . . 1.8100000000000001 110.588 -176.635 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -139.98 118.04 11.87 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 109.086 -0.709 . . . . 1.8999999999999999 109.086 173.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 5.7 p -91.49 147.74 5.07 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 N-CA-C 107.892 -1.151 . . . . 1.3999999999999999 107.892 172.058 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 41.2 t -123.26 141.52 43.26 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.102 0 C-N-CA 124.574 1.15 . . . . 0.60999999999999999 108.691 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 4.8 mp . . . . . 0 CA--C 1.532 0.273 0 C-N-CA 124.052 0.941 . . . . 1.3600000000000001 108.47 -173.353 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 11.5 m . . . . . 0 N--CA 1.448 -0.559 0 N-CA-C 108.457 -0.942 . . . . 0.89000000000000001 108.457 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -72.24 165.47 24.37 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 108.918 -0.771 . . . . 2.7200000000000002 108.918 163.342 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -124.02 151.9 43.21 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 124.91 1.284 . . . . 1.0900000000000001 111.02 -177.2 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.3 mmpt? -137.81 157.12 47.1 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 122.938 0.495 . . . . 4.0599999999999996 110.22 165.26 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -104.24 97.95 7.83 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 127.799 2.439 . . . . 1.9199999999999999 106.28 177.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 10.0 mm -87.01 160.02 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.258 0 N-CA-C 107.378 -1.342 . . . . 2.1200000000000001 107.378 177.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -131.5 139.03 49.21 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 125.71 1.604 . . . . 0.47999999999999998 107.566 178.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 12.5 ptp -156.43 175.19 14.34 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.129 0.571 . . . . 1.8700000000000001 110.132 179.059 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 29.9 mm100 -99.44 162.57 12.96 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 125.265 1.426 . . . . 2.4700000000000002 109.545 179.057 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.425 HG13 HG11 ' A' ' 46' ' ' VAL . 0.0 OUTLIER -130.54 157.08 42.93 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.146 0 C-N-CA 124.343 1.057 . . . . 2.0699999999999998 110.261 176.499 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 62.0 m -146.4 164.7 31.61 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 124.465 1.106 . . . . 0.94999999999999996 109.343 177.109 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 70.53 68.37 1.65 Allowed Glycine 0 CA--C 1.526 0.756 0 N-CA-C 110.02 -1.232 . . . . 1.52 110.02 179.49 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -144.82 165.27 28.58 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 123.723 0.809 . . . . 1.7 110.065 -178.312 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.1 p -113.88 -72.1 0.72 Allowed 'General case' 0 CA--C 1.527 0.068 0 C-N-CA 124.438 1.095 . . . . 2.3700000000000001 108.939 168.29 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 14.4 p -105.82 152.22 23.51 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 121.781 0.801 . . . . 2.0899999999999999 112.023 -173.371 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -75.54 54.5 0.76 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.379 1.072 . . . . 1.9399999999999999 110.527 176.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -146.87 -49.09 0.19 Allowed 'General case' 0 CA--C 1.526 0.045 0 C-N-CA 123.774 0.829 . . . . 0.87 110.597 -179.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 61.9 m -56.99 -36.89 70.91 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 118.67 0.668 . . . . 1.26 110.638 172.657 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.77 ' HB1' HG21 ' A' ' 39' ' ' VAL . . . -50.3 -26.71 5.1 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.758 0.823 . . . . 0.40999999999999998 112.595 171.65 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.45 -48.24 50.63 Favored 'General case' 0 N--CA 1.452 -0.328 0 O-C-N 120.162 -1.586 . . . . 0.37 109.204 174.017 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 61.7 mtt85 -54.36 -42.86 70.77 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 123.542 0.737 . . . . 5.2000000000000002 109.885 -175.249 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.488 HG21 ' CD1' ' A' ' 69' ' ' TYR 0.258 2.1 pt -58.56 -57.8 9.41 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 C-N-CA 120.044 -0.662 . . . . 0.5 110.478 177.478 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -53.1 -40.28 64.0 Favored 'General case' 0 C--O 1.224 -0.28 0 CA-C-N 118.839 0.745 . . . . 2.1899999999999999 111.632 178.248 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 4.1 mptp? -71.32 -48.31 51.33 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 119.446 1.021 . . . . 1.6699999999999999 111.041 -177.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -60.87 -36.43 92.01 Favored Glycine 0 CA--C 1.529 0.962 0 N-CA-C 110.897 -0.881 . . . . 0.56000000000000005 110.897 175.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 8.4 tt -62.54 -49.49 75.1 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 124.739 1.216 . . . . 1.8300000000000001 107.971 175.082 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -57.14 -22.77 42.52 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 124.582 1.153 . . . . 3.4100000000000001 113.062 178.816 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.7 mmt180 -72.65 -10.99 60.45 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.956 0.902 . . . . 3.4700000000000002 112.309 175.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . 0.45 ' CE ' ' HB3' ' A' ' 59' ' ' ALA . 3.1 ptt? -75.79 153.64 85.14 Favored Pre-proline 0 CA--C 1.533 0.302 0 CA-C-N 119.071 0.85 . . . . 4.7599999999999998 111.692 -179.358 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -60.86 136.08 63.76 Favored 'Trans proline' 0 N--CA 1.451 -0.995 0 C-N-CA 121.589 1.526 . . . . 0.77000000000000002 108.972 172.135 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 100.15 -28.79 14.06 Favored Glycine 0 CA--C 1.53 1.003 0 CA-C-O 118.504 -1.164 . . . . 0.68000000000000005 112.978 177.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 24.8 t -95.52 123.16 47.57 Favored 'Isoleucine or valine' 0 C--N 1.346 0.422 0 CA-C-N 119.62 1.71 . . . . 0.68999999999999995 111.185 176.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 86.9 m -90.32 -53.65 4.36 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-O 117.858 -1.068 . . . . 1.2 110.378 -179.007 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -135.97 158.11 45.2 Favored 'General case' 0 C--N 1.343 0.318 0 CA-C-N 119.576 1.08 . . . . 2.4500000000000002 110.698 177.235 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -156.91 148.17 22.11 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 114.38 1.252 . . . . 0.47999999999999998 114.38 177.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -155.15 113.19 3.44 Favored 'General case' 0 C--N 1.344 0.365 0 N-CA-C 107.241 -1.392 . . . . 0.48999999999999999 107.241 -162.328 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.77 HG21 ' HB1' ' A' ' 21' ' ' ALA . 6.4 p -82.36 114.68 23.62 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 N-CA-C 108.952 -0.758 . . . . 0.52000000000000002 108.952 178.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -94.05 57.93 2.48 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 122.994 1.378 . . . . 2.0600000000000001 108.718 -178.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.69 HD23 HG22 ' A' ' 39' ' ' VAL . 0.2 OUTLIER -66.85 -17.54 64.94 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 114.361 -1.291 . . . . 0.85999999999999999 111.094 -177.342 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -41.29 -39.7 1.46 Allowed 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 124.901 1.28 . . . . 0.67000000000000004 112.747 168.605 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 9.1 t -127.43 35.88 4.47 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 117.666 0.212 . . . . 1.24 110.621 172.094 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 61.54 36.23 17.04 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.462 1.105 . . . . 4.3700000000000001 113.195 173.162 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 4.8 m -123.5 161.21 25.33 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.051 1.34 . . . . 0.73999999999999999 109.369 -176.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.425 HG11 HG13 ' A' ' 12' ' ' VAL . 0.8 OUTLIER -127.68 144.18 38.35 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 C-N-CA 124.423 1.089 . . . . 0.64000000000000001 108.417 172.898 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -131.83 145.04 51.33 Favored 'General case' 0 C--N 1.347 0.491 0 N-CA-C 108.327 -0.99 . . . . 0.45000000000000001 108.327 177.108 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 5.4 p -145.46 125.24 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 N-CA-C 106.642 -1.614 . . . . 1.79 106.642 -172.262 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 9.6 mm -105.79 83.53 0.72 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.49 0 C-N-CA 126.286 1.834 . . . . 0.46000000000000002 106.984 -171.029 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 51.6 p90 -119.56 175.9 5.62 Favored 'General case' 0 CA--C 1.506 -0.731 0 N-CA-C 109.197 -0.668 . . . . 1.97 109.197 -172.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -101.65 95.26 5.07 Favored Pre-proline 0 N--CA 1.443 -0.78 0 O-C-N 124.813 1.321 . . . . 4.2999999999999998 110.199 -176.263 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -74.49 14.7 0.74 Allowed 'Trans proline' 0 CA--C 1.537 0.661 0 C-N-CA 122.833 2.355 . . . . 0.93999999999999995 113.56 -173.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -89.09 -21.79 23.21 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 124.021 0.928 . . . . 1.48 109.5 166.117 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -113.63 -62.19 1.63 Allowed 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 125.212 1.405 . . . . 3.52 107.723 -175.497 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.285 0.7 OUTLIER -82.62 -179.75 7.53 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 115.223 1.564 . . . . 0.78000000000000003 115.223 170.319 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -163.53 -128.42 0.95 Allowed Glycine 0 N--CA 1.434 -1.496 0 N-CA-C 104.164 -3.574 . . . . 2.5899999999999999 104.164 175.525 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 18.3 p -81.82 -30.54 32.14 Favored 'General case' 0 C--N 1.318 -0.792 0 C-N-CA 126.874 2.07 . . . . 1.3400000000000001 110.636 172.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -53.2 -62.44 1.65 Allowed 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 124.327 1.051 . . . . 0.62 112.769 -157.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.45 ' HB3' ' CE ' ' A' ' 31' ' ' MET . . . -75.14 -24.58 57.99 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 113.931 -1.486 . . . . 0.77000000000000002 110.285 -172.644 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.5 mt -66.85 -49.16 76.68 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 C-N-CA 124.341 1.056 . . . . 1.3 109.576 -178.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.18 -43.94 93.55 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 107.806 -1.183 . . . . 1.9299999999999999 107.806 -177.501 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -48.5 -59.64 3.32 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 123.833 0.853 . . . . 2.7599999999999998 111.032 172.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 10.3 mmtp -60.65 -42.37 96.83 Favored 'General case' 0 N--CA 1.441 -0.912 0 O-C-N 121.712 -0.617 . . . . 3.0600000000000001 111.716 -178.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -48.82 -54.69 4.57 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 C-N-CA 125.007 1.323 . . . . 0.44 108.745 176.345 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 29.5 mm-40 -60.9 -53.85 52.3 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 123.481 0.712 . . . . 1.9099999999999999 110.197 178.274 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -56.15 -38.41 70.82 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 112.668 0.618 . . . . 4.2000000000000002 112.668 -176.382 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 15.9 mt -69.98 -17.06 63.27 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.617 1.167 . . . . 0.67000000000000004 111.911 176.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 92.86 41.36 4.69 Favored Glycine 0 CA--C 1.522 0.513 0 N-CA-C 110.73 -0.948 . . . . 0.51000000000000001 110.73 175.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.488 ' CD1' HG21 ' A' ' 24' ' ' ILE . 0.2 OUTLIER -133.81 175.3 9.58 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 123.672 0.789 . . . . 2.1000000000000001 110.145 178.993 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 4.2 t60 -139.34 143.73 37.93 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 109.162 -0.681 . . . . 1.71 109.162 170.276 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 12.4 p -112.84 150.07 15.11 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 C-N-CA 126.385 1.874 . . . . 1.9299999999999999 107.987 -175.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 13.5 t -132.33 147.67 32.05 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 C-N-CA 124.283 1.033 . . . . 0.56000000000000005 108.301 -179.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 4.6 mp . . . . . 0 N--CA 1.449 -0.501 0 C-N-CA 124.609 1.163 . . . . 1.45 108.567 179.98 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.4 m . . . . . 0 N--CA 1.456 -0.171 0 N-CA-C 106.077 -1.823 . . . . 0.68999999999999995 106.077 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -70.82 173.75 6.93 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 107.774 -1.195 . . . . 2.1000000000000001 107.774 163.33 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -129.3 151.53 49.85 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 123.491 0.717 . . . . 1.7 109.099 172.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 69.6 mmtt -140.92 157.72 44.97 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.213 1.005 . . . . 3.1800000000000002 111.07 166.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -116.21 91.79 3.7 Favored 'General case' 0 N--CA 1.435 -1.181 0 C-N-CA 128.226 2.61 . . . . 1.46 106.61 -168.442 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 8.0 mm -82.41 158.48 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.261 0 N-CA-C 106.977 -1.49 . . . . 1.9399999999999999 106.977 -178.178 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -131.44 139.01 49.29 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 107.093 -1.447 . . . . 0.62 107.093 172.112 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -155.43 176.28 12.79 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 122.992 0.517 . . . . 1.8200000000000001 109.738 170.541 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 27.4 mm100 -95.35 165.37 12.41 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.627 1.171 . . . . 2.6099999999999999 110.152 -178.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 31.6 t -128.44 132.19 68.26 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 C-N-CA 124.597 1.159 . . . . 1.1599999999999999 109.804 -174.111 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 32.9 m -117.74 176.29 5.26 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 125.195 1.398 . . . . 0.89000000000000001 109.348 169.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 82.15 -44.88 3.23 Favored Glycine 0 CA--C 1.53 0.994 0 O-C-N 121.553 -0.717 . . . . 2.2400000000000002 111.603 178.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -44.52 142.18 1.71 Allowed 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 124.121 0.968 . . . . 2.27 112.691 176.066 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -147.71 -45.71 0.16 Allowed 'General case' 0 CA--C 1.53 0.173 0 C-N-CA 124.559 1.144 . . . . 3.2400000000000002 110.432 171.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 24.3 p -71.16 -16.58 62.54 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 112.616 0.599 . . . . 3.04 112.616 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 59.97 28.32 17.82 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.808 1.243 . . . . 2.0499999999999998 112.209 -179.193 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -130.66 -51.9 1.07 Allowed 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 124.609 1.164 . . . . 0.90000000000000002 110.252 -179.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 52.5 m -51.06 -31.68 19.49 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 125.145 1.378 . . . . 1.6399999999999999 112.548 172.174 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.5 -26.38 31.14 Favored 'General case' 0 CA--C 1.539 0.548 0 O-C-N 121.885 -0.509 . . . . 0.40999999999999998 111.865 173.302 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.02 -46.4 62.2 Favored 'General case' 0 N--CA 1.454 -0.248 0 O-C-N 120.304 -1.497 . . . . 0.38 110.638 169.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 8.9 mtt85 -51.68 -44.69 63.17 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-O 119.171 -0.443 . . . . 3.6600000000000001 110.346 -177.257 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.425 HG21 ' CD1' ' A' ' 69' ' ' TYR 0.262 2.3 pt -59.76 -55.4 24.2 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.201 0 C-N-CA 119.642 -0.823 . . . . 0.64000000000000001 111.217 -178.954 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -55.67 -42.63 75.38 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-N 118.693 0.679 . . . . 2.1600000000000001 112.08 177.454 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -70.88 -46.84 61.88 Favored 'General case' 0 CA--C 1.533 0.294 0 O-C-N 121.68 -0.637 . . . . 1.8200000000000001 110.078 -175.158 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -58.38 -44.38 95.23 Favored Glycine 0 CA--C 1.527 0.815 0 N-CA-C 110.127 -1.189 . . . . 0.72999999999999998 110.127 173.35 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -61.65 -43.14 99.41 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.688 0.795 . . . . 2.3900000000000001 109.486 -179.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 7.3 ttmt -51.98 -29.87 22.47 Favored 'General case' 0 CA--C 1.531 0.237 0 O-C-N 121.036 -1.04 . . . . 2.77 111.595 173.638 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.84 -0.75 19.45 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-O 118.065 -0.969 . . . . 4.4100000000000001 113.352 -175.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 93.8 mmm -89.05 152.7 48.57 Favored Pre-proline 0 CA--C 1.535 0.393 0 C-N-CA 126.738 2.015 . . . . 3.5 111.164 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -60.08 138.92 84.87 Favored 'Trans proline' 0 N--CA 1.453 -0.901 0 C-N-CA 122.236 1.958 . . . . 0.73999999999999999 109.547 175.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 97.29 -30.99 8.2 Favored Glycine 0 CA--C 1.523 0.588 0 CA-C-O 119.0 -0.889 . . . . 0.47999999999999998 112.536 179.478 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 16.3 t -92.04 140.19 16.59 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.212 0 CA-C-N 119.241 1.521 . . . . 0.62 109.114 -179.103 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -119.43 -42.79 2.64 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 118.273 -0.87 . . . . 0.98999999999999999 111.129 179.798 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -138.73 161.85 36.15 Favored 'General case' 0 CA--C 1.518 -0.278 0 CA-C-N 119.838 1.199 . . . . 2.1299999999999999 111.433 171.693 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -157.68 138.94 13.56 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 123.125 0.57 . . . . 0.47999999999999998 111.018 -175.467 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -150.13 102.61 3.11 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 106.7 -1.593 . . . . 0.67000000000000004 106.7 -163.057 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 10.4 p -82.13 107.0 13.68 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 CA-C-O 121.252 0.549 . . . . 0.60999999999999999 110.498 -179.201 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 48.9 t30 -84.43 56.82 3.97 Favored 'General case' 0 CA--C 1.537 0.476 0 O-C-N 120.567 -1.333 . . . . 0.93000000000000005 109.992 179.531 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.418 HD22 ' HA ' ' A' ' 41' ' ' LEU . 0.4 OUTLIER -74.93 -16.1 60.66 Favored 'General case' 0 N--CA 1.461 0.101 0 CA-C-N 115.446 -0.797 . . . . 0.92000000000000004 110.422 176.706 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -45.64 -37.37 5.62 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.742 0.817 . . . . 1.27 111.396 167.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 15.0 t -98.54 -68.48 0.8 Allowed 'General case' 0 C--N 1.344 0.329 0 CA-C-O 117.703 -1.141 . . . . 3.5600000000000001 110.198 165.512 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 159.93 43.55 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 127.61 2.364 . . . . 2.8599999999999999 110.864 -176.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 79.7 m -142.64 162.4 35.56 Favored 'General case' 0 CA--C 1.534 0.333 0 O-C-N 120.464 -1.397 . . . . 0.83999999999999997 108.805 -171.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.4 p -125.75 145.92 32.36 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 O-C-N 121.232 -0.917 . . . . 0.45000000000000001 108.981 172.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -127.79 143.51 51.12 Favored 'General case' 0 C--N 1.345 0.38 0 N-CA-C 108.017 -1.105 . . . . 0.46999999999999997 108.017 170.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.2 p -140.41 127.11 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 N-CA-C 107.226 -1.398 . . . . 1.74 107.226 -176.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 18.5 mm -103.5 90.05 1.58 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.604 0 C-N-CA 125.935 1.694 . . . . 0.51000000000000001 107.107 -173.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 6.8 p90 -128.82 166.42 19.09 Favored 'General case' 0 CA--C 1.508 -0.669 0 CA-C-O 121.452 0.644 . . . . 1.7 111.751 -174.285 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -96.04 108.99 44.5 Favored Pre-proline 0 N--CA 1.444 -0.736 0 CA-C-N 114.172 -1.376 . . . . 4.2199999999999998 109.187 -172.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -73.45 13.97 0.66 Allowed 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 123.009 2.473 . . . . 0.85999999999999999 112.99 -173.523 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -85.23 -35.47 21.57 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 123.823 0.849 . . . . 1.3100000000000001 108.728 166.294 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -109.99 -54.36 2.57 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 108.638 -0.875 . . . . 3.1800000000000002 108.638 -168.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.571 HG22 ' HB3' ' A' ' 59' ' ' ALA 0.314 0.9 OUTLIER -86.56 -173.98 4.77 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-O 121.037 0.446 . . . . 0.56999999999999995 111.674 162.594 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 128.88 88.64 0.56 Allowed Glycine 0 N--CA 1.442 -0.948 0 N-CA-C 103.702 -3.759 . . . . 2.3599999999999999 103.702 -150.379 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 26.5 p -13.75 -18.41 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.499 1 C-N-CA 138.735 6.814 . . . . 1.1699999999999999 119.748 -146.434 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -28.12 -63.36 0.1 Allowed 'General case' 0 N--CA 1.441 -0.877 0 C-N-CA 126.857 2.063 . . . . 0.5 113.841 164.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.571 ' HB3' HG22 ' A' ' 55' ' ' THR . . . -72.02 -41.1 67.94 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 118.098 -1.441 . . . . 0.47999999999999998 109.164 -167.431 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.5 mp -52.32 -54.72 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.845 0 CA-C-N 114.303 -1.317 . . . . 0.85999999999999999 109.146 175.578 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.55 -45.7 85.99 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 118.963 0.801 . . . . 1.6899999999999999 109.294 -175.393 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -52.12 -53.37 43.49 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 122.396 1.093 . . . . 2.9300000000000002 110.27 178.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.414 ' HA ' ' CE ' ' A' ' 63' ' ' LYS . 1.2 mmpt? -70.71 -37.54 73.57 Favored 'General case' 0 N--CA 1.432 -1.363 0 CA-C-O 118.233 -0.889 . . . . 2.4900000000000002 112.369 -177.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.5 mm -47.61 -51.65 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 C-N-CA 124.66 1.184 . . . . 0.40000000000000002 108.233 177.088 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -54.0 -60.31 3.5 Favored 'General case' 0 C--N 1.34 0.182 0 C-N-CA 123.625 0.77 . . . . 2.5499999999999998 110.781 174.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -63.71 -29.52 70.73 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 112.679 0.622 . . . . 5.2000000000000002 112.679 -172.241 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 23.8 mt -70.03 -18.35 63.3 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.425 1.49 . . . . 0.75 111.02 172.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 95.32 39.07 4.59 Favored Glycine 0 CA--C 1.524 0.645 0 C-N-CA 124.959 1.266 . . . . 0.39000000000000001 110.937 175.319 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.425 ' CD1' HG21 ' A' ' 24' ' ' ILE . 0.7 OUTLIER -137.74 175.43 9.59 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.605 0.762 . . . . 2.0299999999999998 111.863 -173.104 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 4.3 t-80 -152.08 111.68 3.96 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 125.008 1.323 . . . . 2.3900000000000001 107.495 -176.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 3.6 m -82.96 160.99 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.239 0 N-CA-C 108.877 -0.786 . . . . 2.3599999999999999 108.877 169.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 21.6 t -122.96 142.12 40.74 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 N-CA-C 108.468 -0.938 . . . . 0.70999999999999996 108.468 176.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 45.4 mm . . . . . 0 N--CA 1.452 -0.353 0 C-N-CA 125.277 1.431 . . . . 1.25 108.164 -175.69 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 25.1 m . . . . . 0 N--CA 1.45 -0.44 0 N-CA-C 106.499 -1.667 . . . . 0.89000000000000001 106.499 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -77.01 179.74 6.05 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 108.817 -0.808 . . . . 2.3599999999999999 108.817 160.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -135.38 147.79 49.17 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 106.693 -1.595 . . . . 1.45 106.693 166.576 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 20.0 mmtp -140.53 156.05 46.43 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 123.343 0.657 . . . . 3.5499999999999998 109.921 165.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -108.06 99.14 8.6 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 128.011 2.524 . . . . 1.9099999999999999 107.615 -174.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.9 mm -82.97 157.44 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.98 0 N-CA-C 107.205 -1.405 . . . . 1.8899999999999999 107.205 177.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -135.66 129.99 33.63 Favored 'General case' 0 C--O 1.231 0.112 0 C-N-CA 124.606 1.162 . . . . 0.45000000000000001 107.893 178.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 10.0 ptt? -156.16 175.54 13.84 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.019 0.528 . . . . 2.6600000000000001 110.485 -176.015 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -101.2 162.16 13.1 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 127.505 2.322 . . . . 3.77 110.701 -177.787 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 46.1 t -119.34 144.86 26.54 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 C-N-CA 124.436 1.094 . . . . 1.3500000000000001 109.316 -176.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 41.3 t -135.72 175.61 9.44 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.767 1.227 . . . . 2.4100000000000001 109.153 173.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 51.66 58.16 10.79 Favored Glycine 0 CA--C 1.529 0.917 0 C-N-CA 124.661 1.124 . . . . 1.6799999999999999 111.254 -175.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -134.41 150.64 50.89 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 123.634 0.773 . . . . 1.6899999999999999 110.827 -172.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -99.62 -57.21 2.2 Favored 'General case' 0 CA--C 1.528 0.113 0 C-N-CA 125.23 1.412 . . . . 2.3900000000000001 111.204 169.22 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 20.8 p -144.29 165.44 27.89 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 121.808 0.813 . . . . 2.3500000000000001 111.941 -169.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -75.64 54.26 0.77 Allowed 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.209 1.404 . . . . 2.0 110.746 178.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -147.62 -58.53 0.26 Allowed 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 124.373 1.069 . . . . 0.85999999999999999 108.709 177.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 26.8 m -57.15 -40.98 78.29 Favored 'General case' 0 CA--C 1.53 0.186 0 O-C-N 121.994 -0.441 . . . . 1.4399999999999999 110.168 176.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.23 -21.03 7.98 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.801 0.84 . . . . 0.55000000000000004 113.032 174.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.515 ' HA ' HG11 ' A' ' 39' ' ' VAL . . . -72.44 -47.37 49.55 Favored 'General case' 0 N--CA 1.453 -0.298 0 O-C-N 120.667 -1.271 . . . . 0.47999999999999998 110.793 170.545 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 54.4 mmm-85 -53.37 -44.65 68.77 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 109.77 -0.456 . . . . 4.3700000000000001 109.77 -172.129 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.501 ' HA ' HD13 ' A' ' 67' ' ' LEU . 3.5 pt -57.85 -54.02 37.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 CA-C-O 118.69 -0.672 . . . . 0.55000000000000004 110.5 178.333 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -57.14 -40.73 77.74 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.797 0.839 . . . . 2.3799999999999999 112.133 179.452 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 31.9 mmtp -70.7 -43.98 67.87 Favored 'General case' 0 CA--C 1.534 0.358 0 O-C-N 121.414 -0.804 . . . . 1.9199999999999999 110.552 -178.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -63.74 -38.68 96.55 Favored Glycine 0 CA--C 1.53 1.019 0 N-CA-C 110.931 -0.868 . . . . 0.51000000000000001 110.931 173.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.47 HD23 ' C ' ' A' ' 28' ' ' LEU . 4.8 tt -60.51 -41.54 94.57 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 125.462 1.505 . . . . 1.8500000000000001 109.512 176.774 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 10.7 ttmt -54.41 -23.37 15.55 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 112.592 0.59 . . . . 2.79 112.592 173.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.82 -2.58 24.2 Favored 'General case' 0 CA--C 1.542 0.659 0 O-C-N 121.285 -0.884 . . . . 3.6600000000000001 112.19 177.634 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . 0.415 ' SD ' ' HB1' ' A' ' 59' ' ' ALA . 9.9 mmt -69.78 152.0 96.22 Favored Pre-proline 0 CA--C 1.532 0.273 0 CA-C-N 119.42 1.009 . . . . 3.2799999999999998 111.689 173.054 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -58.22 141.08 96.43 Favored 'Trans proline' 0 N--CA 1.452 -0.932 0 C-N-CA 122.005 1.803 . . . . 0.93999999999999995 109.47 170.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 86.13 -27.31 5.62 Favored Glycine 0 CA--C 1.524 0.616 0 CA-C-O 119.436 -0.647 . . . . 0.75 113.849 178.295 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 13.7 t -82.57 127.02 40.05 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 CA-C-N 118.777 1.289 . . . . 0.52000000000000002 108.693 -179.178 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.9 m -110.53 -37.26 5.53 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-O 118.601 -0.714 . . . . 0.85999999999999999 110.889 -175.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -148.53 166.94 26.71 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 119.253 0.933 . . . . 1.8400000000000001 110.038 170.333 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -157.25 148.81 22.17 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 123.481 0.712 . . . . 0.57999999999999996 110.507 -175.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -154.46 110.28 3.19 Favored 'General case' 0 CA--C 1.529 0.161 0 N-CA-C 108.437 -0.949 . . . . 0.58999999999999997 108.437 -165.258 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.515 HG11 ' HA ' ' A' ' 22' ' ' ALA . 4.7 p -88.44 93.87 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 C-N-CA 124.142 0.977 . . . . 0.81000000000000005 110.37 -178.146 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 52.5 t-20 -82.79 56.79 3.53 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 120.475 -1.391 . . . . 0.60999999999999999 110.224 -178.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.436 HD23 ' CG2' ' A' ' 39' ' ' VAL . 0.3 OUTLIER -67.01 -21.34 65.95 Favored 'General case' 0 C--O 1.227 -0.097 0 C-N-CA 123.677 0.791 . . . . 0.89000000000000001 110.33 179.907 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -48.26 -33.78 9.29 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.626 0.77 . . . . 0.63 112.144 170.151 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 3.4 t -121.97 27.66 7.96 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 118.026 0.375 . . . . 1.26 110.424 174.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 47.55 58.47 4.92 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 124.824 1.25 . . . . 3.0699999999999998 111.616 -178.096 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 33.2 m -145.44 164.28 32.05 Favored 'General case' 0 N--CA 1.44 -0.927 0 O-C-N 120.713 -1.242 . . . . 0.67000000000000004 107.716 175.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.9 p -139.47 145.01 27.7 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 N-CA-C 108.71 -0.848 . . . . 0.47999999999999998 108.71 174.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 19.5 m120 -131.8 139.45 48.89 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 124.407 1.083 . . . . 0.27000000000000002 108.481 -176.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 22.3 t -133.59 129.53 55.73 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 N-CA-C 105.796 -1.927 . . . . 2.1200000000000001 105.796 -178.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 13.6 mm -105.99 95.23 3.63 Favored 'Isoleucine or valine' 0 C--O 1.24 0.585 0 C-N-CA 124.946 1.298 . . . . 0.44 107.583 -174.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 10.8 p90 -131.95 164.48 26.05 Favored 'General case' 0 CA--C 1.513 -0.446 0 O-C-N 122.03 -0.419 . . . . 2.0499999999999998 111.955 -172.172 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 30.9 t0 -81.46 110.78 20.53 Favored Pre-proline 0 CA--C 1.534 0.365 0 O-C-N 124.392 1.057 . . . . 2.8700000000000001 110.134 172.584 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -73.09 5.97 2.79 Favored 'Trans proline' 0 N--CA 1.452 -0.96 0 C-N-CA 123.007 2.472 . . . . 0.56999999999999995 113.124 -178.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -87.79 -34.09 18.41 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 119.493 1.042 . . . . 0.75 108.797 169.268 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -99.03 -60.47 1.53 Allowed 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 108.687 -0.857 . . . . 3.0099999999999998 108.687 -174.417 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.566 HG22 ' HB3' ' A' ' 59' ' ' ALA 0.345 0.6 OUTLIER -83.53 -174.86 5.53 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 123.807 0.843 . . . . 0.48999999999999999 112.229 162.05 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 126.37 94.95 0.94 Allowed Glycine 0 N--CA 1.442 -0.909 0 N-CA-C 103.913 -3.675 . . . . 2.2000000000000002 103.913 -144.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 68.6 p -14.31 -23.52 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.383 1 C-N-CA 138.161 6.584 . . . . 1.04 119.169 -151.749 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -27.47 -62.74 0.09 Allowed 'General case' 0 N--CA 1.443 -0.787 0 C-N-CA 127.177 2.191 . . . . 0.53000000000000003 113.532 167.222 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.566 ' HB3' HG22 ' A' ' 55' ' ' THR . . . -74.54 -39.55 62.25 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 118.732 -1.187 . . . . 0.5 109.72 -166.741 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.2 mp -54.68 -57.67 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.026 0 CA-C-N 113.687 -1.597 . . . . 0.94999999999999996 109.399 176.397 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -60.76 -43.28 98.22 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 118.093 0.406 . . . . 1.46 109.923 -174.482 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -46.86 -58.82 3.54 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.15 0.58 . . . . 2.7400000000000002 111.41 171.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 3.4 mmpt? -65.44 -42.82 92.01 Favored 'General case' 0 N--CA 1.442 -0.84 0 O-C-N 121.705 -0.622 . . . . 2.3500000000000001 112.331 -179.304 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -47.1 -54.11 2.86 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 C-N-CA 125.403 1.481 . . . . 0.65000000000000002 107.795 178.11 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -60.54 -57.54 12.29 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 124.559 1.144 . . . . 1.6799999999999999 110.633 177.048 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 11.7 mptt -59.66 -31.41 69.52 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 112.795 0.665 . . . . 5.3200000000000003 112.795 -173.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.501 HD13 ' HA ' ' A' ' 24' ' ' ILE . 8.6 mt -67.74 -16.95 64.38 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.307 1.043 . . . . 0.87 112.179 174.634 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 89.84 46.04 4.35 Favored Glycine 0 C--N 1.336 0.58 0 N-CA-C 109.68 -1.368 . . . . 0.66000000000000003 109.68 179.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.422 ' CD1' HG21 ' A' ' 24' ' ' ILE . 0.2 OUTLIER -143.72 175.25 10.12 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 124.562 1.145 . . . . 2.1699999999999999 108.678 -176.352 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 7.7 t-160 -145.28 144.48 30.79 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 109.076 -0.713 . . . . 1.8700000000000001 109.076 174.088 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 5.8 p -113.21 144.37 21.0 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 N-CA-C 107.002 -1.481 . . . . 1.53 107.002 179.18 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 5.7 t -122.86 140.81 45.46 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 N-CA-C 107.615 -1.254 . . . . 0.68999999999999995 107.615 -178.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 4.7 mp . . . . . 0 N--CA 1.45 -0.475 0 N-CA-C 107.975 -1.12 . . . . 1.26 107.975 -175.912 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.5 m . . . . . 0 N--CA 1.446 -0.67 0 N-CA-C 108.838 -0.801 . . . . 0.81999999999999995 108.838 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -65.94 171.63 4.31 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 108.077 -1.083 . . . . 2.29 108.077 162.211 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -131.5 153.88 49.34 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 124.258 1.023 . . . . 1.0800000000000001 109.673 176.501 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -144.94 160.63 41.01 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 124.725 1.21 . . . . 3.23 109.842 170.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -121.25 94.77 4.44 Favored 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 128.082 2.553 . . . . 1.98 106.094 -170.087 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 17.1 mm -82.62 162.05 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.232 0 N-CA-C 107.109 -1.441 . . . . 2.04 107.109 -179.095 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -133.3 140.24 47.33 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 107.068 -1.456 . . . . 0.69999999999999996 107.068 170.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -152.55 175.46 12.74 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 118.522 0.601 . . . . 2.1299999999999999 110.059 172.226 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 22.8 mm100 -98.45 157.99 15.87 Favored 'General case' 0 C--O 1.227 -0.084 0 C-N-CA 124.234 1.014 . . . . 2.6099999999999999 110.049 177.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 43.4 t -111.19 162.19 9.01 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 C-N-CA 124.844 1.257 . . . . 1.21 109.612 -174.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 58.0 m -149.23 164.47 34.7 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 107.535 -1.283 . . . . 0.93000000000000005 107.535 165.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 93.32 -29.97 7.71 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 123.39 0.519 . . . . 2.4700000000000002 112.562 -178.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -53.21 108.2 0.31 Allowed 'General case' 0 C--O 1.225 -0.205 0 CA-C-N 118.026 0.913 . . . . 2.27 112.77 178.233 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -155.91 14.18 0.34 Allowed 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 114.299 1.222 . . . . 3.8100000000000001 114.299 178.326 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 8.3 m -104.28 -58.7 1.84 Allowed 'General case' 0 C--O 1.226 -0.163 0 N-CA-C 108.245 -1.021 . . . . 5.0300000000000002 108.245 -175.16 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -172.86 -56.56 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 126.34 1.856 . . . . 5.4900000000000002 106.579 174.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -164.38 32.1 0.07 Allowed 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 113.204 0.816 . . . . 2.0600000000000001 113.204 -168.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 95.6 m -58.1 -31.62 67.31 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 121.378 -0.826 . . . . 1.1899999999999999 111.424 174.248 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.57 -25.43 17.13 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.197 0.599 . . . . 0.91000000000000003 112.609 170.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.59 ' HA ' HG11 ' A' ' 39' ' ' VAL . . . -70.26 -48.26 57.61 Favored 'General case' 0 N--CA 1.453 -0.307 0 O-C-N 120.261 -1.525 . . . . 0.65000000000000002 110.204 169.367 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 21.0 mmm180 -55.66 -46.86 77.46 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 109.603 -0.517 . . . . 4.2699999999999996 109.603 -178.116 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.411 HG21 ' CD1' ' A' ' 69' ' ' TYR . 3.0 pt -57.21 -54.96 23.71 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.36 0 C-N-CA 119.816 -0.754 . . . . 0.53000000000000003 110.921 178.242 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -55.68 -40.06 71.81 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 119.097 0.862 . . . . 2.2200000000000002 112.324 -179.511 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -71.13 -46.19 62.08 Favored 'General case' 0 N--CA 1.453 -0.284 0 O-C-N 121.722 -0.611 . . . . 1.8899999999999999 109.707 -176.218 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -60.11 -47.62 90.12 Favored Glycine 0 CA--C 1.528 0.856 0 N-CA-C 110.204 -1.158 . . . . 0.92000000000000004 110.204 172.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.441 HD23 ' C ' ' A' ' 28' ' ' LEU . 6.1 tt -52.97 -42.87 65.92 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.793 1.637 . . . . 1.95 110.118 177.599 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 8.6 ttmt -57.54 -32.36 67.0 Favored 'General case' 0 CA--C 1.535 0.373 0 O-C-N 120.942 -1.099 . . . . 3.4500000000000002 112.917 174.104 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -69.01 -7.53 36.44 Favored 'General case' 0 CA--C 1.536 0.427 0 O-C-N 121.297 -0.877 . . . . 5.6500000000000004 112.551 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 20.5 mmt -79.69 148.45 69.24 Favored Pre-proline 0 CA--C 1.532 0.273 0 CA-C-N 119.019 0.827 . . . . 4.7400000000000002 110.419 -174.129 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -56.11 137.17 78.54 Favored 'Trans proline' 0 N--CA 1.452 -0.966 0 C-N-CA 121.89 1.727 . . . . 0.88 108.746 176.102 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 90.89 -7.15 81.59 Favored Glycine 0 N--CA 1.449 -0.481 0 CA-C-O 117.671 -1.627 . . . . 0.88 114.35 179.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.6 t -110.37 135.18 50.2 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 CA-C-N 119.825 1.813 . . . . 0.64000000000000001 109.107 177.294 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 8.4 m -107.45 -49.86 3.18 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 123.442 0.697 . . . . 1.1200000000000001 110.194 -176.532 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -138.96 163.88 31.21 Favored 'General case' 0 C--N 1.343 0.299 0 CA-C-N 118.916 0.78 . . . . 2.0499999999999998 111.456 177.164 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -159.43 144.33 15.5 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 113.152 0.797 . . . . 0.77000000000000002 113.152 -179.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -149.7 105.53 3.44 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 107.97 -1.122 . . . . 1.0 107.97 -164.159 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.59 HG11 ' HA ' ' A' ' 22' ' ' ALA . 4.0 p -83.71 100.98 7.72 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 C-N-CA 123.03 0.532 . . . . 1.02 110.521 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 45.1 t30 -82.55 57.4 3.7 Favored 'General case' 0 CA--C 1.538 0.516 0 O-C-N 120.372 -1.455 . . . . 1.05 110.513 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.45 HD23 ' CG2' ' A' ' 39' ' ' VAL . 0.5 OUTLIER -76.33 -12.11 60.01 Favored 'General case' 0 C--O 1.226 -0.178 0 C-N-CA 124.384 1.074 . . . . 1.03 111.156 176.858 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -43.84 -38.0 3.09 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 123.59 0.756 . . . . 1.21 111.215 167.406 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.47 HG23 ' H ' ' A' ' 44' ' ' GLU . 9.2 t -102.1 -75.95 0.59 Allowed 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 118.755 -0.64 . . . . 3.7400000000000002 109.578 163.575 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.47 ' H ' HG23 ' A' ' 43' ' ' THR . 3.0 tt0 179.37 26.76 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.983 1.313 . . . . 3.25 113.375 -177.053 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 91.9 m -128.51 167.35 17.2 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 124.133 0.973 . . . . 0.76000000000000001 108.759 -163.481 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 1.2 p -138.35 145.36 28.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 N-CA-C 108.516 -0.92 . . . . 0.67000000000000004 108.516 179.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -131.09 139.7 49.9 Favored 'General case' 0 C--N 1.343 0.297 0 N-CA-C 108.187 -1.042 . . . . 0.56000000000000005 108.187 173.416 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 39.8 t -131.34 127.95 60.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 N-CA-C 105.591 -2.003 . . . . 2.1600000000000001 105.591 179.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 13.2 mm -102.44 93.01 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 N-CA-C 106.884 -1.524 . . . . 0.63 106.884 -177.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 9.5 p90 -127.01 168.67 14.25 Favored 'General case' 0 CA--C 1.509 -0.632 0 O-C-N 121.964 -0.46 . . . . 1.76 110.663 -170.207 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -99.1 103.44 20.01 Favored Pre-proline 0 N--CA 1.445 -0.716 0 C-N-CA 124.292 1.037 . . . . 4.3899999999999997 109.123 -176.265 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -72.72 10.4 1.06 Allowed 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 123.402 2.734 . . . . 1.0600000000000001 113.723 -172.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -86.44 -25.72 25.08 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 108.893 -0.78 . . . . 1.23 108.893 167.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -112.42 -55.33 2.53 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 123.816 0.847 . . . . 3.0699999999999998 109.151 -175.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.433 HG22 ' HB3' ' A' ' 59' ' ' ALA 0.324 9.5 p -90.57 -160.56 0.72 Allowed 'General case' 0 C--N 1.343 0.288 0 CA-C-O 119.411 -0.328 . . . . 0.68000000000000005 110.76 165.155 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 118.33 88.41 1.23 Allowed Glycine 0 N--CA 1.445 -0.734 0 N-CA-C 104.192 -3.563 . . . . 2.3399999999999999 104.192 -148.648 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 47.0 p -12.51 -18.28 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.419 1 C-N-CA 138.573 6.749 . . . . 1.25 119.53 -147.082 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -27.29 -63.05 0.09 Allowed 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 127.434 2.294 . . . . 0.60999999999999999 114.327 166.091 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.433 ' HB3' HG22 ' A' ' 55' ' ' THR . . . -72.96 -41.1 64.78 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 117.556 -1.657 . . . . 0.55000000000000004 109.196 -168.056 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.1 mp -53.97 -52.49 35.73 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.051 0 CA-C-N 113.821 -1.536 . . . . 0.89000000000000001 109.542 177.041 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.19 -48.1 79.78 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 119.398 0.999 . . . . 1.7 109.046 -176.793 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -47.83 -56.29 7.8 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 122.4 1.095 . . . . 3.29 110.709 176.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.9 mmpt? -70.58 -39.08 74.08 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-O 118.532 -0.747 . . . . 2.6200000000000001 112.063 -176.3 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -45.55 -53.78 1.86 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 C-N-CA 125.142 1.377 . . . . 0.44 108.046 173.412 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -58.46 -59.66 5.01 Favored 'General case' 0 C--N 1.341 0.2 0 C-N-CA 124.058 0.943 . . . . 1.98 110.288 177.568 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -58.73 -31.97 68.79 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 112.84 0.681 . . . . 5.3499999999999996 112.84 -175.337 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 24.8 mt -69.73 -17.23 63.44 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.969 1.308 . . . . 0.65000000000000002 111.295 176.11 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 94.2 41.85 4.17 Favored Glycine 0 CA--C 1.523 0.569 0 C-N-CA 124.642 1.115 . . . . 0.48999999999999999 110.367 176.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.411 ' CD1' HG21 ' A' ' 24' ' ' ILE . 0.6 OUTLIER -140.61 171.57 13.93 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 123.909 0.884 . . . . 1.98 110.238 -176.089 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -151.08 141.93 22.88 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 108.306 -0.998 . . . . 2.4700000000000002 108.306 168.567 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.0 m -99.27 165.38 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 C-N-CA 124.891 1.277 . . . . 2.4300000000000002 108.531 174.34 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 16.6 t -122.42 143.81 33.92 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 C-N-CA 124.66 1.184 . . . . 0.81000000000000005 108.325 177.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 21.9 mm . . . . . 0 N--CA 1.455 -0.201 0 C-N-CA 125.429 1.492 . . . . 1.5 108.482 -176.938 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 28.2 m . . . . . 0 N--CA 1.444 -0.729 0 N-CA-C 108.051 -1.092 . . . . 1.4399999999999999 108.051 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -108.68 -179.94 4.01 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 128.065 2.546 . . . . 2.1200000000000001 108.985 166.153 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 3.5 mm100 -139.19 147.66 42.11 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.95 1.3 . . . . 1.23 108.015 167.544 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -140.96 159.8 41.43 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 123.735 0.814 . . . . 3.1899999999999999 109.384 160.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -114.89 86.55 2.47 Favored 'General case' 0 N--CA 1.442 -0.83 0 C-N-CA 127.902 2.481 . . . . 1.5700000000000001 106.727 -170.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.527 HD13 ' CE1' ' A' ' 50' ' ' TYR . 2.6 mp -83.5 161.67 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.295 0 N-CA-C 106.262 -1.755 . . . . 2.29 106.262 -176.497 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -128.85 137.68 51.61 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 125.649 1.58 . . . . 0.65000000000000002 108.077 -178.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 1.9 mpt? -140.3 171.4 14.2 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 122.923 0.489 . . . . 2.0800000000000001 110.302 172.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -88.54 159.7 17.8 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 127.005 2.122 . . . . 3.75 109.797 167.091 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 88.9 t -117.86 152.63 19.84 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 C-N-CA 124.623 1.169 . . . . 1.1899999999999999 108.525 -179.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 70.8 m -149.49 160.41 43.48 Favored 'General case' 0 N--CA 1.455 -0.198 0 O-C-N 121.342 -0.849 . . . . 1.1200000000000001 109.853 171.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 70.02 70.29 1.21 Allowed Glycine 0 CA--C 1.528 0.861 0 N-CA-C 110.462 -1.055 . . . . 1.6399999999999999 110.462 -178.408 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -145.2 157.89 43.96 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 124.152 0.981 . . . . 1.9299999999999999 109.529 -175.283 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.7 p -108.63 -66.03 1.08 Allowed 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 125.612 1.565 . . . . 2.3599999999999999 108.692 171.129 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 20.3 p -123.71 161.11 25.8 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 124.485 1.114 . . . . 2.1299999999999999 111.414 -170.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -76.67 53.49 0.89 Allowed 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.322 1.049 . . . . 1.9299999999999999 110.813 178.28 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -138.42 -53.49 0.61 Allowed 'General case' 0 CA--C 1.521 -0.153 0 C-N-CA 124.677 1.191 . . . . 0.69999999999999996 109.234 175.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 59.7 m -57.4 -41.44 80.33 Favored 'General case' 0 CA--C 1.533 0.289 0 O-C-N 121.734 -0.604 . . . . 1.25 111.6 -176.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.466 ' HB1' HG21 ' A' ' 39' ' ' VAL . . . -59.67 -19.13 47.52 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 112.642 0.608 . . . . 0.71999999999999997 112.642 176.66 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.72 -49.12 42.22 Favored 'General case' 0 N--CA 1.455 -0.221 0 O-C-N 120.634 -1.291 . . . . 0.41999999999999998 109.757 169.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 6.3 mtt-85 -53.72 -49.27 68.49 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 123.383 0.673 . . . . 3.8300000000000001 109.397 -175.418 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 5.1 pt -55.23 -53.46 34.81 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 O-C-N 123.883 0.739 . . . . 0.46999999999999997 109.973 179.423 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.612 ' HG3' ' HB1' ' A' ' 37' ' ' ALA . 0.3 OUTLIER -53.72 -45.62 70.53 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.078 0.951 . . . . 2.3100000000000001 112.273 179.51 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.5 mptp? -69.25 -46.71 66.64 Favored 'General case' 0 CA--C 1.532 0.259 0 O-C-N 121.163 -0.96 . . . . 1.48 110.351 -177.091 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -63.94 -31.71 81.73 Favored Glycine 0 CA--C 1.529 0.956 0 N-CA-C 111.439 -0.665 . . . . 0.51000000000000001 111.439 176.2 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 7.6 tt -64.91 -44.05 90.84 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 126.018 1.727 . . . . 1.9199999999999999 109.486 177.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -53.1 -26.51 16.67 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 112.034 0.383 . . . . 2.5600000000000001 112.034 176.037 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 2.3 mtt180 -70.96 1.6 5.42 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 113.671 0.989 . . . . 3.6899999999999999 113.671 177.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 6.6 mmt -71.48 155.52 92.57 Favored Pre-proline 0 CA--C 1.534 0.348 0 CA-C-N 119.519 1.054 . . . . 3.3399999999999999 111.314 167.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -62.62 152.78 75.97 Favored 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 122.411 2.074 . . . . 1.02 110.418 171.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 74.88 -27.03 1.12 Allowed Glycine 0 CA--C 1.533 1.193 0 O-C-N 121.482 -0.761 . . . . 0.75 113.486 177.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 10.3 t -76.4 145.76 9.92 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 CA-C-N 118.83 1.315 . . . . 0.93999999999999995 109.056 173.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -132.22 -38.94 1.06 Allowed 'General case' 0 CA--C 1.529 0.143 0 CA-C-O 118.512 -0.756 . . . . 0.87 112.304 -176.185 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -140.61 166.49 24.6 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-N 119.589 1.086 . . . . 2.2599999999999998 111.867 163.503 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.612 ' HB1' ' HG3' ' A' ' 25' ' ' GLU . . . -158.13 137.26 11.59 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 112.769 0.655 . . . . 0.46999999999999997 112.769 -179.278 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -149.97 107.86 3.71 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 106.463 -1.68 . . . . 0.41999999999999998 106.463 -161.55 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.466 HG21 ' HB1' ' A' ' 21' ' ' ALA . 2.4 p -82.02 128.44 38.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 108.324 -0.991 . . . . 0.67000000000000004 108.324 177.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 39.3 t30 -105.69 57.26 0.67 Allowed 'General case' 0 C--O 1.235 0.341 0 CA-C-O 123.263 1.506 . . . . 0.87 107.887 179.005 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.424 HD23 HG22 ' A' ' 39' ' ' VAL . 0.3 OUTLIER -74.74 -13.49 60.6 Favored 'General case' 0 C--O 1.226 -0.178 0 CA-C-N 113.96 -1.473 . . . . 0.92000000000000004 110.636 177.003 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -44.0 -36.55 2.54 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.914 0.886 . . . . 1.0800000000000001 111.378 165.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 15.2 t -108.21 -68.73 0.89 Allowed 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 117.739 -1.124 . . . . 3.3700000000000001 110.85 167.318 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 161.34 49.13 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 127.561 2.344 . . . . 3.7999999999999998 109.535 -174.108 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -142.52 160.62 39.92 Favored 'General case' 0 N--CA 1.446 -0.667 0 O-C-N 120.292 -1.505 . . . . 0.76000000000000001 109.16 -178.228 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.6 p -130.18 142.79 42.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 108.113 -1.069 . . . . 0.32000000000000001 108.113 171.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -127.04 138.77 53.28 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 107.594 -1.262 . . . . 0.33000000000000002 107.594 176.123 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 3.1 p -137.68 129.67 40.61 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 N-CA-C 106.003 -1.851 . . . . 1.7 106.003 -176.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 11.2 mm -104.92 99.49 8.56 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.612 0 N-CA-C 106.743 -1.577 . . . . 0.45000000000000001 106.743 -171.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.527 ' CE1' HD13 ' A' ' 8' ' ' ILE . 51.2 p90 -139.84 169.44 17.72 Favored 'General case' 0 CA--C 1.512 -0.507 0 C-N-CA 122.629 0.372 . . . . 2.0899999999999999 110.662 -173.601 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 52.6 t0 -90.4 109.27 32.6 Favored Pre-proline 0 C--O 1.235 0.33 0 O-C-N 124.435 1.085 . . . . 3.3199999999999998 109.533 173.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 78.9 Cg_endo -72.41 5.57 2.71 Favored 'Trans proline' 0 N--CA 1.452 -0.95 0 C-N-CA 122.758 2.305 . . . . 0.83999999999999997 113.698 179.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -83.37 -33.24 25.85 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 119.393 0.997 . . . . 1.0600000000000001 108.692 165.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -107.44 -60.83 1.64 Allowed 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 123.446 0.698 . . . . 2.6800000000000002 110.943 -168.386 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.429 HG22 ' HB3' ' A' ' 59' ' ' ALA 0.495 0.2 OUTLIER -79.2 -177.1 5.49 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 114.513 1.301 . . . . 0.64000000000000001 114.513 155.956 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 176.78 -147.91 8.7 Favored Glycine 0 N--CA 1.434 -1.469 0 N-CA-C 103.354 -3.898 . . . . 2.71 103.354 -165.37 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 12.9 p -75.39 -42.68 53.29 Favored 'General case' 0 N--CA 1.443 -0.795 0 C-N-CA 124.711 1.204 . . . . 1.3 108.794 174.32 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -46.67 -63.83 0.92 Allowed 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 114.125 1.157 . . . . 0.70999999999999996 114.125 -165.026 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.429 ' HB3' HG22 ' A' ' 55' ' ' THR . . . -70.82 -34.57 71.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 122.34 1.067 . . . . 0.64000000000000001 108.98 -165.78 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.5 mp -53.78 -58.55 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.122 0 CA-C-N 114.143 -1.389 . . . . 1.1399999999999999 109.534 170.045 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.94 -45.4 92.73 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 123.038 0.535 . . . . 1.6000000000000001 109.957 -173.395 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -43.8 -58.48 2.7 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.236 1.014 . . . . 3.8900000000000001 110.872 172.518 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -67.3 -44.69 78.61 Favored 'General case' 0 N--CA 1.442 -0.845 0 O-C-N 121.937 -0.477 . . . . 3.71 111.809 -178.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -48.46 -53.03 7.23 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 C-N-CA 125.799 1.64 . . . . 0.53000000000000003 107.89 -179.324 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 41.0 mm-40 -60.56 -58.19 9.52 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 124.549 1.14 . . . . 2.0 110.339 176.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 5.9 mmmt -53.66 -37.28 63.01 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 113.25 0.833 . . . . 4.4699999999999998 113.25 -177.256 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 12.1 mt -68.93 -17.74 64.0 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.275 1.03 . . . . 0.96999999999999997 111.985 177.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 92.62 49.61 2.71 Favored Glycine 0 CA--C 1.523 0.534 0 N-CA-C 109.932 -1.267 . . . . 0.56999999999999995 109.932 178.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -147.06 170.27 17.5 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 124.135 0.974 . . . . 1.8 109.799 -175.405 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 12.9 t-80 -140.78 123.72 16.37 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 108.249 -1.019 . . . . 1.9299999999999999 108.249 174.244 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 7.5 p -92.7 144.57 9.07 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.146 0 N-CA-C 107.027 -1.471 . . . . 1.52 107.027 170.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 44.7 t -123.04 139.98 48.14 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.182 0 N-CA-C 107.952 -1.129 . . . . 0.98999999999999999 107.952 178.515 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 5.2 mp . . . . . 0 N--CA 1.451 -0.401 0 N-CA-C 107.749 -1.204 . . . . 1.46 107.749 -173.803 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.5 m . . . . . 0 N--CA 1.448 -0.541 0 N-CA-C 110.739 -0.097 . . . . 1.0600000000000001 110.739 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -63.31 175.15 1.03 Allowed 'General case' 0 CA--C 1.531 0.245 0 CA-C-O 121.494 0.664 . . . . 3.1000000000000001 111.543 165.815 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.2 mm100 -137.97 143.79 40.85 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 125.215 1.406 . . . . 1.05 107.968 165.315 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 46.2 mttm -141.47 156.06 45.79 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 123.808 0.843 . . . . 3.6899999999999999 109.428 164.367 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 12.0 mp0 -114.62 86.34 2.42 Favored 'General case' 0 N--CA 1.445 -0.685 0 C-N-CA 127.164 2.186 . . . . 1.6499999999999999 108.08 -167.138 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.5 mt -83.61 157.99 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 N-CA-C 107.296 -1.372 . . . . 2.3199999999999998 107.296 -176.436 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -126.95 136.2 51.94 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 126.183 1.793 . . . . 0.53000000000000003 107.455 178.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 2.1 mpt? -138.74 169.57 17.56 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 118.337 0.517 . . . . 2.04 110.064 174.069 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -87.59 160.16 18.3 Favored 'General case' 0 N--CA 1.456 -0.133 0 C-N-CA 124.441 1.096 . . . . 3.1499999999999999 109.001 170.48 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 60.3 t -116.55 152.05 18.31 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 C-N-CA 124.202 1.001 . . . . 1.24 108.384 177.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 58.6 m -149.58 173.48 13.58 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.755 1.222 . . . . 1.0800000000000001 108.29 172.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 79.79 -37.12 2.09 Favored Glycine 0 CA--C 1.532 1.151 0 O-C-N 121.737 -0.602 . . . . 2.1000000000000001 112.557 -177.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 3.8 ppp? -47.78 153.64 0.58 Allowed 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.119 1.368 . . . . 3.3799999999999999 113.855 179.754 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.2 p -114.26 -71.51 0.74 Allowed 'General case' 0 N--CA 1.457 -0.086 0 C-N-CA 124.804 1.242 . . . . 2.3199999999999998 108.681 170.559 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 6.7 p -99.09 148.13 24.35 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 121.835 0.826 . . . . 2.1899999999999999 111.331 -178.727 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -77.84 53.44 1.14 Allowed 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.477 0.711 . . . . 1.75 110.493 178.247 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -143.05 -51.09 0.35 Allowed 'General case' 0 C--O 1.231 0.102 0 C-N-CA 123.65 0.78 . . . . 0.66000000000000003 110.682 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 56.1 m -56.01 -36.2 67.68 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 118.728 0.695 . . . . 1.2 110.15 171.025 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -47.97 -33.35 7.67 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.186 1.394 . . . . 0.47999999999999998 112.407 172.442 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.37 -53.27 14.68 Favored 'General case' 0 N--CA 1.454 -0.27 0 O-C-N 121.528 -0.733 . . . . 0.34999999999999998 110.128 172.576 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 6.4 mpt_? -55.3 -50.07 70.51 Favored 'General case' 0 CA--C 1.521 -0.148 0 C-N-CA 122.434 0.294 . . . . 5.8600000000000003 110.251 -175.172 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.48 HG21 ' CD1' ' A' ' 69' ' ' TYR 0.258 2.3 pp -52.86 -50.52 42.87 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 O-C-N 123.183 0.302 . . . . 1.26 110.99 177.578 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.523 ' HG3' ' HB1' ' A' ' 37' ' ' ALA . 3.0 tp10 -59.08 -39.27 81.62 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 114.029 1.122 . . . . 2.7599999999999998 114.029 176.221 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -73.95 -38.07 64.35 Favored 'General case' 0 CA--C 1.533 0.305 0 O-C-N 120.82 -1.175 . . . . 2.4900000000000002 111.974 -178.436 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -66.04 -41.39 95.19 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 109.858 -1.297 . . . . 0.47999999999999998 109.858 170.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 8.0 tt -53.56 -50.45 65.51 Favored 'General case' 0 C--N 1.333 -0.133 0 N-CA-C 108.84 -0.8 . . . . 1.8400000000000001 108.84 174.124 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -50.7 -19.9 1.07 Allowed 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.853 1.261 . . . . 3.3799999999999999 114.125 178.583 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.67 -9.32 59.62 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 118.897 0.772 . . . . 4.3399999999999999 112.528 -179.092 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 8.1 ptp -68.78 154.68 94.49 Favored Pre-proline 0 CA--C 1.534 0.337 0 CA-C-N 119.43 1.013 . . . . 3.8300000000000001 111.474 177.215 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -58.4 137.35 79.95 Favored 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 121.539 1.493 . . . . 0.57999999999999996 109.388 166.123 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 100.83 -35.51 4.8 Favored Glycine 0 CA--C 1.529 0.95 0 CA-C-O 119.274 -0.737 . . . . 0.51000000000000001 113.283 175.354 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 54.7 t -89.21 110.39 21.48 Favored 'Isoleucine or valine' 0 C--N 1.34 0.178 0 CA-C-N 118.76 1.28 . . . . 0.85999999999999999 109.671 178.062 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -81.63 -49.46 10.48 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-O 118.122 -0.942 . . . . 0.90000000000000002 108.577 -178.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -137.36 163.14 31.74 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 119.016 0.826 . . . . 2.1600000000000001 112.096 173.72 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.523 ' HB1' ' HG3' ' A' ' 25' ' ' GLU . . . -157.06 146.92 20.73 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.697 -0.683 . . . . 0.5 112.082 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -156.07 115.04 3.48 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 106.365 -1.717 . . . . 0.46999999999999997 106.365 -163.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.5 p -81.39 130.89 35.09 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.688 0 N-CA-C 107.911 -1.144 . . . . 0.75 107.911 175.541 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 54.1 t-20 -109.63 55.82 0.63 Allowed 'General case' 0 C--O 1.236 0.359 0 N-CA-C 107.187 -1.412 . . . . 0.59999999999999998 107.187 178.495 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.16 -18.34 62.5 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 114.157 -1.383 . . . . 1.01 109.86 -172.658 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -43.13 -37.78 2.16 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.09 0.956 . . . . 0.60999999999999999 112.246 164.105 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 8.9 t -124.23 38.51 4.18 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 122.727 0.411 . . . . 1.3 109.943 173.346 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 50.11 31.85 5.35 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.932 1.693 . . . . 2.6099999999999999 113.412 174.483 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 90.4 m -121.31 157.29 30.7 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 108.264 -1.013 . . . . 0.66000000000000003 108.264 -177.005 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 5.4 p -125.52 142.41 42.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 N-CA-C 108.355 -0.98 . . . . 0.37 108.355 172.17 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -127.37 139.84 52.59 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 108.425 -0.954 . . . . 0.33000000000000002 108.425 -179.515 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 5.5 p -141.29 126.17 17.92 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 N-CA-C 106.936 -1.505 . . . . 1.8100000000000001 106.936 -172.472 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 14.8 mm -107.22 91.8 1.88 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.513 0 C-N-CA 126.092 1.757 . . . . 0.40999999999999998 107.07 -167.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 43.6 p90 -135.38 165.53 25.26 Favored 'General case' 0 CA--C 1.51 -0.583 0 O-C-N 121.975 -0.453 . . . . 1.96 112.037 -166.764 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 59.7 t0 -86.55 109.92 27.67 Favored Pre-proline 0 C--O 1.235 0.321 0 O-C-N 124.574 1.172 . . . . 3.0499999999999998 109.821 176.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -71.23 1.93 4.89 Favored 'Trans proline' 0 N--CA 1.453 -0.892 0 C-N-CA 123.029 2.486 . . . . 0.58999999999999997 113.44 -178.401 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -88.78 -27.17 21.31 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 119.428 1.013 . . . . 0.81999999999999995 109.471 168.559 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -101.71 -53.33 2.99 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 123.492 0.717 . . . . 2.75 109.13 -170.122 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.265 1.0 OUTLIER -101.66 -176.44 3.14 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 125.256 1.422 . . . . 0.46000000000000002 111.998 163.431 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 146.95 91.09 0.1 OUTLIER Glycine 0 N--CA 1.442 -0.931 0 N-CA-C 103.629 -3.789 . . . . 2.3199999999999998 103.629 -155.406 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 77.0 p -13.95 -15.06 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.546 1 C-N-CA 137.737 6.415 . . . . 1.45 120.32 -145.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -25.49 -62.04 0.07 Allowed 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 126.924 2.09 . . . . 0.54000000000000004 114.503 162.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.07 -43.13 58.82 Favored 'General case' 0 C--N 1.332 -0.176 0 C-N-CA 119.088 -1.045 . . . . 0.51000000000000001 109.027 -167.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.7 mt -46.92 -60.03 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.706 0 C-N-CA 126.543 1.937 . . . . 1.27 110.893 172.025 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.78 -46.84 81.26 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 119.778 1.172 . . . . 1.0700000000000001 110.195 179.541 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -51.88 -55.18 21.66 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 121.795 0.807 . . . . 3.3900000000000001 112.022 179.014 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -69.8 -37.96 76.47 Favored 'General case' 0 N--CA 1.438 -1.028 0 O-C-N 121.419 -0.801 . . . . 2.27 111.471 -178.792 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.7 mm -49.95 -54.28 8.26 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 N-CA-C 107.362 -1.347 . . . . 0.48999999999999999 107.362 175.369 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 27.0 mm-40 -58.36 -58.23 9.41 Favored 'General case' 0 C--N 1.342 0.259 0 C-N-CA 124.745 1.218 . . . . 2.2000000000000002 110.387 178.345 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 7.8 mptt -54.48 -39.84 67.9 Favored 'General case' 0 CA--C 1.534 0.334 0 O-C-N 121.877 -0.514 . . . . 4.6500000000000004 112.153 -177.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.456 ' HB3' HG22 ' A' ' 24' ' ' ILE . 44.2 mt -70.63 -17.08 62.88 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.232 1.013 . . . . 0.78000000000000003 112.114 178.1 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 94.46 33.84 6.62 Favored Glycine 0 CA--C 1.524 0.641 0 C-N-CA 124.303 0.954 . . . . 0.44 111.617 173.378 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.48 ' CD1' HG21 ' A' ' 24' ' ' ILE . 1.4 m-85 -124.19 169.94 11.23 Favored 'General case' 0 N--CA 1.457 -0.123 0 C-N-CA 124.793 1.237 . . . . 1.8799999999999999 109.277 177.449 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -135.16 120.33 18.86 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 107.794 -1.187 . . . . 1.77 107.794 172.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 7.6 p -89.55 145.1 7.81 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 N-CA-C 107.597 -1.261 . . . . 1.54 107.597 172.168 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 48.8 t -121.21 141.16 42.89 Favored 'Isoleucine or valine' 0 C--O 1.232 0.136 0 C-N-CA 123.884 0.874 . . . . 0.68999999999999995 108.93 178.042 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 29.8 mm . . . . . 0 N--CA 1.455 -0.182 0 C-N-CA 124.684 1.194 . . . . 1.0600000000000001 109.479 -168.878 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 5.5 m . . . . . 0 N--CA 1.455 -0.181 0 N-CA-C 106.708 -1.59 . . . . 0.79000000000000004 106.708 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -63.55 169.4 3.9 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 107.998 -1.112 . . . . 2.8900000000000001 107.998 161.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -129.28 153.71 47.55 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 108.657 -0.868 . . . . 1.5900000000000001 108.657 171.531 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -139.76 153.26 47.12 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 123.423 0.689 . . . . 3.1400000000000001 110.048 168.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -107.69 90.87 3.43 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 127.633 2.373 . . . . 1.6299999999999999 107.731 -176.4 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 3.4 mm -83.65 159.45 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.179 0 N-CA-C 106.787 -1.56 . . . . 1.98 106.787 -178.603 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -134.14 131.72 39.01 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 124.641 1.176 . . . . 0.46999999999999997 108.385 178.441 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 3.7 mpp? -137.47 167.3 21.92 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.377 0.671 . . . . 2.0299999999999998 110.008 174.45 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 21.4 mm100 -88.01 160.16 17.98 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.14 0.976 . . . . 2.5800000000000001 109.452 174.652 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 81.4 t -115.01 144.2 23.08 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 C-N-CA 124.053 0.941 . . . . 1.49 109.971 -179.291 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 9.1 m -147.21 175.15 10.97 Favored 'General case' 0 C--N 1.341 0.228 0 C-N-CA 125.523 1.529 . . . . 1.3 108.604 171.409 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 55.68 52.47 48.13 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 110.788 -0.925 . . . . 1.8700000000000001 110.788 175.695 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -125.51 149.5 48.24 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 124.559 1.144 . . . . 2.6600000000000001 109.424 -170.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -87.85 -58.54 2.53 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 124.039 0.936 . . . . 3.5699999999999998 109.966 170.379 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 17.7 p -154.68 170.55 21.28 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-O 121.777 0.798 . . . . 2.5800000000000001 111.279 175.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.35 -34.4 68.77 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 124.409 1.084 . . . . 2.4100000000000001 111.893 178.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.76 -49.82 73.5 Favored 'General case' 0 N--CA 1.453 -0.292 0 O-C-N 121.992 -0.443 . . . . 0.76000000000000001 109.898 178.587 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 77.5 m -61.49 -38.92 89.04 Favored 'General case' 0 N--CA 1.456 -0.153 0 O-C-N 121.619 -0.675 . . . . 1.3 110.422 174.64 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.565 ' HB1' HG21 ' A' ' 39' ' ' VAL . . . -56.83 -23.13 41.7 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 112.105 0.409 . . . . 0.42999999999999999 112.105 173.685 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.07 -47.63 61.14 Favored 'General case' 0 N--CA 1.456 -0.165 0 O-C-N 120.039 -1.663 . . . . 0.39000000000000001 110.116 169.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 2.0 mtp85 -51.45 -43.59 62.13 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 122.92 0.488 . . . . 3.6699999999999999 110.039 -175.402 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.517 HG21 ' CD1' ' A' ' 69' ' ' TYR 0.287 1.9 pt -60.88 -60.35 2.79 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.274 0 CA-C-O 118.371 -0.823 . . . . 0.52000000000000002 111.196 178.74 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -54.91 -40.54 69.95 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 119.964 1.256 . . . . 2.2799999999999998 112.002 -179.45 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 14.7 mptt -68.07 -50.2 56.6 Favored 'General case' 0 CA--C 1.537 0.453 0 O-C-N 121.353 -0.842 . . . . 1.8799999999999999 110.38 -179.08 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -67.39 -23.18 73.4 Favored Glycine 0 CA--C 1.53 1.022 0 O-C-N 121.489 -0.757 . . . . 0.69999999999999996 112.265 177.241 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -71.01 -47.75 57.03 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 125.375 1.47 . . . . 2.3199999999999998 108.652 173.106 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 19.9 ttmt -46.5 -39.54 10.96 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 118.959 0.8 . . . . 3.3599999999999999 111.397 178.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.6 mtt180 -67.14 -5.93 15.54 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 114.691 1.367 . . . . 3.5899999999999999 114.691 -177.687 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.67 162.32 73.74 Favored Pre-proline 0 CA--C 1.541 0.626 0 CA-C-N 119.367 0.985 . . . . 4.2199999999999998 111.055 179.304 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -73.68 117.34 5.01 Favored 'Trans proline' 0 N--CA 1.453 -0.898 0 C-N-CA 121.507 1.471 . . . . 1.0 109.191 172.392 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 116.47 -19.39 12.91 Favored Glycine 0 CA--C 1.527 0.794 0 C-N-CA 123.895 0.76 . . . . 0.83999999999999997 113.789 169.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.509 HG22 ' HB3' ' A' ' 50' ' ' TYR . 86.6 t -89.97 145.96 6.77 Favored 'Isoleucine or valine' 0 C--N 1.339 0.143 0 CA-C-N 118.685 1.243 . . . . 0.68999999999999995 108.539 167.386 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.2 m -118.38 -36.63 3.49 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 118.441 -0.79 . . . . 1.0600000000000001 111.256 177.295 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -138.83 164.22 30.21 Favored 'General case' 0 C--N 1.343 0.307 0 CA-C-N 119.955 1.252 . . . . 2.0899999999999999 111.728 168.015 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -159.27 144.98 16.17 Favored 'General case' 0 C--N 1.332 -0.171 0 C-N-CA 123.104 0.562 . . . . 0.42999999999999999 111.868 -178.264 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -155.49 110.19 2.94 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 107.608 -1.256 . . . . 0.47999999999999998 107.608 -165.529 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.565 HG21 ' HB1' ' A' ' 21' ' ' ALA . 7.1 p -82.61 103.97 10.59 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 CA-C-O 121.336 0.588 . . . . 0.59999999999999998 110.79 178.722 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 51.6 t-20 -84.34 57.67 4.39 Favored 'General case' 0 CA--C 1.537 0.451 0 O-C-N 120.336 -1.477 . . . . 0.64000000000000001 110.173 179.73 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.426 HD23 ' CG2' ' A' ' 39' ' ' VAL . 0.2 OUTLIER -69.08 -19.05 64.06 Favored 'General case' 0 N--CA 1.461 0.119 0 CA-C-N 115.593 -0.731 . . . . 0.87 111.24 -176.506 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -44.09 -33.4 1.47 Allowed 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 123.816 0.846 . . . . 0.55000000000000004 111.872 166.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 6.6 t -129.62 42.08 3.34 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 121.392 0.615 . . . . 1.29 109.866 173.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 39.12 40.97 0.54 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 126.614 1.966 . . . . 2.5499999999999998 114.01 -178.28 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 83.8 m -120.34 157.23 29.68 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 124.55 1.14 . . . . 0.65000000000000002 108.568 -178.297 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 1.6 p -125.87 140.26 49.06 Favored 'Isoleucine or valine' 0 C--O 1.232 0.151 0 N-CA-C 108.278 -1.008 . . . . 0.53000000000000003 108.278 172.527 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -126.69 137.26 53.25 Favored 'General case' 0 C--N 1.344 0.365 0 N-CA-C 108.26 -1.015 . . . . 0.33000000000000002 108.26 176.306 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 40.7 t -131.31 125.2 56.55 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 N-CA-C 105.426 -2.065 . . . . 2.0499999999999998 105.426 -177.686 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 14.7 mm -100.46 88.24 1.47 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.592 0 N-CA-C 106.829 -1.545 . . . . 0.40000000000000002 106.829 -176.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.509 ' HB3' HG22 ' A' ' 34' ' ' VAL . 13.2 p90 -124.36 167.7 14.02 Favored 'General case' 0 CA--C 1.507 -0.711 0 CA-C-N 115.794 -0.639 . . . . 1.99 111.503 -171.743 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -99.84 107.48 46.61 Favored Pre-proline 0 N--CA 1.445 -0.677 0 CA-C-N 113.879 -1.51 . . . . 4.3799999999999999 108.113 -171.091 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -72.44 6.18 2.42 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 122.698 2.265 . . . . 0.82999999999999996 113.138 -173.109 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -84.28 -25.2 29.5 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 123.478 0.711 . . . . 1.0800000000000001 109.334 168.401 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 -117.54 -53.64 2.41 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.202 1.001 . . . . 3.02 110.977 -169.636 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.258 0.8 OUTLIER -89.72 -175.77 4.76 Favored 'General case' 0 CA--C 1.517 -0.3 0 C-N-CA 123.766 0.826 . . . . 0.51000000000000001 113.177 160.343 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 141.34 87.5 0.11 Allowed Glycine 0 N--CA 1.44 -1.092 0 N-CA-C 104.902 -3.279 . . . . 2.5299999999999998 104.902 -158.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 82.4 p -9.48 -18.52 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.559 1 C-N-CA 138.126 6.571 . . . . 1.01 119.977 -143.238 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -28.18 -65.98 0.08 Allowed 'General case' 0 N--CA 1.44 -0.972 0 C-N-CA 127.6 2.36 . . . . 0.56999999999999995 113.977 169.639 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -76.81 -25.41 53.25 Favored 'General case' 0 C--N 1.334 -0.106 0 C-N-CA 118.105 -1.438 . . . . 0.67000000000000004 110.042 -169.113 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -63.5 -53.79 40.77 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.855 0 CA-C-O 118.58 -0.724 . . . . 0.90000000000000002 109.072 176.554 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.46 -44.44 96.4 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 108.828 -0.805 . . . . 1.6000000000000001 108.828 -175.547 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -48.13 -58.69 4.15 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-O 121.592 0.711 . . . . 3.7999999999999998 111.726 172.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 13.3 mmmt -65.44 -37.99 88.53 Favored 'General case' 0 N--CA 1.44 -0.946 0 O-C-N 121.618 -0.676 . . . . 3.46 111.739 -177.644 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.421 HD12 HG13 ' A' ' 71' ' ' VAL . 2.5 mm -51.79 -51.81 25.75 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 C-N-CA 125.634 1.574 . . . . 0.57999999999999996 108.302 178.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -57.45 -54.49 46.26 Favored 'General case' 0 C--N 1.341 0.218 0 C-N-CA 123.094 0.558 . . . . 2.04 110.243 174.667 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 5.8 mmtt -53.89 -38.44 64.78 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 112.874 0.694 . . . . 4.0199999999999996 112.874 -179.306 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 32.5 mt -70.95 -17.92 62.66 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 125.737 1.615 . . . . 0.79000000000000004 111.632 177.452 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 93.37 35.64 6.19 Favored Glycine 0 CA--C 1.525 0.668 0 C-N-CA 124.658 1.123 . . . . 0.5 111.229 176.119 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.517 ' CD1' HG21 ' A' ' 24' ' ' ILE . 1.0 OUTLIER -131.96 172.15 12.7 Favored 'General case' 0 N--CA 1.457 -0.123 0 C-N-CA 123.818 0.847 . . . . 1.8999999999999999 110.923 -178.319 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 3.7 t-80 -148.85 116.38 6.21 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 109.041 -0.725 . . . . 1.7 109.041 170.446 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.421 HG13 HD12 ' A' ' 64' ' ' ILE . 25.7 m -81.59 166.35 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 N-CA-C 109.072 -0.714 . . . . 2.4700000000000002 109.072 176.235 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 12.1 t -124.51 142.51 41.09 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 C-N-CA 124.173 0.989 . . . . 0.78000000000000003 108.458 178.603 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 17.9 mm . . . . . 0 N--CA 1.453 -0.303 0 C-N-CA 124.115 0.966 . . . . 1.1200000000000001 109.061 -174.084 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 39.2 m . . . . . 0 N--CA 1.449 -0.486 0 N-CA-C 103.908 -2.627 . . . . 1.27 103.908 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -80.07 -179.7 7.17 Favored 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 125.113 1.365 . . . . 3.0499999999999998 108.025 177.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.2 mm100 -138.78 136.52 35.77 Favored 'General case' 0 CA--C 1.514 -0.438 0 O-C-N 120.843 -1.161 . . . . 1.3200000000000001 108.275 171.548 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.8 mtpt -133.98 151.79 51.6 Favored 'General case' 0 N--CA 1.455 -0.222 0 O-C-N 124.089 0.868 . . . . 2.9199999999999999 109.958 167.658 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -101.9 93.5 5.32 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 127.968 2.507 . . . . 1.4299999999999999 107.457 -176.059 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 2.5 mm -84.01 159.91 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.248 0 N-CA-C 106.669 -1.604 . . . . 2.0600000000000001 106.669 -178.029 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -133.78 130.9 38.67 Favored 'General case' 0 N--CA 1.456 -0.136 0 N-CA-C 108.073 -1.084 . . . . 0.45000000000000001 108.073 176.153 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 4.0 mpp? -139.15 172.1 13.32 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.256 1.022 . . . . 1.8899999999999999 110.19 176.609 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.36 162.46 12.94 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 126.188 1.795 . . . . 3.5 109.468 173.368 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.1 m -118.76 151.5 20.95 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 C-N-CA 123.659 0.784 . . . . 1.8100000000000001 111.35 174.406 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 48.4 m -142.44 165.4 27.51 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 125.495 1.518 . . . . 1.03 109.411 176.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 63.58 67.06 2.21 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 110.686 -0.966 . . . . 2.1000000000000001 110.686 177.645 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -139.72 157.69 45.35 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 123.928 0.891 . . . . 3.5800000000000001 110.753 -175.432 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -76.83 -70.15 0.48 Allowed 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 108.178 -1.045 . . . . 3.1400000000000001 108.178 157.12 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 25.8 p -158.41 -178.91 7.62 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 121.732 0.777 . . . . 2.6099999999999999 112.05 -166.357 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.65 175.6 0.45 Allowed 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 124.793 1.237 . . . . 3.25 110.086 170.455 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.409 ' O ' ' HB3' ' A' ' 22' ' ' ALA . . . 72.03 -56.21 0.65 Allowed 'General case' 0 CA--C 1.528 0.123 0 C-N-CA 124.875 1.27 . . . . 1.0700000000000001 110.196 -174.179 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 28.3 m -57.57 -46.27 84.18 Favored 'General case' 0 C--N 1.33 -0.259 0 O-C-N 121.442 -0.786 . . . . 1.45 109.361 171.328 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -52.01 -23.76 5.63 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.107 0.963 . . . . 0.42999999999999999 112.965 172.227 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.409 ' HB3' ' O ' ' A' ' 19' ' ' ALA . . . -72.22 -49.49 34.79 Favored 'General case' 0 N--CA 1.454 -0.258 0 O-C-N 120.87 -1.144 . . . . 0.34000000000000002 110.607 171.803 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 8.1 mmm180 -56.11 -42.74 77.32 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 109.791 -0.448 . . . . 4.7699999999999996 109.791 -171.588 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.501 ' HA ' HD13 ' A' ' 67' ' ' LEU . 4.1 pt -56.62 -55.99 16.46 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 O-C-N 123.382 0.426 . . . . 0.46999999999999997 110.676 176.351 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -55.45 -43.15 75.18 Favored 'General case' 0 C--O 1.226 -0.163 0 C-N-CA 123.825 0.85 . . . . 3.54 111.75 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 4.0 mptp? -72.0 -42.82 65.97 Favored 'General case' 0 CA--C 1.535 0.366 0 O-C-N 121.168 -0.957 . . . . 1.8999999999999999 110.537 -174.537 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.93 -39.16 97.7 Favored Glycine 0 CA--C 1.53 0.991 0 N-CA-C 110.525 -1.03 . . . . 0.66000000000000003 110.525 170.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 6.8 tt -60.51 -36.31 78.05 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.23 1.012 . . . . 1.95 109.703 175.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.5 ttpm? -61.95 -24.02 66.73 Favored 'General case' 0 CA--C 1.53 0.187 0 O-C-N 120.565 -1.335 . . . . 3.1099999999999999 112.841 172.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 11.3 mmt180 -77.85 -3.81 43.44 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 119.043 0.838 . . . . 3.5299999999999998 111.524 -179.069 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 70.3 mmm -83.95 147.84 52.35 Favored Pre-proline 0 CA--C 1.535 0.369 0 CA-C-N 118.918 0.781 . . . . 3.3999999999999999 111.076 -176.632 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -59.25 136.15 70.46 Favored 'Trans proline' 0 N--CA 1.451 -0.986 0 C-N-CA 122.34 2.027 . . . . 0.56999999999999995 108.961 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 94.66 -23.94 30.24 Favored Glycine 0 CA--C 1.528 0.848 0 CA-C-O 118.919 -0.934 . . . . 0.5 113.084 -178.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 17.0 t -92.35 130.28 41.69 Favored 'Isoleucine or valine' 0 C--N 1.34 0.161 0 CA-C-N 118.6 1.2 . . . . 0.57999999999999996 109.966 -177.139 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 9.3 m -112.13 -39.51 4.45 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 123.823 0.849 . . . . 1.2 111.142 -171.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -145.27 157.21 44.11 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 118.867 0.758 . . . . 2.7999999999999998 109.738 175.038 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -152.0 126.7 9.54 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 123.765 0.826 . . . . 0.75 110.375 -170.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -142.36 107.85 5.06 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 125.723 1.609 . . . . 0.70999999999999996 108.772 -164.45 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.412 HG23 HD23 ' A' ' 41' ' ' LEU . 3.1 p -82.31 88.09 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 N-CA-C 108.734 -0.839 . . . . 1.4099999999999999 108.734 178.41 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 48.9 t-20 -83.31 56.65 3.63 Favored 'General case' 0 CA--C 1.537 0.462 0 O-C-N 120.6 -1.312 . . . . 0.71999999999999997 110.108 -177.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.412 HD23 HG23 ' A' ' 39' ' ' VAL . 0.5 OUTLIER -68.27 -20.74 64.81 Favored 'General case' 0 C--O 1.223 -0.332 0 C-N-CA 124.398 1.079 . . . . 1.0 110.541 -179.792 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -45.7 -30.12 1.48 Allowed 'General case' 0 CA--C 1.529 0.154 0 N-CA-C 112.811 0.671 . . . . 0.93000000000000005 112.811 168.363 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 5.7 t -131.66 32.25 4.16 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 118.019 0.372 . . . . 1.29 110.476 173.087 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 9.1 mp0 50.02 52.79 13.99 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.302 1.041 . . . . 4.1200000000000001 112.591 179.569 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.3 m -137.69 160.43 39.24 Favored 'General case' 0 N--CA 1.443 -0.797 0 O-C-N 121.286 -0.884 . . . . 0.94999999999999996 109.144 176.295 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.5 p -129.91 136.64 58.49 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 N-CA-C 107.044 -1.465 . . . . 0.38 107.044 169.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -125.07 129.51 50.4 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 107.559 -1.275 . . . . 0.55000000000000004 107.559 -178.665 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 3.7 p -132.97 131.14 58.95 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.828 0 N-CA-C 105.1 -2.185 . . . . 1.78 105.1 -176.486 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 2.1 mp -104.2 111.2 32.87 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.762 0 N-CA-C 106.097 -1.816 . . . . 1.72 106.097 178.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 21.4 p90 -143.15 167.58 21.78 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 116.039 -0.528 . . . . 1.6399999999999999 109.914 -178.047 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -87.78 121.82 70.63 Favored Pre-proline 0 CA--C 1.54 0.58 0 O-C-N 125.047 1.467 . . . . 3.3900000000000001 111.506 171.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_endo -80.76 12.12 2.72 Favored 'Trans proline' 0 CA--C 1.537 0.672 0 C-N-CA 123.536 2.824 . . . . 0.93000000000000005 114.181 -176.565 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -98.0 -36.23 10.19 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 119.573 1.079 . . . . 1.3700000000000001 109.578 167.539 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -90.81 -57.22 2.89 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 106.966 -1.494 . . . . 3.23 106.966 -175.09 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.317 6.0 p -95.92 -160.32 0.78 Allowed 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 109.439 -0.578 . . . . 0.64000000000000001 109.439 162.027 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 116.57 92.31 1.7 Allowed Glycine 0 CA--C 1.528 0.856 0 N-CA-C 106.274 -2.731 . . . . 2.29 106.274 -146.593 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 80.9 p -12.73 -19.16 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.435 1 C-N-CA 138.007 6.523 . . . . 1.1000000000000001 119.849 -143.792 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -26.46 -63.39 0.08 Allowed 'General case' 0 N--CA 1.443 -0.787 0 C-N-CA 127.212 2.205 . . . . 0.69999999999999996 113.647 170.671 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -75.31 -42.63 54.18 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 118.212 -1.395 . . . . 0.69999999999999996 109.629 -166.116 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -50.29 -53.95 10.22 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.962 0 CA-C-N 113.965 -1.471 . . . . 0.78000000000000003 110.278 173.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -68.17 -46.08 71.72 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 109.591 -0.522 . . . . 1.9299999999999999 109.591 -173.696 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -45.93 -56.93 4.83 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 122.319 1.056 . . . . 3.4100000000000001 111.344 171.485 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.0 mmpt? -71.52 -38.62 71.08 Favored 'General case' 0 N--CA 1.432 -1.343 0 CA-C-O 118.624 -0.703 . . . . 2.46 112.438 -175.063 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -48.69 -52.82 8.27 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 N-CA-C 106.968 -1.493 . . . . 0.52000000000000002 106.968 175.494 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 37.9 mm-40 -58.82 -58.48 8.44 Favored 'General case' 0 C--N 1.343 0.32 0 C-N-CA 124.392 1.077 . . . . 2.5 110.413 177.449 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 9.4 mmtm -57.71 -32.66 67.61 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 113.457 0.91 . . . . 3.98 113.457 -176.416 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.501 HD13 ' HA ' ' A' ' 24' ' ' ILE . 11.4 mt -70.23 -18.19 63.15 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.609 1.163 . . . . 0.79000000000000004 111.701 174.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 90.58 44.65 4.52 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 110.483 -1.047 . . . . 0.48999999999999999 110.483 179.068 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -137.27 174.96 10.05 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 124.674 1.19 . . . . 2.0 108.549 177.26 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 32.1 t60 -137.54 156.36 48.2 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 109.425 -0.583 . . . . 1.8 109.425 167.137 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 12.8 p -128.09 137.79 56.51 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.113 0 C-N-CA 125.038 1.335 . . . . 1.54 108.03 -177.091 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 13.0 t -110.74 136.14 47.7 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 C-N-CA 124.622 1.169 . . . . 0.68000000000000005 108.75 -178.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 27.8 mm . . . . . 0 N--CA 1.45 -0.429 0 C-N-CA 124.463 1.105 . . . . 1.0600000000000001 108.945 -172.24 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.454 -0.26 0 N-CA-C 106.366 -1.716 . . . . 1.03 106.366 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -79.97 -175.43 4.96 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 108.577 -0.897 . . . . 2.3199999999999998 108.577 173.33 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.4 mm100 -136.53 144.84 44.47 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 107.979 -1.119 . . . . 1.26 107.979 170.566 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 51.7 mttt -143.91 162.18 36.79 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 123.602 0.761 . . . . 2.8199999999999998 110.706 163.225 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -110.77 87.77 2.61 Favored 'General case' 0 N--CA 1.439 -0.98 0 C-N-CA 129.216 3.006 . . . . 1.6899999999999999 105.447 -173.316 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.502 ' N ' HD12 ' A' ' 8' ' ' ILE . 3.4 mp -83.71 162.03 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 N-CA-C 105.771 -1.937 . . . . 2.46 105.771 -179.747 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -133.72 142.1 47.83 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 125.281 1.432 . . . . 0.77000000000000002 107.362 179.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -155.73 175.59 13.73 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 109.125 -0.695 . . . . 2.4500000000000002 109.125 172.082 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 30.0 mm100 -98.55 152.36 19.65 Favored 'General case' 0 C--O 1.223 -0.307 0 C-N-CA 125.477 1.511 . . . . 2.77 108.396 -177.371 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.8 p -111.32 156.43 12.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 CA-C-N 119.166 0.894 . . . . 2.5800000000000001 110.282 -178.72 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 7.6 m -132.92 168.84 17.71 Favored 'General case' 0 C--N 1.339 0.131 0 C-N-CA 124.474 1.11 . . . . 1.22 109.791 171.733 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 58.59 52.44 52.96 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 110.8 -0.92 . . . . 1.5800000000000001 110.8 -179.732 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -131.44 162.36 30.36 Favored 'General case' 0 CA--C 1.521 -0.158 0 C-N-CA 124.377 1.071 . . . . 2.3300000000000001 109.881 -176.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -154.57 -58.61 0.11 Allowed 'General case' 0 CA--C 1.528 0.125 0 C-N-CA 125.457 1.503 . . . . 3.6899999999999999 109.572 168.679 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 9.2 p -81.17 133.19 35.41 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 121.476 0.655 . . . . 2.2999999999999998 109.932 175.509 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -75.6 55.16 0.82 Allowed 'General case' 0 CA--C 1.535 0.391 0 O-C-N 121.626 -0.671 . . . . 1.99 109.473 170.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -152.07 -57.15 0.14 Allowed 'General case' 0 N--CA 1.457 -0.076 0 C-N-CA 124.071 0.948 . . . . 0.91000000000000003 110.457 -169.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 67.9 m -60.61 -42.46 96.85 Favored 'General case' 0 C--N 1.333 -0.141 0 O-C-N 121.237 -0.915 . . . . 1.3700000000000001 109.605 169.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.64 -19.86 6.94 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 113.009 0.744 . . . . 0.63 113.009 170.243 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -73.01 -50.24 24.24 Favored 'General case' 0 N--CA 1.454 -0.228 0 O-C-N 120.299 -1.501 . . . . 0.46999999999999997 110.687 169.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 3.7 mpt_? -49.78 -45.16 49.44 Favored 'General case' 0 CA--C 1.52 -0.198 0 C-N-CA 122.384 0.274 . . . . 4.1799999999999997 110.276 -174.441 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.515 ' HA ' HD13 ' A' ' 67' ' ' LEU . 3.8 pt -57.15 -54.4 30.81 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 O-C-N 123.337 0.398 . . . . 0.5 110.678 -176.677 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -58.01 -43.79 86.91 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 124.033 0.933 . . . . 2.3399999999999999 112.027 176.077 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -66.9 -47.02 73.08 Favored 'General case' 0 CA--C 1.534 0.331 0 O-C-N 121.701 -0.624 . . . . 1.8600000000000001 110.206 -175.444 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.35 -40.47 99.08 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 110.227 -1.149 . . . . 0.62 110.227 173.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -62.29 -37.83 87.03 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 122.115 -0.638 . . . . 2.1800000000000002 109.823 179.264 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.8 ttpm? -52.28 -18.99 1.79 Allowed 'General case' 0 CA--C 1.532 0.286 0 O-C-N 121.201 -0.937 . . . . 3.21 113.358 173.274 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 2.9 mtt180 -88.41 -0.54 57.3 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 119.051 0.841 . . . . 4.3600000000000003 112.277 -179.201 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . 0.617 ' SD ' ' HB1' ' A' ' 59' ' ' ALA . 0.5 OUTLIER -77.97 158.56 77.46 Favored Pre-proline 0 CA--C 1.531 0.215 0 CA-C-N 119.366 0.984 . . . . 3.6099999999999999 111.923 172.537 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -56.87 145.58 83.34 Favored 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 122.494 2.129 . . . . 0.78000000000000003 110.476 170.487 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 82.85 -28.89 3.47 Favored Glycine 0 CA--C 1.53 0.992 0 CA-C-O 119.443 -0.643 . . . . 0.59999999999999998 113.142 176.079 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 16.0 t -84.87 133.65 28.82 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 CA-C-N 118.953 1.377 . . . . 0.56000000000000005 109.655 177.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -115.54 -41.19 3.28 Favored 'General case' 0 N--CA 1.457 -0.106 0 C-N-CA 123.746 0.819 . . . . 0.87 110.184 -175.71 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -143.45 163.16 33.89 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 118.844 0.747 . . . . 2.1200000000000001 109.214 176.026 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -156.14 143.69 19.35 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 122.43 0.292 . . . . 0.47999999999999998 111.76 178.685 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -151.59 101.92 2.83 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 106.245 -1.761 . . . . 0.46999999999999997 106.245 -166.762 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.0 p -81.21 142.83 13.28 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 N-CA-C 108.028 -1.101 . . . . 0.79000000000000004 108.028 176.518 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 53.4 t-20 -136.63 64.07 1.56 Allowed 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 122.705 1.241 . . . . 0.91000000000000003 110.115 -171.196 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.497 HD22 ' H ' ' A' ' 41' ' ' LEU . 1.8 mm? -70.79 -20.05 62.63 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 115.048 -0.978 . . . . 2.8100000000000001 111.253 -173.573 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -46.65 -38.14 9.29 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 124.184 0.993 . . . . 0.83999999999999997 112.202 172.17 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 9.0 t -119.4 29.33 7.69 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.012 0.525 . . . . 1.29 110.371 174.21 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 43.79 59.93 2.9 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 126.049 1.74 . . . . 2.7400000000000002 112.023 -177.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 90.0 m -146.31 164.02 33.69 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 108.697 -0.853 . . . . 0.70999999999999996 108.697 178.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -138.65 143.52 32.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 108.334 -0.988 . . . . 0.46999999999999997 108.334 176.03 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -126.95 137.49 53.13 Favored 'General case' 0 C--N 1.344 0.343 0 N-CA-C 107.787 -1.19 . . . . 0.38 107.787 178.422 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 31.2 t -130.12 130.18 65.75 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 N-CA-C 105.13 -2.174 . . . . 2.27 105.13 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 13.0 mm -101.3 99.15 7.83 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.578 0 N-CA-C 106.959 -1.497 . . . . 0.56000000000000005 106.959 -177.33 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.435 ' CE2' HD13 ' A' ' 8' ' ' ILE . 54.5 p90 -141.42 168.91 18.65 Favored 'General case' 0 CA--C 1.51 -0.591 0 O-C-N 122.055 -0.403 . . . . 2.52 110.245 -171.311 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 42.0 t0 -86.52 107.87 15.5 Favored Pre-proline 0 C--N 1.327 -0.389 0 O-C-N 124.482 1.114 . . . . 3.1299999999999999 109.639 174.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -73.48 4.24 4.12 Favored 'Trans proline' 0 N--CA 1.451 -1.013 0 C-N-CA 122.222 1.948 . . . . 1.1100000000000001 112.68 -179.093 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -82.35 -36.03 27.24 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 119.622 1.101 . . . . 1.3899999999999999 108.508 166.101 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -103.41 -60.47 1.56 Allowed 'General case' 0 N--CA 1.453 -0.315 0 O-C-N 123.724 0.64 . . . . 4.04 109.694 -167.099 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.48 HG22 ' HB3' ' A' ' 59' ' ' ALA 0.459 0.5 OUTLIER -81.54 -172.64 3.95 Favored 'General case' 0 CA--C 1.521 -0.149 0 N-CA-C 113.729 1.011 . . . . 0.72999999999999998 113.729 156.512 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 159.66 -148.6 17.47 Favored Glycine 0 N--CA 1.434 -1.473 1 N-CA-C 102.492 -4.243 . . . . 2.9300000000000002 102.492 -157.246 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 33.2 p -78.34 -37.6 44.12 Favored 'General case' 0 N--CA 1.444 -0.772 0 C-N-CA 124.772 1.229 . . . . 1.1799999999999999 110.104 178.327 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -49.13 -62.54 1.48 Allowed 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.715 1.206 . . . . 0.54000000000000004 113.403 -163.584 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.617 ' HB1' ' SD ' ' A' ' 31' ' ' MET . . . -71.68 -32.25 67.64 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.198 -1.365 . . . . 0.46999999999999997 108.973 -169.236 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.7 mp -60.04 -55.36 24.63 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.795 0 CA-C-N 114.937 -1.029 . . . . 1.1399999999999999 109.876 175.253 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.91 -45.82 89.41 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 119.167 0.894 . . . . 1.3300000000000001 110.1 -178.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -48.76 -56.57 8.25 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 121.449 0.642 . . . . 3.3900000000000001 111.691 174.146 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 3.5 mmmt -64.92 -42.99 94.24 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-O 118.923 -0.561 . . . . 3.3999999999999999 112.043 -178.464 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.4 mm -50.39 -52.74 14.46 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.707 0 C-N-CA 125.71 1.604 . . . . 0.56000000000000005 107.804 -179.622 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -56.27 -56.56 19.5 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 123.769 0.828 . . . . 2.3500000000000001 110.661 175.178 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 12.7 mptt -58.76 -34.66 71.67 Favored 'General case' 0 CA--C 1.536 0.436 0 O-C-N 121.716 -0.615 . . . . 4.7999999999999998 112.435 -175.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.515 HD13 ' HA ' ' A' ' 24' ' ' ILE . 11.8 mt -70.5 -16.63 62.92 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.646 1.178 . . . . 0.69999999999999996 111.965 175.678 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 86.0 42.13 6.84 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 110.288 -1.125 . . . . 0.60999999999999999 110.288 179.178 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -134.95 175.98 9.08 Favored 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 124.315 1.046 . . . . 1.99 109.458 -179.562 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -144.46 157.11 44.4 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 109.2 -0.667 . . . . 2.1099999999999999 109.2 170.662 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 8.0 p -138.33 137.42 43.89 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.19 0 N-CA-C 107.757 -1.201 . . . . 1.52 107.757 -173.732 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 29.6 t -103.53 137.51 31.71 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 C-N-CA 125.364 1.466 . . . . 0.56999999999999995 109.002 -175.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 48.4 mm . . . . . 0 N--CA 1.447 -0.576 0 C-N-CA 124.728 1.211 . . . . 1.1200000000000001 107.979 -176.386 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.0 m . . . . . 0 N--CA 1.447 -0.624 0 N-CA-C 108.713 -0.847 . . . . 0.67000000000000004 108.713 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -70.16 168.95 14.58 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 108.241 -1.022 . . . . 2.02 108.241 162.591 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -129.09 153.56 47.53 Favored 'General case' 0 N--CA 1.457 -0.12 0 C-N-CA 124.548 1.139 . . . . 1.1399999999999999 109.99 178.281 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 85.5 mttt -146.07 162.7 37.33 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 124.28 1.032 . . . . 3.6000000000000001 109.992 168.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 8.9 mp0 -121.18 87.93 2.85 Favored 'General case' 0 N--CA 1.441 -0.89 0 C-N-CA 127.979 2.512 . . . . 1.6200000000000001 106.122 -168.366 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.47 ' N ' HD12 ' A' ' 8' ' ' ILE . 2.6 mp -83.06 161.66 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.369 0 N-CA-C 105.887 -1.894 . . . . 2.0699999999999998 105.887 -177.102 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -128.31 135.21 49.3 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 125.944 1.698 . . . . 0.64000000000000001 106.595 178.283 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 43.1 mtt -140.89 171.98 13.33 Favored 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 109.498 -0.556 . . . . 2.3300000000000001 109.498 174.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 21.8 mm100 -96.96 139.33 33.14 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 125.701 1.601 . . . . 2.4900000000000002 108.624 176.621 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 81.0 t -92.66 153.91 3.25 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 N-CA-C 108.893 -0.78 . . . . 1.3 108.893 175.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 62.9 m -150.77 165.48 33.39 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.074 0.949 . . . . 1.2 109.264 173.177 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 60.32 61.84 6.67 Favored Glycine 0 CA--C 1.528 0.874 0 N-CA-C 110.745 -0.942 . . . . 1.5700000000000001 110.745 -178.697 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -135.58 156.38 48.96 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 123.834 0.854 . . . . 1.75 110.153 -174.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -105.34 -55.81 2.27 Favored 'General case' 0 CA--C 1.528 0.118 0 C-N-CA 125.199 1.4 . . . . 2.3599999999999999 109.764 168.051 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 16.9 p -139.67 159.48 42.07 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 121.914 0.864 . . . . 2.3199999999999998 111.93 -172.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -75.87 39.88 0.18 Allowed 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.963 1.305 . . . . 2.0099999999999998 111.899 179.43 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -128.67 -53.68 1.24 Allowed 'General case' 0 CA--C 1.524 -0.058 0 C-N-CA 124.599 1.159 . . . . 0.78000000000000003 108.612 178.647 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 21.0 m -58.72 -38.15 77.72 Favored 'General case' 0 CA--C 1.532 0.274 0 O-C-N 121.556 -0.715 . . . . 1.2 109.714 170.726 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.656 ' HB1' HG21 ' A' ' 39' ' ' VAL . . . -54.65 -26.69 34.74 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 116.06 -0.518 . . . . 0.40999999999999998 112.082 172.551 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.92 -48.95 41.81 Favored 'General case' 0 N--CA 1.455 -0.177 0 O-C-N 120.08 -1.637 . . . . 0.34000000000000002 109.629 172.368 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 26.9 mmm180 -50.17 -46.02 53.85 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 123.022 0.529 . . . . 5.0800000000000001 110.543 -175.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.434 HG21 ' CD1' ' A' ' 69' ' ' TYR . 3.5 pt -59.0 -53.35 49.1 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 C-N-CA 120.245 -0.582 . . . . 0.46000000000000002 111.066 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -54.42 -44.93 72.83 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 123.296 0.638 . . . . 2.2999999999999998 111.687 177.16 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 32.1 mmtp -70.55 -44.0 68.35 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 118.839 0.745 . . . . 2.1299999999999999 110.657 -175.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -58.95 -39.55 94.26 Favored Glycine 0 CA--C 1.528 0.903 0 N-CA-C 110.488 -1.045 . . . . 0.5 110.488 172.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -66.21 -42.8 88.25 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 109.056 -0.72 . . . . 2.3599999999999999 109.056 179.365 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.6 ttpp -56.96 -14.99 4.06 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.719 1.608 . . . . 2.8900000000000001 114.128 177.283 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.83 -11.6 56.79 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.93 1.692 . . . . 3.9300000000000002 111.794 176.74 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 93.3 mmm -71.6 154.72 93.08 Favored Pre-proline 0 CA--C 1.53 0.185 0 CA-C-N 119.03 0.832 . . . . 3.25 111.378 179.263 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -56.21 141.86 87.63 Favored 'Trans proline' 0 N--CA 1.451 -1.008 0 C-N-CA 121.47 1.447 . . . . 0.58999999999999997 108.596 163.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 88.42 -12.56 64.54 Favored Glycine 0 N--CA 1.448 -0.559 0 CA-C-O 117.932 -1.482 . . . . 0.88 114.463 173.391 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 40.6 t -109.46 125.41 66.6 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 CA-C-N 119.787 1.793 . . . . 0.55000000000000004 109.061 177.586 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 99.7 m -97.49 -50.66 4.43 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-O 118.205 -0.902 . . . . 1.1599999999999999 110.067 -176.764 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -138.71 159.8 41.22 Favored 'General case' 0 C--N 1.342 0.258 0 CA-C-N 119.337 0.971 . . . . 2.1099999999999999 110.803 176.436 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -156.39 146.39 21.19 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 122.98 0.512 . . . . 0.38 112.066 -178.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -155.94 121.31 4.85 Favored 'General case' 0 C--N 1.342 0.273 0 N-CA-C 109.047 -0.723 . . . . 0.5 109.047 -165.792 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.656 HG21 ' HB1' ' A' ' 21' ' ' ALA . 9.2 p -92.87 102.27 13.46 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 C-N-CA 123.055 0.542 . . . . 0.64000000000000001 110.201 -177.63 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 50.5 t-20 -85.53 57.36 4.42 Favored 'General case' 0 CA--C 1.533 0.323 0 O-C-N 120.518 -1.364 . . . . 0.59999999999999998 109.462 179.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.435 HD22 ' HA ' ' A' ' 41' ' ' LEU . 0.2 OUTLIER -68.31 -19.97 64.71 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 115.495 -0.775 . . . . 1.02 110.468 -175.957 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -47.42 -33.83 6.48 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.771 0.828 . . . . 0.62 112.132 168.726 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 15.3 t -120.54 28.76 7.8 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 118.148 0.431 . . . . 1.24 111.158 174.48 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 46.86 57.11 5.91 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 124.557 1.143 . . . . 2.7999999999999998 112.109 -176.505 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 67.2 m -146.59 157.05 43.65 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 108.159 -1.052 . . . . 0.79000000000000004 108.159 178.442 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.4 p -124.92 144.43 34.95 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 N-CA-C 108.071 -1.085 . . . . 0.31 108.071 172.128 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -125.51 137.52 53.95 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 108.132 -1.062 . . . . 0.32000000000000001 108.132 175.347 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 4.4 p -135.1 123.67 40.55 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 N-CA-C 106.165 -1.791 . . . . 1.8200000000000001 106.165 -176.258 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 12.6 mm -101.58 90.02 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 N-CA-C 106.266 -1.753 . . . . 0.44 106.266 -172.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 24.8 p90 -126.55 168.63 14.02 Favored 'General case' 0 CA--C 1.506 -0.742 0 CA-C-O 120.923 0.392 . . . . 2.0600000000000001 110.149 -169.474 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -98.87 103.31 18.64 Favored Pre-proline 0 N--CA 1.44 -0.941 0 CA-C-N 114.537 -1.211 . . . . 4.3799999999999999 108.157 -176.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -73.67 12.02 0.97 Allowed 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 122.632 2.222 . . . . 0.64000000000000001 113.277 -172.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -83.52 -25.26 31.19 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 109.061 -0.718 . . . . 0.95999999999999996 109.061 165.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -116.77 -58.4 2.08 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 123.81 0.844 . . . . 2.8300000000000001 109.454 -170.187 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.307 6.6 p -88.22 -171.98 3.6 Favored 'General case' 0 C--N 1.344 0.327 0 CA-C-N 118.181 0.446 . . . . 0.70999999999999996 110.304 165.522 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 135.7 87.15 0.23 Allowed Glycine 0 N--CA 1.442 -0.936 0 N-CA-C 105.164 -3.174 . . . . 2.3399999999999999 105.164 -155.151 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 52.2 p -8.22 -17.02 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.378 1 C-N-CA 137.794 6.438 . . . . 1.1399999999999999 120.248 -142.018 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -28.08 -66.34 0.08 Allowed 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 127.226 2.211 . . . . 0.64000000000000001 113.59 166.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.48 -36.39 71.14 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 116.978 -1.889 . . . . 0.67000000000000004 109.415 -166.033 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.5 mp -54.19 -57.39 6.07 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.047 0 CA-C-N 114.325 -1.307 . . . . 0.81999999999999995 109.178 175.501 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.09 -47.13 86.02 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 119.306 0.957 . . . . 1.1899999999999999 110.527 -178.032 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -48.89 -55.8 10.66 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 121.902 0.858 . . . . 4.5800000000000001 111.14 177.059 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -70.42 -37.61 74.44 Favored 'General case' 0 N--CA 1.437 -1.104 0 CA-C-O 118.042 -0.98 . . . . 2.3399999999999999 111.877 -177.71 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.1 mm -49.69 -52.74 11.85 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 N-CA-C 107.525 -1.287 . . . . 0.39000000000000001 107.525 178.464 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -57.53 -58.5 8.04 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 123.939 0.896 . . . . 1.8100000000000001 110.64 175.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -58.97 -32.79 69.98 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 112.955 0.724 . . . . 4.0999999999999996 112.955 -175.217 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 15.1 mt -70.58 -17.96 62.9 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.667 1.187 . . . . 0.57999999999999996 111.663 175.425 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 91.97 42.51 4.68 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.676 -0.97 . . . . 0.41999999999999998 110.676 178.154 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.434 ' CD1' HG21 ' A' ' 24' ' ' ILE . 0.3 OUTLIER -136.91 173.26 11.89 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 124.239 1.015 . . . . 1.8700000000000001 109.881 -179.835 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -137.99 128.33 26.21 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 107.773 -1.195 . . . . 1.79 107.773 172.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 4.2 p -104.19 146.69 11.29 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 N-CA-C 107.35 -1.352 . . . . 1.3899999999999999 107.35 170.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 91.3 t -116.29 146.63 20.46 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 C-N-CA 126.733 2.013 . . . . 0.80000000000000004 107.022 176.279 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 4.9 mp . . . . . 0 C--N 1.329 -0.321 0 C-N-CA 124.221 1.008 . . . . 1.4199999999999999 108.786 -174.613 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 57.9 m . . . . . 0 N--CA 1.454 -0.228 0 N-CA-C 106.774 -1.565 . . . . 0.73999999999999999 106.774 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -75.95 177.27 7.15 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 109.311 -0.626 . . . . 2.1600000000000001 109.311 171.604 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -138.52 140.75 39.24 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 107.532 -1.284 . . . . 1.02 107.532 174.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -138.39 160.97 38.16 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 124.573 1.149 . . . . 3.6000000000000001 109.74 168.438 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -119.37 95.87 4.97 Favored 'General case' 0 N--CA 1.441 -0.892 0 C-N-CA 128.903 2.881 . . . . 1.45 106.678 -171.734 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 7.0 mm -84.67 161.71 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.128 0 N-CA-C 106.879 -1.526 . . . . 2.1000000000000001 106.879 178.274 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -137.34 133.05 34.45 Favored 'General case' 0 C--O 1.23 0.076 0 C-N-CA 124.782 1.233 . . . . 0.54000000000000004 107.782 -179.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 9.3 ptp -157.65 175.75 13.51 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 118.664 0.665 . . . . 1.97 111.0 -178.238 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 28.7 mm100 -93.71 164.22 13.23 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.443 1.497 . . . . 2.46 110.655 -178.016 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 60.5 t -121.02 158.67 23.47 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 C-N-CA 124.964 1.306 . . . . 1.1699999999999999 109.427 -177.447 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 14.1 m -149.38 166.4 29.16 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 123.918 0.887 . . . . 0.88 110.08 167.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 68.13 47.52 58.67 Favored Glycine 0 CA--C 1.528 0.862 0 N-CA-C 110.522 -1.031 . . . . 1.6599999999999999 110.522 -171.302 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -125.94 156.93 38.98 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 124.643 1.177 . . . . 2.1800000000000002 109.589 -178.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER 179.85 -44.08 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 127.871 2.468 . . . . 3.7799999999999998 110.881 179.43 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 36.6 m -56.89 -22.59 38.43 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.658 0.783 . . . . 3.0699999999999998 112.704 177.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 57.38 33.32 23.12 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.58 1.152 . . . . 2.3900000000000001 111.602 178.008 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -159.3 -45.09 0.05 Allowed 'General case' 0 C--O 1.226 -0.179 0 C-N-CA 124.433 1.093 . . . . 0.78000000000000003 109.736 -175.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 94.4 m -50.31 -38.44 41.57 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.196 0.998 . . . . 1.23 112.278 171.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.404 ' HB1' HG21 ' A' ' 39' ' ' VAL . . . -56.11 -23.53 34.89 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 122.935 0.494 . . . . 0.47999999999999998 112.252 174.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -72.6 -50.1 27.64 Favored 'General case' 0 N--CA 1.457 -0.115 0 O-C-N 120.556 -1.34 . . . . 0.34000000000000002 111.114 167.022 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 6.6 mmp_? -49.33 -46.42 46.79 Favored 'General case' 0 CA--C 1.52 -0.209 0 N-CA-C 109.691 -0.485 . . . . 6.8600000000000003 109.691 179.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.498 HG21 ' CD1' ' A' ' 69' ' ' TYR 0.272 2.0 pt -59.23 -59.34 3.99 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.442 0 C-N-CA 119.337 -0.945 . . . . 0.46999999999999997 111.033 178.505 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -51.59 -41.68 61.37 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 119.526 1.057 . . . . 3.27 112.298 -179.135 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.2 mptp? -71.38 -43.64 66.49 Favored 'General case' 0 CA--C 1.538 0.484 0 O-C-N 121.13 -0.981 . . . . 1.73 110.708 -177.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -65.76 -32.11 81.94 Favored Glycine 0 CA--C 1.534 1.239 0 O-C-N 121.456 -0.778 . . . . 0.59999999999999998 111.65 174.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.0 tt -63.59 -48.29 77.99 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 126.111 1.764 . . . . 1.8999999999999999 107.914 175.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 12.8 ttmt -47.51 -37.34 11.8 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.039 0.536 . . . . 2.8399999999999999 112.435 174.324 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -66.17 -0.28 2.41 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 114.043 1.127 . . . . 3.3799999999999999 114.043 -176.671 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 13.5 ptp -77.29 164.17 60.13 Favored Pre-proline 0 CA--C 1.538 0.49 0 CA-C-N 119.735 1.152 . . . . 4.2199999999999998 111.788 172.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -69.0 137.56 37.98 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 121.543 1.495 . . . . 0.56999999999999995 109.756 168.407 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 99.91 -31.53 8.3 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 123.49 0.567 . . . . 0.5 113.187 172.243 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 47.1 t -82.56 140.33 16.53 Favored 'Isoleucine or valine' 0 C--N 1.341 0.205 0 CA-C-N 118.672 1.236 . . . . 0.56000000000000005 109.289 171.119 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -114.68 -38.05 4.09 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 118.812 -0.613 . . . . 1.0600000000000001 110.652 178.327 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -143.67 163.23 33.85 Favored 'General case' 0 C--N 1.341 0.238 0 CA-C-N 119.566 1.076 . . . . 1.8700000000000001 110.281 175.16 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -159.37 134.85 8.44 Favored 'General case' 0 C--O 1.239 0.516 0 C-N-CA 123.386 0.674 . . . . 0.42999999999999999 112.05 -171.416 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -148.06 111.86 5.09 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 124.213 1.005 . . . . 0.46000000000000002 109.723 -164.795 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.404 HG21 ' HB1' ' A' ' 21' ' ' ALA . 7.1 p -84.2 98.18 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 C-N-CA 123.53 0.732 . . . . 0.56999999999999995 110.403 179.796 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 49.6 t-20 -84.21 56.59 3.82 Favored 'General case' 0 CA--C 1.537 0.46 0 O-C-N 120.28 -1.512 . . . . 0.58999999999999997 110.027 179.618 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.44 HD22 ' HA ' ' A' ' 41' ' ' LEU . 0.2 OUTLIER -69.99 -17.98 63.31 Favored 'General case' 0 N--CA 1.462 0.128 0 C-N-CA 123.625 0.77 . . . . 0.93999999999999995 110.849 -178.24 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -44.34 -38.18 3.79 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 123.68 0.792 . . . . 0.53000000000000003 111.673 166.416 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 6.5 t -124.89 39.12 4.05 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 122.929 0.492 . . . . 1.27 109.725 172.002 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 50.17 32.06 5.65 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.741 1.617 . . . . 2.8799999999999999 113.804 173.24 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 40.2 m -119.8 163.96 16.7 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.947 1.299 . . . . 0.62 108.43 -177.577 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.8 p -133.15 145.22 34.38 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 O-C-N 121.038 -1.039 . . . . 0.29999999999999999 109.136 171.139 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -132.42 129.48 39.35 Favored 'General case' 0 C--N 1.344 0.346 0 C-N-CA 124.743 1.217 . . . . 0.38 108.445 -178.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.7 p -126.53 128.92 71.66 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 N-CA-C 105.524 -2.028 . . . . 1.78 105.524 -174.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 10.9 mm -105.42 100.44 10.58 Favored 'Isoleucine or valine' 0 C--O 1.239 0.527 0 C-N-CA 124.945 1.298 . . . . 0.41999999999999998 107.898 -173.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 48.0 p90 -141.62 171.05 14.59 Favored 'General case' 0 CA--C 1.512 -0.485 0 O-C-N 121.937 -0.477 . . . . 1.75 111.801 -170.598 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 60.7 t0 -90.62 105.59 12.39 Favored Pre-proline 0 CA--C 1.534 0.362 0 O-C-N 124.742 1.276 . . . . 3.04 110.696 174.597 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -74.88 9.83 1.87 Allowed 'Trans proline' 0 N--CA 1.452 -0.925 0 C-N-CA 122.108 1.872 . . . . 0.63 113.55 179.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -84.15 -27.88 27.81 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 119.238 0.926 . . . . 0.83999999999999997 108.824 164.051 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -108.43 -58.1 2.04 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 123.344 0.658 . . . . 2.6299999999999999 109.359 -170.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.422 0.3 OUTLIER -81.72 179.72 7.72 Favored 'General case' 0 CA--C 1.514 -0.416 0 N-CA-C 116.308 1.966 . . . . 0.46000000000000002 116.308 161.859 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -176.19 -152.35 9.54 Favored Glycine 0 N--CA 1.43 -1.708 1 N-CA-C 102.272 -4.331 . . . . 2.3900000000000001 102.272 -176.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 19.4 p -73.03 -32.4 65.07 Favored 'General case' 0 C--N 1.318 -0.792 0 C-N-CA 124.959 1.304 . . . . 1.2 109.206 178.068 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -42.56 -62.64 0.93 Allowed 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 125.839 1.655 . . . . 0.52000000000000002 113.671 -172.706 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -75.02 -34.69 61.95 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.042 -0.981 . . . . 0.45000000000000001 109.165 -169.697 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -56.17 -52.77 47.09 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.89 0 CA-C-O 117.67 -1.157 . . . . 0.90000000000000002 111.232 175.495 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.41 -46.96 87.95 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 119.864 1.211 . . . . 1.05 109.355 -179.184 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -48.81 -57.3 6.59 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-O 122.105 0.955 . . . . 2.6200000000000001 111.22 176.449 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.9 mmtp -63.02 -44.54 95.67 Favored 'General case' 0 N--CA 1.435 -1.176 0 CA-C-O 118.659 -0.686 . . . . 2.9199999999999999 110.77 -179.379 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -47.43 -52.62 5.19 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 C-N-CA 125.208 1.403 . . . . 0.51000000000000001 108.887 177.559 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -61.67 -55.5 29.81 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 123.762 0.825 . . . . 1.76 110.699 177.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.4 mmmp? -58.07 -31.02 66.67 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 113.366 0.876 . . . . 5.29 113.366 -178.261 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 22.8 mt -73.11 -17.15 61.43 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.583 1.553 . . . . 0.70999999999999996 112.121 174.426 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 93.17 42.55 4.29 Favored Glycine 0 C--N 1.337 0.631 0 C-N-CA 124.918 1.246 . . . . 0.51000000000000001 110.693 175.597 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.498 ' CD1' HG21 ' A' ' 24' ' ' ILE . 0.3 OUTLIER -145.13 177.05 9.07 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 123.348 0.659 . . . . 1.95 111.41 -169.629 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 4.9 t60 -142.25 131.79 23.88 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 107.825 -1.176 . . . . 2.0299999999999998 107.825 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 8.2 p -107.52 138.87 31.58 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.089 0 N-CA-C 108.018 -1.105 . . . . 1.6100000000000001 108.018 175.697 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 5.2 t -116.81 140.79 37.8 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.126 0 N-CA-C 108.598 -0.89 . . . . 0.65000000000000002 108.598 -177.199 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 4.9 mp . . . . . 0 N--CA 1.45 -0.472 0 N-CA-C 108.065 -1.087 . . . . 1.24 108.065 179.433 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 8.1 m . . . . . 0 CA--C 1.533 0.296 0 N-CA-C 109.691 -0.485 . . . . 0.87 109.691 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -64.37 169.97 4.24 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 107.738 -1.208 . . . . 2.0499999999999998 107.738 162.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -131.48 150.46 52.14 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 108.597 -0.89 . . . . 1.29 108.597 173.428 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 44.4 mtpt -143.45 156.79 44.74 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-O 121.695 0.759 . . . . 2.8199999999999998 110.61 169.314 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -100.4 112.77 25.15 Favored 'General case' 0 N--CA 1.44 -0.959 0 C-N-CA 128.188 2.595 . . . . 2.3799999999999999 107.272 -178.301 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.457 HD12 ' C ' ' A' ' 8' ' ' ILE . 2.3 pp -82.64 164.16 2.87 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.157 0 C-N-CA 119.357 -0.937 . . . . 5.2599999999999998 108.559 165.778 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -143.09 113.01 7.07 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 106.16 -1.792 . . . . 0.64000000000000001 106.16 175.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 59.9 mtt -140.29 170.12 16.4 Favored 'General case' 0 C--N 1.334 -0.096 0 CA-C-N 118.306 0.503 . . . . 3.5499999999999998 110.165 -172.595 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 28.8 mm100 -96.0 161.03 14.16 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 123.839 0.856 . . . . 2.5699999999999998 110.173 -176.626 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 44.9 t -120.23 146.2 25.43 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 N-CA-C 108.347 -0.983 . . . . 1.3200000000000001 108.347 -175.316 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 72.3 m -138.61 163.67 31.46 Favored 'General case' 0 N--CA 1.456 -0.154 0 C-N-CA 124.541 1.136 . . . . 0.98999999999999999 109.275 171.114 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 56.92 63.58 5.19 Favored Glycine 0 CA--C 1.528 0.85 0 C-N-CA 123.57 0.605 . . . . 1.6499999999999999 111.668 173.544 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 11.2 ptm -120.47 147.01 45.67 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 124.153 0.981 . . . . 3.0299999999999998 110.762 -177.053 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -81.98 -68.81 0.67 Allowed 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.513 1.125 . . . . 3.9399999999999999 108.65 166.259 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 16.3 p -154.45 169.79 22.92 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-O 121.512 0.672 . . . . 2.5499999999999998 111.119 178.531 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.15 -38.95 66.07 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 124.569 1.148 . . . . 2.5699999999999998 111.925 179.258 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.31 -46.15 90.89 Favored 'General case' 0 N--CA 1.453 -0.287 0 O-C-N 121.959 -0.463 . . . . 1.1299999999999999 110.182 -179.491 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 67.3 m -66.87 -43.75 82.75 Favored 'General case' 0 N--CA 1.454 -0.233 0 O-C-N 121.849 -0.532 . . . . 1.6000000000000001 109.898 175.528 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.0 -18.88 26.95 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 112.856 0.687 . . . . 0.65000000000000002 112.856 176.113 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.27 -50.44 39.49 Favored 'General case' 0 N--CA 1.449 -0.49 0 O-C-N 119.937 -1.727 . . . . 0.52000000000000002 109.074 169.058 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -52.73 -45.07 66.83 Favored 'General case' 0 C--N 1.34 0.16 0 CA-C-O 118.462 -0.78 . . . . 6.3499999999999996 110.426 -177.275 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.4 HG21 ' CD1' ' A' ' 69' ' ' TYR 0.268 3.3 pt -55.4 -59.59 2.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 CA-C-O 118.788 -0.625 . . . . 0.80000000000000004 110.289 179.911 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.46 ' HG3' ' HB1' ' A' ' 37' ' ' ALA . 0.6 OUTLIER -52.51 -45.23 66.14 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 119.516 1.053 . . . . 2.6699999999999999 111.923 178.199 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 35.6 mmtm -66.84 -42.62 85.44 Favored 'General case' 0 CA--C 1.537 0.479 0 O-C-N 121.301 -0.874 . . . . 2.02 111.427 -177.346 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -63.1 -28.57 72.36 Favored Glycine 0 CA--C 1.53 1.023 0 N-CA-C 111.165 -0.774 . . . . 0.57999999999999996 111.165 171.063 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.512 HD22 HG21 ' A' ' 34' ' ' VAL . 0.6 OUTLIER -66.19 -47.63 73.28 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 108.801 -0.814 . . . . 1.6000000000000001 108.801 175.394 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.635 ' HE2' ' HA ' ' A' ' 36' ' ' ASP . 24.9 ttmt -52.09 -37.08 52.85 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 122.822 0.449 . . . . 2.7599999999999998 111.553 174.435 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 13.6 mmt180 -59.62 -11.49 4.99 Favored 'General case' 0 CA--C 1.542 0.669 0 O-C-N 121.097 -1.002 . . . . 3.27 113.477 177.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . 0.629 ' CE ' ' HB1' ' A' ' 59' ' ' ALA . 4.0 ptm -82.74 152.56 66.52 Favored Pre-proline 0 CA--C 1.535 0.376 0 CA-C-N 120.058 1.299 . . . . 3.3100000000000001 112.222 178.464 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -62.25 120.7 8.39 Favored 'Trans proline' 0 N--CA 1.452 -0.92 0 C-N-CA 122.283 1.989 . . . . 1.05 109.17 171.683 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 114.25 -24.85 11.09 Favored Glycine 0 CA--C 1.527 0.792 0 CA-C-O 118.336 -1.258 . . . . 1.01 113.451 172.264 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.512 HG21 HD22 ' A' ' 28' ' ' LEU . 61.5 t -96.99 118.14 42.86 Favored 'Isoleucine or valine' 0 C--N 1.343 0.317 0 CA-C-N 119.408 1.604 . . . . 1.1899999999999999 110.876 174.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 39.6 m -95.59 -35.88 11.46 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-O 117.801 -1.095 . . . . 1.3 112.483 -175.1 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.635 ' HA ' ' HE2' ' A' ' 29' ' ' LYS . 0.2 OUTLIER -145.23 164.27 31.88 Favored 'General case' 0 C--N 1.344 0.329 0 CA-C-N 120.273 1.397 . . . . 2.0499999999999998 110.622 164.258 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.46 ' HB1' ' HG3' ' A' ' 25' ' ' GLU . . . -158.52 135.17 9.54 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 116.313 -0.403 . . . . 0.64000000000000001 110.864 -174.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -149.1 110.14 4.35 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 106.115 -1.809 . . . . 0.59999999999999998 106.115 -161.445 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 10.3 p -89.37 131.79 35.76 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.764 0 N-CA-C 108.384 -0.969 . . . . 0.57999999999999996 108.384 179.196 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 64.1 t-20 -118.96 71.4 0.85 Allowed 'General case' 0 C--O 1.234 0.273 0 C-N-CA 124.758 1.223 . . . . 0.96999999999999997 109.083 -178.029 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.604 HD22 ' H ' ' A' ' 41' ' ' LEU . 2.0 mm? -67.6 -25.59 65.84 Favored 'General case' 0 C--O 1.226 -0.167 0 CA-C-N 115.146 -0.933 . . . . 3.0600000000000001 110.22 -178.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -51.42 -34.78 36.31 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-O 118.802 -0.618 . . . . 0.95999999999999996 111.666 172.254 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.3 t -115.13 22.78 13.05 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 118.278 0.49 . . . . 1.3899999999999999 111.402 172.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 47.14 44.52 15.48 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.574 1.55 . . . . 3.7599999999999998 113.743 179.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 51.8 m -139.89 145.64 38.27 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 108.417 -0.957 . . . . 1.1399999999999999 108.417 -179.704 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 5.2 p -110.73 143.57 20.41 Favored 'Isoleucine or valine' 0 C--O 1.232 0.18 0 C-N-CA 124.404 1.082 . . . . 0.41999999999999998 109.095 175.5 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 26.9 m120 -127.08 137.74 53.08 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 107.446 -1.316 . . . . 0.55000000000000004 107.446 178.523 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 59.9 t -131.47 124.25 54.27 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 N-CA-C 105.279 -2.119 . . . . 2.0499999999999998 105.279 -177.446 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 17.0 mm -102.17 87.51 1.23 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.421 0 C-N-CA 125.498 1.519 . . . . 0.54000000000000004 106.981 -173.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 6.8 p90 -120.24 171.33 8.57 Favored 'General case' 0 CA--C 1.509 -0.631 0 CA-C-N 116.227 -0.442 . . . . 1.8 110.333 -168.684 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -101.28 107.71 51.76 Favored Pre-proline 0 N--CA 1.449 -0.512 0 N-CA-C 108.822 -0.807 . . . . 4.6100000000000003 108.822 -175.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -71.45 7.71 1.42 Allowed 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 123.037 2.492 . . . . 1.1100000000000001 113.552 -174.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -83.03 -22.62 33.52 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 118.706 0.685 . . . . 1.51 109.312 167.524 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -122.36 -55.82 1.83 Allowed 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.367 1.067 . . . . 3.3700000000000001 110.642 -169.546 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.887 HG22 ' HB3' ' A' ' 59' ' ' ALA 0.278 0.8 OUTLIER -86.41 -171.78 3.72 Favored 'General case' 0 CA--C 1.52 -0.18 0 C-N-CA 123.998 0.919 . . . . 0.75 112.391 161.136 . . . . . . . . 4 4 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 134.3 87.02 0.27 Allowed Glycine 0 N--CA 1.443 -0.885 0 N-CA-C 104.265 -3.534 . . . . 2.4199999999999999 104.265 -153.004 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 68.2 p -14.78 -21.2 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.604 1 C-N-CA 138.119 6.568 . . . . 1.6000000000000001 119.42 -143.589 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -28.51 -62.6 0.11 Allowed 'General case' 0 N--CA 1.442 -0.859 0 C-N-CA 127.651 2.381 . . . . 1.1699999999999999 114.13 165.44 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.887 ' HB3' HG22 ' A' ' 55' ' ' THR . . . -74.72 -31.23 61.78 Favored 'General case' 0 C--N 1.332 -0.162 0 C-N-CA 119.06 -1.056 . . . . 0.97999999999999998 109.64 -168.005 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.4 mp -57.95 -55.0 24.43 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.634 0 C-N-CA 123.688 0.795 . . . . 0.80000000000000004 109.794 174.506 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.29 -44.09 88.35 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 119.213 0.915 . . . . 1.46 110.027 -178.354 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -52.77 -53.9 41.6 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 122.143 0.973 . . . . 3.0800000000000001 111.015 176.16 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -65.32 -40.27 93.5 Favored 'General case' 0 N--CA 1.443 -0.816 0 O-C-N 121.171 -0.956 . . . . 2.4500000000000002 111.725 -179.453 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 5.0 mm -49.34 -52.53 11.14 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 C-N-CA 125.298 1.439 . . . . 0.64000000000000001 108.548 175.842 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -56.04 -57.12 13.48 Favored 'General case' 0 C--N 1.342 0.245 0 C-N-CA 123.262 0.625 . . . . 2.23 110.858 175.44 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.47 -38.21 71.37 Favored 'General case' 0 CA--C 1.537 0.46 0 O-C-N 121.844 -0.535 . . . . 5.0099999999999998 111.895 -176.704 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 37.4 mt -67.23 -17.8 64.97 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.975 1.31 . . . . 1.05 111.57 176.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 92.68 32.93 7.74 Favored Glycine 0 CA--C 1.523 0.564 0 C-N-CA 124.543 1.068 . . . . 0.62 111.065 176.366 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.4 ' CD1' HG21 ' A' ' 24' ' ' ILE . 0.3 OUTLIER -128.94 174.14 9.78 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 117.932 0.866 . . . . 1.8899999999999999 110.558 -179.121 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 2.6 t-80 -138.99 128.55 24.52 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 108.126 -1.064 . . . . 1.6699999999999999 108.126 173.177 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.2 t -104.67 152.29 6.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 C-N-CA 124.766 1.226 . . . . 2.0699999999999998 107.82 173.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 96.6 t -117.34 144.88 24.06 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 C-N-CA 125.687 1.595 . . . . 0.68000000000000005 108.657 -179.438 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 34.1 mm . . . . . 0 N--CA 1.453 -0.28 0 C-N-CA 125.162 1.385 . . . . 1.1000000000000001 109.27 -170.798 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.1 m . . . . . 0 N--CA 1.451 -0.404 0 N-CA-C 107.053 -1.462 . . . . 0.91000000000000003 107.053 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -69.05 178.06 2.41 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-O 121.332 0.587 . . . . 2.6499999999999999 109.856 169.463 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -132.14 145.82 51.63 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 106.628 -1.619 . . . . 0.93000000000000005 106.628 162.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 12.9 mmtp -137.63 159.36 42.18 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 124.351 1.06 . . . . 3.6699999999999999 109.394 164.491 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -119.05 102.02 8.44 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 126.915 2.086 . . . . 1.6100000000000001 107.725 -174.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 3.1 mm -83.95 162.92 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 N-CA-C 107.827 -1.175 . . . . 1.9399999999999999 107.827 177.114 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -136.74 117.74 14.28 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 119.404 1.002 . . . . 0.85999999999999999 110.116 176.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 57.5 mtm -135.33 176.53 8.59 Favored 'General case' 0 CA--C 1.535 0.385 0 O-C-N 121.481 -0.762 . . . . 1.9399999999999999 110.388 -174.518 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.61 168.46 9.07 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 125.958 1.703 . . . . 3.6600000000000001 110.018 173.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.497 HG21 HD21 ' A' ' 41' ' ' LEU . 2.7 m -128.7 153.92 38.89 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 C-N-CA 124.019 0.928 . . . . 1.8300000000000001 111.571 174.552 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 71.1 m -119.59 175.13 6.0 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 125.391 1.476 . . . . 1.04 110.131 174.601 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 80.45 -44.87 2.97 Favored Glycine 0 CA--C 1.533 1.2 0 C-N-CA 123.717 0.675 . . . . 2.7000000000000002 113.435 171.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -42.2 141.05 0.99 Allowed 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 125.698 1.599 . . . . 2.0600000000000001 113.91 -178.154 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -148.58 -45.55 0.15 Allowed 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.788 1.235 . . . . 3.02 113.792 178.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 21.8 p -76.02 -4.85 43.52 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 120.286 1.403 . . . . 3.3500000000000001 112.434 -179.195 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 60.81 33.28 20.09 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 124.688 1.195 . . . . 2.4300000000000002 111.826 174.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -143.79 -44.02 0.27 Allowed 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 123.844 0.858 . . . . 1.01 111.136 -179.243 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 11.5 p -51.79 -33.27 34.71 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.53 0.732 . . . . 2.6699999999999999 112.268 174.345 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.539 ' HB1' HG21 ' A' ' 39' ' ' VAL . . . -49.96 -34.2 20.07 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.265 1.026 . . . . 0.40999999999999998 111.855 172.794 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -69.98 -49.65 49.56 Favored 'General case' 0 N--CA 1.453 -0.305 0 O-C-N 120.331 -1.48 . . . . 0.34000000000000002 109.887 172.12 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 20.1 mmm180 -52.74 -44.03 66.15 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 119.007 -0.52 . . . . 4.79 110.655 -174.017 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.2 pt -59.75 -54.22 37.55 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 C-N-CA 119.885 -0.726 . . . . 0.52000000000000002 111.559 178.208 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -55.28 -44.75 75.94 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-N 118.795 0.725 . . . . 2.1899999999999999 111.753 177.408 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 30.7 mmtp -71.77 -39.9 69.64 Favored 'General case' 0 CA--C 1.53 0.183 0 O-C-N 121.61 -0.681 . . . . 1.8500000000000001 110.84 -174.613 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.95 -43.61 98.65 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 109.627 -1.389 . . . . 0.73999999999999999 109.627 170.336 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -59.31 -36.93 76.52 Favored 'General case' 0 CA--C 1.541 0.606 0 O-C-N 121.442 -1.034 . . . . 2.3799999999999999 109.362 178.655 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.6 ttpp -58.68 -20.06 45.07 Favored 'General case' 0 CA--C 1.537 0.473 0 O-C-N 120.556 -1.34 . . . . 2.3900000000000001 113.685 174.214 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 22.3 mtt-85 -83.82 -6.22 59.38 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.847 0.859 . . . . 3.29 111.933 177.229 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 21.9 mmt -86.17 154.23 57.32 Favored Pre-proline 0 CA--C 1.531 0.24 0 CA-C-N 118.763 0.71 . . . . 4.6299999999999999 109.467 -174.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -56.08 148.17 60.36 Favored 'Trans proline' 0 N--CA 1.453 -0.87 0 C-N-CA 121.816 1.678 . . . . 0.72999999999999998 110.34 176.21 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 84.36 -33.18 3.22 Favored Glycine 0 CA--C 1.524 0.636 0 CA-C-O 119.855 -0.414 . . . . 0.5 113.197 175.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 15.3 t -82.78 137.86 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 CA-C-N 118.206 1.003 . . . . 0.56999999999999995 109.204 177.61 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -110.63 -49.89 3.0 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-O 118.255 -0.878 . . . . 0.91000000000000003 109.661 175.91 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -138.39 160.84 38.49 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 119.173 0.897 . . . . 2.3300000000000001 109.98 179.331 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -156.61 147.54 21.93 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 122.846 0.458 . . . . 0.45000000000000001 110.685 -179.473 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.401 HD21 HD11 ' A' ' 49' ' ' ILE . 0.0 OUTLIER -154.07 116.93 4.45 Favored 'General case' 0 C--N 1.34 0.193 0 N-CA-C 108.64 -0.874 . . . . 0.5 108.64 -164.14 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.874 HG22 HD23 ' A' ' 41' ' ' LEU . 8.6 p -93.9 96.65 6.23 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 C-N-CA 123.921 0.888 . . . . 0.59999999999999998 110.026 -175.103 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 51.1 t-20 -83.35 56.96 3.76 Favored 'General case' 0 CA--C 1.536 0.407 0 O-C-N 120.641 -1.287 . . . . 0.60999999999999999 110.248 -175.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.874 HD23 HG22 ' A' ' 39' ' ' VAL . 0.6 OUTLIER -70.5 -21.15 62.79 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 115.486 -0.779 . . . . 1.1399999999999999 110.933 -176.468 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -45.56 -34.67 3.47 Favored 'General case' 0 C--N 1.338 0.096 0 C-N-CA 124.043 0.937 . . . . 0.67000000000000004 112.194 167.81 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 8.7 t -131.8 45.43 2.78 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 108.863 -0.791 . . . . 1.48 108.863 172.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 37.47 52.54 1.29 Allowed 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.886 1.674 . . . . 4.0199999999999996 113.793 175.091 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -134.34 165.97 23.9 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 108.263 -1.014 . . . . 1.6200000000000001 108.263 173.641 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.7 p -139.18 139.37 39.89 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 N-CA-C 107.352 -1.351 . . . . 0.45000000000000001 107.352 173.224 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 20.4 m120 -126.85 137.42 53.18 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 107.816 -1.179 . . . . 0.29999999999999999 107.816 -178.58 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.1 p -135.0 124.23 42.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 N-CA-C 106.562 -1.644 . . . . 1.9099999999999999 106.562 -173.488 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.401 HD11 HD21 ' A' ' 38' ' ' ASN . 7.5 mm -107.12 96.92 5.03 Favored 'Isoleucine or valine' 0 C--O 1.24 0.56 0 C-N-CA 125.332 1.453 . . . . 0.47999999999999998 107.871 -168.048 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 46.8 p90 -137.94 165.38 26.66 Favored 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 112.198 0.444 . . . . 1.73 112.198 -170.284 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 26.8 t0 -84.2 110.49 26.64 Favored Pre-proline 0 CA--C 1.535 0.379 0 O-C-N 124.412 1.07 . . . . 3.0800000000000001 110.551 173.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -72.38 4.4 3.43 Favored 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 123.149 2.566 . . . . 0.63 113.508 -178.345 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -86.12 -29.57 23.21 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 119.46 1.027 . . . . 0.80000000000000004 109.194 167.542 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -104.87 -57.56 2.01 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 123.578 0.751 . . . . 3.6499999999999999 109.102 -168.471 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.404 ' CG2' ' HB3' ' A' ' 59' ' ' ALA 0.308 1.3 p -89.76 -173.91 4.1 Favored 'General case' 0 CA--C 1.521 -0.159 0 CA-C-O 121.015 0.436 . . . . 0.45000000000000001 111.134 158.361 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 136.78 87.77 0.21 Allowed Glycine 0 N--CA 1.442 -0.965 0 N-CA-C 103.71 -3.756 . . . . 2.46 103.71 -152.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 66.6 p -12.35 -17.73 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.49 1 C-N-CA 137.778 6.431 . . . . 1.0700000000000001 119.863 -144.112 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -26.44 -62.98 0.08 Allowed 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 127.085 2.154 . . . . 0.55000000000000004 113.834 165.213 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.404 ' HB3' ' CG2' ' A' ' 55' ' ' THR . . . -72.91 -42.09 63.89 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 117.643 -1.623 . . . . 0.52000000000000002 109.866 -168.83 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.4 mp -49.71 -57.57 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.816 0 CA-C-N 114.237 -1.347 . . . . 0.83999999999999997 109.258 175.444 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.17 -45.82 83.34 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 118.586 0.63 . . . . 1.49 110.856 -174.656 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -45.06 -60.07 2.28 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 122.574 1.178 . . . . 3.1099999999999999 110.374 172.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 4.6 mmpt? -70.18 -38.73 75.44 Favored 'General case' 0 N--CA 1.431 -1.384 0 CA-C-N 115.341 -0.845 . . . . 3.1499999999999999 112.005 -173.802 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -48.66 -54.1 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 C-N-CA 124.889 1.276 . . . . 0.34999999999999998 107.8 175.372 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -60.09 -54.63 43.7 Favored 'General case' 0 C--N 1.34 0.182 0 C-N-CA 123.722 0.809 . . . . 1.6799999999999999 110.231 176.71 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.9 tmtm? -56.83 -35.38 68.74 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 112.937 0.717 . . . . 3.6899999999999999 112.937 -176.185 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 12.9 mt -70.59 -18.7 62.89 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 125.705 1.602 . . . . 0.69999999999999996 111.645 175.678 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 93.05 44.25 3.88 Favored Glycine 0 CA--C 1.525 0.681 0 C-N-CA 124.642 1.115 . . . . 0.56000000000000005 110.553 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -139.6 173.99 10.97 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 123.688 0.795 . . . . 1.9199999999999999 110.663 -177.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 18.8 t-160 -148.78 128.12 13.0 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 108.601 -0.889 . . . . 1.9199999999999999 108.601 175.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 14.5 p -100.28 135.1 37.63 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 C-N-CA 126.259 1.824 . . . . 1.45 108.336 178.621 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 15.8 t -100.32 131.94 46.88 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 C-N-CA 124.272 1.029 . . . . 0.79000000000000004 109.227 -179.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 27.6 mm . . . . . 0 N--CA 1.451 -0.417 0 C-N-CA 124.508 1.123 . . . . 1.1299999999999999 108.601 -173.125 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.2 m . . . . . 0 N--CA 1.451 -0.42 0 N-CA-C 105.029 -2.212 . . . . 0.82999999999999996 105.029 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -78.16 157.02 29.55 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 106.925 -1.509 . . . . 2.3199999999999998 106.925 167.578 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -111.03 148.37 32.74 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 124.436 1.095 . . . . 1.1399999999999999 108.106 176.65 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.433 ' NZ ' ' OE1' ' A' ' 7' ' ' GLU . 0.0 OUTLIER -135.92 153.66 51.37 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 121.769 0.795 . . . . 4.0599999999999996 109.075 159.425 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.433 ' OE1' ' NZ ' ' A' ' 6' ' ' LYS . 0.5 OUTLIER -84.05 144.39 29.11 Favored 'General case' 0 N--CA 1.442 -0.87 0 C-N-CA 126.651 1.981 . . . . 2.04 107.472 168.273 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -125.17 164.16 24.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 107.664 -1.235 . . . . 2.7400000000000002 107.664 168.027 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -136.22 124.05 22.61 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 106.669 -1.604 . . . . 0.59999999999999998 106.669 177.34 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 39.3 mtm -139.6 170.37 16.03 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 108.784 -0.821 . . . . 1.98 108.784 -178.328 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 30.8 mm100 -97.68 163.03 13.0 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.288 1.035 . . . . 2.9100000000000001 109.618 177.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 52.4 t -121.96 149.06 25.23 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 C-N-CA 124.815 1.246 . . . . 1.24 109.138 -173.25 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 17.9 m -155.44 174.3 15.44 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.716 1.206 . . . . 1.29 108.395 169.42 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 64.42 65.6 2.91 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 109.931 -1.268 . . . . 1.9099999999999999 109.931 -179.017 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 5.5 ppp? -139.54 154.32 47.63 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 123.917 0.887 . . . . 3.25 110.103 -171.442 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.8 p -99.54 -63.89 1.09 Allowed 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 125.945 1.698 . . . . 3.48 108.638 171.225 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 19.9 p -138.0 161.75 35.88 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 124.291 1.036 . . . . 2.2599999999999998 110.636 -175.416 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -76.48 49.82 0.62 Allowed 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.43 1.092 . . . . 1.72 111.124 179.552 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -142.31 -49.54 0.37 Allowed 'General case' 0 N--CA 1.457 -0.119 0 C-N-CA 124.878 1.271 . . . . 0.68999999999999995 109.008 178.368 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 38.3 m -57.8 -36.82 72.73 Favored 'General case' 0 CA--C 1.533 0.298 0 O-C-N 121.365 -0.835 . . . . 1.1699999999999999 110.059 168.512 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -51.28 -31.8 22.52 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.951 0.901 . . . . 0.55000000000000004 112.209 170.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -73.58 -53.4 10.59 Favored 'General case' 0 N--CA 1.453 -0.31 0 O-C-N 120.663 -1.273 . . . . 0.48999999999999999 109.647 170.77 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 48.9 mmm-85 -47.56 -46.16 27.71 Favored 'General case' 0 C--O 1.23 0.068 0 C-N-CA 123.609 0.764 . . . . 3.8900000000000001 111.215 -175.054 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.448 HG21 ' CD1' ' A' ' 69' ' ' TYR . 5.4 pt -55.1 -53.13 37.52 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 CA-C-O 119.129 -0.462 . . . . 0.45000000000000001 111.823 177.686 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -60.23 -42.28 94.88 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 118.819 0.736 . . . . 2.25 111.257 179.599 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.6 mptm? -68.24 -44.23 76.13 Favored 'General case' 0 CA--C 1.528 0.108 0 O-C-N 121.743 -0.598 . . . . 2.79 109.897 -176.391 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -57.32 -47.82 85.06 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 109.468 -1.453 . . . . 0.79000000000000004 109.468 171.721 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -58.5 -40.49 82.96 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.702 0.801 . . . . 2.3300000000000001 110.318 -175.373 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 12.8 ttmt -44.22 -34.75 1.99 Allowed 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 118.608 0.64 . . . . 2.8100000000000001 112.358 173.709 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 43.7 ttm-85 -67.27 -8.6 33.23 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 113.414 0.894 . . . . 3.8199999999999998 113.414 -172.869 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 1.6 mpp? -87.56 158.51 51.29 Favored Pre-proline 0 CA--C 1.537 0.463 0 CA-C-N 119.347 0.976 . . . . 4.1699999999999999 111.419 178.749 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -62.99 153.81 71.15 Favored 'Trans proline' 0 N--CA 1.456 -0.694 0 C-N-CA 123.142 2.561 . . . . 0.91000000000000003 112.077 -176.239 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 74.0 -35.65 0.91 Allowed Glycine 0 CA--C 1.525 0.683 0 C-N-CA 124.761 1.172 . . . . 0.80000000000000004 112.616 -178.142 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 11.6 t -71.88 130.97 35.2 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 O-C-N 121.074 -1.25 . . . . 0.54000000000000004 108.655 175.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -118.61 -43.11 2.71 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 118.677 -0.678 . . . . 0.93999999999999995 109.88 179.844 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -140.73 164.85 29.09 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 119.221 0.919 . . . . 2.02 112.016 168.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -157.69 140.65 15.07 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.139 -0.937 . . . . 0.40000000000000002 109.185 -171.595 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -153.52 107.11 2.99 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 106.198 -1.778 . . . . 0.48999999999999999 106.198 -164.839 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 4.2 p -80.23 122.85 36.19 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 N-CA-C 107.232 -1.396 . . . . 0.62 107.232 175.392 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 57.7 t-20 -102.2 56.27 0.8 Allowed 'General case' 0 C--O 1.235 0.311 0 N-CA-C 106.893 -1.521 . . . . 0.57999999999999996 106.893 178.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.14 -20.95 64.04 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 114.259 -1.337 . . . . 1.0700000000000001 109.589 -173.146 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -45.52 -37.15 5.09 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 124.118 0.967 . . . . 0.54000000000000004 112.267 167.015 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 6.3 t -122.75 40.24 3.74 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 121.65 0.738 . . . . 1.27 109.235 173.686 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 39.0 46.61 1.13 Allowed 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 126.888 2.075 . . . . 2.6200000000000001 113.015 178.718 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 52.3 m -128.03 155.51 44.21 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 125.0 1.32 . . . . 0.80000000000000004 108.3 -178.439 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.0 p -121.56 142.23 38.69 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 N-CA-C 108.417 -0.957 . . . . 0.40000000000000002 108.417 168.45 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 21.4 m120 -126.1 139.1 53.65 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 107.28 -1.378 . . . . 0.47999999999999998 107.28 174.771 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 20.5 t -132.89 135.84 56.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 N-CA-C 104.941 -2.244 . . . . 2.0099999999999998 104.941 -178.45 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 15.0 mm -112.05 92.24 2.01 Favored 'Isoleucine or valine' 0 C--O 1.24 0.578 0 N-CA-C 106.758 -1.571 . . . . 0.46999999999999997 106.758 -179.452 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -127.27 171.89 11.08 Favored 'General case' 0 CA--C 1.509 -0.625 0 CA-C-N 116.596 -0.275 . . . . 2.3100000000000001 110.492 -176.368 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 -94.38 105.66 19.15 Favored Pre-proline 0 N--CA 1.448 -0.533 0 O-C-N 124.397 1.061 . . . . 3.7999999999999998 108.615 176.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -69.98 5.75 1.66 Allowed 'Trans proline' 0 CA--C 1.538 0.679 0 C-N-CA 122.323 2.015 . . . . 0.60999999999999999 113.03 -179.245 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -85.66 -27.94 25.06 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 123.72 0.808 . . . . 0.75 109.43 169.044 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -112.47 -61.43 1.73 Allowed 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.281 1.032 . . . . 2.8100000000000001 110.05 -173.455 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.413 ' HB ' ' H ' ' A' ' 56' ' ' GLY 0.486 0.5 OUTLIER -85.12 -169.1 2.49 Favored 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 114.055 1.131 . . . . 0.81999999999999995 114.055 162.908 . . . . . . . . 4 4 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.413 ' H ' ' HB ' ' A' ' 55' ' ' THR . . . 158.59 -150.13 20.66 Favored Glycine 0 N--CA 1.434 -1.437 0 N-CA-C 103.56 -3.816 . . . . 2.6800000000000002 103.56 -157.456 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 15.0 p -75.96 -37.38 58.67 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 124.986 1.314 . . . . 1.49 109.687 -179.322 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -54.48 -63.79 1.04 Allowed 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 124.404 1.082 . . . . 0.70999999999999996 113.191 -164.277 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.77 -35.73 79.2 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 118.483 -1.287 . . . . 0.56999999999999995 108.87 -167.726 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.7 mp -55.17 -58.57 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.115 0 CA-C-N 114.205 -1.361 . . . . 1.25 109.212 173.52 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.63 -46.58 88.58 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 119.698 1.136 . . . . 1.8200000000000001 109.363 -175.46 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -48.86 -55.65 11.05 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 121.394 0.616 . . . . 4.0700000000000003 110.515 177.005 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.0 mmpt? -71.2 -40.68 71.03 Favored 'General case' 0 N--CA 1.435 -1.191 0 CA-C-O 118.333 -0.842 . . . . 2.4300000000000002 112.907 -177.36 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 3.4 mm -47.93 -52.4 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 C-N-CA 126.387 1.875 . . . . 0.62 107.703 176.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -53.74 -61.09 2.53 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 115.689 -0.687 . . . . 3.52 111.138 173.246 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -62.23 -29.38 70.35 Favored 'General case' 0 CA--C 1.542 0.669 0 O-C-N 121.779 -0.576 . . . . 5.2999999999999998 112.088 -172.256 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 36.4 mt -71.06 -19.94 62.43 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.778 1.631 . . . . 0.57999999999999996 111.377 173.043 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 89.56 40.85 5.88 Favored Glycine 0 CA--C 1.525 0.704 0 C-N-CA 124.688 1.137 . . . . 0.48999999999999999 111.474 176.741 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.448 ' CD1' HG21 ' A' ' 24' ' ' ILE . 0.5 OUTLIER -131.6 174.45 10.1 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 124.201 1.0 . . . . 1.8400000000000001 110.268 178.207 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 10.9 t-160 -151.05 126.26 9.94 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 109.608 -0.515 . . . . 2.23 109.608 167.073 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 20.3 m -82.27 167.7 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 N-CA-C 109.216 -0.661 . . . . 2.2400000000000002 109.216 176.013 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 15.2 t -130.9 145.52 35.39 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 N-CA-C 107.837 -1.171 . . . . 0.73999999999999999 107.837 178.723 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 29.4 mm . . . . . 0 CA--C 1.532 0.265 0 C-N-CA 124.356 1.062 . . . . 1.3200000000000001 109.108 -171.252 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 50.3 m . . . . . 0 N--CA 1.453 -0.308 0 N-CA-C 112.843 0.683 . . . . 0.89000000000000001 112.843 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -70.54 -177.39 1.49 Allowed 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 121.321 0.582 . . . . 2.1099999999999999 109.693 174.522 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -134.79 146.02 48.95 Favored 'General case' 0 N--CA 1.447 -0.575 0 N-CA-C 107.258 -1.386 . . . . 1.27 107.258 168.081 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 50.1 mtmt -142.42 162.14 36.25 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 123.271 0.628 . . . . 3.4300000000000002 109.378 159.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.3 mp0 -121.22 86.38 2.56 Favored 'General case' 0 N--CA 1.442 -0.86 0 C-N-CA 127.904 2.482 . . . . 1.8999999999999999 106.855 -166.144 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.494 ' N ' HD12 ' A' ' 8' ' ' ILE . 3.4 mp -82.56 163.06 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.258 0 N-CA-C 106.427 -1.694 . . . . 2.2000000000000002 106.427 -175.133 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -138.67 134.37 33.57 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 125.469 1.508 . . . . 0.47999999999999998 108.31 -176.146 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -156.28 174.32 15.57 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 118.346 0.521 . . . . 2.71 110.736 175.344 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 29.0 mm100 -93.57 160.68 14.68 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.931 1.293 . . . . 2.6800000000000002 109.923 -178.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 21.3 t -119.43 154.87 22.05 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 C-N-CA 124.23 1.012 . . . . 1.22 109.27 -171.117 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 32.1 t -154.47 175.82 13.11 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 118.588 0.631 . . . . 1.97 110.358 170.837 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 59.09 72.53 0.59 Allowed Glycine 0 CA--C 1.528 0.854 0 N-CA-C 110.252 -1.139 . . . . 2.0499999999999998 110.252 -174.322 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -144.83 159.96 42.04 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 123.746 0.818 . . . . 2.0299999999999998 110.567 -172.447 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -100.11 -65.12 0.99 Allowed 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 125.955 1.702 . . . . 3.0699999999999998 110.246 169.1 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 2.0 p -150.54 164.15 36.69 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 123.32 0.648 . . . . 2.0899999999999999 110.371 -166.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -72.75 32.86 0.07 Allowed 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.661 1.584 . . . . 1.78 113.751 -172.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -114.9 -47.84 2.86 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 126.314 1.845 . . . . 0.70999999999999996 108.74 171.616 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 38.0 m -66.0 -38.09 87.58 Favored 'General case' 0 N--CA 1.455 -0.185 0 O-C-N 121.435 -0.791 . . . . 1.25 110.653 -170.296 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.846 ' HB1' HG21 ' A' ' 39' ' ' VAL . . . -56.62 -28.75 61.14 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 116.25 -0.432 . . . . 0.58999999999999997 111.306 173.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.84 -50.25 65.27 Favored 'General case' 0 N--CA 1.455 -0.207 0 O-C-N 120.158 -1.589 . . . . 0.46999999999999997 109.118 171.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 28.5 mmm180 -53.04 -48.53 67.55 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 118.792 -0.623 . . . . 5.1699999999999999 110.336 -178.152 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.496 HG21 ' CD1' ' A' ' 69' ' ' TYR 0.271 1.8 pt -58.14 -56.34 16.59 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.44 0 C-N-CA 119.304 -0.958 . . . . 0.48999999999999999 110.765 179.703 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -53.68 -42.03 67.51 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 119.594 1.088 . . . . 2.6200000000000001 112.582 179.325 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -70.02 -43.67 70.87 Favored 'General case' 0 CA--C 1.535 0.394 0 O-C-N 121.163 -0.961 . . . . 2.0099999999999998 110.717 -177.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -66.89 -33.19 83.25 Favored Glycine 0 CA--C 1.529 0.964 0 N-CA-C 111.254 -0.738 . . . . 0.65000000000000002 111.254 175.281 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -66.03 -46.36 78.16 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 125.021 1.328 . . . . 2.2599999999999998 107.635 178.444 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 14.3 ttmt -49.11 -34.88 14.96 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 118.758 0.708 . . . . 3.25 112.405 176.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -59.61 -20.99 59.69 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 113.124 0.787 . . . . 5.3700000000000001 113.124 179.575 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.52 158.83 84.02 Favored Pre-proline 0 CA--C 1.54 0.573 0 C-N-CA 123.99 0.916 . . . . 4.3099999999999996 111.93 -174.045 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 78.9 Cg_endo -73.05 115.52 4.38 Favored 'Trans proline' 0 N--CA 1.453 -0.901 0 C-N-CA 121.871 1.714 . . . . 1.04 109.691 175.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 124.38 -36.55 2.88 Favored Glycine 0 CA--C 1.529 0.915 0 C-N-CA 124.343 0.973 . . . . 0.80000000000000004 112.446 172.57 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 57.8 t -80.17 142.32 14.08 Favored 'Isoleucine or valine' 0 C--N 1.34 0.192 0 CA-C-N 118.01 0.905 . . . . 0.71999999999999997 109.193 173.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.5 m -115.47 -41.79 3.22 Favored 'General case' 0 C--N 1.338 0.068 0 C-N-CA 123.292 0.637 . . . . 1.6899999999999999 110.947 -176.034 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -136.91 165.83 25.07 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 123.629 0.771 . . . . 2.04 110.329 169.654 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -158.92 142.81 15.25 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 122.73 0.412 . . . . 0.46000000000000002 111.261 -177.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -154.97 107.5 2.75 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 106.228 -1.767 . . . . 0.42999999999999999 106.228 -167.497 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.846 HG21 ' HB1' ' A' ' 21' ' ' ALA . 4.2 p -80.02 135.8 24.73 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 N-CA-C 107.613 -1.255 . . . . 0.83999999999999997 107.613 174.251 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 54.4 t-20 -122.24 55.98 1.12 Allowed 'General case' 0 C--O 1.235 0.294 0 CA-C-O 122.844 1.307 . . . . 0.80000000000000004 107.895 -179.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.655 HD23 HG22 ' A' ' 39' ' ' VAL . 0.4 OUTLIER -64.72 -20.21 66.2 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-N 114.169 -1.378 . . . . 0.96999999999999997 110.515 179.107 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -49.63 -37.2 27.21 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 118.829 -0.605 . . . . 0.55000000000000004 112.124 167.014 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 13.5 t -114.33 23.57 12.71 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 118.362 0.528 . . . . 1.26 111.206 171.436 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 65.67 20.18 11.52 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.665 1.586 . . . . 2.7000000000000002 114.353 175.078 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 25.6 m -122.05 164.17 18.15 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.657 1.183 . . . . 0.67000000000000004 109.797 -173.209 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.7 p -128.5 146.75 33.44 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 O-C-N 120.789 -1.194 . . . . 0.37 109.521 172.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -129.59 136.77 50.19 Favored 'General case' 0 C--N 1.345 0.41 0 N-CA-C 107.814 -1.18 . . . . 0.35999999999999999 107.814 175.696 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -130.75 130.07 64.29 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.797 0 N-CA-C 105.245 -2.131 . . . . 2.3999999999999999 105.245 179.687 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 11.9 mm -103.48 99.33 8.17 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 N-CA-C 106.051 -1.833 . . . . 0.46999999999999997 106.051 -174.401 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.47 ' CE2' HD13 ' A' ' 8' ' ' ILE . 46.0 p90 -136.05 169.86 16.93 Favored 'General case' 0 CA--C 1.51 -0.564 0 O-C-N 121.976 -0.453 . . . . 1.6599999999999999 110.98 -170.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 31.1 t0 -90.69 105.49 12.13 Favored Pre-proline 0 C--O 1.234 0.246 0 O-C-N 124.491 1.119 . . . . 3.02 109.208 175.072 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -75.32 8.31 2.59 Favored 'Trans proline' 0 N--CA 1.45 -1.054 0 C-N-CA 122.396 2.064 . . . . 0.68999999999999995 112.353 -177.59 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -87.94 -28.38 21.53 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 119.328 0.967 . . . . 0.96999999999999997 108.928 167.133 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -102.61 -59.11 1.76 Allowed 'General case' 0 C--N 1.344 0.326 0 N-CA-C 108.872 -0.788 . . . . 2.4199999999999999 108.872 -176.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.334 0.7 OUTLIER -86.46 -172.75 4.19 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 125.345 1.458 . . . . 0.55000000000000004 114.1 166.759 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 167.99 -143.19 7.99 Favored Glycine 0 N--CA 1.43 -1.706 1 N-CA-C 101.819 -4.512 . . . . 2.6299999999999999 101.819 -164.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 36.5 p -77.35 -34.77 55.1 Favored 'General case' 0 N--CA 1.442 -0.851 0 C-N-CA 125.918 1.687 . . . . 1.29 109.494 176.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -48.8 -62.92 1.26 Allowed 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 125.166 1.386 . . . . 0.57999999999999996 113.247 -161.262 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -75.31 -30.11 60.24 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 114.936 -1.029 . . . . 0.65000000000000002 109.795 -173.425 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 4.6 mt -57.76 -57.42 10.47 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.739 0 CA-C-O 118.405 -0.807 . . . . 1.46 110.609 177.043 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.25 -43.82 92.4 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 119.079 0.854 . . . . 1.1100000000000001 108.73 -176.844 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -50.66 -56.5 11.6 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 123.481 0.712 . . . . 3.1200000000000001 110.459 178.524 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -66.03 -43.05 88.75 Favored 'General case' 0 N--CA 1.438 -1.072 0 CA-C-O 118.42 -0.8 . . . . 2.1800000000000002 111.879 -179.836 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 3.3 mm -47.98 -51.71 8.35 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 125.781 1.633 . . . . 0.56999999999999995 108.78 176.483 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 38.9 mm-40 -56.13 -58.6 7.25 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.577 0.751 . . . . 1.53 110.598 174.648 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.09 -36.34 72.71 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 121.412 -0.805 . . . . 5.1600000000000001 112.466 -176.586 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 37.9 mt -68.35 -17.62 64.29 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 125.154 1.382 . . . . 0.68999999999999995 111.02 177.106 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 91.68 38.15 5.91 Favored Glycine 0 C--N 1.338 0.65 0 C-N-CA 124.334 0.969 . . . . 0.46000000000000002 110.984 174.224 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.496 ' CD1' HG21 ' A' ' 24' ' ' ILE . 0.3 OUTLIER -133.44 174.81 10.01 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 123.593 0.757 . . . . 1.8999999999999999 110.702 -177.877 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -140.12 167.81 21.26 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 108.706 -0.85 . . . . 1.6599999999999999 108.706 169.094 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 45.5 t -140.01 145.59 26.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 N-CA-C 105.476 -2.046 . . . . 2.1400000000000001 105.476 -171.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 5.8 t -120.64 136.9 56.16 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 C-N-CA 124.671 1.188 . . . . 0.78000000000000003 107.854 -177.422 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 45.7 mm . . . . . 0 N--CA 1.453 -0.298 0 N-CA-C 106.969 -1.493 . . . . 1.4199999999999999 106.969 -178.67 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 5.2 m . . . . . 0 N--CA 1.451 -0.425 0 N-CA-C 106.995 -1.483 . . . . 0.87 106.995 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -68.25 168.86 11.5 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 107.717 -1.216 . . . . 2.4700000000000002 107.717 164.607 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -127.42 147.78 50.29 Favored 'General case' 0 CA--C 1.516 -0.33 0 C-N-CA 124.415 1.086 . . . . 0.97999999999999998 108.359 177.112 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 52.7 mtmt -144.93 159.61 42.64 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 121.839 0.828 . . . . 3.3599999999999999 111.573 163.572 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -97.34 145.82 25.76 Favored 'General case' 0 N--CA 1.442 -0.873 0 C-N-CA 127.787 2.435 . . . . 1.71 108.16 175.553 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.425 HD11 ' CE2' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -127.87 158.58 39.49 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 N-CA-C 105.841 -1.911 . . . . 2.3100000000000001 105.841 173.588 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -136.87 127.96 27.8 Favored 'General case' 0 C--O 1.226 -0.14 0 N-CA-C 107.854 -1.165 . . . . 0.96999999999999997 107.854 179.46 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 3.5 ptp -156.02 177.51 11.34 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 118.434 0.561 . . . . 2.5699999999999998 110.781 -172.947 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 27.7 mm100 -97.47 161.79 13.62 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.243 1.417 . . . . 2.52 110.453 -175.628 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 49.6 t -116.0 157.76 16.69 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 C-N-CA 124.951 1.3 . . . . 1.1499999999999999 109.818 -174.281 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 6.3 m -153.35 169.78 22.26 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.486 0.714 . . . . 0.91000000000000003 110.615 169.441 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 60.44 59.93 9.43 Favored Glycine 0 CA--C 1.529 0.945 0 N-CA-C 110.016 -1.234 . . . . 1.9199999999999999 110.016 -174.825 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -144.71 167.69 21.96 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 124.21 1.004 . . . . 2.0099999999999998 109.982 -174.448 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -143.22 -67.49 0.36 Allowed 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 124.769 1.228 . . . . 2.3199999999999998 108.982 171.342 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 12.2 p -98.84 150.86 21.45 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-O 121.643 0.735 . . . . 2.1699999999999999 111.205 -178.493 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -78.18 47.11 0.65 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.616 0.766 . . . . 1.8899999999999999 110.794 177.358 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -135.29 -53.72 0.79 Allowed 'General case' 0 N--CA 1.457 -0.12 0 C-N-CA 124.305 1.042 . . . . 0.71999999999999997 109.288 177.952 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 34.7 m -55.78 -38.18 69.56 Favored 'General case' 0 C--N 1.338 0.096 0 O-C-N 121.552 -0.718 . . . . 1.1899999999999999 109.64 168.166 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.558 ' HB1' HG21 ' A' ' 39' ' ' VAL . . . -57.25 -22.88 44.36 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 112.547 0.573 . . . . 0.56000000000000005 112.547 175.766 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -73.24 -40.76 64.42 Favored 'General case' 0 C--O 1.232 0.135 0 O-C-N 120.684 -1.26 . . . . 0.44 110.727 170.665 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 18.1 mmm180 -56.75 -39.36 73.85 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 123.391 0.676 . . . . 4.46 109.761 -171.429 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.3 pt -60.18 -65.62 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 C-N-CA 119.454 -0.898 . . . . 1.6699999999999999 111.183 177.38 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.58 ' HG3' ' HB1' ' A' ' 37' ' ' ALA . 2.5 mp0 -46.95 -45.13 20.54 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-N 119.778 1.172 . . . . 2.4700000000000002 112.156 177.858 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 11.2 mptt -70.84 -33.34 70.56 Favored 'General case' 0 CA--C 1.538 0.504 0 O-C-N 121.377 -0.827 . . . . 1.98 110.641 -176.725 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -72.03 -29.11 67.33 Favored Glycine 0 CA--C 1.531 1.071 0 O-C-N 121.377 -0.827 . . . . 0.60999999999999999 112.061 169.715 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.0 mp -69.78 -43.9 71.2 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 118.378 1.089 . . . . 2.8999999999999999 109.432 175.975 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 61.8 tttm -50.35 -31.74 15.42 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.644 0.777 . . . . 2.6800000000000002 111.964 174.206 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 52.8 mtt180 -75.8 -4.38 40.31 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 113.651 0.982 . . . . 5.2300000000000004 113.651 179.484 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 93.0 mmm -93.17 150.47 39.19 Favored Pre-proline 0 C--O 1.232 0.161 0 CA-C-N 119.422 1.01 . . . . 3.5299999999999998 110.264 -178.116 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -56.95 144.06 90.27 Favored 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 121.869 1.713 . . . . 0.62 109.143 173.99 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 88.69 -32.34 4.57 Favored Glycine 0 CA--C 1.525 0.686 0 CA-C-O 119.419 -0.656 . . . . 0.48999999999999999 113.343 179.238 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 14.0 t -87.3 136.88 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.176 0 CA-C-N 118.888 1.344 . . . . 0.60999999999999999 108.438 179.867 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -109.57 -40.9 4.72 Favored 'General case' 0 N--CA 1.456 -0.135 0 CA-C-O 118.305 -0.855 . . . . 0.85999999999999999 110.663 177.679 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -150.61 164.46 35.99 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 108.336 -0.987 . . . . 1.8700000000000001 108.336 172.94 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.58 ' HB1' ' HG3' ' A' ' 25' ' ' GLU . . . -157.77 145.04 18.29 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 109.256 -0.646 . . . . 0.79000000000000004 109.256 176.693 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -143.54 115.25 8.18 Favored 'General case' 0 N--CA 1.457 -0.114 0 C-N-CA 124.663 1.185 . . . . 0.80000000000000004 108.974 -164.296 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.558 HG21 ' HB1' ' A' ' 21' ' ' ALA . 5.4 p -84.45 116.69 28.58 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.569 0 N-CA-C 108.646 -0.872 . . . . 0.59999999999999998 108.646 173.679 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 53.3 t-20 -101.3 56.85 0.84 Allowed 'General case' 0 C--O 1.235 0.298 0 N-CA-C 107.224 -1.398 . . . . 0.73999999999999999 107.224 176.647 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.442 HD23 ' CG2' ' A' ' 39' ' ' VAL . 0.2 OUTLIER -67.36 -21.58 65.62 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 114.552 -1.203 . . . . 1.04 110.02 -177.003 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -46.32 -35.36 5.28 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 123.687 0.795 . . . . 0.76000000000000001 112.14 166.653 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 13.3 t -125.37 37.18 4.43 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 122.462 0.305 . . . . 1.2 110.383 171.695 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 50.06 34.69 8.64 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.681 1.592 . . . . 2.6200000000000001 113.264 172.988 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 87.0 m -126.03 157.47 37.83 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.445 1.098 . . . . 0.71999999999999997 108.621 -176.595 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 14.9 p -134.12 144.93 34.0 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 O-C-N 121.284 -0.885 . . . . 0.51000000000000001 109.875 172.239 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 25.9 m120 -128.05 136.22 50.94 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 125.344 1.458 . . . . 0.40999999999999998 108.305 -179.083 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 20.6 t -129.5 126.11 62.75 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 N-CA-C 105.475 -2.046 . . . . 2.23 105.475 -176.369 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 21.9 mm -105.85 103.01 14.7 Favored 'Isoleucine or valine' 0 C--O 1.239 0.548 0 N-CA-C 108.007 -1.108 . . . . 0.51000000000000001 108.007 -174.184 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.425 ' CE2' HD11 ' A' ' 8' ' ' ILE . 7.7 p90 -141.62 169.87 16.78 Favored 'General case' 0 CA--C 1.512 -0.504 0 O-C-N 122.218 -0.301 . . . . 2.0699999999999998 111.364 -170.964 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -89.54 109.57 32.82 Favored Pre-proline 0 N--CA 1.449 -0.517 0 O-C-N 124.299 1.0 . . . . 3.8100000000000001 109.444 177.021 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -71.14 8.33 1.12 Allowed 'Trans proline' 0 CA--C 1.54 0.777 0 C-N-CA 122.698 2.265 . . . . 0.62 113.068 179.923 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -88.07 -25.15 23.2 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.033 0.933 . . . . 0.88 109.596 168.837 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -115.52 -59.44 2.0 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 124.305 1.042 . . . . 3.3599999999999999 109.697 -171.062 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.323 3.8 p -91.74 -166.29 1.53 Allowed 'General case' 0 C--N 1.342 0.246 0 N-CA-C 110.35 -0.241 . . . . 0.53000000000000003 110.35 163.132 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 122.84 87.59 0.85 Allowed Glycine 0 N--CA 1.444 -0.784 0 N-CA-C 104.103 -3.599 . . . . 2.1600000000000001 104.103 -142.456 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 72.3 p -14.11 -18.99 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.36 1 C-N-CA 138.344 6.657 . . . . 1.3600000000000001 119.476 -148.022 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -26.39 -62.34 0.08 Allowed 'General case' 0 N--CA 1.443 -0.776 0 C-N-CA 127.124 2.17 . . . . 0.55000000000000004 113.756 166.391 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.69 -41.1 63.11 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 117.97 -1.492 . . . . 0.48999999999999999 109.931 -168.654 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.2 mp -52.81 -53.63 20.19 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.807 0 CA-C-N 114.446 -1.252 . . . . 0.87 109.193 176.305 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -66.92 -45.55 77.55 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 122.69 0.396 . . . . 1.4299999999999999 110.093 -173.765 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -46.06 -57.36 4.52 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 122.57 1.176 . . . . 2.6800000000000002 110.761 170.185 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 5.0 mmmt -67.66 -39.09 84.58 Favored 'General case' 0 N--CA 1.435 -1.178 0 CA-C-N 115.741 -0.663 . . . . 2.9100000000000001 112.409 -176.323 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -52.25 -50.38 37.26 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 N-CA-C 107.49 -1.3 . . . . 0.46000000000000002 107.49 -177.554 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 25.3 mm-40 -57.62 -58.31 8.9 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.033 0.933 . . . . 1.9299999999999999 110.55 174.044 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 24.9 mmtt -52.94 -37.03 60.6 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 113.287 0.847 . . . . 3.8999999999999999 113.287 -178.448 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 18.2 mt -70.64 -18.09 62.86 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.52 1.528 . . . . 0.68000000000000005 111.542 178.232 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 90.32 41.9 5.37 Favored Glycine 0 CA--C 1.525 0.67 0 C-N-CA 124.649 1.119 . . . . 0.46000000000000002 110.488 179.022 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -138.19 175.46 9.56 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 124.157 0.983 . . . . 1.99 109.249 -176.345 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 15.1 t-160 -141.05 157.57 45.13 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 108.649 -0.871 . . . . 2.0299999999999998 108.649 171.182 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 9.5 p -135.83 141.35 42.19 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 N-CA-C 106.528 -1.656 . . . . 1.4299999999999999 106.528 -178.037 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 3.4 t -115.73 130.52 70.24 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 N-CA-C 108.599 -0.889 . . . . 0.57999999999999996 108.599 -175.145 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 45.5 mm . . . . . 0 C--N 1.327 -0.375 0 C-N-CA 124.114 0.966 . . . . 1.25 108.452 -170.059 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 49.3 m . . . . . 0 CA--C 1.531 0.229 0 CA-C-O 120.88 0.371 . . . . 0.93999999999999995 111.451 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -62.92 177.23 0.59 Allowed 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 121.266 0.555 . . . . 2.1099999999999999 110.675 173.637 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -134.69 140.39 45.96 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 108.684 -0.858 . . . . 1.1799999999999999 108.684 173.959 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -133.16 156.79 46.82 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 124.671 1.188 . . . . 4.0899999999999999 108.999 164.664 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -105.36 121.32 43.65 Favored 'General case' 0 N--CA 1.434 -1.261 0 N-CA-C 101.683 -3.451 . . . . 1.8100000000000001 101.683 174.034 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 24.8 mm -101.26 165.17 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.388 0 N-CA-C 106.639 -1.615 . . . . 2.0800000000000001 106.639 168.013 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -139.02 132.62 30.46 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 107.076 -1.453 . . . . 0.46999999999999997 107.076 177.581 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -156.95 178.45 10.35 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 118.883 0.765 . . . . 2.0 110.848 174.211 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 25.0 mm100 -91.47 166.33 12.91 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.314 1.445 . . . . 2.3700000000000001 110.405 -178.68 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -131.64 157.04 43.11 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.136 0 C-N-CA 124.057 0.943 . . . . 2.1600000000000001 110.723 174.936 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 63.7 m -149.84 166.73 28.62 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 125.5 1.52 . . . . 0.96999999999999997 109.018 177.352 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 71.66 67.03 1.96 Allowed Glycine 0 CA--C 1.525 0.691 0 N-CA-C 109.211 -1.556 . . . . 1.74 109.211 -177.394 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -147.55 166.66 26.66 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 124.153 0.981 . . . . 2.48 109.522 -174.731 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.3 p -126.22 -61.36 1.22 Allowed 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 124.049 0.939 . . . . 2.2599999999999998 109.497 168.623 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 30.8 p -109.31 151.61 26.35 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 123.694 0.798 . . . . 2.1699999999999999 111.297 -176.174 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -76.24 53.25 0.8 Allowed 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.604 0.762 . . . . 1.71 110.201 174.764 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -145.52 -51.96 0.26 Allowed 'General case' 0 C--O 1.23 0.048 0 C-N-CA 123.49 0.716 . . . . 0.68999999999999995 110.908 -175.844 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 7.5 p -55.41 -38.02 68.39 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 119.129 0.877 . . . . 2.5099999999999998 109.997 167.764 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.426 ' HB1' HG21 ' A' ' 39' ' ' VAL . . . -47.84 -31.07 4.59 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.483 1.513 . . . . 0.48999999999999999 112.899 171.17 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -72.84 -55.25 6.95 Favored 'General case' 0 N--CA 1.454 -0.272 0 O-C-N 121.099 -1.001 . . . . 0.29999999999999999 109.912 172.454 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 3.5 mpp_? -54.56 -40.4 68.68 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 118.736 -0.649 . . . . 4.2999999999999998 111.5 -174.892 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.414 HG21 ' CD1' ' A' ' 69' ' ' TYR . 5.4 pt -55.45 -54.45 25.24 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 C-N-CA 119.554 -0.858 . . . . 0.48999999999999999 110.802 175.535 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -57.69 -39.2 76.62 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 123.639 0.776 . . . . 3.1000000000000001 111.313 179.496 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 56.5 mmtt -71.43 -45.8 61.73 Favored 'General case' 0 CA--C 1.534 0.339 0 O-C-N 121.484 -0.76 . . . . 2.0600000000000001 110.201 -175.079 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.77 -39.47 98.01 Favored Glycine 0 CA--C 1.53 0.988 0 N-CA-C 110.376 -1.09 . . . . 0.57999999999999996 110.376 172.329 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.0 tt -60.01 -36.11 76.51 Favored 'General case' 0 CA--C 1.538 0.516 0 O-C-N 121.744 -0.857 . . . . 1.8999999999999999 110.279 174.818 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -60.79 -27.99 68.41 Favored 'General case' 0 N--CA 1.454 -0.242 0 O-C-N 120.876 -1.14 . . . . 3.54 111.999 174.464 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 4.4 mmt85 -72.39 -5.92 39.85 Favored 'General case' 0 CA--C 1.536 0.441 0 O-C-N 121.508 -0.745 . . . . 3.3799999999999999 112.009 -177.88 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 78.7 mmm -78.23 148.22 74.09 Favored Pre-proline 0 CA--C 1.533 0.32 0 CA-C-N 119.146 0.884 . . . . 3.2999999999999998 111.05 -179.544 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -56.96 142.62 93.65 Favored 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 122.393 2.062 . . . . 0.65000000000000002 108.832 176.953 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 86.68 -20.54 23.14 Favored Glycine 0 CA--C 1.532 1.107 0 CA-C-O 118.567 -1.13 . . . . 0.57999999999999996 113.498 -178.988 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 14.4 t -94.49 123.78 46.73 Favored 'Isoleucine or valine' 0 C--N 1.344 0.334 0 CA-C-N 119.904 1.852 . . . . 0.63 110.414 -178.244 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -103.37 -37.26 7.7 Favored 'General case' 0 CA--C 1.524 -0.054 0 C-N-CA 124.519 1.127 . . . . 1.0600000000000001 111.21 -171.889 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -149.89 162.37 40.45 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 108.775 -0.824 . . . . 2.1299999999999999 108.775 174.726 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -155.45 139.28 16.22 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 122.781 0.432 . . . . 0.46000000000000002 110.203 -177.268 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -155.78 110.19 2.87 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 109.03 -0.73 . . . . 0.51000000000000001 109.03 -165.56 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.426 HG21 ' HB1' ' A' ' 21' ' ' ALA . 2.8 p -83.02 106.29 13.64 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.638 0 N-CA-C 109.256 -0.646 . . . . 0.65000000000000002 109.256 178.785 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 55.3 t-20 -84.59 56.98 4.08 Favored 'General case' 0 CA--C 1.533 0.323 0 O-C-N 120.821 -1.174 . . . . 0.63 108.819 176.188 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.67 -19.98 64.42 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 115.271 -0.877 . . . . 1.1000000000000001 109.441 -176.86 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -48.37 -38.77 20.18 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.483 0.713 . . . . 0.55000000000000004 111.952 167.491 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 8.8 t -117.08 36.09 4.37 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 118.029 0.377 . . . . 1.24 110.383 170.764 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 55.42 26.59 9.0 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.476 1.11 . . . . 4.1500000000000004 113.639 172.565 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 66.0 m -122.52 162.72 21.23 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.884 1.274 . . . . 0.63 108.679 -173.411 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.4 p -126.64 146.21 32.89 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 O-C-N 121.051 -1.03 . . . . 0.34999999999999998 109.498 170.931 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -131.58 131.02 42.96 Favored 'General case' 0 C--N 1.343 0.295 0 N-CA-C 108.113 -1.069 . . . . 0.32000000000000001 108.113 177.449 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 4.3 p -132.83 132.03 59.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 106.188 -1.782 . . . . 1.73 106.188 -175.024 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 16.9 mm -109.39 105.53 18.98 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 C-N-CA 125.374 1.47 . . . . 0.41999999999999998 107.745 -170.841 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 49.1 p90 -146.43 169.26 19.24 Favored 'General case' 0 CA--C 1.516 -0.365 0 O-C-N 122.073 -0.392 . . . . 1.7 111.677 -171.647 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 41.4 t0 -88.28 108.29 21.2 Favored Pre-proline 0 CA--C 1.533 0.305 0 O-C-N 124.484 1.115 . . . . 3.0600000000000001 110.262 175.731 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -70.89 0.94 5.72 Favored 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 123.036 2.491 . . . . 0.64000000000000001 113.351 -179.21 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -84.15 -30.68 25.68 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 119.502 1.046 . . . . 0.80000000000000004 109.144 167.686 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -105.09 -55.76 2.28 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 124.099 0.96 . . . . 2.7200000000000002 112.007 -167.544 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.263 1.6 p -92.33 -177.63 4.69 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-O 121.496 0.665 . . . . 0.51000000000000001 110.319 155.681 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 155.42 89.77 0.07 OUTLIER Glycine 0 N--CA 1.443 -0.883 0 N-CA-C 105.937 -2.865 . . . . 2.4199999999999999 105.937 -165.545 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 82.1 p -7.89 -16.62 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.561 1 C-N-CA 136.279 5.832 . . . . 1.1699999999999999 119.977 -136.369 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -25.45 -63.23 0.06 Allowed 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 127.756 2.422 . . . . 0.67000000000000004 114.352 169.827 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.81 -43.0 57.0 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 118.349 -1.341 . . . . 0.64000000000000001 109.467 -166.316 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -47.9 -56.19 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.099 0 CA-C-N 113.242 -1.799 . . . . 0.87 110.511 171.985 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -67.0 -46.02 75.82 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 118.952 0.796 . . . . 1.46 110.423 -175.047 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -45.19 -57.99 3.56 Favored 'General case' 0 C--N 1.342 0.282 0 CA-C-O 122.59 1.186 . . . . 3.3700000000000001 110.975 171.954 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.9 mmpt? -71.39 -37.75 71.55 Favored 'General case' 0 N--CA 1.431 -1.399 0 CA-C-O 118.417 -0.801 . . . . 2.4199999999999999 112.225 -174.864 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -47.61 -52.47 5.92 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 N-CA-C 107.482 -1.303 . . . . 0.46000000000000002 107.482 175.629 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -59.8 -56.55 20.35 Favored 'General case' 0 C--N 1.343 0.295 0 C-N-CA 123.693 0.797 . . . . 2.0299999999999998 110.211 175.845 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 2.7 mmmt -60.29 -28.54 68.17 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 114.018 1.118 . . . . 4.54 114.018 -175.683 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 11.8 mt -70.99 -18.24 62.61 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 125.925 1.69 . . . . 0.69999999999999996 111.373 173.741 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 90.72 45.2 4.32 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 110.217 -1.153 . . . . 0.45000000000000001 110.217 178.642 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.414 ' CD1' HG21 ' A' ' 24' ' ' ILE . 0.2 OUTLIER -141.02 173.42 11.5 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 124.039 0.935 . . . . 2.02 110.363 -177.195 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 17.3 t60 -133.64 139.95 46.79 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 109.212 -0.662 . . . . 2.1899999999999999 109.212 170.596 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 6.1 p -112.61 126.18 69.98 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 N-CA-C 107.558 -1.275 . . . . 1.51 107.558 174.863 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 26.5 t -104.46 138.38 29.38 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.154 0 N-CA-C 108.341 -0.985 . . . . 0.51000000000000001 108.341 -177.487 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 4.9 mp . . . . . 0 N--CA 1.45 -0.451 0 C-N-CA 124.197 0.999 . . . . 1.27 108.388 -179.196 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.0 m . . . . . 0 C--O 1.232 0.147 0 N-CA-C 107.061 -1.459 . . . . 1.0 107.061 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -80.02 -178.27 6.42 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 123.552 0.741 . . . . 2.1000000000000001 109.723 179.335 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -136.79 141.82 42.94 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 107.79 -1.189 . . . . 1.0800000000000001 107.79 168.939 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -139.85 163.93 31.34 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 124.509 1.124 . . . . 3.6299999999999999 109.673 168.427 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.8 90.59 3.13 Favored 'General case' 0 N--CA 1.441 -0.905 0 C-N-CA 128.504 2.722 . . . . 1.6699999999999999 106.985 -159.826 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.402 HG13 ' CZ ' ' A' ' 50' ' ' TYR . 7.5 mm -83.75 162.22 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.026 0 N-CA-C 107.324 -1.362 . . . . 1.9399999999999999 107.324 -176.288 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -140.38 134.86 31.46 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 124.704 1.202 . . . . 0.58999999999999997 108.728 179.742 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -156.28 172.23 18.84 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.361 0.664 . . . . 2.3799999999999999 110.52 176.929 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -87.27 168.86 12.81 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.997 1.319 . . . . 3.8199999999999998 110.383 174.898 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.661 HG21 HD21 ' A' ' 41' ' ' LEU . 5.9 m -126.33 152.32 33.69 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 C-N-CA 124.856 1.262 . . . . 1.9199999999999999 111.976 -179.636 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 16.2 m -139.19 146.72 40.88 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 126.031 1.732 . . . . 1.0700000000000001 107.896 164.298 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 123.75 -30.35 4.9 Favored Glycine 0 CA--C 1.531 1.054 0 C-N-CA 124.93 1.252 . . . . 2.0600000000000001 111.751 -177.363 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -54.07 137.66 39.47 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 121.389 0.614 . . . . 1.8899999999999999 112.485 -178.31 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -144.2 -60.37 0.38 Allowed 'General case' 0 C--N 1.333 -0.142 0 C-N-CA 125.484 1.513 . . . . 2.4199999999999999 107.65 178.228 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 26.2 p -78.55 -5.34 52.45 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.625 1.17 . . . . 3.25 112.983 177.559 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 68.59 -55.84 0.52 Allowed 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 126.128 1.771 . . . . 2.8500000000000001 112.111 -170.102 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -46.4 -43.78 16.59 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 125.017 1.327 . . . . 1.29 113.402 -173.753 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 29.5 m -57.82 -25.42 60.6 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 112.689 0.626 . . . . 2.2000000000000002 112.689 -179.061 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.72 ' HB1' HG21 ' A' ' 39' ' ' VAL . . . -56.38 -35.05 67.28 Favored 'General case' 0 CA--C 1.537 0.454 0 O-C-N 121.755 -0.591 . . . . 0.65000000000000002 110.609 172.876 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.97 -46.74 61.82 Favored 'General case' 0 C--O 1.232 0.171 0 O-C-N 120.533 -1.354 . . . . 0.35999999999999999 109.322 171.799 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 6.5 mmm180 -51.2 -45.22 61.77 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-O 117.697 -1.144 . . . . 5.8399999999999999 111.914 -177.765 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.312 2.4 pt -60.31 -59.82 3.52 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-O 117.786 -1.102 . . . . 0.65000000000000002 110.701 -179.033 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.633 ' HG3' ' HB1' ' A' ' 37' ' ' ALA . 1.3 mp0 -43.37 -47.75 6.9 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 120.264 1.393 . . . . 2.2599999999999998 112.254 172.747 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -74.94 -17.72 60.51 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 113.429 0.9 . . . . 2.8399999999999999 113.429 -176.841 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -76.69 -45.23 13.47 Favored Glycine 0 CA--C 1.531 1.033 0 N-CA-C 110.407 -1.077 . . . . 0.67000000000000004 110.407 161.072 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 26.8 mt -61.18 -39.58 90.7 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 117.69 0.745 . . . . 2.3599999999999999 109.814 -175.498 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 9.8 tmtt? -50.31 -28.57 8.1 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.006 1.322 . . . . 3.2799999999999998 112.678 173.519 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 4.3 mtm180 -80.44 -1.64 42.36 Favored 'General case' 0 CA--C 1.535 0.382 0 O-C-N 121.637 -0.664 . . . . 6.7300000000000004 112.643 -177.748 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 61.1 mmm -98.93 146.86 32.39 Favored Pre-proline 0 CA--C 1.533 0.317 0 CA-C-N 118.876 0.762 . . . . 3.54 110.853 -172.15 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -58.22 137.01 78.36 Favored 'Trans proline' 0 N--CA 1.45 -1.034 0 C-N-CA 122.387 2.058 . . . . 0.56000000000000005 109.264 -179.622 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 95.77 -35.3 4.39 Favored Glycine 0 CA--C 1.527 0.839 0 CA-C-O 119.382 -0.677 . . . . 0.57999999999999996 111.969 -175.536 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 9.0 t -85.65 132.19 32.52 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.153 0 CA-C-N 119.27 1.535 . . . . 0.66000000000000003 109.689 -174.712 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -103.1 -46.53 4.61 Favored 'General case' 0 C--N 1.342 0.255 0 CA-C-N 118.269 0.486 . . . . 1.77 110.526 178.88 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -152.8 174.85 13.54 Favored 'General case' 0 CA--C 1.515 -0.371 0 C-N-CA 124.196 0.998 . . . . 3.46 111.101 166.685 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.633 ' HB1' ' HG3' ' A' ' 25' ' ' GLU . . . -157.95 148.48 20.66 Favored 'General case' 0 N--CA 1.441 -0.907 0 C-N-CA 124.109 0.964 . . . . 0.52000000000000002 109.435 -173.956 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -153.85 117.35 4.63 Favored 'General case' 0 CA--C 1.528 0.119 0 N-CA-C 108.054 -1.091 . . . . 0.54000000000000004 108.054 -158.772 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.903 HG22 HD23 ' A' ' 41' ' ' LEU . 7.7 p -96.24 96.48 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 C-N-CA 124.289 1.036 . . . . 0.71999999999999997 110.439 -172.923 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 51.2 t-20 -84.04 57.06 3.98 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 122.628 1.204 . . . . 0.76000000000000001 109.889 -176.968 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.903 HD23 HG22 ' A' ' 39' ' ' VAL . 0.5 OUTLIER -68.45 -21.77 64.62 Favored 'General case' 0 CA--C 1.527 0.07 0 CA-C-N 115.231 -0.895 . . . . 1.1699999999999999 110.742 -176.569 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -45.33 -34.74 3.12 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 123.611 0.764 . . . . 1.01 112.045 166.315 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 4.9 t -126.54 39.34 3.95 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 122.56 0.344 . . . . 1.6399999999999999 110.141 174.329 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 42.5 53.38 4.66 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.285 1.034 . . . . 3.5099999999999998 112.757 175.04 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 41.8 m -145.81 150.54 36.38 Favored 'General case' 0 N--CA 1.438 -1.065 0 N-CA-C 107.889 -1.152 . . . . 0.91000000000000003 107.889 177.991 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 8.9 p -122.5 142.34 39.36 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 N-CA-C 108.465 -0.939 . . . . 0.55000000000000004 108.465 171.159 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -125.3 141.98 51.76 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 124.818 1.247 . . . . 0.40999999999999998 108.173 -179.407 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.433 HG13 ' HB2' ' A' ' 37' ' ' ALA . 35.9 t -135.68 127.31 45.27 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.325 0 N-CA-C 105.981 -1.859 . . . . 2.1800000000000002 105.981 -178.543 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 21.1 mm -100.38 100.42 10.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 C-N-CA 125.774 1.63 . . . . 0.46999999999999997 107.764 -175.096 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.402 ' CZ ' HG13 ' A' ' 8' ' ' ILE . 17.6 p90 -137.53 166.02 24.88 Favored 'General case' 0 CA--C 1.518 -0.259 0 O-C-N 122.192 -0.317 . . . . 1.73 111.764 -173.597 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -84.34 123.92 74.39 Favored Pre-proline 0 C--O 1.24 0.585 0 C-N-CA 123.813 0.845 . . . . 3.1000000000000001 108.915 171.494 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -86.94 11.82 3.16 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 123.823 3.015 . . . . 0.73999999999999999 113.162 -175.155 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -97.19 -46.05 6.29 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 108.448 -0.945 . . . . 1.05 108.448 168.423 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -77.79 -44.98 25.85 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 123.951 0.9 . . . . 3.3599999999999999 109.129 -178.888 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.262 26.3 p -112.01 -137.29 0.37 Allowed 'General case' 0 CA--C 1.518 -0.254 0 C-N-CA 122.107 0.163 . . . . 0.84999999999999998 110.667 165.17 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 105.67 128.23 6.09 Favored Glycine 0 N--CA 1.44 -1.098 0 N-CA-C 105.679 -2.968 . . . . 2.0499999999999998 105.679 -123.938 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 24.0 p -30.56 -30.29 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.463 1 C-N-CA 134.66 5.184 . . . . 1.3300000000000001 113.76 -177.385 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -29.01 -62.42 0.12 Allowed 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 126.018 1.727 . . . . 0.68999999999999995 112.733 167.258 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.87 -44.22 50.17 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 117.505 -1.678 . . . . 0.5 109.907 -170.578 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.1 mp -51.64 -50.14 31.87 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.945 0 CA-C-N 112.915 -1.948 . . . . 0.98999999999999999 110.067 -178.997 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.2 -50.64 67.28 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 107.933 -1.136 . . . . 2.1200000000000001 107.933 -178.162 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.409 ' OE2' ' NZ ' ' A' ' 66' ' ' LYS . 1.3 tm-20 -44.52 -54.29 6.17 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 122.362 1.077 . . . . 3.0 110.77 178.871 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.1 mmpt? -71.4 -40.33 70.56 Favored 'General case' 0 N--CA 1.434 -1.271 0 CA-C-O 118.154 -0.926 . . . . 2.5600000000000001 113.016 179.094 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.3 mm -48.27 -50.98 10.82 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.793 0 N-CA-C 107.805 -1.183 . . . . 0.67000000000000004 107.805 176.664 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 76.1 mm-40 -57.92 -60.73 3.26 Favored 'General case' 0 C--N 1.343 0.283 0 C-N-CA 124.967 1.307 . . . . 2.98 110.284 177.096 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.409 ' NZ ' ' OE2' ' A' ' 62' ' ' GLU . 7.0 mptt -56.37 -35.38 67.63 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 112.577 0.584 . . . . 5.0 112.577 -177.059 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 35.1 mt -70.08 -18.04 63.25 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.348 1.059 . . . . 0.68999999999999995 111.529 177.909 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 98.04 35.38 5.08 Favored Glycine 0 CA--C 1.525 0.716 0 C-N-CA 124.342 0.973 . . . . 0.70999999999999996 111.535 174.453 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -127.47 169.34 13.76 Favored 'General case' 0 N--CA 1.457 -0.102 0 C-N-CA 124.378 1.071 . . . . 2.1499999999999999 108.914 173.727 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 85.9 t60 -137.67 133.66 34.53 Favored 'General case' 0 N--CA 1.453 -0.275 0 N-CA-C 106.187 -1.783 . . . . 2.04 106.187 162.768 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 23.4 m -91.35 144.57 8.91 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.691 0 CA-C-N 119.244 0.929 . . . . 2.2599999999999998 108.863 172.841 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.5 t -103.06 130.94 52.41 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 N-CA-C 107.75 -1.204 . . . . 0.89000000000000001 107.75 178.97 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 28.0 mm . . . . . 0 N--CA 1.453 -0.281 0 C-N-CA 124.363 1.065 . . . . 1.0700000000000001 108.424 -173.196 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.7 m . . . . . 0 N--CA 1.452 -0.37 0 N-CA-C 107.257 -1.386 . . . . 0.71999999999999997 107.257 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -66.63 178.11 1.39 Allowed 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 123.378 0.671 . . . . 3.46 109.529 172.381 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -135.22 150.84 50.17 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 108.393 -0.966 . . . . 0.93999999999999995 108.393 173.753 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 26.7 mmtp -139.74 162.1 35.95 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.481 1.113 . . . . 2.8700000000000001 108.628 163.984 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.3 mp0 -123.02 96.36 4.98 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 127.101 2.16 . . . . 2.3900000000000001 105.953 -176.937 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 23.9 mm -83.29 164.16 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.16 0 N-CA-C 107.067 -1.457 . . . . 2.1099999999999999 107.067 178.327 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -138.48 123.53 19.05 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 125.207 1.403 . . . . 0.55000000000000004 107.585 179.389 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -133.03 166.46 22.36 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 118.85 0.75 . . . . 2.8500000000000001 109.938 178.246 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -84.5 168.13 15.73 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.557 1.143 . . . . 3.6699999999999999 109.368 169.194 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 38.4 t -125.05 146.09 31.28 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 C-N-CA 124.567 1.147 . . . . 1.3 109.411 -175.22 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 11.8 m -154.8 171.16 20.05 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.918 0.887 . . . . 1.3200000000000001 110.418 172.863 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 64.06 70.38 1.08 Allowed Glycine 0 C--N 1.34 0.761 0 N-CA-C 110.5 -1.04 . . . . 1.8799999999999999 110.5 178.261 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -153.05 156.46 38.79 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 116.922 0.361 . . . . 2.73 111.304 -170.124 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -89.76 -60.89 1.82 Allowed 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 125.226 1.411 . . . . 3.27 109.49 168.255 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 21.6 p -144.09 160.81 40.26 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-O 121.836 0.827 . . . . 2.4399999999999999 112.895 -167.269 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -74.69 45.47 0.25 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.473 1.509 . . . . 1.6599999999999999 111.492 175.559 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -137.98 -49.75 0.57 Allowed 'General case' 0 C--N 1.335 -0.057 0 C-N-CA 124.614 1.166 . . . . 0.70999999999999996 108.637 177.804 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 78.3 m -53.52 -38.86 64.17 Favored 'General case' 0 C--O 1.232 0.132 0 O-C-N 121.593 -0.692 . . . . 1.21 110.76 165.643 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.592 ' HB1' HG21 ' A' ' 39' ' ' VAL . . . -45.75 -35.03 4.0 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.006 1.322 . . . . 0.66000000000000003 112.411 170.667 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.61 -54.45 10.4 Favored 'General case' 0 N--CA 1.451 -0.382 0 O-C-N 121.026 -1.046 . . . . 0.40999999999999998 109.64 174.655 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 43.3 mtm105 -48.85 -50.71 33.35 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 123.539 0.735 . . . . 6.2300000000000004 110.45 -175.595 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.463 HG21 ' CD1' ' A' ' 69' ' ' TYR . 4.9 pt -54.49 -52.75 37.12 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.164 0 O-C-N 123.761 0.663 . . . . 0.46000000000000002 109.849 -179.051 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.601 ' HG3' ' HB1' ' A' ' 37' ' ' ALA . 0.5 OUTLIER -56.34 -39.86 73.53 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 123.93 0.892 . . . . 2.1600000000000001 111.431 179.68 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 26.5 mmtt -73.68 -44.89 55.43 Favored 'General case' 0 CA--C 1.531 0.215 0 O-C-N 121.201 -0.937 . . . . 1.9199999999999999 111.509 -176.259 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -59.34 -42.44 97.41 Favored Glycine 0 CA--C 1.529 0.928 0 N-CA-C 109.988 -1.245 . . . . 0.62 109.988 172.197 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.535 HD21 HG12 ' A' ' 60' ' ' ILE . 8.5 tt -58.55 -39.61 80.7 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.571 1.149 . . . . 1.97 110.289 175.668 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -61.52 -30.17 70.46 Favored 'General case' 0 N--CA 1.452 -0.366 0 O-C-N 121.064 -1.023 . . . . 3.5299999999999998 111.66 174.915 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 16.0 mtt180 -72.13 -8.09 52.71 Favored 'General case' 0 CA--C 1.533 0.295 0 O-C-N 121.495 -0.753 . . . . 3.5899999999999999 112.638 -178.888 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 69.2 mmm -73.96 150.55 88.17 Favored Pre-proline 0 CA--C 1.533 0.289 0 CA-C-N 119.291 0.951 . . . . 3.4399999999999999 110.432 179.867 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -56.34 147.31 68.1 Favored 'Trans proline' 0 N--CA 1.451 -1.026 0 C-N-CA 121.595 1.53 . . . . 0.62 108.402 172.573 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 86.15 -22.65 11.62 Favored Glycine 0 CA--C 1.525 0.682 0 C-N-CA 124.143 0.878 . . . . 0.47999999999999998 113.194 -179.93 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 15.6 t -98.19 127.15 50.94 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 CA-C-N 119.459 1.63 . . . . 0.57999999999999996 109.903 -175.788 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -113.11 -31.34 6.68 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 123.388 0.675 . . . . 0.91000000000000003 112.04 -173.37 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -146.67 160.7 41.87 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-N 119.289 0.949 . . . . 2.1099999999999999 108.931 167.004 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.601 ' HB1' ' HG3' ' A' ' 25' ' ' GLU . . . -156.73 138.88 14.58 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 116.832 -0.167 . . . . 0.41999999999999998 111.307 177.582 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -154.23 113.92 3.8 Favored 'General case' 0 C--N 1.341 0.221 0 N-CA-C 107.381 -1.34 . . . . 0.45000000000000001 107.381 -160.466 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.592 HG21 ' HB1' ' A' ' 21' ' ' ALA . 6.0 p -93.15 102.11 13.31 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 C-N-CA 123.267 0.627 . . . . 0.66000000000000003 110.058 -175.501 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 52.0 t-20 -83.04 58.65 4.51 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 122.536 1.16 . . . . 0.59999999999999998 110.012 -177.415 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.1 -20.01 65.72 Favored 'General case' 0 C--O 1.225 -0.194 0 CA-C-N 114.943 -1.026 . . . . 0.89000000000000001 110.675 -177.692 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -48.55 -30.13 4.96 Favored 'General case' 0 CA--C 1.528 0.134 0 C-N-CA 123.789 0.835 . . . . 0.63 112.644 170.424 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 4.3 t -129.74 32.67 4.55 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 109.792 -0.448 . . . . 1.22 109.792 172.583 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 29.0 mp0 54.41 40.53 31.86 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.64 1.176 . . . . 4.0 113.086 175.067 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -124.86 163.55 21.96 Favored 'General case' 0 N--CA 1.454 -0.259 0 O-C-N 121.327 -0.858 . . . . 0.98999999999999999 109.585 176.11 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.7 p -133.56 140.75 46.04 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 N-CA-C 108.795 -0.817 . . . . 0.35999999999999999 108.795 171.893 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 18.7 m120 -129.46 138.55 51.48 Favored 'General case' 0 C--N 1.344 0.365 0 N-CA-C 108.193 -1.039 . . . . 0.28999999999999998 108.193 -178.232 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.432 HG21 HD21 ' A' ' 28' ' ' LEU . 3.8 p -136.65 128.67 44.05 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 N-CA-C 106.529 -1.656 . . . . 1.72 106.529 -176.11 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 9.8 mm -105.9 96.52 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 C-N-CA 125.918 1.687 . . . . 0.40999999999999998 107.278 -171.602 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 44.1 p90 -136.96 165.06 26.87 Favored 'General case' 0 CA--C 1.515 -0.375 0 O-C-N 122.18 -0.325 . . . . 1.72 111.596 -170.76 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 45.0 t0 -86.58 108.85 19.72 Favored Pre-proline 0 C--N 1.329 -0.29 0 C-N-CA 125.198 1.399 . . . . 2.9100000000000001 109.666 176.8 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -71.26 2.03 4.81 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 123.209 2.606 . . . . 0.64000000000000001 113.4 -177.878 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -90.31 -30.22 17.62 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 119.395 0.998 . . . . 0.77000000000000002 109.345 169.057 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -101.71 -51.73 3.37 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.359 0.664 . . . . 3.0899999999999999 110.361 -170.315 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.9 p -99.81 -174.11 2.62 Favored 'General case' 0 C--O 1.225 -0.205 0 C-N-CA 123.872 0.869 . . . . 0.63 110.598 158.096 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 145.16 92.63 0.14 Allowed Glycine 0 N--CA 1.443 -0.899 0 N-CA-C 104.87 -3.292 . . . . 2.4300000000000002 104.87 -158.228 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 48.8 p -10.24 -18.9 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.577 1 C-N-CA 137.068 6.147 . . . . 1.0800000000000001 119.829 -139.087 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -26.8 -61.84 0.08 Allowed 'General case' 0 N--CA 1.439 -0.987 0 C-N-CA 127.893 2.477 . . . . 0.73999999999999999 114.418 170.11 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.14 -44.76 59.62 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 117.991 -1.484 . . . . 0.70999999999999996 109.259 -168.15 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.535 HG12 HD21 ' A' ' 28' ' ' LEU . 2.2 mt -53.21 -52.76 27.7 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 CA-C-N 112.918 -1.946 . . . . 0.90000000000000002 110.682 178.462 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.92 -45.6 85.15 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 120.06 1.3 . . . . 1.75 109.2 -177.019 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -47.59 -57.32 5.6 Favored 'General case' 0 C--N 1.343 0.318 0 CA-C-O 123.148 1.451 . . . . 2.8399999999999999 109.466 177.264 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.4 mmpt? -71.17 -36.04 71.85 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-N 114.768 -1.105 . . . . 2.5 112.979 -175.403 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -50.04 -53.17 11.89 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 N-CA-C 107.405 -1.331 . . . . 0.41999999999999998 107.405 174.501 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 -60.73 -55.72 29.77 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 115.458 -0.792 . . . . 1.8400000000000001 110.74 176.04 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -57.13 -34.47 68.41 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 113.484 0.92 . . . . 4.5599999999999996 113.484 -176.674 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.435 HD13 ' HA ' ' A' ' 24' ' ' ILE . 13.6 mt -71.54 -19.49 62.16 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 125.815 1.646 . . . . 0.66000000000000003 111.918 174.356 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 95.89 45.37 2.89 Favored Glycine 0 CA--C 1.525 0.678 0 C-N-CA 125.169 1.366 . . . . 0.48999999999999999 111.378 175.914 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.463 ' CD1' HG21 ' A' ' 24' ' ' ILE . 0.3 OUTLIER -140.39 173.7 11.24 Favored 'General case' 0 N--CA 1.458 -0.068 0 C-N-CA 124.216 1.006 . . . . 2.02 110.504 -178.061 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -152.44 126.74 9.25 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 109.49 -0.559 . . . . 2.0499999999999998 109.49 171.946 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 16.1 m -83.89 164.64 2.6 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 C-N-CA 123.623 0.769 . . . . 2.4399999999999999 109.61 173.932 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 1.9 t -125.6 136.33 61.16 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 O-C-N 121.439 -0.788 . . . . 1.0600000000000001 108.944 176.434 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 11.2 mm . . . . . 0 N--CA 1.454 -0.267 0 C-N-CA 123.767 0.827 . . . . 1.25 109.329 -171.483 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 21.5 m . . . . . 0 N--CA 1.447 -0.608 0 N-CA-C 106.992 -1.485 . . . . 1.3 106.992 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -91.31 -175.99 4.42 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 108.073 -1.084 . . . . 2.0800000000000001 108.073 157.831 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.6 mm100 -134.47 146.89 50.19 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 106.628 -1.619 . . . . 1.1599999999999999 106.628 165.616 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 75.2 mttt -141.75 156.78 45.58 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 123.918 0.887 . . . . 2.96 110.806 161.504 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -111.03 92.02 3.88 Favored 'General case' 0 N--CA 1.44 -0.969 0 C-N-CA 128.156 2.582 . . . . 1.3600000000000001 107.152 -167.954 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 6.8 mm -83.14 162.01 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.218 0 N-CA-C 106.916 -1.512 . . . . 1.97 106.916 -175.559 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -141.16 116.07 9.78 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 124.409 1.084 . . . . 0.60999999999999999 108.769 -173.804 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 66.3 mtm -138.18 173.17 11.9 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 118.527 0.603 . . . . 1.8600000000000001 110.539 -175.122 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.67 168.43 9.69 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 125.934 1.694 . . . . 3.5499999999999998 108.94 172.598 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 19.6 m -129.04 174.88 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 C-N-CA 123.455 0.702 . . . . 2.0699999999999998 110.12 172.851 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 57.8 m -151.02 175.14 12.37 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 124.304 1.042 . . . . 0.93999999999999995 108.328 173.32 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 85.82 -35.01 3.27 Favored Glycine 0 CA--C 1.531 1.09 0 O-C-N 122.019 -0.426 . . . . 2.3999999999999999 112.573 178.304 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -48.16 141.84 5.88 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.096 0.959 . . . . 1.8500000000000001 112.877 179.325 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -103.94 -46.19 4.55 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 124.684 1.194 . . . . 2.2400000000000002 110.09 171.809 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 18.4 p -132.62 161.3 34.26 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 123.752 0.821 . . . . 2.0699999999999998 110.918 -175.342 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -77.02 56.75 1.27 Allowed 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.104 0.962 . . . . 2.0800000000000001 110.631 178.293 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -142.52 -57.88 0.44 Allowed 'General case' 0 N--CA 1.456 -0.138 0 C-N-CA 123.854 0.862 . . . . 0.96999999999999997 109.549 176.322 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 58.9 m -54.08 -43.32 70.24 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 121.011 0.434 . . . . 1.3899999999999999 111.65 -174.63 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.59 -22.6 13.8 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.232 1.013 . . . . 0.54000000000000004 112.963 178.069 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.437 ' HA ' HG11 ' A' ' 39' ' ' VAL . . . -70.24 -47.64 60.46 Favored 'General case' 0 N--CA 1.452 -0.363 0 O-C-N 121.163 -0.961 . . . . 0.60999999999999999 110.267 172.163 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 52.7 mtp85 -58.61 -48.57 80.55 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 109.486 -0.561 . . . . 4.2199999999999998 109.486 -171.107 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.429 ' HA ' HD13 ' A' ' 67' ' ' LEU . 5.4 pt -55.63 -51.48 58.1 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 O-C-N 123.684 0.615 . . . . 0.64000000000000001 110.005 179.02 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -55.64 -43.86 76.61 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 113.455 0.909 . . . . 4.5199999999999996 113.455 179.116 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 13.4 mptt -72.69 -40.98 65.8 Favored 'General case' 0 CA--C 1.536 0.425 0 O-C-N 121.505 -0.747 . . . . 2.1400000000000001 109.643 -175.954 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -57.16 -39.89 90.69 Favored Glycine 0 CA--C 1.532 1.141 0 N-CA-C 111.147 -0.781 . . . . 0.64000000000000001 111.147 168.727 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.8 tt -65.3 -44.24 88.54 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.401 1.08 . . . . 1.8300000000000001 109.363 179.136 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 27.0 ttmt -54.5 -39.13 67.26 Favored 'General case' 0 CA--C 1.53 0.178 0 O-C-N 121.258 -0.902 . . . . 3.6600000000000001 111.075 175.383 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.91 -8.66 7.53 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 114.389 1.255 . . . . 4.3499999999999996 114.389 -179.589 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 82.6 mmm -81.85 151.98 68.31 Favored Pre-proline 0 CA--C 1.536 0.425 0 CA-C-N 120.089 1.313 . . . . 3.4399999999999999 111.521 -177.633 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -59.05 150.89 70.18 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 122.427 2.085 . . . . 0.77000000000000002 110.628 178.985 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 79.31 -25.92 2.67 Favored Glycine 0 CA--C 1.531 1.06 0 C-N-CA 123.702 0.668 . . . . 0.66000000000000003 112.685 -177.466 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 15.4 t -86.45 141.05 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 CA-C-N 118.901 1.35 . . . . 0.82999999999999996 108.879 176.102 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -119.76 -43.22 2.58 Favored 'General case' 0 C--N 1.34 0.153 0 CA-C-O 118.716 -0.659 . . . . 1.3799999999999999 111.243 179.113 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -143.33 169.13 18.22 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 118.978 0.808 . . . . 1.8899999999999999 110.82 176.69 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -159.64 154.18 24.13 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.908 -0.587 . . . . 1.22 111.079 -177.343 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -155.76 94.52 1.57 Allowed 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 125.567 1.547 . . . . 1.0 109.173 -168.393 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.559 ' CG2' HD23 ' A' ' 41' ' ' LEU . 3.5 p -78.93 93.98 1.67 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 CA-C-O 121.867 0.842 . . . . 0.96999999999999997 109.355 -177.852 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 44.8 t30 -81.67 58.75 3.88 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 122.212 1.006 . . . . 0.62 109.854 -176.196 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.559 HD23 ' CG2' ' A' ' 39' ' ' VAL . 0.4 OUTLIER -69.78 -19.99 63.49 Favored 'General case' 0 N--CA 1.457 -0.081 0 C-N-CA 124.462 1.105 . . . . 1.01 111.016 -179.212 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -43.32 -39.78 3.26 Favored 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 124.064 0.946 . . . . 0.68000000000000005 111.931 169.832 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 9.9 t -128.1 40.3 3.7 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 122.574 0.35 . . . . 1.23 110.291 172.07 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 50.85 51.98 15.9 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.731 1.213 . . . . 3.2999999999999998 113.741 172.259 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -131.49 161.15 33.22 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 124.588 1.155 . . . . 2.0899999999999999 109.013 175.529 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.5 p -131.62 134.74 60.15 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 N-CA-C 107.706 -1.22 . . . . 0.34999999999999998 107.706 167.669 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -123.03 126.79 47.78 Favored 'General case' 0 C--N 1.341 0.233 0 N-CA-C 108.559 -0.904 . . . . 0.58999999999999997 108.559 177.524 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 46.8 t -126.32 130.96 71.95 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 N-CA-C 105.638 -1.986 . . . . 2.21 105.638 -177.169 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 10.6 mm -105.08 99.72 9.04 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 C-N-CA 125.336 1.455 . . . . 0.48999999999999999 107.694 -175.548 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 53.2 p90 -139.61 171.31 14.42 Favored 'General case' 0 CA--C 1.515 -0.369 0 C-N-CA 122.719 0.408 . . . . 2.1699999999999999 111.111 -174.61 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 45.8 t0 -89.23 107.08 15.81 Favored Pre-proline 0 C--O 1.234 0.255 0 CA-C-O 118.35 -0.833 . . . . 3.2200000000000002 109.278 176.683 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -71.78 4.92 2.77 Favored 'Trans proline' 0 N--CA 1.451 -0.978 0 C-N-CA 122.178 1.918 . . . . 0.87 112.915 -179.236 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -86.73 -33.46 19.98 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 119.462 1.028 . . . . 1.0800000000000001 109.163 166.604 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 13.2 tt0 -103.42 -57.04 2.1 Favored 'General case' 0 C--N 1.343 0.323 0 C-N-CA 122.871 0.468 . . . . 2.6800000000000002 110.278 -169.336 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.405 0.6 OUTLIER -84.7 -178.66 6.93 Favored 'General case' 0 C--O 1.224 -0.242 0 CA-C-O 122.537 1.16 . . . . 0.56000000000000005 113.77 155.513 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -179.18 -144.27 5.71 Favored Glycine 0 N--CA 1.434 -1.474 1 N-CA-C 102.944 -4.062 . . . . 2.5299999999999998 102.944 -173.312 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 19.2 p -72.76 -40.29 66.11 Favored 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 124.509 1.124 . . . . 1.6000000000000001 108.398 174.51 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -38.77 -62.65 0.59 Allowed 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 126.235 1.814 . . . . 0.81000000000000005 114.119 -169.682 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -72.62 -42.33 64.58 Favored 'General case' 0 CA--C 1.517 -0.321 0 C-N-CA 119.079 -1.048 . . . . 0.59999999999999998 108.98 -168.753 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -53.35 -55.68 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.17 0 CA-C-N 113.437 -1.71 . . . . 0.79000000000000004 110.394 177.85 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.83 -46.9 87.81 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 119.827 1.194 . . . . 1.5 110.085 -178.759 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -47.58 -57.76 5.06 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 122.406 1.098 . . . . 2.9100000000000001 110.722 176.836 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.2 -39.81 74.96 Favored 'General case' 0 N--CA 1.436 -1.155 0 CA-C-O 118.621 -0.704 . . . . 2.6499999999999999 112.3 -176.802 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.1 mm -48.54 -52.14 9.35 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 C-N-CA 125.175 1.39 . . . . 0.53000000000000003 107.481 175.084 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -60.71 -58.0 10.33 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 124.372 1.069 . . . . 1.9199999999999999 110.875 177.665 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 3.4 mptp? -56.62 -37.61 70.94 Favored 'General case' 0 CA--C 1.536 0.42 0 O-C-N 121.499 -0.75 . . . . 4.0099999999999998 112.375 -176.766 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.429 HD13 ' HA ' ' A' ' 24' ' ' ILE . 13.7 mt -69.82 -17.77 63.42 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.461 1.105 . . . . 0.88 111.787 176.14 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 91.02 45.46 4.15 Favored Glycine 0 C--N 1.336 0.557 0 C-N-CA 124.369 0.985 . . . . 0.69999999999999996 110.986 174.342 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.422 ' CD1' HG21 ' A' ' 24' ' ' ILE . 0.4 OUTLIER -137.49 175.28 9.74 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 123.972 0.909 . . . . 1.9099999999999999 110.685 -177.872 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 2.3 t-80 -142.66 128.26 19.13 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 109.061 -0.718 . . . . 1.8700000000000001 109.061 169.657 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 11.7 p -88.76 148.85 4.26 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 C-N-CA 125.056 1.343 . . . . 1.5600000000000001 108.127 169.679 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 41.1 t -120.3 138.84 49.52 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 C-N-CA 125.249 1.42 . . . . 0.64000000000000001 108.615 179.057 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 26.8 mm . . . . . 0 CA--C 1.532 0.259 0 C-N-CA 124.805 1.242 . . . . 0.93999999999999995 109.564 -168.138 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 57.9 m . . . . . 0 N--CA 1.443 -0.803 0 N-CA-C 108.224 -1.028 . . . . 1.03 108.224 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -64.95 174.92 1.7 Allowed 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 109.095 -0.706 . . . . 2.8599999999999999 109.095 155.013 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -135.08 148.95 49.98 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 106.702 -1.592 . . . . 1.5600000000000001 106.702 168.559 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 10.5 mmpt? -138.62 157.12 46.74 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 123.401 0.68 . . . . 3.8700000000000001 109.677 165.138 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.68 103.88 12.49 Favored 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 128.745 2.818 . . . . 1.6100000000000001 107.847 -177.79 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.547 HD11 ' CG1' ' A' ' 48' ' ' VAL . 2.1 pp -84.95 165.56 2.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 N-CA-C 109.006 -0.739 . . . . 4.7800000000000002 109.006 168.537 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -137.19 119.34 15.53 Favored 'General case' 0 C--O 1.226 -0.169 0 N-CA-C 106.879 -1.526 . . . . 0.78000000000000003 106.879 173.438 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 22.8 mmt -137.4 172.34 13.13 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 119.596 1.089 . . . . 5.2199999999999998 110.411 -177.511 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 17.9 mm100 -91.87 158.87 16.07 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 123.813 0.845 . . . . 2.3700000000000001 110.014 -178.214 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 22.1 t -117.22 153.66 18.99 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 C-N-CA 124.373 1.069 . . . . 1.1200000000000001 109.079 -176.457 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 37.5 m -149.5 175.71 11.25 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.089 0.956 . . . . 0.93000000000000005 109.143 172.004 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 82.12 -36.64 2.54 Favored Glycine 0 CA--C 1.533 1.181 0 O-C-N 121.525 -0.734 . . . . 2.0099999999999998 112.485 -179.132 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -42.05 143.69 0.54 Allowed 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.643 1.577 . . . . 1.8100000000000001 113.786 177.721 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -110.42 -49.04 3.09 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 125.234 1.414 . . . . 2.27 111.532 169.796 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 18.4 p -130.64 161.97 30.42 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 123.186 0.594 . . . . 2.0499999999999998 110.807 -176.136 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -77.0 55.88 1.16 Allowed 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.187 0.995 . . . . 2.21 110.572 179.423 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -143.89 -56.3 0.38 Allowed 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 124.118 0.967 . . . . 0.85999999999999999 109.789 178.132 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 59.4 m -55.88 -40.72 73.38 Favored 'General case' 0 CA--C 1.532 0.269 0 O-C-N 121.916 -0.49 . . . . 1.1899999999999999 111.989 -173.93 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.798 ' HB1' HG21 ' A' ' 39' ' ' VAL . . . -56.29 -24.37 42.69 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.022 0.529 . . . . 0.5 112.32 177.686 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.8 -52.64 34.69 Favored 'General case' 0 N--CA 1.452 -0.355 0 O-C-N 120.353 -1.467 . . . . 0.41999999999999998 108.937 172.809 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 6.6 mtt-85 -53.74 -46.84 71.01 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.318 0.647 . . . . 3.75 110.239 -175.255 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.468 HG21 ' CD1' ' A' ' 69' ' ' TYR . 3.1 pt -57.85 -53.89 39.12 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.455 0 C-N-CA 119.756 -0.778 . . . . 0.5 110.85 -179.763 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -55.01 -43.69 73.88 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 119.299 0.954 . . . . 2.6000000000000001 111.862 177.321 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.2 mptp? -68.83 -46.18 69.24 Favored 'General case' 0 CA--C 1.533 0.291 0 O-C-N 121.298 -0.877 . . . . 1.4399999999999999 110.61 -175.807 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -63.08 -38.85 97.24 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 110.48 -1.048 . . . . 0.67000000000000004 110.48 175.061 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.53 HD11 HG21 ' A' ' 34' ' ' VAL . 2.9 tm? -60.32 -44.56 95.35 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 108.069 -1.086 . . . . 2.4199999999999999 108.069 179.294 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -54.51 -26.07 29.47 Favored 'General case' 0 CA--C 1.542 0.665 0 O-C-N 121.561 -0.712 . . . . 2.9100000000000001 112.683 175.093 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -71.22 -9.11 57.55 Favored 'General case' 0 CA--C 1.539 0.527 0 O-C-N 120.583 -1.323 . . . . 3.6600000000000001 112.659 177.295 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -73.79 158.03 86.6 Favored Pre-proline 0 CA--C 1.539 0.528 0 CA-C-N 118.99 0.813 . . . . 3.6200000000000001 111.552 -179.066 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -70.98 114.5 3.92 Favored 'Trans proline' 0 N--CA 1.45 -1.058 0 C-N-CA 121.811 1.674 . . . . 1.05 109.74 175.577 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 121.32 -30.27 5.46 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 124.08 0.848 . . . . 0.84999999999999998 113.002 170.818 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.53 HG21 HD11 ' A' ' 28' ' ' LEU . 61.6 t -83.37 141.05 15.38 Favored 'Isoleucine or valine' 0 C--N 1.342 0.254 0 CA-C-N 118.338 1.069 . . . . 0.67000000000000004 109.445 172.133 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 7.0 m -118.29 -38.31 3.2 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-O 118.39 -0.814 . . . . 1.1699999999999999 111.126 -177.27 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -136.7 163.6 30.21 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 119.542 1.065 . . . . 2.2400000000000002 111.843 167.132 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -158.36 140.86 14.39 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 112.541 0.571 . . . . 0.39000000000000001 112.541 -177.845 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -153.82 106.85 2.91 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 106.648 -1.612 . . . . 0.41999999999999998 106.648 -165.94 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.798 HG21 ' HB1' ' A' ' 21' ' ' ALA . 4.8 p -81.16 127.99 39.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 N-CA-C 107.351 -1.352 . . . . 0.63 107.351 174.667 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 54.7 t-20 -111.75 57.62 0.64 Allowed 'General case' 0 C--O 1.235 0.291 0 CA-C-O 122.968 1.366 . . . . 0.71999999999999997 107.974 179.878 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.591 HD23 HG22 ' A' ' 39' ' ' VAL . 0.2 OUTLIER -65.78 -20.1 66.14 Favored 'General case' 0 C--O 1.227 -0.11 0 CA-C-N 113.976 -1.465 . . . . 0.90000000000000002 111.12 -176.161 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -46.94 -34.58 5.64 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.447 0.699 . . . . 0.60999999999999999 112.312 166.842 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 14.7 t -122.09 27.66 7.91 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-O 121.284 0.564 . . . . 1.24 110.215 174.249 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 54.39 27.54 8.29 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 126.387 1.875 . . . . 2.6299999999999999 114.431 178.469 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 12.2 m -115.82 153.63 31.12 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.112 0.965 . . . . 0.62 109.136 -178.124 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.1 p -117.36 142.9 29.35 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 C-N-CA 124.121 0.968 . . . . 0.35999999999999999 109.121 170.667 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 21.1 m120 -125.95 131.86 52.2 Favored 'General case' 0 C--N 1.343 0.316 0 N-CA-C 106.673 -1.602 . . . . 0.34000000000000002 106.673 174.217 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.547 ' CG1' HD11 ' A' ' 8' ' ' ILE . 0.1 OUTLIER -132.24 128.06 58.24 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.706 0 N-CA-C 105.755 -1.942 . . . . 1.97 105.755 -178.962 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 10.7 mm -108.96 96.83 5.0 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 C-N-CA 126.113 1.765 . . . . 0.47999999999999998 108.104 -168.778 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.477 ' HB3' HG22 ' A' ' 34' ' ' VAL . 44.9 p90 -130.93 172.54 11.93 Favored 'General case' 0 CA--C 1.511 -0.552 0 O-C-N 121.317 -0.864 . . . . 1.8700000000000001 110.913 -169.649 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 36.0 t0 -90.28 107.7 21.52 Favored Pre-proline 0 CA--C 1.536 0.426 0 O-C-N 124.526 1.142 . . . . 2.8100000000000001 110.051 174.826 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -75.42 6.84 3.32 Favored 'Trans proline' 0 N--CA 1.451 -1.028 0 C-N-CA 122.434 2.089 . . . . 0.62 113.072 -178.903 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -81.77 -26.25 34.61 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 119.473 1.033 . . . . 0.81999999999999995 108.926 165.484 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -108.65 -66.59 1.04 Allowed 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 107.989 -1.115 . . . . 3.8100000000000001 107.989 -170.727 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.483 HG22 ' HB3' ' A' ' 59' ' ' ALA 0.417 0.2 OUTLIER -76.67 178.09 7.02 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 116.573 2.064 . . . . 0.64000000000000001 116.573 165.156 . . . . . . . . 4 4 . 1 . 026 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -163.68 -145.05 4.23 Favored Glycine 0 N--CA 1.432 -1.622 1 N-CA-C 102.424 -4.27 . . . . 2.5499999999999998 102.424 176.39 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 30.9 p -75.23 -37.68 60.95 Favored 'General case' 0 N--CA 1.444 -0.747 0 C-N-CA 125.34 1.456 . . . . 1.21 109.087 172.891 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -49.42 -61.2 2.23 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 124.936 1.294 . . . . 1.21 113.912 -165.601 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.483 ' HB3' HG22 ' A' ' 55' ' ' THR . . . -71.87 -33.66 68.56 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 118.773 -1.171 . . . . 1.0800000000000001 108.834 -168.98 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.5 mp -55.84 -52.5 48.23 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 C-N-CA 123.874 0.87 . . . . 1.1100000000000001 109.835 174.193 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -61.51 -43.16 99.37 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 109.845 -0.428 . . . . 1.6299999999999999 109.845 -176.708 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -48.89 -58.06 5.43 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.163 0.985 . . . . 2.8599999999999999 110.631 171.976 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -67.45 -36.14 80.61 Favored 'General case' 0 N--CA 1.442 -0.85 0 O-C-N 121.396 -0.815 . . . . 3.0299999999999998 112.592 -177.711 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -52.07 -52.18 25.47 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 C-N-CA 124.839 1.256 . . . . 0.39000000000000001 107.839 176.307 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -57.77 -55.56 33.26 Favored 'General case' 0 C--N 1.34 0.189 0 C-N-CA 122.944 0.498 . . . . 2.21 109.965 175.433 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 7.7 mmtt -58.01 -35.02 70.65 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 113.12 0.785 . . . . 4.2999999999999998 113.12 -175.34 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 24.8 mt -70.3 -17.69 63.09 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 125.287 1.435 . . . . 0.92000000000000004 111.416 175.838 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 96.31 38.58 4.49 Favored Glycine 0 CA--C 1.522 0.521 0 C-N-CA 124.754 1.169 . . . . 0.65000000000000002 110.803 175.574 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.468 ' CD1' HG21 ' A' ' 24' ' ' ILE . 0.2 OUTLIER -136.93 175.58 9.49 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 117.654 0.727 . . . . 1.76 111.029 -176.357 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 5.9 t60 -138.68 137.34 36.74 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 109.546 -0.538 . . . . 2.1800000000000002 109.546 169.392 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 8.6 p -110.24 144.01 19.15 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 N-CA-C 106.644 -1.613 . . . . 1.5 106.644 177.403 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 20.5 t -113.39 131.82 64.04 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 N-CA-C 108.455 -0.942 . . . . 0.54000000000000004 108.455 178.997 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 47.8 mm . . . . . 0 N--CA 1.45 -0.43 0 C-N-CA 124.79 1.236 . . . . 1.1100000000000001 107.772 -174.789 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.4 m . . . . . 0 N--CA 1.448 -0.56 0 N-CA-C 105.447 -2.057 . . . . 0.75 105.447 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -89.62 -173.5 3.97 Favored 'General case' 0 N--CA 1.445 -0.679 0 C-N-CA 124.327 1.051 . . . . 2.1699999999999999 108.814 175.174 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.8 mm100 -135.96 147.88 48.25 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 107.425 -1.324 . . . . 1.02 107.425 164.707 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 86.6 mttt -139.36 159.22 42.66 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 109.164 -0.68 . . . . 3.25 109.164 158.037 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -112.59 100.1 8.46 Favored 'General case' 0 N--CA 1.436 -1.152 0 C-N-CA 128.28 2.632 . . . . 1.3100000000000001 105.321 -171.681 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 7.0 mm -80.79 161.31 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.267 0 N-CA-C 106.601 -1.629 . . . . 1.9199999999999999 106.601 178.912 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -133.33 122.56 24.01 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 106.756 -1.572 . . . . 0.47999999999999998 106.756 174.093 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 71.8 mtm -140.46 168.59 19.45 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 123.451 0.7 . . . . 1.97 109.784 -178.687 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 20.6 mm100 -94.69 148.93 21.76 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 125.216 1.407 . . . . 2.5 109.413 177.763 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 69.7 t -99.73 145.72 10.09 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 C-N-CA 123.541 0.736 . . . . 1.3300000000000001 109.346 178.041 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 32.3 t -145.03 176.87 9.18 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 124.475 1.11 . . . . 1.73 108.816 168.881 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 52.29 60.26 7.94 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 124.292 0.949 . . . . 1.8899999999999999 110.773 -176.455 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -128.73 151.33 49.67 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 124.198 0.999 . . . . 2.1299999999999999 110.328 -172.79 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -97.26 -55.38 2.86 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 124.421 1.088 . . . . 3.1200000000000001 109.196 168.639 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 22.8 p -150.27 165.92 31.53 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-O 121.839 0.828 . . . . 2.4300000000000002 111.757 -174.5 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -74.27 48.64 0.33 Allowed 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.462 1.505 . . . . 1.8 111.357 175.701 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -144.02 -51.76 0.32 Allowed 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 124.795 1.238 . . . . 0.72999999999999998 108.18 175.697 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.442 ' SG ' ' NH2' ' A' ' 23' ' ' ARG . 27.1 m -59.37 -36.97 76.75 Favored 'General case' 0 CA--C 1.531 0.248 0 O-C-N 121.38 -0.825 . . . . 1.1799999999999999 109.745 167.998 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.425 ' HB1' HG21 ' A' ' 39' ' ' VAL . . . -59.17 -21.8 59.98 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 112.95 0.722 . . . . 0.47999999999999998 112.95 173.668 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -73.79 -50.94 18.12 Favored 'General case' 0 C--N 1.339 0.152 0 O-C-N 121.019 -1.05 . . . . 0.39000000000000001 110.032 169.943 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.442 ' NH2' ' SG ' ' A' ' 20' ' ' CYS . 17.3 mtm180 -50.04 -42.39 49.53 Favored 'General case' 0 N--CA 1.456 -0.143 0 C-N-CA 123.32 0.648 . . . . 5.6500000000000004 111.196 -175.663 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.442 HG21 ' CG ' ' A' ' 69' ' ' TYR . 3.9 pt -57.82 -53.66 42.12 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.156 0 C-N-CA 119.847 -0.741 . . . . 0.63 111.891 177.341 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -57.88 -46.46 84.84 Favored 'General case' 0 C--O 1.224 -0.266 0 C-N-CA 123.339 0.655 . . . . 3.3500000000000001 110.708 -179.876 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -72.34 -40.3 67.51 Favored 'General case' 0 C--N 1.331 -0.234 0 O-C-N 121.908 -0.495 . . . . 2.1499999999999999 111.034 -173.535 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -59.44 -45.28 95.77 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 109.757 -1.337 . . . . 0.65000000000000002 109.757 169.695 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -61.94 -37.47 84.83 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 121.879 -0.777 . . . . 2.3700000000000001 109.655 -179.839 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 3.3 ttpp -53.98 -25.38 20.64 Favored 'General case' 0 CA--C 1.533 0.3 0 O-C-N 120.724 -1.235 . . . . 2.3999999999999999 113.198 174.505 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -82.15 -1.21 48.17 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.043 0.937 . . . . 3.48 111.836 -179.088 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 21.4 mmt -93.77 149.35 36.93 Favored Pre-proline 0 CA--C 1.535 0.401 0 C-N-CA 124.194 0.998 . . . . 4.6500000000000004 109.995 -175.092 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -58.45 142.86 98.24 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 122.52 2.146 . . . . 0.65000000000000002 111.477 -176.65 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 85.65 -27.3 5.36 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 123.511 0.577 . . . . 0.52000000000000002 112.927 179.422 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.4 t -80.12 140.18 17.11 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 CA-C-N 118.363 1.081 . . . . 0.68000000000000005 108.795 176.33 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 69.8 m -106.7 -60.12 1.71 Allowed 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 118.474 -0.774 . . . . 1.3600000000000001 109.116 178.488 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -140.65 165.35 27.72 Favored 'General case' 0 N--CA 1.446 -0.675 0 N-CA-C 109.052 -0.721 . . . . 2.5800000000000001 109.052 179.821 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -156.43 143.9 19.18 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 109.381 -0.6 . . . . 0.40999999999999998 109.381 -168.335 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -152.2 116.16 4.9 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 123.892 0.877 . . . . 0.75 108.761 -167.209 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.425 HG21 ' HB1' ' A' ' 21' ' ' ALA . 8.6 p -82.2 124.35 39.11 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 N-CA-C 107.208 -1.405 . . . . 0.66000000000000003 107.208 171.542 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 47.2 t30 -108.57 55.38 0.64 Allowed 'General case' 0 C--O 1.235 0.326 0 CA-C-O 123.07 1.414 . . . . 0.72999999999999998 107.22 178.161 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.437 HD22 ' HA ' ' A' ' 41' ' ' LEU . 0.2 OUTLIER -70.65 -18.35 62.85 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 114.171 -1.377 . . . . 0.95999999999999996 110.311 -174.207 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -43.38 -37.61 2.38 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 124.267 1.027 . . . . 0.54000000000000004 111.991 166.033 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 9.3 t -125.87 32.89 5.18 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 122.719 0.407 . . . . 1.2 110.435 173.58 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 59.1 27.62 16.65 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.923 1.689 . . . . 2.9199999999999999 113.609 174.437 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 60.3 m -115.97 164.28 14.67 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.747 1.219 . . . . 0.64000000000000001 109.723 -174.594 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 5.7 p -136.25 143.72 35.02 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 C-N-CA 124.516 1.126 . . . . 0.32000000000000001 108.637 171.998 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -134.92 122.1 21.47 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 124.647 1.179 . . . . 0.57999999999999996 108.153 -175.405 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.7 p -123.85 130.59 73.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 N-CA-C 106.176 -1.787 . . . . 1.73 106.176 -172.705 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 9.7 mm -105.39 97.47 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 N-CA-C 107.158 -1.423 . . . . 0.40999999999999998 107.158 -174.92 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 3.6 p90 -129.72 164.89 23.0 Favored 'General case' 0 CA--C 1.512 -0.481 0 O-C-N 122.161 -0.337 . . . . 2.1000000000000001 110.641 -176.554 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -81.65 124.01 80.16 Favored Pre-proline 0 CA--C 1.536 0.418 0 N-CA-C 108.314 -0.995 . . . . 3.1200000000000001 108.314 167.189 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -86.57 15.54 2.17 Favored 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 122.904 2.403 . . . . 0.60999999999999999 112.888 -175.385 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -97.88 -40.52 8.47 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 123.999 0.92 . . . . 1.0600000000000001 109.069 169.248 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -90.59 -62.08 1.54 Allowed 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 107.143 -1.428 . . . . 3.8399999999999999 107.143 -177.337 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.518 0.2 OUTLIER -78.31 -175.65 4.3 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 115.328 1.603 . . . . 0.69999999999999996 115.328 159.336 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 154.64 -168.3 32.73 Favored Glycine 0 N--CA 1.435 -1.381 1 N-CA-C 102.81 -4.116 . . . . 2.5299999999999998 102.81 -148.83 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 16.7 p -73.34 -34.91 65.9 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 124.14 0.976 . . . . 1.0800000000000001 109.244 -176.679 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -46.96 -60.88 2.15 Favored 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 125.055 1.342 . . . . 0.56000000000000005 113.441 -169.556 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.07 -40.99 74.71 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 118.995 -1.082 . . . . 0.44 108.793 -167.524 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.5 mp -50.71 -54.57 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.944 0 CA-C-N 113.891 -1.504 . . . . 0.95999999999999996 109.787 174.087 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -65.82 -44.58 85.19 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 118.669 0.668 . . . . 2.1899999999999999 110.28 -174.008 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -45.84 -56.7 5.06 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 122.597 1.189 . . . . 2.7999999999999998 110.046 173.252 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.86 -40.47 68.95 Favored 'General case' 0 N--CA 1.438 -1.05 0 N-CA-C 113.536 0.939 . . . . 3.9500000000000002 113.536 -176.314 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -48.26 -52.49 7.78 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 C-N-CA 125.003 1.321 . . . . 0.38 108.017 173.961 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -59.65 -58.83 6.87 Favored 'General case' 0 C--N 1.341 0.219 0 C-N-CA 123.429 0.692 . . . . 1.6299999999999999 110.333 176.588 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 6.6 mmmt -57.76 -33.02 68.06 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 113.62 0.97 . . . . 4.3499999999999996 113.62 -175.732 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 22.6 mt -71.81 -19.02 62.05 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.181 1.392 . . . . 0.73999999999999999 111.666 174.853 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 96.81 43.68 3.05 Favored Glycine 0 CA--C 1.524 0.645 0 C-N-CA 124.704 1.145 . . . . 0.39000000000000001 111.442 174.735 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.442 ' CG ' HG21 ' A' ' 24' ' ' ILE . 0.7 OUTLIER -140.1 174.49 10.47 Favored 'General case' 0 N--CA 1.457 -0.085 0 C-N-CA 124.488 1.115 . . . . 1.97 110.157 -177.799 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 6.9 t-80 -141.55 125.91 17.62 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 109.387 -0.597 . . . . 1.72 109.387 174.279 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 7.8 p -92.77 152.14 3.5 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 108.479 -0.934 . . . . 1.5600000000000001 108.479 174.566 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 38.1 t -127.3 143.65 39.9 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 C-N-CA 124.808 1.243 . . . . 0.52000000000000002 108.323 178.488 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 5.2 mp . . . . . 0 N--CA 1.453 -0.281 0 C-N-CA 124.558 1.143 . . . . 1.4099999999999999 108.789 -172.804 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.3 m . . . . . 0 N--CA 1.449 -0.484 0 N-CA-C 105.596 -2.002 . . . . 0.84999999999999998 105.596 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -84.92 -175.7 5.88 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 108.199 -1.038 . . . . 2.0899999999999999 108.199 163.839 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.18 146.78 49.05 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 107.583 -1.266 . . . . 1.1299999999999999 107.583 169.2 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 54.2 mttm -140.27 156.16 46.58 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 121.44 0.638 . . . . 2.77 110.279 161.873 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -112.89 87.01 2.49 Favored 'General case' 0 N--CA 1.439 -0.978 0 C-N-CA 128.343 2.657 . . . . 1.45 106.444 -168.508 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 20.6 mm -82.62 159.64 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.396 0 N-CA-C 106.575 -1.639 . . . . 2.1800000000000002 106.575 -176.035 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -131.77 138.18 48.47 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 125.784 1.634 . . . . 0.59999999999999998 106.743 -179.694 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -156.31 175.84 13.47 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 118.511 0.596 . . . . 2.71 110.786 172.649 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 30.1 mm100 -94.6 159.35 15.12 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 124.638 1.175 . . . . 2.6800000000000002 109.886 -178.405 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 62.0 t -114.26 156.53 15.2 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 C-N-CA 125.075 1.35 . . . . 1.1799999999999999 108.769 -176.454 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 25.3 m -150.01 165.63 32.13 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 123.725 0.81 . . . . 0.91000000000000003 109.518 168.006 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 63.68 47.56 85.5 Favored Glycine 0 CA--C 1.528 0.899 0 N-CA-C 110.31 -1.116 . . . . 1.6000000000000001 110.31 -171.52 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -120.55 165.17 15.37 Favored 'General case' 0 N--CA 1.457 -0.121 0 C-N-CA 124.663 1.185 . . . . 2.0899999999999999 108.972 175.3 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 174.51 -41.96 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 127.864 2.466 . . . . 3.8100000000000001 110.528 175.447 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 47.9 t -48.02 -41.02 24.5 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.327 1.051 . . . . 2.98 110.932 172.173 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 64.56 19.15 11.72 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.621 1.169 . . . . 2.2200000000000002 111.92 -178.0 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -134.58 -44.22 0.75 Allowed 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 125.395 1.478 . . . . 0.81999999999999995 109.439 176.035 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 20.5 m -47.24 -38.48 12.35 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 123.413 0.685 . . . . 1.6499999999999999 112.599 169.131 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.635 ' HB1' HG21 ' A' ' 39' ' ' VAL . . . -49.26 -33.29 12.52 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.382 0.673 . . . . 0.46000000000000002 112.068 174.545 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.6 -52.88 15.77 Favored 'General case' 0 N--CA 1.456 -0.173 0 O-C-N 120.789 -1.194 . . . . 0.32000000000000001 110.416 171.699 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 46.4 mmm-85 -50.42 -50.63 51.36 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 123.933 0.893 . . . . 3.7799999999999998 110.114 -175.968 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 5.1 pt -56.86 -54.61 27.47 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 CA-C-O 118.79 -0.624 . . . . 0.63 109.946 -179.839 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -55.46 -38.6 69.26 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 119.273 0.942 . . . . 2.29 112.12 179.474 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 42.7 mmtm -71.58 -44.14 65.01 Favored 'General case' 0 CA--C 1.534 0.327 0 O-C-N 121.345 -0.847 . . . . 1.8500000000000001 111.564 -177.49 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -69.58 -33.21 71.65 Favored Glycine 0 CA--C 1.528 0.871 0 C-N-CA 120.218 -0.991 . . . . 0.51000000000000001 110.914 173.088 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 9.6 tt -56.37 -48.64 76.43 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 107.833 -1.173 . . . . 2.0 107.833 173.227 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -54.87 -19.44 6.56 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 113.428 0.899 . . . . 3.6099999999999999 113.428 176.249 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 94.5 mtt180 -77.54 -4.68 46.94 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 119.679 1.127 . . . . 4.8300000000000001 112.289 177.704 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 7.3 ptp -71.11 155.68 92.9 Favored Pre-proline 0 CA--C 1.534 0.339 0 CA-C-N 119.58 1.082 . . . . 3.8100000000000001 111.37 173.335 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -58.86 133.04 51.18 Favored 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 121.769 1.646 . . . . 0.58999999999999997 109.046 163.5 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 108.54 -35.12 5.16 Favored Glycine 0 CA--C 1.53 1.015 0 CA-C-O 119.442 -0.643 . . . . 0.5 113.39 171.892 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 59.9 t -89.28 128.62 41.22 Favored 'Isoleucine or valine' 0 C--N 1.34 0.173 0 CA-C-N 118.454 1.127 . . . . 0.62 110.303 178.772 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 30.7 m -111.06 -28.58 8.25 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 123.582 0.753 . . . . 1.0600000000000001 111.817 -174.747 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -146.78 164.1 33.86 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 119.033 0.833 . . . . 2.3399999999999999 111.359 164.791 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -156.18 133.95 11.07 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 112.571 0.582 . . . . 0.42999999999999999 112.571 -176.478 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -150.34 115.88 5.49 Favored 'General case' 0 C--N 1.341 0.235 0 N-CA-C 108.279 -1.008 . . . . 0.44 108.279 -163.266 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.635 HG21 ' HB1' ' A' ' 21' ' ' ALA . 8.4 p -93.3 100.13 10.75 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 C-N-CA 123.478 0.711 . . . . 0.53000000000000003 110.049 -175.985 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 53.1 t-20 -83.71 57.3 4.02 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 122.651 1.215 . . . . 0.63 109.287 -179.145 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.449 HD22 ' HA ' ' A' ' 41' ' ' LEU . 0.2 OUTLIER -69.98 -19.74 63.33 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 114.915 -1.038 . . . . 0.92000000000000004 110.155 -175.713 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -46.7 -35.67 6.31 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 123.876 0.87 . . . . 0.59999999999999998 112.036 166.046 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 5.6 t -122.11 37.33 4.4 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 121.496 0.665 . . . . 1.3300000000000001 109.553 173.56 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 41.22 40.01 1.07 Allowed 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 126.655 1.982 . . . . 2.6400000000000001 113.503 179.109 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 95.1 m -124.33 160.49 27.96 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 124.971 1.308 . . . . 0.68000000000000005 107.865 -178.799 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.6 p -130.79 146.81 33.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 O-C-N 121.356 -0.84 . . . . 0.42999999999999999 109.321 170.133 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -128.77 138.84 52.31 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 108.253 -1.017 . . . . 0.31 108.253 -179.639 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 34.2 t -135.05 129.28 50.59 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 N-CA-C 106.284 -1.747 . . . . 2.1499999999999999 106.284 -179.395 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 11.4 mm -104.4 99.8 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 N-CA-C 106.874 -1.528 . . . . 0.40999999999999998 106.874 -173.552 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 53.6 p90 -138.3 167.49 21.75 Favored 'General case' 0 CA--C 1.509 -0.602 0 O-C-N 121.622 -0.673 . . . . 2.0600000000000001 111.623 -170.591 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -87.75 109.43 26.88 Favored Pre-proline 0 C--O 1.236 0.343 0 O-C-N 124.448 1.092 . . . . 3.04 109.646 174.992 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -74.56 5.18 3.92 Favored 'Trans proline' 0 N--CA 1.451 -0.989 0 C-N-CA 122.759 2.306 . . . . 0.55000000000000004 112.973 -177.323 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -86.08 -27.61 24.59 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 119.506 1.048 . . . . 0.73999999999999999 109.294 166.721 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.51 -57.5 2.03 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 108.22 -1.03 . . . . 3.46 108.22 -168.666 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.288 1.0 OUTLIER -93.95 -173.63 3.18 Favored 'General case' 0 C--O 1.225 -0.215 0 C-N-CA 124.435 1.094 . . . . 0.42999999999999999 112.494 161.566 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 141.64 91.25 0.17 Allowed Glycine 0 N--CA 1.441 -1.029 0 N-CA-C 103.222 -3.951 . . . . 2.2599999999999998 103.222 -155.896 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -13.02 -13.92 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.7 1 C-N-CA 138.476 6.71 . . . . 3.02 120.472 -149.249 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -26.26 -62.62 0.08 Allowed 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 126.885 2.074 . . . . 0.56999999999999995 114.867 161.228 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.87 -41.5 59.69 Favored 'General case' 0 CA--C 1.521 -0.145 0 CA-C-O 122.255 1.026 . . . . 0.48999999999999999 108.931 -167.802 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.7 mt -44.82 -57.36 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.771 0 C-N-CA 125.829 1.651 . . . . 1.51 110.53 170.452 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.95 -46.35 88.23 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 119.444 1.02 . . . . 1.1799999999999999 110.747 178.999 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -49.3 -55.49 12.6 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 121.944 0.878 . . . . 3.3999999999999999 111.001 179.019 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.462 ' HA ' ' HE3' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -68.95 -41.11 78.44 Favored 'General case' 0 N--CA 1.441 -0.886 0 C-N-CA 124.135 0.974 . . . . 3.0899999999999999 112.319 179.207 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -48.71 -53.18 7.53 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 N-CA-C 108.318 -0.993 . . . . 0.39000000000000001 108.318 175.91 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -59.96 -58.58 7.96 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 124.147 0.979 . . . . 1.51 110.699 177.03 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 2.9 mttp -55.23 -39.73 70.06 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 112.959 0.725 . . . . 4.0099999999999998 112.959 -175.849 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 20.8 mt -67.34 -17.81 64.9 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.327 1.051 . . . . 0.60999999999999999 111.515 177.361 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 96.58 41.03 3.73 Favored Glycine 0 C--N 1.335 0.512 0 C-N-CA 124.827 1.203 . . . . 0.41999999999999998 110.758 173.947 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -138.54 175.89 9.17 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 123.829 0.852 . . . . 1.96 110.334 -175.255 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 16.4 t-160 -142.32 148.6 38.25 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 108.419 -0.956 . . . . 2.0600000000000001 108.419 174.88 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -118.42 152.9 20.55 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.14 0 C-N-CA 125.617 1.567 . . . . 1.8600000000000001 106.942 177.176 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 59.0 t -124.14 145.72 30.81 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 C-N-CA 124.902 1.281 . . . . 0.56000000000000005 108.274 179.141 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 38.9 mm . . . . . 0 N--CA 1.456 -0.174 0 C-N-CA 124.616 1.167 . . . . 1.04 108.884 -173.895 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 11.7 m . . . . . 0 N--CA 1.451 -0.399 0 CA-C-O 120.759 0.314 . . . . 1.2 111.309 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -78.05 161.49 27.42 Favored 'General case' 0 N--CA 1.435 -1.192 0 N-CA-C 106.001 -1.852 . . . . 3.3999999999999999 106.001 171.351 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 9.8 mm100 -129.88 149.34 51.66 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 108.518 -0.919 . . . . 2.3300000000000001 108.518 -178.006 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 71.7 tttt -145.6 155.33 42.97 Favored 'General case' 0 N--CA 1.438 -1.053 0 C-N-CA 124.003 0.921 . . . . 4.1299999999999999 108.973 175.103 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -112.96 92.86 4.16 Favored 'General case' 0 N--CA 1.437 -1.086 0 C-N-CA 129.566 3.146 . . . . 1.6799999999999999 105.229 -173.494 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 19.4 mm -83.78 163.38 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.301 0 N-CA-C 106.797 -1.557 . . . . 2.29 106.797 175.665 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -133.22 138.03 46.36 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 125.457 1.503 . . . . 0.46000000000000002 107.291 177.92 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -155.85 171.38 20.15 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 118.347 0.522 . . . . 1.9299999999999999 109.733 175.946 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -93.32 164.83 13.07 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 124.921 1.288 . . . . 3.5800000000000001 109.893 -174.424 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.8 t -126.29 146.61 31.82 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 C-N-CA 123.754 0.822 . . . . 1.1599999999999999 109.622 -173.579 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 59.9 m -127.48 171.69 11.36 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.742 1.217 . . . . 1.0800000000000001 109.042 170.795 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 79.71 -35.85 2.07 Favored Glycine 0 CA--C 1.534 1.26 0 O-C-N 121.514 -0.741 . . . . 2.2799999999999998 112.871 -179.297 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -44.01 142.64 1.33 Allowed 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 114.248 1.203 . . . . 2.6200000000000001 114.248 -179.712 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -153.02 -60.89 0.15 Allowed 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 126.351 1.861 . . . . 2.71 107.002 177.995 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 31.3 m -63.94 -25.53 68.18 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.077 0.951 . . . . 2.77 112.94 -176.959 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 68.55 -60.18 0.44 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 126.005 1.722 . . . . 2.6699999999999999 110.956 -169.102 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -48.07 -45.5 32.56 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.71 1.204 . . . . 0.81000000000000005 111.682 178.861 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 89.9 m -57.48 -32.32 66.86 Favored 'General case' 0 CA--C 1.529 0.143 0 N-CA-C 112.766 0.654 . . . . 1.54 112.766 177.761 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.668 ' HB1' HG21 ' A' ' 39' ' ' VAL . . . -64.47 -19.17 65.4 Favored 'General case' 0 CA--C 1.538 0.487 0 O-C-N 121.904 -0.498 . . . . 0.56000000000000005 111.051 175.12 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.22 -47.41 61.56 Favored 'General case' 0 N--CA 1.453 -0.279 0 O-C-N 119.452 -2.03 . . . . 0.44 108.607 169.734 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 61.8 mtp180 -55.45 -41.24 72.59 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 118.77 -0.633 . . . . 4.1600000000000001 110.076 -176.386 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.484 HG21 ' CD1' ' A' ' 69' ' ' TYR 0.3 1.4 pt -57.82 -58.38 6.52 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.425 0 C-N-CA 119.373 -0.931 . . . . 0.46999999999999997 110.708 174.877 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.4 ' HG3' ' HB1' ' A' ' 37' ' ' ALA . 0.4 OUTLIER -47.88 -42.55 27.1 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 119.191 0.905 . . . . 2.6699999999999999 112.883 176.293 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 24.4 mmtp -70.25 -48.74 55.56 Favored 'General case' 0 CA--C 1.535 0.378 0 O-C-N 120.938 -1.101 . . . . 2.2400000000000002 111.291 -179.573 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.86 -29.38 73.91 Favored Glycine 0 CA--C 1.53 1.0 0 O-C-N 121.665 -0.647 . . . . 0.92000000000000004 111.582 176.281 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.3 tt -67.4 -54.42 20.56 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 125.314 1.446 . . . . 1.8500000000000001 107.775 176.547 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.501 ' HE2' ' HA ' ' A' ' 36' ' ' ASP . 6.7 ttmt -48.32 -33.11 8.36 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.523 0.729 . . . . 2.5499999999999998 112.115 178.22 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 3.6 mmt180 -55.76 -15.7 3.48 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 114.507 1.299 . . . . 4.2000000000000002 114.507 177.906 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 9.9 ptp -67.68 156.72 88.32 Favored Pre-proline 0 CA--C 1.535 0.38 0 CA-C-N 119.719 1.145 . . . . 3.8900000000000001 112.252 175.941 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -60.74 137.89 76.0 Favored 'Trans proline' 0 N--CA 1.456 -0.735 0 C-N-CA 121.378 1.385 . . . . 0.67000000000000004 109.522 165.846 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 99.33 -28.63 14.51 Favored Glycine 0 CA--C 1.53 0.983 0 CA-C-O 119.14 -0.811 . . . . 0.47999999999999998 113.729 170.553 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 61.5 t -88.64 136.75 22.61 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 CA-C-N 119.288 1.544 . . . . 0.56000000000000005 109.119 171.613 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -108.04 -41.2 5.0 Favored 'General case' 0 C--N 1.341 0.216 0 CA-C-O 118.356 -0.83 . . . . 1.4199999999999999 110.733 178.508 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.501 ' HA ' ' HE2' ' A' ' 29' ' ' LYS . 0.4 OUTLIER -143.21 165.93 26.1 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-N 119.113 0.87 . . . . 2.3700000000000001 110.403 170.963 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.4 ' HB1' ' HG3' ' A' ' 25' ' ' GLU . . . -158.02 148.16 20.28 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 123.538 0.735 . . . . 0.51000000000000001 110.073 179.923 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -156.19 118.37 4.03 Favored 'General case' 0 C--O 1.232 0.143 0 N-CA-C 107.723 -1.214 . . . . 0.53000000000000003 107.723 -163.364 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.668 HG21 ' HB1' ' A' ' 21' ' ' ALA . 8.0 p -89.92 101.4 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 C-N-CA 123.082 0.553 . . . . 0.65000000000000002 110.232 -177.07 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 51.4 t-20 -84.07 56.7 3.83 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-O 122.693 1.235 . . . . 0.59999999999999998 109.277 179.629 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.427 HD22 ' HA ' ' A' ' 41' ' ' LEU . 0.2 OUTLIER -69.07 -19.92 64.08 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 115.229 -0.896 . . . . 1.1100000000000001 110.152 -175.467 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -46.91 -36.8 8.01 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.032 0.933 . . . . 0.68000000000000005 112.363 166.752 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 14.5 t -115.5 23.67 12.2 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 118.499 0.59 . . . . 1.3600000000000001 111.327 174.161 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 55.04 50.37 15.56 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.4 1.08 . . . . 3.5499999999999998 112.859 -179.706 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 7.1 m -145.9 154.78 42.33 Favored 'General case' 0 N--CA 1.445 -0.722 0 O-C-N 120.418 -1.426 . . . . 0.77000000000000002 109.045 178.844 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.3 p -117.81 144.37 25.97 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 N-CA-C 108.455 -0.943 . . . . 0.39000000000000001 108.455 171.347 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -124.68 142.62 51.25 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 108.153 -1.055 . . . . 0.39000000000000001 108.153 176.985 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 4.0 p -139.78 129.35 29.09 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 N-CA-C 106.822 -1.548 . . . . 1.78 106.822 -174.993 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 14.5 mm -108.31 89.03 1.21 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.654 0 C-N-CA 126.007 1.723 . . . . 0.63 107.711 -167.461 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 34.7 p90 -137.12 172.9 12.32 Favored 'General case' 0 CA--C 1.511 -0.542 0 C-N-CA 122.671 0.388 . . . . 1.6399999999999999 111.967 -167.703 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 66.4 t0 -93.36 104.71 13.06 Favored Pre-proline 0 C--O 1.236 0.345 0 O-C-N 125.094 1.496 . . . . 3.0800000000000001 110.177 -179.412 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -73.71 3.19 5.11 Favored 'Trans proline' 0 N--CA 1.448 -1.154 0 C-N-CA 122.003 1.802 . . . . 0.76000000000000001 112.447 -179.286 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -82.23 -29.35 31.38 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 119.819 1.19 . . . . 1.0700000000000001 109.205 165.726 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -108.32 -55.99 2.31 Favored 'General case' 0 C--N 1.343 0.317 0 C-N-CA 122.797 0.439 . . . . 2.52 110.308 -166.355 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.31 0.6 OUTLIER -89.05 177.54 6.62 Favored 'General case' 0 CA--C 1.514 -0.432 0 CA-C-O 123.312 1.53 . . . . 0.52000000000000002 114.212 160.345 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -160.02 -135.9 1.93 Allowed Glycine 0 N--CA 1.433 -1.567 0 N-CA-C 103.978 -3.649 . . . . 2.54 103.978 175.43 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 23.6 p -76.57 -35.29 58.28 Favored 'General case' 0 N--CA 1.444 -0.751 0 C-N-CA 127.031 2.132 . . . . 1.3600000000000001 109.75 177.917 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -49.48 -62.8 1.35 Allowed 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 125.49 1.516 . . . . 0.55000000000000004 113.926 -165.379 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.83 -35.0 69.76 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 114.676 -1.147 . . . . 0.44 108.472 -168.364 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.8 mt -54.26 -57.18 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.908 0 C-N-CA 125.95 1.7 . . . . 1.3200000000000001 111.179 173.155 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.69 -45.22 95.01 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 119.804 1.184 . . . . 1.0900000000000001 109.626 -179.724 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -49.56 -59.36 3.84 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-O 121.392 0.615 . . . . 3.2400000000000002 111.958 176.756 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 4.7 mmpt? -63.61 -40.53 97.16 Favored 'General case' 0 N--CA 1.437 -1.087 0 CA-C-O 118.459 -0.781 . . . . 2.2000000000000002 111.096 -179.452 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.3 mm -49.01 -54.3 5.69 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.558 0 C-N-CA 124.171 0.989 . . . . 0.34999999999999998 108.441 177.204 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 27.0 mm-40 -59.32 -55.71 31.34 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 123.594 0.757 . . . . 1.6200000000000001 110.436 177.0 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 10.2 mmtt -57.11 -36.48 70.69 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 112.905 0.706 . . . . 4.4299999999999997 112.905 -174.931 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 13.0 mt -71.11 -17.8 62.55 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.889 1.276 . . . . 0.64000000000000001 112.144 175.874 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 96.96 39.47 4.06 Favored Glycine 0 CA--C 1.523 0.589 0 C-N-CA 124.571 1.082 . . . . 0.45000000000000001 111.093 175.36 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.484 ' CD1' HG21 ' A' ' 24' ' ' ILE . 0.6 OUTLIER -135.31 175.86 9.2 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 124.131 0.972 . . . . 1.9399999999999999 110.303 -178.39 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 22.4 t-160 -143.86 133.55 23.7 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 107.711 -1.218 . . . . 2.04 107.711 172.631 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 6.5 p -108.86 139.99 29.28 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 C-N-CA 125.296 1.439 . . . . 1.49 107.407 179.782 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 86.3 t -108.72 138.74 34.23 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.137 0 CA-C-O 121.833 0.825 . . . . 0.68000000000000005 109.069 -179.566 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 45.8 mm . . . . . 0 N--CA 1.451 -0.416 0 C-N-CA 125.224 1.41 . . . . 1.1699999999999999 109.123 -169.767 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 11.7 m . . . . . 0 N--CA 1.451 -0.399 0 CA-C-O 120.759 0.314 . . . . 1.2 111.309 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -78.05 161.49 27.42 Favored 'General case' 0 N--CA 1.435 -1.192 0 N-CA-C 106.001 -1.852 . . . . 3.3999999999999999 106.001 171.351 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 9.8 mm100 -129.88 149.34 51.66 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 108.518 -0.919 . . . . 2.3300000000000001 108.518 -178.006 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 71.7 tttt -145.6 155.33 42.97 Favored 'General case' 0 N--CA 1.438 -1.053 0 C-N-CA 124.003 0.921 . . . . 4.1299999999999999 108.973 175.103 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -112.96 92.86 4.16 Favored 'General case' 0 N--CA 1.437 -1.086 0 C-N-CA 129.566 3.146 . . . . 1.6799999999999999 105.229 -173.494 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 19.4 mm -83.78 163.38 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.301 0 N-CA-C 106.797 -1.557 . . . . 2.29 106.797 175.665 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -133.22 138.03 46.36 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 125.457 1.503 . . . . 0.46000000000000002 107.291 177.92 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -155.85 171.38 20.15 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 118.347 0.522 . . . . 1.9299999999999999 109.733 175.946 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -93.32 164.83 13.07 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 124.921 1.288 . . . . 3.5800000000000001 109.893 -174.424 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.8 t -126.29 146.61 31.82 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 C-N-CA 123.754 0.822 . . . . 1.1599999999999999 109.622 -173.579 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 59.9 m -127.48 171.69 11.36 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.742 1.217 . . . . 1.0800000000000001 109.042 170.795 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 79.71 -35.85 2.07 Favored Glycine 0 CA--C 1.534 1.26 0 O-C-N 121.514 -0.741 . . . . 2.2799999999999998 112.871 -179.297 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -44.01 142.64 1.33 Allowed 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 114.248 1.203 . . . . 2.6200000000000001 114.248 -179.712 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -153.02 -60.89 0.15 Allowed 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 126.351 1.861 . . . . 2.71 107.002 177.995 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 31.3 m -63.94 -25.53 68.18 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.077 0.951 . . . . 2.77 112.94 -176.959 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 68.55 -60.18 0.44 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 126.005 1.722 . . . . 2.6699999999999999 110.956 -169.102 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -48.07 -45.5 32.56 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.71 1.204 . . . . 0.81000000000000005 111.682 178.861 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 89.9 m -57.48 -32.32 66.86 Favored 'General case' 0 CA--C 1.529 0.143 0 N-CA-C 112.766 0.654 . . . . 1.54 112.766 177.761 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.668 ' HB1' HG21 ' A' ' 39' ' ' VAL . . . -64.47 -19.17 65.4 Favored 'General case' 0 CA--C 1.538 0.487 0 O-C-N 121.904 -0.498 . . . . 0.56000000000000005 111.051 175.12 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.22 -47.41 61.56 Favored 'General case' 0 N--CA 1.453 -0.279 0 O-C-N 119.452 -2.03 . . . . 0.44 108.607 169.734 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 61.8 mtp180 -55.45 -41.24 72.59 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 118.77 -0.633 . . . . 4.1600000000000001 110.076 -176.386 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.484 HG21 ' CD1' ' A' ' 69' ' ' TYR 0.3 1.4 pt -57.82 -58.38 6.52 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.425 0 C-N-CA 119.373 -0.931 . . . . 0.46999999999999997 110.708 174.877 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.4 ' HG3' ' HB1' ' A' ' 37' ' ' ALA . 0.4 OUTLIER -47.88 -42.55 27.1 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 119.191 0.905 . . . . 2.6699999999999999 112.883 176.293 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 24.4 mmtp -70.25 -48.74 55.56 Favored 'General case' 0 CA--C 1.535 0.378 0 O-C-N 120.938 -1.101 . . . . 2.2400000000000002 111.291 -179.573 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.86 -29.38 73.91 Favored Glycine 0 CA--C 1.53 1.0 0 O-C-N 121.665 -0.647 . . . . 0.92000000000000004 111.582 176.281 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.3 tt -67.4 -54.42 20.56 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 125.314 1.446 . . . . 1.8500000000000001 107.775 176.547 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.501 ' HE2' ' HA ' ' A' ' 36' ' ' ASP . 6.7 ttmt -48.32 -33.11 8.36 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.523 0.729 . . . . 2.5499999999999998 112.115 178.22 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 3.6 mmt180 -55.76 -15.7 3.48 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 114.507 1.299 . . . . 4.2000000000000002 114.507 177.906 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 9.9 ptp -67.68 156.72 88.32 Favored Pre-proline 0 CA--C 1.535 0.38 0 CA-C-N 119.719 1.145 . . . . 3.8900000000000001 112.252 175.941 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -60.74 137.89 76.0 Favored 'Trans proline' 0 N--CA 1.456 -0.735 0 C-N-CA 121.378 1.385 . . . . 0.67000000000000004 109.522 165.846 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 99.33 -28.63 14.51 Favored Glycine 0 CA--C 1.53 0.983 0 CA-C-O 119.14 -0.811 . . . . 0.47999999999999998 113.729 170.553 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 61.5 t -88.64 136.75 22.61 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 CA-C-N 119.288 1.544 . . . . 0.56000000000000005 109.119 171.613 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -108.04 -41.2 5.0 Favored 'General case' 0 C--N 1.341 0.216 0 CA-C-O 118.356 -0.83 . . . . 1.4199999999999999 110.733 178.508 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.501 ' HA ' ' HE2' ' A' ' 29' ' ' LYS . 0.4 OUTLIER -143.21 165.93 26.1 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-N 119.113 0.87 . . . . 2.3700000000000001 110.403 170.963 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.4 ' HB1' ' HG3' ' A' ' 25' ' ' GLU . . . -158.02 148.16 20.28 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 123.538 0.735 . . . . 0.51000000000000001 110.073 179.923 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -156.19 118.37 4.03 Favored 'General case' 0 C--O 1.232 0.143 0 N-CA-C 107.723 -1.214 . . . . 0.53000000000000003 107.723 -163.364 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.668 HG21 ' HB1' ' A' ' 21' ' ' ALA . 8.0 p -89.92 101.4 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 C-N-CA 123.082 0.553 . . . . 0.65000000000000002 110.232 -177.07 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 51.4 t-20 -84.07 56.7 3.83 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-O 122.693 1.235 . . . . 0.59999999999999998 109.277 179.629 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.427 HD22 ' HA ' ' A' ' 41' ' ' LEU . 0.2 OUTLIER -69.07 -19.92 64.08 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 115.229 -0.896 . . . . 1.1100000000000001 110.152 -175.467 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -46.91 -36.8 8.01 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.032 0.933 . . . . 0.68000000000000005 112.363 166.752 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 14.5 t -115.5 23.67 12.2 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 118.499 0.59 . . . . 1.3600000000000001 111.327 174.161 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 55.04 50.37 15.56 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.4 1.08 . . . . 3.5499999999999998 112.859 -179.706 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 7.1 m -145.9 154.78 42.33 Favored 'General case' 0 N--CA 1.445 -0.722 0 O-C-N 120.418 -1.426 . . . . 0.77000000000000002 109.045 178.844 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.3 p -117.81 144.37 25.97 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 N-CA-C 108.455 -0.943 . . . . 0.39000000000000001 108.455 171.347 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -124.68 142.62 51.25 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 108.153 -1.055 . . . . 0.39000000000000001 108.153 176.985 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 4.0 p -139.78 129.35 29.09 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 N-CA-C 106.822 -1.548 . . . . 1.78 106.822 -174.993 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 14.5 mm -108.31 89.03 1.21 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.654 0 C-N-CA 126.007 1.723 . . . . 0.63 107.711 -167.461 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 34.7 p90 -137.12 172.9 12.32 Favored 'General case' 0 CA--C 1.511 -0.542 0 C-N-CA 122.671 0.388 . . . . 1.6399999999999999 111.967 -167.703 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 66.4 t0 -93.36 104.71 13.06 Favored Pre-proline 0 C--O 1.236 0.345 0 O-C-N 125.094 1.496 . . . . 3.0800000000000001 110.177 -179.412 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -73.71 3.19 5.11 Favored 'Trans proline' 0 N--CA 1.448 -1.154 0 C-N-CA 122.003 1.802 . . . . 0.76000000000000001 112.447 -179.286 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -82.23 -29.35 31.38 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 119.819 1.19 . . . . 1.0700000000000001 109.205 165.726 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -108.32 -55.99 2.31 Favored 'General case' 0 C--N 1.343 0.317 0 C-N-CA 122.797 0.439 . . . . 2.52 110.308 -166.355 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.31 0.6 OUTLIER -89.05 177.54 6.62 Favored 'General case' 0 CA--C 1.514 -0.432 0 CA-C-O 123.312 1.53 . . . . 0.52000000000000002 114.212 160.345 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -160.02 -135.9 1.93 Allowed Glycine 0 N--CA 1.433 -1.567 0 N-CA-C 103.978 -3.649 . . . . 2.54 103.978 175.43 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 23.6 p -76.57 -35.29 58.28 Favored 'General case' 0 N--CA 1.444 -0.751 0 C-N-CA 127.031 2.132 . . . . 1.3600000000000001 109.75 177.917 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -49.48 -62.8 1.35 Allowed 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 125.49 1.516 . . . . 0.55000000000000004 113.926 -165.379 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.83 -35.0 69.76 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 114.676 -1.147 . . . . 0.44 108.472 -168.364 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.8 mt -54.26 -57.18 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.908 0 C-N-CA 125.95 1.7 . . . . 1.3200000000000001 111.179 173.155 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.69 -45.22 95.01 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 119.804 1.184 . . . . 1.0900000000000001 109.626 -179.724 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -49.56 -59.36 3.84 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-O 121.392 0.615 . . . . 3.2400000000000002 111.958 176.756 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 4.7 mmpt? -63.61 -40.53 97.16 Favored 'General case' 0 N--CA 1.437 -1.087 0 CA-C-O 118.459 -0.781 . . . . 2.2000000000000002 111.096 -179.452 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.3 mm -49.01 -54.3 5.69 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.558 0 C-N-CA 124.171 0.989 . . . . 0.34999999999999998 108.441 177.204 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 27.0 mm-40 -59.32 -55.71 31.34 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 123.594 0.757 . . . . 1.6200000000000001 110.436 177.0 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 10.2 mmtt -57.11 -36.48 70.69 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 112.905 0.706 . . . . 4.4299999999999997 112.905 -174.931 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 13.0 mt -71.11 -17.8 62.55 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.889 1.276 . . . . 0.64000000000000001 112.144 175.874 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 96.96 39.47 4.06 Favored Glycine 0 CA--C 1.523 0.589 0 C-N-CA 124.571 1.082 . . . . 0.45000000000000001 111.093 175.36 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.484 ' CD1' HG21 ' A' ' 24' ' ' ILE . 0.6 OUTLIER -135.31 175.86 9.2 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 124.131 0.972 . . . . 1.9399999999999999 110.303 -178.39 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 22.4 t-160 -143.86 133.55 23.7 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 107.711 -1.218 . . . . 2.04 107.711 172.631 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 6.5 p -108.86 139.99 29.28 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 C-N-CA 125.296 1.439 . . . . 1.49 107.407 179.782 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 86.3 t -108.72 138.74 34.23 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.137 0 CA-C-O 121.833 0.825 . . . . 0.68000000000000005 109.069 -179.566 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 45.8 mm . . . . . 0 N--CA 1.451 -0.416 0 C-N-CA 125.224 1.41 . . . . 1.1699999999999999 109.123 -169.767 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.5 ttm . . . . . 0 N--CA 1.47 0.54 0 N-CA-C 106.048 -1.834 . . . . 11.02 106.048 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.1 tt -161.66 -74.94 0.05 Allowed 'General case' 0 C--O 1.224 -0.256 0 N-CA-C 107.727 -1.212 . . . . 5.79 107.727 172.288 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.3 m 48.71 93.18 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 126.057 1.743 . . . . 1.05 112.068 176.138 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -72.76 174.97 6.91 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 108.472 -0.936 . . . . 2.3100000000000001 108.472 179.245 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -129.45 141.09 51.11 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 107.304 -1.369 . . . . 1.04 107.304 168.429 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 6.8 mtpm? -139.76 158.43 44.12 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-O 122.225 1.012 . . . . 3.46 109.661 168.028 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -112.67 107.4 16.06 Favored 'General case' 0 N--CA 1.431 -1.402 0 C-N-CA 130.03 3.332 . . . . 1.5900000000000001 104.974 -171.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.476 HD12 ' C ' ' A' ' 8' ' ' ILE . 2.2 pp -84.12 167.02 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 C-N-CA 118.917 -1.113 . . . . 4.9000000000000004 108.599 166.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -137.76 134.01 34.76 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 105.174 -2.158 . . . . 0.44 105.174 170.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 24.2 ptt? -153.11 168.57 25.49 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 118.492 0.587 . . . . 3.1600000000000001 109.75 178.212 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 19.9 mm100 -92.81 163.99 13.51 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 124.122 0.969 . . . . 2.46 109.819 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.9 m -124.17 157.16 31.58 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.126 0 C-N-CA 125.403 1.481 . . . . 1.8799999999999999 110.08 179.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 38.5 m -155.04 166.7 32.75 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 124.8 1.24 . . . . 1.28 108.655 170.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 63.11 74.66 0.4 Allowed Glycine 0 CA--C 1.528 0.877 0 N-CA-C 110.845 -0.902 . . . . 1.8300000000000001 110.845 178.398 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -146.71 155.97 42.81 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 123.228 0.611 . . . . 2.29 110.526 -175.096 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -85.6 -62.81 1.44 Allowed 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 125.915 1.686 . . . . 3.5800000000000001 109.644 172.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.6 p -155.07 161.04 41.42 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 121.724 0.773 . . . . 2.27 112.085 -169.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -72.93 56.1 0.41 Allowed 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 126.751 2.02 . . . . 1.8200000000000001 111.112 -178.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -152.6 -52.57 0.11 Allowed 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 124.804 1.242 . . . . 0.69999999999999996 108.448 -175.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 30.9 m -59.07 -39.26 81.57 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 108.904 -0.776 . . . . 1.1599999999999999 108.904 170.357 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.705 ' HB1' HG21 ' A' ' 39' ' ' VAL . . . -41.3 -36.83 0.86 Allowed 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.663 1.585 . . . . 0.76000000000000001 112.697 166.569 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -69.75 -53.91 16.18 Favored 'General case' 0 N--CA 1.452 -0.34 0 O-C-N 120.228 -1.545 . . . . 0.41999999999999998 109.264 175.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 2.5 mpp_? -57.08 -36.68 70.86 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-O 118.166 -0.921 . . . . 4.4000000000000004 111.639 -174.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.281 2.0 pt -56.78 -57.19 10.47 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 C-N-CA 119.342 -0.943 . . . . 0.65000000000000002 110.742 175.079 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -57.13 -45.66 83.33 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 123.533 0.733 . . . . 2.3199999999999998 112.08 178.001 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 13.4 mptt -66.73 -43.25 84.69 Favored 'General case' 0 CA--C 1.531 0.22 0 O-C-N 121.683 -0.636 . . . . 1.8200000000000001 109.838 -174.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -60.33 -44.37 97.61 Favored Glycine 0 CA--C 1.527 0.811 0 N-CA-C 110.024 -1.23 . . . . 0.60999999999999999 110.024 171.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -60.39 -40.91 92.62 Favored 'General case' 0 CA--C 1.532 0.255 0 O-C-N 122.48 -0.423 . . . . 2.3300000000000001 110.069 -175.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 19.9 ttmt -43.5 -32.25 0.86 Allowed 'General case' 0 CA--C 1.535 0.369 0 O-C-N 121.747 -0.596 . . . . 2.9700000000000002 112.405 173.133 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.93 -4.2 30.58 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 113.588 0.958 . . . . 5.9500000000000002 113.588 -172.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.83 166.39 37.78 Favored Pre-proline 0 CA--C 1.539 0.537 0 C-N-CA 125.111 1.364 . . . . 3.79 111.655 173.232 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_endo -70.5 157.1 59.97 Favored 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 122.881 2.387 . . . . 1.3100000000000001 110.629 -178.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 72.46 -36.15 0.68 Allowed Glycine 0 CA--C 1.525 0.71 0 C-N-CA 124.972 1.273 . . . . 0.92000000000000004 112.798 -179.031 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.5 t -68.45 144.78 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.732 0 CA-C-N 118.411 1.106 . . . . 0.94999999999999996 109.286 176.113 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -133.16 -39.24 0.94 Allowed 'General case' 0 N--CA 1.451 -0.377 0 CA-C-O 118.705 -0.664 . . . . 1.04 110.945 179.196 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -139.55 166.28 25.0 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-N 119.251 0.932 . . . . 2.6200000000000001 111.963 166.055 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -158.17 138.32 12.44 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 115.659 -0.7 . . . . 0.44 110.322 -176.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -149.62 109.83 4.16 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 106.206 -1.776 . . . . 0.41999999999999998 106.206 -163.681 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.705 HG21 ' HB1' ' A' ' 21' ' ' ALA . 9.7 p -81.48 119.09 30.41 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 N-CA-C 108.523 -0.917 . . . . 0.5 108.523 177.286 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 55.7 t-20 -99.65 57.28 1.01 Allowed 'General case' 0 C--O 1.236 0.352 0 CA-C-O 123.017 1.389 . . . . 0.57999999999999996 107.803 -178.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.453 HD22 ' HA ' ' A' ' 41' ' ' LEU . 0.2 OUTLIER -69.48 -19.92 63.75 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 114.095 -1.411 . . . . 0.96999999999999997 110.372 -172.773 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -46.21 -37.0 6.57 Favored 'General case' 0 C--N 1.34 0.189 0 C-N-CA 123.974 0.91 . . . . 0.53000000000000003 111.839 168.086 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 14.9 t -124.31 37.19 4.46 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 109.831 -0.433 . . . . 1.24 109.831 173.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 52.12 31.98 9.77 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 126.317 1.847 . . . . 2.9900000000000002 113.034 171.507 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 95.6 m -122.99 159.92 27.34 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 125.07 1.348 . . . . 0.65000000000000002 108.536 -175.28 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 6.5 p -129.03 143.96 39.65 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 O-C-N 121.249 -0.907 . . . . 0.31 109.413 172.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 20.1 m120 -127.84 138.9 52.86 Favored 'General case' 0 C--N 1.344 0.354 0 N-CA-C 107.774 -1.195 . . . . 0.34999999999999998 107.774 179.198 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 93.3 t -134.17 125.46 48.05 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 N-CA-C 105.062 -2.199 . . . . 1.8899999999999999 105.062 -174.506 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 13.7 mm -104.4 101.0 11.67 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 C-N-CA 126.249 1.82 . . . . 0.44 107.983 -175.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 41.9 p90 -142.23 173.04 11.89 Favored 'General case' 0 CA--C 1.513 -0.457 0 O-C-N 121.785 -0.572 . . . . 1.72 111.183 -172.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -92.97 115.17 64.52 Favored Pre-proline 0 CA--C 1.534 0.343 0 O-C-N 124.199 0.937 . . . . 3.04 108.884 173.188 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -81.76 13.08 2.56 Favored 'Trans proline' 0 N--CA 1.451 -0.998 0 C-N-CA 122.465 2.11 . . . . 0.66000000000000003 113.386 -176.054 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -92.35 -32.27 15.04 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 119.45 1.023 . . . . 0.93000000000000005 109.588 164.052 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -101.1 -55.43 2.56 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 108.495 -0.928 . . . . 2.6899999999999999 108.495 -169.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.499 0.2 OUTLIER -83.67 176.75 8.75 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 115.301 1.593 . . . . 0.64000000000000001 115.301 155.845 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -171.31 -147.54 5.7 Favored Glycine 0 N--CA 1.434 -1.454 0 N-CA-C 103.126 -3.99 . . . . 2.52 103.126 -174.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 23.6 p -76.75 -32.58 57.85 Favored 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 125.108 1.363 . . . . 1.3999999999999999 109.551 174.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -49.98 -61.59 2.06 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 124.723 1.209 . . . . 0.71999999999999997 113.282 -162.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.0 -34.21 73.02 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 114.408 -1.269 . . . . 0.60999999999999999 108.765 -171.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.6 mp -60.68 -51.41 73.42 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.95 0 CA-C-N 114.999 -1.0 . . . . 1.23 109.79 178.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.49 -47.11 85.43 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 108.828 -0.804 . . . . 1.1499999999999999 108.828 -178.068 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -48.7 -54.64 14.03 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 122.038 0.923 . . . . 3.1899999999999999 110.974 174.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.07 -47.17 81.17 Favored 'General case' 0 N--CA 1.44 -0.973 0 CA-C-O 118.664 -0.684 . . . . 2.3999999999999999 111.776 -178.524 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.501 HD12 HG13 ' A' ' 71' ' ' VAL . 1.2 mm -46.76 -50.99 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 C-N-CA 126.412 1.885 . . . . 0.51000000000000001 109.033 -177.091 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -57.73 -57.58 12.12 Favored 'General case' 0 C--N 1.34 0.159 0 C-N-CA 123.387 0.675 . . . . 1.49 110.173 175.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 13.9 mmtt -55.45 -35.6 65.64 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 112.963 0.727 . . . . 4.8499999999999996 112.963 -178.14 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 31.6 mt -71.07 -18.35 62.56 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.74 1.616 . . . . 0.93000000000000005 111.451 177.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 87.15 44.17 5.73 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 110.593 -1.003 . . . . 0.83999999999999997 110.593 178.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -137.93 172.97 12.14 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 124.094 0.957 . . . . 2.6800000000000002 109.72 179.125 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 8.3 t60 -146.35 133.9 20.92 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 109.239 -0.652 . . . . 1.96 109.239 165.048 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.501 HG13 HD12 ' A' ' 64' ' ' ILE . 4.5 m -98.8 161.05 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 C-N-CA 123.823 0.849 . . . . 2.4900000000000002 110.15 176.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 12.0 t -129.55 141.9 45.31 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 C-N-CA 124.902 1.281 . . . . 0.56000000000000005 107.843 -176.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 28.7 mm -118.59 80.5 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 C-N-CA 125.025 1.33 . . . . 1.6499999999999999 108.426 -175.203 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -79.56 -1.35 37.41 Favored 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 124.503 1.121 . . . . 2.8900000000000001 113.97 176.012 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -94.63 -34.67 6.2 Favored Glycine 0 CA--C 1.531 1.053 0 C-N-CA 125.39 1.471 . . . . 3.1000000000000001 113.567 -173.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 46.8 ttm-85 . . . . . 0 C--O 1.25 1.081 0 CA-C-O 116.779 -1.582 . . . . 11.279999999999999 108.85 178.403 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 34.5 mtt . . . . . 0 N--CA 1.475 0.777 0 N-CA-C 109.478 -0.564 . . . . 10.15 109.478 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -53.19 -46.34 68.95 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.215 0.606 . . . . 5.5599999999999996 109.789 -178.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 55.1 m -115.03 163.15 16.01 Favored 'General case' 0 N--CA 1.447 -0.624 0 C-N-CA 125.93 1.692 . . . . 1.3999999999999999 106.507 162.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -111.33 -174.7 2.53 Favored 'General case' 0 N--CA 1.439 -1.025 0 C-N-CA 125.487 1.515 . . . . 2.3399999999999999 107.257 156.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -136.28 152.01 50.25 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 107.473 -1.306 . . . . 1.1699999999999999 107.473 172.711 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 23.9 mttt -143.67 163.35 33.5 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 122.937 0.495 . . . . 2.6800000000000002 110.286 161.075 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -122.47 84.81 2.32 Favored 'General case' 0 N--CA 1.44 -0.969 0 C-N-CA 128.687 2.795 . . . . 1.5600000000000001 106.009 -166.429 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.439 ' N ' HD12 ' A' ' 8' ' ' ILE . 3.1 mp -82.49 160.6 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.405 0 N-CA-C 105.691 -1.966 . . . . 2.0299999999999998 105.691 -178.15 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -120.35 132.92 55.49 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 106.243 -1.762 . . . . 0.53000000000000003 106.243 178.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 2.8 ttm -138.54 161.63 36.57 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 108.355 -0.98 . . . . 2.2400000000000002 108.355 -177.161 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -97.42 146.91 24.74 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 124.235 1.014 . . . . 2.4199999999999999 108.936 177.078 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 49.1 t -103.85 149.76 7.52 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 C-N-CA 123.77 0.828 . . . . 1.24 109.019 -178.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 56.3 m -152.93 164.88 37.1 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 118.866 0.757 . . . . 1.1699999999999999 110.092 171.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 64.02 72.13 0.74 Allowed Glycine 0 CA--C 1.527 0.84 0 N-CA-C 110.93 -0.868 . . . . 1.73 110.93 178.2 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -154.78 170.11 22.37 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 123.825 0.85 . . . . 2.0699999999999998 109.857 -172.727 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -111.87 -44.64 3.43 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 123.922 0.889 . . . . 2.3300000000000001 111.229 168.642 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 20.0 p -147.97 176.43 10.17 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 119.111 0.869 . . . . 2.6600000000000001 111.631 -174.105 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -72.26 -24.41 61.36 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 115.508 -0.769 . . . . 2.6200000000000001 111.809 177.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.7 -49.7 72.09 Favored 'General case' 0 C--O 1.233 0.209 0 O-C-N 121.377 -0.827 . . . . 0.71999999999999997 110.79 -175.614 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 5.2 p -65.06 -38.96 92.49 Favored 'General case' 0 CA--C 1.532 0.279 0 O-C-N 121.633 -0.667 . . . . 2.4500000000000002 110.518 173.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.756 ' HB1' HG21 ' A' ' 39' ' ' VAL . . . -56.61 -29.28 61.97 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-O 121.386 0.613 . . . . 0.40999999999999998 112.074 173.242 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -69.9 -53.41 18.07 Favored 'General case' 0 N--CA 1.45 -0.445 0 O-C-N 119.935 -1.728 . . . . 0.5 108.791 171.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -46.67 -50.96 16.99 Favored 'General case' 0 C--N 1.341 0.231 0 CA-C-O 118.486 -0.769 . . . . 3.9199999999999999 110.755 178.109 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.502 HG21 ' CD1' ' A' ' 69' ' ' TYR 0.268 3.4 pt -57.09 -58.21 6.78 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.159 0 C-N-CA 119.727 -0.789 . . . . 0.51000000000000001 110.69 -176.302 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -51.96 -45.47 64.4 Favored 'General case' 0 N--CA 1.457 -0.095 0 CA-C-N 119.006 0.821 . . . . 2.4199999999999999 111.068 179.184 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.36 -40.15 85.75 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 119.585 -0.846 . . . . 1.53 110.895 -177.239 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -68.93 -24.62 75.7 Favored Glycine 0 CA--C 1.529 0.916 0 O-C-N 121.542 -0.724 . . . . 0.64000000000000001 111.633 174.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.434 ' CD2' HG21 ' A' ' 34' ' ' VAL . 0.9 OUTLIER -70.1 -43.92 70.06 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 108.11 -1.07 . . . . 1.6799999999999999 108.11 173.838 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 3.4 ttpp -50.0 -24.67 2.74 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 125.323 1.449 . . . . 2.3999999999999999 113.505 173.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -83.24 -0.21 48.48 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 118.443 -0.789 . . . . 3.9100000000000001 112.942 -179.5 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . 0.633 ' CE ' ' HB1' ' A' ' 59' ' ' ALA . 4.0 ptm -93.96 156.0 39.66 Favored Pre-proline 0 CA--C 1.536 0.43 0 CA-C-N 119.31 0.959 . . . . 3.2200000000000002 111.658 -178.144 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -62.13 133.22 42.78 Favored 'Trans proline' 0 N--CA 1.456 -0.711 0 C-N-CA 122.433 2.089 . . . . 0.81000000000000005 109.809 173.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 100.11 -39.2 2.82 Favored Glycine 0 CA--C 1.525 0.7 0 CA-C-O 119.08 -0.844 . . . . 0.79000000000000004 112.595 176.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.434 HG21 ' CD2' ' A' ' 28' ' ' LEU . 47.5 t -88.02 118.66 34.12 Favored 'Isoleucine or valine' 0 C--N 1.343 0.314 0 CA-C-N 118.796 1.298 . . . . 1.0900000000000001 110.143 177.653 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 98.1 m -88.82 -52.66 5.0 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-O 118.76 -0.638 . . . . 1.3899999999999999 110.058 -176.236 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -138.23 161.26 37.3 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 123.838 0.855 . . . . 2.7200000000000002 108.757 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -158.22 141.03 14.71 Favored 'General case' 0 C--O 1.238 0.454 0 O-C-N 121.923 -0.486 . . . . 0.44 111.255 -173.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -151.37 110.07 3.83 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 106.648 -1.612 . . . . 0.42999999999999999 106.648 -165.118 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.756 HG21 ' HB1' ' A' ' 21' ' ' ALA . 8.7 p -80.97 136.07 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 N-CA-C 107.816 -1.179 . . . . 0.71999999999999997 107.816 176.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 52.7 t-20 -121.97 56.01 1.1 Allowed 'General case' 0 C--O 1.235 0.342 0 CA-C-O 123.03 1.395 . . . . 0.58999999999999997 107.929 -176.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.429 HD22 ' HA ' ' A' ' 41' ' ' LEU . 0.2 OUTLIER -68.09 -19.55 64.87 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 113.807 -1.542 . . . . 1.04 110.615 -176.018 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -45.46 -37.88 5.63 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 124.067 0.947 . . . . 0.68000000000000005 111.948 165.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 12.2 t -124.53 38.18 4.25 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 109.063 -0.717 . . . . 1.3600000000000001 109.063 172.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 53.77 24.1 4.18 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.773 1.629 . . . . 3.25 113.78 171.085 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 88.0 m -116.51 162.91 16.86 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.814 1.245 . . . . 0.69999999999999996 108.878 -174.347 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.4 p -125.94 145.42 33.42 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 C-N-CA 124.536 1.135 . . . . 0.34000000000000002 108.044 167.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 10.2 m120 -124.17 136.86 54.5 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 107.494 -1.299 . . . . 0.33000000000000002 107.494 172.519 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.1 p -134.93 123.66 41.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 106.252 -1.759 . . . . 1.8799999999999999 106.252 -173.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 13.5 mm -104.32 94.72 3.32 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 N-CA-C 107.194 -1.41 . . . . 0.56000000000000005 107.194 -168.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 31.1 p90 -131.28 164.26 26.0 Favored 'General case' 0 CA--C 1.512 -0.506 0 O-C-N 122.203 -0.31 . . . . 1.6499999999999999 111.691 -169.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 35.7 t0 -83.53 109.23 16.63 Favored Pre-proline 0 CA--C 1.532 0.279 0 O-C-N 124.444 1.09 . . . . 3.02 109.553 174.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -74.22 4.87 3.97 Favored 'Trans proline' 0 N--CA 1.451 -0.981 0 C-N-CA 122.663 2.242 . . . . 0.59999999999999998 113.06 -176.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -85.44 -28.68 24.91 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 119.338 0.972 . . . . 0.77000000000000002 109.215 166.428 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -102.52 -61.16 1.43 Allowed 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 107.941 -1.133 . . . . 4.2999999999999998 107.941 -169.189 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.829 HG22 ' HB3' ' A' ' 59' ' ' ALA 0.283 0.7 OUTLIER -86.75 -176.46 5.8 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 124.933 1.293 . . . . 0.78000000000000003 112.901 162.489 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 131.78 94.02 0.61 Allowed Glycine 0 N--CA 1.442 -0.903 0 N-CA-C 103.515 -3.834 . . . . 2.3100000000000001 103.515 -144.356 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 75.0 p -19.17 -23.25 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.308 1 C-N-CA 138.132 6.573 . . . . 1.28 118.809 -147.43 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -28.21 -62.54 0.1 Allowed 'General case' 0 N--CA 1.442 -0.846 0 C-N-CA 126.503 1.921 . . . . 0.91000000000000003 113.19 165.174 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.829 ' HB3' HG22 ' A' ' 55' ' ' THR . . . -75.27 -32.43 61.05 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 118.396 -1.322 . . . . 0.87 110.014 -168.644 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.6 mp -60.17 -51.72 69.6 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.625 0 CA-C-N 115.579 -0.737 . . . . 0.82999999999999996 109.794 175.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.96 -48.21 82.63 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 119.067 0.849 . . . . 1.1699999999999999 109.151 -178.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -46.13 -58.74 3.37 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-O 121.864 0.84 . . . . 2.5699999999999998 111.24 174.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 15.2 mmmt -67.74 -34.69 77.33 Favored 'General case' 0 N--CA 1.441 -0.913 0 CA-C-O 118.354 -0.832 . . . . 3.7000000000000002 112.082 -177.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.4 mm -53.45 -52.65 30.48 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 N-CA-C 107.943 -1.132 . . . . 0.41999999999999998 107.943 176.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 40.9 mm-40 -58.15 -54.77 43.25 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 123.469 0.708 . . . . 1.54 109.837 176.123 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 13.0 mmtt -59.48 -33.85 71.84 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 113.288 0.848 . . . . 4.1299999999999999 113.288 -176.325 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 32.1 mt -70.78 -18.47 62.75 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.735 1.214 . . . . 1.02 111.289 174.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 95.9 39.88 4.23 Favored Glycine 0 CA--C 1.524 0.597 0 C-N-CA 124.892 1.234 . . . . 0.72999999999999998 111.007 175.173 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.502 ' CD1' HG21 ' A' ' 24' ' ' ILE . 0.2 OUTLIER -136.54 175.47 9.58 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 117.805 0.803 . . . . 1.8700000000000001 111.462 -174.987 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -130.69 147.5 52.37 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 123.487 0.715 . . . . 2.9300000000000002 109.497 167.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 4.1 p -126.52 152.77 34.49 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 N-CA-C 106.581 -1.637 . . . . 1.5 106.581 176.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 11.6 t -129.31 141.89 45.4 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 N-CA-C 107.032 -1.47 . . . . 0.73999999999999999 107.032 -178.571 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 5.0 mp -113.05 80.86 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.201 0 N-CA-C 108.759 -0.83 . . . . 1.3500000000000001 108.759 -175.04 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 26.2 mm-40 -76.77 -2.51 33.49 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 125.648 1.579 . . . . 3.3999999999999999 113.642 174.249 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -129.83 61.45 0.66 Allowed Glycine 0 CA--C 1.523 0.549 0 N-CA-C 108.252 -1.939 . . . . 4.0599999999999996 108.252 175.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 5.6 ttt-85 . . . . . 0 C--O 1.251 1.136 0 CA-C-O 117.846 -1.073 . . . . 13.029999999999999 112.867 -175.386 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.473 0.722 0 N-CA-C 107.036 -1.468 . . . . 10.59 107.036 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 29.8 mt -106.55 -74.9 0.64 Allowed 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 107.781 -1.192 . . . . 5.0800000000000001 107.781 175.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.9 m -137.18 140.38 41.74 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 125.795 1.638 . . . . 0.89000000000000001 106.797 177.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -88.6 -178.29 5.78 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 108.359 -0.978 . . . . 1.95 108.359 163.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 2.9 mm100 -134.58 148.44 50.45 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 107.038 -1.467 . . . . 1.1499999999999999 107.038 169.104 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 37.4 mtpt -140.32 156.91 46.26 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 123.415 0.686 . . . . 2.79 109.167 163.078 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 8.0 mp0 -115.48 89.69 3.16 Favored 'General case' 0 N--CA 1.442 -0.836 0 C-N-CA 127.746 2.418 . . . . 1.8600000000000001 106.326 -170.289 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.514 ' N ' HD12 ' A' ' 8' ' ' ILE . 1.6 mp -83.32 161.25 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.397 0 N-CA-C 105.742 -1.947 . . . . 2.1400000000000001 105.742 -177.321 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -127.81 126.34 41.5 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 125.395 1.478 . . . . 0.41999999999999998 107.021 177.333 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 2.7 mpp? -132.58 170.87 14.57 Favored 'General case' 0 CA--C 1.528 0.124 0 C-N-CA 123.419 0.688 . . . . 2.1000000000000001 109.204 173.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 18.5 mm100 -97.66 145.27 26.47 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 124.438 1.095 . . . . 2.6099999999999999 109.476 178.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 60.3 t -97.5 151.22 4.33 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.158 0 N-CA-C 108.938 -0.764 . . . . 1.26 108.938 178.316 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 13.0 t -141.77 176.77 8.65 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 108.196 -1.039 . . . . 1.6499999999999999 108.196 170.284 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 53.14 57.53 14.66 Favored Glycine 0 CA--C 1.529 0.909 0 C-N-CA 124.112 0.863 . . . . 1.53 111.573 -178.306 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -139.78 137.98 35.49 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 123.767 0.827 . . . . 1.9299999999999999 109.557 -179.344 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -144.44 8.14 1.35 Allowed 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.809 0.843 . . . . 3.7799999999999998 112.716 166.789 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 8.8 m -108.97 -21.0 12.84 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 124.691 1.196 . . . . 2.9100000000000001 111.825 -171.408 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 64.46 -68.06 0.1 Allowed 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.707 1.603 . . . . 2.5499999999999998 110.881 -165.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -44.13 -49.66 8.88 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 125.81 1.644 . . . . 0.83999999999999997 112.603 -175.418 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 96.6 m -52.54 -35.76 54.18 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 123.953 0.901 . . . . 1.1899999999999999 113.126 -178.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.78 ' HB1' HG21 ' A' ' 39' ' ' VAL . . . -63.35 -23.24 67.32 Favored 'General case' 0 CA--C 1.539 0.557 0 O-C-N 122.034 -0.416 . . . . 0.41999999999999998 111.157 179.638 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.13 -52.78 17.36 Favored 'General case' 0 N--CA 1.454 -0.245 0 O-C-N 121.028 -1.045 . . . . 0.31 109.592 171.13 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 4.2 mtt-85 -50.97 -47.99 61.23 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 123.379 0.672 . . . . 3.77 110.219 -176.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.442 HG21 ' CD1' ' A' ' 69' ' ' TYR . 6.8 pt -57.24 -55.07 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.196 0 C-N-CA 119.751 -0.779 . . . . 0.48999999999999999 111.121 179.487 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -54.17 -42.96 70.21 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.753 0.821 . . . . 3.1899999999999999 111.92 179.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 31.9 mmtp -70.66 -47.34 60.44 Favored 'General case' 0 CA--C 1.534 0.357 0 O-C-N 121.061 -1.024 . . . . 1.95 110.914 -178.248 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.37 -28.36 70.9 Favored Glycine 0 CA--C 1.53 0.995 0 O-C-N 121.545 -0.722 . . . . 0.64000000000000001 111.349 174.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.1 tt -68.86 -47.87 64.87 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 125.789 1.636 . . . . 1.8899999999999999 109.215 174.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.2 ttmm -50.45 -34.7 25.66 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 118.664 0.665 . . . . 2.7400000000000002 111.713 175.149 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 14.5 mmt-85 -62.69 -7.15 4.34 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 114.877 1.436 . . . . 4.4000000000000004 114.877 179.338 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . 0.472 ' SD ' ' HB1' ' A' ' 59' ' ' ALA . 27.4 mtm -71.56 169.72 14.61 Favored Pre-proline 0 CA--C 1.533 0.312 0 CA-C-N 120.355 1.434 . . . . 3.4500000000000002 112.44 170.8 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -60.78 162.78 17.57 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 121.777 1.651 . . . . 1.01 110.039 159.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 77.33 -38.72 1.63 Allowed Glycine 0 C--N 1.333 0.373 0 C-N-CA 125.88 1.705 . . . . 0.51000000000000001 114.02 171.455 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 16.3 t -83.66 134.08 27.73 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.875 0 C-N-CA 123.054 0.542 . . . . 0.52000000000000002 109.603 -177.428 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 88.0 m -113.6 -46.45 3.05 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 122.948 0.499 . . . . 1.3700000000000001 110.276 -175.183 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -139.48 165.13 28.05 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-N 118.047 0.385 . . . . 1.74 110.144 173.347 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -158.02 139.03 13.22 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 108.721 -0.844 . . . . 0.41999999999999998 108.721 -172.343 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -155.93 111.85 3.05 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 123.258 0.623 . . . . 0.48999999999999999 109.347 -165.571 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.896 HG22 HD23 ' A' ' 41' ' ' LEU . 4.8 p -86.79 102.57 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 CA-C-O 121.224 0.535 . . . . 0.55000000000000004 109.991 -177.037 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 51.7 t-20 -86.31 56.97 4.23 Favored 'General case' 0 C--O 1.235 0.333 0 O-C-N 120.687 -1.258 . . . . 0.57999999999999996 109.423 -179.213 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.896 HD23 HG22 ' A' ' 39' ' ' VAL . 0.3 OUTLIER -69.47 -19.86 63.75 Favored 'General case' 0 C--O 1.226 -0.158 0 CA-C-N 115.003 -0.998 . . . . 0.88 110.972 -176.195 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -45.27 -36.98 4.33 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.665 0.786 . . . . 0.56999999999999995 112.078 166.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 11.3 t -123.38 30.21 6.37 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 122.494 0.318 . . . . 1.23 110.964 172.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 62.11 26.83 16.16 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.348 1.459 . . . . 2.5099999999999998 114.297 172.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 88.4 m -120.32 163.13 18.29 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.79 1.236 . . . . 0.72999999999999998 109.524 -174.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 5.8 p -129.91 142.92 42.58 Favored 'Isoleucine or valine' 0 C--O 1.232 0.15 0 C-N-CA 124.302 1.041 . . . . 0.33000000000000002 108.835 171.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 10.4 m120 -126.12 129.79 49.78 Favored 'General case' 0 CA--C 1.517 -0.296 0 N-CA-C 108.151 -1.055 . . . . 0.35999999999999999 108.151 177.496 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 6.7 p -128.38 128.92 68.84 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 106.331 -1.729 . . . . 1.8 106.331 -175.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 7.9 mm -104.97 100.65 10.98 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 N-CA-C 107.15 -1.426 . . . . 0.42999999999999999 107.15 -172.003 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.462 ' CE2' HD13 ' A' ' 8' ' ' ILE . 50.2 p90 -138.46 165.15 27.55 Favored 'General case' 0 CA--C 1.516 -0.341 0 O-C-N 122.226 -0.296 . . . . 1.71 111.626 -172.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 37.7 t0 -85.97 110.68 32.43 Favored Pre-proline 0 C--O 1.236 0.382 0 O-C-N 124.458 1.099 . . . . 2.9700000000000002 108.858 175.12 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -71.5 4.26 3.09 Favored 'Trans proline' 0 N--CA 1.452 -0.957 0 C-N-CA 122.772 2.315 . . . . 0.55000000000000004 113.135 -178.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -89.2 -27.32 20.73 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 119.478 1.035 . . . . 0.71999999999999997 109.397 168.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -104.63 -51.53 3.06 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 109.575 -0.528 . . . . 2.8799999999999999 109.575 -171.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.464 HG22 ' HB3' ' A' ' 59' ' ' ALA 0.285 1.1 p -97.7 -177.48 3.8 Favored 'General case' 0 CA--C 1.518 -0.252 0 C-N-CA 123.993 0.917 . . . . 0.51000000000000001 112.275 160.76 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 145.32 88.6 0.09 OUTLIER Glycine 0 N--CA 1.441 -1.011 0 N-CA-C 104.448 -3.461 . . . . 2.52 104.448 -155.295 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 45.1 p -13.07 -17.96 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.556 1 C-N-CA 137.936 6.494 . . . . 1.1399999999999999 119.956 -143.228 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -27.61 -63.48 0.09 Allowed 'General case' 0 N--CA 1.443 -0.803 0 C-N-CA 127.01 2.124 . . . . 0.5 114.317 166.405 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.472 ' HB1' ' SD ' ' A' ' 31' ' ' MET . . . -73.73 -37.3 65.14 Favored 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 118.485 -1.286 . . . . 0.5 109.069 -168.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.5 mp -53.93 -57.5 5.53 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.808 0 CA-C-N 114.402 -1.272 . . . . 1.03 109.884 175.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.04 -48.0 81.42 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 119.047 0.84 . . . . 1.1200000000000001 109.55 -178.414 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -45.57 -57.39 4.2 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 123.312 0.645 . . . . 3.25 111.932 176.393 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.7 mmmm -68.3 -42.34 79.61 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-O 118.545 -0.741 . . . . 3.5299999999999998 111.376 -179.538 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -46.0 -52.65 2.84 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 C-N-CA 125.003 1.321 . . . . 0.42999999999999999 108.579 177.048 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -59.45 -58.44 8.61 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 124.503 1.121 . . . . 1.54 110.545 176.391 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -55.62 -34.87 65.28 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 113.006 0.743 . . . . 3.73 113.006 -176.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 26.6 mt -68.87 -17.32 63.97 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.774 1.229 . . . . 0.55000000000000004 111.721 177.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 92.11 43.47 4.38 Favored Glycine 0 CA--C 1.522 0.531 0 N-CA-C 110.129 -1.189 . . . . 0.40999999999999998 110.129 178.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.442 ' CD1' HG21 ' A' ' 24' ' ' ILE . 0.4 OUTLIER -141.46 171.52 13.94 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 124.189 0.996 . . . . 1.97 110.015 -176.364 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 8.8 t-80 -143.71 127.48 17.2 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 107.842 -1.17 . . . . 1.72 107.842 172.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 5.8 p -97.22 151.74 4.15 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 N-CA-C 108.114 -1.069 . . . . 1.4399999999999999 108.114 174.53 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 38.3 t -120.0 139.76 46.26 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 C-N-CA 125.173 1.389 . . . . 0.56999999999999995 108.358 -179.455 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 26.7 mm -102.48 64.6 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 122.119 0.961 . . . . 1.1100000000000001 109.737 -169.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -65.66 -14.39 61.12 Favored 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 114.193 1.183 . . . . 3.3100000000000001 114.193 -173.771 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -64.36 -36.93 93.81 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 125.101 1.334 . . . . 2.6600000000000001 111.676 175.604 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 2.1 tpm_? . . . . . 0 C--O 1.255 1.378 0 C-N-CA 125.861 1.665 . . . . 11.73 113.739 177.492 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 33.1 mtt . . . . . 0 N--CA 1.474 0.764 0 N-CA-C 108.936 -0.765 . . . . 9.5899999999999999 108.936 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 11.1 tp -110.71 156.19 21.38 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 107.42 -1.326 . . . . 5.2800000000000002 107.42 175.443 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.7 m -64.5 99.43 0.3 Allowed 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 108.655 -0.868 . . . . 0.84999999999999998 108.655 172.057 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -69.78 176.57 3.54 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 109.146 -0.687 . . . . 2.2999999999999998 109.146 173.133 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.67 155.07 45.6 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 124.205 1.002 . . . . 0.92000000000000004 108.431 176.39 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 10.8 ttmt -147.33 158.85 44.12 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 107.733 -1.21 . . . . 3.0699999999999998 107.733 168.268 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -119.13 98.68 6.29 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 127.728 2.411 . . . . 1.9099999999999999 104.669 -176.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 23.0 mm -84.37 164.32 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.171 0 N-CA-C 106.839 -1.541 . . . . 2.4300000000000002 106.839 173.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -134.18 124.83 26.67 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 107.065 -1.458 . . . . 0.48999999999999999 107.065 176.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 24.7 mtm -134.63 172.87 12.33 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.62 0.768 . . . . 2.0800000000000001 109.101 -179.145 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 21.5 mm100 -103.19 154.7 19.04 Favored 'General case' 0 C--O 1.222 -0.35 0 C-N-CA 125.394 1.477 . . . . 2.4500000000000002 109.313 178.089 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.591 HG21 HD21 ' A' ' 41' ' ' LEU . 6.3 m -117.98 165.37 13.39 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 CA-C-N 119.38 0.991 . . . . 1.73 110.419 174.274 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 53.8 m -137.74 171.04 15.03 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.231 1.412 . . . . 1.22 108.902 175.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 80.03 -44.82 2.87 Favored Glycine 0 CA--C 1.533 1.187 0 C-N-CA 123.488 0.566 . . . . 3.1899999999999999 113.311 173.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -38.55 122.37 1.11 Allowed 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 125.13 1.372 . . . . 2.8900000000000001 113.319 -177.231 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -139.48 12.53 2.55 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.896 0.878 . . . . 3.3199999999999998 112.014 177.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 8.9 m -115.59 -26.48 7.47 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 125.528 1.531 . . . . 2.9399999999999999 111.512 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 64.68 -63.71 0.17 Allowed 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.646 1.578 . . . . 2.4700000000000002 110.482 -162.207 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -41.59 -54.66 3.14 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 125.895 1.678 . . . . 0.87 112.748 -179.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 90.0 m -55.82 -31.43 62.68 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 113.183 0.808 . . . . 1.48 113.183 -178.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.817 ' HB1' HG21 ' A' ' 39' ' ' VAL . . . -61.4 -26.8 68.09 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 121.108 0.48 . . . . 0.41999999999999998 110.514 176.519 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.93 -50.74 31.42 Favored 'General case' 0 N--CA 1.452 -0.354 0 O-C-N 120.321 -1.487 . . . . 0.40000000000000002 109.053 170.035 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 55.2 mtm180 -51.33 -46.32 62.6 Favored 'General case' 0 N--CA 1.456 -0.154 0 CA-C-O 118.871 -0.585 . . . . 5.29 110.978 -177.417 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.462 HG21 ' CD1' ' A' ' 69' ' ' TYR . 4.5 pt -58.43 -55.86 19.96 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.237 0 C-N-CA 119.784 -0.766 . . . . 0.48999999999999999 110.681 178.098 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -53.29 -42.28 66.45 Favored 'General case' 0 C--O 1.225 -0.211 0 CA-C-N 119.568 1.076 . . . . 2.6899999999999999 111.715 179.804 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 32.0 mmtp -70.65 -44.93 66.1 Favored 'General case' 0 CA--C 1.536 0.414 0 O-C-N 121.228 -0.92 . . . . 1.95 110.897 -178.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -66.11 -25.8 72.28 Favored Glycine 0 CA--C 1.53 0.991 0 O-C-N 121.583 -0.698 . . . . 1.01 111.875 176.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 7.7 tt -70.38 -53.73 15.38 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 126.915 2.086 . . . . 1.8100000000000001 107.693 172.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -51.1 -18.51 0.86 Allowed 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 126.658 1.983 . . . . 3.4199999999999999 113.987 179.114 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -72.74 -16.05 61.66 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.044 1.338 . . . . 4.0300000000000002 113.035 176.365 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 7.1 ptp -68.01 160.28 75.18 Favored Pre-proline 0 CA--C 1.537 0.456 0 CA-C-N 118.934 0.788 . . . . 3.77 111.178 -179.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -61.51 134.75 53.06 Favored 'Trans proline' 0 N--CA 1.454 -0.829 0 C-N-CA 121.622 1.548 . . . . 0.57999999999999996 109.287 167.064 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 106.58 -54.16 0.59 Allowed Glycine 0 CA--C 1.529 0.943 0 C-N-CA 124.558 1.075 . . . . 1.0 111.933 174.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 56.2 t -73.24 113.11 10.58 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 O-C-N 120.912 -1.346 . . . . 0.93000000000000005 110.914 -173.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -80.83 -48.08 12.93 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-O 117.745 -1.122 . . . . 1.1699999999999999 108.712 -179.505 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -140.65 156.93 46.11 Favored 'General case' 0 C--N 1.342 0.264 0 CA-C-N 119.249 0.931 . . . . 2.2599999999999998 110.496 -177.478 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -154.96 148.56 25.33 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 112.23 0.455 . . . . 0.44 112.23 179.08 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -155.93 124.14 5.78 Favored 'General case' 0 C--N 1.342 0.245 0 N-CA-C 108.75 -0.833 . . . . 0.45000000000000001 108.75 -165.487 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.936 HG22 HD23 ' A' ' 41' ' ' LEU . 6.6 p -93.13 107.46 19.17 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 C-N-CA 123.694 0.798 . . . . 0.53000000000000003 109.614 -177.658 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 52.8 t-20 -88.89 58.36 4.56 Favored 'General case' 0 C--O 1.238 0.469 0 O-C-N 120.492 -1.38 . . . . 0.60999999999999999 109.364 -177.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.936 HD23 HG22 ' A' ' 39' ' ' VAL . 0.3 OUTLIER -68.27 -19.43 64.71 Favored 'General case' 0 N--CA 1.457 -0.114 0 CA-C-N 114.459 -1.246 . . . . 0.87 111.393 -175.223 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -45.85 -35.77 4.75 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 123.601 0.76 . . . . 0.68000000000000005 111.922 166.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 5.3 t -124.58 34.47 5.01 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.063 0.545 . . . . 1.3100000000000001 109.856 173.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 51.79 25.71 3.11 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.609 1.564 . . . . 2.7799999999999998 113.547 175.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 6.9 m -113.51 163.83 14.41 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.582 1.153 . . . . 0.63 108.468 -176.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.7 p -131.5 144.82 36.39 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.121 0 C-N-CA 124.442 1.097 . . . . 0.33000000000000002 108.947 173.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 20.7 m120 -129.55 133.49 47.24 Favored 'General case' 0 C--N 1.342 0.271 0 C-N-CA 124.219 1.008 . . . . 0.33000000000000002 108.399 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 40.1 t -128.74 123.67 59.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 N-CA-C 105.415 -2.069 . . . . 2.0099999999999998 105.415 -177.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 13.5 mm -101.46 94.46 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 N-CA-C 106.978 -1.49 . . . . 0.45000000000000001 106.978 -173.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 28.8 p90 -135.17 173.82 11.29 Favored 'General case' 0 CA--C 1.508 -0.657 0 O-C-N 122.118 -0.364 . . . . 1.76 111.331 -167.188 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 47.5 p-10 -97.12 109.03 47.52 Favored Pre-proline 0 N--CA 1.447 -0.61 0 O-C-N 124.703 1.252 . . . . 4.0899999999999999 112.425 -175.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -69.26 13.93 0.24 Allowed 'Trans proline' 0 CA--C 1.544 1.017 0 C-N-CA 121.43 1.42 . . . . 1.0700000000000001 113.241 178.132 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -99.4 -31.33 11.72 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 125.508 1.523 . . . . 1.0600000000000001 110.841 170.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -114.82 -55.1 2.52 Favored 'General case' 0 C--N 1.345 0.376 0 CA-C-N 118.663 0.665 . . . . 2.9500000000000002 109.533 -177.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.441 1.3 p -83.12 -179.81 7.53 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 114.047 1.128 . . . . 0.58999999999999997 114.047 160.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 135.09 93.09 0.42 Allowed Glycine 0 N--CA 1.445 -0.75 0 N-CA-C 104.512 -3.435 . . . . 2.29 104.512 -148.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 46.1 p -16.45 -17.44 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.462 1 C-N-CA 138.843 6.857 . . . . 1.3700000000000001 119.685 -151.025 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -27.32 -63.38 0.09 Allowed 'General case' 0 N--CA 1.442 -0.83 0 C-N-CA 126.477 1.911 . . . . 0.56999999999999995 113.966 163.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.14 -37.07 64.16 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 118.935 -1.106 . . . . 0.46000000000000002 109.143 -168.397 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 5.9 mt -53.66 -56.53 8.38 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.616 0 C-N-CA 125.5 1.52 . . . . 1.3600000000000001 110.862 174.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.92 -46.02 92.33 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 119.506 1.048 . . . . 1.23 109.665 -179.104 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 -49.58 -59.76 3.48 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 122.002 0.906 . . . . 3.3999999999999999 111.617 176.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 6.2 mmmt -67.05 -35.6 80.23 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-O 118.068 -0.968 . . . . 3.3199999999999998 111.346 -177.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.1 mm -49.54 -54.56 6.42 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 N-CA-C 108.106 -1.072 . . . . 0.40000000000000002 108.106 175.096 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -58.92 -53.96 52.52 Favored 'General case' 0 C--N 1.34 0.162 0 C-N-CA 123.33 0.652 . . . . 1.8899999999999999 109.952 176.134 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.25 -28.77 67.01 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 113.199 0.814 . . . . 5.5499999999999998 113.199 -177.286 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 20.5 mt -73.49 -18.19 61.14 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.973 1.309 . . . . 0.69999999999999996 111.603 175.062 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 89.96 39.39 6.15 Favored Glycine 0 CA--C 1.524 0.634 0 C-N-CA 124.664 1.126 . . . . 0.41999999999999998 110.345 -178.104 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.462 ' CD1' HG21 ' A' ' 24' ' ' ILE . 0.2 OUTLIER -134.59 175.65 9.34 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 123.756 0.823 . . . . 1.8300000000000001 110.415 -179.631 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -143.19 138.77 29.96 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 107.406 -1.331 . . . . 2.25 107.406 171.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 9.2 p -117.98 133.32 65.17 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 C-N-CA 125.212 1.405 . . . . 1.3700000000000001 107.864 178.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 41.9 t -100.85 140.92 18.53 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 C-N-CA 125.956 1.702 . . . . 0.58999999999999997 109.01 -179.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 21.7 mm -99.38 69.82 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 C-N-CA 124.078 0.951 . . . . 0.93000000000000005 108.755 -174.293 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -123.95 4.33 8.7 Favored 'General case' 0 N--CA 1.44 -0.956 0 C-N-CA 127.596 2.359 . . . . 4.2699999999999996 112.149 174.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -85.64 -50.25 4.06 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 111.781 -0.527 . . . . 4.9299999999999997 111.781 -176.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.109 0 N-CA-C 105.532 -2.025 . . . . 9.4100000000000001 105.532 -170.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.472 0.669 0 N-CA-C 108.444 -0.947 . . . . 11.67 108.444 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.436 ' H ' HD23 ' A' ' 2' ' ' LEU . 0.8 OUTLIER -81.89 172.4 13.36 Favored 'General case' 0 CA--C 1.531 0.24 0 O-C-N 124.39 1.056 . . . . 5.0999999999999996 108.284 163.63 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 75.82 89.91 0.08 Allowed 'General case' 0 CA--C 1.529 0.171 0 N-CA-C 107.797 -1.186 . . . . 1.04 107.797 -173.291 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -71.73 153.37 42.06 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 107.037 -1.468 . . . . 3.8700000000000001 107.037 171.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.33 148.61 44.83 Favored 'General case' 0 CA--C 1.518 -0.28 0 C-N-CA 123.602 0.761 . . . . 0.98999999999999999 110.146 -177.346 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 7.0 mtpm? -141.01 159.97 41.07 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 122.157 0.979 . . . . 3.6200000000000001 111.756 166.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -108.39 104.25 13.57 Favored 'General case' 0 N--CA 1.434 -1.238 0 C-N-CA 130.755 3.622 . . . . 1.95 103.919 -176.284 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 5.6 mm -88.68 160.09 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.35 0 N-CA-C 106.982 -1.488 . . . . 1.9099999999999999 106.982 172.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -124.98 137.93 54.24 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 106.517 -1.66 . . . . 0.54000000000000004 106.517 169.524 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 57.9 mtt -144.37 166.16 25.89 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 118.412 0.551 . . . . 2.79 109.659 173.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 11.6 mm100 -88.56 155.4 19.66 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 125.176 1.391 . . . . 2.3500000000000001 109.945 175.567 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 99.3 t -112.34 138.75 40.19 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 C-N-CA 123.935 0.894 . . . . 1.4199999999999999 110.259 -179.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 73.3 m -137.84 165.19 27.08 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.814 1.245 . . . . 1.0900000000000001 109.938 172.376 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 65.73 72.16 0.78 Allowed Glycine 0 CA--C 1.527 0.836 0 N-CA-C 110.891 -0.884 . . . . 1.71 110.891 176.276 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -152.56 158.14 42.06 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 123.739 0.816 . . . . 1.95 109.843 -173.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -105.09 -56.72 2.13 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 124.996 1.319 . . . . 2.4399999999999999 110.463 168.539 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 31.7 p -127.91 156.68 42.23 Favored 'General case' 0 C--N 1.34 0.175 0 CA-C-O 121.814 0.816 . . . . 2.23 111.504 -170.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -76.33 53.09 0.81 Allowed 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.771 0.829 . . . . 1.75 110.401 176.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -151.49 -50.36 0.12 Allowed 'General case' 0 C--O 1.232 0.136 0 C-N-CA 123.131 0.572 . . . . 0.72999999999999998 111.645 -174.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 5.8 p -56.04 -39.18 71.59 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 119.348 0.976 . . . . 2.4300000000000002 109.7 168.316 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.573 ' HB1' HG21 ' A' ' 39' ' ' VAL . . . -50.32 -23.28 2.22 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.869 1.267 . . . . 0.41999999999999998 113.9 171.238 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -72.09 -47.14 53.55 Favored 'General case' 0 N--CA 1.453 -0.3 0 O-C-N 120.447 -1.408 . . . . 0.37 110.133 171.41 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -57.98 -36.56 72.77 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-O 118.961 -0.543 . . . . 4.1900000000000004 110.612 -174.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.573 ' HA ' HD13 ' A' ' 67' ' ' LEU . 2.6 pt -59.68 -55.45 23.82 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.203 0 C-N-CA 119.578 -0.849 . . . . 0.56000000000000005 110.67 178.458 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -57.49 -47.03 82.98 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 123.286 0.634 . . . . 3.2799999999999998 111.294 178.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 14.7 mptt -66.61 -45.86 77.77 Favored 'General case' 0 CA--C 1.532 0.273 0 O-C-N 121.62 -0.675 . . . . 1.73 109.864 -176.192 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -67.75 -23.87 74.07 Favored Glycine 0 CA--C 1.527 0.795 0 CA-C-O 119.04 -0.867 . . . . 0.66000000000000003 111.957 176.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -73.57 -41.23 63.19 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.715 1.206 . . . . 2.4300000000000002 109.753 170.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 2.1 ttpp -56.71 -16.39 6.29 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.78 1.632 . . . . 2.9199999999999999 113.86 178.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.4 mmt180 -83.33 -7.44 59.58 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 126.547 1.939 . . . . 3.6800000000000002 112.338 176.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 96.1 mmm -77.99 150.89 78.59 Favored Pre-proline 0 C--O 1.233 0.209 0 CA-C-N 119.226 0.921 . . . . 3.1800000000000002 111.35 -179.133 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -56.56 135.37 69.97 Favored 'Trans proline' 0 N--CA 1.45 -1.064 0 C-N-CA 121.953 1.769 . . . . 0.59999999999999998 108.973 171.225 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 89.12 -9.66 76.0 Favored Glycine 0 CA--C 1.525 0.716 0 CA-C-O 118.079 -1.401 . . . . 0.54000000000000004 113.738 178.081 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 23.4 t -103.78 122.66 56.75 Favored 'Isoleucine or valine' 0 C--N 1.342 0.269 0 CA-C-N 120.349 2.074 . . . . 0.60999999999999999 109.636 176.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -89.38 -55.41 3.67 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-O 118.611 -0.709 . . . . 1.3200000000000001 109.151 177.127 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -139.61 156.97 46.55 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 118.875 0.761 . . . . 2.6099999999999999 110.425 -175.413 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -155.6 143.75 20.02 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 122.99 0.516 . . . . 0.41999999999999998 111.164 -174.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -155.35 114.39 3.58 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 109.531 -0.544 . . . . 0.58999999999999997 109.531 -165.576 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.573 HG21 ' HB1' ' A' ' 21' ' ' ALA . 4.0 p -81.25 116.7 25.99 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 N-CA-C 108.697 -0.853 . . . . 0.55000000000000004 108.697 175.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 50.1 t-20 -96.15 57.61 1.76 Allowed 'General case' 0 C--O 1.236 0.378 0 CA-C-O 122.961 1.362 . . . . 0.60999999999999999 107.869 177.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.402 HD23 HG22 ' A' ' 39' ' ' VAL . 0.2 OUTLIER -69.35 -18.47 63.8 Favored 'General case' 0 C--O 1.225 -0.203 0 CA-C-N 114.265 -1.334 . . . . 0.95999999999999996 110.419 -173.584 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -46.56 -31.14 2.61 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 124.072 0.949 . . . . 0.56999999999999995 112.502 169.045 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 6.1 t -129.59 33.4 4.48 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 122.787 0.435 . . . . 1.27 110.007 173.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 25.6 mp0 57.17 29.97 17.55 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.02 1.328 . . . . 3.6400000000000001 113.279 175.206 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 62.0 m -118.39 159.62 23.13 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.47 1.108 . . . . 0.68999999999999995 109.241 -176.136 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.6 p -128.72 143.75 40.16 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 O-C-N 121.21 -0.931 . . . . 0.33000000000000002 108.71 171.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -132.85 128.74 37.33 Favored 'General case' 0 C--N 1.342 0.263 0 N-CA-C 108.125 -1.065 . . . . 0.41999999999999998 108.125 -178.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 4.7 p -129.82 128.23 65.01 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.595 0 N-CA-C 106.054 -1.832 . . . . 1.75 106.054 -172.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 11.2 mm -105.27 88.65 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 C-N-CA 125.653 1.581 . . . . 0.42999999999999999 107.168 -174.336 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 31.3 p90 -125.8 175.3 7.73 Favored 'General case' 0 CA--C 1.512 -0.493 0 O-C-N 122.106 -0.371 . . . . 1.72 110.059 -173.012 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -102.43 100.61 16.31 Favored Pre-proline 0 N--CA 1.445 -0.693 0 C-N-CA 125.197 1.399 . . . . 4.2000000000000002 108.688 -176.309 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_endo -72.01 14.39 0.44 Allowed 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 122.288 1.992 . . . . 0.60999999999999999 113.911 -176.085 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -81.77 -30.96 32.12 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 108.92 -0.77 . . . . 0.81999999999999995 108.92 162.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -114.26 -62.61 1.57 Allowed 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 123.769 0.828 . . . . 3.77 108.856 -166.678 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.468 0.6 OUTLIER -77.11 -179.25 5.47 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 114.985 1.476 . . . . 0.51000000000000001 114.985 162.483 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 179.99 -150.32 9.13 Favored Glycine 0 N--CA 1.431 -1.7 1 N-CA-C 102.717 -4.153 . . . . 2.54 102.717 -172.46 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 20.7 p -72.54 -36.75 68.34 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 124.569 1.148 . . . . 1.3200000000000001 108.75 175.385 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -42.07 -63.05 0.8 Allowed 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 126.136 1.775 . . . . 0.55000000000000004 113.409 -171.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -72.0 -38.79 69.59 Favored 'General case' 0 CA--C 1.515 -0.378 0 C-N-CA 118.483 -1.287 . . . . 0.62 109.032 -170.169 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.3 mp -54.46 -55.93 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.931 0 CA-C-N 115.014 -0.994 . . . . 0.77000000000000002 109.663 178.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.2 -46.08 85.49 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 119.094 0.861 . . . . 1.1299999999999999 109.991 -176.481 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -47.54 -57.58 5.25 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 122.664 1.221 . . . . 2.6299999999999999 110.676 175.573 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 11.5 mmmt -68.3 -37.26 80.44 Favored 'General case' 0 N--CA 1.437 -1.121 0 CA-C-N 115.409 -0.814 . . . . 3.77 111.974 -177.122 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.3 mm -52.34 -53.08 20.96 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 N-CA-C 107.937 -1.134 . . . . 0.38 107.937 176.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 21.1 mm-40 -59.32 -56.58 20.22 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.702 0.801 . . . . 1.9299999999999999 110.404 176.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 5.8 mmmt -54.81 -37.28 65.91 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 113.29 0.848 . . . . 4.7000000000000002 113.29 -178.482 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.573 HD13 ' HA ' ' A' ' 24' ' ' ILE . 11.4 mt -71.14 -18.15 62.52 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.542 1.137 . . . . 0.65000000000000002 111.883 175.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 93.58 44.17 3.76 Favored Glycine 0 CA--C 1.525 0.659 0 C-N-CA 124.581 1.086 . . . . 0.41999999999999998 110.799 176.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.459 ' CD1' HG21 ' A' ' 24' ' ' ILE . 0.3 OUTLIER -139.98 172.85 12.18 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 124.033 0.933 . . . . 1.8100000000000001 110.588 -176.635 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -139.98 118.04 11.87 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 109.086 -0.709 . . . . 1.8999999999999999 109.086 173.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 5.7 p -91.49 147.74 5.07 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 N-CA-C 107.892 -1.151 . . . . 1.3999999999999999 107.892 172.058 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 41.2 t -123.26 141.52 43.26 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.102 0 C-N-CA 124.574 1.15 . . . . 0.60999999999999999 108.691 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 4.8 mp -107.46 79.27 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 C-N-CA 124.052 0.941 . . . . 1.3600000000000001 108.47 -173.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -77.91 3.59 14.15 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.592 1.557 . . . . 2.9399999999999999 114.565 177.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 61.68 72.57 0.62 Allowed Glycine 0 CA--C 1.53 1.028 0 N-CA-C 110.692 -0.963 . . . . 3.2400000000000002 110.692 178.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.253 1.265 0 C-N-CA 126.918 2.087 . . . . 11.48 105.503 178.354 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 82.4 mtp . . . . . 0 N--CA 1.473 0.713 0 N-CA-C 106.905 -1.517 . . . . 9.2200000000000006 106.905 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -102.42 159.81 15.1 Favored 'General case' 0 C--O 1.23 0.063 0 O-C-N 124.149 0.905 . . . . 4.7699999999999996 109.021 175.747 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 11.5 m -92.92 108.48 20.03 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 124.746 1.219 . . . . 0.89000000000000001 108.457 176.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -72.24 165.47 24.37 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 108.918 -0.771 . . . . 2.7200000000000002 108.918 163.342 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -124.02 151.9 43.21 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 124.91 1.284 . . . . 1.0900000000000001 111.02 -177.2 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.3 mmpt? -137.81 157.12 47.1 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 122.938 0.495 . . . . 4.0599999999999996 110.22 165.26 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -104.24 97.95 7.83 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 127.799 2.439 . . . . 1.9199999999999999 106.28 177.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 10.0 mm -87.01 160.02 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.258 0 N-CA-C 107.378 -1.342 . . . . 2.1200000000000001 107.378 177.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -131.5 139.03 49.21 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 125.71 1.604 . . . . 0.47999999999999998 107.566 178.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 12.5 ptp -156.43 175.19 14.34 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.129 0.571 . . . . 1.8700000000000001 110.132 179.059 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 29.9 mm100 -99.44 162.57 12.96 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 125.265 1.426 . . . . 2.4700000000000002 109.545 179.057 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.425 HG13 HG11 ' A' ' 46' ' ' VAL . 0.0 OUTLIER -130.54 157.08 42.93 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.146 0 C-N-CA 124.343 1.057 . . . . 2.0699999999999998 110.261 176.499 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 62.0 m -146.4 164.7 31.61 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 124.465 1.106 . . . . 0.94999999999999996 109.343 177.109 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 70.53 68.37 1.65 Allowed Glycine 0 CA--C 1.526 0.756 0 N-CA-C 110.02 -1.232 . . . . 1.52 110.02 179.49 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -144.82 165.27 28.58 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 123.723 0.809 . . . . 1.7 110.065 -178.312 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.1 p -113.88 -72.1 0.72 Allowed 'General case' 0 CA--C 1.527 0.068 0 C-N-CA 124.438 1.095 . . . . 2.3700000000000001 108.939 168.29 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 14.4 p -105.82 152.22 23.51 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 121.781 0.801 . . . . 2.0899999999999999 112.023 -173.371 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -75.54 54.5 0.76 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.379 1.072 . . . . 1.9399999999999999 110.527 176.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -146.87 -49.09 0.19 Allowed 'General case' 0 CA--C 1.526 0.045 0 C-N-CA 123.774 0.829 . . . . 0.87 110.597 -179.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 61.9 m -56.99 -36.89 70.91 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 118.67 0.668 . . . . 1.26 110.638 172.657 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.77 ' HB1' HG21 ' A' ' 39' ' ' VAL . . . -50.3 -26.71 5.1 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.758 0.823 . . . . 0.40999999999999998 112.595 171.65 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.45 -48.24 50.63 Favored 'General case' 0 N--CA 1.452 -0.328 0 O-C-N 120.162 -1.586 . . . . 0.37 109.204 174.017 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 61.7 mtt85 -54.36 -42.86 70.77 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 123.542 0.737 . . . . 5.2000000000000002 109.885 -175.249 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.488 HG21 ' CD1' ' A' ' 69' ' ' TYR 0.258 2.1 pt -58.56 -57.8 9.41 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 C-N-CA 120.044 -0.662 . . . . 0.5 110.478 177.478 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -53.1 -40.28 64.0 Favored 'General case' 0 C--O 1.224 -0.28 0 CA-C-N 118.839 0.745 . . . . 2.1899999999999999 111.632 178.248 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 4.1 mptp? -71.32 -48.31 51.33 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 119.446 1.021 . . . . 1.6699999999999999 111.041 -177.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -60.87 -36.43 92.01 Favored Glycine 0 CA--C 1.529 0.962 0 N-CA-C 110.897 -0.881 . . . . 0.56000000000000005 110.897 175.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 8.4 tt -62.54 -49.49 75.1 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 124.739 1.216 . . . . 1.8300000000000001 107.971 175.082 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -57.14 -22.77 42.52 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 124.582 1.153 . . . . 3.4100000000000001 113.062 178.816 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.7 mmt180 -72.65 -10.99 60.45 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.956 0.902 . . . . 3.4700000000000002 112.309 175.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . 0.45 ' CE ' ' HB3' ' A' ' 59' ' ' ALA . 3.1 ptt? -75.79 153.64 85.14 Favored Pre-proline 0 CA--C 1.533 0.302 0 CA-C-N 119.071 0.85 . . . . 4.7599999999999998 111.692 -179.358 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -60.86 136.08 63.76 Favored 'Trans proline' 0 N--CA 1.451 -0.995 0 C-N-CA 121.589 1.526 . . . . 0.77000000000000002 108.972 172.135 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 100.15 -28.79 14.06 Favored Glycine 0 CA--C 1.53 1.003 0 CA-C-O 118.504 -1.164 . . . . 0.68000000000000005 112.978 177.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 24.8 t -95.52 123.16 47.57 Favored 'Isoleucine or valine' 0 C--N 1.346 0.422 0 CA-C-N 119.62 1.71 . . . . 0.68999999999999995 111.185 176.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 86.9 m -90.32 -53.65 4.36 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-O 117.858 -1.068 . . . . 1.2 110.378 -179.007 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -135.97 158.11 45.2 Favored 'General case' 0 C--N 1.343 0.318 0 CA-C-N 119.576 1.08 . . . . 2.4500000000000002 110.698 177.235 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -156.91 148.17 22.11 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 114.38 1.252 . . . . 0.47999999999999998 114.38 177.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -155.15 113.19 3.44 Favored 'General case' 0 C--N 1.344 0.365 0 N-CA-C 107.241 -1.392 . . . . 0.48999999999999999 107.241 -162.328 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.77 HG21 ' HB1' ' A' ' 21' ' ' ALA . 6.4 p -82.36 114.68 23.62 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 N-CA-C 108.952 -0.758 . . . . 0.52000000000000002 108.952 178.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -94.05 57.93 2.48 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 122.994 1.378 . . . . 2.0600000000000001 108.718 -178.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.69 HD23 HG22 ' A' ' 39' ' ' VAL . 0.2 OUTLIER -66.85 -17.54 64.94 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 114.361 -1.291 . . . . 0.85999999999999999 111.094 -177.342 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -41.29 -39.7 1.46 Allowed 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 124.901 1.28 . . . . 0.67000000000000004 112.747 168.605 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 9.1 t -127.43 35.88 4.47 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 117.666 0.212 . . . . 1.24 110.621 172.094 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 61.54 36.23 17.04 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.462 1.105 . . . . 4.3700000000000001 113.195 173.162 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 4.8 m -123.5 161.21 25.33 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.051 1.34 . . . . 0.73999999999999999 109.369 -176.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.425 HG11 HG13 ' A' ' 12' ' ' VAL . 0.8 OUTLIER -127.68 144.18 38.35 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 C-N-CA 124.423 1.089 . . . . 0.64000000000000001 108.417 172.898 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -131.83 145.04 51.33 Favored 'General case' 0 C--N 1.347 0.491 0 N-CA-C 108.327 -0.99 . . . . 0.45000000000000001 108.327 177.108 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 5.4 p -145.46 125.24 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 N-CA-C 106.642 -1.614 . . . . 1.79 106.642 -172.262 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 9.6 mm -105.79 83.53 0.72 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.49 0 C-N-CA 126.286 1.834 . . . . 0.46000000000000002 106.984 -171.029 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 51.6 p90 -119.56 175.9 5.62 Favored 'General case' 0 CA--C 1.506 -0.731 0 N-CA-C 109.197 -0.668 . . . . 1.97 109.197 -172.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -101.65 95.26 5.07 Favored Pre-proline 0 N--CA 1.443 -0.78 0 O-C-N 124.813 1.321 . . . . 4.2999999999999998 110.199 -176.263 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -74.49 14.7 0.74 Allowed 'Trans proline' 0 CA--C 1.537 0.661 0 C-N-CA 122.833 2.355 . . . . 0.93999999999999995 113.56 -173.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -89.09 -21.79 23.21 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 124.021 0.928 . . . . 1.48 109.5 166.117 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -113.63 -62.19 1.63 Allowed 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 125.212 1.405 . . . . 3.52 107.723 -175.497 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.285 0.7 OUTLIER -82.62 -179.75 7.53 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 115.223 1.564 . . . . 0.78000000000000003 115.223 170.319 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -163.53 -128.42 0.95 Allowed Glycine 0 N--CA 1.434 -1.496 0 N-CA-C 104.164 -3.574 . . . . 2.5899999999999999 104.164 175.525 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 18.3 p -81.82 -30.54 32.14 Favored 'General case' 0 C--N 1.318 -0.792 0 C-N-CA 126.874 2.07 . . . . 1.3400000000000001 110.636 172.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -53.2 -62.44 1.65 Allowed 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 124.327 1.051 . . . . 0.62 112.769 -157.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.45 ' HB3' ' CE ' ' A' ' 31' ' ' MET . . . -75.14 -24.58 57.99 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 113.931 -1.486 . . . . 0.77000000000000002 110.285 -172.644 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.5 mt -66.85 -49.16 76.68 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 C-N-CA 124.341 1.056 . . . . 1.3 109.576 -178.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.18 -43.94 93.55 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 107.806 -1.183 . . . . 1.9299999999999999 107.806 -177.501 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -48.5 -59.64 3.32 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 123.833 0.853 . . . . 2.7599999999999998 111.032 172.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 10.3 mmtp -60.65 -42.37 96.83 Favored 'General case' 0 N--CA 1.441 -0.912 0 O-C-N 121.712 -0.617 . . . . 3.0600000000000001 111.716 -178.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -48.82 -54.69 4.57 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 C-N-CA 125.007 1.323 . . . . 0.44 108.745 176.345 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 29.5 mm-40 -60.9 -53.85 52.3 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 123.481 0.712 . . . . 1.9099999999999999 110.197 178.274 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -56.15 -38.41 70.82 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 112.668 0.618 . . . . 4.2000000000000002 112.668 -176.382 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 15.9 mt -69.98 -17.06 63.27 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.617 1.167 . . . . 0.67000000000000004 111.911 176.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 92.86 41.36 4.69 Favored Glycine 0 CA--C 1.522 0.513 0 N-CA-C 110.73 -0.948 . . . . 0.51000000000000001 110.73 175.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.488 ' CD1' HG21 ' A' ' 24' ' ' ILE . 0.2 OUTLIER -133.81 175.3 9.58 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 123.672 0.789 . . . . 2.1000000000000001 110.145 178.993 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 4.2 t60 -139.34 143.73 37.93 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 109.162 -0.681 . . . . 1.71 109.162 170.276 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 12.4 p -112.84 150.07 15.11 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 C-N-CA 126.385 1.874 . . . . 1.9299999999999999 107.987 -175.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 13.5 t -132.33 147.67 32.05 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 C-N-CA 124.283 1.033 . . . . 0.56000000000000005 108.301 -179.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 4.6 mp -127.1 82.29 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 C-N-CA 124.609 1.163 . . . . 1.45 108.567 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -77.83 -2.36 36.13 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 124.809 1.244 . . . . 3.27 113.536 170.094 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -92.59 -31.91 8.49 Favored Glycine 0 CA--C 1.526 0.735 0 C-N-CA 124.208 0.908 . . . . 2.7200000000000002 113.478 -169.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 23.9 ttt85 . . . . . 0 C--O 1.249 1.077 0 CA-C-O 117.18 -1.39 . . . . 10.75 109.628 -177.132 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 56.7 mtt . . . . . 0 N--CA 1.473 0.724 0 N-CA-C 108.777 -0.823 . . . . 9.7799999999999994 108.777 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -151.61 166.34 31.54 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 108.18 -1.044 . . . . 5.6200000000000001 108.18 177.102 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.4 m -127.1 115.76 19.65 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 106.077 -1.823 . . . . 0.68999999999999995 106.077 167.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -70.82 173.75 6.93 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 107.774 -1.195 . . . . 2.1000000000000001 107.774 163.33 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -129.3 151.53 49.85 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 123.491 0.717 . . . . 1.7 109.099 172.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 69.6 mmtt -140.92 157.72 44.97 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.213 1.005 . . . . 3.1800000000000002 111.07 166.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -116.21 91.79 3.7 Favored 'General case' 0 N--CA 1.435 -1.181 0 C-N-CA 128.226 2.61 . . . . 1.46 106.61 -168.442 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 8.0 mm -82.41 158.48 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.261 0 N-CA-C 106.977 -1.49 . . . . 1.9399999999999999 106.977 -178.178 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -131.44 139.01 49.29 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 107.093 -1.447 . . . . 0.62 107.093 172.112 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -155.43 176.28 12.79 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 122.992 0.517 . . . . 1.8200000000000001 109.738 170.541 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 27.4 mm100 -95.35 165.37 12.41 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.627 1.171 . . . . 2.6099999999999999 110.152 -178.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 31.6 t -128.44 132.19 68.26 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 C-N-CA 124.597 1.159 . . . . 1.1599999999999999 109.804 -174.111 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 32.9 m -117.74 176.29 5.26 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 125.195 1.398 . . . . 0.89000000000000001 109.348 169.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 82.15 -44.88 3.23 Favored Glycine 0 CA--C 1.53 0.994 0 O-C-N 121.553 -0.717 . . . . 2.2400000000000002 111.603 178.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -44.52 142.18 1.71 Allowed 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 124.121 0.968 . . . . 2.27 112.691 176.066 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -147.71 -45.71 0.16 Allowed 'General case' 0 CA--C 1.53 0.173 0 C-N-CA 124.559 1.144 . . . . 3.2400000000000002 110.432 171.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 24.3 p -71.16 -16.58 62.54 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 112.616 0.599 . . . . 3.04 112.616 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 59.97 28.32 17.82 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.808 1.243 . . . . 2.0499999999999998 112.209 -179.193 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -130.66 -51.9 1.07 Allowed 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 124.609 1.164 . . . . 0.90000000000000002 110.252 -179.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 52.5 m -51.06 -31.68 19.49 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 125.145 1.378 . . . . 1.6399999999999999 112.548 172.174 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.5 -26.38 31.14 Favored 'General case' 0 CA--C 1.539 0.548 0 O-C-N 121.885 -0.509 . . . . 0.40999999999999998 111.865 173.302 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.02 -46.4 62.2 Favored 'General case' 0 N--CA 1.454 -0.248 0 O-C-N 120.304 -1.497 . . . . 0.38 110.638 169.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 8.9 mtt85 -51.68 -44.69 63.17 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-O 119.171 -0.443 . . . . 3.6600000000000001 110.346 -177.257 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.425 HG21 ' CD1' ' A' ' 69' ' ' TYR 0.262 2.3 pt -59.76 -55.4 24.2 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.201 0 C-N-CA 119.642 -0.823 . . . . 0.64000000000000001 111.217 -178.954 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -55.67 -42.63 75.38 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-N 118.693 0.679 . . . . 2.1600000000000001 112.08 177.454 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -70.88 -46.84 61.88 Favored 'General case' 0 CA--C 1.533 0.294 0 O-C-N 121.68 -0.637 . . . . 1.8200000000000001 110.078 -175.158 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -58.38 -44.38 95.23 Favored Glycine 0 CA--C 1.527 0.815 0 N-CA-C 110.127 -1.189 . . . . 0.72999999999999998 110.127 173.35 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -61.65 -43.14 99.41 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.688 0.795 . . . . 2.3900000000000001 109.486 -179.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 7.3 ttmt -51.98 -29.87 22.47 Favored 'General case' 0 CA--C 1.531 0.237 0 O-C-N 121.036 -1.04 . . . . 2.77 111.595 173.638 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.84 -0.75 19.45 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-O 118.065 -0.969 . . . . 4.4100000000000001 113.352 -175.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 93.8 mmm -89.05 152.7 48.57 Favored Pre-proline 0 CA--C 1.535 0.393 0 C-N-CA 126.738 2.015 . . . . 3.5 111.164 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -60.08 138.92 84.87 Favored 'Trans proline' 0 N--CA 1.453 -0.901 0 C-N-CA 122.236 1.958 . . . . 0.73999999999999999 109.547 175.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 97.29 -30.99 8.2 Favored Glycine 0 CA--C 1.523 0.588 0 CA-C-O 119.0 -0.889 . . . . 0.47999999999999998 112.536 179.478 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 16.3 t -92.04 140.19 16.59 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.212 0 CA-C-N 119.241 1.521 . . . . 0.62 109.114 -179.103 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -119.43 -42.79 2.64 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 118.273 -0.87 . . . . 0.98999999999999999 111.129 179.798 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -138.73 161.85 36.15 Favored 'General case' 0 CA--C 1.518 -0.278 0 CA-C-N 119.838 1.199 . . . . 2.1299999999999999 111.433 171.693 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -157.68 138.94 13.56 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 123.125 0.57 . . . . 0.47999999999999998 111.018 -175.467 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -150.13 102.61 3.11 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 106.7 -1.593 . . . . 0.67000000000000004 106.7 -163.057 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 10.4 p -82.13 107.0 13.68 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 CA-C-O 121.252 0.549 . . . . 0.60999999999999999 110.498 -179.201 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 48.9 t30 -84.43 56.82 3.97 Favored 'General case' 0 CA--C 1.537 0.476 0 O-C-N 120.567 -1.333 . . . . 0.93000000000000005 109.992 179.531 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.418 HD22 ' HA ' ' A' ' 41' ' ' LEU . 0.4 OUTLIER -74.93 -16.1 60.66 Favored 'General case' 0 N--CA 1.461 0.101 0 CA-C-N 115.446 -0.797 . . . . 0.92000000000000004 110.422 176.706 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -45.64 -37.37 5.62 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.742 0.817 . . . . 1.27 111.396 167.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 15.0 t -98.54 -68.48 0.8 Allowed 'General case' 0 C--N 1.344 0.329 0 CA-C-O 117.703 -1.141 . . . . 3.5600000000000001 110.198 165.512 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 159.93 43.55 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 127.61 2.364 . . . . 2.8599999999999999 110.864 -176.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 79.7 m -142.64 162.4 35.56 Favored 'General case' 0 CA--C 1.534 0.333 0 O-C-N 120.464 -1.397 . . . . 0.83999999999999997 108.805 -171.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.4 p -125.75 145.92 32.36 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 O-C-N 121.232 -0.917 . . . . 0.45000000000000001 108.981 172.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -127.79 143.51 51.12 Favored 'General case' 0 C--N 1.345 0.38 0 N-CA-C 108.017 -1.105 . . . . 0.46999999999999997 108.017 170.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.2 p -140.41 127.11 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 N-CA-C 107.226 -1.398 . . . . 1.74 107.226 -176.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 18.5 mm -103.5 90.05 1.58 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.604 0 C-N-CA 125.935 1.694 . . . . 0.51000000000000001 107.107 -173.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 6.8 p90 -128.82 166.42 19.09 Favored 'General case' 0 CA--C 1.508 -0.669 0 CA-C-O 121.452 0.644 . . . . 1.7 111.751 -174.285 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -96.04 108.99 44.5 Favored Pre-proline 0 N--CA 1.444 -0.736 0 CA-C-N 114.172 -1.376 . . . . 4.2199999999999998 109.187 -172.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -73.45 13.97 0.66 Allowed 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 123.009 2.473 . . . . 0.85999999999999999 112.99 -173.523 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -85.23 -35.47 21.57 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 123.823 0.849 . . . . 1.3100000000000001 108.728 166.294 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -109.99 -54.36 2.57 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 108.638 -0.875 . . . . 3.1800000000000002 108.638 -168.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.571 HG22 ' HB3' ' A' ' 59' ' ' ALA 0.314 0.9 OUTLIER -86.56 -173.98 4.77 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-O 121.037 0.446 . . . . 0.56999999999999995 111.674 162.594 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 128.88 88.64 0.56 Allowed Glycine 0 N--CA 1.442 -0.948 0 N-CA-C 103.702 -3.759 . . . . 2.3599999999999999 103.702 -150.379 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 26.5 p -13.75 -18.41 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.499 1 C-N-CA 138.735 6.814 . . . . 1.1699999999999999 119.748 -146.434 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -28.12 -63.36 0.1 Allowed 'General case' 0 N--CA 1.441 -0.877 0 C-N-CA 126.857 2.063 . . . . 0.5 113.841 164.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.571 ' HB3' HG22 ' A' ' 55' ' ' THR . . . -72.02 -41.1 67.94 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 118.098 -1.441 . . . . 0.47999999999999998 109.164 -167.431 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.5 mp -52.32 -54.72 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.845 0 CA-C-N 114.303 -1.317 . . . . 0.85999999999999999 109.146 175.578 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.55 -45.7 85.99 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 118.963 0.801 . . . . 1.6899999999999999 109.294 -175.393 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -52.12 -53.37 43.49 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 122.396 1.093 . . . . 2.9300000000000002 110.27 178.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.414 ' HA ' ' CE ' ' A' ' 63' ' ' LYS . 1.2 mmpt? -70.71 -37.54 73.57 Favored 'General case' 0 N--CA 1.432 -1.363 0 CA-C-O 118.233 -0.889 . . . . 2.4900000000000002 112.369 -177.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.5 mm -47.61 -51.65 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 C-N-CA 124.66 1.184 . . . . 0.40000000000000002 108.233 177.088 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -54.0 -60.31 3.5 Favored 'General case' 0 C--N 1.34 0.182 0 C-N-CA 123.625 0.77 . . . . 2.5499999999999998 110.781 174.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -63.71 -29.52 70.73 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 112.679 0.622 . . . . 5.2000000000000002 112.679 -172.241 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 23.8 mt -70.03 -18.35 63.3 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.425 1.49 . . . . 0.75 111.02 172.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 95.32 39.07 4.59 Favored Glycine 0 CA--C 1.524 0.645 0 C-N-CA 124.959 1.266 . . . . 0.39000000000000001 110.937 175.319 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.425 ' CD1' HG21 ' A' ' 24' ' ' ILE . 0.7 OUTLIER -137.74 175.43 9.59 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.605 0.762 . . . . 2.0299999999999998 111.863 -173.104 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 4.3 t-80 -152.08 111.68 3.96 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 125.008 1.323 . . . . 2.3900000000000001 107.495 -176.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 3.6 m -82.96 160.99 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.239 0 N-CA-C 108.877 -0.786 . . . . 2.3599999999999999 108.877 169.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 21.6 t -122.96 142.12 40.74 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 N-CA-C 108.468 -0.938 . . . . 0.70999999999999996 108.468 176.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 45.4 mm -114.23 79.24 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 C-N-CA 125.277 1.431 . . . . 1.25 108.164 -175.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -80.37 -0.61 37.67 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 124.38 1.072 . . . . 3.23 113.53 173.054 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -112.27 -19.16 7.27 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 125.212 1.387 . . . . 2.8199999999999998 115.343 -164.221 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 6.4 tpp180 . . . . . 0 C--O 1.25 1.126 0 CA-C-O 116.6 -1.667 . . . . 9.5199999999999996 108.36 178.206 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 44.6 mtt . . . . . 0 N--CA 1.475 0.813 0 N-CA-C 109.137 -0.69 . . . . 8.5299999999999994 109.137 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 173.83 -89.15 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 105.561 -2.014 . . . . 5.6600000000000001 105.561 178.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 25.1 m -157.79 139.74 14.13 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 106.499 -1.667 . . . . 0.89000000000000001 106.499 -174.371 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -77.01 179.74 6.05 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 108.817 -0.808 . . . . 2.3599999999999999 108.817 160.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -135.38 147.79 49.17 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 106.693 -1.595 . . . . 1.45 106.693 166.576 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 20.0 mmtp -140.53 156.05 46.43 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 123.343 0.657 . . . . 3.5499999999999998 109.921 165.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -108.06 99.14 8.6 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 128.011 2.524 . . . . 1.9099999999999999 107.615 -174.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.9 mm -82.97 157.44 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.98 0 N-CA-C 107.205 -1.405 . . . . 1.8899999999999999 107.205 177.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -135.66 129.99 33.63 Favored 'General case' 0 C--O 1.231 0.112 0 C-N-CA 124.606 1.162 . . . . 0.45000000000000001 107.893 178.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 10.0 ptt? -156.16 175.54 13.84 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.019 0.528 . . . . 2.6600000000000001 110.485 -176.015 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -101.2 162.16 13.1 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 127.505 2.322 . . . . 3.77 110.701 -177.787 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 46.1 t -119.34 144.86 26.54 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 C-N-CA 124.436 1.094 . . . . 1.3500000000000001 109.316 -176.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 41.3 t -135.72 175.61 9.44 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.767 1.227 . . . . 2.4100000000000001 109.153 173.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 51.66 58.16 10.79 Favored Glycine 0 CA--C 1.529 0.917 0 C-N-CA 124.661 1.124 . . . . 1.6799999999999999 111.254 -175.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -134.41 150.64 50.89 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 123.634 0.773 . . . . 1.6899999999999999 110.827 -172.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -99.62 -57.21 2.2 Favored 'General case' 0 CA--C 1.528 0.113 0 C-N-CA 125.23 1.412 . . . . 2.3900000000000001 111.204 169.22 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 20.8 p -144.29 165.44 27.89 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 121.808 0.813 . . . . 2.3500000000000001 111.941 -169.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -75.64 54.26 0.77 Allowed 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.209 1.404 . . . . 2.0 110.746 178.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -147.62 -58.53 0.26 Allowed 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 124.373 1.069 . . . . 0.85999999999999999 108.709 177.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 26.8 m -57.15 -40.98 78.29 Favored 'General case' 0 CA--C 1.53 0.186 0 O-C-N 121.994 -0.441 . . . . 1.4399999999999999 110.168 176.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.23 -21.03 7.98 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.801 0.84 . . . . 0.55000000000000004 113.032 174.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.515 ' HA ' HG11 ' A' ' 39' ' ' VAL . . . -72.44 -47.37 49.55 Favored 'General case' 0 N--CA 1.453 -0.298 0 O-C-N 120.667 -1.271 . . . . 0.47999999999999998 110.793 170.545 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 54.4 mmm-85 -53.37 -44.65 68.77 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 109.77 -0.456 . . . . 4.3700000000000001 109.77 -172.129 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.501 ' HA ' HD13 ' A' ' 67' ' ' LEU . 3.5 pt -57.85 -54.02 37.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 CA-C-O 118.69 -0.672 . . . . 0.55000000000000004 110.5 178.333 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -57.14 -40.73 77.74 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.797 0.839 . . . . 2.3799999999999999 112.133 179.452 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 31.9 mmtp -70.7 -43.98 67.87 Favored 'General case' 0 CA--C 1.534 0.358 0 O-C-N 121.414 -0.804 . . . . 1.9199999999999999 110.552 -178.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -63.74 -38.68 96.55 Favored Glycine 0 CA--C 1.53 1.019 0 N-CA-C 110.931 -0.868 . . . . 0.51000000000000001 110.931 173.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.47 HD23 ' C ' ' A' ' 28' ' ' LEU . 4.8 tt -60.51 -41.54 94.57 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 125.462 1.505 . . . . 1.8500000000000001 109.512 176.774 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 10.7 ttmt -54.41 -23.37 15.55 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 112.592 0.59 . . . . 2.79 112.592 173.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.82 -2.58 24.2 Favored 'General case' 0 CA--C 1.542 0.659 0 O-C-N 121.285 -0.884 . . . . 3.6600000000000001 112.19 177.634 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . 0.415 ' SD ' ' HB1' ' A' ' 59' ' ' ALA . 9.9 mmt -69.78 152.0 96.22 Favored Pre-proline 0 CA--C 1.532 0.273 0 CA-C-N 119.42 1.009 . . . . 3.2799999999999998 111.689 173.054 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -58.22 141.08 96.43 Favored 'Trans proline' 0 N--CA 1.452 -0.932 0 C-N-CA 122.005 1.803 . . . . 0.93999999999999995 109.47 170.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 86.13 -27.31 5.62 Favored Glycine 0 CA--C 1.524 0.616 0 CA-C-O 119.436 -0.647 . . . . 0.75 113.849 178.295 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 13.7 t -82.57 127.02 40.05 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 CA-C-N 118.777 1.289 . . . . 0.52000000000000002 108.693 -179.178 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.9 m -110.53 -37.26 5.53 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-O 118.601 -0.714 . . . . 0.85999999999999999 110.889 -175.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -148.53 166.94 26.71 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 119.253 0.933 . . . . 1.8400000000000001 110.038 170.333 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -157.25 148.81 22.17 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 123.481 0.712 . . . . 0.57999999999999996 110.507 -175.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -154.46 110.28 3.19 Favored 'General case' 0 CA--C 1.529 0.161 0 N-CA-C 108.437 -0.949 . . . . 0.58999999999999997 108.437 -165.258 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.515 HG11 ' HA ' ' A' ' 22' ' ' ALA . 4.7 p -88.44 93.87 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 C-N-CA 124.142 0.977 . . . . 0.81000000000000005 110.37 -178.146 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 52.5 t-20 -82.79 56.79 3.53 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 120.475 -1.391 . . . . 0.60999999999999999 110.224 -178.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.436 HD23 ' CG2' ' A' ' 39' ' ' VAL . 0.3 OUTLIER -67.01 -21.34 65.95 Favored 'General case' 0 C--O 1.227 -0.097 0 C-N-CA 123.677 0.791 . . . . 0.89000000000000001 110.33 179.907 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -48.26 -33.78 9.29 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.626 0.77 . . . . 0.63 112.144 170.151 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 3.4 t -121.97 27.66 7.96 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 118.026 0.375 . . . . 1.26 110.424 174.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 47.55 58.47 4.92 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 124.824 1.25 . . . . 3.0699999999999998 111.616 -178.096 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 33.2 m -145.44 164.28 32.05 Favored 'General case' 0 N--CA 1.44 -0.927 0 O-C-N 120.713 -1.242 . . . . 0.67000000000000004 107.716 175.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.9 p -139.47 145.01 27.7 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 N-CA-C 108.71 -0.848 . . . . 0.47999999999999998 108.71 174.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 19.5 m120 -131.8 139.45 48.89 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 124.407 1.083 . . . . 0.27000000000000002 108.481 -176.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 22.3 t -133.59 129.53 55.73 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 N-CA-C 105.796 -1.927 . . . . 2.1200000000000001 105.796 -178.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 13.6 mm -105.99 95.23 3.63 Favored 'Isoleucine or valine' 0 C--O 1.24 0.585 0 C-N-CA 124.946 1.298 . . . . 0.44 107.583 -174.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 10.8 p90 -131.95 164.48 26.05 Favored 'General case' 0 CA--C 1.513 -0.446 0 O-C-N 122.03 -0.419 . . . . 2.0499999999999998 111.955 -172.172 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 30.9 t0 -81.46 110.78 20.53 Favored Pre-proline 0 CA--C 1.534 0.365 0 O-C-N 124.392 1.057 . . . . 2.8700000000000001 110.134 172.584 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -73.09 5.97 2.79 Favored 'Trans proline' 0 N--CA 1.452 -0.96 0 C-N-CA 123.007 2.472 . . . . 0.56999999999999995 113.124 -178.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -87.79 -34.09 18.41 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 119.493 1.042 . . . . 0.75 108.797 169.268 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -99.03 -60.47 1.53 Allowed 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 108.687 -0.857 . . . . 3.0099999999999998 108.687 -174.417 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.566 HG22 ' HB3' ' A' ' 59' ' ' ALA 0.345 0.6 OUTLIER -83.53 -174.86 5.53 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 123.807 0.843 . . . . 0.48999999999999999 112.229 162.05 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 126.37 94.95 0.94 Allowed Glycine 0 N--CA 1.442 -0.909 0 N-CA-C 103.913 -3.675 . . . . 2.2000000000000002 103.913 -144.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 68.6 p -14.31 -23.52 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.383 1 C-N-CA 138.161 6.584 . . . . 1.04 119.169 -151.749 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -27.47 -62.74 0.09 Allowed 'General case' 0 N--CA 1.443 -0.787 0 C-N-CA 127.177 2.191 . . . . 0.53000000000000003 113.532 167.222 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.566 ' HB3' HG22 ' A' ' 55' ' ' THR . . . -74.54 -39.55 62.25 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 118.732 -1.187 . . . . 0.5 109.72 -166.741 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.2 mp -54.68 -57.67 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.026 0 CA-C-N 113.687 -1.597 . . . . 0.94999999999999996 109.399 176.397 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -60.76 -43.28 98.22 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 118.093 0.406 . . . . 1.46 109.923 -174.482 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -46.86 -58.82 3.54 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.15 0.58 . . . . 2.7400000000000002 111.41 171.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 3.4 mmpt? -65.44 -42.82 92.01 Favored 'General case' 0 N--CA 1.442 -0.84 0 O-C-N 121.705 -0.622 . . . . 2.3500000000000001 112.331 -179.304 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -47.1 -54.11 2.86 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 C-N-CA 125.403 1.481 . . . . 0.65000000000000002 107.795 178.11 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -60.54 -57.54 12.29 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 124.559 1.144 . . . . 1.6799999999999999 110.633 177.048 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 11.7 mptt -59.66 -31.41 69.52 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 112.795 0.665 . . . . 5.3200000000000003 112.795 -173.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.501 HD13 ' HA ' ' A' ' 24' ' ' ILE . 8.6 mt -67.74 -16.95 64.38 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.307 1.043 . . . . 0.87 112.179 174.634 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 89.84 46.04 4.35 Favored Glycine 0 C--N 1.336 0.58 0 N-CA-C 109.68 -1.368 . . . . 0.66000000000000003 109.68 179.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.422 ' CD1' HG21 ' A' ' 24' ' ' ILE . 0.2 OUTLIER -143.72 175.25 10.12 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 124.562 1.145 . . . . 2.1699999999999999 108.678 -176.352 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 7.7 t-160 -145.28 144.48 30.79 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 109.076 -0.713 . . . . 1.8700000000000001 109.076 174.088 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 5.8 p -113.21 144.37 21.0 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 N-CA-C 107.002 -1.481 . . . . 1.53 107.002 179.18 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 5.7 t -122.86 140.81 45.46 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 N-CA-C 107.615 -1.254 . . . . 0.68999999999999995 107.615 -178.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 4.7 mp -108.95 80.16 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.475 0 N-CA-C 107.975 -1.12 . . . . 1.26 107.975 -175.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -66.28 -15.31 63.11 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 113.985 1.106 . . . . 3.96 113.985 172.236 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 78.4 79.08 0.78 Allowed Glycine 0 CA--C 1.526 0.72 0 N-CA-C 109.521 -1.432 . . . . 3.9100000000000001 109.521 -175.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 10.7 tpt180 . . . . . 0 C--O 1.252 1.198 0 C-N-CA 126.998 2.119 . . . . 15.210000000000001 112.597 -176.553 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 55.3 mtt . . . . . 0 N--CA 1.472 0.65 0 N-CA-C 107.045 -1.465 . . . . 10.289999999999999 107.045 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 7.2 mt -85.06 157.01 20.84 Favored 'General case' 0 N--CA 1.456 -0.147 0 O-C-N 124.069 0.856 . . . . 4.3600000000000003 109.078 171.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.5 m -59.83 104.71 0.31 Allowed 'General case' 0 N--CA 1.446 -0.67 0 C-N-CA 124.29 1.036 . . . . 0.81999999999999995 108.838 169.328 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -65.94 171.63 4.31 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 108.077 -1.083 . . . . 2.29 108.077 162.211 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -131.5 153.88 49.34 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 124.258 1.023 . . . . 1.0800000000000001 109.673 176.501 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -144.94 160.63 41.01 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 124.725 1.21 . . . . 3.23 109.842 170.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -121.25 94.77 4.44 Favored 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 128.082 2.553 . . . . 1.98 106.094 -170.087 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 17.1 mm -82.62 162.05 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.232 0 N-CA-C 107.109 -1.441 . . . . 2.04 107.109 -179.095 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -133.3 140.24 47.33 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 107.068 -1.456 . . . . 0.69999999999999996 107.068 170.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -152.55 175.46 12.74 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 118.522 0.601 . . . . 2.1299999999999999 110.059 172.226 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 22.8 mm100 -98.45 157.99 15.87 Favored 'General case' 0 C--O 1.227 -0.084 0 C-N-CA 124.234 1.014 . . . . 2.6099999999999999 110.049 177.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 43.4 t -111.19 162.19 9.01 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 C-N-CA 124.844 1.257 . . . . 1.21 109.612 -174.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 58.0 m -149.23 164.47 34.7 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 107.535 -1.283 . . . . 0.93000000000000005 107.535 165.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 93.32 -29.97 7.71 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 123.39 0.519 . . . . 2.4700000000000002 112.562 -178.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -53.21 108.2 0.31 Allowed 'General case' 0 C--O 1.225 -0.205 0 CA-C-N 118.026 0.913 . . . . 2.27 112.77 178.233 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -155.91 14.18 0.34 Allowed 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 114.299 1.222 . . . . 3.8100000000000001 114.299 178.326 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 8.3 m -104.28 -58.7 1.84 Allowed 'General case' 0 C--O 1.226 -0.163 0 N-CA-C 108.245 -1.021 . . . . 5.0300000000000002 108.245 -175.16 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -172.86 -56.56 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 126.34 1.856 . . . . 5.4900000000000002 106.579 174.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -164.38 32.1 0.07 Allowed 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 113.204 0.816 . . . . 2.0600000000000001 113.204 -168.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 95.6 m -58.1 -31.62 67.31 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 121.378 -0.826 . . . . 1.1899999999999999 111.424 174.248 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.57 -25.43 17.13 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.197 0.599 . . . . 0.91000000000000003 112.609 170.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.59 ' HA ' HG11 ' A' ' 39' ' ' VAL . . . -70.26 -48.26 57.61 Favored 'General case' 0 N--CA 1.453 -0.307 0 O-C-N 120.261 -1.525 . . . . 0.65000000000000002 110.204 169.367 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 21.0 mmm180 -55.66 -46.86 77.46 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 109.603 -0.517 . . . . 4.2699999999999996 109.603 -178.116 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.411 HG21 ' CD1' ' A' ' 69' ' ' TYR . 3.0 pt -57.21 -54.96 23.71 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.36 0 C-N-CA 119.816 -0.754 . . . . 0.53000000000000003 110.921 178.242 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -55.68 -40.06 71.81 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 119.097 0.862 . . . . 2.2200000000000002 112.324 -179.511 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -71.13 -46.19 62.08 Favored 'General case' 0 N--CA 1.453 -0.284 0 O-C-N 121.722 -0.611 . . . . 1.8899999999999999 109.707 -176.218 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -60.11 -47.62 90.12 Favored Glycine 0 CA--C 1.528 0.856 0 N-CA-C 110.204 -1.158 . . . . 0.92000000000000004 110.204 172.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.441 HD23 ' C ' ' A' ' 28' ' ' LEU . 6.1 tt -52.97 -42.87 65.92 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.793 1.637 . . . . 1.95 110.118 177.599 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 8.6 ttmt -57.54 -32.36 67.0 Favored 'General case' 0 CA--C 1.535 0.373 0 O-C-N 120.942 -1.099 . . . . 3.4500000000000002 112.917 174.104 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -69.01 -7.53 36.44 Favored 'General case' 0 CA--C 1.536 0.427 0 O-C-N 121.297 -0.877 . . . . 5.6500000000000004 112.551 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 20.5 mmt -79.69 148.45 69.24 Favored Pre-proline 0 CA--C 1.532 0.273 0 CA-C-N 119.019 0.827 . . . . 4.7400000000000002 110.419 -174.129 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -56.11 137.17 78.54 Favored 'Trans proline' 0 N--CA 1.452 -0.966 0 C-N-CA 121.89 1.727 . . . . 0.88 108.746 176.102 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 90.89 -7.15 81.59 Favored Glycine 0 N--CA 1.449 -0.481 0 CA-C-O 117.671 -1.627 . . . . 0.88 114.35 179.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.6 t -110.37 135.18 50.2 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 CA-C-N 119.825 1.813 . . . . 0.64000000000000001 109.107 177.294 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 8.4 m -107.45 -49.86 3.18 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 123.442 0.697 . . . . 1.1200000000000001 110.194 -176.532 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -138.96 163.88 31.21 Favored 'General case' 0 C--N 1.343 0.299 0 CA-C-N 118.916 0.78 . . . . 2.0499999999999998 111.456 177.164 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -159.43 144.33 15.5 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 113.152 0.797 . . . . 0.77000000000000002 113.152 -179.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -149.7 105.53 3.44 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 107.97 -1.122 . . . . 1.0 107.97 -164.159 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.59 HG11 ' HA ' ' A' ' 22' ' ' ALA . 4.0 p -83.71 100.98 7.72 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 C-N-CA 123.03 0.532 . . . . 1.02 110.521 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 45.1 t30 -82.55 57.4 3.7 Favored 'General case' 0 CA--C 1.538 0.516 0 O-C-N 120.372 -1.455 . . . . 1.05 110.513 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.45 HD23 ' CG2' ' A' ' 39' ' ' VAL . 0.5 OUTLIER -76.33 -12.11 60.01 Favored 'General case' 0 C--O 1.226 -0.178 0 C-N-CA 124.384 1.074 . . . . 1.03 111.156 176.858 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -43.84 -38.0 3.09 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 123.59 0.756 . . . . 1.21 111.215 167.406 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.47 HG23 ' H ' ' A' ' 44' ' ' GLU . 9.2 t -102.1 -75.95 0.59 Allowed 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 118.755 -0.64 . . . . 3.7400000000000002 109.578 163.575 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.47 ' H ' HG23 ' A' ' 43' ' ' THR . 3.0 tt0 179.37 26.76 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.983 1.313 . . . . 3.25 113.375 -177.053 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 91.9 m -128.51 167.35 17.2 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 124.133 0.973 . . . . 0.76000000000000001 108.759 -163.481 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 1.2 p -138.35 145.36 28.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 N-CA-C 108.516 -0.92 . . . . 0.67000000000000004 108.516 179.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -131.09 139.7 49.9 Favored 'General case' 0 C--N 1.343 0.297 0 N-CA-C 108.187 -1.042 . . . . 0.56000000000000005 108.187 173.416 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 39.8 t -131.34 127.95 60.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 N-CA-C 105.591 -2.003 . . . . 2.1600000000000001 105.591 179.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 13.2 mm -102.44 93.01 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 N-CA-C 106.884 -1.524 . . . . 0.63 106.884 -177.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 9.5 p90 -127.01 168.67 14.25 Favored 'General case' 0 CA--C 1.509 -0.632 0 O-C-N 121.964 -0.46 . . . . 1.76 110.663 -170.207 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -99.1 103.44 20.01 Favored Pre-proline 0 N--CA 1.445 -0.716 0 C-N-CA 124.292 1.037 . . . . 4.3899999999999997 109.123 -176.265 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -72.72 10.4 1.06 Allowed 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 123.402 2.734 . . . . 1.0600000000000001 113.723 -172.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -86.44 -25.72 25.08 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 108.893 -0.78 . . . . 1.23 108.893 167.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -112.42 -55.33 2.53 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 123.816 0.847 . . . . 3.0699999999999998 109.151 -175.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.433 HG22 ' HB3' ' A' ' 59' ' ' ALA 0.324 9.5 p -90.57 -160.56 0.72 Allowed 'General case' 0 C--N 1.343 0.288 0 CA-C-O 119.411 -0.328 . . . . 0.68000000000000005 110.76 165.155 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 118.33 88.41 1.23 Allowed Glycine 0 N--CA 1.445 -0.734 0 N-CA-C 104.192 -3.563 . . . . 2.3399999999999999 104.192 -148.648 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 47.0 p -12.51 -18.28 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.419 1 C-N-CA 138.573 6.749 . . . . 1.25 119.53 -147.082 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -27.29 -63.05 0.09 Allowed 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 127.434 2.294 . . . . 0.60999999999999999 114.327 166.091 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.433 ' HB3' HG22 ' A' ' 55' ' ' THR . . . -72.96 -41.1 64.78 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 117.556 -1.657 . . . . 0.55000000000000004 109.196 -168.056 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.1 mp -53.97 -52.49 35.73 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.051 0 CA-C-N 113.821 -1.536 . . . . 0.89000000000000001 109.542 177.041 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.19 -48.1 79.78 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 119.398 0.999 . . . . 1.7 109.046 -176.793 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -47.83 -56.29 7.8 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 122.4 1.095 . . . . 3.29 110.709 176.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.9 mmpt? -70.58 -39.08 74.08 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-O 118.532 -0.747 . . . . 2.6200000000000001 112.063 -176.3 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -45.55 -53.78 1.86 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 C-N-CA 125.142 1.377 . . . . 0.44 108.046 173.412 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -58.46 -59.66 5.01 Favored 'General case' 0 C--N 1.341 0.2 0 C-N-CA 124.058 0.943 . . . . 1.98 110.288 177.568 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -58.73 -31.97 68.79 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 112.84 0.681 . . . . 5.3499999999999996 112.84 -175.337 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 24.8 mt -69.73 -17.23 63.44 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.969 1.308 . . . . 0.65000000000000002 111.295 176.11 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 94.2 41.85 4.17 Favored Glycine 0 CA--C 1.523 0.569 0 C-N-CA 124.642 1.115 . . . . 0.48999999999999999 110.367 176.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.411 ' CD1' HG21 ' A' ' 24' ' ' ILE . 0.6 OUTLIER -140.61 171.57 13.93 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 123.909 0.884 . . . . 1.98 110.238 -176.089 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -151.08 141.93 22.88 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 108.306 -0.998 . . . . 2.4700000000000002 108.306 168.567 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.0 m -99.27 165.38 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 C-N-CA 124.891 1.277 . . . . 2.4300000000000002 108.531 174.34 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 16.6 t -122.42 143.81 33.92 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 C-N-CA 124.66 1.184 . . . . 0.81000000000000005 108.325 177.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 21.9 mm -124.74 79.45 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.201 0 C-N-CA 125.429 1.492 . . . . 1.5 108.482 -176.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -78.66 -1.73 35.77 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 114.042 1.127 . . . . 3.2599999999999998 114.042 174.324 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -92.99 -45.37 3.61 Favored Glycine 0 CA--C 1.529 0.915 0 C-N-CA 124.755 1.169 . . . . 3.6400000000000001 113.688 -169.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.255 1.346 0 N-CA-C 106.81 -1.552 . . . . 10.69 106.81 -170.271 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.477 0.916 0 N-CA-C 106.53 -1.655 . . . . 12.119999999999999 106.53 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -58.3 -31.85 67.89 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 119.712 1.142 . . . . 6.1200000000000001 110.67 167.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 28.2 m -125.75 158.61 34.44 Favored 'General case' 0 N--CA 1.444 -0.729 0 C-N-CA 126.286 1.834 . . . . 1.4399999999999999 108.051 179.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -108.68 -179.94 4.01 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 128.065 2.546 . . . . 2.1200000000000001 108.985 166.153 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 3.5 mm100 -139.19 147.66 42.11 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.95 1.3 . . . . 1.23 108.015 167.544 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -140.96 159.8 41.43 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 123.735 0.814 . . . . 3.1899999999999999 109.384 160.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -114.89 86.55 2.47 Favored 'General case' 0 N--CA 1.442 -0.83 0 C-N-CA 127.902 2.481 . . . . 1.5700000000000001 106.727 -170.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.527 HD13 ' CE1' ' A' ' 50' ' ' TYR . 2.6 mp -83.5 161.67 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.295 0 N-CA-C 106.262 -1.755 . . . . 2.29 106.262 -176.497 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -128.85 137.68 51.61 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 125.649 1.58 . . . . 0.65000000000000002 108.077 -178.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 1.9 mpt? -140.3 171.4 14.2 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 122.923 0.489 . . . . 2.0800000000000001 110.302 172.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -88.54 159.7 17.8 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 127.005 2.122 . . . . 3.75 109.797 167.091 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 88.9 t -117.86 152.63 19.84 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 C-N-CA 124.623 1.169 . . . . 1.1899999999999999 108.525 -179.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 70.8 m -149.49 160.41 43.48 Favored 'General case' 0 N--CA 1.455 -0.198 0 O-C-N 121.342 -0.849 . . . . 1.1200000000000001 109.853 171.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 70.02 70.29 1.21 Allowed Glycine 0 CA--C 1.528 0.861 0 N-CA-C 110.462 -1.055 . . . . 1.6399999999999999 110.462 -178.408 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -145.2 157.89 43.96 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 124.152 0.981 . . . . 1.9299999999999999 109.529 -175.283 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.7 p -108.63 -66.03 1.08 Allowed 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 125.612 1.565 . . . . 2.3599999999999999 108.692 171.129 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 20.3 p -123.71 161.11 25.8 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 124.485 1.114 . . . . 2.1299999999999999 111.414 -170.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -76.67 53.49 0.89 Allowed 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.322 1.049 . . . . 1.9299999999999999 110.813 178.28 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -138.42 -53.49 0.61 Allowed 'General case' 0 CA--C 1.521 -0.153 0 C-N-CA 124.677 1.191 . . . . 0.69999999999999996 109.234 175.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 59.7 m -57.4 -41.44 80.33 Favored 'General case' 0 CA--C 1.533 0.289 0 O-C-N 121.734 -0.604 . . . . 1.25 111.6 -176.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.466 ' HB1' HG21 ' A' ' 39' ' ' VAL . . . -59.67 -19.13 47.52 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 112.642 0.608 . . . . 0.71999999999999997 112.642 176.66 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.72 -49.12 42.22 Favored 'General case' 0 N--CA 1.455 -0.221 0 O-C-N 120.634 -1.291 . . . . 0.41999999999999998 109.757 169.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 6.3 mtt-85 -53.72 -49.27 68.49 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 123.383 0.673 . . . . 3.8300000000000001 109.397 -175.418 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 5.1 pt -55.23 -53.46 34.81 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 O-C-N 123.883 0.739 . . . . 0.46999999999999997 109.973 179.423 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.612 ' HG3' ' HB1' ' A' ' 37' ' ' ALA . 0.3 OUTLIER -53.72 -45.62 70.53 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.078 0.951 . . . . 2.3100000000000001 112.273 179.51 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.5 mptp? -69.25 -46.71 66.64 Favored 'General case' 0 CA--C 1.532 0.259 0 O-C-N 121.163 -0.96 . . . . 1.48 110.351 -177.091 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -63.94 -31.71 81.73 Favored Glycine 0 CA--C 1.529 0.956 0 N-CA-C 111.439 -0.665 . . . . 0.51000000000000001 111.439 176.2 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 7.6 tt -64.91 -44.05 90.84 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 126.018 1.727 . . . . 1.9199999999999999 109.486 177.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -53.1 -26.51 16.67 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 112.034 0.383 . . . . 2.5600000000000001 112.034 176.037 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 2.3 mtt180 -70.96 1.6 5.42 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 113.671 0.989 . . . . 3.6899999999999999 113.671 177.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 6.6 mmt -71.48 155.52 92.57 Favored Pre-proline 0 CA--C 1.534 0.348 0 CA-C-N 119.519 1.054 . . . . 3.3399999999999999 111.314 167.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -62.62 152.78 75.97 Favored 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 122.411 2.074 . . . . 1.02 110.418 171.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 74.88 -27.03 1.12 Allowed Glycine 0 CA--C 1.533 1.193 0 O-C-N 121.482 -0.761 . . . . 0.75 113.486 177.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 10.3 t -76.4 145.76 9.92 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 CA-C-N 118.83 1.315 . . . . 0.93999999999999995 109.056 173.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -132.22 -38.94 1.06 Allowed 'General case' 0 CA--C 1.529 0.143 0 CA-C-O 118.512 -0.756 . . . . 0.87 112.304 -176.185 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -140.61 166.49 24.6 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-N 119.589 1.086 . . . . 2.2599999999999998 111.867 163.503 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.612 ' HB1' ' HG3' ' A' ' 25' ' ' GLU . . . -158.13 137.26 11.59 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 112.769 0.655 . . . . 0.46999999999999997 112.769 -179.278 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -149.97 107.86 3.71 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 106.463 -1.68 . . . . 0.41999999999999998 106.463 -161.55 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.466 HG21 ' HB1' ' A' ' 21' ' ' ALA . 2.4 p -82.02 128.44 38.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 108.324 -0.991 . . . . 0.67000000000000004 108.324 177.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 39.3 t30 -105.69 57.26 0.67 Allowed 'General case' 0 C--O 1.235 0.341 0 CA-C-O 123.263 1.506 . . . . 0.87 107.887 179.005 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.424 HD23 HG22 ' A' ' 39' ' ' VAL . 0.3 OUTLIER -74.74 -13.49 60.6 Favored 'General case' 0 C--O 1.226 -0.178 0 CA-C-N 113.96 -1.473 . . . . 0.92000000000000004 110.636 177.003 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -44.0 -36.55 2.54 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.914 0.886 . . . . 1.0800000000000001 111.378 165.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 15.2 t -108.21 -68.73 0.89 Allowed 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 117.739 -1.124 . . . . 3.3700000000000001 110.85 167.318 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 161.34 49.13 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 127.561 2.344 . . . . 3.7999999999999998 109.535 -174.108 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -142.52 160.62 39.92 Favored 'General case' 0 N--CA 1.446 -0.667 0 O-C-N 120.292 -1.505 . . . . 0.76000000000000001 109.16 -178.228 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.6 p -130.18 142.79 42.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 108.113 -1.069 . . . . 0.32000000000000001 108.113 171.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -127.04 138.77 53.28 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 107.594 -1.262 . . . . 0.33000000000000002 107.594 176.123 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 3.1 p -137.68 129.67 40.61 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 N-CA-C 106.003 -1.851 . . . . 1.7 106.003 -176.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 11.2 mm -104.92 99.49 8.56 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.612 0 N-CA-C 106.743 -1.577 . . . . 0.45000000000000001 106.743 -171.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.527 ' CE1' HD13 ' A' ' 8' ' ' ILE . 51.2 p90 -139.84 169.44 17.72 Favored 'General case' 0 CA--C 1.512 -0.507 0 C-N-CA 122.629 0.372 . . . . 2.0899999999999999 110.662 -173.601 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 52.6 t0 -90.4 109.27 32.6 Favored Pre-proline 0 C--O 1.235 0.33 0 O-C-N 124.435 1.085 . . . . 3.3199999999999998 109.533 173.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 78.9 Cg_endo -72.41 5.57 2.71 Favored 'Trans proline' 0 N--CA 1.452 -0.95 0 C-N-CA 122.758 2.305 . . . . 0.83999999999999997 113.698 179.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -83.37 -33.24 25.85 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 119.393 0.997 . . . . 1.0600000000000001 108.692 165.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -107.44 -60.83 1.64 Allowed 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 123.446 0.698 . . . . 2.6800000000000002 110.943 -168.386 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.429 HG22 ' HB3' ' A' ' 59' ' ' ALA 0.495 0.2 OUTLIER -79.2 -177.1 5.49 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 114.513 1.301 . . . . 0.64000000000000001 114.513 155.956 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 176.78 -147.91 8.7 Favored Glycine 0 N--CA 1.434 -1.469 0 N-CA-C 103.354 -3.898 . . . . 2.71 103.354 -165.37 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 12.9 p -75.39 -42.68 53.29 Favored 'General case' 0 N--CA 1.443 -0.795 0 C-N-CA 124.711 1.204 . . . . 1.3 108.794 174.32 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -46.67 -63.83 0.92 Allowed 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 114.125 1.157 . . . . 0.70999999999999996 114.125 -165.026 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.429 ' HB3' HG22 ' A' ' 55' ' ' THR . . . -70.82 -34.57 71.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 122.34 1.067 . . . . 0.64000000000000001 108.98 -165.78 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.5 mp -53.78 -58.55 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.122 0 CA-C-N 114.143 -1.389 . . . . 1.1399999999999999 109.534 170.045 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.94 -45.4 92.73 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 123.038 0.535 . . . . 1.6000000000000001 109.957 -173.395 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -43.8 -58.48 2.7 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.236 1.014 . . . . 3.8900000000000001 110.872 172.518 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -67.3 -44.69 78.61 Favored 'General case' 0 N--CA 1.442 -0.845 0 O-C-N 121.937 -0.477 . . . . 3.71 111.809 -178.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -48.46 -53.03 7.23 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 C-N-CA 125.799 1.64 . . . . 0.53000000000000003 107.89 -179.324 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 41.0 mm-40 -60.56 -58.19 9.52 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 124.549 1.14 . . . . 2.0 110.339 176.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 5.9 mmmt -53.66 -37.28 63.01 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 113.25 0.833 . . . . 4.4699999999999998 113.25 -177.256 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 12.1 mt -68.93 -17.74 64.0 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.275 1.03 . . . . 0.96999999999999997 111.985 177.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 92.62 49.61 2.71 Favored Glycine 0 CA--C 1.523 0.534 0 N-CA-C 109.932 -1.267 . . . . 0.56999999999999995 109.932 178.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -147.06 170.27 17.5 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 124.135 0.974 . . . . 1.8 109.799 -175.405 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 12.9 t-80 -140.78 123.72 16.37 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 108.249 -1.019 . . . . 1.9299999999999999 108.249 174.244 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 7.5 p -92.7 144.57 9.07 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.146 0 N-CA-C 107.027 -1.471 . . . . 1.52 107.027 170.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 44.7 t -123.04 139.98 48.14 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.182 0 N-CA-C 107.952 -1.129 . . . . 0.98999999999999999 107.952 178.515 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 5.2 mp -111.37 83.11 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 N-CA-C 107.749 -1.204 . . . . 1.46 107.749 -173.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 71.2 mt-10 -79.33 -3.71 47.47 Favored 'General case' 0 N--CA 1.443 -0.794 0 C-N-CA 124.349 1.06 . . . . 2.5499999999999998 113.642 170.435 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -98.1 -23.9 12.39 Favored Glycine 0 CA--C 1.524 0.651 0 C-N-CA 125.137 1.351 . . . . 2.7799999999999998 114.666 -165.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 32.4 ttt180 . . . . . 0 C--O 1.25 1.082 0 CA-C-O 116.472 -1.727 . . . . 11.57 108.873 -169.585 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 82.2 mtp . . . . . 0 N--CA 1.475 0.789 0 N-CA-C 106.228 -1.768 . . . . 8.6099999999999994 106.228 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.5 tp 50.14 78.84 0.09 Allowed 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.361 1.465 . . . . 6.1600000000000001 113.071 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.5 m -68.68 107.09 2.86 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 124.329 1.052 . . . . 1.0600000000000001 110.739 -179.261 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -63.31 175.15 1.03 Allowed 'General case' 0 CA--C 1.531 0.245 0 CA-C-O 121.494 0.664 . . . . 3.1000000000000001 111.543 165.815 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.2 mm100 -137.97 143.79 40.85 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 125.215 1.406 . . . . 1.05 107.968 165.315 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 46.2 mttm -141.47 156.06 45.79 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 123.808 0.843 . . . . 3.6899999999999999 109.428 164.367 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 12.0 mp0 -114.62 86.34 2.42 Favored 'General case' 0 N--CA 1.445 -0.685 0 C-N-CA 127.164 2.186 . . . . 1.6499999999999999 108.08 -167.138 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.5 mt -83.61 157.99 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 N-CA-C 107.296 -1.372 . . . . 2.3199999999999998 107.296 -176.436 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -126.95 136.2 51.94 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 126.183 1.793 . . . . 0.53000000000000003 107.455 178.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 2.1 mpt? -138.74 169.57 17.56 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 118.337 0.517 . . . . 2.04 110.064 174.069 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -87.59 160.16 18.3 Favored 'General case' 0 N--CA 1.456 -0.133 0 C-N-CA 124.441 1.096 . . . . 3.1499999999999999 109.001 170.48 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 60.3 t -116.55 152.05 18.31 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 C-N-CA 124.202 1.001 . . . . 1.24 108.384 177.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 58.6 m -149.58 173.48 13.58 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.755 1.222 . . . . 1.0800000000000001 108.29 172.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 79.79 -37.12 2.09 Favored Glycine 0 CA--C 1.532 1.151 0 O-C-N 121.737 -0.602 . . . . 2.1000000000000001 112.557 -177.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 3.8 ppp? -47.78 153.64 0.58 Allowed 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.119 1.368 . . . . 3.3799999999999999 113.855 179.754 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.2 p -114.26 -71.51 0.74 Allowed 'General case' 0 N--CA 1.457 -0.086 0 C-N-CA 124.804 1.242 . . . . 2.3199999999999998 108.681 170.559 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 6.7 p -99.09 148.13 24.35 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 121.835 0.826 . . . . 2.1899999999999999 111.331 -178.727 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -77.84 53.44 1.14 Allowed 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.477 0.711 . . . . 1.75 110.493 178.247 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -143.05 -51.09 0.35 Allowed 'General case' 0 C--O 1.231 0.102 0 C-N-CA 123.65 0.78 . . . . 0.66000000000000003 110.682 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 56.1 m -56.01 -36.2 67.68 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 118.728 0.695 . . . . 1.2 110.15 171.025 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -47.97 -33.35 7.67 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.186 1.394 . . . . 0.47999999999999998 112.407 172.442 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.37 -53.27 14.68 Favored 'General case' 0 N--CA 1.454 -0.27 0 O-C-N 121.528 -0.733 . . . . 0.34999999999999998 110.128 172.576 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 6.4 mpt_? -55.3 -50.07 70.51 Favored 'General case' 0 CA--C 1.521 -0.148 0 C-N-CA 122.434 0.294 . . . . 5.8600000000000003 110.251 -175.172 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.48 HG21 ' CD1' ' A' ' 69' ' ' TYR 0.258 2.3 pp -52.86 -50.52 42.87 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 O-C-N 123.183 0.302 . . . . 1.26 110.99 177.578 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.523 ' HG3' ' HB1' ' A' ' 37' ' ' ALA . 3.0 tp10 -59.08 -39.27 81.62 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 114.029 1.122 . . . . 2.7599999999999998 114.029 176.221 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -73.95 -38.07 64.35 Favored 'General case' 0 CA--C 1.533 0.305 0 O-C-N 120.82 -1.175 . . . . 2.4900000000000002 111.974 -178.436 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -66.04 -41.39 95.19 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 109.858 -1.297 . . . . 0.47999999999999998 109.858 170.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 8.0 tt -53.56 -50.45 65.51 Favored 'General case' 0 C--N 1.333 -0.133 0 N-CA-C 108.84 -0.8 . . . . 1.8400000000000001 108.84 174.124 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -50.7 -19.9 1.07 Allowed 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.853 1.261 . . . . 3.3799999999999999 114.125 178.583 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.67 -9.32 59.62 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 118.897 0.772 . . . . 4.3399999999999999 112.528 -179.092 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 8.1 ptp -68.78 154.68 94.49 Favored Pre-proline 0 CA--C 1.534 0.337 0 CA-C-N 119.43 1.013 . . . . 3.8300000000000001 111.474 177.215 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -58.4 137.35 79.95 Favored 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 121.539 1.493 . . . . 0.57999999999999996 109.388 166.123 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 100.83 -35.51 4.8 Favored Glycine 0 CA--C 1.529 0.95 0 CA-C-O 119.274 -0.737 . . . . 0.51000000000000001 113.283 175.354 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 54.7 t -89.21 110.39 21.48 Favored 'Isoleucine or valine' 0 C--N 1.34 0.178 0 CA-C-N 118.76 1.28 . . . . 0.85999999999999999 109.671 178.062 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -81.63 -49.46 10.48 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-O 118.122 -0.942 . . . . 0.90000000000000002 108.577 -178.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -137.36 163.14 31.74 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 119.016 0.826 . . . . 2.1600000000000001 112.096 173.72 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.523 ' HB1' ' HG3' ' A' ' 25' ' ' GLU . . . -157.06 146.92 20.73 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.697 -0.683 . . . . 0.5 112.082 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -156.07 115.04 3.48 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 106.365 -1.717 . . . . 0.46999999999999997 106.365 -163.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.5 p -81.39 130.89 35.09 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.688 0 N-CA-C 107.911 -1.144 . . . . 0.75 107.911 175.541 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 54.1 t-20 -109.63 55.82 0.63 Allowed 'General case' 0 C--O 1.236 0.359 0 N-CA-C 107.187 -1.412 . . . . 0.59999999999999998 107.187 178.495 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.16 -18.34 62.5 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 114.157 -1.383 . . . . 1.01 109.86 -172.658 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -43.13 -37.78 2.16 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.09 0.956 . . . . 0.60999999999999999 112.246 164.105 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 8.9 t -124.23 38.51 4.18 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 122.727 0.411 . . . . 1.3 109.943 173.346 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 50.11 31.85 5.35 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.932 1.693 . . . . 2.6099999999999999 113.412 174.483 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 90.4 m -121.31 157.29 30.7 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 108.264 -1.013 . . . . 0.66000000000000003 108.264 -177.005 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 5.4 p -125.52 142.41 42.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 N-CA-C 108.355 -0.98 . . . . 0.37 108.355 172.17 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -127.37 139.84 52.59 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 108.425 -0.954 . . . . 0.33000000000000002 108.425 -179.515 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 5.5 p -141.29 126.17 17.92 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 N-CA-C 106.936 -1.505 . . . . 1.8100000000000001 106.936 -172.472 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 14.8 mm -107.22 91.8 1.88 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.513 0 C-N-CA 126.092 1.757 . . . . 0.40999999999999998 107.07 -167.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 43.6 p90 -135.38 165.53 25.26 Favored 'General case' 0 CA--C 1.51 -0.583 0 O-C-N 121.975 -0.453 . . . . 1.96 112.037 -166.764 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 59.7 t0 -86.55 109.92 27.67 Favored Pre-proline 0 C--O 1.235 0.321 0 O-C-N 124.574 1.172 . . . . 3.0499999999999998 109.821 176.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -71.23 1.93 4.89 Favored 'Trans proline' 0 N--CA 1.453 -0.892 0 C-N-CA 123.029 2.486 . . . . 0.58999999999999997 113.44 -178.401 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -88.78 -27.17 21.31 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 119.428 1.013 . . . . 0.81999999999999995 109.471 168.559 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -101.71 -53.33 2.99 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 123.492 0.717 . . . . 2.75 109.13 -170.122 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.265 1.0 OUTLIER -101.66 -176.44 3.14 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 125.256 1.422 . . . . 0.46000000000000002 111.998 163.431 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 146.95 91.09 0.1 OUTLIER Glycine 0 N--CA 1.442 -0.931 0 N-CA-C 103.629 -3.789 . . . . 2.3199999999999998 103.629 -155.406 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 77.0 p -13.95 -15.06 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.546 1 C-N-CA 137.737 6.415 . . . . 1.45 120.32 -145.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -25.49 -62.04 0.07 Allowed 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 126.924 2.09 . . . . 0.54000000000000004 114.503 162.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.07 -43.13 58.82 Favored 'General case' 0 C--N 1.332 -0.176 0 C-N-CA 119.088 -1.045 . . . . 0.51000000000000001 109.027 -167.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.7 mt -46.92 -60.03 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.706 0 C-N-CA 126.543 1.937 . . . . 1.27 110.893 172.025 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.78 -46.84 81.26 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 119.778 1.172 . . . . 1.0700000000000001 110.195 179.541 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -51.88 -55.18 21.66 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 121.795 0.807 . . . . 3.3900000000000001 112.022 179.014 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -69.8 -37.96 76.47 Favored 'General case' 0 N--CA 1.438 -1.028 0 O-C-N 121.419 -0.801 . . . . 2.27 111.471 -178.792 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.7 mm -49.95 -54.28 8.26 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 N-CA-C 107.362 -1.347 . . . . 0.48999999999999999 107.362 175.369 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 27.0 mm-40 -58.36 -58.23 9.41 Favored 'General case' 0 C--N 1.342 0.259 0 C-N-CA 124.745 1.218 . . . . 2.2000000000000002 110.387 178.345 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 7.8 mptt -54.48 -39.84 67.9 Favored 'General case' 0 CA--C 1.534 0.334 0 O-C-N 121.877 -0.514 . . . . 4.6500000000000004 112.153 -177.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.456 ' HB3' HG22 ' A' ' 24' ' ' ILE . 44.2 mt -70.63 -17.08 62.88 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.232 1.013 . . . . 0.78000000000000003 112.114 178.1 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 94.46 33.84 6.62 Favored Glycine 0 CA--C 1.524 0.641 0 C-N-CA 124.303 0.954 . . . . 0.44 111.617 173.378 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.48 ' CD1' HG21 ' A' ' 24' ' ' ILE . 1.4 m-85 -124.19 169.94 11.23 Favored 'General case' 0 N--CA 1.457 -0.123 0 C-N-CA 124.793 1.237 . . . . 1.8799999999999999 109.277 177.449 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -135.16 120.33 18.86 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 107.794 -1.187 . . . . 1.77 107.794 172.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 7.6 p -89.55 145.1 7.81 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 N-CA-C 107.597 -1.261 . . . . 1.54 107.597 172.168 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 48.8 t -121.21 141.16 42.89 Favored 'Isoleucine or valine' 0 C--O 1.232 0.136 0 C-N-CA 123.884 0.874 . . . . 0.68999999999999995 108.93 178.042 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 29.8 mm -110.78 76.99 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 C-N-CA 124.684 1.194 . . . . 1.0600000000000001 109.479 -168.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -72.25 -3.65 24.87 Favored 'General case' 0 N--CA 1.447 -0.575 0 N-CA-C 114.49 1.292 . . . . 3.4100000000000001 114.49 178.351 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 65.99 83.79 0.1 OUTLIER Glycine 0 CA--C 1.529 0.928 0 N-CA-C 109.606 -1.398 . . . . 2.7799999999999998 109.606 -175.34 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 33.2 tpt85 . . . . . 0 C--O 1.253 1.248 0 CA-C-O 115.855 -2.021 . . . . 13.699999999999999 111.737 -173.803 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 37.8 mtt . . . . . 0 N--CA 1.473 0.696 0 N-CA-C 107.625 -1.25 . . . . 9.9399999999999995 107.625 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -156.79 165.88 34.97 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 108.862 -0.792 . . . . 5.9800000000000004 108.862 179.537 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 5.5 m -121.13 103.04 8.71 Favored 'General case' 0 N--CA 1.455 -0.181 0 N-CA-C 106.708 -1.59 . . . . 0.79000000000000004 106.708 166.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -63.55 169.4 3.9 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 107.998 -1.112 . . . . 2.8900000000000001 107.998 161.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -129.28 153.71 47.55 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 108.657 -0.868 . . . . 1.5900000000000001 108.657 171.531 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -139.76 153.26 47.12 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 123.423 0.689 . . . . 3.1400000000000001 110.048 168.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -107.69 90.87 3.43 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 127.633 2.373 . . . . 1.6299999999999999 107.731 -176.4 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 3.4 mm -83.65 159.45 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.179 0 N-CA-C 106.787 -1.56 . . . . 1.98 106.787 -178.603 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -134.14 131.72 39.01 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 124.641 1.176 . . . . 0.46999999999999997 108.385 178.441 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 3.7 mpp? -137.47 167.3 21.92 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.377 0.671 . . . . 2.0299999999999998 110.008 174.45 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 21.4 mm100 -88.01 160.16 17.98 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.14 0.976 . . . . 2.5800000000000001 109.452 174.652 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 81.4 t -115.01 144.2 23.08 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 C-N-CA 124.053 0.941 . . . . 1.49 109.971 -179.291 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 9.1 m -147.21 175.15 10.97 Favored 'General case' 0 C--N 1.341 0.228 0 C-N-CA 125.523 1.529 . . . . 1.3 108.604 171.409 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 55.68 52.47 48.13 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 110.788 -0.925 . . . . 1.8700000000000001 110.788 175.695 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -125.51 149.5 48.24 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 124.559 1.144 . . . . 2.6600000000000001 109.424 -170.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -87.85 -58.54 2.53 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 124.039 0.936 . . . . 3.5699999999999998 109.966 170.379 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 17.7 p -154.68 170.55 21.28 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-O 121.777 0.798 . . . . 2.5800000000000001 111.279 175.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.35 -34.4 68.77 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 124.409 1.084 . . . . 2.4100000000000001 111.893 178.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.76 -49.82 73.5 Favored 'General case' 0 N--CA 1.453 -0.292 0 O-C-N 121.992 -0.443 . . . . 0.76000000000000001 109.898 178.587 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 77.5 m -61.49 -38.92 89.04 Favored 'General case' 0 N--CA 1.456 -0.153 0 O-C-N 121.619 -0.675 . . . . 1.3 110.422 174.64 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.565 ' HB1' HG21 ' A' ' 39' ' ' VAL . . . -56.83 -23.13 41.7 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 112.105 0.409 . . . . 0.42999999999999999 112.105 173.685 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.07 -47.63 61.14 Favored 'General case' 0 N--CA 1.456 -0.165 0 O-C-N 120.039 -1.663 . . . . 0.39000000000000001 110.116 169.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 2.0 mtp85 -51.45 -43.59 62.13 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 122.92 0.488 . . . . 3.6699999999999999 110.039 -175.402 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.517 HG21 ' CD1' ' A' ' 69' ' ' TYR 0.287 1.9 pt -60.88 -60.35 2.79 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.274 0 CA-C-O 118.371 -0.823 . . . . 0.52000000000000002 111.196 178.74 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -54.91 -40.54 69.95 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 119.964 1.256 . . . . 2.2799999999999998 112.002 -179.45 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 14.7 mptt -68.07 -50.2 56.6 Favored 'General case' 0 CA--C 1.537 0.453 0 O-C-N 121.353 -0.842 . . . . 1.8799999999999999 110.38 -179.08 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -67.39 -23.18 73.4 Favored Glycine 0 CA--C 1.53 1.022 0 O-C-N 121.489 -0.757 . . . . 0.69999999999999996 112.265 177.241 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -71.01 -47.75 57.03 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 125.375 1.47 . . . . 2.3199999999999998 108.652 173.106 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 19.9 ttmt -46.5 -39.54 10.96 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 118.959 0.8 . . . . 3.3599999999999999 111.397 178.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.6 mtt180 -67.14 -5.93 15.54 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 114.691 1.367 . . . . 3.5899999999999999 114.691 -177.687 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.67 162.32 73.74 Favored Pre-proline 0 CA--C 1.541 0.626 0 CA-C-N 119.367 0.985 . . . . 4.2199999999999998 111.055 179.304 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -73.68 117.34 5.01 Favored 'Trans proline' 0 N--CA 1.453 -0.898 0 C-N-CA 121.507 1.471 . . . . 1.0 109.191 172.392 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 116.47 -19.39 12.91 Favored Glycine 0 CA--C 1.527 0.794 0 C-N-CA 123.895 0.76 . . . . 0.83999999999999997 113.789 169.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.509 HG22 ' HB3' ' A' ' 50' ' ' TYR . 86.6 t -89.97 145.96 6.77 Favored 'Isoleucine or valine' 0 C--N 1.339 0.143 0 CA-C-N 118.685 1.243 . . . . 0.68999999999999995 108.539 167.386 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.2 m -118.38 -36.63 3.49 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 118.441 -0.79 . . . . 1.0600000000000001 111.256 177.295 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -138.83 164.22 30.21 Favored 'General case' 0 C--N 1.343 0.307 0 CA-C-N 119.955 1.252 . . . . 2.0899999999999999 111.728 168.015 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -159.27 144.98 16.17 Favored 'General case' 0 C--N 1.332 -0.171 0 C-N-CA 123.104 0.562 . . . . 0.42999999999999999 111.868 -178.264 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -155.49 110.19 2.94 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 107.608 -1.256 . . . . 0.47999999999999998 107.608 -165.529 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.565 HG21 ' HB1' ' A' ' 21' ' ' ALA . 7.1 p -82.61 103.97 10.59 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 CA-C-O 121.336 0.588 . . . . 0.59999999999999998 110.79 178.722 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 51.6 t-20 -84.34 57.67 4.39 Favored 'General case' 0 CA--C 1.537 0.451 0 O-C-N 120.336 -1.477 . . . . 0.64000000000000001 110.173 179.73 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.426 HD23 ' CG2' ' A' ' 39' ' ' VAL . 0.2 OUTLIER -69.08 -19.05 64.06 Favored 'General case' 0 N--CA 1.461 0.119 0 CA-C-N 115.593 -0.731 . . . . 0.87 111.24 -176.506 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -44.09 -33.4 1.47 Allowed 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 123.816 0.846 . . . . 0.55000000000000004 111.872 166.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 6.6 t -129.62 42.08 3.34 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 121.392 0.615 . . . . 1.29 109.866 173.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 39.12 40.97 0.54 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 126.614 1.966 . . . . 2.5499999999999998 114.01 -178.28 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 83.8 m -120.34 157.23 29.68 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 124.55 1.14 . . . . 0.65000000000000002 108.568 -178.297 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 1.6 p -125.87 140.26 49.06 Favored 'Isoleucine or valine' 0 C--O 1.232 0.151 0 N-CA-C 108.278 -1.008 . . . . 0.53000000000000003 108.278 172.527 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -126.69 137.26 53.25 Favored 'General case' 0 C--N 1.344 0.365 0 N-CA-C 108.26 -1.015 . . . . 0.33000000000000002 108.26 176.306 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 40.7 t -131.31 125.2 56.55 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 N-CA-C 105.426 -2.065 . . . . 2.0499999999999998 105.426 -177.686 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 14.7 mm -100.46 88.24 1.47 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.592 0 N-CA-C 106.829 -1.545 . . . . 0.40000000000000002 106.829 -176.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.509 ' HB3' HG22 ' A' ' 34' ' ' VAL . 13.2 p90 -124.36 167.7 14.02 Favored 'General case' 0 CA--C 1.507 -0.711 0 CA-C-N 115.794 -0.639 . . . . 1.99 111.503 -171.743 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -99.84 107.48 46.61 Favored Pre-proline 0 N--CA 1.445 -0.677 0 CA-C-N 113.879 -1.51 . . . . 4.3799999999999999 108.113 -171.091 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -72.44 6.18 2.42 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 122.698 2.265 . . . . 0.82999999999999996 113.138 -173.109 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -84.28 -25.2 29.5 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 123.478 0.711 . . . . 1.0800000000000001 109.334 168.401 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 -117.54 -53.64 2.41 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.202 1.001 . . . . 3.02 110.977 -169.636 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.258 0.8 OUTLIER -89.72 -175.77 4.76 Favored 'General case' 0 CA--C 1.517 -0.3 0 C-N-CA 123.766 0.826 . . . . 0.51000000000000001 113.177 160.343 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 141.34 87.5 0.11 Allowed Glycine 0 N--CA 1.44 -1.092 0 N-CA-C 104.902 -3.279 . . . . 2.5299999999999998 104.902 -158.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 82.4 p -9.48 -18.52 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.559 1 C-N-CA 138.126 6.571 . . . . 1.01 119.977 -143.238 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -28.18 -65.98 0.08 Allowed 'General case' 0 N--CA 1.44 -0.972 0 C-N-CA 127.6 2.36 . . . . 0.56999999999999995 113.977 169.639 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -76.81 -25.41 53.25 Favored 'General case' 0 C--N 1.334 -0.106 0 C-N-CA 118.105 -1.438 . . . . 0.67000000000000004 110.042 -169.113 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -63.5 -53.79 40.77 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.855 0 CA-C-O 118.58 -0.724 . . . . 0.90000000000000002 109.072 176.554 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.46 -44.44 96.4 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 108.828 -0.805 . . . . 1.6000000000000001 108.828 -175.547 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -48.13 -58.69 4.15 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-O 121.592 0.711 . . . . 3.7999999999999998 111.726 172.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 13.3 mmmt -65.44 -37.99 88.53 Favored 'General case' 0 N--CA 1.44 -0.946 0 O-C-N 121.618 -0.676 . . . . 3.46 111.739 -177.644 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.421 HD12 HG13 ' A' ' 71' ' ' VAL . 2.5 mm -51.79 -51.81 25.75 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 C-N-CA 125.634 1.574 . . . . 0.57999999999999996 108.302 178.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -57.45 -54.49 46.26 Favored 'General case' 0 C--N 1.341 0.218 0 C-N-CA 123.094 0.558 . . . . 2.04 110.243 174.667 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 5.8 mmtt -53.89 -38.44 64.78 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 112.874 0.694 . . . . 4.0199999999999996 112.874 -179.306 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 32.5 mt -70.95 -17.92 62.66 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 125.737 1.615 . . . . 0.79000000000000004 111.632 177.452 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 93.37 35.64 6.19 Favored Glycine 0 CA--C 1.525 0.668 0 C-N-CA 124.658 1.123 . . . . 0.5 111.229 176.119 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.517 ' CD1' HG21 ' A' ' 24' ' ' ILE . 1.0 OUTLIER -131.96 172.15 12.7 Favored 'General case' 0 N--CA 1.457 -0.123 0 C-N-CA 123.818 0.847 . . . . 1.8999999999999999 110.923 -178.319 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 3.7 t-80 -148.85 116.38 6.21 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 109.041 -0.725 . . . . 1.7 109.041 170.446 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.421 HG13 HD12 ' A' ' 64' ' ' ILE . 25.7 m -81.59 166.35 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 N-CA-C 109.072 -0.714 . . . . 2.4700000000000002 109.072 176.235 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 12.1 t -124.51 142.51 41.09 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 C-N-CA 124.173 0.989 . . . . 0.78000000000000003 108.458 178.603 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 17.9 mm -112.52 72.73 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 C-N-CA 124.115 0.966 . . . . 1.1200000000000001 109.061 -174.084 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -72.93 -9.99 59.31 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 114.043 1.127 . . . . 3.1499999999999999 114.043 176.67 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -122.98 62.42 0.55 Allowed Glycine 0 CA--C 1.523 0.542 0 N-CA-C 108.4 -1.88 . . . . 3.2599999999999998 108.4 174.215 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.177 0 CA-C-O 116.761 -1.59 . . . . 12.359999999999999 111.125 179.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.9 mmt . . . . . 0 N--CA 1.472 0.66 0 N-CA-C 108.492 -0.929 . . . . 9.5700000000000003 108.492 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 63.0 tp -137.15 124.93 22.47 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 105.538 -2.023 . . . . 6.8399999999999999 105.538 173.714 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 39.2 m -131.4 116.54 17.67 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 103.908 -2.627 . . . . 1.27 103.908 170.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -80.07 -179.7 7.17 Favored 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 125.113 1.365 . . . . 3.0499999999999998 108.025 177.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.2 mm100 -138.78 136.52 35.77 Favored 'General case' 0 CA--C 1.514 -0.438 0 O-C-N 120.843 -1.161 . . . . 1.3200000000000001 108.275 171.548 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.8 mtpt -133.98 151.79 51.6 Favored 'General case' 0 N--CA 1.455 -0.222 0 O-C-N 124.089 0.868 . . . . 2.9199999999999999 109.958 167.658 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -101.9 93.5 5.32 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 127.968 2.507 . . . . 1.4299999999999999 107.457 -176.059 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 2.5 mm -84.01 159.91 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.248 0 N-CA-C 106.669 -1.604 . . . . 2.0600000000000001 106.669 -178.029 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -133.78 130.9 38.67 Favored 'General case' 0 N--CA 1.456 -0.136 0 N-CA-C 108.073 -1.084 . . . . 0.45000000000000001 108.073 176.153 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 4.0 mpp? -139.15 172.1 13.32 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.256 1.022 . . . . 1.8899999999999999 110.19 176.609 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.36 162.46 12.94 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 126.188 1.795 . . . . 3.5 109.468 173.368 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.1 m -118.76 151.5 20.95 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 C-N-CA 123.659 0.784 . . . . 1.8100000000000001 111.35 174.406 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 48.4 m -142.44 165.4 27.51 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 125.495 1.518 . . . . 1.03 109.411 176.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 63.58 67.06 2.21 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 110.686 -0.966 . . . . 2.1000000000000001 110.686 177.645 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -139.72 157.69 45.35 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 123.928 0.891 . . . . 3.5800000000000001 110.753 -175.432 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -76.83 -70.15 0.48 Allowed 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 108.178 -1.045 . . . . 3.1400000000000001 108.178 157.12 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 25.8 p -158.41 -178.91 7.62 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 121.732 0.777 . . . . 2.6099999999999999 112.05 -166.357 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.65 175.6 0.45 Allowed 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 124.793 1.237 . . . . 3.25 110.086 170.455 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.409 ' O ' ' HB3' ' A' ' 22' ' ' ALA . . . 72.03 -56.21 0.65 Allowed 'General case' 0 CA--C 1.528 0.123 0 C-N-CA 124.875 1.27 . . . . 1.0700000000000001 110.196 -174.179 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 28.3 m -57.57 -46.27 84.18 Favored 'General case' 0 C--N 1.33 -0.259 0 O-C-N 121.442 -0.786 . . . . 1.45 109.361 171.328 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -52.01 -23.76 5.63 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.107 0.963 . . . . 0.42999999999999999 112.965 172.227 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.409 ' HB3' ' O ' ' A' ' 19' ' ' ALA . . . -72.22 -49.49 34.79 Favored 'General case' 0 N--CA 1.454 -0.258 0 O-C-N 120.87 -1.144 . . . . 0.34000000000000002 110.607 171.803 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 8.1 mmm180 -56.11 -42.74 77.32 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 109.791 -0.448 . . . . 4.7699999999999996 109.791 -171.588 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.501 ' HA ' HD13 ' A' ' 67' ' ' LEU . 4.1 pt -56.62 -55.99 16.46 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 O-C-N 123.382 0.426 . . . . 0.46999999999999997 110.676 176.351 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -55.45 -43.15 75.18 Favored 'General case' 0 C--O 1.226 -0.163 0 C-N-CA 123.825 0.85 . . . . 3.54 111.75 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 4.0 mptp? -72.0 -42.82 65.97 Favored 'General case' 0 CA--C 1.535 0.366 0 O-C-N 121.168 -0.957 . . . . 1.8999999999999999 110.537 -174.537 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.93 -39.16 97.7 Favored Glycine 0 CA--C 1.53 0.991 0 N-CA-C 110.525 -1.03 . . . . 0.66000000000000003 110.525 170.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 6.8 tt -60.51 -36.31 78.05 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.23 1.012 . . . . 1.95 109.703 175.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.5 ttpm? -61.95 -24.02 66.73 Favored 'General case' 0 CA--C 1.53 0.187 0 O-C-N 120.565 -1.335 . . . . 3.1099999999999999 112.841 172.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 11.3 mmt180 -77.85 -3.81 43.44 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 119.043 0.838 . . . . 3.5299999999999998 111.524 -179.069 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 70.3 mmm -83.95 147.84 52.35 Favored Pre-proline 0 CA--C 1.535 0.369 0 CA-C-N 118.918 0.781 . . . . 3.3999999999999999 111.076 -176.632 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -59.25 136.15 70.46 Favored 'Trans proline' 0 N--CA 1.451 -0.986 0 C-N-CA 122.34 2.027 . . . . 0.56999999999999995 108.961 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 94.66 -23.94 30.24 Favored Glycine 0 CA--C 1.528 0.848 0 CA-C-O 118.919 -0.934 . . . . 0.5 113.084 -178.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 17.0 t -92.35 130.28 41.69 Favored 'Isoleucine or valine' 0 C--N 1.34 0.161 0 CA-C-N 118.6 1.2 . . . . 0.57999999999999996 109.966 -177.139 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 9.3 m -112.13 -39.51 4.45 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 123.823 0.849 . . . . 1.2 111.142 -171.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -145.27 157.21 44.11 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 118.867 0.758 . . . . 2.7999999999999998 109.738 175.038 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -152.0 126.7 9.54 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 123.765 0.826 . . . . 0.75 110.375 -170.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -142.36 107.85 5.06 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 125.723 1.609 . . . . 0.70999999999999996 108.772 -164.45 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.412 HG23 HD23 ' A' ' 41' ' ' LEU . 3.1 p -82.31 88.09 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 N-CA-C 108.734 -0.839 . . . . 1.4099999999999999 108.734 178.41 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 48.9 t-20 -83.31 56.65 3.63 Favored 'General case' 0 CA--C 1.537 0.462 0 O-C-N 120.6 -1.312 . . . . 0.71999999999999997 110.108 -177.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.412 HD23 HG23 ' A' ' 39' ' ' VAL . 0.5 OUTLIER -68.27 -20.74 64.81 Favored 'General case' 0 C--O 1.223 -0.332 0 C-N-CA 124.398 1.079 . . . . 1.0 110.541 -179.792 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -45.7 -30.12 1.48 Allowed 'General case' 0 CA--C 1.529 0.154 0 N-CA-C 112.811 0.671 . . . . 0.93000000000000005 112.811 168.363 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 5.7 t -131.66 32.25 4.16 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 118.019 0.372 . . . . 1.29 110.476 173.087 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 9.1 mp0 50.02 52.79 13.99 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.302 1.041 . . . . 4.1200000000000001 112.591 179.569 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.3 m -137.69 160.43 39.24 Favored 'General case' 0 N--CA 1.443 -0.797 0 O-C-N 121.286 -0.884 . . . . 0.94999999999999996 109.144 176.295 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.5 p -129.91 136.64 58.49 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 N-CA-C 107.044 -1.465 . . . . 0.38 107.044 169.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -125.07 129.51 50.4 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 107.559 -1.275 . . . . 0.55000000000000004 107.559 -178.665 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 3.7 p -132.97 131.14 58.95 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.828 0 N-CA-C 105.1 -2.185 . . . . 1.78 105.1 -176.486 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 2.1 mp -104.2 111.2 32.87 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.762 0 N-CA-C 106.097 -1.816 . . . . 1.72 106.097 178.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 21.4 p90 -143.15 167.58 21.78 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 116.039 -0.528 . . . . 1.6399999999999999 109.914 -178.047 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -87.78 121.82 70.63 Favored Pre-proline 0 CA--C 1.54 0.58 0 O-C-N 125.047 1.467 . . . . 3.3900000000000001 111.506 171.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_endo -80.76 12.12 2.72 Favored 'Trans proline' 0 CA--C 1.537 0.672 0 C-N-CA 123.536 2.824 . . . . 0.93000000000000005 114.181 -176.565 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -98.0 -36.23 10.19 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 119.573 1.079 . . . . 1.3700000000000001 109.578 167.539 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -90.81 -57.22 2.89 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 106.966 -1.494 . . . . 3.23 106.966 -175.09 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.317 6.0 p -95.92 -160.32 0.78 Allowed 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 109.439 -0.578 . . . . 0.64000000000000001 109.439 162.027 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 116.57 92.31 1.7 Allowed Glycine 0 CA--C 1.528 0.856 0 N-CA-C 106.274 -2.731 . . . . 2.29 106.274 -146.593 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 80.9 p -12.73 -19.16 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.435 1 C-N-CA 138.007 6.523 . . . . 1.1000000000000001 119.849 -143.792 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -26.46 -63.39 0.08 Allowed 'General case' 0 N--CA 1.443 -0.787 0 C-N-CA 127.212 2.205 . . . . 0.69999999999999996 113.647 170.671 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -75.31 -42.63 54.18 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 118.212 -1.395 . . . . 0.69999999999999996 109.629 -166.116 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -50.29 -53.95 10.22 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.962 0 CA-C-N 113.965 -1.471 . . . . 0.78000000000000003 110.278 173.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -68.17 -46.08 71.72 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 109.591 -0.522 . . . . 1.9299999999999999 109.591 -173.696 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -45.93 -56.93 4.83 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 122.319 1.056 . . . . 3.4100000000000001 111.344 171.485 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.0 mmpt? -71.52 -38.62 71.08 Favored 'General case' 0 N--CA 1.432 -1.343 0 CA-C-O 118.624 -0.703 . . . . 2.46 112.438 -175.063 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -48.69 -52.82 8.27 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 N-CA-C 106.968 -1.493 . . . . 0.52000000000000002 106.968 175.494 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 37.9 mm-40 -58.82 -58.48 8.44 Favored 'General case' 0 C--N 1.343 0.32 0 C-N-CA 124.392 1.077 . . . . 2.5 110.413 177.449 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 9.4 mmtm -57.71 -32.66 67.61 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 113.457 0.91 . . . . 3.98 113.457 -176.416 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.501 HD13 ' HA ' ' A' ' 24' ' ' ILE . 11.4 mt -70.23 -18.19 63.15 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.609 1.163 . . . . 0.79000000000000004 111.701 174.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 90.58 44.65 4.52 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 110.483 -1.047 . . . . 0.48999999999999999 110.483 179.068 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -137.27 174.96 10.05 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 124.674 1.19 . . . . 2.0 108.549 177.26 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 32.1 t60 -137.54 156.36 48.2 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 109.425 -0.583 . . . . 1.8 109.425 167.137 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 12.8 p -128.09 137.79 56.51 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.113 0 C-N-CA 125.038 1.335 . . . . 1.54 108.03 -177.091 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 13.0 t -110.74 136.14 47.7 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 C-N-CA 124.622 1.169 . . . . 0.68000000000000005 108.75 -178.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 27.8 mm -100.68 75.32 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 C-N-CA 124.463 1.105 . . . . 1.0600000000000001 108.945 -172.24 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -68.09 -7.61 31.07 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 114.616 1.339 . . . . 3.54 114.616 178.598 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 77.81 64.47 2.04 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 109.991 -1.244 . . . . 3.0699999999999998 109.991 -177.64 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 71.7 ttt180 . . . . . 0 C--O 1.25 1.118 0 C-N-CA 125.685 1.594 . . . . 14.140000000000001 111.596 -172.509 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 38.5 mtt . . . . . 0 N--CA 1.472 0.65 0 N-CA-C 107.097 -1.446 . . . . 12.16 107.097 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -145.09 114.37 7.06 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 104.344 -2.465 . . . . 7.6799999999999997 104.344 -174.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -148.28 105.34 3.61 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 106.366 -1.716 . . . . 1.03 106.366 169.727 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -79.97 -175.43 4.96 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 108.577 -0.897 . . . . 2.3199999999999998 108.577 173.33 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.4 mm100 -136.53 144.84 44.47 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 107.979 -1.119 . . . . 1.26 107.979 170.566 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 51.7 mttt -143.91 162.18 36.79 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 123.602 0.761 . . . . 2.8199999999999998 110.706 163.225 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -110.77 87.77 2.61 Favored 'General case' 0 N--CA 1.439 -0.98 0 C-N-CA 129.216 3.006 . . . . 1.6899999999999999 105.447 -173.316 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.502 ' N ' HD12 ' A' ' 8' ' ' ILE . 3.4 mp -83.71 162.03 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 N-CA-C 105.771 -1.937 . . . . 2.46 105.771 -179.747 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -133.72 142.1 47.83 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 125.281 1.432 . . . . 0.77000000000000002 107.362 179.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -155.73 175.59 13.73 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 109.125 -0.695 . . . . 2.4500000000000002 109.125 172.082 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 30.0 mm100 -98.55 152.36 19.65 Favored 'General case' 0 C--O 1.223 -0.307 0 C-N-CA 125.477 1.511 . . . . 2.77 108.396 -177.371 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.8 p -111.32 156.43 12.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 CA-C-N 119.166 0.894 . . . . 2.5800000000000001 110.282 -178.72 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 7.6 m -132.92 168.84 17.71 Favored 'General case' 0 C--N 1.339 0.131 0 C-N-CA 124.474 1.11 . . . . 1.22 109.791 171.733 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 58.59 52.44 52.96 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 110.8 -0.92 . . . . 1.5800000000000001 110.8 -179.732 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -131.44 162.36 30.36 Favored 'General case' 0 CA--C 1.521 -0.158 0 C-N-CA 124.377 1.071 . . . . 2.3300000000000001 109.881 -176.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -154.57 -58.61 0.11 Allowed 'General case' 0 CA--C 1.528 0.125 0 C-N-CA 125.457 1.503 . . . . 3.6899999999999999 109.572 168.679 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 9.2 p -81.17 133.19 35.41 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 121.476 0.655 . . . . 2.2999999999999998 109.932 175.509 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -75.6 55.16 0.82 Allowed 'General case' 0 CA--C 1.535 0.391 0 O-C-N 121.626 -0.671 . . . . 1.99 109.473 170.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -152.07 -57.15 0.14 Allowed 'General case' 0 N--CA 1.457 -0.076 0 C-N-CA 124.071 0.948 . . . . 0.91000000000000003 110.457 -169.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 67.9 m -60.61 -42.46 96.85 Favored 'General case' 0 C--N 1.333 -0.141 0 O-C-N 121.237 -0.915 . . . . 1.3700000000000001 109.605 169.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.64 -19.86 6.94 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 113.009 0.744 . . . . 0.63 113.009 170.243 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -73.01 -50.24 24.24 Favored 'General case' 0 N--CA 1.454 -0.228 0 O-C-N 120.299 -1.501 . . . . 0.46999999999999997 110.687 169.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 3.7 mpt_? -49.78 -45.16 49.44 Favored 'General case' 0 CA--C 1.52 -0.198 0 C-N-CA 122.384 0.274 . . . . 4.1799999999999997 110.276 -174.441 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.515 ' HA ' HD13 ' A' ' 67' ' ' LEU . 3.8 pt -57.15 -54.4 30.81 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 O-C-N 123.337 0.398 . . . . 0.5 110.678 -176.677 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -58.01 -43.79 86.91 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 124.033 0.933 . . . . 2.3399999999999999 112.027 176.077 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -66.9 -47.02 73.08 Favored 'General case' 0 CA--C 1.534 0.331 0 O-C-N 121.701 -0.624 . . . . 1.8600000000000001 110.206 -175.444 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.35 -40.47 99.08 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 110.227 -1.149 . . . . 0.62 110.227 173.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -62.29 -37.83 87.03 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 122.115 -0.638 . . . . 2.1800000000000002 109.823 179.264 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.8 ttpm? -52.28 -18.99 1.79 Allowed 'General case' 0 CA--C 1.532 0.286 0 O-C-N 121.201 -0.937 . . . . 3.21 113.358 173.274 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 2.9 mtt180 -88.41 -0.54 57.3 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 119.051 0.841 . . . . 4.3600000000000003 112.277 -179.201 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . 0.617 ' SD ' ' HB1' ' A' ' 59' ' ' ALA . 0.5 OUTLIER -77.97 158.56 77.46 Favored Pre-proline 0 CA--C 1.531 0.215 0 CA-C-N 119.366 0.984 . . . . 3.6099999999999999 111.923 172.537 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -56.87 145.58 83.34 Favored 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 122.494 2.129 . . . . 0.78000000000000003 110.476 170.487 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 82.85 -28.89 3.47 Favored Glycine 0 CA--C 1.53 0.992 0 CA-C-O 119.443 -0.643 . . . . 0.59999999999999998 113.142 176.079 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 16.0 t -84.87 133.65 28.82 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 CA-C-N 118.953 1.377 . . . . 0.56000000000000005 109.655 177.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -115.54 -41.19 3.28 Favored 'General case' 0 N--CA 1.457 -0.106 0 C-N-CA 123.746 0.819 . . . . 0.87 110.184 -175.71 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -143.45 163.16 33.89 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 118.844 0.747 . . . . 2.1200000000000001 109.214 176.026 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -156.14 143.69 19.35 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 122.43 0.292 . . . . 0.47999999999999998 111.76 178.685 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -151.59 101.92 2.83 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 106.245 -1.761 . . . . 0.46999999999999997 106.245 -166.762 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.0 p -81.21 142.83 13.28 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 N-CA-C 108.028 -1.101 . . . . 0.79000000000000004 108.028 176.518 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 53.4 t-20 -136.63 64.07 1.56 Allowed 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 122.705 1.241 . . . . 0.91000000000000003 110.115 -171.196 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.497 HD22 ' H ' ' A' ' 41' ' ' LEU . 1.8 mm? -70.79 -20.05 62.63 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 115.048 -0.978 . . . . 2.8100000000000001 111.253 -173.573 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -46.65 -38.14 9.29 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 124.184 0.993 . . . . 0.83999999999999997 112.202 172.17 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 9.0 t -119.4 29.33 7.69 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.012 0.525 . . . . 1.29 110.371 174.21 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 43.79 59.93 2.9 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 126.049 1.74 . . . . 2.7400000000000002 112.023 -177.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 90.0 m -146.31 164.02 33.69 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 108.697 -0.853 . . . . 0.70999999999999996 108.697 178.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -138.65 143.52 32.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 108.334 -0.988 . . . . 0.46999999999999997 108.334 176.03 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -126.95 137.49 53.13 Favored 'General case' 0 C--N 1.344 0.343 0 N-CA-C 107.787 -1.19 . . . . 0.38 107.787 178.422 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 31.2 t -130.12 130.18 65.75 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 N-CA-C 105.13 -2.174 . . . . 2.27 105.13 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 13.0 mm -101.3 99.15 7.83 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.578 0 N-CA-C 106.959 -1.497 . . . . 0.56000000000000005 106.959 -177.33 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.435 ' CE2' HD13 ' A' ' 8' ' ' ILE . 54.5 p90 -141.42 168.91 18.65 Favored 'General case' 0 CA--C 1.51 -0.591 0 O-C-N 122.055 -0.403 . . . . 2.52 110.245 -171.311 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 42.0 t0 -86.52 107.87 15.5 Favored Pre-proline 0 C--N 1.327 -0.389 0 O-C-N 124.482 1.114 . . . . 3.1299999999999999 109.639 174.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -73.48 4.24 4.12 Favored 'Trans proline' 0 N--CA 1.451 -1.013 0 C-N-CA 122.222 1.948 . . . . 1.1100000000000001 112.68 -179.093 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -82.35 -36.03 27.24 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 119.622 1.101 . . . . 1.3899999999999999 108.508 166.101 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -103.41 -60.47 1.56 Allowed 'General case' 0 N--CA 1.453 -0.315 0 O-C-N 123.724 0.64 . . . . 4.04 109.694 -167.099 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.48 HG22 ' HB3' ' A' ' 59' ' ' ALA 0.459 0.5 OUTLIER -81.54 -172.64 3.95 Favored 'General case' 0 CA--C 1.521 -0.149 0 N-CA-C 113.729 1.011 . . . . 0.72999999999999998 113.729 156.512 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 159.66 -148.6 17.47 Favored Glycine 0 N--CA 1.434 -1.473 1 N-CA-C 102.492 -4.243 . . . . 2.9300000000000002 102.492 -157.246 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 33.2 p -78.34 -37.6 44.12 Favored 'General case' 0 N--CA 1.444 -0.772 0 C-N-CA 124.772 1.229 . . . . 1.1799999999999999 110.104 178.327 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -49.13 -62.54 1.48 Allowed 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.715 1.206 . . . . 0.54000000000000004 113.403 -163.584 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.617 ' HB1' ' SD ' ' A' ' 31' ' ' MET . . . -71.68 -32.25 67.64 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.198 -1.365 . . . . 0.46999999999999997 108.973 -169.236 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.7 mp -60.04 -55.36 24.63 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.795 0 CA-C-N 114.937 -1.029 . . . . 1.1399999999999999 109.876 175.253 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.91 -45.82 89.41 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 119.167 0.894 . . . . 1.3300000000000001 110.1 -178.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -48.76 -56.57 8.25 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 121.449 0.642 . . . . 3.3900000000000001 111.691 174.146 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 3.5 mmmt -64.92 -42.99 94.24 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-O 118.923 -0.561 . . . . 3.3999999999999999 112.043 -178.464 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.4 mm -50.39 -52.74 14.46 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.707 0 C-N-CA 125.71 1.604 . . . . 0.56000000000000005 107.804 -179.622 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -56.27 -56.56 19.5 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 123.769 0.828 . . . . 2.3500000000000001 110.661 175.178 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 12.7 mptt -58.76 -34.66 71.67 Favored 'General case' 0 CA--C 1.536 0.436 0 O-C-N 121.716 -0.615 . . . . 4.7999999999999998 112.435 -175.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.515 HD13 ' HA ' ' A' ' 24' ' ' ILE . 11.8 mt -70.5 -16.63 62.92 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.646 1.178 . . . . 0.69999999999999996 111.965 175.678 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 86.0 42.13 6.84 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 110.288 -1.125 . . . . 0.60999999999999999 110.288 179.178 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -134.95 175.98 9.08 Favored 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 124.315 1.046 . . . . 1.99 109.458 -179.562 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -144.46 157.11 44.4 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 109.2 -0.667 . . . . 2.1099999999999999 109.2 170.662 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 8.0 p -138.33 137.42 43.89 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.19 0 N-CA-C 107.757 -1.201 . . . . 1.52 107.757 -173.732 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 29.6 t -103.53 137.51 31.71 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 C-N-CA 125.364 1.466 . . . . 0.56999999999999995 109.002 -175.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 48.4 mm -105.98 80.23 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 C-N-CA 124.728 1.211 . . . . 1.1200000000000001 107.979 -176.386 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 -76.46 -0.16 21.94 Favored 'General case' 0 N--CA 1.443 -0.779 0 C-N-CA 123.799 0.84 . . . . 2.73 113.241 169.498 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -93.59 -22.29 26.8 Favored Glycine 0 CA--C 1.525 0.672 0 C-N-CA 125.222 1.392 . . . . 3.6000000000000001 114.517 -171.182 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.025 0 CA-C-O 116.452 -1.737 . . . . 10.94 110.219 -169.014 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 mpt? . . . . . 0 N--CA 1.472 0.663 0 N-CA-C 108.032 -1.099 . . . . 9.5099999999999998 108.032 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 19.7 mt -84.35 155.84 22.15 Favored 'General case' 0 C--N 1.332 -0.169 0 O-C-N 123.993 0.808 . . . . 4.5099999999999998 109.45 175.135 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.0 m -67.02 107.86 2.41 Favored 'General case' 0 N--CA 1.447 -0.624 0 C-N-CA 124.369 1.067 . . . . 0.67000000000000004 108.713 171.013 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -70.16 168.95 14.58 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 108.241 -1.022 . . . . 2.02 108.241 162.591 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -129.09 153.56 47.53 Favored 'General case' 0 N--CA 1.457 -0.12 0 C-N-CA 124.548 1.139 . . . . 1.1399999999999999 109.99 178.281 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 85.5 mttt -146.07 162.7 37.33 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 124.28 1.032 . . . . 3.6000000000000001 109.992 168.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 8.9 mp0 -121.18 87.93 2.85 Favored 'General case' 0 N--CA 1.441 -0.89 0 C-N-CA 127.979 2.512 . . . . 1.6200000000000001 106.122 -168.366 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.47 ' N ' HD12 ' A' ' 8' ' ' ILE . 2.6 mp -83.06 161.66 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.369 0 N-CA-C 105.887 -1.894 . . . . 2.0699999999999998 105.887 -177.102 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -128.31 135.21 49.3 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 125.944 1.698 . . . . 0.64000000000000001 106.595 178.283 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 43.1 mtt -140.89 171.98 13.33 Favored 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 109.498 -0.556 . . . . 2.3300000000000001 109.498 174.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 21.8 mm100 -96.96 139.33 33.14 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 125.701 1.601 . . . . 2.4900000000000002 108.624 176.621 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 81.0 t -92.66 153.91 3.25 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 N-CA-C 108.893 -0.78 . . . . 1.3 108.893 175.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 62.9 m -150.77 165.48 33.39 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.074 0.949 . . . . 1.2 109.264 173.177 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 60.32 61.84 6.67 Favored Glycine 0 CA--C 1.528 0.874 0 N-CA-C 110.745 -0.942 . . . . 1.5700000000000001 110.745 -178.697 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -135.58 156.38 48.96 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 123.834 0.854 . . . . 1.75 110.153 -174.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -105.34 -55.81 2.27 Favored 'General case' 0 CA--C 1.528 0.118 0 C-N-CA 125.199 1.4 . . . . 2.3599999999999999 109.764 168.051 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 16.9 p -139.67 159.48 42.07 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 121.914 0.864 . . . . 2.3199999999999998 111.93 -172.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -75.87 39.88 0.18 Allowed 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.963 1.305 . . . . 2.0099999999999998 111.899 179.43 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -128.67 -53.68 1.24 Allowed 'General case' 0 CA--C 1.524 -0.058 0 C-N-CA 124.599 1.159 . . . . 0.78000000000000003 108.612 178.647 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 21.0 m -58.72 -38.15 77.72 Favored 'General case' 0 CA--C 1.532 0.274 0 O-C-N 121.556 -0.715 . . . . 1.2 109.714 170.726 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.656 ' HB1' HG21 ' A' ' 39' ' ' VAL . . . -54.65 -26.69 34.74 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 116.06 -0.518 . . . . 0.40999999999999998 112.082 172.551 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.92 -48.95 41.81 Favored 'General case' 0 N--CA 1.455 -0.177 0 O-C-N 120.08 -1.637 . . . . 0.34000000000000002 109.629 172.368 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 26.9 mmm180 -50.17 -46.02 53.85 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 123.022 0.529 . . . . 5.0800000000000001 110.543 -175.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.434 HG21 ' CD1' ' A' ' 69' ' ' TYR . 3.5 pt -59.0 -53.35 49.1 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 C-N-CA 120.245 -0.582 . . . . 0.46000000000000002 111.066 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -54.42 -44.93 72.83 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 123.296 0.638 . . . . 2.2999999999999998 111.687 177.16 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 32.1 mmtp -70.55 -44.0 68.35 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 118.839 0.745 . . . . 2.1299999999999999 110.657 -175.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -58.95 -39.55 94.26 Favored Glycine 0 CA--C 1.528 0.903 0 N-CA-C 110.488 -1.045 . . . . 0.5 110.488 172.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -66.21 -42.8 88.25 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 109.056 -0.72 . . . . 2.3599999999999999 109.056 179.365 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.6 ttpp -56.96 -14.99 4.06 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.719 1.608 . . . . 2.8900000000000001 114.128 177.283 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.83 -11.6 56.79 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.93 1.692 . . . . 3.9300000000000002 111.794 176.74 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 93.3 mmm -71.6 154.72 93.08 Favored Pre-proline 0 CA--C 1.53 0.185 0 CA-C-N 119.03 0.832 . . . . 3.25 111.378 179.263 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -56.21 141.86 87.63 Favored 'Trans proline' 0 N--CA 1.451 -1.008 0 C-N-CA 121.47 1.447 . . . . 0.58999999999999997 108.596 163.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 88.42 -12.56 64.54 Favored Glycine 0 N--CA 1.448 -0.559 0 CA-C-O 117.932 -1.482 . . . . 0.88 114.463 173.391 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 40.6 t -109.46 125.41 66.6 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 CA-C-N 119.787 1.793 . . . . 0.55000000000000004 109.061 177.586 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 99.7 m -97.49 -50.66 4.43 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-O 118.205 -0.902 . . . . 1.1599999999999999 110.067 -176.764 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -138.71 159.8 41.22 Favored 'General case' 0 C--N 1.342 0.258 0 CA-C-N 119.337 0.971 . . . . 2.1099999999999999 110.803 176.436 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -156.39 146.39 21.19 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 122.98 0.512 . . . . 0.38 112.066 -178.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -155.94 121.31 4.85 Favored 'General case' 0 C--N 1.342 0.273 0 N-CA-C 109.047 -0.723 . . . . 0.5 109.047 -165.792 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.656 HG21 ' HB1' ' A' ' 21' ' ' ALA . 9.2 p -92.87 102.27 13.46 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 C-N-CA 123.055 0.542 . . . . 0.64000000000000001 110.201 -177.63 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 50.5 t-20 -85.53 57.36 4.42 Favored 'General case' 0 CA--C 1.533 0.323 0 O-C-N 120.518 -1.364 . . . . 0.59999999999999998 109.462 179.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.435 HD22 ' HA ' ' A' ' 41' ' ' LEU . 0.2 OUTLIER -68.31 -19.97 64.71 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 115.495 -0.775 . . . . 1.02 110.468 -175.957 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -47.42 -33.83 6.48 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.771 0.828 . . . . 0.62 112.132 168.726 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 15.3 t -120.54 28.76 7.8 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 118.148 0.431 . . . . 1.24 111.158 174.48 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 46.86 57.11 5.91 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 124.557 1.143 . . . . 2.7999999999999998 112.109 -176.505 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 67.2 m -146.59 157.05 43.65 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 108.159 -1.052 . . . . 0.79000000000000004 108.159 178.442 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.4 p -124.92 144.43 34.95 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 N-CA-C 108.071 -1.085 . . . . 0.31 108.071 172.128 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -125.51 137.52 53.95 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 108.132 -1.062 . . . . 0.32000000000000001 108.132 175.347 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 4.4 p -135.1 123.67 40.55 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 N-CA-C 106.165 -1.791 . . . . 1.8200000000000001 106.165 -176.258 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 12.6 mm -101.58 90.02 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 N-CA-C 106.266 -1.753 . . . . 0.44 106.266 -172.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 24.8 p90 -126.55 168.63 14.02 Favored 'General case' 0 CA--C 1.506 -0.742 0 CA-C-O 120.923 0.392 . . . . 2.0600000000000001 110.149 -169.474 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -98.87 103.31 18.64 Favored Pre-proline 0 N--CA 1.44 -0.941 0 CA-C-N 114.537 -1.211 . . . . 4.3799999999999999 108.157 -176.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -73.67 12.02 0.97 Allowed 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 122.632 2.222 . . . . 0.64000000000000001 113.277 -172.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -83.52 -25.26 31.19 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 109.061 -0.718 . . . . 0.95999999999999996 109.061 165.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -116.77 -58.4 2.08 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 123.81 0.844 . . . . 2.8300000000000001 109.454 -170.187 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.307 6.6 p -88.22 -171.98 3.6 Favored 'General case' 0 C--N 1.344 0.327 0 CA-C-N 118.181 0.446 . . . . 0.70999999999999996 110.304 165.522 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 135.7 87.15 0.23 Allowed Glycine 0 N--CA 1.442 -0.936 0 N-CA-C 105.164 -3.174 . . . . 2.3399999999999999 105.164 -155.151 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 52.2 p -8.22 -17.02 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.378 1 C-N-CA 137.794 6.438 . . . . 1.1399999999999999 120.248 -142.018 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -28.08 -66.34 0.08 Allowed 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 127.226 2.211 . . . . 0.64000000000000001 113.59 166.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.48 -36.39 71.14 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 116.978 -1.889 . . . . 0.67000000000000004 109.415 -166.033 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.5 mp -54.19 -57.39 6.07 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.047 0 CA-C-N 114.325 -1.307 . . . . 0.81999999999999995 109.178 175.501 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.09 -47.13 86.02 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 119.306 0.957 . . . . 1.1899999999999999 110.527 -178.032 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -48.89 -55.8 10.66 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 121.902 0.858 . . . . 4.5800000000000001 111.14 177.059 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -70.42 -37.61 74.44 Favored 'General case' 0 N--CA 1.437 -1.104 0 CA-C-O 118.042 -0.98 . . . . 2.3399999999999999 111.877 -177.71 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.1 mm -49.69 -52.74 11.85 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 N-CA-C 107.525 -1.287 . . . . 0.39000000000000001 107.525 178.464 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -57.53 -58.5 8.04 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 123.939 0.896 . . . . 1.8100000000000001 110.64 175.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -58.97 -32.79 69.98 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 112.955 0.724 . . . . 4.0999999999999996 112.955 -175.217 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 15.1 mt -70.58 -17.96 62.9 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.667 1.187 . . . . 0.57999999999999996 111.663 175.425 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 91.97 42.51 4.68 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.676 -0.97 . . . . 0.41999999999999998 110.676 178.154 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.434 ' CD1' HG21 ' A' ' 24' ' ' ILE . 0.3 OUTLIER -136.91 173.26 11.89 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 124.239 1.015 . . . . 1.8700000000000001 109.881 -179.835 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -137.99 128.33 26.21 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 107.773 -1.195 . . . . 1.79 107.773 172.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 4.2 p -104.19 146.69 11.29 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 N-CA-C 107.35 -1.352 . . . . 1.3899999999999999 107.35 170.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 91.3 t -116.29 146.63 20.46 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 C-N-CA 126.733 2.013 . . . . 0.80000000000000004 107.022 176.279 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 4.9 mp -116.96 79.54 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 C-N-CA 124.221 1.008 . . . . 1.4199999999999999 108.786 -174.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -76.76 0.99 18.54 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 125.911 1.685 . . . . 3.3500000000000001 113.569 173.151 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -138.25 59.8 0.6 Allowed Glycine 0 CA--C 1.522 0.523 0 N-CA-C 108.363 -1.895 . . . . 4.1900000000000004 108.363 177.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 17.9 ttt180 . . . . . 0 C--O 1.25 1.126 0 CA-C-O 117.075 -1.44 . . . . 13.19 110.302 177.063 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.9 ptp . . . . . 0 N--CA 1.471 0.594 0 N-CA-C 106.127 -1.805 . . . . 9.2300000000000004 106.127 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 66.14 148.47 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.56 0 O-C-N 124.439 1.087 . . . . 4.7300000000000004 110.364 -168.344 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 57.9 m -145.18 119.91 9.85 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 106.774 -1.565 . . . . 0.73999999999999999 106.774 -174.229 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -75.95 177.27 7.15 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 109.311 -0.626 . . . . 2.1600000000000001 109.311 171.604 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -138.52 140.75 39.24 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 107.532 -1.284 . . . . 1.02 107.532 174.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -138.39 160.97 38.16 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 124.573 1.149 . . . . 3.6000000000000001 109.74 168.438 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -119.37 95.87 4.97 Favored 'General case' 0 N--CA 1.441 -0.892 0 C-N-CA 128.903 2.881 . . . . 1.45 106.678 -171.734 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 7.0 mm -84.67 161.71 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.128 0 N-CA-C 106.879 -1.526 . . . . 2.1000000000000001 106.879 178.274 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -137.34 133.05 34.45 Favored 'General case' 0 C--O 1.23 0.076 0 C-N-CA 124.782 1.233 . . . . 0.54000000000000004 107.782 -179.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 9.3 ptp -157.65 175.75 13.51 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 118.664 0.665 . . . . 1.97 111.0 -178.238 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 28.7 mm100 -93.71 164.22 13.23 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.443 1.497 . . . . 2.46 110.655 -178.016 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 60.5 t -121.02 158.67 23.47 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 C-N-CA 124.964 1.306 . . . . 1.1699999999999999 109.427 -177.447 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 14.1 m -149.38 166.4 29.16 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 123.918 0.887 . . . . 0.88 110.08 167.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 68.13 47.52 58.67 Favored Glycine 0 CA--C 1.528 0.862 0 N-CA-C 110.522 -1.031 . . . . 1.6599999999999999 110.522 -171.302 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -125.94 156.93 38.98 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 124.643 1.177 . . . . 2.1800000000000002 109.589 -178.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER 179.85 -44.08 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 127.871 2.468 . . . . 3.7799999999999998 110.881 179.43 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 36.6 m -56.89 -22.59 38.43 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.658 0.783 . . . . 3.0699999999999998 112.704 177.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 57.38 33.32 23.12 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.58 1.152 . . . . 2.3900000000000001 111.602 178.008 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -159.3 -45.09 0.05 Allowed 'General case' 0 C--O 1.226 -0.179 0 C-N-CA 124.433 1.093 . . . . 0.78000000000000003 109.736 -175.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 94.4 m -50.31 -38.44 41.57 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.196 0.998 . . . . 1.23 112.278 171.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.404 ' HB1' HG21 ' A' ' 39' ' ' VAL . . . -56.11 -23.53 34.89 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 122.935 0.494 . . . . 0.47999999999999998 112.252 174.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -72.6 -50.1 27.64 Favored 'General case' 0 N--CA 1.457 -0.115 0 O-C-N 120.556 -1.34 . . . . 0.34000000000000002 111.114 167.022 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 6.6 mmp_? -49.33 -46.42 46.79 Favored 'General case' 0 CA--C 1.52 -0.209 0 N-CA-C 109.691 -0.485 . . . . 6.8600000000000003 109.691 179.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.498 HG21 ' CD1' ' A' ' 69' ' ' TYR 0.272 2.0 pt -59.23 -59.34 3.99 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.442 0 C-N-CA 119.337 -0.945 . . . . 0.46999999999999997 111.033 178.505 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -51.59 -41.68 61.37 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 119.526 1.057 . . . . 3.27 112.298 -179.135 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.2 mptp? -71.38 -43.64 66.49 Favored 'General case' 0 CA--C 1.538 0.484 0 O-C-N 121.13 -0.981 . . . . 1.73 110.708 -177.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -65.76 -32.11 81.94 Favored Glycine 0 CA--C 1.534 1.239 0 O-C-N 121.456 -0.778 . . . . 0.59999999999999998 111.65 174.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.0 tt -63.59 -48.29 77.99 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 126.111 1.764 . . . . 1.8999999999999999 107.914 175.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 12.8 ttmt -47.51 -37.34 11.8 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.039 0.536 . . . . 2.8399999999999999 112.435 174.324 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -66.17 -0.28 2.41 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 114.043 1.127 . . . . 3.3799999999999999 114.043 -176.671 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 13.5 ptp -77.29 164.17 60.13 Favored Pre-proline 0 CA--C 1.538 0.49 0 CA-C-N 119.735 1.152 . . . . 4.2199999999999998 111.788 172.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -69.0 137.56 37.98 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 121.543 1.495 . . . . 0.56999999999999995 109.756 168.407 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 99.91 -31.53 8.3 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 123.49 0.567 . . . . 0.5 113.187 172.243 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 47.1 t -82.56 140.33 16.53 Favored 'Isoleucine or valine' 0 C--N 1.341 0.205 0 CA-C-N 118.672 1.236 . . . . 0.56000000000000005 109.289 171.119 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -114.68 -38.05 4.09 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 118.812 -0.613 . . . . 1.0600000000000001 110.652 178.327 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -143.67 163.23 33.85 Favored 'General case' 0 C--N 1.341 0.238 0 CA-C-N 119.566 1.076 . . . . 1.8700000000000001 110.281 175.16 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -159.37 134.85 8.44 Favored 'General case' 0 C--O 1.239 0.516 0 C-N-CA 123.386 0.674 . . . . 0.42999999999999999 112.05 -171.416 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -148.06 111.86 5.09 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 124.213 1.005 . . . . 0.46000000000000002 109.723 -164.795 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.404 HG21 ' HB1' ' A' ' 21' ' ' ALA . 7.1 p -84.2 98.18 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 C-N-CA 123.53 0.732 . . . . 0.56999999999999995 110.403 179.796 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 49.6 t-20 -84.21 56.59 3.82 Favored 'General case' 0 CA--C 1.537 0.46 0 O-C-N 120.28 -1.512 . . . . 0.58999999999999997 110.027 179.618 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.44 HD22 ' HA ' ' A' ' 41' ' ' LEU . 0.2 OUTLIER -69.99 -17.98 63.31 Favored 'General case' 0 N--CA 1.462 0.128 0 C-N-CA 123.625 0.77 . . . . 0.93999999999999995 110.849 -178.24 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -44.34 -38.18 3.79 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 123.68 0.792 . . . . 0.53000000000000003 111.673 166.416 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 6.5 t -124.89 39.12 4.05 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 122.929 0.492 . . . . 1.27 109.725 172.002 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 50.17 32.06 5.65 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.741 1.617 . . . . 2.8799999999999999 113.804 173.24 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 40.2 m -119.8 163.96 16.7 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.947 1.299 . . . . 0.62 108.43 -177.577 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.8 p -133.15 145.22 34.38 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 O-C-N 121.038 -1.039 . . . . 0.29999999999999999 109.136 171.139 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -132.42 129.48 39.35 Favored 'General case' 0 C--N 1.344 0.346 0 C-N-CA 124.743 1.217 . . . . 0.38 108.445 -178.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.7 p -126.53 128.92 71.66 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 N-CA-C 105.524 -2.028 . . . . 1.78 105.524 -174.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 10.9 mm -105.42 100.44 10.58 Favored 'Isoleucine or valine' 0 C--O 1.239 0.527 0 C-N-CA 124.945 1.298 . . . . 0.41999999999999998 107.898 -173.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 48.0 p90 -141.62 171.05 14.59 Favored 'General case' 0 CA--C 1.512 -0.485 0 O-C-N 121.937 -0.477 . . . . 1.75 111.801 -170.598 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 60.7 t0 -90.62 105.59 12.39 Favored Pre-proline 0 CA--C 1.534 0.362 0 O-C-N 124.742 1.276 . . . . 3.04 110.696 174.597 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -74.88 9.83 1.87 Allowed 'Trans proline' 0 N--CA 1.452 -0.925 0 C-N-CA 122.108 1.872 . . . . 0.63 113.55 179.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -84.15 -27.88 27.81 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 119.238 0.926 . . . . 0.83999999999999997 108.824 164.051 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -108.43 -58.1 2.04 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 123.344 0.658 . . . . 2.6299999999999999 109.359 -170.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.422 0.3 OUTLIER -81.72 179.72 7.72 Favored 'General case' 0 CA--C 1.514 -0.416 0 N-CA-C 116.308 1.966 . . . . 0.46000000000000002 116.308 161.859 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -176.19 -152.35 9.54 Favored Glycine 0 N--CA 1.43 -1.708 1 N-CA-C 102.272 -4.331 . . . . 2.3900000000000001 102.272 -176.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 19.4 p -73.03 -32.4 65.07 Favored 'General case' 0 C--N 1.318 -0.792 0 C-N-CA 124.959 1.304 . . . . 1.2 109.206 178.068 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -42.56 -62.64 0.93 Allowed 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 125.839 1.655 . . . . 0.52000000000000002 113.671 -172.706 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -75.02 -34.69 61.95 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.042 -0.981 . . . . 0.45000000000000001 109.165 -169.697 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -56.17 -52.77 47.09 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.89 0 CA-C-O 117.67 -1.157 . . . . 0.90000000000000002 111.232 175.495 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.41 -46.96 87.95 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 119.864 1.211 . . . . 1.05 109.355 -179.184 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -48.81 -57.3 6.59 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-O 122.105 0.955 . . . . 2.6200000000000001 111.22 176.449 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.9 mmtp -63.02 -44.54 95.67 Favored 'General case' 0 N--CA 1.435 -1.176 0 CA-C-O 118.659 -0.686 . . . . 2.9199999999999999 110.77 -179.379 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -47.43 -52.62 5.19 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 C-N-CA 125.208 1.403 . . . . 0.51000000000000001 108.887 177.559 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -61.67 -55.5 29.81 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 123.762 0.825 . . . . 1.76 110.699 177.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.4 mmmp? -58.07 -31.02 66.67 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 113.366 0.876 . . . . 5.29 113.366 -178.261 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 22.8 mt -73.11 -17.15 61.43 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.583 1.553 . . . . 0.70999999999999996 112.121 174.426 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 93.17 42.55 4.29 Favored Glycine 0 C--N 1.337 0.631 0 C-N-CA 124.918 1.246 . . . . 0.51000000000000001 110.693 175.597 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.498 ' CD1' HG21 ' A' ' 24' ' ' ILE . 0.3 OUTLIER -145.13 177.05 9.07 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 123.348 0.659 . . . . 1.95 111.41 -169.629 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 4.9 t60 -142.25 131.79 23.88 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 107.825 -1.176 . . . . 2.0299999999999998 107.825 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 8.2 p -107.52 138.87 31.58 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.089 0 N-CA-C 108.018 -1.105 . . . . 1.6100000000000001 108.018 175.697 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 5.2 t -116.81 140.79 37.8 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.126 0 N-CA-C 108.598 -0.89 . . . . 0.65000000000000002 108.598 -177.199 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 4.9 mp -116.13 79.73 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 N-CA-C 108.065 -1.087 . . . . 1.24 108.065 179.433 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -77.93 1.09 21.72 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 125.176 1.39 . . . . 3.4100000000000001 113.148 168.452 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -76.55 -13.67 83.23 Favored Glycine 0 CA--C 1.525 0.698 0 C-N-CA 124.854 1.216 . . . . 2.6099999999999999 113.154 178.482 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 46.1 ttt180 . . . . . 0 C--O 1.251 1.136 0 CA-C-O 116.282 -1.818 . . . . 11.619999999999999 107.569 177.172 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 44.4 mtt . . . . . 0 N--CA 1.47 0.532 0 N-CA-C 107.52 -1.289 . . . . 12.1 107.52 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 6.6 tp -150.75 122.25 7.94 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 102.811 -3.033 . . . . 5.6399999999999997 102.811 167.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 8.1 m 65.19 104.14 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.296 0 O-C-N 124.484 1.115 . . . . 0.87 109.691 -170.077 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -64.37 169.97 4.24 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 107.738 -1.208 . . . . 2.0499999999999998 107.738 162.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -131.48 150.46 52.14 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 108.597 -0.89 . . . . 1.29 108.597 173.428 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 44.4 mtpt -143.45 156.79 44.74 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-O 121.695 0.759 . . . . 2.8199999999999998 110.61 169.314 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -100.4 112.77 25.15 Favored 'General case' 0 N--CA 1.44 -0.959 0 C-N-CA 128.188 2.595 . . . . 2.3799999999999999 107.272 -178.301 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.457 HD12 ' C ' ' A' ' 8' ' ' ILE . 2.3 pp -82.64 164.16 2.87 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.157 0 C-N-CA 119.357 -0.937 . . . . 5.2599999999999998 108.559 165.778 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -143.09 113.01 7.07 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 106.16 -1.792 . . . . 0.64000000000000001 106.16 175.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 59.9 mtt -140.29 170.12 16.4 Favored 'General case' 0 C--N 1.334 -0.096 0 CA-C-N 118.306 0.503 . . . . 3.5499999999999998 110.165 -172.595 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 28.8 mm100 -96.0 161.03 14.16 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 123.839 0.856 . . . . 2.5699999999999998 110.173 -176.626 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 44.9 t -120.23 146.2 25.43 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 N-CA-C 108.347 -0.983 . . . . 1.3200000000000001 108.347 -175.316 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 72.3 m -138.61 163.67 31.46 Favored 'General case' 0 N--CA 1.456 -0.154 0 C-N-CA 124.541 1.136 . . . . 0.98999999999999999 109.275 171.114 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 56.92 63.58 5.19 Favored Glycine 0 CA--C 1.528 0.85 0 C-N-CA 123.57 0.605 . . . . 1.6499999999999999 111.668 173.544 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 11.2 ptm -120.47 147.01 45.67 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 124.153 0.981 . . . . 3.0299999999999998 110.762 -177.053 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -81.98 -68.81 0.67 Allowed 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.513 1.125 . . . . 3.9399999999999999 108.65 166.259 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 16.3 p -154.45 169.79 22.92 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-O 121.512 0.672 . . . . 2.5499999999999998 111.119 178.531 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.15 -38.95 66.07 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 124.569 1.148 . . . . 2.5699999999999998 111.925 179.258 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.31 -46.15 90.89 Favored 'General case' 0 N--CA 1.453 -0.287 0 O-C-N 121.959 -0.463 . . . . 1.1299999999999999 110.182 -179.491 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 67.3 m -66.87 -43.75 82.75 Favored 'General case' 0 N--CA 1.454 -0.233 0 O-C-N 121.849 -0.532 . . . . 1.6000000000000001 109.898 175.528 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.0 -18.88 26.95 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 112.856 0.687 . . . . 0.65000000000000002 112.856 176.113 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.27 -50.44 39.49 Favored 'General case' 0 N--CA 1.449 -0.49 0 O-C-N 119.937 -1.727 . . . . 0.52000000000000002 109.074 169.058 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -52.73 -45.07 66.83 Favored 'General case' 0 C--N 1.34 0.16 0 CA-C-O 118.462 -0.78 . . . . 6.3499999999999996 110.426 -177.275 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.4 HG21 ' CD1' ' A' ' 69' ' ' TYR 0.268 3.3 pt -55.4 -59.59 2.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 CA-C-O 118.788 -0.625 . . . . 0.80000000000000004 110.289 179.911 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.46 ' HG3' ' HB1' ' A' ' 37' ' ' ALA . 0.6 OUTLIER -52.51 -45.23 66.14 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 119.516 1.053 . . . . 2.6699999999999999 111.923 178.199 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 35.6 mmtm -66.84 -42.62 85.44 Favored 'General case' 0 CA--C 1.537 0.479 0 O-C-N 121.301 -0.874 . . . . 2.02 111.427 -177.346 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -63.1 -28.57 72.36 Favored Glycine 0 CA--C 1.53 1.023 0 N-CA-C 111.165 -0.774 . . . . 0.57999999999999996 111.165 171.063 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.512 HD22 HG21 ' A' ' 34' ' ' VAL . 0.6 OUTLIER -66.19 -47.63 73.28 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 108.801 -0.814 . . . . 1.6000000000000001 108.801 175.394 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.635 ' HE2' ' HA ' ' A' ' 36' ' ' ASP . 24.9 ttmt -52.09 -37.08 52.85 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 122.822 0.449 . . . . 2.7599999999999998 111.553 174.435 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 13.6 mmt180 -59.62 -11.49 4.99 Favored 'General case' 0 CA--C 1.542 0.669 0 O-C-N 121.097 -1.002 . . . . 3.27 113.477 177.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . 0.629 ' CE ' ' HB1' ' A' ' 59' ' ' ALA . 4.0 ptm -82.74 152.56 66.52 Favored Pre-proline 0 CA--C 1.535 0.376 0 CA-C-N 120.058 1.299 . . . . 3.3100000000000001 112.222 178.464 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -62.25 120.7 8.39 Favored 'Trans proline' 0 N--CA 1.452 -0.92 0 C-N-CA 122.283 1.989 . . . . 1.05 109.17 171.683 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 114.25 -24.85 11.09 Favored Glycine 0 CA--C 1.527 0.792 0 CA-C-O 118.336 -1.258 . . . . 1.01 113.451 172.264 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.512 HG21 HD22 ' A' ' 28' ' ' LEU . 61.5 t -96.99 118.14 42.86 Favored 'Isoleucine or valine' 0 C--N 1.343 0.317 0 CA-C-N 119.408 1.604 . . . . 1.1899999999999999 110.876 174.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 39.6 m -95.59 -35.88 11.46 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-O 117.801 -1.095 . . . . 1.3 112.483 -175.1 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.635 ' HA ' ' HE2' ' A' ' 29' ' ' LYS . 0.2 OUTLIER -145.23 164.27 31.88 Favored 'General case' 0 C--N 1.344 0.329 0 CA-C-N 120.273 1.397 . . . . 2.0499999999999998 110.622 164.258 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.46 ' HB1' ' HG3' ' A' ' 25' ' ' GLU . . . -158.52 135.17 9.54 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 116.313 -0.403 . . . . 0.64000000000000001 110.864 -174.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -149.1 110.14 4.35 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 106.115 -1.809 . . . . 0.59999999999999998 106.115 -161.445 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 10.3 p -89.37 131.79 35.76 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.764 0 N-CA-C 108.384 -0.969 . . . . 0.57999999999999996 108.384 179.196 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 64.1 t-20 -118.96 71.4 0.85 Allowed 'General case' 0 C--O 1.234 0.273 0 C-N-CA 124.758 1.223 . . . . 0.96999999999999997 109.083 -178.029 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.604 HD22 ' H ' ' A' ' 41' ' ' LEU . 2.0 mm? -67.6 -25.59 65.84 Favored 'General case' 0 C--O 1.226 -0.167 0 CA-C-N 115.146 -0.933 . . . . 3.0600000000000001 110.22 -178.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -51.42 -34.78 36.31 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-O 118.802 -0.618 . . . . 0.95999999999999996 111.666 172.254 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.3 t -115.13 22.78 13.05 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 118.278 0.49 . . . . 1.3899999999999999 111.402 172.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 47.14 44.52 15.48 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.574 1.55 . . . . 3.7599999999999998 113.743 179.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 51.8 m -139.89 145.64 38.27 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 108.417 -0.957 . . . . 1.1399999999999999 108.417 -179.704 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 5.2 p -110.73 143.57 20.41 Favored 'Isoleucine or valine' 0 C--O 1.232 0.18 0 C-N-CA 124.404 1.082 . . . . 0.41999999999999998 109.095 175.5 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 26.9 m120 -127.08 137.74 53.08 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 107.446 -1.316 . . . . 0.55000000000000004 107.446 178.523 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 59.9 t -131.47 124.25 54.27 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 N-CA-C 105.279 -2.119 . . . . 2.0499999999999998 105.279 -177.446 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 17.0 mm -102.17 87.51 1.23 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.421 0 C-N-CA 125.498 1.519 . . . . 0.54000000000000004 106.981 -173.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 6.8 p90 -120.24 171.33 8.57 Favored 'General case' 0 CA--C 1.509 -0.631 0 CA-C-N 116.227 -0.442 . . . . 1.8 110.333 -168.684 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -101.28 107.71 51.76 Favored Pre-proline 0 N--CA 1.449 -0.512 0 N-CA-C 108.822 -0.807 . . . . 4.6100000000000003 108.822 -175.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -71.45 7.71 1.42 Allowed 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 123.037 2.492 . . . . 1.1100000000000001 113.552 -174.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -83.03 -22.62 33.52 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 118.706 0.685 . . . . 1.51 109.312 167.524 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -122.36 -55.82 1.83 Allowed 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.367 1.067 . . . . 3.3700000000000001 110.642 -169.546 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.887 HG22 ' HB3' ' A' ' 59' ' ' ALA 0.278 0.8 OUTLIER -86.41 -171.78 3.72 Favored 'General case' 0 CA--C 1.52 -0.18 0 C-N-CA 123.998 0.919 . . . . 0.75 112.391 161.136 . . . . . . . . 4 4 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 134.3 87.02 0.27 Allowed Glycine 0 N--CA 1.443 -0.885 0 N-CA-C 104.265 -3.534 . . . . 2.4199999999999999 104.265 -153.004 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 68.2 p -14.78 -21.2 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.604 1 C-N-CA 138.119 6.568 . . . . 1.6000000000000001 119.42 -143.589 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -28.51 -62.6 0.11 Allowed 'General case' 0 N--CA 1.442 -0.859 0 C-N-CA 127.651 2.381 . . . . 1.1699999999999999 114.13 165.44 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.887 ' HB3' HG22 ' A' ' 55' ' ' THR . . . -74.72 -31.23 61.78 Favored 'General case' 0 C--N 1.332 -0.162 0 C-N-CA 119.06 -1.056 . . . . 0.97999999999999998 109.64 -168.005 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.4 mp -57.95 -55.0 24.43 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.634 0 C-N-CA 123.688 0.795 . . . . 0.80000000000000004 109.794 174.506 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.29 -44.09 88.35 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 119.213 0.915 . . . . 1.46 110.027 -178.354 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -52.77 -53.9 41.6 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 122.143 0.973 . . . . 3.0800000000000001 111.015 176.16 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -65.32 -40.27 93.5 Favored 'General case' 0 N--CA 1.443 -0.816 0 O-C-N 121.171 -0.956 . . . . 2.4500000000000002 111.725 -179.453 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 5.0 mm -49.34 -52.53 11.14 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 C-N-CA 125.298 1.439 . . . . 0.64000000000000001 108.548 175.842 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -56.04 -57.12 13.48 Favored 'General case' 0 C--N 1.342 0.245 0 C-N-CA 123.262 0.625 . . . . 2.23 110.858 175.44 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.47 -38.21 71.37 Favored 'General case' 0 CA--C 1.537 0.46 0 O-C-N 121.844 -0.535 . . . . 5.0099999999999998 111.895 -176.704 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 37.4 mt -67.23 -17.8 64.97 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.975 1.31 . . . . 1.05 111.57 176.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 92.68 32.93 7.74 Favored Glycine 0 CA--C 1.523 0.564 0 C-N-CA 124.543 1.068 . . . . 0.62 111.065 176.366 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.4 ' CD1' HG21 ' A' ' 24' ' ' ILE . 0.3 OUTLIER -128.94 174.14 9.78 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 117.932 0.866 . . . . 1.8899999999999999 110.558 -179.121 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 2.6 t-80 -138.99 128.55 24.52 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 108.126 -1.064 . . . . 1.6699999999999999 108.126 173.177 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.2 t -104.67 152.29 6.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 C-N-CA 124.766 1.226 . . . . 2.0699999999999998 107.82 173.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 96.6 t -117.34 144.88 24.06 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 C-N-CA 125.687 1.595 . . . . 0.68000000000000005 108.657 -179.438 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 34.1 mm -110.62 76.7 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 C-N-CA 125.162 1.385 . . . . 1.1000000000000001 109.27 -170.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -75.11 -6.09 47.71 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 113.81 1.041 . . . . 2.8100000000000001 113.81 173.566 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -83.32 -77.86 1.09 Allowed Glycine 0 CA--C 1.525 0.687 0 N-CA-C 109.808 -1.317 . . . . 3.5699999999999998 109.808 177.308 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 17.3 ttt-85 . . . . . 0 C--O 1.251 1.152 0 C-N-CA 125.492 1.517 . . . . 13.32 111.084 -171.41 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.476 0.869 0 N-CA-C 113.061 0.763 . . . . 9.4700000000000006 113.061 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.0 mm? 64.03 -176.4 0.16 Allowed 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 118.692 0.678 . . . . 4.4500000000000002 110.394 -173.127 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.1 m -114.58 117.8 31.93 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 125.803 1.641 . . . . 0.91000000000000003 107.053 -176.133 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -69.05 178.06 2.41 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-O 121.332 0.587 . . . . 2.6499999999999999 109.856 169.463 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -132.14 145.82 51.63 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 106.628 -1.619 . . . . 0.93000000000000005 106.628 162.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 12.9 mmtp -137.63 159.36 42.18 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 124.351 1.06 . . . . 3.6699999999999999 109.394 164.491 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -119.05 102.02 8.44 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 126.915 2.086 . . . . 1.6100000000000001 107.725 -174.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 3.1 mm -83.95 162.92 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 N-CA-C 107.827 -1.175 . . . . 1.9399999999999999 107.827 177.114 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -136.74 117.74 14.28 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 119.404 1.002 . . . . 0.85999999999999999 110.116 176.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 57.5 mtm -135.33 176.53 8.59 Favored 'General case' 0 CA--C 1.535 0.385 0 O-C-N 121.481 -0.762 . . . . 1.9399999999999999 110.388 -174.518 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.61 168.46 9.07 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 125.958 1.703 . . . . 3.6600000000000001 110.018 173.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.497 HG21 HD21 ' A' ' 41' ' ' LEU . 2.7 m -128.7 153.92 38.89 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 C-N-CA 124.019 0.928 . . . . 1.8300000000000001 111.571 174.552 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 71.1 m -119.59 175.13 6.0 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 125.391 1.476 . . . . 1.04 110.131 174.601 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 80.45 -44.87 2.97 Favored Glycine 0 CA--C 1.533 1.2 0 C-N-CA 123.717 0.675 . . . . 2.7000000000000002 113.435 171.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -42.2 141.05 0.99 Allowed 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 125.698 1.599 . . . . 2.0600000000000001 113.91 -178.154 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -148.58 -45.55 0.15 Allowed 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.788 1.235 . . . . 3.02 113.792 178.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 21.8 p -76.02 -4.85 43.52 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 120.286 1.403 . . . . 3.3500000000000001 112.434 -179.195 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 60.81 33.28 20.09 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 124.688 1.195 . . . . 2.4300000000000002 111.826 174.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -143.79 -44.02 0.27 Allowed 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 123.844 0.858 . . . . 1.01 111.136 -179.243 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 11.5 p -51.79 -33.27 34.71 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.53 0.732 . . . . 2.6699999999999999 112.268 174.345 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.539 ' HB1' HG21 ' A' ' 39' ' ' VAL . . . -49.96 -34.2 20.07 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.265 1.026 . . . . 0.40999999999999998 111.855 172.794 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -69.98 -49.65 49.56 Favored 'General case' 0 N--CA 1.453 -0.305 0 O-C-N 120.331 -1.48 . . . . 0.34000000000000002 109.887 172.12 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 20.1 mmm180 -52.74 -44.03 66.15 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 119.007 -0.52 . . . . 4.79 110.655 -174.017 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.2 pt -59.75 -54.22 37.55 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 C-N-CA 119.885 -0.726 . . . . 0.52000000000000002 111.559 178.208 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -55.28 -44.75 75.94 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-N 118.795 0.725 . . . . 2.1899999999999999 111.753 177.408 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 30.7 mmtp -71.77 -39.9 69.64 Favored 'General case' 0 CA--C 1.53 0.183 0 O-C-N 121.61 -0.681 . . . . 1.8500000000000001 110.84 -174.613 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.95 -43.61 98.65 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 109.627 -1.389 . . . . 0.73999999999999999 109.627 170.336 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -59.31 -36.93 76.52 Favored 'General case' 0 CA--C 1.541 0.606 0 O-C-N 121.442 -1.034 . . . . 2.3799999999999999 109.362 178.655 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.6 ttpp -58.68 -20.06 45.07 Favored 'General case' 0 CA--C 1.537 0.473 0 O-C-N 120.556 -1.34 . . . . 2.3900000000000001 113.685 174.214 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 22.3 mtt-85 -83.82 -6.22 59.38 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.847 0.859 . . . . 3.29 111.933 177.229 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 21.9 mmt -86.17 154.23 57.32 Favored Pre-proline 0 CA--C 1.531 0.24 0 CA-C-N 118.763 0.71 . . . . 4.6299999999999999 109.467 -174.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -56.08 148.17 60.36 Favored 'Trans proline' 0 N--CA 1.453 -0.87 0 C-N-CA 121.816 1.678 . . . . 0.72999999999999998 110.34 176.21 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 84.36 -33.18 3.22 Favored Glycine 0 CA--C 1.524 0.636 0 CA-C-O 119.855 -0.414 . . . . 0.5 113.197 175.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 15.3 t -82.78 137.86 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 CA-C-N 118.206 1.003 . . . . 0.56999999999999995 109.204 177.61 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -110.63 -49.89 3.0 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-O 118.255 -0.878 . . . . 0.91000000000000003 109.661 175.91 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -138.39 160.84 38.49 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 119.173 0.897 . . . . 2.3300000000000001 109.98 179.331 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -156.61 147.54 21.93 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 122.846 0.458 . . . . 0.45000000000000001 110.685 -179.473 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.401 HD21 HD11 ' A' ' 49' ' ' ILE . 0.0 OUTLIER -154.07 116.93 4.45 Favored 'General case' 0 C--N 1.34 0.193 0 N-CA-C 108.64 -0.874 . . . . 0.5 108.64 -164.14 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.874 HG22 HD23 ' A' ' 41' ' ' LEU . 8.6 p -93.9 96.65 6.23 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 C-N-CA 123.921 0.888 . . . . 0.59999999999999998 110.026 -175.103 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 51.1 t-20 -83.35 56.96 3.76 Favored 'General case' 0 CA--C 1.536 0.407 0 O-C-N 120.641 -1.287 . . . . 0.60999999999999999 110.248 -175.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.874 HD23 HG22 ' A' ' 39' ' ' VAL . 0.6 OUTLIER -70.5 -21.15 62.79 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 115.486 -0.779 . . . . 1.1399999999999999 110.933 -176.468 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -45.56 -34.67 3.47 Favored 'General case' 0 C--N 1.338 0.096 0 C-N-CA 124.043 0.937 . . . . 0.67000000000000004 112.194 167.81 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 8.7 t -131.8 45.43 2.78 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 108.863 -0.791 . . . . 1.48 108.863 172.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 37.47 52.54 1.29 Allowed 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.886 1.674 . . . . 4.0199999999999996 113.793 175.091 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -134.34 165.97 23.9 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 108.263 -1.014 . . . . 1.6200000000000001 108.263 173.641 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.7 p -139.18 139.37 39.89 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 N-CA-C 107.352 -1.351 . . . . 0.45000000000000001 107.352 173.224 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 20.4 m120 -126.85 137.42 53.18 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 107.816 -1.179 . . . . 0.29999999999999999 107.816 -178.58 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.1 p -135.0 124.23 42.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 N-CA-C 106.562 -1.644 . . . . 1.9099999999999999 106.562 -173.488 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.401 HD11 HD21 ' A' ' 38' ' ' ASN . 7.5 mm -107.12 96.92 5.03 Favored 'Isoleucine or valine' 0 C--O 1.24 0.56 0 C-N-CA 125.332 1.453 . . . . 0.47999999999999998 107.871 -168.048 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 46.8 p90 -137.94 165.38 26.66 Favored 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 112.198 0.444 . . . . 1.73 112.198 -170.284 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 26.8 t0 -84.2 110.49 26.64 Favored Pre-proline 0 CA--C 1.535 0.379 0 O-C-N 124.412 1.07 . . . . 3.0800000000000001 110.551 173.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -72.38 4.4 3.43 Favored 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 123.149 2.566 . . . . 0.63 113.508 -178.345 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -86.12 -29.57 23.21 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 119.46 1.027 . . . . 0.80000000000000004 109.194 167.542 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -104.87 -57.56 2.01 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 123.578 0.751 . . . . 3.6499999999999999 109.102 -168.471 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.404 ' CG2' ' HB3' ' A' ' 59' ' ' ALA 0.308 1.3 p -89.76 -173.91 4.1 Favored 'General case' 0 CA--C 1.521 -0.159 0 CA-C-O 121.015 0.436 . . . . 0.45000000000000001 111.134 158.361 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 136.78 87.77 0.21 Allowed Glycine 0 N--CA 1.442 -0.965 0 N-CA-C 103.71 -3.756 . . . . 2.46 103.71 -152.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 66.6 p -12.35 -17.73 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.49 1 C-N-CA 137.778 6.431 . . . . 1.0700000000000001 119.863 -144.112 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -26.44 -62.98 0.08 Allowed 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 127.085 2.154 . . . . 0.55000000000000004 113.834 165.213 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.404 ' HB3' ' CG2' ' A' ' 55' ' ' THR . . . -72.91 -42.09 63.89 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 117.643 -1.623 . . . . 0.52000000000000002 109.866 -168.83 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.4 mp -49.71 -57.57 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.816 0 CA-C-N 114.237 -1.347 . . . . 0.83999999999999997 109.258 175.444 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.17 -45.82 83.34 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 118.586 0.63 . . . . 1.49 110.856 -174.656 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -45.06 -60.07 2.28 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 122.574 1.178 . . . . 3.1099999999999999 110.374 172.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 4.6 mmpt? -70.18 -38.73 75.44 Favored 'General case' 0 N--CA 1.431 -1.384 0 CA-C-N 115.341 -0.845 . . . . 3.1499999999999999 112.005 -173.802 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -48.66 -54.1 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 C-N-CA 124.889 1.276 . . . . 0.34999999999999998 107.8 175.372 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -60.09 -54.63 43.7 Favored 'General case' 0 C--N 1.34 0.182 0 C-N-CA 123.722 0.809 . . . . 1.6799999999999999 110.231 176.71 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.9 tmtm? -56.83 -35.38 68.74 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 112.937 0.717 . . . . 3.6899999999999999 112.937 -176.185 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 12.9 mt -70.59 -18.7 62.89 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 125.705 1.602 . . . . 0.69999999999999996 111.645 175.678 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 93.05 44.25 3.88 Favored Glycine 0 CA--C 1.525 0.681 0 C-N-CA 124.642 1.115 . . . . 0.56000000000000005 110.553 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -139.6 173.99 10.97 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 123.688 0.795 . . . . 1.9199999999999999 110.663 -177.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 18.8 t-160 -148.78 128.12 13.0 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 108.601 -0.889 . . . . 1.9199999999999999 108.601 175.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 14.5 p -100.28 135.1 37.63 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 C-N-CA 126.259 1.824 . . . . 1.45 108.336 178.621 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 15.8 t -100.32 131.94 46.88 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 C-N-CA 124.272 1.029 . . . . 0.79000000000000004 109.227 -179.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 27.6 mm -88.11 75.52 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 C-N-CA 124.508 1.123 . . . . 1.1299999999999999 108.601 -173.125 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -71.2 -0.54 10.06 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 113.767 1.025 . . . . 4.7599999999999998 113.767 -178.306 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 65.52 69.46 1.34 Allowed Glycine 0 CA--C 1.523 0.583 0 C-N-CA 124.978 1.275 . . . . 2.77 111.394 173.155 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 6.6 mtt180 . . . . . 0 C--O 1.255 1.386 0 C-N-CA 125.629 1.572 . . . . 13.279999999999999 106.893 -172.589 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.0 mtt . . . . . 0 N--CA 1.474 0.769 0 N-CA-C 109.349 -0.611 . . . . 12.640000000000001 109.349 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.1 pp -163.03 135.0 5.19 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 106.654 -1.61 . . . . 5.7599999999999998 106.654 171.702 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.2 m -146.67 116.53 7.24 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 105.029 -2.212 . . . . 0.82999999999999996 105.029 174.781 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -78.16 157.02 29.55 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 106.925 -1.509 . . . . 2.3199999999999998 106.925 167.578 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -111.03 148.37 32.74 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 124.436 1.095 . . . . 1.1399999999999999 108.106 176.65 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.433 ' NZ ' ' OE1' ' A' ' 7' ' ' GLU . 0.0 OUTLIER -135.92 153.66 51.37 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 121.769 0.795 . . . . 4.0599999999999996 109.075 159.425 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.433 ' OE1' ' NZ ' ' A' ' 6' ' ' LYS . 0.5 OUTLIER -84.05 144.39 29.11 Favored 'General case' 0 N--CA 1.442 -0.87 0 C-N-CA 126.651 1.981 . . . . 2.04 107.472 168.273 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -125.17 164.16 24.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 107.664 -1.235 . . . . 2.7400000000000002 107.664 168.027 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -136.22 124.05 22.61 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 106.669 -1.604 . . . . 0.59999999999999998 106.669 177.34 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 39.3 mtm -139.6 170.37 16.03 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 108.784 -0.821 . . . . 1.98 108.784 -178.328 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 30.8 mm100 -97.68 163.03 13.0 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.288 1.035 . . . . 2.9100000000000001 109.618 177.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 52.4 t -121.96 149.06 25.23 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 C-N-CA 124.815 1.246 . . . . 1.24 109.138 -173.25 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 17.9 m -155.44 174.3 15.44 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.716 1.206 . . . . 1.29 108.395 169.42 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 64.42 65.6 2.91 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 109.931 -1.268 . . . . 1.9099999999999999 109.931 -179.017 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 5.5 ppp? -139.54 154.32 47.63 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 123.917 0.887 . . . . 3.25 110.103 -171.442 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.8 p -99.54 -63.89 1.09 Allowed 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 125.945 1.698 . . . . 3.48 108.638 171.225 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 19.9 p -138.0 161.75 35.88 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 124.291 1.036 . . . . 2.2599999999999998 110.636 -175.416 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -76.48 49.82 0.62 Allowed 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.43 1.092 . . . . 1.72 111.124 179.552 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -142.31 -49.54 0.37 Allowed 'General case' 0 N--CA 1.457 -0.119 0 C-N-CA 124.878 1.271 . . . . 0.68999999999999995 109.008 178.368 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 38.3 m -57.8 -36.82 72.73 Favored 'General case' 0 CA--C 1.533 0.298 0 O-C-N 121.365 -0.835 . . . . 1.1699999999999999 110.059 168.512 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -51.28 -31.8 22.52 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.951 0.901 . . . . 0.55000000000000004 112.209 170.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -73.58 -53.4 10.59 Favored 'General case' 0 N--CA 1.453 -0.31 0 O-C-N 120.663 -1.273 . . . . 0.48999999999999999 109.647 170.77 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 48.9 mmm-85 -47.56 -46.16 27.71 Favored 'General case' 0 C--O 1.23 0.068 0 C-N-CA 123.609 0.764 . . . . 3.8900000000000001 111.215 -175.054 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.448 HG21 ' CD1' ' A' ' 69' ' ' TYR . 5.4 pt -55.1 -53.13 37.52 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 CA-C-O 119.129 -0.462 . . . . 0.45000000000000001 111.823 177.686 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -60.23 -42.28 94.88 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 118.819 0.736 . . . . 2.25 111.257 179.599 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.6 mptm? -68.24 -44.23 76.13 Favored 'General case' 0 CA--C 1.528 0.108 0 O-C-N 121.743 -0.598 . . . . 2.79 109.897 -176.391 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -57.32 -47.82 85.06 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 109.468 -1.453 . . . . 0.79000000000000004 109.468 171.721 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -58.5 -40.49 82.96 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.702 0.801 . . . . 2.3300000000000001 110.318 -175.373 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 12.8 ttmt -44.22 -34.75 1.99 Allowed 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 118.608 0.64 . . . . 2.8100000000000001 112.358 173.709 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 43.7 ttm-85 -67.27 -8.6 33.23 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 113.414 0.894 . . . . 3.8199999999999998 113.414 -172.869 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 1.6 mpp? -87.56 158.51 51.29 Favored Pre-proline 0 CA--C 1.537 0.463 0 CA-C-N 119.347 0.976 . . . . 4.1699999999999999 111.419 178.749 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -62.99 153.81 71.15 Favored 'Trans proline' 0 N--CA 1.456 -0.694 0 C-N-CA 123.142 2.561 . . . . 0.91000000000000003 112.077 -176.239 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 74.0 -35.65 0.91 Allowed Glycine 0 CA--C 1.525 0.683 0 C-N-CA 124.761 1.172 . . . . 0.80000000000000004 112.616 -178.142 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 11.6 t -71.88 130.97 35.2 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 O-C-N 121.074 -1.25 . . . . 0.54000000000000004 108.655 175.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -118.61 -43.11 2.71 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 118.677 -0.678 . . . . 0.93999999999999995 109.88 179.844 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -140.73 164.85 29.09 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 119.221 0.919 . . . . 2.02 112.016 168.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -157.69 140.65 15.07 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.139 -0.937 . . . . 0.40000000000000002 109.185 -171.595 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -153.52 107.11 2.99 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 106.198 -1.778 . . . . 0.48999999999999999 106.198 -164.839 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 4.2 p -80.23 122.85 36.19 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 N-CA-C 107.232 -1.396 . . . . 0.62 107.232 175.392 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 57.7 t-20 -102.2 56.27 0.8 Allowed 'General case' 0 C--O 1.235 0.311 0 N-CA-C 106.893 -1.521 . . . . 0.57999999999999996 106.893 178.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.14 -20.95 64.04 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 114.259 -1.337 . . . . 1.0700000000000001 109.589 -173.146 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -45.52 -37.15 5.09 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 124.118 0.967 . . . . 0.54000000000000004 112.267 167.015 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 6.3 t -122.75 40.24 3.74 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 121.65 0.738 . . . . 1.27 109.235 173.686 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 39.0 46.61 1.13 Allowed 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 126.888 2.075 . . . . 2.6200000000000001 113.015 178.718 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 52.3 m -128.03 155.51 44.21 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 125.0 1.32 . . . . 0.80000000000000004 108.3 -178.439 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.0 p -121.56 142.23 38.69 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 N-CA-C 108.417 -0.957 . . . . 0.40000000000000002 108.417 168.45 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 21.4 m120 -126.1 139.1 53.65 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 107.28 -1.378 . . . . 0.47999999999999998 107.28 174.771 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 20.5 t -132.89 135.84 56.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 N-CA-C 104.941 -2.244 . . . . 2.0099999999999998 104.941 -178.45 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 15.0 mm -112.05 92.24 2.01 Favored 'Isoleucine or valine' 0 C--O 1.24 0.578 0 N-CA-C 106.758 -1.571 . . . . 0.46999999999999997 106.758 -179.452 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -127.27 171.89 11.08 Favored 'General case' 0 CA--C 1.509 -0.625 0 CA-C-N 116.596 -0.275 . . . . 2.3100000000000001 110.492 -176.368 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 -94.38 105.66 19.15 Favored Pre-proline 0 N--CA 1.448 -0.533 0 O-C-N 124.397 1.061 . . . . 3.7999999999999998 108.615 176.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -69.98 5.75 1.66 Allowed 'Trans proline' 0 CA--C 1.538 0.679 0 C-N-CA 122.323 2.015 . . . . 0.60999999999999999 113.03 -179.245 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -85.66 -27.94 25.06 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 123.72 0.808 . . . . 0.75 109.43 169.044 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -112.47 -61.43 1.73 Allowed 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.281 1.032 . . . . 2.8100000000000001 110.05 -173.455 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.413 ' HB ' ' H ' ' A' ' 56' ' ' GLY 0.486 0.5 OUTLIER -85.12 -169.1 2.49 Favored 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 114.055 1.131 . . . . 0.81999999999999995 114.055 162.908 . . . . . . . . 4 4 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.413 ' H ' ' HB ' ' A' ' 55' ' ' THR . . . 158.59 -150.13 20.66 Favored Glycine 0 N--CA 1.434 -1.437 0 N-CA-C 103.56 -3.816 . . . . 2.6800000000000002 103.56 -157.456 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 15.0 p -75.96 -37.38 58.67 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 124.986 1.314 . . . . 1.49 109.687 -179.322 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -54.48 -63.79 1.04 Allowed 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 124.404 1.082 . . . . 0.70999999999999996 113.191 -164.277 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.77 -35.73 79.2 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 118.483 -1.287 . . . . 0.56999999999999995 108.87 -167.726 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.7 mp -55.17 -58.57 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.115 0 CA-C-N 114.205 -1.361 . . . . 1.25 109.212 173.52 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.63 -46.58 88.58 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 119.698 1.136 . . . . 1.8200000000000001 109.363 -175.46 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -48.86 -55.65 11.05 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 121.394 0.616 . . . . 4.0700000000000003 110.515 177.005 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.0 mmpt? -71.2 -40.68 71.03 Favored 'General case' 0 N--CA 1.435 -1.191 0 CA-C-O 118.333 -0.842 . . . . 2.4300000000000002 112.907 -177.36 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 3.4 mm -47.93 -52.4 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 C-N-CA 126.387 1.875 . . . . 0.62 107.703 176.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -53.74 -61.09 2.53 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 115.689 -0.687 . . . . 3.52 111.138 173.246 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -62.23 -29.38 70.35 Favored 'General case' 0 CA--C 1.542 0.669 0 O-C-N 121.779 -0.576 . . . . 5.2999999999999998 112.088 -172.256 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 36.4 mt -71.06 -19.94 62.43 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.778 1.631 . . . . 0.57999999999999996 111.377 173.043 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 89.56 40.85 5.88 Favored Glycine 0 CA--C 1.525 0.704 0 C-N-CA 124.688 1.137 . . . . 0.48999999999999999 111.474 176.741 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.448 ' CD1' HG21 ' A' ' 24' ' ' ILE . 0.5 OUTLIER -131.6 174.45 10.1 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 124.201 1.0 . . . . 1.8400000000000001 110.268 178.207 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 10.9 t-160 -151.05 126.26 9.94 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 109.608 -0.515 . . . . 2.23 109.608 167.073 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 20.3 m -82.27 167.7 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 N-CA-C 109.216 -0.661 . . . . 2.2400000000000002 109.216 176.013 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 15.2 t -130.9 145.52 35.39 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 N-CA-C 107.837 -1.171 . . . . 0.73999999999999999 107.837 178.723 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 29.4 mm -121.54 76.09 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 C-N-CA 124.356 1.062 . . . . 1.3200000000000001 109.108 -171.252 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -81.08 -0.07 38.28 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 115.325 1.602 . . . . 3.1400000000000001 115.325 -173.61 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 80.55 81.18 0.81 Allowed Glycine 0 CA--C 1.527 0.829 0 N-CA-C 109.648 -1.381 . . . . 4.0499999999999998 109.648 -175.635 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.254 1.318 0 N-CA-C 104.714 -2.328 . . . . 12.33 104.714 177.068 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.474 0.765 0 N-CA-C 108.444 -0.947 . . . . 10.31 108.444 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 10.3 mp -72.48 -175.6 1.66 Allowed 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 108.316 -0.994 . . . . 5.0199999999999996 108.316 161.555 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 50.3 m -22.54 108.65 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 127.088 2.155 . . . . 0.89000000000000001 112.843 164.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -70.54 -177.39 1.49 Allowed 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 121.321 0.582 . . . . 2.1099999999999999 109.693 174.522 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -134.79 146.02 48.95 Favored 'General case' 0 N--CA 1.447 -0.575 0 N-CA-C 107.258 -1.386 . . . . 1.27 107.258 168.081 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 50.1 mtmt -142.42 162.14 36.25 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 123.271 0.628 . . . . 3.4300000000000002 109.378 159.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.3 mp0 -121.22 86.38 2.56 Favored 'General case' 0 N--CA 1.442 -0.86 0 C-N-CA 127.904 2.482 . . . . 1.8999999999999999 106.855 -166.144 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.494 ' N ' HD12 ' A' ' 8' ' ' ILE . 3.4 mp -82.56 163.06 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.258 0 N-CA-C 106.427 -1.694 . . . . 2.2000000000000002 106.427 -175.133 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -138.67 134.37 33.57 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 125.469 1.508 . . . . 0.47999999999999998 108.31 -176.146 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -156.28 174.32 15.57 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 118.346 0.521 . . . . 2.71 110.736 175.344 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 29.0 mm100 -93.57 160.68 14.68 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.931 1.293 . . . . 2.6800000000000002 109.923 -178.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 21.3 t -119.43 154.87 22.05 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 C-N-CA 124.23 1.012 . . . . 1.22 109.27 -171.117 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 32.1 t -154.47 175.82 13.11 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 118.588 0.631 . . . . 1.97 110.358 170.837 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 59.09 72.53 0.59 Allowed Glycine 0 CA--C 1.528 0.854 0 N-CA-C 110.252 -1.139 . . . . 2.0499999999999998 110.252 -174.322 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -144.83 159.96 42.04 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 123.746 0.818 . . . . 2.0299999999999998 110.567 -172.447 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -100.11 -65.12 0.99 Allowed 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 125.955 1.702 . . . . 3.0699999999999998 110.246 169.1 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 2.0 p -150.54 164.15 36.69 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 123.32 0.648 . . . . 2.0899999999999999 110.371 -166.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -72.75 32.86 0.07 Allowed 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.661 1.584 . . . . 1.78 113.751 -172.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -114.9 -47.84 2.86 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 126.314 1.845 . . . . 0.70999999999999996 108.74 171.616 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 38.0 m -66.0 -38.09 87.58 Favored 'General case' 0 N--CA 1.455 -0.185 0 O-C-N 121.435 -0.791 . . . . 1.25 110.653 -170.296 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.846 ' HB1' HG21 ' A' ' 39' ' ' VAL . . . -56.62 -28.75 61.14 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 116.25 -0.432 . . . . 0.58999999999999997 111.306 173.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.84 -50.25 65.27 Favored 'General case' 0 N--CA 1.455 -0.207 0 O-C-N 120.158 -1.589 . . . . 0.46999999999999997 109.118 171.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 28.5 mmm180 -53.04 -48.53 67.55 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 118.792 -0.623 . . . . 5.1699999999999999 110.336 -178.152 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.496 HG21 ' CD1' ' A' ' 69' ' ' TYR 0.271 1.8 pt -58.14 -56.34 16.59 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.44 0 C-N-CA 119.304 -0.958 . . . . 0.48999999999999999 110.765 179.703 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -53.68 -42.03 67.51 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 119.594 1.088 . . . . 2.6200000000000001 112.582 179.325 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -70.02 -43.67 70.87 Favored 'General case' 0 CA--C 1.535 0.394 0 O-C-N 121.163 -0.961 . . . . 2.0099999999999998 110.717 -177.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -66.89 -33.19 83.25 Favored Glycine 0 CA--C 1.529 0.964 0 N-CA-C 111.254 -0.738 . . . . 0.65000000000000002 111.254 175.281 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -66.03 -46.36 78.16 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 125.021 1.328 . . . . 2.2599999999999998 107.635 178.444 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 14.3 ttmt -49.11 -34.88 14.96 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 118.758 0.708 . . . . 3.25 112.405 176.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -59.61 -20.99 59.69 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 113.124 0.787 . . . . 5.3700000000000001 113.124 179.575 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.52 158.83 84.02 Favored Pre-proline 0 CA--C 1.54 0.573 0 C-N-CA 123.99 0.916 . . . . 4.3099999999999996 111.93 -174.045 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 78.9 Cg_endo -73.05 115.52 4.38 Favored 'Trans proline' 0 N--CA 1.453 -0.901 0 C-N-CA 121.871 1.714 . . . . 1.04 109.691 175.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 124.38 -36.55 2.88 Favored Glycine 0 CA--C 1.529 0.915 0 C-N-CA 124.343 0.973 . . . . 0.80000000000000004 112.446 172.57 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 57.8 t -80.17 142.32 14.08 Favored 'Isoleucine or valine' 0 C--N 1.34 0.192 0 CA-C-N 118.01 0.905 . . . . 0.71999999999999997 109.193 173.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.5 m -115.47 -41.79 3.22 Favored 'General case' 0 C--N 1.338 0.068 0 C-N-CA 123.292 0.637 . . . . 1.6899999999999999 110.947 -176.034 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -136.91 165.83 25.07 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 123.629 0.771 . . . . 2.04 110.329 169.654 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -158.92 142.81 15.25 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 122.73 0.412 . . . . 0.46000000000000002 111.261 -177.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -154.97 107.5 2.75 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 106.228 -1.767 . . . . 0.42999999999999999 106.228 -167.497 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.846 HG21 ' HB1' ' A' ' 21' ' ' ALA . 4.2 p -80.02 135.8 24.73 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 N-CA-C 107.613 -1.255 . . . . 0.83999999999999997 107.613 174.251 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 54.4 t-20 -122.24 55.98 1.12 Allowed 'General case' 0 C--O 1.235 0.294 0 CA-C-O 122.844 1.307 . . . . 0.80000000000000004 107.895 -179.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.655 HD23 HG22 ' A' ' 39' ' ' VAL . 0.4 OUTLIER -64.72 -20.21 66.2 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-N 114.169 -1.378 . . . . 0.96999999999999997 110.515 179.107 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -49.63 -37.2 27.21 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 118.829 -0.605 . . . . 0.55000000000000004 112.124 167.014 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 13.5 t -114.33 23.57 12.71 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 118.362 0.528 . . . . 1.26 111.206 171.436 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 65.67 20.18 11.52 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.665 1.586 . . . . 2.7000000000000002 114.353 175.078 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 25.6 m -122.05 164.17 18.15 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.657 1.183 . . . . 0.67000000000000004 109.797 -173.209 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.7 p -128.5 146.75 33.44 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 O-C-N 120.789 -1.194 . . . . 0.37 109.521 172.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -129.59 136.77 50.19 Favored 'General case' 0 C--N 1.345 0.41 0 N-CA-C 107.814 -1.18 . . . . 0.35999999999999999 107.814 175.696 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -130.75 130.07 64.29 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.797 0 N-CA-C 105.245 -2.131 . . . . 2.3999999999999999 105.245 179.687 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 11.9 mm -103.48 99.33 8.17 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 N-CA-C 106.051 -1.833 . . . . 0.46999999999999997 106.051 -174.401 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.47 ' CE2' HD13 ' A' ' 8' ' ' ILE . 46.0 p90 -136.05 169.86 16.93 Favored 'General case' 0 CA--C 1.51 -0.564 0 O-C-N 121.976 -0.453 . . . . 1.6599999999999999 110.98 -170.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 31.1 t0 -90.69 105.49 12.13 Favored Pre-proline 0 C--O 1.234 0.246 0 O-C-N 124.491 1.119 . . . . 3.02 109.208 175.072 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -75.32 8.31 2.59 Favored 'Trans proline' 0 N--CA 1.45 -1.054 0 C-N-CA 122.396 2.064 . . . . 0.68999999999999995 112.353 -177.59 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -87.94 -28.38 21.53 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 119.328 0.967 . . . . 0.96999999999999997 108.928 167.133 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -102.61 -59.11 1.76 Allowed 'General case' 0 C--N 1.344 0.326 0 N-CA-C 108.872 -0.788 . . . . 2.4199999999999999 108.872 -176.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.334 0.7 OUTLIER -86.46 -172.75 4.19 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 125.345 1.458 . . . . 0.55000000000000004 114.1 166.759 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 167.99 -143.19 7.99 Favored Glycine 0 N--CA 1.43 -1.706 1 N-CA-C 101.819 -4.512 . . . . 2.6299999999999999 101.819 -164.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 36.5 p -77.35 -34.77 55.1 Favored 'General case' 0 N--CA 1.442 -0.851 0 C-N-CA 125.918 1.687 . . . . 1.29 109.494 176.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -48.8 -62.92 1.26 Allowed 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 125.166 1.386 . . . . 0.57999999999999996 113.247 -161.262 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -75.31 -30.11 60.24 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 114.936 -1.029 . . . . 0.65000000000000002 109.795 -173.425 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 4.6 mt -57.76 -57.42 10.47 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.739 0 CA-C-O 118.405 -0.807 . . . . 1.46 110.609 177.043 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.25 -43.82 92.4 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 119.079 0.854 . . . . 1.1100000000000001 108.73 -176.844 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -50.66 -56.5 11.6 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 123.481 0.712 . . . . 3.1200000000000001 110.459 178.524 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -66.03 -43.05 88.75 Favored 'General case' 0 N--CA 1.438 -1.072 0 CA-C-O 118.42 -0.8 . . . . 2.1800000000000002 111.879 -179.836 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 3.3 mm -47.98 -51.71 8.35 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 125.781 1.633 . . . . 0.56999999999999995 108.78 176.483 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 38.9 mm-40 -56.13 -58.6 7.25 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.577 0.751 . . . . 1.53 110.598 174.648 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.09 -36.34 72.71 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 121.412 -0.805 . . . . 5.1600000000000001 112.466 -176.586 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 37.9 mt -68.35 -17.62 64.29 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 125.154 1.382 . . . . 0.68999999999999995 111.02 177.106 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 91.68 38.15 5.91 Favored Glycine 0 C--N 1.338 0.65 0 C-N-CA 124.334 0.969 . . . . 0.46000000000000002 110.984 174.224 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.496 ' CD1' HG21 ' A' ' 24' ' ' ILE . 0.3 OUTLIER -133.44 174.81 10.01 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 123.593 0.757 . . . . 1.8999999999999999 110.702 -177.877 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -140.12 167.81 21.26 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 108.706 -0.85 . . . . 1.6599999999999999 108.706 169.094 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 45.5 t -140.01 145.59 26.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 N-CA-C 105.476 -2.046 . . . . 2.1400000000000001 105.476 -171.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 5.8 t -120.64 136.9 56.16 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 C-N-CA 124.671 1.188 . . . . 0.78000000000000003 107.854 -177.422 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 45.7 mm -110.53 74.82 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 N-CA-C 106.969 -1.493 . . . . 1.4199999999999999 106.969 -178.67 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -74.54 -6.12 46.65 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.411 1.085 . . . . 3.4900000000000002 112.591 -178.378 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -131.22 63.8 0.62 Allowed Glycine 0 CA--C 1.524 0.612 0 C-N-CA 126.132 1.825 . . . . 2.8199999999999998 108.549 174.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 9.9 ttt180 . . . . . 0 C--O 1.251 1.175 0 CA-C-O 117.279 -1.344 . . . . 13.0 109.799 173.132 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.7 mtt . . . . . 0 N--CA 1.471 0.612 0 N-CA-C 106.584 -1.635 . . . . 12.23 106.584 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -148.87 37.63 0.8 Allowed 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 124.754 1.222 . . . . 6.8399999999999999 109.718 -172.517 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 5.2 m -100.08 96.74 7.71 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 106.995 -1.483 . . . . 0.87 106.995 175.459 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -68.25 168.86 11.5 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 107.717 -1.216 . . . . 2.4700000000000002 107.717 164.607 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -127.42 147.78 50.29 Favored 'General case' 0 CA--C 1.516 -0.33 0 C-N-CA 124.415 1.086 . . . . 0.97999999999999998 108.359 177.112 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 52.7 mtmt -144.93 159.61 42.64 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 121.839 0.828 . . . . 3.3599999999999999 111.573 163.572 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -97.34 145.82 25.76 Favored 'General case' 0 N--CA 1.442 -0.873 0 C-N-CA 127.787 2.435 . . . . 1.71 108.16 175.553 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.425 HD11 ' CE2' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -127.87 158.58 39.49 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 N-CA-C 105.841 -1.911 . . . . 2.3100000000000001 105.841 173.588 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -136.87 127.96 27.8 Favored 'General case' 0 C--O 1.226 -0.14 0 N-CA-C 107.854 -1.165 . . . . 0.96999999999999997 107.854 179.46 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 3.5 ptp -156.02 177.51 11.34 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 118.434 0.561 . . . . 2.5699999999999998 110.781 -172.947 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 27.7 mm100 -97.47 161.79 13.62 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.243 1.417 . . . . 2.52 110.453 -175.628 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 49.6 t -116.0 157.76 16.69 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 C-N-CA 124.951 1.3 . . . . 1.1499999999999999 109.818 -174.281 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 6.3 m -153.35 169.78 22.26 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.486 0.714 . . . . 0.91000000000000003 110.615 169.441 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 60.44 59.93 9.43 Favored Glycine 0 CA--C 1.529 0.945 0 N-CA-C 110.016 -1.234 . . . . 1.9199999999999999 110.016 -174.825 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -144.71 167.69 21.96 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 124.21 1.004 . . . . 2.0099999999999998 109.982 -174.448 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -143.22 -67.49 0.36 Allowed 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 124.769 1.228 . . . . 2.3199999999999998 108.982 171.342 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 12.2 p -98.84 150.86 21.45 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-O 121.643 0.735 . . . . 2.1699999999999999 111.205 -178.493 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -78.18 47.11 0.65 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.616 0.766 . . . . 1.8899999999999999 110.794 177.358 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -135.29 -53.72 0.79 Allowed 'General case' 0 N--CA 1.457 -0.12 0 C-N-CA 124.305 1.042 . . . . 0.71999999999999997 109.288 177.952 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 34.7 m -55.78 -38.18 69.56 Favored 'General case' 0 C--N 1.338 0.096 0 O-C-N 121.552 -0.718 . . . . 1.1899999999999999 109.64 168.166 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.558 ' HB1' HG21 ' A' ' 39' ' ' VAL . . . -57.25 -22.88 44.36 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 112.547 0.573 . . . . 0.56000000000000005 112.547 175.766 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -73.24 -40.76 64.42 Favored 'General case' 0 C--O 1.232 0.135 0 O-C-N 120.684 -1.26 . . . . 0.44 110.727 170.665 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 18.1 mmm180 -56.75 -39.36 73.85 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 123.391 0.676 . . . . 4.46 109.761 -171.429 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.3 pt -60.18 -65.62 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 C-N-CA 119.454 -0.898 . . . . 1.6699999999999999 111.183 177.38 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.58 ' HG3' ' HB1' ' A' ' 37' ' ' ALA . 2.5 mp0 -46.95 -45.13 20.54 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-N 119.778 1.172 . . . . 2.4700000000000002 112.156 177.858 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 11.2 mptt -70.84 -33.34 70.56 Favored 'General case' 0 CA--C 1.538 0.504 0 O-C-N 121.377 -0.827 . . . . 1.98 110.641 -176.725 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -72.03 -29.11 67.33 Favored Glycine 0 CA--C 1.531 1.071 0 O-C-N 121.377 -0.827 . . . . 0.60999999999999999 112.061 169.715 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.0 mp -69.78 -43.9 71.2 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 118.378 1.089 . . . . 2.8999999999999999 109.432 175.975 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 61.8 tttm -50.35 -31.74 15.42 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.644 0.777 . . . . 2.6800000000000002 111.964 174.206 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 52.8 mtt180 -75.8 -4.38 40.31 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 113.651 0.982 . . . . 5.2300000000000004 113.651 179.484 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 93.0 mmm -93.17 150.47 39.19 Favored Pre-proline 0 C--O 1.232 0.161 0 CA-C-N 119.422 1.01 . . . . 3.5299999999999998 110.264 -178.116 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -56.95 144.06 90.27 Favored 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 121.869 1.713 . . . . 0.62 109.143 173.99 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 88.69 -32.34 4.57 Favored Glycine 0 CA--C 1.525 0.686 0 CA-C-O 119.419 -0.656 . . . . 0.48999999999999999 113.343 179.238 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 14.0 t -87.3 136.88 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.176 0 CA-C-N 118.888 1.344 . . . . 0.60999999999999999 108.438 179.867 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -109.57 -40.9 4.72 Favored 'General case' 0 N--CA 1.456 -0.135 0 CA-C-O 118.305 -0.855 . . . . 0.85999999999999999 110.663 177.679 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -150.61 164.46 35.99 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 108.336 -0.987 . . . . 1.8700000000000001 108.336 172.94 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.58 ' HB1' ' HG3' ' A' ' 25' ' ' GLU . . . -157.77 145.04 18.29 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 109.256 -0.646 . . . . 0.79000000000000004 109.256 176.693 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -143.54 115.25 8.18 Favored 'General case' 0 N--CA 1.457 -0.114 0 C-N-CA 124.663 1.185 . . . . 0.80000000000000004 108.974 -164.296 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.558 HG21 ' HB1' ' A' ' 21' ' ' ALA . 5.4 p -84.45 116.69 28.58 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.569 0 N-CA-C 108.646 -0.872 . . . . 0.59999999999999998 108.646 173.679 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 53.3 t-20 -101.3 56.85 0.84 Allowed 'General case' 0 C--O 1.235 0.298 0 N-CA-C 107.224 -1.398 . . . . 0.73999999999999999 107.224 176.647 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.442 HD23 ' CG2' ' A' ' 39' ' ' VAL . 0.2 OUTLIER -67.36 -21.58 65.62 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 114.552 -1.203 . . . . 1.04 110.02 -177.003 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -46.32 -35.36 5.28 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 123.687 0.795 . . . . 0.76000000000000001 112.14 166.653 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 13.3 t -125.37 37.18 4.43 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 122.462 0.305 . . . . 1.2 110.383 171.695 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 50.06 34.69 8.64 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.681 1.592 . . . . 2.6200000000000001 113.264 172.988 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 87.0 m -126.03 157.47 37.83 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.445 1.098 . . . . 0.71999999999999997 108.621 -176.595 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 14.9 p -134.12 144.93 34.0 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 O-C-N 121.284 -0.885 . . . . 0.51000000000000001 109.875 172.239 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 25.9 m120 -128.05 136.22 50.94 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 125.344 1.458 . . . . 0.40999999999999998 108.305 -179.083 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 20.6 t -129.5 126.11 62.75 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 N-CA-C 105.475 -2.046 . . . . 2.23 105.475 -176.369 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 21.9 mm -105.85 103.01 14.7 Favored 'Isoleucine or valine' 0 C--O 1.239 0.548 0 N-CA-C 108.007 -1.108 . . . . 0.51000000000000001 108.007 -174.184 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.425 ' CE2' HD11 ' A' ' 8' ' ' ILE . 7.7 p90 -141.62 169.87 16.78 Favored 'General case' 0 CA--C 1.512 -0.504 0 O-C-N 122.218 -0.301 . . . . 2.0699999999999998 111.364 -170.964 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -89.54 109.57 32.82 Favored Pre-proline 0 N--CA 1.449 -0.517 0 O-C-N 124.299 1.0 . . . . 3.8100000000000001 109.444 177.021 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -71.14 8.33 1.12 Allowed 'Trans proline' 0 CA--C 1.54 0.777 0 C-N-CA 122.698 2.265 . . . . 0.62 113.068 179.923 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -88.07 -25.15 23.2 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.033 0.933 . . . . 0.88 109.596 168.837 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -115.52 -59.44 2.0 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 124.305 1.042 . . . . 3.3599999999999999 109.697 -171.062 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.323 3.8 p -91.74 -166.29 1.53 Allowed 'General case' 0 C--N 1.342 0.246 0 N-CA-C 110.35 -0.241 . . . . 0.53000000000000003 110.35 163.132 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 122.84 87.59 0.85 Allowed Glycine 0 N--CA 1.444 -0.784 0 N-CA-C 104.103 -3.599 . . . . 2.1600000000000001 104.103 -142.456 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 72.3 p -14.11 -18.99 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.36 1 C-N-CA 138.344 6.657 . . . . 1.3600000000000001 119.476 -148.022 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -26.39 -62.34 0.08 Allowed 'General case' 0 N--CA 1.443 -0.776 0 C-N-CA 127.124 2.17 . . . . 0.55000000000000004 113.756 166.391 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.69 -41.1 63.11 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 117.97 -1.492 . . . . 0.48999999999999999 109.931 -168.654 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.2 mp -52.81 -53.63 20.19 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.807 0 CA-C-N 114.446 -1.252 . . . . 0.87 109.193 176.305 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -66.92 -45.55 77.55 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 122.69 0.396 . . . . 1.4299999999999999 110.093 -173.765 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -46.06 -57.36 4.52 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 122.57 1.176 . . . . 2.6800000000000002 110.761 170.185 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 5.0 mmmt -67.66 -39.09 84.58 Favored 'General case' 0 N--CA 1.435 -1.178 0 CA-C-N 115.741 -0.663 . . . . 2.9100000000000001 112.409 -176.323 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -52.25 -50.38 37.26 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 N-CA-C 107.49 -1.3 . . . . 0.46000000000000002 107.49 -177.554 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 25.3 mm-40 -57.62 -58.31 8.9 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.033 0.933 . . . . 1.9299999999999999 110.55 174.044 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 24.9 mmtt -52.94 -37.03 60.6 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 113.287 0.847 . . . . 3.8999999999999999 113.287 -178.448 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 18.2 mt -70.64 -18.09 62.86 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.52 1.528 . . . . 0.68000000000000005 111.542 178.232 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 90.32 41.9 5.37 Favored Glycine 0 CA--C 1.525 0.67 0 C-N-CA 124.649 1.119 . . . . 0.46000000000000002 110.488 179.022 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -138.19 175.46 9.56 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 124.157 0.983 . . . . 1.99 109.249 -176.345 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 15.1 t-160 -141.05 157.57 45.13 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 108.649 -0.871 . . . . 2.0299999999999998 108.649 171.182 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 9.5 p -135.83 141.35 42.19 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 N-CA-C 106.528 -1.656 . . . . 1.4299999999999999 106.528 -178.037 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 3.4 t -115.73 130.52 70.24 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 N-CA-C 108.599 -0.889 . . . . 0.57999999999999996 108.599 -175.145 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 45.5 mm -101.38 74.55 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 124.114 0.966 . . . . 1.25 108.452 -170.059 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -72.16 0.69 9.03 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 114.528 1.307 . . . . 3.4500000000000002 114.528 -178.568 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 68.03 76.23 0.43 Allowed Glycine 0 CA--C 1.525 0.699 0 N-CA-C 110.195 -1.162 . . . . 2.8300000000000001 110.195 -179.084 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.019 0 N-CA-C 106.334 -1.728 . . . . 11.74 106.334 173.547 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 77' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.3 mtt . . . . . 0 N--CA 1.472 0.656 0 N-CA-C 106.827 -1.546 . . . . 12.109999999999999 106.827 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.3 tp -165.34 170.41 14.68 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 104.502 -2.406 . . . . 5.6600000000000001 104.502 175.087 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 49.3 m 58.9 86.51 0.09 Allowed 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.71 0.804 . . . . 0.93999999999999995 111.451 178.629 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -62.92 177.23 0.59 Allowed 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 121.266 0.555 . . . . 2.1099999999999999 110.675 173.637 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -134.69 140.39 45.96 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 108.684 -0.858 . . . . 1.1799999999999999 108.684 173.959 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -133.16 156.79 46.82 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 124.671 1.188 . . . . 4.0899999999999999 108.999 164.664 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -105.36 121.32 43.65 Favored 'General case' 0 N--CA 1.434 -1.261 0 N-CA-C 101.683 -3.451 . . . . 1.8100000000000001 101.683 174.034 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 24.8 mm -101.26 165.17 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.388 0 N-CA-C 106.639 -1.615 . . . . 2.0800000000000001 106.639 168.013 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -139.02 132.62 30.46 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 107.076 -1.453 . . . . 0.46999999999999997 107.076 177.581 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -156.95 178.45 10.35 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 118.883 0.765 . . . . 2.0 110.848 174.211 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 25.0 mm100 -91.47 166.33 12.91 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.314 1.445 . . . . 2.3700000000000001 110.405 -178.68 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -131.64 157.04 43.11 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.136 0 C-N-CA 124.057 0.943 . . . . 2.1600000000000001 110.723 174.936 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 63.7 m -149.84 166.73 28.62 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 125.5 1.52 . . . . 0.96999999999999997 109.018 177.352 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 71.66 67.03 1.96 Allowed Glycine 0 CA--C 1.525 0.691 0 N-CA-C 109.211 -1.556 . . . . 1.74 109.211 -177.394 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -147.55 166.66 26.66 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 124.153 0.981 . . . . 2.48 109.522 -174.731 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.3 p -126.22 -61.36 1.22 Allowed 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 124.049 0.939 . . . . 2.2599999999999998 109.497 168.623 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 30.8 p -109.31 151.61 26.35 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 123.694 0.798 . . . . 2.1699999999999999 111.297 -176.174 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -76.24 53.25 0.8 Allowed 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.604 0.762 . . . . 1.71 110.201 174.764 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -145.52 -51.96 0.26 Allowed 'General case' 0 C--O 1.23 0.048 0 C-N-CA 123.49 0.716 . . . . 0.68999999999999995 110.908 -175.844 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 7.5 p -55.41 -38.02 68.39 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 119.129 0.877 . . . . 2.5099999999999998 109.997 167.764 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.426 ' HB1' HG21 ' A' ' 39' ' ' VAL . . . -47.84 -31.07 4.59 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.483 1.513 . . . . 0.48999999999999999 112.899 171.17 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -72.84 -55.25 6.95 Favored 'General case' 0 N--CA 1.454 -0.272 0 O-C-N 121.099 -1.001 . . . . 0.29999999999999999 109.912 172.454 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 3.5 mpp_? -54.56 -40.4 68.68 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 118.736 -0.649 . . . . 4.2999999999999998 111.5 -174.892 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.414 HG21 ' CD1' ' A' ' 69' ' ' TYR . 5.4 pt -55.45 -54.45 25.24 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 C-N-CA 119.554 -0.858 . . . . 0.48999999999999999 110.802 175.535 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -57.69 -39.2 76.62 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 123.639 0.776 . . . . 3.1000000000000001 111.313 179.496 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 56.5 mmtt -71.43 -45.8 61.73 Favored 'General case' 0 CA--C 1.534 0.339 0 O-C-N 121.484 -0.76 . . . . 2.0600000000000001 110.201 -175.079 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.77 -39.47 98.01 Favored Glycine 0 CA--C 1.53 0.988 0 N-CA-C 110.376 -1.09 . . . . 0.57999999999999996 110.376 172.329 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.0 tt -60.01 -36.11 76.51 Favored 'General case' 0 CA--C 1.538 0.516 0 O-C-N 121.744 -0.857 . . . . 1.8999999999999999 110.279 174.818 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -60.79 -27.99 68.41 Favored 'General case' 0 N--CA 1.454 -0.242 0 O-C-N 120.876 -1.14 . . . . 3.54 111.999 174.464 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 4.4 mmt85 -72.39 -5.92 39.85 Favored 'General case' 0 CA--C 1.536 0.441 0 O-C-N 121.508 -0.745 . . . . 3.3799999999999999 112.009 -177.88 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 78.7 mmm -78.23 148.22 74.09 Favored Pre-proline 0 CA--C 1.533 0.32 0 CA-C-N 119.146 0.884 . . . . 3.2999999999999998 111.05 -179.544 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -56.96 142.62 93.65 Favored 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 122.393 2.062 . . . . 0.65000000000000002 108.832 176.953 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 86.68 -20.54 23.14 Favored Glycine 0 CA--C 1.532 1.107 0 CA-C-O 118.567 -1.13 . . . . 0.57999999999999996 113.498 -178.988 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 14.4 t -94.49 123.78 46.73 Favored 'Isoleucine or valine' 0 C--N 1.344 0.334 0 CA-C-N 119.904 1.852 . . . . 0.63 110.414 -178.244 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -103.37 -37.26 7.7 Favored 'General case' 0 CA--C 1.524 -0.054 0 C-N-CA 124.519 1.127 . . . . 1.0600000000000001 111.21 -171.889 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -149.89 162.37 40.45 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 108.775 -0.824 . . . . 2.1299999999999999 108.775 174.726 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -155.45 139.28 16.22 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 122.781 0.432 . . . . 0.46000000000000002 110.203 -177.268 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -155.78 110.19 2.87 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 109.03 -0.73 . . . . 0.51000000000000001 109.03 -165.56 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.426 HG21 ' HB1' ' A' ' 21' ' ' ALA . 2.8 p -83.02 106.29 13.64 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.638 0 N-CA-C 109.256 -0.646 . . . . 0.65000000000000002 109.256 178.785 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 55.3 t-20 -84.59 56.98 4.08 Favored 'General case' 0 CA--C 1.533 0.323 0 O-C-N 120.821 -1.174 . . . . 0.63 108.819 176.188 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.67 -19.98 64.42 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 115.271 -0.877 . . . . 1.1000000000000001 109.441 -176.86 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -48.37 -38.77 20.18 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.483 0.713 . . . . 0.55000000000000004 111.952 167.491 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 8.8 t -117.08 36.09 4.37 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 118.029 0.377 . . . . 1.24 110.383 170.764 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 55.42 26.59 9.0 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.476 1.11 . . . . 4.1500000000000004 113.639 172.565 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 66.0 m -122.52 162.72 21.23 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.884 1.274 . . . . 0.63 108.679 -173.411 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.4 p -126.64 146.21 32.89 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 O-C-N 121.051 -1.03 . . . . 0.34999999999999998 109.498 170.931 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -131.58 131.02 42.96 Favored 'General case' 0 C--N 1.343 0.295 0 N-CA-C 108.113 -1.069 . . . . 0.32000000000000001 108.113 177.449 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 4.3 p -132.83 132.03 59.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 106.188 -1.782 . . . . 1.73 106.188 -175.024 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 16.9 mm -109.39 105.53 18.98 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 C-N-CA 125.374 1.47 . . . . 0.41999999999999998 107.745 -170.841 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 49.1 p90 -146.43 169.26 19.24 Favored 'General case' 0 CA--C 1.516 -0.365 0 O-C-N 122.073 -0.392 . . . . 1.7 111.677 -171.647 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 41.4 t0 -88.28 108.29 21.2 Favored Pre-proline 0 CA--C 1.533 0.305 0 O-C-N 124.484 1.115 . . . . 3.0600000000000001 110.262 175.731 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -70.89 0.94 5.72 Favored 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 123.036 2.491 . . . . 0.64000000000000001 113.351 -179.21 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -84.15 -30.68 25.68 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 119.502 1.046 . . . . 0.80000000000000004 109.144 167.686 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -105.09 -55.76 2.28 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 124.099 0.96 . . . . 2.7200000000000002 112.007 -167.544 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.263 1.6 p -92.33 -177.63 4.69 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-O 121.496 0.665 . . . . 0.51000000000000001 110.319 155.681 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 155.42 89.77 0.07 OUTLIER Glycine 0 N--CA 1.443 -0.883 0 N-CA-C 105.937 -2.865 . . . . 2.4199999999999999 105.937 -165.545 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 82.1 p -7.89 -16.62 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.561 1 C-N-CA 136.279 5.832 . . . . 1.1699999999999999 119.977 -136.369 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -25.45 -63.23 0.06 Allowed 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 127.756 2.422 . . . . 0.67000000000000004 114.352 169.827 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.81 -43.0 57.0 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 118.349 -1.341 . . . . 0.64000000000000001 109.467 -166.316 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -47.9 -56.19 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.099 0 CA-C-N 113.242 -1.799 . . . . 0.87 110.511 171.985 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -67.0 -46.02 75.82 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 118.952 0.796 . . . . 1.46 110.423 -175.047 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -45.19 -57.99 3.56 Favored 'General case' 0 C--N 1.342 0.282 0 CA-C-O 122.59 1.186 . . . . 3.3700000000000001 110.975 171.954 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.9 mmpt? -71.39 -37.75 71.55 Favored 'General case' 0 N--CA 1.431 -1.399 0 CA-C-O 118.417 -0.801 . . . . 2.4199999999999999 112.225 -174.864 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -47.61 -52.47 5.92 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 N-CA-C 107.482 -1.303 . . . . 0.46000000000000002 107.482 175.629 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -59.8 -56.55 20.35 Favored 'General case' 0 C--N 1.343 0.295 0 C-N-CA 123.693 0.797 . . . . 2.0299999999999998 110.211 175.845 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 2.7 mmmt -60.29 -28.54 68.17 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 114.018 1.118 . . . . 4.54 114.018 -175.683 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 11.8 mt -70.99 -18.24 62.61 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 125.925 1.69 . . . . 0.69999999999999996 111.373 173.741 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 90.72 45.2 4.32 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 110.217 -1.153 . . . . 0.45000000000000001 110.217 178.642 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.414 ' CD1' HG21 ' A' ' 24' ' ' ILE . 0.2 OUTLIER -141.02 173.42 11.5 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 124.039 0.935 . . . . 2.02 110.363 -177.195 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 17.3 t60 -133.64 139.95 46.79 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 109.212 -0.662 . . . . 2.1899999999999999 109.212 170.596 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 6.1 p -112.61 126.18 69.98 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 N-CA-C 107.558 -1.275 . . . . 1.51 107.558 174.863 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 26.5 t -104.46 138.38 29.38 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.154 0 N-CA-C 108.341 -0.985 . . . . 0.51000000000000001 108.341 -177.487 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 4.9 mp -109.09 77.32 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 C-N-CA 124.197 0.999 . . . . 1.27 108.388 -179.196 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -73.15 -4.21 31.34 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 125.463 1.505 . . . . 2.7000000000000002 113.743 171.985 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -87.0 -76.8 1.26 Allowed Glycine 0 CA--C 1.525 0.7 0 N-CA-C 109.406 -1.477 . . . . 3.1600000000000001 109.406 176.417 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 2.2 ttt180 . . . . . 0 C--O 1.251 1.14 0 C-N-CA 125.629 1.572 . . . . 12.470000000000001 110.457 -177.896 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 77' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.476 0.848 0 N-CA-C 104.522 -2.399 . . . . 7.8799999999999999 104.522 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.7 tt 69.73 155.73 0.14 Allowed 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 107.52 -1.289 . . . . 5.1299999999999999 107.52 -139.019 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.0 m -108.57 118.24 36.27 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 125.423 1.489 . . . . 1.0 107.061 -179.914 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -80.02 -178.27 6.42 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 123.552 0.741 . . . . 2.1000000000000001 109.723 179.335 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -136.79 141.82 42.94 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 107.79 -1.189 . . . . 1.0800000000000001 107.79 168.939 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -139.85 163.93 31.34 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 124.509 1.124 . . . . 3.6299999999999999 109.673 168.427 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.8 90.59 3.13 Favored 'General case' 0 N--CA 1.441 -0.905 0 C-N-CA 128.504 2.722 . . . . 1.6699999999999999 106.985 -159.826 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.402 HG13 ' CZ ' ' A' ' 50' ' ' TYR . 7.5 mm -83.75 162.22 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.026 0 N-CA-C 107.324 -1.362 . . . . 1.9399999999999999 107.324 -176.288 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -140.38 134.86 31.46 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 124.704 1.202 . . . . 0.58999999999999997 108.728 179.742 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -156.28 172.23 18.84 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.361 0.664 . . . . 2.3799999999999999 110.52 176.929 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -87.27 168.86 12.81 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.997 1.319 . . . . 3.8199999999999998 110.383 174.898 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.661 HG21 HD21 ' A' ' 41' ' ' LEU . 5.9 m -126.33 152.32 33.69 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 C-N-CA 124.856 1.262 . . . . 1.9199999999999999 111.976 -179.636 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 16.2 m -139.19 146.72 40.88 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 126.031 1.732 . . . . 1.0700000000000001 107.896 164.298 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 123.75 -30.35 4.9 Favored Glycine 0 CA--C 1.531 1.054 0 C-N-CA 124.93 1.252 . . . . 2.0600000000000001 111.751 -177.363 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -54.07 137.66 39.47 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 121.389 0.614 . . . . 1.8899999999999999 112.485 -178.31 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -144.2 -60.37 0.38 Allowed 'General case' 0 C--N 1.333 -0.142 0 C-N-CA 125.484 1.513 . . . . 2.4199999999999999 107.65 178.228 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 26.2 p -78.55 -5.34 52.45 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.625 1.17 . . . . 3.25 112.983 177.559 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 68.59 -55.84 0.52 Allowed 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 126.128 1.771 . . . . 2.8500000000000001 112.111 -170.102 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -46.4 -43.78 16.59 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 125.017 1.327 . . . . 1.29 113.402 -173.753 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 29.5 m -57.82 -25.42 60.6 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 112.689 0.626 . . . . 2.2000000000000002 112.689 -179.061 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.72 ' HB1' HG21 ' A' ' 39' ' ' VAL . . . -56.38 -35.05 67.28 Favored 'General case' 0 CA--C 1.537 0.454 0 O-C-N 121.755 -0.591 . . . . 0.65000000000000002 110.609 172.876 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.97 -46.74 61.82 Favored 'General case' 0 C--O 1.232 0.171 0 O-C-N 120.533 -1.354 . . . . 0.35999999999999999 109.322 171.799 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 6.5 mmm180 -51.2 -45.22 61.77 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-O 117.697 -1.144 . . . . 5.8399999999999999 111.914 -177.765 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.312 2.4 pt -60.31 -59.82 3.52 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-O 117.786 -1.102 . . . . 0.65000000000000002 110.701 -179.033 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.633 ' HG3' ' HB1' ' A' ' 37' ' ' ALA . 1.3 mp0 -43.37 -47.75 6.9 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 120.264 1.393 . . . . 2.2599999999999998 112.254 172.747 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -74.94 -17.72 60.51 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 113.429 0.9 . . . . 2.8399999999999999 113.429 -176.841 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -76.69 -45.23 13.47 Favored Glycine 0 CA--C 1.531 1.033 0 N-CA-C 110.407 -1.077 . . . . 0.67000000000000004 110.407 161.072 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 26.8 mt -61.18 -39.58 90.7 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 117.69 0.745 . . . . 2.3599999999999999 109.814 -175.498 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 9.8 tmtt? -50.31 -28.57 8.1 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.006 1.322 . . . . 3.2799999999999998 112.678 173.519 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 4.3 mtm180 -80.44 -1.64 42.36 Favored 'General case' 0 CA--C 1.535 0.382 0 O-C-N 121.637 -0.664 . . . . 6.7300000000000004 112.643 -177.748 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 61.1 mmm -98.93 146.86 32.39 Favored Pre-proline 0 CA--C 1.533 0.317 0 CA-C-N 118.876 0.762 . . . . 3.54 110.853 -172.15 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -58.22 137.01 78.36 Favored 'Trans proline' 0 N--CA 1.45 -1.034 0 C-N-CA 122.387 2.058 . . . . 0.56000000000000005 109.264 -179.622 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 95.77 -35.3 4.39 Favored Glycine 0 CA--C 1.527 0.839 0 CA-C-O 119.382 -0.677 . . . . 0.57999999999999996 111.969 -175.536 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 9.0 t -85.65 132.19 32.52 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.153 0 CA-C-N 119.27 1.535 . . . . 0.66000000000000003 109.689 -174.712 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -103.1 -46.53 4.61 Favored 'General case' 0 C--N 1.342 0.255 0 CA-C-N 118.269 0.486 . . . . 1.77 110.526 178.88 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -152.8 174.85 13.54 Favored 'General case' 0 CA--C 1.515 -0.371 0 C-N-CA 124.196 0.998 . . . . 3.46 111.101 166.685 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.633 ' HB1' ' HG3' ' A' ' 25' ' ' GLU . . . -157.95 148.48 20.66 Favored 'General case' 0 N--CA 1.441 -0.907 0 C-N-CA 124.109 0.964 . . . . 0.52000000000000002 109.435 -173.956 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -153.85 117.35 4.63 Favored 'General case' 0 CA--C 1.528 0.119 0 N-CA-C 108.054 -1.091 . . . . 0.54000000000000004 108.054 -158.772 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.903 HG22 HD23 ' A' ' 41' ' ' LEU . 7.7 p -96.24 96.48 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 C-N-CA 124.289 1.036 . . . . 0.71999999999999997 110.439 -172.923 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 51.2 t-20 -84.04 57.06 3.98 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 122.628 1.204 . . . . 0.76000000000000001 109.889 -176.968 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.903 HD23 HG22 ' A' ' 39' ' ' VAL . 0.5 OUTLIER -68.45 -21.77 64.62 Favored 'General case' 0 CA--C 1.527 0.07 0 CA-C-N 115.231 -0.895 . . . . 1.1699999999999999 110.742 -176.569 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -45.33 -34.74 3.12 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 123.611 0.764 . . . . 1.01 112.045 166.315 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 4.9 t -126.54 39.34 3.95 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 122.56 0.344 . . . . 1.6399999999999999 110.141 174.329 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 42.5 53.38 4.66 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.285 1.034 . . . . 3.5099999999999998 112.757 175.04 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 41.8 m -145.81 150.54 36.38 Favored 'General case' 0 N--CA 1.438 -1.065 0 N-CA-C 107.889 -1.152 . . . . 0.91000000000000003 107.889 177.991 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 8.9 p -122.5 142.34 39.36 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 N-CA-C 108.465 -0.939 . . . . 0.55000000000000004 108.465 171.159 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -125.3 141.98 51.76 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 124.818 1.247 . . . . 0.40999999999999998 108.173 -179.407 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.433 HG13 ' HB2' ' A' ' 37' ' ' ALA . 35.9 t -135.68 127.31 45.27 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.325 0 N-CA-C 105.981 -1.859 . . . . 2.1800000000000002 105.981 -178.543 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 21.1 mm -100.38 100.42 10.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 C-N-CA 125.774 1.63 . . . . 0.46999999999999997 107.764 -175.096 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.402 ' CZ ' HG13 ' A' ' 8' ' ' ILE . 17.6 p90 -137.53 166.02 24.88 Favored 'General case' 0 CA--C 1.518 -0.259 0 O-C-N 122.192 -0.317 . . . . 1.73 111.764 -173.597 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -84.34 123.92 74.39 Favored Pre-proline 0 C--O 1.24 0.585 0 C-N-CA 123.813 0.845 . . . . 3.1000000000000001 108.915 171.494 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -86.94 11.82 3.16 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 123.823 3.015 . . . . 0.73999999999999999 113.162 -175.155 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -97.19 -46.05 6.29 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 108.448 -0.945 . . . . 1.05 108.448 168.423 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -77.79 -44.98 25.85 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 123.951 0.9 . . . . 3.3599999999999999 109.129 -178.888 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.262 26.3 p -112.01 -137.29 0.37 Allowed 'General case' 0 CA--C 1.518 -0.254 0 C-N-CA 122.107 0.163 . . . . 0.84999999999999998 110.667 165.17 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 105.67 128.23 6.09 Favored Glycine 0 N--CA 1.44 -1.098 0 N-CA-C 105.679 -2.968 . . . . 2.0499999999999998 105.679 -123.938 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 24.0 p -30.56 -30.29 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.463 1 C-N-CA 134.66 5.184 . . . . 1.3300000000000001 113.76 -177.385 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -29.01 -62.42 0.12 Allowed 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 126.018 1.727 . . . . 0.68999999999999995 112.733 167.258 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.87 -44.22 50.17 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 117.505 -1.678 . . . . 0.5 109.907 -170.578 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.1 mp -51.64 -50.14 31.87 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.945 0 CA-C-N 112.915 -1.948 . . . . 0.98999999999999999 110.067 -178.997 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.2 -50.64 67.28 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 107.933 -1.136 . . . . 2.1200000000000001 107.933 -178.162 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.409 ' OE2' ' NZ ' ' A' ' 66' ' ' LYS . 1.3 tm-20 -44.52 -54.29 6.17 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 122.362 1.077 . . . . 3.0 110.77 178.871 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.1 mmpt? -71.4 -40.33 70.56 Favored 'General case' 0 N--CA 1.434 -1.271 0 CA-C-O 118.154 -0.926 . . . . 2.5600000000000001 113.016 179.094 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.3 mm -48.27 -50.98 10.82 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.793 0 N-CA-C 107.805 -1.183 . . . . 0.67000000000000004 107.805 176.664 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 76.1 mm-40 -57.92 -60.73 3.26 Favored 'General case' 0 C--N 1.343 0.283 0 C-N-CA 124.967 1.307 . . . . 2.98 110.284 177.096 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.409 ' NZ ' ' OE2' ' A' ' 62' ' ' GLU . 7.0 mptt -56.37 -35.38 67.63 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 112.577 0.584 . . . . 5.0 112.577 -177.059 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 35.1 mt -70.08 -18.04 63.25 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.348 1.059 . . . . 0.68999999999999995 111.529 177.909 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 98.04 35.38 5.08 Favored Glycine 0 CA--C 1.525 0.716 0 C-N-CA 124.342 0.973 . . . . 0.70999999999999996 111.535 174.453 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -127.47 169.34 13.76 Favored 'General case' 0 N--CA 1.457 -0.102 0 C-N-CA 124.378 1.071 . . . . 2.1499999999999999 108.914 173.727 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 85.9 t60 -137.67 133.66 34.53 Favored 'General case' 0 N--CA 1.453 -0.275 0 N-CA-C 106.187 -1.783 . . . . 2.04 106.187 162.768 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 23.4 m -91.35 144.57 8.91 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.691 0 CA-C-N 119.244 0.929 . . . . 2.2599999999999998 108.863 172.841 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.5 t -103.06 130.94 52.41 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 N-CA-C 107.75 -1.204 . . . . 0.89000000000000001 107.75 178.97 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 28.0 mm -109.62 75.27 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 C-N-CA 124.363 1.065 . . . . 1.0700000000000001 108.424 -173.196 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -72.64 -14.88 61.7 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 113.917 1.08 . . . . 3.1400000000000001 113.917 -178.43 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -104.13 63.88 0.36 Allowed Glycine 0 CA--C 1.525 0.715 0 N-CA-C 108.115 -1.994 . . . . 3.7999999999999998 108.115 168.191 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 50.9 tpt85 . . . . . 0 C--O 1.249 1.032 0 CA-C-O 117.908 -1.044 . . . . 13.17 112.196 -174.172 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 77' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 37.9 mtt . . . . . 0 N--CA 1.472 0.664 0 N-CA-C 108.85 -0.796 . . . . 10.1 108.85 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.4 tt -150.61 136.68 18.47 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 106.146 -1.798 . . . . 5.6100000000000003 106.146 -175.237 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.7 m -128.2 98.95 5.26 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 107.257 -1.386 . . . . 0.71999999999999997 107.257 179.528 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -66.63 178.11 1.39 Allowed 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 123.378 0.671 . . . . 3.46 109.529 172.381 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -135.22 150.84 50.17 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 108.393 -0.966 . . . . 0.93999999999999995 108.393 173.753 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 26.7 mmtp -139.74 162.1 35.95 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.481 1.113 . . . . 2.8700000000000001 108.628 163.984 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.3 mp0 -123.02 96.36 4.98 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 127.101 2.16 . . . . 2.3900000000000001 105.953 -176.937 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 23.9 mm -83.29 164.16 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.16 0 N-CA-C 107.067 -1.457 . . . . 2.1099999999999999 107.067 178.327 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -138.48 123.53 19.05 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 125.207 1.403 . . . . 0.55000000000000004 107.585 179.389 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -133.03 166.46 22.36 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 118.85 0.75 . . . . 2.8500000000000001 109.938 178.246 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -84.5 168.13 15.73 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.557 1.143 . . . . 3.6699999999999999 109.368 169.194 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 38.4 t -125.05 146.09 31.28 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 C-N-CA 124.567 1.147 . . . . 1.3 109.411 -175.22 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 11.8 m -154.8 171.16 20.05 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.918 0.887 . . . . 1.3200000000000001 110.418 172.863 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 64.06 70.38 1.08 Allowed Glycine 0 C--N 1.34 0.761 0 N-CA-C 110.5 -1.04 . . . . 1.8799999999999999 110.5 178.261 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -153.05 156.46 38.79 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 116.922 0.361 . . . . 2.73 111.304 -170.124 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -89.76 -60.89 1.82 Allowed 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 125.226 1.411 . . . . 3.27 109.49 168.255 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 21.6 p -144.09 160.81 40.26 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-O 121.836 0.827 . . . . 2.4399999999999999 112.895 -167.269 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -74.69 45.47 0.25 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.473 1.509 . . . . 1.6599999999999999 111.492 175.559 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -137.98 -49.75 0.57 Allowed 'General case' 0 C--N 1.335 -0.057 0 C-N-CA 124.614 1.166 . . . . 0.70999999999999996 108.637 177.804 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 78.3 m -53.52 -38.86 64.17 Favored 'General case' 0 C--O 1.232 0.132 0 O-C-N 121.593 -0.692 . . . . 1.21 110.76 165.643 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.592 ' HB1' HG21 ' A' ' 39' ' ' VAL . . . -45.75 -35.03 4.0 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.006 1.322 . . . . 0.66000000000000003 112.411 170.667 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.61 -54.45 10.4 Favored 'General case' 0 N--CA 1.451 -0.382 0 O-C-N 121.026 -1.046 . . . . 0.40999999999999998 109.64 174.655 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 43.3 mtm105 -48.85 -50.71 33.35 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 123.539 0.735 . . . . 6.2300000000000004 110.45 -175.595 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.463 HG21 ' CD1' ' A' ' 69' ' ' TYR . 4.9 pt -54.49 -52.75 37.12 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.164 0 O-C-N 123.761 0.663 . . . . 0.46000000000000002 109.849 -179.051 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.601 ' HG3' ' HB1' ' A' ' 37' ' ' ALA . 0.5 OUTLIER -56.34 -39.86 73.53 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 123.93 0.892 . . . . 2.1600000000000001 111.431 179.68 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 26.5 mmtt -73.68 -44.89 55.43 Favored 'General case' 0 CA--C 1.531 0.215 0 O-C-N 121.201 -0.937 . . . . 1.9199999999999999 111.509 -176.259 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -59.34 -42.44 97.41 Favored Glycine 0 CA--C 1.529 0.928 0 N-CA-C 109.988 -1.245 . . . . 0.62 109.988 172.197 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.535 HD21 HG12 ' A' ' 60' ' ' ILE . 8.5 tt -58.55 -39.61 80.7 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.571 1.149 . . . . 1.97 110.289 175.668 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -61.52 -30.17 70.46 Favored 'General case' 0 N--CA 1.452 -0.366 0 O-C-N 121.064 -1.023 . . . . 3.5299999999999998 111.66 174.915 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 16.0 mtt180 -72.13 -8.09 52.71 Favored 'General case' 0 CA--C 1.533 0.295 0 O-C-N 121.495 -0.753 . . . . 3.5899999999999999 112.638 -178.888 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 69.2 mmm -73.96 150.55 88.17 Favored Pre-proline 0 CA--C 1.533 0.289 0 CA-C-N 119.291 0.951 . . . . 3.4399999999999999 110.432 179.867 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -56.34 147.31 68.1 Favored 'Trans proline' 0 N--CA 1.451 -1.026 0 C-N-CA 121.595 1.53 . . . . 0.62 108.402 172.573 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 86.15 -22.65 11.62 Favored Glycine 0 CA--C 1.525 0.682 0 C-N-CA 124.143 0.878 . . . . 0.47999999999999998 113.194 -179.93 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 15.6 t -98.19 127.15 50.94 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 CA-C-N 119.459 1.63 . . . . 0.57999999999999996 109.903 -175.788 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -113.11 -31.34 6.68 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 123.388 0.675 . . . . 0.91000000000000003 112.04 -173.37 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -146.67 160.7 41.87 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-N 119.289 0.949 . . . . 2.1099999999999999 108.931 167.004 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.601 ' HB1' ' HG3' ' A' ' 25' ' ' GLU . . . -156.73 138.88 14.58 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 116.832 -0.167 . . . . 0.41999999999999998 111.307 177.582 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -154.23 113.92 3.8 Favored 'General case' 0 C--N 1.341 0.221 0 N-CA-C 107.381 -1.34 . . . . 0.45000000000000001 107.381 -160.466 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.592 HG21 ' HB1' ' A' ' 21' ' ' ALA . 6.0 p -93.15 102.11 13.31 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 C-N-CA 123.267 0.627 . . . . 0.66000000000000003 110.058 -175.501 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 52.0 t-20 -83.04 58.65 4.51 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 122.536 1.16 . . . . 0.59999999999999998 110.012 -177.415 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.1 -20.01 65.72 Favored 'General case' 0 C--O 1.225 -0.194 0 CA-C-N 114.943 -1.026 . . . . 0.89000000000000001 110.675 -177.692 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -48.55 -30.13 4.96 Favored 'General case' 0 CA--C 1.528 0.134 0 C-N-CA 123.789 0.835 . . . . 0.63 112.644 170.424 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 4.3 t -129.74 32.67 4.55 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 109.792 -0.448 . . . . 1.22 109.792 172.583 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 29.0 mp0 54.41 40.53 31.86 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.64 1.176 . . . . 4.0 113.086 175.067 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -124.86 163.55 21.96 Favored 'General case' 0 N--CA 1.454 -0.259 0 O-C-N 121.327 -0.858 . . . . 0.98999999999999999 109.585 176.11 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.7 p -133.56 140.75 46.04 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 N-CA-C 108.795 -0.817 . . . . 0.35999999999999999 108.795 171.893 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 18.7 m120 -129.46 138.55 51.48 Favored 'General case' 0 C--N 1.344 0.365 0 N-CA-C 108.193 -1.039 . . . . 0.28999999999999998 108.193 -178.232 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.432 HG21 HD21 ' A' ' 28' ' ' LEU . 3.8 p -136.65 128.67 44.05 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 N-CA-C 106.529 -1.656 . . . . 1.72 106.529 -176.11 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 9.8 mm -105.9 96.52 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 C-N-CA 125.918 1.687 . . . . 0.40999999999999998 107.278 -171.602 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 44.1 p90 -136.96 165.06 26.87 Favored 'General case' 0 CA--C 1.515 -0.375 0 O-C-N 122.18 -0.325 . . . . 1.72 111.596 -170.76 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 45.0 t0 -86.58 108.85 19.72 Favored Pre-proline 0 C--N 1.329 -0.29 0 C-N-CA 125.198 1.399 . . . . 2.9100000000000001 109.666 176.8 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -71.26 2.03 4.81 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 123.209 2.606 . . . . 0.64000000000000001 113.4 -177.878 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -90.31 -30.22 17.62 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 119.395 0.998 . . . . 0.77000000000000002 109.345 169.057 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -101.71 -51.73 3.37 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.359 0.664 . . . . 3.0899999999999999 110.361 -170.315 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.9 p -99.81 -174.11 2.62 Favored 'General case' 0 C--O 1.225 -0.205 0 C-N-CA 123.872 0.869 . . . . 0.63 110.598 158.096 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 145.16 92.63 0.14 Allowed Glycine 0 N--CA 1.443 -0.899 0 N-CA-C 104.87 -3.292 . . . . 2.4300000000000002 104.87 -158.228 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 48.8 p -10.24 -18.9 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.577 1 C-N-CA 137.068 6.147 . . . . 1.0800000000000001 119.829 -139.087 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -26.8 -61.84 0.08 Allowed 'General case' 0 N--CA 1.439 -0.987 0 C-N-CA 127.893 2.477 . . . . 0.73999999999999999 114.418 170.11 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.14 -44.76 59.62 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 117.991 -1.484 . . . . 0.70999999999999996 109.259 -168.15 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.535 HG12 HD21 ' A' ' 28' ' ' LEU . 2.2 mt -53.21 -52.76 27.7 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 CA-C-N 112.918 -1.946 . . . . 0.90000000000000002 110.682 178.462 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.92 -45.6 85.15 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 120.06 1.3 . . . . 1.75 109.2 -177.019 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -47.59 -57.32 5.6 Favored 'General case' 0 C--N 1.343 0.318 0 CA-C-O 123.148 1.451 . . . . 2.8399999999999999 109.466 177.264 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.4 mmpt? -71.17 -36.04 71.85 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-N 114.768 -1.105 . . . . 2.5 112.979 -175.403 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -50.04 -53.17 11.89 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 N-CA-C 107.405 -1.331 . . . . 0.41999999999999998 107.405 174.501 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 -60.73 -55.72 29.77 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 115.458 -0.792 . . . . 1.8400000000000001 110.74 176.04 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -57.13 -34.47 68.41 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 113.484 0.92 . . . . 4.5599999999999996 113.484 -176.674 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.435 HD13 ' HA ' ' A' ' 24' ' ' ILE . 13.6 mt -71.54 -19.49 62.16 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 125.815 1.646 . . . . 0.66000000000000003 111.918 174.356 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 95.89 45.37 2.89 Favored Glycine 0 CA--C 1.525 0.678 0 C-N-CA 125.169 1.366 . . . . 0.48999999999999999 111.378 175.914 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.463 ' CD1' HG21 ' A' ' 24' ' ' ILE . 0.3 OUTLIER -140.39 173.7 11.24 Favored 'General case' 0 N--CA 1.458 -0.068 0 C-N-CA 124.216 1.006 . . . . 2.02 110.504 -178.061 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -152.44 126.74 9.25 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 109.49 -0.559 . . . . 2.0499999999999998 109.49 171.946 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 16.1 m -83.89 164.64 2.6 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 C-N-CA 123.623 0.769 . . . . 2.4399999999999999 109.61 173.932 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 1.9 t -125.6 136.33 61.16 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 O-C-N 121.439 -0.788 . . . . 1.0600000000000001 108.944 176.434 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 11.2 mm -102.59 71.68 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 C-N-CA 123.767 0.827 . . . . 1.25 109.329 -171.483 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -72.82 2.16 7.26 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 114.75 1.389 . . . . 2.75 114.75 -175.108 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 72.75 82.39 0.32 Allowed Glycine 0 CA--C 1.527 0.834 0 N-CA-C 109.03 -1.628 . . . . 3.5600000000000001 109.03 -175.85 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.253 1.26 0 CA-C-O 116.347 -1.787 . . . . 14.58 107.04 -174.625 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 77' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 44.6 mtt . . . . . 0 N--CA 1.473 0.709 0 CA-C-O 118.937 -0.554 . . . . 10.140000000000001 109.571 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.7 pp -52.61 -36.85 57.16 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 122.873 0.469 . . . . 5.6900000000000004 111.472 177.016 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 21.5 m -113.41 146.98 38.63 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 125.73 1.612 . . . . 1.3 106.992 163.214 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -91.31 -175.99 4.42 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 108.073 -1.084 . . . . 2.0800000000000001 108.073 157.831 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.6 mm100 -134.47 146.89 50.19 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 106.628 -1.619 . . . . 1.1599999999999999 106.628 165.616 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 75.2 mttt -141.75 156.78 45.58 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 123.918 0.887 . . . . 2.96 110.806 161.504 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -111.03 92.02 3.88 Favored 'General case' 0 N--CA 1.44 -0.969 0 C-N-CA 128.156 2.582 . . . . 1.3600000000000001 107.152 -167.954 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 6.8 mm -83.14 162.01 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.218 0 N-CA-C 106.916 -1.512 . . . . 1.97 106.916 -175.559 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -141.16 116.07 9.78 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 124.409 1.084 . . . . 0.60999999999999999 108.769 -173.804 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 66.3 mtm -138.18 173.17 11.9 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 118.527 0.603 . . . . 1.8600000000000001 110.539 -175.122 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.67 168.43 9.69 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 125.934 1.694 . . . . 3.5499999999999998 108.94 172.598 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 19.6 m -129.04 174.88 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 C-N-CA 123.455 0.702 . . . . 2.0699999999999998 110.12 172.851 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 57.8 m -151.02 175.14 12.37 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 124.304 1.042 . . . . 0.93999999999999995 108.328 173.32 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 85.82 -35.01 3.27 Favored Glycine 0 CA--C 1.531 1.09 0 O-C-N 122.019 -0.426 . . . . 2.3999999999999999 112.573 178.304 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -48.16 141.84 5.88 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.096 0.959 . . . . 1.8500000000000001 112.877 179.325 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -103.94 -46.19 4.55 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 124.684 1.194 . . . . 2.2400000000000002 110.09 171.809 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 18.4 p -132.62 161.3 34.26 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 123.752 0.821 . . . . 2.0699999999999998 110.918 -175.342 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -77.02 56.75 1.27 Allowed 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.104 0.962 . . . . 2.0800000000000001 110.631 178.293 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -142.52 -57.88 0.44 Allowed 'General case' 0 N--CA 1.456 -0.138 0 C-N-CA 123.854 0.862 . . . . 0.96999999999999997 109.549 176.322 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 58.9 m -54.08 -43.32 70.24 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 121.011 0.434 . . . . 1.3899999999999999 111.65 -174.63 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.59 -22.6 13.8 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.232 1.013 . . . . 0.54000000000000004 112.963 178.069 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.437 ' HA ' HG11 ' A' ' 39' ' ' VAL . . . -70.24 -47.64 60.46 Favored 'General case' 0 N--CA 1.452 -0.363 0 O-C-N 121.163 -0.961 . . . . 0.60999999999999999 110.267 172.163 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 52.7 mtp85 -58.61 -48.57 80.55 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 109.486 -0.561 . . . . 4.2199999999999998 109.486 -171.107 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.429 ' HA ' HD13 ' A' ' 67' ' ' LEU . 5.4 pt -55.63 -51.48 58.1 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 O-C-N 123.684 0.615 . . . . 0.64000000000000001 110.005 179.02 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -55.64 -43.86 76.61 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 113.455 0.909 . . . . 4.5199999999999996 113.455 179.116 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 13.4 mptt -72.69 -40.98 65.8 Favored 'General case' 0 CA--C 1.536 0.425 0 O-C-N 121.505 -0.747 . . . . 2.1400000000000001 109.643 -175.954 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -57.16 -39.89 90.69 Favored Glycine 0 CA--C 1.532 1.141 0 N-CA-C 111.147 -0.781 . . . . 0.64000000000000001 111.147 168.727 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.8 tt -65.3 -44.24 88.54 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.401 1.08 . . . . 1.8300000000000001 109.363 179.136 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 27.0 ttmt -54.5 -39.13 67.26 Favored 'General case' 0 CA--C 1.53 0.178 0 O-C-N 121.258 -0.902 . . . . 3.6600000000000001 111.075 175.383 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.91 -8.66 7.53 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 114.389 1.255 . . . . 4.3499999999999996 114.389 -179.589 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 82.6 mmm -81.85 151.98 68.31 Favored Pre-proline 0 CA--C 1.536 0.425 0 CA-C-N 120.089 1.313 . . . . 3.4399999999999999 111.521 -177.633 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -59.05 150.89 70.18 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 122.427 2.085 . . . . 0.77000000000000002 110.628 178.985 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 79.31 -25.92 2.67 Favored Glycine 0 CA--C 1.531 1.06 0 C-N-CA 123.702 0.668 . . . . 0.66000000000000003 112.685 -177.466 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 15.4 t -86.45 141.05 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 CA-C-N 118.901 1.35 . . . . 0.82999999999999996 108.879 176.102 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -119.76 -43.22 2.58 Favored 'General case' 0 C--N 1.34 0.153 0 CA-C-O 118.716 -0.659 . . . . 1.3799999999999999 111.243 179.113 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -143.33 169.13 18.22 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 118.978 0.808 . . . . 1.8899999999999999 110.82 176.69 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -159.64 154.18 24.13 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.908 -0.587 . . . . 1.22 111.079 -177.343 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -155.76 94.52 1.57 Allowed 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 125.567 1.547 . . . . 1.0 109.173 -168.393 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.559 ' CG2' HD23 ' A' ' 41' ' ' LEU . 3.5 p -78.93 93.98 1.67 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 CA-C-O 121.867 0.842 . . . . 0.96999999999999997 109.355 -177.852 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 44.8 t30 -81.67 58.75 3.88 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 122.212 1.006 . . . . 0.62 109.854 -176.196 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.559 HD23 ' CG2' ' A' ' 39' ' ' VAL . 0.4 OUTLIER -69.78 -19.99 63.49 Favored 'General case' 0 N--CA 1.457 -0.081 0 C-N-CA 124.462 1.105 . . . . 1.01 111.016 -179.212 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -43.32 -39.78 3.26 Favored 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 124.064 0.946 . . . . 0.68000000000000005 111.931 169.832 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 9.9 t -128.1 40.3 3.7 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 122.574 0.35 . . . . 1.23 110.291 172.07 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 50.85 51.98 15.9 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.731 1.213 . . . . 3.2999999999999998 113.741 172.259 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -131.49 161.15 33.22 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 124.588 1.155 . . . . 2.0899999999999999 109.013 175.529 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.5 p -131.62 134.74 60.15 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 N-CA-C 107.706 -1.22 . . . . 0.34999999999999998 107.706 167.669 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -123.03 126.79 47.78 Favored 'General case' 0 C--N 1.341 0.233 0 N-CA-C 108.559 -0.904 . . . . 0.58999999999999997 108.559 177.524 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 46.8 t -126.32 130.96 71.95 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 N-CA-C 105.638 -1.986 . . . . 2.21 105.638 -177.169 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 10.6 mm -105.08 99.72 9.04 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 C-N-CA 125.336 1.455 . . . . 0.48999999999999999 107.694 -175.548 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 53.2 p90 -139.61 171.31 14.42 Favored 'General case' 0 CA--C 1.515 -0.369 0 C-N-CA 122.719 0.408 . . . . 2.1699999999999999 111.111 -174.61 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 45.8 t0 -89.23 107.08 15.81 Favored Pre-proline 0 C--O 1.234 0.255 0 CA-C-O 118.35 -0.833 . . . . 3.2200000000000002 109.278 176.683 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -71.78 4.92 2.77 Favored 'Trans proline' 0 N--CA 1.451 -0.978 0 C-N-CA 122.178 1.918 . . . . 0.87 112.915 -179.236 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -86.73 -33.46 19.98 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 119.462 1.028 . . . . 1.0800000000000001 109.163 166.604 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 13.2 tt0 -103.42 -57.04 2.1 Favored 'General case' 0 C--N 1.343 0.323 0 C-N-CA 122.871 0.468 . . . . 2.6800000000000002 110.278 -169.336 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.405 0.6 OUTLIER -84.7 -178.66 6.93 Favored 'General case' 0 C--O 1.224 -0.242 0 CA-C-O 122.537 1.16 . . . . 0.56000000000000005 113.77 155.513 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -179.18 -144.27 5.71 Favored Glycine 0 N--CA 1.434 -1.474 1 N-CA-C 102.944 -4.062 . . . . 2.5299999999999998 102.944 -173.312 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 19.2 p -72.76 -40.29 66.11 Favored 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 124.509 1.124 . . . . 1.6000000000000001 108.398 174.51 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -38.77 -62.65 0.59 Allowed 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 126.235 1.814 . . . . 0.81000000000000005 114.119 -169.682 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -72.62 -42.33 64.58 Favored 'General case' 0 CA--C 1.517 -0.321 0 C-N-CA 119.079 -1.048 . . . . 0.59999999999999998 108.98 -168.753 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -53.35 -55.68 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.17 0 CA-C-N 113.437 -1.71 . . . . 0.79000000000000004 110.394 177.85 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.83 -46.9 87.81 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 119.827 1.194 . . . . 1.5 110.085 -178.759 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -47.58 -57.76 5.06 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 122.406 1.098 . . . . 2.9100000000000001 110.722 176.836 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.2 -39.81 74.96 Favored 'General case' 0 N--CA 1.436 -1.155 0 CA-C-O 118.621 -0.704 . . . . 2.6499999999999999 112.3 -176.802 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.1 mm -48.54 -52.14 9.35 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 C-N-CA 125.175 1.39 . . . . 0.53000000000000003 107.481 175.084 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -60.71 -58.0 10.33 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 124.372 1.069 . . . . 1.9199999999999999 110.875 177.665 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 3.4 mptp? -56.62 -37.61 70.94 Favored 'General case' 0 CA--C 1.536 0.42 0 O-C-N 121.499 -0.75 . . . . 4.0099999999999998 112.375 -176.766 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.429 HD13 ' HA ' ' A' ' 24' ' ' ILE . 13.7 mt -69.82 -17.77 63.42 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.461 1.105 . . . . 0.88 111.787 176.14 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 91.02 45.46 4.15 Favored Glycine 0 C--N 1.336 0.557 0 C-N-CA 124.369 0.985 . . . . 0.69999999999999996 110.986 174.342 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.422 ' CD1' HG21 ' A' ' 24' ' ' ILE . 0.4 OUTLIER -137.49 175.28 9.74 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 123.972 0.909 . . . . 1.9099999999999999 110.685 -177.872 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 2.3 t-80 -142.66 128.26 19.13 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 109.061 -0.718 . . . . 1.8700000000000001 109.061 169.657 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 11.7 p -88.76 148.85 4.26 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 C-N-CA 125.056 1.343 . . . . 1.5600000000000001 108.127 169.679 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 41.1 t -120.3 138.84 49.52 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 C-N-CA 125.249 1.42 . . . . 0.64000000000000001 108.615 179.057 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 26.8 mm -101.72 75.33 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 C-N-CA 124.805 1.242 . . . . 0.93999999999999995 109.564 -168.138 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -73.6 3.68 5.95 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 115.181 1.549 . . . . 3.27 115.181 -177.022 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 64.58 68.95 1.47 Allowed Glycine 0 CA--C 1.526 0.735 0 N-CA-C 110.254 -1.139 . . . . 3.1099999999999999 110.254 179.573 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.254 1.325 0 N-CA-C 105.005 -2.22 . . . . 12.26 105.005 172.042 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 77' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.8 mtt . . . . . 0 N--CA 1.473 0.696 0 N-CA-C 106.026 -1.842 . . . . 9.5899999999999999 106.026 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -160.8 143.89 13.1 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 106.536 -1.653 . . . . 5.2800000000000002 106.536 -174.777 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 57.9 m -81.45 126.06 31.19 Favored 'General case' 0 N--CA 1.443 -0.803 0 C-N-CA 125.673 1.589 . . . . 1.03 108.224 176.142 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -64.95 174.92 1.7 Allowed 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 109.095 -0.706 . . . . 2.8599999999999999 109.095 155.013 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -135.08 148.95 49.98 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 106.702 -1.592 . . . . 1.5600000000000001 106.702 168.559 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 10.5 mmpt? -138.62 157.12 46.74 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 123.401 0.68 . . . . 3.8700000000000001 109.677 165.138 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.68 103.88 12.49 Favored 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 128.745 2.818 . . . . 1.6100000000000001 107.847 -177.79 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.547 HD11 ' CG1' ' A' ' 48' ' ' VAL . 2.1 pp -84.95 165.56 2.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 N-CA-C 109.006 -0.739 . . . . 4.7800000000000002 109.006 168.537 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -137.19 119.34 15.53 Favored 'General case' 0 C--O 1.226 -0.169 0 N-CA-C 106.879 -1.526 . . . . 0.78000000000000003 106.879 173.438 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 22.8 mmt -137.4 172.34 13.13 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 119.596 1.089 . . . . 5.2199999999999998 110.411 -177.511 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 17.9 mm100 -91.87 158.87 16.07 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 123.813 0.845 . . . . 2.3700000000000001 110.014 -178.214 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 22.1 t -117.22 153.66 18.99 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 C-N-CA 124.373 1.069 . . . . 1.1200000000000001 109.079 -176.457 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 37.5 m -149.5 175.71 11.25 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.089 0.956 . . . . 0.93000000000000005 109.143 172.004 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 82.12 -36.64 2.54 Favored Glycine 0 CA--C 1.533 1.181 0 O-C-N 121.525 -0.734 . . . . 2.0099999999999998 112.485 -179.132 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -42.05 143.69 0.54 Allowed 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.643 1.577 . . . . 1.8100000000000001 113.786 177.721 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -110.42 -49.04 3.09 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 125.234 1.414 . . . . 2.27 111.532 169.796 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 18.4 p -130.64 161.97 30.42 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 123.186 0.594 . . . . 2.0499999999999998 110.807 -176.136 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -77.0 55.88 1.16 Allowed 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.187 0.995 . . . . 2.21 110.572 179.423 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -143.89 -56.3 0.38 Allowed 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 124.118 0.967 . . . . 0.85999999999999999 109.789 178.132 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 59.4 m -55.88 -40.72 73.38 Favored 'General case' 0 CA--C 1.532 0.269 0 O-C-N 121.916 -0.49 . . . . 1.1899999999999999 111.989 -173.93 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.798 ' HB1' HG21 ' A' ' 39' ' ' VAL . . . -56.29 -24.37 42.69 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.022 0.529 . . . . 0.5 112.32 177.686 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.8 -52.64 34.69 Favored 'General case' 0 N--CA 1.452 -0.355 0 O-C-N 120.353 -1.467 . . . . 0.41999999999999998 108.937 172.809 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 6.6 mtt-85 -53.74 -46.84 71.01 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.318 0.647 . . . . 3.75 110.239 -175.255 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.468 HG21 ' CD1' ' A' ' 69' ' ' TYR . 3.1 pt -57.85 -53.89 39.12 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.455 0 C-N-CA 119.756 -0.778 . . . . 0.5 110.85 -179.763 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -55.01 -43.69 73.88 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 119.299 0.954 . . . . 2.6000000000000001 111.862 177.321 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.2 mptp? -68.83 -46.18 69.24 Favored 'General case' 0 CA--C 1.533 0.291 0 O-C-N 121.298 -0.877 . . . . 1.4399999999999999 110.61 -175.807 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -63.08 -38.85 97.24 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 110.48 -1.048 . . . . 0.67000000000000004 110.48 175.061 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.53 HD11 HG21 ' A' ' 34' ' ' VAL . 2.9 tm? -60.32 -44.56 95.35 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 108.069 -1.086 . . . . 2.4199999999999999 108.069 179.294 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -54.51 -26.07 29.47 Favored 'General case' 0 CA--C 1.542 0.665 0 O-C-N 121.561 -0.712 . . . . 2.9100000000000001 112.683 175.093 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -71.22 -9.11 57.55 Favored 'General case' 0 CA--C 1.539 0.527 0 O-C-N 120.583 -1.323 . . . . 3.6600000000000001 112.659 177.295 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -73.79 158.03 86.6 Favored Pre-proline 0 CA--C 1.539 0.528 0 CA-C-N 118.99 0.813 . . . . 3.6200000000000001 111.552 -179.066 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -70.98 114.5 3.92 Favored 'Trans proline' 0 N--CA 1.45 -1.058 0 C-N-CA 121.811 1.674 . . . . 1.05 109.74 175.577 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 121.32 -30.27 5.46 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 124.08 0.848 . . . . 0.84999999999999998 113.002 170.818 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.53 HG21 HD11 ' A' ' 28' ' ' LEU . 61.6 t -83.37 141.05 15.38 Favored 'Isoleucine or valine' 0 C--N 1.342 0.254 0 CA-C-N 118.338 1.069 . . . . 0.67000000000000004 109.445 172.133 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 7.0 m -118.29 -38.31 3.2 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-O 118.39 -0.814 . . . . 1.1699999999999999 111.126 -177.27 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -136.7 163.6 30.21 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 119.542 1.065 . . . . 2.2400000000000002 111.843 167.132 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -158.36 140.86 14.39 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 112.541 0.571 . . . . 0.39000000000000001 112.541 -177.845 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -153.82 106.85 2.91 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 106.648 -1.612 . . . . 0.41999999999999998 106.648 -165.94 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.798 HG21 ' HB1' ' A' ' 21' ' ' ALA . 4.8 p -81.16 127.99 39.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 N-CA-C 107.351 -1.352 . . . . 0.63 107.351 174.667 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 54.7 t-20 -111.75 57.62 0.64 Allowed 'General case' 0 C--O 1.235 0.291 0 CA-C-O 122.968 1.366 . . . . 0.71999999999999997 107.974 179.878 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.591 HD23 HG22 ' A' ' 39' ' ' VAL . 0.2 OUTLIER -65.78 -20.1 66.14 Favored 'General case' 0 C--O 1.227 -0.11 0 CA-C-N 113.976 -1.465 . . . . 0.90000000000000002 111.12 -176.161 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -46.94 -34.58 5.64 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.447 0.699 . . . . 0.60999999999999999 112.312 166.842 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 14.7 t -122.09 27.66 7.91 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-O 121.284 0.564 . . . . 1.24 110.215 174.249 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 54.39 27.54 8.29 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 126.387 1.875 . . . . 2.6299999999999999 114.431 178.469 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 12.2 m -115.82 153.63 31.12 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.112 0.965 . . . . 0.62 109.136 -178.124 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.1 p -117.36 142.9 29.35 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 C-N-CA 124.121 0.968 . . . . 0.35999999999999999 109.121 170.667 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 21.1 m120 -125.95 131.86 52.2 Favored 'General case' 0 C--N 1.343 0.316 0 N-CA-C 106.673 -1.602 . . . . 0.34000000000000002 106.673 174.217 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.547 ' CG1' HD11 ' A' ' 8' ' ' ILE . 0.1 OUTLIER -132.24 128.06 58.24 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.706 0 N-CA-C 105.755 -1.942 . . . . 1.97 105.755 -178.962 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 10.7 mm -108.96 96.83 5.0 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 C-N-CA 126.113 1.765 . . . . 0.47999999999999998 108.104 -168.778 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.477 ' HB3' HG22 ' A' ' 34' ' ' VAL . 44.9 p90 -130.93 172.54 11.93 Favored 'General case' 0 CA--C 1.511 -0.552 0 O-C-N 121.317 -0.864 . . . . 1.8700000000000001 110.913 -169.649 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 36.0 t0 -90.28 107.7 21.52 Favored Pre-proline 0 CA--C 1.536 0.426 0 O-C-N 124.526 1.142 . . . . 2.8100000000000001 110.051 174.826 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -75.42 6.84 3.32 Favored 'Trans proline' 0 N--CA 1.451 -1.028 0 C-N-CA 122.434 2.089 . . . . 0.62 113.072 -178.903 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -81.77 -26.25 34.61 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 119.473 1.033 . . . . 0.81999999999999995 108.926 165.484 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -108.65 -66.59 1.04 Allowed 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 107.989 -1.115 . . . . 3.8100000000000001 107.989 -170.727 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.483 HG22 ' HB3' ' A' ' 59' ' ' ALA 0.417 0.2 OUTLIER -76.67 178.09 7.02 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 116.573 2.064 . . . . 0.64000000000000001 116.573 165.156 . . . . . . . . 4 4 . 1 . 026 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -163.68 -145.05 4.23 Favored Glycine 0 N--CA 1.432 -1.622 1 N-CA-C 102.424 -4.27 . . . . 2.5499999999999998 102.424 176.39 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 30.9 p -75.23 -37.68 60.95 Favored 'General case' 0 N--CA 1.444 -0.747 0 C-N-CA 125.34 1.456 . . . . 1.21 109.087 172.891 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -49.42 -61.2 2.23 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 124.936 1.294 . . . . 1.21 113.912 -165.601 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.483 ' HB3' HG22 ' A' ' 55' ' ' THR . . . -71.87 -33.66 68.56 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 118.773 -1.171 . . . . 1.0800000000000001 108.834 -168.98 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.5 mp -55.84 -52.5 48.23 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 C-N-CA 123.874 0.87 . . . . 1.1100000000000001 109.835 174.193 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -61.51 -43.16 99.37 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 109.845 -0.428 . . . . 1.6299999999999999 109.845 -176.708 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -48.89 -58.06 5.43 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.163 0.985 . . . . 2.8599999999999999 110.631 171.976 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -67.45 -36.14 80.61 Favored 'General case' 0 N--CA 1.442 -0.85 0 O-C-N 121.396 -0.815 . . . . 3.0299999999999998 112.592 -177.711 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -52.07 -52.18 25.47 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 C-N-CA 124.839 1.256 . . . . 0.39000000000000001 107.839 176.307 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -57.77 -55.56 33.26 Favored 'General case' 0 C--N 1.34 0.189 0 C-N-CA 122.944 0.498 . . . . 2.21 109.965 175.433 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 7.7 mmtt -58.01 -35.02 70.65 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 113.12 0.785 . . . . 4.2999999999999998 113.12 -175.34 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 24.8 mt -70.3 -17.69 63.09 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 125.287 1.435 . . . . 0.92000000000000004 111.416 175.838 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 96.31 38.58 4.49 Favored Glycine 0 CA--C 1.522 0.521 0 C-N-CA 124.754 1.169 . . . . 0.65000000000000002 110.803 175.574 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.468 ' CD1' HG21 ' A' ' 24' ' ' ILE . 0.2 OUTLIER -136.93 175.58 9.49 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 117.654 0.727 . . . . 1.76 111.029 -176.357 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 5.9 t60 -138.68 137.34 36.74 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 109.546 -0.538 . . . . 2.1800000000000002 109.546 169.392 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 8.6 p -110.24 144.01 19.15 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 N-CA-C 106.644 -1.613 . . . . 1.5 106.644 177.403 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 20.5 t -113.39 131.82 64.04 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 N-CA-C 108.455 -0.942 . . . . 0.54000000000000004 108.455 178.997 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 47.8 mm -96.88 77.15 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 C-N-CA 124.79 1.236 . . . . 1.1100000000000001 107.772 -174.789 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -71.27 -12.2 61.32 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 113.724 1.009 . . . . 3.2400000000000002 113.724 -179.315 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 77.95 85.23 0.5 Allowed Glycine 0 CA--C 1.526 0.76 0 N-CA-C 109.255 -1.538 . . . . 2.6699999999999999 109.255 -174.066 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.252 1.188 0 N-CA-C 105.893 -1.891 . . . . 13.34 105.893 176.435 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 77' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 56.1 mtt . . . . . 0 N--CA 1.475 0.8 0 CA-C-O 118.975 -0.536 . . . . 9.8699999999999992 110.16 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.9 mp 66.52 178.55 0.22 Allowed 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.749 0.82 . . . . 5.0499999999999998 110.276 -169.986 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.4 m -112.75 140.03 47.87 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 105.447 -2.057 . . . . 0.75 105.447 174.596 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -89.62 -173.5 3.97 Favored 'General case' 0 N--CA 1.445 -0.679 0 C-N-CA 124.327 1.051 . . . . 2.1699999999999999 108.814 175.174 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.8 mm100 -135.96 147.88 48.25 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 107.425 -1.324 . . . . 1.02 107.425 164.707 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 86.6 mttt -139.36 159.22 42.66 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 109.164 -0.68 . . . . 3.25 109.164 158.037 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -112.59 100.1 8.46 Favored 'General case' 0 N--CA 1.436 -1.152 0 C-N-CA 128.28 2.632 . . . . 1.3100000000000001 105.321 -171.681 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 7.0 mm -80.79 161.31 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.267 0 N-CA-C 106.601 -1.629 . . . . 1.9199999999999999 106.601 178.912 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -133.33 122.56 24.01 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 106.756 -1.572 . . . . 0.47999999999999998 106.756 174.093 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 71.8 mtm -140.46 168.59 19.45 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 123.451 0.7 . . . . 1.97 109.784 -178.687 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 20.6 mm100 -94.69 148.93 21.76 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 125.216 1.407 . . . . 2.5 109.413 177.763 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 69.7 t -99.73 145.72 10.09 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 C-N-CA 123.541 0.736 . . . . 1.3300000000000001 109.346 178.041 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 32.3 t -145.03 176.87 9.18 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 124.475 1.11 . . . . 1.73 108.816 168.881 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 52.29 60.26 7.94 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 124.292 0.949 . . . . 1.8899999999999999 110.773 -176.455 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -128.73 151.33 49.67 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 124.198 0.999 . . . . 2.1299999999999999 110.328 -172.79 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -97.26 -55.38 2.86 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 124.421 1.088 . . . . 3.1200000000000001 109.196 168.639 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 22.8 p -150.27 165.92 31.53 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-O 121.839 0.828 . . . . 2.4300000000000002 111.757 -174.5 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -74.27 48.64 0.33 Allowed 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.462 1.505 . . . . 1.8 111.357 175.701 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -144.02 -51.76 0.32 Allowed 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 124.795 1.238 . . . . 0.72999999999999998 108.18 175.697 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.442 ' SG ' ' NH2' ' A' ' 23' ' ' ARG . 27.1 m -59.37 -36.97 76.75 Favored 'General case' 0 CA--C 1.531 0.248 0 O-C-N 121.38 -0.825 . . . . 1.1799999999999999 109.745 167.998 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.425 ' HB1' HG21 ' A' ' 39' ' ' VAL . . . -59.17 -21.8 59.98 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 112.95 0.722 . . . . 0.47999999999999998 112.95 173.668 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -73.79 -50.94 18.12 Favored 'General case' 0 C--N 1.339 0.152 0 O-C-N 121.019 -1.05 . . . . 0.39000000000000001 110.032 169.943 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.442 ' NH2' ' SG ' ' A' ' 20' ' ' CYS . 17.3 mtm180 -50.04 -42.39 49.53 Favored 'General case' 0 N--CA 1.456 -0.143 0 C-N-CA 123.32 0.648 . . . . 5.6500000000000004 111.196 -175.663 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.442 HG21 ' CG ' ' A' ' 69' ' ' TYR . 3.9 pt -57.82 -53.66 42.12 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.156 0 C-N-CA 119.847 -0.741 . . . . 0.63 111.891 177.341 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -57.88 -46.46 84.84 Favored 'General case' 0 C--O 1.224 -0.266 0 C-N-CA 123.339 0.655 . . . . 3.3500000000000001 110.708 -179.876 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -72.34 -40.3 67.51 Favored 'General case' 0 C--N 1.331 -0.234 0 O-C-N 121.908 -0.495 . . . . 2.1499999999999999 111.034 -173.535 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -59.44 -45.28 95.77 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 109.757 -1.337 . . . . 0.65000000000000002 109.757 169.695 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -61.94 -37.47 84.83 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 121.879 -0.777 . . . . 2.3700000000000001 109.655 -179.839 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 3.3 ttpp -53.98 -25.38 20.64 Favored 'General case' 0 CA--C 1.533 0.3 0 O-C-N 120.724 -1.235 . . . . 2.3999999999999999 113.198 174.505 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -82.15 -1.21 48.17 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.043 0.937 . . . . 3.48 111.836 -179.088 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 21.4 mmt -93.77 149.35 36.93 Favored Pre-proline 0 CA--C 1.535 0.401 0 C-N-CA 124.194 0.998 . . . . 4.6500000000000004 109.995 -175.092 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -58.45 142.86 98.24 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 122.52 2.146 . . . . 0.65000000000000002 111.477 -176.65 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 85.65 -27.3 5.36 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 123.511 0.577 . . . . 0.52000000000000002 112.927 179.422 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.4 t -80.12 140.18 17.11 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 CA-C-N 118.363 1.081 . . . . 0.68000000000000005 108.795 176.33 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 69.8 m -106.7 -60.12 1.71 Allowed 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 118.474 -0.774 . . . . 1.3600000000000001 109.116 178.488 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -140.65 165.35 27.72 Favored 'General case' 0 N--CA 1.446 -0.675 0 N-CA-C 109.052 -0.721 . . . . 2.5800000000000001 109.052 179.821 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -156.43 143.9 19.18 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 109.381 -0.6 . . . . 0.40999999999999998 109.381 -168.335 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -152.2 116.16 4.9 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 123.892 0.877 . . . . 0.75 108.761 -167.209 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.425 HG21 ' HB1' ' A' ' 21' ' ' ALA . 8.6 p -82.2 124.35 39.11 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 N-CA-C 107.208 -1.405 . . . . 0.66000000000000003 107.208 171.542 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 47.2 t30 -108.57 55.38 0.64 Allowed 'General case' 0 C--O 1.235 0.326 0 CA-C-O 123.07 1.414 . . . . 0.72999999999999998 107.22 178.161 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.437 HD22 ' HA ' ' A' ' 41' ' ' LEU . 0.2 OUTLIER -70.65 -18.35 62.85 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 114.171 -1.377 . . . . 0.95999999999999996 110.311 -174.207 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -43.38 -37.61 2.38 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 124.267 1.027 . . . . 0.54000000000000004 111.991 166.033 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 9.3 t -125.87 32.89 5.18 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 122.719 0.407 . . . . 1.2 110.435 173.58 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 59.1 27.62 16.65 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.923 1.689 . . . . 2.9199999999999999 113.609 174.437 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 60.3 m -115.97 164.28 14.67 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.747 1.219 . . . . 0.64000000000000001 109.723 -174.594 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 5.7 p -136.25 143.72 35.02 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 C-N-CA 124.516 1.126 . . . . 0.32000000000000001 108.637 171.998 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -134.92 122.1 21.47 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 124.647 1.179 . . . . 0.57999999999999996 108.153 -175.405 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.7 p -123.85 130.59 73.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 N-CA-C 106.176 -1.787 . . . . 1.73 106.176 -172.705 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 9.7 mm -105.39 97.47 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 N-CA-C 107.158 -1.423 . . . . 0.40999999999999998 107.158 -174.92 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 3.6 p90 -129.72 164.89 23.0 Favored 'General case' 0 CA--C 1.512 -0.481 0 O-C-N 122.161 -0.337 . . . . 2.1000000000000001 110.641 -176.554 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -81.65 124.01 80.16 Favored Pre-proline 0 CA--C 1.536 0.418 0 N-CA-C 108.314 -0.995 . . . . 3.1200000000000001 108.314 167.189 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -86.57 15.54 2.17 Favored 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 122.904 2.403 . . . . 0.60999999999999999 112.888 -175.385 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -97.88 -40.52 8.47 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 123.999 0.92 . . . . 1.0600000000000001 109.069 169.248 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -90.59 -62.08 1.54 Allowed 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 107.143 -1.428 . . . . 3.8399999999999999 107.143 -177.337 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.518 0.2 OUTLIER -78.31 -175.65 4.3 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 115.328 1.603 . . . . 0.69999999999999996 115.328 159.336 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 154.64 -168.3 32.73 Favored Glycine 0 N--CA 1.435 -1.381 1 N-CA-C 102.81 -4.116 . . . . 2.5299999999999998 102.81 -148.83 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 16.7 p -73.34 -34.91 65.9 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 124.14 0.976 . . . . 1.0800000000000001 109.244 -176.679 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -46.96 -60.88 2.15 Favored 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 125.055 1.342 . . . . 0.56000000000000005 113.441 -169.556 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.07 -40.99 74.71 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 118.995 -1.082 . . . . 0.44 108.793 -167.524 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.5 mp -50.71 -54.57 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.944 0 CA-C-N 113.891 -1.504 . . . . 0.95999999999999996 109.787 174.087 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -65.82 -44.58 85.19 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 118.669 0.668 . . . . 2.1899999999999999 110.28 -174.008 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -45.84 -56.7 5.06 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 122.597 1.189 . . . . 2.7999999999999998 110.046 173.252 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.86 -40.47 68.95 Favored 'General case' 0 N--CA 1.438 -1.05 0 N-CA-C 113.536 0.939 . . . . 3.9500000000000002 113.536 -176.314 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -48.26 -52.49 7.78 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 C-N-CA 125.003 1.321 . . . . 0.38 108.017 173.961 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -59.65 -58.83 6.87 Favored 'General case' 0 C--N 1.341 0.219 0 C-N-CA 123.429 0.692 . . . . 1.6299999999999999 110.333 176.588 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 6.6 mmmt -57.76 -33.02 68.06 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 113.62 0.97 . . . . 4.3499999999999996 113.62 -175.732 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 22.6 mt -71.81 -19.02 62.05 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.181 1.392 . . . . 0.73999999999999999 111.666 174.853 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 96.81 43.68 3.05 Favored Glycine 0 CA--C 1.524 0.645 0 C-N-CA 124.704 1.145 . . . . 0.39000000000000001 111.442 174.735 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.442 ' CG ' HG21 ' A' ' 24' ' ' ILE . 0.7 OUTLIER -140.1 174.49 10.47 Favored 'General case' 0 N--CA 1.457 -0.085 0 C-N-CA 124.488 1.115 . . . . 1.97 110.157 -177.799 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 6.9 t-80 -141.55 125.91 17.62 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 109.387 -0.597 . . . . 1.72 109.387 174.279 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 7.8 p -92.77 152.14 3.5 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 108.479 -0.934 . . . . 1.5600000000000001 108.479 174.566 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 38.1 t -127.3 143.65 39.9 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 C-N-CA 124.808 1.243 . . . . 0.52000000000000002 108.323 178.488 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 5.2 mp -118.17 81.19 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 C-N-CA 124.558 1.143 . . . . 1.4099999999999999 108.789 -172.804 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -79.04 -5.8 54.86 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 114.34 1.237 . . . . 2.8999999999999999 114.34 173.624 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 79.44 68.86 1.44 Allowed Glycine 0 CA--C 1.53 0.994 0 C-N-CA 124.12 0.867 . . . . 3.2400000000000002 111.973 175.896 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 3.1 ttp180 . . . . . 0 C--O 1.248 0.996 0 CA-C-O 115.98 -1.962 . . . . 12.609999999999999 110.758 175.418 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 77' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 37.3 mtt . . . . . 0 N--CA 1.476 0.852 0 N-CA-C 110.238 -0.282 . . . . 9.1300000000000008 110.238 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -174.63 -65.1 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 107.099 -1.445 . . . . 5.4900000000000002 107.099 171.921 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.3 m -140.84 133.44 28.66 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 127.02 2.128 . . . . 0.84999999999999998 105.596 177.763 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -84.92 -175.7 5.88 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 108.199 -1.038 . . . . 2.0899999999999999 108.199 163.839 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.18 146.78 49.05 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 107.583 -1.266 . . . . 1.1299999999999999 107.583 169.2 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 54.2 mttm -140.27 156.16 46.58 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 121.44 0.638 . . . . 2.77 110.279 161.873 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -112.89 87.01 2.49 Favored 'General case' 0 N--CA 1.439 -0.978 0 C-N-CA 128.343 2.657 . . . . 1.45 106.444 -168.508 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 20.6 mm -82.62 159.64 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.396 0 N-CA-C 106.575 -1.639 . . . . 2.1800000000000002 106.575 -176.035 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -131.77 138.18 48.47 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 125.784 1.634 . . . . 0.59999999999999998 106.743 -179.694 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -156.31 175.84 13.47 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 118.511 0.596 . . . . 2.71 110.786 172.649 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 30.1 mm100 -94.6 159.35 15.12 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 124.638 1.175 . . . . 2.6800000000000002 109.886 -178.405 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 62.0 t -114.26 156.53 15.2 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 C-N-CA 125.075 1.35 . . . . 1.1799999999999999 108.769 -176.454 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 25.3 m -150.01 165.63 32.13 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 123.725 0.81 . . . . 0.91000000000000003 109.518 168.006 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 63.68 47.56 85.5 Favored Glycine 0 CA--C 1.528 0.899 0 N-CA-C 110.31 -1.116 . . . . 1.6000000000000001 110.31 -171.52 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -120.55 165.17 15.37 Favored 'General case' 0 N--CA 1.457 -0.121 0 C-N-CA 124.663 1.185 . . . . 2.0899999999999999 108.972 175.3 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 174.51 -41.96 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 127.864 2.466 . . . . 3.8100000000000001 110.528 175.447 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 47.9 t -48.02 -41.02 24.5 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.327 1.051 . . . . 2.98 110.932 172.173 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 64.56 19.15 11.72 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.621 1.169 . . . . 2.2200000000000002 111.92 -178.0 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -134.58 -44.22 0.75 Allowed 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 125.395 1.478 . . . . 0.81999999999999995 109.439 176.035 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 20.5 m -47.24 -38.48 12.35 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 123.413 0.685 . . . . 1.6499999999999999 112.599 169.131 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.635 ' HB1' HG21 ' A' ' 39' ' ' VAL . . . -49.26 -33.29 12.52 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.382 0.673 . . . . 0.46000000000000002 112.068 174.545 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.6 -52.88 15.77 Favored 'General case' 0 N--CA 1.456 -0.173 0 O-C-N 120.789 -1.194 . . . . 0.32000000000000001 110.416 171.699 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 46.4 mmm-85 -50.42 -50.63 51.36 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 123.933 0.893 . . . . 3.7799999999999998 110.114 -175.968 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 5.1 pt -56.86 -54.61 27.47 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 CA-C-O 118.79 -0.624 . . . . 0.63 109.946 -179.839 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -55.46 -38.6 69.26 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 119.273 0.942 . . . . 2.29 112.12 179.474 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 42.7 mmtm -71.58 -44.14 65.01 Favored 'General case' 0 CA--C 1.534 0.327 0 O-C-N 121.345 -0.847 . . . . 1.8500000000000001 111.564 -177.49 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -69.58 -33.21 71.65 Favored Glycine 0 CA--C 1.528 0.871 0 C-N-CA 120.218 -0.991 . . . . 0.51000000000000001 110.914 173.088 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 9.6 tt -56.37 -48.64 76.43 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 107.833 -1.173 . . . . 2.0 107.833 173.227 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -54.87 -19.44 6.56 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 113.428 0.899 . . . . 3.6099999999999999 113.428 176.249 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 94.5 mtt180 -77.54 -4.68 46.94 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 119.679 1.127 . . . . 4.8300000000000001 112.289 177.704 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 7.3 ptp -71.11 155.68 92.9 Favored Pre-proline 0 CA--C 1.534 0.339 0 CA-C-N 119.58 1.082 . . . . 3.8100000000000001 111.37 173.335 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -58.86 133.04 51.18 Favored 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 121.769 1.646 . . . . 0.58999999999999997 109.046 163.5 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 108.54 -35.12 5.16 Favored Glycine 0 CA--C 1.53 1.015 0 CA-C-O 119.442 -0.643 . . . . 0.5 113.39 171.892 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 59.9 t -89.28 128.62 41.22 Favored 'Isoleucine or valine' 0 C--N 1.34 0.173 0 CA-C-N 118.454 1.127 . . . . 0.62 110.303 178.772 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 30.7 m -111.06 -28.58 8.25 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 123.582 0.753 . . . . 1.0600000000000001 111.817 -174.747 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -146.78 164.1 33.86 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 119.033 0.833 . . . . 2.3399999999999999 111.359 164.791 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -156.18 133.95 11.07 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 112.571 0.582 . . . . 0.42999999999999999 112.571 -176.478 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -150.34 115.88 5.49 Favored 'General case' 0 C--N 1.341 0.235 0 N-CA-C 108.279 -1.008 . . . . 0.44 108.279 -163.266 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.635 HG21 ' HB1' ' A' ' 21' ' ' ALA . 8.4 p -93.3 100.13 10.75 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 C-N-CA 123.478 0.711 . . . . 0.53000000000000003 110.049 -175.985 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 53.1 t-20 -83.71 57.3 4.02 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 122.651 1.215 . . . . 0.63 109.287 -179.145 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.449 HD22 ' HA ' ' A' ' 41' ' ' LEU . 0.2 OUTLIER -69.98 -19.74 63.33 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 114.915 -1.038 . . . . 0.92000000000000004 110.155 -175.713 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -46.7 -35.67 6.31 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 123.876 0.87 . . . . 0.59999999999999998 112.036 166.046 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 5.6 t -122.11 37.33 4.4 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 121.496 0.665 . . . . 1.3300000000000001 109.553 173.56 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 41.22 40.01 1.07 Allowed 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 126.655 1.982 . . . . 2.6400000000000001 113.503 179.109 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 95.1 m -124.33 160.49 27.96 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 124.971 1.308 . . . . 0.68000000000000005 107.865 -178.799 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.6 p -130.79 146.81 33.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 O-C-N 121.356 -0.84 . . . . 0.42999999999999999 109.321 170.133 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -128.77 138.84 52.31 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 108.253 -1.017 . . . . 0.31 108.253 -179.639 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 34.2 t -135.05 129.28 50.59 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 N-CA-C 106.284 -1.747 . . . . 2.1499999999999999 106.284 -179.395 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 11.4 mm -104.4 99.8 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 N-CA-C 106.874 -1.528 . . . . 0.40999999999999998 106.874 -173.552 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 53.6 p90 -138.3 167.49 21.75 Favored 'General case' 0 CA--C 1.509 -0.602 0 O-C-N 121.622 -0.673 . . . . 2.0600000000000001 111.623 -170.591 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -87.75 109.43 26.88 Favored Pre-proline 0 C--O 1.236 0.343 0 O-C-N 124.448 1.092 . . . . 3.04 109.646 174.992 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -74.56 5.18 3.92 Favored 'Trans proline' 0 N--CA 1.451 -0.989 0 C-N-CA 122.759 2.306 . . . . 0.55000000000000004 112.973 -177.323 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -86.08 -27.61 24.59 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 119.506 1.048 . . . . 0.73999999999999999 109.294 166.721 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.51 -57.5 2.03 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 108.22 -1.03 . . . . 3.46 108.22 -168.666 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.288 1.0 OUTLIER -93.95 -173.63 3.18 Favored 'General case' 0 C--O 1.225 -0.215 0 C-N-CA 124.435 1.094 . . . . 0.42999999999999999 112.494 161.566 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 141.64 91.25 0.17 Allowed Glycine 0 N--CA 1.441 -1.029 0 N-CA-C 103.222 -3.951 . . . . 2.2599999999999998 103.222 -155.896 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -13.02 -13.92 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.7 1 C-N-CA 138.476 6.71 . . . . 3.02 120.472 -149.249 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -26.26 -62.62 0.08 Allowed 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 126.885 2.074 . . . . 0.56999999999999995 114.867 161.228 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.87 -41.5 59.69 Favored 'General case' 0 CA--C 1.521 -0.145 0 CA-C-O 122.255 1.026 . . . . 0.48999999999999999 108.931 -167.802 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.7 mt -44.82 -57.36 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.771 0 C-N-CA 125.829 1.651 . . . . 1.51 110.53 170.452 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.95 -46.35 88.23 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 119.444 1.02 . . . . 1.1799999999999999 110.747 178.999 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -49.3 -55.49 12.6 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 121.944 0.878 . . . . 3.3999999999999999 111.001 179.019 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.462 ' HA ' ' HE3' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -68.95 -41.11 78.44 Favored 'General case' 0 N--CA 1.441 -0.886 0 C-N-CA 124.135 0.974 . . . . 3.0899999999999999 112.319 179.207 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -48.71 -53.18 7.53 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 N-CA-C 108.318 -0.993 . . . . 0.39000000000000001 108.318 175.91 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -59.96 -58.58 7.96 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 124.147 0.979 . . . . 1.51 110.699 177.03 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 2.9 mttp -55.23 -39.73 70.06 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 112.959 0.725 . . . . 4.0099999999999998 112.959 -175.849 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 20.8 mt -67.34 -17.81 64.9 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.327 1.051 . . . . 0.60999999999999999 111.515 177.361 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 96.58 41.03 3.73 Favored Glycine 0 C--N 1.335 0.512 0 C-N-CA 124.827 1.203 . . . . 0.41999999999999998 110.758 173.947 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -138.54 175.89 9.17 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 123.829 0.852 . . . . 1.96 110.334 -175.255 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 16.4 t-160 -142.32 148.6 38.25 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 108.419 -0.956 . . . . 2.0600000000000001 108.419 174.88 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -118.42 152.9 20.55 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.14 0 C-N-CA 125.617 1.567 . . . . 1.8600000000000001 106.942 177.176 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 59.0 t -124.14 145.72 30.81 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 C-N-CA 124.902 1.281 . . . . 0.56000000000000005 108.274 179.141 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 38.9 mm -116.45 81.05 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.174 0 C-N-CA 124.616 1.167 . . . . 1.04 108.884 -173.895 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 57.1 mt-10 -72.37 -7.38 49.33 Favored 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 114.29 1.219 . . . . 3.0299999999999998 114.29 172.693 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 61.37 77.14 0.2 Allowed Glycine 0 CA--C 1.528 0.862 0 N-CA-C 110.002 -1.239 . . . . 2.9500000000000002 110.002 -177.453 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.042 0 CA-C-O 116.144 -1.884 . . . . 12.609999999999999 107.142 -164.225 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 77' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.432 ' N ' ' OE2' ' A' ' 4' ' ' GLU . 20.1 mtt . . . . . 0 N--CA 1.48 1.034 0 N-CA-C 109.287 -0.635 . . . . 9.7400000000000002 109.287 . . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.0 mp -64.98 175.31 1.58 Allowed 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 108.014 -1.106 . . . . 5.3200000000000003 108.014 159.166 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 11.7 m -37.65 103.94 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 126.113 1.765 . . . . 1.2 111.309 173.557 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.432 ' OE2' ' N ' ' A' ' 1' ' ' MET . 36.8 mt-10 -78.05 161.49 27.42 Favored 'General case' 0 N--CA 1.435 -1.192 0 N-CA-C 106.001 -1.852 . . . . 3.3999999999999999 106.001 171.351 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 9.8 mm100 -129.88 149.34 51.66 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 108.518 -0.919 . . . . 2.3300000000000001 108.518 -178.006 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 71.7 tttt -145.6 155.33 42.97 Favored 'General case' 0 N--CA 1.438 -1.053 0 C-N-CA 124.003 0.921 . . . . 4.1299999999999999 108.973 175.103 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -112.96 92.86 4.16 Favored 'General case' 0 N--CA 1.437 -1.086 0 C-N-CA 129.566 3.146 . . . . 1.6799999999999999 105.229 -173.494 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 19.4 mm -83.78 163.38 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.301 0 N-CA-C 106.797 -1.557 . . . . 2.29 106.797 175.665 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -133.22 138.03 46.36 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 125.457 1.503 . . . . 0.46000000000000002 107.291 177.92 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -155.85 171.38 20.15 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 118.347 0.522 . . . . 1.9299999999999999 109.733 175.946 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -93.32 164.83 13.07 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 124.921 1.288 . . . . 3.5800000000000001 109.893 -174.424 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.8 t -126.29 146.61 31.82 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 C-N-CA 123.754 0.822 . . . . 1.1599999999999999 109.622 -173.579 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 59.9 m -127.48 171.69 11.36 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.742 1.217 . . . . 1.0800000000000001 109.042 170.795 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 79.71 -35.85 2.07 Favored Glycine 0 CA--C 1.534 1.26 0 O-C-N 121.514 -0.741 . . . . 2.2799999999999998 112.871 -179.297 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -44.01 142.64 1.33 Allowed 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 114.248 1.203 . . . . 2.6200000000000001 114.248 -179.712 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -153.02 -60.89 0.15 Allowed 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 126.351 1.861 . . . . 2.71 107.002 177.995 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 31.3 m -63.94 -25.53 68.18 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.077 0.951 . . . . 2.77 112.94 -176.959 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 68.55 -60.18 0.44 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 126.005 1.722 . . . . 2.6699999999999999 110.956 -169.102 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -48.07 -45.5 32.56 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.71 1.204 . . . . 0.81000000000000005 111.682 178.861 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 89.9 m -57.48 -32.32 66.86 Favored 'General case' 0 CA--C 1.529 0.143 0 N-CA-C 112.766 0.654 . . . . 1.54 112.766 177.761 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.668 ' HB1' HG21 ' A' ' 39' ' ' VAL . . . -64.47 -19.17 65.4 Favored 'General case' 0 CA--C 1.538 0.487 0 O-C-N 121.904 -0.498 . . . . 0.56000000000000005 111.051 175.12 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.22 -47.41 61.56 Favored 'General case' 0 N--CA 1.453 -0.279 0 O-C-N 119.452 -2.03 . . . . 0.44 108.607 169.734 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 61.8 mtp180 -55.45 -41.24 72.59 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 118.77 -0.633 . . . . 4.1600000000000001 110.076 -176.386 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.484 HG21 ' CD1' ' A' ' 69' ' ' TYR 0.3 1.4 pt -57.82 -58.38 6.52 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.425 0 C-N-CA 119.373 -0.931 . . . . 0.46999999999999997 110.708 174.877 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.4 ' HG3' ' HB1' ' A' ' 37' ' ' ALA . 0.4 OUTLIER -47.88 -42.55 27.1 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 119.191 0.905 . . . . 2.6699999999999999 112.883 176.293 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 24.4 mmtp -70.25 -48.74 55.56 Favored 'General case' 0 CA--C 1.535 0.378 0 O-C-N 120.938 -1.101 . . . . 2.2400000000000002 111.291 -179.573 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.86 -29.38 73.91 Favored Glycine 0 CA--C 1.53 1.0 0 O-C-N 121.665 -0.647 . . . . 0.92000000000000004 111.582 176.281 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.3 tt -67.4 -54.42 20.56 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 125.314 1.446 . . . . 1.8500000000000001 107.775 176.547 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.501 ' HE2' ' HA ' ' A' ' 36' ' ' ASP . 6.7 ttmt -48.32 -33.11 8.36 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.523 0.729 . . . . 2.5499999999999998 112.115 178.22 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 3.6 mmt180 -55.76 -15.7 3.48 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 114.507 1.299 . . . . 4.2000000000000002 114.507 177.906 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 9.9 ptp -67.68 156.72 88.32 Favored Pre-proline 0 CA--C 1.535 0.38 0 CA-C-N 119.719 1.145 . . . . 3.8900000000000001 112.252 175.941 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -60.74 137.89 76.0 Favored 'Trans proline' 0 N--CA 1.456 -0.735 0 C-N-CA 121.378 1.385 . . . . 0.67000000000000004 109.522 165.846 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 99.33 -28.63 14.51 Favored Glycine 0 CA--C 1.53 0.983 0 CA-C-O 119.14 -0.811 . . . . 0.47999999999999998 113.729 170.553 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 61.5 t -88.64 136.75 22.61 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 CA-C-N 119.288 1.544 . . . . 0.56000000000000005 109.119 171.613 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -108.04 -41.2 5.0 Favored 'General case' 0 C--N 1.341 0.216 0 CA-C-O 118.356 -0.83 . . . . 1.4199999999999999 110.733 178.508 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.501 ' HA ' ' HE2' ' A' ' 29' ' ' LYS . 0.4 OUTLIER -143.21 165.93 26.1 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-N 119.113 0.87 . . . . 2.3700000000000001 110.403 170.963 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.4 ' HB1' ' HG3' ' A' ' 25' ' ' GLU . . . -158.02 148.16 20.28 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 123.538 0.735 . . . . 0.51000000000000001 110.073 179.923 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -156.19 118.37 4.03 Favored 'General case' 0 C--O 1.232 0.143 0 N-CA-C 107.723 -1.214 . . . . 0.53000000000000003 107.723 -163.364 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.668 HG21 ' HB1' ' A' ' 21' ' ' ALA . 8.0 p -89.92 101.4 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 C-N-CA 123.082 0.553 . . . . 0.65000000000000002 110.232 -177.07 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 51.4 t-20 -84.07 56.7 3.83 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-O 122.693 1.235 . . . . 0.59999999999999998 109.277 179.629 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.427 HD22 ' HA ' ' A' ' 41' ' ' LEU . 0.2 OUTLIER -69.07 -19.92 64.08 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 115.229 -0.896 . . . . 1.1100000000000001 110.152 -175.467 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -46.91 -36.8 8.01 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.032 0.933 . . . . 0.68000000000000005 112.363 166.752 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 14.5 t -115.5 23.67 12.2 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 118.499 0.59 . . . . 1.3600000000000001 111.327 174.161 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 55.04 50.37 15.56 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.4 1.08 . . . . 3.5499999999999998 112.859 -179.706 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 7.1 m -145.9 154.78 42.33 Favored 'General case' 0 N--CA 1.445 -0.722 0 O-C-N 120.418 -1.426 . . . . 0.77000000000000002 109.045 178.844 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.3 p -117.81 144.37 25.97 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 N-CA-C 108.455 -0.943 . . . . 0.39000000000000001 108.455 171.347 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -124.68 142.62 51.25 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 108.153 -1.055 . . . . 0.39000000000000001 108.153 176.985 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 4.0 p -139.78 129.35 29.09 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 N-CA-C 106.822 -1.548 . . . . 1.78 106.822 -174.993 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 14.5 mm -108.31 89.03 1.21 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.654 0 C-N-CA 126.007 1.723 . . . . 0.63 107.711 -167.461 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 34.7 p90 -137.12 172.9 12.32 Favored 'General case' 0 CA--C 1.511 -0.542 0 C-N-CA 122.671 0.388 . . . . 1.6399999999999999 111.967 -167.703 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 66.4 t0 -93.36 104.71 13.06 Favored Pre-proline 0 C--O 1.236 0.345 0 O-C-N 125.094 1.496 . . . . 3.0800000000000001 110.177 -179.412 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -73.71 3.19 5.11 Favored 'Trans proline' 0 N--CA 1.448 -1.154 0 C-N-CA 122.003 1.802 . . . . 0.76000000000000001 112.447 -179.286 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -82.23 -29.35 31.38 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 119.819 1.19 . . . . 1.0700000000000001 109.205 165.726 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -108.32 -55.99 2.31 Favored 'General case' 0 C--N 1.343 0.317 0 C-N-CA 122.797 0.439 . . . . 2.52 110.308 -166.355 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.31 0.6 OUTLIER -89.05 177.54 6.62 Favored 'General case' 0 CA--C 1.514 -0.432 0 CA-C-O 123.312 1.53 . . . . 0.52000000000000002 114.212 160.345 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -160.02 -135.9 1.93 Allowed Glycine 0 N--CA 1.433 -1.567 0 N-CA-C 103.978 -3.649 . . . . 2.54 103.978 175.43 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 23.6 p -76.57 -35.29 58.28 Favored 'General case' 0 N--CA 1.444 -0.751 0 C-N-CA 127.031 2.132 . . . . 1.3600000000000001 109.75 177.917 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -49.48 -62.8 1.35 Allowed 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 125.49 1.516 . . . . 0.55000000000000004 113.926 -165.379 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.83 -35.0 69.76 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 114.676 -1.147 . . . . 0.44 108.472 -168.364 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.8 mt -54.26 -57.18 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.908 0 C-N-CA 125.95 1.7 . . . . 1.3200000000000001 111.179 173.155 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.69 -45.22 95.01 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 119.804 1.184 . . . . 1.0900000000000001 109.626 -179.724 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -49.56 -59.36 3.84 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-O 121.392 0.615 . . . . 3.2400000000000002 111.958 176.756 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 4.7 mmpt? -63.61 -40.53 97.16 Favored 'General case' 0 N--CA 1.437 -1.087 0 CA-C-O 118.459 -0.781 . . . . 2.2000000000000002 111.096 -179.452 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.3 mm -49.01 -54.3 5.69 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.558 0 C-N-CA 124.171 0.989 . . . . 0.34999999999999998 108.441 177.204 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 27.0 mm-40 -59.32 -55.71 31.34 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 123.594 0.757 . . . . 1.6200000000000001 110.436 177.0 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 10.2 mmtt -57.11 -36.48 70.69 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 112.905 0.706 . . . . 4.4299999999999997 112.905 -174.931 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 13.0 mt -71.11 -17.8 62.55 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.889 1.276 . . . . 0.64000000000000001 112.144 175.874 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 96.96 39.47 4.06 Favored Glycine 0 CA--C 1.523 0.589 0 C-N-CA 124.571 1.082 . . . . 0.45000000000000001 111.093 175.36 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.484 ' CD1' HG21 ' A' ' 24' ' ' ILE . 0.6 OUTLIER -135.31 175.86 9.2 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 124.131 0.972 . . . . 1.9399999999999999 110.303 -178.39 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 22.4 t-160 -143.86 133.55 23.7 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 107.711 -1.218 . . . . 2.04 107.711 172.631 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 6.5 p -108.86 139.99 29.28 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 C-N-CA 125.296 1.439 . . . . 1.49 107.407 179.782 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 86.3 t -108.72 138.74 34.23 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.137 0 CA-C-O 121.833 0.825 . . . . 0.68000000000000005 109.069 -179.566 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 45.8 mm -104.86 77.92 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 C-N-CA 125.224 1.41 . . . . 1.1699999999999999 109.123 -169.767 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -74.93 2.46 10.32 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.646 1.179 . . . . 3.2999999999999998 113.696 173.615 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -112.49 -8.24 21.4 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 125.093 1.33 . . . . 3.9300000000000002 114.617 -170.497 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.083 0 C-N-CA 124.74 1.216 . . . . 10.08 107.935 -173.798 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 77' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.432 ' N ' ' OE2' ' A' ' 4' ' ' GLU . 20.1 mtt . . . . . 0 N--CA 1.48 1.034 0 N-CA-C 109.287 -0.635 . . . . 9.7400000000000002 109.287 . . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.0 mp -64.98 175.31 1.58 Allowed 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 108.014 -1.106 . . . . 5.3200000000000003 108.014 159.166 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 11.7 m -37.65 103.94 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 126.113 1.765 . . . . 1.2 111.309 173.557 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.432 ' OE2' ' N ' ' A' ' 1' ' ' MET . 36.8 mt-10 -78.05 161.49 27.42 Favored 'General case' 0 N--CA 1.435 -1.192 0 N-CA-C 106.001 -1.852 . . . . 3.3999999999999999 106.001 171.351 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 9.8 mm100 -129.88 149.34 51.66 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 108.518 -0.919 . . . . 2.3300000000000001 108.518 -178.006 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 71.7 tttt -145.6 155.33 42.97 Favored 'General case' 0 N--CA 1.438 -1.053 0 C-N-CA 124.003 0.921 . . . . 4.1299999999999999 108.973 175.103 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -112.96 92.86 4.16 Favored 'General case' 0 N--CA 1.437 -1.086 0 C-N-CA 129.566 3.146 . . . . 1.6799999999999999 105.229 -173.494 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 19.4 mm -83.78 163.38 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.301 0 N-CA-C 106.797 -1.557 . . . . 2.29 106.797 175.665 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -133.22 138.03 46.36 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 125.457 1.503 . . . . 0.46000000000000002 107.291 177.92 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -155.85 171.38 20.15 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 118.347 0.522 . . . . 1.9299999999999999 109.733 175.946 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -93.32 164.83 13.07 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 124.921 1.288 . . . . 3.5800000000000001 109.893 -174.424 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.8 t -126.29 146.61 31.82 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 C-N-CA 123.754 0.822 . . . . 1.1599999999999999 109.622 -173.579 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 59.9 m -127.48 171.69 11.36 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.742 1.217 . . . . 1.0800000000000001 109.042 170.795 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 79.71 -35.85 2.07 Favored Glycine 0 CA--C 1.534 1.26 0 O-C-N 121.514 -0.741 . . . . 2.2799999999999998 112.871 -179.297 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -44.01 142.64 1.33 Allowed 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 114.248 1.203 . . . . 2.6200000000000001 114.248 -179.712 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -153.02 -60.89 0.15 Allowed 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 126.351 1.861 . . . . 2.71 107.002 177.995 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 31.3 m -63.94 -25.53 68.18 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.077 0.951 . . . . 2.77 112.94 -176.959 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 68.55 -60.18 0.44 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 126.005 1.722 . . . . 2.6699999999999999 110.956 -169.102 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -48.07 -45.5 32.56 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.71 1.204 . . . . 0.81000000000000005 111.682 178.861 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 89.9 m -57.48 -32.32 66.86 Favored 'General case' 0 CA--C 1.529 0.143 0 N-CA-C 112.766 0.654 . . . . 1.54 112.766 177.761 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.668 ' HB1' HG21 ' A' ' 39' ' ' VAL . . . -64.47 -19.17 65.4 Favored 'General case' 0 CA--C 1.538 0.487 0 O-C-N 121.904 -0.498 . . . . 0.56000000000000005 111.051 175.12 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.22 -47.41 61.56 Favored 'General case' 0 N--CA 1.453 -0.279 0 O-C-N 119.452 -2.03 . . . . 0.44 108.607 169.734 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 61.8 mtp180 -55.45 -41.24 72.59 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 118.77 -0.633 . . . . 4.1600000000000001 110.076 -176.386 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.484 HG21 ' CD1' ' A' ' 69' ' ' TYR 0.3 1.4 pt -57.82 -58.38 6.52 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.425 0 C-N-CA 119.373 -0.931 . . . . 0.46999999999999997 110.708 174.877 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.4 ' HG3' ' HB1' ' A' ' 37' ' ' ALA . 0.4 OUTLIER -47.88 -42.55 27.1 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 119.191 0.905 . . . . 2.6699999999999999 112.883 176.293 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 24.4 mmtp -70.25 -48.74 55.56 Favored 'General case' 0 CA--C 1.535 0.378 0 O-C-N 120.938 -1.101 . . . . 2.2400000000000002 111.291 -179.573 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.86 -29.38 73.91 Favored Glycine 0 CA--C 1.53 1.0 0 O-C-N 121.665 -0.647 . . . . 0.92000000000000004 111.582 176.281 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.3 tt -67.4 -54.42 20.56 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 125.314 1.446 . . . . 1.8500000000000001 107.775 176.547 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.501 ' HE2' ' HA ' ' A' ' 36' ' ' ASP . 6.7 ttmt -48.32 -33.11 8.36 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.523 0.729 . . . . 2.5499999999999998 112.115 178.22 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 3.6 mmt180 -55.76 -15.7 3.48 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 114.507 1.299 . . . . 4.2000000000000002 114.507 177.906 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 9.9 ptp -67.68 156.72 88.32 Favored Pre-proline 0 CA--C 1.535 0.38 0 CA-C-N 119.719 1.145 . . . . 3.8900000000000001 112.252 175.941 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -60.74 137.89 76.0 Favored 'Trans proline' 0 N--CA 1.456 -0.735 0 C-N-CA 121.378 1.385 . . . . 0.67000000000000004 109.522 165.846 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 99.33 -28.63 14.51 Favored Glycine 0 CA--C 1.53 0.983 0 CA-C-O 119.14 -0.811 . . . . 0.47999999999999998 113.729 170.553 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 61.5 t -88.64 136.75 22.61 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 CA-C-N 119.288 1.544 . . . . 0.56000000000000005 109.119 171.613 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -108.04 -41.2 5.0 Favored 'General case' 0 C--N 1.341 0.216 0 CA-C-O 118.356 -0.83 . . . . 1.4199999999999999 110.733 178.508 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.501 ' HA ' ' HE2' ' A' ' 29' ' ' LYS . 0.4 OUTLIER -143.21 165.93 26.1 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-N 119.113 0.87 . . . . 2.3700000000000001 110.403 170.963 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.4 ' HB1' ' HG3' ' A' ' 25' ' ' GLU . . . -158.02 148.16 20.28 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 123.538 0.735 . . . . 0.51000000000000001 110.073 179.923 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -156.19 118.37 4.03 Favored 'General case' 0 C--O 1.232 0.143 0 N-CA-C 107.723 -1.214 . . . . 0.53000000000000003 107.723 -163.364 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.668 HG21 ' HB1' ' A' ' 21' ' ' ALA . 8.0 p -89.92 101.4 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 C-N-CA 123.082 0.553 . . . . 0.65000000000000002 110.232 -177.07 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 51.4 t-20 -84.07 56.7 3.83 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-O 122.693 1.235 . . . . 0.59999999999999998 109.277 179.629 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.427 HD22 ' HA ' ' A' ' 41' ' ' LEU . 0.2 OUTLIER -69.07 -19.92 64.08 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 115.229 -0.896 . . . . 1.1100000000000001 110.152 -175.467 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -46.91 -36.8 8.01 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.032 0.933 . . . . 0.68000000000000005 112.363 166.752 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 14.5 t -115.5 23.67 12.2 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 118.499 0.59 . . . . 1.3600000000000001 111.327 174.161 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 55.04 50.37 15.56 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.4 1.08 . . . . 3.5499999999999998 112.859 -179.706 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 7.1 m -145.9 154.78 42.33 Favored 'General case' 0 N--CA 1.445 -0.722 0 O-C-N 120.418 -1.426 . . . . 0.77000000000000002 109.045 178.844 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.3 p -117.81 144.37 25.97 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 N-CA-C 108.455 -0.943 . . . . 0.39000000000000001 108.455 171.347 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -124.68 142.62 51.25 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 108.153 -1.055 . . . . 0.39000000000000001 108.153 176.985 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 4.0 p -139.78 129.35 29.09 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 N-CA-C 106.822 -1.548 . . . . 1.78 106.822 -174.993 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 14.5 mm -108.31 89.03 1.21 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.654 0 C-N-CA 126.007 1.723 . . . . 0.63 107.711 -167.461 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 34.7 p90 -137.12 172.9 12.32 Favored 'General case' 0 CA--C 1.511 -0.542 0 C-N-CA 122.671 0.388 . . . . 1.6399999999999999 111.967 -167.703 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 66.4 t0 -93.36 104.71 13.06 Favored Pre-proline 0 C--O 1.236 0.345 0 O-C-N 125.094 1.496 . . . . 3.0800000000000001 110.177 -179.412 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -73.71 3.19 5.11 Favored 'Trans proline' 0 N--CA 1.448 -1.154 0 C-N-CA 122.003 1.802 . . . . 0.76000000000000001 112.447 -179.286 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -82.23 -29.35 31.38 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 119.819 1.19 . . . . 1.0700000000000001 109.205 165.726 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -108.32 -55.99 2.31 Favored 'General case' 0 C--N 1.343 0.317 0 C-N-CA 122.797 0.439 . . . . 2.52 110.308 -166.355 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.31 0.6 OUTLIER -89.05 177.54 6.62 Favored 'General case' 0 CA--C 1.514 -0.432 0 CA-C-O 123.312 1.53 . . . . 0.52000000000000002 114.212 160.345 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -160.02 -135.9 1.93 Allowed Glycine 0 N--CA 1.433 -1.567 0 N-CA-C 103.978 -3.649 . . . . 2.54 103.978 175.43 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 23.6 p -76.57 -35.29 58.28 Favored 'General case' 0 N--CA 1.444 -0.751 0 C-N-CA 127.031 2.132 . . . . 1.3600000000000001 109.75 177.917 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -49.48 -62.8 1.35 Allowed 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 125.49 1.516 . . . . 0.55000000000000004 113.926 -165.379 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.83 -35.0 69.76 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 114.676 -1.147 . . . . 0.44 108.472 -168.364 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.8 mt -54.26 -57.18 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.908 0 C-N-CA 125.95 1.7 . . . . 1.3200000000000001 111.179 173.155 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.69 -45.22 95.01 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 119.804 1.184 . . . . 1.0900000000000001 109.626 -179.724 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -49.56 -59.36 3.84 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-O 121.392 0.615 . . . . 3.2400000000000002 111.958 176.756 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 4.7 mmpt? -63.61 -40.53 97.16 Favored 'General case' 0 N--CA 1.437 -1.087 0 CA-C-O 118.459 -0.781 . . . . 2.2000000000000002 111.096 -179.452 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.3 mm -49.01 -54.3 5.69 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.558 0 C-N-CA 124.171 0.989 . . . . 0.34999999999999998 108.441 177.204 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 27.0 mm-40 -59.32 -55.71 31.34 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 123.594 0.757 . . . . 1.6200000000000001 110.436 177.0 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 10.2 mmtt -57.11 -36.48 70.69 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 112.905 0.706 . . . . 4.4299999999999997 112.905 -174.931 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 13.0 mt -71.11 -17.8 62.55 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.889 1.276 . . . . 0.64000000000000001 112.144 175.874 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 96.96 39.47 4.06 Favored Glycine 0 CA--C 1.523 0.589 0 C-N-CA 124.571 1.082 . . . . 0.45000000000000001 111.093 175.36 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.484 ' CD1' HG21 ' A' ' 24' ' ' ILE . 0.6 OUTLIER -135.31 175.86 9.2 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 124.131 0.972 . . . . 1.9399999999999999 110.303 -178.39 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 22.4 t-160 -143.86 133.55 23.7 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 107.711 -1.218 . . . . 2.04 107.711 172.631 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 6.5 p -108.86 139.99 29.28 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 C-N-CA 125.296 1.439 . . . . 1.49 107.407 179.782 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 86.3 t -108.72 138.74 34.23 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.137 0 CA-C-O 121.833 0.825 . . . . 0.68000000000000005 109.069 -179.566 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 45.8 mm -104.86 77.92 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 C-N-CA 125.224 1.41 . . . . 1.1699999999999999 109.123 -169.767 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -74.93 2.46 10.32 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.646 1.179 . . . . 3.2999999999999998 113.696 173.615 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -112.49 -8.24 21.4 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 125.093 1.33 . . . . 3.9300000000000002 114.617 -170.497 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.083 0 C-N-CA 124.74 1.216 . . . . 10.08 107.935 -173.798 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 77' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_